<SEC-DOCUMENT>0001656472-23-000015.txt : 20230228
<SEC-HEADER>0001656472-23-000015.hdr.sgml : 20230228
<ACCEPTANCE-DATETIME>20230228073538
ACCESSION NUMBER:		0001656472-23-000015
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		125
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230228
DATE AS OF CHANGE:		20230228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cronos Group Inc.
		CENTRAL INDEX KEY:			0001656472
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38403
		FILM NUMBER:		23678399

	BUSINESS ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2H1
		BUSINESS PHONE:		(416) 504-0004

	MAIL ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2H1

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaCan Capital Corp.
		DATE OF NAME CHANGE:	20151021
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cron-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:bb311be6-8ff8-4549-bdb4-c4f3401e1eb6,g:1fb2bd36-dce5-4c03-be1e-00a7968a9cfb,d:228e12b34e804aa096affae69dd6b9af--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:cron="http://thecronosgroup.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cron-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl80L2ZyYWc6Y2ZkYWRhYjAxNTViNDFmYTk1YWUxMzNmNGYwYjVjOTgvdGFibGU6NmFhNmE2ZTRiMWRiNGM2M2E3ZDE5OGNlMzZmYzhhNDEvdGFibGVyYW5nZTo2YWE2YTZlNGIxZGI0YzYzYTdkMTk4Y2UzNmZjOGE0MV8wLTEtMS0xLTIxMzMzOQ_40609f41-d66a-4879-b633-e3be46390735">false</ix:nonNumeric><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl80L2ZyYWc6Y2ZkYWRhYjAxNTViNDFmYTk1YWUxMzNmNGYwYjVjOTgvdGFibGU6NmFhNmE2ZTRiMWRiNGM2M2E3ZDE5OGNlMzZmYzhhNDEvdGFibGVyYW5nZTo2YWE2YTZlNGIxZGI0YzYzYTdkMTk4Y2UzNmZjOGE0MV8xLTEtMS0xLTIxMzMzOQ_ed3597bb-b73b-4f71-8fcf-3c13ebee6880">2022</ix:nonNumeric><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl80L2ZyYWc6Y2ZkYWRhYjAxNTViNDFmYTk1YWUxMzNmNGYwYjVjOTgvdGFibGU6NmFhNmE2ZTRiMWRiNGM2M2E3ZDE5OGNlMzZmYzhhNDEvdGFibGVyYW5nZTo2YWE2YTZlNGIxZGI0YzYzYTdkMTk4Y2UzNmZjOGE0MV8yLTEtMS0xLTIxMzMzOQ_49af1fa1-1fbf-4412-8c2b-28a02b503e2e">FY</ix:nonNumeric><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl80L2ZyYWc6Y2ZkYWRhYjAxNTViNDFmYTk1YWUxMzNmNGYwYjVjOTgvdGFibGU6NmFhNmE2ZTRiMWRiNGM2M2E3ZDE5OGNlMzZmYzhhNDEvdGFibGVyYW5nZTo2YWE2YTZlNGIxZGI0YzYzYTdkMTk4Y2UzNmZjOGE0MV8zLTEtMS0xLTIxMzMzOQ_06021fe1-ce22-411c-81c2-7c5d49e708ab">0001656472</ix:nonNumeric><ix:nonNumeric contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" name="us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk1MzA0_7f2cac1a-2c68-4900-8eb5-5a1100ca88a2">http://fasb.org/us-gaap/2022#GoodwillAndIntangibleAssetImpairment</ix:nonNumeric><ix:nonNumeric contextRef="i88aac73c8640496db5b02f61155ce7ec_D20200329-20200329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMwOTI_c056cf0d-d43a-4943-8813-3c750ae39789">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ia6f625c309374c1788da24ecf578f6ee_D20220101-20221231" name="cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzYwNDk_6e990025-ef0a-4b0c-8037-643bef788633">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cron-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7656cbe523fc4dd4a341da5f796c9093_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ic0d65956228143c19035678405df018c_I20230224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia33af1f54aa342248ebe7045d0058626_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b61d3b7b8334186a589bb519b652171_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i213ce03ecaa746eab2dd1a12204b5ccb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib50e3b8695d94270935d4f85da07fcb2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i448ef8d1aafa463180aab6c0b5778fb3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14979ed24a294d07bdc9b963b74b1dcf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib07031e3e0734b5f9e1f8b89fae01580_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7574c68cc08a473a9f7033bdb1a91792_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e8196a7813644b399d45186e643bd4c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73de768913af4a8da7accde843797e61_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia825a868fcc44019a5f6ff3e5a1698c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43046ab9dce94a239d679a89675b6368_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8f8709ce2cc42e3956edf7fa925bc71_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e374eda0848449ea8abee147ccfef6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a0581d281ad4b2187170fcbcc40f7bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd33bd509f964d42a39a9c38e627d5ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i624b48e5e23148ebbee8fa21083aed6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94bb0b34a94244f4a78a9b4196581628_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea9d63117e854b719984324586934e8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ad0e599ac854e9584dfae6fd1a9dde7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa6161e6218e4dbcaa62bb22e7be9255_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic024c83103194eceabada95ba475ab43_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i666176ccf3e84f1da351ed843f82f2ad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a99d4e9305649348953f54c8a8a0f17_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34357931c29142239fb75a5dd657419f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04edac1c57f34e7d9b98b2c80dc5b8bc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f39217946e4a43885410306e996d66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a005033016542a286a1ee76f9592489_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05001d975789445693497618980033e5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia69ca1c9942e41d49a89eb53eae07a00_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bbf485b421d43959849aa8ccb24d1ca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c43df2327b4eb88372d7d82971481a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c0b659e27464370a05a56fed607e84e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia421331670e443fd88c2f5410409c16c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88cfcb6b7e764fdda895416627f0ac54_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a60350c90304904bad11f71d612fc4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i048ebc278983416fac723c6b21abb062_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdadd4591de7465e96d360ee40a08559_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36cd7b767d4742089d1b42cfe6220c44_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.CultivationsLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1ead5e405ef545a98117d2329aa9d7f2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.ManufacturingLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if88c1809830e415688a9bf0f65770352_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.StoreLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3882b50d536c49b783a4fe4bc63b1a58_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelGSPharmacyLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b22fb74b27245199caf9dcb11234c12_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacf539ae1af944fabea8af025076759c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a132cce282941e5b9844e95bbad2e28_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49f135f4f3444a5a89ff7d7ac98dad6d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f8f22691c07427aa015ce15f27bf6d2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaa1003c5905486b919409d3896fa96f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:GinkoExclusiveLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cron:segment</xbrli:measure></xbrli:unit><xbrli:context id="i6584e6d786d847d69e0e7fc90b593c5f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae966ba01c1479dacbc7135663a609a_D20220101-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb4e552f78894f18936e22352d25dde5_D20220101-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatueraJVPartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i736040703d9b43138a6d1fbe16c1ea1a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatueraJVPartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied9879f7a9aa480189fcbf72c09fb055_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01e84979c2174a3e959ae14445c4c0b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dd42bcd2c914a09bf216a667b6e31d0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f00d6ff67484222ae48b7e588d07c45_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="ils"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit><xbrli:context id="ib83b7561b10e4723a7df91adaaef20db_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d787bdfa77d4a4eb6ac5ba4b4bdfc00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia965648dd525484799c2e977f7acaf53_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie35ca828c220404d8779f0c05373f981_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6226d0a1598b4591a5b51ab3e76703b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieab708e963a4427d9d3c7720e25e4a43_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf4bf3256f4340b98286607ff670aef5_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i556bef2858d7440aa6698fec9871e28e_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatueraJVPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d84efb4ac7543a7b30a39f637d3feac_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatueraJVPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib684e46ce2ce4e94953b3cd65ed84eb3_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec61439c630842daa57b512a9ded6f1f_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72bd56a3b81845f49fe8b58426c1d15c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2dea108f6474d59838c2f8da2a2200d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06a12ae20ea94eb79a945a18af0871d1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31af1706e07447a382a55519bec4d367_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecc2eafed6534c30b7a6637e2039b9b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6774fc03d1d44059bc5e08321bc61875_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1be163b6b0ca4a5fae2fa3db98dc500e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib48a5f922dc74080be8b4e6b57c7a04d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if46b21ab0b3b47ce84759033415e34a3_I20211215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5412eefc844e484bb12e39c21eac056f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i582e556b4ce74d03ba739d1baa4199e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4575a982e5148c79aec9bf8a66c9c02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e8e633340c54e489bace8e93f8c9aaf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i138038dc2b074762930cd415641ec771_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20a76be7bf924660b23e0d04d6d1d445_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00ed681f413e454dbec8d917d6a28b38_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1b6b387f3bd48568496384bda710bc0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a6151bf97b4479db1915de9cf54196a_D20210614-20210614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-14</xbrli:startDate><xbrli:endDate>2021-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica770eae2c9246a2afe81a80ce6bc6ec_I20210614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-14</xbrli:startDate><xbrli:endDate>2021-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55bbd96bb4154fef93d9f031c4651fa9_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3306701595a04451b85d16301150c1ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d42dad636504862a15f3a4f67554aec_I20211012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:LivWellHoldingsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c9908a800e47b080fb9fb2cfd88973_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5776901e474b3abdf90733e7a30e62_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f60b165c164f1b89ebd97857c42986_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic075132149c24b6f980b4c2955ff29bb_I20210914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="aud"><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unit><xbrli:context id="i3e0794b671294cf4a1a592fd95ab0288_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="seat"><xbrli:measure>cron:seat</xbrli:measure></xbrli:unit><xbrli:context id="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a0de233b3214d3bb109cdfb9f70e304_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66ffd69d80d04eb29f72245ee158a8f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aeb1d824d3f4e9984e927ae64cea18a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2ab3c32bb7547b48229e1aa72f2da89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf3a51f82e6c455ea2fbee1766559fd5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id93c9943632c46e680e9a9c7d3dca0db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdc8fdc92d5e4970acec520cba2b995b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i444e948e17884088a02f8873d27fb530_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4061198d00b42a1b1c3273bd1300f1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebf97cb5d7b14fcaba22a604151aa02c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93ff25f41bfc48f685fe7999f7acb267_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f1e7c50392b48839d2e08df306850ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i031e61530a214b9881c8d518d3c7a377_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a8c1e543ab94dc7ae66690ab16e3743_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icecc95374e7c42d79e927354f15a2d05_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cd678b9cba6400b91b864e4539c08f3_I20190823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="ia9a0f515dda54606a8ec5e2a496990a6_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i310daf76cb31448db1eb956f40893392_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd137ffe84044ae29b17a0f26fcfbcc6_I20190628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a758fc2d72741ca8bd4fd42269ec1a4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cron:CanadianPrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83da444fa44248408487072ea1d3c39e_D20220930-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-30</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if626a2f16cf6417e88022ae91d96abbc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30edf6082b0d4470941e510e7d37ba68_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7200b06da62a43118c5cc7777451847f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if369a901d9af4bfd8ae3d2a027cee610_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f45e6669daa4361a3421b8a2d98c0b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c64e7d2537944ffaf7e5b5f16883925_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437da1842e044616977893cd552a72ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3320ad951dab401c84e0f90c4a96974c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i533957fd53ef49379dec9dedd211cf52_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d18d46bab5242e3bfd554e73da9ea90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i325878c284c54d7983006f5f7cca0186_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b69cfe90a884fb39eba1ca111fc6b2e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05bc2d13ff4b4b3db4cbd143a6dd2d63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bfb0d988c89434bae9a37fc057aca1e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c9593341e604e159c7bc62652cda7b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47c61698f6b548408440dcb1fe8bc8ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if869afc8633e4ac0b98107ef318157c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic368bd11f0df40d4a8c0b2947fe070bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie265b91a4e9a4c02afb8d5eb309f1fcd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c687afbf2874359b7b1e96d6171e47b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1eeef365d9410ba49be0ad28e8a610_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ebea50f3dab40fe940962382c9edd7b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="i7e73aaf3d4da43618c18f1bb5254e468_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:FacilityInStaynerOntarioCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i799ef2d8ae8143d3aabbb83e1a41d9c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7c6daed2ada448ca0191eb31284605b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f24fa047ebd4cafa9ce6895143e5be7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i198f84bb8c8c4495a7592d90fa3b5554_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib098004c6d90459292103b62760beef6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2be1513878243dbbe968f845f1407aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia68b72d6fb624de59f43851c8ada21f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d5db05218e34129ac787a7d7f694b92_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c74a7f5ddc94bfbb03e3906e64f0b91_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25737ffe6e95490d8d2ee87f9448d05a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="subsidiary"><xbrli:measure>cron:subsidiary</xbrli:measure></xbrli:unit><xbrli:context id="i0e10c61d155349978107170ade1b67bd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3011f950a4e94248aeda6558c378e5b3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i755ce371ac6a447c827eb78a659cb733_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77456131101b46f6b16bb4bde937116b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf526b01444e468cb8d268601d3ce639_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib30da315d1e048d1a112a4fd35422a60_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193ecd1934b24649adc30b0af94378ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68c5bd547ca145fda854a6fe88caecfc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad18f350f48747109ed2f62fb103c1ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie918e80cfb4d4ce1bc3659d5c55122dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94520bdab4b544a1a3dbb7a989765e98_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f005ffd354e4072aeeaedc327ce3b95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9aed4863ab04465a720fe0d99d7ada3_D20210821-20210821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-21</xbrli:startDate><xbrli:endDate>2021-08-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcca62b307af4573b49a49b9dc71ed48_I20210821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cadPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i60b0e9b055b34cd29e30bd1cbbc8d4b9_D20210821-20210821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-21</xbrli:startDate><xbrli:endDate>2021-08-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f85047526a4440e97e49b14b9b8c149_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7349eab127d4a66a02ccea7ace9a86f_D20211112-20211112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGVALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-12</xbrli:startDate><xbrli:endDate>2021-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b41514fd424c719fa65a8c6207ec1c_I20211112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGVALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d0cba209df1419b87b954ee194f4270_D20211112-20211112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGVALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-12</xbrli:startDate><xbrli:endDate>2021-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdd20292b768499ba18dd9f93ed614fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGVALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a05578b3601443590c15854ed0c6306_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13628330308147e39eccb6f6d522273c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b0b2dc9d6fc490f9bdff8729d2be639_D20221101-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie08bda6b8bc94e68b9c9453c44196451_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c5418b79bf345ebaf07317235767553_D20221101-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic478134f8b5943789c119b31b737e663_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCVALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c5f202e7a6844d084f318b1a5ed7a48_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCVALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9ad91752c734ce5a3109a2be336ffcf_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCVALicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8e682c2ca040fd975b5501a07eab0b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cac6295dd43471085e94c05e8edc47c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if18d2c03d26d4706b4fbe1f740a27ad6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie54e4c678bed4bb18e9f07294b7c949a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68cc03c90b794e938ba29c4e01d7fff3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic81f17ae580640a7b5c24a884c9ec3bc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50cd01170d1f4a2bb1a30d020e35156b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b6c8d5ea81343f7aa1f596a92eae8fb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f901df38e1c4d6d842edb34f8ab501e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90365f808213420099a7b087ef308b31_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f641a8b2e914e16a1d54db890c168b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbf9404540e541bb8747d3dbaff42a7e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bf6a4d5e23042058bc74e814d9dba02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied1f671988d04e8dba89bbc4bc42a206_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i732550b3992f4da1853152fc684f8d1a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib273218a57a04f388d9cdc27f16e269e_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cannabinoid"><xbrli:measure>cron:cannabinoid</xbrli:measure></xbrli:unit><xbrli:context id="i7756c3f9244a44aea49da07e1988dd28_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79c67a1f55424125bc5bfeab113bb038_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i999046b0a46e46a2bc0eee830f50363f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14d64d8fee424bdfa513430ee56f747e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:BuildingAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44985dd9b7e343f49061a23ef9ab42ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:BuildingAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6710a5308fe240c785bbcd6e071db62b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7304849946e741a0aab1be7f1db2773b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11ee8c20fd4d40938bf05d4422a3ec42_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b6c54c605e40e1b592903c9120fd37_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b7c43afd25849a08ea88b3240e2dd83_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="warrant"><xbrli:measure>cron:warrant</xbrli:measure></xbrli:unit><xbrli:context id="i61396ac601174186a618ab85deae5ee4_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibffb66e7dc494751857b498f2aaeb299_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28817b99a60840b0a33d72934688a602_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9715e946ec664da4bbd57f7a8c864d48_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i221dd5e17e9844b58038afd4bc734784_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa6ab7221f554e87a7c8bf27eb2d5642_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1c27a3694484f45b570f0bb4e534e02_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2fe51cbfc3a4ec9b05ab28c2101a8fe_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7edb25988ef4ca680ec0519a1f7a41c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d8966b6deea4e22966e81612eab4061_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c1c7205fa134b8ea972b207eaabed88_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib95bafb189fd4abdbbf394a634a0b887_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacbae512bdcf437c82335b9fc5c91440_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1937b23e84714a2daaa95f21590a01a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c446ba0830b43c0b39a1930af1ab423_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb314c21396043bfbea5f9a42e79dd19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefda9bc7439d4557845731f8c6e1ee83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb9758c232649229074d49b3b8dc7fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f45cb877964c1ca42caca1ed6a175f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e64ddadb77a4996af4ad68e0b33e84f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if48a2cb5842349feb0ee8180de88046d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad90c5c09604a40bcda1aa60d6f4817_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc817e542af6414480289d7ee595ed36_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia898bc55623845b0ac1ef2856e3c821b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3070e38626248d882307c7013957190_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic82bd6cd39a9499088723cd61326ac33_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c7419e5e8c447b3bc7c086770debb36_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2adebb19e5a4a64b42095549e292edb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife021bb97d6549dba2eb6e2bc3cd674d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb6c95fc236e4a279b1175dd18180f45_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8866b2b61a742bea498367daa68d8a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bfe6a0593fb41159cec5a4ea40d283e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e7af0d7c0e94a61b25b0698337ffed9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cff5c2fa201489099250164076db24e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46e2540982d4ffa8221c6ad142b2e19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i571abff367a8457cb1c603791998861e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9c6c121779f4779b344e53ba7e3d719_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d8bedf7986401cba0cb84c55fb63aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07f1d462f24349299006395485505244_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbe71946d29442afbe7fba287fc77a14_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia83a3433c61045068fbb79983853180d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if393d0d16af2495990ea4ed129432655_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i913c98b4ac7e42aca4f52f0dd64e5065_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id510aed093fc495cb9f8a14f00900436_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94acb806d58748d3b52065bda492be87_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc6cb6f83fce4d5a80cc6961e26b5032_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c829f39e691422b9ee160f08c4ababb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefd833c70e1648639eb7783f93944757_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if138ace4b4c24c6dadebdaf0ce503a42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib017ada887a44e6aa4841154972d1578_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf75cd22b3fc4b0d8ebc327b92866198_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9612d41d77f443cdb2bc20406257be78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98bb2201b5a14d879713cb2138319dea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if87b98056c7642a8a360e6701396a2ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25b512c51525471c9d8ef40e569ddcda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ac729cb13646a08fc56813a3bb06e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40a5d0b4996a4e9eabaf018f06c48779_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d3221f7d1804397b6efac52293924b5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfabefd19c3f47038000b89103cb9ddc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab4b623f778f4729b3d247924c503370_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32e3dc3e21e747538d80089fb902fe97_D20180904-20180904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-04</xbrli:startDate><xbrli:endDate>2018-09-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5d3e80cebf424583d8885fadb9005d_I20180717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e3f054fcf0e476495404c9892296850_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7032a2e2cd3c413ca31f86debd15d280_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8e84bad228742d08e985829ef125a7f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a7b1865015342c2b593cd0e0f101d00_D20181015-20181015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:TechnionResearchAndDevelopmentFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-15</xbrli:startDate><xbrli:endDate>2018-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie33d0799ad12401f8fb8fe45edfe1dae_D20190218-20190218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cron:ConsultingServicesArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaVenturesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-18</xbrli:startDate><xbrli:endDate>2019-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieca7109f30f44b37987e0b2301dbcd00_D20200311-20200312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cron:U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-11</xbrli:startDate><xbrli:endDate>2020-03-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shareholder"><xbrli:measure>cron:shareholder</xbrli:measure></xbrli:unit><xbrli:unit id="complaint"><xbrli:measure>cron:complaint</xbrli:measure></xbrli:unit><xbrli:context id="i8b07f4aa5f60422f8eee91da858d2511_D20221024-20221024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cron:OSCSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-24</xbrli:startDate><xbrli:endDate>2022-10-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0440f861c18e4a33b1c366ca915c82bd_D20200616-20200616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:UnfavorableRegulatoryActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-16</xbrli:startDate><xbrli:endDate>2020-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b4ceff8a6a64ff4a32fbf710974cb5d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a89728a31a45ceb354291ab7902edf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b7a35047644f16be6e005b2808de2d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b53e4753cb24279a0a7dfc9ee30e88a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d59e2073a14df0bddb28f9c82e763b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7b11f56bc6043d89eb5e2c45e96f100_I20180628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b1c08236a742bba4d259f97022d2cd_I20200625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88aac73c8640496db5b02f61155ce7ec_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15bb15a14e724f26b792f23353fb1d1c_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id078cb5a300848a5afd3b1a38b4f82dc_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaec054e4771b4c90b5d921f053336fc3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671a3f82ae654e0995f259326a3baa25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c268295fba144a989d01a9bd99cf5f8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0014408a0e804e82a06b2f923cd14abd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4da8bcc218e7495696143aafa8c5b34e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib632c4ab2a854cfb952e785b1c5b1f92_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82525d4a3a8f469f81973ca388451122_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bafcc4c72134f0384d7d6c79566a00b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic81b826c9f6f47168c91d1cb32f0a31c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3da422e72bff47219c139aac3b9de694_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d50f7ee161742d4869f0c80a6f2c830_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3696af6fe23941a9aca7c712298dc6df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1615a90b3b04370a4c4f8cdb7323bcb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81cf921ce7a8454989e3197113c2db54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a57a4ae358343efa921579efb8a3332_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e0f5c40899c45bab72391f0ad745e88_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6f625c309374c1788da24ecf578f6ee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if649373ae72c46ac8d40aad21853ce38_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea6684c36904e87baf20b2725c37ceb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i211045d7eac247689ade396e222267c3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf37dbf34d9e4ca2a9617b7383689d3e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45e09226123b4314955596439da54b30_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44c6585cf14349b9a9f2167c67b4459e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i831f4a43963e485884c99ebee4119ee1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia45aee9721104c22a2d6be5ae87f587a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5443078b1c0d43fea330c2f7752fe5e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3564953f2ea840f583b304e6f9918665_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie890eaff21934fd69d0a7950a5a10f27_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia60068e6af9e472faf93c6ad942fa0a0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id22735cc325a45779460153828233a0d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2f47442c54744328388ffe428c9d717_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if64d9be38b984e93b7bb3510d65efa19_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74a2533447d449bab879b0c4eab1b547_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74ebbd8e3add46ca819ae30424a73e32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CanadaRevenueAgencyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f71b6661d4743cc8370d986af453519_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27ccc99a2d3a4b069d7d181a25a422c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8aeff2099214e2cb23e3338d1c407e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CanadaRevenueAgencyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iece993f8cd4f47dea213f3a4127ea952_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21d99941dc0142a7be674f746ad9562a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66239904fa4a427a997cee3b6eb5a236_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36bf0818f4cd4583a8aae9102eb5d125_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55cfa304264f4cf8837ffe45ee192e62_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i121d4fac442e45c78f91d9bee9e1e16e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29ebb9a852384198889ab7d716ed3e00_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia97b43ae395a42af8a4d033428bd087c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5c3d94cdeff43b89756b7af65fe6a0f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eb44d5887f747f9b4ded07ef27d1ec9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i982c9bead0644302a7a575aa8cd1fedb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e4ff60cd583466bb936bd3d33219c85_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3de187f960e94096af46a08a23476554_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91930e58e4134eceb3113536ceba2913_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9944daa8d13a40349de5a04ccb8ab1fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05d2bf12c84540e9bc326f458b521a1c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2da2282758b1459e82599ab18062858c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8619acd4824f4abd8be3936adfc26c93_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3b238bf872e4bb7840cf7d5fdb74e4e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i608ae05e92c14b879653819d1ae841a3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a6d526d6e524c51b13f9269371efb1a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280bc038076a4e98bd7729e1879bfc22_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i985cd0089e754ba184a2c698944d2406_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a793c6ff71d45a4a349e560143146c7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0654c9ddca5d49809da1529bb6a3fc61_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i556926f67c0d433b8621f2c3fee78568_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec2ab78532ff4381b0a60888ddda144c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a07b966acb649a498c4e0cf5506ef30_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16a7e8af45ca4dcca2104af0c77f365e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9f56877c24949a6933041095690ce07_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b1cd4cc8c8d4241a55586d19c45fa4e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0dc209f811e486ea094251837a548eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7023f167ac1f48888058f60a0238b324_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fc4f046c82c4e989e9912e652e3393a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69792e5f365c4f74ac7fe11b6718f0e0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6b10325aa474c3f90de9f43306e401c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c3b385a391141238bdff4bb41f0b9de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia591f2aa890f4f499b230f1be9abd0db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81106962b49a4c34889df90bb8006a1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f9ea95f9074479a6d1ec92df88530c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6855068406142e9b4ea4b031e056d70_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61bb5f5a360043fbb4ff433ca5adde3b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8712aa6fe7b7457d9c1f918bd39dc780_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d583d52c40242bca5743643c378dcb6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i908b9b9a8ad74722858339b6ede02cc1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c9ff55d7a0549fdadda5e620d11697b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9101b37e3f454911b9d53d768c617ca0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if24c838134cc4114bf815abbed48d9a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd844fe64c4b404bb46e0d661e0f11cb_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:AustraliaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7260d7d8157b4cd88fc393c43daf539a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:AustraliaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie229aad448624a89855c1cd201833768_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie013c85f34934c4a9ef3fea20f60a42d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i193b7bc4af0a499ca3d6d6f0116acd86_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib404b8bdefcc4f2b8537e5847dcb9f04_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc5ebc2d86264839b4b73bc4ee714946_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice3b1efcf3694f1599f386a8588accf4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib32dbd798ddd41e797792cebc95190b0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie46e12c969dc47b08571eacec89b355c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b9788ac9a6c4a99ae0b6378aa5fbeff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8948b89b8d243ea918ef9455a2869fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69c10d3f86f84221bdab6e26e7800896_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6abf41ffd0443ed90c42968b76c69dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i070e08bd1da74fe0a694c34d5deabb5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c7da359963f4407b13bec57ba12f46d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if30ffde831a0431e9db29021c4b5e73b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20c9a2151d6f4e979229b7d30b202741_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d869fdefbad4a6daafa64f95ebfe973_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf758d42193e47efa6985fa375da7738_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d0a16223e8748fca5daa5a5b730a11e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i397a3256afd747d8b6924425b8505d5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e32c5a6a41470eb8b3053295eb1e32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib95fa6c13bfb4c45adb4622b1026b433_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb28843c408441191244b00e0e9c9c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7178462e779b4050b4f4f598cd80ef6d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i578a803e2dfe4a57855a55c6ddd450a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27823bddabff46fa96994e20b95dfdaa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44db994827904092be31ae9e5e8445bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i311fa3bfafef494e85ad86818daa0cdc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d176a72c724664bab57f3928bc0916_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb4548315c1d4631b6983f6d50ea8397_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fc469d3cfaa48f9808a8fd424589cd6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i251c1f541a4743728ff8c8cd8aad5a51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i483292d9892e405c9fd41c2bc7fe6a89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e29abb1c1a64038b0402ae05946449a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic58ad37f674b4bf1a74ec35c6f4e405c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5241cf1c2d3d48c6829684e7a67b759a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id544276629be4ca58e468c96a96b58ff_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:ThreeMajorCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cbf0d27e1024f2585bc6bbba3a9248a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib624948ee4414abca5cf322e8938b6b9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:ThreeMajorCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8cc4bddc3834a28956294a993ffb1bd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:ThreeMajorCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i318dd49f5d5f4baf9c5d2dbbd7dae763_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:ThreeMajorCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i852bd7bd8fed4a99a245288e27159105_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e6e844f23174cafad959fff0262ccd2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cfb8a95516c46b7ab49a044801b97ed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:OneVendorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf4e03c7d9e40fa8a934f29b9d13609_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:OneVendorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f0e0dbaf50b44ab84666bd8bc9badcc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc524b86dcf94566bb86a2e924b61bb3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d746ad8f524e279e4e4da9248e3e2a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc1ba88d12745e29a44781b9cb2a6b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c47520415b84aa69148a3dd6909c4a3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec05a6d229d94475b72ce77d3e52909d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib982510dffea40dca9be2c62f5c6ee7b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i045cf7db853f4153bd9a03bb1868a622_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida3f84386d9149eaa1274948ebe8ec5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46ed54be0f0b436d89417a7a22f3beae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5a8cde9e54943859cd78bbde842143f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ManufacturingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:VendorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92bdfdf7df22443d9e5a9d09d167facd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ManufacturingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:VendorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i650691423f5e4494934b0fa65dab6839_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b8527b15bc047bdae7fdce3a2c33504_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27ca2cc174af48b58d8f18abbbdf825c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a1afdda86b9422f916cf73765514521_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c8b6276b83842cc84cda8a4835b64c2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40b09d8040b24c29ba9f2d7d4f684f30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i545194e7a7b74577856d5bd7b228128c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iade03f20736843e9b053a88f457f1fe8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f994ee41e2c4a3d8727edc2735ef73d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i034a94c610e3462d98907c2dcb109918_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8955d83865472bb27bd4fb46bf1428_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i919ad19634e44f94b09180aaeb361f67_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f6e48ecac9f43d98f834e8ae0047473_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i228e12b34e804aa096affae69dd6b9af_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:0.55pt"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:391.5pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ5_d46781b6-daa5-41c3-89dc-31d7a5426bfe">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjM4_07db757c-8e7c-4105-bfd3-b257d92cebbf">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">            EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8xNDg0MzQwNjk4MDk0MQ_f4fa8c86-5d7b-4202-a216-12e45bba2182"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8xNDg0MzQwNjk4MDk0MQ_2a7863f0-633f-46cb-87ad-1f07ddb2baaa">December 31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ2_05766dad-db0a-428c-be4c-e5aaa0678f4b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from  to .</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No.  <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ3_9355c1fa-f6b0-46b3-8807-9c8602e2d27f">001-38403</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ0_b00f790c-a188-4d13-8173-047a1b59d4f1">CRONOS GROUP INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"></td><td style="width:48.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">British Columbia, <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF8wLTAtMS0xLTIxMzMzOS90ZXh0cmVnaW9uOjlhNzYzODVhMjRmNDRiZTliYTliOWIxYjU1OTIwZDk5Xzg_69afd405-2df3-4428-812f-c556b56ac2a2">Canada</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(I.R.S.  Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Identification No.)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF80LTAtMS0xLTIxMzMzOQ_d28973ec-2aa4-4034-83bb-5d8a0caef47d">111 Peter St., Suite 300</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF81LTAtMS0xLTIxMzMzOS90ZXh0cmVnaW9uOjc1OTVhNmY0ZTMzYzQzMjY5YjhiYzYzZTQ2ZDdkOTBlXzQ_5b124de3-c62e-40ea-bce4-8d2d7c5b7e7a">Toronto</ix:nonNumeric>, <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF81LTAtMS0xLTIxMzMzOS90ZXh0cmVnaW9uOjc1OTVhNmY0ZTMzYzQzMjY5YjhiYzYzZTQ2ZDdkOTBlXzg_b2ce1fc8-9907-4945-85a5-0f5a947fb766">Ontario</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF81LTItMS0xLTIxMzMzOQ_d903273f-6187-4179-b052-f0f0f378f268">M5V 2H1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV82MDM_5143e23c-7844-42d7-bd43-41576da6e462">416</ix:nonNumeric>-<ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjM1_cd92594a-80b3-4004-bbfa-3b60f5a7cd75">504-0004</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.500%"><tr><td style="width:1.0%"></td><td style="width:31.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDAyZDI5MzUzMTk1NGE2Mzg4N2EyODYxZmI3ZjNhNTkvdGFibGVyYW5nZTo0MDJkMjkzNTMxOTU0YTYzODg3YTI4NjFmYjdmM2E1OV8xLTAtMS0xLTIxMzMzOQ_8e8b4d3f-d379-46bd-b786-0db630ef09b5">Common Shares, no par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDAyZDI5MzUzMTk1NGE2Mzg4N2EyODYxZmI3ZjNhNTkvdGFibGVyYW5nZTo0MDJkMjkzNTMxOTU0YTYzODg3YTI4NjFmYjdmM2E1OV8xLTItMS0xLTIxMzMzOQ_7a6e923f-817f-48c4-95ee-bdbf0b7e125e">CRON</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDAyZDI5MzUzMTk1NGE2Mzg4N2EyODYxZmI3ZjNhNTkvdGFibGVyYW5nZTo0MDJkMjkzNTMxOTU0YTYzODg3YTI4NjFmYjdmM2E1OV8xLTQtMS0xLTIxMzMzOQ_6989589d-6f40-4dbb-9a63-8d6bca0a2688">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  </span><span style="background-color:#dbdbdb;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjM5_745a70b4-ed80-452b-b24c-d8ae8e3a618b">No</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark if the Registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ1_e9a30d85-dff0-4c11-8c40-81cc4157da00">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQx_1eb6dd4e-321d-47ab-8826-43c271b71777">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQy_ae043744-2992-4745-a227-4d2ca8e0ed73">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6ZTUxMjg3MjRjNWRlNDhjMzgwZDAyZjAyNGQ3ZDQxOTgvdGFibGVyYW5nZTplNTEyODcyNGM1ZGU0OGMzODBkMDJmMDI0ZDdkNDE5OF8wLTAtMS0xLTIxMzMzOQ_d81a8d2a-8da0-409a-83b9-a6dec301e8ea">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6ZTUxMjg3MjRjNWRlNDhjMzgwZDAyZjAyNGQ3ZDQxOTgvdGFibGVyYW5nZTplNTEyODcyNGM1ZGU0OGMzODBkMDJmMDI0ZDdkNDE5OF8xLTQtMS0xLTIxMzMzOQ_f0150aba-ada2-4655-9c5c-d7d2eef7d4c7">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6ZTUxMjg3MjRjNWRlNDhjMzgwZDAyZjAyNGQ3ZDQxOTgvdGFibGVyYW5nZTplNTEyODcyNGM1ZGU0OGMzODBkMDJmMDI0ZDdkNDE5OF8yLTEtMS0xLTIxMzMzOQ_e359123e-b3b6-47c1-9a3f-a50f9baa815a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.  &#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:115%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:115%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQw_af5c445d-403a-4e2a-9f4b-d7a13dbd3191">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:115%">o</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjM2_8ed18186-beac-4ccc-a005-41311fc170f0">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the last business day of the Registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of common shares held by non-affiliates of the Registrant computed by reference to the closing price of $2.82 per common share on June 30, 2022 was approximately $<ix:nonFraction unitRef="usd" contextRef="i7656cbe523fc4dd4a341da5f796c9093_I20220630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ4_32f2eb94-76ff-42eb-a6a3-1c45d66d2ca6">562,557,422</ix:nonFraction>.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">As of February 24, 2023, there were <ix:nonFraction unitRef="shares" contextRef="ic0d65956228143c19035678405df018c_I20230224" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zMTI5_3787f744-1180-42e1-9d94-c676893e6fee">380,575,403</ix:nonFraction> common shares of the Registrant issued and outstanding. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:0.55pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQz_39d3de39-3e64-4ad9-81ed-47019cf2c68e" escape="true">Certain information required by Part III of this Annual Report on Form 10-K will either be incorporated into this Annual Report on Form 10-K by reference to the registrant&#8217;s definitive proxy statement for its 2023 Annual Meeting of Shareholders, or will be included in an amendment to this Annual Report on Form 10-K to be filed no later than 120 days after the registrant's fiscal year ended December&#160;31, 2022.</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:9.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_16">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;1B.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_19">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;2.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_22">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;3.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_25">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;4.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_28">Mine Safety Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_28">51</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;5.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_34">Market for Registrant&#8217;s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_34">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;6.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reserved</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_37">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;7.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_40">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_40">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;7A.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_67">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_67">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;8.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_82">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_73">73</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;9.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_148">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_148">123</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;9A.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_151">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_151">123</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;9B.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_154">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_154">125</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_157">Disclosures Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_157">125</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;10.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_232">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_232">126</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;11.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_235">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_235">126</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;12.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_238">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_238">126</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;13.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_241">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_241">126</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;14.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_244">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_244">126</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 15.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_247">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_247">127</a></span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted or the context indicates otherwise, references in this Annual Report on Form 10-K (this &#8220;Annual Report&#8221;) to the &#8220;Company&#8221;, &#8220;Cronos&#8221;, &#8220;we&#8221;, &#8220;us&#8221; and &#8220;our&#8221; refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term &#8220;cannabis&#8221; means the plant of any species or subspecies of genus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cannabis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; the term &#8220;U.S. hemp&#8221; has the meaning given to term &#8220;hemp&#8221; in the U.S. Agricultural Improvement Act of 2018 (the &#8220;2018 Farm Bill&#8221;), including hemp-derived cannabidiol (&#8220;CBD&#8221;); and the term &#8220;U.S. Schedule I cannabis&#8221; means cannabis excluding U.S. hemp.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains references to our trademarks and trade names and to trademarks and trade names belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report may appear without the &#174; or &#8482; symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies&#8217; trademarks or trade names to imply a relationship with, or endorsement or sponsorship of us or our business by, any other companies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All currency amounts in this Annual Report are stated in U.S. dollars, which is our reporting currency, unless otherwise noted. All references to &#8220;dollars&#8221; or &#8220;$&#8221; are to U.S. dollars; all references to &#8220;C$&#8221; are to Canadian dollars; all references to &#8220;A$&#8221; are to Australian dollars; and all references to &#8220;ILS&#8221; are to New Israeli Shekels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Exchange rates are shown as C$ per $)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2541</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3411</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spot rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3554</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2746</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2751</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All summaries of agreements described herein are qualified by the full text of such agreements (certain of which are filed as exhibits hereto). </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report, the documents incorporated into this Annual Report by reference, other reports we file with, or furnish to, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and other regulatory agencies, and statements by our directors, officers, other employees and other persons authorized to speak on our behalf contain information that may constitute forward-looking information and forward-looking statements within the meaning of applicable U.S. and Canadian securities laws and court decisions (collectively, &#8220;Forward-Looking Statements&#8221;), which are based upon our current internal expectations, estimates, projections, assumptions and beliefs. All information that is not clearly historical in nature may constitute Forward-Looking Statements. In some cases, Forward-Looking Statements can be identified by the use of forward-looking terminology, such as &#8220;expect&#8221;, &#8220;likely&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;intend&#8221;, &#8220;anticipate&#8221;, &#8220;potential&#8221;, &#8220;proposed&#8221;, &#8220;estimate&#8221; and other similar words, expressions and phrases, including negative and grammatical variations thereof, or statements that certain events or conditions &#8220;may&#8221; or &#8220;will&#8221; happen, or by discussion of strategy. Forward-Looking Statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of historical fact.</span></div><div style="margin-bottom:2pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-Looking Statements include, but are not limited to, statements with respect to:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expectations related to our announced realignment (the &#8220;Realignment&#8221;) and any progress, challenges and effects related thereto as well as changes in strategy, metrics, investments, reporting structure, costs, operating expenses, employee turnover and other changes with respect thereto; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the timing of the change in the nature of operations at our facility in Stayner, Ontario (the &#8220;Peace Naturals Campus&#8221;) and the expected costs and benefits from the wind-down of cultivation and certain production activities at the Peace Naturals Campus;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to effectively wind-down cultivation and certain production activities at the Peace Naturals Campus in an organized fashion and acquire raw materials from other suppliers, including Cronos Growing Company Inc. (&#8220;Cronos GrowCo&#8221;), and the costs and timing associated therewith;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expectations regarding the potential success of, and the costs and benefits associated with, our joint ventures, strategic alliances and equity investments, including the strategic partnership (the &#8220;Ginkgo Strategic Partnership&#8221;) with Ginkgo Bioworks Holdings, Inc. (&#8220;Ginkgo&#8221;); </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability or plans to identify, develop, commercialize or expand our technology and research and development (&#8220;R&amp;D&#8221;) initiatives in cannabinoids, or the success thereof;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expectations regarding revenues, expenses, gross margins and capital expenditures; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expectations regarding our future production and manufacturing strategy and operations, the costs and timing associated therewith and the receipt of applicable production and sale licenses;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the ongoing impact of the legalization of additional cannabis product types and forms for adult-use in Canada, including federal, provincial, territorial and municipal regulations pertaining thereto, the related timing and impact thereof and our intentions to participate in such markets; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the legalization of the use of cannabis for medical or adult-use in jurisdictions outside of Canada, the related timing and impact thereof and our intentions to participate in such markets, if and when such use is legalized;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the grant, renewal, withdrawal, suspension, delay and impact of any license or supplemental license to conduct activities with cannabis or any amendments thereof;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to successfully create and launch brands and further create, launch and scale U.S. hemp-derived cannabinoid consumer products and cannabis products;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, including CBD and other cannabinoids;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">laws and regulations and any amendments thereto applicable to our business and the impact thereof, including uncertainty regarding the application of United States (&#8220;U.S.&#8221;) state and federal law to U.S. hemp (including CBD and other U.S. hemp-derived cannabinoids) products and the scope of any regulations by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the U.S. Federal Trade Commission (the &#8220;FTC&#8221;), the U.S. Patent and Trademark Office (the &#8220;PTO&#8221;) and any state equivalent regulatory agencies over U.S. hemp (including CBD and other U.S. hemp-derived cannabinoids) products;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the laws and regulations and any amendments thereto relating to the U.S. hemp industry in the U.S., including the promulgation of regulations for the U.S. hemp industry by the U.S. Department of Agriculture (the &#8220;USDA&#8221;) and relevant state regulatory authorities;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the anticipated benefits and impact of Altria Group Inc.&#8217;s investment in the Company (the &#8220;Altria Investment&#8221;), pursuant to a subscription agreement dated December 7, 2018;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">uncertainties as to our ability to exercise our option (the &#8220;PharmaCann Option&#8221;) in PharmaCann Inc. (&#8220;PharmaCann&#8221;), in the near term or the future, in full or in part, including the uncertainties as to the status and future development of federal legalization of cannabis in the U.S. and our ability to realize the anticipated benefits of the transaction with PharmaCann;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expectations regarding the implementation and effectiveness of key personnel changes;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expectations regarding acquisitions and dispositions and the anticipated benefits therefrom;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to timely and effectively remediate any material weaknesses in our internal control over financial reporting; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expectations of the amount or frequency of impairment losses, including as a result of the write-down of intangible assets, including goodwill;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the uncertainties associated with the COVID-19 pandemic, including our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic, the ability to continue our production, distribution and sale of our products, and demand for and the use of our products by consumers;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the impact of the ongoing military conflict between Russia and Ukraine (and resulting sanctions) on our business, financial condition and results of operations or cash flows;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our compliance with the terms of the settlement with the SEC (the &#8220;SEC Order&#8221;) and the settlement with the Ontario Securities Commission (the &#8220;OSC Settlement&#8221;), including complying with any recommendations made by the independent consultant appointed pursuant to the SEC Order (the &#8220;Consultant&#8221;); and</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the impact of the loss of our ability to rely on private offering exemptions under Regulation D of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the loss of our status as a well-known seasoned issuer, each as a result the SEC Order.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Forward-Looking Statements contained herein concerning the industries in which we conduct our business are based on estimates prepared by us using data from publicly available governmental sources, market research, industry analysis and on assumptions based on data and knowledge of these industries, which we believe to be reasonable. However, although generally indicative of relative market positions, market shares and performance characteristics, such data is inherently imprecise. The industries in which we conduct our business involve risks and uncertainties that are subject to change based on various factors, which are described further below.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Forward-Looking Statements contained herein are based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including: (i) our ability to realize the expected cost-savings, efficiencies and other benefits of our Realignment and employee turnover related thereto; (ii) our ability to efficiently and effectively wind-down our cultivation and certain production activities at the Peace Naturals Campus, receive the benefits of the change in the nature of our operations at our Peace Naturals Campus and acquire raw materials on a timely and cost-effective basis from third parties, including Cronos GrowCo; (iii) our ability to realize anticipated benefits, synergies or generate revenue, profits or value from our acquisitions and strategic investments; (iv) the production and manufacturing capabilities and output from our facilities and our joint ventures, strategic alliances and equity investments; (v) government regulation of our activities and products including, but not limited to, the areas of cannabis taxation and environmental protection; (vi) the timely receipt of any required regulatory authorizations, approvals, consents, permits and/or licenses; (vii) consumer interest in our products; (viii) competition; (ix) anticipated and unanticipated costs; (x) our ability to generate cash flow from operations; (xi) our ability to conduct operations in a safe, efficient and effective manner; (xii) our ability to hire and retain qualified staff, and acquire equipment and services in a timely and cost-efficient manner; (xiii) our ability to exercise the PharmaCann Option and realize the anticipated benefits of the transaction with PharmaCann; (xiv) our ability to complete planned dispositions, and, if completed, obtain our anticipated sales price; (xv) our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic and the ability to continue our production, distribution and sale of our products and customer demand for and use of our products; (xvi) general economic, financial market, regulatory and political conditions in which we operate; (xvii) management&#8217;s perceptions of historical trends, current conditions and expected future developments; and (xviii) other considerations that management believes to be appropriate in the circumstances. While our management considers these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By their nature, Forward-Looking Statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the Forward-Looking Statements in this Annual Report and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf. Such factors include, without limitation, that we may not be able to wind-down cultivation and certain production activities at the Peace Naturals Campus in a disciplined manner or achieve the anticipated benefits of the change in the nature of our operations or be able to access raw materials on a timely and cost-effective basis from third-parties, including Cronos GrowCo; the risk that the COVID-19 pandemic and the military conflict between Russia and Ukraine may disrupt our operations and those of our suppliers and distribution channels and negatively impact the demand for and use of our products; the risk that cost savings and any other synergies from the Altria Investment may not be fully realized or may take longer to realize than expected; failure to execute key personnel changes; the risks that our Realignment, the change in the nature of our operations at the Peace Naturals Campus and our further leveraging of our strategic partnerships will not result in the expected cost-savings, efficiencies and other benefits or will result in greater than anticipated turnover in personnel; levels of revenues; the lack of consumer demand for our cannabis and U.S. hemp products; our inability to manage disruptions in credit markets or changes to our credit ratings; unanticipated future levels of capital, environmental or maintenance expenditures, general and administrative and other expenses; growth opportunities not turning out as expected; the lack of cash flow necessary to execute our business plan (either within the expected timeframe or at all); difficulty raising capital; the potential adverse effects of judicial, regulatory or other proceedings, or threatened litigation or proceedings, on our business, financial condition, results of operations and cash flows; volatility in and/or degradation of general economic, market, industry or business conditions; compliance with applicable environmental, economic, health and safety, energy and other policies and regulations and in particular health concerns with respect to vaping and the use of cannabis and U.S. hemp products in vaping devices; the unexpected effects of actions of third parties such as competitors, activist investors or federal (including U.S. federal), state, provincial, territorial or local regulatory authorities or self-regulatory organizations; adverse changes in regulatory requirements in relation to our business and products; legal or regulatory obstacles that could prevent us from being able to exercise the PharmaCann Option and thereby realizing the anticipated benefits of the transaction with PharmaCann; dilution of our fully diluted ownership of PharmaCann and the loss of our rights as a result of that dilution; a delay in our remediation of material weaknesses in our internal control over financial reporting and the improvement of our control environment and our systems, processes and procedures; and the factors discussed under Part I, Item 1A &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Annual Report. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on Forward-Looking Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-Looking Statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management&#8217;s current expectations and plans relating to the future, and the reader is cautioned not to place undue reliance on these Forward-Looking Statements because of their inherent uncertainty and to appreciate the limited purposes for which they are being used by management. While we believe that the assumptions and expectations reflected in the Forward-Looking Statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-Looking Statements are made as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. We undertake no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such Forward-Looking Statements. The Forward-Looking Statements contained in this Annual Report and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos is incorporated under the laws of the Province of British Columbia with principal executive offices located at 111 Peter Street, Suite 300, Toronto, Ontario M5V 2H1. Our telephone number is +1-416-504-0004, our website is https://thecronosgroup.com/ and the investor relations section of our website is https://ir.thecronosgroup.com/. All references to our website are inactive references, are for informational purposes only and are not intended to incorporate any information from or referenced on our website into this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and on the NASDAQ Global Market (&#8220;Nasdaq&#8221;) under the trading symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos&#8217; diverse international brand portfolio includes Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategy</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos seeks to create value for shareholders by focusing on four core strategic priorities:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">growing a portfolio of iconic brands that responsibly elevate the consumer experience;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developing a diversified global sales and distribution network;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing an efficient global supply chain; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">creating and monetizing disruptive intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos reports through two segments: &#8220;United States&#8221; and &#8220;Rest of World.&#8221; These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. operational subsidiaries (collectively, &#8220;Redwood&#8221;) manufacture, market and distribute U.S. hemp-derived cannabinoid products through e-commerce, retail and hospitality partner channels in the United States under the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Investment in PharmaCann, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, Cronos USA Holdings Inc., a wholly owned subsidiary of the Company, purchased an option (the &#8220;PharmaCann Option&#8221;), with an exercise price of $0.0001 per share, to acquire an approximately 10.5% ownership stake in PharmaCann, Inc. (&#8220;PharmaCann&#8221;) on a fully diluted basis for total consideration of approximately $110.4 million. PharmaCann is a leading vertically integrated U.S. cannabis company that has a broad geographic footprint in the U.S. and has built an efficient, effective and scalable operating model. The PharmaCann Option exercise will be based upon various factors, including the status of U.S. federal cannabis legalization, as well as regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise. Following the exercise of the PharmaCann Option, the Company and PharmaCann will enter into commercial agreements that would permit each party to offer its products through either party&#8217;s distribution channels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, PharmaCann closed its merger transaction with LivWell Holdings, Inc. (&#8220;LivWell&#8221;) pursuant to which PharmaCann acquired LivWell (the &#8220;LivWell Transaction&#8221;). LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately 6.4%. As of December 31, 2022, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis was approximately 6.3%. Under the terms of the Company&#8217;s investment in PharmaCann, the Company&#8217;s rights to nominate an observer or a director to the PharmaCann board of directors could be lost if the Company&#8217;s ownership drops below 6% on a fully diluted basis and it sells or transfers all or any portion of the option (subject to certain exceptions). As a result, further dilution could adversely affect the Company&#8217;s rights under the PharmaCann Option.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No U.S. Schedule I Cannabis-Related Activities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2018, the 2018 Farm Bill was enacted in the U.S., removing U.S. hemp from the list of Schedule I controlled substances under the U.S. Controlled Substances Act (the &#8220;CSA&#8221;), and on January 19, 2021, the USDA issued a final rule establishing a domestic U.S. hemp production regulatory program, effective March 2021. Though a number of states in the U.S. have authorized the cultivation, distribution or possession of U.S. Schedule I cannabis and U.S. Schedule I cannabis containing products to various degrees and subject to various requirements or conditions, U.S. Schedule I cannabis continues to be a Schedule I controlled substance under the CSA. Therefore, the cultivation, manufacture, distribution and possession of U.S. Schedule I cannabis violates federal law in the U.S. unless a U.S. federal agency, such as the DEA, grants a registration for a specific activity, such as research, with U.S. Schedule I cannabis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not engage in any activities related to U.S. Schedule I cannabis in the U.S. The Ginkgo Strategic Partnership contemplates the performance of licensed R&amp;D activities in the U.S. in order to produce cultured cannabinoids, but such activities are conducted in compliance with all applicable laws regarding controlled substances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of World operating segment is involved in the cultivation, manufacturing, and marketing of cannabis-derived products for medical and adult-use markets. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In Canada, Cronos operates through two wholly owned license holders under the Cannabis Act (Canada) (the &#8220;Cannabis Act&#8221;), Peace Naturals Project Inc. (&#8220;Peace Naturals&#8221;), which has production facilities near Stayner, Ontario (the &#8220;Peace Naturals Campus&#8221;) and Thanos Holdings Ltd., known as Cronos Fermentation (&#8220;Cronos Fermentation&#8221;), which has a production facility in Winnipeg, Manitoba. Cronos has established two strategic joint ventures in Canada and Israel and holds approximately 10% of the issued capital of Vitura Health Limited (&#8220;Vitura&#8221;), formerly known as Cronos Australia Limited, which is listed on the Australian Securities Exchange under the trading symbol &#8220;VIT.&#8221; Cronos seeks to export cannabis products to countries that permit the import of such products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peace Naturals Campus / Cronos GrowCo</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The production facilities at the Peace Naturals Campus and the production facilities of Cronos GrowCo are licensed by Health Canada under the Cannabis Act to engage in the cultivation, processing, distribution and sale of dried cannabis flower, cannabis resin, cannabis seeds, cannabis plants, cannabis extracts, cannabis topicals and cannabis edibles, among other prescribed activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos Fermentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The production facility at Cronos Fermentation is licensed by Health Canada under the Cannabis Act to engage in the processing and distribution and sale of cannabis seeds and cannabis plants, among other prescribed activities, which includes the production of cultured cannabinoids. The facility also holds a license for Analytical Testing under the Cannabis Regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Israel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Israel, the Company operates under the IMC-GAP, IMC-GMP and IMC-GDP certifications required for the cultivation, production and marketing of dried flower, pre-rolls and oils in the Israeli medical market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operations Outside of Canada, Israel, and the U.S.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos anticipates expanding in the geographic markets outside of Canada and the U.S. in which we currently participate and entering new geographic markets. By leveraging operational, manufacturing and regulatory expertise, quality standards and procedures and intellectual property, we believe that we are well-positioned to effectively access these markets. Subject to applicable regulatory approvals, strategic international business opportunities pursued by us could include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">production, distribution, sales and marketing in jurisdictions that have passed legislation to legalize the production, distribution and possession of cannabis products at all relevant levels of government; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the export of cannabis products to markets that permit the import of such products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to conduct business only in jurisdictions where we believe it is legal to do so and where such operations remain compliant with our listing obligations with the TSX and Nasdaq. Determining whether a business activity is legal in a jurisdiction may require judgment since laws, rules, regulations and licenses may not be clear and legal interpretation and advice of counsel may vary. If a business activity in which we engage in any jurisdiction is determined to be illegal, we could be subject to fines, penalties, reputational harm, delisting from securities exchanges and material civil, criminal and regulatory litigation and proceedings or be enjoined from doing business in the applicable jurisdiction. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Regulation and Compliance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We operate in highly regulated sectors where the regulatory environment is rapidly developing, and we may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where we carry on business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint Ventures/Strategic Investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established two strategic joint ventures in Canada and Israel. Additionally, we hold approximately 10% of the issued capital of Vitura, which we account for as equity securities with a readily determinable fair value, and approximately 13.7% of the issued capital of NatuEra S.&#224;.r.l. (&#8220;Natuera&#8221;), which we account for as equity securities without a readily determinable fair value, as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ownership interest in each of our joint ventures is summarized in the table below.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.485%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership Interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Israel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%/90%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">We define ownership interest as the proportionate share of net income to which we are entitled; equity interest may differ from ownership interest shown above. We consolidate the financial results of Cronos Israel and account for our other joint ventures under the equity method of accounting. See Note 1 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Background, Basis of Presentation, and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221; and Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221; to our consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">A strategic joint venture with Kibbutz Gan Shmuel (&#8220;Gan Shmuel&#8221;), an Israeli agricultural collective settlement, for the production, manufacturing and global distribution of medical cannabis, consisting of a cultivation company (Cronos Israel G.S. Cultivation Ltd.), a manufacturing company (Cronos Israel G.S. Manufacturing Ltd.), a distribution company (Cronos Israel G.S. Store Ltd.) and a pharmacy company (Cronos Israel G.S. Pharmacy Ltd., collectively, &#8220;Cronos Israel&#8221;). We hold a 70% equity interest in the cultivation company and a 90% equity interest in each of the manufacturing, distribution and pharmacy companies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">A strategic joint venture with a group of investors led by Bert Mucci (the &#8220;Greenhouse Partners&#8221;), a Canadian large-scale greenhouse operator. Each of Cronos and the Greenhouse Partners owns a 50% equity interest in Cronos GrowCo and has equal representation on its board of directors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brand Portfolio</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to building a portfolio of iconic brands that responsibly elevate the consumer experience. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., we market and distribute U.S. hemp-derived cannabinoid products through e-commerce, retail and hospitality channels under the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In Canada, we sell a variety of cannabis products through wholesale channels under both our adult-use brand, Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and under our wellness platform, PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In addition, PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> cannabis products are currently available in the Israeli medical market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.094%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:22.096%"></td><td style="width:0.1%"></td></tr><tr style="height:68pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cron-20221231_g1.jpg" alt="cron-20221231_g1.jpg" style="height:55px;margin-bottom:5pt;vertical-align:text-bottom;width:95px"/></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:6pt;text-align:center"><img src="cron-20221231_g2.gif" alt="cron-20221231_g2.gif" style="height:70px;margin-bottom:5pt;vertical-align:text-bottom;width:120px"/></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cron-20221231_g3.jpg" alt="cron-20221231_g3.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:82px"/></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brand Positioning</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mainstream adult-use</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prestige adult consumer goods</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product Offering</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dried cannabis, pre-rolls, vaporizers, edibles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dried cannabis, pre-rolls, cannabis tinctures</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. hemp-derived cannabinoid products</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Availability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada and Israel</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adult-Use</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brand</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the Company&#8217;s adult-use cannabis brand focused on friends, fun and legendary cannabis. The Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand portfolio includes cannabinoid products in a wide range of formats including dried flower, pre-rolls, vaporizers and edibles. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand also has two sub-brands, SOURZ by Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and SPINACH FEELZ&#8482;. SOURZ by Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a line of dual-colored, dual-flavored edibles in a variety of cannabinoid ratios in a distinctive &#8220;S&#8221; shared gummy, featuring proprietary flavor masking technology. SPINACH FEELZ&#8482; prominently features rare cannabinoids in a range of product formats, designed to deliver unique and enhanced experiences made possible through proprietary blends of rare cannabinoids alongside common cannabinoids, like THC and CBD. Each product is formulated to help adult consumers, &#8220;Feelz. The Way You Want.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Wellness Brand</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a global wellness platform committed to producing high-quality cannabis products. PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is focused on building and shaping the global cannabis wellness market and promoting a holistic approach to wellness. The Company currently distributes products under PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the Canadian and non-U.S. medical cannabis markets. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Hemp-derived Cannabinoid Brands</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a prestige U.S. hemp-derived cannabinoid brand in the U.S., for the adult consumer goods market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Happy Dance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PEACE+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were brands focused on the production and distribution of U.S. hemp-derived cannabinoid products. The Company no longer produces or distributes products under the Happy Dance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PEACE+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Marketing Code</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, Cronos released its Marketing Code, which is designed to responsibly move the emerging cannabis industry forward. Cronos believes that those below the legal age of consumption should not be targeted in an adult-use cannabis market. Cronos recognizes there is a clear need for standards.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principles in the Cronos Marketing Code apply to all marketing activities of all Cronos brands globally and are communicated to all business partners in any work they do on the Company&#8217;s behalf. The Marketing Code represents Cronos&#8217; commitment to responsible marketing standards. The code standards are:</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our advertising will be targeted to adults.</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will highlight responsible cannabis consumption and any people depicted in any imagery will be adults.</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our brand websites and social media will be designed for adults.</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our marketing events will be targeted to adults and will promote responsible cannabis consumption.</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will provide our customers with facts and substantiate our claims.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global Sales and Distribution - Principal Markets </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos has developed a diversified global sales and distribution network. We have built a distribution footprint in Canada through the adult-use market, as well as a distribution footprint for U.S. hemp-derived cannabinoid products in the U.S. through e-commerce, retail and hospitality channels. We have also built a distribution channel for the Israeli medical market. Our PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> medical cannabis products are sold in Canada through the Medical Cannabis by Shoppers Drug Mart platform.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States Market and Distribution</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through Redwood, the Company manufactures, markets and distributes U.S. hemp-derived cannabinoid products through e-commerce, retail and hospitality partner channels in the U.S. under the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand. Redwood&#8217;s products use high-quality cannabinoids from U.S. hemp extract that retains naturally occurring phytocannabinoids and terpenes found in the plant. We plan to use our resources to capitalize on market demand and to further create and scale U.S. hemp-derived cannabinoid products and brands. We do not engage in any commercial activities related to the cultivation, distribution or possession of U.S. Schedule I cannabis in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Market and Distribution</span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Medical Market.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> medical cannabis products are sold in Canada through the Medical Cannabis by Shoppers Drug Mart platform.</span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Adult-Use.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We currently sell dried flower, pre-rolls, vaporizers and edibles through our adult-use brand, Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to cannabis control authorities in all provinces of Canada and the Yukon territory, except Saskatchewan, where we sell to private-sector retailers, subject to the relevant province&#8217;s or territory&#8217;s product or other restrictions and requirements. As the Company&#8217;s supply chain grows, the Company continues to expand its portfolio of cannabis products for the existing markets in Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markets and Distribution Outside of Canada </span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Israel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cronos Israel holds the IMC-GAP, IMC-GMP and IMC-GDP certifications required for the cultivation, production and marketing of dried flower, pre-rolls and oils in Israel. Cronos Israel distributes PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> branded cannabis products to the Israeli medical cannabis market through pharmacies. See &#8220;- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licenses and Regulatory Framework in Israel.&#8221;</span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Europe.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have previously distributed PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> branded cannabis products in Germany.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt;text-decoration:underline">Australia and Asia-Pacific.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Vitura holds an import license from the Australian Office of Drug Control to import PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> branded cannabis products for sale in the Australian medical market under the terms of the relevant permits, which Vitura applies for on a case-by-case basis. On November 29, 2022, the shareholders of Cronos Australia approved a proposal to change the name of the company to &#8220;Vitura Health Limited&#8221; (the &#8220;CAU Name Change&#8221;), which change became effective on February 6, 2023. On December 2, 2022, in connection with the CAU Name Change, Vitura and the Company mutually agreed to terminate the intellectual property license that granted Vitura the right to use certain intellectual property of the Company, including, but not limited to, the &#8220;Cronos&#8221; name and the PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> brand. Vitura has 180 days following the date of termination to cease all usage of the Company&#8217;s intellectual property. Vitura did not import PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> branded cannabis products from the Company during 2022.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to seek new international distribution channels in jurisdictions that have legalized the production, distribution and possession of cannabis products at all relevant levels of government.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global Supply Chain</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos is focused on establishing an efficient global supply chain by seeking to develop industry-leading methodologies and best practices at Cronos Fermentation and the Peace Naturals Campus and leveraging this expertise to create beneficial production partnerships. We plan to continue to develop a global supply chain, which will employ a combination of wholly owned production facilities, third party suppliers and global production partnerships, all of which will support the manufacturing of cannabinoid-based consumer goods. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enter into contract manufacturing agreements with suppliers of our products. We may supply these third-party manufacturers with U.S. hemp-derived cannabinoids or infused bulk product, and other inputs such as packaging that we source from other third-party suppliers. The contract manufacturers supply any other necessary ingredients to manufacture products using our formulas and fill and package our finished products. Our contract manufacturing and supply agreements generally do not require us to purchase minimum quantities of materials or products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In producing our supplement products, we source our ingredients from our suppliers on an ongoing as-needed basis. We have not entered into any contracts that obligate us to purchase a minimum quantity or exclusively from any supplier. Our supplements are manufactured according to Good Manufacturing Practices (&#8220;GMP&#8221;), which we employ at our facility in Los Angeles, California.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Supply Chain</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Facilities at Cronos Fermentation and Peace Naturals Campus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cronos Fermentation and the Peace Naturals Campus are licensed for cannabis production and the manufacturing of certain cannabis products. Cronos Fermentation engages in R&amp;D to produce high-quality cultured cannabinoids at commercial scale. In addition to manufacturing cultured cannabinoids, scientists at the facility create cannabinoid product formulations, and engage in product development. The Peace Naturals Campus is engaged in processing, finishing, packaging and shipping activities, as well as R&amp;D activities, including cannabinoid product formulation, product development, tissue culture and micro propagation. The GMP certificate issued under relevant European Economic Area GMP directives by the national competent authority of Germany was retracted in 2022 due to the announcement of the closure of the Peace Naturals Campus.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Cronos GrowCo.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Cronos GrowCo production facility is licensed for cannabis production and the manufacturing of certain cannabis products. Under its current licenses, Cronos GrowCo is permitted to sell certain cannabis products to other license holders in the wholesale channel, as well as to provincial cannabis control authorities. Cronos GrowCo holds Global GAP and ICANN GAP certifications (equivalent to IMC-GAP) for the export of dried cannabis to Israel.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Third Party Supply and Manufacturing Agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the ordinary course of our business, we enter into spot market purchase agreements and supply agreements with suppliers of dried cannabis and other cannabis products. Our supply agreements, for the most part, do not obligate us to purchase minimum quantities of products and generally contain provisions permitting cancellation of orders or termination on notice. We also enter into contract manufacturing agreements with other license holders for certain manufacturing and processing services related to our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply Chain Outside of Canada </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Cronos Israel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cronos Israel holds the IMC-GAP, IMC-GMP and IMC-GDP certifications required for the cultivation, production, distribution, and marketing of dried flower, pre-rolls and oils in Israel. Cronos Israel distributes PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> branded cannabis products to the Israeli medical market. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">- Licenses and Regulatory Framework in Israel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major customers are customers for which sales equaled or exceeded 10% of our consolidated net revenues for the year. We had three major customers, Ontario Cannabis Retail Corporation, Alberta Gaming, Liquor and Cannabis Commission, and Soci&#233;t&#233; Qu&#233;b&#233;coise du Cannabis (the &#8220;SQDC&#8221;), which accounted for approximately 28%, 17% and 10%, respectively, of our consolidated net revenues, before excises taxes, for the year ended December&#160;31, 2022. We mitigate credit risk through verification of the customers&#8217; liquidity prior to the authorization of material transactions.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Contracts</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Canada, we sell cannabis products to cannabis control authorities in all provinces of Canada and the Yukon territory, except for Saskatchewan (where we sell to private-sector retailers), where each such cannabis control authority is the sole wholesale distributor and in certain provinces, the sole retailer, of cannabis products. We sell these products to the various cannabis control authorities under supply agreements that are subject to terms that allow for renegotiation of sale prices and termination at the election of the applicable cannabis control authority. In particular, the cannabis control authorities have in the past and may in the future choose to stop purchasing our products, may change the prices at which they purchase our products, may return our products to us and, in certain circumstances, may cancel purchase orders at any time including after products have been shipped. For the year ended December&#160;31, 2022, we had approximately $77.6&#160;million in sales to cannabis control authorities in Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Activities and Intellectual Property</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ginkgo </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collaboration and license agreement between Ginkgo and the Company (the &#8220;Ginkgo Collaboration Agreement&#8221;) has enabled us to produce certain cultured cannabinoids at commercial scale at a fraction of the cost compared to traditional cultivation practices. The Ginkgo Collaboration Agreement was amended in June 2021 to enable accelerated commercialization of such cultured cannabinoids, ultimately resulting in the Company&#8217;s launching of its first cultured cannabinoid product containing cannabigerol (&#8220;CBG&#8221;) in the second half of 2021. These cultured cannabinoid molecules are identical to those produced by plants grown using traditional cultivation but are created by leveraging the power of biological manufacturing via fermentation. These cultured cannabinoids include rare cannabinoids that are difficult to produce at high purity and scale through traditional cultivation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos is able to produce large volumes of these cultured cannabinoids from custom yeast strains, as they are successfully created through the Ginkgo Strategic Partnership, by leveraging existing fermentation infrastructure at Cronos Fermentation in Winnipeg, Manitoba without incurring significant capital expenditures to build new cultivation and extraction facilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ginkgo Strategic Partnership contemplates the performance of licensed R&amp;D activities in the U.S. in order to produce cultured cannabinoids, and such activities are to be conducted in compliance with all applicable laws regarding controlled substances. We intend to produce and distribute the target cannabinoids globally, where permitted by applicable law, and have received confirmation from Health Canada that this method of production is permitted under the Cannabis Act. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ginkgo has filed certain patent applications pertaining to biosynthesis of cannabinoids to protect the intellectual property developed as part of the research progressing under the Ginkgo Strategic Partnership. Under the partnership, Cronos is the exclusive licensee of the intellectual property covered by the patent applications for the target cannabinoids. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cronos Fermentation </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Fermentation is a GMP-standard fermentation and manufacturing facility in Winnipeg, Manitoba. The state-of-the-art facility includes fully equipped laboratories covering microbiology, organic and analytical chemistry, quality control and method development as well as two large-scale microbial fermentation production areas, chemical manufacturing production areas, three downstream processing plants, and bulk product and packaging capabilities. The facility provides the fermentation and manufacturing capabilities we need in order to capitalize on the progress underway with Ginkgo, by enabling us to produce the target cannabinoids contemplated under the Ginkgo Collaboration Agreement at commercial scale with high quality and high purity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is prioritizing rare cannabinoids, such as CBG, CBC and THCV, over common cannabinoids, such as THC and CBD, and has been sequencing commercial production and subsequent product launches based upon this approach. The Company achieved its first two equity milestones in 2021, and an additional three equity milestones in 2022. The achievement of equity milestones for the remaining target cannabinoids generally will occur sequentially based on Ginkgo&#8217;s ability to produce such target cannabinoids as contemplated under the Ginkgo Collaboration Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competitive Conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competitive Conditions in the United States</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We face competition in all aspects of our business in the U.S. hemp market. In addition to numerous small companies and brands, we compete with larger, national companies that may have larger distribution capabilities with more developed and efficient supply chain operations. The principal factors on which we compete with other U.S. hemp brands are product quality, innovation, intellectual property, brand recognition and price. In the second quarter of 2022, the Company began a phased exit of the wholesale beauty category in the U.S. business to focus the portfolio on adult-use product formats within the direct-to-consumer channel. We believe the Company&#8217;s strong capitalization resulting from the Altria Investment, along with the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> brand recognition and differentiation in the U.S. hemp retail channel, will enable us to provide better quality consumer products, grow our U.S. hemp business and strengthen our market position in the U.S. However, rapidly evolving and developing federal and state regulatory frameworks affect all areas of our business and could result in our inability to compete successfully against our current and future competitors. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">U.S. Hemp Regulatory Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; for further information on regulatory framework on U.S. hemp.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competitive Conditions in Rest of World</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Conditions in Canada</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition in all aspects of our business in the Canadian adult-use and medical markets. As the demand for cannabis increases as a result of the legalization of adult-use cannabis in Canada under the Cannabis Act, we believe that new competitors will continue to enter the market. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal factors on which we compete with other Canadian license holders are product quality, innovation, intellectual property, brand recognition and price. We believe the Company&#8217;s strong capitalization resulting from the Altria Investment, along with the Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand recognition and differentiation in the Canadian adult-use market, will enable us to provide better quality consumer products, grow our Canadian business and strengthen our market position in Canada. However, a rapidly evolving and stringent federal regulatory framework affects all areas of our business. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Regulatory Framework in Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for further information on the regulatory framework applicable to our Canadian business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face competition from illegal market participants that are unlicensed and unregulated. As these illegal market participants do not comply with the regulations governing the cannabis industry, their operations may also have significantly lower costs. Any inability of the Canadian federal or provincial law enforcement authorities to enforce existing laws prohibiting the unlicensed cultivation and sale of cannabis and cannabis-based products could result in the perpetuation of the illegal market for cannabis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Conditions in Europe and Israel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition when entering new markets. The principal factors on which we compete are product quality, innovation, intellectual property, brand recognition, price and physician familiarity. We believe we are positioned to enter certain markets in Europe in a meaningful way while continuing to operate and penetrate the markets we currently serve, such as in Israel, due to our strong capitalization resulting from the Altria Investment, extensive experience and expertise in the highly regulated cannabis industry in Canada, which can be leveraged when entering new markets or growing existing operations, and strong partnerships with local distributors. We believe these factors will enable us to develop greater market penetration, provide a greater variety of quality consumer products and enter into new markets and strengthen our existing market position in Europe and Israel. However, a patchwork of regulatory frameworks and federal regulations in these various regions also affects our ability to compete in emerging markets as evolving regulations and federal frameworks have the potential to affect all areas of our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Altria Strategic Investment</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Altria Investment and Investor Rights Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, Altria beneficially owned 41% of our common shares and had the right to acquire additional common shares under its pre-emptive and top-up rights as discussed under</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pre-Emptive Rights and Top-Up Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrant</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December 16, 2022, Altria had the right to acquire up to an additional </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84,243,223 of our common shares at a per share exercise price of C$19.00 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)</span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2022, Altria notified the Company that its wholly owned subsidiary, Altria Summit LLC, irrevocably relinquished the Warrant </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and all rights that it may have held in the Warrant or any common shares underlying the Warrant for no consideration. The voluntary irrevocable relinquishment of the Warrant does not affect any rights of Altria under the Investor Rights Agreement between the Company and Altria, dated March 8, 2019 (the &#8220;Investor Rights Agreement&#8221;), and Altria continues to beneficially own 156,573,537 of our common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investor Rights Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Altria Investment, we entered into the Investor Rights Agreement with Altria pursuant to which Altria received certain governance rights that are summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Representation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor Rights Agreement provides that, for so long as Altria and certain of its affiliates (the &#8220;Altria Group&#8221;) continue to beneficially own at least 40% of our issued and outstanding common shares and the size of our board of directors (the &#8220;Board&#8221;) is seven directors, we agree to nominate for election as directors to the Board four individuals designated by Altria (the &#8220;Altria Nominees&#8221;). In addition, for so long as the Altria Group continues to beneficially own greater than 10% but less than 40% of our issued and outstanding common shares, Altria shall be entitled to nominate a number of Altria Nominees that represents its proportionate share of the number of directors comprising the Board (rounded up to the next whole number) based on the percentage of our issued and outstanding common shares beneficially owned by the Altria Group at the relevant time. At least one Altria Nominee must be independent as long as Atria has the right to designate at least three Altria Nominees and the Altria Group&#8217;s beneficial ownership of our issued and outstanding common shares does not exceed 50%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor Rights Agreement also provides that, subject to certain exceptions, for so long as Altria is entitled to designate one or more Altria Nominees, we agree to appoint to each committee established by the Board such number of Altria Nominees that represents Altria&#8217;s proportionate share of the number of directors comprising the applicable Board committee (rounded up to the next </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">whole number) based on the percentage of our issued and outstanding common shares beneficially owned by the Altria Group at the relevant time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Approval Rights</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor Rights Agreement also grants Altria, until the Altria Group beneficially owns less than 10% of our issued and outstanding common shares, approval rights over certain transactions that may be undertaken by us. We have agreed that, among other things, we will not (and will use our commercially reasonable efforts to cause our affiliates not to), without the prior written consent of Altria:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consolidate or merge into or with another person or enter into any similar business combination;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquire any shares or similar equity interests, instruments convertible into or exchangeable for shares or similar equity interests, assets, business or operations with an aggregate value of more than C$100,000,000, in a single transaction or a series of related transactions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell, transfer, cause to be transferred, exclusively license, lease, pledge or otherwise dispose of any of our or any of our significant subsidiaries&#8217; assets, business or operations in the aggregate with a value of more than C$60,000,000;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">except as required by applicable law, make any changes to our policy with respect to the declaration and payment of any dividends on our common shares;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subject to certain exceptions, enter into any contract or other agreement, arrangement, or understanding with respect to, or consummate, any transaction or series of related transactions between us or any of our subsidiaries, on the one hand, and any related parties, on the other hand, involving consideration or any other transfer of value required to be disclosed pursuant to Item 404 of Regulation S-K promulgated pursuant to the United States Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;); or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage in the production, cultivation, advertisement, marketing, promotion, sale or distribution of cannabis or any Related Products and Services (as defined in the Investor Rights Agreement) in any jurisdiction, including the U.S., where such activity is prohibited by applicable law as of the date of the Investor Rights Agreement (subject to certain limitations).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusivity Covenant</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Investor Rights Agreement, until the earlier of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the six-month anniversary of the date on which the Altria Group beneficially owns less than 10% of our issued and outstanding common shares; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the six-month anniversary of the termination of the Investor Rights Agreement,</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria has agreed to make us its exclusive partner for pursuing cannabis opportunities throughout the world (subject to certain limited exceptions).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-Emptive Rights and Top-Up Rights</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Investor Rights Agreement and provided the Altria Group continues to beneficially own at least 20% of our issued and outstanding common shares, Altria has a right to purchase, directly or indirectly by another member of the Altria Group, upon the occurrence of certain issuances of common shares by us (including issuances of common shares to Ginkgo under the Ginkgo Collaboration Agreement (each, a &#8220;Ginkgo Issuance&#8221;)) (each, a &#8220;Triggering Event&#8221;) and subject to obtaining the necessary approvals, up to such number of our common shares issuable in connection with the Triggering Event which will, when added to our common shares beneficially owned by the Altria Group immediately prior to the Triggering Event, result in the Altria Group beneficially owning the same percentage of our issued and outstanding common shares that the Altria Group beneficially owned immediately prior to the Triggering Event (in each case, calculated on a non-diluted basis). The price per common share to be paid by Altria pursuant to the exercise of these pre-emptive rights will be, subject to certain limited exceptions, the same price per common share at which the common shares are sold in the relevant Triggering Event; provided that if the consideration paid in connection with any such issuance is non-cash, the price per common share that would have been received had such common shares been issued for cash consideration will be determined by an independent committee (acting reasonably and in good faith); provided further that the price per common share to be paid by Altria pursuant to the exercise of its pre-emptive rights in connection with a Ginkgo Issuance will be C$16.25 per common share.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to (and without duplication of) the aforementioned pre-emptive rights, the Investor Rights Agreement provides Altria with top-up rights, exercisable on a quarterly basis, whereby, subject to obtaining the necessary approvals and for so long as the Altria Group beneficially owns at least 20% of our issued and outstanding common shares, Altria has the right to subscribe for such number of common shares in connection with any Top-Up Securities (as defined below) that we may, from time to time, issue after the date of the Investor Rights Agreement, as will, when added to the common shares beneficially owned by the Altria Group prior to such issuance, result in the Altria Group beneficially owning the same percentage of our issued and outstanding common shares that the Altria Group beneficially owned immediately prior to such issuance. &#8220;Top-Up Securities&#8221; means any of our common shares issued:</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on the exercise, conversion or exchange of our convertible securities issued prior to the date of the Investor Rights Agreement or on the exercise, conversion or exchange of our convertible securities issued after the date of the Investor Rights Agreement in compliance with the terms of the Investor Rights Agreement, in each case, excluding any of our convertible securities owned by any member of the Altria Group;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursuant to any share incentive plan of the Company;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on the exercise of any right granted by us pro rata to all shareholders to purchase additional common shares and/or other securities of the Company (other than a right issued in a rights offering in which Altria had the right to participate);</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in connection with bona fide bank debt, equipment financing or non-equity interim financing transactions with our lenders, in each case, with an equity component; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in connection with bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures undertaken and completed by us, </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in each case, other than (A) common shares issued pursuant to Altria&#8217;s pre-emptive right and (B) common shares issued pursuant to the Ginkgo Collaboration Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price per common share to be paid by Altria pursuant to the exercise of its top-up rights will be, subject to certain limited exceptions, the volume-weighted average price of our common shares on the TSX for the 10 full trading days preceding such exercise by Altria; provided that the price per common share to be paid by Altria pursuant to the exercise of its top-up rights in connection with the issuance of common shares pursuant to the exercise of options or warrants that were outstanding on the date of closing of the Altria Investment will be C$16.25 per common share without any set off, counterclaim, deduction or withholding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standstill Covenant</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Altria Group is permitted to acquire our common shares in the open market upon the falling away of the standstill covenant under the Investor Rights Agreement. The Investor Rights Agreement specifies that the standstill covenant falls away on the expiry or termination of the Warrant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor Rights Agreement provides Altria with the right, subject to certain limitations and to the extent permitted by applicable law, to require us to use reasonable commercial efforts to file a prospectus under applicable securities laws and/or a registration statement, qualifying our common shares held by Altria for distribution in Canada and/or the U.S. In addition, the Investor Rights Agreement provides Altria with the right to require us to include our common shares held by Altria in any proposed distribution of common shares in Canada and/or the U.S. by us for our own account.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Altria Investment, we and Altria have entered into certain commercial arrangements (the &#8220;Commercial Arrangements&#8221;), pursuant to which Altria provides us with consulting services on matters which may include R&amp;D, marketing, advertising and brand management, government relations and regulatory affairs, finance, tax planning, logistics and other corporate administrative matters. The services under the Commercial Arrangements are provided on customary terms and for a services fee payable by us that is equal to Altria&#8217;s reasonably allocated costs plus 5%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Protection of Intangible Assets </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ownership and protection of our intellectual property rights is a significant aspect of our future success. Currently, we rely on trademarks, patents, copyrights, trade secrets, technical know-how and proprietary information. We seek to protect our intellectual property by strategically seeking and obtaining registered protection where appropriate, developing and implementing standard operating procedures to protect inventions, germplasm, trade secrets, technical know-how and proprietary information and entering into agreements with parties that have access to our inventions, germplasm, trade secrets, technical know-how and proprietary information, such as our partners, collaborators, employees and consultants, to protect confidentiality and ownership. We also seek to preserve the integrity and confidentiality of our inventions, germplasm, trade secrets, trademarks, technical know-how and proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have sought trademark protection in many jurisdictions, including Canada, Australia, the U.S., China, Israel and Europe. Our ability to obtain registered trademark protection for cannabis-related goods and services, in particular for cannabis itself, may be limited in certain countries outside of Canada. For example, in the U.S., registered federal trademark protection is only available for goods and services that can be lawfully used in interstate commerce; the PTO is not currently approving any trademark applications for U.S. Schedule I cannabis, or certain goods containing U.S. hemp-derived CBD (such as dietary supplements and food) until the FDA provides clearer guidance on the regulation of such products. In Europe, trademarks cannot be obtained for products that are &#8220;contrary to public policy or accepted principles of morality.&#8221; Accordingly, our ability to obtain intellectual property rights and enforce intellectual property rights against third party uses of similar trademarks may be limited in certain jurisdictions. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Resources</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Our employees are critical to achieving this mission. In order to compete and succeed in our highly competitive and rapidly evolving industry, it is crucial that we continue to attract, develop, motivate and retain skilled, talented and passionate employees. The Company&#8217;s people strategy seeks to build a winning team and to foster a community where everyone feels included and empowered to do to their best work.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we had 447 full-time employees. Of our full-time employees, 269 were in Canada, 69 were in the U.S., and 109 were in Israel. None of our employees are represented by a labor union or covered by a collective bargaining agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our compensation program is designed to attract, motivate and reward talented individuals who possess the skills necessary to support our business objectives, assist in the achievement of our strategic goals and create long-term value for our shareholders. We believe we offer competitive compensation and benefits in each of our locations, including long-term equity awards to eligible employees under our 2020 Omnibus Equity Incentive Plan to reward and retain talented individuals and align employee and shareholder interests.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Safety, Health and Well-being</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The safety, health and well-being of our employees are paramount to the Company. We provide our employees and their families with access to a variety of health and welfare programs, including benefits that support their physical and mental health by providing tools and resources to help them improve or maintain their health status. In response to COVID-19, we implemented extensive safety measures throughout the Company to protect our employees from COVID-19, including complying with social distancing and other health and safety standards as required by federal, provincial, state, local and municipal government agencies, taking into consideration guidelines of applicable public health authorities. These measures have included increased frequency of cleaning and sanitizing throughout the workplace, providing hand sanitizer and/or hand washing stations located throughout the workplace, mandatory mask wearing in all office and production areas, social distancing protocols at our production facilities, and travel restrictions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we continue to follow safety standards as recommended by applicable public health authorities, which may include isolation after symptoms and optional mask wearing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Engagement, Development and Training</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are committed to developing our talent and building an agile and resilient organization with a workforce with the skillset to effectively adapt to changing business needs in order to best position the Company for success. We seek to foster a culture of employee learning, innovation and a drive to succeed through a talent development strategy that adapts to changing business needs. Management is an active enabler of our people strategy as we seek to recruit, retain and engage top talent that will maximize our business performance. Employees are enabled to succeed through our communicated behaviors, development training opportunities, our performance management program and pay for performance philosophy, and using their voice in our employee engagement survey.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity and Inclusion and Ethical Business Practices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe that a diverse, equitable and inclusive work environment mitigates the risk of groupthink, ensures that the Company has the opportunity to benefit from all available talent and enhances, among other things, our organizational strength, problem-solving ability and opportunity for innovation. We continue to focus on understanding our diversity and inclusion strengths and opportunities and executing on a strategy to support further progress. We are committed to hiring, developing, and promoting employees with diverse backgrounds. We are actively reviewing diversity across our Company to drive greater progress. We welcome, embrace, and celebrate all our employees. We seek to ensure this inclusivity is achieved through regular training and support for our employees. We maintain a whistleblower policy and anonymous hotline for the confidential reporting of any suspected policy violations and provide training and education to our global workforce with respect to our Code of Business Conduct and Ethics and related policies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Framework in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Hemp Regulatory Framework </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a portion of our revenues from the manufacture, marketing and distribution of U.S. hemp-derived supplement and cosmetic consumer products through e-commerce, retail and hospitality channels in certain states in the U.S. All U.S. hemp-derived products produced and sold by us constitute &#8220;hemp&#8221; (i) under the 2018 Farm Bill and (ii) the applicable state-law equivalent in all states in which we produce and sell such U.S. hemp-derived products. The 2018 Farm Bill was enacted in the U.S. on December 20, 2018. Prior to this enactment, cannabis was scheduled as a controlled substance (marijuana) under the CSA with limited exemptions based on the portion of the cannabis plant. The 2018 Farm Bill, among other things, removed U.S. hemp (which is defined in the 2018 Farm Bill as &#8220;the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis&#8221;) and its derivatives, extracts and cannabinoids, including CBD, derived from hemp, from the definition of &#8220;marijuana&#8221; in the CSA, thereby removing U.S. hemp and its derivatives as controlled substances. The 2018 Farm Bill also amended the Agricultural Marketing Act of 1946 to allow for production and sale of U.S. hemp and its derivatives in the U.S.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Farm Bill tasked the USDA with promulgating regulations in relation to the cultivation and production of U.S. hemp. The 2018 Farm Bill also directed the USDA to promulgate federal regulations that would apply to the production of U.S. hemp in every state that does not put forth a state U.S. hemp plan for approval by the USDA.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The USDA&#8217;s final rule establishes a federal licensing plan for regulating U.S. hemp producers in states that do not have their own USDA-approved plans. In the absence of a state plan, U.S. hemp producers will be subject to regulation directly by the USDA unless the state prohibits U.S. hemp production. Additionally, the final rule includes requirements for maintaining information on the land where U.S. hemp is produced, testing U.S. hemp for THC levels, disposing of plants with more than 0.3 percent THC on a dry-weight basis and licensing for U.S. hemp producers. The USDA&#8217;s final rule requires hemp producers to use a laboratory that is registered with the DEA, although the USDA is delaying enforcement of this requirement until December 31, 2022. The final rule also includes provisions for producers to dispose or remediate violative hemp plants without the use of a DEA-registered reverse distributor or law enforcement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States may adopt regulatory schemes that impose more stringent levels of regulation and costs on the production of U.S. hemp. Moreover, the 2018 Farm Bill provides that its provisions do not pre-empt or limit state laws that regulate the production of U.S. hemp. Accordingly, some states may choose to restrict or prohibit some or all U.S. hemp production or sales within the state. Variances in states&#8217; laws and regulations on U.S. hemp are likely to persist.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, each state has discretion to develop and implement its own laws and regulations governing the manufacturing, composition, marketing, labeling and sale of U.S. hemp products, which has created a patchwork of different regulatory schemes applicable to such products.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2018 Farm Bill, the FDA has retained authority over the Federal Food, Drug, and Cosmetic Act-regulated products (e.g., drugs, food, dietary supplements and cosmetics) containing U.S. hemp and U.S. hemp-derived ingredients, including CBD and other cannabinoids. Moreover, states have retained regulatory authority through their own analogues to the Federal Food, Drug, and Cosmetic Act (the &#8220;FFDCA&#8221;), and the states may diverge from the federal treatment of the use of U.S. hemp as, or in, food, dietary supplements or cosmetic products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has consistently taken the position that CBD, whether derived from U.S. hemp or U.S. Schedule I cannabis, is prohibited from use as an ingredient in food and dietary supplements. This stems from its interpretation of the exclusionary clauses in the FFDCA because CBD has been approved as a prescription drug and is the subject of substantial clinical investigations as a drug, which have been made public. The exclusionary clauses under the FFDCA provide that a substance that has been approved or has been subject to substantial clinical investigations as a drug may not be used in a food or dietary supplement, unless the substance was first marketed in a food or dietary supplement prior to the initiation of substantial clinical investigations of the substance as a drug. The exclusionary clause does not apply to cosmetics. Cosmetics containing CBD could be viewed as drug products by the FDA if disease claims are made, or if the FDA determines the use of CBD in the product has a structure or function effect on the body (i.e., a drug effect).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the FDA has not issued regulations that elaborate on the exclusionary clauses and the FDA has not taken any enforcement action in the courts asserting a violation of the exclusionary clauses. To date, the FDA has issued a number of warning letters to companies unlawfully marketing CBD products. In many of these cases, the manufacturers made unsubstantiated claims about the product being able to treat medical conditions (e.g., cancer, Alzheimer&#8217;s disease, opioid withdrawal, anxiety and COVID-19) and had not obtained drug approvals. Others were issued to companies marketing CBD products as dietary supplements despite those products which contain CBD not meeting the definition of a dietary supplement, adding CBD to human and animal foods and marketing CBD products for infants and children and other vulnerable populations, selling CBD products that people may confuse for traditional foods or beverages and that may result in unintentional consumption or overconsumption of CBD, and selling unapproved animal drugs containing CBD that are intended for use in food-producing animals. Some of these letters were co-signed with the FTC and cited the companies for making claims about the efficacy of CBD and other ingredients which were not substantiated by competent and reliable scientific evidence. In December 2020, the FTC announced it had entered into settlement agreements with six companies marketing CBD products including oils, gummies, creams, and others with deceptive health claims about serious health conditions. The settlements included monetary penalties ranging from $20,000 to $85,000. The FTC announced another such enforcement action and settlement in May 2021, ordering consumer redress of over $30,000. The FDA has also issued warning letters to dietary supplement manufacturers objecting to CBD supplements on the basis that CBD was not a permissible dietary supplement ingredient.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA periodically updates its &#8220;Consumer Update&#8221; on CBD. Through these Consumer Updates, the FDA has noted that it has approved only one CBD product, a prescription drug product to treat three rare, severe forms of epilepsy. The FDA has also stated that it is illegal to market CBD by adding it to a food or labeling it as a dietary supplement, that the FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason and that some CBD products are being marketed with unproven medical claims and are of unknown quality.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has stated that it recognizes the potential opportunities and significant interest in drug and other consumer products containing CBD, is committed to evaluating the agency&#8217;s regulatory policies related to CBD and has established a dedicated internal working group, the Cannabis Product Committee, to explore potential pathways for various types of CBD products to be lawfully marketed. The FDA held a public hearing in May 2019 to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis or cannabis-derived compounds. The rules and </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulations and enforcement in this area continue to evolve and develop. In July 2020, the FDA sent to the White House Office of Management and Budget (the &#8220;OMB&#8221;) for review a draft guidance, &#8220;Cannabidiol Enforcement Policy,&#8221; the details of which were not made public. This guidance remained under review at the OMB until January 2021, when it was withdrawn by the FDA as a part of the regulatory moratorium Executive Order issued by President Biden. On January 26, 2023, the FDA stated its views publicly that a new regulatory pathway for CBD is needed and it is prepared to work with Congress to create such a pathway. The timeline for further CBD policy development remains uncertain while the administration and the FDA face competing regulatory priorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, with respect to Company&#8217;s development of CBG and other cannabinoids and additional cannabinoid product lines, the FDA has provided no guidance as to how cannabinoids other than CBD (such as CBG) are to be regulated under the FFDCA, and it is unclear at this time how such potential regulation could affect the results of the operations or prospects of the Company or this product line.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information regarding certain risks facing our business in connection with the U.S. hemp regulatory framework in the U.S., see the section below entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors - Risks Relating to Regulation and Compliance - Risks Related to U.S. Regulations and Compliance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Cosmetics Regulation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2022, President Biden signed into law the Modernization of Cosmetics Regulation Act of 2022, which significantly expands the FDA&#8217;s enforcement authorities over cosmetics products and imposes new obligations on the cosmetics industry, including requirements relating to GMP, labeling, safety substantiation, facility registration and product listing with the FDA, adverse event reporting, recordkeeping, among others.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the new legislation, the FDA is required over the next several years to issue additional regulations and reports to clarify requirements. Most enforcement of requirements under the new legislation will not go into effect until a year or later from the date of enactment; however, we expect that regulation of our cosmetic products in the U.S. will become increasingly complex, and compliance with regulatory requirements may take significant additional resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Framework in Canada</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licenses and Regulatory Framework</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 17, 2018, the Cannabis Act and the Cannabis Regulations (the &#8220;Cannabis Regulations&#8221;) came into force. The Cannabis Regulations establish six classes of licenses: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cultivation;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">processing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sale for medical purposes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analytical testing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">research; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cannabis drug.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Regulations also create subclasses for cultivation licenses (standard cultivation, micro-cultivation and nursery) and processing licenses (standard processing and micro-processing). Different licenses and each sub-class therein carry differing rules and requirements that are intended to be proportional to the public health and safety risks posed by each category and sub-class.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Regime</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Act provides a licensing and permitting scheme for, among other things, the cultivation, processing, testing, packaging, labeling, distribution, sale, possession and disposal of adult-use cannabis, implemented by regulations promulgated under the Cannabis Act. The Cannabis Act and Cannabis Regulations include, among other things, strict specifications for the plain packaging and labeling and analytical testing of all cannabis products as well as stringent physical and personnel security requirements for all federally licensed cultivation, processing and sales sites.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 17, 2019, the Regulations Amending the Cannabis Regulations (New Classes of Cannabis) (the &#8220;Further Regulations&#8221;) came into effect. The Further Regulations amend the Cannabis Act and Cannabis Regulations to, among other things, permit the production and sale of cannabis extracts (including concentrates), cannabis topicals and cannabis edibles, in addition to dried cannabis, cannabis oil, fresh cannabis, cannabis plants and cannabis seeds for parties holding the appropriate licenses. The Cannabis Regulations set out certain requirements for the sale of cannabis products, including limiting the THC content and serving size of certain product forms.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Canada allows license holders to export cannabis products with appropriate export permits. Export permits issued by Health Canada are specific to each shipment and may only be obtained for medical or scientific purposes. To apply for a permit to export cannabis, a license holder must submit significant information to Health Canada including information about the substance to be exported (including description, intended use, quantity) and the importer. As part of the application, applicants are also generally required to provide a copy of the import permit issued by a competent authority in the jurisdiction of final destination and to make a declaration to Health Canada that the shipment does not contravene the laws of the jurisdiction of the final destination or any country of transit or transshipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Act requires the federal government to conduct a review of the Cannabis Act after three years, which commenced in September 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The scope of this statutory review includes, among other things, consideration of (i) the administration and operation of the Cannabis Act, (ii) the impact of the Cannabis Act on public health, (iii) the health and consumption habits of young persons, (iv) the impact of cannabis on indigenous persons and communities and (v) the impact of the cultivation of cannabis plants in a dwelling-house. The report resulting from the statutory review may recommend and/or lead to the amendment, removal or addition of provisions in or to the Cannabis Act which could </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adversely affect our business</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the current medical and adult-use regimes under the Cannabis Act, Health Canada has also been considering the implementation of a cannabis health product regime for products with potential therapeutic uses that would not require practitioner oversight. Between June and September 2019, Health Canada held a public consultation titled &#8220;Potential Market for Cannabis Health Products (CHPs) that would not Require Practitioner Oversight&#8221;. The consultation sought feedback from Canadians on the kinds of cannabis health products they would be interested in if such products were made available in Canada. A summary report of the consultation results was published by Health Canada in September 2020. Given the results of the consultation, Health Canada has indicated that it intends to obtain external scientific advice on the appropriate evidence standards required to demonstrate safety, efficacy and quality in cannabis health products, with the information it gathers informing the next steps on a potential implementation of a cannabis health product regime.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, Health Canada opened a consultation into the use of flavors in inhaled cannabis extracts as it claims that the availability of flavors is one of the factors that contributes to the increase in cannabis vaping in youth and young adults. As part of this consultation, Health Canada released proposed regulations that contemplate restricting the production, sale, promotion, packaging and labelling of inhaled cannabis extracts from having a flavor, other than the flavor of cannabis. The proposed amendments would apply equally to inhaled cannabis extracts sold for medical and non-medical purposes. The proposed amendments were pre-published in June 2021 and the consultation period closed in September 2021. No expected in-force date has been publicly announced.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provincial and Territorial Developments </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Cannabis Act provides for the regulation by the Canadian federal government of, among other things, the commercial production of cannabis and the sale of medical cannabis, the various provinces and territories of Canada regulate certain aspects of adult-use cannabis, including but not limited to distribution, sale, minimum age requirements and places where cannabis can be consumed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The governments of each Canadian province and territory have implemented regulatory regimes for the distribution and sale of cannabis for adult-use purposes which continue to evolve over time. Most provinces and territories have announced a minimum age for possession and consumption of 19 years old, except for Qu&#233;bec and Alberta, where the minimum age is 21 and 18, respectively. In addition, provinces and territories may impose additional licensing requirements and restrictions on sales, distribution and promotion which are more stringent than those at the federal level. For example, the SQDC, the exclusive distributor of cannabis in the province and the sole retail and online vendor in Qu&#233;bec, does not permit cannabis vaporizers or other high THC non-edible cannabis products to be sold through its channels. The SQDC has also placed significant restrictions on the types of edibles that may be sold through its channels, prohibiting edibles that are sweet, confectionary, dessert, chocolate or any other product attractive to persons under 21 years of age. Similarly, the Prince Edward Island Cannabis Management Corporation does not allow cannabis vaporizers to be sold through its channels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licenses and Regulatory Framework in Israel</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Israel, cannabis is subject to the Israeli Dangerous Drugs Ordinance [New Version], 5733 &#8211; 1973, and its sale and use are prohibited unless applicable licenses have been obtained. Licenses to cultivate, produce, possess and use cannabis for medical or research purposes in Israel are granted by the Israel Medical Cannabis Agency within the Israeli Ministry of Health (the &#8220;Yakar&#8221; and the &#8220;Israeli MOH&#8221;, respectively). Patients also must obtain licenses either directly from physicians who have been authorized to grant patient licenses or from the Yakar following a request from the patient&#8217;s physician in order to purchase and consume medical cannabis. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, the Israeli government approved, in principle, the export from Israel of medical cannabis products that meet applicable quality standards under the strict supervision of the Israeli authorities. Only products that can be directly marketed to patients (including smoking products, oils, and vaporizer products) may be exported, and only to those countries that have signed the United Nations Single Convention on Narcotic Drugs and that have explicitly approved the import of cannabis. The export of plant substances, including seeds and tissue cultures, is not permitted. In October 2020, the Israeli MOH initiated a pilot program in which certain medical cannabis companies were permitted to export their products, and the Yakar issued guidelines relating to the export of medical cannabis products. These guidelines set forth the process and conditions for obtaining an export license, which can only be issued to an applicant already holding a valid Yakar license.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Director General of the Israeli MOH announced the appointment of a committee (the &#8220;CBD Committee&#8221;) intended to examine the possibility of excluding CBD from being considered a &#8220;dangerous drug&#8221; under the Israeli Dangerous Drugs Ordinance (the &#8220;Ordinance&#8221;). In February 2022, the CBD Committee published its recommendations. The CBD Committee concluded that it would be advisable to exclude CBD from the Ordinance and to allow CBD use, other than in food and cosmetics products, provided that the aggregate concentration of THC does not exceed 0.2%. The CBD Committee further recommended that during the next two years, CBD components not be approved as a component in food, food supplements, and cosmetics and that this issue be re-examined by a committee designated by the Israeli MOH. In March 2022, the Israeli MOH adopted the conclusions of the CBD Committee and published a draft order for public comments which excludes CBD from the Ordinance while setting the threshold of aggregate concentration of THC (or any structural derivative of THC) in any product, to 0.3%. Cosmetics and food products be handled by specific regulations in such fields. As of January 2023, no final order was issued, and CBD has yet to be excluded from the Ordinance.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, the Economic Affairs Committee of the Israeli Parliament held a discussion regarding the adverse effect on the local cannabis industry of significant import of medical cannabis. The discussion was concluded with a request to the Israeli MOH to study the matter and consider banning medical cannabis import until a balance is reached in the market between the import and export of medical cannabis. The Israeli MOH has not yet publicly issued a study on the matter.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, a committee appointed by the Director General of the Israeli MOH concluded that it would be advisable to reform the medical cannabis regulatory framework by transitioning from the grant of personal patient licenses to the issuance of prescriptions available through public healthcare services. In August 2022, the new regulations adopting this reform (the &#8220;Reform Regulations&#8221;) were presented for public comments. The Reform Regulations propose to amend the Ordinance to allow medical cannabis to be prescribed by trained and certified physicians and to be held and distributed by pharmacies. The Reform Regulations will enter into effect 180 days following the adoption by the Israeli Parliament of the HMOs collection plan. As of January 2023, the Reform Regulations have not yet been adopted and are not yet in effect.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, 11 cannabis manufacturers (including Cronos Israel G.S Manufacturing Ltd.) (the &#8220;Petitioners&#8221;) filed an administrative petition to the District Court in Jerusalem regarding the Yakar&#8217;s decision to issue a constructive license (i.e., a license for dealing with medical cannabis, without a direct contact with the drug, such as brokering medical cannabis transactions) (the &#8220;Constructive License&#8221;). The Petitioners claim that the procedure and requirements for other licenses (e.g., for cultivation or production), granted by the Yakar, are unreasonably more stringent than those of the Constructive License. On January 5, 2023, the District Court in Jerusalem ordered the Israeli MOH to stop the issuance of Constructive Licenses, for 60 days, and to formulate a clear policy regarding the issuance of such Constructive Licenses. On February 12, 2023, the director general of the Yakar published a decision regarding the Constructive Licenses, in response to the District Court&#8217;s order. The decision clarifies the Yakar&#8217;s authority to grant Constructive Licenses for the import/export of medical cannabis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cronos Israel Licenses </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel maintains the following certificates and corresponding permits: (1) full Good Agricultural Practices (&#8220;GAP&#8221;) certification, including a permit to propagate and cultivate at the full capacity of the greenhouse; and (2) GMP and Good Distribution Practices (&#8220;GDP&#8221;) certificates and permits to produce and distribute dried flower, cannabis oils and pre-rolls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licenses and Regulatory Framework in Other Jurisdictions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our joint venture partners and strategic investments are subject to comprehensive and evolving regulations in each jurisdiction we and they operate. All aspects of the production, manufacture and distribution of cannabis products are regulated and subject to licensing regimes. These regulations and licensing regimes vary by jurisdiction and we, our joint venture partners and strategic investments spend significant time, effort and money to comply with the applicable requirements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the United States Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and, in accordance with the Exchange Act, we also file reports with and furnish other information to the SEC. The public may obtain any document that we file with or furnish to the SEC from the SEC&#8217;s Electronic Document Gathering, Analysis, and Retrieval system, which can be accessed at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or via the System for Electronic Document Analysis and Retrieval, which can be accessed at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedar.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as from commercial document retrieval services. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Copies of this Annual Report may be obtained on request without charge from our Corporate Secretary, corporate.secretary@thecronosgroup.com, telephone: +1-416-504-0004. We also provide access without charge to all of our SEC filings, including copies of this Annual Report, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as well as Section 16 reports on Forms 3, 4 or 5, as soon as reasonably practicable after filing or furnishing, on our website located at https://thecronosgroup.com. In addition, our website includes, among other things, our Code of Business Conduct and Ethics. The Code of Business Conduct and Ethics is also available in print to any shareholder upon request without charge from our Corporate Secretary, corporate.secretary@thecronosgroup.com, telephone: +1-416-504-0004. Within the time period required by the SEC, we will post on our website any amendment to the Code of Business Conduct and Ethics and any waiver applicable to any executive officer, director or senior financial officer.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we use our website, as well as the following social media sites, as an additional means of disclosing public information to investors, the media and others interested in the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Facebook (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https://www.facebook.com/The-Cronos-Group-419168411987225</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">);</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Twitter (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https://twitter.com/cronosgroup</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">); and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LinkedIn (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https://www.linkedin.com/company/cronosgroupcron/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that certain information we post on our website or these social media sites could be deemed to be material information, and we encourage investors, the media and others interested in the Company to review the business and financial information we or our officers post on our website or these social media sites. None of the information on our website or disclosed through these social media sites is incorporated by reference into this&#160;Annual Report.</span></div><div id="i228e12b34e804aa096affae69dd6b9af_16"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An investment in us involves a number of risks. In addition to the other information contained in this Annual Report and in other filings we make, investors should give careful consideration to the following risk factors. Any of the matters highlighted in these risk factors could adversely affect our business, results of operations and financial condition, causing an investor to lose all, or part of, its, his or her investment. The risks and uncertainties described below are those we currently believe to be material, but they are not the only ones we face. If any of the following risks, or any other risks and uncertainties that we have not yet identified or that we currently consider not to be material, actually occur or become material risks, our business, prospects, financial condition, results of operations and cash flows and consequently the price of our securities could be materially and adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factor Summary</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain of our subsidiaries and joint ventures have limited operating histories and our growth strategy may not be successful.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to achieve or maintain profitability and may continue to incur losses in the future.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products are new; there is limited long-term data with respect to the effects and the safety of our products, which is subject to conflicting medical data; and our products have been and may be in the future subject to recalls.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The production and distribution of our products is subject to disruption, the risks of an agricultural business and the risk third party suppliers and distributors may not perform their obligations to us.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intellectual property is key to our growth strategy, and we may be unable to obtain or enforce our intellectual property rights.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our entry into new markets is subject to risks normally associated with the conduct of business in foreign countries.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to extensive regulation and licensing and may not successfully comply with all applicable laws and regulations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our businesses face highly competitive conditions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Altria has significant influence over us.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of our common shares has been and may continue to be highly volatile.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have had two restatements and seven material weaknesses in our internal control over financial reporting over the last four years, and one material weakness remains unremediated at December 31, 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to other risks generally applicable to our industry and the conduct of our businesses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Growth Strategy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our subsidiaries have limited operating histories and therefore we are subject to many of the risks common to early-stage enterprises.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began carrying on business in 2013; Peace Naturals began operations in 2012 and generated its first revenues in 2013; Redwood began operations in 2017. In addition, many of our joint ventures are in the early stages of their operations and have generated little or no revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are therefore subject to many of the risks common to early-stage enterprises, including limitations with respect to personnel, financial, and other resources and lack of revenues.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to achieve or maintain profitability and may continue to incur losses in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant losses in recent periods. We had negative operating cash flow for the last five fiscal years. We may not be able to achieve or maintain profitability and may continue to incur significant losses in the future even in light of our Realignment and the change in the nature of operations at the Peace Naturals Campus and the exit of the wholesale beauty category in the U.S. In addition, we expect to continue to incur significant operating expenses as we implement initiatives to continue to grow our business. If our revenues do not increase to offset these expected costs and operating expenses, we will not be profitable. If our revenue declines or fails to grow at a rate faster than our operating expenses, we will not be able to achieve and maintain profitability in future periods. As a result, we may continue to generate losses. We may not achieve profitability in the future and, even if we do become profitable, we might not be able to sustain that profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully manage our growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently in an early development stage and may be subject to growth-related risks, including capacity constraints and pressure on our internal systems and controls, which may place significant strain on our operational and managerial resources. While our revenue has generally grown in recent years, our ability to manage and sustain revenue growth will depend on a number of factors, many of which are beyond our control, including, but not limited to, changes in laws and regulations respecting the production of U.S. hemp and cannabis products, competition from other license holders, the size of the illegal market and the adult-use market in Canada, and our ability to produce sufficient volumes of our products to meet customer demand. Our ability to manage growth effectively will require us to continue to implement and improve our operational and financial systems and to expand, train and manage our employee base. There can be no assurances that we will be able to manage growth successfully. Any inability to manage growth successfully could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of joint ventures may expose us to risks associated with jointly owned investments.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate parts of our business through joint ventures with other companies, and we may enter into additional joint ventures and strategic alliances in the future. Joint venture investments may involve risks not otherwise present for investments made solely by us, including: (i) we may not control the joint ventures, either by virtue of our economic or legal ownership share, or our ability to influence day-to-day operational decision-making; (ii) our joint venture partners may not agree to distributions that we believe are appropriate; (iii) where we do not have substantial decision-making authority, we may experience impasses or disputes with our joint venture partners on certain decisions, which could require us to expend additional resources to resolve such impasses or disputes, including litigation or arbitration; (iv) our joint venture partners may become insolvent or bankrupt, fail to fund their share of required capital contributions or fail to fulfill their obligations as a joint venture partner; (v) the arrangements governing our joint ventures may contain certain conditions or milestone events that may never be satisfied or achieved; (vi) our joint venture partners may have business or economic interests that are inconsistent with ours and may take actions contrary to our interests; (vii) we may suffer losses as a result of actions taken by our joint venture partners with respect to our joint venture investments; (viii) it may be difficult for us to exit a joint venture if an impasse arises or if we desire to sell our interest for any reason; (ix) our joint venture partners may exercise termination rights under the relevant agreements and (x) conflicts of interest may arise between our joint ventures and Company personnel who are directors of our joint ventures because of the fact that such directors are employed by us. In addition, we may, in certain circumstances, be liable for the actions of our joint ventures or joint venture partners. Any of the foregoing risks could have a material adverse effect on our business, financial condition and results of operations, and the magnitude of these material adverse effects could be greater to the extent we decide to rely on such joint ventures for certain goods or services, such as the receipt of raw materials from Cronos GrowCo, or decide to outsource certain operating activities to such joint ventures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance of continued growth in Israel and our performance in Israel depends on, among other things, our ability to continue to import cannabis into Israel and our joint venture partners.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our revenue in Israel has experienced a recent period of significant growth, our prior performance is not indicative of any potential future results in Israel. There can be no assurance that our recent growth in the Israeli market can be sustained or will continue. Our ability to manage and sustain revenue growth in Israel will depend on a number of factors, many of which are beyond our control, including, but not limited to, our ability to continue to import cannabis into Israel, changes in laws and regulations respecting the cultivation, production and marketing of dried flower, pre-rolls and oils in Israel, increased competition, our ability to produce sufficient volumes of our products to meet customer demand and our ability to maintain or grow our market share in Israel. Any of these factors could materially and negatively impact our growth in Israel. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Realignment, we have begun to further leverage our strategic joint venture with Cronos GrowCo. Our current efforts to wind-down the cultivation and certain production activities at the Peace Naturals Campus have increased the importance of Cronos GrowCo to our business and operations. Once the cultivation and certain production activities at the Peace Naturals Campus have ceased, Cronos GrowCo&#8217;s production facilities will be our principal source of raw materials. Therefore, our performance in Israel is reliant on our ability to acquire such raw materials on a timely and cost-effective basis from Cronos GrowCo and to continue to import such raw materials and cannabis products to Israel from Cronos GrowCo&#8217;s production facilities. There is no guarantee that we will be able to successfully execute our strategy to expand production at Cronos GrowCo or that we will be able to obtain the regulatory approvals, licenses and permits required for both the export of cannabis from Canada and the import of cannabis into Israel.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our acquisition strategy may not be successful, and we have in the past, and may in the future, need to write down the goodwill and indefinite-lived intangible assets recognized upon the acquisitions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, we wrote off all of the goodwill and substantially all of the indefinite-lived intangible assets recognized upon the acquisition of Redwood. Acquisitions of companies, or equity interests of companies operating in new markets, such as the U.S. hemp market in the U.S., are risky and speculative and may not produce the anticipated revenues and profits. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our acquisition of the PharmaCann Option (the &#8220;PharmaCann Investment&#8221;) presents significant risks. See &#8220;Risk Factors &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Our Growth Strategy &#8211; Our U.S. strategy in part depends on the success of the PharmaCann Investment and there is no guarantee that we will exercise the PharmaCann Option in the near term, or at all, and, even if exercised, that the PharmaCann Investment will achieve the expected benefits of the transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have had two restatements and seven material weaknesses in our internal control over financial reporting over the last four years, and one material weakness remains unremediated at December 31, 2022. We had a material weakness in our control environment, and in 2021 and 2022, we experienced significant turnover, both voluntary and involuntary, in our accounting and financial reporting functions. If we are unable to remediate our existing material weakness and create an appropriate control environment, our business, results of operations, financial condition, cash flows and reputation will be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) and for evaluating and reporting on the effectiveness of our system of internal control. Effective internal control is necessary for us to provide timely, reliable and accurate financial reports, identify and proactively correct any deficiencies, material weaknesses or fraud and meet our reporting obligations. We had two restatements and seven&#160;material weaknesses in the last four years, have one&#160;material weakness existing as of December 31, 2022, and have had significant turnover, both voluntary and involuntary, in our accounting and financial reporting functions. Moreover, we had a material weakness in our control environment. Remediation efforts have placed, and will continue to place, a significant burden on management and add increased pressure on our financial reporting resources and processes. The accuracy of our financial reporting and our ability to timely file with the SEC and the applicable securities regulatory authorities in Canada have in the past been, and may in the future be, adversely impacted if we are unable to successfully remediate material weaknesses in a timely manner, or if any additional material weaknesses in our internal control over financial reporting are identified. In addition, if our remedial efforts are insufficient, or if additional material weaknesses or significant deficiencies in our internal control occur in the future, we could be required to restate our financial statements again, which could materially and adversely affect our business, results of operations and financial condition, restrict our ability to access the capital markets, require us to expend significant resources to correct the material weaknesses or deficiencies, subject us to regulatory investigations and penalties, harm our reputation, cause a decline in investor confidence or otherwise cause a decline in our stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to civil litigation relating to the restatements and we cannot predict the outcome of this litigation, but we have incurred and expect to continue to incur significant costs and expenses in defending against this civil litigation. For more information on this civil litigation and proceedings, see Part 1, Item 3, Legal Proceedings, of this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are subject to disabilities as a result of our settlement with the SEC that may expose us to increased future litigation and adversely affect our ability to raise capital. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of our settlement with the SEC (the &#8220;SEC Order&#8221;), October 24, 2022, and for a period of three years thereafter, we are unable to rely on the safe harbor provisions regarding forward-looking statements provided by the Securities Act and the Exchange Act. Our inability to rely on these safe harbor provisions may expose us to increased future litigation in connection with forward-looking statements in our public disclosures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, as of the date of the SEC Order, we have lost our status as a &#8220;well-known seasoned issuer&#8221; for a period of three years, which places limitations on the manner in which we can market our securities to the public, and we are unable to rely on the private offering exemptions provided by Regulations A and D under the Securities Act for a period of five years, which could impair our ability to raise additional capital in the private market quickly in response to changing requirements and market conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that our current and future strategic alliances or expansions of scope of existing relationships will have a beneficial impact on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have, and may in the future enter into additional, strategic alliances with third parties that we believe will complement or augment our existing business. Our ability to complete strategic alliances is dependent upon, and may be limited by, the availability of suitable candidates and capital. In addition, strategic alliances could present unforeseen integration obstacles or costs, may not enhance our business and may involve risks that could adversely affect us, including significant amounts of management time that may be diverted from operations in order to pursue and complete such transactions or maintain such strategic alliances. Future strategic alliances could result in the incurrence of debt, costs and contingent liabilities, and there can be no assurance that future strategic alliances will achieve, or that our existing strategic alliances will continue to achieve, the expected benefits to our business or that we will be able to consummate future strategic alliances on satisfactory terms, or at all. Any of the foregoing could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of the Ginkgo Strategic Partnership, we have and will continue to obtain, pursuant to the Ginkgo Collaboration Agreement, the exclusive right to use and commercialize the key patented intellectual property related to the production of the target cannabinoids globally (referred to herein as the &#8220;Ginkgo exclusive licenses&#8221;). There can be no assurance that Ginkgo will be able to develop microorganisms that we will be able to commercialize or to obtain patents relating to production of the target cannabinoids, or that third parties will not develop similar microorganisms or obtain patents that may restrict our ability to commercialize the microorganisms developed by Ginkgo, and, as a result, there can be no assurance that we will be able to realize the expected benefits of the Ginkgo Strategic Partnership. Additionally, we have determined, and may determine in the future, that the production of certain cannabinoids is not economically feasible and in our best interests and we have abandoned, and may abandon in the future, the production efforts of Ginkgo with respect to certain target cannabinoids. Even if we are able to commercialize cultured cannabinoids, we may not be able to generate satisfactory returns on them or on the products that incorporate them, and there may not be demand for such cultured cannabinoid products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the Ginkgo Collaboration Agreement, if we undergo a change of control that is approved by the Board, Ginkgo may elect to receive cash payments, which, given the number of Equity Milestone Events (as defined in the Ginkgo Collaboration Agreement) that have occurred to date, could total up to $17 million, in lieu of the common shares that would otherwise become issuable in connection with any Equity Milestone Events achieved following such election (the &#8220;Milestone Cash Election&#8221;). If we undergo a change in control that has not been approved by the Board, then Ginkgo will have the ability to terminate the Ginkgo Collaboration Agreement immediately, in which case, among other things: (i) all rights or licenses granted to us by Ginkgo under the Ginkgo Collaboration Agreement will terminate; (ii) certain expenses and costs incurred by Ginkgo will be accelerated and become due and payable by us; (iii) the then-outstanding and unpaid portion of all cash payments from us to Ginkgo for the achievement of R&amp;D milestones by Ginkgo shall be due immediately as if all R&amp;D milestones had been achieved; and (iv) a lump sum cash payment equal to the aggregate of all Milestone Cash Election amounts in respect of which the relevant Equity Milestone Events have not yet been achieved will be immediately due and payable by us. In addition, should Ginkgo terminate the Ginkgo Collaboration Agreement upon a change of control, we will no longer be able to use or commercialize the key patented intellectual property related to the production of the target cannabinoids, which could have a material adverse effect on our business, financial condition and results of operations. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of Business - Research and Development Activities and Intellectual Property.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As additional equity milestones occur under the Ginkgo Collaboration Agreement, we are required by accounting rules to conduct an impairment analysis related to the new Ginkgo exclusive licenses. These analyses have resulted in impairment charges in the past and may do so in the future as additional equity milestones are achieved. For a discussion of our most recent impairments of the Ginkgo exclusive licenses, see Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in the Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not successfully execute our production capacity strategy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be successful in executing our strategy to expand production capacity at certain of our facilities and joint ventures and wind-down of cultivation and certain production activities at the Peace Naturals Campus. Continuing and expanding operations at our facilities and joint ventures will be subject to obtaining and maintaining the appropriate licenses from the relevant regulatory agencies in those jurisdictions. In particular, continuing and expanding operations at Cronos GrowCo&#8217;s production facilities will be subject to obtaining and maintaining the appropriate licenses from Health Canada. Construction delays or cost over-runs in respect of such operations, howsoever caused, could have a material adverse effect on our business, financial condition and results of operations. Moreover, with the change in the nature of operations at the Peace Naturals Campus, the continued operations of the Cronos GrowCo production facilities will be more important to us. Once cultivation and certain production activities at the Peace Naturals Campus have ceased, these production facilities will be our principal source of raw materials.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may not be successful in obtaining the necessary approvals required to export or import our products to or from the jurisdictions in which we or our joint ventures operate. If we are unable to secure necessary production licenses in respect of our facilities and those of our joint ventures, the expectations of management with respect to the increased future cultivation and growing capacity may not be borne out, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that the Realignment and the change in the nature of operations at the Peace Naturals Campus will have a beneficial impact on our business, financial condition and results of operations. The timing, costs and benefits of the Realignment and the change in the nature of operations at the Peace Naturals Campus cannot be guaranteed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we announced our Realignment to centralize functions under common leadership to increase efficient distribution of resources, improve strategic alignment and eliminate duplication of roles and costs; evaluate our global supply chain and perform product reviews and pricing and distribution optimization in order to reduce fixed expenses and reduce complexity; and implement an operating expense target to optimize cash deployment for activities such as margin accretive innovation and U.S. adult-use cannabis market entry in the future. Additionally, we announced a plan to leverage our strategic partnerships to improve supply chain efficiencies and reduce manufacturing overhead by partially exiting the Peace Naturals Campus.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we announced a shift in our strategic plans for the Realignment. Our intent is to retain select components of our operations at the Peace Naturals Campus, namely distribution and warehousing, certain R&amp;D activities and manufacturing of certain of our proprietary innovation products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that these initiatives will achieve the expected benefits to our business or reduce costs or grow our revenue as intended and, if achieved at all, the timing thereof. The execution and implementation of these initiatives involve risk, including that significant amounts of management&#8217;s time and Company resources could be diverted from our core operations in order to complete such initiatives. In addition, these initiatives could present unforeseen obstacles, lead to operating inefficiencies and negatively disrupt our corporate culture, which could lead to further employee attrition, any of which would have a material adverse effect on our business, financial condition and results of operations. We have and will continue to incur costs to implement these initiatives, and we could be subject to litigation risks and expenses. Our projected costs and expenses to change the nature of our operations at the Peace Naturals Campus may turn out to be too low by a material amount. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The industries and markets in which we operate are relatively new, and these industries and markets may not continue to exist or grow as anticipated or we may ultimately be unable to succeed in these industries and markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cannabis and U.S. hemp industries and markets in which we operate are relatively new, can be highly speculative, are rapidly expanding and may ultimately not be successful. In addition to being subject to general business risks, we need to continue to build brand awareness in these industries and markets through significant investments in our strategy, our production capacity, quality assurance and compliance with regulations. These activities may not promote our brand and products as effectively as intended, or at all. Competitive conditions and consumer tastes, as applicable, and spending patterns in these new industries and markets are relatively unknown and may have unique circumstances that differ from existing industries and markets. We are subject to all of the business risks associated with a new business in a niche market, including risks of unforeseen capital requirements, failure of widespread market acceptance of our products, failure to establish business relationships and competitive disadvantages against larger and more established competitors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, there are no assurances that these industries and markets will continue to exist or grow as currently estimated or anticipated, or function and evolve in a manner consistent with management&#8217;s expectations and assumptions, and a failure to do so could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to supply the provincial purchasers in various provinces and territories of Canada with our products in the quantities or prices anticipated, or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into various supply arrangements for cannabis products with various provincial purchasers and have secured listings with various private retailers in those provinces. We have entered into such supply arrangements with all provinces in Canada and the Yukon territory (where the relevant provincial body is the sole wholesale distributor of cannabis products in the province) and with private retailers in Saskatchewan. Our supply arrangements with provincial and territorial purchasers, each of which we understand to be substantially similar in all material respects with the supply arrangements entered into with the other license holders in the Canadian cannabis industry, do not contain any binding minimum purchase obligations on the part of the relevant provincial purchaser. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect purchase orders to be primarily driven by end-consumer demand for our products and the relevant provincial or territorial purchaser supply at the relevant time. Accordingly, we cannot predict the quantities of our products that will be purchased by the provincial and territorial purchasers, or if our products will be purchased at all. Provincial and territorial purchasers may change the terms of the supply agreements at any time during the supply relationship including pricing, have broad rights of return of products and are under no obligation to purchase our products or maintain any listings of our products for sale. As a result, provincial and territorial purchasers have a significant amount of control over the terms of the supply arrangements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effect of the legalization of adult-use cannabis in Canada on the medical cannabis market in Canada is still uncertain, and it may have a significant negative effect upon our medical cannabis business if consumers decide to purchase products available in the adult-use market instead of purchasing our medical-use products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Act allows individuals over the age of 18 to legally purchase, process and cultivate limited amounts of cannabis for adult-use in Canada, subject to provincial and territorial age restrictions which may increase the age of purchase in the province or territory. As a result, individuals who rely upon the medical cannabis market to supply their medical cannabis and cannabis-based products may cease this reliance, and instead turn to the adult-use cannabis market to supply their cannabis and cannabis-based products. Factors that will influence this decision include the price of medical cannabis products in relation to similar adult-use cannabis products, the amount of active ingredients in medical cannabis products in relation to similar adult-use cannabis products, the types of cannabis products available to adult users and limitations on access to adult-use cannabis products imposed by the regulations under the Cannabis Act and the legislation governing the distribution and sale of cannabis that has been enacted by the individual provinces and territories of Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of the legalization of adult-use cannabis in Canada on the medical cannabis market is uncertain, and while we cannot predict its impact on our sales and revenue prospects, it may be adverse.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The adult-use cannabis market in Canada has in the past been and may in the future become oversupplied following the implementation of the Cannabis Act and the related legalization of cannabis for adult-use.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the implementation of the Cannabis Act and the legalization of adult cannabis use, numerous additional cannabis producers have and may continue to enter the Canadian adult-use market. We and such other cannabis producers have in the past produced and may in the future produce more cannabis than is needed to satisfy the collective demand of the Canadian medical and adult-use markets, and we may be unable to export that over-supply into other markets. As a result, the available supply of cannabis could exceed demand, which has in the past, and may in the future, result in significant inventory write downs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unsuccessful in competing in the legal adult-use cannabis market in Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition from existing license holders licensed under the Cannabis Act. Certain of these competitors may have significantly greater financial, production, marketing, R&amp;D and technical and human resources than we do. As a result, our competitors may be more successful than us in gaining market share in the adult-use cannabis industry in Canada. Our commercial opportunity in the adult-use market could be reduced or eliminated if our competitors produce and commercialize products for the adult-use market that, among other things, are safer, more effective, more convenient or less expensive than the products that we may produce, have greater sales, marketing and distribution support than our products, enjoy enhanced timing of market introduction and perceived effectiveness advantages over our products and receive more favorable publicity than our products. If our adult-use products do not achieve an adequate level of acceptance by the adult-use market, we may not generate sufficient revenue from these products, and our adult-use business may not become profitable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to liability arising from any fraudulent or illegal activity by our employees, contractors and consultants. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk that our employees, independent contractors and consultants may engage in fraudulent or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violates: (i) applicable laws and regulations; (ii) manufacturing standards; (iii) federal and provincial healthcare fraud and abuse of federal, state and provincial laws and regulations; or (iv) laws and regulations that require the true, complete and accurate reporting of financial information or data. It is not always possible for us to identify and deter misconduct by our employees and other third parties, and the precautions taken by us to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations. If any such actions are brought against us, and we are not successful in defending them, those actions could have a significant impact on our business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, contractual damages, reputational harm, diminished profits and future earnings, loss or suspension of licenses and the curtailment of our operations, any of which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some jurisdictions may never develop markets for cannabis and U.S. hemp.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many jurisdictions place restrictions on or prohibit commercial activities involving cannabis and U.S. hemp. Such restrictions or prohibitions may make it impossible or impractical for us to enter or expand our operations in such jurisdictions unless there is a change in law or regulation. For example, U.S. Schedule I cannabis remains illegal under U.S. federal law and may never become legal under U.S. federal law. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our U.S. strategy in part depends on the success of the PharmaCann Investment and there is no guarantee that we will exercise the PharmaCann Option in the near term, or at all, and, even if exercised, that the PharmaCann Investment will achieve the expected benefits of the transaction.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to exercise the PharmaCann Option will depend on the satisfaction of several conditions, including U.S. federal cannabis legalization. In addition, our ability to exercise the PharmaCann Option is subject to the receipt of any required regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise, as well as Altria&#8217;s approval under the Investor Rights Agreement. These conditions are outside of our control and therefore there can be no certainty that the PharmaCann Option will be exercised in the near term, or at all. If the PharmaCann Option is not exercised, we will not receive the benefits of the contemplated commercial arrangements between us and PharmaCann. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the regulatory approval processes in connection with the exercise of any PharmaCann Option may take a prolonged period of time to complete, which could significantly delay our ability to exercise the PharmaCann Option and realize the benefits of the PharmaCann Investment, or result in our not being able to exercise all or part of the PharmaCann Option. Furthermore, in connection with obtaining approvals from or otherwise satisfying the requests of the state regulators or applicable laws, we may be required to divest all or a portion of the PharmaCann Option, or if after the exercise of the PharmaCann Option, our shares of PharmaCann. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to and do exercise the PharmaCann Option, the intended benefits of the PharmaCann Investment may not be realized. We cannot assure you that the PharmaCann Investment will be accretive to us in the near term or at all. For example, if entered into, the commercial arrangements between us and PharmaCann may not be successful or beneficial to us. Furthermore, if we fail to realize the intended benefits of the PharmaCann Investment, our stock price could decline to the extent that the market price anticipates those benefits.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are entitled to certain limited governance rights with respect to PharmaCann, including limited information rights and board observer rights. Therefore, we will have little to no ability to influence the strategy and material decisions of PharmaCann&#8217;s business. Furthermore, until such time as we exercise the PharmaCann Option, we will not have the ability to vote on matters requiring the vote of PharmaCann&#8217;s shareholders and, until the exercise of the PharmaCann Option, will not have the right to appoint directors to the PharmaCann board of directors. Even after exercising the PharmaCann Option, we are entitled to appoint a director of PharmaCann&#8217;s board only if we own at least 10% of the outstanding capital stock of PharmaCann, and in any event may appoint no more than two directors. In addition, we are subject to certain standstill restrictions, both prior to and after the exercise of the PharmaCann Option, which restrictions further limit our ability to influence decisions of PharmaCann.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we are entitled to certain anti-dilution protections with respect to our investment in PharmaCann, such protections are subject to various conditions, and our potential ownership in PharmaCann may be significantly diluted by, among other things, future issuances of PharmaCann securities or acquisition activity in which PharmaCann uses its equity as consideration. On February 28, 2022, PharmaCann closed the previously announced LivWell Transaction. As a result of the LivWell Transaction, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately 6.4%. As of December 31, 2022, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis was approximately 6.3%. Under the terms of our investment in PharmaCann, Cronos&#8217; rights to nominate an observer or a director to the PharmaCann board of directors could be lost if our ownership drops below 6% on a fully diluted basis and we sell or transfer all or any portion of the PharmaCann Option (subject to certain exceptions). As a result, further dilution could adversely affect our rights under the PharmaCann Option. Any other equity event could be significantly dilutive to our ownership in PharmaCann and may adversely impact the potential benefits we may realize from the PharmaCann Investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We must rely largely on our own market research to forecast sales and market demand and market prices may differ from our forecasts. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must rely largely on our own market research and internal data to forecast sales as detailed market data is not generally obtainable from other sources at this early stage of the cannabis or U.S. hemp industries. If our sales forecasts and our expectations regarding market conditions, including prices, influence capital expenditure levels, inventory levels, production and supply chain capacity and operating expenses, prove to be inaccurate, this could have a material adverse effect on our business, financial condition and results of operations. For example, our forecasts for product demand and market conditions were impacted by a decline in market prices for cannabis products in the Canadian market, which contributed to our inventory write-down in the second and fourth quarters of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could have difficulty integrating the operations of businesses that we have acquired and will acquire.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our acquisitions depends upon our ability to integrate any businesses that we acquire. The integration of acquired business operations could disrupt our business by causing unforeseen operating difficulties, diverting management&#8217;s attention from day-to-day operations and requiring significant financial resources that would otherwise be used for the ongoing development of our business. The difficulties of integrations could be increased by the necessity of coordinating geographically dispersed organizations, coordinating personnel with disparate business backgrounds, managing different corporate cultures, or discovering previously unknown liabilities. In addition, we could be unable to retain key employees or customers of the acquired businesses. We could face integration issues including those related to operations, internal control and information systems and operational functions of the acquired companies and we also could fail to realize cost efficiencies or synergies that we anticipated when selecting our acquisition candidates or these acquisitions could fail to compete successfully. Any of these items could adversely affect our business, financial condition and results of operations. For more information on the risks associated with acquisitions, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Our Growth Strategy &#8211; Our acquisition strategy may not be successful and we have in the past, and may in the future, need to write down the goodwill and indefinite-lived intangible assets recognized upon the acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have been and may in the future be required to write down intangible assets, including goodwill, due to impairment, which could have a material adverse effect on our results of operations or financial position.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been and may in the future be required to write down intangible assets, including goodwill, due to impairment, which would reduce earnings. Indefinite-lived intangible assets are reviewed annually or more frequently when events or changes in circumstances indicate that the fair value of the indefinite-lived intangible assets have been reduced to less than their carrying amount. We periodically calculate the fair value of our reporting units and intangible assets to test for impairment. This calculation may be affected by several factors, including general economic conditions, regulatory developments, changes in category growth rates as a result of changing adult consumer preferences, success of planned new product introductions, and competitive activity. Certain events can also trigger an immediate review of goodwill and intangible assets. If the carrying amount of our reporting unit and other intangible assets exceed their fair value, the goodwill and other intangible assets are considered impaired, which would result in impairment losses and could have a material adverse effect on our consolidated financial position or results of operations. We cannot provide any assurance that the U.S. segment will successfully execute its business plans and strategies.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of previous write downs of indefinite-lived intangible assets and goodwill, see Note 6 &#8220;Goodwill and Intangible Assets, net&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Products</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is limited long-term data with respect to the efficacy and side effects of cannabis, U.S. hemp and cannabinoids, and future clinical research studies on the effects of cannabis, U.S. hemp and cannabinoids may lead to conclusions that dispute or conflict with our understanding and belief regarding their benefits, viability, safety, efficacy, dosing and social acceptance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research in Canada, the U.S. and internationally regarding the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, U.S. hemp or isolated cannabinoids (such as CBD and THC) in dietary supplements, food, or cosmetic products remains in early stages. There have been relatively few clinical trials on the potential benefits of cannabis, U.S. hemp or isolated cannabinoids and there is limited long-term data with respect to potential benefits, effects and/or interaction of these substances with human or animal biochemistry. As a result, our products could have unexpected side effects or safety concerns, the discovery of which could lead to civil litigation, regulatory actions and even possibly criminal enforcement actions. In addition, if the products we sell do not or are not perceived to have the effects intended by the end user, this could have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The statements made by the Company, including in this Annual Report, concerning the potential benefits of cannabis, U.S. hemp and isolated cannabinoids are based on published articles and reports and therefore are subject to the experimental parameters, qualifications and limitations in such studies that have been completed. Although we believe that the existing public scientific literature generally supports our beliefs regarding the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, U.S. hemp and cannabinoids, future research and clinical trials may cast doubt or disprove such beliefs, or could raise or heighten concerns regarding, and perceptions relating to, cannabis, U.S. hemp and cannabinoids, which could have a material adverse effect on the demand for our products with the potential to lead to a material adverse effect on our business, financial condition and results of operations. Given these risks, uncertainties and assumptions, undue reliance should not be placed on such literature. In particular, the FDA has raised several questions regarding the safety of CBD and other cannabinoids and gaps in the public scientific literature supporting the use of CBD and other cannabinoids by the general population.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical trials of cannabis-based medical products and treatments are novel terrain with very limited or non-existent history, and any trials may not result in commercially viable products and treatments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials are expensive, time consuming and difficult to design and implement. Regulatory authorities may suspend, delay or terminate any clinical trials we commence at any time, may require us, for various reasons, to conduct additional clinical trials, or may require a particular clinical trial to continue for a longer duration than originally planned. Clinical trials face many risks, including, among others:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of effectiveness of any formulation or delivery system during clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discovery of serious or unexpected toxicities or side effects experienced by trial participants or other safety issues&#894;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">slower than expected subject recruitment and enrollment rates in clinical trials&#894;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or inability in manufacturing or in obtaining sufficient quantities of materials for use in clinical trials due to regulatory and manufacturing constraints&#894;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in obtaining regulatory authorization to commence a trial, including licenses required for obtaining and using cannabis, U.S. hemp or isolated cannabinoids for research, either before or after a trial is commenced&#894;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unfavorable results from ongoing pre-clinical studies and clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trial participants or investigators failing to comply with study protocols&#894;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trial participants failing to return for post-treatment follow-up at the expected rate&#894;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sites participating in an ongoing clinical study withdraw, requiring us to engage new sites&#894; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third party clinical investigators declining to participate in our clinical studies, not performing the clinical studies on the anticipated schedule, or acting in ways inconsistent with the established investigator agreement, clinical study protocol or good clinical practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any of the foregoing could cause our products or treatments not to be commercially viable, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The controversy surrounding vaporizers and vaporizer products may materially and adversely affect the market for vaporizer products and expose us to litigation and additional regulation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been a number of highly publicized cases involving lung and other illnesses and deaths that appear to be related to vaporizer devices and/or products used in such devices (such as vaporizer liquids). The focus is currently on the vaporizer devices, the manner in which the devices were used and the related vaporizer device products &#8211; THC, nicotine, other substances in vaporizer liquids, possibly adulterated products and other illegal unlicensed cannabis vaporizer products. Some states, provinces, territories and municipalities in the U.S. and Canada have already taken steps to prohibit the sale or distribution of vaporizers, restrict the sale and distribution of such products or impose restrictions on flavors, substances and concentration of substances used, or use of such vaporizers. This trend may continue, accelerate and expand.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cannabis vaporizers in Canada are regulated under the Cannabis Act, Cannabis Regulations and other laws and regulations of general application. Although this legislation sets rules and standards for the manufacture, composition, packaging, and marketing of cannabis vaporizer products, these rules and standards predate the spate of vaporizer-related health issues that have recently arisen in the U.S. These issues and accompanying negative public sentiment may prompt Health Canada or individual provinces/territories or municipalities to decide to further limit or defer the industry&#8217;s ability to sell cannabis vaporizer products, and may also diminish consumer demand for such products. Currently, Qu&#233;bec and Prince Edward Island do not allow the sale of cannabis vaporizers in their respective jurisdictions and Health Canada is seeking to limit the flavors of inhaled cannabis extracts. In June 2021, Health Canada opened a consultation into the use of flavors in inhaled cannabis extracts as it claims that the availability of flavors is one of the factors that contributes to the increase in cannabis vaping in youth and young adults. As part of this consultation, Health Canada released proposed regulations that contemplate restricting the production, sale, promotion, packaging and labelling of inhaled cannabis extracts from having a flavor, other than the flavor of cannabis. The proposed amendments would apply equally to inhaled cannabis extracts sold for medical and non-medical purposes. The proposed amendments were pre-published in June 2021 and the consultation period closed in September 2021. No expected in-force date has been publicly announced.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that the jurisdictions in which we operate will allow the sale of cannabis vaporizers in the future, that other jurisdictions will not prohibit the sale of cannabis vaporizers, that we will be able to meet any additional compliance requirements or regulatory restrictions, or that we will remain competitive in face of unexpected changes in market conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An extension of this controversy to non-nicotine vaporizer devices and other product formats could materially and adversely affect our business, financial condition, operating results, liquidity, cash flow and operational performance. In February 2020, the U.S. Centers for Disease Control reported that federal and state agencies were investigating an outbreak of over 2,807 lung injury cases associated with the use of vaporizer products, including non-nicotine containing products. Litigation pertaining to vaporizer products is ongoing and that litigation could potentially expand to include our products, which would materially and adversely affect our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future research may lead to findings that vaporizers, electronic cigarettes and related products are not safe for their intended use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaporizers, electronic cigarettes and related products were recently developed and therefore the scientific or medical communities have had a limited period of time to study the long-term health effects of their use. Currently, there is limited scientific or medical data on the safety of such products for their intended use and the medical community is still studying the health effects of the use of such products, including the long-term health effects. If a consensus were to develop among the scientific or medical community that the use of any or all of these products pose long-term health risks, market demand for these products and their use could materially decline. Such a development could also lead to litigation, reputational harm and significant regulation. Loss of demand for our products, product liability claims and increased regulation stemming from unfavorable scientific studies on vaporizer products could have a material adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We, or the cannabis and U.S. hemp industries more generally, may receive unfavorable publicity or become subject to negative consumer perception.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the cannabis and U.S. hemp industries are highly dependent upon broad social acceptance and consumer perception regarding the safety, efficacy and quality of the cannabis and U.S. hemp products, as well as consumer views concerning regulatory compliance. Consumer perception of our products can be significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention, market rumors or speculation and other publicity regarding the consumption or effects thereof of cannabis and U.S. hemp products. There can be no assurance that future scientific research, findings, regulatory proceedings, litigation, media attention or other research findings or publicity will be favorable to the cannabis or U.S. hemp markets or any particular product, or consistent with earlier publicity. Future research reports, findings, regulatory proceedings, litigation, media attention or other publicity that are perceived as less favorable than, or that question, earlier research reports, findings or publicity could have a material adverse effect on the demand for our products and our business, financial condition and results of operations. Our dependence upon consumer perceptions means that adverse scientific research reports, findings, regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, could have a material adverse effect on the demand for products, and our business, results of operations, financial condition and cash flows. Further, adverse publicity reports or other media attention regarding the safety, efficacy and quality of U.S. hemp or cannabis in general, or our products specifically, or associating the consumption or use of U.S. hemp or cannabis with illness or other negative effects or events, could have such a material adverse effect. Such adverse publicity reports or other media attention could arise even if the adverse effects associated with such products resulted from consumers&#8217; failure to consume such products legally, appropriately or as directed.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increased usage of social media and other web-based tools used to generate, publish and discuss user-generated content and to connect with other users has made it increasingly easier for individuals and groups to communicate and share opinions and views, whether or not true, on our operations and activities and the U.S. hemp and cannabis industries in general, whether true or not. Social media permits user-generated content to be distributed to a broad audience which can respond or react, in near real time, with comments that are often not filtered or checked for accuracy. In many cases, we do not have the ability to filter such comments or verify their accuracy. Accordingly, the speed with which negative publicity (whether true or not) can be disseminated has increased dramatically with the expansion of social media. The dissemination of negative or inaccurate posts, comments or other user-generated content about us on social media (including those published by third-parties) could damage our brand, image and reputation or how the U.S. hemp or cannabis industries are perceived generally, which could have a detrimental impact on the market for our products and thus on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain businesses may have strong economic opposition to the U.S. hemp or cannabis industries. Lobbying by such groups, and any resulting inroads they might make in halting or rolling back the U.S. hemp and cannabis movements, could affect how the U.S. hemp or cannabis industries are perceived by others and could have a detrimental impact on the market for our products and thus on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties with which we do business, may perceive that they are exposed to reputational risk as a result of our cannabis or U.S. hemp business activities. Failure to establish or maintain business relationships could have a material adverse effect on our business, financial condition and results of operations. Any third party service provider or supplier could suspend or withdraw its services to us or require increased fees or compensation if it perceives that the potential risks exceed the potential benefits to such services. For example, we face challenges making U.S. dollar wire transfers or engaging any third party service provider or supplier with a substantial presence where cannabis is not federally legal (including the U.S.). In these circumstances, while we believe that such services can be procured from other institutions, we may in the future have difficulty maintaining existing, or securing new, bank accounts or clearing services, service providers or other vendors or we may be forced to pay increased fees or compensation for such services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we take care in protecting our image and reputation, we do not ultimately have control over how we or the U.S. hemp or cannabis industries are perceived by others. Reputation loss may result in decreased investor confidence, increased challenges in developing and maintaining community relations and an impediment to our overall ability to advance our business strategy and realize on our growth prospects, thereby having a material adverse impact on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to litigation in the ordinary course of our marketing, distribution and sale of our products. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to litigation, claims and other legal and regulatory proceedings from time to time in the ordinary course of our manufacturing, marketing, distribution and sale of our products, some of which may adversely affect our business, financial condition and results of operations. Several companies in the U.S. hemp-derived CBD industry, including the Company, have become party to an increasing number of purported class actions lawsuits relating to their food and dietary supplement products containing U.S. hemp-derived CBD. While one such case against the Company was dismissed, similar class actions may be filed against us again, and the plaintiffs in such class action lawsuits, as well as in other lawsuits against us, may seek very large or indeterminate amounts, including punitive damages, which may remain unknown for substantial periods of time. Should any litigation in which we become involved be determined against us, such a decision could adversely affect our ability to continue operating, adversely affect the market price for our common shares and require the use of significant resources. Even to the extent we ultimately prevail in litigation, litigation can consume and redirect significant resources. Litigation may also create a negative perception of our brands, which could have an adverse effect on our business, financial condition and results of operations. See Part I, Item 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report for a discussion of our legal proceedings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to product liability claims.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a manufacturer and distributor of products designed to be ingested by humans, we face an inherent risk of exposure to product liability claims, regulatory action and litigation if our products are alleged to have caused significant loss or injury. In addition, the manufacture and sale of cannabis and U.S. hemp products involve the risk of injury to consumers due to tampering by unauthorized third parties or product contamination. Previously unknown adverse reactions resulting from human consumption of cannabis or U.S. hemp products alone or in combination with other medications or substances could occur as described above under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; There is limited long-term data with respect to the efficacy and side effects of cannabis, U.S. hemp and cannabinoids and future clinical research studies on the effects of cannabis, U.S. hemp and cannabinoids may lead to conclusions that dispute or conflict with our understanding and belief regarding their benefits, viability, safety, efficacy, dosing and social acceptance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; We have been, and may in the future be, subject to product liability claims that include, among others, our products caused injury or illness, incorrect labeling, inadequate instructions for use or inadequate warnings concerning possible side effects or interactions with other substances. A product liability claim or regulatory action against us could result in increased costs, could adversely affect our reputation with our consumers generally, and could have a material adverse effect on our business, financial condition and results of operations. See Part I, Item 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report for a discussion on our legal proceedings.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurances that we will be able to obtain or maintain product liability insurance on acceptable terms or with adequate coverage against potential liabilities. Such insurance is expensive and may not be available in the future on acceptable terms, or at all. The inability to obtain sufficient insurance coverage on reasonable terms or to otherwise protect against potential product liability claims could prevent or inhibit the commercialization of products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products have in the past and may in the future be subject to recalls.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers and distributors of products are sometimes subject to the recall or return of their products for a variety of reasons, including, among other things, product defects, such as contamination, unintended harmful side effects or interactions with other substances, packaging safety and inadequate or inaccurate labelling disclosure. Some of our products have been subject to recalls in the past.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more of our products are recalled for any reason, we could be required to incur the unexpected expense of the recall and any legal proceedings that might arise in connection with the recall. We may lose a significant number of sales and may not be able to replace those sales at an acceptable margin, or at all. In addition, product recalls have in the past and may in the future require significant management attention. Although we have detailed procedures in place for testing finished products, there can be no assurance that any quality, potency or contamination problems will be detected in time to avoid unforeseen product recalls, regulatory action or lawsuits. If one or more of our products were subject to recall, the public perception of that product and us could be harmed. A recall of one of our products could lead to decreased demand for that product and our other products and could have a material adverse effect on our business, financial condition and results of operations. Additionally, product recalls may lead to increased scrutiny of our operations by Health Canada, the FDA, the California Department of Public Health (the &#8220;CDPH&#8221;), the DEA or other regulatory agencies, requiring further management attention and potential legal fees and other expenses. Furthermore, any product recall affecting the cannabis or U.S. hemp industries more broadly could lead consumers to lose confidence in the safety and security of the products sold by participants in these industries generally, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third party testing and analytical methods which are validated but still being standardized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain of our cannabis and U.S. hemp products, testing for cannabinoid levels, heavy metals and pesticides (among other things) is performed by independent third-party testing laboratories. Testing methods and analytical assays for cannabinoids and levels of detection vary among different testing laboratories in different jurisdictions. There is currently no industry consensus on standards for testing methods or an industry accepted compendium of analytical assays or standard levels of detection. The detected and reported cannabinoid content in our cannabis and U.S. hemp products therefore can differ depending on the laboratory and testing methods (analytical assays) used. Variations in reported cannabinoid content will likely continue until the relevant regulatory agencies and independent certification bodies (e.g., ISO, USP) collaborate to develop, publish and implement standardized analytical assays and levels of detection for cannabis, U.S. hemp, cannabinoids and their derivative products. Until such standardized analytical assays and levels of detection are developed, the existing differences could cause confusion with our consumers which could lead to a negative perception of us and our products, increase the risk of litigation regarding cannabinoid content and regulatory enforcement action and could make it more difficult for us to comply with regulatory requirements regarding contents of ingredients and packaging and labeling. For example, on June 16, 2020, an alleged consumer filed a Statement of Claim, which has since been dismissed as against the Company, on behalf of a class in the Court of King&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and distributors alleging claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. See Part I, Item 3,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The presence of trace amounts of THC in our U.S. hemp products may cause adverse consequences to users of such products that will expose us to the risk of litigation, liability and other consequences.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our products that are intended to primarily contain U.S. hemp-derived CBD, or other U.S. hemp-derived cannabinoids, may contain trace amounts of THC. THC is a controlled substance in many jurisdictions, including under the federal laws of the U.S. Whether or not ingestion of THC (at low levels or otherwise) is permitted in a particular jurisdiction, there may be adverse consequences to consumers of our U.S. hemp products who test positive for any amounts of THC because of the presence of trace amounts of THC in our U.S. hemp products. In addition, certain metabolic processes in the body may negatively affect the results of drug tests. Positive tests for THC may expose us to litigation from our consumers, adversely affect our reputation, our ability to obtain or retain customers and individuals&#8217; participation in certain athletic or other activities. A claim or regulatory action against us based on such positive test results could materially and adversely affect our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully develop new products or find a market for their sale.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legal cannabis and U.S. hemp industries are in their early stages of development and it is likely that we, and our competitors, will seek to introduce new products, including products that contain cannabinoids other than THC and CBD, in the future. In attempting to keep pace with any new market developments, we may need to spend significant amounts of capital in order to successfully develop and generate revenues from new products we introduce. In addition, we may be required to obtain additional regulatory approvals from Health Canada, the FDA and/or any other applicable regulatory authority, which may take significant amounts of time. We may not be successful in developing effective and safe new products, bringing such products to market in time to be effectively commercialized, or obtaining any required regulatory approvals, and, in the event we are successful, it is possible that there may be little or no demand for the products we develop (including products containing cannabinoids other than THC and CBD with which consumers may not be familiar or have significant reservations), which, together with any capital expenditures made in the course of such product development and regulatory approval processes, may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Canadian excise duty framework may affect our profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Canada&#8217;s excise duty framework imposes an excise duty and various regulatory-like restrictions on certain cannabis products sold in Canada. We currently hold licenses issued by the Canada Revenue Agency (&#8220;CRA&#8221;) required to comply with this excise framework. Any change in the rates or application of excise duty to cannabis products sold by us in Canada, and any restrictive interpretations by the CRA or the courts of the provisions of the Excise Act, 2001 (which may be different than those contained in the Cannabis Act) may affect our profitability and ability to compete in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may be impacted as a result of increased rates of inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past year, the worldwide economy has experienced significant inflation and inflationary pressures, including, in particular, on wages. Increased inflation could reduce our purchasing power and result in negative impacts on our ability to obtain goods and services required for the operation of our business, to hire and retain employees, or to pass on rising costs, including increased employee costs, to our customers. To the extent that we are unable to offset such inflation through higher prices of our products or other cost savings, there could be a negative impact on our operating margins, net income, cash flows and the trading price of our common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A period of sustained inflation across the markets in which we operate could result in higher operating costs. Further rising inflation may negatively impact our business, raise cost and reduce profitability. Despite efforts we may take to reduce the impact of inflation on our business across the markets in which we operate, it could become increasingly difficult to effectively mitigate the increases to our costs. In addition, the effects of inflation on consumers&#8217; budgets could result in the reduction of our customers&#8217; spending habits. If we are unable to take actions to effectively mitigate the effect of the resulting higher costs, our operating margins could be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Production and Distribution of Products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our production facilities and those of our strategic joint ventures, are integral to our operations, and any adverse changes or developments affecting such facilities may impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our activities and resources are focused on various production and manufacturing facilities including in the U.S. (for U.S. hemp products), Canada and Israel. Some licenses are specific to those facilities. Adverse changes or developments affecting our facilities and the facilities of our joint venture partners, including but not limited to a breach of security, an inability to successfully grow cannabis plants or produce finished goods, unanticipated cost overruns in growing or producing products, an outbreak of a communicable illness (such as COVID-19) or a force majeure event, could have a material and adverse effect on our business, financial condition and results of operations. As we proceed to wind-down cultivation and certain production activities at the Peace Naturals Campus, the production and manufacturing facilities that we continue to use will become increasingly important to our business. Any breach of the security measures and other facility requirements, including any failure to comply with recommendations or requirements arising from inspections by regulatory agencies, could also have an impact on our ability to continue operating under our licenses or the prospect of renewing our licenses or could result in a revocation of our licenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bear the responsibility for all of the costs of maintenance and upkeep at our facilities and our operations and financial performance may be adversely affected if our facilities are unable to keep up with maintenance requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience breaches of security at our facilities or fraudulent or unpermitted data access or other cybersecurity breaches, which may cause our customers to lose confidence in our security or data protection measures and may expose us to risks related to breaches of applicable privacy and security laws and regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the nature of our products and the concentration of inventory in our facilities, we are subject to a risk of theft. A security breach at one of our facilities could expose us to additional liability and to potentially costly litigation, increase expenses and business disruptions relating to the resolution and future prevention of these breaches and may deter potential customers from choosing our products.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we collect and store personal information about our customers and are responsible for protecting that information from cybersecurity breaches. A cybersecurity breach may occur in a variety of ways, including, without limitation, a procedural or process failure, information technology malfunction, deliberate unauthorized intrusion, computer virus, and direct or indirect cyberattack or other electronic security breach. Theft of data for competitive or fraudulent purposes, such as customer lists and preferences and other consumer and employee personal information, is an ongoing and growing risk. Any such theft or cybersecurity breach may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent upon information technology systems in the conduct of our operations, and we collect, store and use certain data, intellectual property, proprietary business information and certain personal information of our employees and customers on our computer systems. We have been, and expect to continue to be, subject to various cyberattacks and phishing schemes. Additionally, we are undertaking an effort to modernize our information technology systems, which could expose us to additional risks relating to our collection, storage and use of certain data on our systems. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been many highly publicized attacks over the last several years and we expect those to continue. Any fraudulent, malicious or accidental breach of our systems could result in unintended disclosure of, or unauthorized access to, third party, customer, vendor, employee or other confidential information, which could potentially result in additional costs and business disruption to us, including without limitation, to repair or replace damaged systems, enhance security or respond to occurrences, lost sales, violations of data privacy, security or other laws and regulations and subsequent penalties, fines, regulatory action or litigation. We also rely on third party-service providers for certain information technology systems, such as payment processing, and any data security breach at a third-party service provider could have similar effects. In addition, media or other reports of perceived security vulnerabilities to our systems or those of our third-party suppliers, even if no breach has been attempted or occurred, could adversely impact our brand and reputation, and customers could lose confidence in our security measures and reliability, which would harm our ability to retain customers and gain new ones. If any of these were to occur, it could have a material adverse effect on our business, financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are responsible for protecting employee and client health information. In the U.S., for example, we must comply with Americans with Disability Act requirements for confidential employee medical records, including that they must be stored separately from other personal records and access must be restricted to those who need access. With respect to customer health information</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there are a number of federal, state and provincial laws and regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protecting the confidentiality of certain customer health information, including customer records, and restricting the use and disclosure of that protected information. The privacy rules under the Personal Information Protection and Electronics Documents Act (Canada) (&#8220;PIPEDA&#8221;) protect medical records and other personal health information by limiting their use and disclosure of health information to the minimum level reasonably necessary to accomplish the intended purpose and apply to our operations globally. If we were to be found to be in violation of the privacy or security rules under PIPEDA or other applicable laws and regulations protecting the confidentiality of client health information in jurisdictions we operate in, we could be subject to sanctions and civil or criminal penalties, which could increase our liabilities, harm our reputation and have a material adverse effect on our business, results of operations and financial condition. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The jurisdictions in which we operate or which we may enter also have data privacy and security laws and regulations that govern the collection, use, disclosure, transfer, storage, disposal, and protection of personal information (such as the California </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumer Privacy Act (the &#8220;CCPA&#8221;) in California). In Canada, we may be required to retain certain customer personal information for prescribed periods of time pursuant to the Cannabis Act.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, several states, including California, Colorado, and Virginia, have passed laws and regulations, modeled on the E.U. GDPR, that will significantly impact data privacy and security requirements in the U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Privacy Rights Act (&#8220;CPRA&#8221;) imposes broad new requirements on companies covered</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by the legislation. Under the CPRA, California consumers (i.e., California residents) will have new and expanded rights, and businesses covered by the CPRA must disclose these rights to them. These new rights include, but are not limited to, a right of correction (i.e., the right to request that a business correct any inaccurate personal information about them), a right to limit the use and disclosure of &#8220;Sensitive Information&#8221; (a new category of personal information defined by the CPRA), a right to access information about automatic decision making used by the business, and a right to data portability (i.e., that a business transfer their personal information to another entity to the extent technically feasible). Enhanced rights for California consumers under the CPRA include, but are not limited to, expanded rights to know and access their personal information, expanded rights to delete their personal information, and an explicit requirement that California consumers have the right to opt-out of the sharing, in addition to the selling, of their personal information. Separately, the CPRA will codify the following GDPR-inspired requirements: (i) data minimization or the requirement that personal information collected by businesses be reasonably necessary and proportionate to achieve the purpose for which the personal information was collected, (ii) purpose limitation or the requirement that businesses only collect personal information for specific, explicit, and legitimate disclosed purposes that are disclosed in advance to California consumers, (iii) data retention limitations for personal information predicated on the length of time the business intends to retain each category of personal information, and (iv) reasonable data security requirements. Lastly, the CPRA provides for an expanded private right of action in the context of cybersecurity breaches and creates a designated privacy agency, the California Privacy Protection Agency (&#8220;CPPA&#8221;), with authority to implement and enforce the CCPA and CPRA.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While uncertain, the effects of the CCPA, the CPRA and other new state laws and regulations, as well as analogous laws and regulations in Canada (e.g., Bill 64 in Quebec), are potentially significant and may require us to modify our data collection or </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">processing practices and policies, incur substantial costs and expenses to comply with these laws and regulations, and increase our potential exposure to regulatory enforcement and/or litigation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interpretation and enforcement of such laws and regulations are uncertain and subject to change and may require substantial costs to monitor and implement compliance. Failure to comply with data privacy and protection laws and regulations could result in government enforcement actions (which could include substantial civil and/or criminal penalties), litigation, business disruption, the diversion of management&#8217;s attention and/or adverse publicity and could negatively affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our cannabis cultivation and U.S. hemp operations are subject to risks inherent in an agricultural business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and that of our joint venture partners involves the growing of cannabis, an agricultural product, in certain jurisdictions where that activity is permitted. As such, the business is subject to the risks inherent in the agricultural business, such as insects, plant diseases and similar agricultural risks that may create crop failures and supply interruptions for our customers. Although our current operational production facilities, and those of our joint venture partners, grow products indoors (including in greenhouses) under climate-controlled conditions and we and our joint venture partners carefully monitor the growing conditions with trained personnel, there can be no assurance that natural elements will not have a material adverse effect on the production of our products. To the extent we rely on third parties or our joint venture partners to grow cannabis that we intend to commercialize, we are exposed to similar risks and there can be no assurance that such risks will not have a similarly material adverse effect on the production of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business also involves products containing U.S. hemp. U.S. hemp is typically harvested in or around the month of October. U.S. hemp plants can be vulnerable to various pathogens including bacteria, fungi, viruses and other miscellaneous pathogens. Such instances often lead to reduced crop quality, stunted growth and/or death of the plant. Moreover, U.S. hemp is &#8220;phytoremediative&#8221; (meaning that it may extract toxins or other undesirable chemicals or compounds from the ground in which it is planted). Various regulatory agencies have established maximum limits for pathogens, toxins, chemicals and other compounds that may be present in agricultural materials. If U.S. hemp used in our products is found to have levels of pathogens, toxins, chemicals or other undesirable compounds that exceed limits permitted by applicable law, it may have to be destroyed. Should the U.S. hemp used in our products be lost due to pathogens, toxins, chemicals or other undesirable compounds, or if we or our suppliers are otherwise unable to obtain U.S. hemp for use in our products on an ongoing basis, it may have a material and adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The inability of our suppliers to meet their financial or contractual obligations to us may result in disruption to our supply chain and could result in financial losses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face exposure to our third party U.S. hemp and cannabis suppliers that may face financial difficulties which would impact our supply of U.S. hemp and cannabis products. For example, supply chains throughout the world have been negatively impacted by COVID-19 and this has increased the costs of products and shipping. We have in the past, and may in the future, have disruptions in our supply chain.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third party distributors to distribute our products, and those distributors may not perform their obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third party distributors and other courier services, and may in the future rely on other third parties, to distribute our products. If these distributors do not successfully carry out their contractual obligations or terminate or suspend their contractual arrangements with us, if there is a delay or interruption in the distribution of our products or if these third parties damage our products, it could negatively impact our revenue and may require significant management attention. In addition, any damage to our products due to acts or omissions of our third party distributors, such as product spoilage or improper storage or handling, could expose us to potential product liability, damage our reputation and the reputation of our products or brands or otherwise harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Intellectual Property</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to the protection and enforcement of our intellectual property rights, and we may be unable to protect or enforce our intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ownership and protection of our intellectual property rights is a significant aspect of our future success. Currently we rely on trade secrets, technical know-how, proprietary information, trademarks, copyrights, designs and certain patent filings to maintain our competitive position. We try to protect our intellectual property by strategically seeking and obtaining registered protection where appropriate, developing and implementing standard operating procedures to protect trade secrets, technical know-how and proprietary information, and entering into agreements with parties that have access to our inventions, trade secrets, technical know-how and proprietary information, such as our partners, collaborators, employees and consultants, to protect confidentiality and ownership. We also seek to preserve the integrity and confidentiality of our inventions, trade secrets, technical know-how and proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems, and we seek to protect our trademarks and the goodwill associated therewith by monitoring and enforcing against unauthorized use of our trademarks.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that we will inadvertently disclose or otherwise fail or be unable to protect our inventions, trade secrets, technical know-how or proprietary information, or will fail to identify our inventions or trademarks as patentable or registrable intellectual property, or fail to obtain patent or registered trademark protection therefor. Any such disclosure or failure could have a material adverse effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to protect our inventions, trade secrets, and other intellectual property from discovery or unauthorized use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to our agreements with parties that have access to our intellectual property, any of these parties may breach their obligations to us, and we may not have adequate remedies for such breach. In relation to our security measures, such security measures may be breached and we may not have adequate remedies for such breach. In addition, our intellectual property that has not yet been applied for or registered may otherwise become known to, or be independently developed by, competitors, or may already be the subject of applications for intellectual property registrations filed by our competitors, which may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot provide any assurances that our inventions, trade secrets, technical know-how and other proprietary information will not be disclosed in violation of agreements, or that competitors will not otherwise gain access to our intellectual property or independently develop and file applications for intellectual property rights in a manner that adversely impacts our intellectual property rights. Unauthorized parties may attempt to replicate or otherwise obtain and use our inventions, trade secrets, technical know-how and proprietary information. Policing the unauthorized use of our current or future intellectual property rights is difficult, expensive, time-consuming and unpredictable, as is enforcing these rights against unauthorized use by others. Identifying unauthorized use of intellectual property rights is difficult. For example, we may be unable to effectively monitor and evaluate the products being distributed by our competitors, including parties such as unlicensed dispensaries, and the processes used to produce such products. If the steps taken to identify and protect our trade secrets are inadequate, we may be unable to enforce our rights in them against third parties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property rights may be invalid or unenforceable under applicable laws, and we may be unable to have issued or registered, and unable to enforce, our intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws regarding intellectual property rights relating to cannabis and cannabis-related products, and the positions of intellectual property offices administering such laws, are constantly evolving, and there is uncertainty regarding which countries will permit the filing, prosecution, issuance, registration and enforcement of intellectual property rights relating to cannabis and cannabis-related products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, we have sought trademark protection in many countries, including Canada, the U.S. and others. Our ability to obtain registered trademark protection for cannabis and cannabis-related goods and services (including U.S. hemp and U.S. hemp-related goods and services) may be limited in certain countries outside of Canada, including the U.S., where registered federal trademark protection is currently unavailable for trademarks covering the sale of U.S. Schedule I cannabis products or certain goods containing U.S. hemp-derived CBD (such as dietary supplements and foods) until the FDA provides clearer guidance on the regulation of such products, and including Europe, where laws on the legality of cannabis use are not uniform, and trademarks cannot be obtained for products that are &#8220;contrary to public policy or accepted principles of morality.&#8221; Accordingly, our ability to obtain intellectual property rights or enforce intellectual property rights against third party uses of similar trademarks may be limited in certain countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, in any infringement proceeding, some or all of our current or future trademarks, patents or other intellectual property rights or other proprietary know-how, or arrangements or agreements seeking to protect the same for our benefit, may be found invalid, unenforceable, anti-competitive or not infringed. An adverse result in any litigation or defense proceedings could put one or more of our current or future trademarks, patents or other intellectual property rights at risk of being invalidated or interpreted narrowly and could put existing intellectual property applications at risk of not being issued. Any or all of these events could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no guarantee that any patent or other intellectual property applications that we file will result in registration or any enforceable intellectual property rights or the breadth of any such protection. Further, with respect to any patent applications that we file, there is no assurance that we will find all potentially relevant prior art relating to such applications, which may prevent a patent from issuing from such application or invalidate any patent that issues from such application. Even if patents do successfully issue, and cover our products and processes, third parties may challenge their validity, enforceability or scope, which may result in such patents being narrowed, found unenforceable or invalidated. Even if they are unchallenged, any patent applications and future patents may not adequately protect our intellectual property rights, provide exclusivity for our products or processes or prevent others from designing around any issued patent claims. Any of these outcomes could impair our ability to prevent competition from third parties, which could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to allegations that we are in violation of third-party intellectual property rights, and we may be found to infringe third-party intellectual property rights, possibly without the ability to obtain licenses necessary to use such third party intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other parties may claim that our products infringe on their intellectual property rights, including with respect to patents, and our operation of our business, including our development, manufacture and sale of our goods and services, may be found to infringe third party intellectual property rights. There may be third party patents or patent applications with claims to products or processes related to the manufacture, use or sale of our products and processes. There may be currently pending patent applications, some of which may still be confidential, that may later result in issued patents that our products or processes may infringe. In addition, third parties may obtain patents in the future and claim that use of our inventions, trade secrets, technical know-how and proprietary information, or the manufacture, use or sale of our products, infringes upon those patents. Third parties may also claim that our use of our trademarks infringes upon their trademark rights. Such claims, whether or not meritorious, may result in the expenditure of significant financial and managerial resources, legal fees, injunctions, temporary restraining orders, other equitable relief, and/or require the payment of damages, any or all of which may have an adverse impact on our business, financial condition and results of operations. In addition, we may need to obtain licenses from third parties who allege that we have infringed on their purported rights, whether or not such allegations have merit. Such licenses may not be available on terms acceptable to us, and we may be unable to obtain any licenses or other necessary or useful rights to such third-party intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our germplasm relies heavily on intellectual property, and we may be unable to protect, register or enforce our intellectual property rights in germplasm, and may infringe third-party intellectual property rights with respect to germplasm, possibly without the ability to obtain licenses necessary to use such third-party intellectual property rights. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Germplasm, including seeds, clones and cuttings, is the genetic material used in new cannabis varieties and hybrids. We use advanced breeding technologies to produce cannabis germplasm (hybrids and varieties). We rely on parental varieties for the success of our breeding program. Although we believe that the parental germplasm is proprietary to us, we may need to obtain licenses from third parties who may allege that we have appropriated their germplasm or their rights to such germplasm, whether or not such allegations have merit. Such licenses may not be available on terms acceptable to us, and we may be unable to obtain any licenses or other necessary or useful rights under third party intellectual property. We may seek to protect our parental germplasm, as appropriate, relying on intellectual property rights, including rights related to inventions (patents and plant breeders&#8217; rights), trade secrets, technical know-how, and proprietary information. There is a risk that we will fail to protect such germplasm or that we will fail to register rights in relation to such germplasm.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also seek to protect our parental germplasm, hybrids and varieties from pests and diseases and enhance plant productivity and fertility, and we research products to protect against crop pests and fungus. There are several reasons why new product concepts in these areas may be abandoned, including greater than anticipated development costs, technical difficulties, regulatory obstacles, competition, inability to prove the original concept, lack of demand and the need to divert focus, from time to time, to other initiatives. The processes of breeding, development and trait integration are lengthy, and the germplasm we test may not be selected for commercialization. The length of time and the risk associated with breeding may affect our business. Our sales depend, in part, on our germplasm. Commercial success frequently depends on being the first company to the market, and many of our competitors are also making considerable investments in similar new and improved cannabis germplasm products. Consequently, there is no assurance that we will successfully develop new cannabis germplasm to the point of commercial viability in the markets we serve on a timely basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, we seek to protect our germplasm, hybrids and varieties from accidental release, theft, misappropriation and sabotage by maintaining physical security of our premises and through contractual rights with our employees and certain of our suppliers, independent contractors, consultants and licensees. However, such security measures may be insufficient or breached, and our employees, independent contractors, consultants and licensees may engage in the inadvertent disclosure, theft, misappropriation or sabotage. We may not have adequate remedies in the case of any such security breach, inadvertent disclosure, theft, misappropriation or sabotage.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We receive licenses to use some third-party intellectual property rights; the failure of the owner of such intellectual property to properly maintain or enforce the intellectual property underlying such licenses, or our inability to obtain or maintain such licenses, could have a material adverse effect on our business, financial condition and performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to licenses granted by third parties, including through the Ginkgo Strategic Partnership, that give us rights to use third party intellectual property that is necessary or useful to our business. Our success will depend, in part, on the ability of the applicable licensor to maintain and enforce its licensed intellectual property against other third parties, particularly intellectual property rights to which we have secured exclusive rights. Without protection for the intellectual property we have licensed, other companies might be able to offer substantially similar products for sale or utilize substantially similar processes or publicity and marketing rights, any of which could have a material adverse effect on our business, financial condition and results of operations. Our success will also depend, in part, on our ability to obtain licenses to certain intellectual property that we believe are necessary or useful for our business. Such licenses may not be available on terms acceptable to us, or at all, which could adversely affect our ability to commercialize our products or services, as well as have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of our licensors may allege that we have breached our license agreements with those licensors, whether with or without merit, and accordingly seek to terminate our applicable licenses. If successful, this could result in our loss of the right to use applicable licensed intellectual property, which could adversely affect our ability to commercialize our products or services, as well as have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The technologies, process and formulations we use may face competition or become obsolete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rapidly changing markets, technology, emerging industry standards and frequent introduction of new products characterize our business. The introduction of new products embodying new technologies, including new manufacturing processes or formulations, and the emergence of new industry standards may render our products obsolete, less competitive or less marketable. The process of developing our products is complex and requires significant continuing costs, development efforts and third-party commitments, including licensees, researchers, and collaborators. Our failure to develop new technologies and products and the obsolescence of existing technologies or processes could adversely affect our business, financial condition and results of operations. We may be unable to anticipate changes in our potential customer preferences or requirements that could make our existing technology, processes or formulations obsolete. Our success will depend, in part, on our ability to continue to enhance our existing technologies, develop new technology that addresses the increasing sophistication and varied views of the market, and respond to technological advances and emerging industry standards and practices on a timely and cost-effective basis. The development of our proprietary technology, processes and formulations entails significant technical and business risks. We may not be successful in using our new technologies or exploiting our niche markets effectively or adapting our business to evolving customer requirements or preferences or emerging industry standards.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Entry into New Markets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controlled substance and other legislation and treaties may restrict or limit our ability to research, manufacture and develop a commercial market for our products outside of the jurisdictions in which we currently operate, and our expansion into such jurisdictions is subject to risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 250 substances, including cannabis, are listed in the Schedules annexed to the UN Single Convention on Narcotic Drugs (New York, 1961), the Convention on Psychotropic Substances (Vienna, 1971) and the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (introducing control on precursors) (Vienna, 1988). The purpose of these listings is to control and limit the use of these drugs according to a classification of their therapeutic value, risk of abuse and health dangers, and to minimize the diversion of precursor chemicals to illegal drug manufacturers. The 1961 UN Single Convention on Narcotic Drugs, as amended in 1972 classifies cannabis as a Schedule I (&#8220;substances with addictive properties, presenting a serious risk of abuse&#8221;) narcotic drug. In December 2020, the Commission on Narcotic Drugs voted to remove cannabis from Schedule IV (&#8220;the most dangerous substances, already listed in Schedule I, which are particularly harmful and of extremely limited medical or therapeutic value&#8221;). The 1971 UN Convention on Psychotropic Substances classifies THC as a Schedule I psychotropic substance (substances presenting a high risk of abuse, posing a particularly serious threat to public health which are of very little or no therapeutic value). Many countries are parties to these conventions, which govern international trade and domestic control of these substances, including cannabis. They may interpret and implement their obligations in a way that creates legal obstacles to our obtaining manufacturing and/or marketing approval for our products in those countries. These countries may not be willing or able to amend or otherwise modify their laws and regulations to permit our products to be manufactured and/or marketed, and achieving such amendments to the laws and regulations may take a prolonged period of time. There can be no assurance that any market for our products will develop in any jurisdiction in which we do not currently have operations. We may face new or unexpected risks or significantly increase our exposure to one or more existing risk factors, including economic instability, political instability, changes in laws and regulations and the effects of competition. These factors may limit our capability to successfully expand our operations into such jurisdictions and may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments and joint ventures outside of Canada and the U.S. are subject to the risks normally associated with any conduct of business in foreign countries, including varying degrees of political, legal, regulatory and economic risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much of our exposure to markets in jurisdictions outside of Canada and the U.S. is through investments and joint ventures. These investments and joint ventures are subject to the risks normally associated with any conduct of business in foreign and/or emerging countries including political risks; civil disturbance risks; changes in laws, regulations or policies of particular countries, including those relating to royalties, duties, imports, exports and currency; the cancellation or renegotiation of contracts; the imposition of royalties, net profits payments, tax increases or other claims by government entities, including retroactive claims; a disregard for due process and the rule of law by local courts; the risk of expropriation and nationalization; delays in obtaining or the inability to obtain necessary governmental permits or the reimbursement of refundable tax from fiscal authorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Threats or instability in a country caused by political events including elections, change in government, changes in personnel or legislative bodies, foreign relations or military control present serious political and social risk and instability causing interruptions to the flow of business negotiations and influencing relationships with government officials. Changes in policy or law may have a material adverse effect on our business, financial condition and results of operations. The risks include increased &#8220;unpaid&#8221; state participation, higher energy costs, higher taxation levels and potential expropriation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other risks include the potential for fraud and corruption by suppliers or personnel or government officials which may implicate us, compliance with applicable anti-corruption laws and regulations, including the U.S. Foreign Corrupt Practices Act and the Corruption of Foreign Public Officials Act (Canada), by virtue of our or our joint ventures operating in jurisdictions that may be vulnerable to the possibility of bribery, collusion, kickbacks, theft, improper commissions, facilitation payments, conflicts of interest and related party transactions and our or our joint ventures&#8217; possible failure to identify, manage and mitigate instances of fraud, corruption or violations of our Code of Business Conduct and Ethics and applicable regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also the risk of increased disclosure requirements; currency fluctuations; restrictions on the ability of local operating companies to hold Canadian dollars, U.S. dollars or other foreign currencies in offshore bank accounts; import and export restrictions; increased regulatory requirements and restrictions; increased health-related regulations; limitations on the repatriation of earnings or on our ability to assist in minimizing our expatriate workforce&#8217;s exposure to double taxation in both the home and host jurisdictions; and increased financing costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks may limit or disrupt our joint ventures, strategic alliances or investments, restrict the movement of funds, cause us to have to expend more funds than previously expected or required or result in the deprivation of contract rights or the taking of property by nationalization or expropriation without fair compensation, and may materially adversely affect our business, financial position and/or results of operations. In addition, the enforcement by us of our legal rights in foreign countries, including rights to exploit our properties or utilize our permits and licenses and contractual rights may not be recognized by the court systems in such foreign countries or enforced in accordance with the rule of law.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently do, and may in the future, invest in companies, or engage in joint ventures, in countries with developing economies. It is difficult to predict the future political, social and economic direction of the countries in which we or our joint ventures operate, and the impact government decisions may have on our business. Any political or economic instability in the countries in which we operate could have a material and adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Regulation and Compliance</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in highly regulated sectors where the regulatory environment is rapidly developing, and we may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where we carry on business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and activities are heavily regulated in all jurisdictions where we carry on business. Our operations are subject to various laws, regulations and guidelines by governmental authorities (including, in Canada, Health Canada and other federal, provincial and local regulatory agencies and, in the U.S., the FDA, the USDA, CDPH, DEA, PTO and FTC and other federal and state agencies) relating to the cultivation, manufacture, processing, marketing, labeling, packaging, management, transportation, distribution, import, export, storage, sale, pricing and disposal of cannabis and U.S. hemp, and also including laws, regulations and guidelines relating to health and safety, insurance coverage, the conduct of operations and the protection of the environment (including relating to emissions and discharges to water, air and land, and the handling and disposal of hazardous and non-hazardous materials and wastes). Our operations may also be affected in varying degrees by government regulations with respect to, among other things, price controls, import or export controls, controls on currency remittance, increased income taxes, restrictions on foreign investment and government policies rewarding contracts to local competitors or requiring domestic producers or vendors to purchase supplies from a particular jurisdiction. Laws, regulations and guidelines, applied generally, grant government agencies and self-regulatory bodies broad administrative discretion over our activities, including the power to limit or restrict business activities as well as impose additional disclosure requirements on our products and services, as well as on our personnel (including management and our board of directors). </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achievement of our business objectives is contingent, in part, upon compliance with regulatory requirements enacted by these governmental authorities and obtaining all necessary regulatory approvals for the cultivation, production, processing storage, transportation, distribution, sale, import and export, as applicable, of our products. The cannabis and U.S. hemp industries are still new, and in Canada in particular, the Cannabis Act is a new regime that has no close precedent in Canadian law. Similarly, the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory regimes in the jurisdictions in which we and our joint ventures operate outside of the U.S. and Canada are new and are still being developed without close precedent in such jurisdictions. The effect of relevant governmental authorities&#8217; administration, application and enforcement of their respective regulatory regimes and delays in obtaining, or failure to obtain, necessary regulatory approvals may significantly delay or impact the development of markets, products and sales initiatives and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory environment for our products is rapidly developing, and the need to build and maintain robust systems to comply with different and changing regulations in multiple jurisdictions increases the possibility that we may violate one or more applicable requirements. While we endeavor to comply with all relevant laws, regulations and guidelines, any failure to comply with the regulatory requirements applicable to our operations could subject us to negative consequences, including, but not limited to, civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, asset seizures, revocation or imposition of additional conditions on licenses to operate our business, the denial of regulatory applications (including, in the U.S., by other regulatory regimes that rely on the positions of the DEA and FDA in the application of their respective regimes), the suspension or expulsion from a particular market or jurisdiction of our key personnel, or the imposition of additional or more stringent inspection, testing and reporting requirements, any of which could materially adversely affect our business, financial condition and results of operations. Additionally, scheduled or unscheduled inspections of our facilities or facilities of our joint ventures or third-party suppliers by applicable regulatory agencies could result in adverse findings that could require significant remediation efforts and/or temporary or permanent shutdown of our facilities or those of our joint ventures or third-party suppliers. In the U.S., failure to comply with FDA requirements (and analogous state agencies) may result in, among other things, injunctions, product withdrawals, recalls, product seizures, fines and criminal prosecutions. The outcome of any regulatory or agency proceedings, investigations, inspections, audits, and other contingencies could harm our reputation, require us to take, or refrain from taking, actions that could harm our operations or require us to pay substantial amounts of money, harming our results of operations, financial condition and cash flows. There can be no assurance that any pending or future regulatory or agency proceedings, investigations, inspections and audits will not result in substantial costs or a diversion of management&#8217;s attention and resources, negatively impact our future growth plans and opportunities or have a material adverse impact on our business, financial condition and results of operations. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#8217;s U.S. hemp business activities are found to be in violation of any of U.S. federal, state or local laws or any other governmental regulations, in addition to the items described above: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company may be subject to &#8220;Warning Letters,&#8221; fines, penalties, administrative sanctions, settlements, injunctions, product recalls and/or other enforcement actions arising from civil, administrative or other proceedings initiated that could adversely affect the Company&#8217;s business, financial condition, operating results, liquidity, cash flow and operational performance; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the profits or revenues derived therefrom could be subject to anti-money laundering statutes, including the Money Laundering Control Act, which could result in significant disruption to our U.S. hemp business operations and involve significant costs, expenses or other penalties; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s suppliers, service providers and distributors may elect, at any time, to breach, terminate or otherwise cease to participate in supply, service or distribution agreements, or other relationships, on which the Company&#8217;s operations rely.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to U.S. Schedule I cannabis, in the U.S., despite cannabis possession and use having been legalized at the state level for medical use in many states and for adult-use in a number of states, marijuana as defined by the CSA continues to be categorized as a Schedule I controlled substance under the CSA and subject to the Controlled Substances Import and Export Act (&#8220;CSIEA&#8221;). Although we do not engage in any activities related to marijuana as defined by the CSA in the U.S., violations of any U.S. federal laws and regulations, including the CSA and the CSIEA, whether intentional or inadvertent, could result in civil, criminal and/or administrative enforcement actions, which could result in fines, penalties, and other sanctions, including but not limited to, cessation of business activities. Additionally, U.S. border officials could deny entry into the U.S. to those employed at or investing in legal and licensed non-U.S. cannabis companies and such persons could face detention, denial of entry or lifetime bans from the U.S. for their business associations with cannabis businesses.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our joint ventures and strategic investments are reliant on required licenses, authorizations, approvals and permits for our ability to grow, process, store and sell cannabis, U.S. hemp and cannabinoids which are subject to ongoing compliance, reporting and renewal requirements, and we may also be required to obtain additional licenses, authorizations, approvals and permits in connection with our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to grow, process, store and sell cannabis in Canada is dependent on our licenses from Health Canada, and in particular the licenses currently held by Peace Naturals, Cronos Fermentation and Cronos GrowCo. Failure to comply with the requirements of the licenses or failure to maintain the licenses would have a material adverse impact on our business, financial condition and results of operations. Although we believe Peace Naturals, Cronos Fermentation and Cronos GrowCo will meet the requirements of the Cannabis Act for their licenses, there can be no guarantee that Health Canada will extend or renew the licenses or, if they are extended or renewed, that they will be extended or renewed on the same or similar terms or that Health Canada will not revoke the licenses. Should we fail to comply with requirements of the licenses, should Health Canada not extend or renew the licenses, should they be renewed on different terms (including not allowing for anticipated capacity increases) or should the licenses be revoked or suspended, our business, financial condition and results of the operations will be materially adversely affected. To the extent we apply for any additional licenses from Health Canada, there can be no assurance that such licenses will be granted or, if granted, that they will be granted on commercially reasonable terms or within the time period we expect, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to grow, process, store and sell cannabis in Israel is dependent on maintaining our cannabis cultivation, production and distribution licenses and our ability to export products to, or import products from, Cronos Israel is also dependent on obtaining the relevant permits. Cronos GrowCo&#8217;s ability to grow, process, store and sell cannabis at its production facility depends on obtaining and maintaining the appropriate licenses from Health Canada. Should we or our joint ventures fail to comply with the requirements of the licenses, or should they not be extended or renewed by the applicable regulatory authorities, or should they be renewed on different terms (including not allowing for anticipated capacity increases) or should the licenses be revoked, the business, financial condition and results of our and our joint ventures&#8217; operations will be materially adversely affected. There is no assurance that we or our joint ventures will be able to obtain necessary permits or licenses on commercially reasonable terms or within expected time periods, if at all. Moreover, the change in the nature of operations at the Peace Naturals Campus will increase the importance of the licenses of Cronos GrowCo for our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Ginkgo&#8217;s ability to conduct certain R&amp;D activities in the U.S. under the Ginkgo Collaboration Agreement is conditional on Ginkgo continuing to maintain all necessary licenses, permits and approvals required for Ginkgo to perform such R&amp;D activities. There are no assurances that Ginkgo will be able to maintain required licenses, permits and approvals and, to the extent such licenses, permits and approvals are not maintained, we may not realize the expected benefits of the Ginkgo Strategic Partnership. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained a processed food registration from CDPH and may also be required to obtain and maintain certain permits, licenses and approvals in the jurisdictions where we source, process, or sell products derived from U.S. hemp. We may be unable to obtain or maintain any necessary licenses, permits or approvals. Additional government licenses are currently, and in the future, may be, required in connection with our operations, in addition to other unknown permits and approvals which may be required. To the extent such permits, and approvals are required and not obtained, we may be prevented from operating and/or expanding our business, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the laws, regulations and guidelines governing cannabis and U.S. hemp may adversely impact our business.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current operations are subject to various laws, regulations and guidelines promulgated by governmental authorities (including, in Canada, Health Canada and other federal, provincial and local regulatory agencies and, in the U.S., the FDA, the USDA, CDPH, DEA, FTC and PTO and other federal and state agencies) relating to the cultivation, processing, marketing, acquisition, manufacture, packaging/labeling, management, transportation, distribution, import, export, storage, sale and disposal of cannabis or U.S. hemp but also including laws and regulations relating to health and safety, the conduct of operations and the protection of the environment. Additionally, our growth strategy continues to evolve as regulations governing the cannabis industry in the jurisdictions other than Canada and the U.S. in which we and our joint ventures operate become more fully developed. Interpretation of these laws, rules and regulations and their application to our operations and those of our joint ventures is ongoing. No assurance can be given that new laws, regulations and guidelines will not be enacted or that existing laws, regulations and guidelines will not be amended, repealed or interpreted or applied in a manner which could require extensive changes to our operations, increase compliance costs, give rise to material liabilities or a revocation of our licenses and other permits, restrict the growth opportunities that we currently anticipate or otherwise limit or curtail our operations. For example, the Cannabis Act requires the Canadian federal government to conduct a review of the Cannabis Act after three years, which commenced in September 2022. The scope of this statutory review includes, among other things, consideration of (i) the administration and operation of the Cannabis Act, (ii) the impact of the Cannabis Act on public health, (iii) the health and consumption habits of young persons, (iv) the impact of cannabis on Indigenous persons and communities and (v) the impact of cultivation of cannabis plants in a dwelling-house. This report resulting from the statutory review may recommend and/or lead to the amendment, removal or addition of provisions in or to the Cannabis Act which could adversely affect our business. Amendments to current laws, regulations and guidelines governing the production, sale and use of cannabis and cannabis-based products, more stringent implementation or enforcement thereof or other unanticipated events, including changes in political regimes or political instability, currency controls, fluctuations in currency exchange rates and rates of inflation, labor unrest, changes in taxation laws, regulations and policies, restrictions on foreign exchange and repatriation, governmental regulations relating to foreign investment and the cannabis business more generally, and changes in attitudes toward cannabis, are beyond our control and could require extensive changes to our operations, which in turn may result in a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the production of cannabis in Canada, among other things, is under the regulatory oversight of the federal government of Canada, the distribution and retail sale of adult-use cannabis in Canada falls within the jurisdiction of the provincial and territorial governments. The impact of the legislation regulating adult-use cannabis passed in the provinces and territories on the cannabis industry and our business plans and operations is uncertain. Provinces and territories have announced certain restrictions that are more stringent than the federal rules or regulations such as retail sale and marketing restrictions, bans on certain types of cannabis products, raising minimum age of purchase and flavor restrictions. For example, Qu&#233;bec and Prince Edward Island do not currently permit sales of cannabis vaporizers, and Qu&#233;bec limits the sale of other high THC non-edible cannabis products. In addition, the distribution and retail channels and applicable rules and regulations in the provinces continue to evolve, and our ability to distribute and retail cannabis products in Canada is dependent on the ability of the provinces and territories of Canada to establish licensed retail networks and outlets. There is no guarantee that the applicable legislation regulating the distribution and sale of cannabis for adult-use purposes will allow for the growth opportunities we currently anticipate and may result in a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, additional countries continue to pass laws with respect to the production and distribution of cannabis in some form or another. We have subsidiaries, investments, joint ventures and strategic alliances in place outside of the U.S. and Canada, which may be affected if more countries legalize cannabis. Increased international competition and limitations placed on us by Canadian regulations might lower the demand for our products on a global scale. We also face competition in each jurisdiction outside of the U.S. and Canada where we have subsidiaries, investments, joint ventures and strategic alliances with local companies that have more experience, more in-depth knowledge of local markets or applicable laws, regulations and guidelines or longer operating histories in such jurisdictions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to certain restrictions of the TSX and Nasdaq, which may constrain our ability to expand our business internationally.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are listed on the TSX and Nasdaq. We must comply with the TSX and Nasdaq requirements or guidelines when conducting business.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 16, 2017, the TSX provided clarity regarding the application of Section 306 (Minimum Listing Requirements), Section 325 (Management) and Part VII (Halting of Trading, Suspension and Delisting of Securities) of the TSX Company Manual (collectively, the &#8220;Requirements&#8221;) to TSX-listed issuers with business activities in the cannabis sector. In TSX Staff Notice 2017- 0009, the TSX notes that issuers with ongoing business activities that violate U.S. federal law regarding U.S. Schedule I cannabis are not in compliance with the Requirements. The TSX reminded issuers that, among other things, should the TSX find that a listed issuer is engaging in activities contrary to the Requirements, the TSX has the discretion to initiate a delisting review. Although we do not conduct any operations in the U.S. with respect to U.S. Schedule I cannabis, failure to comply with the Requirements could result in a delisting of our common shares from the TSX or the denial of an application for certain approvals, such as to have additional securities listed on the TSX, which could have a material adverse effect on the trading price of our common shares and have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Nasdaq has not issued official rules specific to the cannabis or U.S. hemp industry, stock exchanges in the U.S., including Nasdaq, have historically refused to list certain U.S. Schedule I cannabis related businesses, including U.S. Schedule I cannabis retailers, that operate primarily in the U.S. Failure to comply with any requirements imposed by Nasdaq could result in the delisting of our common shares from Nasdaq or denial of any application to have additional securities listed on Nasdaq which could have a material adverse effect on the trading price of our common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are constrained by law in our ability to market and advertise our products.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing and advertising are subject to regulation by various regulatory bodies in the jurisdictions we operate. In Canada, the development of our business and related results of operations may be hindered by applicable regulatory restrictions on sales and marketing activities. For example, the regulatory environment in Canada limits our ability to compete for market share in a manner similar to other industries. Furthermore, the applicable regulatory restrictions on sales and marketing activities are not always clear, may be subject to interpretation and have in the past, and may in the future, be interpreted or applied inconsistently by the applicable Canadian regulatory agencies, which have broad interpretative and enforcement discretion with respect to such activities. This may result in such restrictions on sales and marketing activities being interpreted unfavorably by a regulatory agency against some market participants, including us, but not others. Furthermore, if our competitors fail to comply with applicable laws relating to sales and marketing activities with which we comply, and regulatory agencies delay or do not take enforcement action against such competitors, or take sporadic enforcement action, our ability to compete for market share and our sales and results of operations could be adversely affected. If we are unable to effectively market our products and compete for market share in Canada, or if the costs of compliance with government legislation and regulation cannot be absorbed through increased selling prices for our products, our sales and results of operations could be adversely affected. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business &#8211;Regulatory Framework in Canada.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., our advertising is subject to regulation by the FTC under the Federal Trade Commission Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as well as the FDA under the FFDCA, including as amended by the Dietary Supplement Health and Education Act of 1994, and by state agencies under analogous and similar state and local laws and regulations. In recent years, the FTC, the FDA and state agencies have initiated numerous investigations of food and dietary supplement products both because of their CBD and/or cannabinoid content and based on allegedly deceptive or misleading marketing claims and have, on occasion, issued &#8220;Warning Letters&#8221; or instituted enforcement actions due to such claims. Some U.S. states also permit content, advertising and labeling laws and regulations to be enforced by state attorneys general, who may seek civil and criminal penalties, relief for consumers, class action certifications, class wide damages and recalls of products sold by us. There has also been an increase in private litigation that seeks, among other things, relief for consumers, class action certifications, class wide damages and recalls of products. We have been subject to such litigation and may be subject to additional private class action litigation. Any actions against us by governmental authorities or private litigants could have a material and adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to U.S. Regulation and Compliance </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to uncertainty regarding the legal and regulatory status of U.S. hemp, including with respect to U.S. federal and state implementation of the 2018 Farm Bill and related laws and regulations, including the FFDCA, and the interpretation or application of, or changes to, such laws and regulations may have material and adverse effects on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2018, the 2018 Farm Bill was signed into law. The 2018 Farm Bill, among other things, removes &#8220;hemp&#8221; (which we refer to as &#8220;U.S. hemp&#8221; in this Annual Report, defined as the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a THC concentration of not more than 0.3% on a dry weight basis and its derivatives) from the U.S. federal Controlled Substances Act and amends the Agricultural Marketing Act of 1946 to permit the production and sale of U.S. hemp in the U.S. The 2018 Farm Bill tasked the USDA with promulgating regulations in relation to the cultivation and production of U.S. hemp. The 2018 Farm Bill also directed the USDA to promulgate federal regulations that would apply to the production of U.S. hemp in every state which does not put forth a state U.S. hemp plan for approval by the USDA, for which the USDA has issued final rules. Beginning in January 2024, the USDA will require hemp producers to use a laboratory that is registered with the DEA for analytical testing of hemp plants. The USDA rules also include provisions for producers to dispose of or remediate violative hemp plants without the use of a DEA-registered reverse distributor or law enforcement. Various states have applied and are in the process of applying to the USDA for approval of their U.S. hemp production regulations which impose different levels of regulation and costs on the production of U.S. hemp, and many such state plans have been approved by the USDA. The 2018 Farm Bill provides that its provisions do not preempt or limit state laws that regulate the production of U.S. hemp. Accordingly, some states may choose to restrict or prohibit some or all U.S. hemp production or sales within the state, and variances in states&#8217; laws and regulations on U.S. hemp are likely to persist. Further, each state has discretion to develop and implement its own laws and regulations governing the manufacturing, marketing, labeling, and sale of U.S. hemp products, which has created a patchwork of different regulatory schemes applicable to such products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA or particular states may ultimately prohibit the sale of some or all dietary supplements or conventional foods containing U.S. hemp and U.S. hemp-derived ingredients, including CBD and other cannabinoids, and we may be required to submit a New Dietary Ingredient notification to the FDA, which may not be accepted without objection.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2018 Farm Bill, the FDA has retained authority over the FFDCA-regulated products (e.g., drugs (human and animal), food (human and animal), dietary supplements and cosmetics) containing U.S. hemp and U.S. hemp-derived ingredients, including CBD. The FDA has consistently taken the position that CBD, whether derived from U.S. hemp or U.S. Schedule I cannabis, is prohibited from use as an ingredient in food and dietary supplements. This stems from its interpretation of the exclusionary clauses in the FFDCA because CBD is the active ingredient in a drug that has been approved as a prescription drug and is the subject of substantial clinical investigations as a drug, which have been made public. The exclusionary clauses under the FFDCA provide that a substance that has been approved or has been subject to substantial clinical investigations as a drug may not be used in a food or dietary supplement, unless the substance was first marketed in a food or dietary supplement prior to the initiation of substantial clinical investigations of the substance as a drug.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the FDA has not issued regulations that elaborate on the exclusionary clauses, and the FDA has not taken any enforcement action in the courts asserting a violation of the exclusionary clauses due to the marketing of U.S. hemp, U.S. hemp extracts, CBD or other cannabinoids. Additionally, on January 26, 2023, the FDA stated its views publicly that a new regulatory pathway for CBD is needed and it is prepared to work with Congress to create such a pathway. To date, the FDA has issued several &#8220;Warning Letters&#8221; to companies unlawfully marketing CBD products. In many of these cases, the manufacturer made unsubstantiated claims about the product being able to treat medical conditions (e.g., cancer, Alzheimer&#8217;s disease, opioid withdrawal, anxiety and COVID-19) and had not obtained drug approvals. Some of these letters were co-signed with the FTC and cited the companies for making claims about the efficacy of CBD or other ingredients which were not substantiated by competent and reliable scientific evidence. In December 2020, the FTC announced it had entered into settlement agreements with six companies marketing CBD products including oils, gummies, creams, and others with deceptive health claims about serious health conditions. The settlements included monetary penalties ranging from $20,000 to $85,000. The FTC announced another CBD enforcement action and settlement in May 2021, ordering more than $30,000 in consumer redress. The FDA has also issued a &#8220;Warning Letter&#8221; to at least one dietary supplement manufacturer for a number of violations observed during an inspection, including manufacturing CBD supplements in a licensed facility. In November 2022, the FDA issued &#8220;Warning Letters&#8221; to five additional companies selling CBD-products in forms that the FDA asserted are appealing to children, including gummies, hard candies and cookies. These letters also outlined additional violations of the FFDCA including that several of the companies made claims that CBD-containing products cure, mitigate, treat or prevent various diseases or were added to animal foods.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the FDA formally adopts regulations with respect to CBD or other U.S. hemp-derived cannabinoid products or announces an official position with respect to CBD or other U.S. hemp-derived cannabinoid products, there is a risk that the FDA could take enforcement action (e.g., a &#8220;Warning Letter,&#8221; seizure, or injunction) against the Company in respect of its U.S. hemp-derived products sold in the U.S.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, states have retained regulatory authority through their own analogues to the FFDCA, and the states may diverge from the federal treatment of the use of U.S. hemp as, or in, food, dietary supplements or cosmetic products. The FDA or applicable states (under their CSA or FFDCA analogues) may ultimately not permit the sale of non-pharmaceutical products containing U.S. hemp-derived ingredients, including CBD and other cannabinoids, which would have a material adverse impact on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the exclusionary clause issue discussed above is resolved in a manner favorable to us, we could be required to submit a NDIN to the FDA with respect to U.S. hemp-derived ingredients, including CBD and other cannabinoids we intend to include in our products, used in dietary supplement products. This could depend on whether we can establish that a particular ingredient was marketed as a dietary ingredient in a dietary supplement prior to October 15, 1994 or is otherwise currently in the food supply in the same chemical form as used in our dietary supplement products. If the FDA objects to our NDIN, this could prevent us from producing, marketing and selling ingestible U.S. hemp products which would have a material adverse impact on our business, financial condition and results of operations. Such an NDIN submitted by one of our competitors was objected to by the FDA in August 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA or particular U.S. states may seek to regulate our cosmetic products containing U.S. hemp-derived ingredients, including CBD and other cannabinoids, as drugs, medical devices, or drug-device combination products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may seek to regulate our cosmetic products containing U.S. hemp-derived ingredients, including CBD and other cannabinoids, under its authorities for medical products (i.e., drugs, medical devices, or drug-device combination products). Specifically, the agency could assert that our lotions, oils, balms and creams are intended for use in diagnosing, treating, mitigating or preventing disease or for use in affecting the structure or any function of the body. In making classification decisions, the agency considers a wide variety of factors to determine a product&#8217;s intended use; indeed, the FDA has sometimes asserted that a product qualifies as a drug based solely on the presence of an ingredient widely understood to have drug effects, even in the absence of express claims about them. Though we do not market our lotions, oils, balms and creams as drugs for use in the treatment of diseases or their symptoms, the FDA could still assert that the products are intended for use as drugs, including based on the understood or presumed physical effects of topically administered cannabinoids. Thus, we may not have the ability to successfully respond to such allegations simply by modifying labeling or advertising claims. Ultimately, if the FDA asserts one of its medical product authorities over our lotion, oil, balm and cream products, and we cannot or elect not to comply with the onerous regulatory requirements applicable to the asserted medical product category (e.g., drug), we could be prevented from producing, marketing and selling cosmetic products containing U.S. hemp-derived ingredients, including CBD or other cannabinoids. In addition, states may similarly seek to regulate our cosmetic products containing U.S. hemp-derived ingredients, including CBD and other cannabinoids, as medical products (i.e., drugs, medical devices, or drug-device combination products) under state analogues to the FFDCA or otherwise. States have also considered and established additional restrictions on, or requirements for, the marketing of cosmetic products containing U.S. hemp-derived ingredients. If states assert their medical product authorities over our cosmetic products containing U.S. hemp-derived ingredients, including CBD or other cannabinoids, in a manner that we cannot address simply by modifying labeling or advertising claims, and we cannot or elect not to comply with the onerous regulatory requirements applicable to the asserted medical product category (e.g., drug), we could be prevented from producing, marketing and selling cosmetic products containing U.S. hemp-derived ingredients, including CBD and other cannabinoids. Likewise, if states enforce or adopt regulatory interpretations or restrictions that limit our ability to market our cosmetic products containing U.S. hemp-derived ingredients, including CBD and other cannabinoids, in such states, it could materially and adversely affect our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent U.S. legislation granting the FDA additional authority to regulate cosmetics products imposes additional requirements relating to the manufacture, labeling, safety reporting, recordkeeping, and other aspects of cosmetics products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with these additional requirements will be complex and we may need significant additional resources to comply with these new requirements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2022, President Biden signed into law the Modernization of Cosmetics Regulation Act of 2022, which significantly expands FDA&#8217;s enforcement authorities over cosmetics products and imposes new obligations on the cosmetics industry, including requirements relating to GMP, labeling, safety substantiation, facility registration and product listing with the FDA, adverse event reporting and recordkeeping, among others.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the new legislation, the FDA is required over the next several years to issue additional regulations and reports to clarify requirements. Most enforcement of requirements under the new legislation will not go into effect until a year or later from the date of enactment; however, we expect that regulation of our cosmetic products in the U.S. will become increasingly complex, and compliance with regulatory requirements may take significant additional resources.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The DEA could take enforcement action against us or other participants in the U.S. hemp industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is substantial uncertainty concerning the legal status of U.S. hemp and U.S. hemp products containing U.S. hemp-derived ingredients, including CBD and other cannabinoids. The status of products derived from the cannabis or hemp plant, under both federal and state law can depend on the THC content of the plant or derivative (including whether the plant meets the statutory definition of &#8220;industrial hemp&#8221; or &#8220;hemp&#8221;), the part of the plant from which an individual or entity produces the derivative (including whether the plant meets the statutory definition of &#8220;marihuana&#8221; under the CSA), the THC concentration during the manufacturing process, whether the cultivator, processor, manufacturer or product marketer engages in cannabis-related activities for research versus purely commercial purposes, as well as the form and intended use of the product. The mere presence of a cannabinoid (such as CBD) is not dispositive as to whether the product is legal or illegal. Under U.S. federal law, products containing CBD may be unlawful if derived from U.S. Schedule I cannabis (including hemp with a concentration greater than 0.3% THC on a dry weight basis), or if derived from U.S. hemp grown outside the parameters of an approved U.S. hemp pilot program or U.S. hemp cultivated in violation of the 2018 Farm Bill. Even after enactment of the 2018 Farm Bill, the DEA may not treat all products containing U.S. hemp-derived ingredients, including CBD and other cannabinoids, as exempt from the CSA. In September 2020, the DEA issued an interim final rule that purported to align the DEA&#8217;s regulations with the statutory changes to the CSA made effective by the 2018 Farm Bill. The DEA received a number of comments objecting to the interim final rule, and the interim final rule has been the subject of litigation. However, the litigation was dismissed by the D.C. Circuit Court in June 2022. If the DEA takes action against us or other participants in the U.S. hemp industry, this could have a material and adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is continuing uncertainty regarding the FDA&#8217;s potential position on CBG and other cannabinoids.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CBG is a cannabinoid that can be lawfully derived from U.S. hemp and the Company has begun and plans to continue developing products with CBG and other rare cannabinoids (i.e., cannabinoids other than THC and CBD). The 2018 Farm Bill preserved the FDA&#8217;s authority over U.S. hemp-derived consumer products and to date, the FDA has provided no guidance as to how cannabinoids other than CBD will be regulated under the FFDCA. Future regulatory changes or enforcement actions by the FDA, with respect to CBG or other U.S. hemp-derived cannabinoids, could have a materially adverse impact on our business, financial condition, results of operations or prospects.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Competition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The markets in which we operate are increasingly competitive, and we may compete for market share with other companies, both domestically and internationally, that may have longer operating histories and more financial resources, manufacturing and marketing experience than us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets for cannabis and U.S. hemp are competitive and evolving and we face strong competition from both existing and emerging companies that offer similar products. Some of our current and potential competitors may have longer operating histories, greater financial, marketing and other resources and larger customer bases than we have. In addition, there is potential that the cannabis and U.S. hemp industries will undergo consolidation, creating larger companies with financial resources, manufacturing and marketing capabilities and product offerings that are greater than ours. As a result of this competition, we may be unable to maintain our operations or develop them as currently proposed on terms we consider acceptable, or at all. Increased competition by larger, better-financed competitors with geographic advantages could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the rapid changes affecting global, national and regional economies generally, and the U.S. hemp industry in particular, we may not be able to create and maintain a competitive advantage in the marketplace. Our success will depend on our ability to respond to, among other things, changes in the economy, regulatory conditions, market conditions and competitive pressures. Any failure by us to anticipate or respond adequately to such changes could have a material and adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Canada, the number of licenses granted by Health Canada could also have an impact on our operations. We expect to face additional competition from new market entrants that are granted licenses under the Cannabis Act or existing license holders which are not yet active in the industry. If a significant number of new licenses are granted by Health Canada in the near term, we may experience increased competition for market share and may experience downward price pressure on our products as new entrants increase production. If the number of users of cannabis in Canada increases, the demand for products will increase and we expect that competition will become more intense, as current and future competitors begin to offer an increasing number of diversified products. To remain competitive, we will require a continued high level of investment in R&amp;D, sales and customer support. We may not have sufficient resources to maintain R&amp;D, sales and customer support efforts on a competitive basis which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, the Canadian federal authorization of home cultivation, outdoor grow, and the easing of other barriers to entry to the Canadian adult-use cannabis market, could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the number of competitors in the U.S. hemp industry has increased significantly in recent years and is expected to continue to increase, which could negatively impact our market share and demand for our products. Additionally, if the U.S. takes steps to legalize U.S. Schedule I cannabis, the impact of such a development could result in new entrants into the market and increased levels of competition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face competition from the illegal cannabis market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition from illegal market operators that are unlicensed and unregulated. As these illegal market participants do not comply with the regulations governing the cannabis industry, their operations may also have significantly lower costs and they may be able to sell products with significantly higher cannabinoid potencies or which include ingredients that are prohibited by law. The perpetuation of the illegal market for cannabis may have a material adverse effect on our business, results of operations, financial condition as well as the perception of cannabis use. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have been and may in the future be required to write down inventory due to downward pressure on market prices, which could have a material adverse effect on our results of operations or financial position. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of each reporting period, management performs an assessment of inventory obsolescence, prices and demand to measure inventory at the lower of cost and net realizable value. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. We also consider factors such as slow-moving or non-marketable products in our determination of obsolescence. As a result of this assessment, inventory write-downs may occur from period to period. Due to continued pricing pressures in the Canadian marketplace, we may incur further inventory write-downs in the future.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have had a series of inventory write-downs due to price compression in the cannabis market. We expect these write-downs to continue as pricing pressures remain elevated. These inventory write-downs have in the past and may in the future materially adversely affect our results of operations and financial position. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to attract or retain skilled labor and personnel with experience in the cannabis or U.S. hemp sector and may be unable to attract, develop and retain additional employees required for our operations and future developments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to attract or retain employees with sufficient experience in the cannabis or U.S. hemp industry, and may prove unable to attract, develop and retain additional employees required for our development and future success.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is currently largely dependent on the performance of our skilled employees. Our future success depends on our continuing ability to attract, develop, motivate and retain highly qualified and skilled employees. Qualified individuals are in high demand, and we may incur significant costs to attract and retain them. In 2022, we announced a Realignment to, among other things, centralize functions under common leadership to increase efficient distribution of resources, optimize collaboration and strategic alignment and eliminate duplication of roles and costs, including a reduction in headcount impacting a number of employees. The Realignment could lead to increased attrition amongst those employees who were not directly affected by the reduction in headcount, and we may not be successful at retaining such employees or attracting new employees, which may have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, certain shareholders, directors, officers and employees in our Canadian operations may require security clearance from Health Canada or require analogous clearance by various provincial agencies. Under the Cannabis Act, a security clearance cannot be valid for more than five years and must be renewed before the expiry of a current security clearance. There is no assurance that any of our existing personnel who presently or may in the future require a security clearance will be able to obtain or renew such clearances or that new personnel who require a security clearance will be able to obtain one. A failure by any of our existing personnel to maintain or renew his or her security clearance may impair our business operations. In addition, if an employee with security clearance leaves and we are unable to find a suitable replacement who has a security clearance required by the Cannabis Act in a timely manner, or at all, there could occur a material adverse effect on our business operations. Similar risks and potential effects apply to analogous security clearances required by various provincial agencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to the Altria Investment</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Altria has significant influence over us following closing of the Altria Investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria is our single largest shareholder. As of December 31, 2022, Altria beneficially owned approximately 41% of our issued and outstanding common shares (calculated on a non-diluted basis). In light of such ownership, Altria is in a position to exercise significant influence over matters affecting shareholders or requiring shareholder approval, including the election of the Board, amendments to our articles and the determination of significant corporate actions. In addition, pursuant to the Investor Rights Agreement, Altria has certain rights, including the right to nominate a specified number of directors to the Board, approval rights over certain Company actions and pre-emptive and top-up rights entitling Altria to maintain its pro rata beneficial ownership in us. Further, as of the date hereof, four of the seven directors on the Board are Altria Nominees. For more information, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business -Altria Strategic Investment &#8211; Investor Rights Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, Altria currently has significant influence over us. There can be no assurance that Altria&#8217;s interests will align with our interests or the interests of other shareholders. In addition, such influence could limit the price that an acquirer might be willing to pay in the future for our common shares and it may have the effect of delaying or preventing a change of control of us, such as a merger or take-over.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have discretion in the use of net proceeds from the Altria Investment and may not use them effectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Subscription Agreement, we have discretion in the use of net proceeds from the Altria Investment, subject to our obligation to consult with Altria, in certain circumstances, seek the approval of Altria (such approval not to be unreasonably conditioned, withheld or delayed) and certain other limitations regarding the use of net proceeds set forth in the Subscription Agreement. Accordingly, shareholders may not agree with the manner in which management chooses to allocate and spend the net proceeds. Our failure to apply the funds effectively could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have cash on hand, including short-term investments, of approximately $878&#160;million as of December 31, 2022. There can be no assurance that we will be able to deploy the available cash in an effective manner that is accretive to us, or at all. Until such time as we are able to deploy the cash available to us, we anticipate holding the net proceeds as cash balances in our bank accounts, investing in certificates of deposit and other instruments issued by banks or obligations of or guaranteed by the Government of Canada or any province thereof, or investing in U.S. Treasury securities or other obligations issued or guaranteed by the U.S. Government, its agencies or instrumentalities. Based on the level of current interest rates, we will not earn any material revenue from such invested cash.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize the benefits of our strategic partnership with Altria, which could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the strategic partnership between us and Altria provides us with additional financial resources, product development and commercialization capabilities, and deep regulatory expertise to better position us to compete, scale and lead the rapidly growing global cannabis industry. We believe that the growth opportunities for us are significant and could extend across the globe as new markets open. With Altria&#8217;s resources, we expect to be even better positioned to support cannabinoid innovation, create differentiated products and brands across medical and adult-use categories and expand our global footprint and growing production capacity. Nevertheless, a number of risks and uncertainties are associated with the expansion into such markets and the pursuit of these other growth opportunities. The successful implementation of the Altria Investment is critical to our growth and capital position. The failure to successfully implement or reap the anticipated benefits of Altria&#8217;s resources and expertise to realize growth and expansion opportunities could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Altria&#8217;s significant interest in us may impact the liquidity of our common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares may be less liquid and trade at a discount relative to the trading that could occur in circumstances where Altria did not have the ability to significantly influence or determine matters affecting us. Additionally, Altria&#8217;s significant voting interest in us may discourage transactions involving a change of control of us, including transactions in which an investor, as a shareholder, might otherwise receive a premium for its common shares over the then-current market price.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales of our common shares by Altria could cause the market price for our common shares to fall.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of our common shares by Altria could occur at any time. Such sales, or the market perception of such sales, could significantly reduce the market price of our common shares. We cannot predict the effect, if any, that future public sales of our common shares beneficially owned by Altria or the availability of these common shares for sale will have on the market price of our common shares. If the market price of our common shares were to drop as a result, this might impede our ability to raise additional capital and might cause a significant decline in the value of the investments of our other shareholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intentions of Altria regarding its long-term economic ownership of our common shares are subject to change as a result of changes in the circumstances of Altria or its affiliates, changes in our management and operation and changes in laws and regulations, market conditions and our financial performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conflicts of interest may arise between us and our directors and officers, including as a result of the continuing involvement of certain of our directors with Altria and its affiliates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to various potential conflicts of interest because of the fact that some of our directors and officers may be engaged in a range of business activities, or have relationships with or are employed by Altria. One of our directors, Jason Adler, is the co-founder and Managing Member of Gotham Green Partners, a private equity firm focused primarily on early-stage investing in companies in the cannabis industry, and Michael Gorenstein, our Chairman, President, and Chief Executive Officer, is a co-founder and non-managing Member of Gotham Green Partners. Three of our directors, Jody Begley, Murray Garnick and Heather Newman, are employed by Altria as Executive Vice President and Chief Operating Officer, Executive Vice President and General Counsel, and Senior Vice President, Corporate Strategy, respectively. As a result of these relationships, conflicts of interests may arise between us and them, as described below.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also become involved in other transactions that are inconsistent or conflict with the interests of our directors and officers, and/or our directors and officers may have interests in persons, firms, institutions, corporations or transactions that are inconsistent or in conflict with our interests and those of our shareholders. In addition, from time to time, Gotham Green Partners or Altria may be competing with us for available investment opportunities. Conflicts of interest, if any, will be subject to the procedures and remedies provided under applicable laws and regulations. In particular, in the event that such a conflict of interest arises at a meeting of our directors, a director who has such a conflict will abstain from voting for or against the approval of the transaction and may recuse himself or herself from any related discussion or deliberation. In accordance with applicable laws and regulations, our directors are required to act honestly, in good faith and in our best interests.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Common Shares</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It is not anticipated that any dividend will be paid to holders of our common shares for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No dividends on our common shares have been paid to date. We currently intend to retain future earnings, if any, for future operation and expansion. Any decision to declare and pay dividends in the future will be made at the discretion of the Board and will depend on, among other things, financial results, cash requirements, contractual restrictions and other factors that the Board may deem relevant. Any changes to our policy with respect to the declaration and payment of any dividends requires Altria&#8217;s approval. As a result, investors may not receive any return on an investment in our common shares unless they sell their shares for a price greater than that which such investors paid for them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price for our common shares may be volatile and subject to fluctuation in response to numerous factors, many of which are beyond our control.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price for our common shares may be volatile and subject to wide fluctuations in response to many factors, including:</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our results of operations;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in estimates of our future results of operations by us or securities research analysts;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the economic performance or market valuations of other companies that investors deem comparable to us;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of our executive officers and other key personnel;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our restating financial results twice in the last four years;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of additional common shares or the perception in the market that such sales might occur;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant acquisitions or business combinations, strategic partnerships, investments, joint ventures or capital commitments by or involving us or our competitors;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in speculative trading activity by investors targeting publicly traded cannabis companies, which can further contribute to the volatility of the market price for our common shares if aggregate short exposure exceeds the number of our common shares available for purchase;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">news reports relating to trends, concerns or competitive developments, regulatory changes or enforcement actions and other related issues in our industry or target markets;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prospect of actual or perceived future changes to the legal and regulatory regimes that govern our products and our industries;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investors&#8217; general perception of us and the public&#8217;s reaction to our press releases, our other public announcements and our filings with the SEC and Canadian securities regulators;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to timely file our public filings with the SEC and Canadian securities regulators;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to comply with the Nasdaq and TSX rules and potential trading halts or delisting notices;</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reports by industry analysts, investor perceptions, and market rumors or speculation; and</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative announcements by our customers, competitors or suppliers regarding their own performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, reports by industry analysts, investor perceptions, market rumors or speculation could trigger a sell-off in our common shares. Any sales of substantial numbers of our common shares in the public market or the perception that such sales might occur may cause the market price of our common shares to decline. In addition, to the extent that other large companies within our industries experience declines in their stock price, the price of our common shares may decline as well. Moreover, if the market price of our common shares drops significantly, shareholders may institute securities class action lawsuits against us. Lawsuits against us could cause us to incur substantial costs and could divert the time and attention of our management and other resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities markets continue to experience significant price and volume fluctuations that have, in some cases, been unrelated to the operating performance, underlying asset values or prospects of public companies. Accordingly, the market price of our common shares may decline even if our results of operations, underlying asset values or prospects have not changed. In addition, certain institutional investors may base their investment decisions on consideration of our environmental, governance, diversity and social practices and performance against such institutions&#8217; respective investment guidelines and criteria, and failure to meet such criteria may result in limited or no investment in our common shares by those institutions, which could adversely affect the trading price of our common shares. There can be no assurance that continuing fluctuations in price and volume will not occur. If such increased levels of volatility and market turmoil continue, the trading price of the common shares may be adversely affected.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities class action litigation often has been brought against companies following periods of volatility in the market price of their securities. We have been the target of such litigation and may in the future be the target of similar litigation. Regardless of merit, such litigation could result in substantial costs and damages and divert management&#8217;s attention and resources, which could adversely affect our business. Any adverse determination in litigation against us could also subject us to significant liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require additional capital in the future or be required to issue common shares pursuant to certain of our agreements, which may dilute holders of our securities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to issue additional common shares pursuant to the Ginkgo Collaboration Agreement. Pursuant to the Ginkgo Collaboration Agreement, upon Ginkgo&#8217;s demonstration that the microorganisms they develop are capable of producing certain target cannabinoids above a minimum productivity level, we will issue to Ginkgo up to approximately 14.7&#160;million common shares in the aggregate. To date, we have issued approximately 7.1&#160;million common shares to Ginkgo in respect of certain Equity Milestone Events that have occurred. Additional tranches of common shares will be issued if and when additional Equity Milestone Events are reached. The issuance of such common shares, if any, would dilute holders of our common shares. In addition, Altria has pre-emptive rights to subscribe for additional common shares in us following any issuances we make to Ginkgo pursuant to the Ginkgo Collaboration Agreement, and the issuance of such common shares, if any, would further dilute holders of our common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of common shares will have no pre-emptive rights in connection with such further issuances. Our Board has the discretion to determine if an issuance of common shares is warranted, the price at which such issuance is effected and the other terms of issue of common shares. Any additional capital raised through the sale of equity will dilute the percentage of ownership of holders of our common shares. Capital raised through debt financing would require us to make periodic interest payments and may impose restrictive covenants on the conduct of our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A substantial number of our securities are owned by a limited number of existing shareholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, directors and employees own a substantial number of our outstanding common shares (on a fully diluted basis). In addition, as of December 31, 2022, Altria beneficially owned approximately 41% of our outstanding common shares (calculated on a non-diluted basis). As such, our management, directors and employees, as a group, and Altria each are in a position to exercise significant influence over matters requiring shareholder approval, including the election of directors and the determination of significant corporate actions. In addition, these shareholders could delay or prevent a change in control that could otherwise be beneficial to holders of common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investors in the U.S. may have difficulty bringing actions and enforcing judgments against us and others based on securities law civil liability provisions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are incorporated under the laws of the Province of British Columbia and our head office is located in the Province of Ontario. Some of our directors and officers and some of the experts named in this Annual Report are residents of Canada or otherwise reside outside of the U.S., and a substantial portion of their assets and our assets are located outside the U.S. Consequently, it may be difficult for investors in the U.S. to bring an action against such directors, officers or experts or to enforce against those persons or us a judgment obtained in a U.S. court predicated upon the civil liability provisions of U.S. federal securities laws or other laws of the U.S. In addition, while statutory provisions exist in British Columbia for derivative actions to be brought in certain circumstances, the circumstances in which a derivative action may be brought, and the procedures and defenses that may be available in respect of any such action, may be different than those of shareholders of a company incorporated in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are a passive foreign investment company for U.S. federal income tax purposes in any year, certain adverse tax rules could apply to U.S. holders of our common shares. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be classified as a passive foreign investment company (&#8220;PFIC&#8221;) for any taxable year for U.S. federal income tax purposes if for a taxable year, (i) 75% or more of our gross income is passive income, or (ii) 50% or more of the value of our assets either produce passive income or are held for the production of passive income, based on the quarterly average of the fair market value of such assets. The determination of PFIC status depends on interpretive rules and computational conventions that are often unclear. In particular, in making our determination, we are relying on the application of certain &#8220;look-through&#8221; rules, taking into account certain intercompany items. There is, however, no direct legal authority applying these look-through rules to our particular situation (including to what extent, they apply to intercompany items). Likewise, in light of the volatility of our common share price, we intend to take the position that the spot trading price of our stock at each quarter end, as adjusted by liabilities, does not dictate the determination of the fair market value of our assets. Based on current business plans and financial expectations, an independent valuation report in respect of our assets, and the application of certain look-through rules (including the taking into account of certain intercompany items), we do not expect to be a PFIC for the taxable year ending December 31, 2023. However, PFIC status is determined annually and depends upon the composition of our gross income and assets, both of which are subject to change. Moreover, there can be no assurance that the Internal Revenue Service (&#8220;IRS&#8221;) or a court will agree with our interpretation of fair market value or its computation, or with our interpretation of the PFIC rules (including the &#8220;look-through&#8221; rules and the scope of their application, including in respect of intercompany items). Therefore, there can be no assurance as to our PFIC status for the current taxable year or for future taxable years, nor any assurance that the IRS or a court will agree with our determination of our PFIC status.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research about our business, our share price and trading volume could decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common shares depends, in part, on the research and reports that securities or industry analysts publish about us or our business. If one or more of the analysts who cover us downgrade our common shares or publish inaccurate or unfavorable research about our business, the trading price of our common shares would likely decline. In addition, if our results of operations fail to meet the forecasts of analysts, the trading price of our common shares would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common shares could decrease, which might cause our trading price and trading volume to decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on our senior management.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is dependent upon the ability, expertise, judgment, discretion and good faith of our senior management. While employment agreements are customarily used as a primary method of retaining the services of key employees, these agreements cannot assure the continued services of our senior management team. Qualified individuals are in high demand, and we may incur significant costs to attract and retain them. The loss of the services of a member of senior management, or an inability to attract other suitably qualified persons when needed, could have a material adverse effect on our ability to execute on our business plan and strategy, and we may be unable to find adequate replacements on a timely basis, or at all. We do not maintain key-person insurance on the lives of any of our officers or employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will seek to maintain adequate insurance coverage in respect of the risks we face; however, insurance premiums for such insurance may not continue to be commercially justifiable, and there may be coverage limitations and other exclusions which may not be sufficient to cover our potential liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have insurance to protect our assets, operations and employees. While we believe our insurance coverage addresses all material risks to which we are exposed in our current state of operations, such insurance is subject to deductibles, coverage limits and exclusions and may not be available or adequate for the risks and hazards to which we are exposed. For example, certain wholesalers, distributors, retailers and other service providers may require suppliers of U.S. hemp products to provide an indemnification from liability in connection with such products, which may not be covered by insurance. In addition, no assurance can be given that such insurance will be adequate to cover our liabilities or will be generally available in the future or, if available, that premiums and deductibles will be commercially justifiable. If we were to incur substantial liability claims and such damages were not covered by insurance or were in excess of policy limits, or if we were to incur such liability at a time when we are not able to obtain liability insurance, there could be a material adverse effect on our business, financial condition and results of operations. Furthermore, our insurers have in the past and may in the future deny us coverage, whether or not such denial is with merit, and we have in the past and may in the future need to commence litigation against such insurers, which could be time consuming and expensive and divert significant management resources, with no assurance that we will be successful in any resulting proceedings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax and accounting requirements may be interpreted or changed in ways that are complex and not necessarily anticipated by us, and we may face difficulty or be unable to implement and/or comply with any such interpretations or changes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous tax and accounting requirements, and changes in existing accounting or taxation rules or practices, or varying interpretations of current rules or practices, could have a significant adverse effect on our financial results, the manner in which we conduct our business or the marketability of any of our products. In many countries, including the U.S., we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported as earned and are taxed accordingly. Although we believe that we are in substantial compliance with all applicable regulations and restrictions, we are subject to the risk that governmental authorities could audit our transfer pricing and related practices and assert that additional taxes are owed or that various jurisdictions could assert that we should file tax returns in jurisdictions where we do not file and subject us to additional tax. In the future, the geographic scope of our business may expand, and such expansion will require us to comply with the tax laws and regulations of additional jurisdictions. Requirements as to taxation vary substantially among jurisdictions. Complying with the tax laws and regulations of these jurisdictions can be time consuming and expensive and could potentially subject us to penalties and fees in the future if we failed to comply. In the event that we failed to comply with applicable tax laws and regulations, this could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business and results of operations have been adversely affected and will likely continue to be materially adversely impacted by the coronavirus pandemic (COVID-19).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has in the past, and could in the future, severely restrict the level of economic activity around the world and in all countries in which we or our affiliates, investments and joint ventures operate (including the U.S., Canada, and Israel). In response to the COVID-19 pandemic the governments of many countries, states, provinces, municipalities, and other geographic regions took preventative or protective actions, such as imposing restrictions on travel and business operations, ordering temporary closures of businesses and advising or requiring individuals to limit or forego their time outside of their homes. Although many preventative or protective actions have been eased or lifted in varying degrees by different governments of various countries, states and municipalities, the situation remains dynamic and subject to rapid and possibly material changes. Notwithstanding widespread </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vaccine availability within Canada, the U.S. and Israel, the emergence of COVID-19 variants and slowing vaccination rates in certain localities have resulted in increased infection rates and has caused, and may continue to cause, several jurisdictions to reinstitute certain COVID-19 restrictions. Additional waves of increased COVID-19 infections as well as COVID-19 related restrictions imposed by various governmental authorities (including, for example, requirements to show proof of vaccination), could negatively impact our supply chain, as well as traffic and sales volume for retailers offering the Company&#8217;s products, which in turn could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further effects of the COVID-19 pandemic and any emerging COVID-19 variants could include closures of our or our joint ventures&#8217; facilities or the facilities of our suppliers and other vendors in our supply chain and other preventive and protective measures in our supply chain. If the pandemic persists, including if and when new variants of the virus emerge, closures or other restrictions on the conduct of business operations of our joint ventures, third party manufacturers, suppliers or vendors could disrupt our supply chain. We have experienced minor delays in shipping and the increased global demand on shipping and transport services, in addition to customs and border control policies put in place in response to COVID-19 that require shipments to undergo quarantine periods, may cause us to experience delays or increased costs in the future which could impact our ability to obtain materials or deliver our products in a timely manner, could otherwise disrupt our operations and could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global impact of the COVID-19 pandemic continues to evolve, and the extent of its effect on our operational and financial performance will depend on future developments, which are highly uncertain, including the duration, scope and severity of the pandemic, the development and availability of effective treatments and vaccines, further actions taken by governments and other third parties to contain or mitigate its impact, the direct and indirect economic effects of the pandemic and related containment measures, and new information that will emerge concerning the severity and impact of COVID-19 and new variants of the virus, among others. Even after the COVID-19 pandemic subsides, our businesses could also be negatively impacted should the effects of the COVID-19 pandemic lead to changes in consumer behavior, including as a result of a decline in the level of vaping or demand for inhalable products in light of certain recent published articles and studies on the potential increased susceptibility of individuals who smoke or vaporize nicotine or cannabis to COVID-19, in light of changes in consumer behavior such as reduced spending on certain product formats historically used in shared experiences such as pre-rolls or in reductions in discretionary spending.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Natural disasters, unusual weather, pandemic outbreaks, boycotts and geo-political events or acts of terrorism could adversely affect our operations and financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of one or more natural disasters, such as hurricanes, floods and earthquakes, unusually adverse weather, pandemic outbreaks, such as the COVID-19 virus, influenza and other highly communicable diseases or viruses, boycotts and geo-political events, such as civil unrest in countries in which our or our joint ventures&#8217; operations are located and acts of terrorism, or similar disruptions could adversely affect our business, financial condition and results of operations. These events could result in physical damage to one or more of our or our joint ventures&#8217; properties, increases in fuel or other energy prices, the temporary or permanent closure of one or more of our or our joint ventures&#8217; facilities, the temporary lack of an adequate workforce in a market, the temporary or long-term disruption in the supply of products from suppliers, the temporary disruption in the transport of goods, delay in the delivery of goods to our or our joint ventures&#8217; facilities, and disruption to our information systems. Such events could also negatively impact consumer sentiment, reduce demand for consumer products like ours and cause general economic slowdown. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our business is subject to evolving corporate governance and public disclosure regulations and expectations, including with respect to environmental, social and governance matters, that could expose us to numerous risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to changing rules and regulations promulgated by a number of governmental and self-regulatory organizations, including the SEC, Nasdaq and the Financial Accounting Standards Board. These rules and regulations continue to evolve in scope and complexity. In addition, increasingly regulators, customers, investors, employees and other stakeholders are focusing on environmental, social and governance (&#8220;ESG&#8221;) matters and related disclosures. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. For example, developing and acting on initiatives within the scope of ESG, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collecting, measuring and reporting ESG related information and metrics can be costly, difficult and time consuming and is subject to evolving reporting standards, including the SEC&#8217;s recently proposed climate-related reporting requirements, and similar proposals by other international regulatory bodies. We may also communicate certain initiatives and goals, regarding environmental matters, diversity, responsible sourcing and social investments and other ESG related matters, in our SEC filings or in other public disclosures. These initiatives and goals within the scope of ESG could be difficult and expensive to implement, the technologies needed to implement them may not be cost effective and may not advance at a sufficient pace, and we could be criticized for the accuracy, adequacy or completeness of the disclosure. Further, statements about our ESG related initiatives and goals, and progress against those goals, may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. In addition, we could be criticized for the scope or nature of such initiatives or goals, or for any revisions to these goals. If our ESG-related data, processes and reporting are incomplete or inaccurate, or if we fail to achieve progress with respect to our initiatives or goals within the scope of ESG on a timely basis, or at all, our reputation, business, financial performance and growth could be adversely affected.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Climate change may disrupt our business and our efforts to address concerns relating to climate change could result in damage to our reputation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and that of our joint venture partners involves the growing of cannabis, an agricultural product, and adverse weather conditions have historically caused volatility in the agricultural industry and consequently in operating results by causing crop failures or significantly reduced harvests, which may negatively affect the supply and pricing of agricultural commodities, such as cannabis. Additionally, the potential physical impacts of climate change are uncertain and may vary by region. These potential effects could include changes in rainfall patterns, water shortages, changing sea levels, changing storm patterns and intensities, and changing temperature levels that could adversely impact our costs and business operations, the location, costs, and competitiveness of cannabis production and related storage and processing facilities and the supply of cannabis.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to risks resulting from changes in public policy, laws and regulations, or market and public perceptions and preferences in connection with the transition to a less carbon-dependent economy. These changes could adversely affect our business, results of operations and reputation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial performance is subject to risks of foreign exchange rate fluctuation, which could result in foreign exchange losses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be exposed to fluctuations of the U.S. dollar against certain other currencies, particularly the Canadian dollar, because we publish our financial statements in U.S. dollars, while a significant portion of our assets, liabilities, revenues and costs are or will be denominated in other currencies. Exchange rates for currencies of the countries in which we operate may fluctuate in relation to the U.S. dollar, and such fluctuations may have a material adverse effect on our earnings or assets when translating foreign currency into U.S. dollars.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business, financial condition, results of operations and cash flows could be adversely affected by disruptions in the global economy caused by the ongoing conflict between Russia and Ukraine.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global economy has been negatively impacted by the military conflict between Russia and Ukraine. Furthermore, governments in the U.S., Canada, United Kingdom, and European Union have each imposed export controls on certain products and financial and economic sanctions on certain industry sectors and parties in Russia. Although we do not have any customers or direct supplier relationships in Russia or Ukraine, businesses in the United States and globally have experienced shortages in materials and increased costs for transportation, energy, and raw material due in part to the negative impact of the Russia-Ukraine military conflict on the global economy. Further escalation of geopolitical tensions related to the military conflict, including increased trade barriers or restrictions on global trade, could result in, among other things, cyberattacks, supply disruptions, lower consumer demand, and changes to foreign exchange rates and financial markets, any of which may adversely affect our business, financial condition, results of operations and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to monitor the situation in Ukraine and globally and assessing its potential impact on our business. Although our business has not been, to the date of this Annual Report, materially impacted by the ongoing military conflict in Ukraine, it is impossible to predict the extent to which our operations, or those of our suppliers and vendors, will be impacted in the short and long term, or the ways in which the conflict may impact our business. The extent and duration of the military action, sanctions and resulting market disruptions are impossible to predict, but may be substantial. In addition, the effects of the ongoing conflict could heighten any of our known risks described above.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_19"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_22"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive offices are located in Toronto, Ontario in Canada, where we lease office space. As of December 31, 2022, our Rest of World segment owned various manufacturing facilities in the Canadian provinces of Manitoba and Ontario, and in Hadera, Israel. As of December 31, 2022, our United States segment leased office space and manufacturing facilities in Los Angeles, California. Management believes that our existing facilities are adequate to meet our current requirements and, to the extent that our facilities are leased, comparable space is readily available.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_25"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these legal proceedings, individually or in the aggregate, will have a material adverse effect on its consolidated financial condition but could be material to its results of operations for any particular reporting period depending, in part, on its results for that period. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class action complaints relating to restatement of 2019 interim financial statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its former Chief Executive Officer (now Executive Chairman) and now former Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were incorrect based on the Company&#8217;s disclosures relating to the Audit Committee of the Board&#8217;s review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names (i) the Company, (ii) its former Chief Executive Officer (now Executive Chairman), (iii) now former Chief Financial Officer, (iv) former Chief Financial Officer and Chief Commercial Officer, and (v) current and former members of the Board as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#8217;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. On June 28, 2021, the Court dismissed motions brought by the plaintiff for leave to commence a claim for misrepresentation under the Ontario Securities Act and for certification of the action as a class action. The plaintiff has appealed the Court&#8217;s dismissal of the motions only with respect to the Company, the former Chief Executive Officer (now Executive Chairman), and the now former Chief Financial Officer; the remaining defendants were dismissed from the matter with prejudice and the Company and all individual defendants agreed not to seek costs from plaintiff in connection with the dismissal of the motions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2022, the Court of Appeal for Ontario reversed the Superior Court&#8217;s dismissal of the leave and certification motions, granted the plaintiff leave to proceed to bring a claim for misrepresentation under the Ontario Securities Act, and remitted the certification motion back to the Superior Court.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory reviews relating to restatement</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously responded to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019 as well as the previously disclosed restatement of the second quarter of 2021 interim financial statements (collectively, the &#8220;Restatements&#8221;). On October 24, 2022, the Company announced settlements with those regulatory authorities as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">SEC Settlement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2022, the SEC issued an Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8(a) of the Securities Act of 1933 (the &#8220;Securities Act&#8221;) and Section 21(c) of the Exchange Act, Making Findings, and Imposing a Cease-and-Desist Order (the &#8220;Settlement Order&#8221;) resolving the Restatements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company agreed to settle with the SEC, without admitting or denying the allegations described in the Settlement Order. The Settlement Order fully and finally disposes of the investigation of the Company by the SEC into the Restatements without the payment of any civil penalty or other amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Order required the Company to cease and desist from committing or causing any violations and any future violations of Section 17(a) of the Securities Act, Sections 10(b), 13(a), 13(b)(2)(B) of the Exchange Act and Rules 10b-5, 13a-13, 13a-15(a), 13a-16 and 12b-20 thereunder. Additionally, the Company agreed to certain undertakings, which include, among other things, retaining a qualified independent consultant (the &#8220;Consultant&#8221;) to engage in a review of, and make recommendations with respect to, certain of the Company&#8217;s internal accounting controls and internal control over financing reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Settlement Order, the Company (i) lost its status as a well-known seasoned issuer for a period of three years, (ii) is unable to rely on the private offering exemptions provided by Regulations A and D under the Securities Act for a period of five years and (iii) is unable to rely on the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 for a period of three years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Ontario Securities Commission Settlement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2022, the Ontario Capital Markets Tribunal approved a settlement agreement (the &#8220;Settlement Agreement&#8221;) between the Company and the staff of the Ontario Securities Commission (&#8220;OSC&#8221;), resolving the Restatements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Settlement Agreement, which fully and finally disposes the investigation of the Company by the OSC, Cronos agreed to pay a total of C$1.34 million to fully settle the matter, and acknowledged that it had failed to comply with the requirement under Section 77 of the Securities Act (Ontario) to file interim financial reports in the manner set out therein and had acted in a manner contrary to the public interest. Additionally, the Company agreed to retain the Consultant to engage in a review of, and make recommendations with respect to, certain of the Company&#8217;s internal accounting controls and internal control over financing reporting, on substantially the same terms as were required by the SEC pursuant the Settlement Order.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation relating to marketing, distribution and sale of products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of King&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$500 million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5 million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of the Claim. On January 31, 2022, upon consent of the Company and the plaintiffs, the court dismissed the case in its entirety as to the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California&#8217;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#8217;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Annual Report, the plaintiff has not refiled the complaint.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect litigation and regulatory proceedings relating to the marketing, distribution and sale of our products to increase.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_28"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURE. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_31"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i228e12b34e804aa096affae69dd6b9af_34"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are traded on Nasdaq and the TSX under the symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;24, 2023, there were approximately 107 holders of record of our common shares. This number of holders of record does not represent the actual number of beneficial owners of our common shares because shares are frequently held in &#8220;street name&#8221; by securities dealers and others for the benefit of individual owners who have the right to vote their shares. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Annual Report, we have not declared any dividends or made any distributions on our common shares. Furthermore, we have no current intention to declare dividends on our common shares in the foreseeable future. Any decision to pay dividends on our common shares in the future will be at the discretion of the Board and will depend on, among other things, our results of operations, current and anticipated cash requirements and surplus, financial condition, any future contractual restrictions and financing agreement covenants, our ability to meet solvency tests imposed by corporate law and other factors that the Board may deem relevant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning securities authorized for issuance under equity compensation plans will be set forth in the Company&#8217;s definitive proxy statement for its 2023 Annual Meeting of Shareholders or an amendment to this Annual Report to be filed within 120 days of our fiscal year end.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Persons</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following performance graph compares the cumulative total shareholder return of our common shares as listed on Nasdaq with the cumulative total return of the S&amp;P 500 Index and a market-weighted index of publicly traded peers over the 58-month period beginning on February 27, 2018 and ending on December 31, 2022. The new peer group includes Aurora Cannabis Inc., Canopy Growth Corporation, Green Thumb Industries, Inc., HEXO Corporation, Organigram Holdings Inc., Tilray Inc., and Trulieve Cannabis Corp., (the &#8220;New Peer Group&#8221;). The graph assumes that $100 is invested in each of our common shares, the S&amp;P 500 Index, and the indices of publicly traded peers on February 27, 2018 and that all dividends, if applicable, were reinvested. Past performance may not be indicative of future performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The old peer group included Aurora Cannabis Inc., Canopy Growth Corporation, Green Thumb Industries, Inc., HEXO Corporation, iAnthus Capital Holdings Inc., Organigram Holdings Inc., and Tilray Inc. (the &#8220;Old Peer Group&#8221;). iAnthus Capital Holdings Inc. was removed from the New Peer Group and replaced with Trulieve Cannabis Corp. to better align the New Peer Group, as iAnthus Capital Holdings Inc.&#8217;s share price has fallen to a nominal value.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img src="cron-20221231_g4.jpg" alt="cron-20221231_g4.jpg" style="height:396px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Old Peer Group</span></td><td colspan="3" style="border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">New Peer Group</span></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2018</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88.32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.22&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.36&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85.56</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.81&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.53&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.42&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">145.93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.76&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.90&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.39&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.61&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">241.86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.71&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.34&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.52&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209.71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.13&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.63&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118.77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.99&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.19&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.09&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.79&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74.41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.27&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.45&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.12&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78.87</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.66&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.99&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.30&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.33&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.71&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.18&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.43&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.65&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.21&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.99&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.50&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112.86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.47&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.52&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.35&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74.28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.25&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.72&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51.44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.14&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.17&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.49&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.70&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.89&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.59&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.66&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.59&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.24&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.13&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.14&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33.33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.07&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.00&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.88&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*$100 invested on 2/27/18 in stock or 2/28/18 in index, including reinvestment of dividends. Fiscal year ending December 31.<br/>Copyright&#169; 2022 Standard &amp; Poor&#8217;s, a division of S&amp;P Global. All rights reserved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_37"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. RESERVED</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_40"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.6pt;font-weight:700;line-height:120%">ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_43">Business Overview</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_43">54</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_46">Recent Developments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_46">55</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_49">Consolidated Results of Operations</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_49">57</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_52">Summary of financial results </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_52">&#8211;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_52"> ROW</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_52">61</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_55">Summary of financial results &#8211; </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_55">U.S.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_55">62</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_61">Non-G</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_61">AAP Measures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_61">62</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_58">Liquidity and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_58">67</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_64">Critical Accounting Estimates</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_64">68</a></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations is provided as a supplement to, and should be read in conjunction with, the consolidated financial statements and related notes, which are included in Item 8 of this Annual Report on Form 10-K (this &#8220;Annual Report&#8221;), to enhance the understanding of our operations and our present business environment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion contains Forward-Looking Statements that involve risks and uncertainties. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information about our operations and the risks facing our business, see Item 1 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and Item 1A &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, respectively, of this Annual Report.</span></div><div id="i228e12b34e804aa096affae69dd6b9af_43"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos&#8217; diverse international brand portfolio includes Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted or the context indicates otherwise, references in this Annual Report to the &#8220;Company&#8221;, &#8220;Cronos&#8221;, &#8220;we&#8221;, &#8220;us&#8221; and &#8220;our&#8221; refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term &#8220;cannabis&#8221; means the plant of any species or subspecies of genus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cannabis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; the term &#8220;U.S. hemp&#8221; has the meaning given to term &#8220;hemp&#8221; in the U.S. Agricultural Improvement Act of 2018, including hemp-derived cannabidiol (&#8220;CBD&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos seeks to create value for shareholders by focusing on four core strategic priorities:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">growing a portfolio of iconic brands that responsibly elevate the consumer experience;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developing a diversified global sales and distribution network;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing an efficient global supply chain; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">creating and monetizing disruptive intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report through two segments: &#8220;United States&#8221; (the &#8220;U.S. segment&#8221;) and &#8220;Rest of World&#8221; (the &#8220;ROW segment&#8221;). These two segments represent the geographic regions in which we operate and the different product offerings within each geographic region. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. segment manufactures, markets and distributes U.S. hemp-derived products through e-commerce, retail and hospitality partner channels in the United States under the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ROW segment is involved in the cultivation, manufacturing, and marketing of cannabis products for the medical and adult-use markets. In Canada, Cronos operates two wholly owned license holders under the Cannabis Act (Canada) (the &#8220;Cannabis Act&#8221;), Peace Naturals Project Inc. (&#8220;Peace Naturals&#8221;), which has production facilities near Stayner, Ontario (the &#8220;Peace Naturals Campus&#8221;), and Thanos Holdings Ltd., known as Cronos Fermentation (&#8220;Cronos Fermentation&#8221;), which has a production facility in Winnipeg, Manitoba. In Israel, the Company operates under the IMC-GAP, IMC-GMP and IMC-GDP certifications required for the cultivation, production and marketing of dried flower, pre-rolls and oils in the Israeli medical market. Cronos has established two strategic joint ventures in Canada and Israel. Additionally, as of December&#160;31, 2022, Cronos held approximately 10% of the issued capital of Vitura Health Limited (&#8220;Vitura&#8221;), formerly known as Cronos Australia Limited, which is listed on the Australian Securities Exchange under the trading symbol &#8220;VIT&#8221; and approximately 13.7% of the issued capital of Natuera.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_46"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, an outbreak of a novel strain of coronavirus, COVID-19, was identified in Wuhan, China. Since then, COVID-19 has spread across the globe, including the U.S., Canada and Israel, and other countries in which Cronos or its affiliates operate, and was recognized as a pandemic by the World Health Organization. The COVID-19 pandemic resulted in a sharp contraction in many areas of the global economy and increased volatility and uncertainty in the capital markets. In response to the pandemic, the governments of many countries, provinces, states, municipalities, and other geographic regions took preventative or protective actions, including closures of certain businesses, mandatory quarantines, limits on individuals&#8217; time outside of their homes, travel restrictions and social distancing or other preventative measures. Such measures have been eased or lifted in varying degrees by different governments of various countries, states and municipalities since implementation in 2020, but the continued spread of COVID-19 and increased infection rates has caused, and may continue to cause, some jurisdictions to roll back reopening plans that had been underway and re-impose quarantines, border closures, closure of certain businesses and stay-at-home orders. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to impact the global economy and, specifically, the U.S., Canada, Israel, and the other countries in which Cronos or its affiliates operate. We continue to closely monitor and respond, where possible, to the ongoing COVID-19 pandemic. As the global situation continues to change rapidly, ensuring the health and safety of our employees remains one of our top priorities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., numerous states have continued to remove their COVID-19 related restrictions. This has resulted in the re-opening of, and increased occupancy capacities in, retail outlets, including those that sell our products. Any reinstatement of restrictions on the operations of retail outlets could negatively impact our short-term results of operations in the U.S. Additionally, in the U.S., there have been a number of supply chain challenges, such as container ships facing delays due to congestion in ports, impacting many industries, including the industries in which we operate. Although we have not yet seen a significant impact from supply chain disruptions, we continue to monitor our supply chain closely.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Canada, COVID-19 restrictions began gradually easing at the end of June 2021 as the vaccination rate increased. The lockdown measures taken in the first six months of 2021 to slow infection rates negatively impacted our short-term revenue growth in Canada in 2021. The increase in cases related to the Omicron variant of COVID-19 beginning in December 2021 caused the reinstatement of some restrictions on non-essential retail stores in some provinces, including Quebec, in early 2022; however, those restrictions have eased in most other provinces. Each province is responsible for implementing re-opening plans and certain provinces, including Ontario, are progressing through phases of re-opening which may permit continued increases to the allowance of in-person shopping, typically in the form of percentage of store capacity. All provinces have some form of cannabis retail open to consumers, and most provinces have lifted the requirement that retail shoppers show proof of vaccination before entering retail stores. The potential for recurring retail restrictions is ongoing, which could negatively impact our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Israel, most COVID-19 restrictions have been removed as vaccination rates have increased. Occupancy limitations in retail outlets have been removed, including those that sell our products. We do not expect the remaining COVID-19 restrictions to have a material impact on our short-term revenue growth in Israel.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collectively, the effects of the COVID-19 pandemic have adversely affected our results of operations and, if the effects continue unabated, could continue to do so as long as measures to combat the COVID-19 pandemic remain in effect or supply chains continue to be challenged. At this time, neither the duration nor scope of the disruption can be predicted; therefore, the ultimate impact to our business cannot be reasonably estimated, but such impact could materially adversely affect our business, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the impacts of the COVID-19 pandemic, we believe that our significant cash on hand and short-term investments will be adequate to meet liquidity and capital requirements for at least the next twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Business Highlights</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Branded Product Portfolio Expansion in Canada</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout 2022, the Company expanded its Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gummies portfolio under both SOURZ by Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Spinach FEELZ&#8482;, with the following new products: </span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">April 2022: SOURZ by Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cherry Lime (Hybrid), 10mg of THC per pack</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">July 2022: Spinach FEELZ&#8482; DEEP DREAMZ CBN, 10mg of THC and 5mg of CBN per pack</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">October 2022: SOURZ by Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Tropical Triple Berry 2:1 CBD:THC, 20mg of CBD and 10mg of THC per pack</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">December 2022: Spinach FEELZ&#8482; 1:3 THC+CBC Mango Lime, 10mg of THC and 30mg of CBC per pack</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, Cronos was also focused on renovating both its vape and pre-roll offerings and launched the products below in those categories in 2022:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Vape:</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">August 2022: Spinach FEELZ&#8482; Deep Dreamz Blackberry Kush (7:1 THC|CBN) 1-gram vape</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">May 2022: Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cosmic Green Apple and Polar Mint Vortex (800 mg/g THC) 1-gram vapes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November, 2022, Cronos launched two infused pre-rolls in Canada. The first, Fully Charged Atomic GMO, was launched under the Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand and is offered in a 5-pack with 0.5 grams per pre-roll. Second, Cronos launched Tropical Diesel CBG, a 3-pack of CBG infused pre-rolls with 0.5 grams per pre-roll under the Spinach FEELZ&#8482; sub-brand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property initiatives</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we continued to progress our fermentation initiative in partnership with Ginkgo. We achieved equity milestones for the following cannabinoids in 2022:</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">June 2022: tetrahydrocannabivaric acid (&#8220;THCVA&#8221;)</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">November 2022: cannabichromenic acid (&#8220;CBCA&#8221;) </span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">December 2022: cannabichromevarinic acid (&#8220;CBCVA&#8221;)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic and Organizational Update</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company announced a shift in its strategic plans for the Realignment, with the intent to retain select components of its operations at the Peace Naturals Campus, namely distribution and warehousing, certain research and development activities and manufacturing of certain of the Company&#8217;s proprietary innovation products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Appointments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Board of Directors appointed Cronos&#8217;s founder, Mike Gorenstein, as Chairman, President and Chief Executive Officer. Mr. Gorenstein previously served as Chairman, President and Chief Executive Officer of Cronos until September 2020, when he transitioned to the Executive Chairman role.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company appointed Terry Doucet as Senior Vice President, Legal, Regulatory Affairs and Corporate Secretary, after serving in an interim capacity since December 2021. Mr. Doucet has been with Cronos since 2018 and has guided Cronos through significant growth over the last few years, including the build-out of the Company&#8217;s Legal and Regulatory Affairs teams, the Altria Investment, the Ginkgo Strategic Partnership, the PharmaCann Option and various product commercialization initiatives.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company appointed Arye Weigensberg as Senior Vice President, Head of Research &amp; Development, after serving in an interim capacity since November 2021. Prior to serving as interim Head of Research and Development, Mr. Weigensberg was the General Manager and Vice President of Research and Technology at Cronos Research Labs. Before joining the Company, Mr. Weigensberg was the CEO of Altria Israel Ltd (an Altria research and development hub). Since joining Cronos, Mr. Weigensberg has played a foundational role developing the scope of our rare cannabinoid work, while advancing our research capabilities to forge new strategies for differentiated cannabis products.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, Jeff Jacobson was appointed Chief Growth Officer. Mr. Jacobson previously served as the Company&#8217;s Senior Vice President, Head of Growth (North America). Mr. Jacobson has been with Cronos since December 2016 and was a co-founder of Peace Naturals Project Inc. Mr. Jacobson&#8217;s expertise and experience in licensing and compliance, new business development, project management and resource management assist Cronos in developing and penetrating domestic and international markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company appointed James Holm as Chief Financial Officer after nearly two decades of finance and accounting experience at leading companies across industries. He most recently served as the Global Vice President of Finance Transformation at Vertiv, a global provider of critical digital infrastructure and continuity solutions, where he led the company&#8217;s centralization, standardization and optimization to a Global Shared Service hub for finance processes. Before joining Vertiv, Mr. Holm served as Finance Leader, Finance Solutions &amp; Process Transformation Organization at Worldpay, one of the largest global payment processors. There he drove financial reporting accuracy, capabilities and enhancements across the company. Earlier in his career, he held multiple positions of increasing seniority in the finance department during his eight-year tenure at Procter and Gamble.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Compared to 2020</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our 2021 results of operations compared to 2020, see Part II, Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our 2021 cash flows compared to 2020, see Part II, Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign currency exchange rates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All currency amounts in this Annual Report are stated in U.S. dollars, which is our reporting currency, unless otherwise noted. All references to &#8220;dollars&#8221; or &#8220;$&#8221; are to U.S. dollars. The assets and liabilities of our foreign operations are translated into dollars at the exchange rate in effect as of December&#160;31, 2022 and December&#160;31, 2021, as reported on Bloomberg. Transactions affecting the shareholders&#8217; equity (deficit) are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and consolidated statements of cash flows of our foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the years ended December&#160;31, 2022, December&#160;31, 2021, and December 31, 2020, as reported on Bloomberg. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exchange rates used to translate from Canadian dollars (&#8220;C$&#8221;) to dollars are shown below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Exchange rates are shown as C$ per $)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2541</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3411</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spot rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3554</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2746</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2751</span></td></tr></table></div><div id="i228e12b34e804aa096affae69dd6b9af_49"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below set forth our consolidated results of operations, expressed in thousands of U.S. dollars for the periods presented. Our consolidated financial results for these periods are not necessarily indicative of the consolidated financial results that we will achieve in future periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue before excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,456</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,486</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,552)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,051)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,935</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,008</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,961</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,969</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,534)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,282</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,937</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,381</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,331</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,178</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,482</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,115</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,151</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,484</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,056</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,619</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,807</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,060</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,838)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560,594)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,721)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,459</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,175)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,204)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,097)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Cronos Group</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396,107)</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of select financial results</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,969&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,534)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,503&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:29.88pt">Gross margin is defined as gross profit divided by net revenue.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported consolidated net revenue of $91.9 million, representing a $17.5 million increase from 2021. This change was primarily due to higher cannabis flower sales in the Israeli medical market and higher cannabis extract sales in the Canadian adult-use market, partially offset by a reduction in revenue in the U.S. segment, lower cannabis flower sales in the Canadian adult-use market driven by an unfavorable price/mix shift and the impact of the weakening Canadian dollar against the U.S. dollar during 2022.</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported consolidated cost of sales of $79.9 million, essentially flat with 2021, despite a 23% increase in net revenue. This was primarily due to lower cannabis biomass costs, lower sales volumes in the U.S. segment and the impact of the weakening Canadian dollar against the U.S. dollar during the period, partially offset by higher sales volumes in the ROW segment and lower fixed cost absorption due to the timing of the wind-down of cultivation and certain production activities associated with the change in the nature of operations at the Peace Naturals Campus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory write-downs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021, we reported inventory write-downs of $12.0 million, primarily related to cannabis strains and potency levels that were no longer in-line with consumer preferences in the Canadian market and adjustments for obsolete inventory in Canada. We reported no inventory write-downs for 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross profit</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported consolidated gross profit of $12.0 million, representing a $29.5 million improvement from 2021. The improvement in gross profit is primarily due to increased revenue in the ROW segment driven mainly by a favorable mix of cannabis extract products, which carry a higher gross profit and gross margin than other product categories, higher sales of cannabis flower in Israel, the absence of inventory write-downs in 2022, and lower cannabis biomass costs, partially offset by lower revenue in the U.S. segment and lower fixed cost absorption due to the timing of the wind-down of cultivation and certain production activities associated with the change in the nature of operations at the Peace Naturals Campus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,655)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,950)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,304)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,807&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,060&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406,253)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and marketing</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported sales and marketing expenses of $22.3 million, representing a decrease of $22.7 million from 2021. The decrease was primarily due to lower advertising and marketing spend and lower personnel-related costs in the U.S. segment as a result of the Realignment.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported research and development expenses of $13.4 million, representing a decrease of $10.0 million from 2021. This decrease was primarily due to lower costs associated with the Ginkgo Collaboration Agreement and cancellation of beauty-focused product development spending in the U.S. segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported general and administrative expenses of $71.2 million, representing a decrease of $25.3 million from 2021. The decrease was primarily due to lower expected credit losses on our loans to joint venture partners when compared to 2021, lower legal and advisory fees associated with strategic initiatives and lower personnel-related costs associated with the Realignment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring costs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported restructuring costs of $5.3 million, compared to no restructuring costs in 2021. The restructuring costs in 2022 were related to Realignment activities. For further information, see Note 16 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-based compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported share-based compensation expenses of $15.1 million, representing an increase of $5.0 million from 2021. The increase was primarily due to the acceleration of expense on equity awards granted to certain executive employees in connection with their separation from the Company as well as the approval for grant of previously held-back equity awards granted to certain executives in connection with the SEC and OSC settlements. For further information, see Note 10 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, depreciation and amortization expenses were $6.0 million, representing an increase of $1.5 million from 2021. The increase was primarily due to higher amortization on our Ginkgo exclusive license intangible assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment loss on goodwill and indefinite-lived intangible assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021, we reported impairment loss on goodwill and intangible assets of $236.1 million due to impairment charges on the goodwill associated with our U.S. reporting unit and impairment on our Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand. For 2022, we reported no such impairment losses. For further information, see Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment loss on long-lived assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we recorded impairment charges of $3.5 million related to the right-of-use lease asset and leasehold improvements associated with our corporate headquarters in Toronto, Ontario, Canada, which the Company plans to sublease. For 2021, we recorded an impairment charge of $119.9 million on long-lived assets related to the previously announced planned exit from the Peace Naturals Campus. Additionally, in 2021, we recorded impairment charges of $4.8 million related to our Ginkgo exclusive licenses for cannabigerolic acid (&#8220;CBGA&#8221;) and cannabigerovarinic acid (&#8220;CBGVA&#8221;) for the difference between the fair value of the licenses and the consideration paid. Furthermore, in 2021, our U.S. segment recorded impairment charges of $1.2&#160;million on property, plant, and equipment where the carrying value of those assets was not recoverable and a $1.7 million impairment charge related to ceasing use of certain leased premise and the derecognition of the associated right-of-use asset. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, plant and equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; Note 6, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and Note 7 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report for additional information.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total other income, income tax benefit (expense) and loss from discontinued operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,392)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,392)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income (loss) from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,313)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,721)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173,180)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,606)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:31.1pt">&#8220;N/M&#8221; is defined as not meaningful.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest income, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported interest income, net of $22.5 million, representing an increase of $13.5 million from 2021 primarily due to higher short-term investment balances and higher interest rates in 2022 when compared to 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain on revaluation of derivative liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported a gain on revaluation of derivative liabilities of $14.1 million, representing a decrease of $137.3 million from 2021 primarily due to the greater impact on the derivative liabilities in 2021 from the decreased estimated term of the derivative instruments and the decreased price of Cronos common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment loss on other investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, impairment loss on other investments was $61.4 million, driven by impairment charges recorded on our PharmaCann Option for the difference between its estimated fair value and its carrying amount. There were no such impairment losses on other investments during 2021. For more information, see Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share of income (loss) from equity method investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported share of income from equity method investments of $3.1 million, representing an increase of $9.4 million from 2021. The change was primarily due to improved results from our equity method investment in Cronos GrowCo.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain (loss) on revaluation of financial instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported a gain on revaluation of financial instruments of $14.7 million, representing an increase of $6.1 million from 2021. The increase was due to the change in fair value of our investment in Vitura. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency transaction loss</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, foreign currency transaction loss was $2.3 million, which related to certain foreign currency-denominated intercompany loans anticipated to be settled in the foreseeable future. There were no such foreign currency transaction gains or losses during 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, other, net was a loss of $0.5 million, compared to income of $0.7 million in 2021. The change was primarily due to loss on disposal of assets associated with the Realignment, partially offset by $0.4 million of dividend income from our Vitura investment during 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax benefit (expense)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, we reported income tax expense of $34.2 million, compared to an income tax benefit of $0.4 million in 2021. The change was due primarily to a capital gain for tax purposes of $479.8 million, which resulted in an income tax liability of $34.2 million, related to the irrevocable relinquishment by Altria of the Warrant on December 16, 2022.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss from discontinued operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021, we reported loss from discontinued operations of $0.5 million. There was no such loss from discontinued operations in 2022.</span></div><div id="i228e12b34e804aa096affae69dd6b9af_52"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations by Business Segment: 2022 compared with 2021</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below set forth our consolidated results of operations by our two business segments: the ROW segment and the U.S. segment, expressed in U.S. dollars and in thousands for the periods presented. Our consolidated financial results for these periods are not necessarily indicative of the consolidated financial results that we will achieve in future periods. Certain totals in the tables below will not sum to exactly 100% due to rounding. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of financial results </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,593)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,029&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,749&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,561&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, the ROW segment reported net revenue of $86.7 million, representing an increase of $22.2 million from 2021. This increase was primarily due to higher cannabis extract sales in the Canadian adult-use market and higher cannabis flower sales in the Israeli medical market, partially offset by lower cannabis flower sales in the Canadian adult-use market driven by an unfavorable price/mix shift and the impact of the weakening Canadian dollar against the U.S. dollar during 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales - ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, the ROW segment reported a year-over-year increase in cost of sales of 2%, while net revenue increased 34%. This increase was primarily due to higher sales volumes and lower fixed cost absorption due to the timing of the wind-down of cultivation and certain production activities associated with the change in the nature of operations at the Peace Naturals Campus, partially offset by lower cannabis biomass costs and the impact of the weakening Canadian dollar against the U.S. dollar during 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory write-downs - ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported no inventory write-downs for 2022. For 2021, we reported inventory write-downs of $12.0 million, primarily related to cannabis strains and potency levels that were no longer in-line with consumer preferences in the Canadian market and adjustments for obsolete inventory in Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross profit - ROW</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, the ROW segment reported gross profit of $15.4 million, representing an increase of $33.0 million from 2021. The improvement in gross profit is primarily due to increased revenue driven mainly by a favorable mix of cannabis extract products, which carry a higher gross profit and gross margin than other product categories, sales of cannabis flower in Israel, the absence of inventory write-downs in 2022, and lower cannabis biomass costs, partially offset by lower fixed cost absorption due to the timing of the wind-down of cultivation and certain production activities at the Peace Naturals Campus.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_55"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of financial results </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,719)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,467)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,526)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, the U.S. segment reported net revenue of $5.2 million, representing a decrease of $4.7 million from 2021. The decrease in sales was driven by the decision to exit the adult beauty business, a decrease in promotional spending and SKU rationalization efforts as the Company implements the Realignment in the U.S. segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, the U.S. segment reported cost of sales of $8.6 million, representing a decrease of $1.2 million from 2021. This decrease was primarily due to lower sales volumes due to the decision to exit the adult beauty business, partially offset by higher inventory reserves associated with discontinued products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, the U.S. segment reported negative gross profit of $3.5 million, representing a decrease in gross profit of $3.5 million from 2021. This decrease was primarily due to the decision to exit the adult beauty business and higher inventory reserves associated with discontinued products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_61"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Measures </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos reports its financial results in accordance with Generally Accepted Accounting Principles in the United States (&#8220;U.S. GAAP&#8221;). This Annual Report refers to measures not recognized under U.S. GAAP (&#8220;non-GAAP measures&#8221;). These non-GAAP measures do not have a standardized meaning prescribed by U.S. GAAP and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP measures are provided as a supplement to corresponding U.S. GAAP measures to provide additional information regarding our results of operations from management&#8217;s perspective. Accordingly, non-GAAP measures should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with U.S. GAAP. All non-GAAP measures presented in this Annual Report are reconciled to their closest reported GAAP measure. Reconciliations of historical adjusted financial measures to corresponding U.S. GAAP measures are provided below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews Adjusted EBITDA, a non-GAAP measure which excludes non-cash items or items that do not reflect management&#8217;s assessment of ongoing business performance of our operating segments. Management defines Adjusted EBITDA as net income (loss) before interest, tax expense (benefit), depreciation and amortization adjusted for: share of income (loss) from equity method investments; impairment loss on goodwill and intangible assets; impairment loss on long-lived assets; (gain) loss on revaluation of derivative liabilities; (gain) loss on revaluation of financial instruments; transaction costs related to strategic projects; impairment loss on other investments; foreign currency transaction loss; other, net; loss from discontinued operations; restructuring costs; share-based compensation; and financial statement review costs and reserves related to the restatements of our 2019 and 2021 interim financial statements (the &#8220;Restatements&#8221;), including the costs related to the settlement of the SEC&#8217;s and the OSC&#8217;s investigations of the Restatements and legal costs defending shareholder class action complaints brought against us as a result of the 2019 restatement (see Part I, Item 3, Legal Proceedings, of this Annual Report for a discussion of the settlement of the SEC&#8217;s and OSC&#8217;s regulatory reviews relating to the Restatements and shareholder class action complaints relating to the restatement of the 2019 interim financial statements).</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that Adjusted EBITDA provides the most useful insight into underlying business trends and results and provides a more meaningful comparison of year-over-year results. Management uses Adjusted EBITDA for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is reconciled to net income (loss) as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,411)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,227)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,336)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,411)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143,974)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ix)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,134)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,230)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,244)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,608)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283,883)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,811)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,031)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283,095)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,699)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391,304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,611)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,611)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(733)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(viii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,717)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,139)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,607)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,463)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,793)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,293)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(viii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">For the year ended December 31, 2021, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to our U.S. segment and impairment on an indefinite-lived trademark related to our ROW segment. For the year ended December 31, 2020, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to our U.S. segment. See Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8221; to the consolidated financial statements under Item 8 of this Annual Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt">For the year ended December 31, 2022, impairment loss on long-lived assets relates to the Company&#8217;s decision to seek a sublease for leased office space in Toronto, Ontario, Canada during the first quarter of 2022. For the year ended December 31, 2021, impairment loss on long-lived assets relates to impairment charges on property, plant and equipment and definite-lived intangible assets in the Canadian asset group, impairment charges for the differences between the consideration paid to Ginkgo for the achievement of two equity milestones in connection with the Ginkgo Collaboration Agreement and the fair values of the CBGA exclusive license and CBGVA exclusive license as well as impairment on leased premises in the U.S. segment. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8221; and Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">For the years ended December&#160;31, 2022, 2021 and 2020, the gain on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 8 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Derivative Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:19.8pt">For the years ended December 31, 2022 and 2021, gain on revaluation of financial instruments relates primarily to our unrealized holding gain on our mark-to-market investment in Vitura as well as revaluations of financial liabilities resulting from deferred share units (&#8220;DSUs&#8221;) granted to directors. For the year ended December 31, 2020, loss on revaluation of financial instruments relates to revaluations of financial liabilities resulting from DSUs. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8221; and Note 10 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Share-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the years ended December 31, 2021 and 2020, transaction costs represent legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:19.8pt">For the year ended December 31, 2022, impairment loss on other investments related to the PharmaCann Option for the difference between its fair value and carrying amount. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt">For the year ended December 31, 2022, other, net primarily related to related to $646 loss on disposal of assets and $390 of dividends declared by Vitura on the Company&#8217;s 55,176,065 ordinary shares in the capital of Vitura. For the years ended December 31, 2021 and 2020, other, net is primarily related to (gain) loss on reclassification of held-for-sale assets and (gain) loss on disposal of assets.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.62pt">For the years ended December 31, 2021 and 2020, loss from discontinued operations relates to the discontinuance of Original B.C. Ltd. (&#8220;OGBC&#8221;).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December 31, 2022, restructuring costs related to the employee-related severance costs and other restructuring costs associated with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. See Note 16 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Restructuring&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:21.24pt">For the years ended December&#160;31, 2022, 2021 and 2020, share-based compensation relates to the vesting expenses of share-based compensation awarded to employees under our share-based award plans as described in Note 10 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Share-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">(xi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:19.5pt">For the years ended December&#160;31, 2022, 2021 and 2020, financial statement review costs include costs related to the restatements of the Company&#8217;s 2019 interim financial statements and second quarter 2021 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatements, the costs related to the Settlement Order and Settlement Agreement and legal costs defending shareholder class action complaints brought against the Company as a result of the 2021 and 2019 restatements. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(xii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.36pt">For the year ended December 31, 2020, gain on disposal of investments is primarily comprised of the gain recorded related to the sale of common shares of Aurora, which were received in connection with the achievement of a milestone related to Aurora&#8217;s acquisition of Whistler (&#8220;Whistler Transaction&#8221;) in 2020 and as a result of the closing of the Whistler Transaction in 2019. There were no disposals of investments during the years ended December 31, 2022 and 2021. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Constant Currency</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement the consolidated financial statements presented in accordance with U.S. GAAP, we have presented constant currency adjusted financial measures for net revenues, gross profit, gross profit margin, operating expenses, net income (loss) and Adjusted EBITDA for 2022, as well as cash and cash equivalents and short-term investment balances as of December 31, 2022 compared to December 31, 2021, which are considered non-GAAP financial measures. We present constant currency information to provide a framework for assessing how our underlying operations performed excluding the effect of foreign currency rate fluctuations. To present this information, current and prior period income statement results in currencies other than U.S. dollars are converted into U.S. dollars using the average exchange rates from the comparative period in 2021 rather than the actual average exchange rates in effect during 2022; constant currency current period balance sheet information is translated at the prior year-end spot rate rather than the current year-end spot rate. All growth comparisons relate to the corresponding period in 2021. We have provided this non-GAAP financial information to aid investors in better understanding the performance of our segments. The non-GAAP financial measures presented in this Annual Report should not be considered as a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth certain measures of consolidated results from continuing operations on an as-reported and constant currency basis for 2022 compared to 2021, as well as cash and cash equivalents and short-term investments as of December 31, 2022, compared to December 31, 2021, on an as-reported and constant currency basis (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.628%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Adjusted for Constant Currency</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Reported Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402,996)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Reported Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,329)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,448)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,607)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash and cash equivalents and short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877,721&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004,657&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,936)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913,771&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,886)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Adjusted for Constant Currency</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Reported Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,469&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Adjusted for Constant Currency</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Reported Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,719)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,719)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,469&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,802&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, net revenue on a constant currency basis was $95.2 million, representing a 28% increase from 2021. Net revenue increased on a constant currency basis primarily due to higher cannabis extract sales in the Canadian adult-use market and higher cannabis flower sales in the Israeli medical market, partially offset by a reduction in revenue in the U.S. segment and lower cannabis flower sales in the Canadian adult-use market driven by an adverse price/mix shift.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, gross profit on a constant currency basis was $12.6 million, representing a 172% increase from 2021. Gross profit increased on a constant currency basis primarily due to increased revenue in the ROW segment driven mainly by a favorable mix of cannabis extract products, which carry a higher gross profit and gross margin than other product categories, higher sales of cannabis flower in Israel, the absence of inventory write-downs in 2022, and lower cannabis biomass costs, partially offset by lower revenue in the U.S. segment and lower fixed cost absorption due to the timing of the wind-down of cultivation and certain production activities associated with the change in the nature of operations at the Peace Naturals Campus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, operating expenses on a constant currency basis was $140.1 million, representing a 74% decrease from 2021. Operating expenses decreased on a constant currency basis primarily due to lower advertising and marketing spend and lower payroll-related costs in the U.S. segment as a result of the Realignment, reduced costs associated with the timing of Ginkgo milestones, cancellation of beauty-focused product development spending in the U.S. segment, and an expected credit loss allowance revaluation recognized in 2021, partially offset by higher restructuring costs related to the Realignment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, net loss on a constant currency basis was $170.9 million, representing a 57% improvement from 2021. Net loss improved primarily due to lower impairment charges, higher gross profit, lower operating expenses, higher interest income and higher income from equity method investments, partially offset by lower gain on revaluation of derivative liabilities and higher share-based compensation expense in 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, adjusted EBITDA on a constant currency basis was $82.1 million, representing a 49% improvement from 2021. Adjusted EBITDA increased on a constant currency basis primarily due to decreases in general and administrative expenses, sales and marketing expenses, and research and development expenses as a result of the Realignment, and an improvement in gross profit.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents &amp; short-term investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents and short-term investments on a constant currency basis decreased 9% to $913.8 million as of December 31, 2022 from $1,004.7 million as of December 31, 2021. The decrease in cash and cash equivalents and short-term investments is primarily due to cash flows used in operating activities in 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_58"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents and short-term investments will be sufficient to fund our business operations and capital expenditures over the next twelve months. Our primary need for liquidity is to fund operations and capital expenditures. Our ability to fund operations and capital expenditures depends on, among other things, future operating performance and cash flows that are subject to general economic conditions and financial and other factors, including factors beyond our control. Since 2019, we have been funded by the C$2.4 billion (approximately $1.8 billion) Altria investment in us, pursuant to which we issued to certain wholly owned subsidiaries of Altria 149,831,154 of our common shares and one warrant, as further discussed under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria Strategic Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Item 1 of this Annual Report. As of December 31, 2022, we had $764.6 million in cash and cash equivalents and $113.1 million in short term investments, compared to $887.0 million in cash and cash equivalents and $117.7 million in short term investments as of December 31, 2021.&#160;As of both December 31, 2022 and December 31, 2021, we had no external financing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144,871)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,842)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,442)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,329)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191,050)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,670)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 cash flows vs 2021 cash flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating&#160;activities&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022,&#160;we&#160;used $88.9 million of cash in operating activities, compared to $153.6 million in 2021, representing a decrease in net cash used of $66.8 million. This change is primarily driven by a $42.0 million increase in net income after adjusting for non-cash items, such as impairment charges, share-based payments, depreciation and amortization, and share of loss from investments in equity method investments in 2022, and a net increase in changes in operating assets and liabilities of $22.7 million related to the timing of collections of accounts receivables, payments for income taxes, payments for accruals and payables, and purchases of inventory.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing&#160;activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022,&#160;we used $1.8 million of cash in investing activities, compared to $28.9 million during 2021, representing a decrease of $27.1 million in net cash used.&#160;This change is primarily driven by the purchase of the PharmaCann Option during 2021, lower purchases of property, plant and equipment and greater repayments than disbursements on loans receivable during 2022, partially offset by a higher level of short-term investments during 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing&#160;activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022,&#160;cash used in financing activities was $2.9 million, as compared to $13.4 million in&#160;2021, representing a decrease of $10.5 million.&#160;This change is primarily driven by a decrease in withholding taxes paid on share-based awards.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash requirements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the near-term, we expect to use our available cash and investments to operate our core business and develop new ways to serve our customers as well as invest in our various strategic partnerships and in our investees. We have maintained adequate liquidity to meet working capital requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material cash requirements include the following contractual and other obligations as of December 31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for buildings and office space, vehicles and land, and a finance lease relating to equipment. As of December&#160;31, 2022, the future minimum payments required under these leases totaled $4.8 million, with $1.6 million payable within 12 months. Refer to Note 7 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report for further information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loans receivable with related parties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into three loan agreements with affiliates. As of December&#160;31, 2022, Cronos GrowCo had approximately $0.7&#160;million undrawn on its loan receivable, with no amounts expected to be drawn within 12 months. All other loans receivable have been fully drawn. Refer to Note 4 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loans Receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statement in Item 8 of this Annual Report for further information.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchase obligations primarily consist of contractual obligations to maintain the ordinary course of business through information technology and capital expenditures related to computer software, agricultural supply services and data analytics. Other purchase obligations consist of noncancellable obligations related to maintenance, internet, and telecommunication service. As of December&#160;31, 2022, we had purchase obligations of $13.5&#160;million, with $10.6&#160;million payable within 12 months.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development obligations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into multiple R&amp;D contracts with partners such as Ginkgo Bioworks Holdings, Inc. (&#8220;Ginkgo&#8221;), as well as maintained internal cash requirements related to R&amp;D activities, to continue to improve processes and gain knowledge on the cannabinoid industry. As of December&#160;31, 2022, we had approximately $1.7&#160;million in cash requirements related to R&amp;D, with $1.7&#160;million payable within 12 months. Refer to Note 9 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report for further information.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_64"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and critical judgments by management</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. These estimates are reviewed periodically, and adjustments are made as appropriate in the year they become known. Items for which actual results may differ materially from these estimates are described in the following section.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 1 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background, Basis of Presentation, and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report for further information on our critical accounting estimates and policies, which are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when the control of the promised goods is transferred to the customer in an amount that reflects the consideration we expect to be entitled to in exchange for the performance obligation. Excise taxes remitted to tax authorities are government-imposed excise taxes on cannabis products. Excise taxes are recorded as a reduction of sales in net revenue in the consolidated statements of income (loss) and comprehensive income (loss) and are recognized as a current liability within accrued liabilities on the consolidated balance sheets, with the liability subsequently reduced when the taxes are remitted to the tax authority.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, amounts disclosed as net revenue are net of allowances, discounts and rebates. In determining the transaction price for the sale of goods, the Company considers the effects of variable consideration and the existence of significant financing components, if any. Some contracts for the sale of goods may provide customers with a right of return, most-favored-customer rights, or early payment discounts. In addition, the Company may provide, in certain circumstances, a retroactive price reduction to a customer based primarily on inventory movement. These items give rise to variable consideration. The Company uses the expected value method to estimate the variable consideration because this method best predicts the amount of variable consideration to which the Company will be entitled. The Company uses historical evidence, current information and forecasts to estimate the variable consideration. The Company reduces revenue and recognizes a contract liability equal to the amount expected to be refunded to the customer in the form of a future rebate or credit for a retroactive price reduction, representing its obligation to return the customer&#8217;s consideration. The estimate is updated at each reporting period date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are not subject to amortization. We test goodwill and indefinite-lived intangible assets for impairment annually, or more frequently if an event occurs or circumstances change that could indicate a potential impairment. We compare the fair value of our reporting units with their carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the accounting estimate for goodwill and indefinite-lived intangible assets is a critical accounting estimate because of the judgment required in assessing the fair value of each of our reporting units. We estimate fair value through various valuation methods, including the use of discounted expected future cash flows of each reporting unit, as well as the use of the relief-from-royalty method on the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand. Significant inputs include discount rates, growth rates, and cash flow projections, and, for the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand, royalty rate. These valuation inputs are considered Level 3 inputs as defined by ASC 820 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected future cash flows for each reporting unit are significantly impacted by current market conditions. If these market conditions and resulting expected future cash flows for each reporting unit decline significantly, the actual results for each segment could differ from our estimate, which would cause goodwill to be impaired. Our accounting for goodwill and indefinite-lived intangible assets represents our best estimate of future events.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, we recognized impairment losses related to goodwill and indefinite-lived intangible assets of $178.4 million and $56.5 million, respectively, in the U.S. reporting unit. During our annual quantitative impairment test in the fourth quarter of 2021, an additional impairment of $1.0&#160;million was recognized on the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand due to the U.S. segment&#8217;s sustained operating losses and lack of revenue growth. In 2020, based on our assessments and after considering potential triggering events, including COVID-19, we recognized an impairment loss related to goodwill and indefinite-lived intangible assets of $35 million and $5 million, respectively, in the U.S. reporting unit. During our annual quantitative impairment test in the fourth quarter of 2020, no further impairment was recorded as both fair values of the goodwill as well as the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand exceeded carrying amount by more than 10%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventory valuation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value our inventory at lower of cost or net realizable value determined using weighted average cost. Inventory is reflected at the lower of cost or net realizable value considering future demand, market conditions and market prices. Our estimates are based upon assumptions believed to be reasonable, but that are inherently uncertain and unpredictable. These valuations require the use of management&#8217;s assumptions that do not reflect unanticipated events and circumstances that may occur. We record an inventory valuation adjustment for excess, slow moving, and obsolete inventory that is equal to the excess of the cost of the inventory over the estimated net realizable value. We also experience inventory write-downs due to reduced market prices. The inventory valuation adjustment to net realizable value establishes a new cost basis of the inventory that cannot be subsequently reversed. Inventory valuation adjustments are based on inventory levels, expected product life, and estimated product demand. In assessing the ultimate realization of inventories, we are required to make judgments as to future demand requirements compared with inventory levels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are primarily comprised of property, plant, and equipment and definite-lived intangible assets. We evaluate long-lived assets for impairment when events or changes in circumstances indicate, in management&#8217;s judgment, that the carrying amount of such assets may not be recoverable. Long-lived asset recoverability is assessed on an asset group basis. We group assets and liabilities for our asset groups at the reporting unit level, which is the lowest level for which cash flows are separately identifiable. Long-lived asset recoverability is measured by comparing the carrying amount of the asset group with its estimated future undiscounted pre-tax cash flows over the remaining life of the primary long-lived asset of the asset group. If the carrying amount exceeds the estimated future undiscounted cash flows as part of the recoverability assessment, an impairment charge is recognized equal to the difference between the carrying amount and fair value of the asset group. The impairment charge is allocated to the underlying long-lived assets in the asset group on a relative carrying amount basis; however, carrying amount after allocated impairment is subject to a floor of fair value on an individual asset basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the accounting estimates used in the long-lived asset impairment assessment are critical accounting estimates because of the judgment required in identifying indicators of impairment, determining asset groups, assessing future undiscounted cash flows of the asset groups, and as applicable, evaluating the fair value of the determined asset groups as well as the underlying long-lived assets, once indicators of impairment have been identified.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically evaluate whether impairment indicators related to our property, plant and equipment, operating leases and other long-lived assets are present. These impairment indicators may include a significant decrease in the market price of a long-lived asset or asset group, early termination of an operating lease, a significant adverse change to the extent or manner in which a long-lived asset or asset group is being used or in its physical condition, or a current-period operating or cash flow loss combined with a history of operating or cash flow losses or a forecast that demonstrates continuing losses associated with the use of a long-lived asset or asset group. If impairment indicators are present, we estimate the fair value for the asset or group of assets. We estimate fair value of long-lived assets through various valuation methods, including the use of the indirect cost approach, income approach, and direct comparison approach. The indirect cost approach is based on the estimated cost to reproduce the asset as if new, adjusted for physical deterioration and consideration of functional and economic obsolescence. The income approach is based on estimated rental and capitalization rates. The direct comparison approach is based on recent observable transactions of comparable assets. The estimation of future undiscounted cash flows of the asset groups as well as each of these fair value approaches are significantly impacted by market conditions. A significant adverse change in market conditions could result in fair values that differ from our estimates, which could adversely impact whether an impairment exists and the extent to which an asset group and underlying assets are impaired. The difference between the fair value and the carrying amount of the asset group is recorded as an impairment charge.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we concluded that indicators of impairment were present with respect to our corporate headquarters, for which we determined we would seek a sublease. As a result, we recognized an impairment charge of $2.0 million related to the right-of-use lease asset associated with our corporate headquarters. In addition, we recognized an impairment charge of $1.5 million during the year ended December 31, 2022 related to leasehold improvements and other office equipment that we plan to include in any potential sublease agreement. The determination to seek a sublease of the property and include leasehold improvements and other office equipment in any potential sublease agreement triggered the impairment charges. Both of the impairment charges are recognized as impairment loss on long-lived assets on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, we concluded that indicators of impairment were present with respect to our Canadian asset group. As a result, we estimated the undiscounted cash flows for the Canadian asset group and found that the carrying amount exceeded its undiscounted cash flows. Subsequently, we estimated the fair values of all long-lived assets in the Canadian asset group using the indirect cost approach for personal property, the income and direct comparison approaches for our facility in Stayner, Ontario, Canada, and the indirect cost approach for our facility in Winnipeg, Manitoba Canada, and compared the fair values attributable to the Canadian asset group to their respective carrying amounts and recorded a non-cash impairment charge on long-lived assets of $119.9&#160;million. Refer to Note 5 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, plant and equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the cannabinoid exclusive licenses originating from the Ginkgo Strategic Partnership as definite-lived intangible assets in accordance with the acquisition method of accounting. The cost of cash and equity in Cronos issued in exchange for the cannabinoid exclusive licenses is initially recognized and measured at the date of acquisition. On the date of acquisition, we then test each cannabinoid exclusive license for impairment by comparing the cost and fair value of each license. We believe that the accounting estimate for the cannabinoid exclusive licenses is a critical accounting estimate because of the judgment required in assessing their fair values and the expected future cash flows are significantly impacted by the future expectations for products containing each cannabinoid. We estimate the fair value using the relief-from-royalty method. Each cannabinoid exclusive license is subject to amortization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Ginkgo Equity Milestone was achieved related to cannabigerolic acid (&#8220;CBGA&#8221;). At that time, we issued 1.5 million common shares valued at $9.0&#160;million based on the observable market price of the shares. In exchange, we received process and background intellectual property related to CBGA, as well as the CBGA exclusive license, which is a perpetual license with exclusivity for 10 years from the date the license is granted. An impairment of $1.8 million was recognized to record the CBGA exclusive license at its fair value of $7.3 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Ginkgo Equity Milestone was achieved related to cannabigerovarinic acid (&#8220;CBGVA&#8221;). At that time, we issued 1.5 million common shares valued at $8.2&#160;million based on the observable market price of the shares. In exchange, we received process and background intellectual property related to CBGVA, as well as the CBGVA exclusive license, which is a perpetual license with exclusivity for 10 years from the date the license is granted. An impairment of $3.0 million, was recognized to record the CBGVA exclusive license at its fair value of $5.3 million.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Ginkgo Equity Milestone was achieved related to tetrahydrocannabivaric acid (&#8220;THCVA&#8221;). At that time, we issued 2.2 million common shares and paid cash of $600, for total consideration of $8.4 million based on the observable market price of the shares. In exchange, we received process and background intellectual property related to THCVA, as well as an exclusive license with respect to THCVA, which is a perpetual license with exclusivity for 10 years from the date the license is granted. No impairment was recorded with respect to the THCVA exclusive license.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Ginkgo Equity Milestone was achieved related to the early commercialization of cannabichromenic acid (&#8220;CBCA&#8221;). At the time we issued 0.5 million common shares valued at $1.5 million based on the observable market price of the shares. In exchange, we received process and background intellectual property related to CBCA, as well as an exclusive license with respect to CBCA, which is a perpetual license with exclusivity for 10 years from the date the license is granted. No impairment was recorded with respect to the CBCA exclusive license.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Ginkgo Equity Milestone was achieved related to cannabichromevarinic acid (&#8220;CBCVA&#8221;). At the time we issued 1.5 million common shares valued at $3.7 million based on the observable market price of the shares. In exchange, we received process and background intellectual property related to CBCVA, as well as an exclusive license with respect to CBCVA, which is a perpetual license with exclusivity for 10 years from the date the license is granted. No impairment was recorded with respect to the CBCVA exclusive license.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of derivative liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December 16, 2022, derivative liabilities consisted of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights. </span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2022, Altria notified us that its wholly owned subsidiary, Altria Summit LLC, irrevocably relinquished the Warrant </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and all rights that it may have held in the Warrant or any common shares underlying the Warrant for no consideration. As of December 31, 2022, derivative liabilities consisted of Pre-emptive Rights and certain Top-up Rights. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure derivative liabilities at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in net income (loss) and comprehensive income (loss). We calculate fair value of the derivative liabilities using the Black-Scholes model. Significant assumptions are used in the valuation of derivative liabilities, including the expected term and our stock price. The assumptions used in computing the fair value of derivative liabilities reflect our best estimates, but involve uncertainties relating to market and other conditions, many of which are outside of our control. Sensitivity is performed on various inputs, refer to Note 8 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of other investments without readily determinable fair values</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold other investments without readily determinable fair values that are measured under the cost method less impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same investee. Each reporting period, we qualitatively assess if indicators of impairment are present, and, if present, we estimate the fair value of the investments and record impairment charges on the consolidated statements of income if the carrying value exceeds fair value. To estimate the fair value of the investments, we use a combination of the income and market approaches. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the income approach, significant assumptions used in the discounted cash flow method that require the use of judgment are the discount rate, growth rates, cash flow projections, and the timing of federal legalization of cannabis in the U.S. Under the market valuation approach, the key assumptions that require judgment under the Guideline Public Companies method are cash flow projections, selected multiples and the discount for lack of marketability. As a result of our analysis, we recorded non-cash impairment charges of $11.2 million, $29.0 million and $21.2 million in the first, third and fourth quarters of 2022, respectively, related to the PharmaCann Option. No such impairments were recorded during the year ended December 31, 2021, as no indicators of impairment were present.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-based compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure the fair value of services received in exchange for all stock options granted based on the fair market value of the award as of the grant date. We compute the fair value of stock options with time-based vesting using the Black-Scholes option-pricing model and recognize the cost of the equity awards over the period that services are provided to earn the award. The Black-Scholes option-pricing model includes assumptions regarding dividend yields, expected volatility, expected option term and risk-free interest rates. The assumptions used in computing the fair value of share-based compensation expense reflect our best estimates, but involve uncertainties relating to market and other conditions, many of which are outside of our control. We estimate expected volatility based primarily on historical daily price changes of our stock and peers. The expected option term is the number of years that we estimate that the stock options will be outstanding prior to exercise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loans receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans receivable are presented net of an allowance for credit losses. In the third quarter of 2021, we changed methodologies for estimating the allowance for credit loss on loans receivable from the historical credit loss method to the probability of default method. The probability of default rate is adjusted for current conditions and reasonable and supportable forecasts of future losses as necessary. We may also record a specific reserve for individual accounts when we become aware of specific customer circumstances, such as in the case of a bankruptcy filing or deterioration in the borrower&#8217;s operating results or financial condition. The allowance for credit loss accrual balance was $13.1 million and $14.6 million as of December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_67"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. During the year ended December&#160;31, 2022 and December&#160;31, 2021, we had interest income, net of $22.5 million and $9.1 million, respectively. A 10% change in the interest rate in effect on December&#160;31, 2022 and December&#160;31, 2021, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income, net. Management continues to monitor external interest rates and revise our investment strategy as a result.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, our average variable interest rate increased by approximately 3.5%. During the year ended December 31, 2021, our average variable interest rate did not materially change.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign currency risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements included in Part II, Item 8 &#8220;Financial Statements and Supplementary Data&#8221; of the annual report are expressed in U.S. dollars. In addition, we have net assets, liabilities, and revenues denominated in foreign currencies, including Canadian dollars and Israeli new shekels. As a result, we are exposed to foreign currency translation gains and losses. Revenue and expenses of all foreign operations are translated into U.S. dollars at the foreign currency exchange rates that approximate the rates in effect during the period when such items are recognized. Appreciating foreign currencies relative to the U.S. dollar will adversely impact operating income and net earnings, while depreciating foreign currencies relative to the U.S. dollar will have a positive impact.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022 and December&#160;31, 2021, we had foreign currency gain (loss) on translation of $(50.6) million and $8.2 million, respectively. A 10% change in the exchange rates for the Canadian dollar would affect the carrying amount of the net assets by approximately $77.4 million and $87.7 million as of December&#160;31, 2022 and December&#160;31, 2021, respectively. The corresponding impact would be recorded in accumulated other comprehensive income. We have not historically engaged in hedging transactions and do not currently contemplate engaging in hedging transactions to mitigate foreign exchange risks. As we continue to recognize gains and losses in foreign currency transactions, depending upon changes in future currency rates, such gains and losses could have a significant, and potentially adverse, effect on our results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_70"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div id="i228e12b34e804aa096affae69dd6b9af_73"></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Table of Contents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reports of Independent Registered Public Accounting Firm (<ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl83My9mcmFnOmE1OWRiOTZjYjZmODQ1YjY4YjYxOWZhM2YwMDBjMWEzL3RhYmxlOjBhYTA0Zjg3MGU2MTQ5ZWZiNGI2ODE0MDkwNmFiODA5L3RhYmxlcmFuZ2U6MGFhMDRmODcwZTYxNDllZmI0YjY4MTQwOTA2YWI4MDlfMS0wLTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjpiOTc4YmFiOGIzMmY0ODMzYTY0YmFiMTZjZWZhNjc0NF8xNQ_dea20def-fdd8-42e3-a128-ebba1997f7ba">KPMG LLP</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl83My9mcmFnOmE1OWRiOTZjYjZmODQ1YjY4YjYxOWZhM2YwMDBjMWEzL3RhYmxlOjBhYTA0Zjg3MGU2MTQ5ZWZiNGI2ODE0MDkwNmFiODA5L3RhYmxlcmFuZ2U6MGFhMDRmODcwZTYxNDllZmI0YjY4MTQwOTA2YWI4MDlfMS0wLTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjpiOTc4YmFiOGIzMmY0ODMzYTY0YmFiMTZjZWZhNjc0NF8xMDk5NTExNjI3OTE5_ec407dd7-7cc4-4911-82a3-2510de930c39">Vaughan, Ontario, Canada</ix:nonNumeric>, Auditor Firm ID: <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl83My9mcmFnOmE1OWRiOTZjYjZmODQ1YjY4YjYxOWZhM2YwMDBjMWEzL3RhYmxlOjBhYTA0Zjg3MGU2MTQ5ZWZiNGI2ODE0MDkwNmFiODA5L3RhYmxlcmFuZ2U6MGFhMDRmODcwZTYxNDllZmI0YjY4MTQwOTA2YWI4MDlfMS0wLTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjpiOTc4YmFiOGIzMmY0ODMzYTY0YmFiMTZjZWZhNjc0NF8yOQ_562dee13-505c-4c94-8e8e-22d4f55211a9">85</ix:nonNumeric>)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_76">74</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_82">77</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_85">78</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Changes in Shareholders&#8217; Equity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_88">79</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_91">80</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_94">82</a></span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_76"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors </span></div><div style="margin-bottom:12pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc.:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Cronos Group Inc. and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of net income (loss) and comprehensive income (loss), changes in shareholders&#8217; equity, and cash flows for each of the years in the three&#8209;year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three&#8209;year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 28, 2023 expressed an adverse opinion on the effectiveness of the Company&#8217;s internal control over financial reporting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of an option to purchase equity securities without a readily determinable fair value </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in note 1(g) of the consolidated financial statements, the Company records its other investments without a readily determinable fair value using the cost method, and assesses such investments for observable price changes and other than temporary impairment on a periodic basis. Changes in the reported value of other investments are reported in the consolidated statements of net income (loss) and comprehensive income (loss). As disclosed in note 3(b) to the consolidated financial statements, the Company&#8217;s investment in an option to purchase equity securities of PharmaCann, Inc. (the &#8220;PharmaCann Option&#8221;) is accounted for as an other investment without a readily determinable fair value.  To estimate the fair value of the PharmaCann Option, management uses a combination of the income and market approaches. Under the income approach, significant assumptions used in the discounted cash flow method that require the use of judgment are the discount rate, terminal growth rate, cash flow projections, and the timing of federal legalization of cannabis in the United States. Under the market valuation approach, the key assumptions which require judgment under the Guideline Public Companies method are cash flow projections, selected multiples and the discount for lack of marketability. As disclosed in note 14(a) of the consolidated financial statements, the Company&#8217;s other investment in PharmaCann Option amounted to $49,000 thousand as of December 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of the impairment assessment of PharmaCann Option as a critical audit matter. As the original cash flow projections of the investee were not prepared by management, a high degree of challenging auditor judgement was required to evaluate fair value of the investment. These assumptions were challenging to test as they represented subjective determinations of future market, economic, and legal conditions that are sensitive to variation. Minor changes to these assumptions could have had a significant </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact on the Company&#8217;s assessment of the fair value of the PharmaCann Option. Additionally, the audit effort associated with this estimate required specialized skills and knowledge.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of an internal control related to the critical audit matter. We compared the historical cash flow projections of PharmaCann to actual results to assess the Company&#8217;s ability to accurately project PharmaCann cash flows. We evaluated the reasonableness of the cash flow projections by comparing them to historical actual results, planned business initiatives, external industry reports, and peer data. We evaluated the reasonableness of the timing of federal legalization of cannabis in the United States by comparing management&#8217;s estimated timing with external industry reports and market information. In addition, we involved valuation professionals with specialized skills and knowledge, who assisted in:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assessing the discount rate used in the income approach and the multiples used in the market approach against ranges that were independently developed using peer data</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluating the terminal growth rate used in the income approach by comparing management&#8217;s assumption against external market information</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">independently developing a discount for lack of marketability and comparing to management&#8217;s assumption used in the market approach.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">/s/ KPMG LLP</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chartered Professional Accountants, Licensed Public Accountants</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2018.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaughan, Canada </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 28, 2023</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of Contents</a></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc.:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on Internal Control Over Financial Reporting </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Cronos Group Inc. and subsidiaries&#8217; (the Company) internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, because of the effect of the material weakness, described below, on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of net income (loss) and comprehensive income (loss), changes in shareholders&#8217; equity, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements), and our report dated February 28, 2023 expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. A material weakness related to the design and maintenance of effective controls over Information Technology General Controls, pertaining to user access management and the provisioning and monitoring of user access, including privileged access was identified by management. This material weakness did not impact any information derived from information systems and did not result in any identified misstatements in the financial statements. The material weakness was considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2022 consolidated financial statements, and this report does not affect our report on those consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">/s/ KPMG LLP</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chartered Professional Accountants, Licensed Public Accountants</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaughan, Canada </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 28, 2023</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_82"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:0.55pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRONOS GROUP INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2022 and 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars)</span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.207%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNC0xLTEtMS0yMTMzMzk_25c13fce-eb8d-4d6d-abc3-2b49ca3c0f45">764,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNC0zLTEtMS0yMTMzMzk_203775bc-3655-46ad-a606-86c7853e9a53">886,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNS0xLTEtMS0yMTMzMzk_83e7cb2c-e557-490d-8401-7d8fe69579b6">113,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNS0zLTEtMS0yMTMzMzk_0dcd42c1-e237-46fd-aed8-073749f927da">117,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNi0xLTEtMS0yMTMzMzk_acf55952-3d76-4b33-b8bf-74c4deef3f0a">23,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNi0zLTEtMS0yMTMzMzk_35729cff-3690-4316-9a00-89485624aaa7">22,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNy0xLTEtMS0yMTMzMzk_f4cc3aed-9d7a-42c4-b217-05a0aa8bd5bc">5,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNy0zLTEtMS0yMTMzMzk_c3e3c2bb-a2ed-4485-a408-c70a48a6302f">5,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of loans receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOC0xLTEtMS0yMTMzMzk_253143ff-817a-4b71-871d-693aadbe5be6">8,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOC0zLTEtMS0yMTMzMzk_2774aa89-a327-4fb8-b799-93b40b937169">5,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOS0xLTEtMS0yNTQxOTk_f88206ae-35f3-4c9e-a264-9207efcd9f0d">37,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOS0zLTEtMS0yNTQxOTk_2d566237-cb92-4439-916e-ab6747fc0b80">32,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOS0xLTEtMS0yMTMzMzk_b6084dc4-0a0c-4cf5-a113-79807deeb1a6">7,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOS0zLTEtMS0yMTMzMzk_02486122-63c4-4ac0-80fc-b77ca26c730d">8,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTItMS0xLTEtMjEzMzM5_117d71f7-5d66-4fb7-ac1e-95524662b803">960,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTItMy0xLTEtMjEzMzM5_8191e6ae-1164-490b-8d6c-89dad7fb2be8">1,079,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTMtMS0xLTEtMjEzMzM5_cedc55df-ea49-4445-99ca-ead87fad672f">18,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTMtMy0xLTEtMjEzMzM5_e4b0f41f-2a66-43ed-9741-d6f868a10410">16,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTQtMS0xLTEtMjEzMzM5_dc7c9379-c010-4b43-adac-fdf162e2d97f">70,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTQtMy0xLTEtMjEzMzM5_65846c20-92e5-4201-9fef-c445bacf052f">118,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion of loans receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTUtMS0xLTEtMjEzMzM5_88c5f5dc-ed9e-4a86-8c40-754516f3408a">72,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTUtMy0xLTEtMjEzMzM5_80a72a8e-8f05-4e3c-b8ed-1aafd2ab8b5c">80,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTYtMS0xLTEtMjEzMzM5_9c84311f-01f2-44ff-9a48-539a574277ba">60,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTYtMy0xLTEtMjEzMzM5_826ede38-38cb-45ec-a08f-0af632e0afef">74,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTctMS0xLTEtMjEzMzM5_1d6ee851-e118-425d-8ffe-6f54c1ea7132">2,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTctMy0xLTEtMjEzMzM5_b7eea965-f5fc-43f9-afe9-4e7c3f26243a">8,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTgtMS0xLTEtMjEzMzM5_ba0f3568-2604-4f96-a078-fbaf39d9d80f">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTgtMy0xLTEtMjEzMzM5_2649261a-ff30-48df-a4dd-d4f3a9f42c62">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTktMS0xLTEtMjEzMzM5_c69809b0-80a7-4418-9a65-fb45257fc2ba">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTktMy0xLTEtMjEzMzM5_7336b908-a5f1-4d00-a912-4c9d6d9ef4bb">18,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjAtMS0xLTEtMjEzMzM5_3a7cb776-0fea-4724-a163-809a8dc20e0e">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjAtMy0xLTEtMjEzMzM5_7f9fec71-535a-4c3d-b2f1-4ed7584e2301">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjEtMS0xLTEtMjEzMzM5_7699116d-2cf7-47e2-b42c-0331eb185bac">1,213,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjEtMy0xLTEtMjEzMzM5_efc9a1ec-28ea-4216-89cf-5cb9b31eec8d">1,397,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjQtMS0xLTEtMjEzMzM5_7171505d-cd5c-49a3-a48d-6e2e1439418e">11,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjQtMy0xLTEtMjEzMzM5_eff5893a-4f68-4ffa-ac52-bc57229f90fd">11,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjUtMS0xLTEtMjQzODY1_3282e39b-30c5-4a48-8993-017f0856a16e">32,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjUtMy0xLTEtMjQzODY1_298b34af-4c53-41dd-8f37-cf32591ee5fe">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjUtMS0xLTEtMjEzMzM5_ca6d5f3b-b5fa-46db-a9a2-177c137ccb92">22,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjUtMy0xLTEtMjEzMzM5_d87c848a-ff4f-4d5b-844f-0da7e734a026">25,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjYtMS0xLTEtMjEzMzM5_1dfbfef4-2808-46cf-9ec8-470b9b9c42e9">1,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjYtMy0xLTEtMjEzMzM5_9fe84d8c-b24e-4310-a7f7-51eb31abc85a">2,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjctMS0xLTEtMjEzMzM5_b9f338b9-4298-4f75-9031-c36a6f5c5cd5">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjctMy0xLTEtMjEzMzM5_0cd95a3f-cb45-4684-9733-91abd0623acd">14,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion due to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DueToRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjgtMS0xLTEtMjIwOTc0_ed9e6e17-b158-432a-8ae5-4ee35a502e49">384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DueToRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjgtMy0xLTEtMjIwOTc0_bd099da9-17c6-4bfe-b6b5-387d10d65893">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjgtMS0xLTEtMjEzMzM5_966c2096-4d5d-451f-8906-f371ce52345b">68,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjgtMy0xLTEtMjEzMzM5_2c0ade0d-be90-4fce-893d-79ac14f81936">54,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion due to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DueToRelatedPartiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjktMS0xLTEtMjEzMzM5_bf644089-855b-430d-a8f4-8bf5d9da49d1">1,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DueToRelatedPartiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjktMy0xLTEtMjEzMzM5_28d6d706-ccad-42f3-93c3-d6ad77586d35">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion of lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzAtMS0xLTEtMjEzMzM5_3edbace1-86a0-49f8-af9c-373e503c17b2">2,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzAtMy0xLTEtMjEzMzM5_b6d36cf4-adce-4354-98fb-36f57b531e1e">7,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzEtMS0xLTEtMjEzMzM5_3513553d-76af-464a-aaea-8d3cb19d9f20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzEtMy0xLTEtMjEzMzM5_49e1d0f5-1b16-4327-8912-e566a96c4f71">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzItMS0xLTEtMjEzMzM5_df2c0267-95d6-40ba-9d90-69d2e5f8e8f8">72,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzItMy0xLTEtMjEzMzM5_87fbf22d-8611-4092-8287-d1309a501435">63,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital (authorized for issue as of December 31, 2022 and 2021: unlimited; shares outstanding as of December 31, 2022 and 2021: <ix:nonFraction unitRef="shares" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzUtMC0xLTEtMjEzMzM5L3RleHRyZWdpb246Y2RmNjQ2MTU4ZjczNDkzMWIyODQ5YWI3MGE0MTE4MzVfMzg0ODI5MDY5NzQ0OQ_69fac538-4c3d-4afd-b66b-9ce15a2483c7">380,575,403</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzUtMC0xLTEtMjEzMzM5L3RleHRyZWdpb246Y2RmNjQ2MTU4ZjczNDkzMWIyODQ5YWI3MGE0MTE4MzVfMzg0ODI5MDY5NzQ2Mw_3357c605-8671-47ff-8508-3fbec62249c3">374,952,693</ix:nonFraction>, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzUtMS0xLTEtMjEzMzM5_9799233a-96bc-495e-9f2a-05712e5f9b05">611,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzUtMy0xLTEtMjEzMzM5_4aa8be29-4919-4c44-bf82-0169ed02fa0d">595,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzYtMS0xLTEtMjEzMzM5_8d57a0a3-d672-49d4-9e6e-1498d3025931">42,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzYtMy0xLTEtMjEzMzM5_f716fd87-72ba-44ab-9bf9-8dc853c2b4b6">32,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzctMS0xLTEtMjEzMzM5_d79295d3-a61e-481b-84aa-1d9391d61581">490,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzctMy0xLTEtMjEzMzM5_0e742b1c-51f0-4845-9bd5-fa053ff93427">659,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzgtMS0xLTEtMjEzMzM5_ebe5dc62-7bc8-4dab-bf3b-8bdbd81b72fa">797</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzgtMy0xLTEtMjEzMzM5_2f46b9a9-9f35-4885-8a0c-50088064275b">49,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity attributable to shareholders of Cronos Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzktMS0xLTEtMjEzMzM5_30a0bc9a-e629-4ac4-aa0d-0f42624b15ba">1,143,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzktMy0xLTEtMjEzMzM5_6335c5a7-0953-4276-a35e-c28e7b68a9a4">1,337,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" sign="-" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDAtMS0xLTEtMjEzMzM5_b0da9b60-9492-4538-aab5-797e70ae894b">2,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" sign="-" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDAtMy0xLTEtMjEzMzM5_d83f6a96-1132-4100-89fb-e4a3bb4a9543">2,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDEtMS0xLTEtMjEzMzM5_75c7a4c7-eda9-4bbc-a670-9ae2ce951e31">1,140,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDEtMy0xLTEtMjEzMzM5_dcb994be-fd01-472d-873f-6e1a849aeb8f">1,334,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDItMS0xLTEtMjEzMzM5_994d551f-568b-42b4-92c7-62e97f33e38a">1,213,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDItMy0xLTEtMjEzMzM5_2543ea77-61a5-4d2d-9445-b792c2167a66">1,397,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_85"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars, except share and per share amounts)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue, before excise taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMi0zLTEtMS0yMTMzMzk_2441ed6c-0182-498f-b65b-cf94f1126900">114,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMi01LTEtMS0yMTMzMzk_d096ec67-c055-4df2-b9e5-fc1d8d07287c">89,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMi03LTEtMS0yMTMzMzk_ee662487-9029-49d5-9628-7776b81b4d5f">54,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ExciseAndSalesTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMy0zLTEtMS0yMTMzMzk_3f056991-90c3-47a2-80b9-cf1c8fae579f">22,552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ExciseAndSalesTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMy01LTEtMS0yMTMzMzk_e3f3cab2-779e-4087-8fad-25f4d6953590">15,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ExciseAndSalesTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMy03LTEtMS0yMTMzMzk_dde556fa-57d5-40e3-b3f9-66cd7c957b70">7,634</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNC0zLTEtMS0yMTMzMzk_a6170dc4-b54d-4e5e-9361-5f56878fd680">91,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNC01LTEtMS0yMTMzMzk_406f29cf-423a-4371-84bc-0f47bd73d957">74,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNC03LTEtMS0yMTMzMzk_49733b38-5b76-4ef6-9784-aecbd6466e93">46,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:OtherCostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNS0zLTEtMS0yMTMzMzk_3c989992-b559-41f9-81a0-e0fb551681b8">79,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:OtherCostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNS01LTEtMS0yMTMzMzk_4937c73b-aecf-4ad9-b550-c487a3ccb1fc">80,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:OtherCostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNS03LTEtMS0yMTMzMzk_a1bd03b6-f8f9-4be1-b200-fc84005a36a6">46,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNi0zLTEtMS0yMTMzMzk_080cb5eb-a1f5-404e-8be1-e2e4494c238c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNi01LTEtMS0yMTMzMzk_547865cb-0b52-4b83-9d14-81e38fc07fc8">11,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNi03LTEtMS0yMTMzMzk_bee7e8c8-026f-474d-b6f9-a05f30f99aa4">26,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNy0zLTEtMS0yMTMzMzk_bd1b36f0-0939-4d41-a072-eb70ddfbf340">11,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNy01LTEtMS0yMTMzMzk_659f60e0-0a0e-4948-ba6f-a02fb2e83a2b">17,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNy03LTEtMS0yMTMzMzk_4a79f9c1-7e3e-45d4-9685-7cef65e1e940">25,833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfOS0zLTEtMS0yMTMzMzk_0a286564-297e-4132-a617-7543be3176de">22,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfOS01LTEtMS0yMTMzMzk_4da938ef-ab19-497b-aad4-d8947b998384">44,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfOS03LTEtMS0yMTMzMzk_96b69170-bb11-4fa1-8662-b106c932a3ed">34,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTAtMy0xLTEtMjEzMzM5_319fadc6-10f6-4868-b8f4-274a443b1070">13,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTAtNS0xLTEtMjEzMzM5_5914cbe1-a7a6-43f0-b403-ee3f7c5beee8">23,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTAtNy0xLTEtMjEzMzM5_9ea31dcd-81d2-4c51-8871-7ed2be9e8471">20,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTEtMy0xLTEtMjEzMzM5_d3c2d472-91f9-4c38-baa3-e176645a9a65">71,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTEtNS0xLTEtMjEzMzM5_92bb8559-df99-41af-94dd-e9eebc4c7294">96,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTEtNy0xLTEtMjEzMzM5_0664a54a-d74a-4767-ae77-501b5ca24c28">80,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItMy0xLTEtMjQwODY2_eb4a1135-d5fb-4050-ab15-ea65b570c14f">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItNS0xLTEtMjQwODY2_277ac942-a2f4-478b-81e2-13a542550f1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItNy0xLTEtMjQwODY2_446f3699-0deb-4c56-afa8-f439cd813d78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItMy0xLTEtMjEzMzM5_4895db4b-0848-4f41-93bb-526037a6c53c">15,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItNS0xLTEtMjEzMzM5_476fb819-9a69-4778-922f-4f2fd1eb4ae1">10,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItNy0xLTEtMjEzMzM5_f12a559e-3068-461e-9abb-e23502b00ab7">15,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTMtMy0xLTEtMjEzMzM5_621667da-50a6-45d6-a708-bf4613e79ec9">6,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTMtNS0xLTEtMjEzMzM5_bbd72913-256c-4e6b-89f6-64a35959f2d7">4,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTMtNy0xLTEtMjEzMzM5_fbbf38d8-1b50-4561-af6f-b4e15d4becc5">2,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTQtMy0xLTEtMjEzMzM5_f311bf81-506f-4e9d-bf5e-2ef22eb527d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTQtNS0xLTEtMjEzMzM5_f74745be-585a-4fe8-a995-e62d2923d60e">236,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTQtNy0xLTEtMjEzMzM5_1e1b9d70-ece9-4721-b31d-ad3fa2146997">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTUtMy0xLTEtMjEzMzM5_ffcf690d-99a2-4d64-a48f-98221a0ed970">3,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTUtNS0xLTEtMjEzMzM5_11b1cbf3-8d7b-450f-9e67-47792ea683a2">127,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTUtNy0xLTEtMjEzMzM5_2b8a403f-a8eb-4e8d-8fef-691096712b75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTctMy0xLTEtMjEzMzM5_34ada74e-471c-46b4-8cae-fd2875a044b9">136,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTctNS0xLTEtMjEzMzM5_1696f82f-9f51-4ca8-bd67-d27fa8edbfa1">543,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTctNy0xLTEtMjEzMzM5_e4ed543e-64e9-459d-9d46-541d276147f4">193,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTgtMy0xLTEtMjEzMzM5_54a3d3d4-acca-40f0-b289-a40dc7ecad24">124,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTgtNS0xLTEtMjEzMzM5_ed9a3a8a-b661-4836-b4a2-70213dec5521">560,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTgtNy0xLTEtMjEzMzM5_e69c8540-5037-473c-9a42-befda8d236f2">219,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjAtMy0xLTEtMjEzMzM5_661f93d3-64f1-45c7-8cf5-ce029f1a75f1">22,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjAtNS0xLTEtMjEzMzM5_a74757f9-1975-4df1-b9a4-a6e623e22b35">9,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjAtNy0xLTEtMjEzMzM5_4d28b72e-a6ff-43db-a59b-f18d66e4fc2a">18,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjEtMy0xLTEtMjEzMzM5_3c44b258-6f1f-49ea-a845-3172a8d7ee2e">14,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjEtNS0xLTEtMjEzMzM5_4ddc4bc3-743f-46f6-ae90-9383471e1a8b">151,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjEtNy0xLTEtMjEzMzM5_cd59b1a5-9681-4005-9f57-f9643d5f6c65">129,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income (loss) from equity method investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjMtMy0xLTEtMjEzMzM5_74a6ee85-b2ea-4130-95cf-f2e9c8a05e33">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjMtNS0xLTEtMjEzMzM5_d7201494-f2dc-4dc5-ac9e-387beea43195">6,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjMtNy0xLTEtMjEzMzM5_84ee75f9-192c-4913-ab6e-d865c1d3687b">4,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on revaluation of financial instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtMy0xLTEtMjEzMzM5_c3932c39-bd5b-4a76-96e4-5544cbcd0071">14,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtNS0xLTEtMjEzMzM5_99a3f229-e316-4b0c-b687-d5bf699c8fa4">8,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtNy0xLTEtMjEzMzM5_7d8a6972-c62f-44c3-8861-aff6a65ca3da">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on other investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtMy0xLTEtMjM0NzA0_c6d8a8a4-29ce-4feb-abf7-5da16f8ff190">61,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtNS0xLTEtMjM0NzA0_befa1e69-5d31-40b3-9538-8840e9ea9394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtNy0xLTEtMjM0NzA0_7bcb96d4-6610-4512-967a-b5990cfc3d85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtMy0xLTEtMjM0NzA0_10d0df3b-d307-4d61-81b1-4086af699873">2,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtNS0xLTEtMjM0NzA0_348f1092-17d8-4013-a110-865283f22370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtNy0xLTEtMjM0NzA0_2fe8fcf2-43ca-4f94-bdfd-83af69f554cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtMy0xLTEtMjMwMjky_5cdb6396-7c88-42d2-acfa-120d371ef4b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtNS0xLTEtMjMwMjky_4ac4fbea-f6b5-4b4b-b83e-02f4aec2cd65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtNy0xLTEtMjMwMjky_7380035e-14a1-44c3-8a8c-0312784292b6">4,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjYtMy0xLTEtMjEzMzM5_2fc29df0-1270-4156-ad19-71964a8e7527">493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjYtNS0xLTEtMjEzMzM5_23fa947c-7bd3-45c0-9410-130482e2e268">730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjYtNy0xLTEtMjEzMzM5_d2c013ed-5d7b-42a6-a4a5-304d283495e9">1,825</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjctMy0xLTEtMjEzMzM5_d1db247b-b01e-4f35-9ce2-23d58aa56392">9,721</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjctNS0xLTEtMjEzMzM5_344ee8da-deda-41b5-9bc3-567e3fad1ed7">163,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjctNy0xLTEtMjEzMzM5_007b22ea-310f-40a7-98f2-5e953e419b2d">146,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjgtMy0xLTEtMjEzMzM5_23c91309-4c0b-4f8d-b55e-1a523d145d02">134,559</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjgtNS0xLTEtMjEzMzM5_491a1384-bab8-489d-9180-4db8a52d565f">397,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjgtNy0xLTEtMjEzMzM5_bc4fbde3-bda7-4679-83cd-9a6616bdc047">73,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjktMy0xLTEtMjEzMzM5_7d1d0edb-15e0-4f96-93e3-4dc3c4477e89">34,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjktNS0xLTEtMjEzMzM5_8bae9fc9-8ed3-47c1-9878-e7f8208cdd58">431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjktNy0xLTEtMjEzMzM5_07aec197-42f4-4e8b-8604-d386036c7fe9">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzAtMy0xLTEtMjEzMzM5_3bd65a5f-60c1-4210-9aa6-6806a338f2a3">168,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzAtNS0xLTEtMjEzMzM5_14e30b07-4929-4e7d-bc93-3a0ab25d78bd">396,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzAtNy0xLTEtMjEzMzM5_4ed6204c-42fb-4e68-aeb0-a702e2806e0a">74,620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzEtMy0xLTEtMjEzMzM5_01067500-1134-4223-9ce3-bd44edc4182b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzEtNS0xLTEtMjEzMzM5_474c9e88-771e-4d39-a25a-a948c08a8630">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzEtNy0xLTEtMjEzMzM5_e7011e25-6ca5-481b-90bd-b7927a80a222">650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzItMy0xLTEtMjEzMzM5_853b0e51-e5ec-4749-8ef5-4027e7170dfe">168,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzItNS0xLTEtMjEzMzM5_f7a49cfc-7928-41d8-8095-6b35d89a41f9">397,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzItNy0xLTEtMjEzMzM5_4656bd76-ab60-4acc-8c17-dd88fff73745">75,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzMtMy0xLTEtMjEzMzM5_d448a44b-5a64-4b50-bca8-551439fd3ae4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzMtNS0xLTEtMjEzMzM5_ac7dd667-50fb-495e-a70e-3213a89b29ca">1,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzMtNy0xLTEtMjEzMzM5_b406b5c2-0dc2-4a89-a422-5556b5ad39f4">2,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss attributable to Cronos Group</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzQtMy0xLTEtMjEzMzM5_ee6a2074-7d3b-450f-9753-f8916b907153">168,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzQtNS0xLTEtMjEzMzM5_4fb2707a-05a9-45df-8aeb-9a57d03880f1">396,107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzQtNy0xLTEtMjEzMzM5_7220fdfd-4627-4a91-aba7-cad30200d0f4">73,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzctMy0xLTEtMjEzMzM5_77f632fe-366b-4194-a611-4a223f3b10fe">168,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzctNS0xLTEtMjEzMzM5_d7cee2c8-c77d-4c77-9d00-74f88147c63d">397,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzctNy0xLTEtMjEzMzM5_feea7c7e-3c0e-48a9-bbeb-5a8bc6a4a15c">75,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss) on translation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzgtMy0xLTEtMjEzMzM5_cc9c6282-b030-47e4-8e7d-57ba549b0e7d">50,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzgtNS0xLTEtMjEzMzM5_db13a0dc-81c8-40b8-99a4-ad6f4e466a2b">8,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzgtNy0xLTEtMjEzMzM5_e8150ce0-b780-4459-9a18-d6c6ce21af2f">14,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzktMy0xLTEtMjEzMzM5_4fbe6c1c-4ad4-40b0-9bd7-3bdf7a684b5b">219,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzktNS0xLTEtMjEzMzM5_1802a5da-51fe-4c71-a614-eee10fb7ed41">389,012</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzktNy0xLTEtMjEzMzM5_3996946d-4bca-4802-a02b-7a1f3ec9696e">60,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to non-controlling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDAtMy0xLTEtMjEzMzM5_51b4867c-81be-4e78-959b-421f80714c2a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDAtNS0xLTEtMjEzMzM5_8a23ba01-92ce-4a78-b726-2e3080ff770d">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDAtNy0xLTEtMjEzMzM5_bb12a9c5-284b-48a9-a87b-ddafc5ed42b4">2,343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive loss attributable to Cronos Group</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDEtMy0xLTEtMjEzMzM5_4d8948b2-cc15-4eeb-9e9a-d52de1c0e488">219,396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDEtNS0xLTEtMjEzMzM5_2080416e-f70b-4ffe-ab20-37f95d1ef953">389,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDEtNy0xLTEtMjEzMzM5_6494535b-74e5-48b7-bd1f-d784f21eeacf">57,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss from continuing operations per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDMtMy0xLTEtMjEzMzM5_32cd0c2e-bcb3-410d-8773-5815461f1a99">0.45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDMtNS0xLTEtMjEzMzM5_c75827b9-b62e-4fac-91ce-30f9b824dfe9">1.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDMtNy0xLTEtMjEzMzM5_29c6a542-42b9-4455-ac50-0764a09ebfdf">0.21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDQtMy0xLTEtMjEzMzM5_83bc4791-1822-4082-b149-1b1ead855e03">0.45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDQtNS0xLTEtMjEzMzM5_60e71588-2860-4eaf-b04b-cf99b9997761">1.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDQtNy0xLTEtMjEzMzM5_31b0cfc0-7bf3-4ab2-9c43-b34163f8665c">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_88"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Shareholders&#8217; Equity</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars, except number of share amounts)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i213ce03ecaa746eab2dd1a12204b5ccb_I20191231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0xLTEtMS0yMTg0ODU_99cb4cf2-e8b9-4c76-93a0-69adee92deb5">348,817,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213ce03ecaa746eab2dd1a12204b5ccb_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0zLTEtMS0yMTg0ODU_e79be766-843f-4c29-8c2c-d81eb0882579">561,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib50e3b8695d94270935d4f85da07fcb2_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS03LTEtMS0yMTg0ODU_4bfb3d15-13d6-46e8-a997-6fb0910d760a">23,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448ef8d1aafa463180aab6c0b5778fb3_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS05LTEtMS0yMTg0ODU_67199d52-e303-47e7-bff4-451bffec942a">1,137,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14979ed24a294d07bdc9b963b74b1dcf_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0xMS0xLTEtMjE4NDg1_a6a59759-3f18-4238-90bf-dd696f9a5990">27,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib07031e3e0734b5f9e1f8b89fae01580_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0xMy0xLTEtMjE4NDg1_d336f470-047a-4818-8f40-a5f0bde9f8c9">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7574c68cc08a473a9f7033bdb1a91792_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0xMy0xLTEtMjQ2MTgz_5357c282-5838-47db-bc11-093a15383fe0">1,749,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activities relating to share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e8196a7813644b399d45186e643bd4c_D20200101-20201231" decimals="INF" name="cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTAtMS0xLTEtMjE4NTUy_f4af89fb-0599-4a03-97ac-ab37f4087e28">11,435,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e8196a7813644b399d45186e643bd4c_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTAtMy0xLTEtMjE4NTUy_5be73c0a-4829-4845-b729-fe70d2beb472">8,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73de768913af4a8da7accde843797e61_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTAtNy0xLTEtMjE4NTUy_ae16d78e-ec4c-4a90-bb71-03bc0b404735">11,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNC0xMy0xLTEtMjQ2MjEy_f1bd3bd8-7d59-411f-a815-9d8dcac97732">19,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia825a868fcc44019a5f6ff3e5a1698c1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTEtOS0xLTEtMjE4NTUy_cd022cb4-7788-4bd3-9389-8a824b67c28f">73,137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43046ab9dce94a239d679a89675b6368_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTEtMTMtMS0xLTIxODU1Mg_20b7197b-9ce7-4d23-a966-eab380b0d583">2,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNS0xMy0xLTEtMjQ2MjA2_0d7a7b77-3168-47b3-b834-88fc22f7c374">75,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss) on translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f8709ce2cc42e3956edf7fa925bc71_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtMTEtMS0xLTIxODU1Mg_0a0c4515-3d1c-4d5a-8257-55810bb1c728">15,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43046ab9dce94a239d679a89675b6368_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtMTMtMS0xLTIxODU1Mg_e2e26e3f-f762-471d-a229-01727c4a0e37">210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNi0xMy0xLTEtMjQ2MjA2_46790e1b-4da1-4ef2-b55c-5cebba497c41">14,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4e374eda0848449ea8abee147ccfef6f_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy0xLTEtMS0yNDYxODE_35235631-4844-41f4-a18f-0515b2c736f7">360,253,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e374eda0848449ea8abee147ccfef6f_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy0zLTEtMS0yNDYxODE_07e75cbb-33a5-4032-a6f4-e1834a406974">569,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0581d281ad4b2187170fcbcc40f7bf_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy01LTEtMS0yNDYxODE_233a2101-15ac-455f-98b0-b5e724a6e41d">34,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd33bd509f964d42a39a9c38e627d5ea_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy03LTEtMS0yNDYxODE_95da8764-0d81-443b-b065-205aca3bdb07">1,064,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i624b48e5e23148ebbee8fa21083aed6d_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy05LTEtMS0yNDYxODE_c597bc8b-78c1-47ea-b1b2-c05035ef9652">42,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94bb0b34a94244f4a78a9b4196581628_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy0xMS0xLTEtMjQ2MTgx_f769aeb9-39a8-4229-b567-d66342a74e64">3,196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy0xMy0xLTEtMjQ2MTgx_7a45a546-d6ad-4409-9470-a17609c86690">1,708,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activities relating to share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231" decimals="INF" name="cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTctMS0xLTEtMjE4NTYy_06e3ab4f-93c1-4f52-b181-7fb8fd8c4663">11,764,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTctMy0xLTEtMjE4NTYy_5a9afb40-e963-4274-883b-f1cc359ab710">7,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad0e599ac854e9584dfae6fd1a9dde7_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTctNy0xLTEtMjE4NTYy_d5caf7bf-98c7-4c4d-813b-3ad6ede55c9a">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa6161e6218e4dbcaa62bb22e7be9255_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTctOS0xLTEtMjE4NTYy_553aeae7-7121-4835-bca8-c670301343a5">12,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTAtMTMtMS0xLTI0NjIwNA_6d9c03ad-6058-4548-86d3-574badae23e7">2,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance pursuant to research and development milestones</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231" decimals="INF" name="cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTgtMS0xLTEtMjE4NTc3_10df1b6a-dd7b-48db-8de5-c8cd17f3ee9f">2,934,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231" decimals="-3" name="cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTgtMy0xLTEtMjE4NTc3_434f9afd-9168-436d-8d94-b7d5b01241cb">17,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTEtMTMtMS0xLTI0NjIwNA_9d92c832-e9bf-4e2c-b5ef-3cd92d93adc7">17,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated restricted share units vesting out-of-period adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItMy0xLTEtMjUyNTY2_60b6c8a3-edd5-4165-9a34-7c1965a75770">4,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ad0e599ac854e9584dfae6fd1a9dde7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItNS0xLTEtMjUyNTc0_c9bb28a7-b316-40a4-9dbf-0d2675815db3">4,802</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItMTMtMS0xLTI1Mjk3MA_9ed67a4f-6683-48b0-8b4f-4e35da62c114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up rights out-of-period adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231" decimals="-3" sign="-" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItMy0xLTEtMjI5MjMx_8e7c6fbd-0bf3-4ebb-8289-158d4c68f10c">3,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6161e6218e4dbcaa62bb22e7be9255_D20210101-20211231" decimals="-3" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItOS0xLTEtMjI5MjMx_6b41bd8a-9411-4432-bfb4-924914edc524">3,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItMTMtMS0xLTI0NjIwMQ_dec4922f-8f0e-4f64-ae10-18cb868d420b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa6161e6218e4dbcaa62bb22e7be9255_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtOS0xLTEtMjI5MjMx_7dfb5aae-0bf8-439d-a317-d093e7ec9a64">396,107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic024c83103194eceabada95ba475ab43_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtMTMtMS0xLTIyOTIzMQ_ce48beeb-db9f-4d7d-b3e1-f75606357045">1,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtMTMtMS0xLTI0NjE5Nw_20f51184-65e4-4708-88a0-a5e60d0c7db0">397,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain on translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i666176ccf3e84f1da351ed843f82f2ad_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTktMTEtMS0xLTIxODU3Nw_4125f974-7c1e-4197-92cd-740ab1b25d26">6,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic024c83103194eceabada95ba475ab43_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTktMTMtMS0xLTIxODU3Nw_113f85ce-b651-41cb-a46b-e7a23da74965">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTQtMTMtMS0xLTI0NjE5Nw_bad3f4db-f438-4eb5-9182-f3ab2b6488b0">8,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a99d4e9305649348953f54c8a8a0f17_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMS0xLTEtMjE4NTYy_107ff611-2da5-4236-8e73-84a8d64354fc">374,952,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a99d4e9305649348953f54c8a8a0f17_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMy0xLTEtMjE4NTYy_6a5ec7c6-b2c0-49d7-bb31-874af65c3d9f">595,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34357931c29142239fb75a5dd657419f_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtNy0xLTEtMjE4NTYy_cdcd2ddd-abc4-4505-8f6b-12bfdf2d8ce8">32,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04edac1c57f34e7d9b98b2c80dc5b8bc_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtOS0xLTEtMjE4NTYy_953cc3bf-306a-4fdc-b491-0c6d18976949">659,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f39217946e4a43885410306e996d66_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMTEtMS0xLTIxODU2Mg_80c34fbd-bced-49f2-8191-88d5edc89473">49,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a005033016542a286a1ee76f9592489_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMTMtMS0xLTIxODU2Mg_4e13e7b7-100a-4e84-8630-faff0854c60e">2,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTUtMTMtMS0xLTI0NjE3OQ_c2e082a0-53cb-487c-bfb4-7621db959fab">1,334,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activities relating to share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05001d975789445693497618980033e5_D20220101-20221231" decimals="INF" name="cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjQtMS0xLTEtMjE4NjUx_4e02fb76-eb2e-43ae-9326-14cfa67a79eb">1,464,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05001d975789445693497618980033e5_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjQtMy0xLTEtMjE4NjUx_a864c28b-4eeb-4414-b14f-951be2735649">4,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69ca1c9942e41d49a89eb53eae07a00_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjQtNy0xLTEtMjE4NjUx_6410d9ba-4b31-4e3a-b4c3-95fe65a4b83b">10,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTgtMTMtMS0xLTI0NjE5NA_5e104803-411b-4b2f-9cd3-189a8eee8b3d">14,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance pursuant to research and development milestones</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05001d975789445693497618980033e5_D20220101-20221231" decimals="INF" name="cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjUtMS0xLTEtMjE4NjUx_aed52021-69be-4d51-bc67-ea29405e9d65">4,157,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05001d975789445693497618980033e5_D20220101-20221231" decimals="-3" name="cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjUtMy0xLTEtMjE4NjUx_9090ba91-7693-4491-91af-e97063b9a999">11,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTktMTMtMS0xLTI0NjE5MQ_a3dc60ec-6309-488e-abdd-400ff505d5dc">11,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bbf485b421d43959849aa8ccb24d1ca_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjYtOS0xLTEtMjE4NjUx_975aa5ad-ff28-43e3-a5a3-447e0289a85b">168,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMTMtMS0xLTI0NjE4OA_aec754a5-d0e9-4b2f-be66-4ff2a0bd8fcd">168,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss) on translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45c43df2327b4eb88372d7d82971481a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjctMTEtMS0xLTIxODY1MQ_505fc647-086a-49bb-a46b-14be4e8507f4">50,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b659e27464370a05a56fed607e84e_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjctMTMtMS0xLTIxODY1MQ_5f601fcf-a8aa-410d-8be6-ad31adeacee0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjEtMTMtMS0xLTI0NjE4Ng_2bed180c-1e49-4ee5-a61e-f448bf08b73f">50,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia421331670e443fd88c2f5410409c16c_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMS0xLTEtMjI5NDQ0_c9faf963-b65f-4b68-b0a1-7dcabec9a60a">380,575,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia421331670e443fd88c2f5410409c16c_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMy0xLTEtMjI5NDQ0_54a58684-804d-490b-a9e8-392848820883">611,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88cfcb6b7e764fdda895416627f0ac54_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItNy0xLTEtMjI5NDQ0_598c3b2a-31be-448f-a6a2-df578a56b3cc">42,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a60350c90304904bad11f71d612fc4f_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItOS0xLTEtMjI5NDQ0_309a43eb-e4f4-4ded-b876-0b33cb4a9105">490,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i048ebc278983416fac723c6b21abb062_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMTEtMS0xLTIyOTQ0NA_fb96c50d-bcd7-408a-873e-b681e452eb22">797</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdadd4591de7465e96d360ee40a08559_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMTEtMS0xLTI0NjE3NA_2a3d2b12-fe58-479a-958a-244ec2fcd2bb">2,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMTMtMS0xLTI0NjE3NA_da4b7529-61e0-441a-bb04-4da7fe37f857">1,140,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_91"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMy0xLTEtMS0yMTMzMzk_1be52928-331e-49c2-b643-bdbf55bb07a5">168,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMy0zLTEtMS0yMTMzMzk_6e2a5e2c-3969-498f-8090-e817b1891439">397,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMy01LTEtMS0yMTMzMzk_7245d827-e5e2-4269-aa66-838387d34df8">75,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNS0xLTEtMS0yMTk4OTM_09309ce0-9015-4e9d-b938-8b0d67103c3a">15,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNS0zLTEtMS0yMTk4OTM_aa262722-ef1c-4812-9c14-252b16f1adbe">10,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNS01LTEtMS0yMTk4OTM_20c9e4fc-7427-40f6-abe5-ed505a68381b">15,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi0xLTEtMS0yMTk5MTA_80f72ecc-1b71-4832-9a86-074134e5cc1a">13,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi0zLTEtMS0yMTk5MTA_e00e58be-3bb3-483f-92b2-5e7a35c30934">15,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi01LTEtMS0yMTk5MTA_29a89c8b-5c09-4615-bb48-5019185efd3c">7,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi0xLTEtMS0yMTMzMzk_5ee02bc2-80c8-4270-acf7-803553c405bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi0zLTEtMS0yMTMzMzk_f7db787a-0a99-45a4-950a-34e9eca2b695">236,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi01LTEtMS0yMTMzMzk_c6f3b772-b051-4970-9b8b-6132c47162a5">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNy0xLTEtMS0yMTMzMzk_b949d88b-cf21-497b-b4f7-eb7bff1f065d">3,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNy0zLTEtMS0yMTMzMzk_8e96fdfb-3b2e-48af-9da4-da01f0cbbd5a">127,619</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNy01LTEtMS0yMTMzMzk_b9448d43-8008-411d-a457-742426813278">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC0xLTEtMS0yMTk4Nzc_2dac8cef-a8dd-406a-a5f5-8e37a7303e13">61,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC0zLTEtMS0yMTk4Nzc_58753da7-4ddc-4fce-9292-e6fc730e6931">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC01LTEtMS0yMTk4Nzc_906f6ef1-6c10-4f06-ad8e-4a5e3bc48a4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss from investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtMS0xLTEtMjE5OTIx_95ee51d3-abe5-46ab-a807-3f9cd3b0278e">17,853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtMy0xLTEtMjE5OTIx_b4261f33-2994-4209-acda-82af501ffd13">1,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtNS0xLTEtMjE5OTIx_aca88184-ffbc-482c-898c-3cc2242bc613">4,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtMS0xLTEtMjE5OTQw_f7c74e16-5f7e-4dd8-ae3f-184a6e22154f">14,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtMy0xLTEtMjE5OTQw_da629b41-27a2-46a6-a39e-f579a9c3cc43">151,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtNS0xLTEtMjE5OTQw_15dd16a2-5231-4e87-8aa6-b4ba08e49970">129,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in expected credit losses on long-term financial assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC0xLTEtMS0yMTMzMzk_3d03f1fe-eafd-4c10-a5d6-875ea50d8c40">662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC0zLTEtMS0yMTMzMzk_4d185de6-faad-450c-9a0e-20eaeb2dcda3">12,202</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC01LTEtMS0yMTMzMzk_d068f21c-57f8-444b-b0cf-1fc144ef0ae2">2,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:GainLossOnDisposalOfInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTItMS0xLTEtMjEzMzM5_583ed865-9154-4bcf-9017-0dc4b342e985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:GainLossOnDisposalOfInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTItMy0xLTEtMjEzMzM5_bf9e2045-3f7b-4e3f-bbac-a2f355ae918f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:GainLossOnDisposalOfInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTItNS0xLTEtMjEzMzM5_2787608e-c08b-4adf-99e8-2dff3e285c18">4,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:NoncashSellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTQtMS0xLTEtMjEzMzM5_212c2982-3c43-43fa-b0ad-6afa543ce075">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:NoncashSellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTQtMy0xLTEtMjEzMzM5_f2ce7daa-2677-4f7e-b754-a3f3c9e87f9f">1,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:NoncashSellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTQtNS0xLTEtMjEzMzM5_fb567217-5b09-4082-8723-e8037fcf57fd">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtMS0xLTEtMjIwMDAw_222b8404-ee70-43d2-b790-d9ccaf1174a2">2,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtMy0xLTEtMjIwMDAw_85eea79d-6504-4c66-a43c-7dcc38b30c4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtNS0xLTEtMjIwMDAw_a8ab635a-3b98-49b6-a534-eff98c4f347e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash operating activities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtMS0xLTEtMjEzMzM5_80df93c6-e07d-423d-8794-2c6f8b38216c">4,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtMy0xLTEtMjEzMzM5_7571d6c8-5da6-4616-9277-87fad2478445">3,886</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtNS0xLTEtMjEzMzM5_e23c5e5e-9f75-48ea-b33c-59a54c013778">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTgtMS0xLTEtMjEzMzM5_321fa247-5304-49e3-a4ab-f1e749f02ae3">2,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTgtMy0xLTEtMjEzMzM5_11cdb19e-1c7b-46f0-81ac-d77b18d04c55">13,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTgtNS0xLTEtMjEzMzM5_898bbfba-13c9-46b1-9464-b87408f162e3">4,724</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTktMS0xLTEtMjEzMzM5_cdf8365a-b0ec-499d-9c85-d1bf789a5e3c">833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTktMy0xLTEtMjEzMzM5_0a71efac-3e17-465d-8b6f-c7048f536c99">3,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTktNS0xLTEtMjEzMzM5_47785de1-1f6d-4997-b45c-ac35cfc82528">5,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjAtMS0xLTEtMjEzMzM5_d98b83df-6b21-4856-b857-723bbcf84fb0">996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjAtMy0xLTEtMjEzMzM5_36dd5e21-990f-4f6d-a939-a8e1a0ccaece">3,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjAtNS0xLTEtMjEzMzM5_d78b8c31-eee3-4bef-817c-43587bc01b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjEtMS0xLTEtMjEzMzM5_f3e57645-f3d7-492c-8837-e808b16dbaea">7,217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjEtMy0xLTEtMjEzMzM5_6e19c9ca-6719-4bae-939e-b6b5499df12e">11,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjEtNS0xLTEtMjEzMzM5_6bea2a16-3a95-45d3-b8d0-85b26bfbc0c1">735</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjItMS0xLTEtMjEzMzM5_8d42aecd-28ab-4da4-a6e4-ec1ee0926c58">863</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjItMy0xLTEtMjEzMzM5_651f3a97-bde9-4699-af70-3f7448817e92">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjItNS0xLTEtMjEzMzM5_3d876df6-9104-45d0-92fe-f1731bced0bf">2,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjUtMS0xLTEtMjQ0NDMx_a4b804b2-e5f7-4b97-82c8-a46cb6264c26">34,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjUtMy0xLTEtMjQ0NDMx_fa0e3c58-cf00-4531-a0db-91ac41d45521">776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjUtNS0xLTEtMjQ0NDMx_84808bec-2e15-4855-91cb-40cf8879765a">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjMtMS0xLTEtMjEzMzM5_966c214f-cad6-4b49-bec6-18ef851e4b06">2,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjMtMy0xLTEtMjEzMzM5_c90eae55-4a50-4a1c-9a2e-113e8f3c7794">4,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjMtNS0xLTEtMjEzMzM5_78a297fc-e620-46ae-8983-937639d2d473">5,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjQtMS0xLTEtMjEzMzM5_64d30dea-b2a1-42c7-92f6-a94ab3c239ca">88,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjQtMy0xLTEtMjEzMzM5_a461e39e-ce7a-45a1-912c-ed85ce01c65f">153,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjQtNS0xLTEtMjEzMzM5_eb8d9702-e799-4457-86ab-6db4cebb39a9">144,871</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjctMS0xLTEtMjEzMzM5_48f9d01a-11df-4a15-9bd2-0800ed69cdb5">268,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjctMy0xLTEtMjEzMzM5_a64bc775-b4f1-4894-aa32-68f78b61caea">215,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjctNS0xLTEtMjEzMzM5_e691de28-4a13-4b6d-bf63-4d2a61cdd82d">296,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjgtMS0xLTEtMjEzMzM5_844afe06-cf6e-4f03-b417-2596651068ed">271,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjgtMy0xLTEtMjEzMzM5_70022748-efcc-4d6e-909a-e3efcebf0b57">119,610</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjgtNS0xLTEtMjEzMzM5_15ba70c4-02cf-4279-a9ee-ab7ef43b42da">201,326</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjktMS0xLTEtMjEzMzM5_adad4ea9-8c17-4b39-a873-a57a624325c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjktMy0xLTEtMjEzMzM5_a2b4f46e-90c9-4f28-b86b-17c9821e00ee">110,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjktNS0xLTEtMjEzMzM5_765fa4d1-a104-4e6c-af2c-5b5d095eec18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:ProceedsFromDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzEtMS0xLTEtMjM5MTQw_7aa2f247-bf74-4c6d-9b99-f9ee84f8040f">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:ProceedsFromDividends" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzEtMy0xLTEtMjM5MTQw_efb7636b-d690-4d0a-b334-ee3b669c2d7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:ProceedsFromDividends" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzEtNS0xLTEtMjM5MTQw_6aa95230-ecb5-4f3f-9134-7d03b1aed771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments (advances) on loan receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzItMS0xLTEtMjEzMzM5_f51ae80e-6dff-43f8-aa1a-281daef7ec55">5,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForProceedsFromLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzItMy0xLTEtMjEzMzM5_9765f580-3366-4cbd-b42f-963988534762">4,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForProceedsFromLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzItNS0xLTEtMjEzMzM5_a2e1ad11-bb58-4325-a449-89e57fa35ff7">44,652</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net of disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzMtMS0xLTEtMjEzMzM5_62252598-b585-4c08-bfb2-6ba1c4e92196">3,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzMtMy0xLTEtMjEzMzM5_46c54789-7438-4443-b3ac-cc982763389f">11,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzMtNS0xLTEtMjEzMzM5_ad90d70e-b00e-4ec3-81bf-67b075b9a72a">31,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of intangible assets, net of disposals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzQtMS0xLTEtMjEzMzM5_b402deea-f8aa-493f-bb12-1e5f3d21220c">1,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzQtMy0xLTEtMjEzMzM5_1e146924-46c2-4dae-a248-6bda6b92b253">1,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzQtNS0xLTEtMjEzMzM5_394b881f-58cf-4d79-aa48-04642edf5dd7">3,979</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzYtMS0xLTEtMjEzMzM5_fd73b753-8611-45c8-954c-352ac0f90ec9">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzYtMy0xLTEtMjEzMzM5_92748375-e878-47c2-a669-041d1ff6b3c7">3,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzYtNS0xLTEtMjEzMzM5_a92ca3f6-b56e-40e9-865f-1b0dcc3f125d">4,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzctMS0xLTEtMjEzMzM5_f5f53c12-2378-41b7-8491-75392b26c1c2">1,842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzctMy0xLTEtMjEzMzM5_5b7321d0-84bc-4ff3-8430-167448b3c863">28,898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzctNS0xLTEtMjEzMzM5_105cd267-6dfd-42c8-9a6b-fdccb0be96d1">20,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows (continued)</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDEtMS0xLTEtMjEzMzM5_c70b86cc-6615-4579-ac70-0719ca9da654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDEtMy0xLTEtMjEzMzM5_b8b73f2a-b6dc-44d5-bfa1-2cfe5203fa67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDEtNS0xLTEtMjEzMzM5_fbd2ae22-0ba9-4047-b2d7-77112831a9c0">1,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes paid on equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDItMS0xLTEtMjEzMzM5_9f30ca81-528f-4143-9407-f767bcf86fa4">2,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDItMy0xLTEtMjEzMzM5_bc1cc4fe-127d-46a9-af73-b4a00c8883e0">13,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDItNS0xLTEtMjEzMzM5_38837a8b-3015-4b8c-b523-78ed0979630e">2,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTAtMS0xLTEtMjEzMzM5_13845ea1-848a-4a3e-9fe8-a47aba1b851f">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTAtMy0xLTEtMjEzMzM5_d28ab508-81a3-4d0d-82be-dd570a7d6a39">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTAtNS0xLTEtMjEzMzM5_9956f1ba-1140-4d10-b4dd-191f76971ba9">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTEtMS0xLTEtMjEzMzM5_eeae5bdc-7339-461a-9b2a-ac44991a7984">2,897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTEtMy0xLTEtMjEzMzM5_c809783d-fa42-4fdd-9212-91b324fd0686">13,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTEtNS0xLTEtMjEzMzM5_5eb2db7c-2def-4cfa-a01c-e612edd2c4d3">3,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTItMS0xLTEtMjEzMzM5_f81b4336-f1f6-4ca2-a7e1-8cf0ccae8ae5">28,642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTItMy0xLTEtMjEzMzM5_e9f8a5bf-a8a0-4c9f-a3ee-de126857a555">4,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTItNS0xLTEtMjEzMzM5_4ca63573-fbaf-4b9c-8813-cecff175df84">6,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTMtMS0xLTEtMjEzMzM5_2086eec3-d909-48f9-8dda-082d24ae97de">122,329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTMtMy0xLTEtMjEzMzM5_7c872817-e66d-4341-9b40-4a72b07d6d46">191,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTMtNS0xLTEtMjEzMzM5_6d222182-5a23-473f-83c4-b67aa9924c20">121,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTQtMS0xLTEtMjEzMzM5_147fa4b1-c013-42f8-8b06-ad827ff58046">886,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTQtMy0xLTEtMjEzMzM5_f906ff37-7e20-4f84-8680-45c6bc26e802">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7574c68cc08a473a9f7033bdb1a91792_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTQtNS0xLTEtMjEzMzM5_e7630802-3dab-4648-9936-dfa9e527d70b">1,199,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTUtMS0xLTEtMjEzMzM5_4d80513c-b675-46f3-8dc6-4af2cc49de4f">764,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTUtMy0xLTEtMjEzMzM5_abf8b008-2fb1-47c0-8a31-751f1753db3c">886,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTUtNS0xLTEtMjEzMzM5_498445b5-13d7-4443-8f35-94f7170753bf">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplementary cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:InterestReceivedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTktMS0xLTEtMjEzMzM5_5ccf7780-2453-451a-a6b0-aa65b1213485">15,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:InterestReceivedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTktMy0xLTEtMjEzMzM5_e6e3c254-1fbe-413a-9831-75279fefee6b">8,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:InterestReceivedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTktNS0xLTEtMjEzMzM5_b7c2ec5b-61c5-48c2-9653-7e3909993c0e">18,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNjAtMS0xLTEtMjEzMzM5_eb77c59c-bf48-41bf-8191-266ac0b0d606">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNjAtMy0xLTEtMjEzMzM5_71aea0ee-f1e8-4603-91ad-1832b780c3b1">892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNjAtNS0xLTEtMjEzMzM5_a77b8b94-1b12-4253-a8a2-075dccc7a919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_94"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 1. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mjc_aad7abc0-db50-4239-8d15-0ee4f6aa981b" continuedAt="ib699cb753d984315a77c684345235fe0" escape="true">Background, Basis of Presentation, and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ib699cb753d984315a77c684345235fe0" continuedAt="i97a3d0c77f9f45b68a1aeab90f91df4f"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Background</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc. (&#8220;Cronos&#8221; or the &#8220;Company&#8221;) is incorporated in the province of British Columbia and under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(British Columbia) with principal executive offices at 111 Peter St., Suite 300, Toronto, Ontario, M5V 2H1. The Company&#8217;s common shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and Nasdaq Global Market (&#8220;Nasdaq&#8221;) under the ticker symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos&#8217; diverse international brand portfolio includes Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mjg_94f30d51-5e8c-4593-84e2-f4e906c0a770" continuedAt="i618492376a2f48e8904843fca3971f15" escape="true">Basis of presentation</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i618492376a2f48e8904843fca3971f15">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Certain prior year amounts have been reclassified to conform to the current year presentation of our consolidated financial statements. These reclassifications had no effect on reported results of operations and ending shareholders&#8217; equity.</ix:continuation></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MTc_5486f8dc-4d64-480c-b195-54c8255aa19e" continuedAt="if8560c32366e44efaa18423ac800b8d2" escape="true">Basis of consolidation</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if8560c32366e44efaa18423ac800b8d2" continuedAt="i881baef682174f38b640ed43a3b64a71">The accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the reporting periods. The Company assesses control under the variable interest entity (&#8220;VIE&#8221;) model to determine whether the Company is the primary beneficiary of that entity&#8217;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting.</ix:continuation> <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDc_dd6355eb-90c5-47ad-878e-1017e58fd1a2" continuedAt="i6b492fa0171248a797fef36494bc6278" escape="true">The Company consolidates the financial results of the following entities, which the Company controls but does not wholly own:</ix:nonNumeric></span></div><ix:continuation id="i6b492fa0171248a797fef36494bc6278" continuedAt="i6270ac6741ed4036baad2caf7cf9437b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:33.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiaries</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction of incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Cultivation Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36cd7b767d4742089d1b42cfe6220c44_D20220101-20221231" decimals="2" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOmNlODU5MGRmYTViZjRkMDA4YTQzNTlmMjMyZThlNTAwL3RhYmxlcmFuZ2U6Y2U4NTkwZGZhNWJmNGQwMDhhNDM1OWYyMzJlOGU1MDBfMS02LTEtMS0yMTMzMzk_6280f038-ef76-4050-bbae-1889b9978981">70</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Manufacturing Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ead5e405ef545a98117d2329aa9d7f2_D20220101-20221231" decimals="2" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOmNlODU5MGRmYTViZjRkMDA4YTQzNTlmMjMyZThlNTAwL3RhYmxlcmFuZ2U6Y2U4NTkwZGZhNWJmNGQwMDhhNDM1OWYyMzJlOGU1MDBfMi02LTEtMS0yMTMzMzk_a899ecbc-5ad0-4153-bf77-121cc03d9e6f">90</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Store Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if88c1809830e415688a9bf0f65770352_D20220101-20221231" decimals="2" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOmNlODU5MGRmYTViZjRkMDA4YTQzNTlmMjMyZThlNTAwL3RhYmxlcmFuZ2U6Y2U4NTkwZGZhNWJmNGQwMDhhNDM1OWYyMzJlOGU1MDBfMy02LTEtMS0yMTMzMzk_88088c14-56c4-4f5d-8b1f-eb1fa04b9f57">90</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Pharmacy Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3882b50d536c49b783a4fe4bc63b1a58_D20220101-20221231" decimals="2" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOmNlODU5MGRmYTViZjRkMDA4YTQzNTlmMjMyZThlNTAwL3RhYmxlcmFuZ2U6Y2U4NTkwZGZhNWJmNGQwMDhhNDM1OWYyMzJlOGU1MDBfNC02LTEtMS0yMTMzMzk_369e68cc-c969-4c3b-99d3-8717e7809116">90</ix:nonFraction>%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">These Israeli entities are collectively referred to as &#8220;Cronos Israel.&#8221;</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="i6270ac6741ed4036baad2caf7cf9437b" continuedAt="i5e8fc8d9f3fe42eab42de7a4e67b5a82">(ii)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"><ix:continuation id="i5e8fc8d9f3fe42eab42de7a4e67b5a82">&#8220;Ownership interest&#8221; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i881baef682174f38b640ed43a3b64a71">In the consolidated statements of net income (loss) and comprehensive income (loss), net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#8217; equity section of the consolidated balance sheets and consolidated statements of shareholders&#8217; equity. All intercompany transactions and balances are eliminated upon consolidation.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjE_51a7b02f-1218-4c8e-a3de-cf2eb51fdfcd" continuedAt="ic17c4528a17442c99153a08c8f3d2092" escape="true">Use of estimates</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic17c4528a17442c99153a08c8f3d2092" continuedAt="i7b31da29583743e19d41b5220926ba6b">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, expected credit losses on long-term financial assets, impairment losses on goodwill and indefinite-lived intangible assets, impairment losses on long-lived assets, </ix:continuation></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i97a3d0c77f9f45b68a1aeab90f91df4f" continuedAt="ic28e60549fc14eaeb8daf2eed067729b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7b31da29583743e19d41b5220926ba6b">inventory write-downs, share-bared payments, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mjk_0d4014cd-1c73-45ac-a580-31b7e0b85e03" continuedAt="i1116996653e049499812a31d6c00c2cf" escape="true">Cash and cash equivalents and short-term investments</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1116996653e049499812a31d6c00c2cf" continuedAt="i00d3534b066e4538b95fecd202a9c8d1">Cash and cash equivalents are comprised of cash and highly liquid short-term investments that are readily convertible into known amounts of cash, generally with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. Short-term investments consist of debt securities that (i) generally have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. </ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i00d3534b066e4538b95fecd202a9c8d1">Short-term investments are classified as either available-for-sale or held-to-maturity and recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheets and interest income, net on the consolidated statements of net income (loss) and comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#8217;s consolidated statements of cash flows.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDI_04e61f22-1f0d-4101-aba9-c6b0a532098a" continuedAt="i5fdac68b88c944b48afcf78d13d598ee" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="i5fdac68b88c944b48afcf78d13d598ee"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of raw materials, finished goods and work-in-progress, such as pre-harvested cannabis plants, dried cannabis flower, by-products to be extracted, cannabis extracts and by-products, dry cannabis and cannabis extract containers, and boxes. When the Company cultivated cannabis, costs capitalized into inventory until the time of harvest included, but were not limited to, labor, utilities, nutrition and irrigation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, contract manufacturer fees, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of net realizable value include slow-moving or non-marketable products.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Investments</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDM_859580eb-3f03-4d05-afab-cc5666f915c9" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable interest entities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A variable interest entity is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#8217;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#8217;s expected losses or receive portions of the VIE&#8217;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on a periodic basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination, the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates a VIE when it is determined that it is the primary beneficiary of the VIE.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDQ_01542af0-9d70-462f-a001-8d093db24f37" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity method investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest using the equity method. Under the equity method, the Company records its proportionate share of income or loss in share of income (loss) from equity method investments within the consolidated statements of net income (loss) and comprehensive income (loss). Cash payments to equity method investees such as additional investments or expenses incurred on behalf of investees, as well as income earned and payments from equity method investees such as dividends and distributions are recorded as adjustments to investment balances. If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized in one period cannot be reversed in subsequent periods.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="ic28e60549fc14eaeb8daf2eed067729b" continuedAt="i9210cc2c552645e88e2a57455747c9e8"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzQ_40e67843-f68c-4b40-83c7-c4feb335ea03" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments include common stock and options in third party entities in which the Company&#8217;s influence is deemed non-significant. The Company holds other investments with and without readily determinable fair values. Other investments with readily determinable fair values are recorded using the fair value method of accounting as of period-end on the consolidated balance sheets. Other investments without readily determinable fair values are recorded using the cost method of accounting on the consolidated balance sheets. Other investments without readily determinable fair values are assessed for observable price changes and other than temporary impairment on a periodic basis. Changes in the reported value of other investments are reported in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mzk_c07696dc-14b5-472a-8ecf-f9d92a56d585" continuedAt="i4a1c7df06bde4c29b293dae1ca6d0697" escape="true">Property, plant and equipment</ix:nonNumeric></span></div><ix:continuation id="i4a1c7df06bde4c29b293dae1ca6d0697"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzA_c724220c-58a4-4786-9bf0-dae77e708c9b" continuedAt="i01c2feb7e48947e0bebb0d48e0ff5036" escape="true">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i01c2feb7e48947e0bebb0d48e0ff5036" continuedAt="i51ba09f97e73438aa8399133e36e9259"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.094%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:60.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1b22fb74b27245199caf9dcb11234c12_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMS00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjplMmQ4NjEwNjExNWM0ZDJmYjQxZDU4YzJhZWMxYjM2MF8xMDk5NTExNjI3Nzk2_3f8dfc2a-de83-4949-95d3-807e70ff15cd">15</ix:nonNumeric> to <ix:nonNumeric contextRef="iacf539ae1af944fabea8af025076759c_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMS00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjplMmQ4NjEwNjExNWM0ZDJmYjQxZDU4YzJhZWMxYjM2MF8xMDk5NTExNjI3ODAx_c037d62e-d27c-4daa-b379-e902449b3f6c">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a132cce282941e5b9844e95bbad2e28_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMi00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjo1OTJjNDdmZThhZTE0ZjU2YjkxMjU1MjFkNWE2OWVkMF8xMDk5NTExNjI3Nzkz_d1f8fad0-38b9-4978-ab7d-e2598df39fb9">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i49f135f4f3444a5a89ff7d7ac98dad6d_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMi00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjo1OTJjNDdmZThhZTE0ZjU2YjkxMjU1MjFkNWE2OWVkMF8xMDk5NTExNjI3Nzk3_7c8b7677-5234-4bbd-b236-9b190d4c977c">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8f22691c07427aa015ce15f27bf6d2_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMy00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjo3ZjFkMjk2OTZlOTQ0ZDgyYWZjODEyNmZiZGJjMTc4Ml8xMDk5NTExNjI3Nzg4_0bf315db-e26e-4bae-91bc-d63eeebc2568">5</ix:nonNumeric> years</span></div></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available for use is defined as the point at which the related property, plant and equipment is operational, including the possession of any requisite licenses. Depreciation commences at the point the assets are available for use.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjI_269c5c6c-3130-47d8-a88e-e443c6a9c955" continuedAt="ia017b8f29b204f448dca7f9619bee0ab" escape="true">Definite-lived intangible assets</ix:nonNumeric></span></div><ix:continuation id="ia017b8f29b204f448dca7f9619bee0ab"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software and payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MTk_e567c397-71b3-4cdd-854c-19f7ce6b10a8" continuedAt="id9d491ca2d8f4c6a82c6784288441414" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjU1YWEyMjBmOTNlNTQwMmE5YWM2ZTM0YzIzNGRkOTBlL3RhYmxlcmFuZ2U6NTVhYTIyMGY5M2U1NDAyYTlhYzZlMzRjMjM0ZGQ5MGVfMS0zLTEtMS0yMTMzMzk_7760d4d1-aef5-4c5a-8c04-34243c6aae39">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibaa1003c5905486b919409d3896fa96f_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjU1YWEyMjBmOTNlNTQwMmE5YWM2ZTM0YzIzNGRkOTBlL3RhYmxlcmFuZ2U6NTVhYTIyMGY5M2U1NDAyYTlhYzZlMzRjMjM0ZGQ5MGVfMy0zLTEtMS0yMTMzMzk_0e4a8d18-0094-4ff5-9f11-a3cd6a78836f">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets originating from the strategic partnership (the &#8220;Ginkgo Strategic Partnership&#8221;) with Ginkgo Bioworks Holdings, Inc. (&#8220;Ginkgo&#8221;) are accounted for in accordance with the acquisition method of accounting. Equity interests issued in exchange for an asset are initially recognized and measured at the date of acquisition at fair value. We estimate fair value using the relief-from-royalty method and key assumptions include the discount rate and estimated life. Definite-lived intangible assets, including intangible assets originating from the Ginkgo Strategic Partnership, are subject to amortization and reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value has been reduced to less than its carrying amount.</span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i9210cc2c552645e88e2a57455747c9e8" continuedAt="i41f5ec9777d343b785da05b5993e88b2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Accrued liabilities</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDA_25d5bd9e-7861-4c89-89bb-bc974a52a8cd" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfMi0xLTEtMS0yMTMzMzk_773ea6dc-7af9-4fd4-acd3-9b2a3a63efca">11,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfMi0zLTEtMS0yMTMzMzk_90945125-30cd-4d43-a4d4-6c48af0a544a">12,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfMy0xLTEtMS0yMTMzMzk_9b98b5cd-745c-485f-92e9-c924d223844e">2,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfMy0zLTEtMS0yMTMzMzk_33f0c34b-a1b2-4f23-a89d-fb516f1c21f2">8,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNC0xLTEtMS0yMTMzMzk_14725a26-2c3d-407d-b190-552487353325">4,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNC0zLTEtMS0yMTMzMzk_8567b2c1-fb06-4db4-a530-fc411b88da69">3,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNS0xLTEtMS0yMTMzMzk_0fa69220-7a99-4e00-bcbc-5da1996ff63c">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNS0zLTEtMS0yMTMzMzk_49c87ac8-aa9d-4071-bf0d-d119f16fbfa0">936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNi0xLTEtMS0yMTMzMzk_462bee07-0e8f-4468-a1b7-6c79c40416dd">22,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNi0zLTEtMS0yMTMzMzk_76593f86-83de-4d13-8137-51ecdfb50ad1">25,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="cron:AccruedLiabilitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDg_c1258999-84ee-4a82-91fd-438aabfaa78f" escape="true">Accrued payroll and related expenses include salaries and wages, bonuses, and other related payroll expenses associated with the Company&#8217;s employees. Accrued professional fees include fees for legal expenses, litigation, consulting, marketing, and other related expenses. Accrued taxes include sales, excise and other taxes owed. Other accrued expenses include the fair value of deferred share units outstanding to directors and other general expenses.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjM_b6b607fa-2c65-42fc-8b30-8e944a7ba3e4" continuedAt="i9977cefac8a641b08c3b33626236f8b3" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i9977cefac8a641b08c3b33626236f8b3"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#8217;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#8217;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#8217;s depreciation policy if the title is to eventually transfer to the Company.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDk_5258263d-1bb4-40ed-b726-766db8483916" continuedAt="ibfb4824244c141cd85ccb7d1ce5b0673" escape="true">Derivative liabilities</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="ibfb4824244c141cd85ccb7d1ce5b0673"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial instruments classified as derivatives that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="cron:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMTQ4NDM0MDcwMzQwOTY_4e0a7080-ffb1-4b54-b626-0e75503ba1ce"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="cron:FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMTQ4NDM0MDcwMzQwOTc_a3785cf1-ff03-486a-b525-c2999b59b49a">consolidated statements of net income (loss)</ix:nonNumeric> and <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="cron:FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMTQ4NDM0MDcwMzQwOTg_24c44722-8ada-4160-9000-be304250066f">comprehensive income (loss)</ix:nonNumeric></ix:nonNumeric> each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in net income (loss) and comprehensive income (loss). For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Derivative Liabilities.&#8221;</span></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.01pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:StockholdersEquityPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NTA_fd629701-328d-49f4-b0c7-38e6b6b396f9" continuedAt="i18ec82460c464aa8ae9cc2bb57426343" escape="true">Capital stock</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i18ec82460c464aa8ae9cc2bb57426343">Capital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.</ix:continuation></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i41f5ec9777d343b785da05b5993e88b2" continuedAt="i816f74ba400043589b6128806f64348c"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjQ_2030ab97-dff8-4bd2-8bcf-0a0fb72dad45" continuedAt="i151e6e0e394740b18a38075ea10f46fb" escape="true">Revenue recognition</ix:nonNumeric></span></div><ix:continuation id="i151e6e0e394740b18a38075ea10f46fb" continuedAt="i729a894b6eaf47b3b4d8a13ef51c2f7f"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606, &#8220;Revenue from Contracts with Customers,&#8221; and is measured based on the consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product or service to a customer. The Company&#8217;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and &#8220;hemp&#8221; (as defined in the U.S. Agricultural Improvement Act of 2018 &#8220;U.S. hemp&#8221;) derived products consist of a single performance obligation. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, depending on the specific contractual terms. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer or third-party location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer&#8217;s usage.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, allowances for customer returns and other forms of variable consideration. Within the Company&#8217;s Rest of World segment (the &#8220;ROW segment&#8221;), dried cannabis sales outside of Canada may include commission arrangements with distributors that give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated using the expected value method, based on the Company&#8217;s historical information, at contract inception. The Company&#8217;s payment terms vary by customer and product type. Refer to Note 12 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information and Disaggregated Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for information on disaggregated revenue.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i729a894b6eaf47b3b4d8a13ef51c2f7f">The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NTE_2825a7e0-21eb-4b3c-8951-8a2ea15de5c7" continuedAt="i85d33d10d9594c44b96add8359348a09" escape="true">Research and development </ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i85d33d10d9594c44b96add8359348a09"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a research and development center in Canada that performs scientific research on the interaction of cannabinoids as well as strain development, growing conditions, extraction technology, and biosynthesis. Fermentation and production related research is performed to further strategic initiatives around rare cannabinoids. In addition, the Company has a collaboration and license agreement with Ginkgo (the &#8220;Ginkgo Collaboration Agreement&#8221;) to research, produce, and commercialize cultured cannabinoids. Technological feasibility is considered to be established once productivity targets or commercialization are achieved, at which point the exclusive license is recognized at cost less impairment charges. As of the acquisition date of each exclusive license, cost less impairment charges is equal to the fair value. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Note 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information on the Ginkgo Collaboration Arrangement. Research and development costs associated with these collective efforts are expensed as incurred as part of operating expenses in the Company&#8217;s consolidated statements of net income (loss) and comprehensive income (loss).</span></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjA_2f8485d0-b520-4556-91cb-96fd81345125" continuedAt="i42dfc6f6eb2c4272b0a3b202d8b3e9bc" escape="true">Advertising costs</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i42dfc6f6eb2c4272b0a3b202d8b3e9bc">Advertising costs include costs to sell the Company&#8217;s products and are expensed as incurred through sales and marketing expenses in the consolidated statements of net income (loss) and comprehensive income (loss).</ix:continuation> Advertising costs were $<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:AdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMjM3MDc_11ea7dcf-4727-4d0f-b4fa-dbec8b708127">928</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMjM3MTE_ccb31e2a-e0f0-4b56-a070-f19bd4fc2045">11,514</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMjM3MTg_9554077e-f904-4317-9326-37d80b2f1a43">6,087</ix:nonFraction> for the years ended December&#160;31, 2022, 2021, and 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzU_d8d2a010-d94e-4e57-8ae2-851a06808b2f" continuedAt="ia5ab5feb9d5b444f93210b92eeb1c6de" escape="true">Share-based compensation</ix:nonNumeric></span></div><ix:continuation id="ia5ab5feb9d5b444f93210b92eeb1c6de" continuedAt="i67fbfb9f7bfe4b3ca2592481f92ae23e"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan, the 2018 Stock Option Plan, the 2015 Stock Option Plan, the Employment Inducement Award Plan and the DSU Plan (each as defined below).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based awards consists of equity-settled share-based awards such as stock options and restricted share units (&#8220;RSUs&#8221;) that are issued to eligible employees, non-executive directors, and non-employees. Cash-settled deferred share units (&#8220;DSUs&#8221;) that are issued to non-executive directors under the DSU Plan are recorded in accrued liabilities with the fair value adjustment recorded in other income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity instruments granted are initially measured at fair value on the grant date. The fair value of stock options is determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price of the Company&#8217;s common shares. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive </span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i816f74ba400043589b6128806f64348c" continuedAt="i2ee004a957ae41428f81e16a5a6e7188"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i67fbfb9f7bfe4b3ca2592481f92ae23e">income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities. The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are settled or exercised. Upon settlement or exercise, shares are issued and the amount previously reflected in additional paid-in capital is, along with any proceeds paid upon settlement or exercise, credited to a combination of share capital and additional paid-in capital. Forfeitures of share-based compensation awards are accounted for as reductions to share-based compensation and additional paid-in capital as they occur.</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzY_226d5fd3-7bda-4d4b-844e-930101017c89" continuedAt="i96a6d659780a49b592d622632741368a" escape="true">Impairment of long-lived assets</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i96a6d659780a49b592d622632741368a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, such as property, plant and equipment and definite-lived intangible assets, for impairment in accordance with ASC Topic 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with ASC Topic 360, long-lived assets to be held are reviewed for events or changes in circumstances that indicate that their carrying amount may not be recoverable. The Company periodically reviews for indicators and, if indicators are present, tests the carrying amount of long-lived assets, assessing their fair values based on estimated undiscounted cash flows over their remaining estimated useful lives. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. If the carrying amount of an asset (or asset group) exceeds its estimated undiscounted future cash flows, an impairment charge is measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset group, based on discounted cash flows.</span></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.45pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjU_2c957b50-93cf-4266-8952-97d477061af9" continuedAt="ic5c3fa2563a849a9b1325ca759b35edc" escape="true">Impairment of goodwill and indefinite-lived intangible assets</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="ic5c3fa2563a849a9b1325ca759b35edc" continuedAt="i47d2e4c2b803470baa3cbc31090819a6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are not amortized. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying amount in accordance with the provisions of ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i47d2e4c2b803470baa3cbc31090819a6">. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDU_1342dac4-2ebc-4322-940f-7c4d2d036285" continuedAt="ifc511dbf7cef4e1c96712ae0c3c6beaf" escape="true">Income taxes</ix:nonNumeric></span></div><ix:continuation id="ifc511dbf7cef4e1c96712ae0c3c6beaf" continuedAt="if847cd48067745ebb899cf224438ef64"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative, including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance against some or all of the net deferred tax assets does not in any way impact the Company&#8217;s ability to use future tax deductions such as the Company&#8217;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#8217;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine whether the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#8220;more likely than not&#8221; to be sustained, no benefits of the position are recognized. If we determine that a position is &#8220;more likely than not&#8221; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards, to the extent not covered by a valuation allowance, could be materially impacted in the period which such determination is made.</span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i2ee004a957ae41428f81e16a5a6e7188" continuedAt="i9763ea5a0b6a4f149b47df8fb0632b3f"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if847cd48067745ebb899cf224438ef64">The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mzc_9a121a30-077c-409b-93a4-76e1294ca291" continuedAt="ic594f3467fb246cd979ca06b216d0b4a" escape="true">Foreign currency</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic594f3467fb246cd979ca06b216d0b4a">The Company&#8217;s functional currency is the Canadian dollar (&#8220;C$&#8221;) and its reporting currency is the U.S. dollar. Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, U.S. dollar and Israeli New Shekel (&#8220;ILS&#8221;). All assets and liabilities of operations with a functional currency other than the Canadian dollar are translated into Canadian dollars at the period-end currency exchange rates and subsequently translated into U.S. dollars at period-end currency exchange rates. The resulting translation adjustments are recorded in accumulated other comprehensive income (loss), net of tax. Revenues and expenses of operations, as well as all cash flows, with a functional currency other than the Canadian dollar are translated into Canadian dollars at the average exchange rates for the period and subsequently translated into U.S. dollars at the average exchange rates for the period. Transaction gains and losses resulting from changes in foreign currency exchange rates are recorded in either cost of sales, general and administrative expenses, or foreign currency transaction gain (loss) in the consolidated statements of net income (loss) and comprehensive income (loss).</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mzg_e7f54cb9-b1d9-4d95-b30e-b8a464c4c3f6" continuedAt="ibd9869346c964fd2b56deda5b8739d2f" escape="true">Segments</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="ibd9869346c964fd2b56deda5b8739d2f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos reports through <ix:nonFraction unitRef="segment" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzMxMjM_e864230d-423e-4b72-9708-b6a108847a48">two</ix:nonFraction> segments: the U.S. segment and the ROW segment. These <ix:nonFraction unitRef="segment" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzMxODA_e2935cf0-f384-4b6d-b4e2-e29a32becea4">two</ix:nonFraction> segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. Refer to Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Segment Information and Disaggregated Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(w)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.12pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDE_cd7bba02-b75d-4dbc-a633-e2fd685a8e35" continuedAt="ie7e54a7858b54409bfbbf4a7833295a8" escape="true">Earnings (loss) per share</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie7e54a7858b54409bfbbf4a7833295a8">The Company presents basic and diluted earnings (loss) per share data for its common shares. Basic earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDY_1a02f844-68fa-4bea-b88c-eade07b1c80a" continuedAt="i5e9e0aba503142ffaf5426a137aa4360" escape="true">Fair value measurements</ix:nonNumeric></span></div><ix:continuation id="i5e9e0aba503142ffaf5426a137aa4360"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company&#8217;s cash and cash equivalents, accounts receivable, other receivables, loans receivable, account payables and other liabilities approximate fair value, given their short-term nature. Cronos uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. </span></div><div style="margin-bottom:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the three levels of inputs used to measure fair value: </span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. </span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. </span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; valuation techniques using the inputs for the asset or liability that are not based on observable market data.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(y)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjY_d9e29e23-adb0-4301-824d-966cff645f1b" continuedAt="i6d8434d551e746cd853fcf5c443941c0" escape="true">Assets held for sale and discontinued operations</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i6d8434d551e746cd853fcf5c443941c0" continuedAt="i1276826c2db242359b94be10f89ce990"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 205-20 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation of Financial Statements: Discontinued Operations</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1276826c2db242359b94be10f89ce990">, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results when the components of an entity meet the criteria in paragraph ASC 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and other liabilities are reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), are reported as components of net income (loss) separate from the net income (loss) of continuing operations.</ix:continuation> </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i9763ea5a0b6a4f149b47df8fb0632b3f"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(z)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzI_5b8f7757-63b8-466d-81c1-7d45409a438e" continuedAt="i0b2f27f0bff9488eb5a5eafb5173ce01" escape="true">Adoption of new accounting pronouncements</ix:nonNumeric></span></div><ix:continuation id="i0b2f27f0bff9488eb5a5eafb5173ce01"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, the Company adopted ASU No. 2020-06, Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No. 2020-06 is part of the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The adoption of ASU No. 2020-06 did not have an impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(aa)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-02, Financial Instruments &#8211; Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (&#8220;ASU No. 2022-02&#8221;). ASU No. 2022-02 eliminates the existing troubled debt restructuring recognition and measurement guidance, and instead aligns the accounting treatment to that of other loan modifications. The amendments enhance existing disclosure requirements and introduce new requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. ASU No. 2022-02 also requires that entities disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases. ASU No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-02 to have a material impact on its consolidated financial statements. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#8220;ASU No. 2022-03&#8221;). ASU No. 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered in measuring fair value. The amendments also require additional disclosures for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-03 to have a material impact on its consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_97"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RleHRyZWdpb246ZmIyYTYyMTQ3ZGY1NDI5YzljNjQ3ZWM5ODRjYzZjM2VfNjU_62231666-88dc-4b0d-a350-6e18abacc36a" continuedAt="i543debba2b8e477486f49cd9f962b8ed" escape="true">Inventory, net</ix:nonNumeric></span></div><ix:continuation id="i543debba2b8e477486f49cd9f962b8ed"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RleHRyZWdpb246ZmIyYTYyMTQ3ZGY1NDI5YzljNjQ3ZWM5ODRjYzZjM2VfNjY_2621a996-77b0-4c6f-8924-0206dfe69b28" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, net is comprised of the following items:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfMi0xLTEtMS0yMTMzMzk_52dafae6-82a8-434a-af9e-2e62c5c89904">7,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfMi0zLTEtMS0yMTMzMzk_032d09be-e233-4bb3-a0b2-379ae60a0128">9,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfMy0xLTEtMS0yMTMzMzk_260c2728-300c-40a7-aa86-7a7b6d2800a4">15,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfMy0zLTEtMS0yMTMzMzk_c7436852-5604-4425-bc24-59d53b763ed1">12,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNC0xLTEtMS0yMTMzMzk_b3fd0de3-0f79-489c-ba1c-145b4bc64954">13,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNC0zLTEtMS0yMTMzMzk_6f77eb90-d595-4478-ae11-5e5f41d14f5f">10,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:InventorySuppliesNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNS0xLTEtMS0yMTMzMzk_f291ae05-a55c-4e81-ad77-5b75e139bf87">989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:InventorySuppliesNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNS0zLTEtMS0yMTMzMzk_2d018ed7-842b-4dfd-b175-59b7651ecbd6">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNi0xLTEtMS0yMTMzMzk_f91d2b46-f4fb-4a15-b9c5-431321be39af">37,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNi0zLTEtMS0yMTMzMzk_07212c59-75f8-4e31-931f-e587a96efcd3">32,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_100"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NzM4_81539143-0906-43ac-a82c-1a7e7e39815a" continuedAt="i97d91c91800647dc8132838255f3f328" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="i97d91c91800647dc8132838255f3f328" continuedAt="i90a2855a1c884c1987e8a4ab902fd13a"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Variable interest entities and investments in equity method investments, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds variable interests in Cronos Growing Company Inc. (&#8220;Cronos GrowCo&#8221;), NatuEra S.&#224;.r.l. (&#8220;Natuera&#8221;) and Cannasoul Lab Services Ltd. (&#8220;CLS&#8221;). The Company&#8217;s investments in Cronos GrowCo and Natuera are exposed to economic variability from each entity&#8217;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entity&#8217;s economic performance. Thus, the Company is not considered the primary beneficiary of either entity. The investment in Cronos GrowCo is accounted for as an equity method investment classified as &#8220;Investments in equity method investments, net&#8221; in the consolidated balance sheets. As of December 31, 2022, the investment in Natuera is accounted for as an equity security without a readily determinable fair value classified as &#8220;Other Investments&#8221; in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos GrowCo</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act on June 14, 2018 with the objective of cultivating and commercializing cannabis and cannabis products. Cronos GrowCo&#8217;s economic performance is driven by the day-to-day operations of Cronos GrowCo, which are controlled by 2645485 Ontario Inc. (&#8220;Mucci&#8221;), the Company&#8217;s joint venture partner. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i90a2855a1c884c1987e8a4ab902fd13a" continuedAt="i01f794e9bf51447694db281485e97209"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company concluded that lower than expected sales forecasts combined with the increase to the aggregate principal amount of the GrowCo Credit Facility (as defined below) were indicators of impairment for the Company&#8217;s equity method investment in Cronos GrowCo. Accordingly, the Company performed a quantitative impairment assessment in the third quarter of 2021 to compare the fair value of the investment in Cronos GrowCo to its carrying amount. The fair value was estimated using the discounted cash flow method. Significant inputs included discount rate, growth rates, and cash flow projections. As a result of this analysis, the Company concluded that as of September 30, 2021, the estimated fair value was higher than the carrying amount and <ix:nonFraction unitRef="usd" contextRef="i6584e6d786d847d69e0e7fc90b593c5f_D20210701-20210930" decimals="INF" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE5NjE_e776c671-6361-4609-b753-cb7acc414ceb">no</ix:nonFraction> impairment charges were recorded. There were no such indicators of impairment present for the year ended December 31, 2022.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Natuera</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon formation, Natuera was a joint venture registered in Luxembourg with the objective of cultivating and commercializing hemp and cannabis products, and its economic performance is driven by the quantity and strains of cannabis grown. Until December 2022, the Company held variable interests in Natuera through its ownership of <ix:nonFraction unitRef="number" contextRef="ieae966ba01c1479dacbc7135663a609a_D20220101-20221130" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzMxMzE_ca48ec29-2767-4d02-8786-4f41eb3aaba1">50</ix:nonFraction>% of Natuera&#8217;s common shares. An affiliate of Agroidea SAS, a Colombian agricultural services provider, owned the remaining <ix:nonFraction unitRef="number" contextRef="icb4e552f78894f18936e22352d25dde5_D20220101-20221130" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzMyNTU_14910bfc-064a-4aee-baed-9172a29f275f">50</ix:nonFraction>% of Natuera&#8217;s common shares (such affiliate, the &#8220;Natuera JV Partner&#8221;). In December 2022, Natuera entered into a $<ix:nonFraction unitRef="usd" contextRef="i736040703d9b43138a6d1fbe16c1ea1a_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2Njc5MzM_d6e3438b-0b73-4b94-9730-b0e1c22c26a2">9.5</ix:nonFraction>&#160;million convertible bridge loan with the Natuera JV Partner and a new investment group, whereby the Natuera JV Partner and the new investment group provided $<ix:nonFraction unitRef="usd" contextRef="i736040703d9b43138a6d1fbe16c1ea1a_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0ODQzNDA3MDIxMTUx_d6e3438b-0b73-4b94-9730-b0e1c22c26a2">9.5</ix:nonFraction>&#160;million in exchange for convertible notes that were converted into equity immediately following the closing of the loan. Post-closing, the Company&#8217;s ownership share was diluted to approximately <ix:nonFraction unitRef="number" contextRef="ied9879f7a9aa480189fcbf72c09fb055_I20221231" decimals="INF" name="cron:InvestmentOwnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NjQ2OTk_2022653e-f0cc-4920-9cf1-97545c1bf040">13.7</ix:nonFraction>% and the Company will no longer have any members on the board of directors of Natuera. Given these changes in ownership and board representation, the Company believes it no longer exerts significant influence over Natuera, has discontinued accounting for the investment under the equity method and has reclassified its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets as of December 31, 2022. </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company concluded that lower than expected sales forecasts as of December 31, 2021 were an other than temporary indicator of impairment for the Company&#8217;s equity method investment in Natuera. Accordingly, the Company performed a qualitative assessment to determine whether there was any value remaining in the investment. As a result of this analysis, the Company concluded that, as of December 31, 2021, the estimated fair value was <ix:nonFraction unitRef="usd" contextRef="i01e84979c2174a3e959ae14445c4c0b6_I20211231" decimals="INF" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzM5NDM_1b816f01-eae5-4cb0-b929-52c21cbd5a01">zero</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i4dd42bcd2c914a09bf216a667b6e31d0_D20210101-20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzM5NTE_47a3951f-96ec-415b-8284-b6d3cdda5053">167</ix:nonFraction> was recorded as an impairment loss on equity method investments on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CLS</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#8220;Cannasoul Collaboration&#8221;). Cronos Israel agreed to advance up to ILS <ix:nonFraction unitRef="ils" contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231" decimals="-3" name="cron:CollaborativeArrangementAmountOfAdvances" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NTY2OTU_655797db-d658-43b4-8bdc-b686661e85d6">8,297</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231" decimals="-3" name="cron:CollaborativeArrangementAmountOfAdvances" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE4NjkxNjk3NzEzNjUz_16eb5dcf-7ecf-4d01-b256-7e23d4b58336">2,664</ix:nonFraction>) by a non-recourse loan (the &#8220;Cannasoul Collaboration Loan&#8221;) to CLS over a period of <ix:nonNumeric contextRef="ib83b7561b10e4723a7df91adaaef20db_D20220101-20221231" name="cron:CollaborativeArrangementTermOfAgreement" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzQ1MTE_85c948d4-df45-4146-8115-9b0d9024409a">two years</ix:nonNumeric> from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan bears interest at <ix:nonFraction unitRef="number" contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NTY3MDM_52e7cb88-1154-4de7-836b-2d37ba487813">3.5</ix:nonFraction>% annually. Cronos Israel will receive <ix:nonFraction unitRef="number" contextRef="i8d787bdfa77d4a4eb6ac5ba4b4bdfc00_I20221231" decimals="INF" name="cron:CollaborativeArrangementPercentageOfProfitsToBeReceived" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzQ2NjI_fd03225b-249a-458f-a4c8-fb616a4f52d7">70</ix:nonFraction>% of the profits of the laboratory until such time as it has recovered <ix:nonFraction unitRef="number" contextRef="i8d787bdfa77d4a4eb6ac5ba4b4bdfc00_I20221231" decimals="INF" name="cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzQ3MzQ_92f9fe41-50c1-4ba2-9c40-4612795b0d20">150</ix:nonFraction>% of the amounts advanced to CLS, after which time it will receive <ix:nonFraction unitRef="number" contextRef="i8d787bdfa77d4a4eb6ac5ba4b4bdfc00_I20221231" decimals="INF" name="cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzQ4MDI_c2628ede-de92-4bbc-a5bf-af105d2b80f1">50</ix:nonFraction>% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#8217;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#8217;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS <ix:nonFraction unitRef="ils" contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231" decimals="-3" name="cron:CollaborativeArrangementAmountOfAdvances" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NTY3MDc_655797db-d658-43b4-8bdc-b686661e85d6">8,297</ix:nonFraction>, represents the Company&#8217;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 4 &#8220;Loans Receivable, net&#8221; for further information regarding loans receivable.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NzM5_c9e3b56d-2fbc-4042-801f-c125f7664aa6" continuedAt="ie03602ec8c944ba8b4bf79f299d54c9a" escape="true"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NzQw_e62b549a-4f5d-41a1-9414-aba17643b5ed" continuedAt="iaf95d924315e4bb596e65bb8cbd60a07" escape="true"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in equity method investments, net is as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia965648dd525484799c2e977f7acaf53_I20221231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzMtMS0xLTEtMjEzMzM5_2774cd69-aac0-4b41-a19d-3f58cf0f0db0">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia965648dd525484799c2e977f7acaf53_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzMtMy0xLTEtMjEzMzM5_560b27b8-af12-4448-a40e-d456838da8ce">18,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie35ca828c220404d8779f0c05373f981_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzMtNS0xLTEtMjEzMzM5_f085ea2b-a71d-43d0-9aa9-17d2bf7eaecc">16,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i, ii, iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied9879f7a9aa480189fcbf72c09fb055_I20221231" decimals="INF" name="cron:InvestmentOwnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzUtMS0xLTEtMjEzMzM5L3RleHRyZWdpb246YzQxNmU5ODY4Mzg2NGYxMjllMTQ0MGQzNjc0Y2Y2M2ZfMzg0ODI5MDY5NzI1Ng_e554994a-33b1-4935-a626-e4e69e4aae03">13.7</ix:nonFraction>% / <ix:nonFraction unitRef="number" contextRef="ied9879f7a9aa480189fcbf72c09fb055_I20221231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzUtMS0xLTEtMjEzMzM5L3RleHRyZWdpb246YzQxNmU5ODY4Mzg2NGYxMjllMTQ0MGQzNjc0Y2Y2M2ZfMzg0ODI5MDY5NzI2Mg_c3b8e677-ec45-4053-9ebf-2e8cb635d414">50</ix:nonFraction>% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6226d0a1598b4591a5b51ab3e76703b5_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzUtNS0xLTEtMjEzMzM5_9a25edff-75d4-415e-a75d-992f59afb8e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzYtMy0xLTEtMjEzMzM5_78ae9be9-dc27-4f61-8aee-f6ae964ec733">18,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzYtNS0xLTEtMjEzMzM5_94e7edb0-76cd-495d-aef9-f38194852cac">16,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On April 1, 2021, the Company and the Natuera JV Partner, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#8220;Natuera Series A Loan&#8221;), plus accrued interest, into equity of Natuera (&#8220;Natuera Debt Conversion&#8221;). Total aggregate gross advances to Natuera under the Natuera Series A Loan were $<ix:nonFraction unitRef="usd" contextRef="ieab708e963a4427d9d3c7720e25e4a43_D20210401-20210401" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzYzODk_b5597b3f-2d9b-4c3a-b4d8-a5eb495118c7">15,500</ix:nonFraction>, of which the Company advanced <ix:nonFraction unitRef="number" contextRef="iaf4bf3256f4340b98286607ff670aef5_I20210401" decimals="INF" name="cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY0MjM_e2b41bf8-76cd-4559-b5e6-4ae9308fadee">50</ix:nonFraction>% and the Natuera JV Partner advanced the remaining <ix:nonFraction unitRef="number" contextRef="i556bef2858d7440aa6698fec9871e28e_I20210401" decimals="INF" name="cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY0NzY_1ec59a5b-f62b-4155-b73c-7652dd0ac401">50</ix:nonFraction>%, or $<ix:nonFraction unitRef="usd" contextRef="i9d84efb4ac7543a7b30a39f637d3feac_D20210401-20210401" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY0ODM_82d5e2c1-4044-4684-89e3-c9d63dcfca1d"><ix:nonFraction unitRef="usd" contextRef="ib684e46ce2ce4e94953b3cd65ed84eb3_D20210401-20210401" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY0ODM_96e0cb54-dcde-4b20-9298-9df25f168c25">7,750</ix:nonFraction></ix:nonFraction> each. As a result, the Company transferred the carrying amount of the Natuera Series A Loan of approximately $<ix:nonFraction unitRef="usd" contextRef="iec61439c630842daa57b512a9ded6f1f_I20210401" decimals="-3" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY1OTU_bd580f65-7330-4f1a-a195-cd714478e79d">2,013</ix:nonFraction> plus accrued interest of $<ix:nonFraction unitRef="usd" contextRef="iec61439c630842daa57b512a9ded6f1f_I20210401" decimals="-3" name="us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY2MjM_fbb96e19-b54a-48e1-b82c-79f8f3a3745c">540</ix:nonFraction>, for a total investment value of $<ix:nonFraction unitRef="usd" contextRef="ieab708e963a4427d9d3c7720e25e4a43_D20210401-20210401" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY2NTk_425b6fd5-70ab-4f22-977e-fbc5c2c158c2">2,553</ix:nonFraction>, which approximated the then fair value, to investments in equity accounted investees in respect of Natuera. See Note 4 &#8220;Loans Receivable, net.&#8221;</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i01f794e9bf51447694db281485e97209" continuedAt="idc34d8c31789435587836b8c9960210e"><ix:continuation id="iaf95d924315e4bb596e65bb8cbd60a07"><ix:continuation id="ie03602ec8c944ba8b4bf79f299d54c9a" continuedAt="ib3c92f3ca59a404099cddd9d753b74a4"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of December 31, 2021, the Company concluded that the estimated fair value of the investment in Natuera was lower than the carrying amount resulting in an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i4dd42bcd2c914a09bf216a667b6e31d0_D20210101-20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NTg5MDA_a53566ce-dba7-49fa-86a2-59c9f8d0f4de">167</ix:nonFraction> being recorded as an impairment loss on equity method investments in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets. As of December 31, 2022, the Company&#8217;s ownership interest in Natuera was approximately <ix:nonFraction unitRef="number" contextRef="ied9879f7a9aa480189fcbf72c09fb055_I20221231" decimals="INF" name="cron:InvestmentOwnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NjgxMjQ_2022653e-f0cc-4920-9cf1-97545c1bf040">13.7</ix:nonFraction>%.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s share of net income (losses) from equity investments accounted for under the equity method of accounting:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitura</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72bd56a3b81845f49fe8b58426c1d15c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzMtMy0xLTEtMjEzMzM5_1ae905dc-838b-4253-81e3-7f1ccba37471">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2dea108f6474d59838c2f8da2a2200d_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzMtNS0xLTEtMjEzMzM5_fd1c39b5-5d2c-460f-a0b8-08884afa5606">363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a12ae20ea94eb79a945a18af0871d1_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzQtMS0xLTEtMjEzMzM5_28af852b-1127-4345-a9f9-1cb656049ec3">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31af1706e07447a382a55519bec4d367_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzQtMy0xLTEtMjEzMzM5_16d034dc-f642-46e7-870d-b7d04cf0d249">2,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecc2eafed6534c30b7a6637e2039b9b7_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzQtNS0xLTEtMjEzMzM5_8ec5ad59-5944-4b91-8ce0-bb766fcdced6">1,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6774fc03d1d44059bc5e08321bc61875_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzYtMy0xLTEtMjE3MTE2_73871394-b72c-4d26-a80a-90a16867905e">3,747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1be163b6b0ca4a5fae2fa3db98dc500e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzYtNS0xLTEtMjE3MTI0_fb8edfc0-140d-45c9-ad00-22c6bfac3c47">2,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzctMS0xLTEtMjEzMzM5_064b8a4f-5dc1-4df4-84b9-eb81ba665649">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzctMy0xLTEtMjEzMzM5_dbcc0080-b96f-4f8d-8d2a-160491ff556f">6,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzctNS0xLTEtMjEzMzM5_ff6de51c-168a-4278-a850-0f81769054db">4,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">As of December 31, 2022, the Company held a <ix:nonFraction unitRef="number" contextRef="ib48a5f922dc74080be8b4e6b57c7a04d_I20221231" decimals="2" name="cron:InvestmentOwnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NTY3OTQ_62131761-ca3b-4258-964c-c9a38364bfc1">10</ix:nonFraction>% ownership interest in Vitura, and Vitura is no longer considered an equity-method investment. As of December 31, 2020, and up to December 16, 2021, the Company held a <ix:nonFraction unitRef="number" contextRef="if46b21ab0b3b47ce84759033415e34a3_I20211215" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE4NjkxNjk3NzEzNjYx_9a2e00e0-651b-431d-bf0e-b788abda121d">31</ix:nonFraction>% ownership interest in Vitura and was considered an equity-method investment. The gross investment balance in Vitura was offset by equity losses as of December 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of December 31, 2021, the combination of the Company&#8217;s share of accumulated net losses and impairment charges was in excess of its equity investment in Natuera, and the net book value of the investment was zero.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheet. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of financial information for the Company&#8217;s equity method investments:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5412eefc844e484bb12e39c21eac056f_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzItMS0xLTEtMjEzMzM5_43ed32bd-01a7-41bd-ab9c-8c42232ec47a">21,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582e556b4ce74d03ba739d1baa4199e8_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzItMy0xLTEtMjEzMzM5_95d2c1f4-fd22-49cd-b926-b66f5059cc1d">5,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4575a982e5148c79aec9bf8a66c9c02_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzItNS0xLTEtMjEzMzM5_685acca0-6e33-472c-a8b3-df1ff795e608">19,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5412eefc844e484bb12e39c21eac056f_I20221231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzMtMS0xLTEtMjEzMzM5_f2ddde35-32fc-4ec4-b794-eb553ce97829">104,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582e556b4ce74d03ba739d1baa4199e8_I20211231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzMtMy0xLTEtMjEzMzM5_1c0aa5f7-142e-4119-aa5d-d4caf9f30a1c">125,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4575a982e5148c79aec9bf8a66c9c02_I20201231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzMtNS0xLTEtMjEzMzM5_3cb02467-12e2-4bf0-ab41-34f220e267dc">122,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5412eefc844e484bb12e39c21eac056f_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzQtMS0xLTEtMjEzMzM5_85fb6dbf-2926-49ce-b402-4628a3c0f51a">5,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582e556b4ce74d03ba739d1baa4199e8_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzQtMy0xLTEtMjEzMzM5_fdb98080-658b-4bcc-9b51-6866f5a62684">13,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4575a982e5148c79aec9bf8a66c9c02_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzQtNS0xLTEtMjEzMzM5_79942113-866b-4ca2-b9d0-4bb720a7f077">24,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5412eefc844e484bb12e39c21eac056f_I20221231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzUtMS0xLTEtMjEzMzM5_668722b6-2ef0-4282-80d5-8b8f28ffcc87">73,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582e556b4ce74d03ba739d1baa4199e8_I20211231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzUtMy0xLTEtMjEzMzM5_7e497986-656a-4396-b63d-76b9e3e3884e">81,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4575a982e5148c79aec9bf8a66c9c02_I20201231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzUtNS0xLTEtMjEzMzM5_cbcd994b-b9d0-47dd-86ff-9522ce4ec3ed">76,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e8e633340c54e489bace8e93f8c9aaf_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzItMS0xLTEtMjEzMzM5_fa6ff4eb-fddf-4205-8e2e-e2ebefbe1da4">39,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138038dc2b074762930cd415641ec771_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzItMy0xLTEtMjEzMzM5_f70abd3f-9580-4a63-acce-1634b9c55646">8,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a76be7bf924660b23e0d04d6d1d445_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzItNS0xLTEtMjEzMzM5_dc7bbe93-67af-457c-ac46-3969b786cb26">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e8e633340c54e489bace8e93f8c9aaf_D20220101-20221231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzMtMS0xLTEtMjEzMzM5_e55b63f9-3daf-47e9-8f64-c7195e9ff992">24,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i138038dc2b074762930cd415641ec771_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzMtMy0xLTEtMjEzMzM5_1f144586-f1a0-4b91-8b63-33e81d97651c">5,059</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20a76be7bf924660b23e0d04d6d1d445_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzMtNS0xLTEtMjEzMzM5_175b5db5-417a-498d-9340-6c0321cebe84">631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e8e633340c54e489bace8e93f8c9aaf_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzQtMS0xLTEtMjEzMzM5_958737ef-220c-4d44-aef8-3524613db654">6,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i138038dc2b074762930cd415641ec771_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzQtMy0xLTEtMjEzMzM5_c66d0486-925f-478a-9522-edd5345b8812">12,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20a76be7bf924660b23e0d04d6d1d445_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzQtNS0xLTEtMjEzMzM5_84a47380-c608-4893-839d-7b2252054e43">11,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the maximum exposure to loss from the Company&#8217;s investments in equity method investments:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia965648dd525484799c2e977f7acaf53_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzItMS0xLTEtMjEzMzM5_901d4417-c2ba-4852-9adb-2c3770fef7ba">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00ed681f413e454dbec8d917d6a28b38_I20221231" decimals="-3" name="cron:OtherNetAssetsLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzItMy0xLTEtMjEzMzM5_2abca393-71aa-46b4-be97-50976d31298e">62,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00ed681f413e454dbec8d917d6a28b38_I20221231" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzItNS0xLTEtMjEzMzM5_6af8c175-f801-4110-bba0-20e56108c3d1">19,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:OtherNetAssetsLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzQtMy0xLTEtMjEzMzM5_9f5c9a92-a4d3-43eb-8b53-fc925ca1f26d">62,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzQtNS0xLTEtMjEzMzM5_21a83e21-40bf-4a42-9321-696ac8976bdf">19,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie35ca828c220404d8779f0c05373f981_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzItMS0xLTEtMjEzMzM5_c2dc0588-8bba-48c9-bac5-31bac3c47964">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b6b387f3bd48568496384bda710bc0_I20211231" decimals="-3" name="cron:OtherNetAssetsLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzItMy0xLTEtMjEzMzM5_eea35774-4cd1-4c23-a1bb-9bd6b4756d53">33,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b6b387f3bd48568496384bda710bc0_I20211231" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzItNS0xLTEtMjEzMzM5_3ef4327e-73c3-49eb-b7ba-1842cab4a641">21,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6226d0a1598b4591a5b51ab3e76703b5_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzQtMS0xLTEtMjEzMzM5_6fc8111c-4a2c-4d60-ae95-f91dc21d1c2c">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e84979c2174a3e959ae14445c4c0b6_I20211231" decimals="-3" name="cron:OtherNetAssetsLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzQtMy0xLTEtMjEzMzM5_ec5d04dc-acb8-4be6-a7dc-61eeded53d5f">2,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e84979c2174a3e959ae14445c4c0b6_I20211231" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzQtNS0xLTEtMjEzMzM5_cb639c20-3aeb-4774-ae51-6f617478b149">7,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:OtherNetAssetsLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzUtMy0xLTEtMjEzMzM5_093bd95d-3fb6-468f-9d34-2dc1bc6325b4">36,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzUtNS0xLTEtMjEzMzM5_0fe43a1c-658e-4106-9be0-4f027e0a3c67">28,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="idc34d8c31789435587836b8c9960210e" continuedAt="idda8b4e242af49d38167f068f8dd724b"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.24pt">Other investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist of investments in common shares and options of two companies in the cannabis industry. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PharmaCann Option</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, the Company purchased an option (the &#8220;PharmaCann Option&#8221;) to acquire <ix:nonFraction unitRef="shares" contextRef="i7a6151bf97b4479db1915de9cf54196a_D20210614-20210614" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzkyODE_42a317ac-a2b4-4971-9901-0d1bb9352571">473,787</ix:nonFraction> shares of Class A Common Stock of PharmaCann, Inc. (&#8220;PharmaCann&#8221;), a vertically integrated cannabis company in the United States, at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ica770eae2c9246a2afe81a80ce6bc6ec_I20210614" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzk0Mzg_dfdf1135-fac5-4758-8555-40b37f34b9d1">0.0001</ix:nonFraction> per share, representing approximately <ix:nonFraction unitRef="number" contextRef="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614" decimals="3" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzk0Nzk_f1a78c01-315c-4b83-88f9-524b6fffe193">10.5</ix:nonFraction>% of PharmaCann&#8217;s issued and outstanding capital stock on a fully diluted basis as of the date of the PharmaCann Option, for an aggregate purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzk2NTA_d13d4645-0021-45f0-8787-47c4967deb44">110,392</ix:nonFraction>. The option exercise will be based upon various factors, including the status of U.S. federal cannabis legalization, as well as regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise. The Company has deemed its influence in PharmaCann to be non-significant. The PharmaCann Option is classified as an investment in an equity security without a readily determinable fair value. The Company measures the PharmaCann Option at cost less accumulated impairment charges, if any, and subsequently adjusted for observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The PharmaCann Option is reported as other investments on the consolidated balance sheet for the periods ended December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, PharmaCann closed its previously announced transaction with LivWell Holdings, Inc. (&#8220;LivWell&#8221;) pursuant to which PharmaCann acquired LivWell (the &#8220;LivWell Transaction&#8221;). LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately <ix:nonFraction unitRef="number" contextRef="i55bbd96bb4154fef93d9f031c4651fa9_I20220228" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE4NjkxNjk3NzEzNjY2_27bc860b-ec00-4cf7-b339-cc25aae9ea7a">6.4</ix:nonFraction>%. As of December 31, 2022, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis was approximately <ix:nonFraction unitRef="number" contextRef="i3306701595a04451b85d16301150c1ee_I20221231" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE4NjkxNjk3NzEzNjcy_8954e235-22c4-42e3-b68c-ac86ffc24f2d">6.3</ix:nonFraction>%. Under the terms of the Company&#8217;s investment in PharmaCann, the Company&#8217;s rights to nominate an observer or a director to the PharmaCann board of directors could be lost if the Company&#8217;s ownership drops below <ix:nonFraction unitRef="number" contextRef="i9d42dad636504862a15f3a4f67554aec_I20211012" decimals="INF" name="cron:MergerAgreementThresholdOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTQy_5e3a5ece-219a-4fdf-bd24-764e278adfbc">6</ix:nonFraction>% on a fully diluted basis and it sells or transfer all or any portion of the option (subject to certain exceptions). As a result, further dilution could adversely affect the Company&#8217;s rights under the PharmaCann Option. The decrease in the Company&#8217;s ownership percentage since acquisition does not materially affect the Company&#8217;s rights under the PharmaCann Option.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first, third and fourth quarters of 2022, the Company identified adverse forecast changes in the financial performance of PharmaCann as indicators of impairment related to the PharmaCann Option and conducted analyses comparing the PharmaCann Option&#8217;s carrying amount to its estimated fair value. The fair value was estimated using a combination of the income approach and the market approach. Under the income approach, significant inputs used in the discounted cash flow method include discount rate, growth rates, and cash flow projections. Under the market valuation approach, the key assumptions are the selected multiples and the discount for lack of marketability. As a result of these analyses, the Company recorded non-cash impairment charges of $<ix:nonFraction unitRef="usd" contextRef="ib2c9908a800e47b080fb9fb2cfd88973_D20220101-20220331" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MDc5_5a78283a-13cd-4e6c-ae9f-7e723f72a9b7">11,238</ix:nonFraction>. $<ix:nonFraction unitRef="usd" contextRef="i5e5776901e474b3abdf90733e7a30e62_D20220701-20220930" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MDg4_5a25fae4-06e2-4a82-baee-63da1fde46f2">28,972</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i53f60b165c164f1b89ebd97857c42986_D20221001-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MDk3_52176de4-6cf2-4980-a709-080ad3c0b4e3">21,182</ix:nonFraction> in the first, third and fourth quarters of 2022, respectively, as the difference between the carrying amount of the PharmaCann Option and its estimated fair value, in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company performed an assessment on the existence of impairment indicators on the PharmaCann Option and noted no indicators of impairment existed. As such, no impairment loss on the investment was recorded during the year ended December 31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vitura (formerly known as Cronos Australia)</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2021, Cronos Australia (now, Vitura Health Limited) entered into a merger agreement to acquire 100% of the issued shares of CDA Health Pty Ltd, an Australian medicinal cannabis company, subject to customary closing conditions, including shareholder approval (the &#8220;Cronos Australia Merger&#8221;). The Cronos Australia Merger closed on December 16, 2021. In connection with the closing of the Cronos Australia Merger, all advances made under the Company&#8217;s A$<ix:nonFraction unitRef="aud" contextRef="ic075132149c24b6f980b4c2955ff29bb_I20210914" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyMDA5_50fd925b-bbe9-4386-a249-c6023689d44b">1,500</ix:nonFraction> unsecured loan to Cronos Australia, plus accrued interest and certain royalties payable, were converted into ordinary shares of Cronos Australia. In addition, the Company&#8217;s ownership interest in Cronos Australia decreased to approximately <ix:nonFraction unitRef="number" contextRef="i3e0794b671294cf4a1a592fd95ab0288_I20211216" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyMjUx_eedcc13e-5f4e-460c-bc9f-d56d0ad1205b">10</ix:nonFraction>% and the Company&#8217;s number of Cronos Australia board seats was reduced from <ix:nonFraction unitRef="seat" contextRef="if46b21ab0b3b47ce84759033415e34a3_I20211215" decimals="INF" name="cron:NumberOfSeatsOnBoardOfDirectors" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyMzI4_e446ba84-6aff-42a3-89e2-64f805ef3f94">two</ix:nonFraction> to <ix:nonFraction unitRef="seat" contextRef="i3e0794b671294cf4a1a592fd95ab0288_I20211216" decimals="INF" name="cron:NumberOfSeatsOnBoardOfDirectors" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyMzM0_7a7f13ea-8d18-451b-89fe-6693e4f25e07">zero</ix:nonFraction>. On November 29, 2022, the shareholders of Cronos Australia approved the proposal to change the name of the company to &#8220;Vitura Health Limited&#8221; (the &#8220;CAU Name Change&#8221;). On December 2, 2022, in connection with the CAU Name Change, Vitura and the Company mutually agreed to terminate the intellectual property license that granted Vitura the right to use certain intellectual property of the Company, including, but not limited to, the &#8220;Cronos&#8221; name and the PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand. Vitura has 180 days following the date of termination to cease all usage of the Company&#8217;s intellectual property. The reduction in ownership interest and loss of all board seats constituted a loss of significant influence and resulted in a reclassification on the consolidated balance sheet from investments in equity method investments using the equity method of accounting to other investments using the fair value method of accounting, with unrealized holding gains and losses included in net income (loss) on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="idda8b4e242af49d38167f068f8dd724b"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a gain on revaluation of other investments of $<ix:nonFraction unitRef="usd" contextRef="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NTg5ODE_b653df29-6d9b-47c2-a2f5-99fd773c5a88">14,739</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i72bd56a3b81845f49fe8b58426c1d15c_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyODg4_302b3dcf-dd9f-436c-ba8e-0a413406155f">8,287</ix:nonFraction>, included in the gain on revaluation of financial instruments on the statements of net income (loss) and comprehensive income (loss), for the years ended December 31, 2022 and 2021, respectively. The Company&#8217;s investment in Vitura was $<ix:nonFraction unitRef="usd" contextRef="ib48a5f922dc74080be8b4e6b57c7a04d_I20221231" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NTg5NTI_3d7ee372-f113-428e-9698-43ab5a4b3943">21,993</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3a0de233b3214d3bb109cdfb9f70e304_I20211231" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NTg5NDY_c6712cff-5741-41b3-9627-3463fee410e7">8,000</ix:nonFraction>, included in other investments on the balance sheet, as of December 31, 2022 and 2021, respectively.</span></div><ix:continuation id="ib3c92f3ca59a404099cddd9d753b74a4"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s other investments activity:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PharmaCann</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ffd69d80d04eb29f72245ee158a8f6_I20211231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtMS0xLTEtMjI1ODg3_29fc8700-9d5f-49c6-9c93-c8dd34501db3">110,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aeb1d824d3f4e9984e927ae64cea18a_D20220101-20221231" decimals="-3" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtMy0xLTEtMjI1ODg3_92dc31b3-3bf7-4f4d-ab10-cf9fa5b68cf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4aeb1d824d3f4e9984e927ae64cea18a_D20220101-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtNS0xLTEtMjI1ODg3_e2946411-fcf1-439e-8b67-996ca3935dbf">61,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aeb1d824d3f4e9984e927ae64cea18a_D20220101-20221231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtNy0xLTEtMjI1ODg3_f9f26217-e16f-48e1-832c-df8ea434518e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2ab3c32bb7547b48229e1aa72f2da89_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtOS0xLTEtMjQ2NTky_a7858e64-2fd6-4c6e-b11d-6b163446e01a">49,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitura</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a0de233b3214d3bb109cdfb9f70e304_I20211231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItMS0xLTEtMjI1ODg3_be34a15d-1502-49a6-aec5-0f5cae8176b7">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231" decimals="-3" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItMy0xLTEtMjI1ODg3_2debe7a0-925f-480a-b535-c2b224e8e1fa">14,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItNS0xLTEtMjI1ODg3_6c9b0833-6c54-4c08-a518-4737a9f9658f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItNy0xLTEtMjI1ODg3_bdc68fb4-98c6-48ef-961f-ba161a1d5f58">746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib48a5f922dc74080be8b4e6b57c7a04d_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItOS0xLTEtMjQ2NTky_abe6c6c5-7912-4062-9bd7-35c400474516">21,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtMS0xLTEtMjQ2NTk4_a6094cca-0efb-4dde-b45b-4f0aecc99ec0">118,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtMy0xLTEtMjQ2NjAy_606d5d2f-e0fd-409c-8b42-1c0144f098e8">14,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtNS0xLTEtMjI1ODg3_c7189973-034d-41a4-a6a6-3f6e613e2bc3">61,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtNy0xLTEtMjQ2NjEy_90883840-23f4-4e21-b8ea-0575953193d1">746</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtOS0xLTEtMjQ2NTky_32bec878-99b9-440a-bdfa-aee377d4620c">70,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Disposal of investments</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NzQ0_a29f606c-841e-4dd2-b91b-04096a050ee0" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s gain from disposals of investments:</span></div><div style="margin-bottom:2pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3a51f82e6c455ea2fbee1766559fd5_D20220101-20221231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZToxZmM3NmQyMWJlYjU0ZGMyODgxYjI2ZjI5Mjc4NmY1ZC90YWJsZXJhbmdlOjFmYzc2ZDIxYmViNTRkYzI4ODFiMjZmMjkyNzg2ZjVkXzUtMS0xLTEtMjEzMzM5_9560c9a0-7a30-4289-a49f-8b13eaeae406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93c9943632c46e680e9a9c7d3dca0db_D20210101-20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZToxZmM3NmQyMWJlYjU0ZGMyODgxYjI2ZjI5Mjc4NmY1ZC90YWJsZXJhbmdlOjFmYzc2ZDIxYmViNTRkYzI4ODFiMjZmMjkyNzg2ZjVkXzUtMy0xLTEtMjEzMzM5_1f88f089-6595-4043-8a5f-d12c257fb84e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdc8fdc92d5e4970acec520cba2b995b_D20200101-20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZToxZmM3NmQyMWJlYjU0ZGMyODgxYjI2ZjI5Mjc4NmY1ZC90YWJsZXJhbmdlOjFmYzc2ZDIxYmViNTRkYzI4ODFiMjZmMjkyNzg2ZjVkXzUtNS0xLTEtMjEzMzM5_00d6529e-c1c2-4c5b-a19e-dd230f6ee00c">4,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received <ix:nonFraction unitRef="shares" contextRef="i444e948e17884088a02f8873d27fb530_D20200101-20201231" decimals="INF" name="cron:InvestmentOwnedNumberOfSharesReceived" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MTE2_d70d8ae7-1bcf-4d28-95a1-013b2ce20671">980,662</ix:nonFraction> common shares of Aurora Cannabis Inc. (&#8220;Aurora&#8221;). The Company sold all <ix:nonFraction unitRef="shares" contextRef="i444e948e17884088a02f8873d27fb530_D20200101-20201231" decimals="INF" name="cron:InvestmentOwnedNumberOfSharesSold" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MTI1_6710cb1a-4265-4f8c-bc93-50b6e1fdf58c">980,662</ix:nonFraction> of the Aurora common shares during the year ended December 31, 2020, for gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="id93c9943632c46e680e9a9c7d3dca0db_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NTQ4_d8e557e1-c03a-44dc-8209-c6f5ec1e4e93">4,789</ix:nonFraction>, resulting in a $<ix:nonFraction unitRef="usd" contextRef="id93c9943632c46e680e9a9c7d3dca0db_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NTY3_85853a48-9d8c-4f07-b8c8-9b598310d787">4,789</ix:nonFraction> gain on disposal of investments being recorded on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2020.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_103"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM1OTI_ca1cd35c-7be0-4a84-ae9d-e7f4612ee7d0" continuedAt="i024509ef8f7a417aad9b1f4e98466506" escape="true">Loans Receivable, net </ix:nonNumeric></span></div><ix:continuation id="i024509ef8f7a417aad9b1f4e98466506" continuedAt="i55d4afcbcbfd4521b16309d063df2db4"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM1OTQ_6ddc82d2-d0f5-457e-b224-4d6744985ced" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans receivable, net consists of the following:</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4061198d00b42a1b1c3273bd1300f1f_I20221231" decimals="-3" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzMtMS0xLTEtMjEzMzM5_e25c32a8-6f40-47a5-b765-1fa9b16d12b1">4,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf97cb5d7b14fcaba22a604151aa02c_I20211231" decimals="-3" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzMtMy0xLTEtMjEzMzM5_4d0235d7-de59-432d-8ce7-d056372235c8">3,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231" decimals="-3" name="cron:FinancingReceivableAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzQtMS0xLTEtMjEzMzM5_c629cfa0-5ee8-47ba-b6ba-f41532eb59b4">4,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231" decimals="-3" name="cron:FinancingReceivableAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzQtMy0xLTEtMjEzMzM5_fdb677c2-5813-42de-8448-f753d0faae69">2,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzUtMS0xLTEtMjEzMzM5_b5127591-a947-48c9-98aa-3cba4222a93a">8,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzUtMy0xLTEtMjEzMzM5_c32f3a9d-a72a-4471-b33d-6af3612141d7">5,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4061198d00b42a1b1c3273bd1300f1f_I20221231" decimals="-3" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzYtMS0xLTEtMjEzMzM5_b46c9247-d615-4932-96d2-dd580d46521e">56,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf97cb5d7b14fcaba22a604151aa02c_I20211231" decimals="-3" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzYtMy0xLTEtMjEzMzM5_ced61089-04fd-4bd7-aec6-066e4e7d8863">64,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1e7c50392b48839d2e08df306850ff_I20221231" decimals="-3" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzctMS0xLTEtMjEzMzM5_f5fe2da1-1804-43ca-b1cc-ac4971c0a7eb">13,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i031e61530a214b9881c8d518d3c7a377_I20211231" decimals="-3" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzctMy0xLTEtMjEzMzM5_9fc9790a-1cc7-449a-ad60-deef4cf4dbe9">14,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8c1e543ab94dc7ae66690ab16e3743_I20221231" decimals="-3" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzgtMS0xLTEtMjEzMzM5_d3bcde7a-3f1a-4bd8-94c6-3676195e62d5">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecc95374e7c42d79e927354f15a2d05_I20211231" decimals="-3" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzgtMy0xLTEtMjEzMzM5_f283fd59-6a1c-4303-8250-20464fdd24b6">2,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Long-term portion of accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231" decimals="-3" name="cron:FinancingReceivableAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzktMS0xLTEtMjEzMzM5_4e76b49f-5346-4b53-841e-3e38a28d1efc">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231" decimals="-3" name="cron:FinancingReceivableAccruedInterestNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzktMy0xLTEtMjEzMzM5_0cb971bd-b493-4f96-a5d7-a7833d6e6009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzEwLTEtMS0xLTIxMzMzOQ_8c47f6b3-285f-4464-98ae-7766a339b589">72,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzEwLTMtMS0xLTIxMzMzOQ_8a927322-066a-4489-b8e2-c315368c4206">80,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231" decimals="-3" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzExLTEtMS0xLTIxMzMzOQ_30c7b8c0-3c5a-4e19-9690-b1db591a3498">81,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231" decimals="-3" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzExLTMtMS0xLTIxMzMzOQ_f3fe02f0-589b-48ef-a02d-fd7eb52cf065">86,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos GrowCo Credit Facility</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2019, the Company, as lender, and Cronos GrowCo, as borrower, entered into a senior secured credit agreement for an aggregate principal amount of C$<ix:nonFraction unitRef="cad" contextRef="i9cd678b9cba6400b91b864e4539c08f3_I20190823" decimals="INF" name="cron:FinancingReceivableFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzkwMA_d4dfa4fe-95a8-4853-b697-aa152328f673">100,000</ix:nonFraction> (the &#8220;GrowCo Credit Facility&#8221;). In August 2021, the GrowCo Credit Facility was amended to increase the aggregate principal amount available to C$<ix:nonFraction unitRef="cad" contextRef="ia9a0f515dda54606a8ec5e2a496990a6_I20210831" decimals="INF" name="cron:FinancingReceivableFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM4NDgyOTA3MDIxMTc_a0d1bf57-399f-4fc6-9912-3b8677f09bd7">105,000</ix:nonFraction>. As a result of the increase in the aggregate principal amount of the GrowCo Credit Facility and lower than expected sales forecasts from Cronos GrowCo, the Company revalued its allowance for credit loss on the GrowCo Credit Facility resulting in an increase in the allowance of $<ix:nonFraction unitRef="usd" contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE2NDkyNjc0NDY3OTg_a5792090-b223-4fb7-b051-4d66ba3577e6">12,748</ix:nonFraction>, which was recorded in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021. In conjunction with the aforementioned revaluation, the Company changed its expected credit loss valuation methodology from the historical credit loss method to the probability of default method. As of December&#160;31, 2022 and 2021, Cronos GrowCo had drawn C$<ix:nonFraction unitRef="cad" contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzEwOTk1MTE2MzMxMzI_2cc21666-6a0b-4f3c-971d-a3d88aea25af">104,000</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzEwOTk1MTE2MzMxNjg_4b8a1442-c15a-401f-9d08-59ac4fb1b96d">76,730</ix:nonFraction>) and C$<ix:nonFraction unitRef="cad" contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE3NDY_fe7a4c25-6295-4933-aca0-6167843afdf5">104,000</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE3NTA_469bcf6f-96b8-4d59-b52c-dd3372e88a1a">81,598</ix:nonFraction>), respectively, from the GrowCo Credit Facility. As of December 31, 2022, Cronos GrowCo had repaid C$<ix:nonFraction unitRef="cad" contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE0ODQzNDA2OTgxMzQ2_9d5a9040-b50d-406f-82b4-4c55630cb132">4,000</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzEwOTk1MTE2Mzc3NTg_7c5711d3-6dae-4bfc-9e9f-637bb2f38b00">3,073</ix:nonFraction>) in principal under the terms of the GrowCo Credit Facility.</span></div></ix:continuation><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i55d4afcbcbfd4521b16309d063df2db4"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mucci Promissory Note</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2019, the Company entered into a promissory note receivable agreement (the &#8220;Mucci Promissory Note&#8221;) for C$<ix:nonFraction unitRef="cad" contextRef="icd137ffe84044ae29b17a0f26fcfbcc6_I20190628" decimals="INF" name="cron:FinancingReceivableFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE5MTI_1841cbe9-b44a-44e8-982e-6749165e17e4">16,350</ix:nonFraction> (approximately $<ix:nonFraction unitRef="usd" contextRef="icd137ffe84044ae29b17a0f26fcfbcc6_I20190628" decimals="INF" name="cron:FinancingReceivableFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzEwOTk1MTE2Mzc4NTU_c2934199-065e-4d95-9a3d-25618ab8211f">12,063</ix:nonFraction>) with Mucci. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci. On September 30, 2022, the Mucci Promissory Note was amended and restated to increase the interest rate from <ix:nonFraction unitRef="number" contextRef="icd137ffe84044ae29b17a0f26fcfbcc6_I20190628" decimals="INF" name="cron:FinancingReceivableInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE4NjkxNjk3Njc3NjQ3_4e5beb09-cd53-4947-9c23-f0e841fef954">3.95</ix:nonFraction>% to the Canadian Prime Rate plus <ix:nonFraction unitRef="number" contextRef="i4a758fc2d72741ca8bd4fd42269ec1a4_I20220930" decimals="INF" name="us-gaap:LoansReceivableBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE4NjkxNjk3Njc3NjU0_ff1144a1-f708-4a77-9710-a4eb5db3876f">1.25</ix:nonFraction>%, change the interest payments from quarterly to annual, and defer Mucci&#8217;s initial cash interest payment from September 30, 2022 to July 1, 2023. This debt modification resulted in an increase of approximately C$<ix:nonFraction unitRef="cad" contextRef="i83da444fa44248408487072ea1d3c39e_D20220930-20220930" decimals="-3" name="cron:FinancingReceivableInterestIncomeIncreaseFromDebtModification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE4NjkxNjk3Njc3NjYx_1e7d997e-2b3a-42e0-bf77-7ee613117dc6">180</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i83da444fa44248408487072ea1d3c39e_D20220930-20220930" decimals="-3" name="cron:FinancingReceivableInterestIncomeIncreaseFromDebtModification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE4NjkxNjk3Njc3NjY4_4956b84c-6c64-4052-b78a-c22c536f3809">140</ix:nonFraction>) in interest income.</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cannasoul Collaboration Loan</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both December&#160;31, 2022 and 2021, CLS has received ILS <ix:nonFraction unitRef="ils" contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231" decimals="-3" name="cron:CollaborativeArrangementInstallmentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzI3OTc_62c7b1f8-3610-4e18-a9a6-01c5f3c5ed50"><ix:nonFraction unitRef="ils" contextRef="if626a2f16cf6417e88022ae91d96abbc_I20211231" decimals="-3" name="cron:CollaborativeArrangementInstallmentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzI3OTc_918349eb-df49-4574-ad48-6a42613eaa5e">8,297</ix:nonFraction></ix:nonFraction> (approximately $<ix:nonFraction unitRef="usd" contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231" decimals="-3" name="cron:CollaborativeArrangementInstallmentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE0ODQzNDA2OTgxMzY1_1ed24ced-7888-4f63-aef7-be8802d56114">2,359</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if626a2f16cf6417e88022ae91d96abbc_I20211231" decimals="-3" name="cron:CollaborativeArrangementInstallmentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzI4Mzc_b9571853-e6b0-4fe3-9a2b-98596892c0f7">2,664</ix:nonFraction>, respectively), from the Cannasoul Collaboration Loan. See Note 3 &#8220;Investments&#8221; for further information regarding the Cannasoul Collaboration Loan.</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM1OTE_50057435-a640-44b0-b3c3-379d70e9094c" escape="true"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> credit loss allowances on the Company&#8217;s long-term financial assets were comprised of the following items:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf97cb5d7b14fcaba22a604151aa02c_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzEtMS0xLTEtMjEzMzM5_06850e43-07b3-483d-aeb8-3bd85ac43082">14,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzEtMy0xLTEtMjEzMzM5_3771e41b-068b-4a09-89e1-80399fb27a68">827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzEtNS0xLTEtMjEzMzM5_0f3ea522-dab3-4df6-b041-00ee26bf9a35">807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4061198d00b42a1b1c3273bd1300f1f_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzEtNy0xLTEtMjEzMzM5_395102d1-a22b-4e21-999e-f30cedcffa36">12,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i031e61530a214b9881c8d518d3c7a377_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzMtMS0xLTEtMjEzMzM5_a3b141bb-383b-489d-96aa-5b07da0c8c9e">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30edf6082b0d4470941e510e7d37ba68_D20220101-20221231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzMtMy0xLTEtMjEzMzM5_b855a41d-8d19-4c99-a141-0ad4f8b4c150">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30edf6082b0d4470941e510e7d37ba68_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzMtNS0xLTEtMjEzMzM5_2a95f1e7-fc14-4674-a6ee-990adfc93883">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1e7c50392b48839d2e08df306850ff_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzMtNy0xLTEtMjEzMzM5_b1a9fd4b-cf96-45d2-aa40-7c75f75a5029">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecc95374e7c42d79e927354f15a2d05_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzQtMS0xLTEtMjEzMzM5_015c5455-3661-46bb-afe1-45ce8fba3560">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7200b06da62a43118c5cc7777451847f_D20220101-20221231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzQtMy0xLTEtMjEzMzM5_8dc70a9d-7c4b-4c7b-8c82-174a5a7031e8">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7200b06da62a43118c5cc7777451847f_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzQtNS0xLTEtMjEzMzM5_d418174b-2376-4840-b26d-8e5a7cb757a8">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8c1e543ab94dc7ae66690ab16e3743_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzQtNy0xLTEtMjEzMzM5_427886b7-e866-488c-a544-5d60297294d5">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzUtMS0xLTEtMjEzMzM5_832846f5-fd50-4cee-8197-3a6048031bf7">14,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzUtMy0xLTEtMjEzMzM5_c9f77668-ce70-4546-9a72-d16c9ab7fc36">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzUtNS0xLTEtMjEzMzM5_a9782f1d-df02-4161-a6d9-69218a3af41f">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzUtNy0xLTEtMjEzMzM5_63b71c67-eac5-40cd-9245-33b2ae3b07e7">13,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if369a901d9af4bfd8ae3d2a027cee610_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzEtMS0xLTEtMjEzMzM5_c4bdc385-7b35-4b3e-9bc1-75b63a553f11">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzEtMy0xLTEtMjEzMzM5_a5792090-b223-4fb7-b051-4d66ba3577e6">12,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzEtNS0xLTEtMjEzMzM5_fe0fff15-29f1-494b-82d0-9faba588bd4c">205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf97cb5d7b14fcaba22a604151aa02c_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzEtNy0xLTEtMjEzMzM5_bd7073af-18a2-4519-99ee-0b873114da44">14,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f45e6669daa4361a3421b8a2d98c0b0_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzItMS0xLTEtMjEzMzM5_e3216ed5-f69f-413c-b25b-1e91032f5358">721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c64e7d2537944ffaf7e5b5f16883925_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzItMy0xLTEtMjEzMzM5_52e1d37d-cb3e-429c-b04a-5be131728eb3">737</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c64e7d2537944ffaf7e5b5f16883925_D20210101-20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzItNS0xLTEtMjEzMzM5_ce4aeafb-41bb-4442-860b-63107a8721f7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437da1842e044616977893cd552a72ee_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzItNy0xLTEtMjEzMzM5_ba277918-b04e-44f3-8a63-8d279c14b60c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3320ad951dab401c84e0f90c4a96974c_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzMtMS0xLTEtMjEzMzM5_01a1c706-9ba9-4776-b25c-e6d9f824706f">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i533957fd53ef49379dec9dedd211cf52_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzMtMy0xLTEtMjEzMzM5_f1217397-3bbc-468a-a8d6-a3aae2e6ea3f">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533957fd53ef49379dec9dedd211cf52_D20210101-20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzMtNS0xLTEtMjEzMzM5_cde3d9e7-24d9-4785-93f0-37d971e5de25">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i031e61530a214b9881c8d518d3c7a377_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzMtNy0xLTEtMjEzMzM5_8e780952-5789-44f1-bd7a-24cd147c7943">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d18d46bab5242e3bfd554e73da9ea90_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzQtMS0xLTEtMjEzMzM5_ad422868-f43c-47f9-bf6a-9f2c9099b509">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i325878c284c54d7983006f5f7cca0186_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzQtMy0xLTEtMjEzMzM5_ae366358-cb33-444d-921b-7f910caa1ad2">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i325878c284c54d7983006f5f7cca0186_D20210101-20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzQtNS0xLTEtMjEzMzM5_9ca42227-5577-43e2-b63c-f1f2ccfd9dd4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecc95374e7c42d79e927354f15a2d05_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzQtNy0xLTEtMjEzMzM5_978204bb-6ba3-4b6b-aafd-1bb3628f970b">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzUtMS0xLTEtMjEzMzM5_44331a32-e48f-4577-bf4a-8bdc567f82a7">2,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzUtMy0xLTEtMjEzMzM5_3c0e3557-b424-4a15-b3f9-2c98fead2c50">12,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzUtNS0xLTEtMjEzMzM5_90f50259-a064-47b8-b1bb-8eef5f0d3b98">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzUtNy0xLTEtMjEzMzM5_4e695238-3c46-4466-9468-76eda1748a5e">14,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December 31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i4c64e7d2537944ffaf7e5b5f16883925_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM4NDgyOTA3MDIxOTY_d99efa81-4636-45e6-b4c5-41472bc2802b">737</ix:nonFraction> of expected credit losses on long-term financial assets was transferred to investments in equity method investments in relation to the Natuera Debt Conversion, as the carrying amount of the loan receivable, net, approximated fair value as of the date of transfer. During the years ended December 31, 2022 and 2021, $(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="cron:FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM4NDgyOTA3MDI0NDM_ffbf0a2e-8bb5-48b5-baa4-821d2a679f61">662</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzc2OTY1ODEzOTk0MzA_4dacc7aa-6791-4e8f-ba43-50bcf171ade9">12,939</ix:nonFraction>, respectively, were recorded to general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss) as a result of adjustments to our expected credit losses.</span></div></ix:nonNumeric></ix:continuation><div id="i228e12b34e804aa096affae69dd6b9af_106"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzMyNjQ_b84bd537-f5fe-437e-ba6e-217afee75dbb" continuedAt="i5b0c941c61fc4f15b884d6b21e387269" escape="true">Property, plant and equipment, net</ix:nonNumeric></span></div><ix:continuation id="i5b0c941c61fc4f15b884d6b21e387269" continuedAt="i9d37a83241e74f1286ab8ec808c7dce4"><ix:continuation id="i51ba09f97e73438aa8399133e36e9259"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b69cfe90a884fb39eba1ca111fc6b2e_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzMtMi0xLTEtMjQyMzc3_759a6084-da55-4d10-b114-5ca8671a1b95">2,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05bc2d13ff4b4b3db4cbd143a6dd2d63_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzMtNC0xLTEtMjQxMzgw_de053f50-7a0d-43af-b4ad-9b4b6d78e41f">2,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bfb0d988c89434bae9a37fc057aca1e_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzQtMi0xLTEtMjQyMzc3_fae56d33-4f95-4957-87f5-6c5e1e4d83b8">177,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9593341e604e159c7bc62652cda7b0_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzQtNC0xLTEtMjQyMzc3_07c3407e-78c8-4195-adb5-1a8628339091">188,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c61698f6b548408440dcb1fe8bc8ac_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzUtMi0xLTEtMjQyMzc3_80864561-6eb6-44a7-bff7-750637569d62">19,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if869afc8633e4ac0b98107ef318157c4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzUtNC0xLTEtMjQyMzc3_653319ef-d0f7-44b9-b15d-af723a21b60c">18,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic368bd11f0df40d4a8c0b2947fe070bb_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzYtMi0xLTEtMjQyMzc3_71a63bc7-eb7d-4e28-8cdc-25ab29dfb9e7">5,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie265b91a4e9a4c02afb8d5eb309f1fcd_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzYtNC0xLTEtMjQyMzc3_343f7404-845f-408a-8ac2-94326deab077">5,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c687afbf2874359b7b1e96d6171e47b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzctMi0xLTEtMjQyMzc3_512c97cb-f923-411a-b6ec-228b2839eff2">841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1eeef365d9410ba49be0ad28e8a610_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzctNC0xLTEtMjQyMzc3_b62aba89-2ad6-48cc-aa80-9fac2db4964e">2,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzgtMi0xLTEtMjQyMzc3_0b5b8518-0207-41bd-911e-0ca367f6e11b">35,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzgtNC0xLTEtMjQyMzc3_5fa09aae-0df2-4dbd-b7a5-f9c859be2c73">30,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:AccumulatedImpairmentOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzktMi0xLTEtMjQyMzc3_ac7886b4-2948-42df-bebf-54a4f63bacab">109,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:AccumulatedImpairmentOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzktNC0xLTEtMjQyMzc3_8cffc6a4-081d-4027-b8fb-69249df8ee68">114,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzEwLTItMS0xLTI0MTQyOQ_16322703-4986-4ded-96cf-fec13f4a0909">60,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzEwLTQtMS0xLTI0NjY3Mg_f3bedb19-6c81-4bdd-a8a6-e89eba3ad6e8">74,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, depreciation expense on property, plant and equipment was $<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQzNTc_95e6c445-f925-446e-b604-6b339c3c6b8e">8,667</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQzMzg_5b935e65-c613-48b1-b852-b4d8210d36b0">11,668</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQzMjc_5d29517f-7d98-4ee5-8964-e6b9e6f7782c">9,052</ix:nonFraction>, respectively, and was included in cost of sales as well as depreciation and amortization in operating expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i9d37a83241e74f1286ab8ec808c7dce4"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-lived Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company recognized an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i6ebea50f3dab40fe940962382c9edd7b_D20220101-20220331" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQzODQ_f9cf834f-5029-4898-8363-31cf458707ce">1,507</ix:nonFraction> related to leasehold improvements and other office equipment that it plans to include in any potential sublease agreement of the Company&#8217;s corporate headquarters, encompassing approximately <ix:nonFraction unitRef="sqft" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzg1MTc_0fbc85de-81e9-4555-a8a6-953c729b197f">29,000</ix:nonFraction> square feet, in Toronto, Ontario, Canada. The determination to seek a sublease of the property and include leasehold improvements and other office equipment in any potential sublease agreement triggered the impairment charges. The impairment charge was recognized as impairment loss on long-lived assets on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company concluded that indicators of impairment were present with respect to its Canadian asset group in connection with the previously anticipated wind-down and closure of the Company&#8217;s facility in Stayner, Ontario. As a result, the Company compared the sum of the undiscounted future cash flows attributable to the Canadian asset group to their respective carrying amounts and recorded a non-cash impairment charge on long-lived assets of $<ix:nonFraction unitRef="usd" contextRef="i7e73aaf3d4da43618c18f1bb5254e468_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQ0MDQ_dd5aea7e-f6d2-4abc-af28-d3b609655f95">113,917</ix:nonFraction> as the difference between the carrying amount of the asset group and its estimated fair value for the year ended December 31, 2021, in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, in connection with the Company&#8217;s reassessment of indicators of impairment relating to the U.S. segment&#8217;s property, plant and equipment asset group for the quarter ended June 30, 2021, the Company concluded that triggers were present that indicated that the carrying amounts of those assets were not recoverable. Accordingly, the Company compared the sum of the undiscounted future cash flows attributable to the U.S. asset group (the lowest level for which identifiable cash flows are available) to their respective carrying amount and recorded a non-cash impairment charge on long-lived assets of $<ix:nonFraction unitRef="usd" contextRef="i799ef2d8ae8143d3aabbb83e1a41d9c1_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzU0OTc1NTgxODc4NA_e4be4268-bc82-454d-b38b-d18791b77cf2">1,214</ix:nonFraction> for the difference between the carrying amount of the asset group and its estimated fair values in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company recognized an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ib7c6daed2ada448ca0191eb31284605b_D20210401-20210630" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzE0ODA_c403ebdd-005c-4c3d-b1d2-35cfe8fba498">1,039</ix:nonFraction> related to leasehold improvements located within leased premises, encompassing approximately <ix:nonFraction unitRef="sqft" contextRef="i2f24fa047ebd4cafa9ce6895143e5be7_D20210401-20210630" decimals="-3" name="cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzE1NzY_f49b5825-4802-41fe-8a41-f2655699a347">6,000</ix:nonFraction> square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leasehold improvements are being used and the expectation that, more likely than not, the leasehold improvements will be disposed of before the end of their useful life triggered an impairment. The impairment charges were recognized in the consolidated statements of net income (loss) and comprehensive income (loss) as an impairment loss on long-lived assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzEwOTk1MTE2MzY3NTg_5e8d6bf6-2f59-43fa-b2e3-e340dedcda59">no</ix:nonFraction> impairment charges on property, plant and equipment during the year ended December 31, 2020.</span></div></ix:continuation><div id="i228e12b34e804aa096affae69dd6b9af_109"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzkxMjg_c6f8c04e-3a5e-45d4-a862-2ebcfe1a2deb" continuedAt="i7554c176be074deea3b58bc1ec91bb18" escape="true">Goodwill and Intangible Assets, net</ix:nonNumeric></span></div><ix:continuation id="i7554c176be074deea3b58bc1ec91bb18" continuedAt="i93c6375689c24e8eb3c65ffb26422965"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Goodwill</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzkxMjk_b49ede13-95f8-4fed-ae65-f684cf5ae9a8" continuedAt="ic60d83f77df24439be96bab1e0bebbf3" escape="true"><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is comprised of the following items:</span></div><div style="margin-bottom:1pt;margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Peace Naturals</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198f84bb8c8c4495a7592d90fa3b5554_I20221231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzItMS0xLTEtMjEzMzM5_dc1852d3-b995-44eb-a999-88157075c534">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198f84bb8c8c4495a7592d90fa3b5554_I20221231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzItMy0xLTEtMjEzMzM5_896951f4-b619-4c97-9d8c-53f8dee1ebcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198f84bb8c8c4495a7592d90fa3b5554_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzItNS0xLTEtMjEzMzM5_5e8c9483-990d-4b79-bad0-0b73a46ee5b8">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib098004c6d90459292103b62760beef6_I20221231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzMtMS0xLTEtMjEzMzM5_0d4c4493-0a64-4c5a-9abd-09a614d2600b">213,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib098004c6d90459292103b62760beef6_I20221231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzMtMy0xLTEtMjEzMzM5_c1c4023e-72ae-468b-b52f-ac3ceffd0e77">213,414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib098004c6d90459292103b62760beef6_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzMtNS0xLTEtMjEzMzM5_8a1edf00-f89b-417a-a3a3-8d1249f0d61f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzQtMS0xLTEtMjEzMzM5_5dc9a8fb-b87f-4037-9223-fbba42397930">214,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzQtMy0xLTEtMjEzMzM5_cd069b73-6c3c-4911-b19b-679a2fdce829">213,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzQtNS0xLTEtMjEzMzM5_64ac4bcb-b573-4521-a315-1a6a67acb930">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peace Naturals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2be1513878243dbbe968f845f1407aa_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzMtMS0xLTEtMjEzMzM5_4d73fb9f-fb01-4b88-81d0-53c1f22383ee">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2be1513878243dbbe968f845f1407aa_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzMtMy0xLTEtMjEzMzM5_8adec6c4-3d8a-42fb-9fc6-4d3018ea591b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2be1513878243dbbe968f845f1407aa_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzMtNS0xLTEtMjEzMzM5_eeb31f84-0075-4f14-a101-cfe4192a54bd">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzQtMS0xLTEtMjEzMzM5_548b8e48-578f-4f25-b4da-583137a0fd32">213,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzQtMy0xLTEtMjEzMzM5_f8140f42-1204-4821-8f23-048f087e4ba4">213,414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzQtNS0xLTEtMjEzMzM5_794a6337-ae1e-48fe-981c-131d54800937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzUtMS0xLTEtMjEzMzM5_0c54358b-472b-4626-aa6c-e34c492b1cc0">214,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzUtMy0xLTEtMjEzMzM5_aca6aa68-dc6f-41d6-ba59-ae25b3503612">213,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzUtNS0xLTEtMjEzMzM5_8e415f5b-c4a5-47fc-b391-d790feaf714b">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated impairment charges on goodwill consist of:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpmZWU4MzUwZGJkMzc0ZDRiOTlmYmY2NTE4NGU4MTdkZC90YWJsZXJhbmdlOmZlZTgzNTBkYmQzNzRkNGI5OWZiZjY1MTg0ZTgxN2RkXzMtMS0xLTEtMjEzMzM5_47eb04a4-e514-4f09-bd77-2197c7eeb15a">213,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d5db05218e34129ac787a7d7f694b92_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpmZWU4MzUwZGJkMzc0ZDRiOTlmYmY2NTE4NGU4MTdkZC90YWJsZXJhbmdlOmZlZTgzNTBkYmQzNzRkNGI5OWZiZjY1MTg0ZTgxN2RkXzMtMy0xLTEtMjEzMzM5_0b989870-03c2-4d1d-b7b3-c7e275fca4e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d5db05218e34129ac787a7d7f694b92_D20220101-20221231" decimals="-3" name="cron:GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpmZWU4MzUwZGJkMzc0ZDRiOTlmYmY2NTE4NGU4MTdkZC90YWJsZXJhbmdlOmZlZTgzNTBkYmQzNzRkNGI5OWZiZjY1MTg0ZTgxN2RkXzMtNS0xLTEtMjEzMzM5_2f92e5a6-4721-4952-8bee-ffc57c18e352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib098004c6d90459292103b62760beef6_I20221231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpmZWU4MzUwZGJkMzc0ZDRiOTlmYmY2NTE4NGU4MTdkZC90YWJsZXJhbmdlOmZlZTgzNTBkYmQzNzRkNGI5OWZiZjY1MTg0ZTgxN2RkXzMtNy0xLTEtMjEzMzM5_31d37e54-37d9-495c-8f59-33a791c341c2">213,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i93c6375689c24e8eb3c65ffb26422965" continuedAt="ia5faf573de6a4674a0f20699ab2bdf9f"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><ix:continuation id="ic60d83f77df24439be96bab1e0bebbf3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c74a7f5ddc94bfbb03e3906e64f0b91_I20201231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxM2Y0NGY3Yjc4M2E0YmQ5YTc5ZDI5MTA0Njg2ZTkxNS90YWJsZXJhbmdlOjEzZjQ0ZjdiNzgzYTRiZDlhNzlkMjkxMDQ2ODZlOTE1XzMtMS0xLTEtMjEzMzM5_d4f3d381-cf20-4e26-9f39-d69e9e272996">35,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25737ffe6e95490d8d2ee87f9448d05a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxM2Y0NGY3Yjc4M2E0YmQ5YTc5ZDI5MTA0Njg2ZTkxNS90YWJsZXJhbmdlOjEzZjQ0ZjdiNzgzYTRiZDlhNzlkMjkxMDQ2ODZlOTE1XzMtMy0xLTEtMjEzMzM5_be8b4ea1-2b8c-4d2a-b656-3984d96d98d2">178,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25737ffe6e95490d8d2ee87f9448d05a_D20210101-20211231" decimals="-3" name="cron:GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxM2Y0NGY3Yjc4M2E0YmQ5YTc5ZDI5MTA0Njg2ZTkxNS90YWJsZXJhbmdlOjEzZjQ0ZjdiNzgzYTRiZDlhNzlkMjkxMDQ2ODZlOTE1XzMtNS0xLTEtMjEzMzM5_c97f4033-a109-43b6-a36f-d89e765b483d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxM2Y0NGY3Yjc4M2E0YmQ5YTc5ZDI5MTA0Njg2ZTkxNS90YWJsZXJhbmdlOjEzZjQ0ZjdiNzgzYTRiZDlhNzlkMjkxMDQ2ODZlOTE1XzMtNy0xLTEtMjEzMzM5_7043a890-bbfd-48a3-976e-5dbb33178efd">213,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company acquired all of the issued and outstanding shares of each of the <ix:nonFraction unitRef="subsidiary" contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzUwMA_72993615-6af1-4c8f-9722-7c3cda63e71c">four</ix:nonFraction> Redwood operating subsidiaries (collectively &#8220;Redwood&#8221;) for an aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzU5Mw_6e087fa5-1feb-47c4-8a53-71f0d25df7c9">283,300</ix:nonFraction> (the &#8220;Redwood Acquisition&#8221;), which included $<ix:nonFraction unitRef="usd" contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzYxMg_084bd38a-d51e-47f3-bf9c-d86fb4edb373">227,191</ix:nonFraction> in cash and <ix:nonFraction unitRef="shares" contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzYyNw_415b488f-78a1-4c21-88f4-673cdf81f140">5,086,586</ix:nonFraction> common shares of the Company with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzY4MA_d498d1f8-5100-4248-8ed1-16e0d379ca86">56,109</ix:nonFraction>. Goodwill attributable to the acquisition was $<ix:nonFraction unitRef="usd" contextRef="i0e10c61d155349978107170ade1b67bd_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzcyOQ_cfa6dede-e611-46bc-bd3a-adb5ae3d17bd">213,414</ix:nonFraction>. The Company is required to perform a quantitative analysis of goodwill to test for impairment on an annual basis or more frequently when events or changes in circumstances indicate that fair value of the reporting unit may be less than its carrying amount. Under ASC 350 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the qualitative assessment requires the consideration of factors such as recent market transactions, macroeconomic conditions, and changes in projected future cash flows or planned revenue or earnings of the reporting unit as indicators of impairment when determining the need for a quantitative assessment of impairment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company reassessed the existence of impairment indicators on goodwill associated with the U.S. reporting unit, derived from the Redwood Acquisition, and the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand indefinite-lived intangible asset as of June 30, 2021, and determined that quantitative impairment analyses were required as of June 30, 2021 due to slower actual revenue growth as compared to previous revenue growth forecasts and significant pricing pressures brought about by increased competition and aggressive discounting in the U.S. reporting unit and associated with the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand indefinite-lived intangible asset. As such, the Company reassessed its estimates and forecasts as of June 30, 2021, to determine the fair values of the reporting unit and intangible asset using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand. Significant inputs include discount rates, growth rates, and cash flow projections, and, for the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand, royalty rate. These valuation inputs are considered Level 3 inputs as defined by ASC 820 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result of the analysis as of June 30, 2021, the Company concluded that the carrying amount of the U.S. reporting unit exceeded its fair value, which resulted in the recognition of an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i25737ffe6e95490d8d2ee87f9448d05a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM4NDk_be8b4ea1-2b8c-4d2a-b656-3984d96d98d2">178,414</ix:nonFraction> on goodwill associated with its U.S. reporting unit on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the second quarter, represented indicators of impairment for the Company&#8217;s U.S. reporting unit. Accordingly, the Company performed an interim impairment analysis as of June 30, 2020, which revealed the carrying amount of the reporting unit exceeded its fair value. As a result, the Company recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i3011f950a4e94248aeda6558c378e5b3_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM5MzY_5552ad13-1d7a-474d-9d89-366affc27d5a">35,000</ix:nonFraction> on goodwill associated with its U.S. reporting unit for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Intangible assets, net</span></div><ix:continuation id="id9d491ca2d8f4c6a82c6784288441414" continuedAt="i42438ff946b649a6820836e4d0a42649"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzkxMzA_e2e2f9d4-1430-40ba-a818-1ac59c76aab4" continuedAt="i4910226420a2435a9d36c46f8385fc4f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net are comprised of the following items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.764%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzItMy0xLTEtMjEzMzM5_0d98a79b-4c00-486c-956a-3b39c72b5850">6,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzItNS0xLTEtMjEzMzM5_19909272-55ef-4e7a-b1ea-e1558c201b3e">2,388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzItNy0xLTEtMjEzMzM5_5d6e1664-af2e-4eb2-966f-5c77816c7af8">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzItOS0xLTEtMjEzMzM5_13471d5e-afb2-49e7-b514-7a9d91706384">3,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzMtMy0xLTEtMjEzMzM5_2d6d4b09-9ecc-4257-bf89-8d8b820107d7">8,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzMtNS0xLTEtMjEzMzM5_0e3d5f89-ac4a-490c-a01c-027c40a80610">1,771</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzMtNy0xLTEtMjEzMzM5_db0fb0d5-718c-4ff5-8fb2-6e3895cbdd3c">6,498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzMtOS0xLTEtMjEzMzM5_93ff77df-4e58-4d16-998d-cf0be7996c44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzQtMy0xLTEtMjEzMzM5_95f59aa4-22a4-4438-af5c-b411500ebe69">27,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzQtNS0xLTEtMjEzMzM5_3e1e378f-5bd9-4668-b0de-9a121ae8e0f6">1,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzQtNy0xLTEtMjEzMzM5_c6b9f44b-2b09-4b86-ac69-1f99cc855f0c">4,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzQtOS0xLTEtMjEzMzM5_7f93b49d-efbc-4972-92c6-de729d77651b">21,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77456131101b46f6b16bb4bde937116b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzUtMy0xLTEtMjEzMzM5_64003c44-847e-4cda-bfb3-cd8be4ce7e15">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77456131101b46f6b16bb4bde937116b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzUtNS0xLTEtMjEzMzM5_910c4bd0-f93d-4d6e-a2b2-65c93149ec81">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77456131101b46f6b16bb4bde937116b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzUtOS0xLTEtMjEzMzM5_f04084ea-08f1-47e9-a42a-3c53ed44ab21">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzYtMy0xLTEtMjEzMzM5_18c6c502-4622-4933-8966-258d1d8092d7">42,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzYtNS0xLTEtMjEzMzM5_9737f32a-1144-47fc-9d37-672295674ab3">6,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzYtNy0xLTEtMjEzMzM5_8e832ee4-463d-4cad-befd-22074b81be07">11,008</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzYtOS0xLTEtMjEzMzM5_5a4c90e7-b514-4e24-8d2e-8495f11708c7">25,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf526b01444e468cb8d268601d3ce639_I20221231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzctMy0xLTEtMjEzMzM5_d0a3fbc9-ddd2-40c9-814c-30554860aaaa">64,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf526b01444e468cb8d268601d3ce639_I20221231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzctNy0xLTEtMjEzMzM5_73c85ea4-c52e-42e9-8a04-556151f1102e">62,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf526b01444e468cb8d268601d3ce639_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzctOS0xLTEtMjEzMzM5_d30d8867-bbc0-4ee1-9f56-d7ea5a333bf0">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib30da315d1e048d1a112a4fd35422a60_I20221231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzgtMy0xLTEtMjEzMzM5_50b67e5e-ab2f-4506-a58e-286b0b9ba457">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib30da315d1e048d1a112a4fd35422a60_I20221231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzgtNy0xLTEtMjEzMzM5_e6cd2545-2cca-46f6-9443-1710331b6548">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib30da315d1e048d1a112a4fd35422a60_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzgtOS0xLTEtMjEzMzM5_2a2e6bae-977a-4b83-a832-b8cc5571c573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzktMy0xLTEtMjEzMzM5_e8bea359-967f-48d1-9e6f-36a270ecee5d">106,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzktNS0xLTEtMjEzMzM5_d5e3d397-99b3-42bf-af66-2c64c3cda981">6,062</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:IntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzktNy0xLTEtMjEzMzM5_550fd32f-87fd-44e2-a40b-06e4b3a0c4be">73,650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzktOS0xLTEtMjEzMzM5_4a11f229-bbd7-4249-9b90-2dd28235bf74">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="ia5faf573de6a4674a0f20699ab2bdf9f" continuedAt="id00b5119b81f4063a9136dc2affe1a19"><ix:continuation id="i42438ff946b649a6820836e4d0a42649" continuedAt="icb49e07124f745a397cc3bf6e15c0772"><ix:continuation id="i4910226420a2435a9d36c46f8385fc4f" continuedAt="i098c08c0f27b49d492a09defda5b0acc"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.764%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzItMy0xLTEtMjEzMzM5_632ebb84-9b78-4045-8bfe-772fb101cd3b">5,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzItNS0xLTEtMjEzMzM5_75923bcb-3a86-4fb8-a1a8-b63d6034822d">1,595</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzItNy0xLTEtMjEzMzM5_03c170d5-4d66-4e68-b00a-6df9fefbaf39">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzItOS0xLTEtMjEzMzM5_3d23a065-23ad-4078-9319-8c9e13c67c0e">4,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzMtMy0xLTEtMjEzMzM5_79402419-1cd3-47f8-85f5-f9556a9bda5b">8,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzMtNS0xLTEtMjEzMzM5_aab898f4-ccff-45b8-8b8f-1094e974223b">1,883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzMtNy0xLTEtMjEzMzM5_fee747c5-2661-4845-b78a-71084722e246">6,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzMtOS0xLTEtMjEzMzM5_1f600b67-6556-47dc-994a-8d6e522e0a67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzQtMy0xLTEtMjI5MDQy_99c2e09a-b9ab-43fd-8b23-add135cac5cf">17,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzQtNS0xLTEtMjI5MDYx_780083c9-2380-486f-a209-d7e60c164ec5">335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzQtNy0xLTEtMjI5MDcz_502f32cb-c597-48d4-8760-a371ac305dbb">4,752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzQtOS0xLTEtMjQ2NzUy_dc393f62-04b7-438d-b35e-de9ed260ed4c">12,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie918e80cfb4d4ce1bc3659d5c55122dd_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzUtMy0xLTEtMjEzMzM5_95892712-f4c5-4667-b00c-2084ee506643">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie918e80cfb4d4ce1bc3659d5c55122dd_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzUtNS0xLTEtMjEzMzM5_eeb13aa3-1348-4307-8c02-dd1a3c05d194">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie918e80cfb4d4ce1bc3659d5c55122dd_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzUtOS0xLTEtMjEzMzM5_1607785b-a762-4e1c-b37f-b7966b23850d">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzYtMy0xLTEtMjEzMzM5_ea6dd905-7da8-4dc5-b223-61327ed7c7a0">32,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzYtNS0xLTEtMjEzMzM5_3c486972-1460-42f9-8427-a258eba82791">3,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzYtNy0xLTEtMjEzMzM5_a4a9ca0c-8caa-4838-be15-e9380170a563">11,666</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzYtOS0xLTEtMjEzMzM5_393a6e71-be2d-460d-af3a-28f1b95486b8">16,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzctMy0xLTEtMjEzMzM5_d3d62941-bdb6-4477-8ada-66053f487fd2">64,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzctNy0xLTEtMjEzMzM5_afa9e5c4-41e8-4e3c-be88-42e53e1a8658">62,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzctOS0xLTEtMjEzMzM5_f5a378bc-25cf-42d1-b759-d319d415048c">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzgtMy0xLTEtMjEzMzM5_995c7788-f8f2-4305-aa2b-0c9555858a55">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzgtNy0xLTEtMjEzMzM5_88f6f1a8-619f-4ade-bdf1-c9429ec1f0fa">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzgtOS0xLTEtMjEzMzM5_934df549-139f-4034-8375-f7e18cac68f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzktMy0xLTEtMjEzMzM5_73833968-76ab-411d-8373-f7459fd38521">96,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzktNS0xLTEtMjEzMzM5_ce0210ff-6797-4d1b-9e82-12c625f04f74">3,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:IntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzktNy0xLTEtMjEzMzM5_429cfb3e-47c7-4805-a2e0-8467525d3439">74,308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzktOS0xLTEtMjEzMzM5_f2872a9b-b1dc-4a4b-bf92-f92dbd9d2e34">18,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ginkgo Exclusive Licenses</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CBGA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company achieved the final productivity target in respect of cannabigerolic acid (&#8220;CBGA&#8221;), under the Ginkgo Collaboration Agreement. As a result, on August 21, 2021, the Company issued <ix:nonFraction unitRef="shares" contextRef="ib9aed4863ab04465a720fe0d99d7ada3_D20210821-20210821" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk1NjI_f2082b02-9c67-484e-a2eb-a8dea6f2f017">1,467,490</ix:nonFraction> common shares at a share price of C$<ix:nonFraction unitRef="cadPerShare" contextRef="ifcca62b307af4573b49a49b9dc71ed48_I20210821" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2MDM_8f53e33a-5a7b-4765-982b-a3032b63cbff">7.90</ix:nonFraction> for total consideration given of C$<ix:nonFraction unitRef="cad" contextRef="i60b0e9b055b34cd29e30bd1cbbc8d4b9_D20210821-20210821" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2MjI_8c42df2f-987e-410c-83e3-505d53b00e27">11,593</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i60b0e9b055b34cd29e30bd1cbbc8d4b9_D20210821-20210821" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2MzM_b393fd72-6792-4ac8-a791-7c980e64ba71">9,042</ix:nonFraction>) to Ginkgo through the Ginkgo Collaboration Agreement for the achievement of commercialization and productivity milestones for CBGA. The estimated fair value of the exclusive license for CBGA (the &#8220;CBGA Exclusive License&#8221;) was $<ix:nonFraction unitRef="usd" contextRef="ifcca62b307af4573b49a49b9dc71ed48_I20210821" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2MTE_3968e9fc-5175-406d-8f99-f58520d34680">7,300</ix:nonFraction> determined using a variation of the income approach called the relief-from-royalty method, which requires an estimate or forecast of the expected future cash flows. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of <ix:nonNumeric contextRef="i60b0e9b055b34cd29e30bd1cbbc8d4b9_D20210821-20210821" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk1MzA4_e43ab80e-fd48-42b7-939a-172c7310b1b8">10</ix:nonNumeric> years. The difference between the consideration paid to Ginkgo and the fair value of the exclusive license intangible asset of $<ix:nonFraction unitRef="usd" contextRef="i5f85047526a4440e97e49b14b9b8c149_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2NTE_313ce4f3-4514-448c-8677-daff01d85dd0">1,784</ix:nonFraction> was recognized as an impairment charge on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CBGVA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November, 2021, the Company achieved the final productivity target in respect of cannabigerovarinic acid (&#8220;CBGVA&#8221;). As a result, on November 12, 2021, the Company issued <ix:nonFraction unitRef="shares" contextRef="ie7349eab127d4a66a02ccea7ace9a86f_D20211112-20211112" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2ODg_57361b58-726c-414d-9a26-0db298ee2f7b">1,467,490</ix:nonFraction> common shares at a share price of C$<ix:nonFraction unitRef="cadPerShare" contextRef="i84b41514fd424c719fa65a8c6207ec1c_I20211112" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4MjY_c6b2bb7d-4002-4519-8815-14de319c26de">7.12</ix:nonFraction> for total consideration given of C$<ix:nonFraction unitRef="cad" contextRef="i0d0cba209df1419b87b954ee194f4270_D20211112-20211112" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4MzQ_05735395-51d5-431d-b0e3-3c33e55bf809">10,449</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i0d0cba209df1419b87b954ee194f4270_D20211112-20211112" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4NDg_58725741-2f98-4877-b620-e1d91e7bad79">8,150</ix:nonFraction>) to Ginkgo. The estimated fair value of the exclusive license for CBGVA (the &#8220;CBGVA Exclusive License&#8221;) was $<ix:nonFraction unitRef="usd" contextRef="i84b41514fd424c719fa65a8c6207ec1c_I20211112" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4NTg_1db5190c-948e-490b-8dd8-654755c36c6a">5,300</ix:nonFraction> determined using a variation of the income approach called the relief-from-royalty method, which requires an estimate or forecast of the expected future cash flows. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of <ix:nonNumeric contextRef="i0d0cba209df1419b87b954ee194f4270_D20211112-20211112" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzU0NjY_b471e94e-8da4-4f36-a60d-bc3ef79d5bb1">10</ix:nonNumeric> years. The difference between the consideration paid to Ginkgo and the fair value of the exclusive license intangible asset of $<ix:nonFraction unitRef="usd" contextRef="ifdd20292b768499ba18dd9f93ed614fc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5NTE_33260ea5-68b5-4264-ac84-cda683c5ce55">3,008</ix:nonFraction> was recognized as an impairment charge on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">THCVA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company achieved the final productivity target in respect of tetrahydrocannabivaric acid (&#8220;THCVA&#8221;) under the Ginkgo Collaboration Agreement. As a result, the Company issued <ix:nonFraction unitRef="shares" contextRef="i4a05578b3601443590c15854ed0c6306_D20220601-20220630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk2MzM0_b1377f07-6d55-45c3-9870-0951c0fbfa4c">2,201,236</ix:nonFraction> common shares at a share price of C$<ix:nonFraction unitRef="cadPerShare" contextRef="i13628330308147e39eccb6f6d522273c_I20220630" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4OTA_dd1c88ff-1800-4376-a6b4-e679e30a7e09">3.47</ix:nonFraction>, and made a cash payment of $<ix:nonFraction unitRef="usd" contextRef="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5MDI_8b4a3ca2-20f9-4bb2-a4dc-e8d007e217f0">600</ix:nonFraction>, for total consideration of C$<ix:nonFraction unitRef="cad" contextRef="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5MjA_2588be54-a955-4252-9c64-5c6db52b1bb5">8,412</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5NDA_b62020da-c789-4d63-af0f-aeb7f48e9deb">6,522</ix:nonFraction>) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of <ix:nonNumeric contextRef="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE4NjkxNjk3Njg3NTIy_a1324645-61f7-45ac-a979-b4bc1483bdcf">10</ix:nonNumeric> years.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CBCA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company achieved the early commercialization milestone in respect of cannabichromenic acid (&#8220;CBCA&#8221;) under the Ginkgo Collaboration Agreement. As a result, the Company issued <ix:nonFraction unitRef="shares" contextRef="i3b0b2dc9d6fc490f9bdff8729d2be639_D20221101-20221130" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5NjI_f83c3320-ca27-476a-91f1-926a0af1523a">489,163</ix:nonFraction> common shares at a share price of C$<ix:nonFraction unitRef="cadPerShare" contextRef="ie08bda6b8bc94e68b9c9453c44196451_I20221130" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5NzE_9c9b5601-d66e-4de0-923e-7e4a92fe3ae9">4.11</ix:nonFraction> for total consideration of C$<ix:nonFraction unitRef="cad" contextRef="i8c5418b79bf345ebaf07317235767553_D20221101-20221130" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5OTg_18cdc55d-158f-45c0-a29e-c91020072594">2,010</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i8c5418b79bf345ebaf07317235767553_D20221101-20221130" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5ODc_a45a5dc5-a3f2-471d-881f-d7c433667105">1,473</ix:nonFraction>) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of <ix:nonNumeric contextRef="i8c5418b79bf345ebaf07317235767553_D20221101-20221130" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE4NjkxNjk3Njg3NTM2_d593676b-0c95-4d08-bfd5-59f9ee37844b">10</ix:nonNumeric> years.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CBCVA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company achieved the final productivity target in respect of cannabichromevarinic acid (&#8220;CBCVA&#8221;) under the Ginkgo Collaboration Agreement. As a result, the Company issued <ix:nonFraction unitRef="shares" contextRef="ic478134f8b5943789c119b31b737e663_D20221201-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwMTA_b292caec-faed-4875-8413-bc0d24757a92">1,467,490</ix:nonFraction> common shares at a share price of C$<ix:nonFraction unitRef="cadPerShare" contextRef="i9c5f202e7a6844d084f318b1a5ed7a48_I20221231" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwMjE_226f8b41-0872-4be4-81b0-801c92034336">3.44</ix:nonFraction> for total consideration of C$<ix:nonFraction unitRef="cad" contextRef="ie9ad91752c734ce5a3109a2be336ffcf_D20221201-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwMzM_e61543ae-82d4-486a-a240-a84ad6b343dd">5,048</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="ie9ad91752c734ce5a3109a2be336ffcf_D20221201-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwNDU_53390b7f-e634-4e38-a371-178976f5e6d5">3,724</ix:nonFraction>) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of <ix:nonNumeric contextRef="ie9ad91752c734ce5a3109a2be336ffcf_D20221201-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE4NjkxNjk3Njg3NTM3_0de2cb47-4d53-495b-b406-666c6fef0eeb">10</ix:nonNumeric> years.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="id00b5119b81f4063a9136dc2affe1a19" continuedAt="i1465c15fb6834eeea9dc80b84848e564"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, the aggregate amortization expense on intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM5OTc_a4e56cf8-709b-4519-b0b0-1ed338568f57">2,751</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM5Nzk_3aa0a70e-3186-4ee9-a698-c0a8c3bea4f1">1,800</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM5ODY_5d0c46f6-61d7-4509-8665-87d8f9b53af1">814</ix:nonFraction>, respectively, and was included in depreciation and amortization in operating expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzkxMjY_9192209c-ed36-4f4a-a3c0-3f742d2092a1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization of definite-lived intangible assets is as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzEtMi0xLTEtMjEzMzM5_ffd8f8f1-19d7-431a-b0a1-9650dfda6787">3,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzItMi0xLTEtMjEzMzM5_3abfffec-f2ac-4966-a068-1904f66e5b4a">3,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzMtMi0xLTEtMjEzMzM5_36949e75-68a5-4930-8b5f-6d29569744f1">3,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzQtMi0xLTEtMjEzMzM5_f3212d0e-729d-4c9f-874b-0c3a7b9d794c">2,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzUtMi0xLTEtMjEzMzM5_b52f0ced-80d4-4c37-927d-d05db3f2a01f">2,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzYtMi0xLTEtMjEzMzM5_f10a7074-58c6-4966-887e-6380717503cd">9,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzctMi0xLTEtMjEzMzM5_5eadc9ba-c799-42f0-ae75-5f61f7427b99">25,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Intangible Assets</span></div><ix:continuation id="icb49e07124f745a397cc3bf6e15c0772"><ix:continuation id="i098c08c0f27b49d492a09defda5b0acc"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated impairment charges on intangible assets, net consist of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzEtMS0xLTEtMjEzMzM5_58020af0-df40-4ba1-8fe3-faea164e4271">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzEtMy0xLTEtMjEzMzM5_3c209894-6a1a-4ed6-a398-c9758c92c381">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231" decimals="-3" sign="-" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzEtNS0xLTEtMjEzMzM5_eba3cfe0-3815-4c35-928c-582c46fc4053">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzEtNy0xLTEtMjEzMzM5_5d324bcf-f809-4928-aa36-ae99cc05df63">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzItMS0xLTEtMjEzMzM5_c16ab24c-8147-41c6-ad5e-58f74a495410">6,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8e682c2ca040fd975b5501a07eab0b_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzItMy0xLTEtMjEzMzM5_3b21ac1c-23bc-497d-9f52-256af6f4ad31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8e682c2ca040fd975b5501a07eab0b_D20220101-20221231" decimals="-3" sign="-" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzItNS0xLTEtMjEzMzM5_c3d4b8d4-c06a-4271-bc02-37f2b31572b9">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzItNy0xLTEtMjEzMzM5_330a8360-c5ca-4ae5-a780-56c2e37fb1a0">6,498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzMtMS0xLTEtMjEzMzM5_19261ccc-4d16-4009-b4e3-fe1801967d9e">4,752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cac6295dd43471085e94c05e8edc47c_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzMtMy0xLTEtMjEzMzM5_9e60f18e-c705-444d-b6b0-42815d4e9177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cac6295dd43471085e94c05e8edc47c_D20220101-20221231" decimals="-3" sign="-" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzMtNS0xLTEtMjEzMzM5_615ca562-2b1c-422e-a998-7660dc9fdcc1">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzMtNy0xLTEtMjEzMzM5_fddeaea5-1472-4d3e-ad78-403337b91e48">4,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">brand</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzQtMS0xLTEtMjEzMzM5_5a415c07-c5f3-4855-af38-1fccf95dcfaf">62,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18d2c03d26d4706b4fbe1f740a27ad6_D20220101-20221231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzQtMy0xLTEtMjEzMzM5_d3d2023e-ef29-408c-812c-623fc228bb98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf526b01444e468cb8d268601d3ce639_I20221231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzQtNy0xLTEtMjEzMzM5_722abd1c-eb18-4978-b565-8d82937b3888">62,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzUtMS0xLTEtMjEzMzM5_99322aea-4132-43c0-a2cf-eb8134e550a1">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie54e4c678bed4bb18e9f07294b7c949a_D20220101-20221231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzUtMy0xLTEtMjEzMzM5_63487f55-efce-41b8-8280-1ca5aaa66b3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib30da315d1e048d1a112a4fd35422a60_I20221231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzUtNy0xLTEtMjEzMzM5_5ce5998d-4574-483f-81c9-ced20915841c">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:IntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzYtMS0xLTEtMjEzMzM5_9f487c5e-7404-4683-93be-bd95fdea7aa4">74,308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzYtMy0xLTEtMjEzMzM5_062386d3-617e-4095-ba76-b924b1547512">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="cron:IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzYtNS0xLTEtMjEzMzM5_cccb033f-2d63-4326-8e41-1a2c6e61542a">734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:IntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzYtNy0xLTEtMjEzMzM5_64cbd44c-e835-40ec-93d0-575ad1ea5bc3">73,650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68cc03c90b794e938ba29c4e01d7fff3_I20201231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtMS0xLTEtMjI5OTA3_9cdbd8ea-5ec8-4395-9580-2b15665f3b66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic81f17ae580640a7b5c24a884c9ec3bc_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtMy0xLTEtMjMwMDQ2_28765d76-56d5-4726-9589-3f4a7432910a">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic81f17ae580640a7b5c24a884c9ec3bc_D20210101-20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtNS0xLTEtMjMwMDQ2_8c937f75-9a72-4f4f-bc0b-a8e9101e1202">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtNy0xLTEtMjQ2ODY2_df1cdbe2-9a13-480c-8ae3-5c9cdb2c5fd5">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50cd01170d1f4a2bb1a30d020e35156b_I20201231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtMS0xLTEtMjEzMzM5_e33fb546-c9a4-4c31-9ef8-49e81e4b636c">1,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b6c8d5ea81343f7aa1f596a92eae8fb_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtMy0xLTEtMjEzMzM5_5dbf8f37-b484-46ae-88a6-89ac741eff57">5,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b6c8d5ea81343f7aa1f596a92eae8fb_D20210101-20211231" decimals="-3" sign="-" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtNS0xLTEtMjEzMzM5_96012ce2-41e1-4dcc-a325-74d0789bdd56">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtNy0xLTEtMjEzMzM5_fecdff94-9347-4598-8cf8-440e9d126fbe">6,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f901df38e1c4d6d842edb34f8ab501e_I20201231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzItMS0xLTEtMjEzMzM5_1437851d-9dd7-4ca1-a0b6-71d4f7a1c21e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90365f808213420099a7b087ef308b31_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzItMy0xLTEtMjEzMzM5_71857a67-b56e-4edb-9048-86a653f89a1e">4,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90365f808213420099a7b087ef308b31_D20210101-20211231" decimals="-3" sign="-" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzItNS0xLTEtMjEzMzM5_7b97ad87-124b-43cc-afec-8c9924b0a583">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231" decimals="-3" name="cron:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzMtNy0xLTEtMjQ2ODY2_456802c4-f5af-452d-bd32-747e6f185b78">4,752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones&#174; brand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f641a8b2e914e16a1d54db890c168b7_I20201231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzMtMS0xLTEtMjEzMzM5_e4835b20-d2d1-440d-a28c-278c52e547dd">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbf9404540e541bb8747d3dbaff42a7e_D20210101-20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzMtMy0xLTEtMjEzMzM5_baf7a7d3-3f0f-4a86-b653-b350c7228951">57,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzMtNy0xLTEtMjEzMzM5_3bc13fac-d5dc-43b8-a00d-415592d318af">62,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf6a4d5e23042058bc74e814d9dba02_I20201231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzUtMS0xLTEtMjI5OTA3_5de122d5-9014-4952-809b-7828ef035dcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied1f671988d04e8dba89bbc4bc42a206_D20210101-20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzUtMy0xLTEtMjMwMDQ2_efcac2b2-134e-4b4a-afb7-f4bafb103253">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231" decimals="-3" name="cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzUtNy0xLTEtMjQ2ODY2_93d0ada3-a6da-4917-9045-7f25bae96418">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" name="cron:IntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzQtMS0xLTEtMjEzMzM5_8c60dc35-bec8-4e5d-ba49-f27cb4a21d96">6,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzQtMy0xLTEtMjEzMzM5_29812f7e-db9e-4794-aa7f-28a238b9750e">68,389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="cron:IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzQtNS0xLTEtMjEzMzM5_b9c8a2c1-6a33-4722-b5a9-1d0c3c0bd483">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:IntangibleAssetsAccumulatedImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzQtNy0xLTEtMjEzMzM5_8734800e-89ba-4bcf-a4ee-c5f830302722">74,308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, in connection with the previously anticipated wind-down and closure of the Company&#8217;s facility in Stayner, Ontario, the Company determined that the Peace Naturals Health Canada license associated with ongoing use of the Peace Naturals Campus for cannabis cultivation and production was also impaired. Accordingly, the Company recorded an impairment loss on long-lived assets in its ROW segment of $<ix:nonFraction unitRef="usd" contextRef="i732550b3992f4da1853152fc684f8d1a_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwNjQ_c882b290-f535-4304-bbf9-dc15724de25c">5,951</ix:nonFraction> in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As mentioned above, during third and fourth quarter of 2021, the fair value of each of the Company&#8217;s Ginkgo exclusive licenses for <ix:nonFraction unitRef="cannabinoid" contextRef="ib273218a57a04f388d9cdc27f16e269e_D20210701-20211231" decimals="INF" name="cron:NumberOfImpairedIntangibles" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzcxMzg_d1f73e56-d556-4158-b39b-54347690b2cc">two</ix:nonFraction> cannabinoids that achieved productivity milestones in 2021 were deemed to be lower than the consideration paid for each of those licenses. As a result, the Company recorded an aggregate impairment loss of $<ix:nonFraction unitRef="usd" contextRef="i90365f808213420099a7b087ef308b31_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzczMzg_a423c54a-47ff-4a52-a0b6-a1da418ad2f1">4,792</ix:nonFraction> on long-lived assets for the year ended December&#160;31, 2021 in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company concluded the carrying amount of the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand exceeded its fair value, which resulted in impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i7756c3f9244a44aea49da07e1988dd28_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwODM_1c6d0017-97b5-4afe-949d-91e7c0cc9992">56,500</ix:nonFraction> on its Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand in the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk1MzA0_7f2cac1a-2c68-4900-8eb5-5a1100ca88a2">consolidated statements of net income (loss) and comprehensive income (loss)</span> for the year ended December 31, 2021. Additionally, in the fourth quarter of 2021, due to the U.S. segment&#8217;s sustained operating losses and lack of revenue growth, the Company performed an additional impairment test on Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand intangible asset. As a result, the Company concluded the carrying amount of the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand exceeded its fair value, which resulted in an additional impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i79c67a1f55424125bc5bfeab113bb038_D20211001-20211231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAxMDI_4afbe23f-a358-405b-8f32-40b356089e18">1,000</ix:nonFraction> on its Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand for the year ended December 31, 2021 in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i1465c15fb6834eeea9dc80b84848e564"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter, represented indicators of impairment for the U.S. reporting unit&#8217;s Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand. Accordingly, the Company performed an interim impairment analysis as of June 30, 2020, which concluded the carrying amount of the brand exceeded its fair value. As a result of the analysis, the Company recorded an impairment loss on indefinite-lived intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i999046b0a46e46a2bc0eee830f50363f_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAxMjA_f02febcc-5ed2-4262-819a-f116f6e9a76f">5,000</ix:nonFraction> on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment charges on the Company&#8217;s Health Canada licenses for the year ended December 31, 2020 are related to the discontinuation of Original B.C. Ltd. (&#8220;OGBC&#8221;).</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_112"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2MzM_132f0ce7-123c-4fd6-9771-943a6574fa9e" continuedAt="ic982b14ea00344efbf3369237e098072" escape="true">Leases </ix:nonNumeric></span></div><ix:continuation id="ic982b14ea00344efbf3369237e098072" continuedAt="i3d3006255fc34caa9c25fc6ba0a805b3"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into leases primarily for the land-use rights, office premises and equipment used in the production of cannabis, U.S. hemp-derived cannabinoids and other related products. The Company&#8217;s leases have terms that range from <ix:nonNumeric contextRef="i14d64d8fee424bdfa513430ee56f747e_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzI1OA_c5165079-d6a7-489f-bf5f-f1ebea627fa6">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="i44985dd9b7e343f49061a23ef9ab42ec_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzI2NA_9c887387-7507-4df7-bbf0-44f3788f3c4b">six years</ix:nonNumeric>, excluding land use rights, which generally extend to <ix:nonNumeric contextRef="i5b69cfe90a884fb39eba1ca111fc6b2e_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzMyMQ_a1ead666-2120-45f0-b4fc-e3af7cdd51ce">15</ix:nonNumeric> years. These leases often include options to extend the term of the lease for up to <ix:nonNumeric contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzQwOA_3157f147-706b-431b-80a8-cc648ec2d1cb">10</ix:nonNumeric> years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company&#8217;s consolidated balance sheet. The Company&#8217;s finance leases were not material for any of the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2MzQ_2aebf8b6-da70-44ed-b8ad-7ceee075b21e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.680%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzMtMS0xLTEtMjEzMzM5_ce771bde-cc61-42ce-8814-9e5805b59622">2,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzMtMy0xLTEtMjEzMzM5_9997b2ab-f493-41f4-86a0-bbc0a092236d">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzMtNS0xLTEtMjQzNjgz_25b1fc01-a871-46d1-a97a-2ae7b15dcccb">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzQtMS0xLTEtMjEzMzM5_71c45482-8988-4d8b-ab52-358b5f6438ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzQtMy0xLTEtMjEzMzM5_f1420576-9215-4483-ac15-1f020271702f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzQtNS0xLTEtMjQzNjgz_b554d397-aeb1-422d-9ca0-08f0769f4260">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzUtMS0xLTEtMjEzMzM5_433c2a36-1987-4ac9-aa1b-fb8b58ac29c7">2,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzUtMy0xLTEtMjEzMzM5_2eae3767-ff5c-48b8-a9e8-9c59250f3468">2,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzUtNS0xLTEtMjQ2OTAw_02b96607-3d2f-49a6-b977-342fbbebbef9">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow and other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows - cash paid for operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzgtMS0xLTEtMjEzMzM5_5e0c7aea-78d1-426b-be55-0aa31bcbaab7">2,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzgtMy0xLTEtMjEzMzM5_1f6486b9-cd6e-49bf-8069-40852ae92196">2,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzgtNS0xLTEtMjQzNzE4_90d5a1c9-3631-4815-a83f-f645c5573c64">2,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activity - right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzktMS0xLTEtMjEzMzM5_2bb71772-50b1-4714-824e-8cc8b32ddf05">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzktMy0xLTEtMjEzMzM5_b980f657-4fc9-4e59-b089-3f54a3730334">3,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzktNS0xLTEtMjQzNzE4_b3b412e2-b33f-404f-8e93-583746ccc678">5,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years) &#8211; operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzExLTEtMS0xLTIxMzMzOQ_824bb6a5-c233-4951-888c-d033bd6d7cac">4.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzExLTMtMS0xLTIxMzMzOQ_cbf0a313-d8dd-4ff9-bbe3-bbba95f1f49f">4.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iea9d63117e854b719984324586934e8e_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzExLTUtMS0xLTI0MzcyNw_b4a6550c-cdec-49a3-a069-fa86e96bfd6e">5.5</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="INF" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzEyLTEtMS0xLTIxMzMzOQ_bcbf3313-8f23-4ef3-bb47-f7880c5827c8">7.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="INF" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzEyLTMtMS0xLTIxMzMzOQ_5b8e5733-5573-40f7-8f91-87815b08fe01">7.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="INF" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzEyLTUtMS0xLTI0MzcyNw_544bbf50-a301-4e92-987d-293b90db59ec">8.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, the aggregate depreciation expense on right-of-use assets was $<ix:nonFraction unitRef="usd" contextRef="i6710a5308fe240c785bbcd6e071db62b_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2NDkyNjc0NDM0OTA_a2574013-0914-4427-b30c-dcecaff99ffa">1,704</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i7304849946e741a0aab1be7f1db2773b_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2NDkyNjc0NDM0ODI_055edd60-576e-44c5-83b0-62223b21215a">1,934</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i11ee8c20fd4d40938bf05d4422a3ec42_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2NDkyNjc0NDM0ODY_c4b75f10-a341-4839-bb0b-c4bd5313c8b4">1,310</ix:nonFraction>, respectively, and was included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company recognized an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzczNzE_009ff30a-24ef-4680-8aa6-5aef0158e575">1,986</ix:nonFraction> related to the right-of-use lease asset associated with the Company&#8217;s corporate headquarters, encompassing approximately <ix:nonFraction unitRef="sqft" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzU0OTc1NTgyMTEyNw_0fbc85de-81e9-4555-a8a6-953c729b197f">29,000</ix:nonFraction> square feet, in Toronto, Ontario, Canada, for which the Company determined it would seek a sublease.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended, December 31, 2021, the Company recognized an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzgyNDI_95786558-fe2c-4f1e-ad4f-7d7379d239e5">702</ix:nonFraction> related to the right-of-use asset associated with leased premises, encompassing approximately <ix:nonFraction unitRef="sqft" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2NDkyNjc0NDY5MTI_7b9622d2-fb4e-4b79-846c-2d023601d142">6,000</ix:nonFraction> square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leased asset was being used and the expectation that, more likely than not, the leased asset would be abandoned before the end of the lease term triggered an impairment.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i3d3006255fc34caa9c25fc6ba0a805b3"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2MzU_359c6878-6df7-4998-8ac9-adb60d6ccae8" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s future minimum lease payments under operating leases for its premises due in future fiscal years:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzEtMS0xLTEtMjEzMzM5_f1d79a30-7eb2-4baf-b128-fe1ff36003f7">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzItMS0xLTEtMjEzMzM5_943e02b8-35b3-4fb2-8da5-49aac51a1c4a">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzMtMS0xLTEtMjEzMzM5_835172ac-f258-44bc-961a-09d748b27af4">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzQtMS0xLTEtMjEzMzM5_76223244-34ce-4a15-ab10-18cb6760f996">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzUtMS0xLTEtMjEzMzM5_cd741f7a-7e9c-476b-9b29-eeaebb1bb088">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzYtMS0xLTEtMjEzMzM5_b5231926-89ac-454f-ad0a-82eadd53e09c">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzctMS0xLTEtMjEzMzM5_17d67e6e-2e22-4196-952d-5dce905c547f">4,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzgtMS0xLTEtMjEzMzM5_21e08f3c-df75-40e8-9bc3-fe9ca80810af">929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzktMS0xLTEtMjEzMzM5_3a1c2006-748f-4f7a-8695-9d456da90472">3,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the minimum lease payments, the Company is required to pay realty taxes and other occupancy costs in accordance with the terms of the lease agreements.<br/></span></div></ix:continuation><div id="i228e12b34e804aa096affae69dd6b9af_115"></div><div style="margin-bottom:12pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc4Mzc_bf873fe9-68a1-4320-8294-091166e3d19d" continuedAt="i67f01b9b8c2446e3a89fd0a3cf9f3a0b" escape="true">Derivative Liabilities </ix:nonNumeric></span></div><ix:continuation id="i67f01b9b8c2446e3a89fd0a3cf9f3a0b" continuedAt="ie5a6171ae8514122987d551b2372df65"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, the Company closed the previously announced investment in the Company (the &#8220;Altria Investment&#8221;) by Altria Group Inc. (&#8220;Altria&#8221;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of <ix:nonFraction unitRef="shares" contextRef="ia4b6c54c605e40e1b592903c9120fd37_D20190308-20190308" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzMwNQ_a13cd936-c1a2-407e-8038-358f70ec7b71">149,831,154</ix:nonFraction> common shares of the Company and <ix:nonFraction unitRef="warrant" contextRef="i7b7c43afd25849a08ea88b3240e2dd83_D20190308-20190308" decimals="INF" name="cron:ClassOfWarrantOrRightNumberOfWarrantsIssued" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzM0MQ_3c53e621-10f4-4b4e-b133-7ff3ea2ab8cb">one</ix:nonFraction> warrant of the Company (the &#8220;Altria Warrant&#8221;), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximate <ix:nonFraction unitRef="number" contextRef="i61396ac601174186a618ab85deae5ee4_I20190308" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzUyNw_0167821c-e960-4a88-9b9c-de6a50ff5663">45</ix:nonFraction>% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately <ix:nonFraction unitRef="number" contextRef="ibffb66e7dc494751857b498f2aaeb299_I20190308" decimals="2" name="cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc5Ng_8e56cc27-2aee-49aa-82b8-dae8d444623a">55</ix:nonFraction>% (calculated on a non-diluted basis). On December 16, 2022, Altria notified the Company that it was irrevocably relinquishing all of its rights, title and interest in the Altria Warrant, effective immediately. As a result, the Company&#8217;s liability associated with the Altria Warrant was reduced to <ix:nonFraction unitRef="usd" contextRef="i28817b99a60840b0a33d72934688a602_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzE0ODQzNDA2OTg2NjE1_52c0a261-4b39-4869-9c94-7e03209dca40">nil</ix:nonFraction>, with the change recorded to gain on revaluation of derivative liabilities for the year ended December 31, 2022. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#8220;Investor Rights Agreement&#8221;), the Company granted Altria certain rights, among others, summarized in this note.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The Altria Warrant entitled the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional <ix:nonFraction unitRef="number" contextRef="i9715e946ec664da4bbd57f7a8c864d48_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzE4MDU_545eccd9-f828-4dac-8898-e88f5a68d0ac">10</ix:nonFraction>% of the common shares of Cronos at a per share exercise price of C$<ix:nonFraction unitRef="cadPerShare" contextRef="i221dd5e17e9844b58038afd4bc734784_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzE5MTY_45a5445c-ac10-47ff-b72c-665202edab0d">19.00</ix:nonFraction>, which was set to expire on March 8, 2023. The Altria Warrant was irrevocably relinquished by Altria on December 16, 2022.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the research and development (&#8220;R&amp;D&#8221;) partnership with Ginkgo, (refer to Note 9 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#8220;Pre-emptive Rights&#8221;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance; provided that if the consideration paid in connection with any such issuance is non-cash, the price per common share of the Company that would have been received had such common shares been issued for cash consideration will be determined by an independent committee (acting reasonably and in good faith); provided further that the price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Collaboration Agreement will be C$<ix:nonFraction unitRef="cadPerShare" contextRef="iaa6ab7221f554e87a7c8bf27eb2d5642_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzM4NDgyOTA3MDgwMTc_ea7a025c-5cad-4ba8-b67c-61e422315b24">16.25</ix:nonFraction> per common share. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below <ix:nonFraction unitRef="number" contextRef="iaa6ab7221f554e87a7c8bf27eb2d5642_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzMyNjg_a8d00fb6-1533-4849-8d16-efd4475249c3">20</ix:nonFraction>%. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="ie5a6171ae8514122987d551b2372df65" continuedAt="iabc35ac1bd5e428cbf3c8853d993ce3a"><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#8220;Top-up Rights&#8221;). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the <ix:nonNumeric contextRef="if1c27a3694484f45b570f0bb4e534e02_D20190308-20190308" name="cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ1NjA_1d2621b6-8a63-4885-9338-5a06548a6ec4">10</ix:nonNumeric>-day volume-weighted average price of the common shares of the Company on the TSX for the <ix:nonNumeric contextRef="if1c27a3694484f45b570f0bb4e534e02_D20190308-20190308" name="cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ2NTI_c76c8bd5-80cd-4778-bb93-3c935815d83a">10</ix:nonNumeric> full days preceding such exercise by Altria; provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$<ix:nonFraction unitRef="cadPerShare" contextRef="ic2fe51cbfc3a4ec9b05ab28c2101a8fe_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5ODY_ab82bccb-880a-40e4-b512-59dce91dcbfd">16.25</ix:nonFraction> per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below <ix:nonFraction unitRef="number" contextRef="ic2fe51cbfc3a4ec9b05ab28c2101a8fe_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzUxOTk_8d591d81-c1b1-43c3-a5fe-e346ec748fc1">20</ix:nonFraction>%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities on the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, Altria beneficially held <ix:nonFraction unitRef="shares" contextRef="ie7edb25988ef4ca680ec0519a1f7a41c_I20221231" decimals="INF" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzU0OTc1NTgyMjIwNQ_ba2b3acd-1cf2-45cc-af72-47b6a0fc487f">156,573,537</ix:nonFraction> of the Company&#8217;s common shares, an approximate <ix:nonFraction unitRef="number" contextRef="ie7edb25988ef4ca680ec0519a1f7a41c_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzU0OTc1NTgyMjI1Ng_262e8804-bb48-4365-b116-f56658144d4e">41</ix:nonFraction>% ownership interest in the Company (calculated on a non-diluted basis).</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc4Mzg_4dd60292-d5fe-446c-8577-2a5919ff1b95" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of the carrying amounts of the derivative liability are presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzEtMS0xLTEtMjEzMzM5_3ea0f4ca-03ed-4211-ac03-d0324f6ec32f">13,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c1c7205fa134b8ea972b207eaabed88_D20220101-20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzEtMy0xLTEtMjEzMzM5_d350bc82-7c5a-4d10-a4d1-11bd0708320f">13,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c1c7205fa134b8ea972b207eaabed88_D20220101-20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzEtNy0xLTEtMjEzMzM5_eb81950d-56c4-4227-8106-7f162b6c8e5b">289</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28817b99a60840b0a33d72934688a602_I20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzEtOS0xLTEtMjEzMzM5_d3698f82-c511-4174-83de-aa94f095e2cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzItMS0xLTEtMjEzMzM5_aa9fef80-3e25-48ef-a464-00bbddf1b0b6">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacbae512bdcf437c82335b9fc5c91440_D20220101-20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzItMy0xLTEtMjEzMzM5_dea7b344-5708-4fbb-80fb-4c0402076b54">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacbae512bdcf437c82335b9fc5c91440_D20220101-20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzItNy0xLTEtMjEzMzM5_8efa3664-e4a0-4637-aaa1-bc3c0f5da701">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1937b23e84714a2daaa95f21590a01a0_I20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzItOS0xLTEtMjEzMzM5_344c327a-1b6b-45fd-b170-a11fc4679245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzMtMS0xLTEtMjEzMzM5_15572a5e-2fc2-4244-b75a-712f5ff0d895">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c446ba0830b43c0b39a1930af1ab423_D20220101-20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzMtMy0xLTEtMjEzMzM5_44ca0932-c125-443f-a9b3-794b0f164659">450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c446ba0830b43c0b39a1930af1ab423_D20220101-20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzMtNy0xLTEtMjEzMzM5_4214a7d9-7518-499e-87c5-e57a28ad0a4e">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb314c21396043bfbea5f9a42e79dd19_I20221231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzMtOS0xLTEtMjEzMzM5_e20c94ec-c840-4c8d-a06a-dddd6f77cd1a">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzQtMS0xLTEtMjEzMzM5_69b0bc3e-7ccc-4dda-8a6d-c3f50d0f646b">14,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzQtMy0xLTEtMjEzMzM5_937f8f92-2374-4def-bda7-61e997f4c5e8">14,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzQtNy0xLTEtMjEzMzM5_6eab003b-62b8-479b-a7e4-3a7dfc89751a">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzQtOS0xLTEtMjEzMzM5_402436ef-e779-47b3-bc1a-344f14ecdde2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefda9bc7439d4557845731f8c6e1ee83_I20201231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzEtMS0xLTEtMjEzMzM5_3890b421-0eac-405f-bb51-ca15d4f9c2fa">138,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fb9758c232649229074d49b3b8dc7fd_D20210101-20211231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzEtMy0xLTEtMjEzMzM5_647abb02-39cf-4252-b949-dcac173f85e0">127,099</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb9758c232649229074d49b3b8dc7fd_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzEtNy0xLTEtMjEzMzM5_84e374ae-6d9e-4db7-a2fe-5468b1eb6d4d">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzEtOS0xLTEtMjEzMzM5_dee2ae52-4f59-4433-8d8e-0c4d0482b454">13,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f45cb877964c1ca42caca1ed6a175f_I20201231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzItMS0xLTEtMjEzMzM5_fd83cb6a-ffe6-4c2b-b7d2-e06a1c1496d3">12,095</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e64ddadb77a4996af4ad68e0b33e84f_D20210101-20211231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzItMy0xLTEtMjEzMzM5_a6b3d931-ff05-42f8-973a-fffe60ed6d56">12,102</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e64ddadb77a4996af4ad68e0b33e84f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzItNy0xLTEtMjEzMzM5_a299762f-32cc-4728-b69b-1313451da48b">187</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzItOS0xLTEtMjEzMzM5_be93b37d-2288-4991-9ff8-c1fbf17f6d1a">180</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48a2cb5842349feb0ee8180de88046d_I20201231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzMtMS0xLTEtMjEzMzM5_3f332502-9da8-46d0-88cf-62facd222ed7">12,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad90c5c09604a40bcda1aa60d6f4817_D20210101-20211231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzMtMy0xLTEtMjEzMzM5_6f631c2b-c0b9-47ec-ba69-3b5d55945039">12,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad90c5c09604a40bcda1aa60d6f4817_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzMtNy0xLTEtMjEzMzM5_0c75eb34-7020-432b-8481-f18487c97a52">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzMtOS0xLTEtMjEzMzM5_532fdbb7-fa19-435e-84b5-9ee878f6f584">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzQtMS0xLTEtMjEzMzM5_a0a4b217-58ed-46c7-8dcb-62dddbf241f6">163,410</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzQtMy0xLTEtMjEzMzM5_f4bcadf4-d7e4-4b8f-9203-78a2a6f614d2">151,360</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzQtNy0xLTEtMjEzMzM5_3bce6194-df14-4c16-a9a7-e4c2dd8d6130">2,325</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzQtOS0xLTEtMjEzMzM5_335d4670-244f-4592-b5a0-0d12c3151a99">14,375</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the expected life of the derivative instruments and the Company&#8217;s share price are primary drivers for the changes in the derivative valuations during each reporting period. As the period of time the derivative liability is expected to be outstanding decreases and the share price decreases, the fair value typically decreases for each related derivative instrument. Weighted-average expected life and share price are two of the significant observable inputs used in the fair value measurement of each of the Company&#8217;s derivative instruments.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc4NDA_21169985-d0f3-4183-897b-25bfb93a9009" continuedAt="i21117c8945da4a3f818d52c6072cbf4f" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model using the following inputs:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.511%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.818%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date (per share in C$)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ibc817e542af6414480289d7ee595ed36_I20221231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzItMy0xLTEtMjEzMzM5_a37bd92e-adf8-4fe3-b5e0-cef3cb4f1083">3.44</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ia898bc55623845b0ac1ef2856e3c821b_I20221231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzItNS0xLTEtMjEzMzM5_91b4b824-9412-402d-aebc-f4bc55849488">3.44</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="id3070e38626248d882307c7013957190_I20221231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzMtMy0xLTEtMjEzMzM5_4f79ea4e-0906-42c5-87c1-3eb956dac40b">16.25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ic82bd6cd39a9499088723cd61326ac33_I20221231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzMtNS0xLTEtMjEzMzM5_e0c79fe0-efe4-4f27-9aea-d83471f6a718">16.25</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c7419e5e8c447b3bc7c086770debb36_I20221231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzQtMy0xLTEtMjEzMzM5_8e5dccf6-faac-4c73-9dfa-3af2191d8820">4.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2adebb19e5a4a64b42095549e292edb_I20221231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzQtNS0xLTEtMjEzMzM5_faa9a283-f63b-420e-82e8-fc4db80458b1">4.28</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife021bb97d6549dba2eb6e2bc3cd674d_D20220101-20221231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzUtMy0xLTEtMjEzMzM5_6a1bdda2-6508-47c5-bd39-e849aeb00c32">0.25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifb6c95fc236e4a279b1175dd18180f45_D20220101-20221231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzUtNS0xLTEtMjEzMzM5_fb75cb4f-9a8a-45b8-92f3-c23b35f8ece1">0.59</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8866b2b61a742bea498367daa68d8a6_I20221231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzYtMy0xLTEtMjEzMzM5_f739de5e-2c43-4ac2-a8de-cb54c7f18e6c">73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7bfe6a0593fb41159cec5a4ea40d283e_I20221231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzYtNS0xLTEtMjEzMzM5_3a75bf27-a5ec-4dc0-ac5f-8ed8b4a335a7">73</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e7af0d7c0e94a61b25b0698337ffed9_I20221231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzctMy0xLTEtMjEzMzM5_c252982c-2aaa-456d-9305-06a36f8f44ef">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1cff5c2fa201489099250164076db24e_I20221231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzctNS0xLTEtMjEzMzM5_0954e1c4-bbb3-47a3-beac-9b053e2f5248">&#8212;</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="iabc35ac1bd5e428cbf3c8853d993ce3a" continuedAt="icec947f5628c41a0acb460ea549c1278"><ix:continuation id="i21117c8945da4a3f818d52c6072cbf4f" continuedAt="i7960d12d03a043dba62880b1ae48274b"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ic46e2540982d4ffa8221c6ad142b2e19_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzItMS0xLTEtMjEzMzM5_bfe87a33-8f97-4c5a-91dc-bccc9582f879">4.98</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i571abff367a8457cb1c603791998861e_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzItMy0xLTEtMjEzMzM5_26f03c1a-7145-47b7-ae74-699d51125bfc">4.98</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ie9c6c121779f4779b344e53ba7e3d719_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzItNS0xLTEtMjEzMzM5_f8c0fd18-f03d-45da-8b53-d0f905475780">4.98</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i76d8bedf7986401cba0cb84c55fb63aa_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzMtMS0xLTEtMjEzMzM5_6a8121b8-8180-4c72-aba3-47eae6dc445d">19.00</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i07f1d462f24349299006395485505244_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzMtMy0xLTEtMjEzMzM5_33955547-20a3-4f1d-89e6-e9874b1eb65c">16.25</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="icbe71946d29442afbe7fba287fc77a14_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzMtNS0xLTEtMjEzMzM5_4e4eb13f-a6b0-44f0-9be9-ebf6aae760f5">16.25</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia83a3433c61045068fbb79983853180d_I20211231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzQtMS0xLTEtMjEzMzM5_f3bb172a-e0ac-46e0-818a-cf70e24ddd6d">0.79</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if393d0d16af2495990ea4ed129432655_I20211231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzQtMy0xLTEtMjEzMzM5_6b7a0ff7-a700-4485-ae50-3525d6b75c8b">0.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i913c98b4ac7e42aca4f52f0dd64e5065_I20211231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzQtNS0xLTEtMjEzMzM5_7f4fe87e-ba01-41c9-b671-0fb42e94b87d">0.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id510aed093fc495cb9f8a14f00900436_D20210101-20211231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzUtMS0xLTEtMjEzMzM5_dfdfcab7-8e47-40bb-beb0-c878323966fb">1.18</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94acb806d58748d3b52065bda492be87_D20210101-20211231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzUtMy0xLTEtMjEzMzM5_af1e5eaf-0746-46a7-ad35-5c615b8e7c16">0.50</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibc6cb6f83fce4d5a80cc6961e26b5032_D20210101-20211231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzUtNS0xLTEtMjEzMzM5_0fd2c6ea-7fbb-45be-b7a3-e78dc00bd00f">0.80</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c829f39e691422b9ee160f08c4ababb_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzYtMS0xLTEtMjEzMzM5_89eb8edd-4ca4-4928-95c6-3f9656380887">80</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iefd833c70e1648639eb7783f93944757_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzYtMy0xLTEtMjEzMzM5_d0855b52-a685-4360-8e1f-6addfad1fd82">80</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if138ace4b4c24c6dadebdaf0ce503a42_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzYtNS0xLTEtMjEzMzM5_10102a6b-4259-4655-8d50-e52d550c3f06">80</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib017ada887a44e6aa4841154972d1578_I20211231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzctMS0xLTEtMjEzMzM5_ebaf94fa-3824-451b-b101-0a3900f18124">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf75cd22b3fc4b0d8ebc327b92866198_I20211231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzctMy0xLTEtMjEzMzM5_4804d28f-d12a-44cc-a8de-93a2346b5085">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9612d41d77f443cdb2bc20406257be78_I20211231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzctNS0xLTEtMjEzMzM5_157c613d-2a5b-485d-9b4a-d783ad082536">&#8212;</ix:nonFraction>%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of December&#160;31, 2022 and December&#160;31, 2021, the risk-free interest rate uses a range of approximately <ix:nonFraction unitRef="number" contextRef="i98bb2201b5a14d879713cb2138319dea_I20221231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzE4NjkxNjk3NjgzNzkw_b28acd74-dfe9-4988-a11a-67e907e286dc">3.81</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="if87b98056c7642a8a360e6701396a2ba_I20221231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyMzE_eb035f97-c60e-40d9-a0fb-063c86ddb034">4.37</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i25b512c51525471c9d8ef40e569ddcda_I20211231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYxOTg_5cb33aba-d00d-4e59-802f-fb54e7a0ad76">0.16</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="if9ac729cb13646a08fc56813a3bb06e3_I20211231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyMDM_da780129-ea8c-47f7-8a5c-fef8c3020171">1.10</ix:nonFraction>%, respectively, for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of December&#160;31, 2022 and December&#160;31, 2021, the expected life uses a range of approximately <ix:nonNumeric contextRef="i40a5d0b4996a4e9eabaf018f06c48779_D20220101-20221231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyNjI_c8d72cf0-5276-4a7a-bb43-b1a319d52475">0.25</ix:nonNumeric> years to <ix:nonNumeric contextRef="i8d3221f7d1804397b6efac52293924b5_D20220101-20221231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyNzI_7da45385-173d-46a2-bfe0-8ad3a79ddc82">2.75</ix:nonNumeric> years and <ix:nonNumeric contextRef="icfabefd19c3f47038000b89103cb9ddc_D20210101-20211231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyMzY_8f575bc6-26af-4102-ba38-3063add43c2e">0.25</ix:nonNumeric> years to <ix:nonNumeric contextRef="iab4b623f778f4729b3d247924c503370_D20210101-20211231" name="cron:DerivativeLiabilityUsefulLifeTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyNDY_38b2c416-5ac4-4d7c-8fa5-a23a95bf29bf">3.75</ix:nonNumeric> years, respectively.</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><ix:continuation id="i7960d12d03a043dba62880b1ae48274b" continuedAt="ia9be693d7ce74f24bbfd7978ddbb9171"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ia9be693d7ce74f24bbfd7978ddbb9171">Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company.</ix:continuation> </span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc4MzY_27039dbe-68c5-482c-8536-86acbf1de128" escape="true"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying amount of the derivative liability, there would also be an equal and opposite impact on net income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.372%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.818%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10% decrease as of December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1937b23e84714a2daaa95f21590a01a0_I20221231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzItMy0xLTEtMjEzMzM5_c80a7e20-6e70-4809-9009-f2f0c7c004cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb314c21396043bfbea5f9a42e79dd19_I20221231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzItNS0xLTEtMjEzMzM5_0635bb16-c0eb-4464-bbca-65ed09c9a44a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1937b23e84714a2daaa95f21590a01a0_I20221231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzMtMy0xLTEtMjEzMzM5_48416bba-c26a-4175-a19b-1b591f5d1130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb314c21396043bfbea5f9a42e79dd19_I20221231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzMtNS0xLTEtMjEzMzM5_48304929-38b6-4d07-904b-dd3d9972a4f5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1937b23e84714a2daaa95f21590a01a0_I20221231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzQtMy0xLTEtMjEzMzM5_b3cd08e9-a3bf-44d6-8517-1fe8a16e4be3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb314c21396043bfbea5f9a42e79dd19_I20221231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzQtNS0xLTEtMjEzMzM5_936fe141-f7ff-4e43-85c2-bd75723223c3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10% decrease as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzItMS0xLTEtMjEzMzM5_10b363f3-d6d9-4c4c-bf2e-a525cae33e86">3,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzItMy0xLTEtMjEzMzM5_39441ffd-ae7d-4220-b7a7-cdcdd618a371">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzItNS0xLTEtMjEzMzM5_2d5e4228-8c0c-4fcc-8f57-e7ab7f9ab288">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzMtMS0xLTEtMjEzMzM5_cda7cd68-d6ae-41b2-a1af-f980366cccc8">2,971</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzMtMy0xLTEtMjEzMzM5_65ce370f-e419-4efb-aabe-6101d03fb0da">171</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzMtNS0xLTEtMjEzMzM5_a3bdcb28-cbbf-40b3-9c5b-8850faca289f">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzQtMS0xLTEtMjEzMzM5_eb0c0bb3-ae59-4802-9894-2cbd351fc807">5,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzQtMy0xLTEtMjEzMzM5_1614f4e7-4873-404e-b068-d3fd156b112c">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzQtNS0xLTEtMjEzMzM5_b56226a6-e868-49c7-9bfd-9bd646a8d9cf">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icec947f5628c41a0acb460ea549c1278">These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside the Company&#8217;s control, which could significantly affect the fair value of these derivative liabilities in future periods.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_118"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzExNDUx_65dab51d-6519-4a7e-bde0-5f52c4606f29" continuedAt="ibcae9edd766b48979fd506d4d531ca41" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ibcae9edd766b48979fd506d4d531ca41" continuedAt="ie5fc476c34df4f75b13ac936a12f8e6b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ginkgo.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On September 4, 2018, the Company announced an R&amp;D partnership with Ginkgo to develop scalable and consistent production of a variety of certain common and lesser-known cannabinoids. As part of this partnership, Cronos agreed to issue up to <ix:nonFraction unitRef="shares" contextRef="i32e3dc3e21e747538d80089fb902fe97_D20180904-20180904" decimals="INF" name="cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE2NDkyNjc0ODQ0NDY_55b63fa4-94fb-4747-8fbf-b3333e885d75">14,674,903</ix:nonFraction> common shares of the Company (aggregate value of approximately $<ix:nonFraction unitRef="usd" contextRef="ief5d3e80cebf424583d8885fadb9005d_I20180717" decimals="-3" name="cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE2NDkyNjc0ODQ0NDE_0deb2ec0-3a2a-4545-868b-7f7d4827cb37">100,000</ix:nonFraction> as of July 17, 2018 assuming all milestones are met, collectively the &#8220;Ginkgo Equity Milestones&#8221;) in tranches and $<ix:nonFraction unitRef="usd" contextRef="i32e3dc3e21e747538d80089fb902fe97_D20180904-20180904" decimals="-3" name="cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE2NDkyNjc0ODQ0NTA_d9a47211-360b-46c3-afc6-934037ea61a5">22,000</ix:nonFraction> in cash subject to Ginkgo&#8217;s achievement of certain milestones and to fund certain R&amp;D expenses, including foundry access fees. During the years ended December 31, 2022 and December 31, 2021, <ix:nonFraction unitRef="shares" contextRef="i4e3f054fcf0e476495404c9892296850_D20220101-20221231" decimals="INF" name="cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzM4NDgyOTA3NDAwNTU_aa854485-1f67-4da4-8236-54dc44f6a8ff">4,157,888</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i7032a2e2cd3c413ca31f86debd15d280_D20210101-20211231" decimals="INF" name="cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzcwNQ_2aec7338-d7b9-4cc6-a08b-adc5679b43d4">2,934,980</ix:nonFraction> shares, respectively, of the Company&#8217;s common stock were issued in conjunction with this partnership. <ix:nonFraction unitRef="shares" contextRef="id8e84bad228742d08e985829ef125a7f_D20200101-20201231" decimals="INF" name="cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzc5NQ_61101973-ddfb-4e88-ac09-38900aac9ef5">No</ix:nonFraction> shares were issued for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion &#8211; Israel Institute of Technology (&#8220;Technion&#8221;). Research was focused on the use of cannabinoids and their role in regulating skin health and skin disorders. This research was conducted by Technion over a three-year period and concluded during the fourth quarter of 2021. During the year ended December 31, 2021, the Company funded $<ix:nonFraction unitRef="usd" contextRef="i9a7b1865015342c2b593cd0e0f101d00_D20181015-20181015" decimals="-3" name="cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzEzNjk_035471e4-f6c2-4e96-917d-9dd23b588b95">60</ix:nonFraction> of cash payments related to this agreement. The Company had no further funding requirements as of both December 31, 2022 and December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the &#8220;Services Agreement&#8221;). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of <ix:nonFraction unitRef="number" contextRef="ie33d0799ad12401f8fb8fe45edfe1dae_D20190218-20190218" decimals="INF" name="cron:LongtermPurchaseCommitmentMonthlyFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE5MTg_ab07a5c3-1458-4e8b-8588-86a7814fecf9">105</ix:nonFraction>% and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party. See Note 15 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Contingencies</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its consolidated financial condition but could be material to its results of operations for any particular reporting period depending, in part, on its results for that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Class action complaints relating to restatement of 2019 interim financial statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11 and 12, 2020, <ix:nonFraction unitRef="shareholder" contextRef="ieca7109f30f44b37987e0b2301dbcd00_D20200311-20200312" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxODk5_7fd3c03e-c804-4261-9ce8-2a98873bc349">two</ix:nonFraction> alleged shareholders of the Company separately filed <ix:nonFraction unitRef="complaint" contextRef="ieca7109f30f44b37987e0b2301dbcd00_D20200311-20200312" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxOTAw_d333d67e-e05f-47e3-b4d5-70b01eb563f7">two</ix:nonFraction> putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its Chief Executive Officer and now former Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal control were incorrect based on the Company&#8217;s disclosures relating to the Audit Committee of the Board of Director&#8217;s review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="ie5fc476c34df4f75b13ac936a12f8e6b" continuedAt="icea4b55fc3bc4ac3b94cc14b32dedc92"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names (i) the Company, (ii) its Chief Executive Officer, (iii) now former Chief Financial Officer, (iv) former Chief Financial Officer and Chief Commercial Officer, and (v) current and former members of the Board of Directors (the &#8220;Board&#8221;) as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#8217;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. On June 28, 2021, the Court dismissed motions brought by the plaintiff for leave to commence a claim for misrepresentation under the Ontario Securities Act and for certification of the action as a class action. The plaintiff appealed the Court&#8217;s dismissal of the motions only with respect to the Company, the Chief Executive Officer, and the now former Chief Financial Officer; the remaining defendants were dismissed from the matter with prejudice, and the Company and all individual defendants agreed not to seek costs from plaintiff in connection with the dismissal of the motions. On September 26, 2022, the Court of Appeal for Ontario reversed the Superior Court&#8217;s dismissal of the leave and certification motions, granted the plaintiff leave to proceed to bring a claim for misrepresentation under the Ontario Securities Act, and remitted the certification motion back to the Superior Court.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt">Regulatory reviews relating to restatements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019 as well as the previously disclosed restatement of the second quarter of 2021 interim financial statements (collectively, the &#8220;Restatements&#8221;). The Company has been responding to all such requests for information and cooperating with all regulatory authorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Securities and Exchange Commission Settlement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2022, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) issued an Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8(a) of the Securities Act of 1933 (the &#8220;Securities Act&#8221;) and Section 21(c) of the Exchange Act, Making Findings, and Imposing a Cease-and-Desist Order (the &#8220;SEC Order&#8221;) resolving the Restatements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to settle with the SEC, without admitting or denying the allegations described in the SEC Order. The SEC Order fully and finally disposes of the investigation of the Company by the SEC into the Restatements without the payment of any civil penalty or other amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC Order required the Company to cease and desist from committing or causing any violations and any future violations of Section 17(a) of the Securities Act, Sections 10(b), 13(a), 13(b)(2)(B) of the Exchange Act and Rules 10b-5, 13a-13, 13a-15(a), 13a-16 and 12b-20 thereunder. Additionally, the Company agreed to certain undertakings, which include, among other things, retaining a qualified independent consultant (the &#8220;Consultant&#8221;) to engage in a review of, and make recommendations with respect to, certain of the Company&#8217;s internal accounting controls and internal control over financing reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the SEC Order, the Company (i) lost its status as a well-known seasoned issuer for a period of three years, (ii) is unable to rely on the private offering exemptions provided by Regulations A and D under the Securities Act for a period of five years and (iii) is unable to rely on the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 for a period of three years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OSC Settlement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2022, the Ontario Capital Markets Tribunal approved a settlement agreement (the &#8220;OSC Settlement&#8221;) between the Company and the staff of the Ontario Securities Commission (the &#8220;OSC&#8221;), resolving the Restatements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the OSC Settlement, which fully and finally disposes the investigation of the Company by the OSC, Cronos agreed to pay a total of C$<ix:nonFraction unitRef="usd" contextRef="i8b07f4aa5f60422f8eee91da858d2511_D20221024-20221024" decimals="-4" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxOTEz_7846f3e6-cc9a-4648-ba6a-a288a2724803">1.34</ix:nonFraction>&#160;million to fully settle the matter, and acknowledged that it had failed to comply with the requirement under Section 77 of the Securities Act (Ontario) to file interim financial reports in the manner set out therein and had acted in a manner contrary to the public interest. Additionally, the Company agreed to retain the Consultant to engage in a review of, and make recommendations with respect to, certain of the Company&#8217;s internal accounting controls and internal control over financing reporting, on substantially the same terms as were required by the SEC pursuant the SEC Order. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="icea4b55fc3bc4ac3b94cc14b32dedc92" continuedAt="i4bfba2b4fac44e7592f88354895a0400"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt">Litigation relating to marketing, distribution and sale of products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of King&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$<ix:nonFraction unitRef="cad" contextRef="i0440f861c18e4a33b1c366ca915c82bd_D20200616-20200616" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxOTI5_f913be5c-d3f1-4270-8e0b-07ffb9d049f1">500</ix:nonFraction>&#160;million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$<ix:nonFraction unitRef="cad" contextRef="i0440f861c18e4a33b1c366ca915c82bd_D20200616-20200616" decimals="-6" name="cron:LossContingencyPunitiveDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxOTQ0_191ad3d3-05de-4021-a6f3-6691a52c9d35">5</ix:nonFraction>&#160;million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. On January 31, 2022, upon consent of the Company and the plaintiffs, the court dismissed the case in its entirety as to the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California&#8217;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#8217;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Annual Report, the plaintiff has not refiled the complaint.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4bfba2b4fac44e7592f88354895a0400">The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_121"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTg_fd8b276c-fa4b-4754-a0d3-3bf1a533a99b" continuedAt="i61e6dd7edcf846f79b80067c634720c7" escape="true">Share-based Compensation</ix:nonNumeric></span></div><ix:continuation id="i61e6dd7edcf846f79b80067c634720c7" continuedAt="iff35507c44c04dddacb74ca444a42829"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Share-based award plans</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has granted stock options, RSUs and DSUs to employees and non-employee directors under the Stock Option Plan dated May 26, 2015 (the &#8220;2015 Stock Option Plan&#8221;), the 2018 Stock Option Plan dated June 28, 2018 (the &#8220;2018 Stock Option Plan&#8221; and, together with the 2015 Stock Option Plan, the &#8220;Prior Option Plans&#8221;), the Employment Inducement Award Plan #1 (the &#8220;Employment Inducement Award Plan&#8221;), the 2020 Omnibus Equity Incentive Plan dated March 29, 2020 (the &#8220;2020 Omnibus Plan&#8221;) and the DSU plan dated August 10, 2019 (the &#8220;DSU Plan&#8221;). The Company can no longer make grants under the Prior Option Plans or the Employment Inducement Award Plan.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4ODk_c015adba-c703-4a8b-bae2-14a3bb211ee2" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total share-based compensation associated with the Company&#8217;s stock options and RSUs:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzItMS0xLTEtMjEzMzM5_92dd4f8b-1c23-4848-94fa-e93034b6e798">6,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzItMy0xLTEtMjEzMzM5_ad9b6f25-13e9-4895-b7bf-ac4519955a15">7,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4ceff8a6a64ff4a32fbf710974cb5d_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzItNS0xLTEtMjEzMzM5_b2cd5f23-6df8-4687-8659-e00fd240ced3">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzMtMS0xLTEtMjEzMzM5_4166d342-c9ac-405c-b2b6-185f0c4515f6">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzMtMy0xLTEtMjEzMzM5_6a9fd633-4de9-451c-83f3-e864b9cfa882">2,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a89728a31a45ceb354291ab7902edf_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzMtNS0xLTEtMjEzMzM5_662a8769-355c-4f8a-ba16-80f58e838280">8,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtMS0xLTEtMjI3Mjcw_ef5eb9d0-6c97-433c-a7ac-67adf7fd256d">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b7a35047644f16be6e005b2808de2d_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtMy0xLTEtMjI3MjU3_41c07ffe-c135-4a81-86f2-2ce8e95eb773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b53e4753cb24279a0a7dfc9ee30e88a_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtNS0xLTEtMjQ3MDYw_1782efb6-e43a-4e79-ba5f-ce3de72bf957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtMS0xLTEtMjEzMzM5_4ca86701-b20c-4765-86b3-6c932ea2182c">15,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtMy0xLTEtMjEzMzM5_24c82745-22bc-4661-b200-d5f67f5624b6">10,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d59e2073a14df0bddb28f9c82e763b_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtNS0xLTEtMjEzMzM5_4a2b2214-9580-4f0a-bd80-65fe257f3755">15,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">Represents share-based compensation awards conditionally approved for grant to one of the Company&#8217;s former executives for a fixed monetary value, but a variable number of shares. These awards were liability-classified until the number of shares was determined.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Stock options</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the 2015 Stock Option Plan, which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Board to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, <ix:nonFraction unitRef="shares" contextRef="if7b11f56bc6043d89eb5e2c45e96f100_I20180628" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzExODg_ac9ec761-e3b0-4ae2-9b28-33dd43675a24">no</ix:nonFraction> further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2018, the shareholders of the Company approved the 2018 Stock Option Plan, which replaced the 2015 Stock Option Plan. The 2018 Stock Option Plan terminated the Company&#8217;s ability to grant equity under the 2015 Stock Option Plan. As of June 25, </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="iff35507c44c04dddacb74ca444a42829" continuedAt="ic17b16c688d042b1a86c1ea9860b72bb"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, the date on which the 2020 Omnibus Plan was approved by the shareholders of the Company, <ix:nonFraction unitRef="shares" contextRef="i43b1c08236a742bba4d259f97022d2cd_I20200625" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzE3NTQ_92d11f8c-9b33-4dce-8da6-ce34c6750cf9">no</ix:nonFraction> further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2020, the Board adopted the 2020 Omnibus Plan, which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, RSUs and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board (the &#8220;Compensation Committee&#8221;), and awards may be granted to eligible employees, non-employee directors and consultants. The 2020 Omnibus Plan terminated the Company&#8217;s ability to grant equity awards under the 2018 Stock Option Plan and RSUs under the Employment Inducement Award Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options represent the right to purchase Company common shares on the date of exercise at a stated exercise price. The exercise price of an option generally must be at least equal to the fair market value of the Company common shares on the date of grant. Vesting conditions for grants of options are determined by the Compensation Committee. The typical vesting for stock option grants is quarterly vesting over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMwOTI_c056cf0d-d43a-4943-8813-3c750ae39789">three</span> to <ix:nonNumeric contextRef="i15bb15a14e724f26b792f23353fb1d1c_D20200329-20200329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMwOTg_57ba6c38-ea8c-422e-ba96-b01116fad993">five years</ix:nonNumeric>. The maximum term of options granted under the 2020 Omnibus Plan is <ix:nonNumeric contextRef="id078cb5a300848a5afd3b1a38b4f82dc_D20200329-20200329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMxNjk_42080b6b-de24-4ad1-84e9-6e4b7c1d9aec">seven years</ix:nonNumeric>. Participants under the 2020 Omnibus Plan are eligible to be granted options to purchase shares at an exercise price established upon approval of the grant by the Compensation Committee. When options are granted, the exercise price is, with respect to a particular date, the closing price as reported by the TSX or the Nasdaq and, if the shares are not traded on the TSX or the Nasdaq, any other stock exchange on which the Company&#8217;s common shares are traded (as selected by the Compensation Committee in good faith taking into account applicable legal and tax requirements) on the immediately preceding trading day (the &#8220;Fair Market Value&#8221;). The 2020 Omnibus Plan does not authorize grants of options with an exercise price below the Fair Market Value.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTE_f3ab5eeb-6383-45b1-90d9-4d6278d460f9" continuedAt="i85076bc0c8104499aa36cd11d4a1d171" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in options:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzEtMS0xLTEtMjEzMzM5_fefa8b3d-7e10-4179-aad4-ba9a54192121">7.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzEtMy0xLTEtMjEzMzM5_62dd7a7e-b559-43ba-8b3a-b0b63e8d0ab6">8,939,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzEtNS0xLTEtMjEzMzM5_73865b78-5b6d-4368-b2a7-117f46afeafe">2.70</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzItMS0xLTEtMjEzMzM5_7386bd1d-db2e-4f75-bce2-f044311de67d">4.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzItMy0xLTEtMjEzMzM5_26a879d1-9360-41eb-9129-725cfe31c49c">113,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzMtMS0xLTEtMjEzMzM5_218833f2-281a-4c4e-814b-8926a36cff02">2.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzMtMy0xLTEtMjEzMzM5_d17e3ea2-5ccf-476a-a07c-197ad339eb5e">2,735,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzQtMS0xLTEtMjEzMzM5_29176eda-16a8-4696-bbcd-125a69a41c2d">5.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzQtMy0xLTEtMjEzMzM5_23a24425-7b16-4106-ac62-f19f37c4a0f8">966,692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzUtMS0xLTEtMjEzMzM5_00183d6e-f540-4cc4-82f2-537a5adc0552">10.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzUtMy0xLTEtMjEzMzM5_590cefe5-1a9f-4323-b65a-686b5f675e08">5,350,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzUtNS0xLTEtMjEzMzM5_e10b56b3-8187-4632-a389-d43c3269543d">0.73</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2022</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzYtMS0xLTEtMjEzMzM5_92cf322e-570b-4aeb-8e95-0054462df158">11.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzYtMy0xLTEtMjEzMzM5_a8d3fd67-a25d-4e60-95b6-5f1925421a0e">3,867,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzYtNS0xLTEtMjEzMzM5_460d345c-66da-4812-8c33-348a43720627">0.66</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzEtMS0xLTEtMjEzMzM5_f9644ad2-a25b-41fa-bc6d-ac6b558c407e">5.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzEtMy0xLTEtMjEzMzM5_cc5f7bf5-51ea-421c-ae0a-0760dbec8188">13,755,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzEtNS0xLTEtMjEzMzM5_398d56c0-b793-40e4-b7db-1bc537884829">2.30</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzItMS0xLTEtMjEzMzM5_0894f5a7-80d0-42ea-8fed-b1c0ad4e14ee">9.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzItMy0xLTEtMjEzMzM5_ddc7b21c-5e80-4c80-9d45-bc5ece831835">900,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzMtMS0xLTEtMjEzMzM5_29b7971e-d2d1-4cc5-aae6-f2b42d615210">2.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzMtMy0xLTEtMjEzMzM5_8a98f2a9-52ab-4b7a-bd10-d9ed56f08dd8">5,598,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzQtMS0xLTEtMjEzMzM5_06f5edce-ec6a-42fe-9d22-9c22ad3b3b2e">12.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzQtMy0xLTEtMjEzMzM5_d7b70737-ebc9-442c-924f-31bbef694b39">117,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzUtMS0xLTEtMjEzMzM5_9d587f3f-d206-426c-8623-825573bb3f8c">7.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzUtMy0xLTEtMjEzMzM5_7da6488c-c4b2-40c4-81e1-3a39c05d8c15">8,939,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzUtNS0xLTEtMjEzMzM5_67349616-e47d-4b58-b5a7-77ec63997493">2.70</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzYtMS0xLTEtMjEzMzM5_66f4b58c-75cb-4265-a50d-a2e1450be0c9">6.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzYtMy0xLTEtMjEzMzM5_ef243358-2fe2-4bb8-b01f-8be49222e631">5,836,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzYtNS0xLTEtMjEzMzM5_1bedda4d-dd6d-4ce5-b026-00ebfa4bac42">1.37</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="ic17b16c688d042b1a86c1ea9860b72bb" continuedAt="i7a0782de0a284945ad9bda7777f610d1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022 and 2021, the fair value per option at grant date was C$<ix:nonFraction unitRef="cadPerShare" contextRef="iaec054e4771b4c90b5d921f053336fc3_I20221231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzE2NDkyNjc0NTA1NTE_09719c3f-d521-4b38-b176-1fc45d66a4c5">2.94</ix:nonFraction> and C$<ix:nonFraction unitRef="cadPerShare" contextRef="i671a3f82ae654e0995f259326a3baa25_I20211231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzE2NDkyNjc0NTA1NDI_2c45e39a-5ba9-4e66-b235-8efb03741bf9">6.39</ix:nonFraction>, respectively. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTI_58d0cc4d-1a5f-43c2-a7f2-d2b6012a5b7d" continuedAt="i6fea7dc45b0d4d6fa658832c7d792d06" escape="true">The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="i6fea7dc45b0d4d6fa658832c7d792d06" continuedAt="i1a6c47e8c20d478dbfe860afd7e64bf9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i9c268295fba144a989d01a9bd99cf5f8_I20221231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzEtMS0xLTEtMjEzMzM5_aec71e91-dc34-48f3-b3ff-63f88dec1af3">4.20</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i0014408a0e804e82a06b2f923cd14abd_I20211231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzEtMy0xLTEtMjEzMzM5_65f9832f-7f99-476a-8ce6-282bba1ce0b9">9.19</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price (per option)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i9c268295fba144a989d01a9bd99cf5f8_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzItMS0xLTEtMjEzMzM5_331e5402-349b-47ee-888a-b0a32a1ea210">4.20</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i0014408a0e804e82a06b2f923cd14abd_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzItMy0xLTEtMjEzMzM5_c3fb2adf-9ddd-48ed-b689-3564e84b0497">9.19</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzMtMS0xLTEtMjEzMzM5_4f792944-7537-4b24-9fb3-34c889ba1d81">3.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzMtMy0xLTEtMjEzMzM5_b8b66518-8eca-4c51-b6cf-a81fec72f0ef">1.39</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of options (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzQtMS0xLTEtMjEzMzM5_8bf64cad-3b4a-49e9-a538-24874d2b7bf5">7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzQtMy0xLTEtMjEzMzM5_1a502489-26af-4af7-92ec-c2c27746caf7">7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzUtMS0xLTEtMjEzMzM5_98469e92-dfcb-4656-a98a-6f542fe77db6">73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzUtMy0xLTEtMjEzMzM5_752692cf-ba83-4af0-831b-0aa872fccecf">75</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzYtMS0xLTEtMjEzMzM5_058db739-b6c1-4d9c-8fcd-3ee3d19b36a5">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzYtMy0xLTEtMjEzMzM5_83d669e3-80f5-4fe1-843e-822e104b80ee">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Black-Scholes value at grant date (per option)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231" decimals="2" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzctMS0xLTEtMjEzMzM5_d12905f7-ad33-4172-ab50-f275159d3edb">2.94</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231" decimals="2" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzctMy0xLTEtMjEzMzM5_ae55c2ce-0ae0-45a4-ae4d-b272fa828cc5">6.39</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231" decimals="INF" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzgtMS0xLTEtMjEzMzM5_72232a8e-0148-4466-9b2d-73390bc8b365">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231" decimals="INF" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzgtMy0xLTEtMjEzMzM5_5a482bbf-725f-42f1-9f3e-910c63f7470e">&#8212;</ix:nonFraction></span></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="i1a6c47e8c20d478dbfe860afd7e64bf9" continuedAt="ifa0c3e0c22a5460d98f016b9b5d734bb">(i)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"><ix:continuation id="ifa0c3e0c22a5460d98f016b9b5d734bb">The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#8217; and non-employees&#8217; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#8217;s share price, adjusted for the Company&#8217;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.</ix:continuation> </span></div><ix:continuation id="i85076bc0c8104499aa36cd11d4a1d171"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options outstanding:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options outstanding as of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4da8bcc218e7495696143aafa8c5b34e_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzItMS0xLTEtMjEzMzM5_21a7723e-d5b1-46e5-91ba-bbf1eb1ac614">2,788,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib632c4ab2a854cfb952e785b1c5b1f92_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzItMy0xLTEtMjEzMzM5_70f6602a-e2aa-4449-9c7f-444009857194">2,900,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82525d4a3a8f469f81973ca388451122_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzItNS0xLTEtMjEzMzM5_85b68241-7e90-4afd-82f5-d6fa336329e2">2,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2bafcc4c72134f0384d7d6c79566a00b_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzMtMS0xLTEtMjEzMzM5_14af8fb4-c153-4888-86b2-ef4bbeb5bd21">1,422,069</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic81b826c9f6f47168c91d1cb32f0a31c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzMtMy0xLTEtMjEzMzM5_46592b38-8ab1-4c05-9871-c0187a01f32e">1,550,074</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3da422e72bff47219c139aac3b9de694_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzMtNS0xLTEtMjEzMzM5_72b277e5-31c2-4dca-9086-c7d109b6d06e">1,627,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d50f7ee161742d4869f0c80a6f2c830_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzQtMS0xLTEtMjEzMzM5_5405cf51-a148-43d9-9cec-68ec09e4a275">1,139,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3696af6fe23941a9aca7c712298dc6df_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzQtMy0xLTEtMjEzMzM5_e71f025e-d61e-416e-a470-e03405a5fc2a">4,489,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1615a90b3b04370a4c4f8cdb7323bcb_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzQtNS0xLTEtMjEzMzM5_8dc79857-a627-4414-868c-272e0682a583">10,127,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzUtMS0xLTEtMjEzMzM5_8651c043-880e-4fd8-a98e-338a6519a6da">5,350,600</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzUtMy0xLTEtMjEzMzM5_9886c788-5599-424e-97fd-e9b9f3126fc1">8,939,330</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzUtNS0xLTEtMjEzMzM5_0f8ad7cb-41b8-4035-b9e2-3573e21faa1e">13,755,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Restricted share units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are granted under the 2020 Omnibus Plan. RSUs represent an equivalent amount of Company common shares on the date of issuance at fair value. Fair value is determined using the closing price of the trading day immediately preceding the date of grant. RSUs issued under the 2020 Omnibus Plan typically vest over a <ix:nonNumeric contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTU_c5c22158-3988-46c6-b85a-ad6dd03a39c7">three-year</ix:nonNumeric> period following the grant date and have no performance requirements.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc5MDE_29c3d252-672d-40c6-871b-2fca6ce49ba0" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i81cf921ce7a8454989e3197113c2db54_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzEtMS0xLTEtMjEzMzM5_7b9096d9-08a5-41cf-a847-f37d4b5199eb">9.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81cf921ce7a8454989e3197113c2db54_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzEtMy0xLTEtMjEzMzM5_56bdc9b7-4c55-4937-bbd4-399ca94eda56">1,225,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzItMS0xLTEtMjEzMzM5_c8cf68cf-b939-4027-bee3-fa825f402bfd">4.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzItMy0xLTEtMjEzMzM5_d7e23710-998d-40b7-baec-8c1b68a37cd0">6,140,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzMtMS0xLTEtMjEzMzM5_c9fc3315-843c-445d-bbef-778976cae7c6">7.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzMtMy0xLTEtMjEzMzM5_0cc74250-e04f-477e-a1a8-5633b3f4e8c8">1,151,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzQtMS0xLTEtMjEzMzM5_536e53c1-11f5-405e-bdae-f4fead78b0ce">5.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzQtMy0xLTEtMjEzMzM5_95b73e1c-3e24-409b-87a2-aebd7cd71e54">489,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i5a57a4ae358343efa921579efb8a3332_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzUtMS0xLTEtMjEzMzM5_94ef8086-70c8-4bf0-9bd4-28fabf3e5ff8">4.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a57a4ae358343efa921579efb8a3332_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzUtMy0xLTEtMjEzMzM5_9d958f05-d804-4644-9521-40a19558c6fe">5,725,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i3e0f5c40899c45bab72391f0ad745e88_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzEtMS0xLTEtMjEzMzM5_a7cf855f-1f9b-4533-ae14-fd7e881f2f69">7.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e0f5c40899c45bab72391f0ad745e88_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzEtMy0xLTEtMjEzMzM5_b1c33a90-2af9-42fa-8a81-0a109a0e5fc8">948,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzItMS0xLTEtMjEzMzM5_cf2b11e2-fc8a-45a1-8651-edb801dc7d3e">11.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzItMy0xLTEtMjEzMzM5_2c474140-adaf-4afe-aeba-39cd57583bcb">576,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzMtMS0xLTEtMjEzMzM5_044dcee5-cd28-4757-a7a0-432ad608d963">7.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzMtMy0xLTEtMjEzMzM5_b1f58235-570a-44e2-998d-2c8a318b2d83">158,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzQtMS0xLTEtMjEzMzM5_77fa3fee-b53c-489b-9d32-9171c133b013">8.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzQtMy0xLTEtMjEzMzM5_5024d2cd-d196-4c08-8f0b-07b6e69b6d2f">141,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i81cf921ce7a8454989e3197113c2db54_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzUtMS0xLTEtMjEzMzM5_4c8f49e5-f0bd-4b6f-9193-0efd7a94a0c0">9.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81cf921ce7a8454989e3197113c2db54_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzUtMy0xLTEtMjEzMzM5_36591261-1c7e-472e-b8f7-47315965db33">1,225,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">RSUs granted in the period vest annually in equal installments over a <ix:nonNumeric contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4ODg_109c7cd7-9868-4eff-9292-119dce235f68">three-year</ix:nonNumeric> period from either the grant date or after a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzYwNDk_6e990025-ef0a-4b0c-8037-643bef788633">three</span> or <ix:nonNumeric contextRef="if649373ae72c46ac8d40aad21853ce38_D20220101-20221231" name="cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTY_35cefe4e-02c0-4499-9663-6af2e0dcc40f">five year</ix:nonNumeric> &#8220;cliff-period.&#8221; All RSUs are subject to such holder&#8217;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">Equity grants for 2020, 2021 and 2022 were held back for certain executives of the Company in connection with ongoing investigations by the SEC and the OSC, which were subsequently settled on October 24, 2022. On August 5, 2022, the Compensation Committee approved the release of these held-back equity grants conditioned upon settlement of the SEC and OSC investigations. These RSUs vest in equal installments over a period of three years from what would have been their original grant dates had the grants not been withheld.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">The weighted-average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i7a0782de0a284945ad9bda7777f610d1"><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Deferred share units</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2019, the Company established the DSU Plan pursuant to which its non-executive directors receive DSUs for Board services. The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX for awards made prior to 2022 and as reported by Nasdaq for awards made in 2022 on the trading day immediately preceding the date of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX for awards made prior to 2022 and as reported by Nasdaq for awards made in 2022 on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities. </span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc5MDQ_f07afa07-bff5-4069-bae7-9478e813768a" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea6684c36904e87baf20b2725c37ceb_I20211231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzEtMS0xLTEtMjEzMzM5_0308937a-bf3f-47d5-9008-da314cc331c7">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaea6684c36904e87baf20b2725c37ceb_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzEtMy0xLTEtMjEzMzM5_0c84605f-b8f3-4139-bc94-473135cd0e75">104,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i211045d7eac247689ade396e222267c3_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzItMS0xLTEtMjEzMzM5_d116c96e-fb5b-4643-841a-f5d7336160e8">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i211045d7eac247689ade396e222267c3_D20220101-20221231" decimals="INF" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzItMy0xLTEtMjEzMzM5_4c5e9c94-ab7e-418d-be34-f2a9f9fa741b">161,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i211045d7eac247689ade396e222267c3_D20220101-20221231" decimals="-3" name="cron:ShareBasedPaymentArrangementGainLossOnRevaluation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzQtMS0xLTEtMjEzMzM5_f44a2704-1b39-4900-adce-1efd4403b8c2">177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf37dbf34d9e4ca2a9617b7383689d3e_I20221231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzUtMS0xLTEtMjEzMzM5_0ee02375-2b48-4295-a908-9e04d020a031">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf37dbf34d9e4ca2a9617b7383689d3e_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzUtMy0xLTEtMjEzMzM5_b7453d60-b97f-46f8-9aca-f4b07d740dd0">265,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e09226123b4314955596439da54b30_I20201231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzEtMS0xLTEtMjEzMzM5_4453cc5c-2b27-48fd-ae74-0fc1d848401c">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45e09226123b4314955596439da54b30_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzEtMy0xLTEtMjEzMzM5_f509c2ec-1c3c-400f-b589-b7a918d35a08">83,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzItMS0xLTEtMjEzMzM5_fbfc60ab-c1da-4579-a49a-26cfa5271fa5">354</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231" decimals="INF" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzItMy0xLTEtMjEzMzM5_8d59d39e-8639-4812-b5dc-b1ff39c21aea">48,913</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231" decimals="-3" name="cron:ShareBasedPaymentArrangementLiabilitiesSettled" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzMtMS0xLTEtMjEzMzM5_d3cddf3c-87d3-472d-bffd-14e92e56650d">203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzMtMy0xLTEtMjEzMzM5_a7e5ca48-0824-4f8e-84f1-c2b03c53d9ae">27,764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231" decimals="-3" name="cron:ShareBasedPaymentArrangementGainLossOnRevaluation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzQtMS0xLTEtMjEzMzM5_c0f5eb4b-ae28-4215-8781-ebcda4e9e535">320</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea6684c36904e87baf20b2725c37ceb_I20211231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzUtMS0xLTEtMjEzMzM5_b7ec741e-0d1c-43cf-8d85-42381f137362">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaea6684c36904e87baf20b2725c37ceb_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzUtMy0xLTEtMjEzMzM5_271deb5c-f855-4c53-a027-47812ffdaa94">104,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Warrants</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTM_13c333f6-0ac3-4edd-b148-c28fd8ce5cf9" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i44c6585cf14349b9a9f2167c67b4459e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzEtMS0xLTEtMjEzMzM5_e0612e87-a4e0-4e38-9cd9-5d852ddf6826">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44c6585cf14349b9a9f2167c67b4459e_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzEtMy0xLTEtMjEzMzM5_80890675-aac4-4a46-bd36-b1067116f413">7,987,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i831f4a43963e485884c99ebee4119ee1_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzItMS0xLTEtMjEzMzM5_18449195-15d6-44d5-bc8e-ea851347aea9">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i831f4a43963e485884c99ebee4119ee1_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzItMy0xLTEtMjEzMzM5_50d2a812-ef3b-425b-8833-1f9ea210d63c">7,987,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ia45aee9721104c22a2d6be5ae87f587a_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzQtMS0xLTEtMjEzMzM5_72452967-ba46-4110-894f-18ada24b6638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia45aee9721104c22a2d6be5ae87f587a_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzQtMy0xLTEtMjEzMzM5_88769bcc-26ee-4388-8774-6c5da0054664">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, there were no warrants outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Liability-classified awards</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Compensation Committee conditionally approved the grant to one of the Company&#8217;s former executives of share-based compensation awards for a fixed monetary amount, but a variable number of common shares. These awards were liability-classified until the number of common shares was determined.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzE2NDkyNjc0NDMwMzEy_0cce9da1-3419-4e28-a747-3676eacf1007" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5443078b1c0d43fea330c2f7752fe5e8_I20211231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTo5NWNmMDUzM2FmNDc0NjFlYmY0ZDA4NDk0YTJjOGViYi90YWJsZXJhbmdlOjk1Y2YwNTMzYWY0NzQ2MWViZjRkMDg0OTRhMmM4ZWJiXzEtMS0xLTEtMjUzMTQ2_35353623-b944-4708-8648-3514503a06b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTo5NWNmMDUzM2FmNDc0NjFlYmY0ZDA4NDk0YTJjOGViYi90YWJsZXJhbmdlOjk1Y2YwNTMzYWY0NzQ2MWViZjRkMDg0OTRhMmM4ZWJiXzItMS0xLTEtMjUwMzY4_750efb11-5d70-4998-a0e2-66df5ec9873a">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers to equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231" decimals="-3" name="cron:DeferredCompensationShareBasedArrangementsTransferToEquityAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTo5NWNmMDUzM2FmNDc0NjFlYmY0ZDA4NDk0YTJjOGViYi90YWJsZXJhbmdlOjk1Y2YwNTMzYWY0NzQ2MWViZjRkMDg0OTRhMmM4ZWJiXzMtMS0xLTEtMjUwNDIw_d84fe702-4b3e-4732-910e-06d1a2323fd0">597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3564953f2ea840f583b304e6f9918665_I20221231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTo5NWNmMDUzM2FmNDc0NjFlYmY0ZDA4NDk0YTJjOGViYi90YWJsZXJhbmdlOjk1Y2YwNTMzYWY0NzQ2MWViZjRkMDg0OTRhMmM4ZWJiXzUtMS0xLTEtMjUzMTQ4_9b574415-20ae-4439-9d7f-d9cbab0153ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, there were no liability-classified awards outstanding.</span></div></ix:continuation><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_124"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzI_87444eaf-63b3-410d-860b-f3ad344ec496" continuedAt="id80f308887f14f0f8a9978be045a8258" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="id80f308887f14f0f8a9978be045a8258" continuedAt="i004264b7448d41bd9455b71d4f76cc3a"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzM_c3fabb28-996b-4809-aec6-bc565e4bfe9c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial reporting purposes, loss from continuing operations before income taxes includes the following components:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie890eaff21934fd69d0a7950a5a10f27_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzItMi0xLTEtMjEzMzM5_f03ee662-7573-4749-9cf6-5ce8038e6326">55,502</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia60068e6af9e472faf93c6ad942fa0a0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzItNC0xLTEtMjEzMzM5_6aa738b8-5365-483c-a15d-3f339385b186">116,267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22735cc325a45779460153828233a0d_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzItNi0xLTEtMjEzMzM5_d454fe2a-df59-4313-a77e-1f320fdfdabc">12,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2f47442c54744328388ffe428c9d717_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzMtMi0xLTEtMjEzMzM5_f0c479fd-3d19-4e85-ad49-c2e9315505d7">79,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzMtNC0xLTEtMjEzMzM5_85ca3bab-95f7-43b4-b045-2e009a8c4475">280,868</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzMtNi0xLTEtMjEzMzM5_356aa3e2-c24c-43dc-908a-4d7b1d254f14">85,952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzQtMi0xLTEtMjEzMzM5_817f17a2-728d-4b0f-9cb9-c5434b236ca5">134,559</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzQtNC0xLTEtMjEzMzM5_28db9007-5d4c-453d-9536-1297dff16826">397,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzQtNi0xLTEtMjEzMzM5_6d24ea00-adc4-4b90-90be-e2fdd1a0be53">73,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss before income taxes above excludes losses from discontinued operations of $<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzM5NzI_159eadb1-ba45-48c2-b550-58efaaa4c1cc">nil</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzE2NDkyNjc0NDY5OTU_103a656c-5202-40e6-947e-b92bbcb945a3">500</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzE2NDkyNjc0NDcwMDA_189ccd72-aeee-40f4-919b-9165f4af11cd">650</ix:nonFraction> for the year ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzU_ce04cd2a-3bf9-4abc-bf46-a2933e06313a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) consists of the following components:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie890eaff21934fd69d0a7950a5a10f27_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzMtMi0xLTEtMjEzMzM5_443f2bb2-b4f3-4e7a-9360-dd59f17ad8fe">34,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia60068e6af9e472faf93c6ad942fa0a0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzMtNC0xLTEtMjEzMzM5_e511c412-6aa7-47f7-8a68-36de20227e38">382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22735cc325a45779460153828233a0d_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzMtNi0xLTEtMjEzMzM5_1c68dd23-76b1-47c4-9712-52fff3fabfb8">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f47442c54744328388ffe428c9d717_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzQtMi0xLTEtMjEzMzM5_7185f1f4-c9ef-4c76-9a99-744b74f85699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzQtNC0xLTEtMjEzMzM5_af7165ad-b684-4972-b2d1-1cf6c5a7dfd0">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzQtNi0xLTEtMjEzMzM5_d7d4b465-c0fb-4d9d-b233-d9585f103d8d">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzUtMi0xLTEtMjEzMzM5_00e377f5-d647-4b2f-b380-846fd96390e7">34,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzUtNC0xLTEtMjEzMzM5_6c3838f7-5754-4cf0-8bec-401b2b9d5c28">471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzUtNi0xLTEtMjEzMzM5_c0db3729-f5c3-4f85-9da6-18e2420dac32">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie890eaff21934fd69d0a7950a5a10f27_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzctMi0xLTEtMjEzMzM5_eb974bbc-8537-4479-95a4-25ab67066dd1">241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia60068e6af9e472faf93c6ad942fa0a0_D20210101-20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzctNC0xLTEtMjEzMzM5_69045f12-f3e2-44bc-931e-9df729d3835b">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22735cc325a45779460153828233a0d_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzctNi0xLTEtMjEzMzM5_c066a527-65f1-402b-a80f-ad8c336d9654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f47442c54744328388ffe428c9d717_D20220101-20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzgtMi0xLTEtMjEzMzM5_b8cfef98-e74e-4af8-aa10-3db46f111bc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzgtNC0xLTEtMjEzMzM5_02dcfc25-f998-4004-8d31-c363a899b08b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzgtNi0xLTEtMjEzMzM5_8e347eb7-2079-422f-8deb-682d8ae3c3cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzktMi0xLTEtMjEzMzM5_f8731a07-2e48-48d8-8c29-81ca5da4473d">241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzktNC0xLTEtMjEzMzM5_24b9cf1b-3428-47da-aac1-3698d63a55cf">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzktNi0xLTEtMjEzMzM5_2fa1f020-8175-4279-bb06-4d271d49dad8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, 2021 and 2020, the Company&#8217;s current income taxes payable were $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzM5ODc_5a9e947a-4083-452e-b64b-d19e6842dafe">32,956</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzM5OTc_3227641d-1d60-441c-8a60-783c52156eb9">105</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwMDc_708cabb3-1c67-4155-9645-7ff2713cc65b">865</ix:nonFraction>, respectively, related to current income tax expense. Included in other receivables as of December&#160;31, 2022, 2021 and 2020 is $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwMTc_7c6cb5e4-5f11-4b7b-af3f-ceb9826d2a44">40</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwMjg_28a9ca5e-15ac-475b-bd83-727589c992fc">543</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwMzI_1d49b9bb-fd83-4a93-a5e7-89f011d48209">nil</ix:nonFraction>, respectively, related to current income tax benefits.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i004264b7448d41bd9455b71d4f76cc3a" continuedAt="ie7f9350e01d14c018afdb5a2c310ab39"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax differs from that computed using the combined Canadian federal and provincial statutory income tax rate of 26.5%. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzY_1289aaa3-8c6d-4429-9343-8334f2390e78" continuedAt="ie4c54271cfe44597b6b77d3e59738480" escape="true">Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="ie4c54271cfe44597b6b77d3e59738480"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:50.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzItMi0xLTEtMjEzMzM5_7ee1a88e-7155-46e2-83b7-6f5af3ca0fcc">134,559</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzItNC0xLTEtMjEzMzM5_773f20fb-f29c-49f4-b735-4609b57d1ce5">397,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzItNi0xLTEtMjEzMzM5_33b536ec-4008-455a-8652-c80bfdfca9ee">73,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzMtMi0xLTEtMjEzMzM5_fd575568-0e87-4324-846a-2dcb5a0a331f">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzMtNC0xLTEtMjEzMzM5_4ba537bc-4bf8-401c-85a6-6b977bd47cf1">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzMtNi0xLTEtMjEzMzM5_1e2bc87b-438e-4085-89d0-c085e9ee389f">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzQtMi0xLTEtMjEzMzM5_23c9a8c4-4771-4269-a0d2-94bc76764883">35,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzQtNC0xLTEtMjEzMzM5_0e5233bd-a9a7-4602-a4a1-ee32775d28d8">105,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzQtNi0xLTEtMjEzMzM5_897f6248-0f16-4937-b76c-b9ce8e5ce6da">19,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzYtMi0xLTEtMjEzMzM5_0a5bd4af-5f38-4bc1-81b9-5ad6012db1d4">2,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzYtNC0xLTEtMjEzMzM5_d83bb794-b23e-474e-8361-7e508dfc035d">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzYtNi0xLTEtMjEzMzM5_33590366-2033-4e9e-8d8d-7b9e46135623">711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzctMi0xLTEtMjEzMzM5_7c92cd18-49b3-4962-aee7-e427b8d6094c">1,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzctNC0xLTEtMjEzMzM5_cef772b8-e6fe-4aab-9ea4-cafcda43db6f">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzctNi0xLTEtMjEzMzM5_d8558188-534a-4443-9710-ae74386d1054">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzgtMi0xLTEtMjEzMzM5_90334747-0ca4-49c6-9cb4-32326d4682a5">836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzgtNC0xLTEtMjEzMzM5_2a3f94d9-0262-4d70-96be-7deb499396ba">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzgtNi0xLTEtMjEzMzM5_c1ffe127-400a-4011-88f1-f97149678ed9">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzktMi0xLTEtMjEzMzM5_cd48ead1-0ef8-4223-bf3b-15a8e3ecc3f3">1,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzktNC0xLTEtMjEzMzM5_bac47782-fdff-4b71-b9c3-cf69ec1ffe19">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzktNi0xLTEtMjEzMzM5_ab1a7737-5dc3-4b02-b278-adc91dd54db6">3,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of provincial tax rate difference</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEwLTItMS0xLTIxMzMzOQ_aab857f0-a773-4899-bc3f-7313e908232d">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEwLTQtMS0xLTIxMzMzOQ_e8c11a63-51de-43d4-ba3b-23d6eea331e7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEwLTYtMS0xLTIxMzMzOQ_016e4b93-5045-4e92-8204-18adaa263d8c">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates outside of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzExLTItMS0xLTIxMzMzOQ_6ac86575-e515-4ff2-be98-f2966cfe2c48">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzExLTQtMS0xLTIxMzMzOQ_a819e3e1-4107-425d-b8f6-a6d58597769e">1,869</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzExLTYtMS0xLTIxMzMzOQ_81376c61-b875-4c8a-9ff4-5a8f497fdbf7">362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in tax rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTItMS0xLTI0OTIwOA_1f6493d8-2a5f-497e-9ad2-14b80d54bb8c">11,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTQtMS0xLTI0OTIwOA_1fbce260-bab4-4c66-b1d6-a7e65475dace">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTYtMS0xLTI0OTIwOA_6b8c71e6-6b90-4580-a653-8cfc173524f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value gain on financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTItMS0xLTIxMzMzOQ_ea9fefc7-f811-47f9-82a1-f462263d5226">3,726</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTQtMS0xLTIxMzMzOQ_f7d39661-94ab-4128-be39-5e8dd0c5f3f3">40,111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTYtMS0xLTIxMzMzOQ_cd9a093e-85d7-43e6-99ae-f5cb3302dbcb">34,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEzLTItMS0xLTIxMzMzOQ_7063db37-96d5-4b4b-8722-98f505e8b4e5">6,873</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEzLTQtMS0xLTIxMzMzOQ_3c8e0a04-e6e7-4ca4-93e3-3fe545295b28">141,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEzLTYtMS0xLTIxMzMzOQ_266664ab-e0ec-4e19-af3c-1df11bce0530">48,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital gain on financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTItMS0xLTI0MjgxNA_0354d26a-5300-47ae-916e-b3d8acc7e671">66,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTQtMS0xLTI0MjgxNA_1284b268-219d-4f9d-be03-f977dd0f1dca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTYtMS0xLTI0MjgxNA_bd27fb06-67cd-4578-8518-47dd07d92bbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTItMS0xLTIxMzMzOQ_084e5530-7e5a-4844-9eb5-966e18b2f040">154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTQtMS0xLTIxMzMzOQ_58070633-db63-4661-9a21-6bc54a43e14b">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTYtMS0xLTIxMzMzOQ_97c2c1ca-f37c-49fc-8a79-3d383a32ebce">867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE1LTItMS0xLTIxMzMzOQ_1d3a6a28-c3c1-4a9b-bfe0-738e63a994a4">34,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE1LTQtMS0xLTIxMzMzOQ_cf8ea9f5-1899-44b5-b3af-3f49c1482c84">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE1LTYtMS0xLTIxMzMzOQ_c521f701-087f-487d-a006-b2f4f5199e83">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance recorded against the loss on discontinued operations is not reflected in the effective tax rate reconciliation presented above for continuing operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, the Company realized a capital gain for tax purposes of $<ix:nonFraction unitRef="usd" contextRef="i2c1c7205fa134b8ea972b207eaabed88_D20220101-20221231" decimals="-3" name="cron:CapitalGainRelinquishmentOfWarrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzgzMDE_e179f018-c5a4-4391-a14c-20db6f6396a7">479,800</ix:nonFraction> as a result of Altria&#8217;s irrevocable relinquishment of the Altria Warrant on December 16, 2022, resulting in an increase in the total income tax expense reported for the year ended December 31, 2022.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="ie7f9350e01d14c018afdb5a2c310ab39" continuedAt="i8f1186a74a5846b7b2adbc86a556a059"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2Mzc_b80fc800-12bf-4182-8ef2-819ab00b72c7" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company&#8217;s deferred tax assets and liabilities:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.291%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzMtMS0xLTEtMjEzMzM5_5a1856fa-2cec-40d5-ba3f-a6fbb3932966">98,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzMtMy0xLTEtMjEzMzM5_4164d2f0-1713-4284-9d3b-947390b3cc7f">111,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetInterestCarryforward" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzQtMS0xLTEtMjEzMzM5_651fa72e-5fd7-46ae-8d91-1f0f03d0d9e5">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetInterestCarryforward" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzQtMy0xLTEtMjEzMzM5_f9a2bdef-f3a7-4d04-8d76-c4b73e57af8b">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:DeferredTaxAssetsDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzUtMS0xLTEtMjEzMzM5_c0b33703-c630-4835-91b2-d4ae4be29026">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:DeferredTaxAssetsDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzUtMy0xLTEtMjEzMzM5_111e8438-ed8b-4e3e-bf47-3f64591a07d2">2,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:DeferredTaxAssetsShareIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzYtMS0xLTEtMjEzMzM5_738a32c3-dd14-4cf8-b9bc-d8ff5dfcc300">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:DeferredTaxAssetsShareIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzYtMy0xLTEtMjEzMzM5_dfcfc00a-1810-4863-9c62-31db29845f03">834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:DeferredTaxAssetsFinanceLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzctMS0xLTEtMjEzMzM5_9804395e-a44b-4ec8-b211-42072ae61592">690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:DeferredTaxAssetsFinanceLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzctMy0xLTEtMjEzMzM5_09e7c123-718c-4cbe-b731-0bf8771459a2">1,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzgtMS0xLTEtMjEzMzM5_538d5c6f-22f3-4e2f-bb28-650af21ad13c">37,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzgtMy0xLTEtMjEzMzM5_df710aa6-39a1-4f01-8ae4-59ec6f0fc865">38,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzktMS0xLTEtMjEzMzM5_1b7d6965-9f1c-4dc9-9ac3-217784333416">13,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzktMy0xLTEtMjEzMzM5_c08b9c40-f82b-42d2-8952-80958a17907c">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEwLTEtMS0xLTIxMzMzOQ_2385def3-5632-44f3-ad78-390592cf475b">53,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEwLTMtMS0xLTIxMzMzOQ_f29ba1c3-48ee-45af-986b-97fbc83c3c2f">65,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzExLTEtMS0xLTI0MjkyNQ_65fd18a7-5148-4ab0-89af-a24022ffbbf2">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzExLTMtMS0xLTI0MjkyNQ_28b038e3-2342-41de-abbd-fced9a9350e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzExLTEtMS0xLTIxMzMzOQ_4192b408-42d6-43ba-a4df-5e6fde313fe1">2,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzExLTMtMS0xLTIxMzMzOQ_5677ba65-e5df-414c-9b6e-d7e00b0be6a0">3,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D investment tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEzLTEtMS0xLTI0MjkyNQ_91177562-e0ca-46e1-9a27-0fb320a55d3e">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEzLTMtMS0xLTI0MjkyNQ_38caa9a2-9717-4c43-b3b5-900c3a2721a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEyLTEtMS0xLTIxMzMzOQ_8a65274a-d12d-4303-ae56-330f187af7ed">3,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEyLTMtMS0xLTIxMzMzOQ_82a5fdba-1195-4401-804a-324aa24b1523">1,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEzLTEtMS0xLTIxMzMzOQ_f61479c2-9c5d-43c7-b159-07047e43bd87">214,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEzLTMtMS0xLTIxMzMzOQ_776a5166-7ec2-4262-b213-92e0819f00df">227,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzE0LTEtMS0xLTIxMzMzOQ_6e5df8fc-a0aa-4fb3-baf5-880334b6bc43">214,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzE0LTMtMS0xLTIxMzMzOQ_45725577-dc6f-4b83-ac09-17032bb7fe83">224,776</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzE1LTEtMS0xLTIxMzMzOQ_121f0beb-a77e-4a35-8526-bf7cf22897ce">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzE1LTMtMS0xLTIxMzMzOQ_32d1d935-a75d-47e8-b679-29dd82527fb6">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzIyLTEtMS0xLTIxMzMzOQ_2e1bf883-7076-4267-b220-55e58412d7d3">365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzIyLTMtMS0xLTIxMzMzOQ_ac01dd6d-9c94-49b8-aadd-5702899548f9">1,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzIzLTEtMS0xLTIxMzMzOQ_0bd11592-17b4-42f4-b481-5d5f8fcc8668">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzIzLTMtMS0xLTIxMzMzOQ_d9a1d146-503f-4f6c-8df2-dcdf8988ce45">483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzI0LTEtMS0xLTIxMzMzOQ_6f2f144b-9428-4c5b-b328-4cf046f6d35d">449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzI0LTMtMS0xLTIxMzMzOQ_04614cfb-6dfe-491b-aa0a-3895764e670a">2,343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzI1LTEtMS0xLTIxMzMzOQ_7311f03b-e8b5-4924-b5e6-4a9857efbd99">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzI1LTMtMS0xLTIxMzMzOQ_ae5cc237-47f2-48de-99ae-b6013c4eb778">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;padding-left:20.88pt;position:relative;top:-3.5pt;vertical-align:baseline">Net deferred tax asset (liability) is reported as Other assets within our consolidated balance sheet.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The realization of deferred tax assets is dependent on the Company&#8217;s generating sufficient taxable income in the years that the temporary differences become deductible. A valuation allowance has been provided for the deferred tax assets that the Company determined did not meet the more-likely-than-not recognition threshold under U.S. GAAP.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and 2021, the Company&#8217;s valuation allowance was $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzM4NDgyOTA3MTIyMzc_11aaf708-1286-4791-bd5e-d0bfb54762fd">214,199</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzM4NDgyOTA3MTIyNDU_71cc7f9b-74ba-4262-b173-1656b9f77f34">224,776</ix:nonFraction>, respectively. The valuation allowance decreased by $<ix:nonFraction unitRef="usd" contextRef="if64d9be38b984e93b7bb3510d65efa19_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzM4NDgyOTA3MTIxOTQ_3102e740-c327-41be-91af-7f683d70bf7c">10,577</ix:nonFraction> during the year ended December 31, 2022, and increased by $<ix:nonFraction unitRef="usd" contextRef="i74a2533447d449bab879b0c4eab1b547_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzM4NDgyOTA3MTIyMjU_164fa997-b2d9-4bc6-8d70-d5e805cac082">138,841</ix:nonFraction> during the year ended December 31, 2021. The decrease in the valuation allowance during the year ended December 31, 2022, was primarily due to the recognition of a portion of deferred tax assets for which a valuation allowance was recorded in the prior year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#8217; taxable income of approximately $<ix:nonFraction unitRef="usd" contextRef="i74ebbd8e3add46ca819ae30424a73e32_I20221231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwNzA_1469f310-ef7c-4abc-8aa7-a9bc2222fb5b">216,120</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i2f71b6661d4743cc8370d986af453519_I20221231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwNzU_636f5dad-f948-46a1-bd46-98d3560951e7">134,593</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i27ccc99a2d3a4b069d7d181a25a422c1_I20221231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwODA_ffa9fa61-159c-4923-b341-62593891e0a4">18,739</ix:nonFraction>, respectively. As of December&#160;31, 2021, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#8217; taxable income of approximately $<ix:nonFraction unitRef="usd" contextRef="ie8aeff2099214e2cb23e3338d1c407e2_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwOTk_8fa1aa33-5f99-448d-bc3f-ff388f5f26fb">276,497</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iece993f8cd4f47dea213f3a4127ea952_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQxMTM_538f8c45-997a-4b69-9467-168e92190de6">117,983</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i21d99941dc0142a7be674f746ad9562a_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQxMjY_8d92150e-1b94-475e-9442-1b859f31674f">24,843</ix:nonFraction>, respectively. The net operating losses in Canada will begin to expire, for purposes of carryforward, in fiscal year 2033. The net operating losses in the U.S. can be carried forward indefinitely for federal purposes. The net operating losses in Israel can be carried forward indefinitely. The decrease in net operating loss carry-forward balance reported in Canada was primarily due to the Company utilizing a portion of its net operating loss carry-forward balance in Canada to offset a portion of the capital gain realized as a result of Altria&#8217;s irrevocable relinquishment of the Altria Warrant on December 16, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss carryforwards may be subject to limitations under the tax laws applicable in each tax jurisdiction due to ownership changes that could occur in the future. These ownership changes could limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax expense. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact the Company&#8217;s effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company has various scientific research and experimental development investment tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzUwNzk_b3547043-2eb2-45aa-a5b5-34ddeb6174ec">293</ix:nonFraction> related to Canadian operations, which, if not utilized, will begin to expire in 2040. Investment tax credits are recognized when realization of the tax credits is more likely than not.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal income tax returns in Canada, Israel and the U.S. The Company has open tax years with the taxation jurisdictions. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i8f1186a74a5846b7b2adbc86a556a059"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulations and tax treaties, as they relate to the amount, timing, or inclusion of revenue and expense. As of December&#160;31, 2022, Peace Naturals is under examination with the Canadian Reserve Agency for tax years 2019 and 2020.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:SummaryOfIncomeTaxExaminationsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzA_a50c43fe-855f-4c0b-86ac-a4a587f28cdb" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Open Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 &#8211; 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2022</span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance clarifies the accounting for uncertain tax positions and prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. Additionally, the authoritative guidance addresses the derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions. Only tax positions that meet the more-likely-than-not recognition threshold may be recognized. There were no identified unrecognized tax benefits as of December&#160;31, 2022 or December&#160;31, 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, deferred income taxes have not been provided for any undistributed earnings from operations outside of Canada. The foreign subsidiaries have accumulated losses and as such the amount of undistributed earnings upon which income taxes have not been provided is immaterial to these consolidated financial statements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_127"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzUyMjE_3774f79d-7474-46c8-82e1-0906bc825cfa" continuedAt="i93fd97cd065e4d4e8c07d5c6d599daf0" escape="true">Segment Information and Disaggregated Revenue</ix:nonNumeric></span></div><ix:continuation id="i93fd97cd065e4d4e8c07d5c6d599daf0" continuedAt="i4d90501f09354f32b5b7948994f26f44"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment reporting is prepared on the same basis that the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) manage the business, make operating decisions and assess the Company&#8217;s performance. For the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company determined that it has the following <ix:nonFraction unitRef="segment" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzI5NQ_bc80ae2b-2bf8-4100-9a47-25dd28ed8a78">two</ix:nonFraction> reportable segments: United States and Rest of World. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States operating segment consists of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacture and distribution of U.S. hemp-derived products. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of World operating segment is involved in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the cultivation, manufacture, and marketing of cannabis-derived products for the medical and adult-use markets</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These <ix:nonFraction unitRef="segment" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzY1OA_ecff44a5-f967-4360-97f7-fa3d77ce4afc">two</ix:nonFraction> segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODM to assess the performance of the segment and make decisions regarding the allocation of resources. The CODM reviews adjusted earnings (loss) before interest, tax, depreciation and amortization (&#8220;Adjusted EBITDA&#8221;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#8217;s assessment of ongoing business performance.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzUyMTY_a70a006e-d051-48f4-962c-6b55ca50bc50" continuedAt="ia6acffb5ed7a4207896e142df159ecc1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below set forth our consolidated results of operations by segment:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66239904fa4a427a997cee3b6eb5a236_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzItMS0xLTEtMjEzMzM5_e94974f5-7f32-4a34-b726-c03e07f00139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36bf0818f4cd4583a8aae9102eb5d125_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzItMy0xLTEtMjEzMzM5_a201fb76-b2e1-4886-bdf3-20903e6aa433">63,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55cfa304264f4cf8837ffe45ee192e62_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzItNS0xLTEtMjEzMzM5_9fe9ca93-4790-431a-91c4-2a06fa3f5525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i121d4fac442e45c78f91d9bee9e1e16e_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzItNy0xLTEtMjEzMzM5_6b65cea4-6745-41b8-9b03-5fd2a10022b9">63,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ebb9a852384198889ab7d716ed3e00_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzMtMS0xLTEtMjEzMzM5_6caf4700-af5a-46b0-bac4-cce178e45998">5,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97b43ae395a42af8a4d033428bd087c_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzMtMy0xLTEtMjEzMzM5_1cdd8ffc-70c2-4fcd-a43c-f1b2389e853b">22,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c3d94cdeff43b89756b7af65fe6a0f_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzMtNS0xLTEtMjEzMzM5_8bab5583-84e1-4ba0-aeac-700554a0d782">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eb44d5887f747f9b4ded07ef27d1ec9_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzMtNy0xLTEtMjEzMzM5_55a17134-a0ca-4f32-8058-218efb3ef647">27,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i982c9bead0644302a7a575aa8cd1fedb_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzQtMS0xLTEtMjEzMzM5_207d9f24-6185-4d96-8e5b-07d39d863d94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e4ff60cd583466bb936bd3d33219c85_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzQtMy0xLTEtMjEzMzM5_f87bb381-5030-427a-93a3-d8d67d788a00">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de187f960e94096af46a08a23476554_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzQtNS0xLTEtMjEzMzM5_be9bff18-94d9-4bb2-84bd-01c3e8a9a1fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91930e58e4134eceb3113536ceba2913_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzQtNy0xLTEtMjEzMzM5_f83d1ebe-bfb0-49a5-b7ba-821865f86c15">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzUtMS0xLTEtMjEzMzM5_e5b15947-b641-4894-93f7-5c1efbf7a665">5,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzUtMy0xLTEtMjEzMzM5_e83c0898-df5f-4f70-85d9-f6e859d41cc5">86,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzUtNS0xLTEtMjEzMzM5_51f785f3-6bcf-4dc7-960a-0d6354b01124">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzUtNy0xLTEtMjEzMzM5_4f998ad9-3660-4524-b239-54846029fbf1">91,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzctMS0xLTEtMjEzMzM5_1686e1b4-0031-4aeb-88d9-eb8639f5112d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzctMy0xLTEtMjEzMzM5_6ee018b7-14c1-4da1-83dc-c8db4790f643">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzctNS0xLTEtMjEzMzM5_a3843eda-9104-4789-8f56-246394ae088b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzctNy0xLTEtMjEzMzM5_1f115b80-c99e-4dfb-98e0-e6acbe330c9d">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzktMS0xLTEtMjEzMzM5_a89282d6-e8c7-4611-bbff-59fc0240fde0">4,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzktMy0xLTEtMjEzMzM5_dd9f18e1-8f59-4df4-8b4f-11cedb62e765">18,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzktNS0xLTEtMjEzMzM5_d77ef701-7bc9-47f1-b6de-14f99d2f17e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzktNy0xLTEtMjEzMzM5_e7102e58-cd4a-4479-981b-fd5d7b74cc68">22,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEwLTEtMS0xLTIxMzMzOQ_cc6b282c-9172-4291-9eef-80c7534dc5d0">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEwLTMtMS0xLTIxMzMzOQ_f475cc3c-22d4-483a-a718-15a81f54a618">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEwLTUtMS0xLTIxMzMzOQ_b1e66c64-37fe-47db-aebd-4136b2716934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEwLTctMS0xLTIxMzMzOQ_1a0555c9-6b24-4284-b054-e92a8455d596">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzExLTEtMS0xLTIxMzMzOQ_bc5a2e80-91ac-4ce3-a6fc-f882933bffcc">4,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzExLTMtMS0xLTIxMzMzOQ_76a68be9-a02a-45aa-9547-35b45c928f21">18,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzExLTUtMS0xLTIxMzMzOQ_8f0553b0-5be7-4f4f-9ce6-bb53d2c52d3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzExLTctMS0xLTIxMzMzOQ_1636193e-2a21-4fb3-9dc9-d796e590adaa">22,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9944daa8d13a40349de5a04ccb8ab1fc_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEzLTEtMS0xLTIxMzMzOQ_430e5584-9ad4-4a11-a985-278313baae13">368,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d2bf12c84540e9bc326f458b521a1c_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEzLTMtMS0xLTIxMzMzOQ_fff250ad-40b4-4c76-bd65-ba8fa8f8d0a5">290,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2da2282758b1459e82599ab18062858c_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEzLTUtMS0xLTIxMzMzOQ_4ec79e1c-f7d4-48ce-8e6d-3163af18d3c7">553,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEzLTctMS0xLTIxMzMzOQ_7e371629-f8d9-4bf1-b57c-976e5dc122a8">1,213,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE0LTEtMS0xLTIxMzMzOQ_c63785ae-fb24-436f-896f-3f9176fad753">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE0LTMtMS0xLTIxMzMzOQ_891e90cb-5f17-42c4-a65b-287f0e38857e">5,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE0LTUtMS0xLTIxMzMzOQ_d4cb9587-b198-4fbc-8e4d-149b6fe5b0ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE0LTctMS0xLTIxMzMzOQ_f441773c-e70e-43bb-9643-47a149a9cc41">6,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE2LTEtMS0xLTIxMzMzOQ_6c567e38-cc65-4e4f-9281-ab288e55d378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE2LTMtMS0xLTIxMzMzOQ_78801f06-3bbd-4b76-a203-92a041d852e8">3,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE2LTUtMS0xLTIxMzMzOQ_e00d8c1b-0c11-4e50-a55a-924242cb9613">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE2LTctMS0xLTIxMzMzOQ_9ae31957-e42f-42db-a48f-301039cf0283">3,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE4LTEtMS0xLTIxMzMzOQ_3a1ce424-3aa6-43ce-a00e-e621b9ea2e7b">20,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE4LTMtMS0xLTIxMzMzOQ_f843c575-aedc-40d2-a795-e1238ffcab59">37,230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE4LTUtMS0xLTIxMzMzOQ_c3bcb2bd-2ae6-496b-a088-c487b7b66edd">23,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE4LTctMS0xLTIxMzMzOQ_8ca81331-6028-4abe-a9aa-20b9164f651c">80,608</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE5LTEtMS0xLTIxMzMzOQ_d7a9bb5b-60ac-4efe-8b39-8774eabd958a">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE5LTMtMS0xLTIxMzMzOQ_d4ade784-0cdd-402f-9d54-c9509aaa23ec">3,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE5LTUtMS0xLTIxMzMzOQ_e66c347b-85a7-4aa8-a934-b29258d01c11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE5LTctMS0xLTIxMzMzOQ_a9bb432e-7de4-48f7-8e10-43e5a8270159">3,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i4d90501f09354f32b5b7948994f26f44" continuedAt="i3570153195384daead54d130f3bb2a95"><ix:continuation id="ia6acffb5ed7a4207896e142df159ecc1" continuedAt="i71b48287a6f14dc8940c9f76943e0612"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8619acd4824f4abd8be3936adfc26c93_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzItMi0xLTEtMjEzMzM5_b0673f4b-cd8a-44fc-879f-2b66209179e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b238bf872e4bb7840cf7d5fdb74e4e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzItNC0xLTEtMjEzMzM5_b0098f44-8516-41e0-acc7-927095740a04">55,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i608ae05e92c14b879653819d1ae841a3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzItNi0xLTEtMjEzMzM5_5e47fa83-3f13-4e9c-a095-702a4b5314a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a6d526d6e524c51b13f9269371efb1a_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzItOC0xLTEtMjEzMzM5_6f1d7b51-9960-4d6d-b36d-f257dd79ef1f">55,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280bc038076a4e98bd7729e1879bfc22_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzMtMi0xLTEtMjEzMzM5_83a378bf-ff27-4481-8a8a-edd439c4d0a9">9,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i985cd0089e754ba184a2c698944d2406_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzMtNC0xLTEtMjEzMzM5_e61c7e13-16ca-422e-9f09-bb6bb9b42c83">8,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a793c6ff71d45a4a349e560143146c7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzMtNi0xLTEtMjEzMzM5_c7a659f4-f3f2-4178-990c-0f10f2ccedf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0654c9ddca5d49809da1529bb6a3fc61_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzMtOC0xLTEtMjEzMzM5_26d2a24d-25b7-458a-9872-322f2d594408">18,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i556926f67c0d433b8621f2c3fee78568_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzQtMi0xLTEtMjEzMzM5_285ad325-7f84-40c4-b170-2b59bb464c9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2ab78532ff4381b0a60888ddda144c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzQtNC0xLTEtMjEzMzM5_44f47e11-fa8f-4f98-895d-0c5de8bc4caa">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a07b966acb649a498c4e0cf5506ef30_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzQtNi0xLTEtMjEzMzM5_adafc1f1-1d47-4a90-9144-8bb901534770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a7e8af45ca4dcca2104af0c77f365e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzQtOC0xLTEtMjEzMzM5_55174ab5-4609-4244-97ae-ab0787f4974b">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzUtMi0xLTEtMjEzMzM5_43f9deb2-7c1b-4696-ba0c-90a0f3de2b03">9,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzUtNC0xLTEtMjEzMzM5_9c6ba56b-d1b5-4231-95e1-cc9f31df264c">64,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzUtNi0xLTEtMjEzMzM5_52bb4a00-8297-4810-aba2-35295cc2da18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzUtOC0xLTEtMjEzMzM5_92c3264d-dbad-4822-a5ea-fdb2a39bf11c">74,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzctMi0xLTEtMjEzMzM5_4847d903-ef46-4331-86ed-e76fbcd89a4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzctNC0xLTEtMjEzMzM5_3b06ba9e-3a42-47e2-9d80-3dc19b479ee1">6,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzctNi0xLTEtMjEzMzM5_de15b399-2d21-4fba-8c23-cecd8e515093">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzctOC0xLTEtMjEzMzM5_7f0ee64d-ad8a-45d9-b31d-cc76b67c4fe3">6,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzktMi0xLTEtMjEzMzM5_1125ca4a-b8d7-4635-b67f-e422d2d7a262">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzktNC0xLTEtMjEzMzM5_1d100590-61e7-4652-9bc3-fd498b54a9b7">9,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzktNi0xLTEtMjEzMzM5_fbd3ba58-0434-443a-b5d5-79b93cf7e56c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzktOC0xLTEtMjEzMzM5_e76d830d-d9a1-45fb-bae5-8ebb55dea5d3">9,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEwLTItMS0xLTIxMzMzOQ_8892abe5-0cb3-4027-b5c4-0d9d044cb5b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEwLTQtMS0xLTIxMzMzOQ_4c656cde-136f-4259-94dd-5087dec0a2ca">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEwLTYtMS0xLTIxMzMzOQ_528532e1-f18a-4ba0-84d9-39f0360515a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEwLTgtMS0xLTIxMzMzOQ_ab60ddf6-5cbe-40a0-976a-78ad51a171d3">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzExLTItMS0xLTIxMzMzOQ_30d31c9e-c02b-4c80-ae0f-4765099c4227">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzExLTQtMS0xLTIxMzMzOQ_847465d1-6514-47cd-bdd1-317f587f9cc1">9,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzExLTYtMS0xLTIxMzMzOQ_0bd1cb5b-594e-417f-a5e7-72e71c5059a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzExLTgtMS0xLTIxMzMzOQ_a6c2eae6-4c87-4d55-a66d-d4cd57aa8e8f">9,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1cd4cc8c8d4241a55586d19c45fa4e_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEzLTItMS0xLTIxMzMzOQ_7ff8977c-3f2c-412e-8c3a-b20aa7f23316">462,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0dc209f811e486ea094251837a548eb_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEzLTQtMS0xLTIxMzMzOQ_093a881e-ea2d-496c-a65e-d3d0c8c220f8">273,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7023f167ac1f48888058f60a0238b324_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEzLTYtMS0xLTIxMzMzOQ_0d3331eb-76bf-4806-8692-c016475d05af">661,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEzLTgtMS0xLTIxMzMzOQ_8780dbdf-4029-48b8-9158-6aa17046976c">1,397,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE0LTItMS0xLTIxMzMzOQ_14680e32-6e93-4eda-87c4-da8e0e9a16e8">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE0LTQtMS0xLTIxMzMzOQ_3dcdcb49-1ccb-4d95-b7e8-ec966f01447a">4,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE0LTYtMS0xLTIxMzMzOQ_dd5dfd46-a725-427b-a6e7-155c73162474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE0LTgtMS0xLTIxMzMzOQ_f92d8d75-de2f-48e4-96d8-904465ad294b">4,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE1LTItMS0xLTIxMzMzOQ_9e237b60-f743-4279-86d2-d90f93c3fda3">236,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE1LTQtMS0xLTIxMzMzOQ_d57d3d98-4b41-4d45-94fc-beaa2b413dba">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE1LTYtMS0xLTIxMzMzOQ_b93d5c8b-e869-480d-b810-979dac695d0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE1LTgtMS0xLTIxMzMzOQ_df24c8cf-2727-4a85-a423-d447ce58b74b">236,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE2LTItMS0xLTIxMzMzOQ_53b19023-91b8-4c9c-bc59-ec3c1e013f16">2,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE2LTQtMS0xLTIxMzMzOQ_dfe2f6d1-eea9-4cbe-808e-b14109cfc9f5">124,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE2LTYtMS0xLTIxMzMzOQ_5a57be45-151f-4487-af07-976202b30908">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE2LTgtMS0xLTIxMzMzOQ_0382c4bb-f0c2-4f50-954a-f577d5c44b1b">127,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE3LTItMS0xLTIxMzMzOQ_78704f83-0a27-4cf7-8957-1c6ff6a5c783">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE3LTQtMS0xLTIxMzMzOQ_f4493980-c897-4184-a61d-40fe0d5bf9f4">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE3LTYtMS0xLTIxMzMzOQ_2f653b67-c289-44bb-93ca-635abdef81fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE3LTgtMS0xLTIxMzMzOQ_614c5190-8a88-47bd-9db5-ba8c4bc951fa">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE4LTItMS0xLTIxMzMzOQ_d478890b-e42a-4487-bb23-b85ddecb1242">40,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE4LTQtMS0xLTIxMzMzOQ_c58cfb91-8890-4c61-9327-3cf32fbd9780">99,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE4LTYtMS0xLTIxMzMzOQ_9a3ea1c7-674a-439c-8887-b8bc7bdff94a">20,607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE4LTgtMS0xLTIxMzMzOQ_7e3e2c49-186a-487b-9bbc-f89335dd793d">160,463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE5LTItMS0xLTIxMzMzOQ_6a2695c6-0a91-44aa-ae7d-ae6d6e7363d0">776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE5LTQtMS0xLTIxMzMzOQ_a20de224-2bc1-47eb-9973-4e34b1a85955">10,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE5LTYtMS0xLTIxMzMzOQ_b7c34531-717d-4cf2-8099-5aa5efa1d2e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE5LTgtMS0xLTIxMzMzOQ_1a0e37f1-8edb-43c4-9c0a-0c6625654f87">11,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc4f046c82c4e989e9912e652e3393a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzItMi0xLTEtMjEzMzM5_6a55f01c-29fa-4485-8024-5a0a14d34cdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69792e5f365c4f74ac7fe11b6718f0e0_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzItNC0xLTEtMjEzMzM5_30ab10ab-c451-42df-8a56-d6671909c526">27,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b10325aa474c3f90de9f43306e401c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzItNi0xLTEtMjEzMzM5_b13340df-194e-41c8-a768-b5d27843d4e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3b385a391141238bdff4bb41f0b9de_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzItOC0xLTEtMjEzMzM5_7d4c99c1-6866-4031-885b-5a794de20538">27,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia591f2aa890f4f499b230f1be9abd0db_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzMtMi0xLTEtMjEzMzM5_404adcc1-9938-43c0-a3b7-e05c0b8e1196">9,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81106962b49a4c34889df90bb8006a1f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzMtNC0xLTEtMjEzMzM5_7398dee7-cb1e-47ef-b501-5d77e3670548">8,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67f9ea95f9074479a6d1ec92df88530c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzMtNi0xLTEtMjEzMzM5_e2d7c205-a62d-4967-84ff-42037ad6e78d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6855068406142e9b4ea4b031e056d70_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzMtOC0xLTEtMjEzMzM5_7f393102-8d59-4f15-ac8e-9e678c3fa96c">18,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bb5f5a360043fbb4ff433ca5adde3b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzQtMi0xLTEtMjEzMzM5_01371b5f-9f14-4c3b-9463-46f8be5f1248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8712aa6fe7b7457d9c1f918bd39dc780_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzQtNC0xLTEtMjEzMzM5_707842b6-016d-4e34-b5be-a45cbf3eab9d">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d583d52c40242bca5743643c378dcb6_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzQtNi0xLTEtMjEzMzM5_d72583c8-b9b6-4205-a1b7-a120608cb1c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i908b9b9a8ad74722858339b6ede02cc1_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzQtOC0xLTEtMjEzMzM5_411c6052-4951-4841-ae34-27edc651c8d5">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzUtMi0xLTEtMjEzMzM5_6841055b-ec1c-46c8-a7a6-bb11f7320acd">9,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzUtNC0xLTEtMjEzMzM5_3aac75ba-d08a-4804-801b-15750403abe5">37,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzUtNi0xLTEtMjEzMzM5_f876f2e7-adef-410b-bec5-b53aaa46701b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzUtOC0xLTEtMjEzMzM5_e656b868-ac27-4a58-909f-ed1d4cdf4209">46,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzctMi0xLTEtMjEzMzM5_3913fc0e-d3f9-410e-85a1-43f4c2e83365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzctNC0xLTEtMjEzMzM5_8fcdf4e3-f2bc-4d69-8cb6-836dbd500d47">4,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzctNi0xLTEtMjEzMzM5_6dcf2087-b73f-4cf3-9007-68e8188ba341">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzctOC0xLTEtMjEzMzM5_949d7e20-9aca-44e4-9937-657cd909ea7f">4,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzktMi0xLTEtMjEzMzM5_d5ce069d-0aaf-4e90-a1c2-d2e93e31b64c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzktNC0xLTEtMjEzMzM5_49158ce6-51dc-4de3-9c3e-9c18ee75c55b">18,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzktNi0xLTEtMjEzMzM5_b5cdf771-82f3-4f1b-8162-806d4a60f8b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzktOC0xLTEtMjEzMzM5_c861cf9c-ab34-4de1-a8a5-fea215ad29bc">18,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEwLTItMS0xLTIxMzMzOQ_f3b8818c-0ce7-45ec-accc-9ade2a76b4e4">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEwLTQtMS0xLTIxMzMzOQ_77c4bd0a-768e-4d3b-960a-58e648beae55">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEwLTYtMS0xLTIxMzMzOQ_cf083ec2-71cf-49b3-9c28-b17894e71fdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEwLTgtMS0xLTIxMzMzOQ_38380d51-15e6-46a6-b3df-2088f03b02c0">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzExLTItMS0xLTIxMzMzOQ_3221136a-66a1-4267-bc60-d15d23001df5">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzExLTQtMS0xLTIxMzMzOQ_2afa4179-55ab-4c01-a89e-d3f0d8006613">18,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzExLTYtMS0xLTIxMzMzOQ_58d04ffa-3da6-4a8a-824d-149cf2c8eb31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzExLTgtMS0xLTIxMzMzOQ_482c668d-9db1-48e9-9bd6-e5c44e3a16f3">18,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c9ff55d7a0549fdadda5e620d11697b_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEzLTItMS0xLTIxMzMzOQ_f5e32277-d201-45ae-bddd-a717ec7a1148">253,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9101b37e3f454911b9d53d768c617ca0_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEzLTQtMS0xLTIxMzMzOQ_7ecc4610-5e66-4f61-8c5b-809b05af60b9">388,351</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if24c838134cc4114bf815abbed48d9a9_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEzLTYtMS0xLTIxMzMzOQ_5beb38c6-c9bd-49a4-8f01-62883bc691be">1,283,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9d63117e854b719984324586934e8e_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEzLTgtMS0xLTIxMzMzOQ_d9c58ef8-46f2-41ce-a63d-d5987765613e">1,925,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE0LTItMS0xLTIxMzMzOQ_b1994f9f-c77c-4623-a005-3507adc2463d">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE0LTQtMS0xLTIxMzMzOQ_c05d9ff5-e017-4e2b-9e77-bb8680a8a671">2,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE0LTYtMS0xLTIxMzMzOQ_198de8f7-dea1-49a5-ad3a-062f991fd85b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE0LTgtMS0xLTIxMzMzOQ_6233f134-89bc-4d2f-861b-d4606b5499c4">2,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on indefinite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE1LTItMS0xLTIxMzMzOQ_6eebdef2-6656-4175-98e7-59d3aad1a0e4">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE1LTQtMS0xLTIxMzMzOQ_e4b272aa-a1fe-4d2b-b2fb-fe6359db85fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE1LTYtMS0xLTIxMzMzOQ_a654270c-3460-4027-8460-9ca41246d8c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE1LTgtMS0xLTIxMzMzOQ_f582356d-d348-43d0-93f9-524b3a643e4d">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE2LTItMS0xLTIxMzMzOQ_1825304b-f31f-4803-b25b-cc370a59b908">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE2LTQtMS0xLTIxMzMzOQ_2b3ba979-7a52-4ba9-9323-9e6ddff38deb">650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE2LTYtMS0xLTIxMzMzOQ_2532f391-936f-45e1-9ac1-15a797931351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE2LTgtMS0xLTIxMzMzOQ_26019feb-a18e-4ae1-945a-8a7e8213b3a7">650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE3LTItMS0xLTIxMzMzOQ_df9f72b8-e8b3-4162-8071-b52da59e780b">28,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE3LTQtMS0xLTIxMzMzOQ_4cd811c6-a814-45ab-8c7f-1b682dff5cfd">98,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE3LTYtMS0xLTIxMzMzOQ_234923be-ec18-40c4-b133-928f79ce3a61">20,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE3LTgtMS0xLTIxMzMzOQ_4e0edd0f-d65f-4c8d-8bb5-4cc4045404c8">147,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE4LTItMS0xLTIxMzMzOQ_6c9efb63-2ea7-4871-8e03-05b70a2aaf24">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE4LTQtMS0xLTIxMzMzOQ_d2bc41db-a19c-4680-8f6e-86adbdd78e4a">31,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE4LTYtMS0xLTIxMzMzOQ_f8ba2e2f-bef6-469c-984f-053f0eb60842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE4LTgtMS0xLTIxMzMzOQ_bfd14b0d-dc2d-4dfd-bb0e-f3390fe3dfed">31,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i3570153195384daead54d130f3bb2a95" continuedAt="icef89cec3e6d4a31858e528ee3a1519b"><ix:continuation id="i71b48287a6f14dc8940c9f76943e0612" continuedAt="i3d0bbecba9394bd79af6cc005d1464e9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzItMS0xLTEtMjEzMzM5_45d2c42b-9ce6-49a1-846e-2d4648a52906">84,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzItMy0xLTEtMjEzMzM5_b7152bec-506b-452f-95a2-589a53f8f7b7">54,129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzItNS0xLTEtMjEzMzM5_6dac41a0-fc73-4dfb-a7f3-cf854d69173b">30,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzItNy0xLTEtMjEzMzM5_03bea143-2566-4070-9859-5e21cf265310">168,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzMtMS0xLTEtMjUyMjg1_9d934869-dfae-4aa0-9933-41d2c5c381f6">4,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzMtMy0xLTEtMjUyMjg1_9356047d-d5f0-4e92-a193-f374d9fb64b5">18,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzMtNS0xLTEtMjUyMjg1_7b8af782-2f27-4b23-93b5-91884288b5fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzMtNy0xLTEtMjUzMTY2_c10ba161-cdff-4927-a404-6e29e995d0ec">22,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzQtMS0xLTEtMjUyMzAw_6a546086-4c59-4827-b6ae-1b493a97ccd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzQtMy0xLTEtMjUyMzAw_08c837cd-3f59-4f6f-8202-68707e69f867">34,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzQtNS0xLTEtMjUyMzAw_be3c3549-52bb-45bf-95f1-27034baa8029">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzQtNy0xLTEtMjUzMTY2_2a5f5fae-78e4-41d9-85a2-910061e65952">34,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtMS0xLTEtMjUyMjk2_4aea5cb9-59ce-4d9f-a3e1-5a79cb849d6b">1,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtMy0xLTEtMjUyMjk2_be87a1e7-96c3-46bd-ad8d-8d337b5e9673">11,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtNS0xLTEtMjUyMjk2_a681e8b1-a7da-47ac-bd87-cdc09a21483b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtNy0xLTEtMjUzMTY2_6a19beba-b67c-46e1-829c-343af911dbd2">13,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzYtMS0xLTEtMjUzMTY4_963168ec-310e-425e-8248-45c050db538c">87,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzYtMy0xLTEtMjUzMTY4_015f6fd3-4da0-48f0-9782-7369de4a2973">26,336</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzYtNS0xLTEtMjUzMTY4_cb91c80e-4587-47d6-a801-f0f7789acf48">30,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzYtNy0xLTEtMjUzMTY4_f4cc6a90-717b-45f0-99f6-94f2f610caa6">143,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtMS0xLTEtMjEzMzM5_ecf919c8-70e3-4821-ac48-fa80dcc78810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtMy0xLTEtMjEzMzM5_8e0ae171-f9c5-41f3-a149-6dbd9686c6f6">3,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtNS0xLTEtMjEzMzM5_89d7f4a8-c4bd-4b8d-a4ef-914230f44570">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtNy0xLTEtMjEzMzM5_fe6073d8-b74b-447b-9f5c-f66aa0d42888">3,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzctMS0xLTEtMjEzMzM5_d62ebf06-27d9-4b06-be19-6d4712e2d903">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzctMy0xLTEtMjEzMzM5_e479b686-f50c-402a-be56-b3d9f5dfa3dc">3,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzctNS0xLTEtMjEzMzM5_68d6bafe-9b7d-4d6a-9485-698718d9fc99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzctNy0xLTEtMjEzMzM5_45a00dd8-b583-4772-80d3-b3d624fe75ee">3,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzgtMS0xLTEtMjEzMzM5_68cba2dd-4126-407e-b642-534c1d4153b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzgtMy0xLTEtMjEzMzM5_af46d71f-6057-4bc4-a9f8-067c426a5883">14,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzgtNS0xLTEtMjEzMzM5_bc29022d-d526-42f8-88dd-c61c9fc4b290">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzgtNy0xLTEtMjEzMzM5_e06fd0fc-386c-4320-ac7f-3d5c4202636a">14,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzktMS0xLTEtMjEzMzM5_3a247c3e-117f-4f1e-b52d-8e672487a92d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzktMy0xLTEtMjEzMzM5_ef4fcb90-4f97-43d7-97f4-a24b09e8ba65">14,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzktNS0xLTEtMjEzMzM5_0d3a5695-2208-4b36-b628-df7d98f9cbff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzktNy0xLTEtMjEzMzM5_e040cd0b-cedc-4f87-9a9b-5e9645dad9ef">14,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzExLTEtMS0xLTIxMzMzOQ_5eb0865a-0321-4e03-9300-927aa911ca55">61,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzExLTMtMS0xLTIxMzMzOQ_2eb81668-c0ea-4f73-aa27-4fac9db3dda8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzExLTUtMS0xLTIxMzMzOQ_b7d13ced-9412-4fe4-8b66-99a41b2e8094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzExLTctMS0xLTIxMzMzOQ_57c96998-32b7-40a6-85f4-b3b85a4b9c4e">61,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTEtMS0xLTIzNTI3Nw_60c7abad-ff30-4cce-bcfd-fe07f7a9c7ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTMtMS0xLTIzNTI3Nw_718d8ec0-6a8b-4a4b-ad14-598bbea2a270">2,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTUtMS0xLTIzNTI3Nw_b9c38dc5-8f16-42bb-a2b6-57111e6d4610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTctMS0xLTIzNjM4Mw_80fb1da1-3f73-4ff3-8b18-2292e0cdd62c">2,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTEtMS0xLTIxMzMzOQ_38bed297-f60a-4147-a5d9-56870d3a5120">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTMtMS0xLTIxMzMzOQ_fc10843d-d38a-408b-8f34-cca70953b326">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTUtMS0xLTIxMzMzOQ_abb5c7c5-b877-4e66-8360-4966ec638aa0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTctMS0xLTIxMzMzOQ_5bdf1b17-d379-44d2-bfd8-3465bed28f27">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ix)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTEtMS0xLTIyMzc4Ng_93874fcb-6a57-4d00-9a7c-a997abe9463f">1,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTMtMS0xLTIyMzc4Ng_06c7211c-91ee-4433-8be1-9ae07c6410b2">3,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTUtMS0xLTIyMzc4Ng_89775f42-34a0-4082-8d71-be47a451436f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTctMS0xLTIzNjM4Mw_f8bae47b-4bfa-4953-9fd9-de4956633c39">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTEtMS0xLTIxMzMzOQ_82671124-1536-48bc-9c9c-ee92174544f1">3,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTMtMS0xLTIxMzMzOQ_824d631a-e0b4-40a5-a188-4b13f7daa523">11,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTUtMS0xLTIxMzMzOQ_b02242cb-c60c-4a14-b490-974acd6083be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTctMS0xLTIxMzMzOQ_fb8b10f6-1303-4c74-a4d2-f50a0031f2c9">15,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTEtMS0xLTIxMzMzOQ_fff4c7c2-186e-4917-83e1-8f6d1cfaf98d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTMtMS0xLTIxMzMzOQ_6c9a67c0-5319-41ff-916c-7191ffad8a35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTUtMS0xLTIxMzMzOQ_de0be0d3-55cf-44f3-96d5-c59b84601961">7,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTctMS0xLTIxMzMzOQ_3cc8bb10-96a4-493e-8292-736553ee5655">7,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE4LTEtMS0xLTIxMzMzOQ_318f44e0-6fec-414d-b41e-2587f0eb8b56">20,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE4LTMtMS0xLTIxMzMzOQ_c72f4836-4953-4ee6-a6ab-e71644ab77b7">37,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE4LTUtMS0xLTIxMzMzOQ_db284900-b263-4c63-a5cb-5ea973b697f2">23,244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE4LTctMS0xLTIxMzMzOQ_e3920879-8e71-44f2-ab50-975ba1f1055d">80,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzItMS0xLTEtMjEzMzM5_aa7c2112-3e1d-49ca-956f-c7386423af98">283,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzItMy0xLTEtMjEzMzM5_97cd85b8-cd11-4a73-b8e4-531b1c99c3b6">81,811</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzItNS0xLTEtMjEzMzM5_ee6a8432-3286-4a91-99f9-2f9cecb29411">31,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzItNy0xLTEtMjEzMzM5_77fd6403-2ec8-48d7-9c27-fc34adaf4341">397,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzMtMS0xLTEtMjUyMzQ0_8f00af37-6532-4ece-b822-5f002d29319a">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzMtMy0xLTEtMjUyMzQ0_2d09372e-bc8d-452c-97e4-e9b7ca4aa3de">9,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzMtNS0xLTEtMjUyMzQ0_1facea7e-ffd5-45bd-880f-0e1ab4d6c666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzMtNy0xLTEtMjUzMTcy_896ef0f5-4442-42d0-a68f-d0afd3be6328">9,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzQtMS0xLTEtMjUyMzQ0_0aded15a-30f3-4963-9d09-c5626ad65032">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzQtMy0xLTEtMjUyMzQ0_54263cb0-be63-4f7e-8de6-8e8e6422fb78">342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzQtNS0xLTEtMjUyMzQ0_459b1605-9282-4ee5-a72c-907c8e4fbee9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzQtNy0xLTEtMjUzMTcy_c9baa332-0664-4a8d-a9e4-76a8490fdd42">431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtMS0xLTEtMjUyMzQ4_57261555-13dc-4636-a90a-b574a8b6d80a">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtMy0xLTEtMjUyMzQ4_8bf17258-c9c2-4af7-b55d-ab25820b6862">14,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtNS0xLTEtMjUyMzQ4_d7d493d7-4bb5-455f-bb0d-a6207cf46577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtNy0xLTEtMjUzMTcy_1b7b7d68-d175-43ff-b7ab-f0e2a359bfb9">15,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtMS0xLTEtMjUzMTcy_ebc9ae96-5acf-4310-8ed8-aab76fd2d941">283,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtMy0xLTEtMjUzMTcy_a4bf12a1-0f1a-45b4-955f-aaf3a04ae289">76,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtNS0xLTEtMjUzMTcy_1a438a29-2661-48a9-b992-205b41afcec8">31,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtNy0xLTEtMjUzMTcy_83f3007a-f0aa-4d0a-ba88-8c7473e752a8">391,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtMS0xLTEtMjEzMzM5_7a5c7e2b-cdad-4704-b829-a8ac060c2d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtMy0xLTEtMjEzMzM5_7f34f8b9-e991-48af-9c4c-46c351385786">6,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtNS0xLTEtMjEzMzM5_e92719cf-3f14-4bbe-bd80-f530ec7f7729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtNy0xLTEtMjEzMzM5_437d2493-3040-4404-8f5a-eff7ae89e5ca">6,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtMS0xLTEtMjEzMzM5_437fef33-5615-4835-9d0e-b7be6dcd2633">236,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtMy0xLTEtMjEzMzM5_676cfda4-7f0e-44e7-a051-2c324c0c51cd">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtNS0xLTEtMjEzMzM5_241e3bc1-45d0-4918-8287-7d268a790dab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtNy0xLTEtMjEzMzM5_2203a01c-421a-489e-9a3b-b74b9fa4bdb9">236,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzctMS0xLTEtMjIzODcx_043a7cc4-1e86-425d-a9b6-b14ba73f2b9e">2,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzctMy0xLTEtMjIzODcx_dce8801b-1b56-44eb-ba33-5b7a1610d3f2">124,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzctNS0xLTEtMjIzODcx_4b28fc28-86a5-4a26-9404-d8eef2922499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzctNy0xLTEtMjM2Mzk5_7405a538-4c78-4226-886f-0a85fb19dfa6">127,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzgtMS0xLTEtMjEzMzM5_81c6ed56-576f-48cb-9772-f58ed2a3b97c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzgtMy0xLTEtMjEzMzM5_2f1a26f9-1b86-4bde-adc4-f180abf5e07d">151,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzgtNS0xLTEtMjEzMzM5_9ee87744-363c-4943-a44e-0f1af06357a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzgtNy0xLTEtMjEzMzM5_dc884bbc-ff1d-43e5-a748-dfdf5c7c6e09">151,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzktMS0xLTEtMjEzMzM5_0b670ff8-4223-4c76-827d-c813d631c67e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzktMy0xLTEtMjEzMzM5_2dadb7c6-436b-4557-a5de-10646cce0136">8,611</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzktNS0xLTEtMjEzMzM5_66d7e031-abda-49f8-84c2-a73db23a322c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzktNy0xLTEtMjEzMzM5_6bb26de7-ab16-4bd0-a4de-26d856dd954c">8,611</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEwLTEtMS0xLTIxMzMzOQ_9e2d70fd-f505-47f7-b8d2-526b3113ceff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEwLTMtMS0xLTIxMzMzOQ_5f8c6249-90c1-459d-84cb-8851fd775832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEwLTUtMS0xLTIxMzMzOQ_96e450ae-3d0a-4ffb-a2b0-1a5c8e570196">3,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEwLTctMS0xLTIxMzMzOQ_039820be-f623-4558-955d-7a5aa58b3d6e">3,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEyLTEtMS0xLTIxMzMzOQ_cea68c3d-8967-420a-b852-c1a4b92d64ba">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEyLTMtMS0xLTIxMzMzOQ_6c04ff1a-84b0-435b-bfde-12d873f40111">733</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEyLTUtMS0xLTIxMzMzOQ_94464115-9de0-43df-b157-a6e236ac8d1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEyLTctMS0xLTIxMzMzOQ_f661aade-0b28-4cff-9b4d-7ae40daa0728">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(viii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEzLTEtMS0xLTIxMzMzOQ_a8453ad1-169d-4b82-99a0-bd2774eba744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEzLTMtMS0xLTIxMzMzOQ_75e336cb-ccf2-4e9a-8e35-c9f9b8c5c9cc">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEzLTUtMS0xLTIxMzMzOQ_d984fe22-b6b7-4a9e-8355-140f12705d62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEzLTctMS0xLTIxMzMzOQ_93e2bbdf-ccf0-4784-84bc-e6700e7b5a0f">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE0LTEtMS0xLTIxMzMzOQ_f0aa0086-fd85-46c7-8a72-9dcb324d5feb">3,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE0LTMtMS0xLTIxMzMzOQ_43065f45-fea2-4627-9c76-fa3dfa4c34d3">6,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE0LTUtMS0xLTIxMzMzOQ_6725449b-5e84-4406-9b93-c906b7b71c5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE0LTctMS0xLTIxMzMzOQ_8e50a98a-23f0-4d21-b573-cfa97329bf8d">10,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE1LTEtMS0xLTIxMzMzOQ_08c8c926-696d-4175-84ea-8b6a84d66db5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE1LTMtMS0xLTIxMzMzOQ_6c1c8923-3835-48d5-9da2-343702b9fff7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE1LTUtMS0xLTIxMzMzOQ_34ab9fd7-60ee-4ee4-9fb1-2eede56bca8d">7,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE1LTctMS0xLTIxMzMzOQ_59674d7b-54d8-4228-a060-60c8e715226f">7,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE3LTEtMS0xLTIxMzMzOQ_8ab641c2-8682-454a-bc72-d761664614cc">40,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE3LTMtMS0xLTIxMzMzOQ_a94965e3-32dc-45b6-9b56-ad1acb14feac">99,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE3LTUtMS0xLTIxMzMzOQ_d08ec2f5-c38b-4036-a603-9652d074aa4f">20,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE3LTctMS0xLTIxMzMzOQ_3dbd143d-c02d-436b-a7d5-06f2ff37afbb">160,463</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="icef89cec3e6d4a31858e528ee3a1519b" continuedAt="i8305353be6b84687bd6cef34a87dd2de"><ix:continuation id="i3d0bbecba9394bd79af6cc005d1464e9"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzItMS0xLTEtMjEzMzM5_03bcdfe2-3b76-432c-a656-b37e6bd57e76">77,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzItMy0xLTEtMjEzMzM5_cbfd0710-a7b1-4e27-b992-41e7c94e1d7e">32,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzItNS0xLTEtMjEzMzM5_448a7075-a08b-4cde-a747-d1277f87dfbe">30,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzItNy0xLTEtMjEzMzM5_21f12ba1-6795-47e5-9adc-6af2743cfb7b">75,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzMtMS0xLTEtMjUyNDEy_882ba1d4-11c7-445e-9734-e15e4c6101b9">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzMtMy0xLTEtMjUyNDEy_5560068f-50e6-418d-8370-b4cabae3018e">18,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzMtNS0xLTEtMjUyNDEy_73a14380-0f55-4f73-af0f-21cb30382725">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzMtNy0xLTEtMjUzMTc0_b374b6d7-4f1f-4534-b931-e71a95e6b389">18,415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzQtMS0xLTEtMjUyNDEy_761b0141-a807-46d7-808f-f773a1dd4fcc">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzQtMy0xLTEtMjUyNDEy_e53b7cc7-a6e8-46a8-9773-6c10c558fc9b">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzQtNS0xLTEtMjUyNDEy_e9e7afc8-6edf-4e1d-b5d4-74e2091eeb81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzQtNy0xLTEtMjUzMTc0_8738342d-9a33-4b45-b8eb-166efb364689">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtMS0xLTEtMjUyNDE2_4d56d619-45d6-46f7-a2f3-aa1a108e4afa">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtMy0xLTEtMjUyNDE2_b2546fcc-4972-4453-94d5-26f46cd6ead3">6,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtNS0xLTEtMjUyNDE2_799e6fa7-f358-4303-9dd2-f5eec15db3d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtNy0xLTEtMjUzMTc0_2ccc591e-563a-4913-8f25-1a5f2a752f2e">7,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtMS0xLTEtMjUzMTc0_eadd766d-91d1-4222-a843-3923e41714b6">76,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtMy0xLTEtMjUzMTc0_6a73462f-4f4e-457d-9702-0acba5c705bb">22,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtNS0xLTEtMjUzMTc0_70dab76d-e043-43f6-9cf4-dca912dd3fd2">30,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="cron:EarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtNy0xLTEtMjUzMTc0_3db0deff-2461-4ae6-9ee3-ea438039d405">85,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtMS0xLTEtMjEzMzM5_d2ae1b83-22ca-4e41-bced-a8a517035314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtMy0xLTEtMjEzMzM5_9e612929-de16-445a-9fd3-a3521559fdb9">4,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtNS0xLTEtMjEzMzM5_7349e6b8-02f5-48e2-946d-aaea9416e4df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtNy0xLTEtMjQ3Mzk1_a3d79825-10c5-4ea8-94a9-0125d9921449">4,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtMS0xLTEtMjEzMzM5_8be1bcad-b630-4e5f-85ee-c5e2adb8e791">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtMy0xLTEtMjEzMzM5_3759bdbc-5e5a-4c11-9211-6f9bf53551ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtNS0xLTEtMjEzMzM5_168e19a8-7667-422f-8477-0cd7d84dfc5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtNy0xLTEtMjEzMzM5_29729b43-2ef8-41ee-8bea-dd33ccc3ee40">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzgtMS0xLTEtMjEzMzM5_9a98c63a-4a2b-4c63-9ee3-751778a5ac11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzgtMy0xLTEtMjEzMzM5_c433260f-57d9-4db4-bd2e-696fae7fd5d2">129,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzgtNS0xLTEtMjEzMzM5_b1ce456d-f7ac-4b5d-ade4-80a3366bcf49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzgtNy0xLTEtMjEzMzM5_f025c7da-7bf0-450a-b0ea-c5b492cbaf87">129,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzktMS0xLTEtMjEzMzM5_8998ed5a-5833-4a1b-a4ac-249fc501fbfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzktMy0xLTEtMjEzMzM5_34bc2619-e84b-47f3-b523-e08ab34cb58d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzktNS0xLTEtMjEzMzM5_8e49b049-0f60-4d4a-b081-633042ccc6fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzktNy0xLTEtMjEzMzM5_3d390ef8-47d1-46a1-b0d1-45e61e70cbcf">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEwLTEtMS0xLTIxMzMzOQ_416d99b1-9d73-43ce-ba28-f01f0ce7de18">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEwLTMtMS0xLTIxMzMzOQ_a98883ed-4df9-4d8d-8fcb-998486f5552a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEwLTUtMS0xLTIxMzMzOQ_59512c08-0502-4ddd-948a-4c86fbdb7cb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEwLTctMS0xLTIxMzMzOQ_a647061a-e15b-4618-bde2-a9c03b55514d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEyLTEtMS0xLTIyMzk5NA_5f48d569-63e9-480e-98e3-235f184e2ed9">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEyLTMtMS0xLTIyMzk5NA_c1e83e90-c74d-40ea-a557-5f58981b35be">1,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEyLTUtMS0xLTIyMzk5NA_252fb2f6-dc51-4f64-a42c-dccdd209ec43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEyLTctMS0xLTI0NzM5NQ_18531791-6490-42e0-8ca4-03b41b40f74e">1,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(viii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE0LTEtMS0xLTIxMzMzOQ_f42df566-e089-4fa6-9237-4b113e6aec0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE0LTMtMS0xLTIxMzMzOQ_78ca0341-c104-4c4a-aada-d956a07143cf">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE0LTUtMS0xLTIxMzMzOQ_d0637d56-0573-468a-8cdf-5f207514b53b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE0LTctMS0xLTIxMzMzOQ_5327dea5-2bd1-49ab-b11b-104863262313">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTEtMS0xLTIxMzMzOQ_dd69d7e3-c20b-4494-b84d-110a13c2e4b7">8,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTMtMS0xLTIxMzMzOQ_5fd3eecf-6f43-4a9b-8579-c3dd7542ca36">6,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTUtMS0xLTIxMzMzOQ_40da5127-f315-4bc1-a854-5f8718f18b02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTctMS0xLTIxMzMzOQ_6cc4c9a0-444b-4a1c-be34-7e243c387fae">15,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTEtMS0xLTIxMzMzOQ_0c8b1981-a020-4237-a01f-c13f4dfd534b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTMtMS0xLTIxMzMzOQ_d9d1d697-0a79-479d-bd7b-f3ecbf2c271c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTUtMS0xLTIxMzMzOQ_07d3a84d-6ba4-400d-b594-8442ed0ced0c">9,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="cron:RestatementReviewExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTctMS0xLTI0NzM5NQ_e743a8e1-caec-4588-81d8-94a88f5aa756">9,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTEtMS0xLTIyNDAyMQ_7cd5c975-b4d9-499f-b94e-d4155055a91d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTMtMS0xLTIyNDAyMQ_651946db-4da6-41f0-93f8-c4c1f39f6a7a">4,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTUtMS0xLTIyNDAyMQ_403f476f-b5cb-44f6-8302-7120a9c77f2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTctMS0xLTI0NzQ1OA_2dedddfc-1b5f-4082-b19c-1f41ba4b3f4f">4,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE5LTEtMS0xLTIxMzMzOQ_28a1543f-201a-4220-afa4-97517dbac995">28,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE5LTMtMS0xLTIxMzMzOQ_3f42a392-9176-472f-8a65-326b2c8b110e">98,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE5LTUtMS0xLTIxMzMzOQ_e5345ccf-2c80-4cb4-ab12-d9db7898e673">20,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE5LTctMS0xLTIxMzMzOQ_d5d3d81f-60d5-471f-9732-180860ba039e">147,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">For the year ended December 31, 2021, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to our U.S. segment and impairment on an indefinite-lived trademark related to the ROW segment. For the year ended December 31, 2020, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to the U.S. segment. See Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">For the year ended December 31, 2022, impairment loss on long-lived assets relates to the Company&#8217;s decision to seek a sublease for leased office space in Toronto, Ontario, Canada during the first quarter of 2022. For the year ended December 31, 2021, impairment loss on long-lived assets relates to impairment charges on property, plant and equipment and definite-lived intangible assets in the Canadian asset group, impairment charges for the differences between the consideration paid to Ginkgo for the achievement of two equity milestones in connection with the Ginkgo Collaboration Agreement and the fair values of the CBGA Exclusive License and CBGVA Exclusive License as well as impairment on leased premises in the U.S. segment. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221; and Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">For the years ended December&#160;31, 2022, 2021 and 2020, the gain on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 8 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Derivative Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December 31, 2022 and 2021, gain on revaluation of financial instruments relates primarily to the Company&#8217;s unrealized holding gain on its mark-to-market investment in Vitura as well as revaluations of financial liabilities resulting from DSUs. For the year ended December 31, 2020, (gain) loss on revaluation of financial instruments relates to revaluations of financial liabilities resulting from DSUs. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the years ended December 31, 2021 and 2020, transaction costs represent legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:19.8pt">For the year ended December 31, 2022, impairment loss on other investments related to the PharmaCann Option for the difference between its fair value and carrying amount. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt">For the year ended December 31, 2022, other, net primarily related to $<ix:nonFraction unitRef="usd" contextRef="ifd844fe64c4b404bb46e0d661e0f11cb_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzE2NDkyNjc0NTYxOTY_c1523aeb-9823-4142-a608-26ea3911909f">877</ix:nonFraction> loss on disposal of assets and $<ix:nonFraction unitRef="usd" contextRef="ifd844fe64c4b404bb46e0d661e0f11cb_D20221001-20221231" decimals="-3" name="us-gaap:Dividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzEwOTk1MTE2NDIzMTM_2f423b60-3200-435e-bed6-750b98a64d30">384</ix:nonFraction> of dividends declared by Vitura on the Company&#8217;s <ix:nonFraction unitRef="shares" contextRef="i7260d7d8157b4cd88fc393c43daf539a_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzEwOTk1MTE2NDIwMzM_7c43f952-adc7-40cd-a2cd-375f382e08a8">55,176,065</ix:nonFraction> ordinary shares in the capital of Vitura. For the years ended December 31, 2021 and 2020, other, net is primarily related to (gain) loss on reclassification of held-for-sale assets and (gain) loss on disposal of assets.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.62pt">For the years ended December 31, 2021 and 2020, loss from discontinued operations relates to the discontinuance of OGBC.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December 31, 2022, restructuring costs related to the employee-related severance costs and other restructuring costs associated with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. See Note 16 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Restructuring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the years ended December&#160;31, 2022, 2021 and 2020, share-based compensation relates to the vesting expenses of share-based compensation awarded to employees under the Company&#8217;s share-based award plans as described in Note 10. &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Share-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(xi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the years ended December&#160;31, 2022, 2021 and 2020, financial statement review costs include costs related to the restatements of the Company&#8217;s 2019 interim financial statements and second quarter 2021 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatements and legal costs defending shareholder class action complaints brought against the Company as a result of the 2019 restatement. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(xii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:18.36pt">For the year ended December 31, 2020, gain on disposal of investments is primarily comprised of the gain recorded related to the sale of common shares of Aurora, which were received in connection with the achievement of a milestone related to the Whistler Transaction in 2020 and as a result of the closing of the Whistler Transaction in 2019. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i8305353be6b84687bd6cef34a87dd2de"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzUyMjM_56258bef-b121-49b6-8350-2f3ed70bae66" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie229aad448624a89855c1cd201833768_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzItMS0xLTEtMjEzMzM5_d59a5780-f073-483b-bacb-96528e9f5b8b">56,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie013c85f34934c4a9ef3fea20f60a42d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzItMy0xLTEtMjEzMzM5_cfa83138-0ab3-4948-ba0f-6d0a370c3e3a">50,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193b7bc4af0a499ca3d6d6f0116acd86_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzItNS0xLTEtMjEzMzM5_c25aabf5-ddbe-4fa3-8d8e-a4127d8bc244">34,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib404b8bdefcc4f2b8537e5847dcb9f04_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzMtMS0xLTEtMjEzMzM5_78507031-4d44-4d31-acf2-90cd1f6609e9">30,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5ebc2d86264839b4b73bc4ee714946_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzMtMy0xLTEtMjEzMzM5_1cceb34f-0ef6-40b0-9355-f9f542858603">13,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice3b1efcf3694f1599f386a8588accf4_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzMtNS0xLTEtMjQ3NDMy_7483745d-9162-4968-bafc-bd6fc7b2d535">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f47442c54744328388ffe428c9d717_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzQtMS0xLTEtMjEzMzM5_ac3fd155-d8be-4e4d-8ede-2dc037213424">5,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzQtMy0xLTEtMjEzMzM5_95d19bd5-89d0-4480-9ae1-19f2f6115ae0">9,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzQtNS0xLTEtMjEzMzM5_e67504b9-aae1-42c9-bdda-cc4d4601faf0">9,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32dbd798ddd41e797792cebc95190b0_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzUtMS0xLTEtMjEzMzM5_8ac8d316-d3a3-478a-ab18-176fc812693f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie46e12c969dc47b08571eacec89b355c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzUtMy0xLTEtMjEzMzM5_0edfda52-a734-4f94-b848-6b4ccbef68c4">891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9788ac9a6c4a99ae0b6378aa5fbeff_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzUtNS0xLTEtMjEzMzM5_554a95c2-97da-400c-99e7-56dd8a4f9f64">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzYtMS0xLTEtMjEzMzM5_5db3dd0a-2187-43e7-8d8f-f2443767fdbd">91,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzYtMy0xLTEtMjEzMzM5_23afd3d6-5ebf-4258-8be5-b89bdf1dedc2">74,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzYtNS0xLTEtMjEzMzM5_2fcd977f-85a4-4c1f-a46f-63b231e87976">46,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net were physically located in the following geographic regions: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8948b89b8d243ea918ef9455a2869fd_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzItMS0xLTEtMjEzMzM5_c767c84d-47a6-4087-bcf7-51d7e94f0014">40,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c10d3f86f84221bdab6e26e7800896_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzItMy0xLTEtMjEzMzM5_8b49ecd5-3db0-4ba1-9210-66a1eb8f1562">49,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6abf41ffd0443ed90c42968b76c69dc_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzMtMS0xLTEtMjEzMzM5_ae9c140b-5fbe-4a0f-9d57-8a434938c359">20,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070e08bd1da74fe0a694c34d5deabb5b_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzMtMy0xLTEtMjEzMzM5_8531316e-8ed4-4546-a1e6-d1c445728adc">24,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c7da359963f4407b13bec57ba12f46d_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzQtMS0xLTEtMjEzMzM5_11948e97-2656-4474-9026-08316e442883">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if30ffde831a0431e9db29021c4b5e73b_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzQtMy0xLTEtMjEzMzM5_2449f0be-9f6b-406c-b9d3-613825ff6c23">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzUtMS0xLTEtMjEzMzM5_2b127a5f-be25-4a48-b1d1-a8392d79d2d8">60,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzUtMy0xLTEtMjEzMzM5_a3c58fcc-7be1-4ece-8bff-7ba0398224e7">74,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_130"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzU2OA_b1784998-4c9b-4af4-9029-d079a46adf95" continuedAt="ia0f61a4c08c645b0be06a2170cae7022" escape="true">Earnings (Loss) per Share</ix:nonNumeric></span></div><ix:continuation id="ia0f61a4c08c645b0be06a2170cae7022" continuedAt="i315ea7edd7524302a7346a870ca36b4f"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzU2OQ_9399c58f-4d4f-4898-99d6-d2000b123b48" continuedAt="ie5723feeb15d47b5851633056f86de34" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continued and discontinued operations are calculated as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic loss per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations attributable to the shareholders of Cronos&#160;Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzMtMS0xLTEtMjI0MjYy_99360930-6fe5-49bb-860c-779025929d92">168,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzMtMy0xLTEtMjI0MjYy_9789724b-1894-4782-8c5b-03ddd187424c">395,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzMtNS0xLTEtMjI0MjYy_b31df59b-a27f-4d59-ab98-8e0dbf74132b">72,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding for computation for basic earnings per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzQtMS0xLTEtMjI0MjYy_6f7894de-3d6e-4e5f-bc29-868510616113">376,961,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzQtMy0xLTEtMjI0MjYy_70615d53-fc2b-497f-af93-fabb0a0ce95e">370,390,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzQtNS0xLTEtMjI0MjYy_3f3dad1f-a161-47e7-b9b1-b6fc6dcd3e29">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzUtMS0xLTEtMjQ3NTA5_4f258b40-aede-415e-8fce-10a61f7d3aba">0.45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzUtMy0xLTEtMjQ3NTA5_ba89d22a-56c2-46b1-b17b-fdd2a1079f46">1.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzUtNS0xLTEtMjQ3NTA5_3797d5c5-ceb7-43d5-838c-66c8e48e2604">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzctMS0xLTEtMjI0MzAx_e60eaf35-5315-4fc6-984f-d58902615488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzctMy0xLTEtMjI0MzAx_13f157c9-16eb-4399-ba08-d109fece94f3">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzctNS0xLTEtMjI0MzAx_bfbb8c14-6ac0-4d25-82b0-c636572a9dfe">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding from computation for basic earnings per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzgtMS0xLTEtMjI0MzAx_2e67e741-5db8-41fa-be2e-29e8b7f7479b">376,961,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzgtMy0xLTEtMjI0MzAx_75d88107-e3fd-4500-9447-c58cbd00a08b">370,390,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzgtNS0xLTEtMjI0MzAx_27817499-018f-4b92-9f98-6acc327505b8">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzktMS0xLTEtMjQ3NTA5_7469f799-b1fe-41c6-8b37-7e2f0927f4a2">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzktMy0xLTEtMjQ3NTA5_d07c5979-56ff-473c-ad4e-c552d5fb8787">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzktNS0xLTEtMjQ3NTA5_a9f08662-ba32-436f-b0d9-f8c6790f5929">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i315ea7edd7524302a7346a870ca36b4f"><ix:continuation id="ie5723feeb15d47b5851633056f86de34"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted loss per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss used in the computation of basic loss from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzExLTEtMS0xLTIyNDU1NQ_cb9fa6c4-8af7-48cd-b353-d7ab9e3a2b0f">168,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzExLTMtMS0xLTIyNDU1NQ_9a6d820b-90d6-4571-ad16-989aab58090c">395,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzExLTUtMS0xLTIyNDU1NQ_1ba4db8a-ec59-4947-851d-ba1cd38f51e9">72,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for exercise of rights on derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:DilutiveSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEyLTEtMS0xLTIyNDU1NQ_3545e307-0575-406a-a86d-9ece4a89035b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:DilutiveSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEyLTMtMS0xLTIyNDU1NQ_9cba970d-8d45-4fba-963d-3614dfce8f7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" name="us-gaap:DilutiveSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEyLTUtMS0xLTIyNDU1NQ_3a3ccd41-6e3e-42ba-9dba-1c78bb7afe17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss used in the computation of diluted loss from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEzLTEtMS0xLTI0NzUxMw_ddb51591-3a57-4335-a50f-fd44fdc44913">168,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEzLTMtMS0xLTI0NzUxMw_4b143ce1-af1c-47e6-af31-022433adc1cc">395,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEzLTUtMS0xLTI0NzUxMw_debe95bf-047a-4806-8d1e-a2708489e4b4">72,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding used in the computation of basic loss per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE1LTEtMS0xLTIyNDU2OA_d6043886-4ef8-45f8-b661-c45d95daae9e">376,961,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE1LTMtMS0xLTIyNDU2OA_aab94936-e174-4d02-97af-f90a9a9dfa32">370,390,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE1LTUtMS0xLTIyNDU2OA_6b1a9575-193e-46fa-a724-94454f1b59e8">351,576,848</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20c9a2151d6f4e979229b7d30b202741_D20220101-20221231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE3LTEtMS0xLTIyNDU2OA_6be79407-f408-469d-b3fd-16f5dfeb0ffe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i831f4a43963e485884c99ebee4119ee1_D20210101-20211231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE3LTMtMS0xLTIyNDU2OA_2f1ca7dc-14fb-480a-ab24-8c050d723992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d869fdefbad4a6daafa64f95ebfe973_D20200101-20201231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE3LTUtMS0xLTIyNDU2OA_04a42e2c-a37f-4e3d-a0e7-00f70522aa1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE4LTEtMS0xLTIyNDU2OA_6c9fa165-bd15-4936-a078-88de6a33c970">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE4LTMtMS0xLTIyNDU2OA_e20eb1b1-bd4e-47af-a2e1-06c742e41b96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf758d42193e47efa6985fa375da7738_D20200101-20201231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE4LTUtMS0xLTIyNDU2OA_a7f2237d-5d4a-425e-a68f-b5fa3f099f6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of Altria Warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE5LTEtMS0xLTIyNDU2OA_f78c161c-d3f3-4de2-b774-21161ff62716">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE5LTMtMS0xLTIyNDU2OA_bf32ea10-b325-4457-8bcb-0ae1544e9786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d0a16223e8748fca5daa5a5b730a11e_D20200101-20201231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE5LTUtMS0xLTIyNDU2OA_1e5d49f2-92d1-4866-a312-b650fc7ac741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Top-up Rights &#8211; market price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIwLTEtMS0xLTIyNDU2OA_7cb8b8c7-9cb0-48c4-b918-9cc3f6cdec3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIwLTMtMS0xLTIyNDU2OA_b6d08ace-e038-4842-8059-ec7627962802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIwLTUtMS0xLTIyNDU2OA_ca44ab58-f064-4de8-946c-867bbf957f71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares for computation of diluted loss from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIxLTEtMS0xLTI0NzUxMw_6693f967-eeea-498a-9853-b8a7759372ca">376,961,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIxLTMtMS0xLTI0NzUxMw_1b1f6262-cd88-4923-a85a-debdf8a695e5">370,390,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIxLTUtMS0xLTI0NzUxMw_8bb69bbd-c47d-45cc-b832-695e9f47e611">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted loss per share from continuing operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIyLTEtMS0xLTI0NzUxMw_51de2f7f-bdc4-4a22-8226-0894ad144d6a">0.45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIyLTMtMS0xLTI0NzUxMw_32beae1b-ab5a-4041-9ff3-914495336463">1.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIyLTUtMS0xLTI0NzUxMw_075a7858-8d40-45ad-82cc-6a7d91afb640">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI0LTEtMS0xLTIyNDYxNw_55d2c1a8-05b6-4b64-96b6-ff8590503883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI0LTMtMS0xLTIyNDYxNw_e8d780e6-9473-491f-aef8-2426b194ca74">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI0LTUtMS0xLTIyNDYxNw_4c74e983-4542-4d7a-a265-b24dd23a3981">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares for computation of diluted loss from discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI1LTEtMS0xLTIyNDYyNQ_32cb0187-e62a-40cf-afc5-9137d2795790">376,961,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI1LTMtMS0xLTIyNDYyNQ_39bb8b93-d19b-42c4-907c-9ae11b88452e">370,390,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI1LTUtMS0xLTIyNDYyNQ_aa6d87b4-5eea-4c08-a150-e5e0eae0620c">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted loss from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI2LTEtMS0xLTI0NzUxMw_2991db0b-249a-4772-8664-7b8732cbadd1">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI2LTMtMS0xLTI0NzUxMw_fc696e70-f65e-48b5-89c1-1b7f52c0b38b">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI2LTUtMS0xLTI0NzUxMw_83d17768-1530-4a95-9277-5e40004b36db">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total securities of <ix:nonFraction unitRef="shares" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzM3Ng_720dd82c-cbfa-4acc-a911-0818ce84ec9f">112,612,579</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzM4MA_42c36f6e-7c7a-4ce0-895b-74447fa5f1e5">125,195,001</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzM4Nw_3a435032-c5e8-483c-b0a9-c7827d315287">151,338,762</ix:nonFraction> were not included in the computation of diluted shares outstanding for the years ended December 31, 2022, 2021 and 2020, respectively, because the effect would be anti-dilutive.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_133"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2Xzk4NTM_e4f525a4-c9e9-454b-b667-0acc2a9a5cd2" continuedAt="i590d7ec947cd43718a482d4248adb717" escape="true">Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i590d7ec947cd43718a482d4248adb717" continuedAt="i8d11571697f44fd59c318329a5eb2bf9"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Fair value measurement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with ASC 820 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i8d11571697f44fd59c318329a5eb2bf9" continuedAt="i5bb83613c4924368ae71657352e460e0"><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2Xzk4NTQ_05cab89c-ad0d-47f7-8049-fa970a457b7c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397a3256afd747d8b6924425b8505d5b_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzItMS0xLTEtMjEzMzM5_4badb3eb-5146-401e-b497-cb98f580af61">764,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e32c5a6a41470eb8b3053295eb1e32_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzItMy0xLTEtMjEzMzM5_7c93c623-f7bb-45b1-a52e-9d1061bbce06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzItNS0xLTEtMjEzMzM5_16a955bf-2934-4881-870e-69451eaa9376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95fa6c13bfb4c45adb4622b1026b433_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzItNy0xLTEtMjEzMzM5_5c2ee593-24c0-434e-9fd7-47a5a5355eee">764,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397a3256afd747d8b6924425b8505d5b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzMtMS0xLTEtMjEzMzM5_0928d0cd-5d58-42e7-9b09-d9db2fbf2de1">113,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e32c5a6a41470eb8b3053295eb1e32_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzMtMy0xLTEtMjEzMzM5_e8d46ee2-26fe-41eb-898c-b6c1947ae2b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzMtNS0xLTEtMjEzMzM5_c600f473-74c6-4864-84c2-00a1ac7841f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95fa6c13bfb4c45adb4622b1026b433_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzMtNy0xLTEtMjEzMzM5_37bad884-4417-4200-8291-eb9c0ca8ef44">113,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397a3256afd747d8b6924425b8505d5b_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzQtMS0xLTEtMjEzMzM5_baa2eff0-19ed-4c97-b9a1-3e4e4510bb81">21,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e32c5a6a41470eb8b3053295eb1e32_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzQtMy0xLTEtMjEzMzM5_b21f0656-e915-4f8e-89ea-39d4b964208b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzQtNS0xLTEtMjEzMzM5_58bc2e04-2209-4b76-8d76-0b20f18684b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95fa6c13bfb4c45adb4622b1026b433_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzQtNy0xLTEtMjEzMzM5_11a83db1-538a-4d02-b325-b10a654d1772">21,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397a3256afd747d8b6924425b8505d5b_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzUtMS0xLTEtMjEzMzM5_44008373-1e25-48fa-9935-588951cf2cdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e32c5a6a41470eb8b3053295eb1e32_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzUtMy0xLTEtMjEzMzM5_eaec61ae-6f09-4803-bb72-15fcb40fdab6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzUtNS0xLTEtMjEzMzM5_4be32524-8b9d-428c-afb8-a9114a2c2c38">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95fa6c13bfb4c45adb4622b1026b433_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzUtNy0xLTEtMjEzMzM5_b6fbde3b-dec3-45ff-8d5e-946c384d491c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb28843c408441191244b00e0e9c9c9_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzItMS0xLTEtMjEzMzM5_c20ed3d8-478a-43b3-a2f1-38fb87020c54">886,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7178462e779b4050b4f4f598cd80ef6d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzItMy0xLTEtMjEzMzM5_e2e5fe3e-e819-4a3d-8f16-584da8359eba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578a803e2dfe4a57855a55c6ddd450a6_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzItNS0xLTEtMjEzMzM5_5c5d56e2-c825-435e-8f98-7707b416dda8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27823bddabff46fa96994e20b95dfdaa_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzItNy0xLTEtMjEzMzM5_0d10dc2d-7fb7-45b8-b502-8ccb5e453c59">886,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb28843c408441191244b00e0e9c9c9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzMtMS0xLTEtMjEzMzM5_aa6c245c-0e25-4c32-a175-a7e0a34accc7">117,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7178462e779b4050b4f4f598cd80ef6d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzMtMy0xLTEtMjEzMzM5_ebbc4ffd-dec9-4a8a-a9d7-ba5d3c002d6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578a803e2dfe4a57855a55c6ddd450a6_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzMtNS0xLTEtMjEzMzM5_ba16b67b-1a10-4190-9989-e38adf1ae576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27823bddabff46fa96994e20b95dfdaa_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzMtNy0xLTEtMjEzMzM5_3c3fec5b-7320-41bd-8f9b-0d956c4352be">117,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb28843c408441191244b00e0e9c9c9_I20211231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtMS0xLTEtMjI2MzMy_8b37bfef-5313-4b7c-bfe5-c81e1d48a7c4">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7178462e779b4050b4f4f598cd80ef6d_I20211231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtMy0xLTEtMjI2Mzk5_c77b2b7c-043b-4f3a-8da4-612ee0d384c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578a803e2dfe4a57855a55c6ddd450a6_I20211231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtNS0xLTEtMjI2NDAy_53f38faf-019e-47a3-a47c-0368130df311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27823bddabff46fa96994e20b95dfdaa_I20211231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtNy0xLTEtMjQ3NTM4_48df2d61-d5f0-4eb7-8d5c-76f9a7adf9c1">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb28843c408441191244b00e0e9c9c9_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtMS0xLTEtMjEzMzM5_a999b5c0-a86a-44e0-b1b1-122cd306224b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7178462e779b4050b4f4f598cd80ef6d_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtMy0xLTEtMjEzMzM5_56ca1738-13b4-45e0-9d30-05f92908f19d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578a803e2dfe4a57855a55c6ddd450a6_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtNS0xLTEtMjEzMzM5_06965bc5-8ee4-49b1-bf2f-ee6a50a35624">14,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27823bddabff46fa96994e20b95dfdaa_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtNy0xLTEtMjEzMzM5_aa79835f-dcfe-4903-9223-b2ca948f85cb">14,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt">On December 16, 2021, Cronos Australia (now, Vitura) closed their merger agreement to acquire CDA Health Pty Ltd, an Australian medicinal cannabis company. In connection with the closing of the Cronos Australia Merger, the Company&#8217;s ownership interest in Cronos Australia decreased to approximately <ix:nonFraction unitRef="number" contextRef="i3e0794b671294cf4a1a592fd95ab0288_I20211216" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2MzkxMjk_d96a148e-71cf-4c83-a3d5-dd90184bf2fe">10</ix:nonFraction>% and the Company&#8217;s number of Cronos Australia board seats was reduced from <ix:nonFraction unitRef="seat" contextRef="if46b21ab0b3b47ce84759033415e34a3_I20211215" decimals="INF" name="cron:NumberOfSeatsOnBoardOfDirectors" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE4NjkxNjk3Njg0MDUx_2fcde515-e4d5-4bfe-ab3e-20c89c4df883">two</ix:nonFraction> to <ix:nonFraction unitRef="seat" contextRef="i3e0794b671294cf4a1a592fd95ab0288_I20211216" decimals="INF" name="cron:NumberOfSeatsOnBoardOfDirectors" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE4NjkxNjk3Njg0MDUy_d289ece0-95df-4393-92a7-2e8dfcd02320">zero</ix:nonFraction> which constituted a loss of significant influence. As such, the Company reclassified the investment from an investment in equity method investments under the equity method of accounting to other investments under the fair value method of accounting. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between fair value categories during the periods presented.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE0ODQzNDA2OTg3MTU4_d3a1db9d-ba74-4a48-99c8-7aff2231a096" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a non-recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db994827904092be31ae9e5e8445bc_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTpiMzJlZjg1YmVjYWY0NGYwYmE5MzNmYmY4YTJkZDkyOC90YWJsZXJhbmdlOmIzMmVmODViZWNhZjQ0ZjBiYTkzM2ZiZjhhMmRkOTI4XzQtMS0xLTEtMjQ3Njky_68defd6a-99cf-4eb0-8872-dd3448aca1e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i311fa3bfafef494e85ad86818daa0cdc_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTpiMzJlZjg1YmVjYWY0NGYwYmE5MzNmYmY4YTJkZDkyOC90YWJsZXJhbmdlOmIzMmVmODViZWNhZjQ0ZjBiYTkzM2ZiZjhhMmRkOTI4XzQtMy0xLTEtMjQ3Njky_e2f22264-3cde-4dd4-8b71-c04f390baab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d176a72c724664bab57f3928bc0916_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTpiMzJlZjg1YmVjYWY0NGYwYmE5MzNmYmY4YTJkZDkyOC90YWJsZXJhbmdlOmIzMmVmODViZWNhZjQ0ZjBiYTkzM2ZiZjhhMmRkOTI4XzQtNS0xLTEtMjQ3Njky_124c13ac-0e6e-404e-8375-9fddcdcda68b">49,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4548315c1d4631b6983f6d50ea8397_I20221231" decimals="-3" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTpiMzJlZjg1YmVjYWY0NGYwYmE5MzNmYmY4YTJkZDkyOC90YWJsZXJhbmdlOmIzMmVmODViZWNhZjQ0ZjBiYTkzM2ZiZjhhMmRkOTI4XzItNy0xLTEtMjQ5NTEx_74febe16-58ec-4feb-9231-9af568eba878">49,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt">On June 14, 2021, the Company purchased an option to acquire <ix:nonFraction unitRef="shares" contextRef="i7a6151bf97b4479db1915de9cf54196a_D20210614-20210614" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDI0ODA_42a317ac-a2b4-4971-9901-0d1bb9352571">473,787</ix:nonFraction> shares of Class A Common Stock of PharmaCann, a vertically integrated cannabis company in the United States, at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ica770eae2c9246a2afe81a80ce6bc6ec_I20210614" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDI2Mzg_dfdf1135-fac5-4758-8555-40b37f34b9d1">0.0001</ix:nonFraction> per share, representing approximately <ix:nonFraction unitRef="number" contextRef="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614" decimals="3" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDI2ODA_f1a78c01-315c-4b83-88f9-524b6fffe193">10.5</ix:nonFraction>% of PharmaCann&#8217;s issued and outstanding capital stock on a fully diluted basis as of the date of the PharmaCann Option, for an aggregate purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDI4NTI_d13d4645-0021-45f0-8787-47c4967deb44">110,392</ix:nonFraction>. On February 28, 2022, PharmaCann closed its previously announced transaction with LivWell pursuant to which PharmaCann acquired LivWell. LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately <ix:nonFraction unitRef="number" contextRef="i55bbd96bb4154fef93d9f031c4651fa9_I20220228" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDM3MjY_27bc860b-ec00-4cf7-b339-cc25aae9ea7a">6.4</ix:nonFraction>%. As of December 31, 2022, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis was approximately <ix:nonFraction unitRef="number" contextRef="i3306701595a04451b85d16301150c1ee_I20221231" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDM4NDg_8954e235-22c4-42e3-b68c-ac86ffc24f2d">6.3</ix:nonFraction>%. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between fair value categories during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Financial risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities expose it to a variety of financial risks, including credit risk, liquidity risk, market risk, interest rate risk, and foreign currency rate risk.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short term investments, loans receivable, and advances to joint ventures. The Company&#8217;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTE5Njc_927ba784-bfb2-4f93-93cd-571667e6f318">987,442</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTE5ODY_e5b98ae5-4b08-4968-8527-743c1b5a8d9c">1,118,684</ix:nonFraction> as of December&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i5bb83613c4924368ae71657352e460e0" continuedAt="id400c70b0cb643adb2cb039de29abc76"><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.57pt">Accounts receivable</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIwMzM_40100210-eb67-4637-b7f0-a9c477c3ea12">23,113</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIwMjg_50859fe4-2a19-46ca-8308-6eb1658008bb">22,067</ix:nonFraction> as of December&#160;31, 2022 and December&#160;31, 2021, respectively. An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than <ix:nonNumeric contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" name="us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM0MDg_fc51078a-f408-4047-9425-dfb81d1bd6f3">120</ix:nonNumeric> days past due. As of December&#160;31, 2022, 2021 and 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i9fc469d3cfaa48f9808a8fd424589cd6_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTMxMDk_a06634be-a145-4052-b512-93415b0962d1">2</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i251c1f541a4743728ff8c8cd8aad5a51_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTMxMTI_db17dbb8-ef0a-45f1-ba93-683e35db17b5">8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i483292d9892e405c9fd41c2bc7fe6a89_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzIxOTkwMjMyNjcwMTE_857038d6-30d6-4db4-8f74-412046ce86ce">9</ix:nonFraction>, respectively, in expected credit losses on receivables from contracts with customers in the ROW segment and $<ix:nonFraction unitRef="usd" contextRef="i3e29abb1c1a64038b0402ae05946449a_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk0NTA_77c6cc71-52b4-4e7d-bbe5-619d19938ade">217</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ic58ad37f674b4bf1a74ec35c6f4e405c_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk0NTg_21cf1034-e85a-417a-bfff-255e89f83c54">104</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5241cf1c2d3d48c6829684e7a67b759a_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk0NjQ_d82458f9-fec1-4688-93b3-4a635e34daa0">65</ix:nonFraction>, respectively, in expected credit losses on receivables from contracts with customers in the U.S. segment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company has assessed that there is a concentration of credit risk as <ix:nonFraction unitRef="number" contextRef="id544276629be4ca58e468c96a96b58ff_D20220101-20221231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxMjU_8c3e3645-e54e-4499-8a0b-7782b9a96830">55</ix:nonFraction>% of the Company&#8217;s accounts receivable were due from three customers with an established credit history with the Company. As of December&#160;31, 2021, <ix:nonFraction unitRef="number" contextRef="i7cbf0d27e1024f2585bc6bbba3a9248a_D20210101-20211231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxMzE_42917971-a4da-419b-b401-bc7f54577985">88</ix:nonFraction>% of the Company&#8217;s accounts receivable were due from four customers with an established credit history with the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#8217;s revenues. During the year ended December&#160;31, 2022, the Company earned a total net revenue before excise taxes of $<ix:nonFraction unitRef="usd" contextRef="ib624948ee4414abca5cf322e8938b6b9_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxMzU_5344c47c-62a7-4dd8-8831-c240d74b2a1b">63,509</ix:nonFraction> from three major customers in the ROW segment, together accounting for <ix:nonFraction unitRef="number" contextRef="ia8cc4bddc3834a28956294a993ffb1bd_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxNTA_812c19f5-7d7b-44bf-b0ed-2179c178cdeb">55</ix:nonFraction>% of the Company&#8217;s total net revenue before excise taxes. During the year ended December&#160;31, 2021, the ROW segment earned a total net revenue before excise taxes of $<ix:nonFraction unitRef="usd" contextRef="i318dd49f5d5f4baf9c5d2dbbd7dae763_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxNTQ_521b98cf-bec4-4693-934a-e4c00a6f4d4c">41,603</ix:nonFraction> from three major customers, together accounting for <ix:nonFraction unitRef="number" contextRef="i318dd49f5d5f4baf9c5d2dbbd7dae763_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxOTQ_fafc76ad-b1a9-4b60-9377-2e347f1be84e">56</ix:nonFraction>% of the Company&#8217;s total net revenue before excise taxes. During the year ended December&#160;31, 2020, the ROW segment earned a total net revenue before excise taxes of $<ix:nonFraction unitRef="usd" contextRef="i852bd7bd8fed4a99a245288e27159105_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxOTg_48f62428-bf89-462a-81a9-4041fc8d99ed">34,295</ix:nonFraction> from four major customers, accounting for <ix:nonFraction unitRef="number" contextRef="i3e6e844f23174cafad959fff0262ccd2_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyMDg_27b873a6-a22d-4f56-ac57-b79f1e787d33">63</ix:nonFraction>% of the Company&#8217;s total net revenues before excise taxes. During the years ended December&#160;31, 2022, 2021, and 2020 the U.S. segment had no major customers. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.8pt"> Cash and cash equivalents, short-term investments, and other receivables</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyMzA_efce5304-9cc2-42cd-92b9-0c74b4bf3df8">764,644</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyMzQ_5594a819-9285-4897-9331-88564e3e7717">886,973</ix:nonFraction> as of December&#160;31, 2022 and December&#160;31, 2021, respectively. The short-term investments and related interest receivable of $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyNjk_6563d078-31de-420e-a139-23e84f55e905">113,077</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyNzQ_bcbff856-917f-489b-a867-83118da5bbaf">117,684</ix:nonFraction> as of December&#160;31, 2022 and December&#160;31, 2021, respectively, represent short-term investments with a maturity of less than a year and accrued interest. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#8217; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#8217;s accounts payable. The Company had trade accounts payable of $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIzMDk_04b9b5b9-2fe9-476c-bd73-e66a9efa727f">8,599</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIzMDU_0f721e56-c46c-4e9e-9ab0-5d081f9f14df">8,395</ix:nonFraction> as of December&#160;31, 2022 and December&#160;31, 2021, respectively, included in accounts payable on the consolidated balance sheet. The Company&#8217;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#8217;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#8217;s funding has primarily been provided in the form of capital raised through the issuance of common shares and warrants. As of December&#160;31, 2022, the Company has assessed a concentration of risk of vendors as <ix:nonFraction unitRef="number" contextRef="i0cfb8a95516c46b7ab49a044801b97ed_D20220101-20221231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIzMzk_f5548a92-4b8a-4f76-9649-a9c7fd49209d">27</ix:nonFraction>% of accounts payable were due to one vendor. As of December&#160;31, 2021, the Company has assessed a concentration risk of vendors as <ix:nonFraction unitRef="number" contextRef="iddf4e03c7d9e40fa8a934f29b9d13609_D20210101-20211231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIzNDQ_1b130608-79a3-4507-a969-f8ecbe624a38">19</ix:nonFraction>% of accounts payable due to one vendor.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that unfavorable market conditions could result in dispositions of investments at less than their carrying amounts. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#8217;s investments, which would have an adverse impact on the Company&#8217;s results of operations, unless these would flow through other comprehensive income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages risk by having a portfolio of securities from multiple issuers, such that the Company was not materially exposed to any one issuer. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="id400c70b0cb643adb2cb039de29abc76"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those that possess a short term to maturity. A 10% change in the interest rate in effect on December&#160;31, 2022 and December&#160;31, 2021, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#8217;s investment strategy as a result.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company had net interest income of $<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzU0OTc1NTgyNTM2Ng_661f93d3-64f1-45c7-8cf5-ce029f1a75f1">22,537</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2Xzg1MjY_6b1ffd25-78b0-48f1-81be-c99796800979">9,071</ix:nonFraction>, respectively. During the year ended December&#160;31, 2022, the Company&#8217;s average variable interest rate increased approximately <ix:nonFraction unitRef="number" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="INF" name="cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM4NDgyOTA3MDg4Nzk_81082e04-e467-4e75-9534-c4017373a482">3.5</ix:nonFraction>%. During the year ended December&#160;31, 2021, the Company&#8217;s average variable interest rate did not change materially.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency risk </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on investments in equity investments denominated in A$ and C$, and other assets and liabilities denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#8217;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#8217;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and December&#160;31, 2021, the Company had foreign currency gain (loss) on translation of $(<ix:nonFraction unitRef="usd" contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk2MDg_f2d15d65-5c22-4962-835d-10842daeb51f">50,616</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk2MTQ_f0655670-cd0d-444d-8324-79205fd41550">8,192</ix:nonFraction>, respectively. A 10% change in the exchange rates for the foreign currencies would affect the carrying amounts of net assets by approximately $<ix:nonFraction unitRef="usd" contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231" decimals="-3" name="cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM4NDgyOTA3MDg4MTc_561d086e-1b02-468b-9d63-6d60adf5c09b">77,414</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM4NDgyOTA3MDg4MjM_88c4888b-543f-4afa-a8ac-1fd988c4b322"><ix:nonFraction unitRef="usd" contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231" decimals="-3" name="cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM4NDgyOTA3MDg4MjM_e4d59a64-182f-4bac-a828-fa7dbe103023">87,705</ix:nonFraction></ix:nonFraction> as of December&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_136"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE0Nzg_d3914e7a-5812-4f52-a838-59856fa1c4bb" continuedAt="i41c9e8e3c2c14f39adf6e5f95499a493" escape="true">Related Party Transactions </ix:nonNumeric></span></div><ix:continuation id="i41c9e8e3c2c14f39adf6e5f95499a493" continuedAt="i0f4831e9e2f642c08aa2a6058df7e38b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Altria</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a <ix:nonFraction unitRef="number" contextRef="i61396ac601174186a618ab85deae5ee4_I20190308" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE1MQ_b25c954d-7a9d-4a09-a045-0f8ffd0d911b">45</ix:nonFraction>% equity interest in the Company. As of December 31, 2022, Altria beneficially held an approximately <ix:nonFraction unitRef="number" contextRef="ie7edb25988ef4ca680ec0519a1f7a41c_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzI1Mw_d71977f8-2c90-46da-8f1f-36f692227a05">41</ix:nonFraction>% ownership interest in the Company (calculated on a non-diluted basis).</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE0Nzk_aed802c2-55fc-4565-b4d8-73afa93842f0" continuedAt="ibf1ad89753e34c2fab46229490e4565d" escape="true"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#8220;Altria Pinnacle&#8221;):</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0e0dbaf50b44ab84666bd8bc9badcc_D20220101-20221231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkZDU0MzYyZjM2NWY0NGMyOWE2ZjBjMjEwYTIwOTQxNC90YWJsZXJhbmdlOmRkNTQzNjJmMzY1ZjQ0YzI5YTZmMGMyMTBhMjA5NDE0XzItMS0xLTEtMjEzMzM5_1b8ca1f6-d88d-40f1-a1ca-3fd9a9519bfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc524b86dcf94566bb86a2e924b61bb3_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkZDU0MzYyZjM2NWY0NGMyOWE2ZjBjMjEwYTIwOTQxNC90YWJsZXJhbmdlOmRkNTQzNjJmMzY1ZjQ0YzI5YTZmMGMyMTBhMjA5NDE0XzItMy0xLTEtMjEzMzM5_b3b0e202-14a2-4ac2-b656-6081085df2e1">436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d746ad8f524e279e4e4da9248e3e2a_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkZDU0MzYyZjM2NWY0NGMyOWE2ZjBjMjEwYTIwOTQxNC90YWJsZXJhbmdlOmRkNTQzNjJmMzY1ZjQ0YzI5YTZmMGMyMTBhMjA5NDE0XzItNS0xLTEtMjEzMzM5_10a08de5-7582-4bda-b468-1ec3cec09aeb">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="ibcc1ba88d12745e29a44781b9cb2a6b2_I20211231" decimals="INF" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzY0OQ_b6b22fdd-9f0f-46b0-96df-8a38a1e1411b"><ix:nonFraction unitRef="usd" contextRef="i7c47520415b84aa69148a3dd6909c4a3_I20221231" decimals="INF" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzY0OQ_c69c5ade-64a5-45e8-b86e-f8ba1f2ac85e">no</ix:nonFraction></ix:nonFraction> amounts payable related to the consulting services with Altria Pinnacle as of December 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 8 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for further information on the derivative liabilities related to the Altria Investment.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><ix:continuation id="i0f4831e9e2f642c08aa2a6058df7e38b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Cronos GrowCo</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company holds a variable interest in Cronos GrowCo through its ownership of <ix:nonFraction unitRef="number" contextRef="ia965648dd525484799c2e977f7acaf53_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4Xzk1Nw_465dd7af-b178-4d01-87bb-68b49d8b368c">50</ix:nonFraction>% of Cronos GrowCo&#8217;s common shares and senior secured debt in Cronos GrowCo. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; for further discussion.</span></div><ix:continuation id="ibf1ad89753e34c2fab46229490e4565d"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company made the following purchases of cannabis products from Cronos GrowCo:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cronos GrowCo &#8211; purchases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec05a6d229d94475b72ce77d3e52909d_D20220101-20221231" decimals="-3" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkYWZhMTQwOTIwNmU0YzA2YTI5OThjZGNhODE3YThlZi90YWJsZXJhbmdlOmRhZmExNDA5MjA2ZTRjMDZhMjk5OGNkY2E4MTdhOGVmXzItMS0xLTEtMjEzMzM5_bc1f3631-5bca-412a-8bae-df75e5175f60">18,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib982510dffea40dca9be2c62f5c6ee7b_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkYWZhMTQwOTIwNmU0YzA2YTI5OThjZGNhODE3YThlZi90YWJsZXJhbmdlOmRhZmExNDA5MjA2ZTRjMDZhMjk5OGNkY2E4MTdhOGVmXzItMy0xLTEtMjEzMzM5_b928536d-8fa6-4580-a99a-7f9891d12107">4,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045cf7db853f4153bd9a03bb1868a622_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkYWZhMTQwOTIwNmU0YzA2YTI5OThjZGNhODE3YThlZi90YWJsZXJhbmdlOmRhZmExNDA5MjA2ZTRjMDZhMjk5OGNkY2E4MTdhOGVmXzItNS0xLTEtMjEzMzM5_8570ebfa-b819-48af-bc6f-1c068f273d85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s outstanding payable balance to Cronos GrowCo was $<ix:nonFraction unitRef="usd" contextRef="ida3f84386d9149eaa1274948ebe8ec5b_I20221231" decimals="-3" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE2NDkyNjc0NDM5MTQ_2a1dca06-0596-4e45-83e8-e577905b5081">2,519</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i46ed54be0f0b436d89417a7a22f3beae_I20211231" decimals="-3" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE2NDkyNjc0NDM5MTA_2be8720a-146d-45c8-abf0-8247ee1c8312">82</ix:nonFraction> as of December 31, 2022 and December 31, 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, on August 23, 2019, the Company, as lender, and Cronos GrowCo, as borrower, entered into the GrowCo Credit Facility. See additional information in Note 4 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Loans Receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:24.91pt">Vendor Agreement</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In November 2022, the Company entered into an agreement with an external vendor whereby the vendor would provide certain manufacturing services to the Company. The vendor then subcontracted out a portion of those services to another company whose chief executive officer is an immediate family member of an executive of the Company.  The Company has no direct contractual relationship with the related party.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During the year-ended 2022, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="id5a8cde9e54943859cd78bbde842143f_D20220101-20221231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzEwOTk1MTE2MzIzNDc_2ee57d84-1126-44d8-bdee-dd2acee9fca1">645</ix:nonFraction> of products and services under this agreement and had <ix:nonFraction unitRef="usd" contextRef="i92bdfdf7df22443d9e5a9d09d167facd_I20221231" decimals="INF" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE0ODQzNDA2OTc5NTYx_eff10150-1f4a-45c5-963f-e95b00f6a252">no</ix:nonFraction> outstanding accounts payable related to the agreement as of December 31, 2022.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_1990"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2022, 2021, and 2020</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_7">nts</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGV4dHJlZ2lvbjoxODAxYzFmM2JhNGU0NjBiYTdlNTZiZDM0MmQ0ZDVhZV8xODY5MTY5NzY3NzQ0Mw_8a31d279-bcf6-489f-8e20-b99a55d1687e" continuedAt="ibc7b7318394b4551a6981817df29aa41" escape="true">Restructuring</ix:nonNumeric></span></div><ix:continuation id="ibc7b7318394b4551a6981817df29aa41"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company initiated a strategic plan to realign the business around its brands, centralize functions and evaluate the Company&#8217;s supply chain (the &#8220;Realignment&#8221;). As part of the Realignment, on February 28, 2022, the Board approved plans to leverage the Company&#8217;s strategic partnerships to improve supply chain efficiencies and reduce manufacturing overhead by exiting its production facility in Stayner, Ontario, Canada (the &#8220;Peace Naturals Campus&#8221;). On February 27, 2023, the Board approved revisions to the Realignment, which are expected to result in the Company maintaining select components of its operations at the Peace Naturals Campus, namely distribution warehousing, certain R&amp;D activities and manufacturing of certain of the Company&#8217;s proprietary innovation products, while seeking to lease the remaining portions of the Peace Naturals Campus to third parties. The Realignment initiatives were intended to position the Company to drive profitable and sustainable growth over time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGV4dHJlZ2lvbjoxODAxYzFmM2JhNGU0NjBiYTdlNTZiZDM0MmQ0ZDVhZV8zODQ4MjkwNzAyMjk0_27a7a5b1-01f5-41a0-8f55-27bf9f5ab791">5,333</ix:nonFraction> of restructuring costs in connection with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. Charges related thereto include employee-related costs such as severance, relocation and other termination benefits, as well as contract termination and other related costs.</span></div><ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGV4dHJlZ2lvbjoxODAxYzFmM2JhNGU0NjBiYTdlNTZiZDM0MmQ0ZDVhZV8xODY5MTY5NzY3NzQ0NA_9a4ad5e5-2812-4d72-b9bf-c78c227b49e2" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following restructuring costs by reportable segment:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i650691423f5e4494934b0fa65dab6839_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF8yLTUtMS0xLTIzODg0Nw_cbafa08a-69e6-42fa-85ae-3593d9c02408">3,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8527b15bc047bdae7fdce3a2c33504_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF8yLTctMS0xLTIzODg0Nw_ef971f55-b6dc-4dee-a1da-b5c713cb8964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ca2cc174af48b58d8f18abbbdf825c_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF8zLTUtMS0xLTIzODg0Nw_f821117b-cf15-4db2-9d51-61e057ab5f3a">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1afdda86b9422f916cf73765514521_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF8zLTctMS0xLTIzODg0Nw_535e450b-e9d2-478c-8e96-8bc848378f49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF80LTUtMS0xLTIzODg0Nw_06e2aab7-eda8-447c-9a1d-f9e1ac0c2bc1">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8b6276b83842cc84cda8a4835b64c2_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF80LTctMS0xLTIzODg0Nw_c6309de2-98a8-4624-a257-0e9b2f8733f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restructuring activity for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:39.764%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments/Write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b09d8040b24c29ba9f2d7d4f684f30_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8xLTEtMS0xLTIzODg0Nw_118eb963-03b7-4897-9cf5-8730d874821b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545194e7a7b74577856d5bd7b228128c_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8xLTMtMS0xLTIzODg0Nw_4b847626-21d3-4866-a94b-ac69f46d1c53">3,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i545194e7a7b74577856d5bd7b228128c_D20220101-20221231" decimals="-3" name="cron:RestructuringReservePaymentsAndWriteoffs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8xLTUtMS0xLTIzODg0Nw_cb69f866-25f4-4efe-8eea-176cf5b230ab">3,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iade03f20736843e9b053a88f457f1fe8_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8xLTktMS0xLTIzODg0Nw_78b4b9a8-19f3-4d08-b0aa-185619182be3">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f994ee41e2c4a3d8727edc2735ef73d_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8zLTEtMS0xLTIzODg0Nw_38ff31c9-b644-45fe-8958-bbaf3818bddc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i034a94c610e3462d98907c2dcb109918_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8zLTMtMS0xLTIzODg0Nw_3981eac1-f841-4439-89e9-9e346a1f3971">1,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i034a94c610e3462d98907c2dcb109918_D20220101-20221231" decimals="-3" name="cron:RestructuringReservePaymentsAndWriteoffs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8zLTUtMS0xLTIzODg0Nw_3f054521-3a27-4c54-aad1-829859c38d92">1,641</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8955d83865472bb27bd4fb46bf1428_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8zLTktMS0xLTIzODg0Nw_3c77bbcb-7902-4b95-a535-885c0515f21b">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919ad19634e44f94b09180aaeb361f67_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV80LTEtMS0xLTIzODg0Nw_e7aeb1b2-25f3-4dd7-afbc-cc63afddc776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV80LTMtMS0xLTIzODg0Nw_6f964496-979c-42ad-9734-26bcde7fa585">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231" decimals="-3" name="cron:RestructuringReservePaymentsAndWriteoffs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV80LTUtMS0xLTIzODg0Nw_93fc8ba9-6def-4e48-aac9-4a1fb6f023cd">4,909</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6e48ecac9f43d98f834e8ae0047473_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV80LTktMS0xLTIzODg0Nw_0c955e79-398c-4fd7-9f84-2f0efa1079ff">424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_145"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xNDUvZnJhZzpkZmE1NTA2ZGMwOTY0ODc1YWUxYjJlZDc4OGJhZGU2NC90ZXh0cmVnaW9uOmRmYTU1MDZkYzA5NjQ4NzVhZTFiMmVkNzg4YmFkZTY0XzIwNDA_a3f84579-2646-4a55-a8ee-2df38c8a8605" continuedAt="i79a0f728e19a4c5b81be3e6537d41fbc" escape="true">Subsequent Events</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i79a0f728e19a4c5b81be3e6537d41fbc">In March 2022, following the evaluation of our global supply chain, we announced the planned exit of our Peace Naturals Campus as part of the Realignment. Given the constantly evolving operating landscape Cronos participates in and our continued work towards building an efficient global supply chain, we continue to remain agile in our evaluation of our footprint and the market&#8217;s capabilities. To that end, in February 2023, the Board approved plans to maintain select components of the Company&#8217;s operations at the Peace Naturals Campus, namely distribution and warehousing, certain R&amp;D activities and manufacturing of certain of the Company&#8217;s proprietary innovation products.</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_148"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_151"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Evaluation of Disclosure Controls and Procedures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, with the participation of the Chief Executive Officer and the Chief Financial Officer, performed an evaluation of the disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), as of December&#160;31, 2022. Based on that evaluation, management has concluded that, as of December&#160;31, 2022, due to the existence of a material weakness in the Company&#8217;s internal control over financial reporting described below, the disclosure controls and procedures were not effective to provide reasonable assurance that the information required to be disclosed by us in reports we file or submit under the Exchange Act were recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and to ensure that the information required to be disclosed by us in reports that we file or submit under the Exchange Act, is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for establishing and maintaining internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based upon criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2013) by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that evaluation, our management concluded that our internal control over financial reporting was not effective as of December 31, 2022 because of the material weakness described below.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not design and maintain effective controls over Information Technology General Controls (&#8220;ITGC&#8221;), pertaining to user access management and the provisioning and monitoring of user access, including privileged access. We believe this weakness to be the result of ineffective monitoring of security administrator activities, insufficient retention of documentation to support access requests and lack of training on the importance of ITGC. This material weakness did not impact any information derived from information systems and did not result in any identified misstatements to our financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm, KPMG LLP, who audited the consolidated financial statements included in this Annual Report, issued an adverse opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Changes in Internal Controls over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the material weakness identified above and measures described below to remediate the material weaknesses previously identified, there were no changes in the Company&#8217;s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), that occurred during the fourth quarter of the year ended December 31, 2022, that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remediation of Previously Reported</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Material Weaknesses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has implemented various initiatives to address the previously reported material weaknesses in internal control over financial reporting. During the fourth quarter of 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company successfully completed the testing necessary to conclude that the material weaknesses have been remediated. Some of our key remedial initiatives included:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Material Weakness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Control, Control Enhancement or Mitigant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Implementation Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Management Testing Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Remediation Status</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:57pt"><td colspan="3" rowspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Control Environment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Company&#8217;s Chief Executive Officer and Chief Financial Officer have reinforced and will continue to reinforce on an ongoing basis the importance of adherence to the Company&#8217;s policies, procedures and standards of conduct, including identifying misconduct and raising and communicating concerns;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:38pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">All accounting personnel that engaged in unprofessional conduct were terminated or resigned from the Company and were replaced with qualified personnel;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:50pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">We have enhanced our existing sub-certification process to include additional certifications regarding certain complex accounting topics and to include additional employees to increase accountability amongst Company personnel;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:38pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">We have expanded our compensation claw back provisions to incorporate all personnel who are subject to our enhanced sub-certification process;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:57pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">We have implemented organizational enhancements including (i) evaluation of the sufficiency, experience and training of personnel within our accounting function and (ii) the hiring of accounting personnel with appropriate knowledge and experience in U.S. GAAP;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:57pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">We have implemented a training program for accounting and finance personnel to enhance their knowledge of U.S. GAAP outlined in our accounting policies, which are used in the preparation of the Company&#8217;s consolidated financial statements; and</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairment Testing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">We have evaluated and will continue to regularly evaluate our policies and procedures relating to certain complex accounting topics and have implemented improvements in those policies and procedures.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the settlements with the SEC and the OSC related to the Restatements, the Company has retained a consultant to review and make recommendations with respect to certain of the Company&#8217;s internal controls and internal control over financial reporting. That review is ongoing and it is possible that review results in the identification of other material weaknesses or other control deficiencies that require material changes to the Company&#8217;s internal control over financial reporting. For additional information of this risk, see Item 1A &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors &#8211; Risks Relating to Our Growth Strategy &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have had two restatements and seven material weaknesses in our internal control over financial reporting over the last four years, and one material weakness remains unremediated at December 31, 2022. We had a material weakness in our control environment, and in 2021 and 2022, we experienced significant turnover, both voluntary and involuntary, in our accounting and financial reporting functions. If we are unable to remediate our existing material weakness and create an appropriate control environment, our business, results of operations, financial condition, cash flows and reputation will be adversely affected.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remediation Plan and Status Related to Material Weakness Identified in the Current Year</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed above, we have identified a material weakness related to ITGCs in user access management and the provisioning and monitoring of privileged access. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the filing date, the Company is in the process of implementing various initiatives intended to address the identified material weakness. In this regard, some of our key remedial initiatives include:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Material Weakness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Control, Control Enhancement or Mitigant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Implementation Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Management Testing Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:100%">Remediation Status</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="5" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITGCs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Train security administrators on access provisioning and approval protocols.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In Planning Stage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Align approval requirements for all privileged access for consistency and appropriate visibility within the IT function.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In Planning Stage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Implement a process to identify instances where privileged access roles or profiles are assigned and, when identified, review activities performed during the period of assigned privileged access.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In Planning Stage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Implement a periodic control to compare each user&#8217;s system access to their responsibilities.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In Planning Stage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Implement an oversight control over security administrator actions.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In Planning Stage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Remediated</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_154"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_157"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_229"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i228e12b34e804aa096affae69dd6b9af_232"></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:115%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_235"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_238"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_241"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div id="i228e12b34e804aa096affae69dd6b9af_244"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2022.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_247"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as part of this Annual Report on Form 10-K, or incorporated herein by reference:</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following financial statements of Cronos Group Inc. are filed as part of this Annual Report on Form 10-K on the pages indicated.</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CRONOS GROUP INC. AND SUBSIDIARIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reports of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_76">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheets as of December 31, 2022 and 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_82">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) for the years ended December 31, 2022, 2021, and 2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_85">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Changes in Shareholders&#8217; (Deficit) Equity for the years ended December 31, 2022, 2021, and 2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_88">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021, and 2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_91">80</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i228e12b34e804aa096affae69dd6b9af_94">82</a></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statement Schedules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Schedules are omitted because the required information is inapplicable, not material, or the information is presented in the consolidated financial statements or related notes.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The exhibits listed in the Exhibit Index immediately below are filed as part of this Annual Report on Form 10-K or are incorporated by reference herein.</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Description </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647221000075/ex21to8k.htm">Options Purchase Agreement, dated June 14, 2021, by and between Cronos USA Holdings Inc. and PharmaCann Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K of Cronos Group Inc. filed June 15, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647221000075/ex22to8k.htm">Option, dated June 14, 2021, issued by PharmaCann Inc. to Cronos USA Holdings Inc. (incorporated by reference to Exhibit 2.2 to the Current Report on Form 8-K of Cronos Group Inc. filed June 15, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518216185/d278879dex41.htm">Certificate of Continuance, Notice of Articles and Articles of Cronos Group Inc. (incorporated by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a41.htm">Form of Cronos Group Inc. Common Share certificate (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit42-descriptionofcap.htm">Description of Capital Stock of Cronos Group Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit42-descriptionofcap.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit42-descriptionofcap.htm">(incorporated by reference to Exhibit 4.2 to the Annual Report on Form 10-K of Cronos Group I</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit42-descriptionofcap.htm">nc., filed March 1, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518345276/d671304dex991.htm">Subscription Agreement, dated as of December 7, 2018, by and among Cronos Group Inc., Altria Summit LLC, and, solely for the purposes specified therein, Altria Group, Inc. (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report of Foreign Private Issuer, filed December 10, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312519076836/d690389dex991.htm">Investor Rights Agreement, dated as of March 8, 2019, by and between Cronos Group Inc. and Altria Group, Inc. (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report of Foreign Private Issuer, filed March 15, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518265476/d618057dex993.htm">Collaboration and License Agreement, dated as of September 1, 2018, by and between Cronos Group Inc. and Ginkgo Bioworks, Inc. (incorporated by reference to Exhibit 99.3 to the Company&#8217;s Current Report of Foreign Private Issuer, filed September 4, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a104.htm">First Amendment to Collaboration and License Agreement, dated as of May 9, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647221000063/ex101finalagr.htm">Amended and Restated Collaboration and License Agreement, dated as of June 3, 2021, by and between Ginkgo Bioworks, Inc. and Cronos Group Inc. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Cronos Group Inc. filed June 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518216185/d278879dex43.htm">Cronos Group Inc. 2015 Amended and Restated Stock Option Plan, dated as of May 26, 2015 (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-8 of Cronos Group Inc., filed July 11, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a106.htm">Form of Option Certificate to 2015 Amended and Restated Stock Option Plan (incorporated by reference to Exhibit 10.6 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a107.htm">First Amendment to the Cronos Group Inc. 2015 Amended and Restated Stock Option Plan, dated as of August 7, 2019 (incorporated by reference to Exhibit 10.7 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a108.htm">Cronos Group Inc. Amended and Restated 2018 Stock Option Plan, dated as of November 11, 2019 (incorporated by reference to Exhibit 10.8 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a109.htm">Cronos Group Inc. Deferred Shared Unit Plan for Non-Executive Directors, dated as of August 7, 2019 (incorporated by reference to the Exhibit 10.9 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1010.htm">Employment Agreement, by and between Cronos Group Inc. (Employment Agreement, by and between Cronos Group Inc. (f/k/a PharmaCann Capital Corporation) and Michael Gorenstein, effective as of August 10, 2016 (incorporated by reference to Exhibit 10.10 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1011.htm">Description of Oral Amendment, effective as of June 2019, to Employment Agreement, by and between Cronos Group Inc. (f/k/a PharmaCann Capital Corporation) and Michael Gorenstein, effective as of August 10, 2016 (incorporated by reference to Exhibit 10.11 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1021.htm">Cronos Group Inc. Employment Inducement Award Plan #1 (incorporated by reference to Exhibit 10.21 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1024.htm">Form of Director and Officer Indemnity Agreement (incorporated by reference to Exhibit 10.24 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000073/ex101omnibusplan1.htm">Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000073/a102rsuawardagreement.htm">Form of Restricted Share Unit Award Agreement to Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000073/a103rsuawardagreementi.htm">Form of Restricted Share Unit Award Agreement (Israel) to Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000079/exhibit101.htm">Executive Employment Agreement, dated as of September 9, 2020, by and among Cronos USA Client Services LLC, Cronos Group Inc. and Kurt Schmidt (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Cronos Group Inc., filed September 9, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000079/exhibit102.htm">Amended and Restated Employment Agreement, dated as of September 9, 2020, by and among Cronos USA Client Services LLC, Cronos Group Inc., and Michael Gorenstein (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of Cronos Group Inc., filed September 9, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647221000091/a10-qq22021102.htm">Amended and Restated Executive Employment Agreement, dated as of June 3, 2021, by and among Cronos USA Client Services LLC, Cronos Group Inc. and Todd Abraham (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647221000091/ex103robertmadoreemploymen.htm">Executive Employment Agreement, dated as of August 6, 2021, between Cronos USA, Cronos Group and Robert Madore (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2021).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1027-johngrieseempl.htm">Executive Employment Agreement, dated as of January 10, 2022, by and among Cronos USA Client Services LLC, Cronos Group Inc., Hortican Inc. and John Griese</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1027-johngrieseempl.htm"> (incorporated by</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1027-johngrieseempl.htm"> reference to Exhibit 10.27 to the Annual Report on Form 10-K of Cronos </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1027-johngrieseempl.htm">Group Inc., filed on March 1, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1027-johngrieseempl.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1027-johngrieseempl.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1028-annashlimaklet.htm">Letter Agreement, dated as of February 17, 2022, by and among Cronos USA Client Services LLC, Cronos Group Inc., and Anna Shlimak</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1028-annashlimaklet.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1028-annashlimaklet.htm">(incorporated by reference to Exhibit 10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1028-annashlimaklet.htm">8</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1028-annashlimaklet.htm"> to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 1, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1028-annashlimaklet.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit1028-annashlimaklet.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000065/a220321mikegorensteinemplo.htm">Amended and Restated Employment Agreement, dated as of March 21, 2022, between Cronos USA Client Services LLC, Cronos Group Inc. and Michael Gorenstein</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000065/a220321mikegorensteinemplo.htm"> (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Cronos Group Inc., filed on March 21, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000065/a220321kurtschmidtseparati.htm">Letter Agreement, dated as of March 21, 2022, between Cronos USA Client Services LLC, Cronos Group Inc. and Kurt Schmidt</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000065/a220321kurtschmidtseparati.htm"> (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of Cronos Group Inc., filed on March 21, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000093/a10-qq12022103.htm">Executive Employment Agreement, dated as of August 16, 2020, among Cronos Israel G.S. Cultivation Ltd., Cronos Group Inc. and Ran Gorelik (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed on May 10, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000162/a10-qq32022101.htm">Letter Agreement by and among Jeffrey Jacobson and Hortican Inc., dated November 7, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000162/a10-qq32022101.htm"> (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed on November 7, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000162/a10qq32022102.htm">Letter Agreement by and among John Griese, Cronos USA Client Services LLC, and Hortican Inc., dated November 7, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000162/a10qq32022102.htm"> (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed on November 7, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000170/ex101-holmemploymentagre.htm">James Holm Employment Agreement, dated November 14, 2022, among Cronos USA, the Company and Mr. Holm</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000170/ex101-holmemploymentagre.htm"> (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Cronos Group Inc., filed on November 14, 2022).</a></span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000201/warrantlettercronos002.htm">Altria&#8217;s notice of abandonment, dated December 16, 2022 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000201/warrantlettercronos002.htm">(incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K of Cronos Group Inc., filed on December 19, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647223000008/ex101-madoreletteragreem.htm">Letter Agreement by and between Robert Madore and Cronos USA Client Services LLC, dated February 8, 2023 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K/A of Cronos Group Inc., filed on February 13, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32&#8224;*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1032-annashlimaklet.htm">Letter Agreement by and between Anna Shlimak and Cronos USA Client Services LLC, dated February </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1032-annashlimaklet.htm">21</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1032-annashlimaklet.htm">, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit141-codeofbusinessc.htm">Cronos Group Inc. Code of Business Conduct and Ethics</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647222000034/exhibit141-codeofbusinessc.htm"> (incorporated by reference to Exhibit 14.1 to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 1, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211-listofsubsidiar.htm">List of Subsidiaries of Cronos Group Inc.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-consentofindepe.htm">Consent of KPMG LLP, Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i228e12b34e804aa096affae69dd6b9af_250">Power of Attorney (included on signature page hereto).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-certificationof.htm">Certification of the Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-certificationof.htm">Certification of the Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-certificationof.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-certificationof.htm">Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.400%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Management contract or compensatory plan or arrangement.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith and not &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><div id="i228e12b34e804aa096affae69dd6b9af_250"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:6.75pt;padding-right:6.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRONOS GROUP INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Gorenstein</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Gorenstein</span></div><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Power of Attorney</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Michael Gorenstein and James Holm, severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Gorenstein</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer <br/>(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Gorenstein</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James Holm</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Holm</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carlos Cortez</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Controller<br/>(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carlos Cortez</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kendrick Ashton, Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kendrick Ashton, Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Heather Newman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heather Newman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James Rudyk</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Rudyk</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jody Begley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jody Begley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jason Adler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Adler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Murray Garnick</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray Garnick</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.32
<SEQUENCE>2
<FILENAME>exhibit1032-annashlimaklet.htm
<DESCRIPTION>EX-10.32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ide1f756cfb4442c0937ebb3cbc4389dc_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.32</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">February 21, 2023</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anna Shlimak</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">At the Address on file with the Company</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dear Anna,</font></div><div style="margin-bottom:8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Further to our recent discussions, this letter agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;), effective as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;), confirms the following amendment to your employment agreement with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;), and solely for the purposes specified therein, Cronos Group Inc., a corporation organized under the laws of the Province of British Columbia, dated as of February 21, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;). Capitalized terms used in this Letter Agreement that are not defined herein have the meanings set forth in the Employment Agreement.</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:9.75pt;text-decoration:underline">Amendment</font></div><div style="margin-bottom:8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Paragraph (c) of Section 6.3 of the Employment Agreement is hereby deleted and replaced with the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">in lieu of notice, provide the Executive with a payment equal to two months of the Executive&#8217;s annual base salary in effect at the time of the termination plus one month of the Executive&#8217;s annual base salary in effect at the time of termination for each completed year of service with the Company, subject to a maximum of twelve months of base salary, payable by way of lump sum payment within sixty days following such termination. </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:9.75pt;text-decoration:underline">General.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Except as expressly modified by this Letter Agreement, all terms and conditions of your employment, as set out in the Employment Agreement, including, without limitation, Section 6 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;) and Section 7 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;), remain unchanged and continue in full force and effect.</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:9.75pt;text-decoration:underline">Independent Legal Advice.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You acknowledge that you have been encouraged to obtain independent legal advice regarding the execution of this Letter Agreement, and that you have either obtained such advice or voluntarily chosen not to do so, and hereby waive any objections or claims you may make resulting from any failure on your part to obtain such advice.</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:9.75pt;text-decoration:underline">Counterparts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Letter Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.  Delivery of an executed counterpart of a signature page to this Letter Agreement by electronic transmission, including in portable document format (.pdf), shall be deemed as effective as delivery of an original executed counterpart of this Letter Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If you agree that this Letter Agreement correctly memorializes our understandings, please sign and return this Agreement, which shall become a binding agreement as the Effective Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sincerely,</font></div><div style="margin-bottom:48pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CRONOS USA CLIENT SERVICES LLC</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Michael Gorenstein&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>Name&#58;&#160;&#160;&#160;&#160;Michael Gorenstein<br>Title&#58;&#160;&#160;&#160;&#160;President </font></div><div style="margin-bottom:48pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CRONOS GROUP INC.</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Michael Gorenstein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>Name&#58;&#160;&#160;&#160;&#160;Michael Gorenstein<br>Title&#58;&#160;&#160;&#160;&#160;President and Chief Executive    &#160;&#160;&#160;&#160;Officer</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accepted and Agreed&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Anna Shlimak&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Anna Shlimak</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; February 21, 2023</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>exhibit211-listofsubsidiar.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i645f44e982124771bb78b6f56d8e051b_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:130%">SUBSIDIARIES OF CRONOS GROUP INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:130%">As of December 31, 2022</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Subsidiaries</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">State or other jurisdiction of incorporation or organization</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Hortican Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Peace Naturals Project Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Global Holdings Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Canada Holdings Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Original BC Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Research Labs Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Israel G.S. Store Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Israel G.S. Cultivation Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Israel G.S. Pharmacy Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Israel G.S. Manufacturing Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Group USA Holdings Company Limited</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">British Columbia, Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos USA Holdings Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos USA Client Services LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Zeus Cannabinoids LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Redwood Wellness, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Redwood IP Holding, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Redwood Retail, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">California, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Redwood Operations CA, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">California, USA</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Thanos Holdings Ltd. d&#47;b&#47;a Cronos Fermentation</font></div></td><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">British Columbia, Canada</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exhibit231-consentofindepe.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic53c74b26e254b45910f1dcc253f2874_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;23.1</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We consent to the use of our reports dated February 28, 2023, with respect to the consolidated financial statements of Cronos Group Inc., and the effectiveness of internal control over financial reporting, incorporated by reference in the Registration Statements (No. 333-237528 and No. 333-226131) on Form S-8.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#47;s&#47; KPMG LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chartered Professional Accountants, Licensed Public Accountants</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 28, 2023</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaughan, Canada</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exhibit311-certificationof.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3f1a4f652fe04912873565f4f58ac989_1"></div><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael Gorenstein, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form&#160;10&#8209;K of Cronos Group Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a&#8209;15(e) and 15d&#8209;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.871%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#47;s&#47; Michael Gorenstein</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Gorenstein</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February 28, 2023</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exhibit312-certificationof.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id0c0f5ef764448cab0f1d09fd2842f23_1"></div><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James Holm, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form&#160;10&#8209;K of Cronos Group Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a&#8209;15(e) and 15d&#8209;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.871%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James Holm</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Holm</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February 28, 2023</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>exhibit321-certificationof.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i45f28bf2899d49f79664cdaf42f655d4_1"></div><div style="min-height:63pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 of Cronos Group&#160;Inc. (the &#8220;Company&#8221;) as filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on the date hereof (the &#8220;Report&#8221;),&#160;I, Michael Gorenstein, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section&#160;13(a)&#160;or Section&#160;15(d), as applicable,&#160;of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:2.25pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.030%"><tr><td style="width:1.0%"></td><td style="width:47.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.262%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#47;s&#47; Michael Gorenstein</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Gorenstein</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February 28, 2023</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form&#160;10-K to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form&#160;10-K), irrespective of any general incorporation language contained in such filing.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>exhibit322-certificationof.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9797030ff4b3462cbc82071569d4322b_1"></div><div style="min-height:63pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 of Cronos Group&#160;Inc. (the &#8220;Company&#8221;) as filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on the date hereof (the &#8220;Report&#8221;),&#160;I, James Holm, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section&#160;13(a)&#160;or Section&#160;15(d), as applicable,&#160;of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.030%"><tr><td style="width:1.0%"></td><td style="width:47.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.262%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James Holm</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Holm</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February 28, 2023</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form&#160;10-K to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form&#160;10-K), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>cron-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bb311be6-8ff8-4549-bdb4-c4f3401e1eb6,g:1fb2bd36-dce5-4c03-be1e-00a7968a9cfb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cron="http://thecronosgroup.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://thecronosgroup.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://thecronosgroup.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://thecronosgroup.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheet" roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheet">
        <link:definition>0000003 - Statement - Consolidated Balance Sheet</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetParenthetical" roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical">
        <link:definition>0000004 - Statement - Consolidated Balance Sheet (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss">
        <link:definition>0000005 - Statement - Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinShareholdersEquity" roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity">
        <link:definition>0000006 - Statement - Consolidated Statements of Changes in Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventorynet" roleURI="http://thecronosgroup.com/role/Inventorynet">
        <link:definition>0000009 - Disclosure - Inventory, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://thecronosgroup.com/role/Investments">
        <link:definition>0000010 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivablenet" roleURI="http://thecronosgroup.com/role/LoansReceivablenet">
        <link:definition>0000011 - Disclosure - Loans Receivable, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnet" roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnet">
        <link:definition>0000012 - Disclosure - Property, Plant and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnet" roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnet">
        <link:definition>0000013 - Disclosure - Goodwill and Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://thecronosgroup.com/role/Leases">
        <link:definition>0000014 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilities" roleURI="http://thecronosgroup.com/role/DerivativeLiabilities">
        <link:definition>0000015 - Disclosure - Derivative Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://thecronosgroup.com/role/CommitmentsandContingencies">
        <link:definition>0000016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensation" roleURI="http://thecronosgroup.com/role/SharebasedCompensation">
        <link:definition>0000017 - Disclosure - Share-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://thecronosgroup.com/role/IncomeTaxes">
        <link:definition>0000018 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandDisaggregatedRevenue" roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenue">
        <link:definition>0000019 - Disclosure - Segment Information and Disaggregated Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperShare" roleURI="http://thecronosgroup.com/role/EarningsLossperShare">
        <link:definition>0000020 - Disclosure - Earnings (Loss) per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://thecronosgroup.com/role/FinancialInstruments">
        <link:definition>0000021 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://thecronosgroup.com/role/RelatedPartyTransactions">
        <link:definition>0000022 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://thecronosgroup.com/role/Restructuring">
        <link:definition>0000023 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://thecronosgroup.com/role/SubsequentEvents">
        <link:definition>0000024 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000025 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000026 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventorynetTables" roleURI="http://thecronosgroup.com/role/InventorynetTables">
        <link:definition>0000027 - Disclosure - Inventory, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://thecronosgroup.com/role/InvestmentsTables">
        <link:definition>0000028 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivablenetTables" roleURI="http://thecronosgroup.com/role/LoansReceivablenetTables">
        <link:definition>0000029 - Disclosure - Loans Receivable, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetTables" roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetTables">
        <link:definition>0000030 - Disclosure - Property, Plant and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetTables" roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables">
        <link:definition>0000031 - Disclosure - Goodwill and Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://thecronosgroup.com/role/LeasesTables">
        <link:definition>0000032 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesTables" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesTables">
        <link:definition>0000033 - Disclosure - Derivative Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationTables" roleURI="http://thecronosgroup.com/role/SharebasedCompensationTables">
        <link:definition>0000034 - Disclosure - Share-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://thecronosgroup.com/role/IncomeTaxesTables">
        <link:definition>0000035 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandDisaggregatedRevenueTables" roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueTables">
        <link:definition>0000036 - Disclosure - Segment Information and Disaggregated Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperShareTables" roleURI="http://thecronosgroup.com/role/EarningsLossperShareTables">
        <link:definition>0000037 - Disclosure - Earnings (Loss) per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsTables">
        <link:definition>0000038 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsTables" roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsTables">
        <link:definition>0000039 - Disclosure - Related Party Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringTables" roleURI="http://thecronosgroup.com/role/RestructuringTables">
        <link:definition>0000040 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails">
        <link:definition>0000041 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails">
        <link:definition>0000042 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails">
        <link:definition>0000043 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails">
        <link:definition>0000044 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000045 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventorynetDetails" roleURI="http://thecronosgroup.com/role/InventorynetDetails">
        <link:definition>0000046 - Disclosure - Inventory, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails">
        <link:definition>0000047 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofInvestmentsDetails" roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails">
        <link:definition>0000048 - Disclosure - Investments - Schedule of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofVariableInterestEntitiesDetails" roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails">
        <link:definition>0000049 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRevaluationofOtherInvestmentsDetails" roleURI="http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails">
        <link:definition>0000050 - Disclosure - Investments - Revaluation of Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails" roleURI="http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails">
        <link:definition>0000051 - Disclosure - Investments - Summary of Gain from Disposals of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivablenetScheduleofLoanReceivableDetails" roleURI="http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails">
        <link:definition>0000052 - Disclosure - Loans Receivable, net - Schedule of Loan Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails" roleURI="http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails">
        <link:definition>0000053 - Disclosure - Loans Receivable, net - Schedule of Expected Credit Loss Allowances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails" roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails">
        <link:definition>0000054 - Disclosure - Property, Plant and Equipment, net - Schedule of Property, Plant &amp; Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetNarrativeDetails" roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails">
        <link:definition>0000055 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails" roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails">
        <link:definition>0000056 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetNarrativeDetails" roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails">
        <link:definition>0000057 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails" roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails">
        <link:definition>0000058 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails" roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails">
        <link:definition>0000059 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails" roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails">
        <link:definition>0000060 - Disclosure - Goodwill and Intangible Assets, net - Impairment Charges on Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://thecronosgroup.com/role/LeasesNarrativeDetails">
        <link:definition>0000061 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostandOtherInformationDetails" roleURI="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails">
        <link:definition>0000062 - Disclosure - Leases - Schedule of Lease Cost and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails" roleURI="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails">
        <link:definition>0000063 - Disclosure - Leases - Schedule of Future Minimum Lease Payments for Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1" roleURI="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1">
        <link:definition>0000063 - Disclosure - Leases - Schedule of Future Minimum Lease Payments for Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesNarrativeDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails">
        <link:definition>0000064 - Disclosure - Derivative Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails">
        <link:definition>0000065 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails">
        <link:definition>0000066 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails">
        <link:definition>0000067 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesRDCommitmentsDetails" roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails">
        <link:definition>0000068 - Disclosure - Commitments and Contingencies - R&amp;D Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesContingenciesDetails" roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails">
        <link:definition>0000069 - Disclosure - Commitments and Contingencies - Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails">
        <link:definition>0000070 - Disclosure - Share-based Compensation - Summary of Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationStockOptionsNarrativeDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails">
        <link:definition>0000071 - Disclosure - Share-based Compensation - Stock Options Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationSummaryoftheChangesinOptionsDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails">
        <link:definition>0000072 - Disclosure - Share-based Compensation - Summary of the Changes in Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationFairValueofOptionsIssuedDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails">
        <link:definition>0000073 - Disclosure - Share-based Compensation - Fair Value of Options Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationScheduleofStockOptionsOutstandingDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails">
        <link:definition>0000074 - Disclosure - Share-based Compensation - Schedule of Stock Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationRestrictedShareUnitsNarrativeDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails">
        <link:definition>0000075 - Disclosure - Share-based Compensation - Restricted Share Units Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails">
        <link:definition>0000076 - Disclosure - Share-based Compensation - Summary of Restricted Share Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails">
        <link:definition>0000077 - Disclosure - Share-based Compensation - Summary of Deferred Share Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationSummaryofChangesinWarrantsDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails">
        <link:definition>0000078 - Disclosure - Share-based Compensation - Summary of Changes in Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationLiabilityClassifiedAwardsDetails" roleURI="http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails">
        <link:definition>0000079 - Disclosure - Share-based Compensation - Liability-Classified Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails">
        <link:definition>0000080 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000081 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesExpenseforIncomeTaxesDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails">
        <link:definition>0000082 - Disclosure - Income Taxes - Expense for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveTaxRateReconciliationDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails">
        <link:definition>0000083 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000084 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandDisaggregatedRevenueNarrativeDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueNarrativeDetails">
        <link:definition>0000085 - Disclosure - Segment Information and Disaggregated Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails">
        <link:definition>0000086 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Segment Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails" roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails">
        <link:definition>0000087 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Adjusted EBITDA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails">
        <link:definition>0000088 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Revenue from External Customers by Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails">
        <link:definition>0000089 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Long-lived Assets by Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperShareScheduleofEarningsLossPerShareDetails" roleURI="http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails">
        <link:definition>0000090 - Disclosure - Earnings (Loss) per Share - Schedule of Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails">
        <link:definition>0000091 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails">
        <link:definition>0000092 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets on Nonrecurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsCreditRiskDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails">
        <link:definition>0000093 - Disclosure - Financial Instruments - Credit Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsLiquidityRiskDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails">
        <link:definition>0000094 - Disclosure - Financial Instruments - Liquidity Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsInterestRateRiskDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails">
        <link:definition>0000095 - Disclosure - Financial Instruments - Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsForeignCurrencyRiskDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsForeignCurrencyRiskDetails">
        <link:definition>0000096 - Disclosure - Financial Instruments - Foreign Currency Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsNarrativeDetails" roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails">
        <link:definition>0000097 - Disclosure - Related Party Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails">
        <link:definition>0000098 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringNarrativeDetails" roleURI="http://thecronosgroup.com/role/RestructuringNarrativeDetails">
        <link:definition>0000099 - Disclosure - Restructuring - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsbySegmentDetails" roleURI="http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails">
        <link:definition>0000100 - Disclosure - Restructuring - Costs by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRestructuringActivityDetails" roleURI="http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails">
        <link:definition>0000101 - Disclosure - Restructuring - Restructuring Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cron_CollaborativeArrangementTermOfAgreement" abstract="false" name="CollaborativeArrangementTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" abstract="false" name="ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CronosIsraelGSPharmacyLtdMember" abstract="true" name="CronosIsraelGSPharmacyLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ProceedsFromDividends" abstract="false" name="ProceedsFromDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" abstract="false" name="SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_MergerAgreementThresholdOwnershipPercentage" abstract="false" name="MergerAgreementThresholdOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_DerivativeLiabilityUsefulLifeTerm" abstract="false" name="DerivativeLiabilityUsefulLifeTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_GinkoExclusiveLicensesMember" abstract="true" name="GinkoExclusiveLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_UnitedStatesSegmentMember" abstract="true" name="UnitedStatesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CronosAustraliaLimitedMember" abstract="true" name="CronosAustraliaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_A2020OmnibusPlanMember" abstract="true" name="A2020OmnibusPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_GinkgoBioworksInc.Member" abstract="true" name="GinkgoBioworksInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_TechnionResearchAndDevelopmentFoundationMember" abstract="true" name="TechnionResearchAndDevelopmentFoundationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_NoncashSellingAndMarketingExpense" abstract="false" name="NoncashSellingAndMarketingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" abstract="false" name="GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_PreEmptiveRightsAndTopUpRightsMember" abstract="true" name="PreEmptiveRightsAndTopUpRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FinancingReceivableAccruedInterestNoncurrent" abstract="false" name="FinancingReceivableAccruedInterestNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_RestatementReviewExpense" abstract="false" name="RestatementReviewExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_PreemptiveRightsMember" abstract="true" name="PreemptiveRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" abstract="true" name="U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OneVendorMember" abstract="true" name="OneVendorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" abstract="false" name="LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ShareBasedPaymentArrangementLiabilitiesSettled" abstract="false" name="ShareBasedPaymentArrangementLiabilitiesSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" abstract="false" name="ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" abstract="false" name="LesseeOperatingLeaseAreaOfLandToBeDisposedOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="cron_LoanReceivableNameAxis" abstract="true" name="LoanReceivableNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cron_BuildingAndEquipmentMember" abstract="true" name="BuildingAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" abstract="false" name="CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodValueTopupRightsExercised" abstract="false" name="StockIssuedDuringPeriodValueTopupRightsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_IndefiniteLivedIntangibleAssetsGross" abstract="false" name="IndefiniteLivedIntangibleAssetsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NatueraJVPartnerMember" abstract="true" name="NatueraJVPartnerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ManufacturingServicesMember" abstract="true" name="ManufacturingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_OtherNetAssetsLiabilities" abstract="false" name="OtherNetAssetsLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_FinancingReceivableBeforeAccruedInterestCurrent" abstract="false" name="FinancingReceivableBeforeAccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" abstract="false" name="IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CollaborativeArrangementAmountOfAdvances" abstract="false" name="CollaborativeArrangementAmountOfAdvances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_HealthCanadaLicensingAgreementsMember" abstract="true" name="HealthCanadaLicensingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" abstract="false" name="ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_A2015StockOptionPlanMember" abstract="true" name="A2015StockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" abstract="false" name="StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" abstract="false" name="StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_CronosIsraelG.S.ManufacturingLtd.Member" abstract="true" name="CronosIsraelG.S.ManufacturingLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_OtherInvestmentsRollForward" abstract="true" name="OtherInvestmentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_CapitalGainRelinquishmentOfWarrant" abstract="false" name="CapitalGainRelinquishmentOfWarrant" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" abstract="false" name="SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_CollaborativeArrangementInstallmentsReceived" abstract="false" name="CollaborativeArrangementInstallmentsReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DeferredTaxAssetsFinanceLeaseLiabilities" abstract="false" name="DeferredTaxAssetsFinanceLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OtherCostOfGoodsAndServicesSold" abstract="false" name="OtherCostOfGoodsAndServicesSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_MeasurementInputSubscriptionPriceMember" abstract="true" name="MeasurementInputSubscriptionPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" abstract="true" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_NatuEraSeriesALoanMember" abstract="true" name="NatuEraSeriesALoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ConsultingServicesMember" abstract="true" name="ConsultingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" abstract="false" name="LongtermPurchaseCommitmentPaymentsSubjectToMilestones" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_AccruedLiabilitiesPolicyPolicyTextBlock" abstract="false" name="AccruedLiabilitiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cron_CronosGroupInc.Member" abstract="true" name="CronosGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" abstract="false" name="IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_LossContingencyPunitiveDamagesSoughtValue" abstract="false" name="LossContingencyPunitiveDamagesSoughtValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_InvestmentOwnedPercentage" abstract="false" name="InvestmentOwnedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_RestructuringReservePaymentsAndWriteoffs" abstract="false" name="RestructuringReservePaymentsAndWriteoffs" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_TopupRightsMember" abstract="true" name="TopupRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_AltriaGroupInc.Member" abstract="true" name="AltriaGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ThreeMajorCustomersMember" abstract="true" name="ThreeMajorCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_AltriaPinnacleLLC.Member" abstract="true" name="AltriaPinnacleLLC.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_LiabilityClassifiedAwardsMember" abstract="true" name="LiabilityClassifiedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_DeferredShareUnitsDSUsMember" abstract="true" name="DeferredShareUnitsDSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_PeaceNaturalsReportingUnitMember" abstract="true" name="PeaceNaturalsReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ConsultingServicesArrangementMember" abstract="true" name="ConsultingServicesArrangementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" abstract="true" name="DeferredCompensationSharebasedArrangementsLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_InterestReceivedNet" abstract="false" name="InterestReceivedNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_AltriaInvestmentMember" abstract="true" name="AltriaInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" abstract="false" name="FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_CronosGrowingCompanyInc.Member" abstract="true" name="CronosGrowingCompanyInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_DeferredTaxAssetsDebtIssuanceCosts" abstract="false" name="DeferredTaxAssetsDebtIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_A2018StockOptionPlanMember" abstract="true" name="A2018StockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" abstract="false" name="SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CBGALicensingAgreementMember" abstract="true" name="CBGALicensingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" abstract="false" name="ClassOfWarrantOrRightNumberOfWarrantsIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_CronosIsraelG.S.CultivationsLtd.Member" abstract="true" name="CronosIsraelG.S.CultivationsLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CronosGrowCoCreditFacilityMember" abstract="true" name="CronosGrowCoCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_AltriaWarrantMember" abstract="true" name="AltriaWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_AltriaVenturesInc.Member" abstract="true" name="AltriaVenturesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_DerivativeInstrumentsRollForward" abstract="true" name="DerivativeInstrumentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_LivWellHoldingsIncMember" abstract="true" name="LivWellHoldingsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" abstract="false" name="FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" abstract="false" name="IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" abstract="false" name="SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NumberOfImpairedIntangibles" abstract="false" name="NumberOfImpairedIntangibles" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" abstract="false" name="AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CBGVALicensingAgreementMember" abstract="true" name="CBGVALicensingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FinancingReceivableFaceAmount" abstract="false" name="FinancingReceivableFaceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" abstract="false" name="CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_RestOfWorldSegmentMember" abstract="true" name="RestOfWorldSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="cron_AustraliaMember" abstract="true" name="AustraliaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CronosIsraelG.S.StoreLtd.Member" abstract="true" name="CronosIsraelG.S.StoreLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FinancingReceivableInterestRateStatedPercentage" abstract="false" name="FinancingReceivableInterestRateStatedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_NatuEraMember" abstract="true" name="NatuEraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FinancingReceivableAccruedInterestCurrent" abstract="false" name="FinancingReceivableAccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_VendorMember" abstract="true" name="VendorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CannasoulAnalyticsLtdMember" abstract="true" name="CannasoulAnalyticsLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ShareBasedPaymentArrangementGainLossOnRevaluation" abstract="false" name="ShareBasedPaymentArrangementGainLossOnRevaluation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CannabisFlowerMember" abstract="true" name="CannabisFlowerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_LongtermPurchaseCommitmentMonthlyFeePercentage" abstract="false" name="LongtermPurchaseCommitmentMonthlyFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_RealignmentMember" abstract="true" name="RealignmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" abstract="false" name="IndefiniteLivedIntangibleAssetsAccumulatedImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" abstract="false" name="ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_CBCVALicensingAgreementMember" abstract="true" name="CBCVALicensingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_EarningsBeforeInterestTaxesDepreciationAndAmortization" abstract="false" name="EarningsBeforeInterestTaxesDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_IntangibleAssetsAccumulatedImpairment" abstract="false" name="IntangibleAssetsAccumulatedImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_LoanReceivableNameDomain" abstract="true" name="LoanReceivableNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" abstract="false" name="ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="cron_CannasoulCollaborationLoanMember" abstract="true" name="CannasoulCollaborationLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FourMajorCustomersMember" abstract="true" name="FourMajorCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" abstract="false" name="AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_AccumulatedImpairmentOfPropertyPlantAndEquipment" abstract="false" name="AccumulatedImpairmentOfPropertyPlantAndEquipment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_InvestmentOwnedNumberOfSharesSold" abstract="false" name="InvestmentOwnedNumberOfSharesSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_RedwoodReportingUnitMember" abstract="true" name="RedwoodReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FinancingReceivableBeforeAccruedInterestNoncurrent" abstract="false" name="FinancingReceivableBeforeAccruedInterestNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_AuroraCannabisInc.Member" abstract="true" name="AuroraCannabisInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CanadianPrimeRateMember" abstract="true" name="CanadianPrimeRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_NumberOfSeatsOnBoardOfDirectors" abstract="false" name="NumberOfSeatsOnBoardOfDirectors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_GainLossOnDisposalOfInvestments" abstract="false" name="GainLossOnDisposalOfInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_IsraeliCodesLicensingAgreementsMember" abstract="true" name="IsraeliCodesLicensingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification" abstract="false" name="FinancingReceivableInterestIncomeIncreaseFromDebtModification" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards" abstract="false" name="DeferredCompensationShareBasedArrangementsTransferToEquityAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CannabisExtractsMember" abstract="true" name="CannabisExtractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_WhistlerMedicalMarijuanaCompanyMember" abstract="true" name="WhistlerMedicalMarijuanaCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" abstract="false" name="StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CBCALicensingAgreementMember" abstract="true" name="CBCALicensingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_PharmacannMember" abstract="true" name="PharmacannMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_InvestmentOwnedNumberOfSharesReceived" abstract="false" name="InvestmentOwnedNumberOfSharesReceived" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_FacilityInStaynerOntarioCanadaMember" abstract="true" name="FacilityInStaynerOntarioCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_RedwoodHoldingGroupLLCMember" abstract="true" name="RedwoodHoldingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OntarioIncMucciPromissoryNoteMember" abstract="true" name="OntarioIncMucciPromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" abstract="false" name="CollaborativeArrangementPercentageOfProfitsToBeReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_CannabisPurchasesMember" abstract="true" name="CannabisPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" abstract="false" name="LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_DeferredTaxAssetsShareIssuanceCost" abstract="false" name="DeferredTaxAssetsShareIssuanceCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OSCSettlementMember" abstract="true" name="OSCSettlementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>cron-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bb311be6-8ff8-4549-bdb4-c4f3401e1eb6,g:1fb2bd36-dce5-4c03-be1e-00a7968a9cfb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedBalanceSheet"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_af611e08-e28a-497f-beb7-471ea88d8422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3b54a707-fc31-4afc-8f6a-dd2c30ae0428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af611e08-e28a-497f-beb7-471ea88d8422" xlink:to="loc_us-gaap_CommonStockValue_3b54a707-fc31-4afc-8f6a-dd2c30ae0428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_9be3b895-6aaa-406e-aa11-6179484b88ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af611e08-e28a-497f-beb7-471ea88d8422" xlink:to="loc_us-gaap_AdditionalPaidInCapital_9be3b895-6aaa-406e-aa11-6179484b88ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5bd5b69f-ef5b-450f-89b9-129322923050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af611e08-e28a-497f-beb7-471ea88d8422" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5bd5b69f-ef5b-450f-89b9-129322923050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2bdc0ca0-7fab-4342-a16c-0191a3682e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af611e08-e28a-497f-beb7-471ea88d8422" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2bdc0ca0-7fab-4342-a16c-0191a3682e53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_82ec7b0d-0eaf-41f1-afda-a13590aa802b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_02708938-3b1c-4dec-8b46-38aa8a3cbb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_82ec7b0d-0eaf-41f1-afda-a13590aa802b" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_02708938-3b1c-4dec-8b46-38aa8a3cbb9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a5076fd0-0ab0-4cd7-b6b9-ff06fbf075e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_82ec7b0d-0eaf-41f1-afda-a13590aa802b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a5076fd0-0ab0-4cd7-b6b9-ff06fbf075e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_40d791a5-cc30-4e4c-9f48-5b13f903cf84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_82ec7b0d-0eaf-41f1-afda-a13590aa802b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_40d791a5-cc30-4e4c-9f48-5b13f903cf84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_44a96ba2-700f-4aaf-975e-e1f4a604fbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_82ec7b0d-0eaf-41f1-afda-a13590aa802b" xlink:to="loc_us-gaap_AccountsPayableCurrent_44a96ba2-700f-4aaf-975e-e1f4a604fbe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_003a4cb5-9eba-44a7-b763-7ad7a0a3ffb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_82ec7b0d-0eaf-41f1-afda-a13590aa802b" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_003a4cb5-9eba-44a7-b763-7ad7a0a3ffb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_edc30503-2f15-4d7f-8de9-ac142c8846eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_82ec7b0d-0eaf-41f1-afda-a13590aa802b" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_edc30503-2f15-4d7f-8de9-ac142c8846eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_af55a721-9111-4b72-b64c-4063cf129eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_AssetsCurrent_af55a721-9111-4b72-b64c-4063cf129eb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_79e73bb9-7402-4d2f-b62d-18e22d775b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_Goodwill_79e73bb9-7402-4d2f-b62d-18e22d775b67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b214aad-5b0f-4a14-865e-902d60b0e55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b214aad-5b0f-4a14-865e-902d60b0e55a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_ea9e7948-74dd-4607-8786-4b24b63a0b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_OtherLongTermInvestments_ea9e7948-74dd-4607-8786-4b24b63a0b0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_17d08c7e-7920-4593-94a1-e9f2262897b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_17d08c7e-7920-4593-94a1-e9f2262897b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_379b9264-8ddc-4906-9fb2-9cc423b8fb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_379b9264-8ddc-4906-9fb2-9cc423b8fb64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e1750425-e689-4500-86b7-244673807f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_EquityMethodInvestments_e1750425-e689-4500-86b7-244673807f53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_264a859f-7623-4b98-8227-4eb02ca17755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_264a859f-7623-4b98-8227-4eb02ca17755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9efe9a68-d268-4976-b62e-129b6fbfa291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98ad7680-3e0e-4b60-bc94-002382446966" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9efe9a68-d268-4976-b62e-129b6fbfa291" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_405d9d87-ebac-4f1e-8754-4c060e28cad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a903ceeb-16cf-4386-8ff8-ddbb012b8872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_405d9d87-ebac-4f1e-8754-4c060e28cad3" xlink:to="loc_us-gaap_StockholdersEquity_a903ceeb-16cf-4386-8ff8-ddbb012b8872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4eaf4003-a7b4-4d18-97ae-a62ccf18e9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_405d9d87-ebac-4f1e-8754-4c060e28cad3" xlink:to="loc_us-gaap_MinorityInterest_4eaf4003-a7b4-4d18-97ae-a62ccf18e9ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e14edbe7-1fc6-41c6-83af-a38ccf3496d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4c331ab7-7644-48a2-8f01-153d802cbcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e14edbe7-1fc6-41c6-83af-a38ccf3496d2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4c331ab7-7644-48a2-8f01-153d802cbcb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_46d38461-6c0a-4898-a3ea-67c69dee3c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e14edbe7-1fc6-41c6-83af-a38ccf3496d2" xlink:to="loc_us-gaap_Liabilities_46d38461-6c0a-4898-a3ea-67c69dee3c32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f6d6d615-b4e0-4afd-8671-0de468be44a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5c01019c-9fa9-4c17-9f9f-f67bd4bea724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f6d6d615-b4e0-4afd-8671-0de468be44a0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5c01019c-9fa9-4c17-9f9f-f67bd4bea724" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b91b86f8-2790-408e-b695-286162359691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f6d6d615-b4e0-4afd-8671-0de468be44a0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b91b86f8-2790-408e-b695-286162359691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_8a845c07-930d-4d66-b5fc-70f6c986dc6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f6d6d615-b4e0-4afd-8671-0de468be44a0" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_8a845c07-930d-4d66-b5fc-70f6c986dc6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_29c589ca-4a54-4ead-b11f-a4b2f3a14e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f6d6d615-b4e0-4afd-8671-0de468be44a0" xlink:to="loc_us-gaap_InventoryNet_29c589ca-4a54-4ead-b11f-a4b2f3a14e4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9346a64a-1885-4bd7-9f95-fd919024ea52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f6d6d615-b4e0-4afd-8671-0de468be44a0" xlink:to="loc_us-gaap_ShortTermInvestments_9346a64a-1885-4bd7-9f95-fd919024ea52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_0ca808b6-c589-4e5c-98b3-28f37b8af6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f6d6d615-b4e0-4afd-8671-0de468be44a0" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_0ca808b6-c589-4e5c-98b3-28f37b8af6bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_fca3dccc-e987-4dbd-b21e-d79b2be8d5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f6d6d615-b4e0-4afd-8671-0de468be44a0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_fca3dccc-e987-4dbd-b21e-d79b2be8d5d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9b4702bd-df3d-4678-a82f-107e5311a187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_54b3a803-4a1c-4b39-9621-05dd0b8c9869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9b4702bd-df3d-4678-a82f-107e5311a187" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_54b3a803-4a1c-4b39-9621-05dd0b8c9869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_66797136-4aca-4fde-bb23-39db2eda1259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9b4702bd-df3d-4678-a82f-107e5311a187" xlink:to="loc_us-gaap_LiabilitiesCurrent_66797136-4aca-4fde-bb23-39db2eda1259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4e75f2e4-b5cd-4dea-b4be-879441206f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9b4702bd-df3d-4678-a82f-107e5311a187" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4e75f2e4-b5cd-4dea-b4be-879441206f38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_460de354-a104-4134-952f-4f733c6a1ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9b4702bd-df3d-4678-a82f-107e5311a187" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_460de354-a104-4134-952f-4f733c6a1ba7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7149962d-d858-4ec1-a5ec-d9d501a90d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6cd35901-7e3f-407a-99b1-67f3dea59c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7149962d-d858-4ec1-a5ec-d9d501a90d8b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6cd35901-7e3f-407a-99b1-67f3dea59c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_06d8f9d1-15b2-436d-9571-e50e354729be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7149962d-d858-4ec1-a5ec-d9d501a90d8b" xlink:to="loc_us-gaap_ProfitLoss_06d8f9d1-15b2-436d-9571-e50e354729be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5656d28b-c7b1-448a-b5be-af94f54555dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80ef5cc1-50e2-4811-9a3e-882da70ebbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5656d28b-c7b1-448a-b5be-af94f54555dc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80ef5cc1-50e2-4811-9a3e-882da70ebbe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold_5c040fa3-5146-4016-8b33-bf17be2de125" xlink:href="cron-20221231.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5656d28b-c7b1-448a-b5be-af94f54555dc" xlink:to="loc_cron_OtherCostOfGoodsAndServicesSold_5c040fa3-5146-4016-8b33-bf17be2de125" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_d00f884d-683e-4bc2-b04b-7f2a45228f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5656d28b-c7b1-448a-b5be-af94f54555dc" xlink:to="loc_us-gaap_InventoryWriteDown_d00f884d-683e-4bc2-b04b-7f2a45228f4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fae68dfa-ba00-4545-b9d5-93be841f0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_de1be37b-072f-4ba0-9c12-385dee182339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fae68dfa-ba00-4545-b9d5-93be841f0c0e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_de1be37b-072f-4ba0-9c12-385dee182339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b212fdd2-1241-4282-af1b-fe5a59656369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fae68dfa-ba00-4545-b9d5-93be841f0c0e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b212fdd2-1241-4282-af1b-fe5a59656369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1d6101d6-a5e7-481b-b6aa-4e9a0503dcbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_a4d5e309-3ad5-4741-ba67-27e3b72f33e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1d6101d6-a5e7-481b-b6aa-4e9a0503dcbd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_a4d5e309-3ad5-4741-ba67-27e3b72f33e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes_75838ead-c63f-40bf-9e87-3e3ae76dee5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1d6101d6-a5e7-481b-b6aa-4e9a0503dcbd" xlink:to="loc_us-gaap_ExciseAndSalesTaxes_75838ead-c63f-40bf-9e87-3e3ae76dee5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1847b521-6c4a-413c-abc4-cf6bdf7d9b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_df7d394c-85ad-4b97-af34-5c74df495f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1847b521-6c4a-413c-abc4-cf6bdf7d9b84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_df7d394c-85ad-4b97-af34-5c74df495f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_79cfb131-0f27-4b5b-adcc-bc7b210477b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1847b521-6c4a-413c-abc4-cf6bdf7d9b84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_79cfb131-0f27-4b5b-adcc-bc7b210477b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_582677c7-2a9a-45d3-9f95-fe4b91d7bc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0b0f5842-ccde-486f-bd9c-ea102b02a4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_582677c7-2a9a-45d3-9f95-fe4b91d7bc87" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0b0f5842-ccde-486f-bd9c-ea102b02a4fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d27e3df5-a6e4-4951-9b32-3168e29eea97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_582677c7-2a9a-45d3-9f95-fe4b91d7bc87" xlink:to="loc_us-gaap_OperatingIncomeLoss_d27e3df5-a6e4-4951-9b32-3168e29eea97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_f7ff824e-26d6-4010-ac4f-d04f3e9b1dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:to="loc_us-gaap_RestructuringCosts_f7ff824e-26d6-4010-ac4f-d04f3e9b1dd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_62ccffab-c76c-4e1f-aae5-6435fbfe0786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:to="loc_us-gaap_SellingAndMarketingExpense_62ccffab-c76c-4e1f-aae5-6435fbfe0786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_70e624a6-90b3-4c58-b2bf-f9a3f7668a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:to="loc_us-gaap_DepreciationAndAmortization_70e624a6-90b3-4c58-b2bf-f9a3f7668a48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_85152410-dfe8-4c21-b264-695c13b18773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_85152410-dfe8-4c21-b264-695c13b18773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b5b09164-9ce6-48db-ae37-336368946735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b5b09164-9ce6-48db-ae37-336368946735" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1c783728-77ea-44ba-8eb8-45196f48c677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1c783728-77ea-44ba-8eb8-45196f48c677" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_11e4ec20-c235-400e-bf6a-eb7c2792b76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_11e4ec20-c235-400e-bf6a-eb7c2792b76e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_d9804e86-3c6c-448e-8b94-d92a2f8768b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a4b6059-bfea-4600-8b33-10e09becc40c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_d9804e86-3c6c-448e-8b94-d92a2f8768b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_52ebd25c-0e70-4cd8-8e73-3a011797beed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_52ebd25c-0e70-4cd8-8e73-3a011797beed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_e7680151-7487-4ad7-990b-4950c73f94e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_e7680151-7487-4ad7-990b-4950c73f94e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c491e397-79db-4ba0-a719-c0d5ea4820d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c491e397-79db-4ba0-a719-c0d5ea4820d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_0f583299-34d2-4b19-9899-af51523b4bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_0f583299-34d2-4b19-9899-af51523b4bd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_b9a56917-9d32-416e-88f6-6ea2b8bae516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_b9a56917-9d32-416e-88f6-6ea2b8bae516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_27fa41b4-f19b-4d22-a912-5111083a4a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_27fa41b4-f19b-4d22-a912-5111083a4a59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_8d0c01be-93df-41fa-84f7-10b69ca4b429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_8d0c01be-93df-41fa-84f7-10b69ca4b429" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0cc3a339-30a0-45ea-a3fe-52412fb855bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5f6735f4-0cdd-4773-ae20-9d476e864967" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0cc3a339-30a0-45ea-a3fe-52412fb855bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_69c918a5-7ab2-41c3-bf0c-73b7afac454d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3f72d1b8-cd02-4694-ba76-045e452e172a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_69c918a5-7ab2-41c3-bf0c-73b7afac454d" xlink:to="loc_us-gaap_ProfitLoss_3f72d1b8-cd02-4694-ba76-045e452e172a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_30c0f4d3-1266-47b9-b545-6caeeee0654c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_69c918a5-7ab2-41c3-bf0c-73b7afac454d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_30c0f4d3-1266-47b9-b545-6caeeee0654c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c89c924a-f0a3-44f4-8f8b-21deddb77022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_059eb6f3-86a1-41cf-97cf-3091da93c6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c89c924a-f0a3-44f4-8f8b-21deddb77022" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_059eb6f3-86a1-41cf-97cf-3091da93c6cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9706f738-5624-4cbb-b016-5a6c074922de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c89c924a-f0a3-44f4-8f8b-21deddb77022" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9706f738-5624-4cbb-b016-5a6c074922de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5680c0c7-050a-4049-a233-181e559b3300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_215f4ee7-6cf5-42be-8cd3-d0e6d5061261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5680c0c7-050a-4049-a233-181e559b3300" xlink:to="loc_us-gaap_OperatingExpenses_215f4ee7-6cf5-42be-8cd3-d0e6d5061261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a13b4e16-21a5-4794-99e5-82cc8f7088a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5680c0c7-050a-4049-a233-181e559b3300" xlink:to="loc_us-gaap_GrossProfit_a13b4e16-21a5-4794-99e5-82cc8f7088a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_32e9e594-9651-4891-b9e3-0aceb60da7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_32e9e594-9651-4891-b9e3-0aceb60da7ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4c97781b-60e2-4a58-8363-8a32e533da6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4c97781b-60e2-4a58-8363-8a32e533da6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromLoansReceivable_ee2051b8-dedb-4537-9544-f4f71c31f082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:to="loc_us-gaap_PaymentsForProceedsFromLoansReceivable_ee2051b8-dedb-4537-9544-f4f71c31f082" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_394c13c5-687a-4557-9ce5-f4a11dc3a3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_394c13c5-687a-4557-9ce5-f4a11dc3a3cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_925905de-5542-4aa6-bf6f-b093f41daaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_925905de-5542-4aa6-bf6f-b093f41daaf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_dfb45d43-8357-4994-b9b6-d35e5b83ffd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_dfb45d43-8357-4994-b9b6-d35e5b83ffd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4435d682-8620-4cad-bd54-24d41da3917a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4435d682-8620-4cad-bd54-24d41da3917a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromDividends_2d74cebc-a364-4ff6-b823-94fb5ee6214d" xlink:href="cron-20221231.xsd#cron_ProceedsFromDividends"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64034627-b926-4fec-b1ae-6cf91bcdd589" xlink:to="loc_cron_ProceedsFromDividends_2d74cebc-a364-4ff6-b823-94fb5ee6214d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_46db4597-29de-43b6-8d45-72ebc6d5df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97985b8f-845e-45f1-870a-45a177f09c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_46db4597-29de-43b6-8d45-72ebc6d5df8e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97985b8f-845e-45f1-870a-45a177f09c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a7be30a3-6aa6-48a3-8a8d-daba161a1a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_46db4597-29de-43b6-8d45-72ebc6d5df8e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a7be30a3-6aa6-48a3-8a8d-daba161a1a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ab9ef9-8c05-4bf3-b423-eabf658ef7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_46db4597-29de-43b6-8d45-72ebc6d5df8e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ab9ef9-8c05-4bf3-b423-eabf658ef7cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_039a20bb-d96b-4112-a116-f7599900c845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_46db4597-29de-43b6-8d45-72ebc6d5df8e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_039a20bb-d96b-4112-a116-f7599900c845" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1848bb20-f474-405b-8d03-9a0584bf4b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1848bb20-f474-405b-8d03-9a0584bf4b2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_484fd66b-79e9-4b2f-8438-cfaa1bb382f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_484fd66b-79e9-4b2f-8438-cfaa1bb382f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GainLossOnDisposalOfInvestments_c2f6e226-5ac8-4ce2-b519-38811ade9cc7" xlink:href="cron-20221231.xsd#cron_GainLossOnDisposalOfInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_cron_GainLossOnDisposalOfInvestments_c2f6e226-5ac8-4ce2-b519-38811ade9cc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2dba39e8-e40c-4690-ac8c-f9f176aa7377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2dba39e8-e40c-4690-ac8c-f9f176aa7377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bde8665-4934-46cc-ae7a-daa03a8fdbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bde8665-4934-46cc-ae7a-daa03a8fdbb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_8751c523-f0d3-4405-816c-9baddd2fe54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_8751c523-f0d3-4405-816c-9baddd2fe54f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_c0550bbf-2dbd-4052-8509-ad099f180821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_c0550bbf-2dbd-4052-8509-ad099f180821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_6e8cad72-a2fb-4997-bbbb-64c0c144319a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_6e8cad72-a2fb-4997-bbbb-64c0c144319a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ba704b49-0d1d-4f4b-947c-39ac863009eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ba704b49-0d1d-4f4b-947c-39ac863009eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_61251f5f-7c95-4b5c-b828-66ddf61f51f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_61251f5f-7c95-4b5c-b828-66ddf61f51f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4fc7c7d4-0388-4760-810f-febdb55d077e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4fc7c7d4-0388-4760-810f-febdb55d077e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_0ec92ff7-10fd-4868-97bf-e2279959d017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_ImpairmentOfInvestments_0ec92ff7-10fd-4868-97bf-e2279959d017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_95e1621a-7948-492d-bd6f-99a688f2f1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_ShareBasedCompensation_95e1621a-7948-492d-bd6f-99a688f2f1c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_b3d96496-6776-4f39-92ae-0fd8a7edf489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_b3d96496-6776-4f39-92ae-0fd8a7edf489" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c9893659-7351-4c12-bb86-ae623716098b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c9893659-7351-4c12-bb86-ae623716098b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_440fba5a-67be-43e8-9966-6e65baeee08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_GainLossOnInvestments_440fba5a-67be-43e8-9966-6e65baeee08b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NoncashSellingAndMarketingExpense_20a12591-9370-4310-8a9a-aa0bde5f95a8" xlink:href="cron-20221231.xsd#cron_NoncashSellingAndMarketingExpense"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_cron_NoncashSellingAndMarketingExpense_20a12591-9370-4310-8a9a-aa0bde5f95a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_6973c5c9-efeb-4e22-a963-756dd681dee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_6973c5c9-efeb-4e22-a963-756dd681dee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_473744d6-c42c-40bd-b416-ed1f6ee6ab28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_473744d6-c42c-40bd-b416-ed1f6ee6ab28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_24c9caac-064e-4665-a019-a12cc076f1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a217cb6-649a-4a83-8028-596250906008" xlink:to="loc_us-gaap_ProfitLoss_24c9caac-064e-4665-a019-a12cc076f1fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf384cda-d59f-4aa9-ad1b-6b7becdbd7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d7ec1692-88fb-4d88-9b1c-7c53511552ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf384cda-d59f-4aa9-ad1b-6b7becdbd7a9" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d7ec1692-88fb-4d88-9b1c-7c53511552ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_ad3fdaa7-2375-4ca7-af88-584aa420ff12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf384cda-d59f-4aa9-ad1b-6b7becdbd7a9" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_ad3fdaa7-2375-4ca7-af88-584aa420ff12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_591fdee1-df9d-4e93-a050-cf5ece7b6525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf384cda-d59f-4aa9-ad1b-6b7becdbd7a9" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_591fdee1-df9d-4e93-a050-cf5ece7b6525" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5dbe941e-37e1-4a15-9eee-112ad26c743e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_c2a370f2-33f0-4a69-a8ce-96d6893f12c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5dbe941e-37e1-4a15-9eee-112ad26c743e" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_c2a370f2-33f0-4a69-a8ce-96d6893f12c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5025ac46-69d1-41a6-80b8-87a9f53b59bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5dbe941e-37e1-4a15-9eee-112ad26c743e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5025ac46-69d1-41a6-80b8-87a9f53b59bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d4069613-57ab-41b0-a429-d4a783adc83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5dbe941e-37e1-4a15-9eee-112ad26c743e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d4069613-57ab-41b0-a429-d4a783adc83a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent_bf6abcf9-ca26-4b3b-9231-57203c5f1e86" xlink:href="cron-20221231.xsd#cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5dbe941e-37e1-4a15-9eee-112ad26c743e" xlink:to="loc_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent_bf6abcf9-ca26-4b3b-9231-57203c5f1e86" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventorynetDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InventorynetDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InventorynetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cb4fe58d-0df0-4c41-9b34-a18c686f01e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_608a93b7-76a7-4e96-8868-b20f38b37d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cb4fe58d-0df0-4c41-9b34-a18c686f01e4" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_608a93b7-76a7-4e96-8868-b20f38b37d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3238fc9e-20cb-46f7-b183-c3fff512bfad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cb4fe58d-0df0-4c41-9b34-a18c686f01e4" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3238fc9e-20cb-46f7-b183-c3fff512bfad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2b8e10a0-ca69-4389-8468-7fccff6597e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cb4fe58d-0df0-4c41-9b34-a18c686f01e4" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2b8e10a0-ca69-4389-8468-7fccff6597e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves_f4a7be42-f591-48e1-aac0-e3a961c5801d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cb4fe58d-0df0-4c41-9b34-a18c686f01e4" xlink:to="loc_us-gaap_InventorySuppliesNetOfReserves_f4a7be42-f591-48e1-aac0-e3a961c5801d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LoansReceivablenetScheduleofLoanReceivableDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_778cb77d-96cf-4db3-9784-a441fc3d54ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_488e2fac-c4eb-4f32-971b-b1105bbf9303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesReceivableNet_778cb77d-96cf-4db3-9784-a441fc3d54ad" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_488e2fac-c4eb-4f32-971b-b1105bbf9303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_f4e75261-107a-4019-946c-05d2506dd409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesReceivableNet_778cb77d-96cf-4db3-9784-a441fc3d54ad" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_f4e75261-107a-4019-946c-05d2506dd409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_de966e5e-7e20-43ce-b62b-ef20bfff05ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_00d1c1c6-f5c1-4d43-9841-11f932daca88" xlink:href="cron-20221231.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_de966e5e-7e20-43ce-b62b-ef20bfff05ad" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_00d1c1c6-f5c1-4d43-9841-11f932daca88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_1d7e9115-2ff7-4a51-96d8-60f4cc84fe1d" xlink:href="cron-20221231.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_de966e5e-7e20-43ce-b62b-ef20bfff05ad" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_1d7e9115-2ff7-4a51-96d8-60f4cc84fe1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68e58161-ed85-4188-9ca1-f18047811601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_837e7b96-910c-4d6b-a26b-8a64e3a92bdc" xlink:href="cron-20221231.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68e58161-ed85-4188-9ca1-f18047811601" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_837e7b96-910c-4d6b-a26b-8a64e3a92bdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_af655360-4f54-4829-ae05-e7ad23aec34a" xlink:href="cron-20221231.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68e58161-ed85-4188-9ca1-f18047811601" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_af655360-4f54-4829-ae05-e7ad23aec34a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bac90c25-271d-4f1c-8a06-a0dc2ca87d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3a7fc9f3-4522-4e19-b60b-8e4ea69989ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_bac90c25-271d-4f1c-8a06-a0dc2ca87d7c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3a7fc9f3-4522-4e19-b60b-8e4ea69989ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9c3bbc68-7a82-4ead-a637-35346c5226cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_bac90c25-271d-4f1c-8a06-a0dc2ca87d7c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9c3bbc68-7a82-4ead-a637-35346c5226cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_d76741d0-a516-47ba-8049-c12cdbf2d61f" xlink:href="cron-20221231.xsd#cron_AccumulatedImpairmentOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_bac90c25-271d-4f1c-8a06-a0dc2ca87d7c" xlink:to="loc_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_d76741d0-a516-47ba-8049-c12cdbf2d61f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c8e857ef-75c4-4761-9944-14ff65c6df03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_5a3b876b-11fb-4861-bae6-d1ed8bbdf3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Goodwill_c8e857ef-75c4-4761-9944-14ff65c6df03" xlink:to="loc_us-gaap_GoodwillGross_5a3b876b-11fb-4861-bae6-d1ed8bbdf3c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_20205a8d-b47d-4321-8490-5be9cec0863d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Goodwill_c8e857ef-75c4-4761-9944-14ff65c6df03" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_20205a8d-b47d-4321-8490-5be9cec0863d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a6826cf3-b50c-4a77-b690-590be4aeaebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_c23d3eac-a4d5-451d-80d4-3e13db76bd53" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a6826cf3-b50c-4a77-b690-590be4aeaebb" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_c23d3eac-a4d5-451d-80d4-3e13db76bd53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsGross_7e0f6bd9-bd2c-487e-bd48-42416c011cb0" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a6826cf3-b50c-4a77-b690-590be4aeaebb" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsGross_7e0f6bd9-bd2c-487e-bd48-42416c011cb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e002c7e2-e359-4fd7-8eb8-18d89753ebb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b68b02e3-a206-40ea-b9db-344e8f3fca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e002c7e2-e359-4fd7-8eb8-18d89753ebb7" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b68b02e3-a206-40ea-b9db-344e8f3fca82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d4f9eecd-fc75-4012-87bc-4d69f021f9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e002c7e2-e359-4fd7-8eb8-18d89753ebb7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d4f9eecd-fc75-4012-87bc-4d69f021f9bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairment_aee4029e-f83d-4c35-a3ed-b617985b17e5" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e002c7e2-e359-4fd7-8eb8-18d89753ebb7" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairment_aee4029e-f83d-4c35-a3ed-b617985b17e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairment_86e1d4d9-31ba-4708-aaf6-46d236c37e6e" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_caa1ec5a-8294-481a-88ac-db61ba1dfc25" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cron_IntangibleAssetsAccumulatedImpairment_86e1d4d9-31ba-4708-aaf6-46d236c37e6e" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_caa1ec5a-8294-481a-88ac-db61ba1dfc25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_318c360c-54c9-402d-800e-1ebb61821a0f" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cron_IntangibleAssetsAccumulatedImpairment_86e1d4d9-31ba-4708-aaf6-46d236c37e6e" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_318c360c-54c9-402d-800e-1ebb61821a0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8bd5e687-c91c-4056-ab0d-97ea99c7ef67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ab4423c8-520c-41aa-aab6-b560bcd2ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8bd5e687-c91c-4056-ab0d-97ea99c7ef67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ab4423c8-520c-41aa-aab6-b560bcd2ab90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_18759f4f-6e14-43f1-80a3-fef496a2514e" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8bd5e687-c91c-4056-ab0d-97ea99c7ef67" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_18759f4f-6e14-43f1-80a3-fef496a2514e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5ed3fe1a-b4d6-4cb6-a933-243c53b6fc76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8bd5e687-c91c-4056-ab0d-97ea99c7ef67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5ed3fe1a-b4d6-4cb6-a933-243c53b6fc76" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9d714100-5b46-4c9a-bbd9-8c14c684bcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5bc3413c-eda9-410e-a06b-e1c800004d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9d714100-5b46-4c9a-bbd9-8c14c684bcb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5bc3413c-eda9-410e-a06b-e1c800004d63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2b2edcbc-db50-4f6d-8949-4643efd030d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9d714100-5b46-4c9a-bbd9-8c14c684bcb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2b2edcbc-db50-4f6d-8949-4643efd030d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3f7ed26e-ecf5-41e1-9bec-9c565cf44674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9d714100-5b46-4c9a-bbd9-8c14c684bcb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3f7ed26e-ecf5-41e1-9bec-9c565cf44674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b16eb95c-243b-47a6-be0d-7f5fae784838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9d714100-5b46-4c9a-bbd9-8c14c684bcb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b16eb95c-243b-47a6-be0d-7f5fae784838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_30e7f5cd-e1ac-45f9-8a7f-a20a1d7e2f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9d714100-5b46-4c9a-bbd9-8c14c684bcb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_30e7f5cd-e1ac-45f9-8a7f-a20a1d7e2f4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ecc895f3-a842-42d3-90d4-6197b8fbc608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9d714100-5b46-4c9a-bbd9-8c14c684bcb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ecc895f3-a842-42d3-90d4-6197b8fbc608" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_153a72a7-6c89-4ed9-aeec-7ad1829a7c0d" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_0de420e7-bc74-4fe9-8254-069924c1c5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_153a72a7-6c89-4ed9-aeec-7ad1829a7c0d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_0de420e7-bc74-4fe9-8254-069924c1c5bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_e66e7df3-4870-43fc-83df-23454b9b9121" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_153a72a7-6c89-4ed9-aeec-7ad1829a7c0d" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_e66e7df3-4870-43fc-83df-23454b9b9121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_76711801-9cda-4120-ad4f-fd7b47fa7e0a" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_74261088-91a9-4d79-8b66-395c066dbd06" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_76711801-9cda-4120-ad4f-fd7b47fa7e0a" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_74261088-91a9-4d79-8b66-395c066dbd06" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesScheduleofLeaseCostandOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_db6b2a80-0f4b-400c-a11f-7448c2a3c0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_b2bd0d69-98f8-4d5f-be53-5a1a69434313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_db6b2a80-0f4b-400c-a11f-7448c2a3c0a1" xlink:to="loc_us-gaap_OperatingLeaseCost_b2bd0d69-98f8-4d5f-be53-5a1a69434313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_5134ee62-4edf-46a1-af38-ea5194c5c690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_db6b2a80-0f4b-400c-a11f-7448c2a3c0a1" xlink:to="loc_us-gaap_ShortTermLeaseCost_5134ee62-4edf-46a1-af38-ea5194c5c690" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa678bd7-958c-4b0e-9f71-8945e50d58b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c090e548-3faf-4cc6-99c4-b94d1af2bca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa678bd7-958c-4b0e-9f71-8945e50d58b8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c090e548-3faf-4cc6-99c4-b94d1af2bca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_da834cb3-8b56-419d-83b8-a4d913ec99ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa678bd7-958c-4b0e-9f71-8945e50d58b8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_da834cb3-8b56-419d-83b8-a4d913ec99ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7e2813b8-1273-4956-a406-4243a086f77b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa678bd7-958c-4b0e-9f71-8945e50d58b8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7e2813b8-1273-4956-a406-4243a086f77b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8b3e3e04-da6d-4e42-890c-7af12d73cdea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa678bd7-958c-4b0e-9f71-8945e50d58b8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8b3e3e04-da6d-4e42-890c-7af12d73cdea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d49a41f6-55ae-479c-a2bf-6de58136a26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa678bd7-958c-4b0e-9f71-8945e50d58b8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d49a41f6-55ae-479c-a2bf-6de58136a26a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bc190f05-0125-4acf-a6c7-81720f45363a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa678bd7-958c-4b0e-9f71-8945e50d58b8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bc190f05-0125-4acf-a6c7-81720f45363a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c8c2a9a-5d09-47d2-b742-ef2264ff37fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8171ccb9-d1b3-4a10-a9e1-97d42a505801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c8c2a9a-5d09-47d2-b742-ef2264ff37fe" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8171ccb9-d1b3-4a10-a9e1-97d42a505801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_afab41e8-424e-407f-a1cc-0fc6ef6a0135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c8c2a9a-5d09-47d2-b742-ef2264ff37fe" xlink:to="loc_us-gaap_OperatingLeaseLiability_afab41e8-424e-407f-a1cc-0fc6ef6a0135" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount_c639950a-0300-4d7d-8af9-293641cbab49" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount_c639950a-0300-4d7d-8af9-293641cbab49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_9ab89734-e448-4432-9881-5217734d3e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_9ab89734-e448-4432-9881-5217734d3e17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5f64ada0-dcae-443f-baa7-f5e3c27cf901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5f64ada0-dcae-443f-baa7-f5e3c27cf901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount_7c4f1d02-3640-42a9-ad99-e03214708668" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount_7c4f1d02-3640-42a9-ad99-e03214708668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e5a8091d-5192-4b59-9c8e-8cd6649ae473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e5a8091d-5192-4b59-9c8e-8cd6649ae473" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d508cd2c-b2d3-4d49-a5a1-a686c8319a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d508cd2c-b2d3-4d49-a5a1-a686c8319a86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_5d79afff-1037-4668-9d66-321dffa1c0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_5d79afff-1037-4668-9d66-321dffa1c0cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_109fcad2-f4ba-4f9b-a568-02099950126e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_109fcad2-f4ba-4f9b-a568-02099950126e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c7d6ff16-a75c-4581-af9a-0ac653512ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c7d6ff16-a75c-4581-af9a-0ac653512ca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount_07810a52-ee60-47eb-a2ef-35a177930f10" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount_07810a52-ee60-47eb-a2ef-35a177930f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_62745aad-899c-4e67-b96a-fcabeba602f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_62745aad-899c-4e67-b96a-fcabeba602f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_ce9a515a-493f-4376-aa7f-6eb9e33bf6ac" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3083612c-9b29-47db-b438-8f470caada11" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_ce9a515a-493f-4376-aa7f-6eb9e33bf6ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_25a6e098-5dbe-4ced-ac37-0cfbbb071284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_399ceb21-303e-46e5-97b6-30829f8a58d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_25a6e098-5dbe-4ced-ac37-0cfbbb071284" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_399ceb21-303e-46e5-97b6-30829f8a58d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_77374ead-68d6-4b5d-a03c-938bf189f085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_25a6e098-5dbe-4ced-ac37-0cfbbb071284" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_77374ead-68d6-4b5d-a03c-938bf189f085" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d6af8390-97f7-474b-902b-47cf258cec03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_a1f7a91f-f043-42dc-9ced-95a85b29ac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d6af8390-97f7-474b-902b-47cf258cec03" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_a1f7a91f-f043-42dc-9ced-95a85b29ac3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a1deec1a-3041-444c-b2d8-e9a38f202895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d6af8390-97f7-474b-902b-47cf258cec03" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a1deec1a-3041-444c-b2d8-e9a38f202895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_23808baf-a398-47f7-bdde-db6f325da2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_23808baf-a398-47f7-bdde-db6f325da2f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9e1bef1c-e63e-428c-9529-0a74af280e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9e1bef1c-e63e-428c-9529-0a74af280e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_ce0cec5d-a3d9-4aec-99f1-bb7a8defe253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_ce0cec5d-a3d9-4aec-99f1-bb7a8defe253" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_12311cdb-faf3-488b-ac2d-25b2ee6c1911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_12311cdb-faf3-488b-ac2d-25b2ee6c1911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_193a3a7f-552d-4661-b1c6-0380333f90ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_193a3a7f-552d-4661-b1c6-0380333f90ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsShareIssuanceCost_6ef743b6-5fa2-4f59-8c87-df255e28cb5d" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsShareIssuanceCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_cron_DeferredTaxAssetsShareIssuanceCost_6ef743b6-5fa2-4f59-8c87-df255e28cb5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_a9479b15-d4e1-4d7a-bb57-aa31a95db636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_a9479b15-d4e1-4d7a-bb57-aa31a95db636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities_5ed5c5fb-98e5-4e6f-94fb-bed817bb9f00" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsFinanceLeaseLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities_5ed5c5fb-98e5-4e6f-94fb-bed817bb9f00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_49cbab68-4e6d-4128-9f09-6878d2c5d95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_49cbab68-4e6d-4128-9f09-6878d2c5d95a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsDebtIssuanceCosts_58cf448a-1c5f-482e-a430-ddc79f3d5779" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsDebtIssuanceCosts"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_cron_DeferredTaxAssetsDebtIssuanceCosts_58cf448a-1c5f-482e-a430-ddc79f3d5779" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_a94b697a-458e-4e84-a9b0-8273abfbbb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_a94b697a-458e-4e84-a9b0-8273abfbbb2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_59c12698-856f-4005-ab6a-bb31cf04a128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_06fbe387-2c1a-4df9-ab08-cc9d40eda4db" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_59c12698-856f-4005-ab6a-bb31cf04a128" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4f07ff20-436a-4a89-a4aa-19a0b99fc401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_25d26643-6940-4556-ba1d-db5fc7f80730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_4f07ff20-436a-4a89-a4aa-19a0b99fc401" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_25d26643-6940-4556-ba1d-db5fc7f80730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_086d5c57-5c5c-41ef-9de9-27c632a0613e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_4f07ff20-436a-4a89-a4aa-19a0b99fc401" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_086d5c57-5c5c-41ef-9de9-27c632a0613e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_404beac5-53cd-4bb8-84d6-0581974bae8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_5cef0875-1f37-4b20-97c2-daedb7bdf54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_404beac5-53cd-4bb8-84d6-0581974bae8d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_5cef0875-1f37-4b20-97c2-daedb7bdf54f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_24d07615-c887-4a54-b773-c9abfe7f7d77" xlink:href="cron-20221231.xsd#cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_404beac5-53cd-4bb8-84d6-0581974bae8d" xlink:to="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_24d07615-c887-4a54-b773-c9abfe7f7d77" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_cd6a4849-fecf-4030-a7b8-5af92ba874ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_985431ea-f016-4ff4-ae83-04b517ae9565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_cd6a4849-fecf-4030-a7b8-5af92ba874ce" xlink:to="loc_us-gaap_InvestmentIncomeInterest_985431ea-f016-4ff4-ae83-04b517ae9565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ae49d4c0-c7a3-4817-8a28-d06cd71cea87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_cd6a4849-fecf-4030-a7b8-5af92ba874ce" xlink:to="loc_us-gaap_InterestExpense_ae49d4c0-c7a3-4817-8a28-d06cd71cea87" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#EarningsLossperShareScheduleofEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7fdb7f5-2072-4ed1-9b81-0121bdf5b403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2c2f26fa-5ba9-463a-9749-e4673d1945e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7fdb7f5-2072-4ed1-9b81-0121bdf5b403" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2c2f26fa-5ba9-463a-9749-e4673d1945e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_56a96a68-f3c3-42f9-b8ff-6f72155db150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7fdb7f5-2072-4ed1-9b81-0121bdf5b403" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_56a96a68-f3c3-42f9-b8ff-6f72155db150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_ef619dea-d976-4d0b-9364-0569e7be5900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7fdb7f5-2072-4ed1-9b81-0121bdf5b403" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_ef619dea-d976-4d0b-9364-0569e7be5900" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_98dfa743-32a3-4c23-b1f7-0784fa7c9f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_fd22ae71-ec28-4020-a117-1995939b4b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_98dfa743-32a3-4c23-b1f7-0784fa7c9f4e" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_fd22ae71-ec28-4020-a117-1995939b4b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_1c25b684-8b41-46c8-99e9-1b09affef0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_98dfa743-32a3-4c23-b1f7-0784fa7c9f4e" xlink:to="loc_us-gaap_DilutiveSecurities_1c25b684-8b41-46c8-99e9-1b09affef0af" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>cron-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bb311be6-8ff8-4549-bdb4-c4f3401e1eb6,g:1fb2bd36-dce5-4c03-be1e-00a7968a9cfb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedStatementsofChangesinShareholdersEquity"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" xlink:type="extended" id="ib86df972a54d408aad42433efe87d07f_ConsolidatedStatementsofChangesinShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_48b72bbf-74f5-4b13-b99d-345d0b93704e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48b72bbf-74f5-4b13-b99d-345d0b93704e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e09ec697-898b-4858-bef6-800fed8d360b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e09ec697-898b-4858-bef6-800fed8d360b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bbba2804-d406-4b07-952d-f0de7ba5535d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bbba2804-d406-4b07-952d-f0de7ba5535d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement_60924008-fdf0-46bf-8527-ffd2ad042223" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement_60924008-fdf0-46bf-8527-ffd2ad042223" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cb1bd282-dac7-4c78-8248-b16bcbf5d9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cb1bd282-dac7-4c78-8248-b16bcbf5d9d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_4c9843f2-44b2-462f-917e-a83772ae6878" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_4c9843f2-44b2-462f-917e-a83772ae6878" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones_5aacc2df-82bb-4db3-9182-ff7962c65e7b" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones_5aacc2df-82bb-4db3-9182-ff7962c65e7b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_903cad46-c781-44b1-aa37-5a33fd07533d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_903cad46-c781-44b1-aa37-5a33fd07533d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_5ee70669-e78c-4875-aa17-f3b98bbfa69f" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_5ee70669-e78c-4875-aa17-f3b98bbfa69f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0c24ad69-cab6-45ac-87d3-756663982831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_ProfitLoss_0c24ad69-cab6-45ac-87d3-756663982831" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_24af190b-0a27-4a8a-b921-3c9ff5439417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_24af190b-0a27-4a8a-b921-3c9ff5439417" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0780447c-3365-43e4-b8d1-0439632346e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62bb1e76-a8a1-4e2e-88a8-b44691119301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_135fabd0-6c1f-4e68-855f-ac1ef63b4f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_48b72bbf-74f5-4b13-b99d-345d0b93704e" xlink:to="loc_us-gaap_StatementTable_135fabd0-6c1f-4e68-855f-ac1ef63b4f06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f4bb9074-2d19-437a-9d4a-3a88e94d56fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_135fabd0-6c1f-4e68-855f-ac1ef63b4f06" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f4bb9074-2d19-437a-9d4a-3a88e94d56fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f4bb9074-2d19-437a-9d4a-3a88e94d56fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f4bb9074-2d19-437a-9d4a-3a88e94d56fc" xlink:to="loc_us-gaap_EquityComponentDomain_f4bb9074-2d19-437a-9d4a-3a88e94d56fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f4bb9074-2d19-437a-9d4a-3a88e94d56fc" xlink:to="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b39cf168-41b1-4cf5-8984-c41267c03f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_CommonStockMember_b39cf168-41b1-4cf5-8984-c41267c03f49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6f23cb89-cec8-4ee0-8f51-600501593226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6f23cb89-cec8-4ee0-8f51-600501593226" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e7d2936b-da37-45ba-b60f-b5cc359c5c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_RetainedEarningsMember_e7d2936b-da37-45ba-b60f-b5cc359c5c9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bfc780aa-ed63-41c0-96bb-6d2c3872914c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bfc780aa-ed63-41c0-96bb-6d2c3872914c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_0d529046-6a96-40ad-b483-9e8a9af9c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_NoncontrollingInterestMember_0d529046-6a96-40ad-b483-9e8a9af9c68f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="extended" id="i1a89333e764a4b2d835f654bf8f37311_BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_4f82b6d6-45a2-4d57-b493-a3f21c47e5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_1bfe6605-8e7c-4a21-b4a6-ba46361c7d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_4f82b6d6-45a2-4d57-b493-a3f21c47e5fa" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_1bfe6605-8e7c-4a21-b4a6-ba46361c7d3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6269db45-c1cf-40d7-a5b2-0bcbe70300e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_4f82b6d6-45a2-4d57-b493-a3f21c47e5fa" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6269db45-c1cf-40d7-a5b2-0bcbe70300e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8220e83b-03b1-4dac-b071-9189841b5680" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6269db45-c1cf-40d7-a5b2-0bcbe70300e5" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8220e83b-03b1-4dac-b071-9189841b5680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8220e83b-03b1-4dac-b071-9189841b5680_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8220e83b-03b1-4dac-b071-9189841b5680" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8220e83b-03b1-4dac-b071-9189841b5680_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8220e83b-03b1-4dac-b071-9189841b5680" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.CultivationsLtd.Member_267330f7-9706-474f-8d7f-4bb0aa0f80d5" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.CultivationsLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:to="loc_cron_CronosIsraelG.S.CultivationsLtd.Member_267330f7-9706-474f-8d7f-4bb0aa0f80d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member_144a2add-5104-429b-aab7-9e63753c0351" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.ManufacturingLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:to="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member_144a2add-5104-429b-aab7-9e63753c0351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.StoreLtd.Member_465edbf3-e74f-44ac-a875-16bf13d182f9" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.StoreLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:to="loc_cron_CronosIsraelG.S.StoreLtd.Member_465edbf3-e74f-44ac-a875-16bf13d182f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelGSPharmacyLtdMember_ac90a296-99dc-4cdd-82ad-c3c1fefc3173" xlink:href="cron-20221231.xsd#cron_CronosIsraelGSPharmacyLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:to="loc_cron_CronosIsraelGSPharmacyLtdMember_ac90a296-99dc-4cdd-82ad-c3c1fefc3173" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="extended" id="if821ae54840f4ffeb3383c7c28c8ca40_BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36681c4d-3f9c-4c4b-b102-b1cf24c95068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1ee0ab37-e9d7-4f3f-b6a1-170f90ebb731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36681c4d-3f9c-4c4b-b102-b1cf24c95068" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1ee0ab37-e9d7-4f3f-b6a1-170f90ebb731" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36681c4d-3f9c-4c4b-b102-b1cf24c95068" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e98ce87-d5e9-46c1-bbaa-766d4131bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e98ce87-d5e9-46c1-bbaa-766d4131bf59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e98ce87-d5e9-46c1-bbaa-766d4131bf59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e98ce87-d5e9-46c1-bbaa-766d4131bf59" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e98ce87-d5e9-46c1-bbaa-766d4131bf59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e98ce87-d5e9-46c1-bbaa-766d4131bf59" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_d50b4ee2-2bc5-4953-a0e3-8fea0f857d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:to="loc_us-gaap_BuildingMember_d50b4ee2-2bc5-4953-a0e3-8fea0f857d55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b832009f-edbf-46f1-8a64-e89503c3e7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b832009f-edbf-46f1-8a64-e89503c3e7cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ced5f1e8-15b4-481f-bd53-ae6cd6d26169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ced5f1e8-15b4-481f-bd53-ae6cd6d26169" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f018bd6a-bbc8-4bf0-a3b9-318238742e77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:to="loc_srt_RangeAxis_f018bd6a-bbc8-4bf0-a3b9-318238742e77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f018bd6a-bbc8-4bf0-a3b9-318238742e77_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f018bd6a-bbc8-4bf0-a3b9-318238742e77" xlink:to="loc_srt_RangeMember_f018bd6a-bbc8-4bf0-a3b9-318238742e77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a323edd-5f5b-498f-ba80-6d17e987d1a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f018bd6a-bbc8-4bf0-a3b9-318238742e77" xlink:to="loc_srt_RangeMember_8a323edd-5f5b-498f-ba80-6d17e987d1a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1c3335de-347b-4640-bd9c-8ce3b3ccae49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a323edd-5f5b-498f-ba80-6d17e987d1a2" xlink:to="loc_srt_MinimumMember_1c3335de-347b-4640-bd9c-8ce3b3ccae49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4aa757a9-0830-475c-a87b-f7a49c2f636f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a323edd-5f5b-498f-ba80-6d17e987d1a2" xlink:to="loc_srt_MaximumMember_4aa757a9-0830-475c-a87b-f7a49c2f636f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="extended" id="i71969e9432ba4c27909ddd5489e1e5ee_BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f47fa8f-6ff4-4cc6-8b40-2ad9fc1c9e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ea07839-09c7-4acf-b385-8ccdb864e007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f47fa8f-6ff4-4cc6-8b40-2ad9fc1c9e71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ea07839-09c7-4acf-b385-8ccdb864e007" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2143d27a-bdc5-4a24-ae82-54dc74abca98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f47fa8f-6ff4-4cc6-8b40-2ad9fc1c9e71" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2143d27a-bdc5-4a24-ae82-54dc74abca98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_93f98196-225c-42ab-b3b6-eba9da129608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2143d27a-bdc5-4a24-ae82-54dc74abca98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_93f98196-225c-42ab-b3b6-eba9da129608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93f98196-225c-42ab-b3b6-eba9da129608_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_93f98196-225c-42ab-b3b6-eba9da129608" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93f98196-225c-42ab-b3b6-eba9da129608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b57f6f18-113b-488b-a920-a73bb1731eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_93f98196-225c-42ab-b3b6-eba9da129608" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b57f6f18-113b-488b-a920-a73bb1731eef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_82235ec0-4612-4017-8cf6-9d0beaa352ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b57f6f18-113b-488b-a920-a73bb1731eef" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_82235ec0-4612-4017-8cf6-9d0beaa352ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkoExclusiveLicensesMember_eab19cb9-729e-4318-a8e6-95a90343f7a0" xlink:href="cron-20221231.xsd#cron_GinkoExclusiveLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b57f6f18-113b-488b-a920-a73bb1731eef" xlink:to="loc_cron_GinkoExclusiveLicensesMember_eab19cb9-729e-4318-a8e6-95a90343f7a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="id5bb7aa5d5ce48d9a0c68bef28e891d1_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_a5227527-5769-4643-9784-1a0368b7456e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_a5227527-5769-4643-9784-1a0368b7456e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_33707804-2baa-4cd6-9afd-7271a948ca43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_33707804-2baa-4cd6-9afd-7271a948ca43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7115bbb1-cb33-485f-91a4-6a6647d13adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7115bbb1-cb33-485f-91a4-6a6647d13adb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedPercentage_52b20c70-89f9-405c-b2b5-ae2e2c748b30" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_InvestmentOwnedPercentage_52b20c70-89f9-405c-b2b5-ae2e2c748b30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d1fce0d5-abba-49bb-8b59-591bddf44ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_EquityMethodInvestments_d1fce0d5-abba-49bb-8b59-591bddf44ec0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances_535ff515-2986-42f6-bd61-9d31700a8bf0" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementAmountOfAdvances_535ff515-2986-42f6-bd61-9d31700a8bf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement_b4e41fd3-d78e-4bb7-9d4e-aefcaeea4d51" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementTermOfAgreement_b4e41fd3-d78e-4bb7-9d4e-aefcaeea4d51" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_650e2cf7-c76c-4a85-96f8-474b5d0d78e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_650e2cf7-c76c-4a85-96f8-474b5d0d78e9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_ce830b0b-409d-426d-ab88-140ba94512c7" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_ce830b0b-409d-426d-ab88-140ba94512c7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_f4a5b00a-d56f-484c-a965-14958b2d757e" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_f4a5b00a-d56f-484c-a965-14958b2d757e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_f1b7fa27-65cc-4fdf-ba47-f25a07f32317" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_f1b7fa27-65cc-4fdf-ba47-f25a07f32317" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3ec5408f-07bd-4d10-adfe-cf33cb501910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3ec5408f-07bd-4d10-adfe-cf33cb501910" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_302d4319-4223-4f12-b1dd-8ec994fdde39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_302d4319-4223-4f12-b1dd-8ec994fdde39" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a4352627-fa9a-445e-8e1c-0d654afad531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a4352627-fa9a-445e-8e1c-0d654afad531" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_f6ab5f1c-75be-4459-92ff-acdf5bce7d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_f6ab5f1c-75be-4459-92ff-acdf5bce7d1b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9030dc05-6f84-4c0a-95ec-86c46d8178df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9030dc05-6f84-4c0a-95ec-86c46d8178df" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MergerAgreementThresholdOwnershipPercentage_c8d2b59e-ac82-4c25-83a3-7c41c36cac36" xlink:href="cron-20221231.xsd#cron_MergerAgreementThresholdOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_MergerAgreementThresholdOwnershipPercentage_c8d2b59e-ac82-4c25-83a3-7c41c36cac36" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_6ef308a5-6bf8-4c86-ab1b-df03d838fdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_6ef308a5-6bf8-4c86-ab1b-df03d838fdb0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_7900fd0a-a238-4848-8e02-bc11b1e027d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_UnsecuredDebt_7900fd0a-a238-4848-8e02-bc11b1e027d1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1a0fe59b-0824-4441-9f1c-b596491352da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1a0fe59b-0824-4441-9f1c-b596491352da" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfSeatsOnBoardOfDirectors_93ced76e-dc9d-43c8-98ab-015fa2410a84" xlink:href="cron-20221231.xsd#cron_NumberOfSeatsOnBoardOfDirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_NumberOfSeatsOnBoardOfDirectors_93ced76e-dc9d-43c8-98ab-015fa2410a84" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_4678bd1c-3f7c-4b17-8e9b-fded86ace034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_4678bd1c-3f7c-4b17-8e9b-fded86ace034" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_f13d06e1-c54e-4267-807d-b68ce9e43236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_OtherLongTermInvestments_f13d06e1-c54e-4267-807d-b68ce9e43236" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_121400c9-15da-4f22-bc05-d75ac5cfc93f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_121400c9-15da-4f22-bc05-d75ac5cfc93f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_121400c9-15da-4f22-bc05-d75ac5cfc93f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_121400c9-15da-4f22-bc05-d75ac5cfc93f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_121400c9-15da-4f22-bc05-d75ac5cfc93f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_121400c9-15da-4f22-bc05-d75ac5cfc93f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_bf2dd3bc-5e40-4c33-b8c9-2847e9cec528" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_bf2dd3bc-5e40-4c33-b8c9-2847e9cec528" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_4135660f-54dd-45a6-aa9d-4ad4c5935e41" xlink:href="cron-20221231.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_NatuEraMember_4135660f-54dd-45a6-aa9d-4ad4c5935e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_997884a5-a949-4bc4-9e5e-cbaded6a6098" xlink:href="cron-20221231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_997884a5-a949-4bc4-9e5e-cbaded6a6098" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_0391d8bf-d9d5-40bd-bb9f-742f9490e26d" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_PharmacannMember_0391d8bf-d9d5-40bd-bb9f-742f9490e26d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_f308f6e2-6471-4f8a-8884-d70f9eb886bb" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_CronosAustraliaLimitedMember_f308f6e2-6471-4f8a-8884-d70f9eb886bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_b5b16c28-a076-44ca-b860-59dedf339325" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_b5b16c28-a076-44ca-b860-59dedf339325" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b5b16c28-a076-44ca-b860-59dedf339325_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b5b16c28-a076-44ca-b860-59dedf339325" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b5b16c28-a076-44ca-b860-59dedf339325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_468a992e-ace9-4a27-a94a-c5d6b8d623a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b5b16c28-a076-44ca-b860-59dedf339325" xlink:to="loc_srt_ConsolidatedEntitiesDomain_468a992e-ace9-4a27-a94a-c5d6b8d623a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_d2d4c885-a415-46c3-8b7d-6d6b8d9b167f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_468a992e-ace9-4a27-a94a-c5d6b8d623a6" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_d2d4c885-a415-46c3-8b7d-6d6b8d9b167f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_e34d1387-6720-4cee-8e21-a8d4bbb002c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_e34d1387-6720-4cee-8e21-a8d4bbb002c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e34d1387-6720-4cee-8e21-a8d4bbb002c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e34d1387-6720-4cee-8e21-a8d4bbb002c4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e34d1387-6720-4cee-8e21-a8d4bbb002c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_00a5d132-e197-4b9a-89dd-aecc44e982fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e34d1387-6720-4cee-8e21-a8d4bbb002c4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_00a5d132-e197-4b9a-89dd-aecc44e982fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_fee9ba83-fe13-40b5-884f-67e6325fcef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BridgeLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_00a5d132-e197-4b9a-89dd-aecc44e982fe" xlink:to="loc_us-gaap_BridgeLoanMember_fee9ba83-fe13-40b5-884f-67e6325fcef0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_def5bbc2-288d-4651-bad7-b956bd6ee21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_def5bbc2-288d-4651-bad7-b956bd6ee21a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_def5bbc2-288d-4651-bad7-b956bd6ee21a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_def5bbc2-288d-4651-bad7-b956bd6ee21a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_def5bbc2-288d-4651-bad7-b956bd6ee21a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3fb0ece-8f77-4886-8c62-1baf2fe236bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_def5bbc2-288d-4651-bad7-b956bd6ee21a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3fb0ece-8f77-4886-8c62-1baf2fe236bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_baceee02-368b-4d28-807f-22322676c845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3fb0ece-8f77-4886-8c62-1baf2fe236bb" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_baceee02-368b-4d28-807f-22322676c845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_7c8f4457-b495-456d-adaa-eb27786b868b" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_cron_LoanReceivableNameAxis_7c8f4457-b495-456d-adaa-eb27786b868b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_7c8f4457-b495-456d-adaa-eb27786b868b_default" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_7c8f4457-b495-456d-adaa-eb27786b868b" xlink:to="loc_cron_LoanReceivableNameDomain_7c8f4457-b495-456d-adaa-eb27786b868b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_1e620835-77f6-404c-84dc-57658e6d7ada" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_7c8f4457-b495-456d-adaa-eb27786b868b" xlink:to="loc_cron_LoanReceivableNameDomain_1e620835-77f6-404c-84dc-57658e6d7ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_0957d407-4194-48cd-b6ec-d50729da62c7" xlink:href="cron-20221231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_1e620835-77f6-404c-84dc-57658e6d7ada" xlink:to="loc_cron_CannasoulCollaborationLoanMember_0957d407-4194-48cd-b6ec-d50729da62c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ab519f88-23fd-4863-b136-a34f3a63ae2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ab519f88-23fd-4863-b136-a34f3a63ae2e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_ab519f88-23fd-4863-b136-a34f3a63ae2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ab519f88-23fd-4863-b136-a34f3a63ae2e" xlink:to="loc_us-gaap_ReceivableTypeDomain_ab519f88-23fd-4863-b136-a34f3a63ae2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_a72083c5-8fbc-4a31-90ed-ddd32d8a9008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ab519f88-23fd-4863-b136-a34f3a63ae2e" xlink:to="loc_us-gaap_ReceivableTypeDomain_a72083c5-8fbc-4a31-90ed-ddd32d8a9008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_a80482dd-4d53-4bc1-9bfc-19d57edd3483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_a72083c5-8fbc-4a31-90ed-ddd32d8a9008" xlink:to="loc_us-gaap_LoansReceivableMember_a80482dd-4d53-4bc1-9bfc-19d57edd3483" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0ae5c142-baa7-4739-acef-d69ab39a8c07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_dei_LegalEntityAxis_0ae5c142-baa7-4739-acef-d69ab39a8c07" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0ae5c142-baa7-4739-acef-d69ab39a8c07_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_0ae5c142-baa7-4739-acef-d69ab39a8c07" xlink:to="loc_dei_EntityDomain_0ae5c142-baa7-4739-acef-d69ab39a8c07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e3729b41-d0cc-4e4e-9c90-283e9c10653e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_0ae5c142-baa7-4739-acef-d69ab39a8c07" xlink:to="loc_dei_EntityDomain_e3729b41-d0cc-4e4e-9c90-283e9c10653e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraJVPartnerMember_5651f189-bd74-4cb6-bfe6-bd5592b1e6db" xlink:href="cron-20221231.xsd#cron_NatueraJVPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e3729b41-d0cc-4e4e-9c90-283e9c10653e" xlink:to="loc_cron_NatueraJVPartnerMember_5651f189-bd74-4cb6-bfe6-bd5592b1e6db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_01bcc681-0796-4854-9913-0d3ed219da77" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e3729b41-d0cc-4e4e-9c90-283e9c10653e" xlink:to="loc_cron_PharmacannMember_01bcc681-0796-4854-9913-0d3ed219da77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_772c6a1e-9891-4612-befb-bc8a8bb0ee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_772c6a1e-9891-4612-befb-bc8a8bb0ee3d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_772c6a1e-9891-4612-befb-bc8a8bb0ee3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_772c6a1e-9891-4612-befb-bc8a8bb0ee3d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_772c6a1e-9891-4612-befb-bc8a8bb0ee3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63c895ae-eaef-4496-ba60-dfb4ab5b4ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_772c6a1e-9891-4612-befb-bc8a8bb0ee3d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63c895ae-eaef-4496-ba60-dfb4ab5b4ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LivWellHoldingsIncMember_07988970-68f8-401a-9dcd-9ec905fdcf41" xlink:href="cron-20221231.xsd#cron_LivWellHoldingsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63c895ae-eaef-4496-ba60-dfb4ab5b4ac3" xlink:to="loc_cron_LivWellHoldingsIncMember_07988970-68f8-401a-9dcd-9ec905fdcf41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_67a0958c-f6c4-4053-a6a1-0513f5c6f765" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_srt_OwnershipAxis_67a0958c-f6c4-4053-a6a1-0513f5c6f765" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_67a0958c-f6c4-4053-a6a1-0513f5c6f765_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_67a0958c-f6c4-4053-a6a1-0513f5c6f765" xlink:to="loc_srt_OwnershipDomain_67a0958c-f6c4-4053-a6a1-0513f5c6f765_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1c9d8824-6a97-4574-9e7b-a035f317a684" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_67a0958c-f6c4-4053-a6a1-0513f5c6f765" xlink:to="loc_srt_OwnershipDomain_1c9d8824-6a97-4574-9e7b-a035f317a684" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_6bb2305d-23c4-4712-84ae-3fd2ab6de5f0" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1c9d8824-6a97-4574-9e7b-a035f317a684" xlink:to="loc_cron_PharmacannMember_6bb2305d-23c4-4712-84ae-3fd2ab6de5f0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsScheduleofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="extended" id="i2dc3a2c0cb2b43e4b2e5ace545d2f518_InvestmentsScheduleofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5152581-6d67-45af-9726-1fd1dd36f11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5152581-6d67-45af-9726-1fd1dd36f11a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedPercentage_59190c81-3d05-4758-9619-0bec1be0459d" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_cron_InvestmentOwnedPercentage_59190c81-3d05-4758-9619-0bec1be0459d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1c7931ed-87f2-4fd7-9519-976b78978323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_EquityMethodInvestments_1c7931ed-87f2-4fd7-9519-976b78978323" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_9fe9b8c9-afb4-4504-96a6-4b33e383e7f4" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_9fe9b8c9-afb4-4504-96a6-4b33e383e7f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_b6a01c74-3d54-4f36-8a28-8b4f5f69d89f" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_b6a01c74-3d54-4f36-8a28-8b4f5f69d89f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_1ae1cded-6f95-4daa-85ba-6a2b8c40c6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_NotesReceivableNet_1ae1cded-6f95-4daa-85ba-6a2b8c40c6a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_46dde9e6-9031-4a89-8b84-32d7935e7eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_46dde9e6-9031-4a89-8b84-32d7935e7eed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_0c05f2cb-a201-4b53-ae98-4ee2aa4dc722" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_0c05f2cb-a201-4b53-ae98-4ee2aa4dc722" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_36841de8-ce11-485a-bf86-5c6cfed99f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_36841de8-ce11-485a-bf86-5c6cfed99f3f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8a326642-407e-4551-97b7-4ecf468b4670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8a326642-407e-4551-97b7-4ecf468b4670" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c4b57dc8-f962-47c0-b97e-94a61b34a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:to="loc_us-gaap_AssetsCurrent_c4b57dc8-f962-47c0-b97e-94a61b34a5bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_70fc6845-9d29-4f1a-ba97-f3a66396304f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:to="loc_us-gaap_AssetsNoncurrent_70fc6845-9d29-4f1a-ba97-f3a66396304f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4fcb9031-ac1a-446c-a242-66b3edd97c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:to="loc_us-gaap_LiabilitiesCurrent_4fcb9031-ac1a-446c-a242-66b3edd97c85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_8a4efd0d-fa60-4511-8e7b-4fc69063eee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_8a4efd0d-fa60-4511-8e7b-4fc69063eee3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b108c2b-4550-4901-95d8-6bf6b0bfabcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b108c2b-4550-4901-95d8-6bf6b0bfabcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ac48779b-0a85-44c4-8318-a84ac3277570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:to="loc_us-gaap_GrossProfit_ac48779b-0a85-44c4-8318-a84ac3277570" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c1190eb3-6d1c-4563-9cdd-6ebc84fafef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:to="loc_us-gaap_ProfitLoss_c1190eb3-6d1c-4563-9cdd-6ebc84fafef9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2603a8e8-aede-48e0-b3e6-064bfd063327" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2603a8e8-aede-48e0-b3e6-064bfd063327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2603a8e8-aede-48e0-b3e6-064bfd063327_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2603a8e8-aede-48e0-b3e6-064bfd063327" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2603a8e8-aede-48e0-b3e6-064bfd063327_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2603a8e8-aede-48e0-b3e6-064bfd063327" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_2c432c83-0cf5-4d99-8ac5-962f12f85dc0" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:to="loc_cron_CronosAustraliaLimitedMember_2c432c83-0cf5-4d99-8ac5-962f12f85dc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_c125df57-3714-488d-b49c-df905ba007cc" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_c125df57-3714-488d-b49c-df905ba007cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_a83d8045-5c0f-4742-902d-9fbf62ce23c3" xlink:href="cron-20221231.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:to="loc_cron_NatuEraMember_a83d8045-5c0f-4742-902d-9fbf62ce23c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_dei_LegalEntityAxis_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d" xlink:to="loc_dei_EntityDomain_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7ef63e1a-5c34-49ad-9942-085ea03c4821" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d" xlink:to="loc_dei_EntityDomain_7ef63e1a-5c34-49ad-9942-085ea03c4821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_ab555a3f-a0ab-4aef-a88b-f8fb28c2ba8b" xlink:href="cron-20221231.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_7ef63e1a-5c34-49ad-9942-085ea03c4821" xlink:to="loc_cron_CronosGroupInc.Member_ab555a3f-a0ab-4aef-a88b-f8fb28c2ba8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraJVPartnerMember_e868160c-0f2b-4068-bb4b-09ad08af2322" xlink:href="cron-20221231.xsd#cron_NatueraJVPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_7ef63e1a-5c34-49ad-9942-085ea03c4821" xlink:to="loc_cron_NatueraJVPartnerMember_e868160c-0f2b-4068-bb4b-09ad08af2322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_777adf57-5b7f-4624-9ac8-c0740f4f1070" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_srt_ConsolidatedEntitiesAxis_777adf57-5b7f-4624-9ac8-c0740f4f1070" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_777adf57-5b7f-4624-9ac8-c0740f4f1070_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_777adf57-5b7f-4624-9ac8-c0740f4f1070" xlink:to="loc_srt_ConsolidatedEntitiesDomain_777adf57-5b7f-4624-9ac8-c0740f4f1070_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_53144f25-c7ec-486e-80a8-30b696ed5f79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_777adf57-5b7f-4624-9ac8-c0740f4f1070" xlink:to="loc_srt_ConsolidatedEntitiesDomain_53144f25-c7ec-486e-80a8-30b696ed5f79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b14002fe-4a3e-4ce8-a309-5be1beb8da33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_53144f25-c7ec-486e-80a8-30b696ed5f79" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b14002fe-4a3e-4ce8-a309-5be1beb8da33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f5b202b2-b464-469b-90e0-c79e6ec23c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f5b202b2-b464-469b-90e0-c79e6ec23c4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_f5b202b2-b464-469b-90e0-c79e6ec23c4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f5b202b2-b464-469b-90e0-c79e6ec23c4f" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_f5b202b2-b464-469b-90e0-c79e6ec23c4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_035f8f2e-659e-4ca3-a4e5-c56888cf4c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f5b202b2-b464-469b-90e0-c79e6ec23c4f" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_035f8f2e-659e-4ca3-a4e5-c56888cf4c64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_9b0b73c6-59c5-4416-b8ed-c65f4f0a42d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_035f8f2e-659e-4ca3-a4e5-c56888cf4c64" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_9b0b73c6-59c5-4416-b8ed-c65f4f0a42d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_a86dcc4f-4338-46af-ae8b-4054cb07caf6" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_cron_LoanReceivableNameAxis_a86dcc4f-4338-46af-ae8b-4054cb07caf6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_a86dcc4f-4338-46af-ae8b-4054cb07caf6_default" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_a86dcc4f-4338-46af-ae8b-4054cb07caf6" xlink:to="loc_cron_LoanReceivableNameDomain_a86dcc4f-4338-46af-ae8b-4054cb07caf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_32db3d4f-9efe-456d-9fb8-60550446ad89" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_a86dcc4f-4338-46af-ae8b-4054cb07caf6" xlink:to="loc_cron_LoanReceivableNameDomain_32db3d4f-9efe-456d-9fb8-60550446ad89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_9c3965b8-71c3-429e-a285-4c88bea75580" xlink:href="cron-20221231.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_32db3d4f-9efe-456d-9fb8-60550446ad89" xlink:to="loc_cron_NatuEraSeriesALoanMember_9c3965b8-71c3-429e-a285-4c88bea75580" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_feae3a56-c99f-4bac-9af5-68894f58ed0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_feae3a56-c99f-4bac-9af5-68894f58ed0c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_feae3a56-c99f-4bac-9af5-68894f58ed0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_feae3a56-c99f-4bac-9af5-68894f58ed0c" xlink:to="loc_us-gaap_ReceivableTypeDomain_feae3a56-c99f-4bac-9af5-68894f58ed0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_ab295fa8-5589-4cff-a202-cd5bb6dcc7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_feae3a56-c99f-4bac-9af5-68894f58ed0c" xlink:to="loc_us-gaap_ReceivableTypeDomain_ab295fa8-5589-4cff-a202-cd5bb6dcc7e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_6ed7b660-fa22-4e78-831a-56e9c2a716f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_ab295fa8-5589-4cff-a202-cd5bb6dcc7e5" xlink:to="loc_us-gaap_LoansReceivableMember_6ed7b660-fa22-4e78-831a-56e9c2a716f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsScheduleofVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="extended" id="i9882c01241444e57b132ddee87fa648c_InvestmentsScheduleofVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cc4e253e-ec14-4d6c-a412-8592f8661837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cc4e253e-ec14-4d6c-a412-8592f8661837" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherNetAssetsLiabilities_4319f44d-a9ed-4dd1-b198-69419ec7c252" xlink:href="cron-20221231.xsd#cron_OtherNetAssetsLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:to="loc_cron_OtherNetAssetsLiabilities_4319f44d-a9ed-4dd1-b198-69419ec7c252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_096f4896-1437-4494-a3a5-3f6c74dd0a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_096f4896-1437-4494-a3a5-3f6c74dd0a60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_870d76a3-7426-4294-a401-ff281ea4a3fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_870d76a3-7426-4294-a401-ff281ea4a3fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_61901642-c225-4c94-8284-6a585bfe386a" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_870d76a3-7426-4294-a401-ff281ea4a3fb" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_61901642-c225-4c94-8284-6a585bfe386a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_09cc9478-e073-48bb-8a66-d71a9bfb34f8" xlink:href="cron-20221231.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_870d76a3-7426-4294-a401-ff281ea4a3fb" xlink:to="loc_cron_NatuEraMember_09cc9478-e073-48bb-8a66-d71a9bfb34f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_dad25c02-a237-418f-a664-47ba401cd9a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_dad25c02-a237-418f-a664-47ba401cd9a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_17e50279-2c63-49c0-90e6-2fc531c6c8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_dad25c02-a237-418f-a664-47ba401cd9a6" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_17e50279-2c63-49c0-90e6-2fc531c6c8fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsRevaluationofOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails" xlink:type="extended" id="i05888abab06348a0a79504a24a974c79_InvestmentsRevaluationofOtherInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_0f073b90-2ede-4774-bc0e-f269428d88ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:href="cron-20221231.xsd#cron_OtherInvestmentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0f073b90-2ede-4774-bc0e-f269428d88ea" xlink:to="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_e4e1f5dd-36d0-4936-b4d4-ffa27964d121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_OtherInvestments_e4e1f5dd-36d0-4936-b4d4-ffa27964d121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_5c72d764-cd0c-4d73-80ce-6e9a99568b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_5c72d764-cd0c-4d73-80ce-6e9a99568b75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a2f65812-9265-4b52-92b9-e96c0313e73e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a2f65812-9265-4b52-92b9-e96c0313e73e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_b798e813-7614-4c60-9c43-47853f1fade8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_b798e813-7614-4c60-9c43-47853f1fade8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_32690b2a-dd1c-48a7-9689-0ad6dcf5efcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_41438da0-3b78-4d15-ab51-e00accd1e12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0f073b90-2ede-4774-bc0e-f269428d88ea" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_41438da0-3b78-4d15-ab51-e00accd1e12a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a402e4e6-ebea-46dc-bebf-6a6eff8d8447" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_41438da0-3b78-4d15-ab51-e00accd1e12a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a402e4e6-ebea-46dc-bebf-6a6eff8d8447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a402e4e6-ebea-46dc-bebf-6a6eff8d8447_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a402e4e6-ebea-46dc-bebf-6a6eff8d8447" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a402e4e6-ebea-46dc-bebf-6a6eff8d8447_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_229c3c03-7535-4d02-9d54-4566cd4d4117" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a402e4e6-ebea-46dc-bebf-6a6eff8d8447" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_229c3c03-7535-4d02-9d54-4566cd4d4117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_c24689ab-b409-4097-923a-28986ff4507d" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_229c3c03-7535-4d02-9d54-4566cd4d4117" xlink:to="loc_cron_PharmacannMember_c24689ab-b409-4097-923a-28986ff4507d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_2a1b0557-357a-4c88-aeee-96df66c6d2b5" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_229c3c03-7535-4d02-9d54-4566cd4d4117" xlink:to="loc_cron_CronosAustraliaLimitedMember_2a1b0557-357a-4c88-aeee-96df66c6d2b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails" xlink:type="extended" id="i556ba476773648c5a38908a85bae233d_InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_eca40025-3bf3-4c52-902b-f314534ca494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_eca40025-3bf3-4c52-902b-f314534ca494" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_091e6c5f-c553-43c0-8741-3941811ce28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_091e6c5f-c553-43c0-8741-3941811ce28c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesReceived_15e6b89e-836c-4762-99ff-eea263ff7c56" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedNumberOfSharesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_cron_InvestmentOwnedNumberOfSharesReceived_15e6b89e-836c-4762-99ff-eea263ff7c56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesSold_704c8298-9369-447e-98ea-58a1348bd9ec" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedNumberOfSharesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_cron_InvestmentOwnedNumberOfSharesSold_704c8298-9369-447e-98ea-58a1348bd9ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_194de422-f5c4-43ed-9c53-bed70b4c5740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:to="loc_us-gaap_InvestmentTypeAxis_194de422-f5c4-43ed-9c53-bed70b4c5740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_194de422-f5c4-43ed-9c53-bed70b4c5740_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_194de422-f5c4-43ed-9c53-bed70b4c5740" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_194de422-f5c4-43ed-9c53-bed70b4c5740_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e055dd6b-5933-4a6c-a426-5d43c84489c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_194de422-f5c4-43ed-9c53-bed70b4c5740" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e055dd6b-5933-4a6c-a426-5d43c84489c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_0e7c0a96-6935-4231-a035-c7f4f9fe5072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e055dd6b-5933-4a6c-a426-5d43c84489c4" xlink:to="loc_us-gaap_EquitySecuritiesMember_0e7c0a96-6935-4231-a035-c7f4f9fe5072" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05619e81-a140-4ce4-a953-6011e212ce40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05619e81-a140-4ce4-a953-6011e212ce40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_05619e81-a140-4ce4-a953-6011e212ce40_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05619e81-a140-4ce4-a953-6011e212ce40" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_05619e81-a140-4ce4-a953-6011e212ce40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b44e94bd-d557-4fc0-aee4-e339c29820b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05619e81-a140-4ce4-a953-6011e212ce40" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b44e94bd-d557-4fc0-aee4-e339c29820b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AuroraCannabisInc.Member_6cdd2f2c-3b0d-47e8-afeb-80d31cc0849e" xlink:href="cron-20221231.xsd#cron_AuroraCannabisInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b44e94bd-d557-4fc0-aee4-e339c29820b2" xlink:to="loc_cron_AuroraCannabisInc.Member_6cdd2f2c-3b0d-47e8-afeb-80d31cc0849e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_WhistlerMedicalMarijuanaCompanyMember_62e956ad-982e-4004-87dd-faeab9532420" xlink:href="cron-20221231.xsd#cron_WhistlerMedicalMarijuanaCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b44e94bd-d557-4fc0-aee4-e339c29820b2" xlink:to="loc_cron_WhistlerMedicalMarijuanaCompanyMember_62e956ad-982e-4004-87dd-faeab9532420" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LoansReceivablenetScheduleofLoanReceivableDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails" xlink:type="extended" id="i4bb510304f7746d3bfe708819eba88a2_LoansReceivablenetScheduleofLoanReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_e5d2a98d-b450-450a-ae4b-66516c3699c1" xlink:href="cron-20221231.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_e5d2a98d-b450-450a-ae4b-66516c3699c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_861a4287-1ad2-46bd-b3c0-530396f41ef7" xlink:href="cron-20221231.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_861a4287-1ad2-46bd-b3c0-530396f41ef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_95c2f7a8-f05d-48c6-aa05-9dd51f1ac0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_95c2f7a8-f05d-48c6-aa05-9dd51f1ac0d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_5f3e1b58-d94c-4870-8dd1-35072995e110" xlink:href="cron-20221231.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_5f3e1b58-d94c-4870-8dd1-35072995e110" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_8e4464c1-17d6-46f0-8a33-0b6b07ec1826" xlink:href="cron-20221231.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_8e4464c1-17d6-46f0-8a33-0b6b07ec1826" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_b990fc17-79eb-4b10-958a-943b5c4490f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_b990fc17-79eb-4b10-958a-943b5c4490f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_78930e39-b428-424a-ac5b-d4828494e204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_NotesReceivableNet_78930e39-b428-424a-ac5b-d4828494e204" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmount_1270f799-f5b5-406b-98f6-77a780d5e61e" xlink:href="cron-20221231.xsd#cron_FinancingReceivableFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableFaceAmount_1270f799-f5b5-406b-98f6-77a780d5e61e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed_c086d035-8c12-4f5d-b394-f97418eb46fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_ProvisionForLoanLossesExpensed_c086d035-8c12-4f5d-b394-f97418eb46fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_b267ad02-239b-47e8-b8d9-c8f536eb3846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_b267ad02-239b-47e8-b8d9-c8f536eb3846" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_567a9aec-e43a-4a4f-a89f-b02db8c63104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_567a9aec-e43a-4a4f-a89f-b02db8c63104" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestRateStatedPercentage_a24a9376-3c7b-4f2d-808b-7b7d53d2cb5f" xlink:href="cron-20221231.xsd#cron_FinancingReceivableInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableInterestRateStatedPercentage_a24a9376-3c7b-4f2d-808b-7b7d53d2cb5f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate_3dd4b681-e4fd-4dd3-a810-75564c348981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate_3dd4b681-e4fd-4dd3-a810-75564c348981" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification_a2753918-3305-4d4b-bbd8-5025580dc6d0" xlink:href="cron-20221231.xsd#cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification_a2753918-3305-4d4b-bbd8-5025580dc6d0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived_d1e4d3f3-0bc9-45a0-ab7d-6299e3bfaf09" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_CollaborativeArrangementInstallmentsReceived_d1e4d3f3-0bc9-45a0-ab7d-6299e3bfaf09" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_cc6a4150-422d-4413-bf46-771bf6ec8de0" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_cron_LoanReceivableNameAxis_cc6a4150-422d-4413-bf46-771bf6ec8de0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_cc6a4150-422d-4413-bf46-771bf6ec8de0_default" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_cc6a4150-422d-4413-bf46-771bf6ec8de0" xlink:to="loc_cron_LoanReceivableNameDomain_cc6a4150-422d-4413-bf46-771bf6ec8de0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_cc6a4150-422d-4413-bf46-771bf6ec8de0" xlink:to="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember_ba5fa339-1092-46d5-bee4-2ffda2dfae9c" xlink:href="cron-20221231.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:to="loc_cron_CronosGrowCoCreditFacilityMember_ba5fa339-1092-46d5-bee4-2ffda2dfae9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OntarioIncMucciPromissoryNoteMember_55a69484-2662-49d5-81a5-4361cb20e2c6" xlink:href="cron-20221231.xsd#cron_OntarioIncMucciPromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:to="loc_cron_OntarioIncMucciPromissoryNoteMember_55a69484-2662-49d5-81a5-4361cb20e2c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_7e6d1950-9d5e-4f74-9f87-5996b75d1d0c" xlink:href="cron-20221231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:to="loc_cron_CannasoulCollaborationLoanMember_7e6d1950-9d5e-4f74-9f87-5996b75d1d0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_0973c255-3838-4b6f-ac07-eac8603289ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_0973c255-3838-4b6f-ac07-eac8603289ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_0973c255-3838-4b6f-ac07-eac8603289ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_0973c255-3838-4b6f-ac07-eac8603289ce" xlink:to="loc_us-gaap_ReceivableTypeDomain_0973c255-3838-4b6f-ac07-eac8603289ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_8221ac64-985e-4e85-b74d-7d9fa1915281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_0973c255-3838-4b6f-ac07-eac8603289ce" xlink:to="loc_us-gaap_ReceivableTypeDomain_8221ac64-985e-4e85-b74d-7d9fa1915281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_ae46efce-d0b2-4edf-b146-8d36c8ab1c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_8221ac64-985e-4e85-b74d-7d9fa1915281" xlink:to="loc_us-gaap_LoansReceivableMember_ae46efce-d0b2-4edf-b146-8d36c8ab1c95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_us-gaap_VariableRateAxis_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56" xlink:to="loc_us-gaap_VariableRateDomain_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ecbfe303-35be-4a53-8e6e-9824ae848bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56" xlink:to="loc_us-gaap_VariableRateDomain_ecbfe303-35be-4a53-8e6e-9824ae848bdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CanadianPrimeRateMember_9a23e189-2375-4052-bf65-459205f42415" xlink:href="cron-20221231.xsd#cron_CanadianPrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ecbfe303-35be-4a53-8e6e-9824ae848bdc" xlink:to="loc_cron_CanadianPrimeRateMember_9a23e189-2375-4052-bf65-459205f42415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_bc92fe06-9d3d-416c-933b-94e5230bddc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_bc92fe06-9d3d-416c-933b-94e5230bddc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bc92fe06-9d3d-416c-933b-94e5230bddc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_bc92fe06-9d3d-416c-933b-94e5230bddc2" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bc92fe06-9d3d-416c-933b-94e5230bddc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9d59caab-388d-4d3b-b808-a4f798a02e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_bc92fe06-9d3d-416c-933b-94e5230bddc2" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9d59caab-388d-4d3b-b808-a4f798a02e46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_a3640f20-3ca8-4ab4-b8c5-52ce918a9c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9d59caab-388d-4d3b-b808-a4f798a02e46" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_a3640f20-3ca8-4ab4-b8c5-52ce918a9c45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_38662dd4-96a9-4a68-8b62-0f4d6eda9223" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_38662dd4-96a9-4a68-8b62-0f4d6eda9223" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_38662dd4-96a9-4a68-8b62-0f4d6eda9223_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_38662dd4-96a9-4a68-8b62-0f4d6eda9223" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_38662dd4-96a9-4a68-8b62-0f4d6eda9223_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ed7d590b-c67e-44cd-9e6e-4052c602c54e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_38662dd4-96a9-4a68-8b62-0f4d6eda9223" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ed7d590b-c67e-44cd-9e6e-4052c602c54e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_23b0d790-bf7c-43c1-991a-506c622ec44b" xlink:href="cron-20221231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed7d590b-c67e-44cd-9e6e-4052c602c54e" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_23b0d790-bf7c-43c1-991a-506c622ec44b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6b9ea757-d21d-400b-8652-8453dc50346a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6b9ea757-d21d-400b-8652-8453dc50346a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6b9ea757-d21d-400b-8652-8453dc50346a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6b9ea757-d21d-400b-8652-8453dc50346a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6b9ea757-d21d-400b-8652-8453dc50346a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5ab2f31c-d70a-43aa-991c-7884e4fc8b1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6b9ea757-d21d-400b-8652-8453dc50346a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5ab2f31c-d70a-43aa-991c-7884e4fc8b1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4497483f-0948-4330-b52a-be2fa5881a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5ab2f31c-d70a-43aa-991c-7884e4fc8b1d" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4497483f-0948-4330-b52a-be2fa5881a9c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails" xlink:type="extended" id="i9d0418848c58499e99efbec6d0307334_LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_0db216ed-3862-44d0-9f6f-0b28ceebbc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLoanAndLeaseLossesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_0db216ed-3862-44d0-9f6f-0b28ceebbc1d" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_9a9d3e00-5eb0-409b-9c8d-0584a4544f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_9a9d3e00-5eb0-409b-9c8d-0584a4544f3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed_be8e1cc8-7726-4e34-832a-a2e9c4a3f7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:to="loc_us-gaap_ProvisionForLoanLossesExpensed_be8e1cc8-7726-4e34-832a-a2e9c4a3f7a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation_bd962ecb-2afe-4ab0-9c8e-d4c185c680cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation_bd962ecb-2afe-4ab0-9c8e-d4c185c680cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_bdf6863e-d0ee-41dc-96f5-230a4358072a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment_ae4392cb-6ca0-4616-94e4-1770aaeba086" xlink:href="cron-20221231.xsd#cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_0db216ed-3862-44d0-9f6f-0b28ceebbc1d" xlink:to="loc_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment_ae4392cb-6ca0-4616-94e4-1770aaeba086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_0db216ed-3862-44d0-9f6f-0b28ceebbc1d" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_3a2c0685-f75d-4ba2-b1d9-50289f5188aa" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:to="loc_cron_LoanReceivableNameAxis_3a2c0685-f75d-4ba2-b1d9-50289f5188aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_3a2c0685-f75d-4ba2-b1d9-50289f5188aa_default" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_3a2c0685-f75d-4ba2-b1d9-50289f5188aa" xlink:to="loc_cron_LoanReceivableNameDomain_3a2c0685-f75d-4ba2-b1d9-50289f5188aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_3a2c0685-f75d-4ba2-b1d9-50289f5188aa" xlink:to="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember_4bde16ed-dfd9-4a17-abea-d716f3181e6c" xlink:href="cron-20221231.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:to="loc_cron_CronosGrowCoCreditFacilityMember_4bde16ed-dfd9-4a17-abea-d716f3181e6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OntarioIncMucciPromissoryNoteMember_ea422e00-3e05-49cb-b888-2fd4f89d792f" xlink:href="cron-20221231.xsd#cron_OntarioIncMucciPromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:to="loc_cron_OntarioIncMucciPromissoryNoteMember_ea422e00-3e05-49cb-b888-2fd4f89d792f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_48f1e90b-4319-425d-bd9f-861f6006391c" xlink:href="cron-20221231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:to="loc_cron_CannasoulCollaborationLoanMember_48f1e90b-4319-425d-bd9f-861f6006391c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_f8d29995-1cda-4cd5-9f59-d3e65fc37c6d" xlink:href="cron-20221231.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:to="loc_cron_NatuEraSeriesALoanMember_f8d29995-1cda-4cd5-9f59-d3e65fc37c6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a" xlink:to="loc_us-gaap_ReceivableTypeDomain_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_b40336a9-8d34-4fa1-9616-783dc7cde831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a" xlink:to="loc_us-gaap_ReceivableTypeDomain_b40336a9-8d34-4fa1-9616-783dc7cde831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_55afc535-5c8d-417e-a1a9-120da2f74d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_b40336a9-8d34-4fa1-9616-783dc7cde831" xlink:to="loc_us-gaap_LoansReceivableMember_55afc535-5c8d-417e-a1a9-120da2f74d54" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails" xlink:type="extended" id="i6a8a26c5e0154cf6b525855f1377c856_PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2b2853ee-ac90-45fe-ac39-849d799bf41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2b2853ee-ac90-45fe-ac39-849d799bf41b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_92ea9744-2ed2-4631-ba7f-c36fb73c0979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_92ea9744-2ed2-4631-ba7f-c36fb73c0979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_e0586e7b-04e1-4c9c-a67c-0375b7dfca64" xlink:href="cron-20221231.xsd#cron_AccumulatedImpairmentOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_e0586e7b-04e1-4c9c-a67c-0375b7dfca64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b35470ae-98f2-4195-a4ca-d694f46c30e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b35470ae-98f2-4195-a4ca-d694f46c30e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_96ee458a-0dba-4ffd-9e73-480e0c1ebfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_96ee458a-0dba-4ffd-9e73-480e0c1ebfc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_96ee458a-0dba-4ffd-9e73-480e0c1ebfc6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_a1318117-cc1c-48af-add1-e208522dac81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_LandMember_a1318117-cc1c-48af-add1-e208522dac81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_1bfadf4e-9ee3-4113-a620-42a86c42fb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_BuildingMember_1bfadf4e-9ee3-4113-a620-42a86c42fb1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_d6360a09-b4b1-466f-b4e6-669b97c0d2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_d6360a09-b4b1-466f-b4e6-669b97c0d2ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5e43f796-8c0b-4ab8-a2cd-44ae2cee9f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5e43f796-8c0b-4ab8-a2cd-44ae2cee9f4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_2ada18a6-566f-4b83-b607-496017cfa298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_ConstructionInProgressMember_2ada18a6-566f-4b83-b607-496017cfa298" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#PropertyPlantandEquipmentnetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails" xlink:type="extended" id="i803e7448fb734b20ab5f55646eca889f_PropertyPlantandEquipmentnetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_6f02fc48-d541-4e9f-ae9d-94e6a922f6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_6f02fc48-d541-4e9f-ae9d-94e6a922f6fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_77c6f795-959c-4cac-9a25-aa04ddb7d090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_77c6f795-959c-4cac-9a25-aa04ddb7d090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_e682e94d-5200-457d-ba56-ce4a3b79d91e" xlink:href="cron-20221231.xsd#cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:to="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_e682e94d-5200-457d-ba56-ce4a3b79d91e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61e6e021-6172-462f-aa54-0950334acaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61e6e021-6172-462f-aa54-0950334acaab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_61e6e021-6172-462f-aa54-0950334acaab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61e6e021-6172-462f-aa54-0950334acaab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_61e6e021-6172-462f-aa54-0950334acaab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c763ea2b-81bd-4c7f-9681-d528b14f4d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61e6e021-6172-462f-aa54-0950334acaab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c763ea2b-81bd-4c7f-9681-d528b14f4d93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FacilityInStaynerOntarioCanadaMember_37f5a289-5d2c-46a8-816a-df3caee224be" xlink:href="cron-20221231.xsd#cron_FacilityInStaynerOntarioCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c763ea2b-81bd-4c7f-9681-d528b14f4d93" xlink:to="loc_cron_FacilityInStaynerOntarioCanadaMember_37f5a289-5d2c-46a8-816a-df3caee224be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_780cf578-d4f5-418f-babb-e9b92dd683e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c763ea2b-81bd-4c7f-9681-d528b14f4d93" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_780cf578-d4f5-418f-babb-e9b92dd683e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3c08ce86-8da0-4327-b331-555d527b2c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3c08ce86-8da0-4327-b331-555d527b2c96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3c08ce86-8da0-4327-b331-555d527b2c96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3c08ce86-8da0-4327-b331-555d527b2c96" xlink:to="loc_us-gaap_SegmentDomain_3c08ce86-8da0-4327-b331-555d527b2c96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07604fa7-80fd-461b-b900-a70c97c40e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3c08ce86-8da0-4327-b331-555d527b2c96" xlink:to="loc_us-gaap_SegmentDomain_07604fa7-80fd-461b-b900-a70c97c40e7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_99c8988c-7579-49fc-9f37-b92f79efcf24" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_07604fa7-80fd-461b-b900-a70c97c40e7a" xlink:to="loc_cron_UnitedStatesSegmentMember_99c8988c-7579-49fc-9f37-b92f79efcf24" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails" xlink:type="extended" id="i1a12130d61d44e6aa8bc3e4966ac4b19_GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_a9cbda6f-9988-4709-87b1-9897a8a227da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_GoodwillGross_a9cbda6f-9988-4709-87b1-9897a8a227da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4a386075-0f89-4dab-9a87-20b7d8c6da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4a386075-0f89-4dab-9a87-20b7d8c6da8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_945c75ad-4905-4583-8b53-bf16c8da300c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_Goodwill_945c75ad-4905-4583-8b53-bf16c8da300c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_756d6b8a-be4b-4eea-98f6-ba3736b83bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3acee819-9ca8-480c-841d-f6f8ad339f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3acee819-9ca8-480c-841d-f6f8ad339f71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments_32416ed7-c7b5-4594-ae1a-e2a3dfed9278" xlink:href="cron-20221231.xsd#cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:to="loc_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments_32416ed7-c7b5-4594-ae1a-e2a3dfed9278" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_88995262-b437-458d-8e01-443e19f03c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_66f1ff8f-82b8-4d19-bdc1-50be04332ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_66f1ff8f-82b8-4d19-bdc1-50be04332ec2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_c20654b5-f3c4-497a-93bd-a05218a78efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_66f1ff8f-82b8-4d19-bdc1-50be04332ec2" xlink:to="loc_us-gaap_ReportingUnitAxis_c20654b5-f3c4-497a-93bd-a05218a78efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_c20654b5-f3c4-497a-93bd-a05218a78efe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_c20654b5-f3c4-497a-93bd-a05218a78efe" xlink:to="loc_us-gaap_ReportingUnitDomain_c20654b5-f3c4-497a-93bd-a05218a78efe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_87ff0034-c5e4-4a4b-8dcd-5f605148e1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_c20654b5-f3c4-497a-93bd-a05218a78efe" xlink:to="loc_us-gaap_ReportingUnitDomain_87ff0034-c5e4-4a4b-8dcd-5f605148e1a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PeaceNaturalsReportingUnitMember_4dba4615-526d-430d-9c4b-40b15b115057" xlink:href="cron-20221231.xsd#cron_PeaceNaturalsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_87ff0034-c5e4-4a4b-8dcd-5f605148e1a2" xlink:to="loc_cron_PeaceNaturalsReportingUnitMember_4dba4615-526d-430d-9c4b-40b15b115057" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodReportingUnitMember_ef3eaffc-6c6f-45cb-98ac-547520ee3721" xlink:href="cron-20221231.xsd#cron_RedwoodReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_87ff0034-c5e4-4a4b-8dcd-5f605148e1a2" xlink:to="loc_cron_RedwoodReportingUnitMember_ef3eaffc-6c6f-45cb-98ac-547520ee3721" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="extended" id="i1922bb04c1f1435cae95a9487e224da4_GoodwillandIntangibleAssetsnetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_681626f2-1b57-4623-801b-2e2272ccd1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_681626f2-1b57-4623-801b-2e2272ccd1dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a68fa6b2-44ed-42dd-a1a4-5a412ce34b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a68fa6b2-44ed-42dd-a1a4-5a412ce34b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_62d80620-8dfc-4ce5-9f9f-e12de35e86f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_62d80620-8dfc-4ce5-9f9f-e12de35e86f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3caebcfd-3a57-4af1-8870-c3828740ff8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3caebcfd-3a57-4af1-8870-c3828740ff8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_bacfee12-0010-4a37-9aea-f07d2b175dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_bacfee12-0010-4a37-9aea-f07d2b175dcc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a5e3681a-9d58-469d-b98d-8324909d00bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_Goodwill_a5e3681a-9d58-469d-b98d-8324909d00bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a57ffb75-8130-4a65-ab57-6fe36e380b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a57ffb75-8130-4a65-ab57-6fe36e380b6d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1139add8-bd08-4592-a4a7-642a2a50067d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1139add8-bd08-4592-a4a7-642a2a50067d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a9a3f146-4fc4-4bcb-9938-3cc37a3a132e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a9a3f146-4fc4-4bcb-9938-3cc37a3a132e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_c86ee3b8-833b-451c-96be-7de105abbba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_c86ee3b8-833b-451c-96be-7de105abbba7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_2532d843-394d-4176-bbc3-cd5f7d90b86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_2532d843-394d-4176-bbc3-cd5f7d90b86a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d28d972a-4abd-4187-9f03-10b7d3e164ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d28d972a-4abd-4187-9f03-10b7d3e164ca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_93a74fe5-ea63-4c7b-8460-bfe3ab385d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_93a74fe5-ea63-4c7b-8460-bfe3ab385d61" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_a3004207-acfc-4d3b-a5f1-293c5f430b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_a3004207-acfc-4d3b-a5f1-293c5f430b8a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9f48b103-7e19-40c8-969c-ff0cf328469f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9f48b103-7e19-40c8-969c-ff0cf328469f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_8aa8830f-fa0c-4f38-adeb-b7942313c5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_8aa8830f-fa0c-4f38-adeb-b7942313c5d0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfImpairedIntangibles_23b0e16e-98ed-4f37-b9a6-9e17538cd503" xlink:href="cron-20221231.xsd#cron_NumberOfImpairedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_cron_NumberOfImpairedIntangibles_23b0e16e-98ed-4f37-b9a6-9e17538cd503" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5169fab6-90bf-4bd9-9388-929a12d9d64a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5169fab6-90bf-4bd9-9388-929a12d9d64a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_65fe5c87-5dd6-4e09-b33c-3e028c8cf87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_65fe5c87-5dd6-4e09-b33c-3e028c8cf87e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_e34727d5-1d61-43e6-8818-054e07bbd70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_ReportingUnitAxis_e34727d5-1d61-43e6-8818-054e07bbd70f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e34727d5-1d61-43e6-8818-054e07bbd70f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_e34727d5-1d61-43e6-8818-054e07bbd70f" xlink:to="loc_us-gaap_ReportingUnitDomain_e34727d5-1d61-43e6-8818-054e07bbd70f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_61b8efbe-66d3-44ac-b8a2-c1840a8366da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_e34727d5-1d61-43e6-8818-054e07bbd70f" xlink:to="loc_us-gaap_ReportingUnitDomain_61b8efbe-66d3-44ac-b8a2-c1840a8366da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_8ed7dd36-a40d-402c-be0e-ab98f3df1ca2" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_61b8efbe-66d3-44ac-b8a2-c1840a8366da" xlink:to="loc_cron_UnitedStatesSegmentMember_8ed7dd36-a40d-402c-be0e-ab98f3df1ca2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PeaceNaturalsReportingUnitMember_7e033aad-8492-4d96-aa53-d6391cb8ac0e" xlink:href="cron-20221231.xsd#cron_PeaceNaturalsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_61b8efbe-66d3-44ac-b8a2-c1840a8366da" xlink:to="loc_cron_PeaceNaturalsReportingUnitMember_7e033aad-8492-4d96-aa53-d6391cb8ac0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d0294911-2b1f-490e-95fa-5f6fe810084e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d0294911-2b1f-490e-95fa-5f6fe810084e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d0294911-2b1f-490e-95fa-5f6fe810084e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d0294911-2b1f-490e-95fa-5f6fe810084e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d0294911-2b1f-490e-95fa-5f6fe810084e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b9e115e-5e45-4ee5-8cc2-49c30a32ea59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d0294911-2b1f-490e-95fa-5f6fe810084e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b9e115e-5e45-4ee5-8cc2-49c30a32ea59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ada000bf-c328-4a8e-b546-f424ba9ffa77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b9e115e-5e45-4ee5-8cc2-49c30a32ea59" xlink:to="loc_us-gaap_TradeNamesMember_ada000bf-c328-4a8e-b546-f424ba9ffa77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08c380c9-7c6b-4606-b1e2-5752cedd386b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08c380c9-7c6b-4606-b1e2-5752cedd386b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08c380c9-7c6b-4606-b1e2-5752cedd386b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08c380c9-7c6b-4606-b1e2-5752cedd386b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08c380c9-7c6b-4606-b1e2-5752cedd386b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08c380c9-7c6b-4606-b1e2-5752cedd386b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_f55c86c8-2304-4fe0-b8ba-98fa56a0e98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_us-gaap_LicensingAgreementsMember_f55c86c8-2304-4fe0-b8ba-98fa56a0e98f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember_d673deb3-c7a8-46c7-aebe-c6e78d64a2ba" xlink:href="cron-20221231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_HealthCanadaLicensingAgreementsMember_d673deb3-c7a8-46c7-aebe-c6e78d64a2ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBGALicensingAgreementMember_a50adc63-6cf0-49e6-8b81-adc133a60fc5" xlink:href="cron-20221231.xsd#cron_CBGALicensingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_CBGALicensingAgreementMember_a50adc63-6cf0-49e6-8b81-adc133a60fc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBGVALicensingAgreementMember_0e90de93-c467-4209-b787-b2ccbddbe5b5" xlink:href="cron-20221231.xsd#cron_CBGVALicensingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_CBGVALicensingAgreementMember_0e90de93-c467-4209-b787-b2ccbddbe5b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBCALicensingAgreementMember_89e3ce36-0b95-42f7-8b87-82c77ebf47ef" xlink:href="cron-20221231.xsd#cron_CBCALicensingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_CBCALicensingAgreementMember_89e3ce36-0b95-42f7-8b87-82c77ebf47ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBCVALicensingAgreementMember_7ef3ce47-7ab8-4b0f-b441-f43baf8ae9a1" xlink:href="cron-20221231.xsd#cron_CBCVALicensingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_CBCVALicensingAgreementMember_7ef3ce47-7ab8-4b0f-b441-f43baf8ae9a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9dc74f17-c014-46fa-9f51-006c6f4a424e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9dc74f17-c014-46fa-9f51-006c6f4a424e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9dc74f17-c014-46fa-9f51-006c6f4a424e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9dc74f17-c014-46fa-9f51-006c6f4a424e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9dc74f17-c014-46fa-9f51-006c6f4a424e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_905790db-8c00-4205-ab28-343034198457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9dc74f17-c014-46fa-9f51-006c6f4a424e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_905790db-8c00-4205-ab28-343034198457" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodHoldingGroupLLCMember_0458d590-9e85-4614-8705-7ab2cd5ef197" xlink:href="cron-20221231.xsd#cron_RedwoodHoldingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_905790db-8c00-4205-ab28-343034198457" xlink:to="loc_cron_RedwoodHoldingGroupLLCMember_0458d590-9e85-4614-8705-7ab2cd5ef197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a81a9245-dc16-43b1-82df-026efbf82bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a81a9245-dc16-43b1-82df-026efbf82bcc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a81a9245-dc16-43b1-82df-026efbf82bcc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a81a9245-dc16-43b1-82df-026efbf82bcc" xlink:to="loc_us-gaap_EquityComponentDomain_a81a9245-dc16-43b1-82df-026efbf82bcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b8fae5d0-dcbf-4b07-aa5a-0a70d0177226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a81a9245-dc16-43b1-82df-026efbf82bcc" xlink:to="loc_us-gaap_EquityComponentDomain_b8fae5d0-dcbf-4b07-aa5a-0a70d0177226" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a76f2fe6-460a-4add-9cfc-ff4d4eca49b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b8fae5d0-dcbf-4b07-aa5a-0a70d0177226" xlink:to="loc_us-gaap_CommonStockMember_a76f2fe6-460a-4add-9cfc-ff4d4eca49b5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails" xlink:type="extended" id="i0f3af130e7c44058b57d53d72e1e547a_GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f08f9c4-123c-4edf-966b-a2fe1ce8bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f08f9c4-123c-4edf-966b-a2fe1ce8bdbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_66814669-1d47-45f0-b320-0bd119d63859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_66814669-1d47-45f0-b320-0bd119d63859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_9b097bd3-f8cc-428b-96f7-bb5a1c96b9d3" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_9b097bd3-f8cc-428b-96f7-bb5a1c96b9d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_daea4e73-5a29-4652-b041-ef579cf49808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_daea4e73-5a29-4652-b041-ef579cf49808" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4145ed84-0d8d-4701-938b-a53714ae81e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4145ed84-0d8d-4701-938b-a53714ae81e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4145ed84-0d8d-4701-938b-a53714ae81e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_ee65ae0f-18ff-4062-bce7-43c60b7b342f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_ee65ae0f-18ff-4062-bce7-43c60b7b342f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember_543beabb-9819-4ae4-81ac-ca168de2b182" xlink:href="cron-20221231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:to="loc_cron_HealthCanadaLicensingAgreementsMember_543beabb-9819-4ae4-81ac-ca168de2b182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_9dbf3a7a-edfa-4e1f-a61f-4a9143b0f339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:to="loc_us-gaap_LicensingAgreementsMember_9dbf3a7a-edfa-4e1f-a61f-4a9143b0f339" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IsraeliCodesLicensingAgreementsMember_526a0c23-ad56-4b5a-9408-8f985bc3a39a" xlink:href="cron-20221231.xsd#cron_IsraeliCodesLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:to="loc_cron_IsraeliCodesLicensingAgreementsMember_526a0c23-ad56-4b5a-9408-8f985bc3a39a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsGross_90657957-cb89-44dd-ad3f-a180feaae5da" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsGross_90657957-cb89-44dd-ad3f-a180feaae5da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_4e1fe3a6-8a4e-47f5-be15-4f45784586d5" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_4e1fe3a6-8a4e-47f5-be15-4f45784586d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e940e5a6-ab53-4361-a818-5fad727ffb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e940e5a6-ab53-4361-a818-5fad727ffb5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9fa8204d-41c5-4fa6-b981-d05337c96550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9fa8204d-41c5-4fa6-b981-d05337c96550" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ff08c6af-a358-4a8d-8e90-e74688342945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9fa8204d-41c5-4fa6-b981-d05337c96550" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ff08c6af-a358-4a8d-8e90-e74688342945" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ff08c6af-a358-4a8d-8e90-e74688342945_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ff08c6af-a358-4a8d-8e90-e74688342945" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ff08c6af-a358-4a8d-8e90-e74688342945_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0ef26a2-1966-4db3-a5c5-c0843916ba09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ff08c6af-a358-4a8d-8e90-e74688342945" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0ef26a2-1966-4db3-a5c5-c0843916ba09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_972a0af9-5639-4889-ad72-04d1d65f2fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0ef26a2-1966-4db3-a5c5-c0843916ba09" xlink:to="loc_us-gaap_TradeNamesMember_972a0af9-5639-4889-ad72-04d1d65f2fdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c6768ddf-8ba0-48ad-ab49-929125821da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0ef26a2-1966-4db3-a5c5-c0843916ba09" xlink:to="loc_us-gaap_TrademarksMember_c6768ddf-8ba0-48ad-ab49-929125821da4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails" xlink:type="extended" id="ia0b9660e6a7b4e6788b64a4a63c8deb2_GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_c90ce7c9-464c-445c-98b1-2d9503fe3bda" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_c90ce7c9-464c-445c-98b1-2d9503fe3bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4f2a6113-99cb-4ee2-b2a8-4801a583aaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4f2a6113-99cb-4ee2-b2a8-4801a583aaa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_68bbfd94-6eb2-4f9b-8637-199def05bc0a" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_68bbfd94-6eb2-4f9b-8637-199def05bc0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_cc37816a-16ec-418f-a716-ecbbe280068a" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_94f50991-0b17-4759-9cf5-28d26a8b21a0" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_94f50991-0b17-4759-9cf5-28d26a8b21a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_6f04444c-a325-497f-9457-5f535c9d216d" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_6f04444c-a325-497f-9457-5f535c9d216d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_44294aa2-3a4f-4ffd-864d-76edec721ce6" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairment_17dd9e3e-a9a0-4e14-86e7-bf68b6b83547" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairment_17dd9e3e-a9a0-4e14-86e7-bf68b6b83547" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_9628cbbc-2249-48c2-aef5-43082b0b57df" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_9628cbbc-2249-48c2-aef5-43082b0b57df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_434fc05c-4f0b-4b96-b9c8-3b0a9f4e9a52" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_434fc05c-4f0b-4b96-b9c8-3b0a9f4e9a52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairment_780b29c6-15b2-491d-918b-69d202403844" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3666db99-effc-4e22-a184-9d37cc4344ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3666db99-effc-4e22-a184-9d37cc4344ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3666db99-effc-4e22-a184-9d37cc4344ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3666db99-effc-4e22-a184-9d37cc4344ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3666db99-effc-4e22-a184-9d37cc4344ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3666db99-effc-4e22-a184-9d37cc4344ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_aef34fcc-5865-4b16-afd5-4561a869d643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_aef34fcc-5865-4b16-afd5-4561a869d643" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember_f1a87ea7-a158-471a-8fd0-bfd122c2f3e6" xlink:href="cron-20221231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:to="loc_cron_HealthCanadaLicensingAgreementsMember_f1a87ea7-a158-471a-8fd0-bfd122c2f3e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_924b63dd-2a0d-497e-9aea-c5f5394f9c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:to="loc_us-gaap_LicensingAgreementsMember_924b63dd-2a0d-497e-9aea-c5f5394f9c34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f38382f9-93d4-4214-8959-daed5ddb69b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f38382f9-93d4-4214-8959-daed5ddb69b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f38382f9-93d4-4214-8959-daed5ddb69b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f38382f9-93d4-4214-8959-daed5ddb69b8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f38382f9-93d4-4214-8959-daed5ddb69b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a9e14438-610b-478e-9518-314c82259a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f38382f9-93d4-4214-8959-daed5ddb69b8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a9e14438-610b-478e-9518-314c82259a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_aee6e56e-5835-446b-8b2d-90f09af5ba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a9e14438-610b-478e-9518-314c82259a4e" xlink:to="loc_us-gaap_TradeNamesMember_aee6e56e-5835-446b-8b2d-90f09af5ba9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4abf3d5f-13a7-46e5-9140-9db9a1413359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a9e14438-610b-478e-9518-314c82259a4e" xlink:to="loc_us-gaap_TrademarksMember_4abf3d5f-13a7-46e5-9140-9db9a1413359" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="extended" id="iaa162b0aca7b4db1978ee933df600b95_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_9049733b-b708-4236-8a00-db277ab259b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_9049733b-b708-4236-8a00-db277ab259b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_ec5f953d-9c86-44e7-a29e-a72101c3f34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_ec5f953d-9c86-44e7-a29e-a72101c3f34f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_a1a5e08e-67d4-4137-a218-97df6fe12afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_a1a5e08e-67d4-4137-a218-97df6fe12afb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_5e4b9179-81fd-418c-a4ec-32de24274548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_5e4b9179-81fd-418c-a4ec-32de24274548" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_262fa7a5-5c7f-4686-b924-a41f92b16a8b" xlink:href="cron-20221231.xsd#cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_262fa7a5-5c7f-4686-b924-a41f92b16a8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1731976c-2adf-4371-822e-b8efd3fdd21b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:to="loc_srt_RangeAxis_1731976c-2adf-4371-822e-b8efd3fdd21b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1731976c-2adf-4371-822e-b8efd3fdd21b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1731976c-2adf-4371-822e-b8efd3fdd21b" xlink:to="loc_srt_RangeMember_1731976c-2adf-4371-822e-b8efd3fdd21b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdcce2b4-d62b-435e-8e2a-b250a543fd76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1731976c-2adf-4371-822e-b8efd3fdd21b" xlink:to="loc_srt_RangeMember_cdcce2b4-d62b-435e-8e2a-b250a543fd76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b0dce84d-d00b-4790-9d23-f014a3a8f807" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdcce2b4-d62b-435e-8e2a-b250a543fd76" xlink:to="loc_srt_MinimumMember_b0dce84d-d00b-4790-9d23-f014a3a8f807" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_56170604-2c6a-412e-bb3f-ebadaeed0c31" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdcce2b4-d62b-435e-8e2a-b250a543fd76" xlink:to="loc_srt_MaximumMember_56170604-2c6a-412e-bb3f-ebadaeed0c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73efdf3f-bbcf-401b-a32b-fac15e3bffc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73efdf3f-bbcf-401b-a32b-fac15e3bffc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BuildingAndEquipmentMember_d98d7a0b-e0e6-4e61-bb3d-422b5a4d25aa" xlink:href="cron-20221231.xsd#cron_BuildingAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73efdf3f-bbcf-401b-a32b-fac15e3bffc0" xlink:to="loc_cron_BuildingAndEquipmentMember_d98d7a0b-e0e6-4e61-bb3d-422b5a4d25aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_839a5354-baa4-43cd-9173-c985f1644cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73efdf3f-bbcf-401b-a32b-fac15e3bffc0" xlink:to="loc_us-gaap_LandMember_839a5354-baa4-43cd-9173-c985f1644cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ea93f05d-91ee-4390-8804-dc913e2c747b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ea93f05d-91ee-4390-8804-dc913e2c747b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ea93f05d-91ee-4390-8804-dc913e2c747b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ea93f05d-91ee-4390-8804-dc913e2c747b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ea93f05d-91ee-4390-8804-dc913e2c747b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e82779b0-b8d5-4c3d-b71f-6b44ad168537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ea93f05d-91ee-4390-8804-dc913e2c747b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e82779b0-b8d5-4c3d-b71f-6b44ad168537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f7189eea-aca2-48ac-a5ad-f0487a7321e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e82779b0-b8d5-4c3d-b71f-6b44ad168537" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f7189eea-aca2-48ac-a5ad-f0487a7321e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="extended" id="i7077bff8cd1b47f8a7a4488056196e81_DerivativeLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_458d58be-993d-4b43-8cb6-1236958fc194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_458d58be-993d-4b43-8cb6-1236958fc194" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_a9bb6180-88fd-4426-9e8a-e6106448fc73" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_a9bb6180-88fd-4426-9e8a-e6106448fc73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_c65bbd7d-efd5-48c6-8b84-a710c5eb5f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_c65bbd7d-efd5-48c6-8b84-a710c5eb5f12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_881ed362-5908-4cc8-953e-9ae808e8185e" xlink:href="cron-20221231.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_881ed362-5908-4cc8-953e-9ae808e8185e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_94d66cd6-f896-473e-9e3c-a7a8645c4278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_DerivativeLiabilities_94d66cd6-f896-473e-9e3c-a7a8645c4278" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_45371c10-049e-4876-b3b2-923ac0ef3399" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_45371c10-049e-4876-b3b2-923ac0ef3399" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3621a85d-3bb2-4e70-a678-6249225b8ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3621a85d-3bb2-4e70-a678-6249225b8ecf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_a704c48e-57cb-4a55-bb3d-a2d98b735d80" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_a704c48e-57cb-4a55-bb3d-a2d98b735d80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_4d07cb8f-ed2c-4847-8cbc-dfe77375fb03" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_4d07cb8f-ed2c-4847-8cbc-dfe77375fb03" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_cc4d821d-a2ac-4688-929b-6999f2fd924f" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_cc4d821d-a2ac-4688-929b-6999f2fd924f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_9d6beadb-767d-4a79-a9fc-d60c5c29428f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_9d6beadb-767d-4a79-a9fc-d60c5c29428f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_eae191ce-0dd4-4751-9ffc-6c2a05914ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_eae191ce-0dd4-4751-9ffc-6c2a05914ad8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_eae191ce-0dd4-4751-9ffc-6c2a05914ad8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eae191ce-0dd4-4751-9ffc-6c2a05914ad8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_eae191ce-0dd4-4751-9ffc-6c2a05914ad8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eae191ce-0dd4-4751-9ffc-6c2a05914ad8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_a1068165-0dcc-4f59-9254-8f4be4998b8a" xlink:href="cron-20221231.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:to="loc_cron_AltriaInvestmentMember_a1068165-0dcc-4f59-9254-8f4be4998b8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_328bd084-5cc8-4e3e-9961-4a21ef294891" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:to="loc_cron_AltriaWarrantMember_328bd084-5cc8-4e3e-9961-4a21ef294891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_d1d21375-1387-4b34-8d90-a0db09d803eb" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:to="loc_cron_PreemptiveRightsMember_d1d21375-1387-4b34-8d90-a0db09d803eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_46261eb9-4351-47ac-b923-22a2a5505a03" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:to="loc_cron_TopupRightsMember_46261eb9-4351-47ac-b923-22a2a5505a03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_227025cc-2d5b-4c17-9bba-ba5bcd873316" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_227025cc-2d5b-4c17-9bba-ba5bcd873316" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_227025cc-2d5b-4c17-9bba-ba5bcd873316_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_227025cc-2d5b-4c17-9bba-ba5bcd873316" xlink:to="loc_srt_ConsolidatedEntitiesDomain_227025cc-2d5b-4c17-9bba-ba5bcd873316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_76106f99-5164-4832-9eda-32c7a6aaa15a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_227025cc-2d5b-4c17-9bba-ba5bcd873316" xlink:to="loc_srt_ConsolidatedEntitiesDomain_76106f99-5164-4832-9eda-32c7a6aaa15a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_b8435e59-ec8c-48f5-b959-a182e56cfa48" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_76106f99-5164-4832-9eda-32c7a6aaa15a" xlink:to="loc_srt_SubsidiariesMember_b8435e59-ec8c-48f5-b959-a182e56cfa48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fd7c9985-9e68-4e69-80a7-a111e7884bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fd7c9985-9e68-4e69-80a7-a111e7884bc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd7c9985-9e68-4e69-80a7-a111e7884bc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fd7c9985-9e68-4e69-80a7-a111e7884bc0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fd7c9985-9e68-4e69-80a7-a111e7884bc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d40a8525-f3f9-4ae3-9c6a-fae75e476ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fd7c9985-9e68-4e69-80a7-a111e7884bc0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d40a8525-f3f9-4ae3-9c6a-fae75e476ed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_3efe7721-0de8-448f-970f-7e3bdea729bc" xlink:href="cron-20221231.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d40a8525-f3f9-4ae3-9c6a-fae75e476ed7" xlink:to="loc_cron_AltriaInvestmentMember_3efe7721-0de8-448f-970f-7e3bdea729bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_33dacba1-f503-445b-a15b-240623d2fcaa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_dei_LegalEntityAxis_33dacba1-f503-445b-a15b-240623d2fcaa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_33dacba1-f503-445b-a15b-240623d2fcaa_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_33dacba1-f503-445b-a15b-240623d2fcaa" xlink:to="loc_dei_EntityDomain_33dacba1-f503-445b-a15b-240623d2fcaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_dfc88c93-c9d1-4e10-82c7-86c2a231b952" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_33dacba1-f503-445b-a15b-240623d2fcaa" xlink:to="loc_dei_EntityDomain_dfc88c93-c9d1-4e10-82c7-86c2a231b952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_5a4f4836-2911-423f-89d7-a9277a9b9c76" xlink:href="cron-20221231.xsd#cron_AltriaGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_dfc88c93-c9d1-4e10-82c7-86c2a231b952" xlink:to="loc_cron_AltriaGroupInc.Member_5a4f4836-2911-423f-89d7-a9277a9b9c76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e74f24e3-b1c8-483b-a054-e82f1e663bee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e74f24e3-b1c8-483b-a054-e82f1e663bee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e74f24e3-b1c8-483b-a054-e82f1e663bee_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e74f24e3-b1c8-483b-a054-e82f1e663bee" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e74f24e3-b1c8-483b-a054-e82f1e663bee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_786cb8cd-e254-456a-9606-37b0ab5e6105" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e74f24e3-b1c8-483b-a054-e82f1e663bee" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_786cb8cd-e254-456a-9606-37b0ab5e6105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_ec865a6a-bca4-4413-968e-c53d83ef2b7d" xlink:href="cron-20221231.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_786cb8cd-e254-456a-9606-37b0ab5e6105" xlink:to="loc_cron_CronosGroupInc.Member_ec865a6a-bca4-4413-968e-c53d83ef2b7d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="extended" id="i9638ca27957248118c2c103f5153cdd6_DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e542795a-b34e-45b6-9d0e-25a21fa1532e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:href="cron-20221231.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e542795a-b34e-45b6-9d0e-25a21fa1532e" xlink:to="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_18656d20-584f-426c-a541-1210e04416a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_18656d20-584f-426c-a541-1210e04416a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_c73cdcdd-472f-40c2-9dc2-60fff691167d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_c73cdcdd-472f-40c2-9dc2-60fff691167d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_4cf6e529-6a2c-44ce-9580-d1fcbb4836e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_4cf6e529-6a2c-44ce-9580-d1fcbb4836e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_6bbf0220-c35b-4046-b790-3ee77cb53973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fe0d4c81-e5ed-490c-9151-05663569abf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e542795a-b34e-45b6-9d0e-25a21fa1532e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fe0d4c81-e5ed-490c-9151-05663569abf3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_43f6c705-3faf-43de-8861-d1c865d27401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fe0d4c81-e5ed-490c-9151-05663569abf3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_43f6c705-3faf-43de-8861-d1c865d27401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_43f6c705-3faf-43de-8861-d1c865d27401_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_43f6c705-3faf-43de-8861-d1c865d27401" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_43f6c705-3faf-43de-8861-d1c865d27401_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_43f6c705-3faf-43de-8861-d1c865d27401" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_8e6665a9-697c-4f84-9ea2-e96da1b318cb" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:to="loc_cron_AltriaWarrantMember_8e6665a9-697c-4f84-9ea2-e96da1b318cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_30d2b302-c2b6-44c2-9926-653e9e3e8820" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:to="loc_cron_PreemptiveRightsMember_30d2b302-c2b6-44c2-9926-653e9e3e8820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_172af34b-7eb9-4739-880a-8cb2188d1774" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:to="loc_cron_TopupRightsMember_172af34b-7eb9-4739-880a-8cb2188d1774" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="extended" id="i7bb9306add5a4b6d89c7acb77dbd6d30_DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f9d1f7bf-291e-4f70-86ee-d4842811c2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_e7c30314-e2c5-448b-ade8-138bcd3148d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f9d1f7bf-291e-4f70-86ee-d4842811c2c2" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_e7c30314-e2c5-448b-ade8-138bcd3148d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm_be8072e5-3a1d-430f-9a17-f9fcad19823b" xlink:href="cron-20221231.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f9d1f7bf-291e-4f70-86ee-d4842811c2c2" xlink:to="loc_cron_DerivativeLiabilityUsefulLifeTerm_be8072e5-3a1d-430f-9a17-f9fcad19823b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f9d1f7bf-291e-4f70-86ee-d4842811c2c2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_80dba73c-fb72-45a4-9fd2-3f901067c787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_80dba73c-fb72-45a4-9fd2-3f901067c787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_80dba73c-fb72-45a4-9fd2-3f901067c787_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_80dba73c-fb72-45a4-9fd2-3f901067c787" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_80dba73c-fb72-45a4-9fd2-3f901067c787_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_80dba73c-fb72-45a4-9fd2-3f901067c787" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_fe77556e-9f91-456b-ab22-a54d42f0b1ca" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:to="loc_cron_AltriaWarrantMember_fe77556e-9f91-456b-ab22-a54d42f0b1ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_e926e253-2584-4ef8-ad4b-0791b0ca7f4b" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:to="loc_cron_PreemptiveRightsMember_e926e253-2584-4ef8-ad4b-0791b0ca7f4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_453288fe-9e2a-4e72-96d1-6f23d81a79db" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:to="loc_cron_TopupRightsMember_453288fe-9e2a-4e72-96d1-6f23d81a79db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember_3d6a0a1f-59f8-4014-82f5-5f19a3b5ce67" xlink:href="cron-20221231.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:to="loc_cron_PreEmptiveRightsAndTopUpRightsMember_3d6a0a1f-59f8-4014-82f5-5f19a3b5ce67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b2a2391-088e-421f-9655-447cc7a524ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:to="loc_srt_RangeAxis_6b2a2391-088e-421f-9655-447cc7a524ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b2a2391-088e-421f-9655-447cc7a524ba_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6b2a2391-088e-421f-9655-447cc7a524ba" xlink:to="loc_srt_RangeMember_6b2a2391-088e-421f-9655-447cc7a524ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6b2a2391-088e-421f-9655-447cc7a524ba" xlink:to="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_441f04a3-9cd8-4e50-a83e-b75b555bf654" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:to="loc_srt_WeightedAverageMember_441f04a3-9cd8-4e50-a83e-b75b555bf654" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e15f1abe-a21a-4c4f-b14d-9c18aad7d904" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:to="loc_srt_MinimumMember_e15f1abe-a21a-4c4f-b14d-9c18aad7d904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ddee98cc-292b-47f6-a668-3ab4f9c37270" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:to="loc_srt_MaximumMember_ddee98cc-292b-47f6-a668-3ab4f9c37270" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1cafa268-4fec-48f2-876f-b06e4d903a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1cafa268-4fec-48f2-876f-b06e4d903a0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1cafa268-4fec-48f2-876f-b06e4d903a0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1cafa268-4fec-48f2-876f-b06e4d903a0c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1cafa268-4fec-48f2-876f-b06e4d903a0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1cafa268-4fec-48f2-876f-b06e4d903a0c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_577faf72-996f-4af6-b6b2-4d50cfe9c317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_577faf72-996f-4af6-b6b2-4d50cfe9c317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember_995abcd2-4035-4e70-8298-03e260f66c84" xlink:href="cron-20221231.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_cron_MeasurementInputSubscriptionPriceMember_995abcd2-4035-4e70-8298-03e260f66c84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_296d284b-c2e7-4ea3-9447-2f7651b27521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_296d284b-c2e7-4ea3-9447-2f7651b27521" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_6c287eb1-ad6c-42c2-89cd-42423b453046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_6c287eb1-ad6c-42c2-89cd-42423b453046" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_79fd6a26-46f7-483c-984e-f0d281623a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_79fd6a26-46f7-483c-984e-f0d281623a4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_a966821f-b93a-45bd-8e3d-ddc58c1a0a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_a966821f-b93a-45bd-8e3d-ddc58c1a0a14" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="extended" id="i7ead1f634e074ec89b075d69f472820c_DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_312c9484-6a97-485f-bcca-53dc91371edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_312c9484-6a97-485f-bcca-53dc91371edf" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_8d4ae840-3b6d-42a4-b8c7-fa03aa0f3276" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_8d4ae840-3b6d-42a4-b8c7-fa03aa0f3276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_b4944ae4-3aad-4bd4-91f8-c7cfd488cde5" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_b4944ae4-3aad-4bd4-91f8-c7cfd488cde5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_e824598a-656f-4551-8887-91f601292799" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_e824598a-656f-4551-8887-91f601292799" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_de047775-0dd5-4271-a8a0-bf79f7d26c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_312c9484-6a97-485f-bcca-53dc91371edf" xlink:to="loc_us-gaap_DerivativeTable_de047775-0dd5-4271-a8a0-bf79f7d26c49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_d22602bb-752f-449f-be6f-eff16ef29415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_de047775-0dd5-4271-a8a0-bf79f7d26c49" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_d22602bb-752f-449f-be6f-eff16ef29415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_d22602bb-752f-449f-be6f-eff16ef29415_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_d22602bb-752f-449f-be6f-eff16ef29415" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_d22602bb-752f-449f-be6f-eff16ef29415_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_d22602bb-752f-449f-be6f-eff16ef29415" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_f5ace78c-99b8-4451-be41-37bb21bffc13" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:to="loc_cron_AltriaWarrantMember_f5ace78c-99b8-4451-be41-37bb21bffc13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_0c57c56f-ed7f-497e-ad32-31c9eff650c5" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:to="loc_cron_PreemptiveRightsMember_0c57c56f-ed7f-497e-ad32-31c9eff650c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_27e5e035-5c7a-4491-9066-83cbdf96212b" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:to="loc_cron_TopupRightsMember_27e5e035-5c7a-4491-9066-83cbdf96212b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#CommitmentsandContingenciesRDCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails" xlink:type="extended" id="i4f5104f704874f0ea37db5c0f0db9dc8_CommitmentsandContingenciesRDCommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_57b0f79b-6586-46ea-bd35-b7cb5306f330" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_57b0f79b-6586-46ea-bd35-b7cb5306f330" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_7b6cb41d-7d39-4ef7-8eca-f8166743fdcf" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_7b6cb41d-7d39-4ef7-8eca-f8166743fdcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_f4ed1a8c-3675-4db9-8753-74d28a0c6de1" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_f4ed1a8c-3675-4db9-8753-74d28a0c6de1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_e796f593-706f-4e14-8d20-f56a67164f8d" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_e796f593-706f-4e14-8d20-f56a67164f8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_6bf4513a-f224-4beb-a93e-cab154c48067" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentMonthlyFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_6bf4513a-f224-4beb-a93e-cab154c48067" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1c4a98dc-3743-4ded-a2ce-396c832d61d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:to="loc_srt_CounterpartyNameAxis_1c4a98dc-3743-4ded-a2ce-396c832d61d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c4a98dc-3743-4ded-a2ce-396c832d61d2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1c4a98dc-3743-4ded-a2ce-396c832d61d2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c4a98dc-3743-4ded-a2ce-396c832d61d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1c4a98dc-3743-4ded-a2ce-396c832d61d2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoBioworksInc.Member_d2f0c9d6-663e-4d3d-82f6-37bf5d92a030" xlink:href="cron-20221231.xsd#cron_GinkgoBioworksInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:to="loc_cron_GinkgoBioworksInc.Member_d2f0c9d6-663e-4d3d-82f6-37bf5d92a030" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TechnionResearchAndDevelopmentFoundationMember_d73689b6-d2ff-4188-bd09-2a2c2fe0a273" xlink:href="cron-20221231.xsd#cron_TechnionResearchAndDevelopmentFoundationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:to="loc_cron_TechnionResearchAndDevelopmentFoundationMember_d73689b6-d2ff-4188-bd09-2a2c2fe0a273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaVenturesInc.Member_5524cf1b-0a74-4b20-b625-045684ec9245" xlink:href="cron-20221231.xsd#cron_AltriaVenturesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:to="loc_cron_AltriaVenturesInc.Member_5524cf1b-0a74-4b20-b625-045684ec9245" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_c051ea91-a02a-4eec-ad2f-676ccb5602f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_c051ea91-a02a-4eec-ad2f-676ccb5602f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_c051ea91-a02a-4eec-ad2f-676ccb5602f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_c051ea91-a02a-4eec-ad2f-676ccb5602f8" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_c051ea91-a02a-4eec-ad2f-676ccb5602f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_682d4e88-d6d9-4ac2-8255-7f0d24df2872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_c051ea91-a02a-4eec-ad2f-676ccb5602f8" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_682d4e88-d6d9-4ac2-8255-7f0d24df2872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementMember_ea2994cb-bfc3-4df2-9763-9b6b054ac545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_682d4e88-d6d9-4ac2-8255-7f0d24df2872" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementMember_ea2994cb-bfc3-4df2-9763-9b6b054ac545" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesArrangementMember_5bcf760a-15d2-4360-8a80-440474d9c6f5" xlink:href="cron-20221231.xsd#cron_ConsultingServicesArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_682d4e88-d6d9-4ac2-8255-7f0d24df2872" xlink:to="loc_cron_ConsultingServicesArrangementMember_5bcf760a-15d2-4360-8a80-440474d9c6f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3c22cbe2-e787-42ae-a456-58b1de213ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3c22cbe2-e787-42ae-a456-58b1de213ec7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c22cbe2-e787-42ae-a456-58b1de213ec7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c22cbe2-e787-42ae-a456-58b1de213ec7" xlink:to="loc_us-gaap_EquityComponentDomain_3c22cbe2-e787-42ae-a456-58b1de213ec7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ead6eb5-0422-4cb6-8f8e-80ac22e31ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c22cbe2-e787-42ae-a456-58b1de213ec7" xlink:to="loc_us-gaap_EquityComponentDomain_5ead6eb5-0422-4cb6-8f8e-80ac22e31ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3140a312-e20c-4a27-ac93-237e0b0f70b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5ead6eb5-0422-4cb6-8f8e-80ac22e31ddd" xlink:to="loc_us-gaap_CommonStockMember_3140a312-e20c-4a27-ac93-237e0b0f70b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#CommitmentsandContingenciesContingenciesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails" xlink:type="extended" id="i39e2ac53fc804a0db604b3bb6701f0d5_CommitmentsandContingenciesContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_38aa3b11-c714-463a-815b-dbe347626e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_38aa3b11-c714-463a-815b-dbe347626e69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_830f7f90-4fc6-4a04-83f2-ef7c6a12341e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_830f7f90-4fc6-4a04-83f2-ef7c6a12341e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_fe4a70fa-a1b7-4cb7-80e7-4146232631e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_fe4a70fa-a1b7-4cb7-80e7-4146232631e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_1303da2e-fe0a-44f9-b97b-9dd17a7d4070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_1303da2e-fe0a-44f9-b97b-9dd17a7d4070" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue_c503ef5d-2833-4ac1-b16e-a2955165bf15" xlink:href="cron-20221231.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_cron_LossContingencyPunitiveDamagesSoughtValue_c503ef5d-2833-4ac1-b16e-a2955165bf15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6a5b4070-5fd9-4fd5-9c94-2163e61020d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:to="loc_srt_LitigationCaseAxis_6a5b4070-5fd9-4fd5-9c94-2163e61020d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6a5b4070-5fd9-4fd5-9c94-2163e61020d2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6a5b4070-5fd9-4fd5-9c94-2163e61020d2" xlink:to="loc_srt_LitigationCaseTypeDomain_6a5b4070-5fd9-4fd5-9c94-2163e61020d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bc536d00-0eae-45d3-b5a4-687e4bcb2724" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6a5b4070-5fd9-4fd5-9c94-2163e61020d2" xlink:to="loc_srt_LitigationCaseTypeDomain_bc536d00-0eae-45d3-b5a4-687e4bcb2724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_a7a6f51f-f625-4de9-88b2-acb29d79aa33" xlink:href="cron-20221231.xsd#cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bc536d00-0eae-45d3-b5a4-687e4bcb2724" xlink:to="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_a7a6f51f-f625-4de9-88b2-acb29d79aa33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OSCSettlementMember_7423afe4-936e-4d58-b46c-291114d1e99d" xlink:href="cron-20221231.xsd#cron_OSCSettlementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bc536d00-0eae-45d3-b5a4-687e4bcb2724" xlink:to="loc_cron_OSCSettlementMember_7423afe4-936e-4d58-b46c-291114d1e99d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_7bd0a744-95ae-4878-abd0-bd2f5b0437c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:to="loc_us-gaap_LitigationStatusAxis_7bd0a744-95ae-4878-abd0-bd2f5b0437c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7bd0a744-95ae-4878-abd0-bd2f5b0437c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_7bd0a744-95ae-4878-abd0-bd2f5b0437c0" xlink:to="loc_us-gaap_LitigationStatusDomain_7bd0a744-95ae-4878-abd0-bd2f5b0437c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_db4b6fcc-e4e2-449f-a65a-eb913d20f23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_7bd0a744-95ae-4878-abd0-bd2f5b0437c0" xlink:to="loc_us-gaap_LitigationStatusDomain_db4b6fcc-e4e2-449f-a65a-eb913d20f23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_fff87134-0c96-4312-bec2-eed0dd104a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_db4b6fcc-e4e2-449f-a65a-eb913d20f23a" xlink:to="loc_us-gaap_PendingLitigationMember_fff87134-0c96-4312-bec2-eed0dd104a4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_afd55030-a91c-4e4f-a7e7-2f3941b7c551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_db4b6fcc-e4e2-449f-a65a-eb913d20f23a" xlink:to="loc_us-gaap_SettledLitigationMember_afd55030-a91c-4e4f-a7e7-2f3941b7c551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6" xlink:to="loc_us-gaap_LossContingencyNatureDomain_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_14939f67-b8a0-4a8e-930d-8050f5cb6e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6" xlink:to="loc_us-gaap_LossContingencyNatureDomain_14939f67-b8a0-4a8e-930d-8050f5cb6e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember_bb6f6d1e-544b-4e8d-a6e2-d43a182bed7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_14939f67-b8a0-4a8e-930d-8050f5cb6e95" xlink:to="loc_us-gaap_UnfavorableRegulatoryActionMember_bb6f6d1e-544b-4e8d-a6e2-d43a182bed7c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails" xlink:type="extended" id="i4853db109c1e473f82c55292921a46b6_SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_323f44ad-fd66-4b62-a462-a58b7a8ae56d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_09bf8517-9fab-429c-b271-2ea92c66cfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_323f44ad-fd66-4b62-a462-a58b7a8ae56d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_09bf8517-9fab-429c-b271-2ea92c66cfe4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_323f44ad-fd66-4b62-a462-a58b7a8ae56d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_714b5557-bbab-4201-8ddf-bb930e9b3335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:to="loc_us-gaap_AwardTypeAxis_714b5557-bbab-4201-8ddf-bb930e9b3335" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_714b5557-bbab-4201-8ddf-bb930e9b3335_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_714b5557-bbab-4201-8ddf-bb930e9b3335" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_714b5557-bbab-4201-8ddf-bb930e9b3335_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_714b5557-bbab-4201-8ddf-bb930e9b3335" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b66e8904-f5ae-4ea4-976b-f864c9ce2cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b66e8904-f5ae-4ea4-976b-f864c9ce2cbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7798c1ff-b0e3-4345-b82c-00df70970423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7798c1ff-b0e3-4345-b82c-00df70970423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LiabilityClassifiedAwardsMember_7d92af21-8f9f-4cef-b417-8ca5a6a94c40" xlink:href="cron-20221231.xsd#cron_LiabilityClassifiedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:to="loc_cron_LiabilityClassifiedAwardsMember_7d92af21-8f9f-4cef-b417-8ca5a6a94c40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_81f711f3-3ede-4cbd-84b8-fd90176b43f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:to="loc_srt_RestatementAxis_81f711f3-3ede-4cbd-84b8-fd90176b43f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_81f711f3-3ede-4cbd-84b8-fd90176b43f7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_81f711f3-3ede-4cbd-84b8-fd90176b43f7" xlink:to="loc_srt_RestatementDomain_81f711f3-3ede-4cbd-84b8-fd90176b43f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_446b7847-9b5e-4494-9da4-fd8f60e53a89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_81f711f3-3ede-4cbd-84b8-fd90176b43f7" xlink:to="loc_srt_RestatementDomain_446b7847-9b5e-4494-9da4-fd8f60e53a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_46c704b4-452a-4c01-bd0d-cef850be5bea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_446b7847-9b5e-4494-9da4-fd8f60e53a89" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_46c704b4-452a-4c01-bd0d-cef850be5bea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationStockOptionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails" xlink:type="extended" id="if2a061bd3ac641f3a36134df91d7e57e_SharebasedCompensationStockOptionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_443240c5-3b77-4a75-bc05-04fae233165c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_443240c5-3b77-4a75-bc05-04fae233165c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72d08cdb-de1f-4292-8fc7-7f9c325164ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72d08cdb-de1f-4292-8fc7-7f9c325164ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_9a58249e-3477-4e96-986a-60771c16a066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:to="loc_us-gaap_SharePrice_9a58249e-3477-4e96-986a-60771c16a066" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_17a0040c-1532-4b7b-9a9d-0555ea3df122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:to="loc_us-gaap_AwardTypeAxis_17a0040c-1532-4b7b-9a9d-0555ea3df122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17a0040c-1532-4b7b-9a9d-0555ea3df122_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_17a0040c-1532-4b7b-9a9d-0555ea3df122" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17a0040c-1532-4b7b-9a9d-0555ea3df122_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8273281e-4348-4f83-8a1a-15a2f4a9e397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_17a0040c-1532-4b7b-9a9d-0555ea3df122" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8273281e-4348-4f83-8a1a-15a2f4a9e397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d2d6ab3f-2134-4bb9-a6a6-4f219cda71cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8273281e-4348-4f83-8a1a-15a2f4a9e397" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d2d6ab3f-2134-4bb9-a6a6-4f219cda71cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a66e6af3-e004-4991-b1ec-c75636df5b37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:to="loc_srt_RangeAxis_a66e6af3-e004-4991-b1ec-c75636df5b37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a66e6af3-e004-4991-b1ec-c75636df5b37_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a66e6af3-e004-4991-b1ec-c75636df5b37" xlink:to="loc_srt_RangeMember_a66e6af3-e004-4991-b1ec-c75636df5b37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a66e6af3-e004-4991-b1ec-c75636df5b37" xlink:to="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_031682a9-2999-4063-974e-fdc8a1c90422" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:to="loc_srt_MinimumMember_031682a9-2999-4063-974e-fdc8a1c90422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b19cbbbd-2a97-4587-9a5f-291cb3fb793a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:to="loc_srt_MaximumMember_b19cbbbd-2a97-4587-9a5f-291cb3fb793a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_d6feb42d-e56e-44ee-a75c-4db5ba599ca1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:to="loc_srt_WeightedAverageMember_d6feb42d-e56e-44ee-a75c-4db5ba599ca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7dae0e19-5887-4943-948b-68675c076e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:to="loc_us-gaap_PlanNameAxis_7dae0e19-5887-4943-948b-68675c076e18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7dae0e19-5887-4943-948b-68675c076e18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7dae0e19-5887-4943-948b-68675c076e18" xlink:to="loc_us-gaap_PlanNameDomain_7dae0e19-5887-4943-948b-68675c076e18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7dae0e19-5887-4943-948b-68675c076e18" xlink:to="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_1d6df3da-50eb-4fa3-9f98-fb269cdd76a7" xlink:href="cron-20221231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:to="loc_cron_A2015StockOptionPlanMember_1d6df3da-50eb-4fa3-9f98-fb269cdd76a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_e417fb4b-5490-49c1-8912-3ff27819acf0" xlink:href="cron-20221231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:to="loc_cron_A2018StockOptionPlanMember_e417fb4b-5490-49c1-8912-3ff27819acf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_f365279d-5fee-44ee-be94-5497d25a3890" xlink:href="cron-20221231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:to="loc_cron_A2020OmnibusPlanMember_f365279d-5fee-44ee-be94-5497d25a3890" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationFairValueofOptionsIssuedDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails" xlink:type="extended" id="i7638ec2a9240454493f3cff6cee57f69_SharebasedCompensationFairValueofOptionsIssuedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_5ad6374b-265e-484a-b117-b283af2927a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_SharePrice_5ad6374b-265e-484a-b117-b283af2927a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2dd51c0e-844e-44fe-a656-179ca50ddef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2dd51c0e-844e-44fe-a656-179ca50ddef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d6e0e4b3-1e05-43b1-8442-d3dc919d83ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d6e0e4b3-1e05-43b1-8442-d3dc919d83ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_110b2f22-3be2-4991-8a1d-1455eac22cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_110b2f22-3be2-4991-8a1d-1455eac22cd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_20393a89-e501-4d7f-96cb-76af52f09fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_20393a89-e501-4d7f-96cb-76af52f09fde" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12cc5cbf-13bc-4496-bf70-718ec143019b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12cc5cbf-13bc-4496-bf70-718ec143019b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_29dd65ac-447c-4a39-9679-eb5d9e1b8243" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_29dd65ac-447c-4a39-9679-eb5d9e1b8243" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_a8e3684e-2f19-47a5-b5d7-0e2e22756db1" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_a8e3684e-2f19-47a5-b5d7-0e2e22756db1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db69423-2719-403a-b5cf-89fdb4de2768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db69423-2719-403a-b5cf-89fdb4de2768" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_749f61cf-7adf-4f55-9297-66893a5f2fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db69423-2719-403a-b5cf-89fdb4de2768" xlink:to="loc_us-gaap_AwardTypeAxis_749f61cf-7adf-4f55-9297-66893a5f2fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_749f61cf-7adf-4f55-9297-66893a5f2fdb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_749f61cf-7adf-4f55-9297-66893a5f2fdb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_749f61cf-7adf-4f55-9297-66893a5f2fdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51d7d738-2b9b-4701-83e0-1f3adc31f66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_749f61cf-7adf-4f55-9297-66893a5f2fdb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51d7d738-2b9b-4701-83e0-1f3adc31f66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5c11c92e-80fa-487f-95c1-c47554cedf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51d7d738-2b9b-4701-83e0-1f3adc31f66f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5c11c92e-80fa-487f-95c1-c47554cedf5e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationScheduleofStockOptionsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails" xlink:type="extended" id="i1092b92222d64db0993dc537a0d8774f_SharebasedCompensationScheduleofStockOptionsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a130d-d7b0-43d1-aeb5-1b7d40e53797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a46868b-c006-45ed-966f-0a721d0a3237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a130d-d7b0-43d1-aeb5-1b7d40e53797" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a46868b-c006-45ed-966f-0a721d0a3237" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af586114-8171-4a74-9e60-83666e6cf54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a130d-d7b0-43d1-aeb5-1b7d40e53797" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af586114-8171-4a74-9e60-83666e6cf54b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3c48adfd-f17f-4867-8c5d-ef12ff9861e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af586114-8171-4a74-9e60-83666e6cf54b" xlink:to="loc_us-gaap_PlanNameAxis_3c48adfd-f17f-4867-8c5d-ef12ff9861e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3c48adfd-f17f-4867-8c5d-ef12ff9861e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3c48adfd-f17f-4867-8c5d-ef12ff9861e3" xlink:to="loc_us-gaap_PlanNameDomain_3c48adfd-f17f-4867-8c5d-ef12ff9861e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3c48adfd-f17f-4867-8c5d-ef12ff9861e3" xlink:to="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_cb6a41e4-1db7-4938-8305-50d8fa638f49" xlink:href="cron-20221231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:to="loc_cron_A2020OmnibusPlanMember_cb6a41e4-1db7-4938-8305-50d8fa638f49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_6e233d98-1621-4c2b-8998-3f5e11432b46" xlink:href="cron-20221231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:to="loc_cron_A2018StockOptionPlanMember_6e233d98-1621-4c2b-8998-3f5e11432b46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_afab235a-139b-479d-b26d-d056841325e6" xlink:href="cron-20221231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:to="loc_cron_A2015StockOptionPlanMember_afab235a-139b-479d-b26d-d056841325e6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationRestrictedShareUnitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails" xlink:type="extended" id="if89aaf13a748447c90688d04079a242b_SharebasedCompensationRestrictedShareUnitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_802c9774-0eae-4ca1-90be-cd1bcf01f28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c7494ab0-ed15-4676-b413-fcb8a3f34edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_802c9774-0eae-4ca1-90be-cd1bcf01f28f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c7494ab0-ed15-4676-b413-fcb8a3f34edc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d293bc5d-11f1-494f-83f8-054d43a0ae00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_802c9774-0eae-4ca1-90be-cd1bcf01f28f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d293bc5d-11f1-494f-83f8-054d43a0ae00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1c050408-9b97-48f5-b30c-2830935a5b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d293bc5d-11f1-494f-83f8-054d43a0ae00" xlink:to="loc_us-gaap_AwardTypeAxis_1c050408-9b97-48f5-b30c-2830935a5b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c050408-9b97-48f5-b30c-2830935a5b5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1c050408-9b97-48f5-b30c-2830935a5b5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c050408-9b97-48f5-b30c-2830935a5b5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425ff1e7-8c2f-41ed-a09b-ed624aa1541a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1c050408-9b97-48f5-b30c-2830935a5b5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425ff1e7-8c2f-41ed-a09b-ed624aa1541a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_07a8e8e6-b004-442c-a021-33b10b51fd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425ff1e7-8c2f-41ed-a09b-ed624aa1541a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_07a8e8e6-b004-442c-a021-33b10b51fd3b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails" xlink:type="extended" id="i55c24af3872d469590933ea93c69ccbe_SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:href="cron-20221231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3e2c6e2d-1016-4d53-a072-2a3f9bb4b0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3e2c6e2d-1016-4d53-a072-2a3f9bb4b0dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6b6a2f67-e5ac-448d-a253-68c3d7311f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6b6a2f67-e5ac-448d-a253-68c3d7311f3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1a1b052a-4318-4636-94f0-4cca7d0fa42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1a1b052a-4318-4636-94f0-4cca7d0fa42c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_515a803d-0792-4f1c-93d9-cb948f443537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_515a803d-0792-4f1c-93d9-cb948f443537" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0c45e235-b835-4711-8c01-340f9c2a36f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_09d0d7b6-83ac-454e-a9cd-c821cfb11090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_09d0d7b6-83ac-454e-a9cd-c821cfb11090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_33df6065-62da-4f7a-86d0-6c8afb501585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_33df6065-62da-4f7a-86d0-6c8afb501585" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_01e1f2c8-48aa-4fda-86a7-953c0b4e27f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_01e1f2c8-48aa-4fda-86a7-953c0b4e27f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_531efa92-52f4-463e-9158-e193b38d5941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_531efa92-52f4-463e-9158-e193b38d5941" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f1948f38-46df-4e51-a453-0c7d942965b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_73118010-c55f-41db-9733-0fbea3a27020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_73118010-c55f-41db-9733-0fbea3a27020" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod_3b9f1c53-69f3-4544-b481-0a87b8eff120" xlink:href="cron-20221231.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod_3b9f1c53-69f3-4544-b481-0a87b8eff120" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_becdc2eb-b865-4d48-a0d8-7f74c9241145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:to="loc_us-gaap_AwardTypeAxis_becdc2eb-b865-4d48-a0d8-7f74c9241145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_becdc2eb-b865-4d48-a0d8-7f74c9241145_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_becdc2eb-b865-4d48-a0d8-7f74c9241145" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_becdc2eb-b865-4d48-a0d8-7f74c9241145_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d6958fd-d272-4b0c-9d9f-010aa88a9bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_becdc2eb-b865-4d48-a0d8-7f74c9241145" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d6958fd-d272-4b0c-9d9f-010aa88a9bb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4d28dccb-e8f8-49e3-a957-74237fb482da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d6958fd-d272-4b0c-9d9f-010aa88a9bb6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4d28dccb-e8f8-49e3-a957-74237fb482da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_56a0f352-63f9-4f1e-b259-e1b64f784e1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:to="loc_srt_RangeAxis_56a0f352-63f9-4f1e-b259-e1b64f784e1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_56a0f352-63f9-4f1e-b259-e1b64f784e1e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_56a0f352-63f9-4f1e-b259-e1b64f784e1e" xlink:to="loc_srt_RangeMember_56a0f352-63f9-4f1e-b259-e1b64f784e1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_31d78995-ff71-4c30-8bf0-faa86dee5d53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_56a0f352-63f9-4f1e-b259-e1b64f784e1e" xlink:to="loc_srt_RangeMember_31d78995-ff71-4c30-8bf0-faa86dee5d53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a2e069b1-9e80-4c81-9204-7985284f7961" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_31d78995-ff71-4c30-8bf0-faa86dee5d53" xlink:to="loc_srt_MinimumMember_a2e069b1-9e80-4c81-9204-7985284f7961" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3b818a8a-13a2-457d-8034-1078362cb0e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_31d78995-ff71-4c30-8bf0-faa86dee5d53" xlink:to="loc_srt_MaximumMember_3b818a8a-13a2-457d-8034-1078362cb0e2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails" xlink:type="extended" id="ifca3066a080847bcba2af8ab32445627_SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e348bd0c-8df5-442f-885f-4524a2bd0943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:href="cron-20221231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e348bd0c-8df5-442f-885f-4524a2bd0943" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_48676a71-2d25-442f-84b6-e5029d061a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_48676a71-2d25-442f-84b6-e5029d061a7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_34e7b32b-9f1a-4601-9527-51a2c666c3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_34e7b32b-9f1a-4601-9527-51a2c666c3b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_4758079d-c2d3-4321-910e-e83716cc777e" xlink:href="cron-20221231.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_4758079d-c2d3-4321-910e-e83716cc777e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_f6d4fe9c-69d9-4e1c-b3b9-9958f4705b97" xlink:href="cron-20221231.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_f6d4fe9c-69d9-4e1c-b3b9-9958f4705b97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_dfa45492-4d75-4e6d-bd7c-623c3f3f1124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e348bd0c-8df5-442f-885f-4524a2bd0943" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_02511ab7-c7fc-4b12-b3c5-b27d1e777568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_02511ab7-c7fc-4b12-b3c5-b27d1e777568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_983dc193-25ca-4e6f-8f61-fefc40a803b0" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_983dc193-25ca-4e6f-8f61-fefc40a803b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_494b1ba8-a2cb-48dd-95c3-6a752e382a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_494b1ba8-a2cb-48dd-95c3-6a752e382a66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cca10d5f-8d0d-482c-8c8a-805a78eb4a80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31a83f3-788c-4340-adbd-70c145317983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e348bd0c-8df5-442f-885f-4524a2bd0943" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31a83f3-788c-4340-adbd-70c145317983" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_856e2dab-d17e-4063-baac-cdfbeddce1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31a83f3-788c-4340-adbd-70c145317983" xlink:to="loc_us-gaap_AwardTypeAxis_856e2dab-d17e-4063-baac-cdfbeddce1d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_856e2dab-d17e-4063-baac-cdfbeddce1d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_856e2dab-d17e-4063-baac-cdfbeddce1d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_856e2dab-d17e-4063-baac-cdfbeddce1d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c382e2e-cd32-4116-83d7-c8b7325b08ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_856e2dab-d17e-4063-baac-cdfbeddce1d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c382e2e-cd32-4116-83d7-c8b7325b08ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember_628fc830-eca6-44f6-b4ce-6e5e0ec0daed" xlink:href="cron-20221231.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c382e2e-cd32-4116-83d7-c8b7325b08ab" xlink:to="loc_cron_DeferredShareUnitsDSUsMember_628fc830-eca6-44f6-b4ce-6e5e0ec0daed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryofChangesinWarrantsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails" xlink:type="extended" id="ibdfb1a0f1dcd47938bc96526cc25e705_SharebasedCompensationSummaryofChangesinWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb81554-ec61-4a3b-be08-6b51dae45885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb81554-ec61-4a3b-be08-6b51dae45885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cec7fade-5adb-444e-af06-1240c3510905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cec7fade-5adb-444e-af06-1240c3510905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ea32886c-67d1-4da3-9000-57a0e7de7555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ea32886c-67d1-4da3-9000-57a0e7de7555" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2bfc3de-c0d7-4ff1-888c-fb4a4d1189e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb81554-ec61-4a3b-be08-6b51dae45885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_66b4de84-bb4a-4e54-a17c-7252c7196aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_66b4de84-bb4a-4e54-a17c-7252c7196aa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_96010850-21b8-49db-8adf-39b7432fc266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_96010850-21b8-49db-8adf-39b7432fc266" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c9b14261-ea92-42d0-ab0d-f2216ba347d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1b818ae-f0f3-4bdf-a8f1-f8ce4178b648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb81554-ec61-4a3b-be08-6b51dae45885" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1b818ae-f0f3-4bdf-a8f1-f8ce4178b648" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d3f73601-86e9-4b3d-9d4d-9709061296f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1b818ae-f0f3-4bdf-a8f1-f8ce4178b648" xlink:to="loc_us-gaap_AwardTypeAxis_d3f73601-86e9-4b3d-9d4d-9709061296f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3f73601-86e9-4b3d-9d4d-9709061296f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d3f73601-86e9-4b3d-9d4d-9709061296f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3f73601-86e9-4b3d-9d4d-9709061296f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cbe48e71-7645-40d4-a251-47c9cda2036e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d3f73601-86e9-4b3d-9d4d-9709061296f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cbe48e71-7645-40d4-a251-47c9cda2036e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_72e38f2c-d865-4429-9957-cacd49fe77e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cbe48e71-7645-40d4-a251-47c9cda2036e" xlink:to="loc_us-gaap_WarrantMember_72e38f2c-d865-4429-9957-cacd49fe77e9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationLiabilityClassifiedAwardsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails" xlink:type="extended" id="ib447cb86be124ed482f247cb2ee6e5f0_SharebasedCompensationLiabilityClassifiedAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45093f20-eb53-47ef-80fe-bf3341d3c6e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:href="cron-20221231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45093f20-eb53-47ef-80fe-bf3341d3c6e8" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_5be8ef26-bacd-44c3-af76-e708d158d728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_5be8ef26-bacd-44c3-af76-e708d158d728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e6c91c24-b727-4614-8ce5-0e85cf586479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e6c91c24-b727-4614-8ce5-0e85cf586479" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards_5a1cdeb1-67c4-4534-b9c6-ee50227838cc" xlink:href="cron-20221231.xsd#cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:to="loc_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards_5a1cdeb1-67c4-4534-b9c6-ee50227838cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_47039ddf-b24c-4fac-b2f7-1223d6a9f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb70fc-d2a8-464d-8fa8-4da562f9252a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45093f20-eb53-47ef-80fe-bf3341d3c6e8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb70fc-d2a8-464d-8fa8-4da562f9252a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb70fc-d2a8-464d-8fa8-4da562f9252a" xlink:to="loc_us-gaap_AwardTypeAxis_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b0ebc8f5-adb6-41e0-b5c9-5d5d6457154a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b0ebc8f5-adb6-41e0-b5c9-5d5d6457154a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LiabilityClassifiedAwardsMember_fae9d78d-3bdd-4f9d-8a55-2e6503f0eb66" xlink:href="cron-20221231.xsd#cron_LiabilityClassifiedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b0ebc8f5-adb6-41e0-b5c9-5d5d6457154a" xlink:to="loc_cron_LiabilityClassifiedAwardsMember_fae9d78d-3bdd-4f9d-8a55-2e6503f0eb66" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="extended" id="i497c58c40f234bde95552fb841f5e4c2_IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_5141e5fb-e58b-46a0-b0ca-a90599d8aa40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1f931cfc-f08d-41db-9e02-194c992e4154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_5141e5fb-e58b-46a0-b0ca-a90599d8aa40" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1f931cfc-f08d-41db-9e02-194c992e4154" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_20676396-6e9c-4582-af09-d0b8394b5000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_5141e5fb-e58b-46a0-b0ca-a90599d8aa40" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_20676396-6e9c-4582-af09-d0b8394b5000" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3eeb0c85-3461-4fd4-a119-6db60abe9a85" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_20676396-6e9c-4582-af09-d0b8394b5000" xlink:to="loc_srt_StatementGeographicalAxis_3eeb0c85-3461-4fd4-a119-6db60abe9a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3eeb0c85-3461-4fd4-a119-6db60abe9a85_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3eeb0c85-3461-4fd4-a119-6db60abe9a85" xlink:to="loc_srt_SegmentGeographicalDomain_3eeb0c85-3461-4fd4-a119-6db60abe9a85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7531b7ab-ee4f-4a2d-9982-ec9cc9352d25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3eeb0c85-3461-4fd4-a119-6db60abe9a85" xlink:to="loc_srt_SegmentGeographicalDomain_7531b7ab-ee4f-4a2d-9982-ec9cc9352d25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_dddecdd7-e916-4fa0-9c8c-b3fa870bad53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7531b7ab-ee4f-4a2d-9982-ec9cc9352d25" xlink:to="loc_us-gaap_NonUsMember_dddecdd7-e916-4fa0-9c8c-b3fa870bad53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_32ceeb52-1069-42e2-9bf3-5c07b0ac2f7e" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7531b7ab-ee4f-4a2d-9982-ec9cc9352d25" xlink:to="loc_country_US_32ceeb52-1069-42e2-9bf3-5c07b0ac2f7e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="icbf740e6e0b94ee58a8a821cbb6ee6a2_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_a6bb7a68-a620-4f28-9768-5e0d1b10ef3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_a6bb7a68-a620-4f28-9768-5e0d1b10ef3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_6c9a9d73-d471-419e-93b9-213df97f8f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_TaxesPayableCurrent_6c9a9d73-d471-419e-93b9-213df97f8f06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_bcc7f881-0a1a-46da-8484-0a20c87c19f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_IncomeTaxesReceivable_bcc7f881-0a1a-46da-8484-0a20c87c19f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CapitalGainRelinquishmentOfWarrant_636dda6f-9ff6-456d-b8ce-d7f062fc42d1" xlink:href="cron-20221231.xsd#cron_CapitalGainRelinquishmentOfWarrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_cron_CapitalGainRelinquishmentOfWarrant_636dda6f-9ff6-456d-b8ce-d7f062fc42d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_3fd3638a-69fa-48dd-8e56-afe19d7ffd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_3fd3638a-69fa-48dd-8e56-afe19d7ffd8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b3b743ab-819a-43d4-b1bb-5e0a99b2bc70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b3b743ab-819a-43d4-b1bb-5e0a99b2bc70" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4c44b9b4-95d6-43f4-a9e2-a75171757138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4c44b9b4-95d6-43f4-a9e2-a75171757138" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_c9109b28-13b0-4a63-a9c6-f902325f2ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_c9109b28-13b0-4a63-a9c6-f902325f2ccd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0d1aaa53-f8b3-4b9e-9a39-744059798b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0d1aaa53-f8b3-4b9e-9a39-744059798b25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0d1aaa53-f8b3-4b9e-9a39-744059798b25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d1aaa53-f8b3-4b9e-9a39-744059798b25" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0d1aaa53-f8b3-4b9e-9a39-744059798b25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_d5edb133-aab6-40c7-aa85-c514d637ec02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d1aaa53-f8b3-4b9e-9a39-744059798b25" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_d5edb133-aab6-40c7-aa85-c514d637ec02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_66eddb40-3fba-4009-9e37-cc797cd8ea89" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d5edb133-aab6-40c7-aa85-c514d637ec02" xlink:to="loc_cron_AltriaWarrantMember_66eddb40-3fba-4009-9e37-cc797cd8ea89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_19ac23db-8187-4a96-b180-05a0f99221fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_19ac23db-8187-4a96-b180-05a0f99221fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_19ac23db-8187-4a96-b180-05a0f99221fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_19ac23db-8187-4a96-b180-05a0f99221fa" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_19ac23db-8187-4a96-b180-05a0f99221fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_b16bdacd-d229-4af6-8169-a485b2c67e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_19ac23db-8187-4a96-b180-05a0f99221fa" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_b16bdacd-d229-4af6-8169-a485b2c67e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_5f0dad55-021d-423f-a0cf-99117f7aa5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_b16bdacd-d229-4af6-8169-a485b2c67e24" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_5f0dad55-021d-423f-a0cf-99117f7aa5c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_98884499-be0a-4244-b1b6-b8e21ffdcd77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_98884499-be0a-4244-b1b6-b8e21ffdcd77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_98884499-be0a-4244-b1b6-b8e21ffdcd77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_98884499-be0a-4244-b1b6-b8e21ffdcd77" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_98884499-be0a-4244-b1b6-b8e21ffdcd77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_98884499-be0a-4244-b1b6-b8e21ffdcd77" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CanadaRevenueAgencyMember_52afcdf6-13ff-4360-8b6d-f44b130cde63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CanadaRevenueAgencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:to="loc_us-gaap_CanadaRevenueAgencyMember_52afcdf6-13ff-4360-8b6d-f44b130cde63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_337575df-0b90-4004-b460-c186b9b55152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_337575df-0b90-4004-b460-c186b9b55152" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_abef2572-7055-4dfe-9361-35bab861cf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_abef2572-7055-4dfe-9361-35bab861cf1e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesExpenseforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="extended" id="i43570b37b7ea45f7ad91292de319b177_IncomeTaxesExpenseforIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_cee25370-3991-4a37-9f88-223d2bf020f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_375b6ba4-7475-43ab-a60f-3f5cc6767324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cee25370-3991-4a37-9f88-223d2bf020f7" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_375b6ba4-7475-43ab-a60f-3f5cc6767324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4304cf33-7ff3-410c-88c7-6f28a8d6c9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_375b6ba4-7475-43ab-a60f-3f5cc6767324" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4304cf33-7ff3-410c-88c7-6f28a8d6c9dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_dac1d243-f260-40b8-89a0-89e331fbf2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cee25370-3991-4a37-9f88-223d2bf020f7" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_dac1d243-f260-40b8-89a0-89e331fbf2c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ae7ec6a-0e59-4860-88a1-d5028756b02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_dac1d243-f260-40b8-89a0-89e331fbf2c6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ae7ec6a-0e59-4860-88a1-d5028756b02f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_f5bdc7db-1c4a-4789-a584-1beaaef4cbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cee25370-3991-4a37-9f88-223d2bf020f7" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_f5bdc7db-1c4a-4789-a584-1beaaef4cbdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ab07b26d-d7af-4b3b-8897-59dcb4b4963d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_f5bdc7db-1c4a-4789-a584-1beaaef4cbdf" xlink:to="loc_srt_StatementGeographicalAxis_ab07b26d-d7af-4b3b-8897-59dcb4b4963d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ab07b26d-d7af-4b3b-8897-59dcb4b4963d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ab07b26d-d7af-4b3b-8897-59dcb4b4963d" xlink:to="loc_srt_SegmentGeographicalDomain_ab07b26d-d7af-4b3b-8897-59dcb4b4963d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_13410ec1-d189-4763-96e1-e7bd9f79debe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ab07b26d-d7af-4b3b-8897-59dcb4b4963d" xlink:to="loc_srt_SegmentGeographicalDomain_13410ec1-d189-4763-96e1-e7bd9f79debe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_02aab4f3-16fe-451e-aeb2-e046d3b37792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_13410ec1-d189-4763-96e1-e7bd9f79debe" xlink:to="loc_us-gaap_NonUsMember_02aab4f3-16fe-451e-aeb2-e046d3b37792" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0945bae9-a05f-49ea-97ba-4d79f11f95e4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_13410ec1-d189-4763-96e1-e7bd9f79debe" xlink:to="loc_country_US_0945bae9-a05f-49ea-97ba-4d79f11f95e4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails" xlink:type="extended" id="i5c0e1724177a4f3387def9bab896fbe3_SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90c61147-3226-41b8-bf57-887e63536f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90c61147-3226-41b8-bf57-887e63536f55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_78579f6b-45b7-4521-af65-c4b7c36f242b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_78579f6b-45b7-4521-af65-c4b7c36f242b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_81006362-8e77-4e82-b2bb-3252e04bbafd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_81006362-8e77-4e82-b2bb-3252e04bbafd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_208082f3-f323-49b5-aef6-984fbc1510e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_InterestExpense_208082f3-f323-49b5-aef6-984fbc1510e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7370cb38-2888-44d4-a6c2-c24f9c38e279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7370cb38-2888-44d4-a6c2-c24f9c38e279" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_01a1a838-04aa-4071-b081-fb51739b904a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_Assets_01a1a838-04aa-4071-b081-fb51739b904a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ecf83a8b-3b4e-4e34-9350-1deaaeda124b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_DepreciationAndAmortization_ecf83a8b-3b4e-4e34-9350-1deaaeda124b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_dde605ea-12bc-4a6c-9909-0eb86e895ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_dde605ea-12bc-4a6c-9909-0eb86e895ee5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_aa3a6849-cec0-419e-8c98-cf40800f43eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_aa3a6849-cec0-419e-8c98-cf40800f43eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_eb3788bb-08c2-4db3-9243-2d69cbb8fdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_eb3788bb-08c2-4db3-9243-2d69cbb8fdf0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_29ed73b1-2dc2-48c5-ad27-bc0b6593ce00" xlink:href="cron-20221231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_29ed73b1-2dc2-48c5-ad27-bc0b6593ce00" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_560e8245-f282-40c2-bd80-3558ce1cc2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_560e8245-f282-40c2-bd80-3558ce1cc2a6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2928f543-0a97-4807-b001-1e5ba08deb86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:to="loc_srt_ProductOrServiceAxis_2928f543-0a97-4807-b001-1e5ba08deb86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2928f543-0a97-4807-b001-1e5ba08deb86_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2928f543-0a97-4807-b001-1e5ba08deb86" xlink:to="loc_srt_ProductsAndServicesDomain_2928f543-0a97-4807-b001-1e5ba08deb86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2928f543-0a97-4807-b001-1e5ba08deb86" xlink:to="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember_6097f6dd-ef18-48c3-a44e-bed08337d5e6" xlink:href="cron-20221231.xsd#cron_CannabisFlowerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:to="loc_cron_CannabisFlowerMember_6097f6dd-ef18-48c3-a44e-bed08337d5e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember_c9bfceca-c646-40e7-af52-f5774f6e2772" xlink:href="cron-20221231.xsd#cron_CannabisExtractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:to="loc_cron_CannabisExtractsMember_c9bfceca-c646-40e7-af52-f5774f6e2772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_a75092ce-959b-4d9e-a95c-5f7b8ba04721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_a75092ce-959b-4d9e-a95c-5f7b8ba04721" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_917981c4-daba-440e-9810-9eecb94256b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:to="loc_srt_ConsolidationItemsAxis_917981c4-daba-440e-9810-9eecb94256b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_917981c4-daba-440e-9810-9eecb94256b9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_917981c4-daba-440e-9810-9eecb94256b9" xlink:to="loc_srt_ConsolidationItemsDomain_917981c4-daba-440e-9810-9eecb94256b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a445af58-a1d6-46a2-b893-2fd493e53b91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_917981c4-daba-440e-9810-9eecb94256b9" xlink:to="loc_srt_ConsolidationItemsDomain_a445af58-a1d6-46a2-b893-2fd493e53b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_07b499b4-81b2-4195-a72a-3cf2654d9842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a445af58-a1d6-46a2-b893-2fd493e53b91" xlink:to="loc_us-gaap_OperatingSegmentsMember_07b499b4-81b2-4195-a72a-3cf2654d9842" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_53129561-1fa8-4771-9f75-ee010506ae2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a445af58-a1d6-46a2-b893-2fd493e53b91" xlink:to="loc_us-gaap_CorporateNonSegmentMember_53129561-1fa8-4771-9f75-ee010506ae2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47" xlink:to="loc_us-gaap_SegmentDomain_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_15837f1a-e8a1-44a5-991f-11564c22166a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47" xlink:to="loc_us-gaap_SegmentDomain_15837f1a-e8a1-44a5-991f-11564c22166a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_4b654ba1-ddd4-4264-8293-bcfc766a2029" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_15837f1a-e8a1-44a5-991f-11564c22166a" xlink:to="loc_cron_UnitedStatesSegmentMember_4b654ba1-ddd4-4264-8293-bcfc766a2029" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_c16d6e56-3588-4a1a-9a40-d1a1ec4e72ac" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_15837f1a-e8a1-44a5-991f-11564c22166a" xlink:to="loc_cron_RestOfWorldSegmentMember_c16d6e56-3588-4a1a-9a40-d1a1ec4e72ac" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails" xlink:type="extended" id="i3028cd3584f240ae866b906b53d853af_SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5db818e5-4db1-4784-9c9f-e55ff48a2305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_ProfitLoss_5db818e5-4db1-4784-9c9f-e55ff48a2305" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_43ec4852-83d3-4865-9990-3bd6791c3a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_43ec4852-83d3-4865-9990-3bd6791c3a0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9dd39805-b59d-4f4c-900f-503c23dbb41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9dd39805-b59d-4f4c-900f-503c23dbb41d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a706ff84-1705-4d31-9581-713a86cfe882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a706ff84-1705-4d31-9581-713a86cfe882" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization_b8c89579-d239-4b99-8f5e-a829630de331" xlink:href="cron-20221231.xsd#cron_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization_b8c89579-d239-4b99-8f5e-a829630de331" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7a4b4102-dd60-4819-b5a8-8c767a4d13e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7a4b4102-dd60-4819-b5a8-8c767a4d13e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b55090df-23de-463a-8e24-89d54ede0fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b55090df-23de-463a-8e24-89d54ede0fe0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_dc6141f4-79d3-433d-81ed-bdc79c58be78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_dc6141f4-79d3-433d-81ed-bdc79c58be78" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_4fad328e-fa4c-4a1f-911e-65628727031b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_4fad328e-fa4c-4a1f-911e-65628727031b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_3d0101ad-a334-4e8e-a77b-51ef99a67a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_3d0101ad-a334-4e8e-a77b-51ef99a67a26" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_74fdd5e4-9495-428d-ac25-133afcf8d303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_74fdd5e4-9495-428d-ac25-133afcf8d303" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_8ca88498-dea9-4242-af63-104c27188ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_AcquisitionCosts_8ca88498-dea9-4242-af63-104c27188ff7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_567fb42e-4a6c-49e6-80d7-be93991798d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_567fb42e-4a6c-49e6-80d7-be93991798d7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8834f032-c702-413e-9eb7-55d28606276a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8834f032-c702-413e-9eb7-55d28606276a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_da95794a-38b2-4212-977f-0ebd8b300b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_da95794a-38b2-4212-977f-0ebd8b300b9e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_4557fd23-f346-4942-becf-938cf86f2be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_RestructuringCosts_4557fd23-f346-4942-becf-938cf86f2be1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2db65a8d-e59f-41fc-8533-d23acdd036ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2db65a8d-e59f-41fc-8533-d23acdd036ec" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense_73a6626c-f5ff-4f5f-8d3e-08fe6e76cb94" xlink:href="cron-20221231.xsd#cron_RestatementReviewExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_cron_RestatementReviewExpense_73a6626c-f5ff-4f5f-8d3e-08fe6e76cb94" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5f9a838b-01ae-41f5-8af8-666ec2e3ca83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5f9a838b-01ae-41f5-8af8-666ec2e3ca83" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_ea4389c0-0672-4cf3-8f51-6cceae139465" xlink:href="cron-20221231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_ea4389c0-0672-4cf3-8f51-6cceae139465" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8ae16ce6-3dab-44c9-abe9-67cac968d663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8ae16ce6-3dab-44c9-abe9-67cac968d663" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_e3f785be-b4d8-4516-82e5-92bdbd7e5611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_Dividends_e3f785be-b4d8-4516-82e5-92bdbd7e5611" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9fdf2390-3a52-4f3b-99fe-b82df167a45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9fdf2390-3a52-4f3b-99fe-b82df167a45a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_38d43320-6ec4-459d-8d41-05163f732c78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:to="loc_srt_ConsolidationItemsAxis_38d43320-6ec4-459d-8d41-05163f732c78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_38d43320-6ec4-459d-8d41-05163f732c78_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_38d43320-6ec4-459d-8d41-05163f732c78" xlink:to="loc_srt_ConsolidationItemsDomain_38d43320-6ec4-459d-8d41-05163f732c78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9cafd477-56d9-4f63-8982-a94e3bea752d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_38d43320-6ec4-459d-8d41-05163f732c78" xlink:to="loc_srt_ConsolidationItemsDomain_9cafd477-56d9-4f63-8982-a94e3bea752d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d47185ec-d7b7-418b-a120-38bb6d16a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9cafd477-56d9-4f63-8982-a94e3bea752d" xlink:to="loc_us-gaap_OperatingSegmentsMember_d47185ec-d7b7-418b-a120-38bb6d16a3d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_28861cd4-2338-43d4-af73-3366aee93eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9cafd477-56d9-4f63-8982-a94e3bea752d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_28861cd4-2338-43d4-af73-3366aee93eec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_42ab4513-d49e-4637-b27f-facb65f6599e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_42ab4513-d49e-4637-b27f-facb65f6599e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42ab4513-d49e-4637-b27f-facb65f6599e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42ab4513-d49e-4637-b27f-facb65f6599e" xlink:to="loc_us-gaap_SegmentDomain_42ab4513-d49e-4637-b27f-facb65f6599e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42ab4513-d49e-4637-b27f-facb65f6599e" xlink:to="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_8f2cc184-d751-47a3-a64b-eb319979386b" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:to="loc_cron_UnitedStatesSegmentMember_8f2cc184-d751-47a3-a64b-eb319979386b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_d0cb7a2a-7b1f-4365-b29e-a4896c717810" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:to="loc_cron_RestOfWorldSegmentMember_d0cb7a2a-7b1f-4365-b29e-a4896c717810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AustraliaMember_53e2fa9f-2e68-4b1d-a42e-f25493db4df7" xlink:href="cron-20221231.xsd#cron_AustraliaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:to="loc_cron_AustraliaMember_53e2fa9f-2e68-4b1d-a42e-f25493db4df7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="extended" id="ibf5249af097848bfacdebf570974b11c_SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_83c8b1a9-7c56-4367-ab98-2bbec6332c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_799aa2f6-b6f3-4cab-a2d1-0295c69a68f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_83c8b1a9-7c56-4367-ab98-2bbec6332c88" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_799aa2f6-b6f3-4cab-a2d1-0295c69a68f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7d8c2878-00bc-41cd-94f4-0d51448a78cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_83c8b1a9-7c56-4367-ab98-2bbec6332c88" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7d8c2878-00bc-41cd-94f4-0d51448a78cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e5736508-4802-4d2c-8db1-aec5d53d24f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7d8c2878-00bc-41cd-94f4-0d51448a78cf" xlink:to="loc_srt_StatementGeographicalAxis_e5736508-4802-4d2c-8db1-aec5d53d24f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e5736508-4802-4d2c-8db1-aec5d53d24f3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e5736508-4802-4d2c-8db1-aec5d53d24f3" xlink:to="loc_srt_SegmentGeographicalDomain_e5736508-4802-4d2c-8db1-aec5d53d24f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e5736508-4802-4d2c-8db1-aec5d53d24f3" xlink:to="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_9fd9af69-e417-4468-b758-210efdc8e7e2" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:to="loc_country_CA_9fd9af69-e417-4468-b758-210efdc8e7e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_72f91957-88cd-43ca-bfe5-0cdf2aee81f0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:to="loc_country_IL_72f91957-88cd-43ca-bfe5-0cdf2aee81f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eb70ed2b-7542-4734-882e-92cf61ef00cc" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:to="loc_country_US_eb70ed2b-7542-4734-882e-92cf61ef00cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember_e2c3af6a-c2fa-4cdc-b2f5-f10c732a8fd2" xlink:href="cron-20221231.xsd#cron_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:to="loc_cron_OtherCountriesMember_e2c3af6a-c2fa-4cdc-b2f5-f10c732a8fd2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="extended" id="i742121a534144207b130cc2a0cec0db3_SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d6033047-df31-4eb9-a087-1ea56aacb1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_fc9dc33d-7c21-446b-a16b-7ed910058df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d6033047-df31-4eb9-a087-1ea56aacb1b8" xlink:to="loc_us-gaap_NoncurrentAssets_fc9dc33d-7c21-446b-a16b-7ed910058df9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_49428dfd-07d3-4b04-bb65-d714832e3ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d6033047-df31-4eb9-a087-1ea56aacb1b8" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_49428dfd-07d3-4b04-bb65-d714832e3ce2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_49428dfd-07d3-4b04-bb65-d714832e3ce2" xlink:to="loc_srt_StatementGeographicalAxis_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15" xlink:to="loc_srt_SegmentGeographicalDomain_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15" xlink:to="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_34601373-eabc-4aa5-8717-041e6f336a96" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:to="loc_country_CA_34601373-eabc-4aa5-8717-041e6f336a96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_95569589-7ffc-4d86-9bc5-7726099e0198" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:to="loc_country_US_95569589-7ffc-4d86-9bc5-7726099e0198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_3916eacd-c545-4751-8501-e23b2270d006" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:to="loc_country_IL_3916eacd-c545-4751-8501-e23b2270d006" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#EarningsLossperShareScheduleofEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails" xlink:type="extended" id="ie06def2f2fa2476cbc32b6edfca42976_EarningsLossperShareScheduleofEarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2478c50d-b5b7-4c20-9a55-66690ca89a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2478c50d-b5b7-4c20-9a55-66690ca89a1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a36360a-8f1c-4c61-b9dc-57b614daff98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a36360a-8f1c-4c61-b9dc-57b614daff98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_124f99a7-5026-4a9e-974b-4ddac3885b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_124f99a7-5026-4a9e-974b-4ddac3885b77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_0ec2f858-65af-4427-9dba-acb9aab93b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_0ec2f858-65af-4427-9dba-acb9aab93b7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_136e2b7f-6627-467f-b1f2-54b24218c842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_3111a900-908e-40bf-bfb3-861d792524fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_3111a900-908e-40bf-bfb3-861d792524fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_e46f26e2-3a88-496a-9c85-4e866d4539d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_c57139ea-90be-4529-ac5c-1251b26c945a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_DilutiveSecurities_c57139ea-90be-4529-ac5c-1251b26c945a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_08bed379-0a52-45e8-bac1-f9cb7ac58750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_08bed379-0a52-45e8-bac1-f9cb7ac58750" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_93994bb4-5e56-41e5-b222-843b1cd2ae20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_257d6dab-0cf7-43e7-be25-eaacf42eb3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_257d6dab-0cf7-43e7-be25-eaacf42eb3cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3a55154e-2616-48e1-a1b4-fb747bb19633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3a55154e-2616-48e1-a1b4-fb747bb19633" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef117d95-4fac-42c7-8bdc-b26ea1a61fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef117d95-4fac-42c7-8bdc-b26ea1a61fc9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_550307e3-9c63-46f7-ad07-dede27db1deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_550307e3-9c63-46f7-ad07-dede27db1deb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_2decfae7-690f-4918-a03b-82d3cb7dc5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_2decfae7-690f-4918-a03b-82d3cb7dc5e9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6c163aa9-2e3a-4181-a2f5-12d3838d5dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_4a80041c-5145-4843-9e19-41f78e469865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_4a80041c-5145-4843-9e19-41f78e469865" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_09c294db-94a1-4dcd-b501-7a08aa481ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_09c294db-94a1-4dcd-b501-7a08aa481ef0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_a5ea615b-5d7e-4526-9d0a-0d39680dc25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_a5ea615b-5d7e-4526-9d0a-0d39680dc25e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2311422d-fd0d-4940-83fe-829577afd6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_a5ea615b-5d7e-4526-9d0a-0d39680dc25e" xlink:to="loc_us-gaap_AwardTypeAxis_2311422d-fd0d-4940-83fe-829577afd6cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2311422d-fd0d-4940-83fe-829577afd6cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2311422d-fd0d-4940-83fe-829577afd6cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2311422d-fd0d-4940-83fe-829577afd6cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2311422d-fd0d-4940-83fe-829577afd6cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_bb0c4cde-f874-4678-9d8d-158d6bd18a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:to="loc_us-gaap_WarrantMember_bb0c4cde-f874-4678-9d8d-158d6bd18a82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cf3f8a9e-169e-433a-b86c-a66be3866b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cf3f8a9e-169e-433a-b86c-a66be3866b66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_86076276-b6db-4339-b6f6-9dc7feb9cd61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_86076276-b6db-4339-b6f6-9dc7feb9cd61" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails" xlink:type="extended" id="i74ecc95ec2ed4a1db7712a89682a0275_FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2c9c648a-3374-470e-82cf-233a8977fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2c9c648a-3374-470e-82cf-233a8977fc95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fa317564-218b-49ee-b658-35add164d663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fa317564-218b-49ee-b658-35add164d663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_c7ad46e4-0d09-407d-9d38-5d2dc59a0680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_OtherInvestments_c7ad46e4-0d09-407d-9d38-5d2dc59a0680" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_43a22a36-bca3-457f-85c8-0d0b5a0a3f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_43a22a36-bca3-457f-85c8-0d0b5a0a3f98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b99c90e1-30c1-4817-b839-189711a8c804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b99c90e1-30c1-4817-b839-189711a8c804" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfSeatsOnBoardOfDirectors_3e8d95b0-7841-4056-ae6b-9a08a480e973" xlink:href="cron-20221231.xsd#cron_NumberOfSeatsOnBoardOfDirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_cron_NumberOfSeatsOnBoardOfDirectors_3e8d95b0-7841-4056-ae6b-9a08a480e973" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_93cdefeb-033d-45bc-8d1e-c063cc79f484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_93cdefeb-033d-45bc-8d1e-c063cc79f484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_93cdefeb-033d-45bc-8d1e-c063cc79f484_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_93cdefeb-033d-45bc-8d1e-c063cc79f484" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_93cdefeb-033d-45bc-8d1e-c063cc79f484_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_93cdefeb-033d-45bc-8d1e-c063cc79f484" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5abdf343-c56f-4d05-a1e7-e9edd273b35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5abdf343-c56f-4d05-a1e7-e9edd273b35e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_36913d69-b601-4717-8066-ba233b663ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_36913d69-b601-4717-8066-ba233b663ff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_afb72c6d-1e9e-49b5-bfe7-3c33d6e7b70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_afb72c6d-1e9e-49b5-bfe7-3c33d6e7b70a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_238907b6-c899-447b-8378-a29c9399e64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_238907b6-c899-447b-8378-a29c9399e64d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_238907b6-c899-447b-8378-a29c9399e64d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_238907b6-c899-447b-8378-a29c9399e64d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_238907b6-c899-447b-8378-a29c9399e64d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_98f9fb33-4293-4e5b-9ad1-c21803a1a3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_238907b6-c899-447b-8378-a29c9399e64d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_98f9fb33-4293-4e5b-9ad1-c21803a1a3ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ca90be65-e080-4389-9f9b-6cd713b807db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_98f9fb33-4293-4e5b-9ad1-c21803a1a3ed" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ca90be65-e080-4389-9f9b-6cd713b807db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_965ae77a-4a90-4c9c-99a7-64f6360f5e0f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_965ae77a-4a90-4c9c-99a7-64f6360f5e0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_965ae77a-4a90-4c9c-99a7-64f6360f5e0f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_965ae77a-4a90-4c9c-99a7-64f6360f5e0f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_965ae77a-4a90-4c9c-99a7-64f6360f5e0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3bb63bbd-c0b0-4c7a-b128-053120b71c20" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_965ae77a-4a90-4c9c-99a7-64f6360f5e0f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3bb63bbd-c0b0-4c7a-b128-053120b71c20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_fb188609-f375-4188-9b14-bb2d5a968609" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3bb63bbd-c0b0-4c7a-b128-053120b71c20" xlink:to="loc_cron_CronosAustraliaLimitedMember_fb188609-f375-4188-9b14-bb2d5a968609" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails" xlink:type="extended" id="i6cd487b6ca4f47a0bea27b7b611f6723_FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_c77391dc-f361-44e9-a39b-cc9b9a61a6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_OtherInvestments_c77391dc-f361-44e9-a39b-cc9b9a61a6ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0b95fcbd-3cd8-4e0a-93cb-ee9c60ce7c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0b95fcbd-3cd8-4e0a-93cb-ee9c60ce7c90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_f79dd227-8aa9-4869-8e1d-a2b69e8f406b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_f79dd227-8aa9-4869-8e1d-a2b69e8f406b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_c39fa509-3d45-4244-94fb-a839c375ce22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_c39fa509-3d45-4244-94fb-a839c375ce22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_c6da7b9a-55ed-4e57-ae7d-30848ec65d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_c6da7b9a-55ed-4e57-ae7d-30848ec65d8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9d6d2fe6-e1b3-4f90-9837-fa85f8ecf282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9d6d2fe6-e1b3-4f90-9837-fa85f8ecf282" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8812c97-8fe7-4ade-80da-e00d3859ec94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8812c97-8fe7-4ade-80da-e00d3859ec94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b8812c97-8fe7-4ade-80da-e00d3859ec94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8812c97-8fe7-4ade-80da-e00d3859ec94" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b8812c97-8fe7-4ade-80da-e00d3859ec94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8812c97-8fe7-4ade-80da-e00d3859ec94" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_31d60e5d-3dea-4ce8-bea5-e5eab0c64cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_31d60e5d-3dea-4ce8-bea5-e5eab0c64cbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a7a228b2-1065-4991-91d8-3bc10f1dddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a7a228b2-1065-4991-91d8-3bc10f1dddfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_80caf88e-6243-4bb4-a05a-962f31bcae60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_80caf88e-6243-4bb4-a05a-962f31bcae60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c0d417e-c4ac-4209-a2e9-6f9286a78d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c0d417e-c4ac-4209-a2e9-6f9286a78d01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2c0d417e-c4ac-4209-a2e9-6f9286a78d01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c0d417e-c4ac-4209-a2e9-6f9286a78d01" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2c0d417e-c4ac-4209-a2e9-6f9286a78d01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a2be6cd3-523b-4620-8111-3e5d5dc2e428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c0d417e-c4ac-4209-a2e9-6f9286a78d01" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a2be6cd3-523b-4620-8111-3e5d5dc2e428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_2684784a-ab1f-490c-aceb-9ab8fb3dde46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a2be6cd3-523b-4620-8111-3e5d5dc2e428" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_2684784a-ab1f-490c-aceb-9ab8fb3dde46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f3c3412e-3667-4c7c-b5e8-25af087cfe69" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_dei_LegalEntityAxis_f3c3412e-3667-4c7c-b5e8-25af087cfe69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f3c3412e-3667-4c7c-b5e8-25af087cfe69_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f3c3412e-3667-4c7c-b5e8-25af087cfe69" xlink:to="loc_dei_EntityDomain_f3c3412e-3667-4c7c-b5e8-25af087cfe69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_eef9ee86-697f-4690-a780-bb9c1d10eace" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f3c3412e-3667-4c7c-b5e8-25af087cfe69" xlink:to="loc_dei_EntityDomain_eef9ee86-697f-4690-a780-bb9c1d10eace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_599e44f5-3d1e-4a58-ba0b-555ba64869c3" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_eef9ee86-697f-4690-a780-bb9c1d10eace" xlink:to="loc_cron_PharmacannMember_599e44f5-3d1e-4a58-ba0b-555ba64869c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5a822987-f8f4-4698-b000-e27180927743" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_srt_OwnershipAxis_5a822987-f8f4-4698-b000-e27180927743" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5a822987-f8f4-4698-b000-e27180927743_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_5a822987-f8f4-4698-b000-e27180927743" xlink:to="loc_srt_OwnershipDomain_5a822987-f8f4-4698-b000-e27180927743_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_49f102b5-81e6-43e2-b73c-82e08d777e40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_5a822987-f8f4-4698-b000-e27180927743" xlink:to="loc_srt_OwnershipDomain_49f102b5-81e6-43e2-b73c-82e08d777e40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_90fe7908-4d93-493f-b7b6-7fdbc8d2cf22" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_49f102b5-81e6-43e2-b73c-82e08d777e40" xlink:to="loc_cron_PharmacannMember_90fe7908-4d93-493f-b7b6-7fdbc8d2cf22" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsCreditRiskDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails" xlink:type="extended" id="ia390d070e7134549b95dc2c68b21a2e2_FinancialInstrumentsCreditRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_6c1e2310-072d-4e29-b713-fd6798cd57b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_6c1e2310-072d-4e29-b713-fd6798cd57b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_70556404-93cf-4039-a6fb-27724fe7349f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_70556404-93cf-4039-a6fb-27724fe7349f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_4daf85b8-6cc5-4fbc-aca6-a0f69285a15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_4daf85b8-6cc5-4fbc-aca6-a0f69285a15a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f0e7e791-bd9d-4f73-add2-dac2d14c24b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f0e7e791-bd9d-4f73-add2-dac2d14c24b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_efb559cb-1d0c-497e-a433-3e80bb59ff5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_efb559cb-1d0c-497e-a433-3e80bb59ff5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_accb24f5-4c77-4cc6-976b-7c44b744955f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_accb24f5-4c77-4cc6-976b-7c44b744955f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e7b0ba9-214d-4a6d-971f-da882538e3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e7b0ba9-214d-4a6d-971f-da882538e3f2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_a9444c80-0aad-4316-a594-8ee6d2bd1324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_ShortTermInvestments_a9444c80-0aad-4316-a594-8ee6d2bd1324" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_d48a9024-8d5b-485e-a548-243abceba982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_d48a9024-8d5b-485e-a548-243abceba982" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_20befa96-9cc3-4286-89c0-aa4b6011e5cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_srt_MajorCustomersAxis_20befa96-9cc3-4286-89c0-aa4b6011e5cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_20befa96-9cc3-4286-89c0-aa4b6011e5cb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_20befa96-9cc3-4286-89c0-aa4b6011e5cb" xlink:to="loc_srt_NameOfMajorCustomerDomain_20befa96-9cc3-4286-89c0-aa4b6011e5cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cb627ded-4258-480a-a7bd-f78d2ccf2e5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_20befa96-9cc3-4286-89c0-aa4b6011e5cb" xlink:to="loc_srt_NameOfMajorCustomerDomain_cb627ded-4258-480a-a7bd-f78d2ccf2e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ThreeMajorCustomersMember_464ef050-6b4b-4604-a5c5-a5cb0e7e757a" xlink:href="cron-20221231.xsd#cron_ThreeMajorCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cb627ded-4258-480a-a7bd-f78d2ccf2e5d" xlink:to="loc_cron_ThreeMajorCustomersMember_464ef050-6b4b-4604-a5c5-a5cb0e7e757a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember_13e84505-a0b2-411d-86e1-204a96fc8629" xlink:href="cron-20221231.xsd#cron_FourMajorCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cb627ded-4258-480a-a7bd-f78d2ccf2e5d" xlink:to="loc_cron_FourMajorCustomersMember_13e84505-a0b2-411d-86e1-204a96fc8629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_22f575cb-435c-4e2a-9072-8e45ba63936f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_22f575cb-435c-4e2a-9072-8e45ba63936f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_22f575cb-435c-4e2a-9072-8e45ba63936f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_22f575cb-435c-4e2a-9072-8e45ba63936f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_22f575cb-435c-4e2a-9072-8e45ba63936f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_913333c5-aefa-4524-bf8c-b9c565071139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_22f575cb-435c-4e2a-9072-8e45ba63936f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_913333c5-aefa-4524-bf8c-b9c565071139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_9d74471e-508f-430f-a3b1-7f4c6af155b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_913333c5-aefa-4524-bf8c-b9c565071139" xlink:to="loc_us-gaap_AccountsReceivableMember_9d74471e-508f-430f-a3b1-7f4c6af155b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_721fd1be-03a7-479a-8d47-5c6272a89dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_913333c5-aefa-4524-bf8c-b9c565071139" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_721fd1be-03a7-479a-8d47-5c6272a89dea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_665eaf95-f766-4e49-83bf-ef35dd44d230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_665eaf95-f766-4e49-83bf-ef35dd44d230" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_665eaf95-f766-4e49-83bf-ef35dd44d230_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_665eaf95-f766-4e49-83bf-ef35dd44d230" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_665eaf95-f766-4e49-83bf-ef35dd44d230_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_21da6c65-6b01-41c3-822a-b2e1f9510dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_665eaf95-f766-4e49-83bf-ef35dd44d230" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_21da6c65-6b01-41c3-822a-b2e1f9510dea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_36524946-068d-4be5-9b3f-d3b4b9ae5d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_21da6c65-6b01-41c3-822a-b2e1f9510dea" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_36524946-068d-4be5-9b3f-d3b4b9ae5d9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_42b61cc5-d5e5-44b6-a796-f2fe88736cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_42b61cc5-d5e5-44b6-a796-f2fe88736cca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42b61cc5-d5e5-44b6-a796-f2fe88736cca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42b61cc5-d5e5-44b6-a796-f2fe88736cca" xlink:to="loc_us-gaap_SegmentDomain_42b61cc5-d5e5-44b6-a796-f2fe88736cca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8c2c066c-91f9-4725-953e-0a9af87eff16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42b61cc5-d5e5-44b6-a796-f2fe88736cca" xlink:to="loc_us-gaap_SegmentDomain_8c2c066c-91f9-4725-953e-0a9af87eff16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_874f5a84-a370-4e18-962b-0386e037f357" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8c2c066c-91f9-4725-953e-0a9af87eff16" xlink:to="loc_cron_RestOfWorldSegmentMember_874f5a84-a370-4e18-962b-0386e037f357" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_2144e14a-2a64-4323-94ca-59265117bcfd" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8c2c066c-91f9-4725-953e-0a9af87eff16" xlink:to="loc_cron_UnitedStatesSegmentMember_2144e14a-2a64-4323-94ca-59265117bcfd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsLiquidityRiskDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails" xlink:type="extended" id="i44fb3ca139124681a0945e55c5df3fc1_FinancialInstrumentsLiquidityRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_ee7966c0-6a07-4c65-a006-15b71427a9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_c8430d71-2d61-478b-8089-b99bd3fee11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ee7966c0-6a07-4c65-a006-15b71427a9e5" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_c8430d71-2d61-478b-8089-b99bd3fee11e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_2fc8ee11-7080-4d5e-aa2b-0d017abb9f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ee7966c0-6a07-4c65-a006-15b71427a9e5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_2fc8ee11-7080-4d5e-aa2b-0d017abb9f7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ee7966c0-6a07-4c65-a006-15b71427a9e5" xlink:to="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_851efa1b-6780-4beb-b817-460095f88178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_851efa1b-6780-4beb-b817-460095f88178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_851efa1b-6780-4beb-b817-460095f88178_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_851efa1b-6780-4beb-b817-460095f88178" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_851efa1b-6780-4beb-b817-460095f88178_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b7fabf1-0e3a-4e8f-899a-2c6a6bc01b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_851efa1b-6780-4beb-b817-460095f88178" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b7fabf1-0e3a-4e8f-899a-2c6a6bc01b8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_6faeb907-a22f-4e91-a983-7b1083b393d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b7fabf1-0e3a-4e8f-899a-2c6a6bc01b8c" xlink:to="loc_us-gaap_AccountsPayableMember_6faeb907-a22f-4e91-a983-7b1083b393d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d272faa3-9bf4-4645-8579-78d213bbae81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d272faa3-9bf4-4645-8579-78d213bbae81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d272faa3-9bf4-4645-8579-78d213bbae81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d272faa3-9bf4-4645-8579-78d213bbae81" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d272faa3-9bf4-4645-8579-78d213bbae81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8e699394-c5d1-41a1-833d-927d6e3fcd71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d272faa3-9bf4-4645-8579-78d213bbae81" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8e699394-c5d1-41a1-833d-927d6e3fcd71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_e89e9fb4-619f-4d4e-a646-b079afc5c7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8e699394-c5d1-41a1-833d-927d6e3fcd71" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_e89e9fb4-619f-4d4e-a646-b079afc5c7a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_dc0738d1-6061-4bd5-8334-3c44d8fc90bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_dc0738d1-6061-4bd5-8334-3c44d8fc90bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneVendorMember_e676b254-604d-4905-bcc4-9335805b3b48" xlink:href="cron-20221231.xsd#cron_OneVendorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_dc0738d1-6061-4bd5-8334-3c44d8fc90bb" xlink:to="loc_cron_OneVendorMember_e676b254-604d-4905-bcc4-9335805b3b48" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended" id="i1b2d9d62f7464547ac7c77a9cfab130e_RelatedPartyTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_aa8383e5-3467-49fe-b3ea-5454b30acbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_aa8383e5-3467-49fe-b3ea-5454b30acbb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_81482176-1de3-4cb2-a7fc-5c32a4405a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_81482176-1de3-4cb2-a7fc-5c32a4405a9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8a258df5-3d75-4fc2-b11d-a39eb69da4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8a258df5-3d75-4fc2-b11d-a39eb69da4cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9e17969f-6362-49ae-85b8-d0560e55a2df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9e17969f-6362-49ae-85b8-d0560e55a2df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9e17969f-6362-49ae-85b8-d0560e55a2df_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9e17969f-6362-49ae-85b8-d0560e55a2df" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9e17969f-6362-49ae-85b8-d0560e55a2df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a4ff7129-524f-4175-b46e-342347200c56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9e17969f-6362-49ae-85b8-d0560e55a2df" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a4ff7129-524f-4175-b46e-342347200c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_1576fa36-79b9-4b70-adc9-9dbe3c60114b" xlink:href="cron-20221231.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a4ff7129-524f-4175-b46e-342347200c56" xlink:to="loc_cron_CronosGroupInc.Member_1576fa36-79b9-4b70-adc9-9dbe3c60114b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_99385ef7-7073-4a2c-a71a-22abed5eb768" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a4ff7129-524f-4175-b46e-342347200c56" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_99385ef7-7073-4a2c-a71a-22abed5eb768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e3c9148a-b652-4623-9253-c3bc517ee8be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_dei_LegalEntityAxis_e3c9148a-b652-4623-9253-c3bc517ee8be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e3c9148a-b652-4623-9253-c3bc517ee8be_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e3c9148a-b652-4623-9253-c3bc517ee8be" xlink:to="loc_dei_EntityDomain_e3c9148a-b652-4623-9253-c3bc517ee8be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_910c5357-647c-43de-bc04-af1488d0b097" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e3c9148a-b652-4623-9253-c3bc517ee8be" xlink:to="loc_dei_EntityDomain_910c5357-647c-43de-bc04-af1488d0b097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_fa1387d8-2676-4af2-b254-d99b4f64386f" xlink:href="cron-20221231.xsd#cron_AltriaGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_910c5357-647c-43de-bc04-af1488d0b097" xlink:to="loc_cron_AltriaGroupInc.Member_fa1387d8-2676-4af2-b254-d99b4f64386f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7480f593-a496-45c4-acfe-b0783d946227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7480f593-a496-45c4-acfe-b0783d946227" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7480f593-a496-45c4-acfe-b0783d946227_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7480f593-a496-45c4-acfe-b0783d946227" xlink:to="loc_us-gaap_RelatedPartyDomain_7480f593-a496-45c4-acfe-b0783d946227_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7480f593-a496-45c4-acfe-b0783d946227" xlink:to="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member_83264ec1-45e2-43d5-bde4-62312426166f" xlink:href="cron-20221231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:to="loc_cron_AltriaPinnacleLLC.Member_83264ec1-45e2-43d5-bde4-62312426166f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_03a78de4-12af-4677-a91a-6a1aa860a51a" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_03a78de4-12af-4677-a91a-6a1aa860a51a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VendorMember_1a60d62e-fffd-4064-a6df-ef4c091b8288" xlink:href="cron-20221231.xsd#cron_VendorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:to="loc_cron_VendorMember_1a60d62e-fffd-4064-a6df-ef4c091b8288" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_95267273-6641-4ad5-aaef-d4fd0db85952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_95267273-6641-4ad5-aaef-d4fd0db85952" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_95267273-6641-4ad5-aaef-d4fd0db85952_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_95267273-6641-4ad5-aaef-d4fd0db85952" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_95267273-6641-4ad5-aaef-d4fd0db85952_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4b66705c-852e-4692-9b48-3c9df53f4f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_95267273-6641-4ad5-aaef-d4fd0db85952" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4b66705c-852e-4692-9b48-3c9df53f4f4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisPurchasesMember_17049bc9-65be-4906-beec-350150575655" xlink:href="cron-20221231.xsd#cron_CannabisPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4b66705c-852e-4692-9b48-3c9df53f4f4b" xlink:to="loc_cron_CannabisPurchasesMember_17049bc9-65be-4906-beec-350150575655" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ManufacturingServicesMember_e45d0cbd-b374-40e1-abe0-cf4f548e16c8" xlink:href="cron-20221231.xsd#cron_ManufacturingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4b66705c-852e-4692-9b48-3c9df53f4f4b" xlink:to="loc_cron_ManufacturingServicesMember_e45d0cbd-b374-40e1-abe0-cf4f548e16c8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="extended" id="ie5ac32f6fed94750be4d4fbec9aeb08b_RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_3770517d-4cbc-4ac3-a53f-8ba3d90eb608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_33c3701c-37f7-48fc-88ef-190e3eb19606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3770517d-4cbc-4ac3-a53f-8ba3d90eb608" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_33c3701c-37f7-48fc-88ef-190e3eb19606" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_00dac05c-20c9-4878-a373-8058cc79a0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3770517d-4cbc-4ac3-a53f-8ba3d90eb608" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_00dac05c-20c9-4878-a373-8058cc79a0ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3770517d-4cbc-4ac3-a53f-8ba3d90eb608" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4858190c-4921-49f3-b996-f8caa47b7359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4858190c-4921-49f3-b996-f8caa47b7359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesMember_86715def-5310-4a24-90e5-42965bdbc250" xlink:href="cron-20221231.xsd#cron_ConsultingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4858190c-4921-49f3-b996-f8caa47b7359" xlink:to="loc_cron_ConsultingServicesMember_86715def-5310-4a24-90e5-42965bdbc250" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisPurchasesMember_373cdc95-5cac-4d01-a9a3-18cc934f7922" xlink:href="cron-20221231.xsd#cron_CannabisPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4858190c-4921-49f3-b996-f8caa47b7359" xlink:to="loc_cron_CannabisPurchasesMember_373cdc95-5cac-4d01-a9a3-18cc934f7922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b" xlink:to="loc_us-gaap_RelatedPartyDomain_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6e4881fd-d200-4aa1-8bf1-78080da2ad6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b" xlink:to="loc_us-gaap_RelatedPartyDomain_6e4881fd-d200-4aa1-8bf1-78080da2ad6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member_d41d2517-f0ee-4670-b243-ee448107ede9" xlink:href="cron-20221231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_6e4881fd-d200-4aa1-8bf1-78080da2ad6c" xlink:to="loc_cron_AltriaPinnacleLLC.Member_d41d2517-f0ee-4670-b243-ee448107ede9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_b24a2a97-eb17-4b23-b105-1e2fae272c3b" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_6e4881fd-d200-4aa1-8bf1-78080da2ad6c" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_b24a2a97-eb17-4b23-b105-1e2fae272c3b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RestructuringNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RestructuringNarrativeDetails" xlink:type="extended" id="i8803766f4c104624b9eea97e3ea4ce93_RestructuringNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9ddfc377-e3f8-4b42-8b39-bbbbc8460219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_2c59596d-d19b-4960-9467-0e329f22d838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9ddfc377-e3f8-4b42-8b39-bbbbc8460219" xlink:to="loc_us-gaap_RestructuringCosts_2c59596d-d19b-4960-9467-0e329f22d838" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1faa011e-c855-4b4a-879c-9947db0d01e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9ddfc377-e3f8-4b42-8b39-bbbbc8460219" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1faa011e-c855-4b4a-879c-9947db0d01e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_cf08227a-0bc8-4b77-a1df-109734a98df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1faa011e-c855-4b4a-879c-9947db0d01e7" xlink:to="loc_us-gaap_RestructuringPlanAxis_cf08227a-0bc8-4b77-a1df-109734a98df5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cf08227a-0bc8-4b77-a1df-109734a98df5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_cf08227a-0bc8-4b77-a1df-109734a98df5" xlink:to="loc_us-gaap_RestructuringPlanDomain_cf08227a-0bc8-4b77-a1df-109734a98df5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_caac68bc-7b6e-432a-9189-db92254de469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_cf08227a-0bc8-4b77-a1df-109734a98df5" xlink:to="loc_us-gaap_RestructuringPlanDomain_caac68bc-7b6e-432a-9189-db92254de469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RealignmentMember_9c4f9d5b-7354-4ef7-8a62-1a526c9171e2" xlink:href="cron-20221231.xsd#cron_RealignmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_caac68bc-7b6e-432a-9189-db92254de469" xlink:to="loc_cron_RealignmentMember_9c4f9d5b-7354-4ef7-8a62-1a526c9171e2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RestructuringCostsbySegmentDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails" xlink:type="extended" id="id5656a13f0e74785a09925eee1a1b4e2_RestructuringCostsbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8eaca002-c6ed-4ff6-96a0-fbc8db6d20e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_e59347d4-c590-4392-b2e6-c1455fc2cc74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8eaca002-c6ed-4ff6-96a0-fbc8db6d20e2" xlink:to="loc_us-gaap_RestructuringCosts_e59347d4-c590-4392-b2e6-c1455fc2cc74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8eaca002-c6ed-4ff6-96a0-fbc8db6d20e2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d" xlink:to="loc_us-gaap_SegmentDomain_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1ae3ff43-b0f0-4083-8fce-c399af84bee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d" xlink:to="loc_us-gaap_SegmentDomain_1ae3ff43-b0f0-4083-8fce-c399af84bee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_b698fd34-66c3-476e-9852-412c079c2dfb" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1ae3ff43-b0f0-4083-8fce-c399af84bee9" xlink:to="loc_cron_RestOfWorldSegmentMember_b698fd34-66c3-476e-9852-412c079c2dfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_a04f7df4-f5bf-4ecc-a961-de8e41c47db3" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1ae3ff43-b0f0-4083-8fce-c399af84bee9" xlink:to="loc_cron_UnitedStatesSegmentMember_a04f7df4-f5bf-4ecc-a961-de8e41c47db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_732fad2a-07d3-4d13-81f0-37a1d65ae3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:to="loc_us-gaap_RestructuringPlanAxis_732fad2a-07d3-4d13-81f0-37a1d65ae3a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_732fad2a-07d3-4d13-81f0-37a1d65ae3a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_732fad2a-07d3-4d13-81f0-37a1d65ae3a7" xlink:to="loc_us-gaap_RestructuringPlanDomain_732fad2a-07d3-4d13-81f0-37a1d65ae3a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_724f92eb-de85-47a9-9cc2-637ac5c13dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_732fad2a-07d3-4d13-81f0-37a1d65ae3a7" xlink:to="loc_us-gaap_RestructuringPlanDomain_724f92eb-de85-47a9-9cc2-637ac5c13dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RealignmentMember_4ea895a1-f97d-4c24-8d31-2ab84642fb9f" xlink:href="cron-20221231.xsd#cron_RealignmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_724f92eb-de85-47a9-9cc2-637ac5c13dde" xlink:to="loc_cron_RealignmentMember_4ea895a1-f97d-4c24-8d31-2ab84642fb9f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RestructuringRestructuringActivityDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails" xlink:type="extended" id="i258e373838f445daaa8ece8bb1c3c52d_RestructuringRestructuringActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c24b4e9a-3d29-4e6c-a8d7-e37bc1556f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c24b4e9a-3d29-4e6c-a8d7-e37bc1556f0d" xlink:to="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4e33e617-bcbf-4193-852a-7ee642541014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:to="loc_us-gaap_RestructuringReserve_4e33e617-bcbf-4193-852a-7ee642541014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f0f4d0c3-2cbc-4a94-a4db-7d82e54cba97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:to="loc_us-gaap_RestructuringCharges_f0f4d0c3-2cbc-4a94-a4db-7d82e54cba97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestructuringReservePaymentsAndWriteoffs_9d58ab0d-0288-49be-8069-5ee589f842aa" xlink:href="cron-20221231.xsd#cron_RestructuringReservePaymentsAndWriteoffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:to="loc_cron_RestructuringReservePaymentsAndWriteoffs_9d58ab0d-0288-49be-8069-5ee589f842aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_1f4b177a-5097-4cfe-9f91-23758b78f3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c24b4e9a-3d29-4e6c-a8d7-e37bc1556f0d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_f0d706e1-c15b-4ae2-b861-f8dbbe835c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_f0d706e1-c15b-4ae2-b861-f8dbbe835c37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f0d706e1-c15b-4ae2-b861-f8dbbe835c37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_f0d706e1-c15b-4ae2-b861-f8dbbe835c37" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f0d706e1-c15b-4ae2-b861-f8dbbe835c37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7ae981e5-3bb5-4ced-9cb2-bac740bbe602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_f0d706e1-c15b-4ae2-b861-f8dbbe835c37" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7ae981e5-3bb5-4ced-9cb2-bac740bbe602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_2e6f2cf4-2e96-4a3e-861c-9359b01d85d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7ae981e5-3bb5-4ced-9cb2-bac740bbe602" xlink:to="loc_us-gaap_EmployeeSeveranceMember_2e6f2cf4-2e96-4a3e-861c-9359b01d85d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_d02e0f09-af05-4ba5-83b2-34b89ed69ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7ae981e5-3bb5-4ced-9cb2-bac740bbe602" xlink:to="loc_us-gaap_OtherRestructuringMember_d02e0f09-af05-4ba5-83b2-34b89ed69ead" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_729790b7-23cf-4662-9f51-989f226b50af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:to="loc_us-gaap_RestructuringPlanAxis_729790b7-23cf-4662-9f51-989f226b50af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_729790b7-23cf-4662-9f51-989f226b50af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_729790b7-23cf-4662-9f51-989f226b50af" xlink:to="loc_us-gaap_RestructuringPlanDomain_729790b7-23cf-4662-9f51-989f226b50af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_64dcc0ed-c250-4e83-a2c9-81829fd802c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_729790b7-23cf-4662-9f51-989f226b50af" xlink:to="loc_us-gaap_RestructuringPlanDomain_64dcc0ed-c250-4e83-a2c9-81829fd802c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RealignmentMember_0a0c292a-9ca9-4276-93b8-d32c8e2fc32c" xlink:href="cron-20221231.xsd#cron_RealignmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_64dcc0ed-c250-4e83-a2c9-81829fd802c5" xlink:to="loc_cron_RealignmentMember_0a0c292a-9ca9-4276-93b8-d32c8e2fc32c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>cron-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bb311be6-8ff8-4549-bdb4-c4f3401e1eb6,g:1fb2bd36-dce5-4c03-be1e-00a7968a9cfb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e72b8e13-7c60-4ceb-9fef-3e8d87a30ea7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod_22ca65fb-ca77-480b-b8f1-0bd0a21edade_terseLabel_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cliff period</link:label>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod_label_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Cliff Period</link:label>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod_documentation_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Cliff Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" xlink:href="cron-20221231.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" xlink:to="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_848ce244-1963-4abc-a9f4-60daa5dc6fbc_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e40a42e7-66bc-4325-8110-fbf3d7f939db_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_edb9a8e9-cd04-4292-bd65-57683920996e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_ff83c944-9e19-4dec-ac44-5a0206008437_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in expected credit losses on long-term financial assets</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RestOfWorldSegmentMember_e8f2935e-9bc4-4809-94f6-5eb035b31ce1_terseLabel_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_cron_RestOfWorldSegmentMember_label_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World Segment [Member]</link:label>
    <link:label id="lab_cron_RestOfWorldSegmentMember_documentation_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RestOfWorldSegmentMember" xlink:to="lab_cron_RestOfWorldSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGroupInc.Member_da6b5f75-a9f5-4e9b-93d6-62ab295955a4_terseLabel_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc.</link:label>
    <link:label id="lab_cron_CronosGroupInc.Member_label_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc. [Member]</link:label>
    <link:label id="lab_cron_CronosGroupInc.Member_documentation_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member" xlink:href="cron-20221231.xsd#cron_CronosGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGroupInc.Member" xlink:to="lab_cron_CronosGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GinkoExclusiveLicensesMember_4112db8f-23f9-4ced-af34-e211ad8bff03_terseLabel_en-US" xlink:label="lab_cron_GinkoExclusiveLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo exclusive licenses</link:label>
    <link:label id="lab_cron_GinkoExclusiveLicensesMember_label_en-US" xlink:label="lab_cron_GinkoExclusiveLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginko Exclusive Licenses [Member]</link:label>
    <link:label id="lab_cron_GinkoExclusiveLicensesMember_documentation_en-US" xlink:label="lab_cron_GinkoExclusiveLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginko Exclusive Licenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkoExclusiveLicensesMember" xlink:href="cron-20221231.xsd#cron_GinkoExclusiveLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GinkoExclusiveLicensesMember" xlink:to="lab_cron_GinkoExclusiveLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_7e0e0c06-ab41-4e11-8b77-f0bcc88ea9b0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ecf59dc0-a9c9-4c92-aba5-011594111f65_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CanadianPrimeRateMember_d199d512-bed6-482c-9190-fb57854b7e74_terseLabel_en-US" xlink:label="lab_cron_CanadianPrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Prime Rate</link:label>
    <link:label id="lab_cron_CanadianPrimeRateMember_label_en-US" xlink:label="lab_cron_CanadianPrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Prime Rate [Member]</link:label>
    <link:label id="lab_cron_CanadianPrimeRateMember_documentation_en-US" xlink:label="lab_cron_CanadianPrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Prime Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CanadianPrimeRateMember" xlink:href="cron-20221231.xsd#cron_CanadianPrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CanadianPrimeRateMember" xlink:to="lab_cron_CanadianPrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_18dcd604-1289-464c-8054-095559c877cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) loss from investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_dc8e41fa-3525-4e27-a6a9-19c93a34d125_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_5d682234-3ae7-4eb1-a7b9-ec9fe8cd80a2_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional subscription percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Maximum Additional Subscription Percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Maximum Additional Subscription Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:to="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_8130dc3b-ea95-4025-bde5-19fb349fd0fa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_0319d233-e964-4487-a745-b7db10fbb959_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_8c25d99b-ea86-44f4-bf7b-6e588cb30d58_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_c073ea54-abf9-4767-a49c-baaa383342e0_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of income taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_1faafcd5-c79f-494e-9a2c-492bc5fdcbaf_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price at issuance date</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_46b61396-4876-46a3-893f-d26d958e8361_terseLabel_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo</link:label>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_label_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Growing Company Inc. [Member]</link:label>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_documentation_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Growing Company Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGrowingCompanyInc.Member" xlink:to="lab_cron_CronosGrowingCompanyInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_4ca7c332-22cb-4428-a4a0-4b7f42afb74e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of alleged shareholders</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_70b2a651-0c44-4b60-af2e-2cf5cadf51ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5fa02211-e9bb-441c-959c-755d25f78d02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_d20130ab-11de-47a9-ae30-1c85c0dcfc55_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ff7abcdc-4b87-43d7-bcea-2d9a5bbecaf8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate &#8211; operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1551c906-8e2b-4d6e-b19d-e37ca2fe78a4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_e9ac31fa-43d1-422e-9fdc-559ace9784f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (per option) (in Canadian dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_b7a2a62f-a620-4104-85c1-e106fe463d38_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash operating activities, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_173de702-87dd-46ec-8d19-400881cdc4c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_fe81fa9e-a457-4fcc-8d8c-51babcacea71_terseLabel_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_label_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_documentation_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward" xlink:href="cron-20221231.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DerivativeInstrumentsRollForward" xlink:to="lab_cron_DerivativeInstrumentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_db2f777a-14c7-44d8-9522-cb440ecde574_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_5e22b926-3672-4af1-85c6-c575ed363045_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_9ceb7cb5-4ecd-4415-91f8-431c6aca73a4_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of loans receivable, net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_41a39f25-9530-454d-b971-6cc6607f8239_totalLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current portion of loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b1965541-decc-4124-8a43-7ec82a84b953_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total anti-dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_bf4ed66f-b3f2-448b-b2d3-3fc8a29a6797_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_05f665a4-c51b-48ac-a5c5-bb8b0171d99a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_40693b01-385e-4bd3-b13b-516bfc7f4cc0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_e6f1098c-0d7b-42a7-af45-e45140537fdc_terseLabel_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription price (in canadian dollars per share)</link:label>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_label_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Subscription Price [Member]</link:label>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_documentation_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Subscription Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember" xlink:href="cron-20221231.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_MeasurementInputSubscriptionPriceMember" xlink:to="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_e7a49aeb-acb1-45dc-8081-1dd4a0f5b0c6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from continuing operations per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_e2699ee4-ce5a-4781-9845-39af92a24089_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_876364f6-8aa7-4b11-89d1-91aba7619c91_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_d5f5278b-5f6c-4ef4-b258-2d31f23f3d98_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_d5135c54-3c3c-4f0e-ba8b-bf658a0d1890_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_b78ea2f4-fa97-4d81-8b49-4579b78b3e2d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag_cfda3448-5e83-4d0a-96eb-316a82e69416_terseLabel_en-US" xlink:label="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative, Asset (Liability) Gain (Loss), Statement Of Other Comprehensive Income, Extensible List, Not Disclosed Flag</link:label>
    <link:label id="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative, Asset (Liability) Gain (Loss), Statement Of Other Comprehensive Income, Extensible List, Not Disclosed Flag</link:label>
    <link:label id="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative, Asset (Liability) Gain (Loss), Statement Of Other Comprehensive Income, Extensible List, Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="cron-20221231.xsd#cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_66b6e8ee-71ab-4556-8ee8-b93fc23debe2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on other investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_bd973943-eac1-4ce4-8f4c-3adbe5f654e1_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_39f84abc-687f-483d-87d9-41c56a85c48a_negatedLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a8ad4b6-29cb-4115-b9b0-0d5fbf03db1c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_ed00d940-0251-4a7b-89f7-6ba4cbe48486_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_bbd15d29-8fe9-4f2e-9c37-66db5675f724_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplementary cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_c4ea72e5-e51d-4cd0-a45a-4c89472a8faf_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annualized volatility</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_9e044f72-ebd8-49a3-812d-7806bfdaa187_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_892fcf88-902a-4c7d-8360-6ba64590c17b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_4b6a26a8-ef01-4afd-a3fe-f824e5c3c3dd_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_6e073378-2acc-45e3-b144-a448874112c5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9b77d6c8-40c3-423a-b0f1-7f073ba4e359_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_64f052cc-5830-42ac-acf5-df4b5c2a6a58_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_30283c5d-2d58-4b31-acf8-f74c9bcbb46b_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_f4cd0f0b-ca96-46ce-b954-5e7b85d5f33f_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term portion of loans receivable, before accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Noncurrent</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:href="cron-20221231.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:to="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_298b2a02-ea42-4865-803a-b21ad7772c5a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_abf5a159-b499-415b-b051-d6fefc7e671d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bf8eed35-5c97-4dd6-a6ad-6303ab4749ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_4097fe50-677a-487a-b0e1-99e6c4bb5824_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BridgeLoanMember_54e32bf9-b0d5-4495-acbc-1ee72556a3e9_terseLabel_en-US" xlink:label="lab_us-gaap_BridgeLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loan</link:label>
    <link:label id="lab_us-gaap_BridgeLoanMember_label_en-US" xlink:label="lab_us-gaap_BridgeLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BridgeLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BridgeLoanMember" xlink:to="lab_us-gaap_BridgeLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_4475bf20-ed78-446f-ad5b-97f6111a2866_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_ee15eff0-30ae-4aad-af47-5554a513172a_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, profits to be received, maximum percentage of amounts advanced</link:label>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_label_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</link:label>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:to="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cecac531-81a0-42ff-9c73-985df01f2bfc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_2a13547d-7dc7-485d-942c-ce56d0576de0_terseLabel_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage, if warrant exercised</link:label>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_label_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</link:label>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_documentation_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:href="cron-20221231.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:to="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_711b554a-c734-4dcc-a977-9f09ca303ef1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8722d000-d343-4121-8b3b-05c9e1e09dec_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (years) &#8211; operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bcf22aa-937f-451f-84ff-d022f439fe22_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IsraelTaxAuthorityMember_306fcbea-3717-4e32-99e7-41de9280c6e2_terseLabel_en-US" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel</link:label>
    <link:label id="lab_us-gaap_IsraelTaxAuthorityMember_label_en-US" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IsraelTaxAuthorityMember" xlink:to="lab_us-gaap_IsraelTaxAuthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f7c9bc4-e0e9-4f50-b7e0-5d5a013b2745_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f33b1908-e8a3-4d62-89a1-eea5bc0c785d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4e5dd3e5-2600-446d-a470-4d9885ff47f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_1bcb1bd9-30ca-4d7d-8211-94fa98892540_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3ed1dbc4-dc8b-4ada-a949-0f4c86c5c8c8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b5958af8-a657-4604-a055-c6e698a6005b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_410a4756-17ef-4296-a3ce-e4fe05471598_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17a93b10-c33b-45ae-ab20-8a905cc9ded7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_4fcc2537-9187-4be8-a8f7-76aa24165fc3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant &amp; equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_52cc1a69-6734-413a-88ba-a0ba5424381e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc867f62-3cf5-49d4-bb85-50fa5bf36d00_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_50039fa5-f4b8-4406-bb71-41d9cb32cf15_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_437f1f5c-b781-4e69-b0f1-d0965729cb18_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4c7f0881-8f5e-4343-bb96-b744e134570a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_165580c1-39fc-4f24-963d-5091607352c3_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to investments in equity accounted investees</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_84a16fb2-60a7-4819-b6fd-bc32fd0f4088_terseLabel_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitura</link:label>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_label_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Australia Limited [Member]</link:label>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_documentation_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Australia Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosAustraliaLimitedMember" xlink:to="lab_cron_CronosAustraliaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome_610b2e7c-3e56-4ae8-b761-647be357f2c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-taxable income (loss)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_f10fc954-930c-46b6-a718-67f848e8a823_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_032db89d-68bc-4f7a-9135-6ee0d8f50eef_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_e35ba1d8-b8cc-4b5c-94e7-89fda5abb7c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_e32c3b46-0a5d-43a6-87bc-32e439639a97_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_1a46dc89-ff9b-48df-9dee-95d2d50f6974_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e907386-dd2d-4f19-968b-d3df2e9737ff_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_5df7a38c-cf15-4dd6-93b5-298096d8d48e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_36ad4520-f842-477f-a1ab-de85de26d984_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5afbb29b-c01d-4997-ba42-e25aa6402354_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExciseAndSalesTaxes_107e29db-4af9-41c2-9f8e-9a60432942fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ExciseAndSalesTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise taxes</link:label>
    <link:label id="lab_us-gaap_ExciseAndSalesTaxes_label_en-US" xlink:label="lab_us-gaap_ExciseAndSalesTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise and Sales Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExciseAndSalesTaxes" xlink:to="lab_us-gaap_ExciseAndSalesTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_d8091d44-0060-463a-a7ac-59d128e4783c_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_7209267c-8ae0-4aef-9fb5-dbb8220b82d1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Outstanding Warrants</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a3da1d96-8ea1-4839-ba9a-54713428f7b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Options Issued</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_808d91b0-cf97-4d59-ad94-b73d0448ab05_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_6b79f832-f9e6-418d-a385-edafdaf16942_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expense for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_5ac87f91-1dcf-4d89-bae1-ea708676d4bc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e8bd0355-bba5-4103-8808-6252734fda4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets Amortization Methods and Rates</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_dbd42e96-9d2a-4c6e-bceb-e28663b4ac11_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_974fbffd-76fd-4a52-97cc-79cfca309240_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_52f0b55d-07dc-4c59-81e7-2f0688f027da_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire other investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_874b1943-0fa4-42e4-abeb-f62df3ad2673_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_bbd8090f-0634-4995-b129-cee026ff7964_verboseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_89059451-5f99-4afb-ab5f-fc4786a26f6b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_738a2941-3f7d-4b7f-89a8-b12f122d268f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_fc1995f1-fcba-42b6-b53a-530f16f8ccc7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c63d023d-fffb-4d3e-bc9f-a17a9986105d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_eba62036-079c-4bde-9994-02742cd19f77_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_4d68a3e8-353c-42c2-90c1-7da5c619eb51_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight average expected life</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a104754-9d59-49dc-a745-64d9b0c1d036_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a5bd9ccc-71f1-4b80-9456-441a3759661a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a8c26bcc-4b0f-4cad-8a58-6db627e696c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9f078fa4-57ce-42e0-90aa-35aaf1be0156_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_eb7943ee-d865-401c-ac8a-610a39dfe196_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromLoansReceivable_adb8ac6c-f78e-4a94-976c-74211836cc32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments (advances) on loan receivables</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromLoansReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Loans Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:to="lab_us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a7bfb823-2740-42cf-8427-0eb47bd01750_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b17f5df3-33cc-4b19-a49c-40e069aca943_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_fc015833-b140-4a61-9286-7a9cae33a661_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_ad33a6ad-2bdc-4219-82bb-87c043d9fd89_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_4dbedb89-ba62-47ea-a712-a8a638d0d6ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-Based Arrangements, Liability, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_af15f633-30cb-4693-89ab-7470c94c5f09_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96a3523e-95f8-4dcc-84d6-de8f3796a717_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c6f5cf55-1811-4cce-8ed7-9bf24eda47b5_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_bf104d78-2323-4002-9c8a-b9371ff6665c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_17a957b7-802d-48b7-a8e8-5ff76795459e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_8d4ad42e-e58a-4829-aa4e-7ce74ca8f49a_terseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on revaluation of financial instruments</link:label>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_74aca2e9-abd5-4302-aa37-33d250749b97_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation of financial instruments</link:label>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_label_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:to="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b84b5217-1689-43d9-a2f1-aaa9740421e0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_c3aba2a4-3baf-48bc-8781-b3a872de1808_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of ownership after transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0e9e8a23-349a-4c04-bd2a-d9d50fdd0c39_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_5a15daf6-b771-4875-a028-63649df41124_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ed1fbd87-92e3-4405-8dea-b84de2a69277_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_e2c4ac6c-a415-473e-a7af-edb4acfa074a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_8383d7a7-dfcb-4100-9edf-36c7eac123e6_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesNoncurrent_2b5b8a44-b8b4-48ba-88f3-946f8e6b15c1_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion due to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_ffc3dddf-28a1-4f6d-95a5-cc6e32e2e0cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6087076c-8b69-4ee7-a934-d81ae80e3374_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_b43ef250-b0af-4344-af2a-4654d801d443_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_4e45e6e4-cef7-439d-aadc-b22b2f25e47f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AuditInformationAbstract_label_en-US" xlink:label="lab_cron_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_cron_AuditInformationAbstract_documentation_en-US" xlink:label="lab_cron_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AuditInformationAbstract" xlink:href="cron-20221231.xsd#cron_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AuditInformationAbstract" xlink:to="lab_cron_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8530e716-f6ee-490e-b9e8-2e7d848792d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_dea47a77-056b-497d-b64b-11c5b1d6af77_terseLabel_en-US" xlink:label="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, operating lease, area of land to be disposed of</link:label>
    <link:label id="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_label_en-US" xlink:label="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Area Of Land To Be Disposed Of</link:label>
    <link:label id="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_documentation_en-US" xlink:label="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Area Of Land To Be Disposed Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:href="cron-20221231.xsd#cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:to="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_92c831a8-bf51-4ab1-8dd6-ecbad1bf8497_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts payable</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_e2f90a9a-5977-4ca1-b2d5-609fb122b9a6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b43218c6-2d3e-4d26-bc95-8abbc75c5780_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_07148690-1fb1-46e9-a151-a1ed4d909793_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_118a7e42-aa39-4010-8c99-e900b48b6a8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_8b76a31d-679f-432f-864c-7d6e2c426c25_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_ea258ed1-6de0-470c-a85c-d7d0bfd8fd5c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_d5d648c5-7b5b-468b-8d3c-f0f3ade9e905_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NoncashSellingAndMarketingExpense_9d15a169-94eb-4617-bdd9-0a6e3afbf687_terseLabel_en-US" xlink:label="lab_cron_NoncashSellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash sales and marketing</link:label>
    <link:label id="lab_cron_NoncashSellingAndMarketingExpense_label_en-US" xlink:label="lab_cron_NoncashSellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Selling And Marketing Expense</link:label>
    <link:label id="lab_cron_NoncashSellingAndMarketingExpense_documentation_en-US" xlink:label="lab_cron_NoncashSellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Selling And Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NoncashSellingAndMarketingExpense" xlink:href="cron-20221231.xsd#cron_NoncashSellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NoncashSellingAndMarketingExpense" xlink:to="lab_cron_NoncashSellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_b023f7f5-9067-49b4-a7f9-951b11ae8f00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_28e0b721-2050-42c9-a129-4da4075587ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_78a6b640-e860-448c-b2dd-a2a872737f86_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fdc1b50a-010e-40d5-8183-353da6ce2985_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_2e17954f-27e7-4e84-9904-8cc95af7a848_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_a6dc65e3-55a3-4d01-aaab-5916f9bb1dcb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5363512a-10f7-48d1-be44-fa7bcbfc8fbc_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_971612f0-bce6-4083-9e6e-ce8ab2e88a5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, threshold period past due, writeoff</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Noncurrent, Threshold Period Past Due, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:to="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ad5904bf-852b-45d4-a4d9-34caf6a9e52c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_b8c857e5-7b28-4d9b-8821-b41e40419654_terseLabel_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GrowCo Credit Facility</link:label>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_label_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo Credit Facility [Member]</link:label>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_documentation_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember" xlink:href="cron-20221231.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGrowCoCreditFacilityMember" xlink:to="lab_cron_CronosGrowCoCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9f3278a1-0bcb-4c37-9426-16b76d0ded16_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InterestReceivedNet_6666977e-5a4b-4fcb-9c8f-6117b26f92c2_terseLabel_en-US" xlink:label="lab_cron_InterestReceivedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_cron_InterestReceivedNet_label_en-US" xlink:label="lab_cron_InterestReceivedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Received, Net</link:label>
    <link:label id="lab_cron_InterestReceivedNet_documentation_en-US" xlink:label="lab_cron_InterestReceivedNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Received, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InterestReceivedNet" xlink:href="cron-20221231.xsd#cron_InterestReceivedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InterestReceivedNet" xlink:to="lab_cron_InterestReceivedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_c6951b1a-1d3c-4d8b-be57-ad775c27d7b6_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_81ab232a-7a3e-4415-962d-83100832d468_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a5882267-a722-40ab-b209-c33c7ddbfc29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9124e8da-66d7-4d54-a389-795a87bcd0a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_6657a0ba-9bfe-4f27-a430-70db3446a26c_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale and discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_a0365c55-575c-48ed-92c7-820646aea97d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_42a6e27c-0220-4bff-be5a-4ccc4572ef78_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ThreeMajorCustomersMember_0e5c8957-7102-4d09-9d17-ad6cc63b2dfc_terseLabel_en-US" xlink:label="lab_cron_ThreeMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Major Customers</link:label>
    <link:label id="lab_cron_ThreeMajorCustomersMember_label_en-US" xlink:label="lab_cron_ThreeMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Major Customers [Member]</link:label>
    <link:label id="lab_cron_ThreeMajorCustomersMember_documentation_en-US" xlink:label="lab_cron_ThreeMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Major Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ThreeMajorCustomersMember" xlink:href="cron-20221231.xsd#cron_ThreeMajorCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ThreeMajorCustomersMember" xlink:to="lab_cron_ThreeMajorCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_c9c11fce-ebf8-4184-bccc-d423c87cc95d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, extension term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_ef49267f-52d6-4fbb-aefd-6266aeba813a_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_64786b22-0744-42bd-9c44-9f00c227d64b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_455545b4-09ea-4527-afaa-13de291d706c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ProceedsFromDividends_709987d8-192f-4243-b276-8d65f99583ff_terseLabel_en-US" xlink:label="lab_cron_ProceedsFromDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend proceeds</link:label>
    <link:label id="lab_cron_ProceedsFromDividends_label_en-US" xlink:label="lab_cron_ProceedsFromDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Dividends</link:label>
    <link:label id="lab_cron_ProceedsFromDividends_documentation_en-US" xlink:label="lab_cron_ProceedsFromDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromDividends" xlink:href="cron-20221231.xsd#cron_ProceedsFromDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ProceedsFromDividends" xlink:to="lab_cron_ProceedsFromDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_94a0b808-a541-4b59-95e2-4c983aa3e5af_terseLabel_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Collaboration Loan</link:label>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_label_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Collaboration Loan [Member]</link:label>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_documentation_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Collaboration Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember" xlink:href="cron-20221231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannasoulCollaborationLoanMember" xlink:to="lab_cron_CannasoulCollaborationLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_2db435c3-eb46-4cd6-9552-590dddae9d91_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_89d20460-09b9-4aa0-b4d3-6a03b766da53_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_93d42a32-10a4-4a75-9969-aecfd0e3789f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_1706c4b1-9ab2-4028-8a2a-32c230de604f_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Long-term portion of accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Noncurrent</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:href="cron-20221231.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:to="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_33b51ce1-218d-4cd5-a15a-2d974d3e207c_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_df9d26af-d8c0-411d-b29d-2fa1fbaedee7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecurities_6e1644dc-cb20-4298-b936-a4d38987776b_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for exercise of rights on derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DilutiveSecurities_label_en-US" xlink:label="lab_us-gaap_DilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecurities" xlink:to="lab_us-gaap_DilutiveSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6d758543-7609-4a02-9d65-b1b90155f2da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_67fbd059-12a9-47a0-8890-41fe042e31c4_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_76b61ae8-aee7-41fa-8f53-1a341a82c11f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LiabilityClassifiedAwardsMember_f5759409-a94d-4f95-b407-c2ddabe3dad7_terseLabel_en-US" xlink:label="lab_cron_LiabilityClassifiedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Classified Awards</link:label>
    <link:label id="lab_cron_LiabilityClassifiedAwardsMember_label_en-US" xlink:label="lab_cron_LiabilityClassifiedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Classified Awards [Member]</link:label>
    <link:label id="lab_cron_LiabilityClassifiedAwardsMember_documentation_en-US" xlink:label="lab_cron_LiabilityClassifiedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Classified Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LiabilityClassifiedAwardsMember" xlink:href="cron-20221231.xsd#cron_LiabilityClassifiedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LiabilityClassifiedAwardsMember" xlink:to="lab_cron_LiabilityClassifiedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf91131c-2cc6-42d2-9c80-22d6b6d68d88_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4cfb5b5c-5895-4cab-b138-dc5d2ec5413d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_70f31bd5-a23f-440b-a674-ac23816f87c0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_cc76db32-2090-4789-aae2-1fa2ff77d28b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_add3590c-bd6a-4df9-85a1-08ccc8b2f147_terseLabel_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs)</link:label>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_label_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs) [Member]</link:label>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_documentation_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember" xlink:href="cron-20221231.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredShareUnitsDSUsMember" xlink:to="lab_cron_DeferredShareUnitsDSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_982d23aa-cdf8-462c-b637-861a60c352ee_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_f206ccf0-0cdf-4b4f-bc6f-13f7203bee8a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RestatementReviewExpense_3c43a393-aac0-4e46-af59-fd489852b706_verboseLabel_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial statement review costs</link:label>
    <link:label id="lab_cron_RestatementReviewExpense_label_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Review Expense</link:label>
    <link:label id="lab_cron_RestatementReviewExpense_documentation_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Review Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense" xlink:href="cron-20221231.xsd#cron_RestatementReviewExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RestatementReviewExpense" xlink:to="lab_cron_RestatementReviewExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_01f78367-dd7c-4db3-ae23-6b62cb7e2bb1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_6debaa8b-cc6b-4a48-816a-f005120b2d98_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2020OmnibusPlanMember_e00167a7-9e96-461e-9784-b2091a311149_terseLabel_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan</link:label>
    <link:label id="lab_cron_A2020OmnibusPlanMember_label_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan [Member]</link:label>
    <link:label id="lab_cron_A2020OmnibusPlanMember_documentation_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember" xlink:href="cron-20221231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2020OmnibusPlanMember" xlink:to="lab_cron_A2020OmnibusPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_99fe45b8-58b2-4864-8d6a-d36ad89c56a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Liability-Classified Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_0da206c1-2ecf-452f-afd7-c2f90bdeeb9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_31368520-630d-4125-9fc4-93d0dbbf30bc_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c0d21387-8e0c-463a-834c-abd184b8b6a7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c9a314fb-0b7e-46c2-b3ad-c8a36dad4ea0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b0242896-849b-4bc0-ac45-49b397fecde6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_1d7b1557-0955-4cee-9e13-89dcfa110dde_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_61e2f31b-2f7a-4cd5-bd34-d55b97b1fbab_totalLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_Goodwill_c51459a3-500f-454e-9d32-c06cb71c3e23_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TechnionResearchAndDevelopmentFoundationMember_a5f4a4b2-307b-4331-935f-c26b39b3aab3_terseLabel_en-US" xlink:label="lab_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technion</link:label>
    <link:label id="lab_cron_TechnionResearchAndDevelopmentFoundationMember_label_en-US" xlink:label="lab_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technion Research And Development Foundation [Member]</link:label>
    <link:label id="lab_cron_TechnionResearchAndDevelopmentFoundationMember_documentation_en-US" xlink:label="lab_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technion Research And Development Foundation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:href="cron-20221231.xsd#cron_TechnionResearchAndDevelopmentFoundationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:to="lab_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e94b5451-47e4-4bcb-ad24-3f2cda8e935c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_6b955708-e21f-4ca9-9752-0ac4c1d3889a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bacf468d-295c-4660-9183-8ba86511b590_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1b418442-198e-4e18-aaa0-6c8a37c21cef_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit), net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_f4293a9e-62ab-4070-9ee9-c2914f842537_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7a8caf30-18ba-487a-bb48-0fdbfc6f22eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_8cd4c0f2-8888-48a7-b4e0-aa6756a78371_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_a5200c24-fb6b-4c94-824e-0ba6c346d393_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionCosts_ad73a468-42b6-4e40-b9db-12b0a6b003d7_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Costs, Period Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionCosts" xlink:to="lab_us-gaap_AcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_a9ec1268-5c7e-46f2-ab53-77a1d091dd6f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e5b33ad2-9ec1-4a73-a5ed-6a2f6da7a11f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_8c193e8d-87ae-4cb0-9eed-abf7a21b940a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_373d8592-e6be-44f2-b566-11eb6e266587_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d882733f-4bd4-4971-be84-b32784efd294_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_4d7fc5d8-7687-482b-959a-f60120e8f1aa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments_f39a7216-47b0-49be-b36b-dadda3be72e7_terseLabel_en-US" xlink:label="lab_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange effect</link:label>
    <link:label id="lab_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments_documentation_en-US" xlink:label="lab_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" xlink:href="cron-20221231.xsd#cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f7c24906-0380-460e-b5fa-824af879d2a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share capital (authorized for issue as of December 31, 2022 and 2021: unlimited; shares outstanding as of December 31, 2022 and 2021: 380,575,403 and 374,952,693, respectively)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_7a534903-c42e-4905-b603-8bdca2827384_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted loss from discontinued operations per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_c9d30997-b309-47a0-9524-89705a5d1d5e_terseLabel_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_label_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Useful Life, Term</link:label>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_documentation_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Useful Life, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm" xlink:href="cron-20221231.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DerivativeLiabilityUsefulLifeTerm" xlink:to="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4d28040d-9c59-4300-906a-cf0b91b65e96_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2015StockOptionPlanMember_2b494604-6a88-4b07-bf9b-c5ae459fa2c4_terseLabel_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan</link:label>
    <link:label id="lab_cron_A2015StockOptionPlanMember_label_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan [Member]</link:label>
    <link:label id="lab_cron_A2015StockOptionPlanMember_documentation_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember" xlink:href="cron-20221231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2015StockOptionPlanMember" xlink:to="lab_cron_A2015StockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_59f0d83d-565a-4d62-b940-81915a3b3441_periodStartLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_6089cb49-cff7-4b86-bd93-b8153c7430ae_periodEndLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_e3b63a58-e19b-4715-8146-81a6ea2674b0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7cc2df2f-328e-47cb-8306-b70cd14c4030_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_03d0b721-ba14-48da-8ce9-638c9949b43c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bc89e217-83f2-4623-91d4-53db17c36bb7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gain (loss) on translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_993b71eb-3e98-4d1b-9f40-ca5d0be63c9a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gain (loss) on translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ConsultingServicesMember_5055f9fe-028a-4070-afbc-e077d688afa8_terseLabel_en-US" xlink:label="lab_cron_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services</link:label>
    <link:label id="lab_cron_ConsultingServicesMember_label_en-US" xlink:label="lab_cron_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services [Member]</link:label>
    <link:label id="lab_cron_ConsultingServicesMember_documentation_en-US" xlink:label="lab_cron_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesMember" xlink:href="cron-20221231.xsd#cron_ConsultingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ConsultingServicesMember" xlink:to="lab_cron_ConsultingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_e2959e53-b529-4611-83a5-1b5699e6b27b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price at valuation date (in canadian dollars per share)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4aca9e4a-44c7-46d9-910d-7350d2c042cc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_3b6309a7-c969-4616-826d-b530aa3d8bf1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from continuing operations attributable to the shareholders of Cronos&#160;Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_f0d7524f-cd4a-43e4-9850-df8d3c6d9f35_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss used in the computation of basic loss from continuing operations per share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_75e015d5-9519-4b4d-a755-c1577762826f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_77d272d3-fd22-481d-840a-c47ba2097c01_terseLabel_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granting and vesting of DSUs (in shares)</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_label_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_documentation_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:to="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_6b2e3c53-efd0-4c2d-9458-5538ac323a78_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_5d265332-d7e0-4afb-9016-4964f9c6da0a_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants issued</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Warrants Issued</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Warrants Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:to="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_dd7dc8ee-78ec-46fe-86d1-f8af9af9e29b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fef7582f-8e59-47d3-a96f-acd8e33b7c67_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ec88befb-6142-4785-a569-529b58cac516_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_8b09f64e-f89d-436c-95bc-2542a22a83ed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ManufacturingServicesMember_eb5764ce-494e-4ddc-903b-f9a949dee7c7_terseLabel_en-US" xlink:label="lab_cron_ManufacturingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Services</link:label>
    <link:label id="lab_cron_ManufacturingServicesMember_label_en-US" xlink:label="lab_cron_ManufacturingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Services [Member]</link:label>
    <link:label id="lab_cron_ManufacturingServicesMember_documentation_en-US" xlink:label="lab_cron_ManufacturingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ManufacturingServicesMember" xlink:href="cron-20221231.xsd#cron_ManufacturingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ManufacturingServicesMember" xlink:to="lab_cron_ManufacturingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RedwoodReportingUnitMember_1d6be952-75de-4459-ab60-db909eab862c_terseLabel_en-US" xlink:label="lab_cron_RedwoodReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood</link:label>
    <link:label id="lab_cron_RedwoodReportingUnitMember_label_en-US" xlink:label="lab_cron_RedwoodReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Reporting Unit [Member]</link:label>
    <link:label id="lab_cron_RedwoodReportingUnitMember_documentation_en-US" xlink:label="lab_cron_RedwoodReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodReportingUnitMember" xlink:href="cron-20221231.xsd#cron_RedwoodReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RedwoodReportingUnitMember" xlink:to="lab_cron_RedwoodReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_3e482f96-4304-40ed-804e-4097111e60a4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_3bc8ef8c-efe1-44b1-845a-6680841d295b_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_96f2e892-abb7-4865-a5d4-f0b5b5072fd8_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_59ed0fa4-5e30-4137-bc40-a5c70a4ac640_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_e6080342-9190-4133-8eae-ae0d1cc0bbd7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f3172560-5aa4-41ea-b347-4f15d1ec571b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill and indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_87aa2c6b-e336-4d83-8a0c-4740f324cfd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7b4f77cc-1a13-42a5-ab17-1ecc50cfc204_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a4d245a3-d446-45ef-8e12-d4ae6aa2f387_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfSeatsOnBoardOfDirectors_f88c7208-d75e-440c-9b33-46e8405a37f6_terseLabel_en-US" xlink:label="lab_cron_NumberOfSeatsOnBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of seats on board of directors</link:label>
    <link:label id="lab_cron_NumberOfSeatsOnBoardOfDirectors_label_en-US" xlink:label="lab_cron_NumberOfSeatsOnBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Seats on Board of Directors</link:label>
    <link:label id="lab_cron_NumberOfSeatsOnBoardOfDirectors_documentation_en-US" xlink:label="lab_cron_NumberOfSeatsOnBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Seats on Board of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfSeatsOnBoardOfDirectors" xlink:href="cron-20221231.xsd#cron_NumberOfSeatsOnBoardOfDirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfSeatsOnBoardOfDirectors" xlink:to="lab_cron_NumberOfSeatsOnBoardOfDirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GinkgoBioworksInc.Member_91c58352-fc16-4fab-b4e3-fd656715d49b_terseLabel_en-US" xlink:label="lab_cron_GinkgoBioworksInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo</link:label>
    <link:label id="lab_cron_GinkgoBioworksInc.Member_label_en-US" xlink:label="lab_cron_GinkgoBioworksInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Bioworks Inc. [Member]</link:label>
    <link:label id="lab_cron_GinkgoBioworksInc.Member_documentation_en-US" xlink:label="lab_cron_GinkgoBioworksInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Bioworks Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoBioworksInc.Member" xlink:href="cron-20221231.xsd#cron_GinkgoBioworksInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GinkgoBioworksInc.Member" xlink:to="lab_cron_GinkgoBioworksInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9b35975b-1b12-4311-9aa8-4baa55b8372b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_9b1af4aa-b2a5-4524-a719-c351f5f723c5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_4c30c519-5617-4337-81ec-19e0c75c0a1f_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_17ec1093-6998-401d-82cd-ca86067d4848_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TopupRightsMember_3043e4a3-6d89-4012-9189-080a7bab71c9_verboseLabel_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights</link:label>
    <link:label id="lab_cron_TopupRightsMember_label_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights [Member]</link:label>
    <link:label id="lab_cron_TopupRightsMember_documentation_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TopupRightsMember" xlink:to="lab_cron_TopupRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_df8689f6-1a41-4518-a193-9d2542ab56f4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_3922d6ce-f986-4a2a-8aa0-0f00782bb458_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows - cash paid for operating lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosIsraelG.S.CultivationsLtd.Member_2a09fdb7-98fa-4ed8-95a9-dded8ea32e0c_terseLabel_en-US" xlink:label="lab_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Cultivations Ltd.</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.CultivationsLtd.Member_label_en-US" xlink:label="lab_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Cultivations Ltd. [Member]</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.CultivationsLtd.Member_documentation_en-US" xlink:label="lab_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Cultivations Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.CultivationsLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:to="lab_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_8fb668d9-1c79-4c4d-be42-817c39e83df1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2eca6abe-65d6-4610-aee4-775c5c70a87f_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current expected credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_455b2731-4094-4c0c-aef2-95a59eed55a2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Interest Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxAssetsShareIssuanceCost_b85aade5-93e2-465b-b7a0-aa30a5acb403_terseLabel_en-US" xlink:label="lab_cron_DeferredTaxAssetsShareIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issuance cost</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsShareIssuanceCost_label_en-US" xlink:label="lab_cron_DeferredTaxAssetsShareIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Share Issuance Cost</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsShareIssuanceCost_documentation_en-US" xlink:label="lab_cron_DeferredTaxAssetsShareIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Share Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsShareIssuanceCost" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsShareIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxAssetsShareIssuanceCost" xlink:to="lab_cron_DeferredTaxAssetsShareIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_b268def0-ade8-4a9e-b64e-fdb5a76778d1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite life intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e623d21b-c7cc-4285-a273-927e86a28a60_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_80e2dd05-b7be-44c7-b822-612d9d0f8941_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaVenturesInc.Member_0120d736-7153-4ef5-86e5-7cccb01325d5_terseLabel_en-US" xlink:label="lab_cron_AltriaVenturesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Ventures</link:label>
    <link:label id="lab_cron_AltriaVenturesInc.Member_label_en-US" xlink:label="lab_cron_AltriaVenturesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Ventures Inc. [Member]</link:label>
    <link:label id="lab_cron_AltriaVenturesInc.Member_documentation_en-US" xlink:label="lab_cron_AltriaVenturesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Ventures Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaVenturesInc.Member" xlink:href="cron-20221231.xsd#cron_AltriaVenturesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaVenturesInc.Member" xlink:to="lab_cron_AltriaVenturesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_58f0d2e2-c3d5-4f3d-8f18-d6785ae262c0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_3fb80aea-7b17-4466-9029-55262c7f8eda_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_fc87da8d-7ac7-4f7d-bdd4-04f04cc8c1e4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_317210ea-e0b5-45fb-9eaf-589b382d917b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_0d76e74e-d52d-4eba-a52f-97714960abdb_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c8f9df4d-2ece-43ea-bae6-c87886cc6b62_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LoanReceivableNameAxis_8e0af883-8d09-480a-a569-1fc97c3debf2_terseLabel_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:label id="lab_cron_LoanReceivableNameAxis_label_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:label id="lab_cron_LoanReceivableNameAxis_documentation_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LoanReceivableNameAxis" xlink:to="lab_cron_LoanReceivableNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_86d587df-42d8-4efb-bf82-e342ac856de6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_509385b6-952c-4279-b39e-b01edbbd9bd9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_af66c2e0-d961-4146-a174-71ba5f65f833_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_d0c0fa0e-af06-407c-8eeb-da94d6f794b7_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange effect</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherInvestmentsRollForward_7ea7e5fb-b7c5-4c08-b005-a16253dcccf8_terseLabel_en-US" xlink:label="lab_cron_OtherInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Roll Forward]</link:label>
    <link:label id="lab_cron_OtherInvestmentsRollForward_label_en-US" xlink:label="lab_cron_OtherInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Roll Forward]</link:label>
    <link:label id="lab_cron_OtherInvestmentsRollForward_documentation_en-US" xlink:label="lab_cron_OtherInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherInvestmentsRollForward" xlink:href="cron-20221231.xsd#cron_OtherInvestmentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherInvestmentsRollForward" xlink:to="lab_cron_OtherInvestmentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_d4bc140d-8a93-4e93-9f59-fe031b237508_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AccruedLiabilitiesPolicyPolicyTextBlock_41b64a08-460e-49f8-b7ab-faa3d0300ade_terseLabel_en-US" xlink:label="lab_cron_AccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_cron_AccruedLiabilitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cron_AccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cron_AccruedLiabilitiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cron_AccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccruedLiabilitiesPolicyPolicyTextBlock" xlink:href="cron-20221231.xsd#cron_AccruedLiabilitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AccruedLiabilitiesPolicyPolicyTextBlock" xlink:to="lab_cron_AccruedLiabilitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_41d1ae86-aa34-423d-b6b6-fa92f82fb03e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_fe8643b2-af60-4a7c-9581-5c304a9ee7a1_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_9e432cb5-e34d-4b6a-95be-df60cd0459de_verboseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to affiliates</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LoanReceivableNameDomain_b708f31e-8ae3-4cc6-9053-260d3d18071f_terseLabel_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Domain]</link:label>
    <link:label id="lab_cron_LoanReceivableNameDomain_label_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Domain]</link:label>
    <link:label id="lab_cron_LoanReceivableNameDomain_documentation_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Loan Receivable, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LoanReceivableNameDomain" xlink:to="lab_cron_LoanReceivableNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_ad247dc2-997f-4b99-a1ed-aef39a8fe696_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5cee16c6-633b-490b-976f-8bb855dd377b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ed4c002b-b141-4024-94d9-37b515909194_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_90005a88-8a55-44c0-80dd-89f97053fc14_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement_a7b60e99-110e-47bd-8cf3-8a825e8aff19_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activities relating to share-based compensation (in shares)</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Payment Arrangement</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" xlink:to="lab_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_f24eda2d-7d58-40a4-a7ba-67e849f50621_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatueraJVPartnerMember_4d33f0a6-a091-4547-8682-34d1b0e90040_terseLabel_en-US" xlink:label="lab_cron_NatueraJVPartnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera JV Partner</link:label>
    <link:label id="lab_cron_NatueraJVPartnerMember_label_en-US" xlink:label="lab_cron_NatueraJVPartnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera JV Partner [Member]</link:label>
    <link:label id="lab_cron_NatueraJVPartnerMember_documentation_en-US" xlink:label="lab_cron_NatueraJVPartnerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera JV Partner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraJVPartnerMember" xlink:href="cron-20221231.xsd#cron_NatueraJVPartnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatueraJVPartnerMember" xlink:to="lab_cron_NatueraJVPartnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_84753ca1-9019-4bf3-8272-43989a2eeb7d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information and Disaggregated Revenue</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_1d9b67a3-1d0d-4a6f-b05f-af6247b3fafd_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annualized volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_7e4815ec-1b2e-4c7b-b23f-1e6339546e21_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_f93cf4e0-cc3f-4432-aae3-2c54ac660a1a_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_09376825-c72c-4a72-aca2-752d3cfe1d1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_88110d52-8ae0-46b1-ae75-932e787dd978_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_86c4736b-4e97-4ecb-8676-0add4772aaa8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaInvestmentMember_1cad7814-066e-40ba-8e50-7d88da014757_terseLabel_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment</link:label>
    <link:label id="lab_cron_AltriaInvestmentMember_label_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment [Member]</link:label>
    <link:label id="lab_cron_AltriaInvestmentMember_documentation_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember" xlink:href="cron-20221231.xsd#cron_AltriaInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaInvestmentMember" xlink:to="lab_cron_AltriaInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_384eff39-d0d9-444e-9adf-ed2a908283a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_d5136a45-99dd-47e6-95cc-d848b6f4ce55_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation, forfeiture and expiry of options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_cd3c4ba6-d688-4e5f-88ca-bd411f41a539_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_2e8a1cc1-9668-412e-b7ff-f00de75566fc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_48208583-3e06-45ec-9ffc-4b7578c0b5c4_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_25b34be7-1470-44a7-a40a-291ee0a1f437_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_46a65807-4198-40a2-a0cc-5ecd6c7a737d_negatedTotalLabel_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_label_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Accumulated Impairment, Impairment in Period</link:label>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_documentation_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Accumulated Impairment, Impairment in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:to="lab_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_4e01ab84-8dbc-4533-8255-1fdb571a48ba_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating subsidiaries acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_b65e92b3-637b-4a65-8a8c-f2fa3e225fd6_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up rights out-of-period adjustment</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Top-up Rights Exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Top-up Rights Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:to="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_681c20c3-89a4-4856-a4a4-42dd2e46a4ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_5116f654-51b1-4de3-8928-cefb213e980d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic loss from continuing operations per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_4b01494b-d883-40fd-99e1-f00b1bdbe6ab_negatedTerseLabel_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:href="cron-20221231.xsd#cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:to="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_55bea3d4-6993-48e4-9791-b3a7d55e7e43_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares outstanding used in the computation of basic earnings (loss) per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f0e9678e-28ed-4f4e-a299-a810c085e908_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_011fb3b6-94e5-409e-8b38-153f450db487_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_b96d4894-b082-4a95-8e9d-4fae8d984686_terseLabel_en-US" xlink:label="lab_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Intangible Asset, Finite-Lived, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag</link:label>
    <link:label id="lab_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Intangible Asset, Finite-Lived, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag</link:label>
    <link:label id="lab_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Intangible Asset, Finite-Lived, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:href="cron-20221231.xsd#cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_388e19e1-242b-405e-9b3b-407289ac6d9f_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sensitivity Analysis</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:to="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_fc25ee6e-99f8-41cb-9e3b-014978648486_negatedTotalLabel_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange effect</link:label>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_documentation_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_e5983ed5-de8e-47ca-acd1-022382d0ebf0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_ea8eee69-91ff-4df6-af0b-4cb04fe10a34_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsGross_193ef5c6-1ef2-4a2b-94dc-122cfd302017_terseLabel_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsGross_documentation_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsGross" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IndefiniteLivedIntangibleAssetsGross" xlink:to="lab_cron_IndefiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_ddc931bb-ddfe-4967-ba53-592e5d67ea9c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_c5124441-1f2c-4747-9d4b-24fa85b78b90_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_5f0b1c52-3958-4bd7-a729-cd578050e9c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_faee79de-3139-42ca-b715-7f5bc2264f01_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bf0ca47a-9bbc-4203-bd64-ca6c2b71c297_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_bff1c549-9f5f-4177-89a4-d8ccbade8e26_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_77cd21a2-4a4e-4255-88cf-06f85e00a0eb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_1194a9cc-dbdd-4107-8bb7-dc4a0ccddc8f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_78f9295e-7576-4e12-b64c-e372391e0be8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0aaff9af-8c9c-4fc7-b244-0295889e1d9f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OneVendorMember_4a059175-a543-41c2-8bfd-fec8731a91d9_terseLabel_en-US" xlink:label="lab_cron_OneVendorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Vendor</link:label>
    <link:label id="lab_cron_OneVendorMember_label_en-US" xlink:label="lab_cron_OneVendorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Vendor [Member]</link:label>
    <link:label id="lab_cron_OneVendorMember_documentation_en-US" xlink:label="lab_cron_OneVendorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Vendor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneVendorMember" xlink:href="cron-20221231.xsd#cron_OneVendorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OneVendorMember" xlink:to="lab_cron_OneVendorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_268fdc09-daa6-4aa9-9768-2415fc4fadff_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_19c1d5e6-fdc9-4d7e-a02c-292b4a4ac1b1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_1df7dbd7-8f8b-4142-97e1-b14823242a9d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FourMajorCustomersMember_b13c8656-c5d6-4a25-b5cc-393fd754432a_terseLabel_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers</link:label>
    <link:label id="lab_cron_FourMajorCustomersMember_label_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers [Member]</link:label>
    <link:label id="lab_cron_FourMajorCustomersMember_documentation_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember" xlink:href="cron-20221231.xsd#cron_FourMajorCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FourMajorCustomersMember" xlink:to="lab_cron_FourMajorCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount_8eed8138-acad-4b91-8056-23c43b9dba08_terseLabel_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible transaction costs</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount_label_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs, Amount</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount_documentation_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" xlink:to="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_6efd78b9-6d58-4fdf-ba03-41edbbb79006_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherCountriesMember_93d3eb80-156b-4448-911f-fb55ab0c86a7_terseLabel_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries</link:label>
    <link:label id="lab_cron_OtherCountriesMember_label_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_cron_OtherCountriesMember_documentation_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember" xlink:href="cron-20221231.xsd#cron_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherCountriesMember" xlink:to="lab_cron_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1728708e-ff6c-4ac0-9935-571049282b34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_4ce126e6-b640-462a-ab3f-a5af97a3e6ea_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_03a4c597-6d0f-4545-a581-f26060b2da8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_6474e1bb-c2e7-4b66-8a78-9d7f3d5642c0_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e3772b21-fc4e-4ce9-b534-d82e604abdfe_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_b3d28b33-cb7d-4bc1-a71b-ace8b40c5b96_negatedLabel_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_aa27a4c5-3e36-4289-a8cd-43468cb5b5a7_negatedPeriodStartLabel_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_f2d06d89-6815-47b7-9a65-5f0f395ede74_negatedPeriodEndLabel_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_label_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Accumulated Impairment</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_documentation_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Accumulated Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:to="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_16d96546-04ef-45ef-8350-35b5de3d429b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_a21bacbd-9d27-41b7-b894-5edd940fc627_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f52ead9b-ba4a-4cb6-aa43-5d9576e51e5a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_7c8a6458-808f-4b98-a99c-f3701ebcbc34_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d2db0228-b8e7-45fd-b520-b9913837509f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a4aa78d5-857f-409b-b7f7-34a3e9bbae8e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab4762bd-0560-42e4-88b6-b2c099d9c336_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ce4eb0c3-0226-4340-8cd0-a1360f7a9b01_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1666fdba-2967-44c3-bcde-80f1a20eb024_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a3a0e8bf-772c-4920-8e2d-d2294ae1d469_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0abb93c0-7b88-4d17-a9dc-3a78a436bb04_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activities relating to share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_214d9363-9334-4140-84d2-586e0cda77b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_19b17946-f8a9-4e0b-9e3a-b903dd187a94_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_5037a933-a91d-4cf7-8ec9-2f81a9d8f4ef_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_477b04a9-8ebe-485d-b259-24c108d4ac44_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_30df3ed3-be29-4e4d-aa3c-b1ce28eb1dea_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_4577f6da-eacc-4bc2-a0e7-9a39b1a6666b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other restructuring costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AuroraCannabisInc.Member_45f304b8-0cd2-442a-9a5e-1a4cc2462899_terseLabel_en-US" xlink:label="lab_cron_AuroraCannabisInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurora</link:label>
    <link:label id="lab_cron_AuroraCannabisInc.Member_label_en-US" xlink:label="lab_cron_AuroraCannabisInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurora Cannabis Inc. [Member]</link:label>
    <link:label id="lab_cron_AuroraCannabisInc.Member_documentation_en-US" xlink:label="lab_cron_AuroraCannabisInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurora Cannabis Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AuroraCannabisInc.Member" xlink:href="cron-20221231.xsd#cron_AuroraCannabisInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AuroraCannabisInc.Member" xlink:to="lab_cron_AuroraCannabisInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_20fa9bf8-de08-4d2a-8d0b-e9a082be24eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loan Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_16716705-72e4-4ce2-9f36-6057d25d041e_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, percentage of profits to be received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_label_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:to="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_3f936a3a-8859-4dcb-ab16-8d83c1d94357_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OSCSettlementMember_f62bfd2c-43b8-4e34-9301-449d35c47e57_terseLabel_en-US" xlink:label="lab_cron_OSCSettlementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OSC Settlement</link:label>
    <link:label id="lab_cron_OSCSettlementMember_label_en-US" xlink:label="lab_cron_OSCSettlementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OSC Settlement [Member]</link:label>
    <link:label id="lab_cron_OSCSettlementMember_documentation_en-US" xlink:label="lab_cron_OSCSettlementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OSC Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OSCSettlementMember" xlink:href="cron-20221231.xsd#cron_OSCSettlementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OSCSettlementMember" xlink:to="lab_cron_OSCSettlementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_402e7abf-6af0-44de-a74e-d0875175be56_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to the shareholders of Cronos Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_16a09fb4-aaac-447e-9487-2fc4ac7f5de5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanLossesExpensed_00a0ddf2-c6b3-4156-b493-5d2c25ae70cc_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in the allowance</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLossesExpensed_07cdc258-c955-4126-a78b-93e7d9cb029f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease)</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLossesExpensed_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Loss, Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanLossesExpensed" xlink:to="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_7f2fd06f-08ec-419c-aba2-6fdc59d22db9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Share Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CBCALicensingAgreementMember_4c1dd69a-8312-4bf4-b130-173a8ff487bb_terseLabel_en-US" xlink:label="lab_cron_CBCALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBCA Licensing Agreement</link:label>
    <link:label id="lab_cron_CBCALicensingAgreementMember_label_en-US" xlink:label="lab_cron_CBCALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBCA Licensing Agreement [Member]</link:label>
    <link:label id="lab_cron_CBCALicensingAgreementMember_documentation_en-US" xlink:label="lab_cron_CBCALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBCA Licensing Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBCALicensingAgreementMember" xlink:href="cron-20221231.xsd#cron_CBCALicensingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CBCALicensingAgreementMember" xlink:to="lab_cron_CBCALicensingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_89670eb5-6e11-4bc5-805b-61f6175076bd_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3a1eb6e-678a-430f-83e0-24714ad778a2_terseLabel_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_af676c5c-1bb4-49e3-b070-243e1b77b664_verboseLabel_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liability</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_label_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_documentation_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:href="cron-20221231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:to="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_54bdf964-bbae-432d-8318-0398a496ae2f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_50d8adc4-d0e8-43aa-a3ae-0b035ca4172f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of change in tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_af686b9a-ccd2-48e9-b13c-7fe45b813e47_terseLabel_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issuable (up to) (in shares)</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_label_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_documentation_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:to="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_40be887b-1956-4423-9da1-92b76eb086de_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_7db4e1f9-12de-4d9f-8fdb-efa0340a43bd_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_40642485-2b4f-4b03-8f83-8ab0c25d9230_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived (excluding goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_cb67fa69-86a8-4219-ac73-2cd071be1591_terseLabel_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issuable, value assigned</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_documentation_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansReceivableMember_06ebe4cc-791f-46bd-8939-e4338940464b_terseLabel_en-US" xlink:label="lab_us-gaap_LoansReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable</link:label>
    <link:label id="lab_us-gaap_LoansReceivableMember_label_en-US" xlink:label="lab_us-gaap_LoansReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansReceivableMember" xlink:to="lab_us-gaap_LoansReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ffaf653e-3406-49c6-b23c-95492082954f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LivWellHoldingsIncMember_80956621-cf76-4872-b3cb-c02d69a79da8_terseLabel_en-US" xlink:label="lab_cron_LivWellHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LivWell Holdings, Inc.</link:label>
    <link:label id="lab_cron_LivWellHoldingsIncMember_label_en-US" xlink:label="lab_cron_LivWellHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LivWell Holdings, Inc. [Member]</link:label>
    <link:label id="lab_cron_LivWellHoldingsIncMember_documentation_en-US" xlink:label="lab_cron_LivWellHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LivWell Holdings, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LivWellHoldingsIncMember" xlink:href="cron-20221231.xsd#cron_LivWellHoldingsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LivWellHoldingsIncMember" xlink:to="lab_cron_LivWellHoldingsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate_e2a6a8cf-70da-45e4-8693-4d966cfab233_terseLabel_en-US" xlink:label="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation_1fb15ae2-f33c-440c-b5f0-d7c0878cd44d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange effect</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a7832ebf-cf86-4070-a3b9-5db94329f804_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities settled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5591d2af-99f9-45ed-994b-be004cd728bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_b387fb32-df07-4687-b81e-6dd54d0f367d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnfavorableRegulatoryActionMember_309d2c32-e065-4dc4-9d04-20745afb895d_terseLabel_en-US" xlink:label="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable Regulatory Action</link:label>
    <link:label id="lab_us-gaap_UnfavorableRegulatoryActionMember_label_en-US" xlink:label="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable Regulatory Action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnfavorableRegulatoryActionMember" xlink:to="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_d6c09cee-d98b-49d3-add6-5c4c58912fea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_58798987-02cd-47b6-b91c-9ed5f65d0281_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_21c2700e-ece7-44b2-a32d-657d2511d95e_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, volume-weighted average price, measurement period, days preceding exercise</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:to="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_c842998d-b144-4599-a83b-9b708242fd71_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_e4f58799-25dd-494f-a22d-e73a6c37ef59_terseLabel_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost Of Goods And Services Sold</link:label>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_documentation_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost Of Goods And Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold" xlink:href="cron-20221231.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherCostOfGoodsAndServicesSold" xlink:to="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4bf754ae-88f4-4a24-b21c-0ce6355f5d00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b44a23cc-6d6c-403e-8521-72a1033d95ff_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_276643d8-8e06-47fb-a537-fe940287ece5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of provincial tax rate difference</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_3e5a24a7-604f-4eae-b4cd-e89b340b3bd8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Plan Information and Restructuring-Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PharmacannMember_c4d10d9c-a100-4938-908d-521bc1686fc8_terseLabel_en-US" xlink:label="lab_cron_PharmacannMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacann</link:label>
    <link:label id="lab_cron_PharmacannMember_label_en-US" xlink:label="lab_cron_PharmacannMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacann [Member]</link:label>
    <link:label id="lab_cron_PharmacannMember_documentation_en-US" xlink:label="lab_cron_PharmacannMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacann</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PharmacannMember" xlink:to="lab_cron_PharmacannMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_5bc98ab1-cef7-416f-9f0a-9fbcb22cb5f1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8a664232-26ce-40f8-b52e-eb1c11ead0b7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_edb9cdc0-5a3a-4896-9446-b8a7cd7849c2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ebe41786-2e6f-4509-b1e3-68cee408a5fc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1c9ad1c2-6539-4811-ac22-ea3be0e1cefd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86cc16f2-e4d5-483e-a742-470502368cac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_7b5b9de2-eac4-4b1f-9851-e13c202a7a07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, measurement input</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9a719de2-d11e-4fa8-b993-bb6cdce7fdfe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_52413897-fb6f-4266-875a-1dcaa0b7e2bc_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RedwoodHoldingGroupLLCMember_33bb78c5-8dc4-45e8-83b2-3fa89417a3df_terseLabel_en-US" xlink:label="lab_cron_RedwoodHoldingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood</link:label>
    <link:label id="lab_cron_RedwoodHoldingGroupLLCMember_label_en-US" xlink:label="lab_cron_RedwoodHoldingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Holding Group, LLC [Member]</link:label>
    <link:label id="lab_cron_RedwoodHoldingGroupLLCMember_documentation_en-US" xlink:label="lab_cron_RedwoodHoldingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Holding Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodHoldingGroupLLCMember" xlink:href="cron-20221231.xsd#cron_RedwoodHoldingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RedwoodHoldingGroupLLCMember" xlink:to="lab_cron_RedwoodHoldingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_d000d4a5-35e6-475e-b3bb-ab9ebeb53cba_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ec50da1e-2c4a-40a6-8745-3fa26669ea0d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_c3bdc155-1513-4556-9c80-2bcbf5b0528c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2786a0fa-c0a2-4240-a1d7-fa51213e0ba4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_663ebe57-c652-4891-b50b-7ff5b4f7c6e1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableInterestRateStatedPercentage_ec3c6275-5b97-427c-bb2b-073ea5bc329f_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_cron_FinancingReceivableInterestRateStatedPercentage_label_en-US" xlink:label="lab_cron_FinancingReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_cron_FinancingReceivableInterestRateStatedPercentage_documentation_en-US" xlink:label="lab_cron_FinancingReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestRateStatedPercentage" xlink:href="cron-20221231.xsd#cron_FinancingReceivableInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableInterestRateStatedPercentage" xlink:to="lab_cron_FinancingReceivableInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_c3e0ba3e-95a3-4d72-8437-557e43b27ac6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_3dadccb2-d61c-4939-8605-195c40fae818_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_f9b88be0-17e3-49b5-a516-942c02555035_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_c57c4556-4a6c-42f6-ba53-6ad874f028c7_terseLabel_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Emptive Rights and Top-Up Rights</link:label>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_label_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Emptive Rights And Top-Up Rights [Member]</link:label>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_documentation_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Emptive Rights And Top-Up Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:href="cron-20221231.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:to="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f4c7f091-b4b3-476b-a7fb-491c55442cb8_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_e40e254c-9a5d-42d7-ba47-4f8d43651446_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of income (loss) from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_af091781-fad0-4ff9-ae13-4c72d9e304a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of income from equity accounted investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesSold_d5ed025f-c6fa-44a4-856c-5e3a174c768d_terseLabel_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned, number of shares sold (in shares)</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesSold_label_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Shares Sold</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesSold_documentation_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Shares Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesSold" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedNumberOfSharesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentOwnedNumberOfSharesSold" xlink:to="lab_cron_InvestmentOwnedNumberOfSharesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosIsraelG.S.StoreLtd.Member_1b315f7b-5e92-46dd-b7ec-468eca99bb89_terseLabel_en-US" xlink:label="lab_cron_CronosIsraelG.S.StoreLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Store Ltd.</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.StoreLtd.Member_label_en-US" xlink:label="lab_cron_CronosIsraelG.S.StoreLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Store Ltd. [Member]</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.StoreLtd.Member_documentation_en-US" xlink:label="lab_cron_CronosIsraelG.S.StoreLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Store Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.StoreLtd.Member" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.StoreLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosIsraelG.S.StoreLtd.Member" xlink:to="lab_cron_CronosIsraelG.S.StoreLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8f92c61c-aad0-405b-b4cf-d0be0c720c90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment, net of disposals</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_c40fa1c4-97c2-472a-b336-828984d0be22_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_31013857-7a74-4e42-88ec-019def1a01c7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_91ac855e-ff61-4652-8cf5-3c10ed0a8f40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a282d9d5-788a-4d51-a8f6-d239b0492167_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash activity - right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementMember_93bf50ea-051c-43f4-812d-77a529cdd11b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_059ba403-2846-41dd-916f-921eda2c0aac_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ec7cb8a6-72d5-431f-9c12-253410fad41b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9853b79c-53ba-4d58-9311-8dff8e881814_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_9805ade0-9e2f-4197-a33f-3c619380b99c_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_4296b0e3-f921-4112-aa96-92b85d4d981c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_0f5d9cb5-aebf-44ae-9001-5ff6e4cd8d94_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfImpairedIntangibles_b7128a0a-8fae-43c3-a510-55b80248c39f_terseLabel_en-US" xlink:label="lab_cron_NumberOfImpairedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of impaired cannabinoids</link:label>
    <link:label id="lab_cron_NumberOfImpairedIntangibles_label_en-US" xlink:label="lab_cron_NumberOfImpairedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Impaired Intangibles</link:label>
    <link:label id="lab_cron_NumberOfImpairedIntangibles_documentation_en-US" xlink:label="lab_cron_NumberOfImpairedIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Impaired Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfImpairedIntangibles" xlink:href="cron-20221231.xsd#cron_NumberOfImpairedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfImpairedIntangibles" xlink:to="lab_cron_NumberOfImpairedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_487957af-e07a-4d51-9bc4-f4da7042992a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_VendorMember_b8c3e63b-70ed-4d8b-a920-58f71a91ed99_terseLabel_en-US" xlink:label="lab_cron_VendorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor</link:label>
    <link:label id="lab_cron_VendorMember_label_en-US" xlink:label="lab_cron_VendorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor [Member]</link:label>
    <link:label id="lab_cron_VendorMember_documentation_en-US" xlink:label="lab_cron_VendorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VendorMember" xlink:href="cron-20221231.xsd#cron_VendorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_VendorMember" xlink:to="lab_cron_VendorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CBGALicensingAgreementMember_313068cd-66de-466d-a714-4484e41abb79_terseLabel_en-US" xlink:label="lab_cron_CBGALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBGA Licensing Agreement</link:label>
    <link:label id="lab_cron_CBGALicensingAgreementMember_label_en-US" xlink:label="lab_cron_CBGALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBGA Licensing Agreement [Member]</link:label>
    <link:label id="lab_cron_CBGALicensingAgreementMember_documentation_en-US" xlink:label="lab_cron_CBGALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBGA Licensing Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBGALicensingAgreementMember" xlink:href="cron-20221231.xsd#cron_CBGALicensingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CBGALicensingAgreementMember" xlink:to="lab_cron_CBGALicensingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_d0665149-e277-4abe-913d-e1c5a2e7cc6a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceLineItems" xlink:to="lab_us-gaap_ValuationAllowanceLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_5c802c08-bce3-461f-aaa3-018fa0970343_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Warrants and DSUs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_5c2be09c-d28f-4cf1-a05e-123a50d0717d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_76aba41e-6201-45d7-96c8-555710e8cb64_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_7f9ce9cd-9e7c-4f41-a7de-f46a50850024_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_59158a97-3e3e-488e-95a7-3015fc37e58d_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_ec0013d0-5d19-45d4-9681-f3cb0d53c4cc_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Ending Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_BuildingAndEquipmentMember_badd7d1f-e9d6-4718-bd62-cc1d47f702da_terseLabel_en-US" xlink:label="lab_cron_BuildingAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Premises and Equipment</link:label>
    <link:label id="lab_cron_BuildingAndEquipmentMember_label_en-US" xlink:label="lab_cron_BuildingAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building And Equipment [Member]</link:label>
    <link:label id="lab_cron_BuildingAndEquipmentMember_documentation_en-US" xlink:label="lab_cron_BuildingAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BuildingAndEquipmentMember" xlink:href="cron-20221231.xsd#cron_BuildingAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_BuildingAndEquipmentMember" xlink:to="lab_cron_BuildingAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatuEraMember_463810ba-4b32-4a87-84b7-8706d466bc75_terseLabel_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera</link:label>
    <link:label id="lab_cron_NatuEraMember_label_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra [Member]</link:label>
    <link:label id="lab_cron_NatuEraMember_documentation_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember" xlink:href="cron-20221231.xsd#cron_NatuEraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatuEraMember" xlink:to="lab_cron_NatuEraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_UnitedStatesSegmentMember_1796c5a3-4df4-43c6-a221-3e716425b195_terseLabel_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_cron_UnitedStatesSegmentMember_label_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Segment [Member]</link:label>
    <link:label id="lab_cron_UnitedStatesSegmentMember_documentation_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_UnitedStatesSegmentMember" xlink:to="lab_cron_UnitedStatesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_62cc2308-4949-4281-82a9-89990bf92be1_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5779f14e-7831-4ce3-bfef-ba0b2b96dde6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ebbde9a9-cc0a-4065-ab51-cc3bae5f1ea4_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b6f3f9f8-f815-48e6-bb04-1e7439f418bb_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_f85c8676-f2ca-4631-b389-368b22d402b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_9fef5ef0-2e3f-4f71-83a4-177b954a7b0e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5f27190b-bdb3-400a-b550-2d729cda33c0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_dd67c2eb-5908-4997-a734-f2a694599f34_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Loan and Lease Losses [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_label_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Loan and Lease Losses [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLoanAndLeaseLossesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward" xlink:to="lab_us-gaap_AllowanceForLoanAndLeaseLossesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_59fc8898-de61-43e6-ac31-79a6bcddfc04_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaPinnacleLLC.Member_33134bea-2fa4-41a9-8f41-a2bcd3e94482_terseLabel_en-US" xlink:label="lab_cron_AltriaPinnacleLLC.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Pinnacle LLC</link:label>
    <link:label id="lab_cron_AltriaPinnacleLLC.Member_label_en-US" xlink:label="lab_cron_AltriaPinnacleLLC.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Pinnacle LLC. [Member]</link:label>
    <link:label id="lab_cron_AltriaPinnacleLLC.Member_documentation_en-US" xlink:label="lab_cron_AltriaPinnacleLLC.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Pinnacle LLC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member" xlink:href="cron-20221231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaPinnacleLLC.Member" xlink:to="lab_cron_AltriaPinnacleLLC.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_9b4a7224-f4df-4d19-abce-a723ced2d7ec_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Cronos Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_039a3246-02f7-439e-905f-4c87ce981b9d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annualized volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_11929a40-8243-49d1-91e9-6cd133135ad1_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issuance pursuant to research and development milestone (in shares)</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Research And Development Milestones</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Research And Development Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" xlink:to="lab_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_97627527-c201-416e-9afc-5bbccd907643_terseLabel_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera Series A Loan</link:label>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_label_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan [Member]</link:label>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_documentation_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember" xlink:href="cron-20221231.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatuEraSeriesALoanMember" xlink:to="lab_cron_NatuEraSeriesALoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_37c3e564-754c-47e5-ad01-3d3cd7492ed0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_13414a7c-c0ba-4cf9-9450-3c0626b95054_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a854e2d8-17bd-4f7e-b4b1-10d366409dee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_a1645f3c-ca91-48bd-8038-738da7fc8039_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_c68b311c-f8a1-4fbe-b090-846b132b04a8_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_3c544a7b-878f-4da2-b364-d18025c9cd5b_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_label_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:to="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_64faa235-93d8-4246-a58c-5e804c45aab6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_79b28fce-489f-46d1-8ef2-5072366d9ecb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted loss per share from continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RestructuringReservePaymentsAndWriteoffs_3ee6a73a-d27d-4327-b4c3-a65036f289b2_negatedTerseLabel_en-US" xlink:label="lab_cron_RestructuringReservePaymentsAndWriteoffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments/Write-offs</link:label>
    <link:label id="lab_cron_RestructuringReservePaymentsAndWriteoffs_label_en-US" xlink:label="lab_cron_RestructuringReservePaymentsAndWriteoffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Payments and Writeoffs</link:label>
    <link:label id="lab_cron_RestructuringReservePaymentsAndWriteoffs_documentation_en-US" xlink:label="lab_cron_RestructuringReservePaymentsAndWriteoffs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Payments and Writeoffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestructuringReservePaymentsAndWriteoffs" xlink:href="cron-20221231.xsd#cron_RestructuringReservePaymentsAndWriteoffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RestructuringReservePaymentsAndWriteoffs" xlink:to="lab_cron_RestructuringReservePaymentsAndWriteoffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_92926530-aec6-4a56-9299-de1ba2c51ac3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_73536da7-8740-4dbc-aa7d-3ae69bac6e7f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_03435c97-a524-428f-99b6-48862d069358_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_52f38783-791d-40bb-8f51-d3ee98048280_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Unrealized Currency Transaction Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_336ae85e-2715-4b6c-849a-d7eb3ee7cae1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_62a42057-3e79-45b8-a9cf-11c1d837f4d6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1d930ade-b885-4b10-8afc-f021cfcfc84a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_f2279ad8-8c3f-4183-a931-027461bdf732_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_239d9e8f-1e1b-4544-ab2b-5a4dcbdd2a4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_0544218e-65be-41e9-aed6-cf6896251ece_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_a0b7d895-008e-4513-8a74-9f33377c0ddd_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_46941652-5d3e-42dd-acc2-8e0bd8764aa0_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_1cf33e55-dd4e-4416-a915-c5297eb32833_terseLabel_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Punitive damages sought</link:label>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_label_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Sought, Value</link:label>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_documentation_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:href="cron-20221231.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:to="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount_eac5834b-d01f-4119-a7d3-79ff91277bc6_negatedTerseLabel_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value gain on financial liabilities</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount_label_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities, Amount</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount_documentation_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" xlink:to="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_e5bfdc2a-8a0e-4a27-af64-02a636e2ae13_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc.</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_5986d894-6d6f-4187-a857-76854c9843cb_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, volume-weighted average price, measurement period</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:to="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_8314efd5-82b2-45c9-bd61-dfe57ae36b80_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_34c627d3-6c73-4cf0-b66b-64242cf3bd55_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration given</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_137fbdf5-52a7-48cf-8088-cf54dc119613_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_ed4ee53a-25ff-4eb9-a5b0-bae0f18c06be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_e825ba7a-d747-4bc2-b758-0e631e48f746_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Exposure to Loss</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_e3941b5a-fed1-4cd7-8f3b-b8d9715d0ffe_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_4b9479d0-1313-4aa9-9dca-83be97a30ac6_verboseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Establishment of a Commercial Cannabis Analytical Testing Laboratoy</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_c6241953-7e01-4214-9981-4ee2c2a2f5c1_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment, Useful Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_b1bf7e72-f3c0-498b-b478-fb6e6ae56fe5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_ad04d82e-12ca-4b89-8afa-82b252e4b14d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ae1aff27-8bff-42b9-a77c-f51bd90e179a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of RSUs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_989d8641-93d9-49bc-89bf-32ade9680718_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of DSUs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_879daf22-3134-4012-b04b-98943958e70a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow and other information</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventorySuppliesNetOfReserves_be0c7531-25d5-4b06-aad8-26dff39f9bc0_terseLabel_en-US" xlink:label="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies and consumables</link:label>
    <link:label id="lab_us-gaap_InventorySuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventorySuppliesNetOfReserves" xlink:to="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_f9b36870-cc2c-4dad-ad2d-92192c4685a6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_0155a19e-08dd-4b1e-91f5-40580e133fab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_4965e9d0-3922-4ac8-9419-db0b183b6e63_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_52bc9c37-1df8-4e25-a4de-bc194e5bde0a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_1574bfcd-cd8b-4825-9bf7-e817bb775684_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities_6b19671e-bbdb-414f-a9a0-e8e75b050e34_terseLabel_en-US" xlink:label="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities_label_en-US" xlink:label="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Finance Lease Liabilities</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities_documentation_en-US" xlink:label="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Finance Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsFinanceLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:to="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_7cf54d2c-2995-4c20-bb87-73979fac6aac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_b6c9697b-bc3c-4018-9118-f31678b331e7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_2eacc771-a05b-42df-86c5-0db699163bf3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_856fe045-3e2d-4dd5-80d4-b83504dab2d4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1ab40d79-780e-4167-a954-b966bb7715f7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a9e5eac8-5aeb-4c80-9a6c-0112c3d72f28_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestments_2bf036f9-26d4-41fb-a37d-008c9c20defd_periodStartLabel_en-US" xlink:label="lab_us-gaap_OtherInvestments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments, beginning balance</link:label>
    <link:label id="lab_us-gaap_OtherInvestments_bf9450d3-29cb-4d11-81c6-22a7ec0702b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_OtherInvestments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments, ending balance</link:label>
    <link:label id="lab_us-gaap_OtherInvestments_61faa363-85e1-461a-a142-8f539df8969d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestments_label_en-US" xlink:label="lab_us-gaap_OtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestments" xlink:to="lab_us-gaap_OtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_5c826c2c-dc0c-43cf-b716-a43e06d34891_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_7153e8f7-3c49-4441-97ee-3ce0bdf7a341_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4f7f4e79-2e20-4d00-bf50-c02553eaadc4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b2e38215-a2da-41d3-ab44-255047451c82_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance increase (decrease)</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_dc705489-4393-4d83-99ab-caeaa87bd02f_terseLabel_en-US" xlink:label="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative Asset (Liability) Gain (Loss), Statement Of Income, Extensible List, Not Disclosed Flag</link:label>
    <link:label id="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative Asset (Liability) Gain (Loss), Statement Of Income, Extensible List, Not Disclosed Flag</link:label>
    <link:label id="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative Asset (Liability) Gain (Loss), Statement Of Income, Extensible List, Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:href="cron-20221231.xsd#cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e7f4fed9-156a-4662-a834-4ac0e8f20a18_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_7fc7ace5-f869-44eb-83aa-532a6424ee3c_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OntarioIncMucciPromissoryNoteMember_01187715-d193-43d6-a512-49dc20ec0983_terseLabel_en-US" xlink:label="lab_cron_OntarioIncMucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mucci Promissory Note</link:label>
    <link:label id="lab_cron_OntarioIncMucciPromissoryNoteMember_label_en-US" xlink:label="lab_cron_OntarioIncMucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ontario Inc. Mucci Promissory Note [Member]</link:label>
    <link:label id="lab_cron_OntarioIncMucciPromissoryNoteMember_documentation_en-US" xlink:label="lab_cron_OntarioIncMucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ontario Inc. Mucci Promissory Note [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OntarioIncMucciPromissoryNoteMember" xlink:href="cron-20221231.xsd#cron_OntarioIncMucciPromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OntarioIncMucciPromissoryNoteMember" xlink:to="lab_cron_OntarioIncMucciPromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_b3314e26-1279-48ed-a420-268171e260fc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_7ffbf58c-57e8-40b2-a1d1-f3fd7ffe28a7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_695efda0-8133-482d-9ad9-bba10683b630_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to the shareholders of Cronos Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CBCVALicensingAgreementMember_6f968769-06ca-4762-b87d-cc1fc5757700_terseLabel_en-US" xlink:label="lab_cron_CBCVALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBCVA Licensing Agreement</link:label>
    <link:label id="lab_cron_CBCVALicensingAgreementMember_label_en-US" xlink:label="lab_cron_CBCVALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBCVA Licensing Agreement [Member]</link:label>
    <link:label id="lab_cron_CBCVALicensingAgreementMember_documentation_en-US" xlink:label="lab_cron_CBCVALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBCVA Licensing Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBCVALicensingAgreementMember" xlink:href="cron-20221231.xsd#cron_CBCVALicensingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CBCVALicensingAgreementMember" xlink:to="lab_cron_CBCVALicensingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ec7ff50e-226c-4229-9b90-f34bdf767c85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5927d846-6bc0-4174-9381-6b601df72970_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8f291b68-294f-4696-b25a-09ae505c3675_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3deb0095-f052-4cd4-92da-5922d8301cae_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2c66abe4-5e3d-4eca-a232-28fce07666ae_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_453ea73b-5e7d-4807-99d1-6c80173dd63e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent_e9c24434-eb3b-4348-8d05-dbc9a96e9db9_terseLabel_en-US" xlink:label="lab_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes</link:label>
    <link:label id="lab_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent_label_en-US" xlink:label="lab_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income and Sales and Excise Taxes Payable, Current</link:label>
    <link:label id="lab_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent_documentation_en-US" xlink:label="lab_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income and Sales and Excise Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" xlink:href="cron-20221231.xsd#cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" xlink:to="lab_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_b31879ce-cbc1-4c17-972c-345533ff1a70_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_52574888-d14b-4568-9033-7cdaba03b238_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d26150be-006a-4b6d-9420-80fe4ee6f8ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of Top-up Rights - market price (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_422b2002-4104-460d-9f5d-8f75bd525337_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_6286877d-8e9d-4da9-ae29-58c82c47b082_terseLabel_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments subject to milestones</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_label_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Payments Subject To Milestones</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_documentation_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Payments Subject To Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:to="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_89595287-b6a8-46d6-a002-6ebac38eae1c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2c6ccbad-260e-479a-bc12-bf39a2201a36_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and short-term investments</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3219a45c-d6af-4019-b7a3-94e8955bc6fd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_3ae5551a-c419-4759-9551-09608bdd2f8e_terseLabel_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Analytics Ltd.</link:label>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_label_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Analytics Ltd. [Member]</link:label>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_documentation_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Analytics Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember" xlink:href="cron-20221231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannasoulAnalyticsLtdMember" xlink:to="lab_cron_CannasoulAnalyticsLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e97faaf-2899-4ee4-83f2-01a626c90cf0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaWarrantMember_be59b34d-d431-433b-a605-7ccadc6d2853_terseLabel_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_07047ce6-e5b5-4981-a882-7b5265d6c0aa_verboseLabel_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_label_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant [Member]</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_documentation_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaWarrantMember" xlink:to="lab_cron_AltriaWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_ae9f5c85-155a-4e27-a392-d0a6798a42d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes receivable, current</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PreemptiveRightsMember_cbfebb63-cabf-49f2-be71-ef3582408701_verboseLabel_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights</link:label>
    <link:label id="lab_cron_PreemptiveRightsMember_label_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights [Member]</link:label>
    <link:label id="lab_cron_PreemptiveRightsMember_documentation_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PreemptiveRightsMember" xlink:to="lab_cron_PreemptiveRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c7e285a6-e369-4c38-8e70-e1b2e8949a46_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue, before excise taxes</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1db55964-82b8-4c7f-b3aa-ac15e9d60ad6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_3e14df6b-c402-448a-bb10-2231c4df67dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic loss from discontinued operations per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_26e89fa2-09bd-4aee-b793-bd4f8f7367ef_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic loss per share computation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_2cbb9302-00df-4a63-bded-a5d372c48204_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_277de5be-c334-441f-8640-661a0ebbd27d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_4ceb98b3-43b6-4dbb-94c2-833babb74728_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_149f5780-be78-4ff6-9a5a-6423cbad52e4_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3e67c11f-fc32-4982-9beb-e6a12a6b2a30_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_21c98e61-c20e-4b6d-9cd6-0ca5303b2074_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense on right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_label_en-US" xlink:label="lab_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Excluding Lessor Asset under Operating Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:to="lab_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_25f421ea-2a63-45f1-8c18-336f96cde239_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9c6bb21b-dceb-49a5-9819-b3e14cb09489_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_9569ac7c-3993-45d0-a6ac-cd417586b583_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_9f9a5fcc-d0cb-49af-a6f9-24011f867e10_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price at grant date (in Canadian dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_5c946951-6604-4fa9-ae76-dbf53ceadd92_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_260f5fad-7091-4a27-b4dc-032140a20a19_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, trade, current</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_f66d8c1c-572b-49cd-9490-71b68efc4cba_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_e2c2a752-b03f-478b-b3c8-467ded5107bb_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_fb656aba-fe58-4023-8e05-ba15e488441d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_6bb6817c-81d3-4b0b-9631-0f8bf9048ff4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_0183feb4-bce2-4808-b148-b17bde4fe617_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Consolidated Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:to="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_afe4e46f-b3dc-43fe-950d-8d59ed1cddbf_negatedTerseLabel_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_label_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Gain (Loss) On Revaluation</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_documentation_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Gain (Loss) On Revaluation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:href="cron-20221231.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:to="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_33b20d56-bdcb-4d10-88af-d4fed5ad5220_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_551752d4-ebac-4028-9929-e9a5b5fda97c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f8ef2edc-72d9-45e6-a248-1fd2c6a145d4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_71744899-d59f-4c82-a7b5-218c5bec467e_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Background, Basis of Presentation, and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_d2de3b4f-043d-4746-94f3-198beb887e10_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a60ba437-af57-4d38-b295-43fced1fba3b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4b61e2ec-d926-491a-8d53-c8c90cc78bee_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_c9edb1dc-7eb4-4a20-8703-f1f700a12985_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c28188ed-3581-4245-8d91-1da2c5be5891_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableMember_f510816e-7e97-4250-8e29-b8497d0cf880_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableMember" xlink:to="lab_us-gaap_AccountsPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IsraeliCodesLicensingAgreementsMember_a64ac654-6fb3-4e91-a849-67af33fc5c72_terseLabel_en-US" xlink:label="lab_cron_IsraeliCodesLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli codes</link:label>
    <link:label id="lab_cron_IsraeliCodesLicensingAgreementsMember_label_en-US" xlink:label="lab_cron_IsraeliCodesLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Codes, Licensing Agreements [Member]</link:label>
    <link:label id="lab_cron_IsraeliCodesLicensingAgreementsMember_documentation_en-US" xlink:label="lab_cron_IsraeliCodesLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Codes, Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IsraeliCodesLicensingAgreementsMember" xlink:href="cron-20221231.xsd#cron_IsraeliCodesLicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IsraeliCodesLicensingAgreementsMember" xlink:to="lab_cron_IsraeliCodesLicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_c4d80900-9499-4ebf-ae3a-d391bccc671a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_dac0c777-4101-4615-b636-4527f6fd192b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_824cd825-74ef-4537-a018-5dd99c7cdaee_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_67efe2ba-d8eb-46d3-8f4a-25ba90ff3c0a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e19f9885-8b7a-4e8a-bea9-adcc3b49235d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity attributable to shareholders of Cronos Group</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_d46cd783-5cc6-405b-9c98-833b47d3b38d_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of change in average variable rate, percent</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_label_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:to="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_133b83ab-e96d-4ff1-8097-a653bdbc72ff_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4a5d8de0-fe89-4b87-9023-a15751a9d26e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation and forfeitures (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_dc78cd91-24b3-4e25-a996-701ee6f3932f_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, amount of advances</link:label>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_label_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Amount Of Advances</link:label>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Amount Of Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementAmountOfAdvances" xlink:to="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_0dfe490b-44e5-432c-85a3-541841c23df0_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_2e707b39-8017-4bad-91fb-d9c5f7320f54_totalLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_0e36e50c-1a26-4c9a-b48c-b6f83a8bd75f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_5faa9666-669b-4a1f-85c1-1bc5b77ee824_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Changes in Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3c5047db-97fc-46ef-8aa1-ecdce8070b83_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ba654b3f-9bed-4aad-9589-549acae998cc_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_19eb1cda-ad51-44eb-bc38-d2818702f229_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding commitment percentage</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, Funding Commitment Percentage</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, Funding Commitment Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IL_fd1738f2-2061-4682-a027-a54dfe6ee243_terseLabel_en-US" xlink:label="lab_country_IL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel</link:label>
    <link:label id="lab_country_IL_label_en-US" xlink:label="lab_country_IL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ISRAEL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL" xlink:to="lab_country_IL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_af065aab-1f61-4095-8b03-dfec7b0cd220_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_c769ddf1-b176-4725-ad3d-db8e53f1d84e_negatedLabel_en-US" xlink:label="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange effect</link:label>
    <link:label id="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_documentation_en-US" xlink:label="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_24720dbb-2f3a-43a8-a44c-054cc7247c01_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_abe6fea6-aaee-4afc-954b-29ac6685aa14_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_fb86daab-648b-40ad-a840-cc0e40128d42_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_34bcf504-d989-4a9d-95f8-d4d6b7555587_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_ef93bdc9-b35c-4939-b078-52375e4b3693_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceTable" xlink:to="lab_us-gaap_ValuationAllowanceTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d1027bd5-553b-47a7-9a71-6fb7a140935e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_f5990e99-d35b-4c58-9bde-c89f24353172_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Cost and Other Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_73d39e6f-01d4-409b-a1cb-8b46b6197427_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future awards to be granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannabisPurchasesMember_62ead844-40cc-48ad-a652-04e383a88e7b_terseLabel_en-US" xlink:label="lab_cron_CannabisPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Purchases</link:label>
    <link:label id="lab_cron_CannabisPurchasesMember_label_en-US" xlink:label="lab_cron_CannabisPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Purchases [Member]</link:label>
    <link:label id="lab_cron_CannabisPurchasesMember_documentation_en-US" xlink:label="lab_cron_CannabisPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisPurchasesMember" xlink:href="cron-20221231.xsd#cron_CannabisPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannabisPurchasesMember" xlink:to="lab_cron_CannabisPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_f466680e-9332-48e1-ae5a-f70b2b5ec503_terseLabel_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average Black-Scholes value at grant date (per option) (in Canadian dollars per share)</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:to="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_bf7aff8f-4701-4d09-ba5b-f54abe9d98a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a102b66f-2df2-4af8-a652-5ec0fcb567b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_f186cbea-0bdc-49e0-9a88-179ab6df6d17_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_a3733b1a-55b0-4e55-b077-df30636c3ef0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_28a3ca2f-3d2f-43fb-98cf-56be2497a1f2_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_623eb7de-43ad-4b37-a32c-6a76660d7b15_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_064e38e0-80cf-4353-88d8-08cd33133ab9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D investment tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableFaceAmount_98dd1b77-2f43-4692-8afd-30de114ba9a5_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_cron_FinancingReceivableFaceAmount_label_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Face Amount</link:label>
    <link:label id="lab_cron_FinancingReceivableFaceAmount_documentation_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmount" xlink:href="cron-20221231.xsd#cron_FinancingReceivableFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableFaceAmount" xlink:to="lab_cron_FinancingReceivableFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_4f7554c7-9a1c-4646-8c1d-3bde066035a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Values of Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3e46c850-3355-46ce-bf52-b78617d269a2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_55065ae5-ef01-4d3b-9320-59129c2a149f_totalLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_197840b2-8f96-4348-9479-fb1a219e23c0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_139492a9-7c9b-4dac-9b28-8f7567eef309_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_2a0c5db7-a66a-4ae5-a1f6-b85e841eadd2_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannabisFlowerMember_830142df-c413-4d40-93cd-1b7bf4954f56_terseLabel_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis flower</link:label>
    <link:label id="lab_cron_CannabisFlowerMember_label_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Flower [Member]</link:label>
    <link:label id="lab_cron_CannabisFlowerMember_documentation_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Flower [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember" xlink:href="cron-20221231.xsd#cron_CannabisFlowerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannabisFlowerMember" xlink:to="lab_cron_CannabisFlowerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7665c4cb-e84c-44b8-9795-9923459e852f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_db6bd9ae-014f-48ef-8e66-9bb825cd93ce_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_c47c06d0-a1a1-4bae-b1aa-6ccdf8344bc0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_f306b9fc-1674-4759-bcdc-1febfa0777ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated restricted share units vesting out-of-period adjustment</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_cbf37ade-5267-407b-939d-ec74a1310b08_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_fd4933fa-30d5-4b8f-a20d-10c45fd57249_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_c8887925-50f6-498a-b8d6-27a7f0f585ef_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income (expense), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_a589e3ce-e5c2-4739-9819-7e760c3e1f8c_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_d964d056-fd43-4559-9d8e-dd75f77785fc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_cc929b69-61f7-4806-a868-05a743f74987_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_84ea135f-ea66-4d0b-aeb4-1b6dc2a0e3f5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ebca9627-ad12-4e0c-99b1-221788a82427_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_66bd1ff1-c9ce-42bf-98dd-dbdb08a01191_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_d8f8429a-ce2b-4d95-9da6-f89a7ac39eac_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_52204b6e-a93a-446d-b8c1-2ac52a1e7a97_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4778e5bc-3763-4ade-a610-38b901244a88_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5027165d-90df-45b8-a157-2ae6528dc44f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c3dd164b-87ec-47b0-9c01-279baecee5b5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_832cc8e5-2afe-4c4a-8b68-0e82a17528a4_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_e4647af7-7090-46d0-80e0-dabcb519fbbf_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_34cd3c74-8b8d-490d-b0d7-638272b2ac63_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9aefb71e-468b-4960-9b79-ace40bfd8239_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_48857232-549b-4d38-bfac-018a4a7e0d37_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_5c8a91ee-4989-4370-aebe-ad6f93ed295e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_8fe6314d-f7a9-408c-9ce1-4b01d2f70728_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0ddbb2a3-8401-4455-b0db-5f986593db23_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting pronouncements and New accounting pronouncements not yet adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5a9c03e0-7d86-4bb1-adc2-954146fbebbc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_05fe69f3-86e8-47c8-8f86-33dac68ea13e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted loss per share computation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaGroupInc.Member_55d382e2-bdfe-4ff4-a92e-94e14c2da669_terseLabel_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc.</link:label>
    <link:label id="lab_cron_AltriaGroupInc.Member_label_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc. [Member]</link:label>
    <link:label id="lab_cron_AltriaGroupInc.Member_documentation_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member" xlink:href="cron-20221231.xsd#cron_AltriaGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaGroupInc.Member" xlink:to="lab_cron_AltriaGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_aab410c5-b8c0-4126-bdc5-57239406a550_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on goodwill and indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_HealthCanadaLicensingAgreementsMember_45211aac-9c50-4169-a3fa-979643329ba5_terseLabel_en-US" xlink:label="lab_cron_HealthCanadaLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Canada licenses</link:label>
    <link:label id="lab_cron_HealthCanadaLicensingAgreementsMember_label_en-US" xlink:label="lab_cron_HealthCanadaLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Canada Licensing Agreements [Member]</link:label>
    <link:label id="lab_cron_HealthCanadaLicensingAgreementsMember_documentation_en-US" xlink:label="lab_cron_HealthCanadaLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Canada Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember" xlink:href="cron-20221231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_HealthCanadaLicensingAgreementsMember" xlink:to="lab_cron_HealthCanadaLicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannabisExtractsMember_0db82f5e-d017-4fef-8b6b-19661e962626_terseLabel_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis extracts</link:label>
    <link:label id="lab_cron_CannabisExtractsMember_label_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Extracts [Member]</link:label>
    <link:label id="lab_cron_CannabisExtractsMember_documentation_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Extracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember" xlink:href="cron-20221231.xsd#cron_CannabisExtractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannabisExtractsMember" xlink:to="lab_cron_CannabisExtractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_fce96008-8268-47d6-8464-65b46cbd16dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of tax rates outside of Canada</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2d2ae6a8-972f-4790-8cab-a36e866ef189_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_dc2d0b32-df09-484b-afc9-431963bee3c7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant &amp; equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d6ac5dd6-a731-4e72-a1f1-a179af42c09f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_978c3d57-cdae-44a3-8afc-b7c36b425e18_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_362cab96-fcb4-4da9-85f1-9d79d45a9edd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_29f41823-b52b-41df-aa9e-3eee3c46abd1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_103d554e-10f4-4f70-80db-9d8adb367915_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_62cef1cd-a592-477d-a464-db3860100376_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo exclusive licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_903e3ef5-6006-49ff-a755-080dccbae027_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_5217c912-c30b-48c2-b8bd-fa7a646628c9_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Current</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent" xlink:href="cron-20221231.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableAccruedInterestCurrent" xlink:to="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_17da53a0-47b3-426a-b4ce-9dcc7b2b0415_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares for computation of diluted loss from continuing operations per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d86b9366-0171-4af0-bc87-c655350b32d3_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares for computation of diluted loss from discontinued operations per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e90785fe-4b5a-4f32-ac48-84da9cc385bb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_a04d591d-3ad3-416e-9aa1-9907e4f99e0c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0a3de08b-1290-42eb-9969-eb70e3d65883_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bfa25b7a-fb08-4463-bd3c-33f7c816f7e4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life of options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2018StockOptionPlanMember_5c90e5a1-0e05-49db-b92a-4896020b3668_terseLabel_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan</link:label>
    <link:label id="lab_cron_A2018StockOptionPlanMember_label_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan [Member]</link:label>
    <link:label id="lab_cron_A2018StockOptionPlanMember_documentation_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember" xlink:href="cron-20221231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2018StockOptionPlanMember" xlink:to="lab_cron_A2018StockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairment_f48b55cb-4001-4d4b-ad47-f75e1582a6b0_negatedTotalLabel_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairment_29f4a486-c454-47c4-ab5b-2d88ff04344f_negatedPeriodStartLabel_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairment_68c03418-b8d9-442b-8628-27d6d207fc58_negatedPeriodEndLabel_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairment_label_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Accumulated Impairment</link:label>
    <link:label id="lab_cron_IntangibleAssetsAccumulatedImpairment_documentation_en-US" xlink:label="lab_cron_IntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Accumulated Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairment" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IntangibleAssetsAccumulatedImpairment" xlink:to="lab_cron_IntangibleAssetsAccumulatedImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_478a755e-aa80-4f2a-b461-464fbe212952_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_5014b68c-bde0-4efc-91a6-d5ea0a1c2d5d_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Examinations</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Examinations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxExaminationsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RealignmentMember_01196f3d-1093-4b3a-935c-680f81ee3eaa_terseLabel_en-US" xlink:label="lab_cron_RealignmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realignment</link:label>
    <link:label id="lab_cron_RealignmentMember_label_en-US" xlink:label="lab_cron_RealignmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realignment [Member]</link:label>
    <link:label id="lab_cron_RealignmentMember_documentation_en-US" xlink:label="lab_cron_RealignmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realignment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RealignmentMember" xlink:href="cron-20221231.xsd#cron_RealignmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RealignmentMember" xlink:to="lab_cron_RealignmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_ac2032c5-2d17-45c5-a813-ebd296508880_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_00048963-d6a2-41fe-8a1c-eea1474a38ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_4f0116f4-bc68-4ee5-adf4-d5d305252ec5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate depreciation expense</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d2eca935-f694-422e-8800-a84ab8144467_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_41a20aa8-7c0d-4890-a67c-7e6a01b82ea6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_2e41f263-1204-4b4e-9927-51d735b37029_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_5a11db5d-9077-4afa-8424-a493cf18d1c2_negatedLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_29782ab9-1cd5-45b9-9498-271b5fa10bfe_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance held (in shares)</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:to="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5cc9beb3-86d0-4142-8559-b32d3bcc0552_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f36079c8-e0e5-4698-b6a1-c9a838ed32fd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_3f0c45a8-3d28-47d5-a5ff-048e9c116e6f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d4d2cc3e-fa87-4f4f-9cda-0f53b78b138d_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_7cee78c6-9b31-4f3c-ab0c-f7bb79655fc7_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesReceived_144f71c8-14b0-46cb-87f4-bd58ef82ff85_terseLabel_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares received (in shares)</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesReceived_label_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Shares Received</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesReceived_documentation_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Shares Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesReceived" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedNumberOfSharesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentOwnedNumberOfSharesReceived" xlink:to="lab_cron_InvestmentOwnedNumberOfSharesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_f4a2f739-88ef-40fc-b709-dc917b983727_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_58f175af-9614-4c13-ba3f-f62fb14bf6a7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_3b3589b4-999e-49a7-8185-84ebd408d8a8_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments, net</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PeaceNaturalsReportingUnitMember_728a3d81-57fd-4744-9572-c1bfff89bfca_terseLabel_en-US" xlink:label="lab_cron_PeaceNaturalsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peace Naturals</link:label>
    <link:label id="lab_cron_PeaceNaturalsReportingUnitMember_label_en-US" xlink:label="lab_cron_PeaceNaturalsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peace Naturals Reporting Unit [Member]</link:label>
    <link:label id="lab_cron_PeaceNaturalsReportingUnitMember_documentation_en-US" xlink:label="lab_cron_PeaceNaturalsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peace Naturals Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PeaceNaturalsReportingUnitMember" xlink:href="cron-20221231.xsd#cron_PeaceNaturalsReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PeaceNaturalsReportingUnitMember" xlink:to="lab_cron_PeaceNaturalsReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentOwnedPercentage_7f7982a2-8001-4928-9e14-db79282f529d_terseLabel_en-US" xlink:label="lab_cron_InvestmentOwnedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_cron_InvestmentOwnedPercentage_label_en-US" xlink:label="lab_cron_InvestmentOwnedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Percentage</link:label>
    <link:label id="lab_cron_InvestmentOwnedPercentage_documentation_en-US" xlink:label="lab_cron_InvestmentOwnedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedPercentage" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentOwnedPercentage" xlink:to="lab_cron_InvestmentOwnedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_7888c949-c8e2-414d-a4d6-e3ee5bb12ea6_verboseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Gain from Disposals of Investments</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f6c08653-5796-48c3-b09c-e6ac8ad51185_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5994b99f-c291-4f94-a9e3-67b4f50615f7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_f1aae5bf-c763-4aad-b381-1ca842b38432_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Carrying Amounts</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9bc77fbf-a3b3-463f-a6dd-2bdd4840b02a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_71ba5d5b-86fc-4654-8a18-e76176023467_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Untied States</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment_53e26d28-3821-4d48-89cb-dc05ad0328c1_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable, credit loss, expense, including transferred into investment</link:label>
    <link:label id="lab_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment_label_en-US" xlink:label="lab_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Loss, Expense (Reversal), Including Transferred Into Investment</link:label>
    <link:label id="lab_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment_documentation_en-US" xlink:label="lab_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Loss, Expense (Reversal), Including Transferred Into Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" xlink:href="cron-20221231.xsd#cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" xlink:to="lab_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_7b0b274a-10d9-4f29-be4f-1709e3ef7182_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of putative class action complaints</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_c5694f65-4471-4e82-ab3f-157de7b9c591_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_3e4b6207-eeff-4195-adf7-f467dbeb4ea6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to Cronos Group</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_33260042-884e-46c6-9251-d4df7a4ed998_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable_eaa8ba07-7123-46e2-982c-352fe33cfb03_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from loans receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Loans Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_15e399e0-6eb8-49b3-ba0a-be824de2d8ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Data and Adjusted EBITDA</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3337bb89-a10b-4683-9098-ee993f740c94_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_dfbeb9bb-bacd-4beb-9578-5639ba7134ad_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_88882ee3-2be8-4586-99f3-4f47c1fe3fb8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7949608f-8f8b-43c4-a769-15e32bdfcac8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_fd4a8566-8e56-41d5-8597-00dc755130ab_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise rights, minimum ownership percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Minimum Ownership Percentage Required</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Minimum Ownership Percentage Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:to="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_2c234c4d-d125-4976-ac9c-992c1d0d5dcf_terseLabel_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_label_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_documentation_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:to="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_9bcc6d1a-fcd6-4e3c-8a18-58d6970a391b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, impairment loss</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_bb218b09-ad83-4394-9a14-52c1a4fe66a5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_b31c7744-3f0b-4998-bb1e-0ea547f01bf3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_41373cd8-d8e0-45fb-b056-7975c22ab871_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_35b5549a-6323-4c24-99e3-b8669241bbdf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3fc0333b-b74c-4f1d-adf6-807adabc586a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_97186598-2f0a-4114-a207-ffc9ca9a3205_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a70485b9-8b5f-4391-930c-bbfae6f7a624_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency translation on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_baf9dad7-82b3-4d87-aa3c-a704b9b2745c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_6f041487-7021-40a0-a030-b88178ba9f9c_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8ce3185d-e27e-4773-acbf-9c4c97deb4da_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_593a2981-17ed-493b-ba50-250daa4a35bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_7741a36d-2771-48ba-893d-e3eb171c0e1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period decrease</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_f5cbe030-2033-41ac-a9fe-eccbc292926c_terseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount_9f798224-d7d4-47a6-95b7-9fc3109f5ea8_terseLabel_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital gain on financial liabilities</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount_label_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Capital Gain, Financial Liabilities, Amount</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount_documentation_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Capital Gain, Financial Liabilities, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" xlink:to="lab_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_394299c8-0a34-40ca-9eef-c84885827582_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation and forfeitures (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_323abc30-7c57-42e3-9569-e317f1ec8054_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d3735085-feab-4bd1-9bf3-663e656e604a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_60991ea0-1df3-43a5-8787-38ac64a57c57_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_3e15aade-ee9f-4c24-abac-63f3f9589c06_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_26824f9a-a881-40bb-aa1c-8c0644360379_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_40b7f4ed-894d-45d5-95e3-34cf641fbf82_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6744341-8e0a-4f47-9d93-003c9aeebd0c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization_bab1c02f-924a-44cb-bcd5-4397ea643b2b_terseLabel_en-US" xlink:label="lab_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA</link:label>
    <link:label id="lab_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization_label_en-US" xlink:label="lab_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Interest, Taxes, Depreciation And Amortization</link:label>
    <link:label id="lab_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Interest, Taxes, Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="cron-20221231.xsd#cron_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="lab_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_fb207b36-55fc-449c-9c56-0cafa70dc182_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_28e20f73-0ebc-4607-9567-7da0a08450c5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_7ec13401-514a-4423-b190-a9ec860caecc_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable, current</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_225ee6f1-ec27-44ec-9243-ca08657926f5_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_6d2244bd-ade5-4238-964d-0f2bf0057d2f_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7e034763-7f9a-4223-9396-9188bd5e64e0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_8988fe01-934c-40b7-b954-9c54a48b9217_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_3daa2b0b-1327-43ac-97b1-795f04bf1a99_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_34773a04-2881-4f5f-9d05-0459613a0493_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6e433f3-baa4-45ee-8aa6-da02f0c84792_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_58a13e33-18a1-4f5f-95fb-6a4513137725_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_f83bddaa-28f5-4c68-a62f-349ba9716813_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_b12346a0-5e3c-4035-94ff-f3b7832756de_negatedTerseLabel_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities settled</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_label_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Liabilities Settled</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_documentation_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Liabilities Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:href="cron-20221231.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:to="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_835d8179-7350-4cfe-b8c1-7bdcb45ed38a_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_ab99b9bb-4e70-4696-a3ac-f4c11739a638_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of loans receivable, before accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Current</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:href="cron-20221231.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:to="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebt_96bc7c56-a6f1-43a7-88bc-10e0b041aa88_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured loan</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebt" xlink:to="lab_us-gaap_UnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ConsultingServicesArrangementMember_643cf2f9-204e-463d-8781-37248e43c1c2_terseLabel_en-US" xlink:label="lab_cron_ConsultingServicesArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services Arrangement</link:label>
    <link:label id="lab_cron_ConsultingServicesArrangementMember_label_en-US" xlink:label="lab_cron_ConsultingServicesArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services Arrangement [Member]</link:label>
    <link:label id="lab_cron_ConsultingServicesArrangementMember_documentation_en-US" xlink:label="lab_cron_ConsultingServicesArrangementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesArrangementMember" xlink:href="cron-20221231.xsd#cron_ConsultingServicesArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ConsultingServicesArrangementMember" xlink:to="lab_cron_ConsultingServicesArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_29647f65-4b8e-42fc-bb79-e8fb6205277d_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of ten percent change in exchange rate</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_label_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:to="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_fbd55971-1977-40c5-9aab-c47e6b46ca58_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_8f1ab3a9-f831-49bb-8417-cf6f4c3bce65_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_511bdbee-a45b-460a-b85c-dab9cc6f8977_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_412ff4cd-ce40-4410-ad83-c18d6dc860a9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_985c36df-4c1a-4273-b025-4a264e15baa0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxAssetsDebtIssuanceCosts_6ba1934c-2e16-4901-93ed-ba5a4bfe12d3_terseLabel_en-US" xlink:label="lab_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsDebtIssuanceCosts_label_en-US" xlink:label="lab_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Debt Issuance Costs</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsDebtIssuanceCosts_documentation_en-US" xlink:label="lab_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:to="lab_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CanadaRevenueAgencyMember_407b44c2-cd56-46ab-9584-3523f4d14526_terseLabel_en-US" xlink:label="lab_us-gaap_CanadaRevenueAgencyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_us-gaap_CanadaRevenueAgencyMember_label_en-US" xlink:label="lab_us-gaap_CanadaRevenueAgencyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada Revenue Agency [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CanadaRevenueAgencyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CanadaRevenueAgencyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CanadaRevenueAgencyMember" xlink:to="lab_us-gaap_CanadaRevenueAgencyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e7a8d8b6-8b7b-467a-8f9a-9dccc7fb5b5b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_4eb34fb7-de27-4b57-8e2e-40e4a29ca2a6_negatedLabel_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_label_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Accumulated Impairment, Impairment in Period</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_documentation_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Accumulated Impairment, Impairment in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:to="lab_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7ed50530-c9e1-4d28-9b8f-63a20ebe9f04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_fa27df7c-1b57-4236-a1bd-0692ed8fc7f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets, net of disposals</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_fd1ddaf6-ccd9-4b5a-97a7-875471b1cbbb_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosIsraelGSPharmacyLtdMember_ddd622c5-c0e8-4b11-990f-9910d9f212df_terseLabel_en-US" xlink:label="lab_cron_CronosIsraelGSPharmacyLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Pharmacy Ltd.</link:label>
    <link:label id="lab_cron_CronosIsraelGSPharmacyLtdMember_label_en-US" xlink:label="lab_cron_CronosIsraelGSPharmacyLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Pharmacy Ltd. [Member]</link:label>
    <link:label id="lab_cron_CronosIsraelGSPharmacyLtdMember_documentation_en-US" xlink:label="lab_cron_CronosIsraelGSPharmacyLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Pharmacies Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelGSPharmacyLtdMember" xlink:href="cron-20221231.xsd#cron_CronosIsraelGSPharmacyLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosIsraelGSPharmacyLtdMember" xlink:to="lab_cron_CronosIsraelGSPharmacyLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_c1f27ffe-edf9-4e79-9784-3dfac38bc391_terseLabel_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected income tax benefit</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_label_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_documentation_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:to="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_967eed1b-20c8-4b8f-9c03-e8757ea57e52_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_6ff9118c-7c7f-4bc7-aa5a-9999d326ae09_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on other investments</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfInvestments" xlink:to="lab_us-gaap_ImpairmentOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_bbd4bc6e-b5fb-4c39-8e3a-5f5e97fb126f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GainLossOnDisposalOfInvestments_34b2ed6a-1e56-4356-b8b2-2723e7cf4970_negatedLabel_en-US" xlink:label="lab_cron_GainLossOnDisposalOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of investments</link:label>
    <link:label id="lab_cron_GainLossOnDisposalOfInvestments_label_en-US" xlink:label="lab_cron_GainLossOnDisposalOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposal of Investments</link:label>
    <link:label id="lab_cron_GainLossOnDisposalOfInvestments_documentation_en-US" xlink:label="lab_cron_GainLossOnDisposalOfInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposal of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GainLossOnDisposalOfInvestments" xlink:href="cron-20221231.xsd#cron_GainLossOnDisposalOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GainLossOnDisposalOfInvestments" xlink:to="lab_cron_GainLossOnDisposalOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_a6beafa9-f54b-42d4-84f1-a5aa0292b509_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_ad352f26-2c1e-47d9-bd9c-3f2b486200d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_603ca8ad-80dc-4a94-b3fc-eaa232aec758_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_52454d02-ebeb-479d-8f12-ab5a3879c2ad_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b824b56f-38a9-4f5c-be3a-12a938a51a23_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_b177a311-8915-4949-973e-e1e25b98a134_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CBGVALicensingAgreementMember_149cde73-ec4f-4d9f-9c9e-561011c668a8_terseLabel_en-US" xlink:label="lab_cron_CBGVALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBGVA Licensing Agreement</link:label>
    <link:label id="lab_cron_CBGVALicensingAgreementMember_label_en-US" xlink:label="lab_cron_CBGVALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBGVA Licensing Agreement [Member]</link:label>
    <link:label id="lab_cron_CBGVALicensingAgreementMember_documentation_en-US" xlink:label="lab_cron_CBGVALicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CBGVA Licensing Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBGVALicensingAgreementMember" xlink:href="cron-20221231.xsd#cron_CBGVALicensingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CBGVALicensingAgreementMember" xlink:to="lab_cron_CBGVALicensingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_8d94608c-b1da-4100-8a0e-e718aedc9c7a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b5c152d9-9af2-4c3b-9cf0-ccc14d68d9b5_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8ea8e873-f1c9-4bfe-92d4-c79cd369eb36_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_abda73f8-7ff0-4fff-8993-18a33fe5134c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_46150e21-9f71-41da-b087-0ea98b4486a6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_f339a56a-1182-49fc-98fe-9024a4112b16_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss used in the computation of diluted loss from continuing operations per share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d6cbe63-ef38-4168-ad35-6da3eaaf21bb_totalLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86eebcac-9caf-496f-be9c-1c28d319da08_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e25f5c03-fa4c-401e-8dae-bfa7037c9563_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification_a770b82e-71cf-40c9-b1de-60cd65db94fc_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in interest income from debt modification</link:label>
    <link:label id="lab_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification_label_en-US" xlink:label="lab_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Interest Income, Increase From Debt Modification</link:label>
    <link:label id="lab_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification_documentation_en-US" xlink:label="lab_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Interest Income, Increase From Debt Modification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification" xlink:href="cron-20221231.xsd#cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification" xlink:to="lab_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_c00310be-dda9-4754-9101-9573ed3b74a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, common shares, amount</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_e60c1505-fa7d-4913-9c33-db96c4472375_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_53136c4c-d084-4d51-9af9-3ae26c0c4aa9_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_a6558fb0-1ecd-4d20-992c-b7795bf78339_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_40693437-c5ba-4a40-b1d2-c40920e8e562_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_8dc1dc7e-a943-417e-9d36-49f891f20d9a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_7d0ae64a-ee08-4be0-bc74-a991edf47399_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_d403f7c5-a382-4cf7-9cd8-ec1cb4543754_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_23f8588e-12e1-4ab9-897a-3cf8bbf53835_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_15cf6ca9-b90b-4794-9445-97dc061d3d98_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average expected life</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_f32675d8-2243-408c-a445-6041d535c58f_negatedLabel_en-US" xlink:label="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_10d1b4b9-d6e4-48ba-a19a-84c9632382be_negatedPeriodStartLabel_en-US" xlink:label="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_7d39a75b-f83a-441c-8ae8-a8cb92fa7a13_negatedPeriodEndLabel_en-US" xlink:label="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_label_en-US" xlink:label="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Impairment</link:label>
    <link:label id="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_documentation_en-US" xlink:label="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:to="lab_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_796c4e85-642b-4f2e-9cde-e24e29a697d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets on Nonrecurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLoansReceivable_c956ddd3-f835-4146-9fe0-25ff48d594c8_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Draw downs</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLoansReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Loans Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLoansReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_79f6f81f-61e3-4cf0-b8f7-877f8a151e0d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af468e68-c517-4fbc-892e-a91f44c3e065_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_1519d223-24b0-499e-b6c6-62b7c41bffd5_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4d2761f3-d202-48bc-92e4-88e4b7aaecb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding taxes paid on equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e2eb671b-e8dd-4e2a-8523-fa6cfbf3a6c3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fac7288a-59da-4c61-b4ef-5ae676b8578d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_a7fe721d-45b8-4d0c-9c5f-67a027254603_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_e82f17b0-c37c-4631-96b6-01d8f9db0ae6_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member_abf48f46-2a13-4e9c-9cf5-4f1d215a3ac3_terseLabel_en-US" xlink:label="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Manufacturing Ltd.</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member_label_en-US" xlink:label="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Manufacturing Ltd. [Member]</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member_documentation_en-US" xlink:label="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Manufacturing Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.ManufacturingLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:to="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_903dd75f-c386-4fc6-a39a-618cb8fbb623_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income (Loss) before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4fa84515-53af-412f-bdf4-cbffa7facc95_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_1644a454-38da-4b23-bcbe-d7f38990bbf7_negatedTerseLabel_en-US" xlink:label="lab_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated impairment charges</link:label>
    <link:label id="lab_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Impairment Of Property, Plant, And Equipment</link:label>
    <link:label id="lab_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Impairment Of Property, Plant, And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment" xlink:href="cron-20221231.xsd#cron_AccumulatedImpairmentOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment" xlink:to="lab_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3d6cf9a5-ebe1-4b80-8c6b-a6cb736f8073_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_5b690228-1079-4abf-b886-eead997bf8f3_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of loans receivable, net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_4c0945d4-7090-4e42-8329-91960f025c19_totalLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_1a8f04fe-7e02-4ecf-8f74-8032e78a054d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_9be53f7f-b980-4575-b2b1-17f8ce2f57c3_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_0be53b96-30a8-4e93-a9b8-b42a0a62a358_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_57eb418a-c716-4959-a7ee-8dda09ca2636_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AustraliaMember_540d29ed-0c51-43db-be57-d0e9f55ac827_terseLabel_en-US" xlink:label="lab_cron_AustraliaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia</link:label>
    <link:label id="lab_cron_AustraliaMember_label_en-US" xlink:label="lab_cron_AustraliaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia [Member]</link:label>
    <link:label id="lab_cron_AustraliaMember_documentation_en-US" xlink:label="lab_cron_AustraliaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AustraliaMember" xlink:href="cron-20221231.xsd#cron_AustraliaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AustraliaMember" xlink:to="lab_cron_AustraliaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_7f519461-1cb5-4921-af1c-d19cc9147958_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_51ebcc94-a114-476f-95d8-1221e8040453_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f13f5d53-fc58-4cac-aec5-dc807685d81b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_978c871f-d5a8-45b3-93a6-db458cd7a779_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_eb1a339d-d65e-419c-8b4f-f8979a42f386_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_WhistlerMedicalMarijuanaCompanyMember_4a28d08f-40e9-4516-beff-9ec21ddf36f3_terseLabel_en-US" xlink:label="lab_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Whistler</link:label>
    <link:label id="lab_cron_WhistlerMedicalMarijuanaCompanyMember_label_en-US" xlink:label="lab_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Whistler Medical Marijuana Company [Member]</link:label>
    <link:label id="lab_cron_WhistlerMedicalMarijuanaCompanyMember_documentation_en-US" xlink:label="lab_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Whistler Medical Marijuana Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:href="cron-20221231.xsd#cron_WhistlerMedicalMarijuanaCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:to="lab_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CapitalGainRelinquishmentOfWarrant_c43777bc-9d79-4e25-a053-7ec06a7d7dfc_terseLabel_en-US" xlink:label="lab_cron_CapitalGainRelinquishmentOfWarrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital gain on relinquishment of warrant</link:label>
    <link:label id="lab_cron_CapitalGainRelinquishmentOfWarrant_label_en-US" xlink:label="lab_cron_CapitalGainRelinquishmentOfWarrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Gain, Relinquishment Of Warrant</link:label>
    <link:label id="lab_cron_CapitalGainRelinquishmentOfWarrant_documentation_en-US" xlink:label="lab_cron_CapitalGainRelinquishmentOfWarrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Gain, Relinquishment Of Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CapitalGainRelinquishmentOfWarrant" xlink:href="cron-20221231.xsd#cron_CapitalGainRelinquishmentOfWarrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CapitalGainRelinquishmentOfWarrant" xlink:to="lab_cron_CapitalGainRelinquishmentOfWarrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2339cc56-f755-4069-8018-650a12cd0f51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b96df66b-8071-4cdb-a97c-e4fe76650835_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_07e50502-0b7d-4998-a6a5-d61c60b65b4f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments for Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_234eeef4-de36-4228-be17-cf868dbb8f45_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones_ba8b9c39-e398-4162-aba5-21fd5b5166c1_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issuance pursuant to research and development milestones</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Research And Development Milestones</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Research And Development Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" xlink:to="lab_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_24a6aa2f-44cd-48ea-9297-7eb3288cb3fe_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Purchase Commitment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_380eb380-d975-444d-8301-9f8bc88df1ec_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_6afa1990-d46e-4eab-aaef-1d89e4ce4e45_terseLabel_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA</link:label>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_label_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</link:label>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="cron-20221231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3e3ea970-9d7d-4bf4-952d-6ee764e19e02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ab73f4e8-b78e-4920-833b-3fcad515a402_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lord Jones brand</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_48fcd383-f37d-4f4f-bb0f-8d00e165fc21_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_14500ad4-766f-47ef-89ed-cd9879a90ac5_terseLabel_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly fee, percentage of direct and indirect service costs</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_label_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Monthly Fee, Percentage</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_documentation_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Monthly Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentMonthlyFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:to="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_MergerAgreementThresholdOwnershipPercentage_58979efa-cc14-4c39-bd8d-41b18bb7622a_terseLabel_en-US" xlink:label="lab_cron_MergerAgreementThresholdOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger agreement, threshold ownership percentage</link:label>
    <link:label id="lab_cron_MergerAgreementThresholdOwnershipPercentage_label_en-US" xlink:label="lab_cron_MergerAgreementThresholdOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Agreement, Threshold Ownership Percentage</link:label>
    <link:label id="lab_cron_MergerAgreementThresholdOwnershipPercentage_documentation_en-US" xlink:label="lab_cron_MergerAgreementThresholdOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Agreement, Threshold Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MergerAgreementThresholdOwnershipPercentage" xlink:href="cron-20221231.xsd#cron_MergerAgreementThresholdOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_MergerAgreementThresholdOwnershipPercentage" xlink:to="lab_cron_MergerAgreementThresholdOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_01256718-7885-4bd4-9427-cda68db4a4f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_c0e902ef-a82f-4da9-a1d6-cf906565a4b0_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Net</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables, Excluding Allowance for Credit Losses [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_225d52ca-eb1c-4ab4-8c3a-76e2bb35ccda_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_1da6b474-1c9d-464a-ac17-e78f79dabe34_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_1f2e0e55-da70-443c-954b-da287664b4c3_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_5d195e85-7a03-4d59-8a5b-bf2f0f40f4ff_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and leasehold improvements</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_aea452d0-14b2-47e2-ace7-15839bd7268a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_bc00349a-c7db-455e-8168-f541761753a6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum exposure to credit risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:to="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_63dfeb20-7303-4239-99ea-374326f01c83_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_14452586-b02a-400c-ad0c-8bd5282ba455_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_b671722f-af98-4503-b20b-4e97b5760479_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_3d6fbb6d-56bb-4279-9704-cf6e91cac8c9_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_e0d0c6d1-f4cc-4b70-a5a4-0884241dd487_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_e2420cfd-b8f6-493d-bbbb-bed2fc339deb_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9322b492-bf46-4b7e-8b9f-d4c6f542c5b7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards_74298c08-0d49-4da3-b6b5-1a6ee0e3acba_negatedTerseLabel_en-US" xlink:label="lab_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers to equity awards</link:label>
    <link:label id="lab_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards_label_en-US" xlink:label="lab_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-Based Arrangements, Transfer to Equity Awards</link:label>
    <link:label id="lab_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards_documentation_en-US" xlink:label="lab_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-Based Arrangements, Transfer to Equity Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards" xlink:href="cron-20221231.xsd#cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards" xlink:to="lab_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_6418b6b1-d98c-4ba5-8b8c-b558cf17a48a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_b14aa613-1b79-44d6-883f-a950888deace_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8c76db65-b447-4416-8e17-3b61069fadfe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_aef60fa0-6d5b-49d4-bfc3-a77e1fbccf2b_terseLabel_en-US" xlink:label="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos</link:label>
    <link:label id="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_label_en-US" xlink:label="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos [Member]</link:label>
    <link:label id="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_documentation_en-US" xlink:label="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:href="cron-20221231.xsd#cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:to="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_b6cb8ebd-5570-4385-a10a-42c33070b5ef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_49484eda-b520-4fb4-bf36-72d2eb7a623d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_c3160d95-c21b-494f-a404-04e2bf6dc89c_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_d748f9ee-4090-4ec2-a1e0-4cedebf6e883_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange effect</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7b01f256-2b88-4631-be92-ed6a25e3e947_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_e9b5d6f8-d3ba-4fda-ae34-17d3063f565b_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, term of agreement</link:label>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_label_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term Of Agreement</link:label>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementTermOfAgreement" xlink:to="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_8b602902-af9a-4460-bcd9-ea1e3d5c9567_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherNetAssetsLiabilities_d52a5aee-1612-4283-afac-006c8eb66830_terseLabel_en-US" xlink:label="lab_cron_OtherNetAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Net Assets (Liabilities)</link:label>
    <link:label id="lab_cron_OtherNetAssetsLiabilities_label_en-US" xlink:label="lab_cron_OtherNetAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Net Assets (Liabilities)</link:label>
    <link:label id="lab_cron_OtherNetAssetsLiabilities_documentation_en-US" xlink:label="lab_cron_OtherNetAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Net Assets (Liabilities)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherNetAssetsLiabilities" xlink:href="cron-20221231.xsd#cron_OtherNetAssetsLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherNetAssetsLiabilities" xlink:to="lab_cron_OtherNetAssetsLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_adc85236-4a08-421c-a432-9815d74baf99_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_676e05ed-0ca0-4ca4-80ef-50d02d7e81a9_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion due to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_81c7c9ca-712e-4fb1-aef4-c8fe145e1fc6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_445e20c6-1384-4103-9a43-38b0a146c56f_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, installment received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_label_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Installments Received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Installments Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementInstallmentsReceived" xlink:to="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FacilityInStaynerOntarioCanadaMember_029c9e18-3f64-4016-81c0-0c5ffc5a6829_terseLabel_en-US" xlink:label="lab_cron_FacilityInStaynerOntarioCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility in Stayner, Ontario, Canada</link:label>
    <link:label id="lab_cron_FacilityInStaynerOntarioCanadaMember_label_en-US" xlink:label="lab_cron_FacilityInStaynerOntarioCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility in Stayner, Ontario, Canada [Member]</link:label>
    <link:label id="lab_cron_FacilityInStaynerOntarioCanadaMember_documentation_en-US" xlink:label="lab_cron_FacilityInStaynerOntarioCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility in Stayner, Ontario, Canada</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FacilityInStaynerOntarioCanadaMember" xlink:href="cron-20221231.xsd#cron_FacilityInStaynerOntarioCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FacilityInStaynerOntarioCanadaMember" xlink:to="lab_cron_FacilityInStaynerOntarioCanadaMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>cron-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bb311be6-8ff8-4549-bdb4-c4f3401e1eb6,g:1fb2bd36-dce5-4c03-be1e-00a7968a9cfb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://thecronosgroup.com/role/CoverPage" xlink:type="simple" xlink:href="cron-20221231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_61152dfd-627f-4070-baa3-b5fd8e70b586" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_DocumentType_61152dfd-627f-4070-baa3-b5fd8e70b586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_681f4ac4-b20f-440b-8f40-7277c7a9e552" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_DocumentAnnualReport_681f4ac4-b20f-440b-8f40-7277c7a9e552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e39bd0ae-5973-426e-baeb-2bac531e4cf2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_DocumentPeriodEndDate_e39bd0ae-5973-426e-baeb-2bac531e4cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_67c9c38d-f5af-4287-8ea4-1e45a8ed1ae5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_CurrentFiscalYearEndDate_67c9c38d-f5af-4287-8ea4-1e45a8ed1ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_cdfd87df-7e20-4336-b998-73c458c1c8a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_DocumentTransitionReport_cdfd87df-7e20-4336-b998-73c458c1c8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b54298d2-d3e9-4a16-b9fb-e78cd64c26af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityFileNumber_b54298d2-d3e9-4a16-b9fb-e78cd64c26af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_895a6d6c-381b-48ab-8cb8-0d572689dc97" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityRegistrantName_895a6d6c-381b-48ab-8cb8-0d572689dc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ed7c668d-e2e8-4897-a802-12850aedef0b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ed7c668d-e2e8-4897-a802-12850aedef0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2d2aae00-608a-4764-b6c1-85c0f10e3e9b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityAddressAddressLine1_2d2aae00-608a-4764-b6c1-85c0f10e3e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ff00fd25-ba42-4d7a-b5c5-1151c715d86b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityAddressCityOrTown_ff00fd25-ba42-4d7a-b5c5-1151c715d86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8b7d0988-a5a1-4c92-ae52-1585103a1982" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityAddressStateOrProvince_8b7d0988-a5a1-4c92-ae52-1585103a1982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_62c6e5b0-dcb4-4809-9fae-c22057389578" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityAddressPostalZipCode_62c6e5b0-dcb4-4809-9fae-c22057389578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_8b5b52bf-f208-40b0-bf7d-cdb93811ff26" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_CityAreaCode_8b5b52bf-f208-40b0-bf7d-cdb93811ff26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_dc4c1b0f-a549-47c3-93c1-1c62c28b2410" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_LocalPhoneNumber_dc4c1b0f-a549-47c3-93c1-1c62c28b2410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b150293c-98f7-4019-a37b-5cbe0ae02a91" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_Security12bTitle_b150293c-98f7-4019-a37b-5cbe0ae02a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9d0e8dc6-0259-431f-94b8-7c6dc9bb1369" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_TradingSymbol_9d0e8dc6-0259-431f-94b8-7c6dc9bb1369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6bf256cc-e386-40f8-8e73-d12a94b13efb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_SecurityExchangeName_6bf256cc-e386-40f8-8e73-d12a94b13efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_d24cfc98-d314-473b-8822-7a43ab6847fe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_d24cfc98-d314-473b-8822-7a43ab6847fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_86f3b76f-d371-4ee4-a0c2-b05bc442b07e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityVoluntaryFilers_86f3b76f-d371-4ee4-a0c2-b05bc442b07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_684c897d-abbb-45b9-a3a5-9af28c309d13" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityCurrentReportingStatus_684c897d-abbb-45b9-a3a5-9af28c309d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_2d65cc87-95b8-4c47-a97d-6463f0f760e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityInteractiveDataCurrent_2d65cc87-95b8-4c47-a97d-6463f0f760e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_75ad0743-3763-4ac5-bda8-a086467a8239" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityFilerCategory_75ad0743-3763-4ac5-bda8-a086467a8239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_53b6483b-48ac-4fca-b016-817280efbada" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntitySmallBusiness_53b6483b-48ac-4fca-b016-817280efbada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4ae05a11-3410-4f18-b59e-34c5d6261a58" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityEmergingGrowthCompany_4ae05a11-3410-4f18-b59e-34c5d6261a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_0a25ca2c-3b03-4871-9b1c-670f8c96e683" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_0a25ca2c-3b03-4871-9b1c-670f8c96e683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_bdb17a1a-f9be-48c3-91c7-b67ba7815652" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityShellCompany_bdb17a1a-f9be-48c3-91c7-b67ba7815652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_eb03c5a5-6677-4426-8f67-037564b5dd83" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityPublicFloat_eb03c5a5-6677-4426-8f67-037564b5dd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_70998a29-ea50-49b1-9357-78f1494dd3f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_70998a29-ea50-49b1-9357-78f1494dd3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_a1f91182-8859-47d2-b409-c6eb7516d4ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_a1f91182-8859-47d2-b409-c6eb7516d4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b13f3428-eb20-4668-8e0f-b6afcfac9dae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_AmendmentFlag_b13f3428-eb20-4668-8e0f-b6afcfac9dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d58c0a4b-dec7-41b1-8a98-8f65c16f3157" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_DocumentFiscalYearFocus_d58c0a4b-dec7-41b1-8a98-8f65c16f3157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_fecfb570-9c0f-40b8-8dd4-f8dc2cfab0c0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_fecfb570-9c0f-40b8-8dd4-f8dc2cfab0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_623576fa-86e3-49b9-8b4c-e8e80f28ccfa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24d4e36a-792a-4e36-aae8-5144ed7b1d8e" xlink:to="loc_dei_EntityCentralIndexKey_623576fa-86e3-49b9-8b4c-e8e80f28ccfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AuditInformation" xlink:type="simple" xlink:href="cron-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cron_AuditInformationAbstract_d05c2a7e-6fe0-4213-b693-502e623fbd79" xlink:href="cron-20221231.xsd#cron_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_7360d07e-af68-45d0-9029-5cddf44f1c2d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_AuditInformationAbstract_d05c2a7e-6fe0-4213-b693-502e623fbd79" xlink:to="loc_dei_AuditorName_7360d07e-af68-45d0-9029-5cddf44f1c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_0670fc91-886a-43ba-90da-0585542720a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_AuditInformationAbstract_d05c2a7e-6fe0-4213-b693-502e623fbd79" xlink:to="loc_dei_AuditorFirmId_0670fc91-886a-43ba-90da-0585542720a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_771dec79-89bb-473b-8be5-9b4968a727ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_AuditInformationAbstract_d05c2a7e-6fe0-4213-b693-502e623fbd79" xlink:to="loc_dei_AuditorLocation_771dec79-89bb-473b-8be5-9b4968a727ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedBalanceSheet"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_df1cc327-c8d2-4253-a054-f71d3f49c573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df1cc327-c8d2-4253-a054-f71d3f49c573" xlink:to="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ddcb0a42-c39d-4906-8002-f15c91dbca28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ddcb0a42-c39d-4906-8002-f15c91dbca28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_80c0fa57-20d4-4e0a-9859-54218b157f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:to="loc_us-gaap_ShortTermInvestments_80c0fa57-20d4-4e0a-9859-54218b157f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cc43965e-8fa3-422f-83c2-a4263cc548d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cc43965e-8fa3-422f-83c2-a4263cc548d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_72323cd0-0733-4439-aff0-ffcbb638ca10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_72323cd0-0733-4439-aff0-ffcbb638ca10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_98cb5379-ed86-43a6-a481-169e98268a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_98cb5379-ed86-43a6-a481-169e98268a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fcb973db-a9a9-4ee0-840f-c94418b4165c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:to="loc_us-gaap_InventoryNet_fcb973db-a9a9-4ee0-840f-c94418b4165c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6705ed88-bd55-462f-bc90-9f7ad2a2e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6705ed88-bd55-462f-bc90-9f7ad2a2e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7d0af0e1-3e92-4b88-9c20-f2b876b726f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_09032be3-8861-4d43-9fbc-15875d12b364" xlink:to="loc_us-gaap_AssetsCurrent_7d0af0e1-3e92-4b88-9c20-f2b876b726f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_4cdce6c4-e8a2-4729-bd9b-96bcbd0852a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_EquityMethodInvestments_4cdce6c4-e8a2-4729-bd9b-96bcbd0852a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_27668a60-5076-4c06-979d-fe1b090a8094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_OtherLongTermInvestments_27668a60-5076-4c06-979d-fe1b090a8094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_a0e84b04-0ef0-45bf-bb56-5dc8b3734f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_a0e84b04-0ef0-45bf-bb56-5dc8b3734f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9e667a6c-12c8-485a-943d-08792b10c9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9e667a6c-12c8-485a-943d-08792b10c9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ed70fc32-3791-4d40-bdf1-0715da4f5890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ed70fc32-3791-4d40-bdf1-0715da4f5890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2527fdda-b825-4e1b-9755-845c9c85ae28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_Goodwill_2527fdda-b825-4e1b-9755-845c9c85ae28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_763c7975-6fab-4a87-a38a-84bbb6e1d8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_763c7975-6fab-4a87-a38a-84bbb6e1d8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f9097ba1-92ba-4a44-bfc6-46b19ab5411d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f9097ba1-92ba-4a44-bfc6-46b19ab5411d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7f5aa221-bcfe-48dc-b7cb-70b549a0d259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41adc1e5-b6c2-483c-8867-fef4bebb5266" xlink:to="loc_us-gaap_Assets_7f5aa221-bcfe-48dc-b7cb-70b549a0d259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_67847cc5-a89a-43da-ba97-03889b4988e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df1cc327-c8d2-4253-a054-f71d3f49c573" xlink:to="loc_us-gaap_LiabilitiesAbstract_67847cc5-a89a-43da-ba97-03889b4988e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_67847cc5-a89a-43da-ba97-03889b4988e5" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_fd391827-9324-459c-b9b6-61bb804f4623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:to="loc_us-gaap_AccountsPayableCurrent_fd391827-9324-459c-b9b6-61bb804f4623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0773409b-a838-402e-8edd-738ade23fa9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0773409b-a838-402e-8edd-738ade23fa9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_fcffadbf-efb4-420e-9246-57291dbf802c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_fcffadbf-efb4-420e-9246-57291dbf802c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_fabcf13a-442d-4461-a900-f2894fd200fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_fabcf13a-442d-4461-a900-f2894fd200fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_349d9689-5ca9-48b5-9b2a-717ed4e52519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_349d9689-5ca9-48b5-9b2a-717ed4e52519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_d802a0b2-57dd-4cc3-ad3e-b6023d77c902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_d802a0b2-57dd-4cc3-ad3e-b6023d77c902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c1c4137e-ae64-4d94-bf1c-04b1a8108489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f964c6a-d18b-4ca6-81a7-9f353d1fa730" xlink:to="loc_us-gaap_LiabilitiesCurrent_c1c4137e-ae64-4d94-bf1c-04b1a8108489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_a383e0c8-9000-4e90-beaa-f332fadd9658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_67847cc5-a89a-43da-ba97-03889b4988e5" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_a383e0c8-9000-4e90-beaa-f332fadd9658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a28933e8-28b5-473b-ab35-c27d49342e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_67847cc5-a89a-43da-ba97-03889b4988e5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a28933e8-28b5-473b-ab35-c27d49342e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fc9322cd-937e-4139-bef8-a1e594842f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_67847cc5-a89a-43da-ba97-03889b4988e5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fc9322cd-937e-4139-bef8-a1e594842f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_93391ed2-890a-4d51-bc8e-86f62ba1e2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_67847cc5-a89a-43da-ba97-03889b4988e5" xlink:to="loc_us-gaap_Liabilities_93391ed2-890a-4d51-bc8e-86f62ba1e2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df1cc327-c8d2-4253-a054-f71d3f49c573" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_acc394ef-0da1-48fe-b008-9260e657c47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:to="loc_us-gaap_CommonStockValue_acc394ef-0da1-48fe-b008-9260e657c47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_280d5e8e-a30b-485d-9bef-653fb3385f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_280d5e8e-a30b-485d-9bef-653fb3385f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_60666817-b731-48e3-a359-01eab36f7e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_60666817-b731-48e3-a359-01eab36f7e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0acaf0eb-d897-48e8-9de7-e0e7fa35e2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0acaf0eb-d897-48e8-9de7-e0e7fa35e2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_949924e0-2057-4109-a174-b19de6030d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:to="loc_us-gaap_StockholdersEquity_949924e0-2057-4109-a174-b19de6030d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_02718f5f-d4c7-4180-a5f1-46ee2f3e8cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:to="loc_us-gaap_MinorityInterest_02718f5f-d4c7-4180-a5f1-46ee2f3e8cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_752b8872-a766-4f56-956e-826a9ebd4c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8e95db07-19b2-45c4-aff2-ffcbfe6a16e4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_752b8872-a766-4f56-956e-826a9ebd4c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_760b1693-f424-4feb-9b2b-910aaa930aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df1cc327-c8d2-4253-a054-f71d3f49c573" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_760b1693-f424-4feb-9b2b-910aaa930aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedBalanceSheetParenthetical"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9bf3d162-a906-494d-907f-113ae2c6cf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_12325b32-03b6-4cc8-9e81-a293bb9a0b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9bf3d162-a906-494d-907f-113ae2c6cf9b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_12325b32-03b6-4cc8-9e81-a293bb9a0b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_93332175-a021-490c-9eba-590ada0fa65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_93332175-a021-490c-9eba-590ada0fa65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes_e1f09e07-7a61-4371-8ee7-87a50a48a0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_ExciseAndSalesTaxes_e1f09e07-7a61-4371-8ee7-87a50a48a0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b4e6a5c-196c-4246-8cee-5b28b8ddaec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b4e6a5c-196c-4246-8cee-5b28b8ddaec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold_8cd86934-4e1e-4dac-becb-e778fe124165" xlink:href="cron-20221231.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_cron_OtherCostOfGoodsAndServicesSold_8cd86934-4e1e-4dac-becb-e778fe124165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9dbe5715-cac5-4061-98e9-87914ad02ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_InventoryWriteDown_9dbe5715-cac5-4061-98e9-87914ad02ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4a49d49b-5f0b-405a-9d2c-c0988e000601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_GrossProfit_4a49d49b-5f0b-405a-9d2c-c0988e000601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_71038758-9fd8-4664-a1f8-99d4581b9c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_SellingAndMarketingExpense_71038758-9fd8-4664-a1f8-99d4581b9c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_040577fa-aa09-4376-8313-3e67c6c094eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_040577fa-aa09-4376-8313-3e67c6c094eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_25cb91ba-0b2c-4315-8e2e-b17665bf45cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_25cb91ba-0b2c-4315-8e2e-b17665bf45cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_e4b5887c-31a6-4b4e-9ec3-b786c38d3b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_RestructuringCosts_e4b5887c-31a6-4b4e-9ec3-b786c38d3b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_966f1f9b-2986-4345-bd1d-f06c961d457b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_966f1f9b-2986-4345-bd1d-f06c961d457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_b380057b-c663-4f90-b8c8-ea399cfe3086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_DepreciationAndAmortization_b380057b-c663-4f90-b8c8-ea399cfe3086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_415c0cad-08ac-4035-844d-5b6e3144bd13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_415c0cad-08ac-4035-844d-5b6e3144bd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_e5388532-dbf6-46fc-9548-7253017c6f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_e5388532-dbf6-46fc-9548-7253017c6f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6ae6ba6d-a242-4d99-bfde-93e701700986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_23743baa-552a-4a84-8846-d3bc5e60c626" xlink:to="loc_us-gaap_OperatingExpenses_6ae6ba6d-a242-4d99-bfde-93e701700986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_23c7e403-d7eb-4da7-853a-465125280ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_OperatingIncomeLoss_23c7e403-d7eb-4da7-853a-465125280ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_0e0b6f26-f167-4d45-8f41-2a99ef728a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_0e0b6f26-f167-4d45-8f41-2a99ef728a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_265fa08f-d6eb-4c1f-a549-e5aee2057c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_265fa08f-d6eb-4c1f-a549-e5aee2057c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_24bd843f-0fe1-45fb-a095-aed8b192f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_24bd843f-0fe1-45fb-a095-aed8b192f53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_d7dc1e30-a03c-4490-a9e6-488cb73a272c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_d7dc1e30-a03c-4490-a9e6-488cb73a272c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_80352eff-ed6b-4abf-9add-5331a91c6361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_80352eff-ed6b-4abf-9add-5331a91c6361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0a603107-4ea2-46c7-a11d-aa147d6abba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0a603107-4ea2-46c7-a11d-aa147d6abba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_adc58eba-1c5a-41e4-a965-db4fc6fc386f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_adc58eba-1c5a-41e4-a965-db4fc6fc386f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7357e193-aae8-446f-be15-29b7af77a9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7357e193-aae8-446f-be15-29b7af77a9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_04be61fa-1d91-4eac-ba3e-d6ff47c8236a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9454cae6-cfc1-45c0-8226-e5cadf1bef59" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_04be61fa-1d91-4eac-ba3e-d6ff47c8236a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_599c65a4-76aa-4f38-9648-1a1dacb4e5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_599c65a4-76aa-4f38-9648-1a1dacb4e5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f778cc6d-146d-4ca2-8b9f-b057146d785d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f778cc6d-146d-4ca2-8b9f-b057146d785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d2263492-c7a3-42ec-a12e-1a09b5d81fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d2263492-c7a3-42ec-a12e-1a09b5d81fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8e850d28-60c8-4c88-83c6-2ef14e592d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8e850d28-60c8-4c88-83c6-2ef14e592d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e2d90926-ddcf-4a56-9719-138e7ce58c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_ProfitLoss_e2d90926-ddcf-4a56-9719-138e7ce58c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a1ffd374-e614-4eb3-a25b-2664887efbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a1ffd374-e614-4eb3-a25b-2664887efbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5960553e-d1bd-40e3-8986-bd39ce7b4ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_NetIncomeLoss_5960553e-d1bd-40e3-8986-bd39ce7b4ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8d902567-1ec4-4f48-87a1-9d3fdcd48c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8d902567-1ec4-4f48-87a1-9d3fdcd48c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3c19e024-15fc-449c-9b6e-394f26456a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8d902567-1ec4-4f48-87a1-9d3fdcd48c03" xlink:to="loc_us-gaap_ProfitLoss_3c19e024-15fc-449c-9b6e-394f26456a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c0c8ad68-e74c-4ec0-b191-e186950598e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8d902567-1ec4-4f48-87a1-9d3fdcd48c03" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c0c8ad68-e74c-4ec0-b191-e186950598e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_437d96a9-a8c3-42b9-a580-bd9330f2a257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8d902567-1ec4-4f48-87a1-9d3fdcd48c03" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_437d96a9-a8c3-42b9-a580-bd9330f2a257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_75bf56fd-c8fd-4fb9-9b3a-8f4cb0e715ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8d902567-1ec4-4f48-87a1-9d3fdcd48c03" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_75bf56fd-c8fd-4fb9-9b3a-8f4cb0e715ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8e587e0e-632b-4858-901f-f569dfc9ba9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8d902567-1ec4-4f48-87a1-9d3fdcd48c03" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8e587e0e-632b-4858-901f-f569dfc9ba9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_e5279c75-715d-4054-a6bb-c56f2916d543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4b845714-1d59-40b0-9534-c01cb92931f1" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_e5279c75-715d-4054-a6bb-c56f2916d543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_dc632795-db1b-4aa3-98dd-e8f076e551b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_e5279c75-715d-4054-a6bb-c56f2916d543" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_dc632795-db1b-4aa3-98dd-e8f076e551b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_f1138350-48f2-419f-b9a5-28bf9ed677bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_e5279c75-715d-4054-a6bb-c56f2916d543" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_f1138350-48f2-419f-b9a5-28bf9ed677bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedStatementsofChangesinShareholdersEquity"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3cf63882-3458-45a0-90ef-a1d1a39159f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_135fabd0-6c1f-4e68-855f-ac1ef63b4f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3cf63882-3458-45a0-90ef-a1d1a39159f4" xlink:to="loc_us-gaap_StatementTable_135fabd0-6c1f-4e68-855f-ac1ef63b4f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f4bb9074-2d19-437a-9d4a-3a88e94d56fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_135fabd0-6c1f-4e68-855f-ac1ef63b4f06" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f4bb9074-2d19-437a-9d4a-3a88e94d56fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f4bb9074-2d19-437a-9d4a-3a88e94d56fc" xlink:to="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b39cf168-41b1-4cf5-8984-c41267c03f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_CommonStockMember_b39cf168-41b1-4cf5-8984-c41267c03f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6f23cb89-cec8-4ee0-8f51-600501593226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6f23cb89-cec8-4ee0-8f51-600501593226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e7d2936b-da37-45ba-b60f-b5cc359c5c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_RetainedEarningsMember_e7d2936b-da37-45ba-b60f-b5cc359c5c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bfc780aa-ed63-41c0-96bb-6d2c3872914c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bfc780aa-ed63-41c0-96bb-6d2c3872914c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_0d529046-6a96-40ad-b483-9e8a9af9c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2cfb958d-8bd4-4079-8f01-3958bd271e9b" xlink:to="loc_us-gaap_NoncontrollingInterestMember_0d529046-6a96-40ad-b483-9e8a9af9c68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_48b72bbf-74f5-4b13-b99d-345d0b93704e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_135fabd0-6c1f-4e68-855f-ac1ef63b4f06" xlink:to="loc_us-gaap_StatementLineItems_48b72bbf-74f5-4b13-b99d-345d0b93704e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48b72bbf-74f5-4b13-b99d-345d0b93704e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e09ec697-898b-4858-bef6-800fed8d360b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e09ec697-898b-4858-bef6-800fed8d360b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bbba2804-d406-4b07-952d-f0de7ba5535d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bbba2804-d406-4b07-952d-f0de7ba5535d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement_60924008-fdf0-46bf-8527-ffd2ad042223" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement_60924008-fdf0-46bf-8527-ffd2ad042223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cb1bd282-dac7-4c78-8248-b16bcbf5d9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cb1bd282-dac7-4c78-8248-b16bcbf5d9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_4c9843f2-44b2-462f-917e-a83772ae6878" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_4c9843f2-44b2-462f-917e-a83772ae6878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones_5aacc2df-82bb-4db3-9182-ff7962c65e7b" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones_5aacc2df-82bb-4db3-9182-ff7962c65e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_903cad46-c781-44b1-aa37-5a33fd07533d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_903cad46-c781-44b1-aa37-5a33fd07533d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_5ee70669-e78c-4875-aa17-f3b98bbfa69f" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_5ee70669-e78c-4875-aa17-f3b98bbfa69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0c24ad69-cab6-45ac-87d3-756663982831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_ProfitLoss_0c24ad69-cab6-45ac-87d3-756663982831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_24af190b-0a27-4a8a-b921-3c9ff5439417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_24af190b-0a27-4a8a-b921-3c9ff5439417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0780447c-3365-43e4-b8d1-0439632346e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0780447c-3365-43e4-b8d1-0439632346e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62bb1e76-a8a1-4e2e-88a8-b44691119301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01acd281-de05-492e-80ca-f2fbbebdcad2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62bb1e76-a8a1-4e2e-88a8-b44691119301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cron-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c67779a3-9c7f-4905-a9f3-a0f5b90f72ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c67779a3-9c7f-4905-a9f3-a0f5b90f72ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0c41f97c-dd6d-4f3b-993d-4156dd6c2c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_ProfitLoss_0c41f97c-dd6d-4f3b-993d-4156dd6c2c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f5f22fef-58aa-49f7-9843-eac793d65721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_ShareBasedCompensation_f5f22fef-58aa-49f7-9843-eac793d65721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5a56cc3c-eee0-428f-8ab1-6ca2ca20f37c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5a56cc3c-eee0-428f-8ab1-6ca2ca20f37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_c83846c3-bbd7-4906-a00e-bc1ca211728e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_c83846c3-bbd7-4906-a00e-bc1ca211728e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_aa65e4c2-caec-47de-936e-2c4d43587878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_aa65e4c2-caec-47de-936e-2c4d43587878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_0c40ecce-77d2-47bf-880e-411775237c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_ImpairmentOfInvestments_0c40ecce-77d2-47bf-880e-411775237c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_c37d4c67-034e-45a3-a774-506eceb153d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_GainLossOnInvestments_c37d4c67-034e-45a3-a774-506eceb153d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_9143bd08-ce9f-40fa-9eff-bf85ff35f1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_9143bd08-ce9f-40fa-9eff-bf85ff35f1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_16f2bfa1-cdcd-48f3-8b56-29d3121b60fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_16f2bfa1-cdcd-48f3-8b56-29d3121b60fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GainLossOnDisposalOfInvestments_7f4f3d90-5afd-4748-a30c-320c3a3e4d1f" xlink:href="cron-20221231.xsd#cron_GainLossOnDisposalOfInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_cron_GainLossOnDisposalOfInvestments_7f4f3d90-5afd-4748-a30c-320c3a3e4d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NoncashSellingAndMarketingExpense_e4d0f4b3-01ae-4a66-b266-d87ec1354fdd" xlink:href="cron-20221231.xsd#cron_NoncashSellingAndMarketingExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_cron_NoncashSellingAndMarketingExpense_e4d0f4b3-01ae-4a66-b266-d87ec1354fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_3d29f431-32a9-4444-afeb-a530aebb785f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_3d29f431-32a9-4444-afeb-a530aebb785f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_054b9405-bef2-47cd-a1c5-c5d2f91d317b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_054b9405-bef2-47cd-a1c5-c5d2f91d317b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2cef7c76-8bc6-41f5-affd-9326a6a8fdd5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_60e7c571-6d48-43b8-aab0-c894be58d75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_60e7c571-6d48-43b8-aab0-c894be58d75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_a49efa8a-dccb-4ce0-81dd-f8d65fa93a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_a49efa8a-dccb-4ce0-81dd-f8d65fa93a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4fb4a191-9893-4694-8394-1098d8fc20f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4fb4a191-9893-4694-8394-1098d8fc20f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a596f5e8-6f4b-4f35-9401-8f9d802b6110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a596f5e8-6f4b-4f35-9401-8f9d802b6110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6047bacd-71bc-4e80-b89c-0d72a5352c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6047bacd-71bc-4e80-b89c-0d72a5352c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_140d847d-fcc9-433c-b1b8-44adacd75224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_140d847d-fcc9-433c-b1b8-44adacd75224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b6104475-1dc5-4478-b7eb-d9232150b7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5976c97f-e07e-4841-8fe6-f7a3be8f0685" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b6104475-1dc5-4478-b7eb-d9232150b7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cfac45e5-39cb-4d95-a049-b127bc8a90d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cfac45e5-39cb-4d95-a049-b127bc8a90d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_4064cfda-683d-437e-ba63-60a6e4026876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_4064cfda-683d-437e-ba63-60a6e4026876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_280cc398-b0dc-4b76-b30d-fb511e30e384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_280cc398-b0dc-4b76-b30d-fb511e30e384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_6390c290-66c1-4c1b-b4b6-d0a843a0a7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_6390c290-66c1-4c1b-b4b6-d0a843a0a7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromDividends_c762671f-fbd3-4c2e-8ce9-d7e1f1114928" xlink:href="cron-20221231.xsd#cron_ProceedsFromDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_cron_ProceedsFromDividends_c762671f-fbd3-4c2e-8ce9-d7e1f1114928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromLoansReceivable_effcbd7b-9756-402c-8610-a21663735acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_us-gaap_PaymentsForProceedsFromLoansReceivable_effcbd7b-9756-402c-8610-a21663735acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2386809f-59f3-48e4-ad3a-af85897882e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2386809f-59f3-48e4-ad3a-af85897882e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_8bb9cf01-34a8-46c8-adf9-7d1fe5614c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_8bb9cf01-34a8-46c8-adf9-7d1fe5614c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5dca2a67-bdf5-442d-8008-18371952c1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5dca2a67-bdf5-442d-8008-18371952c1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a6904c87-8cd2-4632-999f-31b573b11906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36499861-bf66-4842-a692-d379f0c3b6f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a6904c87-8cd2-4632-999f-31b573b11906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5050a152-771e-4b0d-90b0-e5d76bd288c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5050a152-771e-4b0d-90b0-e5d76bd288c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_718637e8-cab4-440a-9793-a901c582ed4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5050a152-771e-4b0d-90b0-e5d76bd288c8" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_718637e8-cab4-440a-9793-a901c582ed4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3a069115-8775-473d-85ce-3b7c4b513873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5050a152-771e-4b0d-90b0-e5d76bd288c8" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3a069115-8775-473d-85ce-3b7c4b513873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_61cca36c-a445-4c8f-bbe8-ebdbef852d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5050a152-771e-4b0d-90b0-e5d76bd288c8" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_61cca36c-a445-4c8f-bbe8-ebdbef852d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ab9f90c8-f149-4af5-b85e-d0705cf6fbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5050a152-771e-4b0d-90b0-e5d76bd288c8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ab9f90c8-f149-4af5-b85e-d0705cf6fbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e79a6012-8940-4894-8286-18db1c8f7b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e79a6012-8940-4894-8286-18db1c8f7b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9c5c4906-7f4f-42b6-bd74-ced46d77a63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9c5c4906-7f4f-42b6-bd74-ced46d77a63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4ccc0dd-428b-43e3-9a9f-7f645eb51823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4ccc0dd-428b-43e3-9a9f-7f645eb51823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c4d9739a-7791-48a7-a811-772c6326de0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c4d9739a-7791-48a7-a811-772c6326de0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_0975833d-5e92-4c53-bb4d-3f66d09c7aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32b05bd2-675c-496d-a6e6-80812fea110f" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_0975833d-5e92-4c53-bb4d-3f66d09c7aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InterestReceivedNet_95f83ae6-652a-4d83-8b48-e310aac582dc" xlink:href="cron-20221231.xsd#cron_InterestReceivedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0975833d-5e92-4c53-bb4d-3f66d09c7aed" xlink:to="loc_cron_InterestReceivedNet_95f83ae6-652a-4d83-8b48-e310aac582dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_8570932b-3529-45ad-b689-f0e2a63e0ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0975833d-5e92-4c53-bb4d-3f66d09c7aed" xlink:to="loc_us-gaap_IncomeTaxesPaid_8570932b-3529-45ad-b689-f0e2a63e0ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_84c007ce-1d61-485d-8d17-c68b7cb0fd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_c2e57e1e-eb53-4d55-b35f-66358a2234fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84c007ce-1d61-485d-8d17-c68b7cb0fd65" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_c2e57e1e-eb53-4d55-b35f-66358a2234fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Inventorynet" xlink:type="simple" xlink:href="cron-20221231.xsd#Inventorynet"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Inventorynet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_b5b5341c-15d9-418d-958a-b51aa57eb1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_e8f5f467-3aae-4965-9b10-89a0df3526ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b5b5341c-15d9-418d-958a-b51aa57eb1d0" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_e8f5f467-3aae-4965-9b10-89a0df3526ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Investments" xlink:type="simple" xlink:href="cron-20221231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_1e96eea1-5b9d-4a84-bc08-fbaeffe1456f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_638ad65a-a0dc-4550-ab79-4e18bd19be49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_1e96eea1-5b9d-4a84-bc08-fbaeffe1456f" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_638ad65a-a0dc-4550-ab79-4e18bd19be49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenet" xlink:type="simple" xlink:href="cron-20221231.xsd#LoansReceivablenet"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_53ed15f8-0b50-471c-b960-677057ffe89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_d1c4ccb0-ecd4-4548-a9ba-33ee138a750b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_53ed15f8-0b50-471c-b960-677057ffe89d" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_d1c4ccb0-ecd4-4548-a9ba-33ee138a750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnet" xlink:type="simple" xlink:href="cron-20221231.xsd#PropertyPlantandEquipmentnet"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bb799b73-0f95-4d93-b6fd-fc9081f51c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8f1158f0-5ddf-4437-8bcf-cb5563a833b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bb799b73-0f95-4d93-b6fd-fc9081f51c2e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8f1158f0-5ddf-4437-8bcf-cb5563a833b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnet" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnet"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7a8a6ce4-93d4-476b-bb2d-5c4e98461b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_508b9a7a-ad1b-42a2-9de6-c6ccaaf629c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7a8a6ce4-93d4-476b-bb2d-5c4e98461b06" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_508b9a7a-ad1b-42a2-9de6-c6ccaaf629c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Leases" xlink:type="simple" xlink:href="cron-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f7f8b1eb-630d-4618-bef1-1b5df3c1f2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_61576d1f-8874-44e1-80f4-1fc907d193d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f7f8b1eb-630d-4618-bef1-1b5df3c1f2ff" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_61576d1f-8874-44e1-80f4-1fc907d193d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilities"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c15f9e9c-f92c-42f4-b110-9175a71c222b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_cd3fb38b-5c8d-4b99-95f7-9878c53b37c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c15f9e9c-f92c-42f4-b110-9175a71c222b" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_cd3fb38b-5c8d-4b99-95f7-9878c53b37c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cron-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08327b56-39a0-47ae-86df-b9dff412ee07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0cc124f2-a698-4e17-b69a-e448dcf80d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08327b56-39a0-47ae-86df-b9dff412ee07" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0cc124f2-a698-4e17-b69a-e448dcf80d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensation" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensation"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_00d101c1-42ad-48ca-aa82-6be90bf11fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_37293964-06a5-420b-a649-156dc4e92249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_00d101c1-42ad-48ca-aa82-6be90bf11fa6" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_37293964-06a5-420b-a649-156dc4e92249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_32d4a261-b715-4a8d-aa2e-965526ea7a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d9ff20fb-3cf5-4b6b-8223-a30691fc848b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_32d4a261-b715-4a8d-aa2e-965526ea7a7b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d9ff20fb-3cf5-4b6b-8223-a30691fc848b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenue" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenue"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b41f1b23-f346-4ebe-aff7-241bcfcdafa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_00cf68d5-62e3-4e10-92bd-810d6cd861ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b41f1b23-f346-4ebe-aff7-241bcfcdafa3" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_00cf68d5-62e3-4e10-92bd-810d6cd861ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossperShare" xlink:type="simple" xlink:href="cron-20221231.xsd#EarningsLossperShare"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningsLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a8228167-cbd5-4b41-ba92-d502ef191303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_12b8fbd7-3984-4a62-ad64-e88514142a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a8228167-cbd5-4b41-ba92-d502ef191303" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_12b8fbd7-3984-4a62-ad64-e88514142a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_888a2f0d-2b23-4141-a388-8e52affeb921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_d9ea8c43-99e8-478c-8d45-a091d5f3d388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_888a2f0d-2b23-4141-a388-8e52affeb921" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_d9ea8c43-99e8-478c-8d45-a091d5f3d388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="cron-20221231.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0978c7ec-4a78-457a-9935-4f50a4d7b8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b224c55b-dbed-45b8-8da0-afa42ceec528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0978c7ec-4a78-457a-9935-4f50a4d7b8b1" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b224c55b-dbed-45b8-8da0-afa42ceec528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Restructuring" xlink:type="simple" xlink:href="cron-20221231.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_47f2f2e9-d2de-4cd2-91a8-c85cbe03838b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_63abf6b4-206f-4581-89c8-95f1b6f4cfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_47f2f2e9-d2de-4cd2-91a8-c85cbe03838b" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_63abf6b4-206f-4581-89c8-95f1b6f4cfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SubsequentEvents" xlink:type="simple" xlink:href="cron-20221231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d852b8d0-d5c9-46e3-a758-b59d0c6c521f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_2694db86-8d95-4799-b8cd-71f174a6ee01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d852b8d0-d5c9-46e3-a758-b59d0c6c521f" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_2694db86-8d95-4799-b8cd-71f174a6ee01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3ffa11d4-f9eb-41e5-bf5f-8f64ae839777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3ffa11d4-f9eb-41e5-bf5f-8f64ae839777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_acb0d10c-d677-4fba-a1d2-2488895e883c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_acb0d10c-d677-4fba-a1d2-2488895e883c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_8b8267b0-2d27-48e2-8fd0-73b131a17d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_UseOfEstimates_8b8267b0-2d27-48e2-8fd0-73b131a17d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9a725e3f-8b59-45c6-b217-14f8e24df6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9a725e3f-8b59-45c6-b217-14f8e24df6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_92a2cb6e-aa26-42e6-8562-978ac318474b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_92a2cb6e-aa26-42e6-8562-978ac318474b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_1bece9f6-0a4b-45fc-83b2-035edc54f633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_1bece9f6-0a4b-45fc-83b2-035edc54f633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_6f66367b-6da2-4a54-b365-b99ec919ee5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_6f66367b-6da2-4a54-b365-b99ec919ee5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_f645f388-d939-4f11-b950-70fa1de5a6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_f645f388-d939-4f11-b950-70fa1de5a6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a8954d5e-6220-4d88-9642-8f15d2d2699b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a8954d5e-6220-4d88-9642-8f15d2d2699b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_e713c9e7-1f9b-4a11-89bb-807ca960f147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_e713c9e7-1f9b-4a11-89bb-807ca960f147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccruedLiabilitiesPolicyPolicyTextBlock_613a019e-ede0-4f65-9d5f-bd1b875a8590" xlink:href="cron-20221231.xsd#cron_AccruedLiabilitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_cron_AccruedLiabilitiesPolicyPolicyTextBlock_613a019e-ede0-4f65-9d5f-bd1b875a8590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_363ae0ec-321f-4a7a-a570-3bf1097017d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_363ae0ec-321f-4a7a-a570-3bf1097017d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_7818c3cc-1509-478c-9c69-632140418f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_7818c3cc-1509-478c-9c69-632140418f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_f8322f45-26f4-410c-bacc-2925bbc83bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_f8322f45-26f4-410c-bacc-2925bbc83bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f149b180-863e-446e-9885-d6356a332800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f149b180-863e-446e-9885-d6356a332800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7ee330ef-cbd6-4428-8f9e-18e42f50857e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7ee330ef-cbd6-4428-8f9e-18e42f50857e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_8674d9db-270e-4795-b6af-1b700bd53fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_8674d9db-270e-4795-b6af-1b700bd53fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_61b0565a-3bb0-4731-bcdf-68a83bfcc65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_61b0565a-3bb0-4731-bcdf-68a83bfcc65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_5fef18e4-f38d-4ae2-9001-27ef4c2083a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_5fef18e4-f38d-4ae2-9001-27ef4c2083a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_d78eb492-11ae-47b9-bde5-b7ea211202e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_d78eb492-11ae-47b9-bde5-b7ea211202e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_f1d050a2-3df8-4616-801d-465fdd780fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_f1d050a2-3df8-4616-801d-465fdd780fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b79a04d5-7210-4b98-bf09-cba9bfd1341f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b79a04d5-7210-4b98-bf09-cba9bfd1341f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2818a49a-71f9-406c-9a1d-7239ff434c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2818a49a-71f9-406c-9a1d-7239ff434c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_6ffd1f44-c4e2-466e-953f-0ffe08857fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_6ffd1f44-c4e2-466e-953f-0ffe08857fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_c0f3e416-f764-4ccd-8586-d00378f4811b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_c0f3e416-f764-4ccd-8586-d00378f4811b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_22605fea-1dde-4c61-883a-f6532dcdff87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_22605fea-1dde-4c61-883a-f6532dcdff87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6e036185-1a6b-4f02-9518-2bb6e2544bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc6e8924-65f1-4849-9a92-533f5a02cafa" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6e036185-1a6b-4f02-9518-2bb6e2544bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_626e8100-4805-42a5-ae5d-dd00105f6c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_0fa71851-cdb2-4740-a2f5-4e50354dce6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_626e8100-4805-42a5-ae5d-dd00105f6c14" xlink:to="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_0fa71851-cdb2-4740-a2f5-4e50354dce6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8d344272-f808-4d87-b55c-640797ddd038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_626e8100-4805-42a5-ae5d-dd00105f6c14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8d344272-f808-4d87-b55c-640797ddd038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a64ae4fb-b52a-40eb-96cd-af89688357b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_626e8100-4805-42a5-ae5d-dd00105f6c14" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a64ae4fb-b52a-40eb-96cd-af89688357b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9af7713d-e98a-497e-b6f7-d3c278ead2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_626e8100-4805-42a5-ae5d-dd00105f6c14" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9af7713d-e98a-497e-b6f7-d3c278ead2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventorynetTables" xlink:type="simple" xlink:href="cron-20221231.xsd#InventorynetTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InventorynetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_a51f0f38-2a4f-4c87-bd88-d74b93823a81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_81e27616-0bba-4eb2-966a-ed6967972b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a51f0f38-2a4f-4c87-bd88-d74b93823a81" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_81e27616-0bba-4eb2-966a-ed6967972b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_87201a58-5039-4ced-b39f-5abe0dd6d0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_658bb5b8-41ac-4f01-8f28-f685784729e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_87201a58-5039-4ced-b39f-5abe0dd6d0f8" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_658bb5b8-41ac-4f01-8f28-f685784729e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_bcd5d56d-3063-402e-9231-1984f78ae457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_87201a58-5039-4ced-b39f-5abe0dd6d0f8" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_bcd5d56d-3063-402e-9231-1984f78ae457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_dc410dae-37a2-4286-9509-5be01b10808d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_87201a58-5039-4ced-b39f-5abe0dd6d0f8" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_dc410dae-37a2-4286-9509-5be01b10808d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetTables" xlink:type="simple" xlink:href="cron-20221231.xsd#LoansReceivablenetTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_09082605-f794-4c46-8297-833bbdee5aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d2d77247-ad7d-4f89-ad2d-bd3484585098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_09082605-f794-4c46-8297-833bbdee5aa6" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d2d77247-ad7d-4f89-ad2d-bd3484585098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_29c93859-49c8-4678-b132-a3e5f6abdcec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_09082605-f794-4c46-8297-833bbdee5aa6" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_29c93859-49c8-4678-b132-a3e5f6abdcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetTables" xlink:type="simple" xlink:href="cron-20221231.xsd#PropertyPlantandEquipmentnetTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3126af69-ac31-4543-8565-7c80b8f5677c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_33aff9ce-f1b6-492c-b87b-f163549b96d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3126af69-ac31-4543-8565-7c80b8f5677c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_33aff9ce-f1b6-492c-b87b-f163549b96d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0570e65c-4e3c-4607-8078-c471965039cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_64cd5fdf-07fd-4021-aa54-d0092d8ab6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0570e65c-4e3c-4607-8078-c471965039cc" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_64cd5fdf-07fd-4021-aa54-d0092d8ab6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_fcfa199e-1350-4637-b18e-433de2d3614a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0570e65c-4e3c-4607-8078-c471965039cc" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_fcfa199e-1350-4637-b18e-433de2d3614a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_1c405492-2f4a-4696-8820-6423055835c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0570e65c-4e3c-4607-8078-c471965039cc" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_1c405492-2f4a-4696-8820-6423055835c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7c72122d-3b06-4bb6-9000-e7ee998bfb83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0570e65c-4e3c-4607-8078-c471965039cc" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7c72122d-3b06-4bb6-9000-e7ee998bfb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesTables" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f6280394-b407-4c64-9326-ea8053729ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_04a15cb5-ef35-4891-bd85-6bfd5919d0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f6280394-b407-4c64-9326-ea8053729ef6" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_04a15cb5-ef35-4891-bd85-6bfd5919d0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3721fad0-a4d4-4c7f-8956-154296633ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f6280394-b407-4c64-9326-ea8053729ef6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3721fad0-a4d4-4c7f-8956-154296633ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4b813bbb-1011-4460-a694-f0ce5f6f1ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_32457f7a-5e41-4d36-b3c9-14cd76bde791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4b813bbb-1011-4460-a694-f0ce5f6f1ac7" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_32457f7a-5e41-4d36-b3c9-14cd76bde791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a658135b-df0c-4276-b990-76e9be4d72cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4b813bbb-1011-4460-a694-f0ce5f6f1ac7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a658135b-df0c-4276-b990-76e9be4d72cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_e468ed8c-e6e5-4f62-9fc6-fc5413a35cd9" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4b813bbb-1011-4460-a694-f0ce5f6f1ac7" xlink:to="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_e468ed8c-e6e5-4f62-9fc6-fc5413a35cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationTables" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc179e1f-0554-4654-8e8f-701e7ae6f7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_5a735caa-d7ba-4b9a-b406-6ffd57714ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc179e1f-0554-4654-8e8f-701e7ae6f7de" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_5a735caa-d7ba-4b9a-b406-6ffd57714ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_93982b7f-6836-435a-9446-ec75abf6b3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc179e1f-0554-4654-8e8f-701e7ae6f7de" xlink:to="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_93982b7f-6836-435a-9446-ec75abf6b3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3532511b-5b68-41b8-ac56-91c749459a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc179e1f-0554-4654-8e8f-701e7ae6f7de" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3532511b-5b68-41b8-ac56-91c749459a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_2a4107b1-adc2-422f-b576-9f3fe0d09363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc179e1f-0554-4654-8e8f-701e7ae6f7de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_2a4107b1-adc2-422f-b576-9f3fe0d09363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_010ca7a1-5e5c-43ed-8f79-c901732f4781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc179e1f-0554-4654-8e8f-701e7ae6f7de" xlink:to="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_010ca7a1-5e5c-43ed-8f79-c901732f4781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_e0e8cfd6-a717-48bc-9029-025e83308b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc179e1f-0554-4654-8e8f-701e7ae6f7de" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_e0e8cfd6-a717-48bc-9029-025e83308b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_cdb3c524-ff8e-4273-925c-efae5c91f9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc179e1f-0554-4654-8e8f-701e7ae6f7de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_cdb3c524-ff8e-4273-925c-efae5c91f9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4b16426e-43e2-4067-a5c4-0106fb671e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_58cbb323-7707-4381-8c79-78d96bd99c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b16426e-43e2-4067-a5c4-0106fb671e2b" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_58cbb323-7707-4381-8c79-78d96bd99c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e52950f2-14f3-4b60-8dec-105f688140c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b16426e-43e2-4067-a5c4-0106fb671e2b" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e52950f2-14f3-4b60-8dec-105f688140c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1d5e73a8-a0b4-4665-860d-9a6fd92991c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b16426e-43e2-4067-a5c4-0106fb671e2b" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1d5e73a8-a0b4-4665-860d-9a6fd92991c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_78f46c46-d78e-4c0a-a25b-036930d2cea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b16426e-43e2-4067-a5c4-0106fb671e2b" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_78f46c46-d78e-4c0a-a25b-036930d2cea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_a38e1647-ea7f-4a8c-9195-1e0a85ea36a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxExaminationsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b16426e-43e2-4067-a5c4-0106fb671e2b" xlink:to="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_a38e1647-ea7f-4a8c-9195-1e0a85ea36a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueTables" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0ad10de9-2d21-4dbe-b48c-d0d2233d1543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1241aa36-b4b2-47c8-96c3-f481d8239e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0ad10de9-2d21-4dbe-b48c-d0d2233d1543" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1241aa36-b4b2-47c8-96c3-f481d8239e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_584f4506-dacb-4709-8ef1-63e4e26db5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0ad10de9-2d21-4dbe-b48c-d0d2233d1543" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_584f4506-dacb-4709-8ef1-63e4e26db5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossperShareTables" xlink:type="simple" xlink:href="cron-20221231.xsd#EarningsLossperShareTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningsLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dd2c5f70-fbc3-4e53-a39a-5781be4edb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b32edce2-b256-412b-9f4e-b6a4e3fe59db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dd2c5f70-fbc3-4e53-a39a-5781be4edb2f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b32edce2-b256-412b-9f4e-b6a4e3fe59db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_b4947540-6fbb-46f5-b625-de85b7cf07d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c34e859c-59c6-411d-b77d-f8969752afcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_b4947540-6fbb-46f5-b625-de85b7cf07d8" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c34e859c-59c6-411d-b77d-f8969752afcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_e441c9ef-1b1e-45c0-ae96-482a4287d934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_b4947540-6fbb-46f5-b625-de85b7cf07d8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_e441c9ef-1b1e-45c0-ae96-482a4287d934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsTables" xlink:type="simple" xlink:href="cron-20221231.xsd#RelatedPartyTransactionsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_64de7d1f-382d-4428-ad2e-e677bb2f9107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_6b2ada6a-c3de-4a98-8164-d33b8b0e0159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_64de7d1f-382d-4428-ad2e-e677bb2f9107" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_6b2ada6a-c3de-4a98-8164-d33b8b0e0159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RestructuringTables" xlink:type="simple" xlink:href="cron-20221231.xsd#RestructuringTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RestructuringTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f047f893-ae4a-4251-8c00-5c93cc2ac074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_96bc1872-b753-40e3-a5c8-7963fb902c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f047f893-ae4a-4251-8c00-5c93cc2ac074" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_96bc1872-b753-40e3-a5c8-7963fb902c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d7e79ddc-da24-4c3e-99b7-fa3704f3ea20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6269db45-c1cf-40d7-a5b2-0bcbe70300e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7e79ddc-da24-4c3e-99b7-fa3704f3ea20" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6269db45-c1cf-40d7-a5b2-0bcbe70300e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8220e83b-03b1-4dac-b071-9189841b5680" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6269db45-c1cf-40d7-a5b2-0bcbe70300e5" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8220e83b-03b1-4dac-b071-9189841b5680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8220e83b-03b1-4dac-b071-9189841b5680" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.CultivationsLtd.Member_267330f7-9706-474f-8d7f-4bb0aa0f80d5" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.CultivationsLtd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:to="loc_cron_CronosIsraelG.S.CultivationsLtd.Member_267330f7-9706-474f-8d7f-4bb0aa0f80d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member_144a2add-5104-429b-aab7-9e63753c0351" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.ManufacturingLtd.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:to="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member_144a2add-5104-429b-aab7-9e63753c0351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.StoreLtd.Member_465edbf3-e74f-44ac-a875-16bf13d182f9" xlink:href="cron-20221231.xsd#cron_CronosIsraelG.S.StoreLtd.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:to="loc_cron_CronosIsraelG.S.StoreLtd.Member_465edbf3-e74f-44ac-a875-16bf13d182f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelGSPharmacyLtdMember_ac90a296-99dc-4cdd-82ad-c3c1fefc3173" xlink:href="cron-20221231.xsd#cron_CronosIsraelGSPharmacyLtdMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e7e37610-2075-4209-889c-92d4d19232c6" xlink:to="loc_cron_CronosIsraelGSPharmacyLtdMember_ac90a296-99dc-4cdd-82ad-c3c1fefc3173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_4f82b6d6-45a2-4d57-b493-a3f21c47e5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6269db45-c1cf-40d7-a5b2-0bcbe70300e5" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_4f82b6d6-45a2-4d57-b493-a3f21c47e5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_1bfe6605-8e7c-4a21-b4a6-ba46361c7d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_4f82b6d6-45a2-4d57-b493-a3f21c47e5fa" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_1bfe6605-8e7c-4a21-b4a6-ba46361c7d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_89e39331-aa6f-4c4d-af86-1a920f0d2b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89e39331-aa6f-4c4d-af86-1a920f0d2b67" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e98ce87-d5e9-46c1-bbaa-766d4131bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e98ce87-d5e9-46c1-bbaa-766d4131bf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e98ce87-d5e9-46c1-bbaa-766d4131bf59" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_d50b4ee2-2bc5-4953-a0e3-8fea0f857d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:to="loc_us-gaap_BuildingMember_d50b4ee2-2bc5-4953-a0e3-8fea0f857d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b832009f-edbf-46f1-8a64-e89503c3e7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b832009f-edbf-46f1-8a64-e89503c3e7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ced5f1e8-15b4-481f-bd53-ae6cd6d26169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b8167cc-28a5-4a37-9866-4c23a4fd88f4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ced5f1e8-15b4-481f-bd53-ae6cd6d26169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f018bd6a-bbc8-4bf0-a3b9-318238742e77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:to="loc_srt_RangeAxis_f018bd6a-bbc8-4bf0-a3b9-318238742e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a323edd-5f5b-498f-ba80-6d17e987d1a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f018bd6a-bbc8-4bf0-a3b9-318238742e77" xlink:to="loc_srt_RangeMember_8a323edd-5f5b-498f-ba80-6d17e987d1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1c3335de-347b-4640-bd9c-8ce3b3ccae49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a323edd-5f5b-498f-ba80-6d17e987d1a2" xlink:to="loc_srt_MinimumMember_1c3335de-347b-4640-bd9c-8ce3b3ccae49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4aa757a9-0830-475c-a87b-f7a49c2f636f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a323edd-5f5b-498f-ba80-6d17e987d1a2" xlink:to="loc_srt_MaximumMember_4aa757a9-0830-475c-a87b-f7a49c2f636f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36681c4d-3f9c-4c4b-b102-b1cf24c95068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3bdcde49-931e-4917-8a45-5ae3f54e6217" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36681c4d-3f9c-4c4b-b102-b1cf24c95068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1ee0ab37-e9d7-4f3f-b6a1-170f90ebb731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36681c4d-3f9c-4c4b-b102-b1cf24c95068" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1ee0ab37-e9d7-4f3f-b6a1-170f90ebb731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_99d47c0f-f7bc-4894-9ae1-08f1af9c90bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2143d27a-bdc5-4a24-ae82-54dc74abca98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_99d47c0f-f7bc-4894-9ae1-08f1af9c90bd" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2143d27a-bdc5-4a24-ae82-54dc74abca98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_93f98196-225c-42ab-b3b6-eba9da129608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2143d27a-bdc5-4a24-ae82-54dc74abca98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_93f98196-225c-42ab-b3b6-eba9da129608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b57f6f18-113b-488b-a920-a73bb1731eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_93f98196-225c-42ab-b3b6-eba9da129608" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b57f6f18-113b-488b-a920-a73bb1731eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_82235ec0-4612-4017-8cf6-9d0beaa352ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b57f6f18-113b-488b-a920-a73bb1731eef" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_82235ec0-4612-4017-8cf6-9d0beaa352ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkoExclusiveLicensesMember_eab19cb9-729e-4318-a8e6-95a90343f7a0" xlink:href="cron-20221231.xsd#cron_GinkoExclusiveLicensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b57f6f18-113b-488b-a920-a73bb1731eef" xlink:to="loc_cron_GinkoExclusiveLicensesMember_eab19cb9-729e-4318-a8e6-95a90343f7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f47fa8f-6ff4-4cc6-8b40-2ad9fc1c9e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2143d27a-bdc5-4a24-ae82-54dc74abca98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f47fa8f-6ff4-4cc6-8b40-2ad9fc1c9e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ea07839-09c7-4acf-b385-8ccdb864e007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f47fa8f-6ff4-4cc6-8b40-2ad9fc1c9e71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ea07839-09c7-4acf-b385-8ccdb864e007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_641c105c-8ded-44e4-8cfc-e7813f5a6267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b4773708-d28f-488a-87bb-42fefd97d151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_641c105c-8ded-44e4-8cfc-e7813f5a6267" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b4773708-d28f-488a-87bb-42fefd97d151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_d9fdb9e7-ff64-4cb2-ad9e-36569d502617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_641c105c-8ded-44e4-8cfc-e7813f5a6267" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_d9fdb9e7-ff64-4cb2-ad9e-36569d502617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent_7cf54f87-b7fd-4221-9a9e-be6d194d9786" xlink:href="cron-20221231.xsd#cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_641c105c-8ded-44e4-8cfc-e7813f5a6267" xlink:to="loc_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent_7cf54f87-b7fd-4221-9a9e-be6d194d9786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2f2135f5-fa3d-4d7f-b040-d6983f813d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_641c105c-8ded-44e4-8cfc-e7813f5a6267" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2f2135f5-fa3d-4d7f-b040-d6983f813d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6e3b4e30-6953-45b5-8a59-b65c46665c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_641c105c-8ded-44e4-8cfc-e7813f5a6267" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6e3b4e30-6953-45b5-8a59-b65c46665c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fb81b992-98ef-4d59-8bf8-cda2203ff3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_e79afc9b-77b4-45ad-b1c6-db6841276d5e" xlink:href="cron-20221231.xsd#cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb81b992-98ef-4d59-8bf8-cda2203ff3d3" xlink:to="loc_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_e79afc9b-77b4-45ad-b1c6-db6841276d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_5089e5d1-6fb5-49ee-8c03-d081af45beab" xlink:href="cron-20221231.xsd#cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb81b992-98ef-4d59-8bf8-cda2203ff3d3" xlink:to="loc_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_5089e5d1-6fb5-49ee-8c03-d081af45beab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag_4a19f0da-d694-4892-80d0-1263c5325643" xlink:href="cron-20221231.xsd#cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb81b992-98ef-4d59-8bf8-cda2203ff3d3" xlink:to="loc_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag_4a19f0da-d694-4892-80d0-1263c5325643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_cb07acd8-22bd-41f5-a71d-12a85848e114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb81b992-98ef-4d59-8bf8-cda2203ff3d3" xlink:to="loc_us-gaap_AdvertisingExpense_cb07acd8-22bd-41f5-a71d-12a85848e114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3e8b9d91-99f4-4c37-bb02-b891a0d37877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb81b992-98ef-4d59-8bf8-cda2203ff3d3" xlink:to="loc_us-gaap_NumberOfReportableSegments_3e8b9d91-99f4-4c37-bb02-b891a0d37877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventorynetDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InventorynetDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InventorynetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_b33d6e4a-3852-4c11-bff0-ae2be0809f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3c56a826-03b6-4d4d-a5cb-f4adbaaab96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b33d6e4a-3852-4c11-bff0-ae2be0809f2b" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3c56a826-03b6-4d4d-a5cb-f4adbaaab96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c9cb2a97-2af8-48d4-b43a-b8f187602869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b33d6e4a-3852-4c11-bff0-ae2be0809f2b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c9cb2a97-2af8-48d4-b43a-b8f187602869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_70096b23-e2c0-4337-a7fd-e7f1a3928e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b33d6e4a-3852-4c11-bff0-ae2be0809f2b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_70096b23-e2c0-4337-a7fd-e7f1a3928e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves_a4c725a3-b944-4fcd-bfc5-cd071b8c3080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b33d6e4a-3852-4c11-bff0-ae2be0809f2b" xlink:to="loc_us-gaap_InventorySuppliesNetOfReserves_a4c725a3-b944-4fcd-bfc5-cd071b8c3080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_26e2decf-79f1-43be-b3cc-b39948a8b5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b33d6e4a-3852-4c11-bff0-ae2be0809f2b" xlink:to="loc_us-gaap_InventoryNet_26e2decf-79f1-43be-b3cc-b39948a8b5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6ec46ace-7216-4ba3-9b16-54aa5a2e10af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6ec46ace-7216-4ba3-9b16-54aa5a2e10af" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_121400c9-15da-4f22-bc05-d75ac5cfc93f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_121400c9-15da-4f22-bc05-d75ac5cfc93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_121400c9-15da-4f22-bc05-d75ac5cfc93f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_bf2dd3bc-5e40-4c33-b8c9-2847e9cec528" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_bf2dd3bc-5e40-4c33-b8c9-2847e9cec528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_4135660f-54dd-45a6-aa9d-4ad4c5935e41" xlink:href="cron-20221231.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_NatuEraMember_4135660f-54dd-45a6-aa9d-4ad4c5935e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_997884a5-a949-4bc4-9e5e-cbaded6a6098" xlink:href="cron-20221231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_997884a5-a949-4bc4-9e5e-cbaded6a6098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_0391d8bf-d9d5-40bd-bb9f-742f9490e26d" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_PharmacannMember_0391d8bf-d9d5-40bd-bb9f-742f9490e26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_f308f6e2-6471-4f8a-8884-d70f9eb886bb" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af446e01-3af3-4685-93a1-f2634a581ce0" xlink:to="loc_cron_CronosAustraliaLimitedMember_f308f6e2-6471-4f8a-8884-d70f9eb886bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_b5b16c28-a076-44ca-b860-59dedf339325" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_b5b16c28-a076-44ca-b860-59dedf339325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_468a992e-ace9-4a27-a94a-c5d6b8d623a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b5b16c28-a076-44ca-b860-59dedf339325" xlink:to="loc_srt_ConsolidatedEntitiesDomain_468a992e-ace9-4a27-a94a-c5d6b8d623a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_d2d4c885-a415-46c3-8b7d-6d6b8d9b167f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_468a992e-ace9-4a27-a94a-c5d6b8d623a6" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_d2d4c885-a415-46c3-8b7d-6d6b8d9b167f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_e34d1387-6720-4cee-8e21-a8d4bbb002c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_e34d1387-6720-4cee-8e21-a8d4bbb002c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_00a5d132-e197-4b9a-89dd-aecc44e982fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e34d1387-6720-4cee-8e21-a8d4bbb002c4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_00a5d132-e197-4b9a-89dd-aecc44e982fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_fee9ba83-fe13-40b5-884f-67e6325fcef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BridgeLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_00a5d132-e197-4b9a-89dd-aecc44e982fe" xlink:to="loc_us-gaap_BridgeLoanMember_fee9ba83-fe13-40b5-884f-67e6325fcef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_def5bbc2-288d-4651-bad7-b956bd6ee21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_def5bbc2-288d-4651-bad7-b956bd6ee21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3fb0ece-8f77-4886-8c62-1baf2fe236bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_def5bbc2-288d-4651-bad7-b956bd6ee21a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3fb0ece-8f77-4886-8c62-1baf2fe236bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_baceee02-368b-4d28-807f-22322676c845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3fb0ece-8f77-4886-8c62-1baf2fe236bb" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_baceee02-368b-4d28-807f-22322676c845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_7c8f4457-b495-456d-adaa-eb27786b868b" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_cron_LoanReceivableNameAxis_7c8f4457-b495-456d-adaa-eb27786b868b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_1e620835-77f6-404c-84dc-57658e6d7ada" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_7c8f4457-b495-456d-adaa-eb27786b868b" xlink:to="loc_cron_LoanReceivableNameDomain_1e620835-77f6-404c-84dc-57658e6d7ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_0957d407-4194-48cd-b6ec-d50729da62c7" xlink:href="cron-20221231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_1e620835-77f6-404c-84dc-57658e6d7ada" xlink:to="loc_cron_CannasoulCollaborationLoanMember_0957d407-4194-48cd-b6ec-d50729da62c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ab519f88-23fd-4863-b136-a34f3a63ae2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ab519f88-23fd-4863-b136-a34f3a63ae2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_a72083c5-8fbc-4a31-90ed-ddd32d8a9008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ab519f88-23fd-4863-b136-a34f3a63ae2e" xlink:to="loc_us-gaap_ReceivableTypeDomain_a72083c5-8fbc-4a31-90ed-ddd32d8a9008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_a80482dd-4d53-4bc1-9bfc-19d57edd3483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_a72083c5-8fbc-4a31-90ed-ddd32d8a9008" xlink:to="loc_us-gaap_LoansReceivableMember_a80482dd-4d53-4bc1-9bfc-19d57edd3483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0ae5c142-baa7-4739-acef-d69ab39a8c07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_dei_LegalEntityAxis_0ae5c142-baa7-4739-acef-d69ab39a8c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e3729b41-d0cc-4e4e-9c90-283e9c10653e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_0ae5c142-baa7-4739-acef-d69ab39a8c07" xlink:to="loc_dei_EntityDomain_e3729b41-d0cc-4e4e-9c90-283e9c10653e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraJVPartnerMember_5651f189-bd74-4cb6-bfe6-bd5592b1e6db" xlink:href="cron-20221231.xsd#cron_NatueraJVPartnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e3729b41-d0cc-4e4e-9c90-283e9c10653e" xlink:to="loc_cron_NatueraJVPartnerMember_5651f189-bd74-4cb6-bfe6-bd5592b1e6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_01bcc681-0796-4854-9913-0d3ed219da77" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e3729b41-d0cc-4e4e-9c90-283e9c10653e" xlink:to="loc_cron_PharmacannMember_01bcc681-0796-4854-9913-0d3ed219da77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_772c6a1e-9891-4612-befb-bc8a8bb0ee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_772c6a1e-9891-4612-befb-bc8a8bb0ee3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63c895ae-eaef-4496-ba60-dfb4ab5b4ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_772c6a1e-9891-4612-befb-bc8a8bb0ee3d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63c895ae-eaef-4496-ba60-dfb4ab5b4ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LivWellHoldingsIncMember_07988970-68f8-401a-9dcd-9ec905fdcf41" xlink:href="cron-20221231.xsd#cron_LivWellHoldingsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63c895ae-eaef-4496-ba60-dfb4ab5b4ac3" xlink:to="loc_cron_LivWellHoldingsIncMember_07988970-68f8-401a-9dcd-9ec905fdcf41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_67a0958c-f6c4-4053-a6a1-0513f5c6f765" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_srt_OwnershipAxis_67a0958c-f6c4-4053-a6a1-0513f5c6f765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1c9d8824-6a97-4574-9e7b-a035f317a684" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_67a0958c-f6c4-4053-a6a1-0513f5c6f765" xlink:to="loc_srt_OwnershipDomain_1c9d8824-6a97-4574-9e7b-a035f317a684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_6bb2305d-23c4-4712-84ae-3fd2ab6de5f0" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1c9d8824-6a97-4574-9e7b-a035f317a684" xlink:to="loc_cron_PharmacannMember_6bb2305d-23c4-4712-84ae-3fd2ab6de5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe59f3bf-c40f-49ff-b147-817bf6bf1a4b" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_a5227527-5769-4643-9784-1a0368b7456e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_a5227527-5769-4643-9784-1a0368b7456e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_33707804-2baa-4cd6-9afd-7271a948ca43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_33707804-2baa-4cd6-9afd-7271a948ca43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7115bbb1-cb33-485f-91a4-6a6647d13adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7115bbb1-cb33-485f-91a4-6a6647d13adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedPercentage_52b20c70-89f9-405c-b2b5-ae2e2c748b30" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_InvestmentOwnedPercentage_52b20c70-89f9-405c-b2b5-ae2e2c748b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d1fce0d5-abba-49bb-8b59-591bddf44ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_EquityMethodInvestments_d1fce0d5-abba-49bb-8b59-591bddf44ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances_535ff515-2986-42f6-bd61-9d31700a8bf0" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementAmountOfAdvances_535ff515-2986-42f6-bd61-9d31700a8bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement_b4e41fd3-d78e-4bb7-9d4e-aefcaeea4d51" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementTermOfAgreement_b4e41fd3-d78e-4bb7-9d4e-aefcaeea4d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_650e2cf7-c76c-4a85-96f8-474b5d0d78e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_650e2cf7-c76c-4a85-96f8-474b5d0d78e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_ce830b0b-409d-426d-ab88-140ba94512c7" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_ce830b0b-409d-426d-ab88-140ba94512c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_f4a5b00a-d56f-484c-a965-14958b2d757e" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_f4a5b00a-d56f-484c-a965-14958b2d757e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_f1b7fa27-65cc-4fdf-ba47-f25a07f32317" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_f1b7fa27-65cc-4fdf-ba47-f25a07f32317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3ec5408f-07bd-4d10-adfe-cf33cb501910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3ec5408f-07bd-4d10-adfe-cf33cb501910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_302d4319-4223-4f12-b1dd-8ec994fdde39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_302d4319-4223-4f12-b1dd-8ec994fdde39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a4352627-fa9a-445e-8e1c-0d654afad531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a4352627-fa9a-445e-8e1c-0d654afad531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_f6ab5f1c-75be-4459-92ff-acdf5bce7d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_f6ab5f1c-75be-4459-92ff-acdf5bce7d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9030dc05-6f84-4c0a-95ec-86c46d8178df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9030dc05-6f84-4c0a-95ec-86c46d8178df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MergerAgreementThresholdOwnershipPercentage_c8d2b59e-ac82-4c25-83a3-7c41c36cac36" xlink:href="cron-20221231.xsd#cron_MergerAgreementThresholdOwnershipPercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_MergerAgreementThresholdOwnershipPercentage_c8d2b59e-ac82-4c25-83a3-7c41c36cac36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_6ef308a5-6bf8-4c86-ab1b-df03d838fdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_6ef308a5-6bf8-4c86-ab1b-df03d838fdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_7900fd0a-a238-4848-8e02-bc11b1e027d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_UnsecuredDebt_7900fd0a-a238-4848-8e02-bc11b1e027d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1a0fe59b-0824-4441-9f1c-b596491352da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1a0fe59b-0824-4441-9f1c-b596491352da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfSeatsOnBoardOfDirectors_93ced76e-dc9d-43c8-98ab-015fa2410a84" xlink:href="cron-20221231.xsd#cron_NumberOfSeatsOnBoardOfDirectors"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_cron_NumberOfSeatsOnBoardOfDirectors_93ced76e-dc9d-43c8-98ab-015fa2410a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_4678bd1c-3f7c-4b17-8e9b-fded86ace034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_4678bd1c-3f7c-4b17-8e9b-fded86ace034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_f13d06e1-c54e-4267-807d-b68ce9e43236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_dd14269c-1619-4d50-ac16-e12b6395ce42" xlink:to="loc_us-gaap_OtherLongTermInvestments_f13d06e1-c54e-4267-807d-b68ce9e43236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsScheduleofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a4c9db94-9497-45b6-b604-ba38c219a6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a4c9db94-9497-45b6-b604-ba38c219a6e0" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2603a8e8-aede-48e0-b3e6-064bfd063327" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2603a8e8-aede-48e0-b3e6-064bfd063327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2603a8e8-aede-48e0-b3e6-064bfd063327" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_2c432c83-0cf5-4d99-8ac5-962f12f85dc0" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:to="loc_cron_CronosAustraliaLimitedMember_2c432c83-0cf5-4d99-8ac5-962f12f85dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_c125df57-3714-488d-b49c-df905ba007cc" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_c125df57-3714-488d-b49c-df905ba007cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_a83d8045-5c0f-4742-902d-9fbf62ce23c3" xlink:href="cron-20221231.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2b86c2ac-a252-429a-a73b-132f6807eedd" xlink:to="loc_cron_NatuEraMember_a83d8045-5c0f-4742-902d-9fbf62ce23c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_dei_LegalEntityAxis_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7ef63e1a-5c34-49ad-9942-085ea03c4821" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5dcdf6cf-2113-47b2-988f-8ba9c52c3d8d" xlink:to="loc_dei_EntityDomain_7ef63e1a-5c34-49ad-9942-085ea03c4821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_ab555a3f-a0ab-4aef-a88b-f8fb28c2ba8b" xlink:href="cron-20221231.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7ef63e1a-5c34-49ad-9942-085ea03c4821" xlink:to="loc_cron_CronosGroupInc.Member_ab555a3f-a0ab-4aef-a88b-f8fb28c2ba8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraJVPartnerMember_e868160c-0f2b-4068-bb4b-09ad08af2322" xlink:href="cron-20221231.xsd#cron_NatueraJVPartnerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7ef63e1a-5c34-49ad-9942-085ea03c4821" xlink:to="loc_cron_NatueraJVPartnerMember_e868160c-0f2b-4068-bb4b-09ad08af2322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_777adf57-5b7f-4624-9ac8-c0740f4f1070" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_srt_ConsolidatedEntitiesAxis_777adf57-5b7f-4624-9ac8-c0740f4f1070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_53144f25-c7ec-486e-80a8-30b696ed5f79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_777adf57-5b7f-4624-9ac8-c0740f4f1070" xlink:to="loc_srt_ConsolidatedEntitiesDomain_53144f25-c7ec-486e-80a8-30b696ed5f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b14002fe-4a3e-4ce8-a309-5be1beb8da33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_53144f25-c7ec-486e-80a8-30b696ed5f79" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b14002fe-4a3e-4ce8-a309-5be1beb8da33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f5b202b2-b464-469b-90e0-c79e6ec23c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f5b202b2-b464-469b-90e0-c79e6ec23c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_035f8f2e-659e-4ca3-a4e5-c56888cf4c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f5b202b2-b464-469b-90e0-c79e6ec23c4f" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_035f8f2e-659e-4ca3-a4e5-c56888cf4c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_9b0b73c6-59c5-4416-b8ed-c65f4f0a42d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_035f8f2e-659e-4ca3-a4e5-c56888cf4c64" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_9b0b73c6-59c5-4416-b8ed-c65f4f0a42d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_a86dcc4f-4338-46af-ae8b-4054cb07caf6" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_cron_LoanReceivableNameAxis_a86dcc4f-4338-46af-ae8b-4054cb07caf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_32db3d4f-9efe-456d-9fb8-60550446ad89" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_a86dcc4f-4338-46af-ae8b-4054cb07caf6" xlink:to="loc_cron_LoanReceivableNameDomain_32db3d4f-9efe-456d-9fb8-60550446ad89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_9c3965b8-71c3-429e-a285-4c88bea75580" xlink:href="cron-20221231.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_32db3d4f-9efe-456d-9fb8-60550446ad89" xlink:to="loc_cron_NatuEraSeriesALoanMember_9c3965b8-71c3-429e-a285-4c88bea75580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_feae3a56-c99f-4bac-9af5-68894f58ed0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_feae3a56-c99f-4bac-9af5-68894f58ed0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_ab295fa8-5589-4cff-a202-cd5bb6dcc7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_feae3a56-c99f-4bac-9af5-68894f58ed0c" xlink:to="loc_us-gaap_ReceivableTypeDomain_ab295fa8-5589-4cff-a202-cd5bb6dcc7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_6ed7b660-fa22-4e78-831a-56e9c2a716f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_ab295fa8-5589-4cff-a202-cd5bb6dcc7e5" xlink:to="loc_us-gaap_LoansReceivableMember_6ed7b660-fa22-4e78-831a-56e9c2a716f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3144b993-f812-4fb0-9ccf-135ca1256b46" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5152581-6d67-45af-9726-1fd1dd36f11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5152581-6d67-45af-9726-1fd1dd36f11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedPercentage_59190c81-3d05-4758-9619-0bec1be0459d" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_cron_InvestmentOwnedPercentage_59190c81-3d05-4758-9619-0bec1be0459d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1c7931ed-87f2-4fd7-9519-976b78978323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_EquityMethodInvestments_1c7931ed-87f2-4fd7-9519-976b78978323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_9fe9b8c9-afb4-4504-96a6-4b33e383e7f4" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_9fe9b8c9-afb4-4504-96a6-4b33e383e7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_b6a01c74-3d54-4f36-8a28-8b4f5f69d89f" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_b6a01c74-3d54-4f36-8a28-8b4f5f69d89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_1ae1cded-6f95-4daa-85ba-6a2b8c40c6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_NotesReceivableNet_1ae1cded-6f95-4daa-85ba-6a2b8c40c6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_46dde9e6-9031-4a89-8b84-32d7935e7eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_46dde9e6-9031-4a89-8b84-32d7935e7eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_0c05f2cb-a201-4b53-ae98-4ee2aa4dc722" xlink:href="cron-20221231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_0c05f2cb-a201-4b53-ae98-4ee2aa4dc722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_36841de8-ce11-485a-bf86-5c6cfed99f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_36841de8-ce11-485a-bf86-5c6cfed99f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8a326642-407e-4551-97b7-4ecf468b4670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8a326642-407e-4551-97b7-4ecf468b4670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c4b57dc8-f962-47c0-b97e-94a61b34a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:to="loc_us-gaap_AssetsCurrent_c4b57dc8-f962-47c0-b97e-94a61b34a5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_70fc6845-9d29-4f1a-ba97-f3a66396304f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:to="loc_us-gaap_AssetsNoncurrent_70fc6845-9d29-4f1a-ba97-f3a66396304f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4fcb9031-ac1a-446c-a242-66b3edd97c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:to="loc_us-gaap_LiabilitiesCurrent_4fcb9031-ac1a-446c-a242-66b3edd97c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_8a4efd0d-fa60-4511-8e7b-4fc69063eee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_c234bcec-6e71-401b-8fa8-2851c1528667" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_8a4efd0d-fa60-4511-8e7b-4fc69063eee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_79b59e49-11a5-4c9d-a12d-d1f79db829fb" xlink:to="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b108c2b-4550-4901-95d8-6bf6b0bfabcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b108c2b-4550-4901-95d8-6bf6b0bfabcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ac48779b-0a85-44c4-8318-a84ac3277570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:to="loc_us-gaap_GrossProfit_ac48779b-0a85-44c4-8318-a84ac3277570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c1190eb3-6d1c-4563-9cdd-6ebc84fafef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b81e4319-13c4-4fbb-a989-e9c59915a9e0" xlink:to="loc_us-gaap_ProfitLoss_c1190eb3-6d1c-4563-9cdd-6ebc84fafef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsScheduleofVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_36207e13-c994-48a4-a25c-a5a558e89de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_36207e13-c994-48a4-a25c-a5a558e89de1" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_870d76a3-7426-4294-a401-ff281ea4a3fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8c0ec014-9acf-49bc-99ee-f1bb4b3ea9be" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_870d76a3-7426-4294-a401-ff281ea4a3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_61901642-c225-4c94-8284-6a585bfe386a" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_870d76a3-7426-4294-a401-ff281ea4a3fb" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_61901642-c225-4c94-8284-6a585bfe386a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_09cc9478-e073-48bb-8a66-d71a9bfb34f8" xlink:href="cron-20221231.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_870d76a3-7426-4294-a401-ff281ea4a3fb" xlink:to="loc_cron_NatuEraMember_09cc9478-e073-48bb-8a66-d71a9bfb34f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_dad25c02-a237-418f-a664-47ba401cd9a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4ae0d803-e7a9-4d11-9a02-2f4b8f2a08d8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_dad25c02-a237-418f-a664-47ba401cd9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_17e50279-2c63-49c0-90e6-2fc531c6c8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_dad25c02-a237-418f-a664-47ba401cd9a6" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_17e50279-2c63-49c0-90e6-2fc531c6c8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_11fdd9e7-e362-47ae-9cda-1e6c75fe7f9c" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cc4e253e-ec14-4d6c-a412-8592f8661837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cc4e253e-ec14-4d6c-a412-8592f8661837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherNetAssetsLiabilities_4319f44d-a9ed-4dd1-b198-69419ec7c252" xlink:href="cron-20221231.xsd#cron_OtherNetAssetsLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:to="loc_cron_OtherNetAssetsLiabilities_4319f44d-a9ed-4dd1-b198-69419ec7c252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_096f4896-1437-4494-a3a5-3f6c74dd0a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f50f3c63-adb9-4e44-bafc-027b3ad58307" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_096f4896-1437-4494-a3a5-3f6c74dd0a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsRevaluationofOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_4b071223-2104-4da0-b356-5094e0b54c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_41438da0-3b78-4d15-ab51-e00accd1e12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_4b071223-2104-4da0-b356-5094e0b54c59" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_41438da0-3b78-4d15-ab51-e00accd1e12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a402e4e6-ebea-46dc-bebf-6a6eff8d8447" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_41438da0-3b78-4d15-ab51-e00accd1e12a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a402e4e6-ebea-46dc-bebf-6a6eff8d8447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_229c3c03-7535-4d02-9d54-4566cd4d4117" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a402e4e6-ebea-46dc-bebf-6a6eff8d8447" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_229c3c03-7535-4d02-9d54-4566cd4d4117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_c24689ab-b409-4097-923a-28986ff4507d" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_229c3c03-7535-4d02-9d54-4566cd4d4117" xlink:to="loc_cron_PharmacannMember_c24689ab-b409-4097-923a-28986ff4507d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_2a1b0557-357a-4c88-aeee-96df66c6d2b5" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_229c3c03-7535-4d02-9d54-4566cd4d4117" xlink:to="loc_cron_CronosAustraliaLimitedMember_2a1b0557-357a-4c88-aeee-96df66c6d2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_0f073b90-2ede-4774-bc0e-f269428d88ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_41438da0-3b78-4d15-ab51-e00accd1e12a" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_0f073b90-2ede-4774-bc0e-f269428d88ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:href="cron-20221231.xsd#cron_OtherInvestmentsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0f073b90-2ede-4774-bc0e-f269428d88ea" xlink:to="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_e4e1f5dd-36d0-4936-b4d4-ffa27964d121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_OtherInvestments_e4e1f5dd-36d0-4936-b4d4-ffa27964d121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_5c72d764-cd0c-4d73-80ce-6e9a99568b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_5c72d764-cd0c-4d73-80ce-6e9a99568b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a2f65812-9265-4b52-92b9-e96c0313e73e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a2f65812-9265-4b52-92b9-e96c0313e73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_b798e813-7614-4c60-9c43-47853f1fade8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_b798e813-7614-4c60-9c43-47853f1fade8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_32690b2a-dd1c-48a7-9689-0ad6dcf5efcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_OtherInvestmentsRollForward_16e8f625-e4cf-4e16-9ea5-f4a51542a3ef" xlink:to="loc_us-gaap_OtherInvestments_32690b2a-dd1c-48a7-9689-0ad6dcf5efcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_904968db-ee01-44c8-b0a1-01b128387190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_904968db-ee01-44c8-b0a1-01b128387190" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_194de422-f5c4-43ed-9c53-bed70b4c5740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:to="loc_us-gaap_InvestmentTypeAxis_194de422-f5c4-43ed-9c53-bed70b4c5740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e055dd6b-5933-4a6c-a426-5d43c84489c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_194de422-f5c4-43ed-9c53-bed70b4c5740" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e055dd6b-5933-4a6c-a426-5d43c84489c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_0e7c0a96-6935-4231-a035-c7f4f9fe5072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e055dd6b-5933-4a6c-a426-5d43c84489c4" xlink:to="loc_us-gaap_EquitySecuritiesMember_0e7c0a96-6935-4231-a035-c7f4f9fe5072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05619e81-a140-4ce4-a953-6011e212ce40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05619e81-a140-4ce4-a953-6011e212ce40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b44e94bd-d557-4fc0-aee4-e339c29820b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05619e81-a140-4ce4-a953-6011e212ce40" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b44e94bd-d557-4fc0-aee4-e339c29820b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AuroraCannabisInc.Member_6cdd2f2c-3b0d-47e8-afeb-80d31cc0849e" xlink:href="cron-20221231.xsd#cron_AuroraCannabisInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b44e94bd-d557-4fc0-aee4-e339c29820b2" xlink:to="loc_cron_AuroraCannabisInc.Member_6cdd2f2c-3b0d-47e8-afeb-80d31cc0849e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_WhistlerMedicalMarijuanaCompanyMember_62e956ad-982e-4004-87dd-faeab9532420" xlink:href="cron-20221231.xsd#cron_WhistlerMedicalMarijuanaCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b44e94bd-d557-4fc0-aee4-e339c29820b2" xlink:to="loc_cron_WhistlerMedicalMarijuanaCompanyMember_62e956ad-982e-4004-87dd-faeab9532420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_69104a40-18f0-480c-8646-484a2baa0c43" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_eca40025-3bf3-4c52-902b-f314534ca494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_eca40025-3bf3-4c52-902b-f314534ca494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_091e6c5f-c553-43c0-8741-3941811ce28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_091e6c5f-c553-43c0-8741-3941811ce28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesReceived_15e6b89e-836c-4762-99ff-eea263ff7c56" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedNumberOfSharesReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_cron_InvestmentOwnedNumberOfSharesReceived_15e6b89e-836c-4762-99ff-eea263ff7c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesSold_704c8298-9369-447e-98ea-58a1348bd9ec" xlink:href="cron-20221231.xsd#cron_InvestmentOwnedNumberOfSharesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7b935d30-3d58-4dd6-a6c5-ccf654c91101" xlink:to="loc_cron_InvestmentOwnedNumberOfSharesSold_704c8298-9369-447e-98ea-58a1348bd9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LoansReceivablenetScheduleofLoanReceivableDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_0cf6ec1b-9762-4633-8345-da936710b608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_0cf6ec1b-9762-4633-8345-da936710b608" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_cc6a4150-422d-4413-bf46-771bf6ec8de0" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_cron_LoanReceivableNameAxis_cc6a4150-422d-4413-bf46-771bf6ec8de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_cc6a4150-422d-4413-bf46-771bf6ec8de0" xlink:to="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember_ba5fa339-1092-46d5-bee4-2ffda2dfae9c" xlink:href="cron-20221231.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:to="loc_cron_CronosGrowCoCreditFacilityMember_ba5fa339-1092-46d5-bee4-2ffda2dfae9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OntarioIncMucciPromissoryNoteMember_55a69484-2662-49d5-81a5-4361cb20e2c6" xlink:href="cron-20221231.xsd#cron_OntarioIncMucciPromissoryNoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:to="loc_cron_OntarioIncMucciPromissoryNoteMember_55a69484-2662-49d5-81a5-4361cb20e2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_7e6d1950-9d5e-4f74-9f87-5996b75d1d0c" xlink:href="cron-20221231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_8927574b-8f5b-43e6-9fdf-ef434813c4fd" xlink:to="loc_cron_CannasoulCollaborationLoanMember_7e6d1950-9d5e-4f74-9f87-5996b75d1d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_0973c255-3838-4b6f-ac07-eac8603289ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_0973c255-3838-4b6f-ac07-eac8603289ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_8221ac64-985e-4e85-b74d-7d9fa1915281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_0973c255-3838-4b6f-ac07-eac8603289ce" xlink:to="loc_us-gaap_ReceivableTypeDomain_8221ac64-985e-4e85-b74d-7d9fa1915281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_ae46efce-d0b2-4edf-b146-8d36c8ab1c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_8221ac64-985e-4e85-b74d-7d9fa1915281" xlink:to="loc_us-gaap_LoansReceivableMember_ae46efce-d0b2-4edf-b146-8d36c8ab1c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_us-gaap_VariableRateAxis_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ecbfe303-35be-4a53-8e6e-9824ae848bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f08b64f3-9ff3-4d8b-b02e-92c49fc2bf56" xlink:to="loc_us-gaap_VariableRateDomain_ecbfe303-35be-4a53-8e6e-9824ae848bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CanadianPrimeRateMember_9a23e189-2375-4052-bf65-459205f42415" xlink:href="cron-20221231.xsd#cron_CanadianPrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ecbfe303-35be-4a53-8e6e-9824ae848bdc" xlink:to="loc_cron_CanadianPrimeRateMember_9a23e189-2375-4052-bf65-459205f42415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_bc92fe06-9d3d-416c-933b-94e5230bddc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_bc92fe06-9d3d-416c-933b-94e5230bddc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9d59caab-388d-4d3b-b808-a4f798a02e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_bc92fe06-9d3d-416c-933b-94e5230bddc2" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9d59caab-388d-4d3b-b808-a4f798a02e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_a3640f20-3ca8-4ab4-b8c5-52ce918a9c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9d59caab-388d-4d3b-b808-a4f798a02e46" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_a3640f20-3ca8-4ab4-b8c5-52ce918a9c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_38662dd4-96a9-4a68-8b62-0f4d6eda9223" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_38662dd4-96a9-4a68-8b62-0f4d6eda9223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ed7d590b-c67e-44cd-9e6e-4052c602c54e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_38662dd4-96a9-4a68-8b62-0f4d6eda9223" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ed7d590b-c67e-44cd-9e6e-4052c602c54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_23b0d790-bf7c-43c1-991a-506c622ec44b" xlink:href="cron-20221231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed7d590b-c67e-44cd-9e6e-4052c602c54e" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_23b0d790-bf7c-43c1-991a-506c622ec44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6b9ea757-d21d-400b-8652-8453dc50346a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6b9ea757-d21d-400b-8652-8453dc50346a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5ab2f31c-d70a-43aa-991c-7884e4fc8b1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6b9ea757-d21d-400b-8652-8453dc50346a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5ab2f31c-d70a-43aa-991c-7884e4fc8b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4497483f-0948-4330-b52a-be2fa5881a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5ab2f31c-d70a-43aa-991c-7884e4fc8b1d" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4497483f-0948-4330-b52a-be2fa5881a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1c6a21f1-b589-4d24-ad53-9bd8858b074a" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_e5d2a98d-b450-450a-ae4b-66516c3699c1" xlink:href="cron-20221231.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_e5d2a98d-b450-450a-ae4b-66516c3699c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_861a4287-1ad2-46bd-b3c0-530396f41ef7" xlink:href="cron-20221231.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_861a4287-1ad2-46bd-b3c0-530396f41ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_95c2f7a8-f05d-48c6-aa05-9dd51f1ac0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_95c2f7a8-f05d-48c6-aa05-9dd51f1ac0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_5f3e1b58-d94c-4870-8dd1-35072995e110" xlink:href="cron-20221231.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_5f3e1b58-d94c-4870-8dd1-35072995e110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_8e4464c1-17d6-46f0-8a33-0b6b07ec1826" xlink:href="cron-20221231.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_8e4464c1-17d6-46f0-8a33-0b6b07ec1826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_b990fc17-79eb-4b10-958a-943b5c4490f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_b990fc17-79eb-4b10-958a-943b5c4490f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_78930e39-b428-424a-ac5b-d4828494e204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_NotesReceivableNet_78930e39-b428-424a-ac5b-d4828494e204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmount_1270f799-f5b5-406b-98f6-77a780d5e61e" xlink:href="cron-20221231.xsd#cron_FinancingReceivableFaceAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableFaceAmount_1270f799-f5b5-406b-98f6-77a780d5e61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed_c086d035-8c12-4f5d-b394-f97418eb46fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_ProvisionForLoanLossesExpensed_c086d035-8c12-4f5d-b394-f97418eb46fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_b267ad02-239b-47e8-b8d9-c8f536eb3846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_b267ad02-239b-47e8-b8d9-c8f536eb3846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_567a9aec-e43a-4a4f-a89f-b02db8c63104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_567a9aec-e43a-4a4f-a89f-b02db8c63104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestRateStatedPercentage_a24a9376-3c7b-4f2d-808b-7b7d53d2cb5f" xlink:href="cron-20221231.xsd#cron_FinancingReceivableInterestRateStatedPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableInterestRateStatedPercentage_a24a9376-3c7b-4f2d-808b-7b7d53d2cb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate_3dd4b681-e4fd-4dd3-a810-75564c348981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate_3dd4b681-e4fd-4dd3-a810-75564c348981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification_a2753918-3305-4d4b-bbd8-5025580dc6d0" xlink:href="cron-20221231.xsd#cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification_a2753918-3305-4d4b-bbd8-5025580dc6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived_d1e4d3f3-0bc9-45a0-ab7d-6299e3bfaf09" xlink:href="cron-20221231.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_fb04e824-df97-4026-8ae6-0460975096e4" xlink:to="loc_cron_CollaborativeArrangementInstallmentsReceived_d1e4d3f3-0bc9-45a0-ab7d-6299e3bfaf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_65d84948-825d-43ce-b044-5e48220921e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_65d84948-825d-43ce-b044-5e48220921e0" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_3a2c0685-f75d-4ba2-b1d9-50289f5188aa" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:to="loc_cron_LoanReceivableNameAxis_3a2c0685-f75d-4ba2-b1d9-50289f5188aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:href="cron-20221231.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_3a2c0685-f75d-4ba2-b1d9-50289f5188aa" xlink:to="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember_4bde16ed-dfd9-4a17-abea-d716f3181e6c" xlink:href="cron-20221231.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:to="loc_cron_CronosGrowCoCreditFacilityMember_4bde16ed-dfd9-4a17-abea-d716f3181e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OntarioIncMucciPromissoryNoteMember_ea422e00-3e05-49cb-b888-2fd4f89d792f" xlink:href="cron-20221231.xsd#cron_OntarioIncMucciPromissoryNoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:to="loc_cron_OntarioIncMucciPromissoryNoteMember_ea422e00-3e05-49cb-b888-2fd4f89d792f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_48f1e90b-4319-425d-bd9f-861f6006391c" xlink:href="cron-20221231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:to="loc_cron_CannasoulCollaborationLoanMember_48f1e90b-4319-425d-bd9f-861f6006391c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_f8d29995-1cda-4cd5-9f59-d3e65fc37c6d" xlink:href="cron-20221231.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_86a8ec1e-07c2-4afc-a78b-8d1d153cb675" xlink:to="loc_cron_NatuEraSeriesALoanMember_f8d29995-1cda-4cd5-9f59-d3e65fc37c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_b40336a9-8d34-4fa1-9616-783dc7cde831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_10fabdf7-f09d-4b05-a3a7-4cadcc4dc44a" xlink:to="loc_us-gaap_ReceivableTypeDomain_b40336a9-8d34-4fa1-9616-783dc7cde831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_55afc535-5c8d-417e-a1a9-120da2f74d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_b40336a9-8d34-4fa1-9616-783dc7cde831" xlink:to="loc_us-gaap_LoansReceivableMember_55afc535-5c8d-417e-a1a9-120da2f74d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_0db216ed-3862-44d0-9f6f-0b28ceebbc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_c205ca53-d259-47c2-9687-a3d8ae1f61cd" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_0db216ed-3862-44d0-9f6f-0b28ceebbc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLoanAndLeaseLossesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_0db216ed-3862-44d0-9f6f-0b28ceebbc1d" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_9a9d3e00-5eb0-409b-9c8d-0584a4544f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_9a9d3e00-5eb0-409b-9c8d-0584a4544f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed_be8e1cc8-7726-4e34-832a-a2e9c4a3f7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:to="loc_us-gaap_ProvisionForLoanLossesExpensed_be8e1cc8-7726-4e34-832a-a2e9c4a3f7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation_bd962ecb-2afe-4ab0-9c8e-d4c185c680cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation_bd962ecb-2afe-4ab0-9c8e-d4c185c680cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_bdf6863e-d0ee-41dc-96f5-230a4358072a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesRollForward_a4dfab29-0d13-48e2-b615-050189365c7c" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_bdf6863e-d0ee-41dc-96f5-230a4358072a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment_ae4392cb-6ca0-4616-94e4-1770aaeba086" xlink:href="cron-20221231.xsd#cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_0db216ed-3862-44d0-9f6f-0b28ceebbc1d" xlink:to="loc_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment_ae4392cb-6ca0-4616-94e4-1770aaeba086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_87c19d3d-5d91-42b2-869b-c035a998af5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_96ee458a-0dba-4ffd-9e73-480e0c1ebfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_87c19d3d-5d91-42b2-869b-c035a998af5a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_96ee458a-0dba-4ffd-9e73-480e0c1ebfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_96ee458a-0dba-4ffd-9e73-480e0c1ebfc6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5d082bcf-d5ad-4a62-b062-fb306f3b7ebf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_a1318117-cc1c-48af-add1-e208522dac81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_LandMember_a1318117-cc1c-48af-add1-e208522dac81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_1bfadf4e-9ee3-4113-a620-42a86c42fb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_BuildingMember_1bfadf4e-9ee3-4113-a620-42a86c42fb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_d6360a09-b4b1-466f-b4e6-669b97c0d2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_d6360a09-b4b1-466f-b4e6-669b97c0d2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5e43f796-8c0b-4ab8-a2cd-44ae2cee9f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5e43f796-8c0b-4ab8-a2cd-44ae2cee9f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_2ada18a6-566f-4b83-b607-496017cfa298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44252bdf-34c3-4067-83de-75ebeb13ec9e" xlink:to="loc_us-gaap_ConstructionInProgressMember_2ada18a6-566f-4b83-b607-496017cfa298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_96ee458a-0dba-4ffd-9e73-480e0c1ebfc6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2b2853ee-ac90-45fe-ac39-849d799bf41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2b2853ee-ac90-45fe-ac39-849d799bf41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_92ea9744-2ed2-4631-ba7f-c36fb73c0979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_92ea9744-2ed2-4631-ba7f-c36fb73c0979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_e0586e7b-04e1-4c9c-a67c-0375b7dfca64" xlink:href="cron-20221231.xsd#cron_AccumulatedImpairmentOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment_e0586e7b-04e1-4c9c-a67c-0375b7dfca64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b35470ae-98f2-4195-a4ca-d694f46c30e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4215c15-f4ac-451d-863b-94cf1789aa9b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b35470ae-98f2-4195-a4ca-d694f46c30e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#PropertyPlantandEquipmentnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3f97f3e6-37b1-480f-a532-6438005c39cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3f97f3e6-37b1-480f-a532-6438005c39cb" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61e6e021-6172-462f-aa54-0950334acaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61e6e021-6172-462f-aa54-0950334acaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c763ea2b-81bd-4c7f-9681-d528b14f4d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61e6e021-6172-462f-aa54-0950334acaab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c763ea2b-81bd-4c7f-9681-d528b14f4d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FacilityInStaynerOntarioCanadaMember_37f5a289-5d2c-46a8-816a-df3caee224be" xlink:href="cron-20221231.xsd#cron_FacilityInStaynerOntarioCanadaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c763ea2b-81bd-4c7f-9681-d528b14f4d93" xlink:to="loc_cron_FacilityInStaynerOntarioCanadaMember_37f5a289-5d2c-46a8-816a-df3caee224be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_780cf578-d4f5-418f-babb-e9b92dd683e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c763ea2b-81bd-4c7f-9681-d528b14f4d93" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_780cf578-d4f5-418f-babb-e9b92dd683e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3c08ce86-8da0-4327-b331-555d527b2c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3c08ce86-8da0-4327-b331-555d527b2c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07604fa7-80fd-461b-b900-a70c97c40e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3c08ce86-8da0-4327-b331-555d527b2c96" xlink:to="loc_us-gaap_SegmentDomain_07604fa7-80fd-461b-b900-a70c97c40e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_99c8988c-7579-49fc-9f37-b92f79efcf24" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_07604fa7-80fd-461b-b900-a70c97c40e7a" xlink:to="loc_cron_UnitedStatesSegmentMember_99c8988c-7579-49fc-9f37-b92f79efcf24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_563dfc46-93b5-488b-8e48-402c371b00fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_6f02fc48-d541-4e9f-ae9d-94e6a922f6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_6f02fc48-d541-4e9f-ae9d-94e6a922f6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_77c6f795-959c-4cac-9a25-aa04ddb7d090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_77c6f795-959c-4cac-9a25-aa04ddb7d090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_e682e94d-5200-457d-ba56-ce4a3b79d91e" xlink:href="cron-20221231.xsd#cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_93cb4ece-8c30-48e6-beee-192bab48da7e" xlink:to="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_e682e94d-5200-457d-ba56-ce4a3b79d91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3ec88e95-8ea9-4a37-b9cf-3b9916da3602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_66f1ff8f-82b8-4d19-bdc1-50be04332ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3ec88e95-8ea9-4a37-b9cf-3b9916da3602" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_66f1ff8f-82b8-4d19-bdc1-50be04332ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_c20654b5-f3c4-497a-93bd-a05218a78efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_66f1ff8f-82b8-4d19-bdc1-50be04332ec2" xlink:to="loc_us-gaap_ReportingUnitAxis_c20654b5-f3c4-497a-93bd-a05218a78efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_87ff0034-c5e4-4a4b-8dcd-5f605148e1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_c20654b5-f3c4-497a-93bd-a05218a78efe" xlink:to="loc_us-gaap_ReportingUnitDomain_87ff0034-c5e4-4a4b-8dcd-5f605148e1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PeaceNaturalsReportingUnitMember_4dba4615-526d-430d-9c4b-40b15b115057" xlink:href="cron-20221231.xsd#cron_PeaceNaturalsReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_87ff0034-c5e4-4a4b-8dcd-5f605148e1a2" xlink:to="loc_cron_PeaceNaturalsReportingUnitMember_4dba4615-526d-430d-9c4b-40b15b115057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodReportingUnitMember_ef3eaffc-6c6f-45cb-98ac-547520ee3721" xlink:href="cron-20221231.xsd#cron_RedwoodReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_87ff0034-c5e4-4a4b-8dcd-5f605148e1a2" xlink:to="loc_cron_RedwoodReportingUnitMember_ef3eaffc-6c6f-45cb-98ac-547520ee3721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_66f1ff8f-82b8-4d19-bdc1-50be04332ec2" xlink:to="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_a9cbda6f-9988-4709-87b1-9897a8a227da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_GoodwillGross_a9cbda6f-9988-4709-87b1-9897a8a227da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4a386075-0f89-4dab-9a87-20b7d8c6da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4a386075-0f89-4dab-9a87-20b7d8c6da8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_945c75ad-4905-4583-8b53-bf16c8da300c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_Goodwill_945c75ad-4905-4583-8b53-bf16c8da300c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8fc0babc-1cbf-414f-ae17-85c53256284b" xlink:to="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_756d6b8a-be4b-4eea-98f6-ba3736b83bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_756d6b8a-be4b-4eea-98f6-ba3736b83bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3acee819-9ca8-480c-841d-f6f8ad339f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3acee819-9ca8-480c-841d-f6f8ad339f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments_32416ed7-c7b5-4594-ae1a-e2a3dfed9278" xlink:href="cron-20221231.xsd#cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:to="loc_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments_32416ed7-c7b5-4594-ae1a-e2a3dfed9278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_88995262-b437-458d-8e01-443e19f03c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cc5cd09e-0cdd-4c64-be3d-0f3ff6c9a6b8" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_88995262-b437-458d-8e01-443e19f03c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6cb8f4e0-1b17-483c-aed6-7e0009d55442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6cb8f4e0-1b17-483c-aed6-7e0009d55442" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_e34727d5-1d61-43e6-8818-054e07bbd70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_ReportingUnitAxis_e34727d5-1d61-43e6-8818-054e07bbd70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_61b8efbe-66d3-44ac-b8a2-c1840a8366da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_e34727d5-1d61-43e6-8818-054e07bbd70f" xlink:to="loc_us-gaap_ReportingUnitDomain_61b8efbe-66d3-44ac-b8a2-c1840a8366da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_8ed7dd36-a40d-402c-be0e-ab98f3df1ca2" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_61b8efbe-66d3-44ac-b8a2-c1840a8366da" xlink:to="loc_cron_UnitedStatesSegmentMember_8ed7dd36-a40d-402c-be0e-ab98f3df1ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PeaceNaturalsReportingUnitMember_7e033aad-8492-4d96-aa53-d6391cb8ac0e" xlink:href="cron-20221231.xsd#cron_PeaceNaturalsReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_61b8efbe-66d3-44ac-b8a2-c1840a8366da" xlink:to="loc_cron_PeaceNaturalsReportingUnitMember_7e033aad-8492-4d96-aa53-d6391cb8ac0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d0294911-2b1f-490e-95fa-5f6fe810084e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d0294911-2b1f-490e-95fa-5f6fe810084e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b9e115e-5e45-4ee5-8cc2-49c30a32ea59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d0294911-2b1f-490e-95fa-5f6fe810084e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b9e115e-5e45-4ee5-8cc2-49c30a32ea59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ada000bf-c328-4a8e-b546-f424ba9ffa77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b9e115e-5e45-4ee5-8cc2-49c30a32ea59" xlink:to="loc_us-gaap_TradeNamesMember_ada000bf-c328-4a8e-b546-f424ba9ffa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08c380c9-7c6b-4606-b1e2-5752cedd386b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08c380c9-7c6b-4606-b1e2-5752cedd386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08c380c9-7c6b-4606-b1e2-5752cedd386b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_f55c86c8-2304-4fe0-b8ba-98fa56a0e98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_us-gaap_LicensingAgreementsMember_f55c86c8-2304-4fe0-b8ba-98fa56a0e98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember_d673deb3-c7a8-46c7-aebe-c6e78d64a2ba" xlink:href="cron-20221231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_HealthCanadaLicensingAgreementsMember_d673deb3-c7a8-46c7-aebe-c6e78d64a2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBGALicensingAgreementMember_a50adc63-6cf0-49e6-8b81-adc133a60fc5" xlink:href="cron-20221231.xsd#cron_CBGALicensingAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_CBGALicensingAgreementMember_a50adc63-6cf0-49e6-8b81-adc133a60fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBGVALicensingAgreementMember_0e90de93-c467-4209-b787-b2ccbddbe5b5" xlink:href="cron-20221231.xsd#cron_CBGVALicensingAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_CBGVALicensingAgreementMember_0e90de93-c467-4209-b787-b2ccbddbe5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBCALicensingAgreementMember_89e3ce36-0b95-42f7-8b87-82c77ebf47ef" xlink:href="cron-20221231.xsd#cron_CBCALicensingAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_CBCALicensingAgreementMember_89e3ce36-0b95-42f7-8b87-82c77ebf47ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CBCVALicensingAgreementMember_7ef3ce47-7ab8-4b0f-b441-f43baf8ae9a1" xlink:href="cron-20221231.xsd#cron_CBCVALicensingAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13ceb3f8-9195-4207-b7d6-d5a9ebd7ca47" xlink:to="loc_cron_CBCVALicensingAgreementMember_7ef3ce47-7ab8-4b0f-b441-f43baf8ae9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9dc74f17-c014-46fa-9f51-006c6f4a424e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9dc74f17-c014-46fa-9f51-006c6f4a424e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_905790db-8c00-4205-ab28-343034198457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9dc74f17-c014-46fa-9f51-006c6f4a424e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_905790db-8c00-4205-ab28-343034198457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodHoldingGroupLLCMember_0458d590-9e85-4614-8705-7ab2cd5ef197" xlink:href="cron-20221231.xsd#cron_RedwoodHoldingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_905790db-8c00-4205-ab28-343034198457" xlink:to="loc_cron_RedwoodHoldingGroupLLCMember_0458d590-9e85-4614-8705-7ab2cd5ef197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a81a9245-dc16-43b1-82df-026efbf82bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a81a9245-dc16-43b1-82df-026efbf82bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b8fae5d0-dcbf-4b07-aa5a-0a70d0177226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a81a9245-dc16-43b1-82df-026efbf82bcc" xlink:to="loc_us-gaap_EquityComponentDomain_b8fae5d0-dcbf-4b07-aa5a-0a70d0177226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a76f2fe6-460a-4add-9cfc-ff4d4eca49b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b8fae5d0-dcbf-4b07-aa5a-0a70d0177226" xlink:to="loc_us-gaap_CommonStockMember_a76f2fe6-460a-4add-9cfc-ff4d4eca49b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_6d07cd07-1121-40e3-819a-fd093cc2445f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_681626f2-1b57-4623-801b-2e2272ccd1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_681626f2-1b57-4623-801b-2e2272ccd1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a68fa6b2-44ed-42dd-a1a4-5a412ce34b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a68fa6b2-44ed-42dd-a1a4-5a412ce34b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_62d80620-8dfc-4ce5-9f9f-e12de35e86f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_62d80620-8dfc-4ce5-9f9f-e12de35e86f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3caebcfd-3a57-4af1-8870-c3828740ff8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3caebcfd-3a57-4af1-8870-c3828740ff8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_bacfee12-0010-4a37-9aea-f07d2b175dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_bacfee12-0010-4a37-9aea-f07d2b175dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a5e3681a-9d58-469d-b98d-8324909d00bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_Goodwill_a5e3681a-9d58-469d-b98d-8324909d00bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a57ffb75-8130-4a65-ab57-6fe36e380b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a57ffb75-8130-4a65-ab57-6fe36e380b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1139add8-bd08-4592-a4a7-642a2a50067d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1139add8-bd08-4592-a4a7-642a2a50067d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a9a3f146-4fc4-4bcb-9938-3cc37a3a132e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a9a3f146-4fc4-4bcb-9938-3cc37a3a132e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_c86ee3b8-833b-451c-96be-7de105abbba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_c86ee3b8-833b-451c-96be-7de105abbba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_2532d843-394d-4176-bbc3-cd5f7d90b86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_2532d843-394d-4176-bbc3-cd5f7d90b86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d28d972a-4abd-4187-9f03-10b7d3e164ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d28d972a-4abd-4187-9f03-10b7d3e164ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_93a74fe5-ea63-4c7b-8460-bfe3ab385d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_93a74fe5-ea63-4c7b-8460-bfe3ab385d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_a3004207-acfc-4d3b-a5f1-293c5f430b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_a3004207-acfc-4d3b-a5f1-293c5f430b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9f48b103-7e19-40c8-969c-ff0cf328469f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9f48b103-7e19-40c8-969c-ff0cf328469f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_8aa8830f-fa0c-4f38-adeb-b7942313c5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_8aa8830f-fa0c-4f38-adeb-b7942313c5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfImpairedIntangibles_23b0e16e-98ed-4f37-b9a6-9e17538cd503" xlink:href="cron-20221231.xsd#cron_NumberOfImpairedIntangibles"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_cron_NumberOfImpairedIntangibles_23b0e16e-98ed-4f37-b9a6-9e17538cd503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5169fab6-90bf-4bd9-9388-929a12d9d64a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5169fab6-90bf-4bd9-9388-929a12d9d64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_65fe5c87-5dd6-4e09-b33c-3e028c8cf87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b09291dd-254e-49ed-9e70-771a30f7a9d6" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_65fe5c87-5dd6-4e09-b33c-3e028c8cf87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7c61eb12-3597-431e-a307-27f0e3465dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4145ed84-0d8d-4701-938b-a53714ae81e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7c61eb12-3597-431e-a307-27f0e3465dab" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4145ed84-0d8d-4701-938b-a53714ae81e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4145ed84-0d8d-4701-938b-a53714ae81e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4f85e5c-2f69-4ca8-8208-c9fc5fb483a9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_ee65ae0f-18ff-4062-bce7-43c60b7b342f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_ee65ae0f-18ff-4062-bce7-43c60b7b342f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember_543beabb-9819-4ae4-81ac-ca168de2b182" xlink:href="cron-20221231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:to="loc_cron_HealthCanadaLicensingAgreementsMember_543beabb-9819-4ae4-81ac-ca168de2b182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_9dbf3a7a-edfa-4e1f-a61f-4a9143b0f339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:to="loc_us-gaap_LicensingAgreementsMember_9dbf3a7a-edfa-4e1f-a61f-4a9143b0f339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IsraeliCodesLicensingAgreementsMember_526a0c23-ad56-4b5a-9408-8f985bc3a39a" xlink:href="cron-20221231.xsd#cron_IsraeliCodesLicensingAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863da31c-33dc-4b50-96d7-220106408517" xlink:to="loc_cron_IsraeliCodesLicensingAgreementsMember_526a0c23-ad56-4b5a-9408-8f985bc3a39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4145ed84-0d8d-4701-938b-a53714ae81e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f08f9c4-123c-4edf-966b-a2fe1ce8bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f08f9c4-123c-4edf-966b-a2fe1ce8bdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_66814669-1d47-45f0-b320-0bd119d63859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_66814669-1d47-45f0-b320-0bd119d63859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_9b097bd3-f8cc-428b-96f7-bb5a1c96b9d3" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_9b097bd3-f8cc-428b-96f7-bb5a1c96b9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_daea4e73-5a29-4652-b041-ef579cf49808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d1905773-ded1-4997-98ea-bd98cdc1ef4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_daea4e73-5a29-4652-b041-ef579cf49808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9fa8204d-41c5-4fa6-b981-d05337c96550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7c61eb12-3597-431e-a307-27f0e3465dab" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9fa8204d-41c5-4fa6-b981-d05337c96550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ff08c6af-a358-4a8d-8e90-e74688342945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9fa8204d-41c5-4fa6-b981-d05337c96550" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ff08c6af-a358-4a8d-8e90-e74688342945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0ef26a2-1966-4db3-a5c5-c0843916ba09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ff08c6af-a358-4a8d-8e90-e74688342945" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0ef26a2-1966-4db3-a5c5-c0843916ba09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_972a0af9-5639-4889-ad72-04d1d65f2fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0ef26a2-1966-4db3-a5c5-c0843916ba09" xlink:to="loc_us-gaap_TradeNamesMember_972a0af9-5639-4889-ad72-04d1d65f2fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c6768ddf-8ba0-48ad-ab49-929125821da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0ef26a2-1966-4db3-a5c5-c0843916ba09" xlink:to="loc_us-gaap_TrademarksMember_c6768ddf-8ba0-48ad-ab49-929125821da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9fa8204d-41c5-4fa6-b981-d05337c96550" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsGross_90657957-cb89-44dd-ad3f-a180feaae5da" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsGross_90657957-cb89-44dd-ad3f-a180feaae5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_4e1fe3a6-8a4e-47f5-be15-4f45784586d5" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_4e1fe3a6-8a4e-47f5-be15-4f45784586d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e940e5a6-ab53-4361-a818-5fad727ffb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_85fbe816-b5f6-4fc4-b3f8-ecfb89d4c6a3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e940e5a6-ab53-4361-a818-5fad727ffb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_e2897dec-1612-404d-942a-ecd5ad80714c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7c61eb12-3597-431e-a307-27f0e3465dab" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_e2897dec-1612-404d-942a-ecd5ad80714c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4081c2c9-6d4e-44bf-8824-07d6d5cf008b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_e2897dec-1612-404d-942a-ecd5ad80714c" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4081c2c9-6d4e-44bf-8824-07d6d5cf008b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c72a7fca-96fd-4b73-aef8-26f8365fb9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_e2897dec-1612-404d-942a-ecd5ad80714c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c72a7fca-96fd-4b73-aef8-26f8365fb9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairment_a09b5d45-8f88-444c-988a-31c4676e03ce" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_e2897dec-1612-404d-942a-ecd5ad80714c" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairment_a09b5d45-8f88-444c-988a-31c4676e03ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ee816a5b-5e9e-4518-8982-e94a7803b221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_e2897dec-1612-404d-942a-ecd5ad80714c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ee816a5b-5e9e-4518-8982-e94a7803b221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a70c3a76-ef97-4d21-b0aa-2b5dfdfb6ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a70c3a76-ef97-4d21-b0aa-2b5dfdfb6ff4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_60597148-7a91-420d-b61b-44d530783a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_60597148-7a91-420d-b61b-44d530783a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a06244ec-55dc-4ba9-bd85-24ac1ae14355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a06244ec-55dc-4ba9-bd85-24ac1ae14355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_85561f16-4b8b-4c6a-af6e-1d1d96922846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_85561f16-4b8b-4c6a-af6e-1d1d96922846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_83c9cf0d-5c02-400d-88ca-880d079f6f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_83c9cf0d-5c02-400d-88ca-880d079f6f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_659a3423-e5cd-4da3-89a7-7df8fb13cb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_659a3423-e5cd-4da3-89a7-7df8fb13cb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9b51e475-b9a2-4181-bd82-b81d780c1a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9b51e475-b9a2-4181-bd82-b81d780c1a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7af96a41-6ec5-411b-ab94-abc0b66ec8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_755262c9-da8f-4843-bb14-bbf12016e774" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7af96a41-6ec5-411b-ab94-abc0b66ec8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_138f22af-15a2-4842-b46d-eb91537d7eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_138f22af-15a2-4842-b46d-eb91537d7eef" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3666db99-effc-4e22-a184-9d37cc4344ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3666db99-effc-4e22-a184-9d37cc4344ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3666db99-effc-4e22-a184-9d37cc4344ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_aef34fcc-5865-4b16-afd5-4561a869d643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_aef34fcc-5865-4b16-afd5-4561a869d643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember_f1a87ea7-a158-471a-8fd0-bfd122c2f3e6" xlink:href="cron-20221231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:to="loc_cron_HealthCanadaLicensingAgreementsMember_f1a87ea7-a158-471a-8fd0-bfd122c2f3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_924b63dd-2a0d-497e-9aea-c5f5394f9c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3f2edd-006d-4e03-a1d2-4f4a06195f0d" xlink:to="loc_us-gaap_LicensingAgreementsMember_924b63dd-2a0d-497e-9aea-c5f5394f9c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f38382f9-93d4-4214-8959-daed5ddb69b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f38382f9-93d4-4214-8959-daed5ddb69b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a9e14438-610b-478e-9518-314c82259a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f38382f9-93d4-4214-8959-daed5ddb69b8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a9e14438-610b-478e-9518-314c82259a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_aee6e56e-5835-446b-8b2d-90f09af5ba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a9e14438-610b-478e-9518-314c82259a4e" xlink:to="loc_us-gaap_TradeNamesMember_aee6e56e-5835-446b-8b2d-90f09af5ba9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4abf3d5f-13a7-46e5-9140-9db9a1413359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a9e14438-610b-478e-9518-314c82259a4e" xlink:to="loc_us-gaap_TrademarksMember_4abf3d5f-13a7-46e5-9140-9db9a1413359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251e59e5-f43c-4796-a131-9dd2282fd1bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_c90ce7c9-464c-445c-98b1-2d9503fe3bda" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_c90ce7c9-464c-445c-98b1-2d9503fe3bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4f2a6113-99cb-4ee2-b2a8-4801a583aaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4f2a6113-99cb-4ee2-b2a8-4801a583aaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_68bbfd94-6eb2-4f9b-8637-199def05bc0a" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_68bbfd94-6eb2-4f9b-8637-199def05bc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_cc37816a-16ec-418f-a716-ecbbe280068a" xlink:href="cron-20221231.xsd#cron_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_91fe45ad-9369-4d5a-ba36-74524b73c6c5" xlink:to="loc_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment_cc37816a-16ec-418f-a716-ecbbe280068a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_94f50991-0b17-4759-9cf5-28d26a8b21a0" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_94f50991-0b17-4759-9cf5-28d26a8b21a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_6f04444c-a325-497f-9457-5f535c9d216d" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_6f04444c-a325-497f-9457-5f535c9d216d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_44294aa2-3a4f-4ffd-864d-76edec721ce6" xlink:href="cron-20221231.xsd#cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b481b994-e75b-4cb2-b784-88b66e4f9fdd" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment_44294aa2-3a4f-4ffd-864d-76edec721ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairment_17dd9e3e-a9a0-4e14-86e7-bf68b6b83547" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairment_17dd9e3e-a9a0-4e14-86e7-bf68b6b83547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_9628cbbc-2249-48c2-aef5-43082b0b57df" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod_9628cbbc-2249-48c2-aef5-43082b0b57df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_434fc05c-4f0b-4b96-b9c8-3b0a9f4e9a52" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments_434fc05c-4f0b-4b96-b9c8-3b0a9f4e9a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IntangibleAssetsAccumulatedImpairment_780b29c6-15b2-491d-918b-69d202403844" xlink:href="cron-20221231.xsd#cron_IntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a2dea23-8ef2-4170-afc6-faee225bbbd5" xlink:to="loc_cron_IntangibleAssetsAccumulatedImpairment_780b29c6-15b2-491d-918b-69d202403844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_99d0e6ac-3ace-473c-b6bb-a47c3a34f9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99d0e6ac-3ace-473c-b6bb-a47c3a34f9ce" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1731976c-2adf-4371-822e-b8efd3fdd21b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:to="loc_srt_RangeAxis_1731976c-2adf-4371-822e-b8efd3fdd21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdcce2b4-d62b-435e-8e2a-b250a543fd76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1731976c-2adf-4371-822e-b8efd3fdd21b" xlink:to="loc_srt_RangeMember_cdcce2b4-d62b-435e-8e2a-b250a543fd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b0dce84d-d00b-4790-9d23-f014a3a8f807" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cdcce2b4-d62b-435e-8e2a-b250a543fd76" xlink:to="loc_srt_MinimumMember_b0dce84d-d00b-4790-9d23-f014a3a8f807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_56170604-2c6a-412e-bb3f-ebadaeed0c31" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cdcce2b4-d62b-435e-8e2a-b250a543fd76" xlink:to="loc_srt_MaximumMember_56170604-2c6a-412e-bb3f-ebadaeed0c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73efdf3f-bbcf-401b-a32b-fac15e3bffc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3aedcd9c-1eaf-4d9e-b0fe-ba803d9ce2c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73efdf3f-bbcf-401b-a32b-fac15e3bffc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BuildingAndEquipmentMember_d98d7a0b-e0e6-4e61-bb3d-422b5a4d25aa" xlink:href="cron-20221231.xsd#cron_BuildingAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73efdf3f-bbcf-401b-a32b-fac15e3bffc0" xlink:to="loc_cron_BuildingAndEquipmentMember_d98d7a0b-e0e6-4e61-bb3d-422b5a4d25aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_839a5354-baa4-43cd-9173-c985f1644cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73efdf3f-bbcf-401b-a32b-fac15e3bffc0" xlink:to="loc_us-gaap_LandMember_839a5354-baa4-43cd-9173-c985f1644cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ea93f05d-91ee-4390-8804-dc913e2c747b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ea93f05d-91ee-4390-8804-dc913e2c747b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e82779b0-b8d5-4c3d-b71f-6b44ad168537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ea93f05d-91ee-4390-8804-dc913e2c747b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e82779b0-b8d5-4c3d-b71f-6b44ad168537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f7189eea-aca2-48ac-a5ad-f0487a7321e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e82779b0-b8d5-4c3d-b71f-6b44ad168537" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f7189eea-aca2-48ac-a5ad-f0487a7321e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4597efb9-3af5-46fe-97a4-6be1cfc47e5b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_9049733b-b708-4236-8a00-db277ab259b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_9049733b-b708-4236-8a00-db277ab259b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_ec5f953d-9c86-44e7-a29e-a72101c3f34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_ec5f953d-9c86-44e7-a29e-a72101c3f34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_a1a5e08e-67d4-4137-a218-97df6fe12afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_a1a5e08e-67d4-4137-a218-97df6fe12afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_5e4b9179-81fd-418c-a4ec-32de24274548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_5e4b9179-81fd-418c-a4ec-32de24274548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_262fa7a5-5c7f-4686-b924-a41f92b16a8b" xlink:href="cron-20221231.xsd#cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d985a8e2-7965-47c0-8461-f1792e141c32" xlink:to="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_262fa7a5-5c7f-4686-b924-a41f92b16a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesScheduleofLeaseCostandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f00ca78e-cb3a-4529-88a2-c59b04367801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_4e5aaa6e-98cd-4222-875d-4305b68c05d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f00ca78e-cb3a-4529-88a2-c59b04367801" xlink:to="loc_us-gaap_LeaseCostAbstract_4e5aaa6e-98cd-4222-875d-4305b68c05d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_d276c558-ca01-4212-9be6-0267ab3efa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_4e5aaa6e-98cd-4222-875d-4305b68c05d4" xlink:to="loc_us-gaap_OperatingLeaseCost_d276c558-ca01-4212-9be6-0267ab3efa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_abbf79bd-2b65-4a2d-9d09-791ee66ea294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_4e5aaa6e-98cd-4222-875d-4305b68c05d4" xlink:to="loc_us-gaap_ShortTermLeaseCost_abbf79bd-2b65-4a2d-9d09-791ee66ea294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_1cc0fef5-a81b-45be-a56f-8cdb997bce09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_4e5aaa6e-98cd-4222-875d-4305b68c05d4" xlink:to="loc_us-gaap_LeaseCost_1cc0fef5-a81b-45be-a56f-8cdb997bce09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_fcb8bd5e-084a-428b-9438-b2c6ad685874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f00ca78e-cb3a-4529-88a2-c59b04367801" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_fcb8bd5e-084a-428b-9438-b2c6ad685874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_4d46ce12-3861-4c92-9046-bea4101dfa50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_fcb8bd5e-084a-428b-9438-b2c6ad685874" xlink:to="loc_us-gaap_OperatingLeasePayments_4d46ce12-3861-4c92-9046-bea4101dfa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_96560d61-9144-406d-906f-0f0ee1222e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_fcb8bd5e-084a-428b-9438-b2c6ad685874" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_96560d61-9144-406d-906f-0f0ee1222e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1a3aa8e1-ac91-4cb0-a363-10c73cdea979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f00ca78e-cb3a-4529-88a2-c59b04367801" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1a3aa8e1-ac91-4cb0-a363-10c73cdea979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b4df2a8f-a9cc-47cb-9c4e-81c1164abfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f00ca78e-cb3a-4529-88a2-c59b04367801" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b4df2a8f-a9cc-47cb-9c4e-81c1164abfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_663a65a8-1760-4c90-9486-b1f1c239f953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_663a65a8-1760-4c90-9486-b1f1c239f953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9264e2a0-3c6d-4dd6-934a-af0e8ed41b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9264e2a0-3c6d-4dd6-934a-af0e8ed41b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1fb225b4-af08-4a5c-b3a4-b3c31ba0e181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1fb225b4-af08-4a5c-b3a4-b3c31ba0e181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ea9f1367-dfa3-443a-83c0-bb7707909043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ea9f1367-dfa3-443a-83c0-bb7707909043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fa72e07f-d093-4399-bed1-bc01eee46d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fa72e07f-d093-4399-bed1-bc01eee46d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ea6bb3ad-1651-4704-9ec8-7d60288c821d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ea6bb3ad-1651-4704-9ec8-7d60288c821d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c93f341-98b6-464b-bf6d-603bf502244f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c93f341-98b6-464b-bf6d-603bf502244f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_37401b94-0a1a-4150-b6ee-f563d5d9de05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_37401b94-0a1a-4150-b6ee-f563d5d9de05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d6169c8d-5d25-4a7b-936b-4e43904579d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_99081a04-c1f6-47d0-ac89-2ed66c7e1680" xlink:to="loc_us-gaap_OperatingLeaseLiability_d6169c8d-5d25-4a7b-936b-4e43904579d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1" xlink:type="simple" xlink:href="cron-20221231.xsd#LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_65e95b07-bc4a-40c4-b0c2-5473b37376ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_65e95b07-bc4a-40c4-b0c2-5473b37376ec" xlink:to="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_eae191ce-0dd4-4751-9ffc-6c2a05914ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_eae191ce-0dd4-4751-9ffc-6c2a05914ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eae191ce-0dd4-4751-9ffc-6c2a05914ad8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_a1068165-0dcc-4f59-9254-8f4be4998b8a" xlink:href="cron-20221231.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:to="loc_cron_AltriaInvestmentMember_a1068165-0dcc-4f59-9254-8f4be4998b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_328bd084-5cc8-4e3e-9961-4a21ef294891" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:to="loc_cron_AltriaWarrantMember_328bd084-5cc8-4e3e-9961-4a21ef294891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_d1d21375-1387-4b34-8d90-a0db09d803eb" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:to="loc_cron_PreemptiveRightsMember_d1d21375-1387-4b34-8d90-a0db09d803eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_46261eb9-4351-47ac-b923-22a2a5505a03" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_375553ff-40d4-4b55-8945-b2153af74910" xlink:to="loc_cron_TopupRightsMember_46261eb9-4351-47ac-b923-22a2a5505a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_227025cc-2d5b-4c17-9bba-ba5bcd873316" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_227025cc-2d5b-4c17-9bba-ba5bcd873316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_76106f99-5164-4832-9eda-32c7a6aaa15a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_227025cc-2d5b-4c17-9bba-ba5bcd873316" xlink:to="loc_srt_ConsolidatedEntitiesDomain_76106f99-5164-4832-9eda-32c7a6aaa15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_b8435e59-ec8c-48f5-b959-a182e56cfa48" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_76106f99-5164-4832-9eda-32c7a6aaa15a" xlink:to="loc_srt_SubsidiariesMember_b8435e59-ec8c-48f5-b959-a182e56cfa48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fd7c9985-9e68-4e69-80a7-a111e7884bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fd7c9985-9e68-4e69-80a7-a111e7884bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d40a8525-f3f9-4ae3-9c6a-fae75e476ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fd7c9985-9e68-4e69-80a7-a111e7884bc0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d40a8525-f3f9-4ae3-9c6a-fae75e476ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_3efe7721-0de8-448f-970f-7e3bdea729bc" xlink:href="cron-20221231.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d40a8525-f3f9-4ae3-9c6a-fae75e476ed7" xlink:to="loc_cron_AltriaInvestmentMember_3efe7721-0de8-448f-970f-7e3bdea729bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_33dacba1-f503-445b-a15b-240623d2fcaa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_dei_LegalEntityAxis_33dacba1-f503-445b-a15b-240623d2fcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_dfc88c93-c9d1-4e10-82c7-86c2a231b952" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_33dacba1-f503-445b-a15b-240623d2fcaa" xlink:to="loc_dei_EntityDomain_dfc88c93-c9d1-4e10-82c7-86c2a231b952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_5a4f4836-2911-423f-89d7-a9277a9b9c76" xlink:href="cron-20221231.xsd#cron_AltriaGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_dfc88c93-c9d1-4e10-82c7-86c2a231b952" xlink:to="loc_cron_AltriaGroupInc.Member_5a4f4836-2911-423f-89d7-a9277a9b9c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e74f24e3-b1c8-483b-a054-e82f1e663bee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e74f24e3-b1c8-483b-a054-e82f1e663bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_786cb8cd-e254-456a-9606-37b0ab5e6105" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e74f24e3-b1c8-483b-a054-e82f1e663bee" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_786cb8cd-e254-456a-9606-37b0ab5e6105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_ec865a6a-bca4-4413-968e-c53d83ef2b7d" xlink:href="cron-20221231.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_786cb8cd-e254-456a-9606-37b0ab5e6105" xlink:to="loc_cron_CronosGroupInc.Member_ec865a6a-bca4-4413-968e-c53d83ef2b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f1f7932-d47a-4a14-b0c1-a1efcf2b830b" xlink:to="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_458d58be-993d-4b43-8cb6-1236958fc194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_458d58be-993d-4b43-8cb6-1236958fc194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_a9bb6180-88fd-4426-9e8a-e6106448fc73" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_a9bb6180-88fd-4426-9e8a-e6106448fc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_c65bbd7d-efd5-48c6-8b84-a710c5eb5f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_c65bbd7d-efd5-48c6-8b84-a710c5eb5f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_881ed362-5908-4cc8-953e-9ae808e8185e" xlink:href="cron-20221231.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_881ed362-5908-4cc8-953e-9ae808e8185e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_94d66cd6-f896-473e-9e3c-a7a8645c4278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_DerivativeLiabilities_94d66cd6-f896-473e-9e3c-a7a8645c4278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_45371c10-049e-4876-b3b2-923ac0ef3399" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_45371c10-049e-4876-b3b2-923ac0ef3399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3621a85d-3bb2-4e70-a678-6249225b8ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3621a85d-3bb2-4e70-a678-6249225b8ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_a704c48e-57cb-4a55-bb3d-a2d98b735d80" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_a704c48e-57cb-4a55-bb3d-a2d98b735d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_4d07cb8f-ed2c-4847-8cbc-dfe77375fb03" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_4d07cb8f-ed2c-4847-8cbc-dfe77375fb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_cc4d821d-a2ac-4688-929b-6999f2fd924f" xlink:href="cron-20221231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_cc4d821d-a2ac-4688-929b-6999f2fd924f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_9d6beadb-767d-4a79-a9fc-d60c5c29428f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_53fc8a60-1647-4c1b-9573-3101083cb989" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_9d6beadb-767d-4a79-a9fc-d60c5c29428f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_32184950-1a9b-49f0-9e91-1c5ccd8f8c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fe0d4c81-e5ed-490c-9151-05663569abf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_32184950-1a9b-49f0-9e91-1c5ccd8f8c84" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fe0d4c81-e5ed-490c-9151-05663569abf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_43f6c705-3faf-43de-8861-d1c865d27401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fe0d4c81-e5ed-490c-9151-05663569abf3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_43f6c705-3faf-43de-8861-d1c865d27401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_43f6c705-3faf-43de-8861-d1c865d27401" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_8e6665a9-697c-4f84-9ea2-e96da1b318cb" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:to="loc_cron_AltriaWarrantMember_8e6665a9-697c-4f84-9ea2-e96da1b318cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_30d2b302-c2b6-44c2-9926-653e9e3e8820" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:to="loc_cron_PreemptiveRightsMember_30d2b302-c2b6-44c2-9926-653e9e3e8820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_172af34b-7eb9-4739-880a-8cb2188d1774" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4bb881bb-0e28-4688-901c-c6959e09449c" xlink:to="loc_cron_TopupRightsMember_172af34b-7eb9-4739-880a-8cb2188d1774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e542795a-b34e-45b6-9d0e-25a21fa1532e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fe0d4c81-e5ed-490c-9151-05663569abf3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e542795a-b34e-45b6-9d0e-25a21fa1532e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:href="cron-20221231.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e542795a-b34e-45b6-9d0e-25a21fa1532e" xlink:to="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_18656d20-584f-426c-a541-1210e04416a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_18656d20-584f-426c-a541-1210e04416a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_c73cdcdd-472f-40c2-9dc2-60fff691167d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_c73cdcdd-472f-40c2-9dc2-60fff691167d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_4cf6e529-6a2c-44ce-9580-d1fcbb4836e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_4cf6e529-6a2c-44ce-9580-d1fcbb4836e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_6bbf0220-c35b-4046-b790-3ee77cb53973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_6fd92609-1cf0-4c95-90db-c84745c59f26" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_6bbf0220-c35b-4046-b790-3ee77cb53973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d2c60763-c3fe-48b2-bbd9-3659e888a624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d2c60763-c3fe-48b2-bbd9-3659e888a624" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_80dba73c-fb72-45a4-9fd2-3f901067c787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_80dba73c-fb72-45a4-9fd2-3f901067c787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_80dba73c-fb72-45a4-9fd2-3f901067c787" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_fe77556e-9f91-456b-ab22-a54d42f0b1ca" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:to="loc_cron_AltriaWarrantMember_fe77556e-9f91-456b-ab22-a54d42f0b1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_e926e253-2584-4ef8-ad4b-0791b0ca7f4b" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:to="loc_cron_PreemptiveRightsMember_e926e253-2584-4ef8-ad4b-0791b0ca7f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_453288fe-9e2a-4e72-96d1-6f23d81a79db" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:to="loc_cron_TopupRightsMember_453288fe-9e2a-4e72-96d1-6f23d81a79db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember_3d6a0a1f-59f8-4014-82f5-5f19a3b5ce67" xlink:href="cron-20221231.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cd315fd-d3ae-45d9-8de0-44f2714ac6e8" xlink:to="loc_cron_PreEmptiveRightsAndTopUpRightsMember_3d6a0a1f-59f8-4014-82f5-5f19a3b5ce67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b2a2391-088e-421f-9655-447cc7a524ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:to="loc_srt_RangeAxis_6b2a2391-088e-421f-9655-447cc7a524ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6b2a2391-088e-421f-9655-447cc7a524ba" xlink:to="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_441f04a3-9cd8-4e50-a83e-b75b555bf654" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:to="loc_srt_WeightedAverageMember_441f04a3-9cd8-4e50-a83e-b75b555bf654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e15f1abe-a21a-4c4f-b14d-9c18aad7d904" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:to="loc_srt_MinimumMember_e15f1abe-a21a-4c4f-b14d-9c18aad7d904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ddee98cc-292b-47f6-a668-3ab4f9c37270" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d41c41b4-4930-42a0-8de6-c210a0a4beba" xlink:to="loc_srt_MaximumMember_ddee98cc-292b-47f6-a668-3ab4f9c37270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1cafa268-4fec-48f2-876f-b06e4d903a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1cafa268-4fec-48f2-876f-b06e4d903a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1cafa268-4fec-48f2-876f-b06e4d903a0c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_577faf72-996f-4af6-b6b2-4d50cfe9c317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_577faf72-996f-4af6-b6b2-4d50cfe9c317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember_995abcd2-4035-4e70-8298-03e260f66c84" xlink:href="cron-20221231.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_cron_MeasurementInputSubscriptionPriceMember_995abcd2-4035-4e70-8298-03e260f66c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_296d284b-c2e7-4ea3-9447-2f7651b27521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_296d284b-c2e7-4ea3-9447-2f7651b27521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_6c287eb1-ad6c-42c2-89cd-42423b453046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_6c287eb1-ad6c-42c2-89cd-42423b453046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_79fd6a26-46f7-483c-984e-f0d281623a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_79fd6a26-46f7-483c-984e-f0d281623a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_a966821f-b93a-45bd-8e3d-ddc58c1a0a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e48bbf84-b9ff-402e-bd09-f3505b4b3dad" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_a966821f-b93a-45bd-8e3d-ddc58c1a0a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f9d1f7bf-291e-4f70-86ee-d4842811c2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e54f341e-400e-48a2-85cc-b613495e7fc5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f9d1f7bf-291e-4f70-86ee-d4842811c2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_e7c30314-e2c5-448b-ade8-138bcd3148d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f9d1f7bf-291e-4f70-86ee-d4842811c2c2" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_e7c30314-e2c5-448b-ade8-138bcd3148d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm_be8072e5-3a1d-430f-9a17-f9fcad19823b" xlink:href="cron-20221231.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f9d1f7bf-291e-4f70-86ee-d4842811c2c2" xlink:to="loc_cron_DerivativeLiabilityUsefulLifeTerm_be8072e5-3a1d-430f-9a17-f9fcad19823b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a394fb4-a034-4fac-9d5e-3487b214e648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_de047775-0dd5-4271-a8a0-bf79f7d26c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a394fb4-a034-4fac-9d5e-3487b214e648" xlink:to="loc_us-gaap_DerivativeTable_de047775-0dd5-4271-a8a0-bf79f7d26c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_d22602bb-752f-449f-be6f-eff16ef29415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_de047775-0dd5-4271-a8a0-bf79f7d26c49" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_d22602bb-752f-449f-be6f-eff16ef29415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_d22602bb-752f-449f-be6f-eff16ef29415" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_f5ace78c-99b8-4451-be41-37bb21bffc13" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:to="loc_cron_AltriaWarrantMember_f5ace78c-99b8-4451-be41-37bb21bffc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_0c57c56f-ed7f-497e-ad32-31c9eff650c5" xlink:href="cron-20221231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:to="loc_cron_PreemptiveRightsMember_0c57c56f-ed7f-497e-ad32-31c9eff650c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_27e5e035-5c7a-4491-9066-83cbdf96212b" xlink:href="cron-20221231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_54b07931-3eac-44ec-b214-f16fe9291915" xlink:to="loc_cron_TopupRightsMember_27e5e035-5c7a-4491-9066-83cbdf96212b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_312c9484-6a97-485f-bcca-53dc91371edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_de047775-0dd5-4271-a8a0-bf79f7d26c49" xlink:to="loc_us-gaap_DerivativeLineItems_312c9484-6a97-485f-bcca-53dc91371edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_312c9484-6a97-485f-bcca-53dc91371edf" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_8d4ae840-3b6d-42a4-b8c7-fa03aa0f3276" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_8d4ae840-3b6d-42a4-b8c7-fa03aa0f3276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_b4944ae4-3aad-4bd4-91f8-c7cfd488cde5" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_b4944ae4-3aad-4bd4-91f8-c7cfd488cde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_e824598a-656f-4551-8887-91f601292799" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_cab4c095-379d-42c6-a56a-d4578a5b2e60" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_e824598a-656f-4551-8887-91f601292799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#CommitmentsandContingenciesRDCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5ddcb5fd-b5a2-49ac-b760-51fedaa8f9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5ddcb5fd-b5a2-49ac-b760-51fedaa8f9da" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1c4a98dc-3743-4ded-a2ce-396c832d61d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:to="loc_srt_CounterpartyNameAxis_1c4a98dc-3743-4ded-a2ce-396c832d61d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1c4a98dc-3743-4ded-a2ce-396c832d61d2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoBioworksInc.Member_d2f0c9d6-663e-4d3d-82f6-37bf5d92a030" xlink:href="cron-20221231.xsd#cron_GinkgoBioworksInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:to="loc_cron_GinkgoBioworksInc.Member_d2f0c9d6-663e-4d3d-82f6-37bf5d92a030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TechnionResearchAndDevelopmentFoundationMember_d73689b6-d2ff-4188-bd09-2a2c2fe0a273" xlink:href="cron-20221231.xsd#cron_TechnionResearchAndDevelopmentFoundationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:to="loc_cron_TechnionResearchAndDevelopmentFoundationMember_d73689b6-d2ff-4188-bd09-2a2c2fe0a273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaVenturesInc.Member_5524cf1b-0a74-4b20-b625-045684ec9245" xlink:href="cron-20221231.xsd#cron_AltriaVenturesInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e44927b-43b6-4845-b933-dacacc884e39" xlink:to="loc_cron_AltriaVenturesInc.Member_5524cf1b-0a74-4b20-b625-045684ec9245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_c051ea91-a02a-4eec-ad2f-676ccb5602f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_c051ea91-a02a-4eec-ad2f-676ccb5602f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_682d4e88-d6d9-4ac2-8255-7f0d24df2872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_c051ea91-a02a-4eec-ad2f-676ccb5602f8" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_682d4e88-d6d9-4ac2-8255-7f0d24df2872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementMember_ea2994cb-bfc3-4df2-9763-9b6b054ac545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_682d4e88-d6d9-4ac2-8255-7f0d24df2872" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementMember_ea2994cb-bfc3-4df2-9763-9b6b054ac545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesArrangementMember_5bcf760a-15d2-4360-8a80-440474d9c6f5" xlink:href="cron-20221231.xsd#cron_ConsultingServicesArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_682d4e88-d6d9-4ac2-8255-7f0d24df2872" xlink:to="loc_cron_ConsultingServicesArrangementMember_5bcf760a-15d2-4360-8a80-440474d9c6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3c22cbe2-e787-42ae-a456-58b1de213ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3c22cbe2-e787-42ae-a456-58b1de213ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ead6eb5-0422-4cb6-8f8e-80ac22e31ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c22cbe2-e787-42ae-a456-58b1de213ec7" xlink:to="loc_us-gaap_EquityComponentDomain_5ead6eb5-0422-4cb6-8f8e-80ac22e31ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3140a312-e20c-4a27-ac93-237e0b0f70b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5ead6eb5-0422-4cb6-8f8e-80ac22e31ddd" xlink:to="loc_us-gaap_CommonStockMember_3140a312-e20c-4a27-ac93-237e0b0f70b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_7ee0c98c-c9a9-496a-b4a9-f59c1f6d8627" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_57b0f79b-6586-46ea-bd35-b7cb5306f330" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_57b0f79b-6586-46ea-bd35-b7cb5306f330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_7b6cb41d-7d39-4ef7-8eca-f8166743fdcf" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_7b6cb41d-7d39-4ef7-8eca-f8166743fdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_f4ed1a8c-3675-4db9-8753-74d28a0c6de1" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_f4ed1a8c-3675-4db9-8753-74d28a0c6de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_e796f593-706f-4e14-8d20-f56a67164f8d" xlink:href="cron-20221231.xsd#cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones_e796f593-706f-4e14-8d20-f56a67164f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_6bf4513a-f224-4beb-a93e-cab154c48067" xlink:href="cron-20221231.xsd#cron_LongtermPurchaseCommitmentMonthlyFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_5936cd73-37f3-4c3d-9f7c-c4cd40181a34" xlink:to="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_6bf4513a-f224-4beb-a93e-cab154c48067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#CommitmentsandContingenciesContingenciesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_036ffa72-82dd-4a42-9d43-92f9d38e72f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_036ffa72-82dd-4a42-9d43-92f9d38e72f1" xlink:to="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6a5b4070-5fd9-4fd5-9c94-2163e61020d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:to="loc_srt_LitigationCaseAxis_6a5b4070-5fd9-4fd5-9c94-2163e61020d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bc536d00-0eae-45d3-b5a4-687e4bcb2724" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6a5b4070-5fd9-4fd5-9c94-2163e61020d2" xlink:to="loc_srt_LitigationCaseTypeDomain_bc536d00-0eae-45d3-b5a4-687e4bcb2724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_a7a6f51f-f625-4de9-88b2-acb29d79aa33" xlink:href="cron-20221231.xsd#cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bc536d00-0eae-45d3-b5a4-687e4bcb2724" xlink:to="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_a7a6f51f-f625-4de9-88b2-acb29d79aa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OSCSettlementMember_7423afe4-936e-4d58-b46c-291114d1e99d" xlink:href="cron-20221231.xsd#cron_OSCSettlementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bc536d00-0eae-45d3-b5a4-687e4bcb2724" xlink:to="loc_cron_OSCSettlementMember_7423afe4-936e-4d58-b46c-291114d1e99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_7bd0a744-95ae-4878-abd0-bd2f5b0437c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:to="loc_us-gaap_LitigationStatusAxis_7bd0a744-95ae-4878-abd0-bd2f5b0437c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_db4b6fcc-e4e2-449f-a65a-eb913d20f23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_7bd0a744-95ae-4878-abd0-bd2f5b0437c0" xlink:to="loc_us-gaap_LitigationStatusDomain_db4b6fcc-e4e2-449f-a65a-eb913d20f23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_fff87134-0c96-4312-bec2-eed0dd104a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_db4b6fcc-e4e2-449f-a65a-eb913d20f23a" xlink:to="loc_us-gaap_PendingLitigationMember_fff87134-0c96-4312-bec2-eed0dd104a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_afd55030-a91c-4e4f-a7e7-2f3941b7c551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_db4b6fcc-e4e2-449f-a65a-eb913d20f23a" xlink:to="loc_us-gaap_SettledLitigationMember_afd55030-a91c-4e4f-a7e7-2f3941b7c551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_14939f67-b8a0-4a8e-930d-8050f5cb6e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a16aea5a-0f26-4a28-9c81-0c0cd47c58a6" xlink:to="loc_us-gaap_LossContingencyNatureDomain_14939f67-b8a0-4a8e-930d-8050f5cb6e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember_bb6f6d1e-544b-4e8d-a6e2-d43a182bed7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_14939f67-b8a0-4a8e-930d-8050f5cb6e95" xlink:to="loc_us-gaap_UnfavorableRegulatoryActionMember_bb6f6d1e-544b-4e8d-a6e2-d43a182bed7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_24d48184-00a1-4f37-85de-bb502c488fdb" xlink:to="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_38aa3b11-c714-463a-815b-dbe347626e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_38aa3b11-c714-463a-815b-dbe347626e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_830f7f90-4fc6-4a04-83f2-ef7c6a12341e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_830f7f90-4fc6-4a04-83f2-ef7c6a12341e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_fe4a70fa-a1b7-4cb7-80e7-4146232631e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_fe4a70fa-a1b7-4cb7-80e7-4146232631e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_1303da2e-fe0a-44f9-b97b-9dd17a7d4070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_1303da2e-fe0a-44f9-b97b-9dd17a7d4070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue_c503ef5d-2833-4ac1-b16e-a2955165bf15" xlink:href="cron-20221231.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a360ac2-c0a6-4ce0-b9d6-cab37b068a8c" xlink:to="loc_cron_LossContingencyPunitiveDamagesSoughtValue_c503ef5d-2833-4ac1-b16e-a2955165bf15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f9e5b770-67f7-44de-9975-ca0f1d539e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f9e5b770-67f7-44de-9975-ca0f1d539e3c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_714b5557-bbab-4201-8ddf-bb930e9b3335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:to="loc_us-gaap_AwardTypeAxis_714b5557-bbab-4201-8ddf-bb930e9b3335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_714b5557-bbab-4201-8ddf-bb930e9b3335" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b66e8904-f5ae-4ea4-976b-f864c9ce2cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b66e8904-f5ae-4ea4-976b-f864c9ce2cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7798c1ff-b0e3-4345-b82c-00df70970423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7798c1ff-b0e3-4345-b82c-00df70970423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LiabilityClassifiedAwardsMember_7d92af21-8f9f-4cef-b417-8ca5a6a94c40" xlink:href="cron-20221231.xsd#cron_LiabilityClassifiedAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad9a7c9d-258c-4ecc-8b15-39c96c58f0dd" xlink:to="loc_cron_LiabilityClassifiedAwardsMember_7d92af21-8f9f-4cef-b417-8ca5a6a94c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_81f711f3-3ede-4cbd-84b8-fd90176b43f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:to="loc_srt_RestatementAxis_81f711f3-3ede-4cbd-84b8-fd90176b43f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_446b7847-9b5e-4494-9da4-fd8f60e53a89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_81f711f3-3ede-4cbd-84b8-fd90176b43f7" xlink:to="loc_srt_RestatementDomain_446b7847-9b5e-4494-9da4-fd8f60e53a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_46c704b4-452a-4c01-bd0d-cef850be5bea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_446b7847-9b5e-4494-9da4-fd8f60e53a89" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_46c704b4-452a-4c01-bd0d-cef850be5bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_323f44ad-fd66-4b62-a462-a58b7a8ae56d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8268eba9-862f-4fde-b104-5ea0170ac133" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_323f44ad-fd66-4b62-a462-a58b7a8ae56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_09bf8517-9fab-429c-b271-2ea92c66cfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_323f44ad-fd66-4b62-a462-a58b7a8ae56d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_09bf8517-9fab-429c-b271-2ea92c66cfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationStockOptionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37d7c4c2-dd8a-4308-9228-ca83460b1364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37d7c4c2-dd8a-4308-9228-ca83460b1364" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_17a0040c-1532-4b7b-9a9d-0555ea3df122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:to="loc_us-gaap_AwardTypeAxis_17a0040c-1532-4b7b-9a9d-0555ea3df122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8273281e-4348-4f83-8a1a-15a2f4a9e397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_17a0040c-1532-4b7b-9a9d-0555ea3df122" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8273281e-4348-4f83-8a1a-15a2f4a9e397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d2d6ab3f-2134-4bb9-a6a6-4f219cda71cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8273281e-4348-4f83-8a1a-15a2f4a9e397" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d2d6ab3f-2134-4bb9-a6a6-4f219cda71cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a66e6af3-e004-4991-b1ec-c75636df5b37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:to="loc_srt_RangeAxis_a66e6af3-e004-4991-b1ec-c75636df5b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a66e6af3-e004-4991-b1ec-c75636df5b37" xlink:to="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_031682a9-2999-4063-974e-fdc8a1c90422" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:to="loc_srt_MinimumMember_031682a9-2999-4063-974e-fdc8a1c90422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b19cbbbd-2a97-4587-9a5f-291cb3fb793a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:to="loc_srt_MaximumMember_b19cbbbd-2a97-4587-9a5f-291cb3fb793a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_d6feb42d-e56e-44ee-a75c-4db5ba599ca1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ebe6baf9-72ad-4826-9f97-c5965f7a32b5" xlink:to="loc_srt_WeightedAverageMember_d6feb42d-e56e-44ee-a75c-4db5ba599ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7dae0e19-5887-4943-948b-68675c076e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:to="loc_us-gaap_PlanNameAxis_7dae0e19-5887-4943-948b-68675c076e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7dae0e19-5887-4943-948b-68675c076e18" xlink:to="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_1d6df3da-50eb-4fa3-9f98-fb269cdd76a7" xlink:href="cron-20221231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:to="loc_cron_A2015StockOptionPlanMember_1d6df3da-50eb-4fa3-9f98-fb269cdd76a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_e417fb4b-5490-49c1-8912-3ff27819acf0" xlink:href="cron-20221231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:to="loc_cron_A2018StockOptionPlanMember_e417fb4b-5490-49c1-8912-3ff27819acf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_f365279d-5fee-44ee-be94-5497d25a3890" xlink:href="cron-20221231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ea0df803-eb7f-4398-9c13-4a76d52d7eb4" xlink:to="loc_cron_A2020OmnibusPlanMember_f365279d-5fee-44ee-be94-5497d25a3890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa7922c-6375-49a9-bf39-da7e891bba1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_443240c5-3b77-4a75-bc05-04fae233165c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_443240c5-3b77-4a75-bc05-04fae233165c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72d08cdb-de1f-4292-8fc7-7f9c325164ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72d08cdb-de1f-4292-8fc7-7f9c325164ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_9a58249e-3477-4e96-986a-60771c16a066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af9e2f0f-0262-4fc7-842f-48a87d74a02d" xlink:to="loc_us-gaap_SharePrice_9a58249e-3477-4e96-986a-60771c16a066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryoftheChangesinOptionsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1888986-eb95-4bbe-ae9e-8ac5975fb870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b3d21482-86df-475c-8fda-0ab9e1bdb2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1888986-eb95-4bbe-ae9e-8ac5975fb870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b3d21482-86df-475c-8fda-0ab9e1bdb2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_74e9a42b-92f7-4193-8571-9917dfd007de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b3d21482-86df-475c-8fda-0ab9e1bdb2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_74e9a42b-92f7-4193-8571-9917dfd007de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1e2ea55e-c3df-4bd3-aceb-091e8d010ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b3d21482-86df-475c-8fda-0ab9e1bdb2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1e2ea55e-c3df-4bd3-aceb-091e8d010ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6b01d6a4-0b59-4d1b-9955-c859ba17c04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b3d21482-86df-475c-8fda-0ab9e1bdb2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6b01d6a4-0b59-4d1b-9955-c859ba17c04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_424c8347-1c6b-4b17-a987-d1ead91a16de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b3d21482-86df-475c-8fda-0ab9e1bdb2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_424c8347-1c6b-4b17-a987-d1ead91a16de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aa4c3394-121c-46b8-9bc7-9f3d79bddca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b3d21482-86df-475c-8fda-0ab9e1bdb2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aa4c3394-121c-46b8-9bc7-9f3d79bddca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4b838791-e78e-4ca5-9c6b-32e03ec947dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1888986-eb95-4bbe-ae9e-8ac5975fb870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4b838791-e78e-4ca5-9c6b-32e03ec947dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0bc512b8-a375-4873-a203-99826be28d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1888986-eb95-4bbe-ae9e-8ac5975fb870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0bc512b8-a375-4873-a203-99826be28d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0d20c59a-a00d-4d15-abba-7a1d2a8b6989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0bc512b8-a375-4873-a203-99826be28d33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0d20c59a-a00d-4d15-abba-7a1d2a8b6989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_809bfbd8-e564-43dc-9427-bdeae4c07d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0bc512b8-a375-4873-a203-99826be28d33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_809bfbd8-e564-43dc-9427-bdeae4c07d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea6a180f-c558-41ad-a2a2-9685cbaa62c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0bc512b8-a375-4873-a203-99826be28d33" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea6a180f-c558-41ad-a2a2-9685cbaa62c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d00abbcb-f14a-485d-be71-78d5f0466c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0bc512b8-a375-4873-a203-99826be28d33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d00abbcb-f14a-485d-be71-78d5f0466c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2cbc1975-a83c-44ff-9e0f-24d2b1e89519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0bc512b8-a375-4873-a203-99826be28d33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2cbc1975-a83c-44ff-9e0f-24d2b1e89519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4af43707-b47f-4c8d-a980-2c934617d6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1888986-eb95-4bbe-ae9e-8ac5975fb870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4af43707-b47f-4c8d-a980-2c934617d6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4a851458-7a5f-4ca3-a451-7265c3f8d332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1888986-eb95-4bbe-ae9e-8ac5975fb870" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4a851458-7a5f-4ca3-a451-7265c3f8d332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_bdc699e6-1e36-4442-aa0e-f71e6b013a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4a851458-7a5f-4ca3-a451-7265c3f8d332" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_bdc699e6-1e36-4442-aa0e-f71e6b013a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2dd4ce6d-a209-42a7-8d73-3b64961a48d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4a851458-7a5f-4ca3-a451-7265c3f8d332" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2dd4ce6d-a209-42a7-8d73-3b64961a48d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationFairValueofOptionsIssuedDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa09f43b-a199-4a97-a338-8f7d9afb88a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db69423-2719-403a-b5cf-89fdb4de2768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa09f43b-a199-4a97-a338-8f7d9afb88a7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db69423-2719-403a-b5cf-89fdb4de2768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_749f61cf-7adf-4f55-9297-66893a5f2fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db69423-2719-403a-b5cf-89fdb4de2768" xlink:to="loc_us-gaap_AwardTypeAxis_749f61cf-7adf-4f55-9297-66893a5f2fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51d7d738-2b9b-4701-83e0-1f3adc31f66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_749f61cf-7adf-4f55-9297-66893a5f2fdb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51d7d738-2b9b-4701-83e0-1f3adc31f66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5c11c92e-80fa-487f-95c1-c47554cedf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51d7d738-2b9b-4701-83e0-1f3adc31f66f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5c11c92e-80fa-487f-95c1-c47554cedf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db69423-2719-403a-b5cf-89fdb4de2768" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_5ad6374b-265e-484a-b117-b283af2927a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_SharePrice_5ad6374b-265e-484a-b117-b283af2927a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2dd51c0e-844e-44fe-a656-179ca50ddef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2dd51c0e-844e-44fe-a656-179ca50ddef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d6e0e4b3-1e05-43b1-8442-d3dc919d83ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d6e0e4b3-1e05-43b1-8442-d3dc919d83ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_110b2f22-3be2-4991-8a1d-1455eac22cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_110b2f22-3be2-4991-8a1d-1455eac22cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_20393a89-e501-4d7f-96cb-76af52f09fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_20393a89-e501-4d7f-96cb-76af52f09fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12cc5cbf-13bc-4496-bf70-718ec143019b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12cc5cbf-13bc-4496-bf70-718ec143019b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_29dd65ac-447c-4a39-9679-eb5d9e1b8243" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_29dd65ac-447c-4a39-9679-eb5d9e1b8243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_a8e3684e-2f19-47a5-b5d7-0e2e22756db1" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb5e80d0-b786-4145-a2ab-0d1f5a64eebd" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_a8e3684e-2f19-47a5-b5d7-0e2e22756db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationScheduleofStockOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c177f3ce-864a-4b18-bf84-402644c3e1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af586114-8171-4a74-9e60-83666e6cf54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c177f3ce-864a-4b18-bf84-402644c3e1ae" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af586114-8171-4a74-9e60-83666e6cf54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3c48adfd-f17f-4867-8c5d-ef12ff9861e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af586114-8171-4a74-9e60-83666e6cf54b" xlink:to="loc_us-gaap_PlanNameAxis_3c48adfd-f17f-4867-8c5d-ef12ff9861e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3c48adfd-f17f-4867-8c5d-ef12ff9861e3" xlink:to="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_cb6a41e4-1db7-4938-8305-50d8fa638f49" xlink:href="cron-20221231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:to="loc_cron_A2020OmnibusPlanMember_cb6a41e4-1db7-4938-8305-50d8fa638f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_6e233d98-1621-4c2b-8998-3f5e11432b46" xlink:href="cron-20221231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:to="loc_cron_A2018StockOptionPlanMember_6e233d98-1621-4c2b-8998-3f5e11432b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_afab235a-139b-479d-b26d-d056841325e6" xlink:href="cron-20221231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_683b4824-1061-4e06-909d-5d78e7b1b9d5" xlink:to="loc_cron_A2015StockOptionPlanMember_afab235a-139b-479d-b26d-d056841325e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a130d-d7b0-43d1-aeb5-1b7d40e53797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af586114-8171-4a74-9e60-83666e6cf54b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a130d-d7b0-43d1-aeb5-1b7d40e53797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a46868b-c006-45ed-966f-0a721d0a3237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a130d-d7b0-43d1-aeb5-1b7d40e53797" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a46868b-c006-45ed-966f-0a721d0a3237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationRestrictedShareUnitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2f7a7d0d-2941-4904-8e72-18d344cb6922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d293bc5d-11f1-494f-83f8-054d43a0ae00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2f7a7d0d-2941-4904-8e72-18d344cb6922" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d293bc5d-11f1-494f-83f8-054d43a0ae00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1c050408-9b97-48f5-b30c-2830935a5b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d293bc5d-11f1-494f-83f8-054d43a0ae00" xlink:to="loc_us-gaap_AwardTypeAxis_1c050408-9b97-48f5-b30c-2830935a5b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425ff1e7-8c2f-41ed-a09b-ed624aa1541a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1c050408-9b97-48f5-b30c-2830935a5b5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425ff1e7-8c2f-41ed-a09b-ed624aa1541a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_07a8e8e6-b004-442c-a021-33b10b51fd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425ff1e7-8c2f-41ed-a09b-ed624aa1541a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_07a8e8e6-b004-442c-a021-33b10b51fd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_802c9774-0eae-4ca1-90be-cd1bcf01f28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d293bc5d-11f1-494f-83f8-054d43a0ae00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_802c9774-0eae-4ca1-90be-cd1bcf01f28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c7494ab0-ed15-4676-b413-fcb8a3f34edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_802c9774-0eae-4ca1-90be-cd1bcf01f28f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c7494ab0-ed15-4676-b413-fcb8a3f34edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c26f2b1-a9ed-4e18-9a59-66e8b481cbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c26f2b1-a9ed-4e18-9a59-66e8b481cbb5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_becdc2eb-b865-4d48-a0d8-7f74c9241145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:to="loc_us-gaap_AwardTypeAxis_becdc2eb-b865-4d48-a0d8-7f74c9241145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d6958fd-d272-4b0c-9d9f-010aa88a9bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_becdc2eb-b865-4d48-a0d8-7f74c9241145" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d6958fd-d272-4b0c-9d9f-010aa88a9bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4d28dccb-e8f8-49e3-a957-74237fb482da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d6958fd-d272-4b0c-9d9f-010aa88a9bb6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4d28dccb-e8f8-49e3-a957-74237fb482da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_56a0f352-63f9-4f1e-b259-e1b64f784e1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:to="loc_srt_RangeAxis_56a0f352-63f9-4f1e-b259-e1b64f784e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_31d78995-ff71-4c30-8bf0-faa86dee5d53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_56a0f352-63f9-4f1e-b259-e1b64f784e1e" xlink:to="loc_srt_RangeMember_31d78995-ff71-4c30-8bf0-faa86dee5d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a2e069b1-9e80-4c81-9204-7985284f7961" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_31d78995-ff71-4c30-8bf0-faa86dee5d53" xlink:to="loc_srt_MinimumMember_a2e069b1-9e80-4c81-9204-7985284f7961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3b818a8a-13a2-457d-8034-1078362cb0e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_31d78995-ff71-4c30-8bf0-faa86dee5d53" xlink:to="loc_srt_MaximumMember_3b818a8a-13a2-457d-8034-1078362cb0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_035a347a-acb4-4c19-8e24-c5fab469d679" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:href="cron-20221231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3e2c6e2d-1016-4d53-a072-2a3f9bb4b0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3e2c6e2d-1016-4d53-a072-2a3f9bb4b0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6b6a2f67-e5ac-448d-a253-68c3d7311f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6b6a2f67-e5ac-448d-a253-68c3d7311f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1a1b052a-4318-4636-94f0-4cca7d0fa42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1a1b052a-4318-4636-94f0-4cca7d0fa42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_515a803d-0792-4f1c-93d9-cb948f443537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_515a803d-0792-4f1c-93d9-cb948f443537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0c45e235-b835-4711-8c01-340f9c2a36f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_b802ce26-a955-4294-8434-dcf94c06b66b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0c45e235-b835-4711-8c01-340f9c2a36f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_09d0d7b6-83ac-454e-a9cd-c821cfb11090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_09d0d7b6-83ac-454e-a9cd-c821cfb11090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_33df6065-62da-4f7a-86d0-6c8afb501585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_33df6065-62da-4f7a-86d0-6c8afb501585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_01e1f2c8-48aa-4fda-86a7-953c0b4e27f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_01e1f2c8-48aa-4fda-86a7-953c0b4e27f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_531efa92-52f4-463e-9158-e193b38d5941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_531efa92-52f4-463e-9158-e193b38d5941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f1948f38-46df-4e51-a453-0c7d942965b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fcd43413-eddb-42f8-84d3-5aeda54d0c73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f1948f38-46df-4e51-a453-0c7d942965b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_73118010-c55f-41db-9733-0fbea3a27020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_73118010-c55f-41db-9733-0fbea3a27020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod_3b9f1c53-69f3-4544-b481-0a87b8eff120" xlink:href="cron-20221231.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aa114ed7-9890-4f2c-8499-170b196ff8c2" xlink:to="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod_3b9f1c53-69f3-4544-b481-0a87b8eff120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b52c2683-e2a7-426e-8788-4f078ba2baaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31a83f3-788c-4340-adbd-70c145317983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b52c2683-e2a7-426e-8788-4f078ba2baaf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31a83f3-788c-4340-adbd-70c145317983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_856e2dab-d17e-4063-baac-cdfbeddce1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31a83f3-788c-4340-adbd-70c145317983" xlink:to="loc_us-gaap_AwardTypeAxis_856e2dab-d17e-4063-baac-cdfbeddce1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c382e2e-cd32-4116-83d7-c8b7325b08ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_856e2dab-d17e-4063-baac-cdfbeddce1d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c382e2e-cd32-4116-83d7-c8b7325b08ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember_628fc830-eca6-44f6-b4ce-6e5e0ec0daed" xlink:href="cron-20221231.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c382e2e-cd32-4116-83d7-c8b7325b08ab" xlink:to="loc_cron_DeferredShareUnitsDSUsMember_628fc830-eca6-44f6-b4ce-6e5e0ec0daed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e348bd0c-8df5-442f-885f-4524a2bd0943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31a83f3-788c-4340-adbd-70c145317983" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e348bd0c-8df5-442f-885f-4524a2bd0943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:href="cron-20221231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e348bd0c-8df5-442f-885f-4524a2bd0943" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_48676a71-2d25-442f-84b6-e5029d061a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_48676a71-2d25-442f-84b6-e5029d061a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_34e7b32b-9f1a-4601-9527-51a2c666c3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_34e7b32b-9f1a-4601-9527-51a2c666c3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_4758079d-c2d3-4321-910e-e83716cc777e" xlink:href="cron-20221231.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_4758079d-c2d3-4321-910e-e83716cc777e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_f6d4fe9c-69d9-4e1c-b3b9-9958f4705b97" xlink:href="cron-20221231.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_f6d4fe9c-69d9-4e1c-b3b9-9958f4705b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_dfa45492-4d75-4e6d-bd7c-623c3f3f1124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d7d5544f-fdc0-47dd-8277-83fcbffa1c43" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_dfa45492-4d75-4e6d-bd7c-623c3f3f1124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e348bd0c-8df5-442f-885f-4524a2bd0943" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_02511ab7-c7fc-4b12-b3c5-b27d1e777568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_02511ab7-c7fc-4b12-b3c5-b27d1e777568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_983dc193-25ca-4e6f-8f61-fefc40a803b0" xlink:href="cron-20221231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_983dc193-25ca-4e6f-8f61-fefc40a803b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_494b1ba8-a2cb-48dd-95c3-6a752e382a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_494b1ba8-a2cb-48dd-95c3-6a752e382a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cca10d5f-8d0d-482c-8c8a-805a78eb4a80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b7c53347-a01c-4a7b-974e-7200ca4c6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cca10d5f-8d0d-482c-8c8a-805a78eb4a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationSummaryofChangesinWarrantsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3010b142-8670-4e0f-93d7-370c85394d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1b818ae-f0f3-4bdf-a8f1-f8ce4178b648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3010b142-8670-4e0f-93d7-370c85394d8e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1b818ae-f0f3-4bdf-a8f1-f8ce4178b648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d3f73601-86e9-4b3d-9d4d-9709061296f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1b818ae-f0f3-4bdf-a8f1-f8ce4178b648" xlink:to="loc_us-gaap_AwardTypeAxis_d3f73601-86e9-4b3d-9d4d-9709061296f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cbe48e71-7645-40d4-a251-47c9cda2036e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d3f73601-86e9-4b3d-9d4d-9709061296f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cbe48e71-7645-40d4-a251-47c9cda2036e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_72e38f2c-d865-4429-9957-cacd49fe77e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cbe48e71-7645-40d4-a251-47c9cda2036e" xlink:to="loc_us-gaap_WarrantMember_72e38f2c-d865-4429-9957-cacd49fe77e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb81554-ec61-4a3b-be08-6b51dae45885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1b818ae-f0f3-4bdf-a8f1-f8ce4178b648" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb81554-ec61-4a3b-be08-6b51dae45885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb81554-ec61-4a3b-be08-6b51dae45885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cec7fade-5adb-444e-af06-1240c3510905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cec7fade-5adb-444e-af06-1240c3510905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ea32886c-67d1-4da3-9000-57a0e7de7555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ea32886c-67d1-4da3-9000-57a0e7de7555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2bfc3de-c0d7-4ff1-888c-fb4a4d1189e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e3252df-4026-4df0-8ce9-8dfe03a4c8ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2bfc3de-c0d7-4ff1-888c-fb4a4d1189e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb81554-ec61-4a3b-be08-6b51dae45885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_66b4de84-bb4a-4e54-a17c-7252c7196aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_66b4de84-bb4a-4e54-a17c-7252c7196aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_96010850-21b8-49db-8adf-39b7432fc266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_96010850-21b8-49db-8adf-39b7432fc266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c9b14261-ea92-42d0-ab0d-f2216ba347d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5da66c16-96aa-4ce1-a2c2-931e141aeb7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c9b14261-ea92-42d0-ab0d-f2216ba347d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SharebasedCompensationLiabilityClassifiedAwardsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e06cd40-a162-4118-926e-2990d2ec5610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_f07bd616-6657-45ee-97be-7b48bd82aebe" xlink:href="cron-20221231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e06cd40-a162-4118-926e-2990d2ec5610" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_f07bd616-6657-45ee-97be-7b48bd82aebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb70fc-d2a8-464d-8fa8-4da562f9252a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e06cd40-a162-4118-926e-2990d2ec5610" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb70fc-d2a8-464d-8fa8-4da562f9252a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb70fc-d2a8-464d-8fa8-4da562f9252a" xlink:to="loc_us-gaap_AwardTypeAxis_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b0ebc8f5-adb6-41e0-b5c9-5d5d6457154a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e80bc745-0bd9-4651-9b89-e1f60f5a5cbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b0ebc8f5-adb6-41e0-b5c9-5d5d6457154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LiabilityClassifiedAwardsMember_fae9d78d-3bdd-4f9d-8a55-2e6503f0eb66" xlink:href="cron-20221231.xsd#cron_LiabilityClassifiedAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b0ebc8f5-adb6-41e0-b5c9-5d5d6457154a" xlink:to="loc_cron_LiabilityClassifiedAwardsMember_fae9d78d-3bdd-4f9d-8a55-2e6503f0eb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45093f20-eb53-47ef-80fe-bf3341d3c6e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb70fc-d2a8-464d-8fa8-4da562f9252a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45093f20-eb53-47ef-80fe-bf3341d3c6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:href="cron-20221231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45093f20-eb53-47ef-80fe-bf3341d3c6e8" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_5be8ef26-bacd-44c3-af76-e708d158d728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_5be8ef26-bacd-44c3-af76-e708d158d728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e6c91c24-b727-4614-8ce5-0e85cf586479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e6c91c24-b727-4614-8ce5-0e85cf586479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards_5a1cdeb1-67c4-4534-b9c6-ee50227838cc" xlink:href="cron-20221231.xsd#cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:to="loc_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards_5a1cdeb1-67c4-4534-b9c6-ee50227838cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_47039ddf-b24c-4fac-b2f7-1223d6a9f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6b0bdd9c-e418-4961-8b24-5f6c5afee6a3" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_47039ddf-b24c-4fac-b2f7-1223d6a9f88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bd56d257-770d-4d49-b459-3517a6979c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_20676396-6e9c-4582-af09-d0b8394b5000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bd56d257-770d-4d49-b459-3517a6979c02" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_20676396-6e9c-4582-af09-d0b8394b5000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3eeb0c85-3461-4fd4-a119-6db60abe9a85" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_20676396-6e9c-4582-af09-d0b8394b5000" xlink:to="loc_srt_StatementGeographicalAxis_3eeb0c85-3461-4fd4-a119-6db60abe9a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7531b7ab-ee4f-4a2d-9982-ec9cc9352d25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3eeb0c85-3461-4fd4-a119-6db60abe9a85" xlink:to="loc_srt_SegmentGeographicalDomain_7531b7ab-ee4f-4a2d-9982-ec9cc9352d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_dddecdd7-e916-4fa0-9c8c-b3fa870bad53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7531b7ab-ee4f-4a2d-9982-ec9cc9352d25" xlink:to="loc_us-gaap_NonUsMember_dddecdd7-e916-4fa0-9c8c-b3fa870bad53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_32ceeb52-1069-42e2-9bf3-5c07b0ac2f7e" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7531b7ab-ee4f-4a2d-9982-ec9cc9352d25" xlink:to="loc_country_US_32ceeb52-1069-42e2-9bf3-5c07b0ac2f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_5141e5fb-e58b-46a0-b0ca-a90599d8aa40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_20676396-6e9c-4582-af09-d0b8394b5000" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_5141e5fb-e58b-46a0-b0ca-a90599d8aa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1f931cfc-f08d-41db-9e02-194c992e4154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_5141e5fb-e58b-46a0-b0ca-a90599d8aa40" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1f931cfc-f08d-41db-9e02-194c992e4154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_98012039-2bb3-4a22-84d1-9219f747608e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98012039-2bb3-4a22-84d1-9219f747608e" xlink:to="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0d1aaa53-f8b3-4b9e-9a39-744059798b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0d1aaa53-f8b3-4b9e-9a39-744059798b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_d5edb133-aab6-40c7-aa85-c514d637ec02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d1aaa53-f8b3-4b9e-9a39-744059798b25" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_d5edb133-aab6-40c7-aa85-c514d637ec02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_66eddb40-3fba-4009-9e37-cc797cd8ea89" xlink:href="cron-20221231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d5edb133-aab6-40c7-aa85-c514d637ec02" xlink:to="loc_cron_AltriaWarrantMember_66eddb40-3fba-4009-9e37-cc797cd8ea89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_19ac23db-8187-4a96-b180-05a0f99221fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_19ac23db-8187-4a96-b180-05a0f99221fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_b16bdacd-d229-4af6-8169-a485b2c67e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_19ac23db-8187-4a96-b180-05a0f99221fa" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_b16bdacd-d229-4af6-8169-a485b2c67e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_5f0dad55-021d-423f-a0cf-99117f7aa5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_b16bdacd-d229-4af6-8169-a485b2c67e24" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_5f0dad55-021d-423f-a0cf-99117f7aa5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_98884499-be0a-4244-b1b6-b8e21ffdcd77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_98884499-be0a-4244-b1b6-b8e21ffdcd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_98884499-be0a-4244-b1b6-b8e21ffdcd77" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CanadaRevenueAgencyMember_52afcdf6-13ff-4360-8b6d-f44b130cde63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CanadaRevenueAgencyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:to="loc_us-gaap_CanadaRevenueAgencyMember_52afcdf6-13ff-4360-8b6d-f44b130cde63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_337575df-0b90-4004-b460-c186b9b55152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_337575df-0b90-4004-b460-c186b9b55152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_abef2572-7055-4dfe-9361-35bab861cf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_84be43f7-2ea3-496a-9a75-208492c14828" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_abef2572-7055-4dfe-9361-35bab861cf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_6e3e89eb-ba52-4e3d-96ef-9f79a93188c9" xlink:to="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_a6bb7a68-a620-4f28-9768-5e0d1b10ef3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_a6bb7a68-a620-4f28-9768-5e0d1b10ef3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_6c9a9d73-d471-419e-93b9-213df97f8f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_TaxesPayableCurrent_6c9a9d73-d471-419e-93b9-213df97f8f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_bcc7f881-0a1a-46da-8484-0a20c87c19f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_IncomeTaxesReceivable_bcc7f881-0a1a-46da-8484-0a20c87c19f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CapitalGainRelinquishmentOfWarrant_636dda6f-9ff6-456d-b8ce-d7f062fc42d1" xlink:href="cron-20221231.xsd#cron_CapitalGainRelinquishmentOfWarrant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_cron_CapitalGainRelinquishmentOfWarrant_636dda6f-9ff6-456d-b8ce-d7f062fc42d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_3fd3638a-69fa-48dd-8e56-afe19d7ffd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_3fd3638a-69fa-48dd-8e56-afe19d7ffd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b3b743ab-819a-43d4-b1bb-5e0a99b2bc70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b3b743ab-819a-43d4-b1bb-5e0a99b2bc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4c44b9b4-95d6-43f4-a9e2-a75171757138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4c44b9b4-95d6-43f4-a9e2-a75171757138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_c9109b28-13b0-4a63-a9c6-f902325f2ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_cb42f2a8-e616-411b-9bd7-01c9d0ed5d33" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_c9109b28-13b0-4a63-a9c6-f902325f2ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesExpenseforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a590db8f-ba82-4eef-ad7b-09a514473341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_f5bdc7db-1c4a-4789-a584-1beaaef4cbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a590db8f-ba82-4eef-ad7b-09a514473341" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_f5bdc7db-1c4a-4789-a584-1beaaef4cbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ab07b26d-d7af-4b3b-8897-59dcb4b4963d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_f5bdc7db-1c4a-4789-a584-1beaaef4cbdf" xlink:to="loc_srt_StatementGeographicalAxis_ab07b26d-d7af-4b3b-8897-59dcb4b4963d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_13410ec1-d189-4763-96e1-e7bd9f79debe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ab07b26d-d7af-4b3b-8897-59dcb4b4963d" xlink:to="loc_srt_SegmentGeographicalDomain_13410ec1-d189-4763-96e1-e7bd9f79debe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_02aab4f3-16fe-451e-aeb2-e046d3b37792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_13410ec1-d189-4763-96e1-e7bd9f79debe" xlink:to="loc_us-gaap_NonUsMember_02aab4f3-16fe-451e-aeb2-e046d3b37792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0945bae9-a05f-49ea-97ba-4d79f11f95e4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_13410ec1-d189-4763-96e1-e7bd9f79debe" xlink:to="loc_country_US_0945bae9-a05f-49ea-97ba-4d79f11f95e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_cee25370-3991-4a37-9f88-223d2bf020f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_f5bdc7db-1c4a-4789-a584-1beaaef4cbdf" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_cee25370-3991-4a37-9f88-223d2bf020f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_375b6ba4-7475-43ab-a60f-3f5cc6767324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cee25370-3991-4a37-9f88-223d2bf020f7" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_375b6ba4-7475-43ab-a60f-3f5cc6767324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4304cf33-7ff3-410c-88c7-6f28a8d6c9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_375b6ba4-7475-43ab-a60f-3f5cc6767324" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4304cf33-7ff3-410c-88c7-6f28a8d6c9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_dac1d243-f260-40b8-89a0-89e331fbf2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cee25370-3991-4a37-9f88-223d2bf020f7" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_dac1d243-f260-40b8-89a0-89e331fbf2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ae7ec6a-0e59-4860-88a1-d5028756b02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_dac1d243-f260-40b8-89a0-89e331fbf2c6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ae7ec6a-0e59-4860-88a1-d5028756b02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_22a2097f-0e2c-407b-8965-ab66f81d64b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_22a2097f-0e2c-407b-8965-ab66f81d64b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7da6ce6a-d4b9-4d1e-b6cb-7263b81cb55e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7da6ce6a-d4b9-4d1e-b6cb-7263b81cb55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_05dd2851-cc40-4645-9b1b-25d87351d2fd" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_05dd2851-cc40-4645-9b1b-25d87351d2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_bb0787e0-3653-4824-aa26-650c036e7999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_bb0787e0-3653-4824-aa26-650c036e7999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_904bc0a3-5c6a-4c51-9503-daff3d58365b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_904bc0a3-5c6a-4c51-9503-daff3d58365b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_6abb3f8a-65a4-4f90-ae95-728ce456b04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_6abb3f8a-65a4-4f90-ae95-728ce456b04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount_90c5efb3-d90e-44f9-a1d5-50b1352cc4ad" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount_90c5efb3-d90e-44f9-a1d5-50b1352cc4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_8bc4e61d-ae53-4785-96e1-7a49e73a655f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_8bc4e61d-ae53-4785-96e1-7a49e73a655f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_d7f537d5-2da8-45d4-9701-7bb0c37b12b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_d7f537d5-2da8-45d4-9701-7bb0c37b12b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_af84a7fb-eef5-4bf0-9ee6-6b0a0878b5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_af84a7fb-eef5-4bf0-9ee6-6b0a0878b5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount_6248e585-e9d5-4315-9695-90665fe452e7" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount_6248e585-e9d5-4315-9695-90665fe452e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f97544d0-f721-414b-8fc7-01c490081ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f97544d0-f721-414b-8fc7-01c490081ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount_f4622cde-8b74-4c27-87f7-330a0e758d56" xlink:href="cron-20221231.xsd#cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount_f4622cde-8b74-4c27-87f7-330a0e758d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_538ca47f-8c47-4adf-a442-ed7c8d128e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_538ca47f-8c47-4adf-a442-ed7c8d128e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a02e3739-5659-4f05-8c39-bf503a82b915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17f00ef-8da1-4a3c-ad37-c6606a417a46" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a02e3739-5659-4f05-8c39-bf503a82b915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d994e265-009c-4c9f-a026-5349b88ced90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d994e265-009c-4c9f-a026-5349b88ced90" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d424b965-b4cd-4274-9497-c9d27f2304a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d424b965-b4cd-4274-9497-c9d27f2304a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_70f305d5-f9e3-46ff-b397-385135282f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_70f305d5-f9e3-46ff-b397-385135282f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsDebtIssuanceCosts_bb90a27a-30b0-47b0-a9b3-2c2d242e63a3" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_cron_DeferredTaxAssetsDebtIssuanceCosts_bb90a27a-30b0-47b0-a9b3-2c2d242e63a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsShareIssuanceCost_1a3b190f-2aba-4c6f-a626-4ee977f08143" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsShareIssuanceCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_cron_DeferredTaxAssetsShareIssuanceCost_1a3b190f-2aba-4c6f-a626-4ee977f08143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities_90ae047f-b4e2-41c3-86a2-112402d3c348" xlink:href="cron-20221231.xsd#cron_DeferredTaxAssetsFinanceLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities_90ae047f-b4e2-41c3-86a2-112402d3c348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_365db085-a908-4da7-98a6-339f726bea27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_365db085-a908-4da7-98a6-339f726bea27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_ff13cfc2-8b3f-424f-a760-6af73dbcaec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_ff13cfc2-8b3f-424f-a760-6af73dbcaec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_5599989d-fe1d-4227-a32d-810bbebc75cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_5599989d-fe1d-4227-a32d-810bbebc75cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_8206f6b9-c2d8-41ac-ac34-5d7f69e017b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_8206f6b9-c2d8-41ac-ac34-5d7f69e017b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_42e2786b-3f00-4715-a68c-50292bf6fb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_42e2786b-3f00-4715-a68c-50292bf6fb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_a1312916-3c44-482d-bdc7-b6f4ca77e4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_a1312916-3c44-482d-bdc7-b6f4ca77e4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_1e59a971-8a08-497e-aac5-aeee920a4fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_1e59a971-8a08-497e-aac5-aeee920a4fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d4e6aaec-617b-4c0c-8249-ae8720721f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d4e6aaec-617b-4c0c-8249-ae8720721f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_67072525-7ce4-435b-874e-9ac8db9ce67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_67072525-7ce4-435b-874e-9ac8db9ce67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_6ad64329-80b1-4391-8cf6-9db0fd8ed153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_fad47e0f-da1b-4333-a7fa-458cd7973d25" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_6ad64329-80b1-4391-8cf6-9db0fd8ed153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_42a361d5-6226-432b-8e94-b48b53caa162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d994e265-009c-4c9f-a026-5349b88ced90" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_42a361d5-6226-432b-8e94-b48b53caa162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_2020f953-d3c3-4942-adc4-8c07900e65c7" xlink:href="cron-20221231.xsd#cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_42a361d5-6226-432b-8e94-b48b53caa162" xlink:to="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_2020f953-d3c3-4942-adc4-8c07900e65c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_494dedf0-cae2-468e-8e4a-fdceaa0cffc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_42a361d5-6226-432b-8e94-b48b53caa162" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_494dedf0-cae2-468e-8e4a-fdceaa0cffc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e464f5c6-7b2c-41e2-9ef6-d4a4f64eda0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_42a361d5-6226-432b-8e94-b48b53caa162" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e464f5c6-7b2c-41e2-9ef6-d4a4f64eda0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d1e54cc0-0ed8-4f78-88d9-bd774390a1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d994e265-009c-4c9f-a026-5349b88ced90" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d1e54cc0-0ed8-4f78-88d9-bd774390a1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_db11e83f-e920-48c3-907f-6d3130313416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d994e265-009c-4c9f-a026-5349b88ced90" xlink:to="loc_us-gaap_DeferredTaxLiabilities_db11e83f-e920-48c3-907f-6d3130313416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ea4436fe-2a48-44fd-a220-7a047517a36b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_c55a574c-7f68-4639-aa89-82cbef0f7c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ea4436fe-2a48-44fd-a220-7a047517a36b" xlink:to="loc_us-gaap_NumberOfReportableSegments_c55a574c-7f68-4639-aa89-82cbef0f7c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_da3ae342-f0e1-4d6c-9f30-6acefe9af963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_da3ae342-f0e1-4d6c-9f30-6acefe9af963" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2928f543-0a97-4807-b001-1e5ba08deb86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:to="loc_srt_ProductOrServiceAxis_2928f543-0a97-4807-b001-1e5ba08deb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2928f543-0a97-4807-b001-1e5ba08deb86" xlink:to="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember_6097f6dd-ef18-48c3-a44e-bed08337d5e6" xlink:href="cron-20221231.xsd#cron_CannabisFlowerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:to="loc_cron_CannabisFlowerMember_6097f6dd-ef18-48c3-a44e-bed08337d5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember_c9bfceca-c646-40e7-af52-f5774f6e2772" xlink:href="cron-20221231.xsd#cron_CannabisExtractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:to="loc_cron_CannabisExtractsMember_c9bfceca-c646-40e7-af52-f5774f6e2772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_a75092ce-959b-4d9e-a95c-5f7b8ba04721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_420f5c83-7930-44cf-8b09-38bc1037769c" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_a75092ce-959b-4d9e-a95c-5f7b8ba04721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_917981c4-daba-440e-9810-9eecb94256b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:to="loc_srt_ConsolidationItemsAxis_917981c4-daba-440e-9810-9eecb94256b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a445af58-a1d6-46a2-b893-2fd493e53b91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_917981c4-daba-440e-9810-9eecb94256b9" xlink:to="loc_srt_ConsolidationItemsDomain_a445af58-a1d6-46a2-b893-2fd493e53b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_07b499b4-81b2-4195-a72a-3cf2654d9842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a445af58-a1d6-46a2-b893-2fd493e53b91" xlink:to="loc_us-gaap_OperatingSegmentsMember_07b499b4-81b2-4195-a72a-3cf2654d9842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_53129561-1fa8-4771-9f75-ee010506ae2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a445af58-a1d6-46a2-b893-2fd493e53b91" xlink:to="loc_us-gaap_CorporateNonSegmentMember_53129561-1fa8-4771-9f75-ee010506ae2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_15837f1a-e8a1-44a5-991f-11564c22166a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f49bf2d5-4e41-49b3-ae55-3f0dbbb99e47" xlink:to="loc_us-gaap_SegmentDomain_15837f1a-e8a1-44a5-991f-11564c22166a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_4b654ba1-ddd4-4264-8293-bcfc766a2029" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_15837f1a-e8a1-44a5-991f-11564c22166a" xlink:to="loc_cron_UnitedStatesSegmentMember_4b654ba1-ddd4-4264-8293-bcfc766a2029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_c16d6e56-3588-4a1a-9a40-d1a1ec4e72ac" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_15837f1a-e8a1-44a5-991f-11564c22166a" xlink:to="loc_cron_RestOfWorldSegmentMember_c16d6e56-3588-4a1a-9a40-d1a1ec4e72ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb89fd46-e51d-4a50-9c2d-04417c7d3153" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90c61147-3226-41b8-bf57-887e63536f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90c61147-3226-41b8-bf57-887e63536f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_78579f6b-45b7-4521-af65-c4b7c36f242b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_78579f6b-45b7-4521-af65-c4b7c36f242b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_81006362-8e77-4e82-b2bb-3252e04bbafd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_81006362-8e77-4e82-b2bb-3252e04bbafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_208082f3-f323-49b5-aef6-984fbc1510e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_InterestExpense_208082f3-f323-49b5-aef6-984fbc1510e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7370cb38-2888-44d4-a6c2-c24f9c38e279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7370cb38-2888-44d4-a6c2-c24f9c38e279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_01a1a838-04aa-4071-b081-fb51739b904a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_Assets_01a1a838-04aa-4071-b081-fb51739b904a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ecf83a8b-3b4e-4e34-9350-1deaaeda124b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_DepreciationAndAmortization_ecf83a8b-3b4e-4e34-9350-1deaaeda124b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_dde605ea-12bc-4a6c-9909-0eb86e895ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_dde605ea-12bc-4a6c-9909-0eb86e895ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_aa3a6849-cec0-419e-8c98-cf40800f43eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_aa3a6849-cec0-419e-8c98-cf40800f43eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_eb3788bb-08c2-4db3-9243-2d69cbb8fdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_eb3788bb-08c2-4db3-9243-2d69cbb8fdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_29ed73b1-2dc2-48c5-ad27-bc0b6593ce00" xlink:href="cron-20221231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_29ed73b1-2dc2-48c5-ad27-bc0b6593ce00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_560e8245-f282-40c2-bd80-3558ce1cc2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ca6c4e09-88ee-4935-9a5b-d538075cb3c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_560e8245-f282-40c2-bd80-3558ce1cc2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e63c67ff-7607-4bbd-9f29-998c767f750a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e63c67ff-7607-4bbd-9f29-998c767f750a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_38d43320-6ec4-459d-8d41-05163f732c78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:to="loc_srt_ConsolidationItemsAxis_38d43320-6ec4-459d-8d41-05163f732c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9cafd477-56d9-4f63-8982-a94e3bea752d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_38d43320-6ec4-459d-8d41-05163f732c78" xlink:to="loc_srt_ConsolidationItemsDomain_9cafd477-56d9-4f63-8982-a94e3bea752d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d47185ec-d7b7-418b-a120-38bb6d16a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9cafd477-56d9-4f63-8982-a94e3bea752d" xlink:to="loc_us-gaap_OperatingSegmentsMember_d47185ec-d7b7-418b-a120-38bb6d16a3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_28861cd4-2338-43d4-af73-3366aee93eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9cafd477-56d9-4f63-8982-a94e3bea752d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_28861cd4-2338-43d4-af73-3366aee93eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_42ab4513-d49e-4637-b27f-facb65f6599e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_42ab4513-d49e-4637-b27f-facb65f6599e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42ab4513-d49e-4637-b27f-facb65f6599e" xlink:to="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_8f2cc184-d751-47a3-a64b-eb319979386b" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:to="loc_cron_UnitedStatesSegmentMember_8f2cc184-d751-47a3-a64b-eb319979386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_d0cb7a2a-7b1f-4365-b29e-a4896c717810" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:to="loc_cron_RestOfWorldSegmentMember_d0cb7a2a-7b1f-4365-b29e-a4896c717810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AustraliaMember_53e2fa9f-2e68-4b1d-a42e-f25493db4df7" xlink:href="cron-20221231.xsd#cron_AustraliaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2c6a71f1-7043-4867-a624-fac8dfae94a4" xlink:to="loc_cron_AustraliaMember_53e2fa9f-2e68-4b1d-a42e-f25493db4df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1dfebac9-6343-4cd1-863e-6368ce2f0a7e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5db818e5-4db1-4784-9c9f-e55ff48a2305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_ProfitLoss_5db818e5-4db1-4784-9c9f-e55ff48a2305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_43ec4852-83d3-4865-9990-3bd6791c3a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_43ec4852-83d3-4865-9990-3bd6791c3a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9dd39805-b59d-4f4c-900f-503c23dbb41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9dd39805-b59d-4f4c-900f-503c23dbb41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a706ff84-1705-4d31-9581-713a86cfe882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a706ff84-1705-4d31-9581-713a86cfe882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization_b8c89579-d239-4b99-8f5e-a829630de331" xlink:href="cron-20221231.xsd#cron_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization_b8c89579-d239-4b99-8f5e-a829630de331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7a4b4102-dd60-4819-b5a8-8c767a4d13e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7a4b4102-dd60-4819-b5a8-8c767a4d13e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b55090df-23de-463a-8e24-89d54ede0fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b55090df-23de-463a-8e24-89d54ede0fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_dc6141f4-79d3-433d-81ed-bdc79c58be78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_dc6141f4-79d3-433d-81ed-bdc79c58be78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_4fad328e-fa4c-4a1f-911e-65628727031b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_4fad328e-fa4c-4a1f-911e-65628727031b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_3d0101ad-a334-4e8e-a77b-51ef99a67a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_3d0101ad-a334-4e8e-a77b-51ef99a67a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_74fdd5e4-9495-428d-ac25-133afcf8d303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_74fdd5e4-9495-428d-ac25-133afcf8d303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_8ca88498-dea9-4242-af63-104c27188ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_AcquisitionCosts_8ca88498-dea9-4242-af63-104c27188ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_567fb42e-4a6c-49e6-80d7-be93991798d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_567fb42e-4a6c-49e6-80d7-be93991798d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8834f032-c702-413e-9eb7-55d28606276a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8834f032-c702-413e-9eb7-55d28606276a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_da95794a-38b2-4212-977f-0ebd8b300b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_da95794a-38b2-4212-977f-0ebd8b300b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_4557fd23-f346-4942-becf-938cf86f2be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_RestructuringCosts_4557fd23-f346-4942-becf-938cf86f2be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2db65a8d-e59f-41fc-8533-d23acdd036ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2db65a8d-e59f-41fc-8533-d23acdd036ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense_73a6626c-f5ff-4f5f-8d3e-08fe6e76cb94" xlink:href="cron-20221231.xsd#cron_RestatementReviewExpense"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_cron_RestatementReviewExpense_73a6626c-f5ff-4f5f-8d3e-08fe6e76cb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5f9a838b-01ae-41f5-8af8-666ec2e3ca83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5f9a838b-01ae-41f5-8af8-666ec2e3ca83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_ea4389c0-0672-4cf3-8f51-6cceae139465" xlink:href="cron-20221231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_ea4389c0-0672-4cf3-8f51-6cceae139465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8ae16ce6-3dab-44c9-abe9-67cac968d663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8ae16ce6-3dab-44c9-abe9-67cac968d663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_e3f785be-b4d8-4516-82e5-92bdbd7e5611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_Dividends_e3f785be-b4d8-4516-82e5-92bdbd7e5611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9fdf2390-3a52-4f3b-99fe-b82df167a45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6b12ac05-1b7c-4149-a6d3-f9e4187a9a17" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9fdf2390-3a52-4f3b-99fe-b82df167a45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_718ca292-0d30-4680-b867-78c6091b3466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7d8c2878-00bc-41cd-94f4-0d51448a78cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_718ca292-0d30-4680-b867-78c6091b3466" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7d8c2878-00bc-41cd-94f4-0d51448a78cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e5736508-4802-4d2c-8db1-aec5d53d24f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7d8c2878-00bc-41cd-94f4-0d51448a78cf" xlink:to="loc_srt_StatementGeographicalAxis_e5736508-4802-4d2c-8db1-aec5d53d24f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e5736508-4802-4d2c-8db1-aec5d53d24f3" xlink:to="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_9fd9af69-e417-4468-b758-210efdc8e7e2" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:to="loc_country_CA_9fd9af69-e417-4468-b758-210efdc8e7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_72f91957-88cd-43ca-bfe5-0cdf2aee81f0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:to="loc_country_IL_72f91957-88cd-43ca-bfe5-0cdf2aee81f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eb70ed2b-7542-4734-882e-92cf61ef00cc" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:to="loc_country_US_eb70ed2b-7542-4734-882e-92cf61ef00cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember_e2c3af6a-c2fa-4cdc-b2f5-f10c732a8fd2" xlink:href="cron-20221231.xsd#cron_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_073ea9f3-1134-466d-8a70-94788faa1a77" xlink:to="loc_cron_OtherCountriesMember_e2c3af6a-c2fa-4cdc-b2f5-f10c732a8fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_83c8b1a9-7c56-4367-ab98-2bbec6332c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7d8c2878-00bc-41cd-94f4-0d51448a78cf" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_83c8b1a9-7c56-4367-ab98-2bbec6332c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_799aa2f6-b6f3-4cab-a2d1-0295c69a68f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_83c8b1a9-7c56-4367-ab98-2bbec6332c88" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_799aa2f6-b6f3-4cab-a2d1-0295c69a68f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_933d69e4-a051-464d-b48f-c8f5b7fe07a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_49428dfd-07d3-4b04-bb65-d714832e3ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_933d69e4-a051-464d-b48f-c8f5b7fe07a9" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_49428dfd-07d3-4b04-bb65-d714832e3ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_49428dfd-07d3-4b04-bb65-d714832e3ce2" xlink:to="loc_srt_StatementGeographicalAxis_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1d42ae65-c12c-47fb-a9e7-79dbb9c12c15" xlink:to="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_34601373-eabc-4aa5-8717-041e6f336a96" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:to="loc_country_CA_34601373-eabc-4aa5-8717-041e6f336a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_95569589-7ffc-4d86-9bc5-7726099e0198" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:to="loc_country_US_95569589-7ffc-4d86-9bc5-7726099e0198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_3916eacd-c545-4751-8501-e23b2270d006" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6c4e3afa-72e3-4006-8d39-df5c350a6100" xlink:to="loc_country_IL_3916eacd-c545-4751-8501-e23b2270d006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d6033047-df31-4eb9-a087-1ea56aacb1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_49428dfd-07d3-4b04-bb65-d714832e3ce2" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d6033047-df31-4eb9-a087-1ea56aacb1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_fc9dc33d-7c21-446b-a16b-7ed910058df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d6033047-df31-4eb9-a087-1ea56aacb1b8" xlink:to="loc_us-gaap_NoncurrentAssets_fc9dc33d-7c21-446b-a16b-7ed910058df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#EarningsLossperShareScheduleofEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_af818261-8851-4c7b-a8e3-f3e6d8781a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_a5ea615b-5d7e-4526-9d0a-0d39680dc25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af818261-8851-4c7b-a8e3-f3e6d8781a06" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_a5ea615b-5d7e-4526-9d0a-0d39680dc25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2311422d-fd0d-4940-83fe-829577afd6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_a5ea615b-5d7e-4526-9d0a-0d39680dc25e" xlink:to="loc_us-gaap_AwardTypeAxis_2311422d-fd0d-4940-83fe-829577afd6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2311422d-fd0d-4940-83fe-829577afd6cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_bb0c4cde-f874-4678-9d8d-158d6bd18a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:to="loc_us-gaap_WarrantMember_bb0c4cde-f874-4678-9d8d-158d6bd18a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cf3f8a9e-169e-433a-b86c-a66be3866b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cf3f8a9e-169e-433a-b86c-a66be3866b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_86076276-b6db-4339-b6f6-9dc7feb9cd61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9970da3-2eb8-4cd8-add8-9d95d2c9840e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_86076276-b6db-4339-b6f6-9dc7feb9cd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_a5ea615b-5d7e-4526-9d0a-0d39680dc25e" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2478c50d-b5b7-4c20-9a55-66690ca89a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2478c50d-b5b7-4c20-9a55-66690ca89a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a36360a-8f1c-4c61-b9dc-57b614daff98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a36360a-8f1c-4c61-b9dc-57b614daff98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_124f99a7-5026-4a9e-974b-4ddac3885b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_124f99a7-5026-4a9e-974b-4ddac3885b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_0ec2f858-65af-4427-9dba-acb9aab93b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_0ec2f858-65af-4427-9dba-acb9aab93b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_136e2b7f-6627-467f-b1f2-54b24218c842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_136e2b7f-6627-467f-b1f2-54b24218c842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_3111a900-908e-40bf-bfb3-861d792524fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_886fe664-a106-4733-916e-890c87366841" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_3111a900-908e-40bf-bfb3-861d792524fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_e46f26e2-3a88-496a-9c85-4e866d4539d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_e46f26e2-3a88-496a-9c85-4e866d4539d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_c57139ea-90be-4529-ac5c-1251b26c945a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_DilutiveSecurities_c57139ea-90be-4529-ac5c-1251b26c945a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_08bed379-0a52-45e8-bac1-f9cb7ac58750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_08bed379-0a52-45e8-bac1-f9cb7ac58750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_93994bb4-5e56-41e5-b222-843b1cd2ae20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_93994bb4-5e56-41e5-b222-843b1cd2ae20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_257d6dab-0cf7-43e7-be25-eaacf42eb3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_257d6dab-0cf7-43e7-be25-eaacf42eb3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3a55154e-2616-48e1-a1b4-fb747bb19633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3a55154e-2616-48e1-a1b4-fb747bb19633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef117d95-4fac-42c7-8bdc-b26ea1a61fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef117d95-4fac-42c7-8bdc-b26ea1a61fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_550307e3-9c63-46f7-ad07-dede27db1deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_550307e3-9c63-46f7-ad07-dede27db1deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_2decfae7-690f-4918-a03b-82d3cb7dc5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_2decfae7-690f-4918-a03b-82d3cb7dc5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6c163aa9-2e3a-4181-a2f5-12d3838d5dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6c163aa9-2e3a-4181-a2f5-12d3838d5dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_4a80041c-5145-4843-9e19-41f78e469865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_55823510-3e29-4b6d-af71-5757dd3af38f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_4a80041c-5145-4843-9e19-41f78e469865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_09c294db-94a1-4dcd-b501-7a08aa481ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_3d96317d-238c-47e4-9497-f8e4a4e2a557" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_09c294db-94a1-4dcd-b501-7a08aa481ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_5edb2ae1-786b-44ab-875a-4be2294f1c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_5edb2ae1-786b-44ab-875a-4be2294f1c4d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_93cdefeb-033d-45bc-8d1e-c063cc79f484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_93cdefeb-033d-45bc-8d1e-c063cc79f484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_93cdefeb-033d-45bc-8d1e-c063cc79f484" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5abdf343-c56f-4d05-a1e7-e9edd273b35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5abdf343-c56f-4d05-a1e7-e9edd273b35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_36913d69-b601-4717-8066-ba233b663ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_36913d69-b601-4717-8066-ba233b663ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_afb72c6d-1e9e-49b5-bfe7-3c33d6e7b70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c26a8b8b-0c34-439d-9215-41f577995796" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_afb72c6d-1e9e-49b5-bfe7-3c33d6e7b70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_238907b6-c899-447b-8378-a29c9399e64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_238907b6-c899-447b-8378-a29c9399e64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_98f9fb33-4293-4e5b-9ad1-c21803a1a3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_238907b6-c899-447b-8378-a29c9399e64d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_98f9fb33-4293-4e5b-9ad1-c21803a1a3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ca90be65-e080-4389-9f9b-6cd713b807db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_98f9fb33-4293-4e5b-9ad1-c21803a1a3ed" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ca90be65-e080-4389-9f9b-6cd713b807db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_965ae77a-4a90-4c9c-99a7-64f6360f5e0f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_965ae77a-4a90-4c9c-99a7-64f6360f5e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3bb63bbd-c0b0-4c7a-b128-053120b71c20" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_965ae77a-4a90-4c9c-99a7-64f6360f5e0f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3bb63bbd-c0b0-4c7a-b128-053120b71c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_fb188609-f375-4188-9b14-bb2d5a968609" xlink:href="cron-20221231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3bb63bbd-c0b0-4c7a-b128-053120b71c20" xlink:to="loc_cron_CronosAustraliaLimitedMember_fb188609-f375-4188-9b14-bb2d5a968609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1d2da20f-a520-42d8-87b0-1a7fee1185fa" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2c9c648a-3374-470e-82cf-233a8977fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2c9c648a-3374-470e-82cf-233a8977fc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fa317564-218b-49ee-b658-35add164d663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fa317564-218b-49ee-b658-35add164d663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_c7ad46e4-0d09-407d-9d38-5d2dc59a0680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_OtherInvestments_c7ad46e4-0d09-407d-9d38-5d2dc59a0680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_43a22a36-bca3-457f-85c8-0d0b5a0a3f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_43a22a36-bca3-457f-85c8-0d0b5a0a3f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b99c90e1-30c1-4817-b839-189711a8c804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b99c90e1-30c1-4817-b839-189711a8c804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfSeatsOnBoardOfDirectors_3e8d95b0-7841-4056-ae6b-9a08a480e973" xlink:href="cron-20221231.xsd#cron_NumberOfSeatsOnBoardOfDirectors"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46d68962-ea39-442e-82df-b8591860be56" xlink:to="loc_cron_NumberOfSeatsOnBoardOfDirectors_3e8d95b0-7841-4056-ae6b-9a08a480e973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_121ca93a-5638-42ea-8ad5-d60123bf22ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_121ca93a-5638-42ea-8ad5-d60123bf22ef" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8812c97-8fe7-4ade-80da-e00d3859ec94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8812c97-8fe7-4ade-80da-e00d3859ec94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8812c97-8fe7-4ade-80da-e00d3859ec94" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_31d60e5d-3dea-4ce8-bea5-e5eab0c64cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_31d60e5d-3dea-4ce8-bea5-e5eab0c64cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a7a228b2-1065-4991-91d8-3bc10f1dddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a7a228b2-1065-4991-91d8-3bc10f1dddfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_80caf88e-6243-4bb4-a05a-962f31bcae60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82754e38-f76a-49e3-b83e-0d0d97ff42f1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_80caf88e-6243-4bb4-a05a-962f31bcae60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c0d417e-c4ac-4209-a2e9-6f9286a78d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c0d417e-c4ac-4209-a2e9-6f9286a78d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a2be6cd3-523b-4620-8111-3e5d5dc2e428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c0d417e-c4ac-4209-a2e9-6f9286a78d01" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a2be6cd3-523b-4620-8111-3e5d5dc2e428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_2684784a-ab1f-490c-aceb-9ab8fb3dde46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a2be6cd3-523b-4620-8111-3e5d5dc2e428" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_2684784a-ab1f-490c-aceb-9ab8fb3dde46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f3c3412e-3667-4c7c-b5e8-25af087cfe69" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_dei_LegalEntityAxis_f3c3412e-3667-4c7c-b5e8-25af087cfe69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_eef9ee86-697f-4690-a780-bb9c1d10eace" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f3c3412e-3667-4c7c-b5e8-25af087cfe69" xlink:to="loc_dei_EntityDomain_eef9ee86-697f-4690-a780-bb9c1d10eace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_599e44f5-3d1e-4a58-ba0b-555ba64869c3" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_eef9ee86-697f-4690-a780-bb9c1d10eace" xlink:to="loc_cron_PharmacannMember_599e44f5-3d1e-4a58-ba0b-555ba64869c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5a822987-f8f4-4698-b000-e27180927743" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_srt_OwnershipAxis_5a822987-f8f4-4698-b000-e27180927743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_49f102b5-81e6-43e2-b73c-82e08d777e40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_5a822987-f8f4-4698-b000-e27180927743" xlink:to="loc_srt_OwnershipDomain_49f102b5-81e6-43e2-b73c-82e08d777e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_90fe7908-4d93-493f-b7b6-7fdbc8d2cf22" xlink:href="cron-20221231.xsd#cron_PharmacannMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_49f102b5-81e6-43e2-b73c-82e08d777e40" xlink:to="loc_cron_PharmacannMember_90fe7908-4d93-493f-b7b6-7fdbc8d2cf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9feea330-637f-4421-94ee-25fcdeed2bc5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_c77391dc-f361-44e9-a39b-cc9b9a61a6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_OtherInvestments_c77391dc-f361-44e9-a39b-cc9b9a61a6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0b95fcbd-3cd8-4e0a-93cb-ee9c60ce7c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0b95fcbd-3cd8-4e0a-93cb-ee9c60ce7c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_f79dd227-8aa9-4869-8e1d-a2b69e8f406b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_f79dd227-8aa9-4869-8e1d-a2b69e8f406b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_c39fa509-3d45-4244-94fb-a839c375ce22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_c39fa509-3d45-4244-94fb-a839c375ce22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_c6da7b9a-55ed-4e57-ae7d-30848ec65d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_c6da7b9a-55ed-4e57-ae7d-30848ec65d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9d6d2fe6-e1b3-4f90-9837-fa85f8ecf282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f558bd38-a0bc-41d7-a55f-e40b404fd347" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9d6d2fe6-e1b3-4f90-9837-fa85f8ecf282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsCreditRiskDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_786f4f04-3913-43f0-a8c3-e8f8741adadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_786f4f04-3913-43f0-a8c3-e8f8741adadb" xlink:to="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_20befa96-9cc3-4286-89c0-aa4b6011e5cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_srt_MajorCustomersAxis_20befa96-9cc3-4286-89c0-aa4b6011e5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cb627ded-4258-480a-a7bd-f78d2ccf2e5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_20befa96-9cc3-4286-89c0-aa4b6011e5cb" xlink:to="loc_srt_NameOfMajorCustomerDomain_cb627ded-4258-480a-a7bd-f78d2ccf2e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ThreeMajorCustomersMember_464ef050-6b4b-4604-a5c5-a5cb0e7e757a" xlink:href="cron-20221231.xsd#cron_ThreeMajorCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cb627ded-4258-480a-a7bd-f78d2ccf2e5d" xlink:to="loc_cron_ThreeMajorCustomersMember_464ef050-6b4b-4604-a5c5-a5cb0e7e757a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember_13e84505-a0b2-411d-86e1-204a96fc8629" xlink:href="cron-20221231.xsd#cron_FourMajorCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cb627ded-4258-480a-a7bd-f78d2ccf2e5d" xlink:to="loc_cron_FourMajorCustomersMember_13e84505-a0b2-411d-86e1-204a96fc8629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_22f575cb-435c-4e2a-9072-8e45ba63936f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_22f575cb-435c-4e2a-9072-8e45ba63936f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_913333c5-aefa-4524-bf8c-b9c565071139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_22f575cb-435c-4e2a-9072-8e45ba63936f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_913333c5-aefa-4524-bf8c-b9c565071139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_9d74471e-508f-430f-a3b1-7f4c6af155b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_913333c5-aefa-4524-bf8c-b9c565071139" xlink:to="loc_us-gaap_AccountsReceivableMember_9d74471e-508f-430f-a3b1-7f4c6af155b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_721fd1be-03a7-479a-8d47-5c6272a89dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_913333c5-aefa-4524-bf8c-b9c565071139" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_721fd1be-03a7-479a-8d47-5c6272a89dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_665eaf95-f766-4e49-83bf-ef35dd44d230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_665eaf95-f766-4e49-83bf-ef35dd44d230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_21da6c65-6b01-41c3-822a-b2e1f9510dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_665eaf95-f766-4e49-83bf-ef35dd44d230" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_21da6c65-6b01-41c3-822a-b2e1f9510dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_36524946-068d-4be5-9b3f-d3b4b9ae5d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_21da6c65-6b01-41c3-822a-b2e1f9510dea" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_36524946-068d-4be5-9b3f-d3b4b9ae5d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_42b61cc5-d5e5-44b6-a796-f2fe88736cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_42b61cc5-d5e5-44b6-a796-f2fe88736cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8c2c066c-91f9-4725-953e-0a9af87eff16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42b61cc5-d5e5-44b6-a796-f2fe88736cca" xlink:to="loc_us-gaap_SegmentDomain_8c2c066c-91f9-4725-953e-0a9af87eff16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_874f5a84-a370-4e18-962b-0386e037f357" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8c2c066c-91f9-4725-953e-0a9af87eff16" xlink:to="loc_cron_RestOfWorldSegmentMember_874f5a84-a370-4e18-962b-0386e037f357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_2144e14a-2a64-4323-94ca-59265117bcfd" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8c2c066c-91f9-4725-953e-0a9af87eff16" xlink:to="loc_cron_UnitedStatesSegmentMember_2144e14a-2a64-4323-94ca-59265117bcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_90d0eb8a-d4d6-41cd-a2a7-96305b71f00e" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_6c1e2310-072d-4e29-b713-fd6798cd57b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_6c1e2310-072d-4e29-b713-fd6798cd57b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_70556404-93cf-4039-a6fb-27724fe7349f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_70556404-93cf-4039-a6fb-27724fe7349f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_4daf85b8-6cc5-4fbc-aca6-a0f69285a15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_4daf85b8-6cc5-4fbc-aca6-a0f69285a15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f0e7e791-bd9d-4f73-add2-dac2d14c24b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f0e7e791-bd9d-4f73-add2-dac2d14c24b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_efb559cb-1d0c-497e-a433-3e80bb59ff5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_efb559cb-1d0c-497e-a433-3e80bb59ff5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_accb24f5-4c77-4cc6-976b-7c44b744955f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_accb24f5-4c77-4cc6-976b-7c44b744955f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e7b0ba9-214d-4a6d-971f-da882538e3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e7b0ba9-214d-4a6d-971f-da882538e3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_a9444c80-0aad-4316-a594-8ee6d2bd1324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_ShortTermInvestments_a9444c80-0aad-4316-a594-8ee6d2bd1324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_d48a9024-8d5b-485e-a548-243abceba982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_81a3013f-2ba7-450a-8f1f-aa67fc6c6284" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_d48a9024-8d5b-485e-a548-243abceba982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsLiquidityRiskDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_a6df9d04-a18f-49fe-b6b8-cb6189af2713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_a6df9d04-a18f-49fe-b6b8-cb6189af2713" xlink:to="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_851efa1b-6780-4beb-b817-460095f88178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_851efa1b-6780-4beb-b817-460095f88178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b7fabf1-0e3a-4e8f-899a-2c6a6bc01b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_851efa1b-6780-4beb-b817-460095f88178" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b7fabf1-0e3a-4e8f-899a-2c6a6bc01b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_6faeb907-a22f-4e91-a983-7b1083b393d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b7fabf1-0e3a-4e8f-899a-2c6a6bc01b8c" xlink:to="loc_us-gaap_AccountsPayableMember_6faeb907-a22f-4e91-a983-7b1083b393d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d272faa3-9bf4-4645-8579-78d213bbae81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d272faa3-9bf4-4645-8579-78d213bbae81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8e699394-c5d1-41a1-833d-927d6e3fcd71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d272faa3-9bf4-4645-8579-78d213bbae81" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8e699394-c5d1-41a1-833d-927d6e3fcd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_e89e9fb4-619f-4d4e-a646-b079afc5c7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8e699394-c5d1-41a1-833d-927d6e3fcd71" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_e89e9fb4-619f-4d4e-a646-b079afc5c7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_dc0738d1-6061-4bd5-8334-3c44d8fc90bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_ca327c47-b10f-4fc6-8fa5-eb8ff42b30ab" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_dc0738d1-6061-4bd5-8334-3c44d8fc90bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneVendorMember_e676b254-604d-4905-bcc4-9335805b3b48" xlink:href="cron-20221231.xsd#cron_OneVendorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_dc0738d1-6061-4bd5-8334-3c44d8fc90bb" xlink:to="loc_cron_OneVendorMember_e676b254-604d-4905-bcc4-9335805b3b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_ee7966c0-6a07-4c65-a006-15b71427a9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c5e9e09d-3521-44d1-890d-08c13637ff9e" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_ee7966c0-6a07-4c65-a006-15b71427a9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_c8430d71-2d61-478b-8089-b99bd3fee11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ee7966c0-6a07-4c65-a006-15b71427a9e5" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_c8430d71-2d61-478b-8089-b99bd3fee11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_2fc8ee11-7080-4d5e-aa2b-0d017abb9f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ee7966c0-6a07-4c65-a006-15b71427a9e5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_2fc8ee11-7080-4d5e-aa2b-0d017abb9f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsInterestRateRiskDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_38e06783-c8a1-419b-9fce-83ddd93df336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ae865b3a-9aeb-447d-bc78-f38074588e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_38e06783-c8a1-419b-9fce-83ddd93df336" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ae865b3a-9aeb-447d-bc78-f38074588e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_02e2024b-8e79-4e13-b15e-5b98a1678cb7" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_38e06783-c8a1-419b-9fce-83ddd93df336" xlink:to="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_02e2024b-8e79-4e13-b15e-5b98a1678cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsForeignCurrencyRiskDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#FinancialInstrumentsForeignCurrencyRiskDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsForeignCurrencyRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_7185d126-b705-4b83-b975-1c1b77598e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6669a7e3-0fc7-4203-b4c8-1ff4cb091696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_7185d126-b705-4b83-b975-1c1b77598e8c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6669a7e3-0fc7-4203-b4c8-1ff4cb091696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_fff062e8-eb23-4054-a52e-f3cfd0db4c52" xlink:href="cron-20221231.xsd#cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_7185d126-b705-4b83-b975-1c1b77598e8c" xlink:to="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_fff062e8-eb23-4054-a52e-f3cfd0db4c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_10649d6d-b7e7-467e-a186-209feba93b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_10649d6d-b7e7-467e-a186-209feba93b72" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9e17969f-6362-49ae-85b8-d0560e55a2df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9e17969f-6362-49ae-85b8-d0560e55a2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a4ff7129-524f-4175-b46e-342347200c56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9e17969f-6362-49ae-85b8-d0560e55a2df" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a4ff7129-524f-4175-b46e-342347200c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_1576fa36-79b9-4b70-adc9-9dbe3c60114b" xlink:href="cron-20221231.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a4ff7129-524f-4175-b46e-342347200c56" xlink:to="loc_cron_CronosGroupInc.Member_1576fa36-79b9-4b70-adc9-9dbe3c60114b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_99385ef7-7073-4a2c-a71a-22abed5eb768" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a4ff7129-524f-4175-b46e-342347200c56" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_99385ef7-7073-4a2c-a71a-22abed5eb768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e3c9148a-b652-4623-9253-c3bc517ee8be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_dei_LegalEntityAxis_e3c9148a-b652-4623-9253-c3bc517ee8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_910c5357-647c-43de-bc04-af1488d0b097" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e3c9148a-b652-4623-9253-c3bc517ee8be" xlink:to="loc_dei_EntityDomain_910c5357-647c-43de-bc04-af1488d0b097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_fa1387d8-2676-4af2-b254-d99b4f64386f" xlink:href="cron-20221231.xsd#cron_AltriaGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_910c5357-647c-43de-bc04-af1488d0b097" xlink:to="loc_cron_AltriaGroupInc.Member_fa1387d8-2676-4af2-b254-d99b4f64386f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7480f593-a496-45c4-acfe-b0783d946227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7480f593-a496-45c4-acfe-b0783d946227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7480f593-a496-45c4-acfe-b0783d946227" xlink:to="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member_83264ec1-45e2-43d5-bde4-62312426166f" xlink:href="cron-20221231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:to="loc_cron_AltriaPinnacleLLC.Member_83264ec1-45e2-43d5-bde4-62312426166f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_03a78de4-12af-4677-a91a-6a1aa860a51a" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_03a78de4-12af-4677-a91a-6a1aa860a51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VendorMember_1a60d62e-fffd-4064-a6df-ef4c091b8288" xlink:href="cron-20221231.xsd#cron_VendorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0cae11d5-c4e8-4612-be04-179de15138e1" xlink:to="loc_cron_VendorMember_1a60d62e-fffd-4064-a6df-ef4c091b8288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_95267273-6641-4ad5-aaef-d4fd0db85952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_95267273-6641-4ad5-aaef-d4fd0db85952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4b66705c-852e-4692-9b48-3c9df53f4f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_95267273-6641-4ad5-aaef-d4fd0db85952" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4b66705c-852e-4692-9b48-3c9df53f4f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisPurchasesMember_17049bc9-65be-4906-beec-350150575655" xlink:href="cron-20221231.xsd#cron_CannabisPurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4b66705c-852e-4692-9b48-3c9df53f4f4b" xlink:to="loc_cron_CannabisPurchasesMember_17049bc9-65be-4906-beec-350150575655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ManufacturingServicesMember_e45d0cbd-b374-40e1-abe0-cf4f548e16c8" xlink:href="cron-20221231.xsd#cron_ManufacturingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4b66705c-852e-4692-9b48-3c9df53f4f4b" xlink:to="loc_cron_ManufacturingServicesMember_e45d0cbd-b374-40e1-abe0-cf4f548e16c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_de35d9da-3874-4358-adee-33c53d7cf84b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_aa8383e5-3467-49fe-b3ea-5454b30acbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_aa8383e5-3467-49fe-b3ea-5454b30acbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_81482176-1de3-4cb2-a7fc-5c32a4405a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_81482176-1de3-4cb2-a7fc-5c32a4405a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8a258df5-3d75-4fc2-b11d-a39eb69da4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8f9986ba-82fd-4e93-a3b9-eb23a2ab37fa" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8a258df5-3d75-4fc2-b11d-a39eb69da4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ae357eda-102c-4438-b952-567d49251914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ae357eda-102c-4438-b952-567d49251914" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4858190c-4921-49f3-b996-f8caa47b7359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0ccd0272-0c94-4ee5-92b7-074dd1b73d0f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4858190c-4921-49f3-b996-f8caa47b7359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesMember_86715def-5310-4a24-90e5-42965bdbc250" xlink:href="cron-20221231.xsd#cron_ConsultingServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4858190c-4921-49f3-b996-f8caa47b7359" xlink:to="loc_cron_ConsultingServicesMember_86715def-5310-4a24-90e5-42965bdbc250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisPurchasesMember_373cdc95-5cac-4d01-a9a3-18cc934f7922" xlink:href="cron-20221231.xsd#cron_CannabisPurchasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4858190c-4921-49f3-b996-f8caa47b7359" xlink:to="loc_cron_CannabisPurchasesMember_373cdc95-5cac-4d01-a9a3-18cc934f7922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6e4881fd-d200-4aa1-8bf1-78080da2ad6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8c712939-9bd7-4bd4-bab3-49a5a0cfb83b" xlink:to="loc_us-gaap_RelatedPartyDomain_6e4881fd-d200-4aa1-8bf1-78080da2ad6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member_d41d2517-f0ee-4670-b243-ee448107ede9" xlink:href="cron-20221231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6e4881fd-d200-4aa1-8bf1-78080da2ad6c" xlink:to="loc_cron_AltriaPinnacleLLC.Member_d41d2517-f0ee-4670-b243-ee448107ede9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_b24a2a97-eb17-4b23-b105-1e2fae272c3b" xlink:href="cron-20221231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6e4881fd-d200-4aa1-8bf1-78080da2ad6c" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_b24a2a97-eb17-4b23-b105-1e2fae272c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_3770517d-4cbc-4ac3-a53f-8ba3d90eb608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_07a61df1-37d9-48fd-b9f1-c1c1cbd195aa" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_3770517d-4cbc-4ac3-a53f-8ba3d90eb608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_33c3701c-37f7-48fc-88ef-190e3eb19606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3770517d-4cbc-4ac3-a53f-8ba3d90eb608" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_33c3701c-37f7-48fc-88ef-190e3eb19606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_00dac05c-20c9-4878-a373-8058cc79a0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3770517d-4cbc-4ac3-a53f-8ba3d90eb608" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_00dac05c-20c9-4878-a373-8058cc79a0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RestructuringNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RestructuringNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3fe81250-e060-4fdb-b788-f5f0bd5b7248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1faa011e-c855-4b4a-879c-9947db0d01e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3fe81250-e060-4fdb-b788-f5f0bd5b7248" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1faa011e-c855-4b4a-879c-9947db0d01e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_cf08227a-0bc8-4b77-a1df-109734a98df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1faa011e-c855-4b4a-879c-9947db0d01e7" xlink:to="loc_us-gaap_RestructuringPlanAxis_cf08227a-0bc8-4b77-a1df-109734a98df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_caac68bc-7b6e-432a-9189-db92254de469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_cf08227a-0bc8-4b77-a1df-109734a98df5" xlink:to="loc_us-gaap_RestructuringPlanDomain_caac68bc-7b6e-432a-9189-db92254de469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RealignmentMember_9c4f9d5b-7354-4ef7-8a62-1a526c9171e2" xlink:href="cron-20221231.xsd#cron_RealignmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_caac68bc-7b6e-432a-9189-db92254de469" xlink:to="loc_cron_RealignmentMember_9c4f9d5b-7354-4ef7-8a62-1a526c9171e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9ddfc377-e3f8-4b42-8b39-bbbbc8460219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1faa011e-c855-4b4a-879c-9947db0d01e7" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_9ddfc377-e3f8-4b42-8b39-bbbbc8460219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_2c59596d-d19b-4960-9467-0e329f22d838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9ddfc377-e3f8-4b42-8b39-bbbbc8460219" xlink:to="loc_us-gaap_RestructuringCosts_2c59596d-d19b-4960-9467-0e329f22d838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RestructuringCostsbySegmentDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_334d245b-157a-4ad6-9152-f3c11c53f6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_334d245b-157a-4ad6-9152-f3c11c53f6e1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1ae3ff43-b0f0-4083-8fce-c399af84bee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_928d9dcd-7100-4e85-9bf0-300dc7ce5f0d" xlink:to="loc_us-gaap_SegmentDomain_1ae3ff43-b0f0-4083-8fce-c399af84bee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_b698fd34-66c3-476e-9852-412c079c2dfb" xlink:href="cron-20221231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1ae3ff43-b0f0-4083-8fce-c399af84bee9" xlink:to="loc_cron_RestOfWorldSegmentMember_b698fd34-66c3-476e-9852-412c079c2dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_a04f7df4-f5bf-4ecc-a961-de8e41c47db3" xlink:href="cron-20221231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1ae3ff43-b0f0-4083-8fce-c399af84bee9" xlink:to="loc_cron_UnitedStatesSegmentMember_a04f7df4-f5bf-4ecc-a961-de8e41c47db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_732fad2a-07d3-4d13-81f0-37a1d65ae3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:to="loc_us-gaap_RestructuringPlanAxis_732fad2a-07d3-4d13-81f0-37a1d65ae3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_724f92eb-de85-47a9-9cc2-637ac5c13dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_732fad2a-07d3-4d13-81f0-37a1d65ae3a7" xlink:to="loc_us-gaap_RestructuringPlanDomain_724f92eb-de85-47a9-9cc2-637ac5c13dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RealignmentMember_4ea895a1-f97d-4c24-8d31-2ab84642fb9f" xlink:href="cron-20221231.xsd#cron_RealignmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_724f92eb-de85-47a9-9cc2-637ac5c13dde" xlink:to="loc_cron_RealignmentMember_4ea895a1-f97d-4c24-8d31-2ab84642fb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8eaca002-c6ed-4ff6-96a0-fbc8db6d20e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43ad031-4263-49a4-a0a2-26a629f1a150" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8eaca002-c6ed-4ff6-96a0-fbc8db6d20e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_e59347d4-c590-4392-b2e6-c1455fc2cc74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8eaca002-c6ed-4ff6-96a0-fbc8db6d20e2" xlink:to="loc_us-gaap_RestructuringCosts_e59347d4-c590-4392-b2e6-c1455fc2cc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails" xlink:type="simple" xlink:href="cron-20221231.xsd#RestructuringRestructuringActivityDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1479807a-6cdc-4623-bd88-5438af1c1a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1479807a-6cdc-4623-bd88-5438af1c1a64" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_f0d706e1-c15b-4ae2-b861-f8dbbe835c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_f0d706e1-c15b-4ae2-b861-f8dbbe835c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7ae981e5-3bb5-4ced-9cb2-bac740bbe602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_f0d706e1-c15b-4ae2-b861-f8dbbe835c37" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7ae981e5-3bb5-4ced-9cb2-bac740bbe602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_2e6f2cf4-2e96-4a3e-861c-9359b01d85d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7ae981e5-3bb5-4ced-9cb2-bac740bbe602" xlink:to="loc_us-gaap_EmployeeSeveranceMember_2e6f2cf4-2e96-4a3e-861c-9359b01d85d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_d02e0f09-af05-4ba5-83b2-34b89ed69ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7ae981e5-3bb5-4ced-9cb2-bac740bbe602" xlink:to="loc_us-gaap_OtherRestructuringMember_d02e0f09-af05-4ba5-83b2-34b89ed69ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_729790b7-23cf-4662-9f51-989f226b50af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:to="loc_us-gaap_RestructuringPlanAxis_729790b7-23cf-4662-9f51-989f226b50af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_64dcc0ed-c250-4e83-a2c9-81829fd802c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_729790b7-23cf-4662-9f51-989f226b50af" xlink:to="loc_us-gaap_RestructuringPlanDomain_64dcc0ed-c250-4e83-a2c9-81829fd802c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RealignmentMember_0a0c292a-9ca9-4276-93b8-d32c8e2fc32c" xlink:href="cron-20221231.xsd#cron_RealignmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_64dcc0ed-c250-4e83-a2c9-81829fd802c5" xlink:to="loc_cron_RealignmentMember_0a0c292a-9ca9-4276-93b8-d32c8e2fc32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c24b4e9a-3d29-4e6c-a8d7-e37bc1556f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1485490e-7870-4a06-8663-d4d01d1872c3" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_c24b4e9a-3d29-4e6c-a8d7-e37bc1556f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c24b4e9a-3d29-4e6c-a8d7-e37bc1556f0d" xlink:to="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4e33e617-bcbf-4193-852a-7ee642541014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:to="loc_us-gaap_RestructuringReserve_4e33e617-bcbf-4193-852a-7ee642541014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f0f4d0c3-2cbc-4a94-a4db-7d82e54cba97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:to="loc_us-gaap_RestructuringCharges_f0f4d0c3-2cbc-4a94-a4db-7d82e54cba97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestructuringReservePaymentsAndWriteoffs_9d58ab0d-0288-49be-8069-5ee589f842aa" xlink:href="cron-20221231.xsd#cron_RestructuringReservePaymentsAndWriteoffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:to="loc_cron_RestructuringReservePaymentsAndWriteoffs_9d58ab0d-0288-49be-8069-5ee589f842aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_1f4b177a-5097-4cfe-9f91-23758b78f3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cf5261-dfce-45dd-a3cc-a4f813afa3c0" xlink:to="loc_us-gaap_RestructuringReserve_1f4b177a-5097-4cfe-9f91-23758b78f3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>cron-20221231_g1.jpg
<TEXT>
begin 644 cron-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "< 08# 2(  A$! Q$!_\0
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M+_M-:'-)IT3Z/XALE4WVBW,JL\8/21& ^>,GC=@$'J!D9/41[Q1110,****
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MC16 SUD;UK\=M/L)]5U"VLK6)I[FYE2&*-1DN[,%51[DD?G7]"GP\\+0^!/
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M_: \1?M&>/Y_$_B 1P8C%O9Z?;Y\FTA!)6-<\DY8L6/4D]!@+Y]HNN:AX=U
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M;N8@;YI"!RQ(''0 *!P */(2[L[R"!;>,(@"JH"JJC  '  'TJ2BBD6%%%%
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M.R\>?\%5_B/XFE-KX/\ #NF>&4D;;$TBM?W1)) "DA4R>.-AZUGZ'\,_VO\
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M?P_=_MG:;8J]Y;P>+(XKR_\ *D7*2$^6QCRIQNV!CG/)/0<5^B?P/^ _@WX
M^$X]%\'Z9]CCD"O=7<S;[F[D QOE? R>2< !1D[0,TR;:F1^S;^S+X4_9L\%
MII&B0_:]5N%5M2UF9 )KR0#KU^1 2=J \>I.2?7U4+T%+12*"BBB@ HHHH *
J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cron-20221231_g2.gif
<TEXT>
begin 644 cron-20221231_g2.gif
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M,-"A/X<>Z!2#VKX_HB[(Y91RZ=&G+X\.O41KXV0YKR9"0("  0/<QW=O0OX
M#>[=*] 2B(' [)P5-Y"  'BFT&KQU"-&?>ZU]]Y[\PE 0'P'N!> !F*<AUY9
M"<@'X7P@Q@<??!\*<$ @!9F6VG8'&9@B:PH6\*"('XYHXXT2#D+@AE\%TIX&
M!=PWXGL&P%>DD ,$"6$!6BS@6X -@>8BBP(%XH^(1]YWI 8DWC@D?/UHR"-7
MJ?5SP $C'OF>!D4:P*7_ 44&J8$7-AYPA$$K#I3=0"X21%L"\1WIY@!9'ADD
MDH0F*L A8Y:UVBD0%LFFC5EZ:6-^1^PIX!%:\-<:@;0!((8 APIJ9)9!MFF
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M+ I6U8E:Q"=V"5+=7V<+;:H+V0)(<\=\8LV0-:C9L)F2VFDW(+M>WDM8U\U
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ML0!@@)(,L0"&  :%D"):@ 1?\ 4X^04FD)-@  9(L),]B9.&<#T)  9SDXX
ML 5:L 4NY))!"08YF9-(\))'('Z&@ 1.R1!'@ 1:0&VH49$%F8^"\ 5=$(]1
M9PA;< 1@L !=L)(WB!(),) 'F8_VB(_Z* B&D)0 4 ($8(\'69 0^04'69@$
MP'4[@@!@0) '&6VQYD(E@ 0%F9&$B9$9>8]%:1I;D(]_699X>9><R9%F9(\H
M*6M29P@&)Y"':1 )T"FNJ05@D)4'"9NN"0:=@I@ H 4$_U"3#C$%$>E"&6D(
M;\DO"9"5EPF32MB-U9212("6";$ ?]D076@(P5D(UCD%NAD 77 ])8!K6Y
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7Q35777?EM5=??P4V6&&');98*0," #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cron-20221231_g3.jpg
<TEXT>
begin 644 cron-20221231_g3.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1#N17AI9@  34T *@    @ ! $[  (
M   ,   (2H=I  0    !   (5IR=  $    8   0SNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-0+"!0<F%V
M965N   %D ,  @   !0  !"DD 0  @   !0  !"XDI$  @    ,R,   DI(
M @    ,R,   ZAP !P  " P   B8     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*O_  !$( K<"N ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
M     0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @, !!$%$B$Q
M008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4
ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+C
MY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!         0(#! 4&
M!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R
M@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(
M24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JB
MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR
M\_3U]O?X^?K_V@ , P$  A$#$0 _ /I&L7QAXEM_"'A*_P!;NAO6UBRD><>8
MY.$7\6('MUK:KQOXRZC!J_C;PCX+N&8V=Q=)=WZ*2-T>[:!Q["3]#0!6^ VG
MZE=>(_$OB/6YC-=W20;I/5I5\YA[8#1C';IVKVVN(^$<1?P&FJR*$FUF[GOY
M% P%WN0H'L$5![8KMZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKF[M[.$RWD\5O&.KRN%
M _$UF>+M</AKP?JFLK&)'L[9Y40]&8#Y0?;.,UX_\(D\._$&UU+4_''E:MKZ
M7)W?VA+N5(B!M\N,G:JYW#@=A[4 >B3?$BVOK^6P\&:9=>)[F#B:2S=$MHCZ
M-.Y"Y]AFF2_$2ZTA2_BWPCK&DPC):ZA5+R%!ZLT1) _X#5U;.ZT348;;2-,2
MTM(5E%I%918MY@RAC'(JL!')F,XD8;1G&<MAN8^+_CC4O"-[I,6G:I_9:3V]
MU,TAM5G$[QJOEQ8;IDGJ".HH&=_HGB+1_$EE]KT+4;>^A[F%P2OLPZJ?8@5I
M5\_>#+[2/B=<7-SHD#^$_&]G;F<7.F'9!=#(&63H1N*@@\\CD]!V7PW^+#^(
M-1;PWXOM/[*\1P_+Y;H8UN,#G /W6QSCOU'H #T^BBB@04444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!X[;_$/5M._:&U'0=5FD;1)W
MBM(59/DMY6B#1\^KG</?/M7L5>'?$+2W?XC>)+6+*RZCX=34;9T/S"XM9,KC
MT.$(_'ZUZYX7UI/$7A33-7CQ_IELDK ?PL1\P_ Y'X4#-6BBB@05\K^-M0N=
M6^-OB34H,F+1K:<;NT?EP^4/SE8?]]5]45\LZ9!_:FI?%F,E3<O!<3@#AB$N
M=[8'IP/TH&CZ+\%6?]G^ ]"M.\.GP*WN?+&?US6W7-^&_$6F_P#"N-(UF\O;
M>VLVL(F>:60(J'8 023U!!&/45XM\2OCS)K$<VA^"RUM:2GRY=2?*/(#P=@Z
MJO\ M'GV% C?\4>*M0^('Q2TOPCX?EFCT&WO,WMU%D+<M#AY%W#^%>!_O,#S
M\M>W5Y=\'M*MY(9M:LH2FF00+IFDLR%3+$C%II\?]-)23Z_*!VKU&@ HJA9Z
M[I>H:I>:;8WT-Q>6.W[3#&V3%G. ??@\=JOT %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &5XHT1?$GA34]'
M=_+^VVSQ*Y_@8CY3^!P:^=O"_P"SUJ^MZ#<7FIWW]D7L<[Q16L]L6#A#@L6R
M, G." >!GG-?3U% 'B_P\U'Q!H=YJG@5-(M;+6+:'S8Y9]2F>%E)VB2*-E;Y
M!D$@,,\# YQZEK/AG2?$NF1V/B*QAU&./##S5P0V,;@1RI^AKAOBK;K9>+/!
M6MJ&0MJ7]EW$B.R,89QM(W+@C WD8.03D4OC3Q#K7A&V?6G:\@EDOE_T61O-
MLW6-=NS> 6B$JE2,C D0YZDD&=AHO@?PUX<OQ>Z%H]O8W(MS;&2$$%HRP8@\
M_,<J.3D\=:^:_C)!%HWQ"^UZ3-<).DQDCG&I+<A""&&T8WPD,2=K$]<CBO8Y
M]8\6:Q874VGV>J3VOF;I;-U_L_4;%CSMC<KY4Z =.^,9)/->"_$KS7U=);Z>
MY>]/$B:CIOV2\VXX,A4;)!Q@/G)^E (^J/ GB3_A+? VEZTVT2W,/[X*, 2*
M2KX'8;@<>V*Z&O+/V=YC+\*PA'$5],@Y_P!UO_9J]3H$%%%% !1110 4444
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MX;^S=02/3M;0?Z@2 QW&.IC;OZ[>3CH2,F@+'I%%%% @HHHH **** "BBB@
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M[9S716'A72O%FK3^&_AO:_V=X:MV\O6-=4EY+T]?(C=LDKZX^4]<8QN ./\
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MF.!U/EN^/3 ]!6[!=:%\+OA]I]OK%Y%9VUE;K%GJTLF,MM4<L2V3P.] SJP
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MMS?7;;(+:)II&]%4$D_D*!'R]X%T+5_$>JZGI7AO54T_6=$OY+RQGER%V/\
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MZ5XW\-?!=AJGB$ZTK-J=A83&0:K=+F35+WD&49R1%'DA1W;G)(X]IH ****
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M^(-%\!K=?VC>+=_VYXINU.X-(O*1$]QN.,'U!ZDX]WH&%%%% @HHHH ****
M.%^,7BH^%/AM?3P/LN[S_0[8CJ&<')_!0Q^H%)\'?"*>$_AW9+)'MO;]1=W1
M(P06&54_[JX&/7/K7#?&"XB\1?%[PEX5G(:R@9;F[7/&UFRX/TCC)^C5VMA\
M4[>_:#R--=8Y_P"SE3=+@AKN9T QC^%%W^_3CK0,@^*;+=Z]X'TB7_57&MI<
MR>A6%<D'V^:O)[G7Y/''BZX\3WEL-4_TW^S?#>D2\Q22<'?(/[J*4=O4NH)
M%>D_$QY+[XE>%].MSAX;#4KG(Y^8VY5/R8=*\ TKQ!!I>DVS)(RSK9WMLFP_
M-%+( -_ME6VY'I[4 >L?;=)M[V:9[&W\9:U$_EW^OZU,L6FVDG4QQE_EPO.
MHSW'H/1_!&J37-M=75[K.E/:VZ#?;Z?8/;00D\[_ #)#EQ@'D8%<-X<@\3ZO
MKMYX?\#ZS:^&](\,P16P8V23R3R.H+.0PZEE8YX_')KE_'&D:QJ/C2;0]?\
M&E]K-AI5K]OU9U@6!(1U6-(U)4R-E0.."X]#0!](6=[:ZA:1W5A<PW5O(,I-
M!('1QG'##@U-7G/@[QCH&@Z1#H-V\.FO9%;<VZN75)R 6@CZO(R9&]L8W-^
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MD'8WMCWKI_\ A:%GXA\$KJFDSRZ?'(HCN+Q(OM!TR?J!-%C_ %1P1O''/;J
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M&\-^#6%M:PXRMQ=@8+>X3 'X*>YKU:@"*VM8+*UBMK.&.""%0D<4:A511T
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MD-O$L:Y[*HP/T%>5>+OC8R7+Z9\/-*DU^\$@A:[2-G@20YPJ[?OG@]P.,C-
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MX?*FCD'1HGZ%AVQSCJ,'%8=WIFJ:?KEA9>(;]+/Q)9DIH/B8C$.HI_S[7/\
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M"[R2LI9=Y/;'3C(KWIK3PEX[\#Q2O:)#I5W(%M93&('5A(8XWC/526^[T)#
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M.:4-"\+Z9I0(/V*TB@)'<JH!/XD5X_\ \)7I?B3Q;_PGOBF\6S\*Z'<-:Z-
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MAK2&XD#Z?K\,9(7T++W3D;@/F4\@D=09[Y\-O%=[,UQX0\7-Y?B/2/D8L?\
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M>']/\+Z#;:1I$(BMK9-H]7/=F/=B>2:\=_9YTR?5M3\0>--4_>75U,8$D/\
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MYVW$@22WC2JI)ZY#,?\ @-?05<OX"\!Z;X T$Z?IK/-)*_F7%S( &E;&.@Z
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MC4 DX QP._L!BCXD_:-T&SW0>&+.;5)R=JSS_N(1Z'GYC],#ZT =G9:'X/\
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ML=M&#Z;B&D8?5_P'2N@O_BAH]GKSZ7#%-<R1PNYD0JJO(HSY2$G#D#)9A\J
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M'[T:7J#W264MU@[5=@1$[8_ASE&)SP0,'I6EXMOH/''Q0\.^&-(<74&BW?\
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MYBA0MO"*"W)'5B?:O5O!WC:V\6?;;9[*XTS5=.<)>Z?= ;XB1D$$?>4]C_\
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M+JX-Q=3R33,<F21RS'\3S0%CZY\2?%_PCIMM<V<?B'['J.S"$Z?+*8F[$H0
M?H2*\4\8?%S6]9UJUM='\17\NG*T>YH+)+:1GSR4 ))[8R1S^=>;6\%[J]]#
M;0"6ZN96V1)G<S'^Z,]_:NRT/X=W5[J$,26D][>1)OO-"N0;&[VXP6C+Y5@"
M>N<\<K0,]8\%ZIX8OM0;2?$.IZE=HX+0Z;XUM(WD\TD#,<S<<GC;U.>!P:];
MGO6M?#LMY<VT]J8;=G>&W599(\#HH&0Q'8<UX]:M/IVGMX:T:_C\56-VJK-X
M9\0R?9;^W4@':CN5SCTQP0"M>IG3(M%\&Q6VF7K:+!81!TDNI!*L*KR5D9R<
MH.A^88 X(Q0(^<?$L\<OC_0];<"\>?48)(M8M%V1:A$'7ETX$<ZX 91CW QE
MOJROG3XCBRNO'=E%8R3Z1>2ZQ;+J6DR8$<[;L1W<6.'!&02,'D9 YKZ+H **
M**!!1110 4444 %%%% !1110 5X#^U!#F/PS. O!N48]SGRB/Y&O?J\<_:5L
M3-X"TZ\7DV^H*I]E9'Y_,#\Z /)_#%_IT?@>]TU;I],M'"S:UJ:+F:XR3Y5G
M N1G."3D@<,3\HY]$T?X\>$O#7@W3],\/Z'J#RP(8TLV90%.X\M)W+$[N%/)
M->":2FGRZE"FM7%Q;V&297MHQ))@ G"@D#).!DGC.><5Z/X2<>(+]]$^&]CI
MV@,R[9-5U2Z62^D4\'RSCY3C.1&O''S"@HOWGB7Q#\3-0NI+_7-)\%Z?;@BY
M3[3Y4T@'&'4'?(1T .U?3FLJU\)>$[R8Q^&]/\5>,9HSB2>UC6UMF/\ O%&8
M?CBNN\"_"_0)]:#:7!%XHM[&1DOM1OBT=J9 .(X$7/F$'[S,2N",9S5+P)XT
M\6:;\6H-*\8ZE%H]G;12)>VUR4A@5%5V3:#\J\LN"N,C'7N"/,YO#E]HNH7D
MNL:.UG#:@L+;5$F DR<*H>,+N/(P<J#UZ5:&C)KNA7E]:0:3HUWIL:RBPCEG
M%Q>(VT^8HE=@0%);Y2#CMR*]L^)/C/X8:M8W!U#4YM7NHX=L=E97EPD4Q4EE
M!*9C'S?Q$$].N*\:\'RV<3:S(O@VYUO[3"R6&8VN%M6R<;L ;NP)&#QQUH&=
M[^S_ .%O#7B>/6+O7[*/4M1MY4PEU\ZJC _-M/#$D').<8'K7M,GPX\%RON;
MPKI /^S9HH_("OF'P!KNI_#/QU8ZCK%A>6-E=9@N4F@=-\1(R0".=IVM^&.]
M?8$,T=Q!'-!(LD4BAT=#D,I&00>XH$SF7^&7@F2,HWA;2P#_ ';=5/YCFO/_
M !+^S[ EV-3^'VJ3:->QG<D,DK[ ?]F0?.O_ (]^%>TT4"/G%/&_C7X>:E#)
M\0?"5OJGD-B'4W@02C(QE;A05)P3U^8YY-;,_C#X-^/9/M>OVK:5J38S,\3Q
M2;O[WF19!^K5[FZ)+&R2*KHPPRL,@CZ5R>H_"KP/JLK27?AJR#M]XP*8<^_R
M$<^] SSO5/B[';Z=;^$?A@-0\1ZB\1BBU"XW,Z9[\J"Y4'J0 , G/-=1X+TK
M3_@Y\-Y+KQ7>1175Q(9[R3.XO(1\L2]V( _/<>G-=;HWACPWX+L;B31M.MM-
MA"%YY5'S%5&?F<Y) YZFO#/%>HIXLLY_B)XHD8^'K>X:TT7164@WAP1N+ X3
M)!+'!.%8#&%- #]=^-OBWQ&TC^%8H/#^D*Y07UV%+,?3+ @MCG8@9AGO5.ST
MSXE:M(LZ:]XRD/426]N\<+]P5\V:+(Z]5%1>%M>6=X_$FK3VYN8QN"1.B&!
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M1AE0?OK="@E3^]M8%7!ZY! ]* /2M"^)7PXBTN*WT;6]-L+6,82 K]G"_P#
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MU8XARTAX[?+GGG)H UOAGX-L?A1X(N]?\32I!?3PB6\=N?LZ#E8AZG)YQU;
M&<"D\':5>>*_$,OQ*\7PO#;Q1M_8NGR+G[/  3YI'=B.1]<_W<;EMX<O_&NH
M6VL>-K;[-86[>98Z"QW!6[2W'9GQT3HON<UW$DD<$322NL<:#+,QP% [D]J
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M4C W2#_@/XUZ':^!O$4-DT%GXBT_P_&P_P"/?0M'CB0'W9RS'\-M=\    ,
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M<?JHJEJ.L^--7M_LVK?"&UOX0<[+C6K61<^N&6@#SA_C3\0+A$3_ (D&GJ%
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M9)D4,1&@ Y)+*W'3.TD@ F@1!\1/&FF:EXFT_5_AG=7NH>*+ _9W-A:/-#/
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M#6O^!-9L2;"9V2>0[T ?9\P&"-RE/ND9^A% 'AKQZGX=6XLM/M;RV:>U,D$
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M!7QRL"/LVMW=WLS@KJH;/_?PC/XU[QK/B;1/#L/F:YJMI8 C*B>8*S?1>I_
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M%>-?$/B'QI<Z1K^J3ZG8RV,CM%=GS.0RCO[$C'2@#VWPKXST/QGIHO- O4G
M \R%OEEA/HR]1]>A[$UXC^TEH,D.NV/B P,]M<V@L_,4G$4RN7!/U4D ?[)/
M:F_$OX?R>$O%D6L>!WGT-IF'EL)?*MRY_A63.(R3_!)A3V/\(WK7XAROI/\
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M?#GPSK%ZFJ6]LVG:C]Y-0TN4V\O/?*\-G_:!KJI(TE0I*BNIZJPR#2@!5"J
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MX>WF4Y212.00?3MD=Z^3OBAH7B;1_%0E\80V_P!LO(E?[3:+B.X(&TMP -W
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M?8="TOQ-% TLV@:E#=$IU$18+(/H01GZ4 >@44V.198UDC8,C@,K#H0>].H
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MKH8K XWKGMD]Z-H#8Z=Q2-"R)GYCGKCFL_6-9MO#^BW.J:JQ6TM4W,5^\>P
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M>8GG;=_E[ANVYQG'IGO7'Z!XZ.K6\VO:E]ET3PVRE;*2_<1S76"/WN2P")U
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M"CG<.]<K\1;J0?#'7H\?>M&S^8KM&C\ILL0BM@ MTS7&_%*/;\,M>D!*C[.
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MKUJGP,\ZG\2/19$<*PR3\V0"*\P^/9)^'%FDN Z:HFWCH#')D?Y]*];D!/7
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M\@M;#2DCX>3.7D. 2Q^Z,G"J.O7-=#69JEC<3/#=Z9%91ZBI6+[3<Q;VCA+
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M68X'\Z^Y=046<-O:1C;]E@2(%&P!@>GY5\N_ 3PT/$/Q2LY9T+6VEJ;V0D<
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M+I>DVLUE8;@\WG,"\Q'0''  /.,\G'I7G-8X:BZ:YI;FM>KSNRV/JWX,,A^
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MCKP_I)>-+2]@O)[IW'W%B164Y_[Z_*@#AO#?Q;2'4-4O==N,Z=?:W<6MD9)
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MWQL\8IHVG,8;5B72UWD06Z#J[D#YC[GN<#TK7U+]GK7;#>VFZS974L1'\+Q
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MZ]I3"*]C7[LH(^29.Q5P,\<?@17E^ENOP6^-DFE.[)X:UY5,3.3MB))"G/\
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MH_E7'0C>LWV.FM*U)+N9%A#]HU"WA)QYDJIGZD"OL_Q/L34((P2ODVZ( #C
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M;0T<:DM*Q[ XV@]@WJ37K7C[Q+'X/\#VFF>#88EO]1D2PTN"W4 1,P!W =B
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M(BETLR5? R,,K8SZ94?E5WP3?3RZ%'!>PSVQC9H[=;FR6R\R-<8\N#<61%&
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MT)^M9NM3W=OX9G\.?%'P]J%I<K,DT/B/3(?-621%V)(Y! 8[0 3G<1C(!YH
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M8; S_K--N^OUP=I]C*/2MOQ;:WGA+6M?O=8AF.EP>(=/UVPE5249S(PD7/\
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M&FM+:WDMC"\GB'684"V]GC<R6R,/]9("X7:">2>I)Q>\&VMOXUOK_P ;ZK8
M0:C;G3["VNE#?Z$"=Q=3QF1BQ(Z;<#G))BT_PUHMQ\,+:R\6Z.-!T2PG^T1V
MD]YAFC4<-<$8&YBS,4R><=^!Y)\1_C?+XATNY\.>&;)+#2&/DF<'#S1+T 4
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MJMOEB-7_ (2;QK?%0;_5IE.2"S.L?]%'7T%=1I/PI\96["YBMM.C?'W+P1S
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MC#Q9?:A>2X,K1)S]-[EB?R'TKHK+X"^ -,C,EY9W%XL8RTEY=L ,=SLVC^E
MSA/#O[3%W'((_%>C1S1YYGT\E&4?[C$@_P#?0KF/B'KL_P 5?$UEJ7@[PQJF
M^WC\IID@+O+ALJ3L! QSW/7VKZ$\-Z1X"N(G/A6RT&X%LVUWLXXI&1O=ADY]
MR:N-XST*/Q%<Z&+L&[L;<W%WM0^7;1@ _._W5X/3- 'FJZO\=-<A5;;1]-T5
M" //D";LXZE69O\ T&JT_P $?%?BZYAN/B%XR^T&+.V&V0N%SUVYVJI.!G"G
MI710_&[3M6C>+PSHM]J=^\QCM;4XC\V, ;IF//EQ@G&6'\CBA\1/B!JNJ:#;
MVWPX,UR;B[^RSWMFC$EP,^7"V/F. Q+CY0!UR10!77X,?#/P_J]A8:O>7MY>
MWS[;>UGN#NE..3MB4$+P>3P.YKT#P6/!\<-[:>"(;-([.;R+EK6(@;P.A<CY
MS[Y-<D_PNUB_SJU]JZQ>(=1=([Z[4D_8[3:0T-MQPY^52YZC<>YRM]\)UM9F
MN+;7(['3K##:5INPQVMO(,?O9OFS*V03DXSQDD<4 +KOPPU>;5M1U72=9:?5
MM8=K:6]N^!I]FV25A0=6QA<Y'!/0DFM;P/<W?AVUL]$\3>1IT]X[1Z1I,(\U
MH8(D&=\B @L>6+$XR>.N*ECL_&L5G;6>DZ]8:D99#)>:Q>1KF,''[N*"/ ]_
MF;O7;4"/)_BWH=W#KMMXML5(CL=%U"&YD!P%S"RQ#_OJ5C^%<SIVL6^F>"B)
MP#>Q^ V92S?PO*RH/S9?S[<5[-XMT1O$GA'4]&CD2)[VW:)9'&0I(X)QZ&O
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M\-K,[I/9(?/T=W_C49P\)8MN7C&[ [8!H] \&^,M*\;Z!%J>D2@D@">W+?/
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M+29?&7BJSO-=\/G3H])AE>*UM;LE9;PH,G9QR2/<>G8FNAU5C_9=T8LY\A\
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MGN8R,$ ]B."%/W3VP>?J2L[7M TSQ-H\VEZW:I=6LPY5NJGLRGJ".Q% SGO
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MIZG- '>?#'Q!!:Z'I/AB0.UQ;R7UF9">%>VE7"?4I(#_ ,!-5M!_T3]I3Q/
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MN+>,7RQ,L%QD@J>=N2.HSV/K7#_#7QQ>?"K7]0L]=L;^6.XA"K91D?ZW<-K
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M>(YR$CMHP7$)/3<!R6]%'/KCC(!N^//B)HW@#2_/U)_.O) ?LUE&W[R8^O\
MLKZL?PR>*\UT_P &^+?C#?0:UX_GDTG04;?:Z7""C.O8X/3/]YLD]@ 0:WO
M/PIN#J7_  EGQ&E.IZ_.1(D$Q#);'MG'!8<8 ^5>WK7K% RGI6DV&AZ7#IVD
MVL=I:0+MCBC& !_4^I/)[UXQ\8/B];PV?B+PAIT9^U8BM3.#D,&#&8>V!M3W
M+-Z5W?Q2^(EOX!\+^?"4EU2\!2QA/()[R'_97(^I('?(\Z^&/P5EU&X7Q1\0
M4::2X?[1%8R\F1F.[?-]2<[?S]* .7\ ?"G6_B1?KKWBJ>X@TM\?OGXEN0
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MMQ<(?^FKG]U".GWB3_LU[5X8^'.N(COJ%Z=!BG4"=+*X,]_< =!+=MR,>D8
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M#4+,,^J7ZN%L[<#&5!(SA3P6/4D*%SC/*-$ZQK(4;RV)"OC@D=?YT >^Z/\
MM.?.J:_X=^7^*6RGY'_ &'_LU>@:+\;? NM%4&L"PE;_ )9WT9BQ]6^Y_P"/
M5\@ %B H))Z 5ZYX1^"MKXZ\ 6NM:)K36U^6>*XM[F,-'O4G@,N"H(VGHW6@
M1].V]S;WMNLUI-%<0N/EDB<,K?B.*ALM*T[39)Y-.L+6T>X(:9H(50RD="Q
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M'C[PMX7+)K>MVMO,O6 /OE'_  !<M^E>9Z_^TMI-MOC\.:/<7SC@373B%/J
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M_M3)GMI1@@-&<*K=""%YX(.* '6GBKXIZFGVRU\$:?9VIY2WO;W;.P_3:?\
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M\::8^H7\#"YCB\R'4=/4M. !D%=@)DZ<+@D]N:\K6/XE^#+Z?2[;Q<^I+;G
M2WC2_9!MR \;$S)P1T4C'>@#1U?P=XJ^&%M<-X?:3Q-X1D.Z?2IF/FVXSG<A
M7E6!Y#I@@X)'&:]"\-?$CP_XUT&6^TF-[J\LX_/DTPJIN$8#^$$X;V(/?'!X
MKS!OB9XRCF-O-XV\+VLH."E[8W4$BG_:5H<"O*]=U+4]+\<R:O8Z[:7FH9$Y
MO](7RXP3P> B@>_&#GG.30!]7W7C5'T&+6O#UA)KE@KE;Q+1\7-OCK^Y(RS#
MNA*L/0USTNN:/JEYI_B&:XB2%F"6GB*Q!1(FR,VUTA)*J2?XCCGJC8)\X\,>
M/K7Q5J*W,-_%X4\9L%7[8.+'5<=%G3H&/3/7T/11WMKINHRZU)?V]E%X?\1R
M$+J.ESG=8:TN#ED89&[&3D#</X@0<T >HIN\M=[*S8&2HP"?8<TZF0HL4*1Q
MQK$BJ%5%  4 =!CTI] @KRO5?@Q/KGQ!E\57_BNXAN#*KPK8V@A:$*,* Y9L
MD #G'//'.*[76/'7A;0-PU?7K"W=>L1F#2#_ ( N6_2N#U7]H[PA9;ETVWU#
M4G[,D0C0_BQ!_P#': .\U[P3X?\ %5I!!XET^/4F@7:DTOR2>_S)M(SU(&![
M5H:+H>F^'=+CT[1;1+2TC)*Q(20"3D]23UKY^U+]IK692PTG0;&V'8W,KS$?
MELKD[_XY^/[V7<FLK:)G(CM[:, ?B5)_6@=CZVN;2VO(_+N[>*=,YVRH&'Y&
MG06\-K$(K:&.&,=$C4*!^ KXTF^('Q U<#_B?ZRX<X'V:1T#'T^3'Y55GL/'
M5[DW-KXAN,X)\R.=L^G6@+'VM)+'"NZ:18USC+-@5%_:%G_S]P?]_!7Q9#\/
MO&=XIFC\,:NX8YW-9R#=[\CFGO\ #?QC%$\L_AR_@BC4L\D\7EHH'<LV * L
M?:D5S!.2(9HY".H1P<5)7P#TJQ!J5]:X^S7EQ#@8'ERLN!^!H"Q]Z21I*A25
M%=3U5AD56M-)TZPF>:QL+6VED 5WAA5&8#L2!S7QI8ZQX^:U%[IVH>)&M_NB
M>":<IP>FX''6KMM\7?'^G-M3Q'=[E."+A$E(^N]30%CZ9\3_  L\)>+KY[[6
MM.DDO' !G2XD5L 8' .WL.U8US\()5T$Z+I'C77[/3678;:21)5"]U! 4A2#
MC&<5X_I_[1/C:TQ]J&G7X[^=;E2?^^"O\J[#1_VG+5B%U_P]-$.\EE,'S_P!
ML?\ H5 :GM^EZ=;Z/I%IIMDNVWM(4@B!Z[5  _E5JO/]%^-_@7676/\ M8V$
MK=%OHS$/^^N5'YUW5K>6U] )[*XAN8FZ20N'4_B*!"W5P+2TEG:.601J6V0Q
MEW;V"CDFN$U![[7[J*+Q)<_V;!.IDM/#EO/BYNP#]Z=TR0OJJ<#^)CTKOVR5
M.P@-C@D9 ->3ZQHU]87NI_Z1=:5ITA!U;Q#(=]]J+$<06R@$H@R%&![ '!)
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M@QJ,QL? /AN^U6];A&FC.![A$RS#ZE:JZ5\*_%OC[6(=9^*^H.EM&=T6F1.
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M77KT'<?M( AW>NSG=_P(D>U>J44"&QQI#$L<*+'&@VJJC 4>@%.HHH ****
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MM%@82SY/W1)LR$/MD^V:S?"GP]U+5=>7QA\2G2[U?(:STY3F&P'4 #."P_$
M\Y)Y'1>#?AQH'@E&DTV!I[^4?OK^Y.^:0GKSV!]!C/?-=70(**** "BBB@!J
M(D:[8U51G.%&*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
&**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cron-20221231_g4.jpg
<TEXT>
begin 644 cron-20221231_g4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R96YT($=O
M;V1W:6X   60 P "    %   $*:0!  "    %   $+J2D0 "     S0P  "2
MD@ "     S0P  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M[<J%'FLX  ZL=O&<C'.0VT\!_$/P0+_2_AMJV@-H5U(\]O%K$<HEL'<G*QE
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M/FIAHQ"A8N=V$,@+;<G:"2#][9H **** "BBB@ HHHH **** "BBB@ HHHH
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M/."R].*V['0]"LM'U:_UOP^MEH%]>0R:?X?%N1YSJFQ6-J !OD.#Y; XV(S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9'39(X2-G8*1&&8A07*Y/'4&NCH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /(-(T+Q7H_Q=UK4=!T&2PTV
M6WDFN;:6_#6NH2EI#&8V(+1NS,&8;0%^;/52SU\->)CX@'B1- GB@@UR._72
MI+B![QP;5XIG\WS"C#>Z[5:3A4(&T;5KURB@#PR#X:>)[+0SI8L%G.L:;9VT
M\\<\>RPD2\>:3?E@7 27 *!LE2, $&O;KF%YX=D5Q+;-G/F1!2?_ !X$?I4M
M% %'1YI9M/)N)3*Z3S1;V !8)*R@G  SA1T%7JSM#_Y!\O\ U^77_H^2M&@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** ,[0_\ D'R_]?EU_P"CY*T:SM#_ .0?+_U^77_H^2M&@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH \'TZS.C_%SQ']E\,7^I:2UI<W%_::AI:RRQES,2MO( 0ZS,<!,L6#'/W"
M[3K"_P!6TTZYK,>NZ3>7>M6MY<VNF>'Y6.GQ0Q.D$866/]YM(4LZ1R $*-H&
M&KW:B@#P6\L/&&K6,KZ]I=]-JNMZ7806DT=HV(WBOG?=*5&+=O+,<C;MH!R!
MRNT>ZW,+SP[(KB6V;.?,B"D_^/ C]*EHH S/#ZE-*96=I"MU<@NV,M^_?DX
M&?H*TZSM#_Y!\O\ U^77_H^2M&@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_9LWDWA'>TE(60GV1A')](SZUT] !1110 4444 %%%% !1110 4444 %%%%
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MB@ HHHH **** "BBB@ HHHH **** ,[0_P#D'R_]?EU_Z/DK1K.T/_D'R_\
M7Y=?^CY*T: "BBB@ HHHH **** "BBB@ HHHH *XSQD]UXBU2V\%Z;*T,5W'
M]HUBZB;#06F<"-3V:5@5![*LAQP*ZC5-2M=&TB[U/4)/+M;.%YYGQT102?T%
M8?@.SO1H)U?6X?*U;6I/MMU'S^Y# "*'GD;(PJD?WMQ[T 6XO!?AZ OY&EQ1
M[VMF^1F&W[.RM"JX/RJK(IV#"DY)!W'//WOA^Q\"^*%\4Z' MI8ZA,(-<@1F
MV-O8".X"YPI1SAL#&V1V/(S7>55U33;;6-(N],OT\RUO('@F3.-R,I4C/T-
M%JBN7^'NHWEWX5%CJ\GF:IHT[Z9>R8/[QXL!9.>3OC,<F?\ ;KJ* "BBB@ K
M&\7:I-H_A+4;RT&;M8?+M5/\4[D)$/Q=E'XULUS/B+_B8^*O#VC#E%F?4[@?
M[$  0'_MK)$P_P!P^E &SHNF1:)H5CI=MS%9VZ0(3U(50,GW.,U=HHH ****
M "BBB@ HHHH AO+2"_L9[.[C$MO<1M%*AZ,K#!'Y&L3P3=SR^'_[/OY#+?:1
M*VGW+MU=H\;'/N\9C?\ X'70US$W_$F^(T$OW;;7[?R&]/M4(+)^+1&3_ORM
M '3T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 451U?6M.T*S2ZU>Z2U@>9
M(%=P3EW8*HX]SR>@&2< $U>H **** "BBL;6O%6F:!J>EV.H.ZS:G-Y46T A
M.0NY^>%+O&F>?FD4=\@ V:"<#)K,OM=M[0P+!!=:@\TWD!;*(RA&!^;>WW4
MSD[B/;)XJ&;1KC5UU"V\1R6]SIT[J(+.!7CVHI/^L?=\^[C*X"X&,')) )IM
M5DEU"XTW3K6=KF. R"YFA86R.0-BE^-V<YPF< ')!Q42:#]K^P7&NW#WE[9D
MN&A>2&%GW;@?*#D';@ ;MQ'KFM:.-(8DBA18XT4*B*,!0.@ ["G4 <5!X/\
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MDC.,(0, @L0?O<9:MR&:*X@CGMY$EBD4.DB,&5U(R"".H([T /HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HJ-;B%[AX$E1IHU5GC# LH;.TD=0#M./7!]*DH **** ,[0_\
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M+^SK$G!#W$@5[B0=^%\N/Z[_ 'H ZRQLK?3=/M[&RC$5M;1+##&O1$4 *!]
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MS6MZHX GC)1\>Q(W#V8&@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BJ.H:SI^E26\>H74<,MT_EP1')>5N.%4<G&1G
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M1110 4444 %%%% &=H?_ "#Y?^ORZ_\ 1\E:-9VA_P#(/E_Z_+K_ -'R5HT
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M6TR3S+2\A6:)N^&&<$=B.A'8@B@"]45S<PV=I+<W<J0P0HTDLCG"HH&22>P
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MPH)/ XY-;=% %+2M%TK0K5K70],L]-MW<R-%9VZPHS$ %B% &< #/L*NT44
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MD]SC 4=  !P*YKX4:+?66@K"^J:U'8V,TMK'87EE]G251]V1?-B655((;:"
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M*** "BBB@ HHHH **** "BBB@ JIJFJ66C:=+?:G.L%O$/F=N<D\  #DDG@
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M.?\ D&NQXA8_\\23A&_A.%/!4@ Z^BBB@ HHHH **** "BBB@ HHHH ****
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M>3QA>:CX>\(ZA!9W]A:VK7<TEH9H?)DN&)6%IU!)$XP688(Y5NE>H44 <?\
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MGNH7,<L$5PC/&PZJ5!R"/0TFBZ+:Z#8&ULS+)OD::::=R\DTC'+.['J3^0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M,[0_^0?+_P!?EU_Z/DK1K.T/_D'R_P#7Y=?^CY*T: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "L_P 0:7_;GAK4])$P@^WVDMMYI3<$WH5W;<C.,YQD?45H44 >(R? W5[_
M %E;V\U+3[6\A$,B:S!YLMW-<1-*PE93M"!C)'E S "%57'!7H;?X@^(?"EP
MMC\0M')3.R/4K5E"2\X'WB%8G@8RCD](L5Z;39(TFB:.9%DC<;61AD,/0B@#
M#L?&_AS4)EMX]6@@NFZ6EYFWG_[]R!6_2M[KTK'UWPU::[HR:8[O:0QE2GD1
M1,% & NR1&0KCL5(X%<G:?#2YTV\C%G=VRVF\;OL/GZ;*B]S^XD\I_\ =,8'
MY\ 'HE%><^*WU7PKIUR#XAU:73GMG,D]U8&X6%<$$>=;;)8B!SYC!@O7/''E
MGA_XM:OJGB6WT?Q7JLNF:9>16MK/JMK<;@,&=E'FKA(I)-P1Y$Y'DG&W&8P#
MZ9HIJ.LL:O&RNC %64Y!![@TZ@ JMJ&FV.KV$EEJMG;WUI+CS+>YB62-\$$9
M5@0<$ _459HH Q-/\%>%M(OX[W2O#6CV-W%GR[BVL(HY$R"#AE4$9!(^AK;H
MHH **** "BBB@ K(UCPOI6N31W-W T5[",0WUM(8;B(=<"1<''JIRI[@UKT4
M <P(O%VC8$,MIXCM5Z"X(M;H#_>4&.0_\!C^M<[KOBG6[KQ5I>F1V?B;04>R
MNIYH[*VLYY)F1[=4(9O-78!(^<8.67->DUD:SX8TW7KJVNK_ .V)<6J21Q2V
M=_/:NJN4+J3$ZD@F-#@Y^Z* .,T+6?&3^*=4TJUCO;N)+*UGBF\1M;0M 7>X
M5F"6L8+JWE@!6VD%#R 1GIK;P@MQ=QWWBF^;7+N([HDDC$=K ?6.$$C/HSEV
M'8BKNC>&--T&ZN;JP^V/<721QRRWE_/=.RH7**#*[$ &1S@8^\:UZ "D9E12
MSD*JC)). !4-]?6NF6$U[J%Q';6L"%Y9I6VJBCN37+K:7/CQ!+JT$UGX=/,5
MA*"DM^.S3#JL?I%U;^/CY: .>\;:CJ_CVU@T'P?IX?3KV0[M=FC)BC\L@F2(
M]MI(VOG+,/DX#2))\%M(NO"GA.ST'4-":QGFM$OS>)"P68N%W)-NY29"VW:>
MH&5Z,JZ7Q U5M+N]"T[.H0Z?>-+&8]+/E2W$RA/*MQ("/+# NQ.5XBZ@9S6\
M KK,OB;5H-1UB>XLM.$?DVBW/VA8)) Q>&2=AOE9%6-N3QYN.< T =!?:EK&
MJWLNG>'86LHX7V7&JW<)VH1U6&,_ZQO]H_(/]KD5MZ?9_8-/AM3<3W)C7!FN
M'WR2'N6/K^GI@58HH **** "BBB@ HHHH X?Q#X2UF?4]0N-#EMS'J,B7#&2
M]FM);6X2,1>8CQ*V]2BH#&P X.20<"YX1T3Q#X7MX-+O[RTUFR9I9I;W88)T
MFD9I')3YE=6=FY!4KD##<FNLHH BCG@N&ECBECE:)MDJJP)0XS@CL<$'!]:Y
MF70K_P ,RR7G@]!/:.V^?1))-D9SU:W8\1-_LGY#_LDEJOZOX6MK^^_M.PGE
MTK6 H47]KC<ZCHDJGY94YZ,..Q4\U:L[N[L='\[Q1/I]O+&Q62>%RD+#=A6^
M?[A.1\N6P3C<: #1=>L->MI)+"4^9"WEW%O*I26W?&=DB'E3_/J,CFJ-SX!\
M'WEU+=7GA30Y[B9S)+++IL+/(Q.2S$KDDDY)-3:SX9M]3NDU"TGETW5HEVQW
M]M@.1_<D!XD3/\+9]L'FO+_$GQ(\8> /$&G:5XI_L^X%]?/);7J31P0RPF*1
M?+EW?-$J2O"V_!.T$9<@E@#OI/#%UX:)N? <=O;PY+3:(_[NVF]XR ?(?W *
MGNN?F&IHGB:RUN22V59;/48%#7&G72A)X0>A*Y(*GLRDJ>QJQH272:':_P!H
M:C'J=RR[Y+N)%1)"Q)^0+P%&<#J< 9).28]:\/:?KT<7VV-TN(#NM[N!S'-
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MM5&,",X^0<#ICI6C0!F>'V+Z4S,C1EKJY)1L97]^_!P2,_0UIUG:'_R#Y?\
MK\NO_1\E:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %;4M/MM7TF[TV
M_0R6MY \$R!BI9'4JPR.1P3R*\^M?@UIXFCBU*[BGT^*&*'R;6U^RR3K%N,7
MFR(^"REB=R+&Q(&3@8KTJB@#S"[EU/P%JDCV\,.GZ;+,2B-(3ILP)X7)RUE)
M^<)/H3QV^A>)K+7?,@19+34(%#7.GW("S0YZ$@$AE/9U)4]C6M)&DL;1RHKH
MX*LK#(8'J"*Y;Q5X9$NB62^'],A6XTUE%L+:46LT,0&"L#@;5/3Y6&Q@-K8!
MR #JZ*\_T+XA20K)!XD21DMSB:]2W,<EMV NH.6B/_31=T38)#**[9M4T]-/
M2_:^MELY"H2X,R^6Q9@JX;.#EB /4D"@"U15635-/B+B6^MD,<Z6SAIE&V9P
MI2,\\.P=,+U.Y<=15J@ HHK%U+QAH.E71M;K4HWO!_RYVRM/<'Z11AG_ $H
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M,5UJ]Q%E(V!(9(4/^L<$8)/R*?[Q!6K>CRZ[J-Y_:&I1KI=EL(ATXA7F;/\
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MV#E3[4 :VDZ[I6NP&71]0MKU%.'\F0,4/HPZJ?8X-4]4\):3JEX;XQ/9ZC@
M7]C(8)\#H"R_?'^RV1[4[4/#6@>(3'>W5E!/,5!BOH&,<P7MLF0AP/HU4O[
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M_A87A4?ZS6(H?^NR/'_Z$!3XOB!X.F;;'XJT4O\ W#J$0;\BV: &>1XW//\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH KO86DE_'?/:PM=Q(8TN#&/,53U4-U /I7DGQ/T:\\+^'
M];U>RM;9--N J/'IH\LDR.L8$MK('AN,EN6'EL<@>K#V.HKNTM[^SFM+V".X
MMYT,<L4JAE=2,$$'J"* /F/P5<>+- \;PR>(FAEADU)K.V?7 V^UN1:0[&95
M;/F-%Y,8;Y^20&^;+^L?\)AK5Y\D6K1KG^'3_"][,Y^C,0H^I!KL-)\):-HE
MX;NPMI/M'E^4LMQ<RSM&F0=B&1FV+D#Y5P.!Z5LT <5)X6N-4T/[9=W6J:S>
M2H&CLM5O#8PC)Z2);H!@#/#*_OZB72O"VN6<4<,.HZ9H-HI!-IH6F(N<'O))
MN!]/N UV%% ',>./""^+-/L_+DV7>G7(NK8/+(D;M@J5?8P/*EAN'*YR,\@X
MWAGX:P6/BB+7]2L+*RGLU=;&UL;J:9(GD)\V5G?;N9LXQM Y.=Q/'H%% &1J
MNCZC>7:W.F>(+S365 I@6*&6%^O+*Z%L\_PLO04ND1:_%))'KUSIMY%M_=S6
MD#P,3Z,C,XZ=PWX5K44 <5J?]B?;IH]6^'MS.JN=MR-,M[E)1GAAL9FY]" ?
M:N?U[3-"UN_T72X]/DT#0[\W,=Y$MC]@EOI$6,QV^XA2%8-(2!][RR,]:]5J
MO?6%GJ=F]IJ5I!>6TGWX;B,2(WU4\&@#QCX6Z#XHTB]U+0O#^I"QT6SAMTG^
MWJEQ)%=%?WGE+&Y1"0-S(78*9%/)SGVNWB:&UBBEF>XDC0*TT@4-(0,%B%
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M70>,?"N@ZC:^'XS))"=0BEN8+IEDB422!Y/EW$*5#;1^YC.X8)B^G;O2]/U
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M1110 4444 %%%% &=H?_ "#Y?^ORZ_\ 1\E:-9VA_P#(/E_Z_+K_ -'R5HT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 50U?1K76[5(;PS(8G\V*6
MWF:*2)P" RLI!'!(QT()!!'%7Z* .1D\-ZC?2QZ;XE^S:WIR9:VU,$VU]:N!
MP24P"QZ>9'Y9_P!GDFJ\USX@TV._T_3-4A\0+!&4?RY84U*Q++E6(;]U(0""
M-X3/!);-=M6!XM\'Z9XMTBYM[R"-+Q[:2"WOE7$MN64C*L,'&3G&<'O0!Y)H
M?QLO?$7B:7P_+J]CHSM;0(VIW!C2)&5I#)+"'SNDD1H JL612K$%@!O]SM;V
MUO8]]E<PW"?WHI X_,5X[IOPJN9(8--?2;K3662V>;4I;NWG6W\AY),VN%WL
MSO,^3,O1CG.,'I[GX>W=S)NN],\#WK_\]9/#S1L/_(K?SH ]"ILDL<0S*ZH/
M5CBN.C^&^B?V*4FT#P]_:>PXD73LP!LG'R%LXQC/S?X5F1_"]@<_8_!$)_Z9
M>% 6_P"^FG/\J .OUG7DT_2)[O3U@U">$!A:BZ2-I%R-P4GC=MR0#@$@ D9R
M.9T+XKZ;XJU<Z?X9M_[0D%TB%A+L6.W,44CS297Y"&D:,1\EFC(X&XK7\??#
MJ"_\ 7-MX8T718]741N&73HD\X*P+HOIN ( )P>A(!)'F7ACX/W)\<0WMC9Q
MWEFET)+P:[HS00O"4163RW'^LW&5E6,>6-JY8?*% /I*BN(U?X:Z6_E'PYI/
MA[3]N?-6;3&;?TQM,<L>W'/8YR.F.:^G?#R:.^3^TA9K:X.[^SKJ]MY.G&/W
MQ'6@#OZI:GK%AHZ6[ZG<"WCN9UMXY&4[?,;.T%@,+DC )P,D#.2 >/U3P;JE
MO>#_ (1[[5-;;1S=>+=0B8-WX*RC'2N.\>:;XGL_#D=K?M?1VNHW<=A-C6A<
MP[)%<?.TL"^6NX(I<Y^]P"V!0!ZQ!XHT>YOK:S@O1)<W4MQ#%$L;;BT#LDI(
MQ\JJR%=QPI. "=PSK5X7\&M.U7P=XWO-$U25M3^VQW!DNA"[26[QW,HC\PG)
M1)5$DJDMM8L,#))?W2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "N#^,%]XDTWP2;KPL;A!'+F^DL]GVB.#:W,>_C.[:#C)P3CUKO*Q?%/A+2
M?&&EK9:S%(5C;?#-!*T4L+8(RKKR."0>Q!YH \PE^(FM36;:CIFOB\M=(L-,
MFD9;)(EU-KBY:*4R*P+1X5< (1ALGD8 ]DN;E+6'S)5E9<XQ%$TA_)037G>G
MCX7ZC$+JQ0+#X?L4N,[;F&-K:)V9)<'"W**Z,P?YP&YSEN>EC\?^'9=2N-/A
MN[B6ZMQ+NCCL)V\PQ$"1(R$Q(ZEAE$W,.<C@X )]*U2&VLW2>WOU8W,\@'V"
M<_*TKLIX3T(-7/[<M/\ GE?_ /@OG_\ B*SK#QYX?U)+UK>ZN$-C<0VUREQ8
M3P/'+,P6--LB*26++P!_$,]:=/XZ\-V\>K2/JL;+HTJ07QC1G\J1\!8QM!W,
M20-JY.>,9XH O_VY:?\ /*__ /!?/_\ $4?VY:?\\K__ ,%\_P#\12Z)KNG>
M(M/-[I,[30K*\+AXGB>.1&*NCHX#*P(/# '\ZL:A?VNE:;<7^HSI;VMM&TLT
MKGA%49)/X4 5O[<M/^>5_P#^"^?_ .(J"QUU6TZV-]!?+<F)3,!I\^ ^!NZ)
MCKFH[#QEH6I:>U[:7CF);N.S=9+>6.1)I&541HV4.N2ZG) &#GIS44OCSPU%
M;:E<?VJDD>EW2V=T88WD*SM@"-0H)=LL!A<G.1U!H T/[<M/^>5__P""^?\
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M#(J.T9 D5)"H1V4L-RJQ*\Y P: +7]N6G_/*_P#_  7S_P#Q%']N6G_/*_\
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M2A(!ZT 36^NJ9[K[1!?",2@0$:?/RFQ<_P '][=4_P#;EI_SRO\ _P %\_\
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M \ GH": *]YKJB!?L<%\TGFQ@@Z?/]S>N_JG]W=4_P#;EI_SRO\ _P %\_\
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M_P \K_\ \%\__P 11_;EI_SRO_\ P7S_ /Q%4QXV\.FRTBZ&J1>5K4JPZ?\
M*VZ=S_"%QN&#P<@;3P<5NT 9W]N6G_/*_P#_  7S_P#Q%']N6G_/*_\ _!?/
M_P#$5HUA3^-?#MN^M)+JL(;08TDU+:&;[.'#%0<#ECM/RC+9P,9(R 2W&NJ)
M[7[/!?&,RD3DZ?/PFQL?P?WMM3_VY:?\\K__ ,%\_P#\152U\9Z#=Z<;Z.^,
M<*W1LY/M$$D+Q3 9*.CJ&0A?F^8  <].:AT[Q]X:U32[W4;;4O+M;&%)[A[J
M"2W,<3J623;(JDJP!PP&#@XS0!H_VY:?\\K_ /\ !?/_ /$4?VY:?\\K_P#\
M%\__ ,15C3=0M=7TJTU+3Y?.M+R%)X)-I7>CJ&4X(!&01P1FK- &=_;EI_SR
MO_\ P7S_ /Q%0/KJ_P!HPA(+[[,8I#(?[/GR'RFW^#/3?^51ZAXRT'2]>AT:
M^O\ RKZ8Q@+Y,C(AD)6,/(%*(6*D*&()(XS5?5?B#X9T6YE@U#4'26%G658[
M6:7RP@0N[%$.U%$B9<_*"<9R"  :?]N6G_/*_P#_  7S_P#Q%']N6G_/*_\
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MHU:3;L5F4$JK$$C&!R,@&I_;EI_SRO\ _P %\_\ \11_;EI_SRO_ /P7S_\
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MVM9X/M%I>W5L!#=1[L;E96;:3P0KA&(.0.N.DH **** "BBB@ HHHH ****
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M8Z1827NJWEO8VD6/,N+F58XTR0!EF( R2!]36)_PL;P1_P!#EX?_ /!I!_\
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M^49=SIN7& V[#=<C=7?^#_#(\*Z&]FUU]LN+BZFO+JX\ORQ)+*Y=B%R=HR<
F9/ ZFMVB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523361248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 24, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CRONOS GROUP INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">Z4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">111 Peter St., Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Toronto<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">M5V 2H1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">504-0004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, no par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 562,557,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,575,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Certain information required by Part III of this Annual Report on Form 10-K will either be incorporated into this Annual Report on Form 10-K by reference to the registrant&#8217;s definitive proxy statement for its 2023 Annual Meeting of Shareholders, or will be included in an amendment to this Annual Report on Form 10-K to be filed no later than 120 days after the registrant's fiscal year ended December&#160;31, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001656472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523274768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Vaughan, Ontario, Canada<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259524634688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 764,644<span></span>
</td>
<td class="nump">$ 886,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">113,077<span></span>
</td>
<td class="nump">117,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">23,113<span></span>
</td>
<td class="nump">22,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">5,767<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Current portion of loans receivable, net</a></td>
<td class="nump">8,890<span></span>
</td>
<td class="nump">5,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">37,559<span></span>
</td>
<td class="nump">32,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaids and other current assets</a></td>
<td class="nump">7,106<span></span>
</td>
<td class="nump">8,967<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">960,156<span></span>
</td>
<td class="nump">1,079,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="nump">18,755<span></span>
</td>
<td class="nump">16,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other investments</a></td>
<td class="nump">70,993<span></span>
</td>
<td class="nump">118,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Non-current portion of loans receivable, net</a></td>
<td class="nump">72,345<span></span>
</td>
<td class="nump">80,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">60,557<span></span>
</td>
<td class="nump">74,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">2,273<span></span>
</td>
<td class="nump">8,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">26,704<span></span>
</td>
<td class="nump">18,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,213,009<span></span>
</td>
<td class="nump">1,397,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">11,163<span></span>
</td>
<td class="nump">11,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">32,956<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">22,268<span></span>
</td>
<td class="nump">25,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease obligation</a></td>
<td class="nump">1,330<span></span>
</td>
<td class="nump">2,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Current portion due to non-controlling interests</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">68,116<span></span>
</td>
<td class="nump">54,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Non-current portion due to non-controlling interests</a></td>
<td class="nump">1,383<span></span>
</td>
<td class="nump">1,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current portion of lease obligation</a></td>
<td class="nump">2,546<span></span>
</td>
<td class="nump">7,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">72,045<span></span>
</td>
<td class="nump">63,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital (authorized for issue as of December 31, 2022 and 2021: unlimited; shares outstanding as of December 31, 2022 and 2021: 380,575,403 and 374,952,693, respectively)</a></td>
<td class="nump">611,318<span></span>
</td>
<td class="nump">595,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">42,682<span></span>
</td>
<td class="nump">32,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">490,682<span></span>
</td>
<td class="nump">659,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(797)<span></span>
</td>
<td class="nump">49,865<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity attributable to shareholders of Cronos Group</a></td>
<td class="nump">1,143,885<span></span>
</td>
<td class="nump">1,337,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="num">(2,921)<span></span>
</td>
<td class="num">(2,967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">1,140,964<span></span>
</td>
<td class="nump">1,334,276<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 1,213,009<span></span>
</td>
<td class="nump">$ 1,397,738<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259526004016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">380,575,403<span></span>
</td>
<td class="nump">374,952,693<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259519121120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="nump">$ 114,456,000<span></span>
</td>
<td class="nump">$ 89,486,000<span></span>
</td>
<td class="nump">$ 54,353,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExciseAndSalesTaxes', window );">Excise taxes</a></td>
<td class="num">(22,552,000)<span></span>
</td>
<td class="num">(15,051,000)<span></span>
</td>
<td class="num">(7,634,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">91,904,000<span></span>
</td>
<td class="nump">74,435,000<span></span>
</td>
<td class="nump">46,719,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_OtherCostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">79,935,000<span></span>
</td>
<td class="nump">80,008,000<span></span>
</td>
<td class="nump">46,497,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,961,000<span></span>
</td>
<td class="nump">26,055,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">11,969,000<span></span>
</td>
<td class="num">(17,534,000)<span></span>
</td>
<td class="num">(25,833,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">22,282,000<span></span>
</td>
<td class="nump">44,937,000<span></span>
</td>
<td class="nump">34,386,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">13,381,000<span></span>
</td>
<td class="nump">23,331,000<span></span>
</td>
<td class="nump">20,366,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">71,178,000<span></span>
</td>
<td class="nump">96,482,000<span></span>
</td>
<td class="nump">80,569,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">5,333,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">15,115,000<span></span>
</td>
<td class="nump">10,151,000<span></span>
</td>
<td class="nump">15,361,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,025,000<span></span>
</td>
<td class="nump">4,484,000<span></span>
</td>
<td class="nump">2,872,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">236,056,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">3,493,000<span></span>
</td>
<td class="nump">127,619,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">136,807,000<span></span>
</td>
<td class="nump">543,060,000<span></span>
</td>
<td class="nump">193,554,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(124,838,000)<span></span>
</td>
<td class="num">(560,594,000)<span></span>
</td>
<td class="num">(219,387,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">22,537,000<span></span>
</td>
<td class="nump">9,071,000<span></span>
</td>
<td class="nump">18,415,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="nump">14,060,000<span></span>
</td>
<td class="nump">151,360,000<span></span>
</td>
<td class="nump">129,254,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="nump">3,114,000<span></span>
</td>
<td class="num">(6,313,000)<span></span>
</td>
<td class="num">(4,510,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain (loss) on revaluation of financial instruments</a></td>
<td class="nump">14,739,000<span></span>
</td>
<td class="nump">8,611,000<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment loss on other investments</a></td>
<td class="num">(61,392,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency transaction loss</a></td>
<td class="num">(2,286,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,789,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(493,000)<span></span>
</td>
<td class="nump">730,000<span></span>
</td>
<td class="num">(1,825,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(9,721,000)<span></span>
</td>
<td class="nump">163,459,000<span></span>
</td>
<td class="nump">146,114,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(134,559,000)<span></span>
</td>
<td class="num">(397,135,000)<span></span>
</td>
<td class="num">(73,273,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">34,175,000<span></span>
</td>
<td class="num">(431,000)<span></span>
</td>
<td class="nump">1,347,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Loss from continuing operations</a></td>
<td class="num">(168,734,000)<span></span>
</td>
<td class="num">(396,704,000)<span></span>
</td>
<td class="num">(74,620,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(650,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(168,734,000)<span></span>
</td>
<td class="num">(397,204,000)<span></span>
</td>
<td class="num">(75,270,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,097,000)<span></span>
</td>
<td class="num">(2,133,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Cronos Group</a></td>
<td class="num">(168,734,000)<span></span>
</td>
<td class="num">(396,107,000)<span></span>
</td>
<td class="num">(73,137,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(168,734,000)<span></span>
</td>
<td class="num">(397,204,000)<span></span>
</td>
<td class="num">(75,270,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="num">(50,616,000)<span></span>
</td>
<td class="nump">8,192,000<span></span>
</td>
<td class="nump">14,951,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(219,350,000)<span></span>
</td>
<td class="num">(389,012,000)<span></span>
</td>
<td class="num">(60,319,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income (loss) attributable to non-controlling interest</a></td>
<td class="nump">46,000<span></span>
</td>
<td class="nump">229,000<span></span>
</td>
<td class="num">(2,343,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Cronos Group</a></td>
<td class="num">$ (219,396,000)<span></span>
</td>
<td class="num">$ (389,241,000)<span></span>
</td>
<td class="num">$ (57,976,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Net loss from continuing operations per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.45)<span></span>
</td>
<td class="num">$ (1.07)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.45)<span></span>
</td>
<td class="num">$ (1.07)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_OtherCostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Cost Of Goods And Services Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_OtherCostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExciseAndSalesTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExciseAndSalesTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523745616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Non-controlling interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,817,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,749,030<span></span>
</td>
<td class="nump">$ 561,165<span></span>
</td>
<td class="nump">$ 23,234<span></span>
</td>
<td class="nump">$ 1,137,646<span></span>
</td>
<td class="nump">$ 27,838<span></span>
</td>
<td class="num">$ (853)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement', window );">Activities relating to share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,435,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Activities relating to share-based compensation</a></td>
<td class="nump">19,457<span></span>
</td>
<td class="nump">$ 8,095<span></span>
</td>
<td class="nump">11,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(75,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="nump">14,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,161<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,253,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">1,708,168<span></span>
</td>
<td class="nump">$ 569,260<span></span>
</td>
<td class="nump">34,596<span></span>
</td>
<td class="nump">1,064,509<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="num">(3,196)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement', window );">Activities relating to share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,764,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Activities relating to share-based compensation</a></td>
<td class="num">(2,254)<span></span>
</td>
<td class="nump">$ 7,288<span></span>
</td>
<td class="nump">2,671<span></span>
</td>
<td class="num">(12,213)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones', window );">Share issuance pursuant to research and development milestone (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,934,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones', window );">Share issuance pursuant to research and development milestones</a></td>
<td class="nump">17,374<span></span>
</td>
<td class="nump">$ 17,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Accelerated restricted share units vesting out-of-period adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,802<span></span>
</td>
<td class="num">(4,802)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueTopupRightsExercised', window );">Top-up rights out-of-period adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (3,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(397,204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(396,107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,097)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="nump">$ 8,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,866<span></span>
</td>
<td class="nump">1,326<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">374,952,693<span></span>
</td>
<td class="nump">374,952,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 1,334,276<span></span>
</td>
<td class="nump">$ 595,497<span></span>
</td>
<td class="nump">32,465<span></span>
</td>
<td class="nump">659,416<span></span>
</td>
<td class="nump">49,865<span></span>
</td>
<td class="num">(2,967)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement', window );">Activities relating to share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,464,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Activities relating to share-based compensation</a></td>
<td class="nump">14,834<span></span>
</td>
<td class="nump">$ 4,617<span></span>
</td>
<td class="nump">10,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones', window );">Share issuance pursuant to research and development milestone (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,157,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones', window );">Share issuance pursuant to research and development milestones</a></td>
<td class="nump">11,204<span></span>
</td>
<td class="nump">$ 11,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(168,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="num">$ (50,616)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,662)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">380,575,403<span></span>
</td>
<td class="nump">380,575,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 1,140,964<span></span>
</td>
<td class="nump">$ 611,318<span></span>
</td>
<td class="nump">$ 42,682<span></span>
</td>
<td class="nump">$ 490,682<span></span>
</td>
<td class="num">$ (797)<span></span>
</td>
<td class="num">$ (2,921)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Research And Development Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Share-based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Research And Development Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodValueTopupRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Top-up Rights Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodValueTopupRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259524576448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (168,734,000)<span></span>
</td>
<td class="num">$ (397,204,000)<span></span>
</td>
<td class="num">$ (75,270,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">15,115,000<span></span>
</td>
<td class="nump">10,151,000<span></span>
</td>
<td class="nump">15,361,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">13,122,000<span></span>
</td>
<td class="nump">15,402,000<span></span>
</td>
<td class="nump">7,045,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">236,056,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">3,493,000<span></span>
</td>
<td class="nump">127,619,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment loss on other investments</a></td>
<td class="nump">61,392,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">(Income) loss from investments</a></td>
<td class="num">(17,853,000)<span></span>
</td>
<td class="num">(1,974,000)<span></span>
</td>
<td class="nump">4,510,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="num">(14,060,000)<span></span>
</td>
<td class="num">(151,360,000)<span></span>
</td>
<td class="num">(129,254,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Changes in expected credit losses on long-term financial assets</a></td>
<td class="num">(662,000)<span></span>
</td>
<td class="nump">12,202,000<span></span>
</td>
<td class="nump">2,437,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_GainLossOnDisposalOfInvestments', window );">Gain on disposal of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,789,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_NoncashSellingAndMarketingExpense', window );">Non-cash sales and marketing</a></td>
<td class="nump">341,000<span></span>
</td>
<td class="nump">1,383,000<span></span>
</td>
<td class="nump">2,863,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency transaction loss</a></td>
<td class="nump">2,286,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash operating activities, net</a></td>
<td class="num">(4,051,000)<span></span>
</td>
<td class="num">(3,886,000)<span></span>
</td>
<td class="num">(123,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(2,711,000)<span></span>
</td>
<td class="num">(13,163,000)<span></span>
</td>
<td class="num">(4,724,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="num">(833,000)<span></span>
</td>
<td class="nump">3,838,000<span></span>
</td>
<td class="num">(5,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="nump">996,000<span></span>
</td>
<td class="nump">3,102,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory, net</a></td>
<td class="num">(7,217,000)<span></span>
</td>
<td class="nump">11,565,000<span></span>
</td>
<td class="num">(735,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(863,000)<span></span>
</td>
<td class="num">(1,597,000)<span></span>
</td>
<td class="num">(2,784,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">34,212,000<span></span>
</td>
<td class="num">(776,000)<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(2,921,000)<span></span>
</td>
<td class="num">(4,974,000)<span></span>
</td>
<td class="nump">5,053,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(88,948,000)<span></span>
</td>
<td class="num">(153,616,000)<span></span>
</td>
<td class="num">(144,871,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from short-term investments</a></td>
<td class="nump">268,870,000<span></span>
</td>
<td class="nump">215,303,000<span></span>
</td>
<td class="nump">296,730,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(271,378,000)<span></span>
</td>
<td class="num">(119,610,000)<span></span>
</td>
<td class="num">(201,326,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(110,392,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ProceedsFromDividends', window );">Dividend proceeds</a></td>
<td class="nump">384,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromLoansReceivable', window );">Repayments (advances) on loan receivables</a></td>
<td class="nump">5,246,000<span></span>
</td>
<td class="num">(4,967,000)<span></span>
</td>
<td class="num">(44,652,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment, net of disposals</a></td>
<td class="num">(3,451,000)<span></span>
</td>
<td class="num">(11,144,000)<span></span>
</td>
<td class="num">(31,412,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets, net of disposals</a></td>
<td class="num">(1,581,000)<span></span>
</td>
<td class="num">(1,118,000)<span></span>
</td>
<td class="num">(3,979,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="nump">68,000<span></span>
</td>
<td class="nump">3,030,000<span></span>
</td>
<td class="nump">4,789,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(1,842,000)<span></span>
</td>
<td class="num">(28,898,000)<span></span>
</td>
<td class="nump">20,150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Advance to non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,019,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Withholding taxes paid on equity awards</a></td>
<td class="num">(2,829,000)<span></span>
</td>
<td class="num">(13,458,000)<span></span>
</td>
<td class="num">(2,148,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="num">(68,000)<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">116,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(2,897,000)<span></span>
</td>
<td class="num">(13,442,000)<span></span>
</td>
<td class="num">(3,051,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency translation on cash and cash equivalents</a></td>
<td class="num">(28,642,000)<span></span>
</td>
<td class="nump">4,906,000<span></span>
</td>
<td class="nump">6,102,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="num">(122,329,000)<span></span>
</td>
<td class="num">(191,050,000)<span></span>
</td>
<td class="num">(121,670,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">886,973,000<span></span>
</td>
<td class="nump">1,078,023,000<span></span>
</td>
<td class="nump">1,199,693,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">764,644,000<span></span>
</td>
<td class="nump">886,973,000<span></span>
</td>
<td class="nump">1,078,023,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplementary cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InterestReceivedNet', window );">Interest received</a></td>
<td class="nump">15,548,000<span></span>
</td>
<td class="nump">8,988,000<span></span>
</td>
<td class="nump">18,105,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="nump">$ 177,000<span></span>
</td>
<td class="nump">$ 892,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_GainLossOnDisposalOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Disposal of Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_GainLossOnDisposalOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InterestReceivedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Received, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InterestReceivedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NoncashSellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Selling And Marketing Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NoncashSellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ProceedsFromDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Dividends</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ProceedsFromDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259607029984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation, and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Background, Basis of Presentation, and Summary of Significant Accounting Policies</a></td>
<td class="text">Background, Basis of Presentation, and Summary of Significant Accounting Policies<div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Background</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc. (&#8220;Cronos&#8221; or the &#8220;Company&#8221;) is incorporated in the province of British Columbia and under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(British Columbia) with principal executive offices at 111 Peter St., Suite 300, Toronto, Ontario, M5V 2H1. The Company&#8217;s common shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and Nasdaq Global Market (&#8220;Nasdaq&#8221;) under the ticker symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos&#8217; diverse international brand portfolio includes Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Basis of presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Certain prior year amounts have been reclassified to conform to the current year presentation of our consolidated financial statements. These reclassifications had no effect on reported results of operations and ending shareholders&#8217; equity.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Basis of consolidation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the reporting periods. The Company assesses control under the variable interest entity (&#8220;VIE&#8221;) model to determine whether the Company is the primary beneficiary of that entity&#8217;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting. The Company consolidates the financial results of the following entities, which the Company controls but does not wholly own:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:33.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiaries</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction of incorporation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Cultivation Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Manufacturing Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Store Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Pharmacy Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">These Israeli entities are collectively referred to as &#8220;Cronos Israel.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">&#8220;Ownership interest&#8221; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the consolidated statements of net income (loss) and comprehensive income (loss), net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#8217; equity section of the consolidated balance sheets and consolidated statements of shareholders&#8217; equity. All intercompany transactions and balances are eliminated upon consolidation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Use of estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, expected credit losses on long-term financial assets, impairment losses on goodwill and indefinite-lived intangible assets, impairment losses on long-lived assets, </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inventory write-downs, share-bared payments, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Cash and cash equivalents and short-term investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are comprised of cash and highly liquid short-term investments that are readily convertible into known amounts of cash, generally with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. Short-term investments consist of debt securities that (i) generally have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments are classified as either available-for-sale or held-to-maturity and recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheets and interest income, net on the consolidated statements of net income (loss) and comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#8217;s consolidated statements of cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Inventory</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of raw materials, finished goods and work-in-progress, such as pre-harvested cannabis plants, dried cannabis flower, by-products to be extracted, cannabis extracts and by-products, dry cannabis and cannabis extract containers, and boxes. When the Company cultivated cannabis, costs capitalized into inventory until the time of harvest included, but were not limited to, labor, utilities, nutrition and irrigation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, contract manufacturer fees, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of net realizable value include slow-moving or non-marketable products.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable interest entities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A variable interest entity is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#8217;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#8217;s expected losses or receive portions of the VIE&#8217;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on a periodic basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination, the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates a VIE when it is determined that it is the primary beneficiary of the VIE.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity method investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest using the equity method. Under the equity method, the Company records its proportionate share of income or loss in share of income (loss) from equity method investments within the consolidated statements of net income (loss) and comprehensive income (loss). Cash payments to equity method investees such as additional investments or expenses incurred on behalf of investees, as well as income earned and payments from equity method investees such as dividends and distributions are recorded as adjustments to investment balances. If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized in one period cannot be reversed in subsequent periods.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments include common stock and options in third party entities in which the Company&#8217;s influence is deemed non-significant. The Company holds other investments with and without readily determinable fair values. Other investments with readily determinable fair values are recorded using the fair value method of accounting as of period-end on the consolidated balance sheets. Other investments without readily determinable fair values are recorded using the cost method of accounting on the consolidated balance sheets. Other investments without readily determinable fair values are assessed for observable price changes and other than temporary impairment on a periodic basis. Changes in the reported value of other investments are reported in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Property, plant and equipment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.094%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:60.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available for use is defined as the point at which the related property, plant and equipment is operational, including the possession of any requisite licenses. Depreciation commences at the point the assets are available for use.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Definite-lived intangible assets</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software and payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets originating from the strategic partnership (the &#8220;Ginkgo Strategic Partnership&#8221;) with Ginkgo Bioworks Holdings, Inc. (&#8220;Ginkgo&#8221;) are accounted for in accordance with the acquisition method of accounting. Equity interests issued in exchange for an asset are initially recognized and measured at the date of acquisition at fair value. We estimate fair value using the relief-from-royalty method and key assumptions include the discount rate and estimated life. Definite-lived intangible assets, including intangible assets originating from the Ginkgo Strategic Partnership, are subject to amortization and reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value has been reduced to less than its carrying amount.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Accrued liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,636&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued payroll and related expenses include salaries and wages, bonuses, and other related payroll expenses associated with the Company&#8217;s employees. Accrued professional fees include fees for legal expenses, litigation, consulting, marketing, and other related expenses. Accrued taxes include sales, excise and other taxes owed. Other accrued expenses include the fair value of deferred share units outstanding to directors and other general expenses.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Leases</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#8217;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#8217;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#8217;s depreciation policy if the title is to eventually transfer to the Company.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Derivative liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial instruments classified as derivatives that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in net income (loss) and comprehensive income (loss). For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Derivative Liabilities.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.01pt">Capital stock</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Revenue recognition</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606, &#8220;Revenue from Contracts with Customers,&#8221; and is measured based on the consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product or service to a customer. The Company&#8217;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and &#8220;hemp&#8221; (as defined in the U.S. Agricultural Improvement Act of 2018 &#8220;U.S. hemp&#8221;) derived products consist of a single performance obligation. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, depending on the specific contractual terms. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer or third-party location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer&#8217;s usage.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, allowances for customer returns and other forms of variable consideration. Within the Company&#8217;s Rest of World segment (the &#8220;ROW segment&#8221;), dried cannabis sales outside of Canada may include commission arrangements with distributors that give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated using the expected value method, based on the Company&#8217;s historical information, at contract inception. The Company&#8217;s payment terms vary by customer and product type. Refer to Note 12 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information and Disaggregated Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for information on disaggregated revenue.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Research and development </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a research and development center in Canada that performs scientific research on the interaction of cannabinoids as well as strain development, growing conditions, extraction technology, and biosynthesis. Fermentation and production related research is performed to further strategic initiatives around rare cannabinoids. In addition, the Company has a collaboration and license agreement with Ginkgo (the &#8220;Ginkgo Collaboration Agreement&#8221;) to research, produce, and commercialize cultured cannabinoids. Technological feasibility is considered to be established once productivity targets or commercialization are achieved, at which point the exclusive license is recognized at cost less impairment charges. As of the acquisition date of each exclusive license, cost less impairment charges is equal to the fair value. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Note 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information on the Ginkgo Collaboration Arrangement. Research and development costs associated with these collective efforts are expensed as incurred as part of operating expenses in the Company&#8217;s consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Advertising costs</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs include costs to sell the Company&#8217;s products and are expensed as incurred through sales and marketing expenses in the consolidated statements of net income (loss) and comprehensive income (loss). Advertising costs were $928, $11,514 and $6,087 for the years ended December&#160;31, 2022, 2021, and 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Share-based compensation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan, the 2018 Stock Option Plan, the 2015 Stock Option Plan, the Employment Inducement Award Plan and the DSU Plan (each as defined below).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based awards consists of equity-settled share-based awards such as stock options and restricted share units (&#8220;RSUs&#8221;) that are issued to eligible employees, non-executive directors, and non-employees. Cash-settled deferred share units (&#8220;DSUs&#8221;) that are issued to non-executive directors under the DSU Plan are recorded in accrued liabilities with the fair value adjustment recorded in other income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity instruments granted are initially measured at fair value on the grant date. The fair value of stock options is determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price of the Company&#8217;s common shares. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities. The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are settled or exercised. Upon settlement or exercise, shares are issued and the amount previously reflected in additional paid-in capital is, along with any proceeds paid upon settlement or exercise, credited to a combination of share capital and additional paid-in capital. Forfeitures of share-based compensation awards are accounted for as reductions to share-based compensation and additional paid-in capital as they occur.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Impairment of long-lived assets</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, such as property, plant and equipment and definite-lived intangible assets, for impairment in accordance with ASC Topic 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with ASC Topic 360, long-lived assets to be held are reviewed for events or changes in circumstances that indicate that their carrying amount may not be recoverable. The Company periodically reviews for indicators and, if indicators are present, tests the carrying amount of long-lived assets, assessing their fair values based on estimated undiscounted cash flows over their remaining estimated useful lives. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. If the carrying amount of an asset (or asset group) exceeds its estimated undiscounted future cash flows, an impairment charge is measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset group, based on discounted cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.45pt">Impairment of goodwill and indefinite-lived intangible assets</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are not amortized. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying amount in accordance with the provisions of ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Income taxes</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative, including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance against some or all of the net deferred tax assets does not in any way impact the Company&#8217;s ability to use future tax deductions such as the Company&#8217;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#8217;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine whether the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#8220;more likely than not&#8221; to be sustained, no benefits of the position are recognized. If we determine that a position is &#8220;more likely than not&#8221; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards, to the extent not covered by a valuation allowance, could be materially impacted in the period which such determination is made.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Foreign currency</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s functional currency is the Canadian dollar (&#8220;C$&#8221;) and its reporting currency is the U.S. dollar. Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, U.S. dollar and Israeli New Shekel (&#8220;ILS&#8221;). All assets and liabilities of operations with a functional currency other than the Canadian dollar are translated into Canadian dollars at the period-end currency exchange rates and subsequently translated into U.S. dollars at period-end currency exchange rates. The resulting translation adjustments are recorded in accumulated other comprehensive income (loss), net of tax. Revenues and expenses of operations, as well as all cash flows, with a functional currency other than the Canadian dollar are translated into Canadian dollars at the average exchange rates for the period and subsequently translated into U.S. dollars at the average exchange rates for the period. Transaction gains and losses resulting from changes in foreign currency exchange rates are recorded in either cost of sales, general and administrative expenses, or foreign currency transaction gain (loss) in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos reports through two segments: the U.S. segment and the ROW segment. These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. Refer to Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Segment Information and Disaggregated Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(w)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.12pt">Earnings (loss) per share</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents basic and diluted earnings (loss) per share data for its common shares. Basic earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Fair value measurements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company&#8217;s cash and cash equivalents, accounts receivable, other receivables, loans receivable, account payables and other liabilities approximate fair value, given their short-term nature. Cronos uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. </span></div><div style="margin-bottom:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the three levels of inputs used to measure fair value: </span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. </span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. </span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; valuation techniques using the inputs for the asset or liability that are not based on observable market data.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(y)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Assets held for sale and discontinued operations</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 205-20 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation of Financial Statements: Discontinued Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results when the components of an entity meet the criteria in paragraph ASC 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and other liabilities are reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), are reported as components of net income (loss) separate from the net income (loss) of continuing operations. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(z)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Adoption of new accounting pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, the Company adopted ASU No. 2020-06, Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No. 2020-06 is part of the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The adoption of ASU No. 2020-06 did not have an impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(aa)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-02, Financial Instruments &#8211; Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (&#8220;ASU No. 2022-02&#8221;). ASU No. 2022-02 eliminates the existing troubled debt restructuring recognition and measurement guidance, and instead aligns the accounting treatment to that of other loan modifications. The amendments enhance existing disclosure requirements and introduce new requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. ASU No. 2022-02 also requires that entities disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases. ASU No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-02 to have a material impact on its consolidated financial statements. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#8220;ASU No. 2022-03&#8221;). ASU No. 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered in measuring fair value. The amendments also require additional disclosures for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-03 to have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259607059488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory, net</a></td>
<td class="text">Inventory, net<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, net is comprised of the following items:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,802&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259607019984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Variable interest entities and investments in equity method investments, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds variable interests in Cronos Growing Company Inc. (&#8220;Cronos GrowCo&#8221;), NatuEra S.&#224;.r.l. (&#8220;Natuera&#8221;) and Cannasoul Lab Services Ltd. (&#8220;CLS&#8221;). The Company&#8217;s investments in Cronos GrowCo and Natuera are exposed to economic variability from each entity&#8217;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entity&#8217;s economic performance. Thus, the Company is not considered the primary beneficiary of either entity. The investment in Cronos GrowCo is accounted for as an equity method investment classified as &#8220;Investments in equity method investments, net&#8221; in the consolidated balance sheets. As of December 31, 2022, the investment in Natuera is accounted for as an equity security without a readily determinable fair value classified as &#8220;Other Investments&#8221; in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos GrowCo</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act on June 14, 2018 with the objective of cultivating and commercializing cannabis and cannabis products. Cronos GrowCo&#8217;s economic performance is driven by the day-to-day operations of Cronos GrowCo, which are controlled by 2645485 Ontario Inc. (&#8220;Mucci&#8221;), the Company&#8217;s joint venture partner. </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company concluded that lower than expected sales forecasts combined with the increase to the aggregate principal amount of the GrowCo Credit Facility (as defined below) were indicators of impairment for the Company&#8217;s equity method investment in Cronos GrowCo. Accordingly, the Company performed a quantitative impairment assessment in the third quarter of 2021 to compare the fair value of the investment in Cronos GrowCo to its carrying amount. The fair value was estimated using the discounted cash flow method. Significant inputs included discount rate, growth rates, and cash flow projections. As a result of this analysis, the Company concluded that as of September 30, 2021, the estimated fair value was higher than the carrying amount and no impairment charges were recorded. There were no such indicators of impairment present for the year ended December 31, 2022.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Natuera</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon formation, Natuera was a joint venture registered in Luxembourg with the objective of cultivating and commercializing hemp and cannabis products, and its economic performance is driven by the quantity and strains of cannabis grown. Until December 2022, the Company held variable interests in Natuera through its ownership of 50% of Natuera&#8217;s common shares. An affiliate of Agroidea SAS, a Colombian agricultural services provider, owned the remaining 50% of Natuera&#8217;s common shares (such affiliate, the &#8220;Natuera JV Partner&#8221;). In December 2022, Natuera entered into a $9.5&#160;million convertible bridge loan with the Natuera JV Partner and a new investment group, whereby the Natuera JV Partner and the new investment group provided $9.5&#160;million in exchange for convertible notes that were converted into equity immediately following the closing of the loan. Post-closing, the Company&#8217;s ownership share was diluted to approximately 13.7% and the Company will no longer have any members on the board of directors of Natuera. Given these changes in ownership and board representation, the Company believes it no longer exerts significant influence over Natuera, has discontinued accounting for the investment under the equity method and has reclassified its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets as of December 31, 2022. </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company concluded that lower than expected sales forecasts as of December 31, 2021 were an other than temporary indicator of impairment for the Company&#8217;s equity method investment in Natuera. Accordingly, the Company performed a qualitative assessment to determine whether there was any value remaining in the investment. As a result of this analysis, the Company concluded that, as of December 31, 2021, the estimated fair value was zero, and $167 was recorded as an impairment loss on equity method investments on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CLS</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#8220;Cannasoul Collaboration&#8221;). Cronos Israel agreed to advance up to ILS 8,297 ($2,664) by a non-recourse loan (the &#8220;Cannasoul Collaboration Loan&#8221;) to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan bears interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#8217;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#8217;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company&#8217;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 4 &#8220;Loans Receivable, net&#8221; for further information regarding loans receivable.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in equity method investments, net is as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i, ii, iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7% / 50% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On April 1, 2021, the Company and the Natuera JV Partner, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#8220;Natuera Series A Loan&#8221;), plus accrued interest, into equity of Natuera (&#8220;Natuera Debt Conversion&#8221;). Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and the Natuera JV Partner advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying amount of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximated the then fair value, to investments in equity accounted investees in respect of Natuera. See Note 4 &#8220;Loans Receivable, net.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of December 31, 2021, the Company concluded that the estimated fair value of the investment in Natuera was lower than the carrying amount resulting in an impairment charge of $167 being recorded as an impairment loss on equity method investments in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets. As of December 31, 2022, the Company&#8217;s ownership interest in Natuera was approximately 13.7%.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s share of net income (losses) from equity investments accounted for under the equity method of accounting:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitura</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,313)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">As of December 31, 2022, the Company held a 10% ownership interest in Vitura, and Vitura is no longer considered an equity-method investment. As of December 31, 2020, and up to December 16, 2021, the Company held a 31% ownership interest in Vitura and was considered an equity-method investment. The gross investment balance in Vitura was offset by equity losses as of December 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of December 31, 2021, the combination of the Company&#8217;s share of accumulated net losses and impairment charges was in excess of its equity investment in Natuera, and the net book value of the investment was zero.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheet. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of financial information for the Company&#8217;s equity method investments:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the maximum exposure to loss from the Company&#8217;s investments in equity method investments:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,368&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,866&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,386&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,951&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.24pt">Other investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist of investments in common shares and options of two companies in the cannabis industry. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PharmaCann Option</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, the Company purchased an option (the &#8220;PharmaCann Option&#8221;) to acquire 473,787 shares of Class A Common Stock of PharmaCann, Inc. (&#8220;PharmaCann&#8221;), a vertically integrated cannabis company in the United States, at an exercise price of $0.0001 per share, representing approximately 10.5% of PharmaCann&#8217;s issued and outstanding capital stock on a fully diluted basis as of the date of the PharmaCann Option, for an aggregate purchase price of approximately $110,392. The option exercise will be based upon various factors, including the status of U.S. federal cannabis legalization, as well as regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise. The Company has deemed its influence in PharmaCann to be non-significant. The PharmaCann Option is classified as an investment in an equity security without a readily determinable fair value. The Company measures the PharmaCann Option at cost less accumulated impairment charges, if any, and subsequently adjusted for observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The PharmaCann Option is reported as other investments on the consolidated balance sheet for the periods ended December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, PharmaCann closed its previously announced transaction with LivWell Holdings, Inc. (&#8220;LivWell&#8221;) pursuant to which PharmaCann acquired LivWell (the &#8220;LivWell Transaction&#8221;). LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately 6.4%. As of December 31, 2022, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis was approximately 6.3%. Under the terms of the Company&#8217;s investment in PharmaCann, the Company&#8217;s rights to nominate an observer or a director to the PharmaCann board of directors could be lost if the Company&#8217;s ownership drops below 6% on a fully diluted basis and it sells or transfer all or any portion of the option (subject to certain exceptions). As a result, further dilution could adversely affect the Company&#8217;s rights under the PharmaCann Option. The decrease in the Company&#8217;s ownership percentage since acquisition does not materially affect the Company&#8217;s rights under the PharmaCann Option.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first, third and fourth quarters of 2022, the Company identified adverse forecast changes in the financial performance of PharmaCann as indicators of impairment related to the PharmaCann Option and conducted analyses comparing the PharmaCann Option&#8217;s carrying amount to its estimated fair value. The fair value was estimated using a combination of the income approach and the market approach. Under the income approach, significant inputs used in the discounted cash flow method include discount rate, growth rates, and cash flow projections. Under the market valuation approach, the key assumptions are the selected multiples and the discount for lack of marketability. As a result of these analyses, the Company recorded non-cash impairment charges of $11,238. $28,972 and $21,182 in the first, third and fourth quarters of 2022, respectively, as the difference between the carrying amount of the PharmaCann Option and its estimated fair value, in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company performed an assessment on the existence of impairment indicators on the PharmaCann Option and noted no indicators of impairment existed. As such, no impairment loss on the investment was recorded during the year ended December 31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vitura (formerly known as Cronos Australia)</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2021, Cronos Australia (now, Vitura Health Limited) entered into a merger agreement to acquire 100% of the issued shares of CDA Health Pty Ltd, an Australian medicinal cannabis company, subject to customary closing conditions, including shareholder approval (the &#8220;Cronos Australia Merger&#8221;). The Cronos Australia Merger closed on December 16, 2021. In connection with the closing of the Cronos Australia Merger, all advances made under the Company&#8217;s A$1,500 unsecured loan to Cronos Australia, plus accrued interest and certain royalties payable, were converted into ordinary shares of Cronos Australia. In addition, the Company&#8217;s ownership interest in Cronos Australia decreased to approximately 10% and the Company&#8217;s number of Cronos Australia board seats was reduced from two to zero. On November 29, 2022, the shareholders of Cronos Australia approved the proposal to change the name of the company to &#8220;Vitura Health Limited&#8221; (the &#8220;CAU Name Change&#8221;). On December 2, 2022, in connection with the CAU Name Change, Vitura and the Company mutually agreed to terminate the intellectual property license that granted Vitura the right to use certain intellectual property of the Company, including, but not limited to, the &#8220;Cronos&#8221; name and the PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand. Vitura has 180 days following the date of termination to cease all usage of the Company&#8217;s intellectual property. The reduction in ownership interest and loss of all board seats constituted a loss of significant influence and resulted in a reclassification on the consolidated balance sheet from investments in equity method investments using the equity method of accounting to other investments using the fair value method of accounting, with unrealized holding gains and losses included in net income (loss) on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a gain on revaluation of other investments of $14,739 and $8,287, included in the gain on revaluation of financial instruments on the statements of net income (loss) and comprehensive income (loss), for the years ended December 31, 2022 and 2021, respectively. The Company&#8217;s investment in Vitura was $21,993 and $8,000, included in other investments on the balance sheet, as of December 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s other investments activity:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.487%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PharmaCann</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitura</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(746)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,739&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,392)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(746)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,993&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Disposal of investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s gain from disposals of investments:</span></div><div style="margin-bottom:2pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:1pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received 980,662 common shares of Aurora Cannabis Inc. (&#8220;Aurora&#8221;). The Company sold all 980,662 of the Aurora common shares during the year ended December 31, 2020, for gross proceeds of approximately $4,789, resulting in a $4,789 gain on disposal of investments being recorded on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259522784080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock', window );">Loan Receivable, Net</a></td>
<td class="text">Loans Receivable, net <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans receivable, net consists of the following:</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,890&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Long-term portion of accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos GrowCo Credit Facility</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2019, the Company, as lender, and Cronos GrowCo, as borrower, entered into a senior secured credit agreement for an aggregate principal amount of C$100,000 (the &#8220;GrowCo Credit Facility&#8221;). In August 2021, the GrowCo Credit Facility was amended to increase the aggregate principal amount available to C$105,000. As a result of the increase in the aggregate principal amount of the GrowCo Credit Facility and lower than expected sales forecasts from Cronos GrowCo, the Company revalued its allowance for credit loss on the GrowCo Credit Facility resulting in an increase in the allowance of $12,748, which was recorded in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021. In conjunction with the aforementioned revaluation, the Company changed its expected credit loss valuation methodology from the historical credit loss method to the probability of default method. As of December&#160;31, 2022 and 2021, Cronos GrowCo had drawn C$104,000 ($76,730) and C$104,000 ($81,598), respectively, from the GrowCo Credit Facility. As of December 31, 2022, Cronos GrowCo had repaid C$4,000 ($3,073) in principal under the terms of the GrowCo Credit Facility.</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mucci Promissory Note</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2019, the Company entered into a promissory note receivable agreement (the &#8220;Mucci Promissory Note&#8221;) for C$16,350 (approximately $12,063) with Mucci. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci. On September 30, 2022, the Mucci Promissory Note was amended and restated to increase the interest rate from 3.95% to the Canadian Prime Rate plus 1.25%, change the interest payments from quarterly to annual, and defer Mucci&#8217;s initial cash interest payment from September 30, 2022 to July 1, 2023. This debt modification resulted in an increase of approximately C$180 ($140) in interest income.</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cannasoul Collaboration Loan</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both December&#160;31, 2022 and 2021, CLS has received ILS 8,297 (approximately $2,359 and $2,664, respectively), from the Cannasoul Collaboration Loan. See Note 3 &#8220;Investments&#8221; for further information regarding the Cannasoul Collaboration Loan.</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> credit loss allowances on the Company&#8217;s long-term financial assets were comprised of the following items:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(827)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(807)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,594&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(866)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,066&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December 31, 2021, $737 of expected credit losses on long-term financial assets was transferred to investments in equity method investments in relation to the Natuera Debt Conversion, as the carrying amount of the loan receivable, net, approximated fair value as of the date of transfer. During the years ended December 31, 2022 and 2021, $(662) and $12,939, respectively, were recorded to general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss) as a result of adjustments to our expected credit losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a company, excluding disclosure for allowance for credit losses. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Also excludes disclosure for financing receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259615522720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, net</a></td>
<td class="text">Property, plant and equipment, net<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,306)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114,301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,070&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, depreciation expense on property, plant and equipment was $8,667, $11,668 and $9,052, respectively, and was included in cost of sales as well as depreciation and amortization in operating expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-lived Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company recognized an impairment charge of $1,507 related to leasehold improvements and other office equipment that it plans to include in any potential sublease agreement of the Company&#8217;s corporate headquarters, encompassing approximately 29,000 square feet, in Toronto, Ontario, Canada. The determination to seek a sublease of the property and include leasehold improvements and other office equipment in any potential sublease agreement triggered the impairment charges. The impairment charge was recognized as impairment loss on long-lived assets on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company concluded that indicators of impairment were present with respect to its Canadian asset group in connection with the previously anticipated wind-down and closure of the Company&#8217;s facility in Stayner, Ontario. As a result, the Company compared the sum of the undiscounted future cash flows attributable to the Canadian asset group to their respective carrying amounts and recorded a non-cash impairment charge on long-lived assets of $113,917 as the difference between the carrying amount of the asset group and its estimated fair value for the year ended December 31, 2021, in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, in connection with the Company&#8217;s reassessment of indicators of impairment relating to the U.S. segment&#8217;s property, plant and equipment asset group for the quarter ended June 30, 2021, the Company concluded that triggers were present that indicated that the carrying amounts of those assets were not recoverable. Accordingly, the Company compared the sum of the undiscounted future cash flows attributable to the U.S. asset group (the lowest level for which identifiable cash flows are available) to their respective carrying amount and recorded a non-cash impairment charge on long-lived assets of $1,214 for the difference between the carrying amount of the asset group and its estimated fair values in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company recognized an impairment charge of $1,039 related to leasehold improvements located within leased premises, encompassing approximately 6,000 square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leasehold improvements are being used and the expectation that, more likely than not, the leasehold improvements will be disposed of before the end of their useful life triggered an impairment. The impairment charges were recognized in the consolidated statements of net income (loss) and comprehensive income (loss) as an impairment loss on long-lived assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no impairment charges on property, plant and equipment during the year ended December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259607037072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, net</a></td>
<td class="text">Goodwill and Intangible Assets, net<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Goodwill</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is comprised of the following items:</span></div><div style="margin-bottom:1pt;margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Peace Naturals</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peace Naturals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated impairment charges on goodwill consist of:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company acquired all of the issued and outstanding shares of each of the four Redwood operating subsidiaries (collectively &#8220;Redwood&#8221;) for an aggregate consideration of $283,300 (the &#8220;Redwood Acquisition&#8221;), which included $227,191 in cash and 5,086,586 common shares of the Company with a fair value of $56,109. Goodwill attributable to the acquisition was $213,414. The Company is required to perform a quantitative analysis of goodwill to test for impairment on an annual basis or more frequently when events or changes in circumstances indicate that fair value of the reporting unit may be less than its carrying amount. Under ASC 350 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the qualitative assessment requires the consideration of factors such as recent market transactions, macroeconomic conditions, and changes in projected future cash flows or planned revenue or earnings of the reporting unit as indicators of impairment when determining the need for a quantitative assessment of impairment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company reassessed the existence of impairment indicators on goodwill associated with the U.S. reporting unit, derived from the Redwood Acquisition, and the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand indefinite-lived intangible asset as of June 30, 2021, and determined that quantitative impairment analyses were required as of June 30, 2021 due to slower actual revenue growth as compared to previous revenue growth forecasts and significant pricing pressures brought about by increased competition and aggressive discounting in the U.S. reporting unit and associated with the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand indefinite-lived intangible asset. As such, the Company reassessed its estimates and forecasts as of June 30, 2021, to determine the fair values of the reporting unit and intangible asset using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand. Significant inputs include discount rates, growth rates, and cash flow projections, and, for the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand, royalty rate. These valuation inputs are considered Level 3 inputs as defined by ASC 820 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result of the analysis as of June 30, 2021, the Company concluded that the carrying amount of the U.S. reporting unit exceeded its fair value, which resulted in the recognition of an impairment charge of $178,414 on goodwill associated with its U.S. reporting unit on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the second quarter, represented indicators of impairment for the Company&#8217;s U.S. reporting unit. Accordingly, the Company performed an interim impairment analysis as of June 30, 2020, which revealed the carrying amount of the reporting unit exceeded its fair value. As a result, the Company recorded an impairment charge of $35,000 on goodwill associated with its U.S. reporting unit for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Intangible assets, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net are comprised of the following items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.764%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,388)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,008)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,416&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,062)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,650)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.764%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,666)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,079&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ginkgo Exclusive Licenses</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CBGA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company achieved the final productivity target in respect of cannabigerolic acid (&#8220;CBGA&#8221;), under the Ginkgo Collaboration Agreement. As a result, on August 21, 2021, the Company issued 1,467,490 common shares at a share price of C$7.90 for total consideration given of C$11,593 ($9,042) to Ginkgo through the Ginkgo Collaboration Agreement for the achievement of commercialization and productivity milestones for CBGA. The estimated fair value of the exclusive license for CBGA (the &#8220;CBGA Exclusive License&#8221;) was $7,300 determined using a variation of the income approach called the relief-from-royalty method, which requires an estimate or forecast of the expected future cash flows. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years. The difference between the consideration paid to Ginkgo and the fair value of the exclusive license intangible asset of $1,784 was recognized as an impairment charge on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CBGVA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November, 2021, the Company achieved the final productivity target in respect of cannabigerovarinic acid (&#8220;CBGVA&#8221;). As a result, on November 12, 2021, the Company issued 1,467,490 common shares at a share price of C$7.12 for total consideration given of C$10,449 ($8,150) to Ginkgo. The estimated fair value of the exclusive license for CBGVA (the &#8220;CBGVA Exclusive License&#8221;) was $5,300 determined using a variation of the income approach called the relief-from-royalty method, which requires an estimate or forecast of the expected future cash flows. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years. The difference between the consideration paid to Ginkgo and the fair value of the exclusive license intangible asset of $3,008 was recognized as an impairment charge on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">THCVA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company achieved the final productivity target in respect of tetrahydrocannabivaric acid (&#8220;THCVA&#8221;) under the Ginkgo Collaboration Agreement. As a result, the Company issued 2,201,236 common shares at a share price of C$3.47, and made a cash payment of $600, for total consideration of C$8,412 ($6,522) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CBCA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company achieved the early commercialization milestone in respect of cannabichromenic acid (&#8220;CBCA&#8221;) under the Ginkgo Collaboration Agreement. As a result, the Company issued 489,163 common shares at a share price of C$4.11 for total consideration of C$2,010 ($1,473) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CBCVA</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company achieved the final productivity target in respect of cannabichromevarinic acid (&#8220;CBCVA&#8221;) under the Ginkgo Collaboration Agreement. As a result, the Company issued 1,467,490 common shares at a share price of C$3.44 for total consideration of C$5,048 ($3,724) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, the aggregate amortization expense on intangible assets was $2,751, $1,800 and $814, respectively, and was included in depreciation and amortization in operating expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization of definite-lived intangible assets is as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated impairment charges on intangible assets, net consist of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">brand</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,650)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,792)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones&#174; brand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,053)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,389)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, in connection with the previously anticipated wind-down and closure of the Company&#8217;s facility in Stayner, Ontario, the Company determined that the Peace Naturals Health Canada license associated with ongoing use of the Peace Naturals Campus for cannabis cultivation and production was also impaired. Accordingly, the Company recorded an impairment loss on long-lived assets in its ROW segment of $5,951 in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As mentioned above, during third and fourth quarter of 2021, the fair value of each of the Company&#8217;s Ginkgo exclusive licenses for two cannabinoids that achieved productivity milestones in 2021 were deemed to be lower than the consideration paid for each of those licenses. As a result, the Company recorded an aggregate impairment loss of $4,792 on long-lived assets for the year ended December&#160;31, 2021 in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company concluded the carrying amount of the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand exceeded its fair value, which resulted in impairment charges of $56,500 on its Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand in the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk1MzA0_7f2cac1a-2c68-4900-8eb5-5a1100ca88a2">consolidated statements of net income (loss) and comprehensive income (loss)</span> for the year ended December 31, 2021. Additionally, in the fourth quarter of 2021, due to the U.S. segment&#8217;s sustained operating losses and lack of revenue growth, the Company performed an additional impairment test on Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand intangible asset. As a result, the Company concluded the carrying amount of the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand exceeded its fair value, which resulted in an additional impairment charge of $1,000 on its Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand for the year ended December 31, 2021 in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter, represented indicators of impairment for the U.S. reporting unit&#8217;s Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand. Accordingly, the Company performed an interim impairment analysis as of June 30, 2020, which concluded the carrying amount of the brand exceeded its fair value. As a result of the analysis, the Company recorded an impairment loss on indefinite-lived intangible assets of $5,000 on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment charges on the Company&#8217;s Health Canada licenses for the year ended December 31, 2020 are related to the discontinuation of Original B.C. Ltd. (&#8220;OGBC&#8221;).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521563920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into leases primarily for the land-use rights, office premises and equipment used in the production of cannabis, U.S. hemp-derived cannabinoids and other related products. The Company&#8217;s leases have terms that range from three years to six years, excluding land use rights, which generally extend to 15 years. These leases often include options to extend the term of the lease for up to 10 years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company&#8217;s consolidated balance sheet. The Company&#8217;s finance leases were not material for any of the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.680%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow and other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows - cash paid for operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activity - right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years) &#8211; operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, the aggregate depreciation expense on right-of-use assets was $1,704, $1,934 and $1,310, respectively, and was included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company recognized an impairment charge of $1,986 related to the right-of-use lease asset associated with the Company&#8217;s corporate headquarters, encompassing approximately 29,000 square feet, in Toronto, Ontario, Canada, for which the Company determined it would seek a sublease.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended, December 31, 2021, the Company recognized an impairment charge of $702 related to the right-of-use asset associated with leased premises, encompassing approximately 6,000 square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leased asset was being used and the expectation that, more likely than not, the leased asset would be abandoned before the end of the lease term triggered an impairment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s future minimum lease payments under operating leases for its premises due in future fiscal years:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the minimum lease payments, the Company is required to pay realty taxes and other occupancy costs in accordance with the terms of the lease agreements.<br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259607016256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Liabilities</a></td>
<td class="text">Derivative Liabilities <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, the Company closed the previously announced investment in the Company (the &#8220;Altria Investment&#8221;) by Altria Group Inc. (&#8220;Altria&#8221;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company and one warrant of the Company (the &#8220;Altria Warrant&#8221;), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximate 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). On December 16, 2022, Altria notified the Company that it was irrevocably relinquishing all of its rights, title and interest in the Altria Warrant, effective immediately. As a result, the Company&#8217;s liability associated with the Altria Warrant was reduced to nil, with the change recorded to gain on revaluation of derivative liabilities for the year ended December 31, 2022. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#8220;Investor Rights Agreement&#8221;), the Company granted Altria certain rights, among others, summarized in this note.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The Altria Warrant entitled the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional 10% of the common shares of Cronos at a per share exercise price of C$19.00, which was set to expire on March 8, 2023. The Altria Warrant was irrevocably relinquished by Altria on December 16, 2022.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the research and development (&#8220;R&amp;D&#8221;) partnership with Ginkgo, (refer to Note 9 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#8220;Pre-emptive Rights&#8221;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance; provided that if the consideration paid in connection with any such issuance is non-cash, the price per common share of the Company that would have been received had such common shares been issued for cash consideration will be determined by an independent committee (acting reasonably and in good faith); provided further that the price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Collaboration Agreement will be C$16.25 per common share. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below 20%. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#8220;Top-up Rights&#8221;). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the 10 full days preceding such exercise by Altria; provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below 20%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities on the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, Altria beneficially held 156,573,537 of the Company&#8217;s common shares, an approximate 41% ownership interest in the Company (calculated on a non-diluted basis).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of the carrying amounts of the derivative liability are presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,431)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,375&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,060)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,099)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,102)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,360)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,375&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the expected life of the derivative instruments and the Company&#8217;s share price are primary drivers for the changes in the derivative valuations during each reporting period. As the period of time the derivative liability is expected to be outstanding decreases and the share price decreases, the fair value typically decreases for each related derivative instrument. Weighted-average expected life and share price are two of the significant observable inputs used in the fair value measurement of each of the Company&#8217;s derivative instruments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model using the following inputs:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.511%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date (per share in C$)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.44</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.98</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.98</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.98</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.79%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of December&#160;31, 2022 and December&#160;31, 2021, the risk-free interest rate uses a range of approximately 3.81% to 4.37% and 0.16% to 1.10%, respectively, for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of December&#160;31, 2022 and December&#160;31, 2021, the expected life uses a range of approximately 0.25 years to 2.75 years and 0.25 years to 3.75 years, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company. </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying amount of the derivative liability, there would also be an equal and opposite impact on net income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.372%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10% decrease as of December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10% decrease as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside the Company&#8217;s control, which could significantly affect the fair value of these derivative liabilities in future periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259522758656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ginkgo.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On September 4, 2018, the Company announced an R&amp;D partnership with Ginkgo to develop scalable and consistent production of a variety of certain common and lesser-known cannabinoids. As part of this partnership, Cronos agreed to issue up to 14,674,903 common shares of the Company (aggregate value of approximately $100,000 as of July 17, 2018 assuming all milestones are met, collectively the &#8220;Ginkgo Equity Milestones&#8221;) in tranches and $22,000 in cash subject to Ginkgo&#8217;s achievement of certain milestones and to fund certain R&amp;D expenses, including foundry access fees. During the years ended December 31, 2022 and December 31, 2021, 4,157,888 shares and 2,934,980 shares, respectively, of the Company&#8217;s common stock were issued in conjunction with this partnership. No shares were issued for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion &#8211; Israel Institute of Technology (&#8220;Technion&#8221;). Research was focused on the use of cannabinoids and their role in regulating skin health and skin disorders. This research was conducted by Technion over a three-year period and concluded during the fourth quarter of 2021. During the year ended December 31, 2021, the Company funded $60 of cash payments related to this agreement. The Company had no further funding requirements as of both December 31, 2022 and December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the &#8220;Services Agreement&#8221;). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of 105% and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party. See Note 15 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Contingencies</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its consolidated financial condition but could be material to its results of operations for any particular reporting period depending, in part, on its results for that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Class action complaints relating to restatement of 2019 interim financial statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its Chief Executive Officer and now former Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal control were incorrect based on the Company&#8217;s disclosures relating to the Audit Committee of the Board of Director&#8217;s review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names (i) the Company, (ii) its Chief Executive Officer, (iii) now former Chief Financial Officer, (iv) former Chief Financial Officer and Chief Commercial Officer, and (v) current and former members of the Board of Directors (the &#8220;Board&#8221;) as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#8217;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. On June 28, 2021, the Court dismissed motions brought by the plaintiff for leave to commence a claim for misrepresentation under the Ontario Securities Act and for certification of the action as a class action. The plaintiff appealed the Court&#8217;s dismissal of the motions only with respect to the Company, the Chief Executive Officer, and the now former Chief Financial Officer; the remaining defendants were dismissed from the matter with prejudice, and the Company and all individual defendants agreed not to seek costs from plaintiff in connection with the dismissal of the motions. On September 26, 2022, the Court of Appeal for Ontario reversed the Superior Court&#8217;s dismissal of the leave and certification motions, granted the plaintiff leave to proceed to bring a claim for misrepresentation under the Ontario Securities Act, and remitted the certification motion back to the Superior Court.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt">Regulatory reviews relating to restatements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019 as well as the previously disclosed restatement of the second quarter of 2021 interim financial statements (collectively, the &#8220;Restatements&#8221;). The Company has been responding to all such requests for information and cooperating with all regulatory authorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Securities and Exchange Commission Settlement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2022, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) issued an Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8(a) of the Securities Act of 1933 (the &#8220;Securities Act&#8221;) and Section 21(c) of the Exchange Act, Making Findings, and Imposing a Cease-and-Desist Order (the &#8220;SEC Order&#8221;) resolving the Restatements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to settle with the SEC, without admitting or denying the allegations described in the SEC Order. The SEC Order fully and finally disposes of the investigation of the Company by the SEC into the Restatements without the payment of any civil penalty or other amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC Order required the Company to cease and desist from committing or causing any violations and any future violations of Section 17(a) of the Securities Act, Sections 10(b), 13(a), 13(b)(2)(B) of the Exchange Act and Rules 10b-5, 13a-13, 13a-15(a), 13a-16 and 12b-20 thereunder. Additionally, the Company agreed to certain undertakings, which include, among other things, retaining a qualified independent consultant (the &#8220;Consultant&#8221;) to engage in a review of, and make recommendations with respect to, certain of the Company&#8217;s internal accounting controls and internal control over financing reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the SEC Order, the Company (i) lost its status as a well-known seasoned issuer for a period of three years, (ii) is unable to rely on the private offering exemptions provided by Regulations A and D under the Securities Act for a period of five years and (iii) is unable to rely on the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 for a period of three years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OSC Settlement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2022, the Ontario Capital Markets Tribunal approved a settlement agreement (the &#8220;OSC Settlement&#8221;) between the Company and the staff of the Ontario Securities Commission (the &#8220;OSC&#8221;), resolving the Restatements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the OSC Settlement, which fully and finally disposes the investigation of the Company by the OSC, Cronos agreed to pay a total of C$1.34&#160;million to fully settle the matter, and acknowledged that it had failed to comply with the requirement under Section 77 of the Securities Act (Ontario) to file interim financial reports in the manner set out therein and had acted in a manner contrary to the public interest. Additionally, the Company agreed to retain the Consultant to engage in a review of, and make recommendations with respect to, certain of the Company&#8217;s internal accounting controls and internal control over financing reporting, on substantially the same terms as were required by the SEC pursuant the SEC Order. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt">Litigation relating to marketing, distribution and sale of products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of King&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$500&#160;million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5&#160;million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. On January 31, 2022, upon consent of the Company and the plaintiffs, the court dismissed the case in its entirety as to the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California&#8217;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#8217;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Annual Report, the plaintiff has not refiled the complaint.</span></div>The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259522755872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Compensation</a></td>
<td class="text">Share-based Compensation<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Share-based award plans</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has granted stock options, RSUs and DSUs to employees and non-employee directors under the Stock Option Plan dated May 26, 2015 (the &#8220;2015 Stock Option Plan&#8221;), the 2018 Stock Option Plan dated June 28, 2018 (the &#8220;2018 Stock Option Plan&#8221; and, together with the 2015 Stock Option Plan, the &#8220;Prior Option Plans&#8221;), the Employment Inducement Award Plan #1 (the &#8220;Employment Inducement Award Plan&#8221;), the 2020 Omnibus Equity Incentive Plan dated March 29, 2020 (the &#8220;2020 Omnibus Plan&#8221;) and the DSU plan dated August 10, 2019 (the &#8220;DSU Plan&#8221;). The Company can no longer make grants under the Prior Option Plans or the Employment Inducement Award Plan.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total share-based compensation associated with the Company&#8217;s stock options and RSUs:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">Represents share-based compensation awards conditionally approved for grant to one of the Company&#8217;s former executives for a fixed monetary value, but a variable number of shares. These awards were liability-classified until the number of shares was determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Stock options</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the 2015 Stock Option Plan, which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Board to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, no further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2018, the shareholders of the Company approved the 2018 Stock Option Plan, which replaced the 2015 Stock Option Plan. The 2018 Stock Option Plan terminated the Company&#8217;s ability to grant equity under the 2015 Stock Option Plan. As of June 25, </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, the date on which the 2020 Omnibus Plan was approved by the shareholders of the Company, no further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2020, the Board adopted the 2020 Omnibus Plan, which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, RSUs and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board (the &#8220;Compensation Committee&#8221;), and awards may be granted to eligible employees, non-employee directors and consultants. The 2020 Omnibus Plan terminated the Company&#8217;s ability to grant equity awards under the 2018 Stock Option Plan and RSUs under the Employment Inducement Award Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options represent the right to purchase Company common shares on the date of exercise at a stated exercise price. The exercise price of an option generally must be at least equal to the fair market value of the Company common shares on the date of grant. Vesting conditions for grants of options are determined by the Compensation Committee. The typical vesting for stock option grants is quarterly vesting over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMwOTI_c056cf0d-d43a-4943-8813-3c750ae39789">three</span> to five years. The maximum term of options granted under the 2020 Omnibus Plan is seven years. Participants under the 2020 Omnibus Plan are eligible to be granted options to purchase shares at an exercise price established upon approval of the grant by the Compensation Committee. When options are granted, the exercise price is, with respect to a particular date, the closing price as reported by the TSX or the Nasdaq and, if the shares are not traded on the TSX or the Nasdaq, any other stock exchange on which the Company&#8217;s common shares are traded (as selected by the Compensation Committee in good faith taking into account applicable legal and tax requirements) on the immediately preceding trading day (the &#8220;Fair Market Value&#8221;). The 2020 Omnibus Plan does not authorize grants of options with an exercise price below the Fair Market Value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in options:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,939,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,735,985)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(966,692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,350,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2022</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.48&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,867,887&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,598,695)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,939,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.69&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,836,616&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022 and 2021, the fair value per option at grant date was C$2.94 and C$6.39, respectively. The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$4.20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$9.19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price (per option)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$4.20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$9.19</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.39%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of options (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Black-Scholes value at grant date (per option)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$2.94</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.39</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#8217; and non-employees&#8217; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#8217;s share price, adjusted for the Company&#8217;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options outstanding:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options outstanding as of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422,069</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550,074</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,139,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,489,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,127,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,350,600</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,939,330</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Restricted share units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are granted under the 2020 Omnibus Plan. RSUs represent an equivalent amount of Company common shares on the date of issuance at fair value. Fair value is determined using the closing price of the trading day immediately preceding the date of grant. RSUs issued under the 2020 Omnibus Plan typically vest over a three-year period following the grant date and have no performance requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,140,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,151,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(489,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,725,470&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">RSUs granted in the period vest annually in equal installments over a three-year period from either the grant date or after a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzYwNDk_6e990025-ef0a-4b0c-8037-643bef788633">three</span> or five year &#8220;cliff-period.&#8221; All RSUs are subject to such holder&#8217;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">Equity grants for 2020, 2021 and 2022 were held back for certain executives of the Company in connection with ongoing investigations by the SEC and the OSC, which were subsequently settled on October 24, 2022. On August 5, 2022, the Compensation Committee approved the release of these held-back equity grants conditioned upon settlement of the SEC and OSC investigations. These RSUs vest in equal installments over a period of three years from what would have been their original grant dates had the grants not been withheld.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">The weighted-average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Deferred share units</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2019, the Company established the DSU Plan pursuant to which its non-executive directors receive DSUs for Board services. The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX for awards made prior to 2022 and as reported by Nasdaq for awards made in 2022 on the trading day immediately preceding the date of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX for awards made prior to 2022 and as reported by Nasdaq for awards made in 2022 on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,913&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Warrants</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,987,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, there were no warrants outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Liability-classified awards</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Compensation Committee conditionally approved the grant to one of the Company&#8217;s former executives of share-based compensation awards for a fixed monetary amount, but a variable number of common shares. These awards were liability-classified until the number of common shares was determined.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers to equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, there were no liability-classified awards outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259522754480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial reporting purposes, loss from continuing operations before income taxes includes the following components:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.043%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,502)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,267)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,135)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,273)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss before income taxes above excludes losses from discontinued operations of $nil, $500 and $650 for the year ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) consists of the following components:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.043%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,416&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, 2021 and 2020, the Company&#8217;s current income taxes payable were $32,956, $105 and $865, respectively, related to current income tax expense. Included in other receivables as of December&#160;31, 2022, 2021 and 2020 is $40, $543 and $nil, respectively, related to current income tax benefits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax differs from that computed using the combined Canadian federal and provincial statutory income tax rate of 26.5%. Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.082%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.199%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.199%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,559)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,135)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,273)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,658)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,241)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of provincial tax rate difference</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates outside of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in tax rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value gain on financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,726)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,873)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital gain on financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance recorded against the loss on discontinued operations is not reflected in the effective tax rate reconciliation presented above for continuing operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, the Company realized a capital gain for tax purposes of $479,800 as a result of Altria&#8217;s irrevocable relinquishment of the Altria Warrant on December 16, 2022, resulting in an increase in the total income tax expense reported for the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company&#8217;s deferred tax assets and liabilities:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.291%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D investment tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,841&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224,776)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,343)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;padding-left:20.88pt;position:relative;top:-3.5pt;vertical-align:baseline">Net deferred tax asset (liability) is reported as Other assets within our consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The realization of deferred tax assets is dependent on the Company&#8217;s generating sufficient taxable income in the years that the temporary differences become deductible. A valuation allowance has been provided for the deferred tax assets that the Company determined did not meet the more-likely-than-not recognition threshold under U.S. GAAP.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and 2021, the Company&#8217;s valuation allowance was $214,199 and $224,776, respectively. The valuation allowance decreased by $10,577 during the year ended December 31, 2022, and increased by $138,841 during the year ended December 31, 2021. The decrease in the valuation allowance during the year ended December 31, 2022, was primarily due to the recognition of a portion of deferred tax assets for which a valuation allowance was recorded in the prior year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#8217; taxable income of approximately $216,120, $134,593, $18,739, respectively. As of December&#160;31, 2021, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#8217; taxable income of approximately $276,497, $117,983, and $24,843, respectively. The net operating losses in Canada will begin to expire, for purposes of carryforward, in fiscal year 2033. The net operating losses in the U.S. can be carried forward indefinitely for federal purposes. The net operating losses in Israel can be carried forward indefinitely. The decrease in net operating loss carry-forward balance reported in Canada was primarily due to the Company utilizing a portion of its net operating loss carry-forward balance in Canada to offset a portion of the capital gain realized as a result of Altria&#8217;s irrevocable relinquishment of the Altria Warrant on December 16, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss carryforwards may be subject to limitations under the tax laws applicable in each tax jurisdiction due to ownership changes that could occur in the future. These ownership changes could limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax expense. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact the Company&#8217;s effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company has various scientific research and experimental development investment tax credit carryforwards of $293 related to Canadian operations, which, if not utilized, will begin to expire in 2040. Investment tax credits are recognized when realization of the tax credits is more likely than not.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal income tax returns in Canada, Israel and the U.S. The Company has open tax years with the taxation jurisdictions. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulations and tax treaties, as they relate to the amount, timing, or inclusion of revenue and expense. As of December&#160;31, 2022, Peace Naturals is under examination with the Canadian Reserve Agency for tax years 2019 and 2020.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Open Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 &#8211; 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2022</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance clarifies the accounting for uncertain tax positions and prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. Additionally, the authoritative guidance addresses the derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions. Only tax positions that meet the more-likely-than-not recognition threshold may be recognized. There were no identified unrecognized tax benefits as of December&#160;31, 2022 or December&#160;31, 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, deferred income taxes have not been provided for any undistributed earnings from operations outside of Canada. The foreign subsidiaries have accumulated losses and as such the amount of undistributed earnings upon which income taxes have not been provided is immaterial to these consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521595152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Disaggregated Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information and Disaggregated Revenue</a></td>
<td class="text">Segment Information and Disaggregated Revenue<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment reporting is prepared on the same basis that the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) manage the business, make operating decisions and assess the Company&#8217;s performance. For the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company determined that it has the following two reportable segments: United States and Rest of World. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States operating segment consists of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacture and distribution of U.S. hemp-derived products. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of World operating segment is involved in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the cultivation, manufacture, and marketing of cannabis-derived products for the medical and adult-use markets</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODM to assess the performance of the segment and make decisions regarding the allocation of resources. The CODM reviews adjusted earnings (loss) before interest, tax, depreciation and amortization (&#8220;Adjusted EBITDA&#8221;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#8217;s assessment of ongoing business performance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below set forth our consolidated results of operations by segment:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,749&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,019&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,537&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,313)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,313)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,351</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,925,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on indefinite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,411)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,227)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,336)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,411)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143,974)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ix)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,134)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,230)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,244)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,608)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283,883)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,811)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,031)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283,095)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,699)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391,304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,611)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,611)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(733)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(viii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,717)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,139)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,607)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,463)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,793)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,293)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(viii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">For the year ended December 31, 2021, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to our U.S. segment and impairment on an indefinite-lived trademark related to the ROW segment. For the year ended December 31, 2020, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to the U.S. segment. See Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">For the year ended December 31, 2022, impairment loss on long-lived assets relates to the Company&#8217;s decision to seek a sublease for leased office space in Toronto, Ontario, Canada during the first quarter of 2022. For the year ended December 31, 2021, impairment loss on long-lived assets relates to impairment charges on property, plant and equipment and definite-lived intangible assets in the Canadian asset group, impairment charges for the differences between the consideration paid to Ginkgo for the achievement of two equity milestones in connection with the Ginkgo Collaboration Agreement and the fair values of the CBGA Exclusive License and CBGVA Exclusive License as well as impairment on leased premises in the U.S. segment. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221; and Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">For the years ended December&#160;31, 2022, 2021 and 2020, the gain on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 8 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Derivative Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December 31, 2022 and 2021, gain on revaluation of financial instruments relates primarily to the Company&#8217;s unrealized holding gain on its mark-to-market investment in Vitura as well as revaluations of financial liabilities resulting from DSUs. For the year ended December 31, 2020, (gain) loss on revaluation of financial instruments relates to revaluations of financial liabilities resulting from DSUs. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the years ended December 31, 2021 and 2020, transaction costs represent legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:19.8pt">For the year ended December 31, 2022, impairment loss on other investments related to the PharmaCann Option for the difference between its fair value and carrying amount. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt">For the year ended December 31, 2022, other, net primarily related to $877 loss on disposal of assets and $384 of dividends declared by Vitura on the Company&#8217;s 55,176,065 ordinary shares in the capital of Vitura. For the years ended December 31, 2021 and 2020, other, net is primarily related to (gain) loss on reclassification of held-for-sale assets and (gain) loss on disposal of assets.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.62pt">For the years ended December 31, 2021 and 2020, loss from discontinued operations relates to the discontinuance of OGBC.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December 31, 2022, restructuring costs related to the employee-related severance costs and other restructuring costs associated with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. See Note 16 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Restructuring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the years ended December&#160;31, 2022, 2021 and 2020, share-based compensation relates to the vesting expenses of share-based compensation awarded to employees under the Company&#8217;s share-based award plans as described in Note 10. &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Share-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(xi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the years ended December&#160;31, 2022, 2021 and 2020, financial statement review costs include costs related to the restatements of the Company&#8217;s 2019 interim financial statements and second quarter 2021 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatements and legal costs defending shareholder class action complaints brought against the Company as a result of the 2019 restatement. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(xii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:18.36pt">For the year ended December 31, 2020, gain on disposal of investments is primarily comprised of the gain recorded related to the sale of common shares of Aurora, which were received in connection with the achievement of a milestone related to the Whistler Transaction in 2020 and as a result of the closing of the Whistler Transaction in 2019. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net were physically located in the following geographic regions: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,070&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523259200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) per Share</a></td>
<td class="text">Earnings (Loss) per Share<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continued and discontinued operations are calculated as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic loss per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations attributable to the shareholders of Cronos&#160;Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395,607)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding for computation for basic earnings per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding from computation for basic earnings per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted loss per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss used in the computation of basic loss from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395,607)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for exercise of rights on derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss used in the computation of diluted loss from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395,607)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding used in the computation of basic loss per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of Altria Warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Top-up Rights &#8211; market price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares for computation of diluted loss from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted loss per share from continuing operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares for computation of diluted loss from discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted loss from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total securities of 112,612,579, 125,195,001 and 151,338,762 were not included in the computation of diluted shares outstanding for the years ended December 31, 2022, 2021 and 2020, respectively, because the effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259522753088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments<div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Fair value measurement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with ASC 820 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt">On December 16, 2021, Cronos Australia (now, Vitura) closed their merger agreement to acquire CDA Health Pty Ltd, an Australian medicinal cannabis company. In connection with the closing of the Cronos Australia Merger, the Company&#8217;s ownership interest in Cronos Australia decreased to approximately 10% and the Company&#8217;s number of Cronos Australia board seats was reduced from two to zero which constituted a loss of significant influence. As such, the Company reclassified the investment from an investment in equity method investments under the equity method of accounting to other investments under the fair value method of accounting. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between fair value categories during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a non-recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt">On June 14, 2021, the Company purchased an option to acquire 473,787 shares of Class A Common Stock of PharmaCann, a vertically integrated cannabis company in the United States, at an exercise price of $0.0001 per share, representing approximately 10.5% of PharmaCann&#8217;s issued and outstanding capital stock on a fully diluted basis as of the date of the PharmaCann Option, for an aggregate purchase price of approximately $110,392. On February 28, 2022, PharmaCann closed its previously announced transaction with LivWell pursuant to which PharmaCann acquired LivWell. LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately 6.4%. As of December 31, 2022, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis was approximately 6.3%. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between fair value categories during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Financial risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities expose it to a variety of financial risks, including credit risk, liquidity risk, market risk, interest rate risk, and foreign currency rate risk.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short term investments, loans receivable, and advances to joint ventures. The Company&#8217;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $987,442 and $1,118,684 as of December&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.57pt">Accounts receivable</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had accounts receivable of $23,113 and $22,067 as of December&#160;31, 2022 and December&#160;31, 2021, respectively. An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than 120 days past due. As of December&#160;31, 2022, 2021 and 2020, the Company had $2, $8 and $9, respectively, in expected credit losses on receivables from contracts with customers in the ROW segment and $217, $104 and $65, respectively, in expected credit losses on receivables from contracts with customers in the U.S. segment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company has assessed that there is a concentration of credit risk as 55% of the Company&#8217;s accounts receivable were due from three customers with an established credit history with the Company. As of December&#160;31, 2021, 88% of the Company&#8217;s accounts receivable were due from four customers with an established credit history with the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#8217;s revenues. During the year ended December&#160;31, 2022, the Company earned a total net revenue before excise taxes of $63,509 from three major customers in the ROW segment, together accounting for 55% of the Company&#8217;s total net revenue before excise taxes. During the year ended December&#160;31, 2021, the ROW segment earned a total net revenue before excise taxes of $41,603 from three major customers, together accounting for 56% of the Company&#8217;s total net revenue before excise taxes. During the year ended December&#160;31, 2020, the ROW segment earned a total net revenue before excise taxes of $34,295 from four major customers, accounting for 63% of the Company&#8217;s total net revenues before excise taxes. During the years ended December&#160;31, 2022, 2021, and 2020 the U.S. segment had no major customers. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.8pt"> Cash and cash equivalents, short-term investments, and other receivables</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held cash and cash equivalents of $764,644 and $886,973 as of December&#160;31, 2022 and December&#160;31, 2021, respectively. The short-term investments and related interest receivable of $113,077 and $117,684 as of December&#160;31, 2022 and December&#160;31, 2021, respectively, represent short-term investments with a maturity of less than a year and accrued interest. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#8217; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#8217;s accounts payable. The Company had trade accounts payable of $8,599 and $8,395 as of December&#160;31, 2022 and December&#160;31, 2021, respectively, included in accounts payable on the consolidated balance sheet. The Company&#8217;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#8217;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#8217;s funding has primarily been provided in the form of capital raised through the issuance of common shares and warrants. As of December&#160;31, 2022, the Company has assessed a concentration of risk of vendors as 27% of accounts payable were due to one vendor. As of December&#160;31, 2021, the Company has assessed a concentration risk of vendors as 19% of accounts payable due to one vendor.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that unfavorable market conditions could result in dispositions of investments at less than their carrying amounts. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#8217;s investments, which would have an adverse impact on the Company&#8217;s results of operations, unless these would flow through other comprehensive income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages risk by having a portfolio of securities from multiple issuers, such that the Company was not materially exposed to any one issuer. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those that possess a short term to maturity. A 10% change in the interest rate in effect on December&#160;31, 2022 and December&#160;31, 2021, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#8217;s investment strategy as a result.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company had net interest income of $22,537 and $9,071, respectively. During the year ended December&#160;31, 2022, the Company&#8217;s average variable interest rate increased approximately 3.5%. During the year ended December&#160;31, 2021, the Company&#8217;s average variable interest rate did not change materially.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency risk </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on investments in equity investments denominated in A$ and C$, and other assets and liabilities denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#8217;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#8217;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and December&#160;31, 2021, the Company had foreign currency gain (loss) on translation of $(50,616) and $8,192, respectively. A 10% change in the exchange rates for the foreign currencies would affect the carrying amounts of net assets by approximately $77,414 and $87,705 as of December&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521315152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Altria</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a 45% equity interest in the Company. As of December 31, 2022, Altria beneficially held an approximately 41% ownership interest in the Company (calculated on a non-diluted basis).</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#8220;Altria Pinnacle&#8221;):</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no amounts payable related to the consulting services with Altria Pinnacle as of December 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 8 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for further information on the derivative liabilities related to the Altria Investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Cronos GrowCo</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company holds a variable interest in Cronos GrowCo through its ownership of 50% of Cronos GrowCo&#8217;s common shares and senior secured debt in Cronos GrowCo. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; for further discussion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company made the following purchases of cannabis products from Cronos GrowCo:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cronos GrowCo &#8211; purchases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s outstanding payable balance to Cronos GrowCo was $2,519 and $82 as of December 31, 2022 and December 31, 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, on August 23, 2019, the Company, as lender, and Cronos GrowCo, as borrower, entered into the GrowCo Credit Facility. See additional information in Note 4 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Loans Receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:24.91pt">Vendor Agreement</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In November 2022, the Company entered into an agreement with an external vendor whereby the vendor would provide certain manufacturing services to the Company. The vendor then subcontracted out a portion of those services to another company whose chief executive officer is an immediate family member of an executive of the Company.  The Company has no direct contractual relationship with the related party.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During the year-ended 2022, the Company purchased $645 of products and services under this agreement and had no outstanding accounts payable related to the agreement as of December 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259607372576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Repurposing Charges</a></td>
<td class="text">Restructuring<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company initiated a strategic plan to realign the business around its brands, centralize functions and evaluate the Company&#8217;s supply chain (the &#8220;Realignment&#8221;). As part of the Realignment, on February 28, 2022, the Board approved plans to leverage the Company&#8217;s strategic partnerships to improve supply chain efficiencies and reduce manufacturing overhead by exiting its production facility in Stayner, Ontario, Canada (the &#8220;Peace Naturals Campus&#8221;). On February 27, 2023, the Board approved revisions to the Realignment, which are expected to result in the Company maintaining select components of its operations at the Peace Naturals Campus, namely distribution warehousing, certain R&amp;D activities and manufacturing of certain of the Company&#8217;s proprietary innovation products, while seeking to lease the remaining portions of the Peace Naturals Campus to third parties. The Realignment initiatives were intended to position the Company to drive profitable and sustainable growth over time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company recognized $5,333 of restructuring costs in connection with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. Charges related thereto include employee-related costs such as severance, relocation and other termination benefits, as well as contract termination and other related costs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following restructuring costs by reportable segment:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restructuring activity for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:39.764%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments/Write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,641)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,909)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521315152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsIn March 2022, following the evaluation of our global supply chain, we announced the planned exit of our Peace Naturals Campus as part of the Realignment. Given the constantly evolving operating landscape Cronos participates in and our continued work towards building an efficient global supply chain, we continue to remain agile in our evaluation of our footprint and the market&#8217;s capabilities. To that end, in February 2023, the Board approved plans to maintain select components of the Company&#8217;s operations at the Peace Naturals Campus, namely distribution and warehousing, certain R&amp;D activities and manufacturing of certain of the Company&#8217;s proprietary innovation products.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259524610704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation, and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text">Basis of presentationThe accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Certain prior year amounts have been reclassified to conform to the current year presentation of our consolidated financial statements. These reclassifications had no effect on reported results of operations and ending shareholders&#8217; equity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of consolidation</a></td>
<td class="text">Basis of consolidationThe accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the reporting periods. The Company assesses control under the variable interest entity (&#8220;VIE&#8221;) model to determine whether the Company is the primary beneficiary of that entity&#8217;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting.In the consolidated statements of net income (loss) and comprehensive income (loss), net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#8217; equity section of the consolidated balance sheets and consolidated statements of shareholders&#8217; equity. All intercompany transactions and balances are eliminated upon consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, expected credit losses on long-term financial assets, impairment losses on goodwill and indefinite-lived intangible assets, impairment losses on long-lived assets, inventory write-downs, share-bared payments, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents and short-term investments</a></td>
<td class="text">Cash and cash equivalents and short-term investmentsCash and cash equivalents are comprised of cash and highly liquid short-term investments that are readily convertible into known amounts of cash, generally with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. Short-term investments consist of debt securities that (i) generally have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. Short-term investments are classified as either available-for-sale or held-to-maturity and recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheets and interest income, net on the consolidated statements of net income (loss) and comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#8217;s consolidated statements of cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of raw materials, finished goods and work-in-progress, such as pre-harvested cannabis plants, dried cannabis flower, by-products to be extracted, cannabis extracts and by-products, dry cannabis and cannabis extract containers, and boxes. When the Company cultivated cannabis, costs capitalized into inventory until the time of harvest included, but were not limited to, labor, utilities, nutrition and irrigation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, contract manufacturer fees, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of net realizable value include slow-moving or non-marketable products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable interest entities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable interest entities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A variable interest entity is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#8217;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#8217;s expected losses or receive portions of the VIE&#8217;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on a periodic basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination, the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates a VIE when it is determined that it is the primary beneficiary of the VIE.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity method investments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity method investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest using the equity method. Under the equity method, the Company records its proportionate share of income or loss in share of income (loss) from equity method investments within the consolidated statements of net income (loss) and comprehensive income (loss). Cash payments to equity method investees such as additional investments or expenses incurred on behalf of investees, as well as income earned and payments from equity method investees such as dividends and distributions are recorded as adjustments to investment balances. If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized in one period cannot be reversed in subsequent periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Other investments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments include common stock and options in third party entities in which the Company&#8217;s influence is deemed non-significant. The Company holds other investments with and without readily determinable fair values. Other investments with readily determinable fair values are recorded using the fair value method of accounting as of period-end on the consolidated balance sheets. Other investments without readily determinable fair values are recorded using the cost method of accounting on the consolidated balance sheets. Other investments without readily determinable fair values are assessed for observable price changes and other than temporary impairment on a periodic basis. Changes in the reported value of other investments are reported in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, plant &amp; equipment</a></td>
<td class="text">Property, plant and equipment<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.094%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:60.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available for use is defined as the point at which the related property, plant and equipment is operational, including the possession of any requisite licenses. Depreciation commences at the point the assets are available for use.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Definite life intangible assets</a></td>
<td class="text">Definite-lived intangible assets<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software and payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets originating from the strategic partnership (the &#8220;Ginkgo Strategic Partnership&#8221;) with Ginkgo Bioworks Holdings, Inc. (&#8220;Ginkgo&#8221;) are accounted for in accordance with the acquisition method of accounting. Equity interests issued in exchange for an asset are initially recognized and measured at the date of acquisition at fair value. We estimate fair value using the relief-from-royalty method and key assumptions include the discount rate and estimated life. Definite-lived intangible assets, including intangible assets originating from the Ginkgo Strategic Partnership, are subject to amortization and reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value has been reduced to less than its carrying amount.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AccruedLiabilitiesPolicyPolicyTextBlock', window );">Accrued liabilities</a></td>
<td class="text">Accrued payroll and related expenses include salaries and wages, bonuses, and other related payroll expenses associated with the Company&#8217;s employees. Accrued professional fees include fees for legal expenses, litigation, consulting, marketing, and other related expenses. Accrued taxes include sales, excise and other taxes owed. Other accrued expenses include the fair value of deferred share units outstanding to directors and other general expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#8217;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#8217;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#8217;s depreciation policy if the title is to eventually transfer to the Company.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative liabilities</a></td>
<td class="text">Derivative liabilities<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial instruments classified as derivatives that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in net income (loss) and comprehensive income (loss). For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Derivative Liabilities.&#8221;</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Capital stock</a></td>
<td class="text">Capital stockCapital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text">Revenue recognition<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606, &#8220;Revenue from Contracts with Customers,&#8221; and is measured based on the consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product or service to a customer. The Company&#8217;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and &#8220;hemp&#8221; (as defined in the U.S. Agricultural Improvement Act of 2018 &#8220;U.S. hemp&#8221;) derived products consist of a single performance obligation. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, depending on the specific contractual terms. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer or third-party location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer&#8217;s usage.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, allowances for customer returns and other forms of variable consideration. Within the Company&#8217;s Rest of World segment (the &#8220;ROW segment&#8221;), dried cannabis sales outside of Canada may include commission arrangements with distributors that give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated using the expected value method, based on the Company&#8217;s historical information, at contract inception. The Company&#8217;s payment terms vary by customer and product type. Refer to Note 12 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information and Disaggregated Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for information on disaggregated revenue.</span></div>The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development</a></td>
<td class="text">Research and development <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a research and development center in Canada that performs scientific research on the interaction of cannabinoids as well as strain development, growing conditions, extraction technology, and biosynthesis. Fermentation and production related research is performed to further strategic initiatives around rare cannabinoids. In addition, the Company has a collaboration and license agreement with Ginkgo (the &#8220;Ginkgo Collaboration Agreement&#8221;) to research, produce, and commercialize cultured cannabinoids. Technological feasibility is considered to be established once productivity targets or commercialization are achieved, at which point the exclusive license is recognized at cost less impairment charges. As of the acquisition date of each exclusive license, cost less impairment charges is equal to the fair value. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Note 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information on the Ginkgo Collaboration Arrangement. Research and development costs associated with these collective efforts are expensed as incurred as part of operating expenses in the Company&#8217;s consolidated statements of net income (loss) and comprehensive income (loss).</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising costs</a></td>
<td class="text">Advertising costsAdvertising costs include costs to sell the Company&#8217;s products and are expensed as incurred through sales and marketing expenses in the consolidated statements of net income (loss) and comprehensive income (loss).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text">Share-based compensation<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan, the 2018 Stock Option Plan, the 2015 Stock Option Plan, the Employment Inducement Award Plan and the DSU Plan (each as defined below).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based awards consists of equity-settled share-based awards such as stock options and restricted share units (&#8220;RSUs&#8221;) that are issued to eligible employees, non-executive directors, and non-employees. Cash-settled deferred share units (&#8220;DSUs&#8221;) that are issued to non-executive directors under the DSU Plan are recorded in accrued liabilities with the fair value adjustment recorded in other income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity instruments granted are initially measured at fair value on the grant date. The fair value of stock options is determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price of the Company&#8217;s common shares. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive </span></div>income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities. The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are settled or exercised. Upon settlement or exercise, shares are issued and the amount previously reflected in additional paid-in capital is, along with any proceeds paid upon settlement or exercise, credited to a combination of share capital and additional paid-in capital. Forfeitures of share-based compensation awards are accounted for as reductions to share-based compensation and additional paid-in capital as they occur.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text">Impairment of long-lived assets<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, such as property, plant and equipment and definite-lived intangible assets, for impairment in accordance with ASC Topic 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with ASC Topic 360, long-lived assets to be held are reviewed for events or changes in circumstances that indicate that their carrying amount may not be recoverable. The Company periodically reviews for indicators and, if indicators are present, tests the carrying amount of long-lived assets, assessing their fair values based on estimated undiscounted cash flows over their remaining estimated useful lives. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. If the carrying amount of an asset (or asset group) exceeds its estimated undiscounted future cash flows, an impairment charge is measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset group, based on discounted cash flows.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Impairment of goodwill and indefinite-lived intangible assets</a></td>
<td class="text">Impairment of goodwill and indefinite-lived intangible assets<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are not amortized. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying amount in accordance with the provisions of ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other</span>. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text">Income taxes<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative, including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance against some or all of the net deferred tax assets does not in any way impact the Company&#8217;s ability to use future tax deductions such as the Company&#8217;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#8217;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine whether the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#8220;more likely than not&#8221; to be sustained, no benefits of the position are recognized. If we determine that a position is &#8220;more likely than not&#8221; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards, to the extent not covered by a valuation allowance, could be materially impacted in the period which such determination is made.</span></div>The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currency</a></td>
<td class="text">Foreign currencyThe Company&#8217;s functional currency is the Canadian dollar (&#8220;C$&#8221;) and its reporting currency is the U.S. dollar. Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, U.S. dollar and Israeli New Shekel (&#8220;ILS&#8221;). All assets and liabilities of operations with a functional currency other than the Canadian dollar are translated into Canadian dollars at the period-end currency exchange rates and subsequently translated into U.S. dollars at period-end currency exchange rates. The resulting translation adjustments are recorded in accumulated other comprehensive income (loss), net of tax. Revenues and expenses of operations, as well as all cash flows, with a functional currency other than the Canadian dollar are translated into Canadian dollars at the average exchange rates for the period and subsequently translated into U.S. dollars at the average exchange rates for the period. Transaction gains and losses resulting from changes in foreign currency exchange rates are recorded in either cost of sales, general and administrative expenses, or foreign currency transaction gain (loss) in the consolidated statements of net income (loss) and comprehensive income (loss).<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text">Segments<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos reports through two segments: the U.S. segment and the ROW segment. These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. Refer to Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Segment Information and Disaggregated Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (loss) per share</a></td>
<td class="text">Earnings (loss) per shareThe Company presents basic and diluted earnings (loss) per share data for its common shares. Basic earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurements</a></td>
<td class="text">Fair value measurements<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company&#8217;s cash and cash equivalents, accounts receivable, other receivables, loans receivable, account payables and other liabilities approximate fair value, given their short-term nature. Cronos uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. </span></div><div style="margin-bottom:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the three levels of inputs used to measure fair value: </span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. </span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. </span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; valuation techniques using the inputs for the asset or liability that are not based on observable market data.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Assets held for sale and discontinued operations</a></td>
<td class="text">Assets held for sale and discontinued operations<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 205-20 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation of Financial Statements: Discontinued Operations</span>, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results when the components of an entity meet the criteria in paragraph ASC 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and other liabilities are reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), are reported as components of net income (loss) separate from the net income (loss) of continuing operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Adoption of new accounting pronouncements and New accounting pronouncements not yet adopted</a></td>
<td class="text">Adoption of new accounting pronouncements<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, the Company adopted ASU No. 2020-06, Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No. 2020-06 is part of the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The adoption of ASU No. 2020-06 did not have an impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(aa)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-02, Financial Instruments &#8211; Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (&#8220;ASU No. 2022-02&#8221;). ASU No. 2022-02 eliminates the existing troubled debt restructuring recognition and measurement guidance, and instead aligns the accounting treatment to that of other loan modifications. The amendments enhance existing disclosure requirements and introduce new requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. ASU No. 2022-02 also requires that entities disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases. ASU No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-02 to have a material impact on its consolidated financial statements. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#8220;ASU No. 2022-03&#8221;). ASU No. 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered in measuring fair value. The amendments also require additional disclosures for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-03 to have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AccruedLiabilitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AccruedLiabilitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21459-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259522835968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation, and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock', window );">Schedule of Consolidated Entities</a></td>
<td class="text">The Company consolidates the financial results of the following entities, which the Company controls but does not wholly own:<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:33.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiaries</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction of incorporation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Cultivation Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Manufacturing Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Store Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Pharmacy Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">These Israeli entities are collectively referred to as &#8220;Cronos Israel.&#8221;</span></div>(ii)&#8220;Ownership interest&#8221; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment, Useful Lives</a></td>
<td class="text">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.094%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:60.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr></table><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,306)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114,301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,070&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets Amortization Methods and Rates</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net are comprised of the following items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.764%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,388)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,008)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,416&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,062)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,650)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.764%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,666)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,079&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated impairment charges on intangible assets, net consist of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">brand</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,650)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,792)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones&#174; brand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,053)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,389)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,636&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259525618992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, net is comprised of the following items:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,802&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259526000896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Investments</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in equity method investments, net is as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i, ii, iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7% / 50% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On April 1, 2021, the Company and the Natuera JV Partner, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#8220;Natuera Series A Loan&#8221;), plus accrued interest, into equity of Natuera (&#8220;Natuera Debt Conversion&#8221;). Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and the Natuera JV Partner advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying amount of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximated the then fair value, to investments in equity accounted investees in respect of Natuera. See Note 4 &#8220;Loans Receivable, net.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of December 31, 2021, the Company concluded that the estimated fair value of the investment in Natuera was lower than the carrying amount resulting in an impairment charge of $167 being recorded as an impairment loss on equity method investments in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets. As of December 31, 2022, the Company&#8217;s ownership interest in Natuera was approximately 13.7%.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s share of net income (losses) from equity investments accounted for under the equity method of accounting:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitura</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,313)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">As of December 31, 2022, the Company held a 10% ownership interest in Vitura, and Vitura is no longer considered an equity-method investment. As of December 31, 2020, and up to December 16, 2021, the Company held a 31% ownership interest in Vitura and was considered an equity-method investment. The gross investment balance in Vitura was offset by equity losses as of December 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of December 31, 2021, the combination of the Company&#8217;s share of accumulated net losses and impairment charges was in excess of its equity investment in Natuera, and the net book value of the investment was zero.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheet. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of financial information for the Company&#8217;s equity method investments:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s other investments activity:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.487%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PharmaCann</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitura</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(746)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,739&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,392)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(746)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,993&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in equity method investments, net is as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i, ii, iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7% / 50% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On April 1, 2021, the Company and the Natuera JV Partner, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#8220;Natuera Series A Loan&#8221;), plus accrued interest, into equity of Natuera (&#8220;Natuera Debt Conversion&#8221;). Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and the Natuera JV Partner advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying amount of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximated the then fair value, to investments in equity accounted investees in respect of Natuera. See Note 4 &#8220;Loans Receivable, net.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of December 31, 2021, the Company concluded that the estimated fair value of the investment in Natuera was lower than the carrying amount resulting in an impairment charge of $167 being recorded as an impairment loss on equity method investments in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets. As of December 31, 2022, the Company&#8217;s ownership interest in Natuera was approximately 13.7%.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s share of net income (losses) from equity investments accounted for under the equity method of accounting:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitura</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,313)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">As of December 31, 2022, the Company held a 10% ownership interest in Vitura, and Vitura is no longer considered an equity-method investment. As of December 31, 2020, and up to December 16, 2021, the Company held a 31% ownership interest in Vitura and was considered an equity-method investment. The gross investment balance in Vitura was offset by equity losses as of December 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of December 31, 2021, the combination of the Company&#8217;s share of accumulated net losses and impairment charges was in excess of its equity investment in Natuera, and the net book value of the investment was zero.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheet. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of financial information for the Company&#8217;s equity method investments:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the maximum exposure to loss from the Company&#8217;s investments in equity method investments:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,368&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,866&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,386&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,951&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Summary of Gain from Disposals of Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s gain from disposals of investments:</span></div><div style="margin-bottom:2pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:1pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received 980,662 common shares of Aurora Cannabis Inc. (&#8220;Aurora&#8221;). The Company sold all 980,662 of the Aurora common shares during the year ended December 31, 2020, for gross proceeds of approximately $4,789, resulting in a $4,789 gain on disposal of investments being recorded on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521398576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Loan Receivable</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans receivable, net consists of the following:</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,890&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Long-term portion of accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Financing Receivable, Allowance for Credit Loss</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> credit loss allowances on the Company&#8217;s long-term financial assets were comprised of the following items:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(827)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(807)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,594&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(866)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,066&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December 31, 2021, $737 of expected credit losses on long-term financial assets was transferred to investments in equity method investments in relation to the Natuera Debt Conversion, as the carrying amount of the loan receivable, net, approximated fair value as of the date of transfer. During the years ended December 31, 2022 and 2021, $(662) and $12,939, respectively, were recorded to general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss) as a result of adjustments to our expected credit losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521405664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.094%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:60.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr></table><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,306)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114,301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,070&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259520662224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is comprised of the following items:</span></div><div style="margin-bottom:1pt;margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Peace Naturals</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peace Naturals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated impairment charges on goodwill consist of:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net are comprised of the following items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.764%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,388)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,008)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,416&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,062)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,650)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.764%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,666)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,079&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated impairment charges on intangible assets, net consist of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">brand</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,650)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,792)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones&#174; brand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,053)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,389)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net are comprised of the following items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.764%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,388)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,008)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,416&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,062)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,650)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.764%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total definite-lived intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,666)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,079&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated impairment charges on intangible assets, net consist of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">brand</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,650)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo exclusive licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,792)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones&#174; brand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,053)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,389)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization of definite-lived intangible assets is as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521457264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost and Other Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.680%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow and other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows - cash paid for operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activity - right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years) &#8211; operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments for Operating Leases</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s future minimum lease payments under operating leases for its premises due in future fiscal years:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259524585200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Schedule of Reconciliation of Carrying Amounts</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of the carrying amounts of the derivative liability are presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,431)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,375&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,060)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,099)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,102)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,360)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,375&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Values of Derivative Liabilities</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model using the following inputs:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.511%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date (per share in C$)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.44</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.98</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.98</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.98</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.79%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of December&#160;31, 2022 and December&#160;31, 2021, the risk-free interest rate uses a range of approximately 3.81% to 4.37% and 0.16% to 1.10%, respectively, for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of December&#160;31, 2022 and December&#160;31, 2021, the expected life uses a range of approximately 0.25 years to 2.75 years and 0.25 years to 3.75 years, respectively.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span>Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock', window );">Schedule of Sensitivity Analysis</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying amount of the derivative liability, there would also be an equal and opposite impact on net income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.372%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10% decrease as of December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10% decrease as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514885616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total share-based compensation associated with the Company&#8217;s stock options and RSUs:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">Represents share-based compensation awards conditionally approved for grant to one of the Company&#8217;s former executives for a fixed monetary value, but a variable number of shares. These awards were liability-classified until the number of shares was determined.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Summary of the Changes in Options</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in options:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,939,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,735,985)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(966,692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,350,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2022</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.48&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,867,887&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,598,695)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,939,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.69&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,836,616&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options outstanding:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options outstanding as of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422,069</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550,074</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,139,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,489,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,127,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,350,600</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,939,330</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair Value of Options Issued</a></td>
<td class="text">The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$4.20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$9.19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price (per option)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$4.20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$9.19</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.39%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of options (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Black-Scholes value at grant date (per option)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$2.94</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.39</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table>(i)The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#8217; and non-employees&#8217; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#8217;s share price, adjusted for the Company&#8217;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Share Units Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,140,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,151,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(489,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,725,470&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">RSUs granted in the period vest annually in equal installments over a three-year period from either the grant date or after a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzYwNDk_6e990025-ef0a-4b0c-8037-643bef788633">three</span> or five year &#8220;cliff-period.&#8221; All RSUs are subject to such holder&#8217;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">Equity grants for 2020, 2021 and 2022 were held back for certain executives of the Company in connection with ongoing investigations by the SEC and the OSC, which were subsequently settled on October 24, 2022. On August 5, 2022, the Compensation Committee approved the release of these held-back equity grants conditioned upon settlement of the SEC and OSC investigations. These RSUs vest in equal installments over a period of three years from what would have been their original grant dates had the grants not been withheld.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">The weighted-average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', window );">Summary of Changes in Warrants and DSUs</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,913&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Summary of Outstanding Warrants</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,987,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of Liability-Classified Awards</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers to equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523477232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) before Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial reporting purposes, loss from continuing operations before income taxes includes the following components:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.043%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,502)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,267)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,135)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,273)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Expense for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) consists of the following components:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.043%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,416&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.082%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.199%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.199%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,559)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,135)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,273)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,658)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,241)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of provincial tax rate difference</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates outside of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in tax rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value gain on financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,726)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,873)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital gain on financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company&#8217;s deferred tax assets and liabilities:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.291%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D investment tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,841&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224,776)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,343)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;padding-left:20.88pt;position:relative;top:-3.5pt;vertical-align:baseline">Net deferred tax asset (liability) is reported as Other assets within our consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock', window );">Summary of Income Tax Examinations</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Open Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 &#8211; 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2022</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxExaminationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259515107776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Disaggregated Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Data and Adjusted EBITDA</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below set forth our consolidated results of operations by segment:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,749&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,019&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,537&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,313)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,313)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,351</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,925,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on indefinite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,411)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,227)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,336)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,411)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143,974)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of income from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ix)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,134)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,230)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,244)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,608)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283,883)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,811)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397,204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,031)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283,095)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,699)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391,304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,611)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,611)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(733)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(viii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,717)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,139)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,607)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,463)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,793)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,293)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(viii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(x)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement review costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(xii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">For the year ended December 31, 2021, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to our U.S. segment and impairment on an indefinite-lived trademark related to the ROW segment. For the year ended December 31, 2020, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to the U.S. segment. See Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">For the year ended December 31, 2022, impairment loss on long-lived assets relates to the Company&#8217;s decision to seek a sublease for leased office space in Toronto, Ontario, Canada during the first quarter of 2022. For the year ended December 31, 2021, impairment loss on long-lived assets relates to impairment charges on property, plant and equipment and definite-lived intangible assets in the Canadian asset group, impairment charges for the differences between the consideration paid to Ginkgo for the achievement of two equity milestones in connection with the Ginkgo Collaboration Agreement and the fair values of the CBGA Exclusive License and CBGVA Exclusive License as well as impairment on leased premises in the U.S. segment. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221; and Note 6 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">For the years ended December&#160;31, 2022, 2021 and 2020, the gain on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 8 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Derivative Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December 31, 2022 and 2021, gain on revaluation of financial instruments relates primarily to the Company&#8217;s unrealized holding gain on its mark-to-market investment in Vitura as well as revaluations of financial liabilities resulting from DSUs. For the year ended December 31, 2020, (gain) loss on revaluation of financial instruments relates to revaluations of financial liabilities resulting from DSUs. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the years ended December 31, 2021 and 2020, transaction costs represent legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:19.8pt">For the year ended December 31, 2022, impairment loss on other investments related to the PharmaCann Option for the difference between its fair value and carrying amount. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt">For the year ended December 31, 2022, other, net primarily related to $877 loss on disposal of assets and $384 of dividends declared by Vitura on the Company&#8217;s 55,176,065 ordinary shares in the capital of Vitura. For the years ended December 31, 2021 and 2020, other, net is primarily related to (gain) loss on reclassification of held-for-sale assets and (gain) loss on disposal of assets.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.62pt">For the years ended December 31, 2021 and 2020, loss from discontinued operations relates to the discontinuance of OGBC.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December 31, 2022, restructuring costs related to the employee-related severance costs and other restructuring costs associated with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. See Note 16 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Restructuring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the years ended December&#160;31, 2022, 2021 and 2020, share-based compensation relates to the vesting expenses of share-based compensation awarded to employees under the Company&#8217;s share-based award plans as described in Note 10. &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Share-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(xi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the years ended December&#160;31, 2022, 2021 and 2020, financial statement review costs include costs related to the restatements of the Company&#8217;s 2019 interim financial statements and second quarter 2021 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatements and legal costs defending shareholder class action complaints brought against the Company as a result of the 2019 restatement. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(xii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:18.36pt">For the year ended December 31, 2020, gain on disposal of investments is primarily comprised of the gain recorded related to the sale of common shares of Aurora, which were received in connection with the achievement of a milestone related to the Whistler Transaction in 2020 and as a result of the closing of the Whistler Transaction in 2019. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net were physically located in the following geographic regions: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,070&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521385248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continued and discontinued operations are calculated as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic loss per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations attributable to the shareholders of Cronos&#160;Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395,607)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding for computation for basic earnings per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding from computation for basic earnings per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted loss per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss used in the computation of basic loss from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395,607)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for exercise of rights on derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss used in the computation of diluted loss from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,734)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395,607)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding used in the computation of basic loss per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of Altria Warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Top-up Rights &#8211; market price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares for computation of diluted loss from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted loss per share from continuing operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares for computation of diluted loss from discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,961,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,390,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted loss from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523325808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value of Assets on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt">On December 16, 2021, Cronos Australia (now, Vitura) closed their merger agreement to acquire CDA Health Pty Ltd, an Australian medicinal cannabis company. In connection with the closing of the Cronos Australia Merger, the Company&#8217;s ownership interest in Cronos Australia decreased to approximately 10% and the Company&#8217;s number of Cronos Australia board seats was reduced from two to zero which constituted a loss of significant influence. As such, the Company reclassified the investment from an investment in equity method investments under the equity method of accounting to other investments under the fair value method of accounting. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock', window );">Schedule of Fair Value of Assets on Nonrecurring Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a non-recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt">On June 14, 2021, the Company purchased an option to acquire 473,787 shares of Class A Common Stock of PharmaCann, a vertically integrated cannabis company in the United States, at an exercise price of $0.0001 per share, representing approximately 10.5% of PharmaCann&#8217;s issued and outstanding capital stock on a fully diluted basis as of the date of the PharmaCann Option, for an aggregate purchase price of approximately $110,392. On February 28, 2022, PharmaCann closed its previously announced transaction with LivWell pursuant to which PharmaCann acquired LivWell. LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately 6.4%. As of December 31, 2022, the Company&#8217;s ownership percentage in PharmaCann on a fully diluted basis was approximately 6.3%. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521411776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#8220;Altria Pinnacle&#8221;):</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company made the following purchases of cannabis products from Cronos GrowCo:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cronos GrowCo &#8211; purchases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521563328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Plan Information and Restructuring-Related Costs</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following restructuring costs by reportable segment:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restructuring activity for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:39.764%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments/Write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,641)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,909)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259515139392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.CultivationsLtd.Member', window );">Cronos Israel G.S. Cultivations Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership interest</a></td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.ManufacturingLtd.Member', window );">Cronos Israel G.S. Manufacturing Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership interest</a></td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.StoreLtd.Member', window );">Cronos Israel G.S. Store Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership interest</a></td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelGSPharmacyLtdMember', window );">Cronos Israel G.S. Pharmacy Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership interest</a></td>
<td class="nump">90.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.CultivationsLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.CultivationsLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.ManufacturingLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.ManufacturingLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.StoreLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.StoreLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelGSPharmacyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cron_CronosIsraelGSPharmacyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514784544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building and leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building and leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259522908160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_GinkoExclusiveLicensesMember', window );">Ginkgo exclusive licenses</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_GinkoExclusiveLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_GinkoExclusiveLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518108096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">$ 11,492<span></span>
</td>
<td class="nump">$ 12,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">2,414<span></span>
</td>
<td class="nump">8,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent', window );">Accrued taxes</a></td>
<td class="nump">4,132<span></span>
</td>
<td class="nump">3,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">4,230<span></span>
</td>
<td class="nump">936<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 22,268<span></span>
</td>
<td class="nump">$ 25,636<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Income and Sales and Excise Taxes Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523733136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag', window );">Impairment Of Intangible Asset, Finite-Lived, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag</a></td>
<td class="text">consolidated statements of net income (loss) and comprehensive income (loss)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag', window );">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative Asset (Liability) Gain (Loss), Statement Of Income, Extensible List, Not Disclosed Flag</a></td>
<td class="text">consolidated statements of net income (loss)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative, Asset (Liability) Gain (Loss), Statement Of Other Comprehensive Income, Extensible List, Not Disclosed Flag</a></td>
<td class="text">comprehensive income (loss)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs | $</a></td>
<td class="nump">$ 928<span></span>
</td>
<td class="nump">$ 11,514<span></span>
</td>
<td class="nump">$ 6,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative Asset (Liability) Gain (Loss), Statement Of Income, Extensible List, Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative, Asset (Liability) Gain (Loss), Statement Of Other Comprehensive Income, Extensible List, Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Of Intangible Asset, Finite-Lived, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259515005344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 7,421<span></span>
</td>
<td class="nump">$ 9,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-progress</a></td>
<td class="nump">15,646<span></span>
</td>
<td class="nump">12,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">13,503<span></span>
</td>
<td class="nump">10,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventorySuppliesNetOfReserves', window );">Supplies and consumables</a></td>
<td class="nump">989<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 37,559<span></span>
</td>
<td class="nump">$ 32,802<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventorySuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventorySuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259512619600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details)<br> $ / shares in Units, &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 14, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th">
<div>Dec. 16, 2021 </div>
<div>seat</div>
</th>
<th class="th">
<div>Dec. 15, 2021 </div>
<div>seat</div>
</th>
<th class="th"><div>Oct. 12, 2021</div></th>
<th class="th">
<div>Sep. 14, 2021 </div>
<div>AUD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,755,000<span></span>
</td>
<td class="nump">$ 16,764,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Percentage of ownership after transaction</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Payments to acquire other investments</a></td>
<td class="nump">$ 110,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,392,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain (loss) on revaluation of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,739,000<span></span>
</td>
<td class="nump">8,611,000<span></span>
</td>
<td class="num">$ (9,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,993,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,993,000<span></span>
</td>
<td class="nump">118,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=cron_PharmacannMember', window );">Pharmacann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_PharmacannMember', window );">Pharmacann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">473,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,755,000<span></span>
</td>
<td class="nump">$ 16,764,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentOwnedPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary | Natuera JV Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary | Bridge Loan | Natuera JV Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember', window );">Cannasoul Analytics Ltd. | Variable Interest Entity, Not Primary Beneficiary | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived', window );">Collaborative arrangement, percentage of profits to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced', window );">Collaborative arrangement, profits to be received, maximum percentage of amounts advanced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet', window );">Collaborative arrangement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember', window );">Cannasoul Analytics Ltd. | Variable Interest Entity, Not Primary Beneficiary | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Cannasoul Collaboration Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_CollaborativeArrangementAmountOfAdvances', window );">Collaboration agreement, amount of advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_CollaborativeArrangementTermOfAgreement', window );">Collaborative arrangement, term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_PharmacannMember', window );">Pharmacann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,182,000<span></span>
</td>
<td class="nump">$ 28,972,000<span></span>
</td>
<td class="nump">$ 11,238,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_PharmacannMember', window );">Pharmacann | LivWell Holdings, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_MergerAgreementThresholdOwnershipPercentage', window );">Merger agreement, threshold ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Vitura</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentOwnedPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_NumberOfSeatsOnBoardOfDirectors', window );">Number of seats on board of directors | seat</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain (loss) on revaluation of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,739,000<span></span>
</td>
<td class="nump">8,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,993,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,993,000<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementAmountOfAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Amount Of Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementAmountOfAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Percentage Of Profits To Be Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementPercentageOfProfitsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentOwnedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentOwnedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_MergerAgreementThresholdOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Threshold Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_MergerAgreementThresholdOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfSeatsOnBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Seats on Board of Directors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfSeatsOnBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=cron_PharmacannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=cron_PharmacannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_PharmacannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_PharmacannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_NatueraJVPartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_NatueraJVPartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_PharmacannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_PharmacannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cron_LivWellHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cron_LivWellHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518777472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Schedule of Investments (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 16, 2021</div></th>
<th class="th"><div>Dec. 15, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,755,000<span></span>
</td>
<td class="nump">$ 16,764,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,114,000<span></span>
</td>
<td class="num">(6,313,000)<span></span>
</td>
<td class="num">$ (4,510,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract', window );"><strong>Equity Method Investment, Summarized Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960,156,000<span></span>
</td>
<td class="nump">1,079,718,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,116,000<span></span>
</td>
<td class="nump">54,373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,904,000<span></span>
</td>
<td class="nump">74,435,000<span></span>
</td>
<td class="nump">46,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,969,000<span></span>
</td>
<td class="num">(17,534,000)<span></span>
</td>
<td class="num">(25,833,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168,734,000)<span></span>
</td>
<td class="num">(397,204,000)<span></span>
</td>
<td class="num">(75,270,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember', window );">Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,235,000<span></span>
</td>
<td class="nump">86,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">Natuera Series A Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Loans receivable</a></td>
<td class="nump">2,013,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss', window );">Accrued interest</a></td>
<td class="nump">540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="nump">2,553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract', window );"><strong>Equity Method Investment, Summarized Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,158,000<span></span>
</td>
<td class="nump">5,660,000<span></span>
</td>
<td class="nump">19,126,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,227,000<span></span>
</td>
<td class="nump">125,777,000<span></span>
</td>
<td class="nump">122,099,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,593,000<span></span>
</td>
<td class="nump">13,457,000<span></span>
</td>
<td class="nump">24,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,779,000<span></span>
</td>
<td class="nump">81,594,000<span></span>
</td>
<td class="nump">76,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,110,000<span></span>
</td>
<td class="nump">8,186,000<span></span>
</td>
<td class="nump">367,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,379,000<span></span>
</td>
<td class="num">(5,059,000)<span></span>
</td>
<td class="num">(631,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,569,000<span></span>
</td>
<td class="num">(12,603,000)<span></span>
</td>
<td class="num">(11,453,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_CronosGroupInc.Member', window );">Cronos Group, Inc. | Natuera Series A Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 7,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_NatueraJVPartnerMember', window );">Natuera JV Partner | Natuera Series A Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 7,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Vitura</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentOwnedPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (48,000)<span></span>
</td>
<td class="num">(363,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,755,000<span></span>
</td>
<td class="nump">$ 16,764,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,114,000<span></span>
</td>
<td class="num">$ (2,518,000)<span></span>
</td>
<td class="num">(1,537,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentOwnedPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,747,000)<span></span>
</td>
<td class="num">$ (2,610,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentOwnedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentOwnedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, Funding Commitment Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of accrued interest on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_NatueraJVPartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_NatueraJVPartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259511563088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Variable Interest Entities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_OtherNetAssetsLiabilities', window );">Other Net Assets (Liabilities)</a></td>
<td class="nump">$ 62,368<span></span>
</td>
<td class="nump">$ 36,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="nump">$ 19,866<span></span>
</td>
<td class="nump">$ 28,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_OtherNetAssetsLiabilities', window );">Other Net Assets (Liabilities)</a></td>
<td class="nump">$ 62,368<span></span>
</td>
<td class="nump">$ 33,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="nump">$ 19,866<span></span>
</td>
<td class="nump">$ 21,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_OtherNetAssetsLiabilities', window );">Other Net Assets (Liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,826<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_OtherNetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Net Assets (Liabilities)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_OtherNetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259511518016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Revaluation of Other Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_OtherInvestmentsRollForward', window );"><strong>Other Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other Investments, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,392<span></span>
</td>
<td class="nump">$ 118,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,392)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign exchange effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(746)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other Investments, ending balance</a></td>
<td class="nump">$ 70,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,993<span></span>
</td>
<td class="nump">118,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_PharmacannMember', window );">Pharmacann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_OtherInvestmentsRollForward', window );"><strong>Other Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other Investments, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,392<span></span>
</td>
<td class="nump">110,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="num">(21,182)<span></span>
</td>
<td class="num">$ (28,972)<span></span>
</td>
<td class="num">(11,238)<span></span>
</td>
<td class="num">(61,392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign exchange effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other Investments, ending balance</a></td>
<td class="nump">49,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="nump">110,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Vitura</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_OtherInvestmentsRollForward', window );"><strong>Other Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other Investments, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign exchange effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(746)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other Investments, ending balance</a></td>
<td class="nump">$ 21,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,993<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_OtherInvestmentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_OtherInvestmentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_PharmacannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_PharmacannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523716336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Summary of Gain from Disposals of Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities | Aurora</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 4,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi', window );">Proceeds from sale of equity securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities | Whistler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfSharesReceived', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">980,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfSharesSold', window );">Investment owned, number of shares sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">980,662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentOwnedNumberOfSharesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Number Of Shares Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentOwnedNumberOfSharesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentOwnedNumberOfSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Number Of Shares Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentOwnedNumberOfSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_AuroraCannabisInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_AuroraCannabisInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_WhistlerMedicalMarijuanaCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_WhistlerMedicalMarijuanaCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259511348896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable, net - Schedule of Loan Receivable (Details)<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 23, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Total current portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Total long-term portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase in the allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification', window );">Increase in interest income from debt modification</a></td>
<td class="nump">$ 140,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember', window );">Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableAccruedInterestCurrent', window );">Add: Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,463,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,322,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Total current portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableAccruedInterestNoncurrent', window );">Add: Long-term portion of accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Total long-term portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember', window );">GrowCo Credit Facility | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestCurrent', window );">Current portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,427,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,898,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,367,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,000,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase in the allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(827,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,748,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLoansReceivable', window );">Draw downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,730,000<span></span>
</td>
<td class="nump">$ 104,000,000<span></span>
</td>
<td class="nump">81,598,000<span></span>
</td>
<td class="nump">$ 104,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLoansReceivable', window );">Proceeds from loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,073,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_OntarioIncMucciPromissoryNoteMember', window );">Mucci Promissory Note | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,438,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,019,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,063,000<span></span>
</td>
<td class="nump">$ 16,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase in the allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_OntarioIncMucciPromissoryNoteMember', window );">Mucci Promissory Note | Loans Receivable | Canadian Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate', window );">Loans receivable, basis spread on variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember', window );">Cannasoul Collaboration Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,837,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,249,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase in the allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember', window );">Cannasoul Collaboration Loan | Loans Receivable | Establishment of a Commercial Cannabis Analytical Testing Laboratoy | Cannasoul Analytics Ltd. | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_CollaborativeArrangementInstallmentsReceived', window );">Collaborative arrangement, installment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,297<span></span>
</td>
<td class="nump">&#8362; 8,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementInstallmentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Installments Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementInstallmentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableAccruedInterestNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Accrued Interest, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableAccruedInterestNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableBeforeAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Before Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableBeforeAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Before Accrued Interest, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableBeforeAccruedInterestNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Face Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Interest Income, Increase From Debt Modification</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Interest Rate, Stated Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage added to reference rate used to compute variable rate on loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansReceivableBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of loan receivable arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLossesExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of credit loss expense (reversal of expense) for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLossesExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_OntarioIncMucciPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_OntarioIncMucciPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=cron_CanadianPrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=cron_CanadianPrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259511261056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable, net - Schedule of Expected Credit Loss Allowances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForLoanAndLeaseLossesRollForward', window );"><strong>Allowance for Loan and Lease Losses [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Beginning balance</a></td>
<td class="nump">$ 14,594<span></span>
</td>
<td class="nump">$ 2,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase (decrease)</a></td>
<td class="num">(662)<span></span>
</td>
<td class="nump">12,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation', window );">Foreign exchange effect</a></td>
<td class="num">(866)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Ending balance</a></td>
<td class="nump">13,066<span></span>
</td>
<td class="nump">14,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment', window );">Financing receivable, credit loss, expense, including transferred into investment</a></td>
<td class="num">(662)<span></span>
</td>
<td class="nump">12,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember', window );">GrowCo Credit Facility | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForLoanAndLeaseLossesRollForward', window );"><strong>Allowance for Loan and Lease Losses [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Beginning balance</a></td>
<td class="nump">14,089<span></span>
</td>
<td class="nump">1,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase (decrease)</a></td>
<td class="num">(827)<span></span>
</td>
<td class="nump">12,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation', window );">Foreign exchange effect</a></td>
<td class="num">(807)<span></span>
</td>
<td class="num">(205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Ending balance</a></td>
<td class="nump">12,455<span></span>
</td>
<td class="nump">14,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_OntarioIncMucciPromissoryNoteMember', window );">Mucci Promissory Note | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForLoanAndLeaseLossesRollForward', window );"><strong>Allowance for Loan and Lease Losses [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Beginning balance</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase (decrease)</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(183)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation', window );">Foreign exchange effect</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Ending balance</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember', window );">Cannasoul Collaboration Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForLoanAndLeaseLossesRollForward', window );"><strong>Allowance for Loan and Lease Losses [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Beginning balance</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase (decrease)</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation', window );">Foreign exchange effect</a></td>
<td class="num">(54)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Ending balance</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">Natuera Series A Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForLoanAndLeaseLossesRollForward', window );"><strong>Allowance for Loan and Lease Losses [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(737)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation', window );">Foreign exchange effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Credit Loss, Expense (Reversal), Including Transferred Into Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForLoanAndLeaseLossesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForLoanAndLeaseLossesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (3)<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (c)<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLossesExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of credit loss expense (reversal of expense) for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLossesExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_OntarioIncMucciPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_OntarioIncMucciPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259515222608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment, net - Schedule of Property, Plant &amp; Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">$ (35,347)<span></span>
</td>
<td class="num">$ (30,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment', window );">Less: accumulated impairment charges</a></td>
<td class="num">(109,063)<span></span>
</td>
<td class="num">(114,301)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">60,557<span></span>
</td>
<td class="nump">74,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">2,556<span></span>
</td>
<td class="nump">2,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">177,095<span></span>
</td>
<td class="nump">188,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">19,130<span></span>
</td>
<td class="nump">18,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">5,345<span></span>
</td>
<td class="nump">5,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 841<span></span>
</td>
<td class="nump">$ 2,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AccumulatedImpairmentOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Impairment Of Property, Plant, And Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AccumulatedImpairmentOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514916064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net - Narrative (Details)<br> ft&#178; in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease', window );">Aggregate depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,667,000<span></span>
</td>
<td class="nump">$ 11,668,000<span></span>
</td>
<td class="nump">$ 9,052,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,493,000<span></span>
</td>
<td class="nump">$ 127,619,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf', window );">Lessee, operating lease, area of land to be disposed of | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cron_FacilityInStaynerOntarioCanadaMember', window );">Facility in Stayner, Ontario, Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,917,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">$ 1,507,000<span></span>
</td>
<td class="nump">$ 1,039,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Area Of Land To Be Disposed Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accumulated depreciation, depletion and amortization of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cron_FacilityInStaynerOntarioCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cron_FacilityInStaynerOntarioCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514992256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Schedule of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Cost</a></td>
<td class="nump">$ 214,447<span></span>
</td>
<td class="nump">$ 214,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(213,414)<span></span>
</td>
<td class="num">(213,414)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Net</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Balance at beginning of period</a></td>
<td class="num">(213,414)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Balance at end of period</a></td>
<td class="num">(213,414)<span></span>
</td>
<td class="num">(213,414)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember', window );">Peace Naturals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Cost</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Net</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Balance at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Balance at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_RedwoodReportingUnitMember', window );">Redwood</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Cost</a></td>
<td class="nump">213,414<span></span>
</td>
<td class="nump">213,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(213,414)<span></span>
</td>
<td class="num">(213,414)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Balance at beginning of period</a></td>
<td class="num">(213,414)<span></span>
</td>
<td class="num">(35,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(178,414)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange effect</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Balance at end of period</a></td>
<td class="num">$ (213,414)<span></span>
</td>
<td class="num">$ (213,414)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Impaired, Accumulated Impairment Loss, Translation and Purchase Accounting Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cron_RedwoodReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cron_RedwoodReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259510440496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Narrative (Details)<br> $ / shares in Units, $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 12, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 12, 2021 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 21, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 21, 2021 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>cannabinoid</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>subsidiary </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 12, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 21, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 14, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,098,000<span></span>
</td>
<td class="nump">$ 1,098,000<span></span>
</td>
<td class="nump">$ 1,033,000<span></span>
</td>
<td class="nump">$ 1,098,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,581,000<span></span>
</td>
<td class="nump">1,118,000<span></span>
</td>
<td class="nump">$ 3,979,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,751,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">814,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,493,000<span></span>
</td>
<td class="nump">$ 127,619,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Impairment loss on goodwill and indefinite-lived intangible assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember', window );">Redwood</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of operating subsidiaries acquired | subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 283,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227,191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Consideration transferred, common shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,086,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Consideration transferred, common shares, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,109,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 213,414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Ginkgo exclusive licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Consideration given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,522,000<span></span>
</td>
<td class="nump">$ 8,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,792,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_NumberOfImpairedIntangibles', window );">Number of impaired cannabinoids | cannabinoid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Ginkgo exclusive licenses | Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,201,236<span></span>
</td>
<td class="nump">2,201,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBGALicensingAgreementMember', window );">CBGA Licensing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Consideration given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,042,000<span></span>
</td>
<td class="nump">$ 11,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Period decrease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,784,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBGALicensingAgreementMember', window );">CBGA Licensing Agreement | Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,467,490<span></span>
</td>
<td class="nump">1,467,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBGVALicensingAgreementMember', window );">CBGVA Licensing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Consideration given</a></td>
<td class="nump">$ 8,150,000<span></span>
</td>
<td class="nump">$ 10,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Fair value</a></td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Period decrease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,008,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBGVALicensingAgreementMember', window );">CBGVA Licensing Agreement | Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">1,467,490<span></span>
</td>
<td class="nump">1,467,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBCALicensingAgreementMember', window );">CBCA Licensing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Consideration given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,473,000<span></span>
</td>
<td class="nump">$ 2,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBCALicensingAgreementMember', window );">CBCA Licensing Agreement | Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489,163<span></span>
</td>
<td class="nump">489,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBCVALicensingAgreementMember', window );">CBCVA Licensing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Consideration given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,724,000<span></span>
</td>
<td class="nump">$ 5,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBCVALicensingAgreementMember', window );">CBCVA Licensing Agreement | Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,467,490<span></span>
</td>
<td class="nump">1,467,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember', window );">United States | Lord Jones brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived (excluding goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,500,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember', window );">Peace Naturals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,098,000<span></span>
</td>
<td class="nump">$ 1,098,000<span></span>
</td>
<td class="nump">$ 1,033,000<span></span>
</td>
<td class="nump">1,098,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember', window );">Peace Naturals | Health Canada licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,951,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfImpairedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Impaired Intangibles</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfImpairedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of indefinite-lived intangible asset excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBGALicensingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBGALicensingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBGVALicensingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBGVALicensingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBCALicensingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBCALicensingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBCVALicensingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_CBCVALicensingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518058640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 42,274<span></span>
</td>
<td class="nump">$ 32,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(6,062)<span></span>
</td>
<td class="num">(3,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Accumulated impairment charges</a></td>
<td class="num">(11,008)<span></span>
</td>
<td class="num">(11,666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">25,204<span></span>
</td>
<td class="nump">16,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">106,416<span></span>
</td>
<td class="nump">96,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(6,062)<span></span>
</td>
<td class="num">(3,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IntangibleAssetsAccumulatedImpairment', window );">Accumulated impairment charges</a></td>
<td class="num">(73,650)<span></span>
</td>
<td class="num">(74,308)<span></span>
</td>
<td class="num">$ (6,053)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets</a></td>
<td class="nump">26,704<span></span>
</td>
<td class="nump">18,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Lord Jones brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">64,000<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Accumulated impairment charges</a></td>
<td class="num">(62,500)<span></span>
</td>
<td class="num">(62,500)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Accumulated impairment charges</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">6,037<span></span>
</td>
<td class="nump">5,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(2,388)<span></span>
</td>
<td class="num">(1,595)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Accumulated impairment charges</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">3,573<span></span>
</td>
<td class="nump">4,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(2,388)<span></span>
</td>
<td class="num">(1,595)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember', window );">Health Canada licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">8,269<span></span>
</td>
<td class="nump">8,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,771)<span></span>
</td>
<td class="num">(1,883)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Accumulated impairment charges</a></td>
<td class="num">(6,498)<span></span>
</td>
<td class="num">(6,910)<span></span>
</td>
<td class="num">(1,053)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,771)<span></span>
</td>
<td class="num">(1,883)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Ginkgo exclusive licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">27,676<span></span>
</td>
<td class="nump">17,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,854)<span></span>
</td>
<td class="num">(335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Accumulated impairment charges</a></td>
<td class="num">(4,434)<span></span>
</td>
<td class="num">(4,752)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">21,388<span></span>
</td>
<td class="nump">12,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,854)<span></span>
</td>
<td class="num">(335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_IsraeliCodesLicensingAgreementsMember', window );">Israeli codes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(49)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (49)<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FiniteLivedIntangibleAssetsAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IndefiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IndefiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IntangibleAssetsAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IntangibleAssetsAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_IsraeliCodesLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_IsraeliCodesLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259525719360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 3,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">3,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">3,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">2,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">2,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">9,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 25,204<span></span>
</td>
<td class="nump">$ 16,579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523413984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Impairment Charges on Intangible Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Finite-lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Beginning balance</a></td>
<td class="num">$ (11,666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Ending balance</a></td>
<td class="num">(11,008)<span></span>
</td>
<td class="num">$ (11,666)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite-Lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IntangibleAssetsAccumulatedImpairment', window );">Beginning balance</a></td>
<td class="num">(74,308)<span></span>
</td>
<td class="num">(6,053)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod', window );">Impairment charges</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(68,389)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange effect</a></td>
<td class="nump">734<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IntangibleAssetsAccumulatedImpairment', window );">Ending balance</a></td>
<td class="num">(73,650)<span></span>
</td>
<td class="num">(74,308)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Lord Jones brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite-Lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Beginning balance</a></td>
<td class="num">(62,500)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(57,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Ending balance</a></td>
<td class="num">(62,500)<span></span>
</td>
<td class="num">(62,500)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite-Lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Beginning balance</a></td>
<td class="num">(142)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Ending balance</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Finite-lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Beginning balance</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment charges</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange effect</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Ending balance</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember', window );">Health Canada licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Finite-lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Beginning balance</a></td>
<td class="num">(6,910)<span></span>
</td>
<td class="num">(1,053)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange effect</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Ending balance</a></td>
<td class="num">(6,498)<span></span>
</td>
<td class="num">(6,910)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Ginkgo exclusive licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Finite-lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Beginning balance</a></td>
<td class="num">(4,752)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,792)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange effect</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Ending balance</a></td>
<td class="num">$ (4,434)<span></span>
</td>
<td class="num">$ (4,752)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FiniteLivedIntangibleAssetsAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Accumulated Impairment, Impairment in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IntangibleAssetsAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IntangibleAssetsAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Accumulated Impairment, Impairment in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259510389616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> ft&#178; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Operating lease, impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,986<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf', window );">Lessee, operating lease, area of land to be disposed of | ft&#178;</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease', window );">Depreciation expense on right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,704<span></span>
</td>
<td class="nump">$ 1,934<span></span>
</td>
<td class="nump">$ 1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Office Premises and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Office Premises and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Area Of Land To Be Disposed Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of depreciation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919398-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cron_BuildingAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cron_BuildingAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523762080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Cost and Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,209<span></span>
</td>
<td class="nump">$ 2,530<span></span>
</td>
<td class="nump">$ 2,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">2,209<span></span>
</td>
<td class="nump">2,540<span></span>
</td>
<td class="nump">2,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow and other information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows - cash paid for operating lease obligations</a></td>
<td class="nump">2,491<span></span>
</td>
<td class="nump">2,458<span></span>
</td>
<td class="nump">2,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Non-cash activity - right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">$ 443<span></span>
</td>
<td class="nump">$ 3,277<span></span>
</td>
<td class="nump">$ 5,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (years) &#8211; operating leases</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate &#8211; operating leases</a></td>
<td class="nump">7.19%<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="nump">8.86%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259512543664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Minimum Lease Payments for Operating Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 1,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">4,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(929)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 3,876<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514979872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Liabilities - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 08, 2019 </div>
<div>warrant </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_AltriaGroupInc.Member', window );">Altria Group, Inc. | Cronos Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Balance held (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,573,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">149,831,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Cronos Group, Inc. | Altria Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised', window );">Ownership percentage, if warrant exercised</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage', window );">Maximum additional subscription percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued', window );">Number of warrants issued | warrant</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired', window );">Exercise rights, minimum ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired', window );">Exercise rights, minimum ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod', window );">Exercise price, volume-weighted average price, measurement period</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise', window );">Exercise price, volume-weighted average price, measurement period, days preceding exercise</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Maximum Additional Subscription Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Minimum Ownership Percentage Required</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Number Of Warrants Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightNumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_AltriaGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_AltriaGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514793072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">$ 14,375<span></span>
</td>
<td class="nump">$ 163,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="num">(14,060)<span></span>
</td>
<td class="num">(151,360)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Foreign exchange effect</a></td>
<td class="num">(300)<span></span>
</td>
<td class="nump">2,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14,375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">13,720<span></span>
</td>
<td class="nump">138,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="num">(13,431)<span></span>
</td>
<td class="num">(127,099)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Foreign exchange effect</a></td>
<td class="num">(289)<span></span>
</td>
<td class="nump">1,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">12,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="num">(179)<span></span>
</td>
<td class="num">(12,102)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Foreign exchange effect</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">12,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="num">(450)<span></span>
</td>
<td class="num">(12,159)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Foreign exchange effect</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 475<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DerivativeInstrumentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DerivativeInstrumentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259517869232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Share price at valuation date (in canadian dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Subscription price (in canadian dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Weighted Average | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 4 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Share price at valuation date (in canadian dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">3.44<span></span>
</td>
<td class="nump">4.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Subscription price (in canadian dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">16.25<span></span>
</td>
<td class="nump">16.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.73<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0414<span></span>
</td>
<td class="nump">0.0039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Weighted Average | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Share price at valuation date (in canadian dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">3.44<span></span>
</td>
<td class="nump">4.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Subscription price (in canadian dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">16.25<span></span>
</td>
<td class="nump">16.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.73<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0428<span></span>
</td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Weighted Average | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">7 months 2 days<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-Emptive Rights and Top-Up Rights | Minimum | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0381<span></span>
</td>
<td class="nump">0.0016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-Emptive Rights and Top-Up Rights | Minimum | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-Emptive Rights and Top-Up Rights | Maximum | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0437<span></span>
</td>
<td class="nump">0.0110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-Emptive Rights and Top-Up Rights | Maximum | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">2 years 9 months<span></span>
</td>
<td class="text">3 years 9 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DerivativeLiabilityUsefulLifeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Liability, Useful Life, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DerivativeLiabilityUsefulLifeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=cron_MeasurementInputSubscriptionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=cron_MeasurementInputSubscriptionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518124752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Sensitivity Analysis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price at issuance date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price at issuance date</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price at issuance date</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259511263776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - R&amp;D Commitments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 18, 2019</div></th>
<th class="th"><div>Oct. 15, 2018</div></th>
<th class="th"><div>Sep. 04, 2018</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 17, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones', window );">Share issuance pursuant to research and development milestone (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,157,888<span></span>
</td>
<td class="nump">2,934,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cron_GinkgoBioworksInc.Member', window );">Ginkgo | Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones', window );">Share issuance pursuant to research and development milestone (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,157,888<span></span>
</td>
<td class="nump">2,934,980<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cron_GinkgoBioworksInc.Member', window );">Ginkgo | Research and Development Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares', window );">Common shares issuable (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,674,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned', window );">Common shares issuable, value assigned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones', window );">Payments subject to milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cron_TechnionResearchAndDevelopmentFoundationMember', window );">Technion | Research and Development Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones', window );">Payments subject to milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cron_AltriaVenturesInc.Member', window );">Altria Ventures | Consulting Services Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentMonthlyFeePercentage', window );">Monthly fee, percentage of direct and indirect service costs</a></td>
<td class="nump">105.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongtermPurchaseCommitmentMonthlyFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Monthly Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongtermPurchaseCommitmentMonthlyFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Payments Subject To Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Research And Development Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_GinkgoBioworksInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_GinkgoBioworksInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_TechnionResearchAndDevelopmentFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_TechnionResearchAndDevelopmentFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_AltriaVenturesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_AltriaVenturesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cron_ConsultingServicesArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cron_ConsultingServicesArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518825680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Contingencies (Details)<br> $ in Thousands, $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 24, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 16, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 12, 2020 </div>
<div>complaint </div>
<div>shareholder</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation | Unfavorable Regulatory Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_LossContingencyPunitiveDamagesSoughtValue', window );">Punitive damages sought</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember', window );">U.S. District Court of Eastern District of New York Vs. Cronos | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of alleged shareholders | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of putative class action complaints | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cron_OSCSettlementMember', window );">OSC Settlement | Settled Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for Legal Settlements</a></td>
<td class="nump">$ 1,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LossContingencyPunitiveDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Sought, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LossContingencyPunitiveDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_UnfavorableRegulatoryActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_UnfavorableRegulatoryActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cron_OSCSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cron_OSCSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259515046528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Summary of Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 15,115<span></span>
</td>
<td class="nump">$ 10,151<span></span>
</td>
<td class="nump">$ 15,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">6,778<span></span>
</td>
<td class="nump">7,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">7,740<span></span>
</td>
<td class="nump">2,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cron_LiabilityClassifiedAwardsMember', window );">Liability Classified Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cron_LiabilityClassifiedAwardsMember', window );">Liability Classified Awards | Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cron_LiabilityClassifiedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cron_LiabilityClassifiedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259511202560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-based Compensation - Stock Options Narrative (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 29, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 25, 2020</div></th>
<th class="th"><div>Jun. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in Canadian dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 9.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">2015 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Future awards to be granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">2018 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Future awards to be granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">2020 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in Canadian dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.94<span></span>
</td>
<td class="nump">$ 6.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514830576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Summary of the Changes in Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Issuance of options (in dollars per share)</a></td>
<td class="nump">4.20<span></span>
</td>
<td class="nump">9.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">2.79<span></span>
</td>
<td class="nump">2.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancellation, forfeiture and expiry of options (in dollars per share)</a></td>
<td class="nump">5.74<span></span>
</td>
<td class="nump">12.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (in dollars per share)</a></td>
<td class="nump">10.57<span></span>
</td>
<td class="nump">7.75<span></span>
</td>
<td class="nump">$ 5.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 11.48<span></span>
</td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">8,939,330<span></span>
</td>
<td class="nump">13,755,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of options (in shares)</a></td>
<td class="nump">113,947<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(2,735,985)<span></span>
</td>
<td class="num">(5,598,695)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancellation of options (in shares)</a></td>
<td class="num">(966,692)<span></span>
</td>
<td class="num">(117,123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">5,350,600<span></span>
</td>
<td class="nump">8,939,330<span></span>
</td>
<td class="nump">13,755,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">3,867,887<span></span>
</td>
<td class="nump">5,836,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted average remaining contractual term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">8 months 23 days<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">7 months 28 days<span></span>
</td>
<td class="text">1 year 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259515224528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Fair Value of Options Issued (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in Canadian dollars per share)</a></td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 9.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (per option) (in Canadian dollars per share)</a></td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 9.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.14%<span></span>
</td>
<td class="nump">1.39%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of options</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected annualized volatility</a></td>
<td class="nump">73.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue', window );">Weighted average Black-Scholes value at grant date (per option) (in Canadian dollars per share)</a></td>
<td class="nump">$ 2.94<span></span>
</td>
<td class="nump">$ 6.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate', window );">Forfeiture rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259511246432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-based Compensation - Schedule of Stock Options Outstanding (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">5,350,600<span></span>
</td>
<td class="nump">8,939,330<span></span>
</td>
<td class="nump">13,755,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember', window );">2020 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">2,788,947<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember', window );">2018 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">1,422,069<span></span>
</td>
<td class="nump">1,550,074<span></span>
</td>
<td class="nump">1,627,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember', window );">2015 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">1,139,584<span></span>
</td>
<td class="nump">4,489,256<span></span>
</td>
<td class="nump">10,127,433<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521625472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Restricted Share Units Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514854192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Summary of Restricted Share Units Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">$ 2.79<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(2,735,985)<span></span>
</td>
<td class="num">(5,598,695)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 9.22<span></span>
</td>
<td class="nump">$ 7.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">4.27<span></span>
</td>
<td class="nump">11.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">7.40<span></span>
</td>
<td class="nump">7.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancellation and forfeitures (in dollars per share)</a></td>
<td class="nump">5.08<span></span>
</td>
<td class="nump">8.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at end of period (in dollars per share)</a></td>
<td class="nump">$ 4.63<span></span>
</td>
<td class="nump">$ 9.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">1,225,870<span></span>
</td>
<td class="nump">948,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">6,140,492<span></span>
</td>
<td class="nump">576,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(1,151,292)<span></span>
</td>
<td class="num">(158,178)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancellation and forfeitures (in shares)</a></td>
<td class="num">(489,600)<span></span>
</td>
<td class="num">(141,185)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">5,725,470<span></span>
</td>
<td class="nump">1,225,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod', window );">Cliff period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod', window );">Cliff period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Award Cliff Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518057104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Summary of Deferred Share Units Activity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Grants</a></td>
<td class="nump">$ 15,115<span></span>
</td>
<td class="nump">$ 10,151<span></span>
</td>
<td class="nump">$ 15,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember', window );">Deferred Share Units (DSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent', window );">Balance at beginning of period</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Grants</a></td>
<td class="nump">443<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ShareBasedPaymentArrangementGainLossOnRevaluation', window );">Gain on revaluation</a></td>
<td class="num">(177)<span></span>
</td>
<td class="num">(320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_ShareBasedPaymentArrangementLiabilitiesSettled', window );">Liabilities settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent', window );">Balance at end of period</a></td>
<td class="nump">$ 674<span></span>
</td>
<td class="nump">$ 408<span></span>
</td>
<td class="nump">$ 577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of DSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">104,442<span></span>
</td>
<td class="nump">83,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod', window );">Granting and vesting of DSUs (in shares)</a></td>
<td class="nump">161,290<span></span>
</td>
<td class="nump">48,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Liabilities settled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,764)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">265,732<span></span>
</td>
<td class="nump">104,442<span></span>
</td>
<td class="nump">83,293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedPaymentArrangementGainLossOnRevaluation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Gain (Loss) On Revaluation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedPaymentArrangementGainLossOnRevaluation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedPaymentArrangementLiabilitiesSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Liabilities Settled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedPaymentArrangementLiabilitiesSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259510423952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Summary of Changes in Warrants (Details) - Warrant<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Exercise of warrants (in dollars per share) | $ / shares</a></td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of DSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares) | shares</a></td>
<td class="nump">7,987,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Exercise of warrants (in shares) | shares</a></td>
<td class="num">(7,987,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259514943360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Liability-Classified Awards (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Grants</a></td>
<td class="nump">$ 15,115<span></span>
</td>
<td class="nump">$ 10,151<span></span>
</td>
<td class="nump">$ 15,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cron_LiabilityClassifiedAwardsMember', window );">Liability Classified Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent', window );">Balance at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Grants</a></td>
<td class="nump">597<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards', window );">Transfers to equity awards</a></td>
<td class="num">(597)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent', window );">Balance at end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Share-Based Arrangements, Transfer to Equity Awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cron_LiabilityClassifiedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cron_LiabilityClassifiedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259526000480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income (Loss) before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="num">$ (134,559)<span></span>
</td>
<td class="num">$ (397,135)<span></span>
</td>
<td class="num">$ (73,273)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="num">(55,502)<span></span>
</td>
<td class="num">(116,267)<span></span>
</td>
<td class="nump">12,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="num">$ (79,057)<span></span>
</td>
<td class="num">$ (280,868)<span></span>
</td>
<td class="num">$ (85,952)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259511215808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax', window );">Income (loss) from discontinued operations, net of income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (500)<span></span>
</td>
<td class="num">$ (650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable, current</a></td>
<td class="nump">32,956<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Taxes receivable, current</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Valuation allowance</a></td>
<td class="nump">214,199<span></span>
</td>
<td class="nump">224,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D investment tax credits</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CanadaRevenueAgencyMember', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">216,120<span></span>
</td>
<td class="nump">276,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Untied States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">134,593<span></span>
</td>
<td class="nump">117,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">18,739<span></span>
</td>
<td class="nump">24,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease', window );">Valuation allowance increase (decrease)</a></td>
<td class="num">(10,577)<span></span>
</td>
<td class="nump">$ 138,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_CapitalGainRelinquishmentOfWarrant', window );">Capital gain on relinquishment of warrant</a></td>
<td class="nump">$ 479,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CapitalGainRelinquishmentOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Gain, Relinquishment Of Warrant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CapitalGainRelinquishmentOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CanadaRevenueAgencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CanadaRevenueAgencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259525701088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Expense for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="nump">$ 34,416<span></span>
</td>
<td class="num">$ (471)<span></span>
</td>
<td class="nump">$ 1,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="num">(241)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="nump">34,416<span></span>
</td>
<td class="num">(382)<span></span>
</td>
<td class="nump">1,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="num">(241)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518118592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (134,559)<span></span>
</td>
<td class="num">$ (397,135)<span></span>
</td>
<td class="num">$ (73,273)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective income tax rate</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount', window );">Expected income tax benefit</a></td>
<td class="num">$ (35,658)<span></span>
</td>
<td class="num">$ (105,241)<span></span>
</td>
<td class="num">$ (19,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxExemptIncome', window );">Non-taxable income (loss)</a></td>
<td class="num">(2,140)<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="num">(711)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Non-deductible share-based compensation</a></td>
<td class="nump">1,198<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">2,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Non-deductible expenses</a></td>
<td class="nump">836<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">1,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount', window );">Non-deductible transaction costs</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">2,917<span></span>
</td>
<td class="nump">3,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">Effect of provincial tax rate difference</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Effect of tax rates outside of Canada</a></td>
<td class="nump">1,848<span></span>
</td>
<td class="num">(1,869)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Effect of change in tax rates</a></td>
<td class="nump">11,041<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount', window );">Fair value gain on financial liabilities</a></td>
<td class="num">(3,726)<span></span>
</td>
<td class="num">(40,111)<span></span>
</td>
<td class="num">(34,250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="num">(6,873)<span></span>
</td>
<td class="nump">141,639<span></span>
</td>
<td class="nump">48,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount', window );">Capital gain on financial liabilities</a></td>
<td class="nump">66,193<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(154)<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit), net</a></td>
<td class="nump">$ 34,175<span></span>
</td>
<td class="num">$ (431)<span></span>
</td>
<td class="nump">$ 1,347<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Capital Gain, Financial Liabilities, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518727792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Tax loss carryforwards</a></td>
<td class="nump">$ 98,074<span></span>
</td>
<td class="nump">$ 111,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">Interest expense carryforwards</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredTaxAssetsDebtIssuanceCosts', window );">Deferred financing costs</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">2,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredTaxAssetsShareIssuanceCost', window );">Share issuance cost</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredTaxAssetsFinanceLeaseLiabilities', window );">Finance lease obligation</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Plant and equipment</a></td>
<td class="nump">37,662<span></span>
</td>
<td class="nump">38,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInvestments', window );">Investment</a></td>
<td class="nump">13,359<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible asset</a></td>
<td class="nump">53,365<span></span>
</td>
<td class="nump">65,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Reserve</a></td>
<td class="nump">2,972<span></span>
</td>
<td class="nump">3,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D investment tax credits</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">3,099<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">214,841<span></span>
</td>
<td class="nump">227,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(214,199)<span></span>
</td>
<td class="num">(224,776)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="num">(365)<span></span>
</td>
<td class="num">(1,860)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains', window );">Unrealized foreign exchange</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(483)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(449)<span></span>
</td>
<td class="num">(2,343)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (40)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxAssetsDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Debt Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxAssetsDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxAssetsFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Finance Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxAssetsFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxAssetsShareIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Share Issuance Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxAssetsShareIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521055920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Disaggregated Revenue - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259519787600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Disaggregated Revenue - Schedule of Segment Data (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 91,904,000<span></span>
</td>
<td class="nump">$ 74,435,000<span></span>
</td>
<td class="nump">$ 46,719,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="nump">3,114,000<span></span>
</td>
<td class="num">(6,313,000)<span></span>
</td>
<td class="num">(4,510,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">22,550,000<span></span>
</td>
<td class="nump">9,098,000<span></span>
</td>
<td class="nump">18,601,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(13,000)<span></span>
</td>
<td class="num">(27,000)<span></span>
</td>
<td class="num">(186,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">22,537,000<span></span>
</td>
<td class="nump">9,071,000<span></span>
</td>
<td class="nump">18,415,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,213,009,000<span></span>
</td>
<td class="nump">1,397,738,000<span></span>
</td>
<td class="nump">1,925,682,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,025,000<span></span>
</td>
<td class="nump">4,484,000<span></span>
</td>
<td class="nump">2,872,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">236,056,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">3,493,000<span></span>
</td>
<td class="nump">127,619,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(650,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(80,608,000)<span></span>
</td>
<td class="num">(160,463,000)<span></span>
</td>
<td class="num">(147,253,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment, net</a></td>
<td class="nump">3,451,000<span></span>
</td>
<td class="nump">11,144,000<span></span>
</td>
<td class="nump">31,412,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">5,155,000<span></span>
</td>
<td class="nump">9,874,000<span></span>
</td>
<td class="nump">9,495,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">4,519,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">4,518,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="num">(18,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">368,588,000<span></span>
</td>
<td class="nump">462,830,000<span></span>
</td>
<td class="nump">253,745,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">344,000<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
<td class="nump">234,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,019,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,955,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(20,134,000)<span></span>
</td>
<td class="num">(40,717,000)<span></span>
</td>
<td class="num">(28,019,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment, net</a></td>
<td class="nump">183,000<span></span>
</td>
<td class="nump">776,000<span></span>
</td>
<td class="nump">385,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">86,749,000<span></span>
</td>
<td class="nump">64,561,000<span></span>
</td>
<td class="nump">37,224,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="nump">3,114,000<span></span>
</td>
<td class="num">(6,313,000)<span></span>
</td>
<td class="num">(4,510,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">18,031,000<span></span>
</td>
<td class="nump">9,058,000<span></span>
</td>
<td class="nump">18,585,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(12,000)<span></span>
</td>
<td class="num">(27,000)<span></span>
</td>
<td class="num">(152,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">18,019,000<span></span>
</td>
<td class="nump">9,031,000<span></span>
</td>
<td class="nump">18,433,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">290,799,000<span></span>
</td>
<td class="nump">273,484,000<span></span>
</td>
<td class="nump">388,351,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">5,681,000<span></span>
</td>
<td class="nump">4,189,000<span></span>
</td>
<td class="nump">2,638,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">3,493,000<span></span>
</td>
<td class="nump">124,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(650,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(37,230,000)<span></span>
</td>
<td class="num">(99,139,000)<span></span>
</td>
<td class="num">(98,349,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment, net</a></td>
<td class="nump">3,268,000<span></span>
</td>
<td class="nump">10,368,000<span></span>
</td>
<td class="nump">31,027,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income (loss) from equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">553,622,000<span></span>
</td>
<td class="nump">661,424,000<span></span>
</td>
<td class="nump">1,283,586,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(23,244,000)<span></span>
</td>
<td class="num">(20,607,000)<span></span>
</td>
<td class="num">(20,885,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">63,593,000<span></span>
</td>
<td class="nump">55,194,000<span></span>
</td>
<td class="nump">27,932,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">63,593,000<span></span>
</td>
<td class="nump">55,194,000<span></span>
</td>
<td class="nump">27,932,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">27,677,000<span></span>
</td>
<td class="nump">18,681,000<span></span>
</td>
<td class="nump">18,254,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">5,155,000<span></span>
</td>
<td class="nump">9,874,000<span></span>
</td>
<td class="nump">9,495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">22,522,000<span></span>
</td>
<td class="nump">8,807,000<span></span>
</td>
<td class="nump">8,759,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">634,000<span></span>
</td>
<td class="nump">560,000<span></span>
</td>
<td class="nump">533,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">634,000<span></span>
</td>
<td class="nump">560,000<span></span>
</td>
<td class="nump">533,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cron_CannabisFlowerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cron_CannabisExtractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259519336704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Disaggregated Revenue - Schedule of Adjusted EBITDA (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (168,734,000)<span></span>
</td>
<td class="num">$ (397,204,000)<span></span>
</td>
<td class="num">$ (75,270,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,537,000)<span></span>
</td>
<td class="num">(9,071,000)<span></span>
</td>
<td class="num">(18,415,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,175,000<span></span>
</td>
<td class="num">(431,000)<span></span>
</td>
<td class="nump">1,347,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,122,000<span></span>
</td>
<td class="nump">15,402,000<span></span>
</td>
<td class="nump">7,045,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(143,974,000)<span></span>
</td>
<td class="num">(391,304,000)<span></span>
</td>
<td class="num">(85,293,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income from equity accounted investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,114,000)<span></span>
</td>
<td class="nump">6,313,000<span></span>
</td>
<td class="nump">4,510,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">236,056,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,493,000<span></span>
</td>
<td class="nump">127,619,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,060,000)<span></span>
</td>
<td class="num">(151,360,000)<span></span>
</td>
<td class="num">(129,254,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain on revaluation of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,739,000)<span></span>
</td>
<td class="num">(8,611,000)<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,392,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,801,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency transaction loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,286,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,000<span></span>
</td>
<td class="num">(730,000)<span></span>
</td>
<td class="nump">1,825,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,333,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,115,000<span></span>
</td>
<td class="nump">10,151,000<span></span>
</td>
<td class="nump">15,361,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Financial statement review costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,167,000<span></span>
</td>
<td class="nump">7,102,000<span></span>
</td>
<td class="nump">9,688,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,789,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (80,608,000)<span></span>
</td>
<td class="num">$ (160,463,000)<span></span>
</td>
<td class="num">(147,253,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">380,575,403<span></span>
</td>
<td class="nump">380,575,403<span></span>
</td>
<td class="nump">374,952,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_AustraliaMember', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of assets</a></td>
<td class="num">$ (877,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="nump">$ 384,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">55,176,065<span></span>
</td>
<td class="nump">55,176,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (84,194,000)<span></span>
</td>
<td class="num">(283,883,000)<span></span>
</td>
<td class="num">(77,368,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,518,000)<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(89,000)<span></span>
</td>
<td class="nump">323,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,485,000<span></span>
</td>
<td class="nump">917,000<span></span>
</td>
<td class="nump">234,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87,227,000)<span></span>
</td>
<td class="num">(283,095,000)<span></span>
</td>
<td class="num">(76,793,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income from equity accounted investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,019,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,955,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain on revaluation of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency transaction loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,788,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,744,000<span></span>
</td>
<td class="nump">3,401,000<span></span>
</td>
<td class="nump">8,714,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Financial statement review costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,134,000)<span></span>
</td>
<td class="num">(40,717,000)<span></span>
</td>
<td class="num">(28,019,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,129,000)<span></span>
</td>
<td class="num">(81,811,000)<span></span>
</td>
<td class="nump">32,671,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,019,000)<span></span>
</td>
<td class="num">(9,031,000)<span></span>
</td>
<td class="num">(18,433,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,175,000<span></span>
</td>
<td class="num">(342,000)<span></span>
</td>
<td class="nump">1,024,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,637,000<span></span>
</td>
<td class="nump">14,485,000<span></span>
</td>
<td class="nump">6,811,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,336,000)<span></span>
</td>
<td class="num">(76,699,000)<span></span>
</td>
<td class="nump">22,073,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income from equity accounted investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,114,000)<span></span>
</td>
<td class="nump">6,313,000<span></span>
</td>
<td class="nump">4,510,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,493,000<span></span>
</td>
<td class="nump">124,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,060,000)<span></span>
</td>
<td class="num">(151,360,000)<span></span>
</td>
<td class="num">(129,254,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain on revaluation of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,739,000)<span></span>
</td>
<td class="num">(8,611,000)<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency transaction loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,286,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="num">(733,000)<span></span>
</td>
<td class="nump">1,805,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,545,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,371,000<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="nump">6,647,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Financial statement review costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,789,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,230,000)<span></span>
</td>
<td class="num">(99,139,000)<span></span>
</td>
<td class="num">(98,349,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,411,000)<span></span>
</td>
<td class="num">(31,510,000)<span></span>
</td>
<td class="num">(30,573,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,411,000)<span></span>
</td>
<td class="num">(31,510,000)<span></span>
</td>
<td class="num">(30,573,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income from equity accounted investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain on revaluation of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,801,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency transaction loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Financial statement review costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,167,000<span></span>
</td>
<td class="nump">7,102,000<span></span>
</td>
<td class="nump">9,688,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,244,000)<span></span>
</td>
<td class="num">$ (20,607,000)<span></span>
</td>
<td class="num">$ (20,885,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_EarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Before Interest, Taxes, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_EarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_RestatementReviewExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restatement Review Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_RestatementReviewExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(3)(ii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_AustraliaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_AustraliaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518630800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Disaggregated Revenue - Schedule of Revenue from External Customers by Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 91,904<span></span>
</td>
<td class="nump">$ 74,435<span></span>
</td>
<td class="nump">$ 46,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">56,233<span></span>
</td>
<td class="nump">50,294<span></span>
</td>
<td class="nump">34,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">30,516<span></span>
</td>
<td class="nump">13,376<span></span>
</td>
<td class="nump">2,539<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">5,155<span></span>
</td>
<td class="nump">9,874<span></span>
</td>
<td class="nump">9,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cron_OtherCountriesMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 891<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cron_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cron_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259525755856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information and Disaggregated Revenue - Schedule of Long-lived Assets by Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 60,557<span></span>
</td>
<td class="nump">$ 74,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">40,052<span></span>
</td>
<td class="nump">49,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">20,251<span></span>
</td>
<td class="nump">24,473<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259510990752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Share - Schedule of Earnings (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Basic loss per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net loss from continuing operations attributable to the shareholders of Cronos&#160;Group</a></td>
<td class="num">$ (168,734)<span></span>
</td>
<td class="num">$ (395,607)<span></span>
</td>
<td class="num">$ (72,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding used in the computation of basic earnings (loss) per share (in shares)</a></td>
<td class="nump">376,961,797<span></span>
</td>
<td class="nump">370,390,965<span></span>
</td>
<td class="nump">351,576,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic loss from continuing operations per share (in dollars per share)</a></td>
<td class="num">$ (0.45)<span></span>
</td>
<td class="num">$ (1.07)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic', window );">Loss from discontinued operations attributable to the shareholders of Cronos Group</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (500)<span></span>
</td>
<td class="num">$ (650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding (in shares)</a></td>
<td class="nump">376,961,797<span></span>
</td>
<td class="nump">370,390,965<span></span>
</td>
<td class="nump">351,576,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic loss from discontinued operations per share (in dollars per share)</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted loss per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net loss used in the computation of basic loss from continuing operations per share</a></td>
<td class="num">$ (168,734)<span></span>
</td>
<td class="num">$ (395,607)<span></span>
</td>
<td class="num">$ (72,487)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Adjustment for exercise of rights on derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted', window );">Net loss used in the computation of diluted loss from continuing operations per share</a></td>
<td class="num">$ (168,734)<span></span>
</td>
<td class="num">$ (395,607)<span></span>
</td>
<td class="num">$ (72,487)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding used in the computation of basic earnings (loss) per share (in shares)</a></td>
<td class="nump">376,961,797<span></span>
</td>
<td class="nump">370,390,965<span></span>
</td>
<td class="nump">351,576,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Dilutive effect of Top-up Rights - market price (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares for computation of diluted loss from continuing operations per share (in shares)</a></td>
<td class="nump">376,961,797<span></span>
</td>
<td class="nump">370,390,965<span></span>
</td>
<td class="nump">351,576,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted loss per share from continuing operations (in dollars per share)</a></td>
<td class="num">$ (0.45)<span></span>
</td>
<td class="num">$ (1.07)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted', window );">Loss from discontinued operations attributable to the shareholders of Cronos Group</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (500)<span></span>
</td>
<td class="num">$ (650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares for computation of diluted loss from discontinued operations per share (in shares)</a></td>
<td class="nump">376,961,797<span></span>
</td>
<td class="nump">370,390,965<span></span>
</td>
<td class="nump">351,576,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Diluted loss from discontinued operations per share (in dollars per share)</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">112,612,579<span></span>
</td>
<td class="nump">125,195,001<span></span>
</td>
<td class="nump">151,338,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted loss per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted loss per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted loss per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259519949744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Schedule of Fair Value of Assets on Recurring Basis (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 16, 2021 </div>
<div>seat</div>
</th>
<th class="th">
<div>Dec. 15, 2021 </div>
<div>seat</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="nump">$ 70,993<span></span>
</td>
<td class="nump">$ 118,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Vitura</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="nump">21,993<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_NumberOfSeatsOnBoardOfDirectors', window );">Number of seats on board of directors | seat</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">764,644<span></span>
</td>
<td class="nump">886,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">113,077<span></span>
</td>
<td class="nump">117,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="nump">21,993<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">764,644<span></span>
</td>
<td class="nump">886,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">113,077<span></span>
</td>
<td class="nump">117,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="nump">21,993<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 14,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfSeatsOnBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Seats on Board of Directors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfSeatsOnBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259523787264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Schedule of Fair Value of Assets on Nonrecurring Basis (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 14, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Percentage of ownership after transaction</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Payments to acquire other investments</a></td>
<td class="nump">$ 110,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=cron_PharmacannMember', window );">Pharmacann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_PharmacannMember', window );">Pharmacann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="nump">473,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=cron_PharmacannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=cron_PharmacannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_PharmacannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_PharmacannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259524474832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Credit Risk (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Maximum exposure to credit risk</a></td>
<td class="nump">$ 987,442<span></span>
</td>
<td class="nump">$ 1,118,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 23,113<span></span>
</td>
<td class="nump">22,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff', window );">Accounts receivable, threshold period past due, writeoff</a></td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="nump">$ 114,456<span></span>
</td>
<td class="nump">89,486<span></span>
</td>
<td class="nump">$ 54,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">764,644<span></span>
</td>
<td class="nump">886,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">113,077<span></span>
</td>
<td class="nump">117,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade, current</a></td>
<td class="nump">8,599<span></span>
</td>
<td class="nump">8,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_ThreeMajorCustomersMember', window );">Three Major Customers | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="nump">$ 63,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_ThreeMajorCustomersMember', window );">Three Major Customers | Accounts Receivable | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_ThreeMajorCustomersMember', window );">Three Major Customers | Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember', window );">Four Major Customers | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember', window );">Four Major Customers | Accounts Receivable | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember', window );">Four Major Customers | Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period for when accounts receivable, classified as noncurrent, is considered past due to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_ThreeMajorCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_ThreeMajorCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_FourMajorCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259515127424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Liquidity Risk (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade, current</a></td>
<td class="nump">$ 8,599<span></span>
</td>
<td class="nump">$ 8,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember', window );">Accounts Payable | Supplier Concentration Risk | One Vendor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_OneVendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_OneVendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521298384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Interest Rate Risk (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">$ 22,537<span></span>
</td>
<td class="nump">$ 9,071<span></span>
</td>
<td class="nump">$ 18,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent', window );">Impact of change in average variable rate, percent</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259617289824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Foreign Currency Risk (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="num">$ (50,616)<span></span>
</td>
<td class="nump">$ 8,192<span></span>
</td>
<td class="nump">$ 14,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate', window );">Impact of ten percent change in exchange rate</a></td>
<td class="nump">$ 77,414<span></span>
</td>
<td class="nump">$ 87,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259512606672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 08, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_AltriaPinnacleLLC.Member', window );">Altria Pinnacle LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amounts payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Cannabis Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amounts payable</a></td>
<td class="nump">2,519,000<span></span>
</td>
<td class="nump">$ 82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_VendorMember', window );">Vendor | Manufacturing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expense</a></td>
<td class="nump">$ 645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member', window );">Cronos Group, Inc. | Altria Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_AltriaPinnacleLLC.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_AltriaPinnacleLLC.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cron_CannabisPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cron_CannabisPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_VendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_VendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cron_ManufacturingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cron_ManufacturingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_AltriaGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_AltriaGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259525776624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cron_ConsultingServicesMember', window );">Consulting Services | Altria Pinnacle LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 436<span></span>
</td>
<td class="nump">$ 1,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cron_CannabisPurchasesMember', window );">Cannabis Purchases | Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Purchases</a></td>
<td class="nump">$ 18,144<span></span>
</td>
<td class="nump">$ 4,820<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cron_ConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cron_ConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_AltriaPinnacleLLC.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_AltriaPinnacleLLC.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cron_CannabisPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cron_CannabisPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259525684432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">$ 5,333<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=cron_RealignmentMember', window );">Realignment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">$ 5,333<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=cron_RealignmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=cron_RealignmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259521898768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Costs by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">$ 5,333<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=cron_RealignmentMember', window );">Realignment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">5,333<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember', window );">Rest of World | Realignment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">3,544<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember', window );">United States | Realignment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">$ 1,789<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=cron_RealignmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=cron_RealignmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140259518629856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Restructuring Activity (Details) - Realignment<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, Beginning Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Expenses</a></td>
<td class="nump">5,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_RestructuringReservePaymentsAndWriteoffs', window );">Payments/Write-offs</a></td>
<td class="num">(4,909)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, Ending Balance</a></td>
<td class="nump">424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Expenses</a></td>
<td class="nump">3,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_RestructuringReservePaymentsAndWriteoffs', window );">Payments/Write-offs</a></td>
<td class="num">(3,268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, Ending Balance</a></td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Expenses</a></td>
<td class="nump">1,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cron_RestructuringReservePaymentsAndWriteoffs', window );">Payments/Write-offs</a></td>
<td class="num">(1,641)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, Ending Balance</a></td>
<td class="nump">$ 21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_RestructuringReservePaymentsAndWriteoffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve, Payments and Writeoffs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_RestructuringReservePaymentsAndWriteoffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=cron_RealignmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=cron_RealignmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>cron-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:cron="http://thecronosgroup.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cron-20221231.xsd" xlink:type="simple"/>
    <context id="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7656cbe523fc4dd4a341da5f796c9093_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic0d65956228143c19035678405df018c_I20230224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2023-02-24</instant>
        </period>
    </context>
    <context id="ia33af1f54aa342248ebe7045d0058626_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b61d3b7b8334186a589bb519b652171_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i213ce03ecaa746eab2dd1a12204b5ccb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib50e3b8695d94270935d4f85da07fcb2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i448ef8d1aafa463180aab6c0b5778fb3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i14979ed24a294d07bdc9b963b74b1dcf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib07031e3e0734b5f9e1f8b89fae01580_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7574c68cc08a473a9f7033bdb1a91792_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2e8196a7813644b399d45186e643bd4c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73de768913af4a8da7accde843797e61_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia825a868fcc44019a5f6ff3e5a1698c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i43046ab9dce94a239d679a89675b6368_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8f8709ce2cc42e3956edf7fa925bc71_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e374eda0848449ea8abee147ccfef6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a0581d281ad4b2187170fcbcc40f7bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd33bd509f964d42a39a9c38e627d5ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i624b48e5e23148ebbee8fa21083aed6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94bb0b34a94244f4a78a9b4196581628_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea9d63117e854b719984324586934e8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ad0e599ac854e9584dfae6fd1a9dde7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifa6161e6218e4dbcaa62bb22e7be9255_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic024c83103194eceabada95ba475ab43_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i666176ccf3e84f1da351ed843f82f2ad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7a99d4e9305649348953f54c8a8a0f17_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34357931c29142239fb75a5dd657419f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04edac1c57f34e7d9b98b2c80dc5b8bc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39f39217946e4a43885410306e996d66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a005033016542a286a1ee76f9592489_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i05001d975789445693497618980033e5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia69ca1c9942e41d49a89eb53eae07a00_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7bbf485b421d43959849aa8ccb24d1ca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i45c43df2327b4eb88372d7d82971481a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c0b659e27464370a05a56fed607e84e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia421331670e443fd88c2f5410409c16c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88cfcb6b7e764fdda895416627f0ac54_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9a60350c90304904bad11f71d612fc4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i048ebc278983416fac723c6b21abb062_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icdadd4591de7465e96d360ee40a08559_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i36cd7b767d4742089d1b42cfe6220c44_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.CultivationsLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1ead5e405ef545a98117d2329aa9d7f2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.ManufacturingLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if88c1809830e415688a9bf0f65770352_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.StoreLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3882b50d536c49b783a4fe4bc63b1a58_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelGSPharmacyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1b22fb74b27245199caf9dcb11234c12_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iacf539ae1af944fabea8af025076759c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1a132cce282941e5b9844e95bbad2e28_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i49f135f4f3444a5a89ff7d7ac98dad6d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f8f22691c07427aa015ce15f27bf6d2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibaa1003c5905486b919409d3896fa96f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:GinkoExclusiveLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6584e6d786d847d69e0e7fc90b593c5f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieae966ba01c1479dacbc7135663a609a_D20220101-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="icb4e552f78894f18936e22352d25dde5_D20220101-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatueraJVPartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i736040703d9b43138a6d1fbe16c1ea1a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatueraJVPartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ied9879f7a9aa480189fcbf72c09fb055_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i01e84979c2174a3e959ae14445c4c0b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4dd42bcd2c914a09bf216a667b6e31d0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1f00d6ff67484222ae48b7e588d07c45_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib83b7561b10e4723a7df91adaaef20db_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8d787bdfa77d4a4eb6ac5ba4b4bdfc00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia965648dd525484799c2e977f7acaf53_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie35ca828c220404d8779f0c05373f981_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6226d0a1598b4591a5b51ab3e76703b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieab708e963a4427d9d3c7720e25e4a43_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="iaf4bf3256f4340b98286607ff670aef5_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i556bef2858d7440aa6698fec9871e28e_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatueraJVPartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i9d84efb4ac7543a7b30a39f637d3feac_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatueraJVPartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ib684e46ce2ce4e94953b3cd65ed84eb3_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="iec61439c630842daa57b512a9ded6f1f_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i72bd56a3b81845f49fe8b58426c1d15c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id2dea108f6474d59838c2f8da2a2200d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06a12ae20ea94eb79a945a18af0871d1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i31af1706e07447a382a55519bec4d367_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iecc2eafed6534c30b7a6637e2039b9b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6774fc03d1d44059bc5e08321bc61875_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1be163b6b0ca4a5fae2fa3db98dc500e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib48a5f922dc74080be8b4e6b57c7a04d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if46b21ab0b3b47ce84759033415e34a3_I20211215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-15</instant>
        </period>
    </context>
    <context id="i5412eefc844e484bb12e39c21eac056f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i582e556b4ce74d03ba739d1baa4199e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4575a982e5148c79aec9bf8a66c9c02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e8e633340c54e489bace8e93f8c9aaf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i138038dc2b074762930cd415641ec771_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i20a76be7bf924660b23e0d04d6d1d445_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i00ed681f413e454dbec8d917d6a28b38_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1b6b387f3bd48568496384bda710bc0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a6151bf97b4479db1915de9cf54196a_D20210614-20210614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-14</startDate>
            <endDate>2021-06-14</endDate>
        </period>
    </context>
    <context id="ica770eae2c9246a2afe81a80ce6bc6ec_I20210614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2021-06-14</instant>
        </period>
    </context>
    <context id="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2021-06-14</startDate>
            <endDate>2021-06-14</endDate>
        </period>
    </context>
    <context id="i55bbd96bb4154fef93d9f031c4651fa9_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i3306701595a04451b85d16301150c1ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d42dad636504862a15f3a4f67554aec_I20211012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:LivWellHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-12</instant>
        </period>
    </context>
    <context id="ib2c9908a800e47b080fb9fb2cfd88973_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5e5776901e474b3abdf90733e7a30e62_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i53f60b165c164f1b89ebd97857c42986_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic075132149c24b6f980b4c2955ff29bb_I20210914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-14</instant>
        </period>
    </context>
    <context id="i3e0794b671294cf4a1a592fd95ab0288_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3a0de233b3214d3bb109cdfb9f70e304_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66ffd69d80d04eb29f72245ee158a8f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4aeb1d824d3f4e9984e927ae64cea18a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic2ab3c32bb7547b48229e1aa72f2da89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf3a51f82e6c455ea2fbee1766559fd5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id93c9943632c46e680e9a9c7d3dca0db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibdc8fdc92d5e4970acec520cba2b995b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i444e948e17884088a02f8873d27fb530_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4061198d00b42a1b1c3273bd1300f1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iebf97cb5d7b14fcaba22a604151aa02c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93ff25f41bfc48f685fe7999f7acb267_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f1e7c50392b48839d2e08df306850ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i031e61530a214b9881c8d518d3c7a377_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a8c1e543ab94dc7ae66690ab16e3743_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icecc95374e7c42d79e927354f15a2d05_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9cd678b9cba6400b91b864e4539c08f3_I20190823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-23</instant>
        </period>
    </context>
    <context id="ia9a0f515dda54606a8ec5e2a496990a6_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i310daf76cb31448db1eb956f40893392_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd137ffe84044ae29b17a0f26fcfbcc6_I20190628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-28</instant>
        </period>
    </context>
    <context id="i4a758fc2d72741ca8bd4fd42269ec1a4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cron:CanadianPrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i83da444fa44248408487072ea1d3c39e_D20220930-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if626a2f16cf6417e88022ae91d96abbc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30edf6082b0d4470941e510e7d37ba68_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7200b06da62a43118c5cc7777451847f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if369a901d9af4bfd8ae3d2a027cee610_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f45e6669daa4361a3421b8a2d98c0b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c64e7d2537944ffaf7e5b5f16883925_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i437da1842e044616977893cd552a72ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3320ad951dab401c84e0f90c4a96974c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i533957fd53ef49379dec9dedd211cf52_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:OntarioIncMucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2d18d46bab5242e3bfd554e73da9ea90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i325878c284c54d7983006f5f7cca0186_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b69cfe90a884fb39eba1ca111fc6b2e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05bc2d13ff4b4b3db4cbd143a6dd2d63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7bfb0d988c89434bae9a37fc057aca1e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c9593341e604e159c7bc62652cda7b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47c61698f6b548408440dcb1fe8bc8ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if869afc8633e4ac0b98107ef318157c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic368bd11f0df40d4a8c0b2947fe070bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie265b91a4e9a4c02afb8d5eb309f1fcd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c687afbf2874359b7b1e96d6171e47b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a1eeef365d9410ba49be0ad28e8a610_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ebea50f3dab40fe940962382c9edd7b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7e73aaf3d4da43618c18f1bb5254e468_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:FacilityInStaynerOntarioCanadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i799ef2d8ae8143d3aabbb83e1a41d9c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib7c6daed2ada448ca0191eb31284605b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2f24fa047ebd4cafa9ce6895143e5be7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i198f84bb8c8c4495a7592d90fa3b5554_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib098004c6d90459292103b62760beef6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie2be1513878243dbbe968f845f1407aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia68b72d6fb624de59f43851c8ada21f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d5db05218e34129ac787a7d7f694b92_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2c74a7f5ddc94bfbb03e3906e64f0b91_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25737ffe6e95490d8d2ee87f9448d05a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0e10c61d155349978107170ade1b67bd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3011f950a4e94248aeda6558c378e5b3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i755ce371ac6a447c827eb78a659cb733_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i77456131101b46f6b16bb4bde937116b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf526b01444e468cb8d268601d3ce639_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib30da315d1e048d1a112a4fd35422a60_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i193ecd1934b24649adc30b0af94378ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i68c5bd547ca145fda854a6fe88caecfc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad18f350f48747109ed2f62fb103c1ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie918e80cfb4d4ce1bc3659d5c55122dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94520bdab4b544a1a3dbb7a989765e98_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f005ffd354e4072aeeaedc327ce3b95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9aed4863ab04465a720fe0d99d7ada3_D20210821-20210821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGALicensingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-21</startDate>
            <endDate>2021-08-21</endDate>
        </period>
    </context>
    <context id="ifcca62b307af4573b49a49b9dc71ed48_I20210821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGALicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-21</instant>
        </period>
    </context>
    <context id="i60b0e9b055b34cd29e30bd1cbbc8d4b9_D20210821-20210821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGALicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-21</startDate>
            <endDate>2021-08-21</endDate>
        </period>
    </context>
    <context id="i5f85047526a4440e97e49b14b9b8c149_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGALicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7349eab127d4a66a02ccea7ace9a86f_D20211112-20211112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGVALicensingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-12</startDate>
            <endDate>2021-11-12</endDate>
        </period>
    </context>
    <context id="i84b41514fd424c719fa65a8c6207ec1c_I20211112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGVALicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-12</instant>
        </period>
    </context>
    <context id="i0d0cba209df1419b87b954ee194f4270_D20211112-20211112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGVALicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-12</startDate>
            <endDate>2021-11-12</endDate>
        </period>
    </context>
    <context id="ifdd20292b768499ba18dd9f93ed614fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBGVALicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a05578b3601443590c15854ed0c6306_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i13628330308147e39eccb6f6d522273c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3b0b2dc9d6fc490f9bdff8729d2be639_D20221101-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCALicensingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ie08bda6b8bc94e68b9c9453c44196451_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCALicensingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i8c5418b79bf345ebaf07317235767553_D20221101-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCALicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ic478134f8b5943789c119b31b737e663_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCVALicensingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9c5f202e7a6844d084f318b1a5ed7a48_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCVALicensingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9ad91752c734ce5a3109a2be336ffcf_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:CBCVALicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b8e682c2ca040fd975b5501a07eab0b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4cac6295dd43471085e94c05e8edc47c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if18d2c03d26d4706b4fbe1f740a27ad6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie54e4c678bed4bb18e9f07294b7c949a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i68cc03c90b794e938ba29c4e01d7fff3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic81f17ae580640a7b5c24a884c9ec3bc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i50cd01170d1f4a2bb1a30d020e35156b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b6c8d5ea81343f7aa1f596a92eae8fb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4f901df38e1c4d6d842edb34f8ab501e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90365f808213420099a7b087ef308b31_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5f641a8b2e914e16a1d54db890c168b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbf9404540e541bb8747d3dbaff42a7e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4bf6a4d5e23042058bc74e814d9dba02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied1f671988d04e8dba89bbc4bc42a206_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i732550b3992f4da1853152fc684f8d1a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib273218a57a04f388d9cdc27f16e269e_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7756c3f9244a44aea49da07e1988dd28_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79c67a1f55424125bc5bfeab113bb038_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i999046b0a46e46a2bc0eee830f50363f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i14d64d8fee424bdfa513430ee56f747e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:BuildingAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i44985dd9b7e343f49061a23ef9ab42ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:BuildingAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6710a5308fe240c785bbcd6e071db62b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7304849946e741a0aab1be7f1db2773b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11ee8c20fd4d40938bf05d4422a3ec42_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4b6c54c605e40e1b592903c9120fd37_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="i7b7c43afd25849a08ea88b3240e2dd83_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="i61396ac601174186a618ab85deae5ee4_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="ibffb66e7dc494751857b498f2aaeb299_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i28817b99a60840b0a33d72934688a602_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9715e946ec664da4bbd57f7a8c864d48_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i221dd5e17e9844b58038afd4bc734784_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="iaa6ab7221f554e87a7c8bf27eb2d5642_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="if1c27a3694484f45b570f0bb4e534e02_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="ic2fe51cbfc3a4ec9b05ab28c2101a8fe_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="ie7edb25988ef4ca680ec0519a1f7a41c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3d8966b6deea4e22966e81612eab4061_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c1c7205fa134b8ea972b207eaabed88_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib95bafb189fd4abdbbf394a634a0b887_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacbae512bdcf437c82335b9fc5c91440_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1937b23e84714a2daaa95f21590a01a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c446ba0830b43c0b39a1930af1ab423_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibb314c21396043bfbea5f9a42e79dd19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iefda9bc7439d4557845731f8c6e1ee83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0fb9758c232649229074d49b3b8dc7fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie5f45cb877964c1ca42caca1ed6a175f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e64ddadb77a4996af4ad68e0b33e84f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if48a2cb5842349feb0ee8180de88046d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icad90c5c09604a40bcda1aa60d6f4817_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibc817e542af6414480289d7ee595ed36_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia898bc55623845b0ac1ef2856e3c821b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id3070e38626248d882307c7013957190_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic82bd6cd39a9499088723cd61326ac33_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c7419e5e8c447b3bc7c086770debb36_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2adebb19e5a4a64b42095549e292edb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife021bb97d6549dba2eb6e2bc3cd674d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifb6c95fc236e4a279b1175dd18180f45_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie8866b2b61a742bea498367daa68d8a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7bfe6a0593fb41159cec5a4ea40d283e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0e7af0d7c0e94a61b25b0698337ffed9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1cff5c2fa201489099250164076db24e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic46e2540982d4ffa8221c6ad142b2e19_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i571abff367a8457cb1c603791998861e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9c6c121779f4779b344e53ba7e3d719_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76d8bedf7986401cba0cb84c55fb63aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07f1d462f24349299006395485505244_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbe71946d29442afbe7fba287fc77a14_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia83a3433c61045068fbb79983853180d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if393d0d16af2495990ea4ed129432655_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i913c98b4ac7e42aca4f52f0dd64e5065_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id510aed093fc495cb9f8a14f00900436_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i94acb806d58748d3b52065bda492be87_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibc6cb6f83fce4d5a80cc6961e26b5032_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6c829f39e691422b9ee160f08c4ababb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iefd833c70e1648639eb7783f93944757_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if138ace4b4c24c6dadebdaf0ce503a42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib017ada887a44e6aa4841154972d1578_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf75cd22b3fc4b0d8ebc327b92866198_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9612d41d77f443cdb2bc20406257be78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98bb2201b5a14d879713cb2138319dea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if87b98056c7642a8a360e6701396a2ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25b512c51525471c9d8ef40e569ddcda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9ac729cb13646a08fc56813a3bb06e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40a5d0b4996a4e9eabaf018f06c48779_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8d3221f7d1804397b6efac52293924b5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icfabefd19c3f47038000b89103cb9ddc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iab4b623f778f4729b3d247924c503370_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i32e3dc3e21e747538d80089fb902fe97_D20180904-20180904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-04</startDate>
            <endDate>2018-09-04</endDate>
        </period>
    </context>
    <context id="ief5d3e80cebf424583d8885fadb9005d_I20180717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-17</instant>
        </period>
    </context>
    <context id="i4e3f054fcf0e476495404c9892296850_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7032a2e2cd3c413ca31f86debd15d280_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id8e84bad228742d08e985829ef125a7f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a7b1865015342c2b593cd0e0f101d00_D20181015-20181015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:TechnionResearchAndDevelopmentFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="ie33d0799ad12401f8fb8fe45edfe1dae_D20190218-20190218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaVenturesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cron:ConsultingServicesArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-18</startDate>
            <endDate>2019-02-18</endDate>
        </period>
    </context>
    <context id="ieca7109f30f44b37987e0b2301dbcd00_D20200311-20200312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cron:U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-11</startDate>
            <endDate>2020-03-12</endDate>
        </period>
    </context>
    <context id="i8b07f4aa5f60422f8eee91da858d2511_D20221024-20221024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cron:OSCSettlementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-24</startDate>
            <endDate>2022-10-24</endDate>
        </period>
    </context>
    <context id="i0440f861c18e4a33b1c366ca915c82bd_D20200616-20200616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:UnfavorableRegulatoryActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-16</startDate>
            <endDate>2020-06-16</endDate>
        </period>
    </context>
    <context id="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b4ceff8a6a64ff4a32fbf710974cb5d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45a89728a31a45ceb354291ab7902edf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i55b7a35047644f16be6e005b2808de2d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6b53e4753cb24279a0a7dfc9ee30e88a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i52d59e2073a14df0bddb28f9c82e763b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if7b11f56bc6043d89eb5e2c45e96f100_I20180628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-28</instant>
        </period>
    </context>
    <context id="i43b1c08236a742bba4d259f97022d2cd_I20200625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-25</instant>
        </period>
    </context>
    <context id="i88aac73c8640496db5b02f61155ce7ec_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i15bb15a14e724f26b792f23353fb1d1c_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="id078cb5a300848a5afd3b1a38b4f82dc_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="iaec054e4771b4c90b5d921f053336fc3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i671a3f82ae654e0995f259326a3baa25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c268295fba144a989d01a9bd99cf5f8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0014408a0e804e82a06b2f923cd14abd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4da8bcc218e7495696143aafa8c5b34e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib632c4ab2a854cfb952e785b1c5b1f92_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82525d4a3a8f469f81973ca388451122_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2bafcc4c72134f0384d7d6c79566a00b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic81b826c9f6f47168c91d1cb32f0a31c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3da422e72bff47219c139aac3b9de694_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d50f7ee161742d4869f0c80a6f2c830_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3696af6fe23941a9aca7c712298dc6df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1615a90b3b04370a4c4f8cdb7323bcb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81cf921ce7a8454989e3197113c2db54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a57a4ae358343efa921579efb8a3332_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e0f5c40899c45bab72391f0ad745e88_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6f625c309374c1788da24ecf578f6ee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if649373ae72c46ac8d40aad21853ce38_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaea6684c36904e87baf20b2725c37ceb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i211045d7eac247689ade396e222267c3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idf37dbf34d9e4ca2a9617b7383689d3e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i45e09226123b4314955596439da54b30_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i44c6585cf14349b9a9f2167c67b4459e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i831f4a43963e485884c99ebee4119ee1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia45aee9721104c22a2d6be5ae87f587a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5443078b1c0d43fea330c2f7752fe5e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3564953f2ea840f583b304e6f9918665_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:LiabilityClassifiedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie890eaff21934fd69d0a7950a5a10f27_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia60068e6af9e472faf93c6ad942fa0a0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id22735cc325a45779460153828233a0d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie2f47442c54744328388ffe428c9d717_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if64d9be38b984e93b7bb3510d65efa19_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i74a2533447d449bab879b0c4eab1b547_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i74ebbd8e3add46ca819ae30424a73e32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CanadaRevenueAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f71b6661d4743cc8370d986af453519_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i27ccc99a2d3a4b069d7d181a25a422c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8aeff2099214e2cb23e3338d1c407e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CanadaRevenueAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iece993f8cd4f47dea213f3a4127ea952_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21d99941dc0142a7be674f746ad9562a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66239904fa4a427a997cee3b6eb5a236_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i36bf0818f4cd4583a8aae9102eb5d125_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i55cfa304264f4cf8837ffe45ee192e62_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i121d4fac442e45c78f91d9bee9e1e16e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i29ebb9a852384198889ab7d716ed3e00_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia97b43ae395a42af8a4d033428bd087c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if5c3d94cdeff43b89756b7af65fe6a0f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2eb44d5887f747f9b4ded07ef27d1ec9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i982c9bead0644302a7a575aa8cd1fedb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6e4ff60cd583466bb936bd3d33219c85_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3de187f960e94096af46a08a23476554_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i91930e58e4134eceb3113536ceba2913_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9944daa8d13a40349de5a04ccb8ab1fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05d2bf12c84540e9bc326f458b521a1c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2da2282758b1459e82599ab18062858c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8619acd4824f4abd8be3936adfc26c93_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib3b238bf872e4bb7840cf7d5fdb74e4e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i608ae05e92c14b879653819d1ae841a3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0a6d526d6e524c51b13f9269371efb1a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i280bc038076a4e98bd7729e1879bfc22_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i985cd0089e754ba184a2c698944d2406_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5a793c6ff71d45a4a349e560143146c7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0654c9ddca5d49809da1529bb6a3fc61_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i556926f67c0d433b8621f2c3fee78568_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iec2ab78532ff4381b0a60888ddda144c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9a07b966acb649a498c4e0cf5506ef30_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i16a7e8af45ca4dcca2104af0c77f365e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib9f56877c24949a6933041095690ce07_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b1cd4cc8c8d4241a55586d19c45fa4e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0dc209f811e486ea094251837a548eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7023f167ac1f48888058f60a0238b324_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fc4f046c82c4e989e9912e652e3393a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69792e5f365c4f74ac7fe11b6718f0e0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie6b10325aa474c3f90de9f43306e401c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c3b385a391141238bdff4bb41f0b9de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia591f2aa890f4f499b230f1be9abd0db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81106962b49a4c34889df90bb8006a1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67f9ea95f9074479a6d1ec92df88530c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id6855068406142e9b4ea4b031e056d70_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61bb5f5a360043fbb4ff433ca5adde3b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8712aa6fe7b7457d9c1f918bd39dc780_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d583d52c40242bca5743643c378dcb6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i908b9b9a8ad74722858339b6ede02cc1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6c9ff55d7a0549fdadda5e620d11697b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9101b37e3f454911b9d53d768c617ca0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if24c838134cc4114bf815abbed48d9a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd844fe64c4b404bb46e0d661e0f11cb_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:AustraliaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7260d7d8157b4cd88fc393c43daf539a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:AustraliaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie229aad448624a89855c1cd201833768_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie013c85f34934c4a9ef3fea20f60a42d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i193b7bc4af0a499ca3d6d6f0116acd86_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib404b8bdefcc4f2b8537e5847dcb9f04_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifc5ebc2d86264839b4b73bc4ee714946_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice3b1efcf3694f1599f386a8588accf4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib32dbd798ddd41e797792cebc95190b0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie46e12c969dc47b08571eacec89b355c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6b9788ac9a6c4a99ae0b6378aa5fbeff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8948b89b8d243ea918ef9455a2869fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i69c10d3f86f84221bdab6e26e7800896_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6abf41ffd0443ed90c42968b76c69dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i070e08bd1da74fe0a694c34d5deabb5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c7da359963f4407b13bec57ba12f46d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if30ffde831a0431e9db29021c4b5e73b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20c9a2151d6f4e979229b7d30b202741_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8d869fdefbad4a6daafa64f95ebfe973_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaf758d42193e47efa6985fa375da7738_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d0a16223e8748fca5daa5a5b730a11e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i397a3256afd747d8b6924425b8505d5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i85e32c5a6a41470eb8b3053295eb1e32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib95fa6c13bfb4c45adb4622b1026b433_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ideb28843c408441191244b00e0e9c9c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7178462e779b4050b4f4f598cd80ef6d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i578a803e2dfe4a57855a55c6ddd450a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27823bddabff46fa96994e20b95dfdaa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44db994827904092be31ae9e5e8445bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i311fa3bfafef494e85ad86818daa0cdc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2d176a72c724664bab57f3928bc0916_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb4548315c1d4631b6983f6d50ea8397_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9fc469d3cfaa48f9808a8fd424589cd6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i251c1f541a4743728ff8c8cd8aad5a51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i483292d9892e405c9fd41c2bc7fe6a89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e29abb1c1a64038b0402ae05946449a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic58ad37f674b4bf1a74ec35c6f4e405c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5241cf1c2d3d48c6829684e7a67b759a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id544276629be4ca58e468c96a96b58ff_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:ThreeMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7cbf0d27e1024f2585bc6bbba3a9248a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib624948ee4414abca5cf322e8938b6b9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:ThreeMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia8cc4bddc3834a28956294a993ffb1bd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:ThreeMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i318dd49f5d5f4baf9c5d2dbbd7dae763_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:ThreeMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i852bd7bd8fed4a99a245288e27159105_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e6e844f23174cafad959fff0262ccd2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0cfb8a95516c46b7ab49a044801b97ed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:OneVendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iddf4e03c7d9e40fa8a934f29b9d13609_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:OneVendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f0e0dbaf50b44ab84666bd8bc9badcc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idc524b86dcf94566bb86a2e924b61bb3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85d746ad8f524e279e4e4da9248e3e2a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibcc1ba88d12745e29a44781b9cb2a6b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c47520415b84aa69148a3dd6909c4a3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec05a6d229d94475b72ce77d3e52909d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib982510dffea40dca9be2c62f5c6ee7b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i045cf7db853f4153bd9a03bb1868a622_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ida3f84386d9149eaa1274948ebe8ec5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i46ed54be0f0b436d89417a7a22f3beae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:CannabisPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5a8cde9e54943859cd78bbde842143f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:VendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i92bdfdf7df22443d9e5a9d09d167facd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cron:VendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i650691423f5e4494934b0fa65dab6839_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2b8527b15bc047bdae7fdce3a2c33504_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27ca2cc174af48b58d8f18abbbdf825c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3a1afdda86b9422f916cf73765514521_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c8b6276b83842cc84cda8a4835b64c2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40b09d8040b24c29ba9f2d7d4f684f30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i545194e7a7b74577856d5bd7b228128c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iade03f20736843e9b053a88f457f1fe8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f994ee41e2c4a3d8727edc2735ef73d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i034a94c610e3462d98907c2dcb109918_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6e8955d83865472bb27bd4fb46bf1428_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i919ad19634e44f94b09180aaeb361f67_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f6e48ecac9f43d98f834e8ae0047473_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RealignmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>cron:segment</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="aud">
        <measure>iso4217:AUD</measure>
    </unit>
    <unit id="seat">
        <measure>cron:seat</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="subsidiary">
        <measure>cron:subsidiary</measure>
    </unit>
    <unit id="cadPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cannabinoid">
        <measure>cron:cannabinoid</measure>
    </unit>
    <unit id="warrant">
        <measure>cron:warrant</measure>
    </unit>
    <unit id="shareholder">
        <measure>cron:shareholder</measure>
    </unit>
    <unit id="complaint">
        <measure>cron:complaint</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl80L2ZyYWc6Y2ZkYWRhYjAxNTViNDFmYTk1YWUxMzNmNGYwYjVjOTgvdGFibGU6NmFhNmE2ZTRiMWRiNGM2M2E3ZDE5OGNlMzZmYzhhNDEvdGFibGVyYW5nZTo2YWE2YTZlNGIxZGI0YzYzYTdkMTk4Y2UzNmZjOGE0MV8wLTEtMS0xLTIxMzMzOQ_40609f41-d66a-4879-b633-e3be46390735">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl80L2ZyYWc6Y2ZkYWRhYjAxNTViNDFmYTk1YWUxMzNmNGYwYjVjOTgvdGFibGU6NmFhNmE2ZTRiMWRiNGM2M2E3ZDE5OGNlMzZmYzhhNDEvdGFibGVyYW5nZTo2YWE2YTZlNGIxZGI0YzYzYTdkMTk4Y2UzNmZjOGE0MV8xLTEtMS0xLTIxMzMzOQ_ed3597bb-b73b-4f71-8fcf-3c13ebee6880">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl80L2ZyYWc6Y2ZkYWRhYjAxNTViNDFmYTk1YWUxMzNmNGYwYjVjOTgvdGFibGU6NmFhNmE2ZTRiMWRiNGM2M2E3ZDE5OGNlMzZmYzhhNDEvdGFibGVyYW5nZTo2YWE2YTZlNGIxZGI0YzYzYTdkMTk4Y2UzNmZjOGE0MV8yLTEtMS0xLTIxMzMzOQ_49af1fa1-1fbf-4412-8c2b-28a02b503e2e">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl80L2ZyYWc6Y2ZkYWRhYjAxNTViNDFmYTk1YWUxMzNmNGYwYjVjOTgvdGFibGU6NmFhNmE2ZTRiMWRiNGM2M2E3ZDE5OGNlMzZmYzhhNDEvdGFibGVyYW5nZTo2YWE2YTZlNGIxZGI0YzYzYTdkMTk4Y2UzNmZjOGE0MV8zLTEtMS0xLTIxMzMzOQ_06021fe1-ce22-411c-81c2-7c5d49e708ab">0001656472</dei:EntityCentralIndexKey>
    <us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk1MzA0_7f2cac1a-2c68-4900-8eb5-5a1100ca88a2">http://fasb.org/us-gaap/2022#GoodwillAndIntangibleAssetImpairment</us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i88aac73c8640496db5b02f61155ce7ec_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMwOTI_c056cf0d-d43a-4943-8813-3c750ae39789">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod
      contextRef="ia6f625c309374c1788da24ecf578f6ee_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzYwNDk_6e990025-ef0a-4b0c-8037-643bef788633">P3Y</cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod>
    <dei:DocumentType
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ5_d46781b6-daa5-41c3-89dc-31d7a5426bfe">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjM4_07db757c-8e7c-4105-bfd3-b257d92cebbf">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8xNDg0MzQwNjk4MDk0MQ_f4fa8c86-5d7b-4202-a216-12e45bba2182">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8xNDg0MzQwNjk4MDk0MQ_2a7863f0-633f-46cb-87ad-1f07ddb2baaa">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ2_05766dad-db0a-428c-be4c-e5aaa0678f4b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ3_9355c1fa-f6b0-46b3-8807-9c8602e2d27f">001-38403</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ0_b00f790c-a188-4d13-8173-047a1b59d4f1">CRONOS GROUP INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF8wLTAtMS0xLTIxMzMzOS90ZXh0cmVnaW9uOjlhNzYzODVhMjRmNDRiZTliYTliOWIxYjU1OTIwZDk5Xzg_69afd405-2df3-4428-812f-c556b56ac2a2">Z4</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF80LTAtMS0xLTIxMzMzOQ_d28973ec-2aa4-4034-83bb-5d8a0caef47d">111 Peter St., Suite 300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF81LTAtMS0xLTIxMzMzOS90ZXh0cmVnaW9uOjc1OTVhNmY0ZTMzYzQzMjY5YjhiYzYzZTQ2ZDdkOTBlXzQ_5b124de3-c62e-40ea-bce4-8d2d7c5b7e7a">Toronto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF81LTAtMS0xLTIxMzMzOS90ZXh0cmVnaW9uOjc1OTVhNmY0ZTMzYzQzMjY5YjhiYzYzZTQ2ZDdkOTBlXzg_b2ce1fc8-9907-4945-85a5-0f5a947fb766">ON</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDliYzIyYjlkY2Y5NGJlNGI0MDA4ZWFjYzUyNGFjMzAvdGFibGVyYW5nZTo0OWJjMjJiOWRjZjk0YmU0YjQwMDhlYWNjNTI0YWMzMF81LTItMS0xLTIxMzMzOQ_d903273f-6187-4179-b052-f0f0f378f268">M5V 2H1</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV82MDM_5143e23c-7844-42d7-bd43-41576da6e462">416</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjM1_cd92594a-80b3-4004-bbfa-3b60f5a7cd75">504-0004</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDAyZDI5MzUzMTk1NGE2Mzg4N2EyODYxZmI3ZjNhNTkvdGFibGVyYW5nZTo0MDJkMjkzNTMxOTU0YTYzODg3YTI4NjFmYjdmM2E1OV8xLTAtMS0xLTIxMzMzOQ_8e8b4d3f-d379-46bd-b786-0db630ef09b5">Common Shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDAyZDI5MzUzMTk1NGE2Mzg4N2EyODYxZmI3ZjNhNTkvdGFibGVyYW5nZTo0MDJkMjkzNTMxOTU0YTYzODg3YTI4NjFmYjdmM2E1OV8xLTItMS0xLTIxMzMzOQ_7a6e923f-817f-48c4-95ee-bdbf0b7e125e">CRON</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6NDAyZDI5MzUzMTk1NGE2Mzg4N2EyODYxZmI3ZjNhNTkvdGFibGVyYW5nZTo0MDJkMjkzNTMxOTU0YTYzODg3YTI4NjFmYjdmM2E1OV8xLTQtMS0xLTIxMzMzOQ_6989589d-6f40-4dbb-9a63-8d6bca0a2688">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjM5_745a70b4-ed80-452b-b24c-d8ae8e3a618b">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ1_e9a30d85-dff0-4c11-8c40-81cc4157da00">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQx_1eb6dd4e-321d-47ab-8826-43c271b71777">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQy_ae043744-2992-4745-a227-4d2ca8e0ed73">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6ZTUxMjg3MjRjNWRlNDhjMzgwZDAyZjAyNGQ3ZDQxOTgvdGFibGVyYW5nZTplNTEyODcyNGM1ZGU0OGMzODBkMDJmMDI0ZDdkNDE5OF8wLTAtMS0xLTIxMzMzOQ_d81a8d2a-8da0-409a-83b9-a6dec301e8ea">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6ZTUxMjg3MjRjNWRlNDhjMzgwZDAyZjAyNGQ3ZDQxOTgvdGFibGVyYW5nZTplNTEyODcyNGM1ZGU0OGMzODBkMDJmMDI0ZDdkNDE5OF8xLTQtMS0xLTIxMzMzOQ_f0150aba-ada2-4655-9c5c-d7d2eef7d4c7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGFibGU6ZTUxMjg3MjRjNWRlNDhjMzgwZDAyZjAyNGQ3ZDQxOTgvdGFibGVyYW5nZTplNTEyODcyNGM1ZGU0OGMzODBkMDJmMDI0ZDdkNDE5OF8yLTEtMS0xLTIxMzMzOQ_e359123e-b3b6-47c1-9a3f-a50f9baa815a">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQw_af5c445d-403a-4e2a-9f4b-d7a13dbd3191">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjM2_8ed18186-beac-4ccc-a005-41311fc170f0">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i7656cbe523fc4dd4a341da5f796c9093_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQ4_32f2eb94-76ff-42eb-a6a3-1c45d66d2ca6"
      unitRef="usd">562557422</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ic0d65956228143c19035678405df018c_I20230224"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zMTI5_3787f744-1180-42e1-9d94-c676893e6fee"
      unitRef="shares">380575403</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xL2ZyYWc6YmJlY2E1MWI0ZmM0NDA2Nzg3MTRkZDNlZjc3YjkzMmEvdGV4dHJlZ2lvbjpiYmVjYTUxYjRmYzQ0MDY3ODcxNGRkM2VmNzdiOTMyYV8zNjQz_39d3de39-3e64-4ad9-81ed-47019cf2c68e">Certain information required by Part III of this Annual Report on Form 10-K will either be incorporated into this Annual Report on Form 10-K by reference to the registrant&#x2019;s definitive proxy statement for its 2023 Annual Meeting of Shareholders, or will be included in an amendment to this Annual Report on Form 10-K to be filed no later than 120 days after the registrant's fiscal year ended December&#160;31, 2022.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl83My9mcmFnOmE1OWRiOTZjYjZmODQ1YjY4YjYxOWZhM2YwMDBjMWEzL3RhYmxlOjBhYTA0Zjg3MGU2MTQ5ZWZiNGI2ODE0MDkwNmFiODA5L3RhYmxlcmFuZ2U6MGFhMDRmODcwZTYxNDllZmI0YjY4MTQwOTA2YWI4MDlfMS0wLTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjpiOTc4YmFiOGIzMmY0ODMzYTY0YmFiMTZjZWZhNjc0NF8xNQ_dea20def-fdd8-42e3-a128-ebba1997f7ba">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl83My9mcmFnOmE1OWRiOTZjYjZmODQ1YjY4YjYxOWZhM2YwMDBjMWEzL3RhYmxlOjBhYTA0Zjg3MGU2MTQ5ZWZiNGI2ODE0MDkwNmFiODA5L3RhYmxlcmFuZ2U6MGFhMDRmODcwZTYxNDllZmI0YjY4MTQwOTA2YWI4MDlfMS0wLTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjpiOTc4YmFiOGIzMmY0ODMzYTY0YmFiMTZjZWZhNjc0NF8xMDk5NTExNjI3OTE5_ec407dd7-7cc4-4911-82a3-2510de930c39">Vaughan, Ontario, Canada</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl83My9mcmFnOmE1OWRiOTZjYjZmODQ1YjY4YjYxOWZhM2YwMDBjMWEzL3RhYmxlOjBhYTA0Zjg3MGU2MTQ5ZWZiNGI2ODE0MDkwNmFiODA5L3RhYmxlcmFuZ2U6MGFhMDRmODcwZTYxNDllZmI0YjY4MTQwOTA2YWI4MDlfMS0wLTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjpiOTc4YmFiOGIzMmY0ODMzYTY0YmFiMTZjZWZhNjc0NF8yOQ_562dee13-505c-4c94-8e8e-22d4f55211a9">85</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNC0xLTEtMS0yMTMzMzk_25c13fce-eb8d-4d6d-abc3-2b49ca3c0f45"
      unitRef="usd">764644000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNC0zLTEtMS0yMTMzMzk_203775bc-3655-46ad-a606-86c7853e9a53"
      unitRef="usd">886973000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNS0xLTEtMS0yMTMzMzk_83e7cb2c-e557-490d-8401-7d8fe69579b6"
      unitRef="usd">113077000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNS0zLTEtMS0yMTMzMzk_0dcd42c1-e237-46fd-aed8-073749f927da"
      unitRef="usd">117684000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNi0xLTEtMS0yMTMzMzk_acf55952-3d76-4b33-b8bf-74c4deef3f0a"
      unitRef="usd">23113000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNi0zLTEtMS0yMTMzMzk_35729cff-3690-4316-9a00-89485624aaa7"
      unitRef="usd">22067000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNy0xLTEtMS0yMTMzMzk_f4cc3aed-9d7a-42c4-b217-05a0aa8bd5bc"
      unitRef="usd">5767000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNy0zLTEtMS0yMTMzMzk_c3e3c2bb-a2ed-4485-a408-c70a48a6302f"
      unitRef="usd">5765000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOC0xLTEtMS0yMTMzMzk_253143ff-817a-4b71-871d-693aadbe5be6"
      unitRef="usd">8890000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOC0zLTEtMS0yMTMzMzk_2774aa89-a327-4fb8-b799-93b40b937169"
      unitRef="usd">5460000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOS0xLTEtMS0yNTQxOTk_f88206ae-35f3-4c9e-a264-9207efcd9f0d"
      unitRef="usd">37559000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOS0zLTEtMS0yNTQxOTk_2d566237-cb92-4439-916e-ab6747fc0b80"
      unitRef="usd">32802000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOS0xLTEtMS0yMTMzMzk_b6084dc4-0a0c-4cf5-a113-79807deeb1a6"
      unitRef="usd">7106000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfOS0zLTEtMS0yMTMzMzk_02486122-63c4-4ac0-80fc-b77ca26c730d"
      unitRef="usd">8967000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTItMS0xLTEtMjEzMzM5_117d71f7-5d66-4fb7-ac1e-95524662b803"
      unitRef="usd">960156000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTItMy0xLTEtMjEzMzM5_8191e6ae-1164-490b-8d6c-89dad7fb2be8"
      unitRef="usd">1079718000</us-gaap:AssetsCurrent>
    <us-gaap:EquityMethodInvestments
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTMtMS0xLTEtMjEzMzM5_cedc55df-ea49-4445-99ca-ead87fad672f"
      unitRef="usd">18755000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTMtMy0xLTEtMjEzMzM5_e4b0f41f-2a66-43ed-9741-d6f868a10410"
      unitRef="usd">16764000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTQtMS0xLTEtMjEzMzM5_dc7c9379-c010-4b43-adac-fdf162e2d97f"
      unitRef="usd">70993000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTQtMy0xLTEtMjEzMzM5_65846c20-92e5-4201-9fef-c445bacf052f"
      unitRef="usd">118392000</us-gaap:OtherLongTermInvestments>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTUtMS0xLTEtMjEzMzM5_88c5f5dc-ed9e-4a86-8c40-754516f3408a"
      unitRef="usd">72345000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTUtMy0xLTEtMjEzMzM5_80a72a8e-8f05-4e3c-b8ed-1aafd2ab8b5c"
      unitRef="usd">80635000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTYtMS0xLTEtMjEzMzM5_9c84311f-01f2-44ff-9a48-539a574277ba"
      unitRef="usd">60557000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTYtMy0xLTEtMjEzMzM5_826ede38-38cb-45ec-a08f-0af632e0afef"
      unitRef="usd">74070000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTctMS0xLTEtMjEzMzM5_1d6ee851-e118-425d-8ffe-6f54c1ea7132"
      unitRef="usd">2273000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTctMy0xLTEtMjEzMzM5_b7eea965-f5fc-43f9-afe9-4e7c3f26243a"
      unitRef="usd">8882000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTgtMS0xLTEtMjEzMzM5_ba0f3568-2604-4f96-a078-fbaf39d9d80f"
      unitRef="usd">1033000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTgtMy0xLTEtMjEzMzM5_2649261a-ff30-48df-a4dd-d4f3a9f42c62"
      unitRef="usd">1098000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTktMS0xLTEtMjEzMzM5_c69809b0-80a7-4418-9a65-fb45257fc2ba"
      unitRef="usd">26704000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMTktMy0xLTEtMjEzMzM5_7336b908-a5f1-4d00-a912-4c9d6d9ef4bb"
      unitRef="usd">18079000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjAtMS0xLTEtMjEzMzM5_3a7cb776-0fea-4724-a163-809a8dc20e0e"
      unitRef="usd">193000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjAtMy0xLTEtMjEzMzM5_7f9fec71-535a-4c3d-b2f1-4ed7584e2301"
      unitRef="usd">100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjEtMS0xLTEtMjEzMzM5_7699116d-2cf7-47e2-b42c-0331eb185bac"
      unitRef="usd">1213009000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjEtMy0xLTEtMjEzMzM5_efc9a1ec-28ea-4216-89cf-5cb9b31eec8d"
      unitRef="usd">1397738000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjQtMS0xLTEtMjEzMzM5_7171505d-cd5c-49a3-a48d-6e2e1439418e"
      unitRef="usd">11163000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjQtMy0xLTEtMjEzMzM5_eff5893a-4f68-4ffa-ac52-bc57229f90fd"
      unitRef="usd">11113000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjUtMS0xLTEtMjQzODY1_3282e39b-30c5-4a48-8993-017f0856a16e"
      unitRef="usd">32956000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjUtMy0xLTEtMjQzODY1_298b34af-4c53-41dd-8f37-cf32591ee5fe"
      unitRef="usd">105000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjUtMS0xLTEtMjEzMzM5_ca6d5f3b-b5fa-46db-a9a2-177c137ccb92"
      unitRef="usd">22268000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjUtMy0xLTEtMjEzMzM5_d87c848a-ff4f-4d5b-844f-0da7e734a026"
      unitRef="usd">25636000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjYtMS0xLTEtMjEzMzM5_1dfbfef4-2808-46cf-9ec8-470b9b9c42e9"
      unitRef="usd">1330000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjYtMy0xLTEtMjEzMzM5_9fe84d8c-b24e-4310-a7f7-51eb31abc85a"
      unitRef="usd">2711000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjctMS0xLTEtMjEzMzM5_b9f338b9-4298-4f75-9031-c36a6f5c5cd5"
      unitRef="usd">15000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjctMy0xLTEtMjEzMzM5_0cd95a3f-cb45-4684-9733-91abd0623acd"
      unitRef="usd">14375000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjgtMS0xLTEtMjIwOTc0_ed9e6e17-b158-432a-8ae5-4ee35a502e49"
      unitRef="usd">384000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjgtMy0xLTEtMjIwOTc0_bd099da9-17c6-4bfe-b6b5-387d10d65893"
      unitRef="usd">433000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjgtMS0xLTEtMjEzMzM5_966c2096-4d5d-451f-8906-f371ce52345b"
      unitRef="usd">68116000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjgtMy0xLTEtMjEzMzM5_2c0ade0d-be90-4fce-893d-79ac14f81936"
      unitRef="usd">54373000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjktMS0xLTEtMjEzMzM5_bf644089-855b-430d-a8f4-8bf5d9da49d1"
      unitRef="usd">1383000</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMjktMy0xLTEtMjEzMzM5_28d6d706-ccad-42f3-93c3-d6ad77586d35"
      unitRef="usd">1913000</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzAtMS0xLTEtMjEzMzM5_3edbace1-86a0-49f8-af9c-373e503c17b2"
      unitRef="usd">2546000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzAtMy0xLTEtMjEzMzM5_b6d36cf4-adce-4354-98fb-36f57b531e1e"
      unitRef="usd">7095000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzEtMS0xLTEtMjEzMzM5_3513553d-76af-464a-aaea-8d3cb19d9f20"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzEtMy0xLTEtMjEzMzM5_49e1d0f5-1b16-4327-8912-e566a96c4f71"
      unitRef="usd">81000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzItMS0xLTEtMjEzMzM5_df2c0267-95d6-40ba-9d90-69d2e5f8e8f8"
      unitRef="usd">72045000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzItMy0xLTEtMjEzMzM5_87fbf22d-8611-4092-8287-d1309a501435"
      unitRef="usd">63462000</us-gaap:Liabilities>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzUtMC0xLTEtMjEzMzM5L3RleHRyZWdpb246Y2RmNjQ2MTU4ZjczNDkzMWIyODQ5YWI3MGE0MTE4MzVfMzg0ODI5MDY5NzQ0OQ_69fac538-4c3d-4afd-b66b-9ce15a2483c7"
      unitRef="shares">380575403</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzUtMC0xLTEtMjEzMzM5L3RleHRyZWdpb246Y2RmNjQ2MTU4ZjczNDkzMWIyODQ5YWI3MGE0MTE4MzVfMzg0ODI5MDY5NzQ2Mw_3357c605-8671-47ff-8508-3fbec62249c3"
      unitRef="shares">374952693</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzUtMS0xLTEtMjEzMzM5_9799233a-96bc-495e-9f2a-05712e5f9b05"
      unitRef="usd">611318000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzUtMy0xLTEtMjEzMzM5_4aa8be29-4919-4c44-bf82-0169ed02fa0d"
      unitRef="usd">595497000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzYtMS0xLTEtMjEzMzM5_8d57a0a3-d672-49d4-9e6e-1498d3025931"
      unitRef="usd">42682000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzYtMy0xLTEtMjEzMzM5_f716fd87-72ba-44ab-9bf9-8dc853c2b4b6"
      unitRef="usd">32465000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzctMS0xLTEtMjEzMzM5_d79295d3-a61e-481b-84aa-1d9391d61581"
      unitRef="usd">490682000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzctMy0xLTEtMjEzMzM5_0e742b1c-51f0-4845-9bd5-fa053ff93427"
      unitRef="usd">659416000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzgtMS0xLTEtMjEzMzM5_ebe5dc62-7bc8-4dab-bf3b-8bdbd81b72fa"
      unitRef="usd">-797000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzgtMy0xLTEtMjEzMzM5_2f46b9a9-9f35-4885-8a0c-50088064275b"
      unitRef="usd">49865000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzktMS0xLTEtMjEzMzM5_30a0bc9a-e629-4ac4-aa0d-0f42624b15ba"
      unitRef="usd">1143885000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfMzktMy0xLTEtMjEzMzM5_6335c5a7-0953-4276-a35e-c28e7b68a9a4"
      unitRef="usd">1337243000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDAtMS0xLTEtMjEzMzM5_b0da9b60-9492-4538-aab5-797e70ae894b"
      unitRef="usd">-2921000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDAtMy0xLTEtMjEzMzM5_d83f6a96-1132-4100-89fb-e4a3bb4a9543"
      unitRef="usd">-2967000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDEtMS0xLTEtMjEzMzM5_75c7a4c7-eda9-4bbc-a670-9ae2ce951e31"
      unitRef="usd">1140964000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDEtMy0xLTEtMjEzMzM5_dcb994be-fd01-472d-873f-6e1a849aeb8f"
      unitRef="usd">1334276000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDItMS0xLTEtMjEzMzM5_994d551f-568b-42b4-92c7-62e97f33e38a"
      unitRef="usd">1213009000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84Mi9mcmFnOjllYjA3OTk1YmJkNzRmMDhiMjQwMjY3OTBhNTNiNWQ5L3RhYmxlOmRmZDM1ODFjYjY2ZTRhYTU5ODkyZjU0MjcwOWE4ZDY2L3RhYmxlcmFuZ2U6ZGZkMzU4MWNiNjZlNGFhNTk4OTJmNTQyNzA5YThkNjZfNDItMy0xLTEtMjEzMzM5_2543ea77-61a5-4d2d-9445-b792c2167a66"
      unitRef="usd">1397738000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMi0zLTEtMS0yMTMzMzk_2441ed6c-0182-498f-b65b-cf94f1126900"
      unitRef="usd">114456000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMi01LTEtMS0yMTMzMzk_d096ec67-c055-4df2-b9e5-fc1d8d07287c"
      unitRef="usd">89486000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMi03LTEtMS0yMTMzMzk_ee662487-9029-49d5-9628-7776b81b4d5f"
      unitRef="usd">54353000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMy0zLTEtMS0yMTMzMzk_3f056991-90c3-47a2-80b9-cf1c8fae579f"
      unitRef="usd">22552000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMy01LTEtMS0yMTMzMzk_e3f3cab2-779e-4087-8fad-25f4d6953590"
      unitRef="usd">15051000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMy03LTEtMS0yMTMzMzk_dde556fa-57d5-40e3-b3f9-66cd7c957b70"
      unitRef="usd">7634000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNC0zLTEtMS0yMTMzMzk_a6170dc4-b54d-4e5e-9361-5f56878fd680"
      unitRef="usd">91904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNC01LTEtMS0yMTMzMzk_406f29cf-423a-4371-84bc-0f47bd73d957"
      unitRef="usd">74435000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNC03LTEtMS0yMTMzMzk_49733b38-5b76-4ef6-9784-aecbd6466e93"
      unitRef="usd">46719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNS0zLTEtMS0yMTMzMzk_3c989992-b559-41f9-81a0-e0fb551681b8"
      unitRef="usd">79935000</cron:OtherCostOfGoodsAndServicesSold>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNS01LTEtMS0yMTMzMzk_4937c73b-aecf-4ad9-b550-c487a3ccb1fc"
      unitRef="usd">80008000</cron:OtherCostOfGoodsAndServicesSold>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNS03LTEtMS0yMTMzMzk_a1bd03b6-f8f9-4be1-b200-fc84005a36a6"
      unitRef="usd">46497000</cron:OtherCostOfGoodsAndServicesSold>
    <us-gaap:InventoryWriteDown
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNi0zLTEtMS0yMTMzMzk_080cb5eb-a1f5-404e-8be1-e2e4494c238c"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNi01LTEtMS0yMTMzMzk_547865cb-0b52-4b83-9d14-81e38fc07fc8"
      unitRef="usd">11961000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNi03LTEtMS0yMTMzMzk_bee7e8c8-026f-474d-b6f9-a05f30f99aa4"
      unitRef="usd">26055000</us-gaap:InventoryWriteDown>
    <us-gaap:GrossProfit
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNy0zLTEtMS0yMTMzMzk_bd1b36f0-0939-4d41-a072-eb70ddfbf340"
      unitRef="usd">11969000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNy01LTEtMS0yMTMzMzk_659f60e0-0a0e-4948-ba6f-a02fb2e83a2b"
      unitRef="usd">-17534000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNy03LTEtMS0yMTMzMzk_4a79f9c1-7e3e-45d4-9685-7cef65e1e940"
      unitRef="usd">-25833000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfOS0zLTEtMS0yMTMzMzk_0a286564-297e-4132-a617-7543be3176de"
      unitRef="usd">22282000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfOS01LTEtMS0yMTMzMzk_4da938ef-ab19-497b-aad4-d8947b998384"
      unitRef="usd">44937000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfOS03LTEtMS0yMTMzMzk_96b69170-bb11-4fa1-8662-b106c932a3ed"
      unitRef="usd">34386000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTAtMy0xLTEtMjEzMzM5_319fadc6-10f6-4868-b8f4-274a443b1070"
      unitRef="usd">13381000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTAtNS0xLTEtMjEzMzM5_5914cbe1-a7a6-43f0-b403-ee3f7c5beee8"
      unitRef="usd">23331000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTAtNy0xLTEtMjEzMzM5_9ea31dcd-81d2-4c51-8871-7ed2be9e8471"
      unitRef="usd">20366000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTEtMy0xLTEtMjEzMzM5_d3c2d472-91f9-4c38-baa3-e176645a9a65"
      unitRef="usd">71178000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTEtNS0xLTEtMjEzMzM5_92bb8559-df99-41af-94dd-e9eebc4c7294"
      unitRef="usd">96482000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTEtNy0xLTEtMjEzMzM5_0664a54a-d74a-4767-ae77-501b5ca24c28"
      unitRef="usd">80569000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCosts
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItMy0xLTEtMjQwODY2_eb4a1135-d5fb-4050-ab15-ea65b570c14f"
      unitRef="usd">5333000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItNS0xLTEtMjQwODY2_277ac942-a2f4-478b-81e2-13a542550f1d"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItNy0xLTEtMjQwODY2_446f3699-0deb-4c56-afa8-f439cd813d78"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItMy0xLTEtMjEzMzM5_4895db4b-0848-4f41-93bb-526037a6c53c"
      unitRef="usd">15115000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItNS0xLTEtMjEzMzM5_476fb819-9a69-4778-922f-4f2fd1eb4ae1"
      unitRef="usd">10151000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTItNy0xLTEtMjEzMzM5_f12a559e-3068-461e-9abb-e23502b00ab7"
      unitRef="usd">15361000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTMtMy0xLTEtMjEzMzM5_621667da-50a6-45d6-a708-bf4613e79ec9"
      unitRef="usd">6025000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTMtNS0xLTEtMjEzMzM5_bbd72913-256c-4e6b-89f6-64a35959f2d7"
      unitRef="usd">4484000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTMtNy0xLTEtMjEzMzM5_fbbf38d8-1b50-4561-af6f-b4e15d4becc5"
      unitRef="usd">2872000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTQtMy0xLTEtMjEzMzM5_f311bf81-506f-4e9d-bf5e-2ef22eb527d1"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTQtNS0xLTEtMjEzMzM5_f74745be-585a-4fe8-a995-e62d2923d60e"
      unitRef="usd">236056000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTQtNy0xLTEtMjEzMzM5_1e1b9d70-ece9-4721-b31d-ad3fa2146997"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTUtMy0xLTEtMjEzMzM5_ffcf690d-99a2-4d64-a48f-98221a0ed970"
      unitRef="usd">3493000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTUtNS0xLTEtMjEzMzM5_11b1cbf3-8d7b-450f-9e67-47792ea683a2"
      unitRef="usd">127619000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTUtNy0xLTEtMjEzMzM5_2b8a403f-a8eb-4e8d-8fef-691096712b75"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingExpenses
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTctMy0xLTEtMjEzMzM5_34ada74e-471c-46b4-8cae-fd2875a044b9"
      unitRef="usd">136807000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTctNS0xLTEtMjEzMzM5_1696f82f-9f51-4ca8-bd67-d27fa8edbfa1"
      unitRef="usd">543060000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTctNy0xLTEtMjEzMzM5_e4ed543e-64e9-459d-9d46-541d276147f4"
      unitRef="usd">193554000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTgtMy0xLTEtMjEzMzM5_54a3d3d4-acca-40f0-b289-a40dc7ecad24"
      unitRef="usd">-124838000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTgtNS0xLTEtMjEzMzM5_ed9a3a8a-b661-4836-b4a2-70213dec5521"
      unitRef="usd">-560594000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMTgtNy0xLTEtMjEzMzM5_e69c8540-5037-473c-9a42-befda8d236f2"
      unitRef="usd">-219387000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjAtMy0xLTEtMjEzMzM5_661f93d3-64f1-45c7-8cf5-ce029f1a75f1"
      unitRef="usd">22537000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjAtNS0xLTEtMjEzMzM5_a74757f9-1975-4df1-b9a4-a6e623e22b35"
      unitRef="usd">9071000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjAtNy0xLTEtMjEzMzM5_4d28b72e-a6ff-43db-a59b-f18d66e4fc2a"
      unitRef="usd">18415000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjEtMy0xLTEtMjEzMzM5_3c44b258-6f1f-49ea-a845-3172a8d7ee2e"
      unitRef="usd">14060000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjEtNS0xLTEtMjEzMzM5_4ddc4bc3-743f-46f6-ae90-9383471e1a8b"
      unitRef="usd">151360000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjEtNy0xLTEtMjEzMzM5_cd59b1a5-9681-4005-9f57-f9643d5f6c65"
      unitRef="usd">129254000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjMtMy0xLTEtMjEzMzM5_74a6ee85-b2ea-4130-95cf-f2e9c8a05e33"
      unitRef="usd">3114000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjMtNS0xLTEtMjEzMzM5_d7201494-f2dc-4dc5-ac9e-387beea43195"
      unitRef="usd">-6313000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjMtNy0xLTEtMjEzMzM5_84ee75f9-192c-4913-ab6e-d865c1d3687b"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtMy0xLTEtMjEzMzM5_c3932c39-bd5b-4a76-96e4-5544cbcd0071"
      unitRef="usd">14739000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtNS0xLTEtMjEzMzM5_99a3f229-e316-4b0c-b687-d5bf699c8fa4"
      unitRef="usd">8611000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtNy0xLTEtMjEzMzM5_7d8a6972-c62f-44c3-8861-aff6a65ca3da"
      unitRef="usd">-9000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtMy0xLTEtMjM0NzA0_c6d8a8a4-29ce-4feb-abf7-5da16f8ff190"
      unitRef="usd">61392000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtNS0xLTEtMjM0NzA0_befa1e69-5d31-40b3-9538-8840e9ea9394"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtNy0xLTEtMjM0NzA0_7bcb96d4-6610-4512-967a-b5990cfc3d85"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtMy0xLTEtMjM0NzA0_10d0df3b-d307-4d61-81b1-4086af699873"
      unitRef="usd">-2286000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtNS0xLTEtMjM0NzA0_348f1092-17d8-4013-a110-865283f22370"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjUtNy0xLTEtMjM0NzA0_2fe8fcf2-43ca-4f94-bdfd-83af69f554cc"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtMy0xLTEtMjMwMjky_5cdb6396-7c88-42d2-acfa-120d371ef4b5"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtNS0xLTEtMjMwMjky_4ac4fbea-f6b5-4b4b-b83e-02f4aec2cd65"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjQtNy0xLTEtMjMwMjky_7380035e-14a1-44c3-8a8c-0312784292b6"
      unitRef="usd">4789000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjYtMy0xLTEtMjEzMzM5_2fc29df0-1270-4156-ad19-71964a8e7527"
      unitRef="usd">-493000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjYtNS0xLTEtMjEzMzM5_23fa947c-7bd3-45c0-9410-130482e2e268"
      unitRef="usd">730000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjYtNy0xLTEtMjEzMzM5_d2c013ed-5d7b-42a6-a4a5-304d283495e9"
      unitRef="usd">-1825000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjctMy0xLTEtMjEzMzM5_d1db247b-b01e-4f35-9ce2-23d58aa56392"
      unitRef="usd">-9721000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjctNS0xLTEtMjEzMzM5_344ee8da-deda-41b5-9bc3-567e3fad1ed7"
      unitRef="usd">163459000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjctNy0xLTEtMjEzMzM5_007b22ea-310f-40a7-98f2-5e953e419b2d"
      unitRef="usd">146114000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjgtMy0xLTEtMjEzMzM5_23c91309-4c0b-4f8d-b55e-1a523d145d02"
      unitRef="usd">-134559000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjgtNS0xLTEtMjEzMzM5_491a1384-bab8-489d-9180-4db8a52d565f"
      unitRef="usd">-397135000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjgtNy0xLTEtMjEzMzM5_bc4fbde3-bda7-4679-83cd-9a6616bdc047"
      unitRef="usd">-73273000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjktMy0xLTEtMjEzMzM5_7d1d0edb-15e0-4f96-93e3-4dc3c4477e89"
      unitRef="usd">34175000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjktNS0xLTEtMjEzMzM5_8bae9fc9-8ed3-47c1-9878-e7f8208cdd58"
      unitRef="usd">-431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMjktNy0xLTEtMjEzMzM5_07aec197-42f4-4e8b-8604-d386036c7fe9"
      unitRef="usd">1347000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzAtMy0xLTEtMjEzMzM5_3bd65a5f-60c1-4210-9aa6-6806a338f2a3"
      unitRef="usd">-168734000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzAtNS0xLTEtMjEzMzM5_14e30b07-4929-4e7d-bc93-3a0ab25d78bd"
      unitRef="usd">-396704000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzAtNy0xLTEtMjEzMzM5_4ed6204c-42fb-4e68-aeb0-a702e2806e0a"
      unitRef="usd">-74620000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzEtMy0xLTEtMjEzMzM5_01067500-1134-4223-9ce3-bd44edc4182b"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzEtNS0xLTEtMjEzMzM5_474c9e88-771e-4d39-a25a-a948c08a8630"
      unitRef="usd">-500000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzEtNy0xLTEtMjEzMzM5_e7011e25-6ca5-481b-90bd-b7927a80a222"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzItMy0xLTEtMjEzMzM5_853b0e51-e5ec-4749-8ef5-4027e7170dfe"
      unitRef="usd">-168734000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzItNS0xLTEtMjEzMzM5_f7a49cfc-7928-41d8-8095-6b35d89a41f9"
      unitRef="usd">-397204000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzItNy0xLTEtMjEzMzM5_4656bd76-ab60-4acc-8c17-dd88fff73745"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzMtMy0xLTEtMjEzMzM5_d448a44b-5a64-4b50-bca8-551439fd3ae4"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzMtNS0xLTEtMjEzMzM5_ac7dd667-50fb-495e-a70e-3213a89b29ca"
      unitRef="usd">-1097000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzMtNy0xLTEtMjEzMzM5_b406b5c2-0dc2-4a89-a422-5556b5ad39f4"
      unitRef="usd">-2133000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzQtMy0xLTEtMjEzMzM5_ee6a2074-7d3b-450f-9753-f8916b907153"
      unitRef="usd">-168734000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzQtNS0xLTEtMjEzMzM5_4fb2707a-05a9-45df-8aeb-9a57d03880f1"
      unitRef="usd">-396107000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzQtNy0xLTEtMjEzMzM5_7220fdfd-4627-4a91-aba7-cad30200d0f4"
      unitRef="usd">-73137000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzctMy0xLTEtMjEzMzM5_77f632fe-366b-4194-a611-4a223f3b10fe"
      unitRef="usd">-168734000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzctNS0xLTEtMjEzMzM5_d7cee2c8-c77d-4c77-9d00-74f88147c63d"
      unitRef="usd">-397204000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzctNy0xLTEtMjEzMzM5_feea7c7e-3c0e-48a9-bbeb-5a8bc6a4a15c"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzgtMy0xLTEtMjEzMzM5_cc9c6282-b030-47e4-8e7d-57ba549b0e7d"
      unitRef="usd">-50616000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzgtNS0xLTEtMjEzMzM5_db13a0dc-81c8-40b8-99a4-ad6f4e466a2b"
      unitRef="usd">8192000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzgtNy0xLTEtMjEzMzM5_e8150ce0-b780-4459-9a18-d6c6ce21af2f"
      unitRef="usd">14951000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzktMy0xLTEtMjEzMzM5_4fbe6c1c-4ad4-40b0-9bd7-3bdf7a684b5b"
      unitRef="usd">-219350000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzktNS0xLTEtMjEzMzM5_1802a5da-51fe-4c71-a614-eee10fb7ed41"
      unitRef="usd">-389012000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfMzktNy0xLTEtMjEzMzM5_3996946d-4bca-4802-a02b-7a1f3ec9696e"
      unitRef="usd">-60319000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDAtMy0xLTEtMjEzMzM5_51b4867c-81be-4e78-959b-421f80714c2a"
      unitRef="usd">46000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDAtNS0xLTEtMjEzMzM5_8a23ba01-92ce-4a78-b726-2e3080ff770d"
      unitRef="usd">229000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDAtNy0xLTEtMjEzMzM5_bb12a9c5-284b-48a9-a87b-ddafc5ed42b4"
      unitRef="usd">-2343000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDEtMy0xLTEtMjEzMzM5_4d8948b2-cc15-4eeb-9e9a-d52de1c0e488"
      unitRef="usd">-219396000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDEtNS0xLTEtMjEzMzM5_2080416e-f70b-4ffe-ab20-37f95d1ef953"
      unitRef="usd">-389241000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDEtNy0xLTEtMjEzMzM5_6494535b-74e5-48b7-bd1f-d784f21eeacf"
      unitRef="usd">-57976000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDMtMy0xLTEtMjEzMzM5_32cd0c2e-bcb3-410d-8773-5815461f1a99"
      unitRef="usdPerShare">-0.45</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDMtNS0xLTEtMjEzMzM5_c75827b9-b62e-4fac-91ce-30f9b824dfe9"
      unitRef="usdPerShare">-1.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDMtNy0xLTEtMjEzMzM5_29c6a542-42b9-4455-ac50-0764a09ebfdf"
      unitRef="usdPerShare">-0.21</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDQtMy0xLTEtMjEzMzM5_83bc4791-1822-4082-b149-1b1ead855e03"
      unitRef="usdPerShare">-0.45</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDQtNS0xLTEtMjEzMzM5_60e71588-2860-4eaf-b04b-cf99b9997761"
      unitRef="usdPerShare">-1.07</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84NS9mcmFnOjkzYTNmOGI2ZjU5NjQzY2NiNzhmYTAxODg5NjY3NmFkL3RhYmxlOjQwNGFmMTAyOTE4MjQ3YTY4YmVkYmUyOGMxYjAxODU5L3RhYmxlcmFuZ2U6NDA0YWYxMDI5MTgyNDdhNjhiZWRiZTI4YzFiMDE4NTlfNDQtNy0xLTEtMjEzMzM5_31b0cfc0-7bf3-4ab2-9c43-b34163f8665c"
      unitRef="usdPerShare">-0.21</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i213ce03ecaa746eab2dd1a12204b5ccb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0xLTEtMS0yMTg0ODU_99cb4cf2-e8b9-4c76-93a0-69adee92deb5"
      unitRef="shares">348817472</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i213ce03ecaa746eab2dd1a12204b5ccb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0zLTEtMS0yMTg0ODU_e79be766-843f-4c29-8c2c-d81eb0882579"
      unitRef="usd">561165000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib50e3b8695d94270935d4f85da07fcb2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS03LTEtMS0yMTg0ODU_4bfb3d15-13d6-46e8-a997-6fb0910d760a"
      unitRef="usd">23234000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i448ef8d1aafa463180aab6c0b5778fb3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS05LTEtMS0yMTg0ODU_67199d52-e303-47e7-bff4-451bffec942a"
      unitRef="usd">1137646000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14979ed24a294d07bdc9b963b74b1dcf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0xMS0xLTEtMjE4NDg1_a6a59759-3f18-4238-90bf-dd696f9a5990"
      unitRef="usd">27838000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib07031e3e0734b5f9e1f8b89fae01580_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0xMy0xLTEtMjE4NDg1_d336f470-047a-4818-8f40-a5f0bde9f8c9"
      unitRef="usd">-853000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7574c68cc08a473a9f7033bdb1a91792_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMS0xMy0xLTEtMjQ2MTgz_5357c282-5838-47db-bc11-093a15383fe0"
      unitRef="usd">1749030000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement
      contextRef="i2e8196a7813644b399d45186e643bd4c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTAtMS0xLTEtMjE4NTUy_f4af89fb-0599-4a03-97ac-ab37f4087e28"
      unitRef="shares">11435860</cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2e8196a7813644b399d45186e643bd4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTAtMy0xLTEtMjE4NTUy_5be73c0a-4829-4845-b729-fe70d2beb472"
      unitRef="usd">8095000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i73de768913af4a8da7accde843797e61_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTAtNy0xLTEtMjE4NTUy_ae16d78e-ec4c-4a90-bb71-03bc0b404735"
      unitRef="usd">11362000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNC0xMy0xLTEtMjQ2MjEy_f1bd3bd8-7d59-411f-a815-9d8dcac97732"
      unitRef="usd">19457000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="ia825a868fcc44019a5f6ff3e5a1698c1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTEtOS0xLTEtMjE4NTUy_cd022cb4-7788-4bd3-9389-8a824b67c28f"
      unitRef="usd">-73137000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i43046ab9dce94a239d679a89675b6368_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTEtMTMtMS0xLTIxODU1Mg_20b7197b-9ce7-4d23-a966-eab380b0d583"
      unitRef="usd">-2133000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNS0xMy0xLTEtMjQ2MjA2_0d7a7b77-3168-47b3-b834-88fc22f7c374"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id8f8709ce2cc42e3956edf7fa925bc71_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtMTEtMS0xLTIxODU1Mg_0a0c4515-3d1c-4d5a-8257-55810bb1c728"
      unitRef="usd">15161000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i43046ab9dce94a239d679a89675b6368_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtMTMtMS0xLTIxODU1Mg_e2e26e3f-f762-471d-a229-01727c4a0e37"
      unitRef="usd">-210000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNi0xMy0xLTEtMjQ2MjA2_46790e1b-4da1-4ef2-b55c-5cebba497c41"
      unitRef="usd">14951000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4e374eda0848449ea8abee147ccfef6f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy0xLTEtMS0yNDYxODE_35235631-4844-41f4-a18f-0515b2c736f7"
      unitRef="shares">360253332</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e374eda0848449ea8abee147ccfef6f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy0zLTEtMS0yNDYxODE_07e75cbb-33a5-4032-a6f4-e1834a406974"
      unitRef="usd">569260000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a0581d281ad4b2187170fcbcc40f7bf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy01LTEtMS0yNDYxODE_233a2101-15ac-455f-98b0-b5e724a6e41d"
      unitRef="usd">34596000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd33bd509f964d42a39a9c38e627d5ea_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy03LTEtMS0yNDYxODE_95da8764-0d81-443b-b065-205aca3bdb07"
      unitRef="usd">1064509000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i624b48e5e23148ebbee8fa21083aed6d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy05LTEtMS0yNDYxODE_c597bc8b-78c1-47ea-b1b2-c05035ef9652"
      unitRef="usd">42999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i94bb0b34a94244f4a78a9b4196581628_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy0xMS0xLTEtMjQ2MTgx_f769aeb9-39a8-4229-b567-d66342a74e64"
      unitRef="usd">-3196000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfNy0xMy0xLTEtMjQ2MTgx_7a45a546-d6ad-4409-9470-a17609c86690"
      unitRef="usd">1708168000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement
      contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTctMS0xLTEtMjE4NTYy_06e3ab4f-93c1-4f52-b181-7fb8fd8c4663"
      unitRef="shares">11764381</cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTctMy0xLTEtMjE4NTYy_5a9afb40-e963-4274-883b-f1cc359ab710"
      unitRef="usd">7288000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0ad0e599ac854e9584dfae6fd1a9dde7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTctNy0xLTEtMjE4NTYy_d5caf7bf-98c7-4c4d-813b-3ad6ede55c9a"
      unitRef="usd">2671000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifa6161e6218e4dbcaa62bb22e7be9255_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTctOS0xLTEtMjE4NTYy_553aeae7-7121-4835-bca8-c670301343a5"
      unitRef="usd">-12213000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTAtMTMtMS0xLTI0NjIwNA_6d9c03ad-6058-4548-86d3-574badae23e7"
      unitRef="usd">-2254000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones
      contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTgtMS0xLTEtMjE4NTc3_10df1b6a-dd7b-48db-8de5-c8cd17f3ee9f"
      unitRef="shares">2934980</cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones>
    <cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones
      contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTgtMy0xLTEtMjE4NTc3_434f9afd-9168-436d-8d94-b7d5b01241cb"
      unitRef="usd">17374000</cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones>
    <cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTEtMTMtMS0xLTI0NjIwNA_9d92c832-e9bf-4e2c-b5ef-3cd92d93adc7"
      unitRef="usd">17374000</cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItMy0xLTEtMjUyNTY2_60b6c8a3-edd5-4165-9a34-7c1965a75770"
      unitRef="usd">4802000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i0ad0e599ac854e9584dfae6fd1a9dde7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItNS0xLTEtMjUyNTc0_c9bb28a7-b316-40a4-9dbf-0d2675815db3"
      unitRef="usd">-4802000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItMTMtMS0xLTI1Mjk3MA_9ed67a4f-6683-48b0-8b4f-4e35da62c114"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="i5ae9a07cbf9f425a868aa80f46cb0d06_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItMy0xLTEtMjI5MjMx_8e7c6fbd-0bf3-4ebb-8289-158d4c68f10c"
      unitRef="usd">-3227000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="ifa6161e6218e4dbcaa62bb22e7be9255_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItOS0xLTEtMjI5MjMx_6b41bd8a-9411-4432-bfb4-924914edc524"
      unitRef="usd">3227000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTItMTMtMS0xLTI0NjIwMQ_dec4922f-8f0e-4f64-ae10-18cb868d420b"
      unitRef="usd">0</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <us-gaap:ProfitLoss
      contextRef="ifa6161e6218e4dbcaa62bb22e7be9255_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtOS0xLTEtMjI5MjMx_7dfb5aae-0bf8-439d-a317-d093e7ec9a64"
      unitRef="usd">-396107000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic024c83103194eceabada95ba475ab43_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtMTMtMS0xLTIyOTIzMQ_ce48beeb-db9f-4d7d-b3e1-f75606357045"
      unitRef="usd">-1097000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTMtMTMtMS0xLTI0NjE5Nw_20f51184-65e4-4708-88a0-a5e60d0c7db0"
      unitRef="usd">-397204000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i666176ccf3e84f1da351ed843f82f2ad_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTktMTEtMS0xLTIxODU3Nw_4125f974-7c1e-4197-92cd-740ab1b25d26"
      unitRef="usd">6866000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic024c83103194eceabada95ba475ab43_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTktMTMtMS0xLTIxODU3Nw_113f85ce-b651-41cb-a46b-e7a23da74965"
      unitRef="usd">1326000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTQtMTMtMS0xLTI0NjE5Nw_bad3f4db-f438-4eb5-9182-f3ab2b6488b0"
      unitRef="usd">8192000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7a99d4e9305649348953f54c8a8a0f17_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMS0xLTEtMjE4NTYy_107ff611-2da5-4236-8e73-84a8d64354fc"
      unitRef="shares">374952693</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a99d4e9305649348953f54c8a8a0f17_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMy0xLTEtMjE4NTYy_6a5ec7c6-b2c0-49d7-bb31-874af65c3d9f"
      unitRef="usd">595497000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34357931c29142239fb75a5dd657419f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtNy0xLTEtMjE4NTYy_cdcd2ddd-abc4-4505-8f6b-12bfdf2d8ce8"
      unitRef="usd">32465000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04edac1c57f34e7d9b98b2c80dc5b8bc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtOS0xLTEtMjE4NTYy_953cc3bf-306a-4fdc-b491-0c6d18976949"
      unitRef="usd">659416000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39f39217946e4a43885410306e996d66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMTEtMS0xLTIxODU2Mg_80c34fbd-bced-49f2-8191-88d5edc89473"
      unitRef="usd">49865000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a005033016542a286a1ee76f9592489_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMTMtMS0xLTIxODU2Mg_4e13e7b7-100a-4e84-8630-faff0854c60e"
      unitRef="usd">-2967000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTUtMTMtMS0xLTI0NjE3OQ_c2e082a0-53cb-487c-bfb4-7621db959fab"
      unitRef="usd">1334276000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement
      contextRef="i05001d975789445693497618980033e5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjQtMS0xLTEtMjE4NjUx_4e02fb76-eb2e-43ae-9326-14cfa67a79eb"
      unitRef="shares">1464822</cron:StockIssuedDuringPeriodSharesShareBasedPaymentArrangement>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i05001d975789445693497618980033e5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjQtMy0xLTEtMjE4NjUx_a864c28b-4eeb-4414-b14f-951be2735649"
      unitRef="usd">4617000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia69ca1c9942e41d49a89eb53eae07a00_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjQtNy0xLTEtMjE4NjUx_6410d9ba-4b31-4e3a-b4c3-95fe65a4b83b"
      unitRef="usd">10217000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTgtMTMtMS0xLTI0NjE5NA_5e104803-411b-4b2f-9cd3-189a8eee8b3d"
      unitRef="usd">14834000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones
      contextRef="i05001d975789445693497618980033e5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjUtMS0xLTEtMjE4NjUx_aed52021-69be-4d51-bc67-ea29405e9d65"
      unitRef="shares">4157888</cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones>
    <cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones
      contextRef="i05001d975789445693497618980033e5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjUtMy0xLTEtMjE4NjUx_9090ba91-7693-4491-91af-e97063b9a999"
      unitRef="usd">11204000</cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones>
    <cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMTktMTMtMS0xLTI0NjE5MQ_a3dc60ec-6309-488e-abdd-400ff505d5dc"
      unitRef="usd">11204000</cron:StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones>
    <us-gaap:ProfitLoss
      contextRef="i7bbf485b421d43959849aa8ccb24d1ca_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjYtOS0xLTEtMjE4NjUx_975aa5ad-ff28-43e3-a5a3-447e0289a85b"
      unitRef="usd">-168734000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjAtMTMtMS0xLTI0NjE4OA_aec754a5-d0e9-4b2f-be66-4ff2a0bd8fcd"
      unitRef="usd">-168734000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i45c43df2327b4eb88372d7d82971481a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjctMTEtMS0xLTIxODY1MQ_505fc647-086a-49bb-a46b-14be4e8507f4"
      unitRef="usd">-50662000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6c0b659e27464370a05a56fed607e84e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjctMTMtMS0xLTIxODY1MQ_5f601fcf-a8aa-410d-8be6-ad31adeacee0"
      unitRef="usd">46000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjEtMTMtMS0xLTI0NjE4Ng_2bed180c-1e49-4ee5-a61e-f448bf08b73f"
      unitRef="usd">-50616000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia421331670e443fd88c2f5410409c16c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMS0xLTEtMjI5NDQ0_c9faf963-b65f-4b68-b0a1-7dcabec9a60a"
      unitRef="shares">380575403</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia421331670e443fd88c2f5410409c16c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMy0xLTEtMjI5NDQ0_54a58684-804d-490b-a9e8-392848820883"
      unitRef="usd">611318000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i88cfcb6b7e764fdda895416627f0ac54_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItNy0xLTEtMjI5NDQ0_598c3b2a-31be-448f-a6a2-df578a56b3cc"
      unitRef="usd">42682000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a60350c90304904bad11f71d612fc4f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItOS0xLTEtMjI5NDQ0_309a43eb-e4f4-4ded-b876-0b33cb4a9105"
      unitRef="usd">490682000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i048ebc278983416fac723c6b21abb062_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMTEtMS0xLTIyOTQ0NA_fb96c50d-bcd7-408a-873e-b681e452eb22"
      unitRef="usd">-797000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icdadd4591de7465e96d360ee40a08559_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMTEtMS0xLTI0NjE3NA_2a3d2b12-fe58-479a-958a-244ec2fcd2bb"
      unitRef="usd">-2921000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl84OC9mcmFnOjkzYjRhMTIzYTNjMDRjYTNhYWI0NmNmOGY1NjU2YWZhL3RhYmxlOmRjZTlmOTVmNjg1MTRmMzY5YTgwMDc2NDcxMTY1ZmY2L3RhYmxlcmFuZ2U6ZGNlOWY5NWY2ODUxNGYzNjlhODAwNzY0NzExNjVmZjZfMjItMTMtMS0xLTI0NjE3NA_da4b7529-61e0-441a-bb04-4da7fe37f857"
      unitRef="usd">1140964000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMy0xLTEtMS0yMTMzMzk_1be52928-331e-49c2-b643-bdbf55bb07a5"
      unitRef="usd">-168734000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMy0zLTEtMS0yMTMzMzk_6e2a5e2c-3969-498f-8090-e817b1891439"
      unitRef="usd">-397204000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMy01LTEtMS0yMTMzMzk_7245d827-e5e2-4269-aa66-838387d34df8"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNS0xLTEtMS0yMTk4OTM_09309ce0-9015-4e9d-b938-8b0d67103c3a"
      unitRef="usd">15115000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNS0zLTEtMS0yMTk4OTM_aa262722-ef1c-4812-9c14-252b16f1adbe"
      unitRef="usd">10151000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNS01LTEtMS0yMTk4OTM_20c9e4fc-7427-40f6-abe5-ed505a68381b"
      unitRef="usd">15361000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi0xLTEtMS0yMTk5MTA_80f72ecc-1b71-4832-9a86-074134e5cc1a"
      unitRef="usd">13122000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi0zLTEtMS0yMTk5MTA_e00e58be-3bb3-483f-92b2-5e7a35c30934"
      unitRef="usd">15402000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi01LTEtMS0yMTk5MTA_29a89c8b-5c09-4615-bb48-5019185efd3c"
      unitRef="usd">7045000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi0xLTEtMS0yMTMzMzk_5ee02bc2-80c8-4270-acf7-803553c405bc"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi0zLTEtMS0yMTMzMzk_f7db787a-0a99-45a4-950a-34e9eca2b695"
      unitRef="usd">236056000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNi01LTEtMS0yMTMzMzk_c6f3b772-b051-4970-9b8b-6132c47162a5"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNy0xLTEtMS0yMTMzMzk_b949d88b-cf21-497b-b4f7-eb7bff1f065d"
      unitRef="usd">3493000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNy0zLTEtMS0yMTMzMzk_8e96fdfb-3b2e-48af-9da4-da01f0cbbd5a"
      unitRef="usd">127619000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNy01LTEtMS0yMTMzMzk_b9448d43-8008-411d-a457-742426813278"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC0xLTEtMS0yMTk4Nzc_2dac8cef-a8dd-406a-a5f5-8e37a7303e13"
      unitRef="usd">61392000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC0zLTEtMS0yMTk4Nzc_58753da7-4ddc-4fce-9292-e6fc730e6931"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC01LTEtMS0yMTk4Nzc_906f6ef1-6c10-4f06-ad8e-4a5e3bc48a4d"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtMS0xLTEtMjE5OTIx_95ee51d3-abe5-46ab-a807-3f9cd3b0278e"
      unitRef="usd">17853000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtMy0xLTEtMjE5OTIx_b4261f33-2994-4209-acda-82af501ffd13"
      unitRef="usd">1974000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtNS0xLTEtMjE5OTIx_aca88184-ffbc-482c-898c-3cc2242bc613"
      unitRef="usd">-4510000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtMS0xLTEtMjE5OTQw_f7c74e16-5f7e-4dd8-ae3f-184a6e22154f"
      unitRef="usd">14060000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtMy0xLTEtMjE5OTQw_da629b41-27a2-46a6-a39e-f579a9c3cc43"
      unitRef="usd">151360000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTEtNS0xLTEtMjE5OTQw_15dd16a2-5231-4e87-8aa6-b4ba08e49970"
      unitRef="usd">129254000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC0xLTEtMS0yMTMzMzk_3d03f1fe-eafd-4c10-a5d6-875ea50d8c40"
      unitRef="usd">-662000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC0zLTEtMS0yMTMzMzk_4d185de6-faad-450c-9a0e-20eaeb2dcda3"
      unitRef="usd">12202000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfOC01LTEtMS0yMTMzMzk_d068f21c-57f8-444b-b0cf-1fc144ef0ae2"
      unitRef="usd">2437000</us-gaap:ProvisionForDoubtfulAccounts>
    <cron:GainLossOnDisposalOfInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTItMS0xLTEtMjEzMzM5_583ed865-9154-4bcf-9017-0dc4b342e985"
      unitRef="usd">0</cron:GainLossOnDisposalOfInvestments>
    <cron:GainLossOnDisposalOfInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTItMy0xLTEtMjEzMzM5_bf9e2045-3f7b-4e3f-bbac-a2f355ae918f"
      unitRef="usd">0</cron:GainLossOnDisposalOfInvestments>
    <cron:GainLossOnDisposalOfInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTItNS0xLTEtMjEzMzM5_2787608e-c08b-4adf-99e8-2dff3e285c18"
      unitRef="usd">4789000</cron:GainLossOnDisposalOfInvestments>
    <cron:NoncashSellingAndMarketingExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTQtMS0xLTEtMjEzMzM5_212c2982-3c43-43fa-b0ad-6afa543ce075"
      unitRef="usd">341000</cron:NoncashSellingAndMarketingExpense>
    <cron:NoncashSellingAndMarketingExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTQtMy0xLTEtMjEzMzM5_f2ce7daa-2677-4f7e-b754-a3f3c9e87f9f"
      unitRef="usd">1383000</cron:NoncashSellingAndMarketingExpense>
    <cron:NoncashSellingAndMarketingExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTQtNS0xLTEtMjEzMzM5_fb567217-5b09-4082-8723-e8037fcf57fd"
      unitRef="usd">2863000</cron:NoncashSellingAndMarketingExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtMS0xLTEtMjIwMDAw_222b8404-ee70-43d2-b790-d9ccaf1174a2"
      unitRef="usd">-2286000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtMy0xLTEtMjIwMDAw_85eea79d-6504-4c66-a43c-7dcc38b30c4d"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtNS0xLTEtMjIwMDAw_a8ab635a-3b98-49b6-a534-eff98c4f347e"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtMS0xLTEtMjEzMzM5_80df93c6-e07d-423d-8794-2c6f8b38216c"
      unitRef="usd">4051000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtMy0xLTEtMjEzMzM5_7571d6c8-5da6-4616-9277-87fad2478445"
      unitRef="usd">3886000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTYtNS0xLTEtMjEzMzM5_e23c5e5e-9f75-48ea-b33c-59a54c013778"
      unitRef="usd">123000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTgtMS0xLTEtMjEzMzM5_321fa247-5304-49e3-a4ab-f1e749f02ae3"
      unitRef="usd">2711000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTgtMy0xLTEtMjEzMzM5_11cdb19e-1c7b-46f0-81ac-d77b18d04c55"
      unitRef="usd">13163000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTgtNS0xLTEtMjEzMzM5_898bbfba-13c9-46b1-9464-b87408f162e3"
      unitRef="usd">4724000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTktMS0xLTEtMjEzMzM5_cdf8365a-b0ec-499d-9c85-d1bf789a5e3c"
      unitRef="usd">833000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTktMy0xLTEtMjEzMzM5_0a71efac-3e17-465d-8b6f-c7048f536c99"
      unitRef="usd">-3838000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMTktNS0xLTEtMjEzMzM5_47785de1-1f6d-4997-b45c-ac35cfc82528"
      unitRef="usd">5300000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjAtMS0xLTEtMjEzMzM5_d98b83df-6b21-4856-b857-723bbcf84fb0"
      unitRef="usd">-996000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjAtMy0xLTEtMjEzMzM5_36dd5e21-990f-4f6d-a939-a8e1a0ccaece"
      unitRef="usd">-3102000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjAtNS0xLTEtMjEzMzM5_d78b8c31-eee3-4bef-817c-43587bc01b7e"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjEtMS0xLTEtMjEzMzM5_f3e57645-f3d7-492c-8837-e808b16dbaea"
      unitRef="usd">7217000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjEtMy0xLTEtMjEzMzM5_6e19c9ca-6719-4bae-939e-b6b5499df12e"
      unitRef="usd">-11565000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjEtNS0xLTEtMjEzMzM5_6bea2a16-3a95-45d3-b8d0-85b26bfbc0c1"
      unitRef="usd">735000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjItMS0xLTEtMjEzMzM5_8d42aecd-28ab-4da4-a6e4-ec1ee0926c58"
      unitRef="usd">-863000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjItMy0xLTEtMjEzMzM5_651f3a97-bde9-4699-af70-3f7448817e92"
      unitRef="usd">-1597000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjItNS0xLTEtMjEzMzM5_3d876df6-9104-45d0-92fe-f1731bced0bf"
      unitRef="usd">-2784000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjUtMS0xLTEtMjQ0NDMx_a4b804b2-e5f7-4b97-82c8-a46cb6264c26"
      unitRef="usd">34212000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjUtMy0xLTEtMjQ0NDMx_fa0e3c58-cf00-4531-a0db-91ac41d45521"
      unitRef="usd">-776000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjUtNS0xLTEtMjQ0NDMx_84808bec-2e15-4855-91cb-40cf8879765a"
      unitRef="usd">839000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjMtMS0xLTEtMjEzMzM5_966c214f-cad6-4b49-bec6-18ef851e4b06"
      unitRef="usd">-2921000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjMtMy0xLTEtMjEzMzM5_c90eae55-4a50-4a1c-9a2e-113e8f3c7794"
      unitRef="usd">-4974000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjMtNS0xLTEtMjEzMzM5_78a297fc-e620-46ae-8983-937639d2d473"
      unitRef="usd">5053000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjQtMS0xLTEtMjEzMzM5_64d30dea-b2a1-42c7-92f6-a94ab3c239ca"
      unitRef="usd">-88948000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjQtMy0xLTEtMjEzMzM5_a461e39e-ce7a-45a1-912c-ed85ce01c65f"
      unitRef="usd">-153616000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjQtNS0xLTEtMjEzMzM5_eb8d9702-e799-4457-86ab-6db4cebb39a9"
      unitRef="usd">-144871000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjctMS0xLTEtMjEzMzM5_48f9d01a-11df-4a15-9bd2-0800ed69cdb5"
      unitRef="usd">268870000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjctMy0xLTEtMjEzMzM5_a64bc775-b4f1-4894-aa32-68f78b61caea"
      unitRef="usd">215303000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjctNS0xLTEtMjEzMzM5_e691de28-4a13-4b6d-bf63-4d2a61cdd82d"
      unitRef="usd">296730000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjgtMS0xLTEtMjEzMzM5_844afe06-cf6e-4f03-b417-2596651068ed"
      unitRef="usd">271378000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjgtMy0xLTEtMjEzMzM5_70022748-efcc-4d6e-909a-e3efcebf0b57"
      unitRef="usd">119610000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjgtNS0xLTEtMjEzMzM5_15ba70c4-02cf-4279-a9ee-ab7ef43b42da"
      unitRef="usd">201326000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjktMS0xLTEtMjEzMzM5_adad4ea9-8c17-4b39-a873-a57a624325c3"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjktMy0xLTEtMjEzMzM5_a2b4f46e-90c9-4f28-b86b-17c9821e00ee"
      unitRef="usd">110392000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMjktNS0xLTEtMjEzMzM5_765fa4d1-a104-4e6c-af2c-5b5d095eec18"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <cron:ProceedsFromDividends
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzEtMS0xLTEtMjM5MTQw_7aa2f247-bf74-4c6d-9b99-f9ee84f8040f"
      unitRef="usd">384000</cron:ProceedsFromDividends>
    <cron:ProceedsFromDividends
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzEtMy0xLTEtMjM5MTQw_efb7636b-d690-4d0a-b334-ee3b669c2d7c"
      unitRef="usd">0</cron:ProceedsFromDividends>
    <cron:ProceedsFromDividends
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzEtNS0xLTEtMjM5MTQw_6aa95230-ecb5-4f3f-9134-7d03b1aed771"
      unitRef="usd">0</cron:ProceedsFromDividends>
    <us-gaap:PaymentsForProceedsFromLoansReceivable
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzItMS0xLTEtMjEzMzM5_f51ae80e-6dff-43f8-aa1a-281daef7ec55"
      unitRef="usd">-5246000</us-gaap:PaymentsForProceedsFromLoansReceivable>
    <us-gaap:PaymentsForProceedsFromLoansReceivable
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzItMy0xLTEtMjEzMzM5_9765f580-3366-4cbd-b42f-963988534762"
      unitRef="usd">4967000</us-gaap:PaymentsForProceedsFromLoansReceivable>
    <us-gaap:PaymentsForProceedsFromLoansReceivable
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzItNS0xLTEtMjEzMzM5_a2e1ad11-bb58-4325-a449-89e57fa35ff7"
      unitRef="usd">44652000</us-gaap:PaymentsForProceedsFromLoansReceivable>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzMtMS0xLTEtMjEzMzM5_62252598-b585-4c08-bfb2-6ba1c4e92196"
      unitRef="usd">3451000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzMtMy0xLTEtMjEzMzM5_46c54789-7438-4443-b3ac-cc982763389f"
      unitRef="usd">11144000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzMtNS0xLTEtMjEzMzM5_ad90d70e-b00e-4ec3-81bf-67b075b9a72a"
      unitRef="usd">31412000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzQtMS0xLTEtMjEzMzM5_b402deea-f8aa-493f-bb12-1e5f3d21220c"
      unitRef="usd">1581000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzQtMy0xLTEtMjEzMzM5_1e146924-46c2-4dae-a248-6bda6b92b253"
      unitRef="usd">1118000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzQtNS0xLTEtMjEzMzM5_394b881f-58cf-4d79-aa48-04642edf5dd7"
      unitRef="usd">3979000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzYtMS0xLTEtMjEzMzM5_fd73b753-8611-45c8-954c-352ac0f90ec9"
      unitRef="usd">-68000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzYtMy0xLTEtMjEzMzM5_92748375-e878-47c2-a669-041d1ff6b3c7"
      unitRef="usd">-3030000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzYtNS0xLTEtMjEzMzM5_a92ca3f6-b56e-40e9-865f-1b0dcc3f125d"
      unitRef="usd">-4789000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzctMS0xLTEtMjEzMzM5_f5f53c12-2378-41b7-8491-75392b26c1c2"
      unitRef="usd">-1842000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzctMy0xLTEtMjEzMzM5_5b7321d0-84bc-4ff3-8430-167448b3c863"
      unitRef="usd">-28898000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfMzctNS0xLTEtMjEzMzM5_105cd267-6dfd-42c8-9a6b-fdccb0be96d1"
      unitRef="usd">20150000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDEtMS0xLTEtMjEzMzM5_c70b86cc-6615-4579-ac70-0719ca9da654"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDEtMy0xLTEtMjEzMzM5_b8b73f2a-b6dc-44d5-bfa1-2cfe5203fa67"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDEtNS0xLTEtMjEzMzM5_fbd2ae22-0ba9-4047-b2d7-77112831a9c0"
      unitRef="usd">1019000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDItMS0xLTEtMjEzMzM5_9f30ca81-528f-4143-9407-f767bcf86fa4"
      unitRef="usd">2829000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDItMy0xLTEtMjEzMzM5_bc1cc4fe-127d-46a9-af73-b4a00c8883e0"
      unitRef="usd">13458000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNDItNS0xLTEtMjEzMzM5_38837a8b-3015-4b8c-b523-78ed0979630e"
      unitRef="usd">2148000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTAtMS0xLTEtMjEzMzM5_13845ea1-848a-4a3e-9fe8-a47aba1b851f"
      unitRef="usd">-68000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTAtMy0xLTEtMjEzMzM5_d28ab508-81a3-4d0d-82be-dd570a7d6a39"
      unitRef="usd">16000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTAtNS0xLTEtMjEzMzM5_9956f1ba-1140-4d10-b4dd-191f76971ba9"
      unitRef="usd">116000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTEtMS0xLTEtMjEzMzM5_eeae5bdc-7339-461a-9b2a-ac44991a7984"
      unitRef="usd">-2897000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTEtMy0xLTEtMjEzMzM5_c809783d-fa42-4fdd-9212-91b324fd0686"
      unitRef="usd">-13442000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTEtNS0xLTEtMjEzMzM5_5eb2db7c-2def-4cfa-a01c-e612edd2c4d3"
      unitRef="usd">-3051000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTItMS0xLTEtMjEzMzM5_f81b4336-f1f6-4ca2-a7e1-8cf0ccae8ae5"
      unitRef="usd">-28642000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTItMy0xLTEtMjEzMzM5_e9f8a5bf-a8a0-4c9f-a3ee-de126857a555"
      unitRef="usd">4906000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTItNS0xLTEtMjEzMzM5_4ca63573-fbaf-4b9c-8813-cecff175df84"
      unitRef="usd">6102000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTMtMS0xLTEtMjEzMzM5_2086eec3-d909-48f9-8dda-082d24ae97de"
      unitRef="usd">-122329000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTMtMy0xLTEtMjEzMzM5_7c872817-e66d-4341-9b40-4a72b07d6d46"
      unitRef="usd">-191050000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTMtNS0xLTEtMjEzMzM5_6d222182-5a23-473f-83c4-b67aa9924c20"
      unitRef="usd">-121670000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTQtMS0xLTEtMjEzMzM5_147fa4b1-c013-42f8-8b06-ad827ff58046"
      unitRef="usd">886973000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTQtMy0xLTEtMjEzMzM5_f906ff37-7e20-4f84-8680-45c6bc26e802"
      unitRef="usd">1078023000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7574c68cc08a473a9f7033bdb1a91792_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTQtNS0xLTEtMjEzMzM5_e7630802-3dab-4648-9936-dfa9e527d70b"
      unitRef="usd">1199693000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTUtMS0xLTEtMjEzMzM5_4d80513c-b675-46f3-8dc6-4af2cc49de4f"
      unitRef="usd">764644000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTUtMy0xLTEtMjEzMzM5_abf8b008-2fb1-47c0-8a31-751f1753db3c"
      unitRef="usd">886973000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTUtNS0xLTEtMjEzMzM5_498445b5-13d7-4443-8f35-94f7170753bf"
      unitRef="usd">1078023000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cron:InterestReceivedNet
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTktMS0xLTEtMjEzMzM5_5ccf7780-2453-451a-a6b0-aa65b1213485"
      unitRef="usd">15548000</cron:InterestReceivedNet>
    <cron:InterestReceivedNet
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTktMy0xLTEtMjEzMzM5_e6e3c254-1fbe-413a-9831-75279fefee6b"
      unitRef="usd">8988000</cron:InterestReceivedNet>
    <cron:InterestReceivedNet
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNTktNS0xLTEtMjEzMzM5_b7c2ec5b-61c5-48c2-9653-7e3909993c0e"
      unitRef="usd">18105000</cron:InterestReceivedNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNjAtMS0xLTEtMjEzMzM5_eb77c59c-bf48-41bf-8191-266ac0b0d606"
      unitRef="usd">177000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNjAtMy0xLTEtMjEzMzM5_71aea0ee-f1e8-4603-91ad-1832b780c3b1"
      unitRef="usd">892000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85MS9mcmFnOjJiMjIxZGIwNGE2YjQ4MjFiNmVjNjkyMzUxOTQ0MWQ0L3RhYmxlOjc5MWQ4MjU2ZDU4NTQ1ZjQ5YmMxZjI1ZWViNmQyZjE1L3RhYmxlcmFuZ2U6NzkxZDgyNTZkNTg1NDVmNDliYzFmMjVlZWI2ZDJmMTVfNjAtNS0xLTEtMjEzMzM5_a77b8b94-1b12-4253-a8a2-075dccc7a919"
      unitRef="usd">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mjc_aad7abc0-db50-4239-8d15-0ee4f6aa981b">Background, Basis of Presentation, and Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group Inc. (&#x201c;Cronos&#x201d; or the &#x201c;Company&#x201d;) is incorporated in the province of British Columbia and under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Corporations Act &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(British Columbia) with principal executive offices at 111 Peter St., Suite 300, Toronto, Ontario, M5V 2H1. The Company&#x2019;s common shares are currently listed on the Toronto Stock Exchange (&#x201c;TSX&#x201d;) and Nasdaq Global Market (&#x201c;Nasdaq&#x201d;) under the ticker symbol &#x201c;CRON.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos&#x2019; diverse international brand portfolio includes Spinach&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, PEACE NATURALS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). Certain prior year amounts have been reclassified to conform to the current year presentation of our consolidated financial statements. These reclassifications had no effect on reported results of operations and ending shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the reporting periods. The Company assesses control under the variable interest entity (&#x201c;VIE&#x201d;) model to determine whether the Company is the primary beneficiary of that entity&#x2019;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting. The Company consolidates the financial results of the following entities, which the Company controls but does not wholly own:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jurisdiction of incorporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incorporation date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Cultivation Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 4, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Manufacturing Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 4, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Store Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 28, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Pharmacy Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 15, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;These Israeli entities are collectively referred to as &#x201c;Cronos Israel.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;&#x201c;Ownership interest&#x201d; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the consolidated statements of net income (loss) and comprehensive income (loss), net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#x2019; equity section of the consolidated balance sheets and consolidated statements of shareholders&#x2019; equity. All intercompany transactions and balances are eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, expected credit losses on long-term financial assets, impairment losses on goodwill and indefinite-lived intangible assets, impairment losses on long-lived assets, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;inventory write-downs, share-bared payments, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Cash and cash equivalents and short-term investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents are comprised of cash and highly liquid short-term investments that are readily convertible into known amounts of cash, generally with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. Short-term investments consist of debt securities that (i) generally have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments are classified as either available-for-sale or held-to-maturity and recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheets and interest income, net on the consolidated statements of net income (loss) and comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#x2019;s consolidated statements of cash flows.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(f)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is comprised of raw materials, finished goods and work-in-progress, such as pre-harvested cannabis plants, dried cannabis flower, by-products to be extracted, cannabis extracts and by-products, dry cannabis and cannabis extract containers, and boxes. When the Company cultivated cannabis, costs capitalized into inventory until the time of harvest included, but were not limited to, labor, utilities, nutrition and irrigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, contract manufacturer fees, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of net realizable value include slow-moving or non-marketable products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(g)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable interest entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A variable interest entity is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#x2019;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#x2019;s expected losses or receive portions of the VIE&#x2019;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on a periodic basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination, the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates a VIE when it is determined that it is the primary beneficiary of the VIE.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity method investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest using the equity method. Under the equity method, the Company records its proportionate share of income or loss in share of income (loss) from equity method investments within the consolidated statements of net income (loss) and comprehensive income (loss). Cash payments to equity method investees such as additional investments or expenses incurred on behalf of investees, as well as income earned and payments from equity method investees such as dividends and distributions are recorded as adjustments to investment balances. If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized in one period cannot be reversed in subsequent periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments include common stock and options in third party entities in which the Company&#x2019;s influence is deemed non-significant. The Company holds other investments with and without readily determinable fair values. Other investments with readily determinable fair values are recorded using the fair value method of accounting as of period-end on the consolidated balance sheets. Other investments without readily determinable fair values are recorded using the cost method of accounting on the consolidated balance sheets. Other investments without readily determinable fair values are assessed for observable price changes and other than temporary impairment on a periodic basis. Changes in the reported value of other investments are reported in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(h)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available for use is defined as the point at which the related property, plant and equipment is operational, including the possession of any requisite licenses. Depreciation commences at the point the assets are available for use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software and payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with definite useful lives are amortized over their estimated useful lives using the following methods and rates:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#x201c;Israeli codes&#x201d;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets originating from the strategic partnership (the &#x201c;Ginkgo Strategic Partnership&#x201d;) with Ginkgo Bioworks Holdings, Inc. (&#x201c;Ginkgo&#x201d;) are accounted for in accordance with the acquisition method of accounting. Equity interests issued in exchange for an asset are initially recognized and measured at the date of acquisition at fair value. We estimate fair value using the relief-from-royalty method and key assumptions include the discount rate and estimated life. Definite-lived intangible assets, including intangible assets originating from the Ginkgo Strategic Partnership, are subject to amortization and reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value has been reduced to less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(j)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"&gt;Accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued payroll and related expenses include salaries and wages, bonuses, and other related payroll expenses associated with the Company&#x2019;s employees. Accrued professional fees include fees for legal expenses, litigation, consulting, marketing, and other related expenses. Accrued taxes include sales, excise and other taxes owed. Other accrued expenses include the fair value of deferred share units outstanding to directors and other general expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(k)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#x2019;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#x2019;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#x2019;s depreciation policy if the title is to eventually transfer to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(l)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt"&gt;Derivative liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial instruments classified as derivatives that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in net income (loss) and comprehensive income (loss). For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 8 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Derivative Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(m)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.01pt"&gt;Capital stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(n)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606, &#x201c;Revenue from Contracts with Customers,&#x201d; and is measured based on the consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product or service to a customer. The Company&#x2019;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and &#x201c;hemp&#x201d; (as defined in the U.S. Agricultural Improvement Act of 2018 &#x201c;U.S. hemp&#x201d;) derived products consist of a single performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, depending on the specific contractual terms. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer or third-party location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer&#x2019;s usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, allowances for customer returns and other forms of variable consideration. Within the Company&#x2019;s Rest of World segment (the &#x201c;ROW segment&#x201d;), dried cannabis sales outside of Canada may include commission arrangements with distributors that give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated using the expected value method, based on the Company&#x2019;s historical information, at contract inception. The Company&#x2019;s payment terms vary by customer and product type. Refer to Note 12 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information and Disaggregated Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for information on disaggregated revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(o)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Research and development &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a research and development center in Canada that performs scientific research on the interaction of cannabinoids as well as strain development, growing conditions, extraction technology, and biosynthesis. Fermentation and production related research is performed to further strategic initiatives around rare cannabinoids. In addition, the Company has a collaboration and license agreement with Ginkgo (the &#x201c;Ginkgo Collaboration Agreement&#x201d;) to research, produce, and commercialize cultured cannabinoids. Technological feasibility is considered to be established once productivity targets or commercialization are achieved, at which point the exclusive license is recognized at cost less impairment charges. As of the acquisition date of each exclusive license, cost less impairment charges is equal to the fair value. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Note 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information on the Ginkgo Collaboration Arrangement. Research and development costs associated with these collective efforts are expensed as incurred as part of operating expenses in the Company&#x2019;s consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(p)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Advertising costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs include costs to sell the Company&#x2019;s products and are expensed as incurred through sales and marketing expenses in the consolidated statements of net income (loss) and comprehensive income (loss). Advertising costs were $928, $11,514 and $6,087 for the years ended December&#160;31, 2022, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(q)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan, the 2018 Stock Option Plan, the 2015 Stock Option Plan, the Employment Inducement Award Plan and the DSU Plan (each as defined below).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based awards consists of equity-settled share-based awards such as stock options and restricted share units (&#x201c;RSUs&#x201d;) that are issued to eligible employees, non-executive directors, and non-employees. Cash-settled deferred share units (&#x201c;DSUs&#x201d;) that are issued to non-executive directors under the DSU Plan are recorded in accrued liabilities with the fair value adjustment recorded in other income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity instruments granted are initially measured at fair value on the grant date. The fair value of stock options is determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price of the Company&#x2019;s common shares. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#x2019;s common shares at the reporting date and is recorded within other liabilities. The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are settled or exercised. Upon settlement or exercise, shares are issued and the amount previously reflected in additional paid-in capital is, along with any proceeds paid upon settlement or exercise, credited to a combination of share capital and additional paid-in capital. Forfeitures of share-based compensation awards are accounted for as reductions to share-based compensation and additional paid-in capital as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(r)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its long-lived assets, such as property, plant and equipment and definite-lived intangible assets, for impairment in accordance with ASC Topic 360, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In accordance with ASC Topic 360, long-lived assets to be held are reviewed for events or changes in circumstances that indicate that their carrying amount may not be recoverable. The Company periodically reviews for indicators and, if indicators are present, tests the carrying amount of long-lived assets, assessing their fair values based on estimated undiscounted cash flows over their remaining estimated useful lives. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. If the carrying amount of an asset (or asset group) exceeds its estimated undiscounted future cash flows, an impairment charge is measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset group, based on discounted cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(s)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.45pt"&gt;Impairment of goodwill and indefinite-lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and indefinite-lived intangible assets are not amortized. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying amount in accordance with the provisions of ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(t)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative, including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance against some or all of the net deferred tax assets does not in any way impact the Company&#x2019;s ability to use future tax deductions such as the Company&#x2019;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification (&#x201c;ASC&#x201d;) 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#x2019;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine whether the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#x201c;more likely than not&#x201d; to be sustained, no benefits of the position are recognized. If we determine that a position is &#x201c;more likely than not&#x201d; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards, to the extent not covered by a valuation allowance, could be materially impacted in the period which such determination is made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(u)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Foreign currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s functional currency is the Canadian dollar (&#x201c;C$&#x201d;) and its reporting currency is the U.S. dollar. Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, U.S. dollar and Israeli New Shekel (&#x201c;ILS&#x201d;). All assets and liabilities of operations with a functional currency other than the Canadian dollar are translated into Canadian dollars at the period-end currency exchange rates and subsequently translated into U.S. dollars at period-end currency exchange rates. The resulting translation adjustments are recorded in accumulated other comprehensive income (loss), net of tax. Revenues and expenses of operations, as well as all cash flows, with a functional currency other than the Canadian dollar are translated into Canadian dollars at the average exchange rates for the period and subsequently translated into U.S. dollars at the average exchange rates for the period. Transaction gains and losses resulting from changes in foreign currency exchange rates are recorded in either cost of sales, general and administrative expenses, or foreign currency transaction gain (loss) in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(v)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos reports through two segments: the U.S. segment and the ROW segment. These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. Refer to Note 12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Segment Information and Disaggregated Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(w)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.12pt"&gt;Earnings (loss) per share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents basic and diluted earnings (loss) per share data for its common shares. Basic earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(x)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of the Company&#x2019;s cash and cash equivalents, accounts receivable, other receivables, loans receivable, account payables and other liabilities approximate fair value, given their short-term nature. Cronos uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the three levels of inputs used to measure fair value: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; valuation techniques using the inputs for the asset or liability that are not based on observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(y)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Assets held for sale and discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 205-20 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Presentation of Financial Statements: Discontinued Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#x2019;s operations and financial results when the components of an entity meet the criteria in paragraph ASC 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and other liabilities are reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), are reported as components of net income (loss) separate from the net income (loss) of continuing operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(z)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Adoption of new accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022, the Company adopted ASU No. 2020-06, Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815&#x2013;40) (&#x201c;ASU No. 2020-06&#x201d;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. ASU No. 2020-06 is part of the Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The adoption of ASU No. 2020-06 did not have an impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(aa)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt"&gt;New accounting pronouncements not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASU 2022-02, Financial Instruments &#x2013; Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (&#x201c;ASU No. 2022-02&#x201d;). ASU No. 2022-02 eliminates the existing troubled debt restructuring recognition and measurement guidance, and instead aligns the accounting treatment to that of other loan modifications. The amendments enhance existing disclosure requirements and introduce new requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. ASU No. 2022-02 also requires that entities disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases. ASU No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-02 to have a material impact on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#x201c;ASU No. 2022-03&#x201d;). ASU No. 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered in measuring fair value. The amendments also require additional disclosures for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-03 to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mjg_94f30d51-5e8c-4593-84e2-f4e906c0a770">Basis of presentationThe accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). Certain prior year amounts have been reclassified to conform to the current year presentation of our consolidated financial statements. These reclassifications had no effect on reported results of operations and ending shareholders&#x2019; equity.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MTc_5486f8dc-4d64-480c-b195-54c8255aa19e">Basis of consolidationThe accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the reporting periods. The Company assesses control under the variable interest entity (&#x201c;VIE&#x201d;) model to determine whether the Company is the primary beneficiary of that entity&#x2019;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting.In the consolidated statements of net income (loss) and comprehensive income (loss), net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#x2019; equity section of the consolidated balance sheets and consolidated statements of shareholders&#x2019; equity. All intercompany transactions and balances are eliminated upon consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDc_dd6355eb-90c5-47ad-878e-1017e58fd1a2">The Company consolidates the financial results of the following entities, which the Company controls but does not wholly own:&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jurisdiction of incorporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incorporation date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Cultivation Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 4, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Manufacturing Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 4, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Store Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 28, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Pharmacy Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 15, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;These Israeli entities are collectively referred to as &#x201c;Cronos Israel.&#x201d;&lt;/span&gt;&lt;/div&gt;(ii)&#x201c;Ownership interest&#x201d; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein.</us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="i36cd7b767d4742089d1b42cfe6220c44_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOmNlODU5MGRmYTViZjRkMDA4YTQzNTlmMjMyZThlNTAwL3RhYmxlcmFuZ2U6Y2U4NTkwZGZhNWJmNGQwMDhhNDM1OWYyMzJlOGU1MDBfMS02LTEtMS0yMTMzMzk_6280f038-ef76-4050-bbae-1889b9978981"
      unitRef="number">0.70</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="i1ead5e405ef545a98117d2329aa9d7f2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOmNlODU5MGRmYTViZjRkMDA4YTQzNTlmMjMyZThlNTAwL3RhYmxlcmFuZ2U6Y2U4NTkwZGZhNWJmNGQwMDhhNDM1OWYyMzJlOGU1MDBfMi02LTEtMS0yMTMzMzk_a899ecbc-5ad0-4153-bf77-121cc03d9e6f"
      unitRef="number">0.90</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="if88c1809830e415688a9bf0f65770352_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOmNlODU5MGRmYTViZjRkMDA4YTQzNTlmMjMyZThlNTAwL3RhYmxlcmFuZ2U6Y2U4NTkwZGZhNWJmNGQwMDhhNDM1OWYyMzJlOGU1MDBfMy02LTEtMS0yMTMzMzk_88088c14-56c4-4f5d-8b1f-eb1fa04b9f57"
      unitRef="number">0.90</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="i3882b50d536c49b783a4fe4bc63b1a58_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOmNlODU5MGRmYTViZjRkMDA4YTQzNTlmMjMyZThlNTAwL3RhYmxlcmFuZ2U6Y2U4NTkwZGZhNWJmNGQwMDhhNDM1OWYyMzJlOGU1MDBfNC02LTEtMS0yMTMzMzk_369e68cc-c969-4c3b-99d3-8717e7809116"
      unitRef="number">0.90</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:UseOfEstimates
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjE_51a7b02f-1218-4c8e-a3de-cf2eb51fdfcd">Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, expected credit losses on long-term financial assets, impairment losses on goodwill and indefinite-lived intangible assets, impairment losses on long-lived assets, inventory write-downs, share-bared payments, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mjk_0d4014cd-1c73-45ac-a580-31b7e0b85e03">Cash and cash equivalents and short-term investmentsCash and cash equivalents are comprised of cash and highly liquid short-term investments that are readily convertible into known amounts of cash, generally with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. Short-term investments consist of debt securities that (i) generally have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. Short-term investments are classified as either available-for-sale or held-to-maturity and recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheets and interest income, net on the consolidated statements of net income (loss) and comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#x2019;s consolidated statements of cash flows.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDI_04e61f22-1f0d-4101-aba9-c6b0a532098a">Inventory&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is comprised of raw materials, finished goods and work-in-progress, such as pre-harvested cannabis plants, dried cannabis flower, by-products to be extracted, cannabis extracts and by-products, dry cannabis and cannabis extract containers, and boxes. When the Company cultivated cannabis, costs capitalized into inventory until the time of harvest included, but were not limited to, labor, utilities, nutrition and irrigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, contract manufacturer fees, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of net realizable value include slow-moving or non-marketable products.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDM_859580eb-3f03-4d05-afab-cc5666f915c9">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable interest entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A variable interest entity is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#x2019;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#x2019;s expected losses or receive portions of the VIE&#x2019;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on a periodic basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination, the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates a VIE when it is determined that it is the primary beneficiary of the VIE.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDQ_01542af0-9d70-462f-a001-8d093db24f37">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity method investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest using the equity method. Under the equity method, the Company records its proportionate share of income or loss in share of income (loss) from equity method investments within the consolidated statements of net income (loss) and comprehensive income (loss). Cash payments to equity method investees such as additional investments or expenses incurred on behalf of investees, as well as income earned and payments from equity method investees such as dividends and distributions are recorded as adjustments to investment balances. If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized in one period cannot be reversed in subsequent periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzQ_40e67843-f68c-4b40-83c7-c4feb335ea03">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments include common stock and options in third party entities in which the Company&#x2019;s influence is deemed non-significant. The Company holds other investments with and without readily determinable fair values. Other investments with readily determinable fair values are recorded using the fair value method of accounting as of period-end on the consolidated balance sheets. Other investments without readily determinable fair values are recorded using the cost method of accounting on the consolidated balance sheets. Other investments without readily determinable fair values are assessed for observable price changes and other than temporary impairment on a periodic basis. Changes in the reported value of other investments are reported in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mzk_c07696dc-14b5-472a-8ecf-f9d92a56d585">Property, plant and equipment&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available for use is defined as the point at which the related property, plant and equipment is operational, including the possession of any requisite licenses. Depreciation commences at the point the assets are available for use.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzA_c724220c-58a4-4786-9bf0-dae77e708c9b">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(109,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(114,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1b22fb74b27245199caf9dcb11234c12_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMS00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjplMmQ4NjEwNjExNWM0ZDJmYjQxZDU4YzJhZWMxYjM2MF8xMDk5NTExNjI3Nzk2_3f8dfc2a-de83-4949-95d3-807e70ff15cd">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iacf539ae1af944fabea8af025076759c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMS00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjplMmQ4NjEwNjExNWM0ZDJmYjQxZDU4YzJhZWMxYjM2MF8xMDk5NTExNjI3ODAx_c037d62e-d27c-4daa-b379-e902449b3f6c">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1a132cce282941e5b9844e95bbad2e28_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMi00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjo1OTJjNDdmZThhZTE0ZjU2YjkxMjU1MjFkNWE2OWVkMF8xMDk5NTExNjI3Nzkz_d1f8fad0-38b9-4978-ab7d-e2598df39fb9">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i49f135f4f3444a5a89ff7d7ac98dad6d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMi00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjo1OTJjNDdmZThhZTE0ZjU2YjkxMjU1MjFkNWE2OWVkMF8xMDk5NTExNjI3Nzk3_7c8b7677-5234-4bbd-b236-9b190d4c977c">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1f8f22691c07427aa015ce15f27bf6d2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjcyOTg0YTg0ZDA1NDQzZjg5YzExMWEwNGNlNDUxMzFhL3RhYmxlcmFuZ2U6NzI5ODRhODRkMDU0NDNmODljMTExYTA0Y2U0NTEzMWFfMy00LTEtMS0yMTMzMzkvdGV4dHJlZ2lvbjo3ZjFkMjk2OTZlOTQ0ZDgyYWZjODEyNmZiZGJjMTc4Ml8xMDk5NTExNjI3Nzg4_0bf315db-e26e-4bae-91bc-d63eeebc2568">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjI_269c5c6c-3130-47d8-a88e-e443c6a9c955">Definite-lived intangible assets&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software and payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with definite useful lives are amortized over their estimated useful lives using the following methods and rates:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#x201c;Israeli codes&#x201d;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets originating from the strategic partnership (the &#x201c;Ginkgo Strategic Partnership&#x201d;) with Ginkgo Bioworks Holdings, Inc. (&#x201c;Ginkgo&#x201d;) are accounted for in accordance with the acquisition method of accounting. Equity interests issued in exchange for an asset are initially recognized and measured at the date of acquisition at fair value. We estimate fair value using the relief-from-royalty method and key assumptions include the discount rate and estimated life. Definite-lived intangible assets, including intangible assets originating from the Ginkgo Strategic Partnership, are subject to amortization and reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value has been reduced to less than its carrying amount.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MTk_e567c397-71b3-4cdd-854c-19f7ce6b10a8">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with definite useful lives are amortized over their estimated useful lives using the following methods and rates:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#x201c;Israeli codes&#x201d;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net are comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,008)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated impairment charges on intangible assets, net consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&#xae; brand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjU1YWEyMjBmOTNlNTQwMmE5YWM2ZTM0YzIzNGRkOTBlL3RhYmxlcmFuZ2U6NTVhYTIyMGY5M2U1NDAyYTlhYzZlMzRjMjM0ZGQ5MGVfMS0zLTEtMS0yMTMzMzk_7760d4d1-aef5-4c5a-8c04-34243c6aae39">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibaa1003c5905486b919409d3896fa96f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjU1YWEyMjBmOTNlNTQwMmE5YWM2ZTM0YzIzNGRkOTBlL3RhYmxlcmFuZ2U6NTVhYTIyMGY5M2U1NDAyYTlhYzZlMzRjMjM0ZGQ5MGVfMy0zLTEtMS0yMTMzMzk_0e4a8d18-0094-4ff5-9f11-a3cd6a78836f">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDA_25d5bd9e-7861-4c89-89bb-bc974a52a8cd">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfMi0xLTEtMS0yMTMzMzk_773ea6dc-7af9-4fd4-acd3-9b2a3a63efca"
      unitRef="usd">11492000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfMi0zLTEtMS0yMTMzMzk_90945125-30cd-4d43-a4d4-6c48af0a544a"
      unitRef="usd">12875000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfMy0xLTEtMS0yMTMzMzk_9b98b5cd-745c-485f-92e9-c924d223844e"
      unitRef="usd">2414000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfMy0zLTEtMS0yMTMzMzk_33f0c34b-a1b2-4f23-a89d-fb516f1c21f2"
      unitRef="usd">8337000</us-gaap:AccruedProfessionalFeesCurrent>
    <cron:AccruedIncomeAndSalesAndExciseTaxesPayableCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNC0xLTEtMS0yMTMzMzk_14725a26-2c3d-407d-b190-552487353325"
      unitRef="usd">4132000</cron:AccruedIncomeAndSalesAndExciseTaxesPayableCurrent>
    <cron:AccruedIncomeAndSalesAndExciseTaxesPayableCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNC0zLTEtMS0yMTMzMzk_8567b2c1-fb06-4db4-a530-fc411b88da69"
      unitRef="usd">3488000</cron:AccruedIncomeAndSalesAndExciseTaxesPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNS0xLTEtMS0yMTMzMzk_0fa69220-7a99-4e00-bcbc-5da1996ff63c"
      unitRef="usd">4230000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNS0zLTEtMS0yMTMzMzk_49c87ac8-aa9d-4071-bf0d-d119f16fbfa0"
      unitRef="usd">936000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNi0xLTEtMS0yMTMzMzk_462bee07-0e8f-4468-a1b7-6c79c40416dd"
      unitRef="usd">22268000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RhYmxlOjY4ZmFjNWVlZjhhOTQ1MmQ4N2ExNzUxMmI3NzQ4NzFhL3RhYmxlcmFuZ2U6NjhmYWM1ZWVmOGE5NDUyZDg3YTE3NTEyYjc3NDg3MWFfNi0zLTEtMS0yMTMzMzk_76593f86-83de-4d13-8137-51ecdfb50ad1"
      unitRef="usd">25636000</us-gaap:AccruedLiabilitiesCurrent>
    <cron:AccruedLiabilitiesPolicyPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDg_c1258999-84ee-4a82-91fd-438aabfaa78f">Accrued payroll and related expenses include salaries and wages, bonuses, and other related payroll expenses associated with the Company&#x2019;s employees. Accrued professional fees include fees for legal expenses, litigation, consulting, marketing, and other related expenses. Accrued taxes include sales, excise and other taxes owed. Other accrued expenses include the fair value of deferred share units outstanding to directors and other general expenses.</cron:AccruedLiabilitiesPolicyPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjM_b6b607fa-2c65-42fc-8b30-8e944a7ba3e4">Leases&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#x2019;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#x2019;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#x2019;s depreciation policy if the title is to eventually transfer to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDk_5258263d-1bb4-40ed-b726-766db8483916">Derivative liabilities&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial instruments classified as derivatives that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in net income (loss) and comprehensive income (loss). For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 8 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Derivative Liabilities.&#x201d;&lt;/span&gt;</us-gaap:DerivativesPolicyTextBlock>
    <cron:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMTQ4NDM0MDcwMzQwOTY_4e0a7080-ffb1-4b54-b626-0e75503ba1ce">consolidated statements of net income (loss) and comprehensive income (loss)</cron:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag>
    <cron:FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMTQ4NDM0MDcwMzQwOTc_a3785cf1-ff03-486a-b525-c2999b59b49a">consolidated statements of net income (loss)</cron:FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag>
    <cron:FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMTQ4NDM0MDcwMzQwOTg_24c44722-8ada-4160-9000-be304250066f">comprehensive income (loss)</cron:FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NTA_fd629701-328d-49f4-b0c7-38e6b6b396f9">Capital stockCapital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjQ_2030ab97-dff8-4bd2-8bcf-0a0fb72dad45">Revenue recognition&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606, &#x201c;Revenue from Contracts with Customers,&#x201d; and is measured based on the consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product or service to a customer. The Company&#x2019;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and &#x201c;hemp&#x201d; (as defined in the U.S. Agricultural Improvement Act of 2018 &#x201c;U.S. hemp&#x201d;) derived products consist of a single performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, depending on the specific contractual terms. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer or third-party location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer&#x2019;s usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, allowances for customer returns and other forms of variable consideration. Within the Company&#x2019;s Rest of World segment (the &#x201c;ROW segment&#x201d;), dried cannabis sales outside of Canada may include commission arrangements with distributors that give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated using the expected value method, based on the Company&#x2019;s historical information, at contract inception. The Company&#x2019;s payment terms vary by customer and product type. Refer to Note 12 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information and Disaggregated Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for information on disaggregated revenue.&lt;/span&gt;&lt;/div&gt;The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NTE_2825a7e0-21eb-4b3c-8951-8a2ea15de5c7">Research and development &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a research and development center in Canada that performs scientific research on the interaction of cannabinoids as well as strain development, growing conditions, extraction technology, and biosynthesis. Fermentation and production related research is performed to further strategic initiatives around rare cannabinoids. In addition, the Company has a collaboration and license agreement with Ginkgo (the &#x201c;Ginkgo Collaboration Agreement&#x201d;) to research, produce, and commercialize cultured cannabinoids. Technological feasibility is considered to be established once productivity targets or commercialization are achieved, at which point the exclusive license is recognized at cost less impairment charges. As of the acquisition date of each exclusive license, cost less impairment charges is equal to the fair value. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Note 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information on the Ginkgo Collaboration Arrangement. Research and development costs associated with these collective efforts are expensed as incurred as part of operating expenses in the Company&#x2019;s consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjA_2f8485d0-b520-4556-91cb-96fd81345125">Advertising costsAdvertising costs include costs to sell the Company&#x2019;s products and are expensed as incurred through sales and marketing expenses in the consolidated statements of net income (loss) and comprehensive income (loss).</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMjM3MDc_11ea7dcf-4727-4d0f-b4fa-dbec8b708127"
      unitRef="usd">928000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMjM3MTE_ccb31e2a-e0f0-4b56-a070-f19bd4fc2045"
      unitRef="usd">11514000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMjM3MTg_9554077e-f904-4317-9326-37d80b2f1a43"
      unitRef="usd">6087000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzU_d8d2a010-d94e-4e57-8ae2-851a06808b2f">Share-based compensation&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan, the 2018 Stock Option Plan, the 2015 Stock Option Plan, the Employment Inducement Award Plan and the DSU Plan (each as defined below).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based awards consists of equity-settled share-based awards such as stock options and restricted share units (&#x201c;RSUs&#x201d;) that are issued to eligible employees, non-executive directors, and non-employees. Cash-settled deferred share units (&#x201c;DSUs&#x201d;) that are issued to non-executive directors under the DSU Plan are recorded in accrued liabilities with the fair value adjustment recorded in other income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity instruments granted are initially measured at fair value on the grant date. The fair value of stock options is determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price of the Company&#x2019;s common shares. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive &lt;/span&gt;&lt;/div&gt;income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#x2019;s common shares at the reporting date and is recorded within other liabilities. The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are settled or exercised. Upon settlement or exercise, shares are issued and the amount previously reflected in additional paid-in capital is, along with any proceeds paid upon settlement or exercise, credited to a combination of share capital and additional paid-in capital. Forfeitures of share-based compensation awards are accounted for as reductions to share-based compensation and additional paid-in capital as they occur.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzY_226d5fd3-7bda-4d4b-844e-930101017c89">Impairment of long-lived assets&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its long-lived assets, such as property, plant and equipment and definite-lived intangible assets, for impairment in accordance with ASC Topic 360, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In accordance with ASC Topic 360, long-lived assets to be held are reviewed for events or changes in circumstances that indicate that their carrying amount may not be recoverable. The Company periodically reviews for indicators and, if indicators are present, tests the carrying amount of long-lived assets, assessing their fair values based on estimated undiscounted cash flows over their remaining estimated useful lives. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. If the carrying amount of an asset (or asset group) exceeds its estimated undiscounted future cash flows, an impairment charge is measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset group, based on discounted cash flows.&lt;/span&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjU_2c957b50-93cf-4266-8952-97d477061af9">Impairment of goodwill and indefinite-lived intangible assets&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and indefinite-lived intangible assets are not amortized. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying amount in accordance with the provisions of ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&lt;/span&gt;. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDU_1342dac4-2ebc-4322-940f-7c4d2d036285">Income taxes&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative, including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance against some or all of the net deferred tax assets does not in any way impact the Company&#x2019;s ability to use future tax deductions such as the Company&#x2019;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification (&#x201c;ASC&#x201d;) 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#x2019;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine whether the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#x201c;more likely than not&#x201d; to be sustained, no benefits of the position are recognized. If we determine that a position is &#x201c;more likely than not&#x201d; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards, to the extent not covered by a valuation allowance, could be materially impacted in the period which such determination is made.&lt;/span&gt;&lt;/div&gt;The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mzc_9a121a30-077c-409b-93a4-76e1294ca291">Foreign currencyThe Company&#x2019;s functional currency is the Canadian dollar (&#x201c;C$&#x201d;) and its reporting currency is the U.S. dollar. Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, U.S. dollar and Israeli New Shekel (&#x201c;ILS&#x201d;). All assets and liabilities of operations with a functional currency other than the Canadian dollar are translated into Canadian dollars at the period-end currency exchange rates and subsequently translated into U.S. dollars at period-end currency exchange rates. The resulting translation adjustments are recorded in accumulated other comprehensive income (loss), net of tax. Revenues and expenses of operations, as well as all cash flows, with a functional currency other than the Canadian dollar are translated into Canadian dollars at the average exchange rates for the period and subsequently translated into U.S. dollars at the average exchange rates for the period. Transaction gains and losses resulting from changes in foreign currency exchange rates are recorded in either cost of sales, general and administrative expenses, or foreign currency transaction gain (loss) in the consolidated statements of net income (loss) and comprehensive income (loss).</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3Mzg_e7f54cb9-b1d9-4d95-b30e-b8a464c4c3f6">Segments&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos reports through two segments: the U.S. segment and the ROW segment. These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. Refer to Note 12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Segment Information and Disaggregated Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information.&lt;/span&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzMxMjM_e864230d-423e-4b72-9708-b6a108847a48"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzMxODA_e2935cf0-f384-4b6d-b4e2-e29a32becea4"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDE_cd7bba02-b75d-4dbc-a633-e2fd685a8e35">Earnings (loss) per shareThe Company presents basic and diluted earnings (loss) per share data for its common shares. Basic earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3NDY_1a02f844-68fa-4bea-b88c-eade07b1c80a">Fair value measurements&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of the Company&#x2019;s cash and cash equivalents, accounts receivable, other receivables, loans receivable, account payables and other liabilities approximate fair value, given their short-term nature. Cronos uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the three levels of inputs used to measure fair value: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; valuation techniques using the inputs for the asset or liability that are not based on observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MjY_d9e29e23-adb0-4301-824d-966cff645f1b">Assets held for sale and discontinued operations&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 205-20 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Presentation of Financial Statements: Discontinued Operations&lt;/span&gt;, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#x2019;s operations and financial results when the components of an entity meet the criteria in paragraph ASC 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and other liabilities are reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), are reported as components of net income (loss) separate from the net income (loss) of continuing operations.</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85NC9mcmFnOmZmNDU0MWE1MGIxNzRiMGE4OTI5Yjk4MDZlZjMxMmE0L3RleHRyZWdpb246ZmY0NTQxYTUwYjE3NGIwYTg5MjliOTgwNmVmMzEyYTRfMzg3MzI_5b8f7757-63b8-466d-81c1-7d45409a438e">Adoption of new accounting pronouncements&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022, the Company adopted ASU No. 2020-06, Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815&#x2013;40) (&#x201c;ASU No. 2020-06&#x201d;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. ASU No. 2020-06 is part of the Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The adoption of ASU No. 2020-06 did not have an impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(aa)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt"&gt;New accounting pronouncements not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASU 2022-02, Financial Instruments &#x2013; Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (&#x201c;ASU No. 2022-02&#x201d;). ASU No. 2022-02 eliminates the existing troubled debt restructuring recognition and measurement guidance, and instead aligns the accounting treatment to that of other loan modifications. The amendments enhance existing disclosure requirements and introduce new requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. ASU No. 2022-02 also requires that entities disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases. ASU No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-02 to have a material impact on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#x201c;ASU No. 2022-03&#x201d;). ASU No. 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered in measuring fair value. The amendments also require additional disclosures for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and is to be adopted prospectively. The Company does not expect the adoption of ASU No. 2022-03 to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RleHRyZWdpb246ZmIyYTYyMTQ3ZGY1NDI5YzljNjQ3ZWM5ODRjYzZjM2VfNjU_62231666-88dc-4b0d-a350-6e18abacc36a">Inventory, net&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, net is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplies and consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RleHRyZWdpb246ZmIyYTYyMTQ3ZGY1NDI5YzljNjQ3ZWM5ODRjYzZjM2VfNjY_2621a996-77b0-4c6f-8924-0206dfe69b28">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, net is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplies and consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfMi0xLTEtMS0yMTMzMzk_52dafae6-82a8-434a-af9e-2e62c5c89904"
      unitRef="usd">7421000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfMi0zLTEtMS0yMTMzMzk_032d09be-e233-4bb3-a0b2-379ae60a0128"
      unitRef="usd">9211000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfMy0xLTEtMS0yMTMzMzk_260c2728-300c-40a7-aa86-7a7b6d2800a4"
      unitRef="usd">15646000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfMy0zLTEtMS0yMTMzMzk_c7436852-5604-4425-bc24-59d53b763ed1"
      unitRef="usd">12405000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNC0xLTEtMS0yMTMzMzk_b3fd0de3-0f79-489c-ba1c-145b4bc64954"
      unitRef="usd">13503000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNC0zLTEtMS0yMTMzMzk_6f77eb90-d595-4478-ae11-5e5f41d14f5f"
      unitRef="usd">10778000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventorySuppliesNetOfReserves
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNS0xLTEtMS0yMTMzMzk_f291ae05-a55c-4e81-ad77-5b75e139bf87"
      unitRef="usd">989000</us-gaap:InventorySuppliesNetOfReserves>
    <us-gaap:InventorySuppliesNetOfReserves
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNS0zLTEtMS0yMTMzMzk_2d018ed7-842b-4dfd-b175-59b7651ecbd6"
      unitRef="usd">408000</us-gaap:InventorySuppliesNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNi0xLTEtMS0yMTMzMzk_f91d2b46-f4fb-4a15-b9c5-431321be39af"
      unitRef="usd">37559000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl85Ny9mcmFnOmZiMmE2MjE0N2RmNTQyOWM5YzY0N2VjOTg0Y2M2YzNlL3RhYmxlOjY1M2I1ZjhhOWNkMDQwNGU4YWRiZDUzZjAxZTdhNzAyL3RhYmxlcmFuZ2U6NjUzYjVmOGE5Y2QwNDA0ZThhZGJkNTNmMDFlN2E3MDJfNi0zLTEtMS0yMTMzMzk_07212c59-75f8-4e31-931f-e587a96efcd3"
      unitRef="usd">32802000</us-gaap:InventoryNet>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NzM4_81539143-0906-43ac-a82c-1a7e7e39815a">Investments&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Variable interest entities and investments in equity method investments, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds variable interests in Cronos Growing Company Inc. (&#x201c;Cronos GrowCo&#x201d;), NatuEra S.&#xe0;.r.l. (&#x201c;Natuera&#x201d;) and Cannasoul Lab Services Ltd. (&#x201c;CLS&#x201d;). The Company&#x2019;s investments in Cronos GrowCo and Natuera are exposed to economic variability from each entity&#x2019;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entity&#x2019;s economic performance. Thus, the Company is not considered the primary beneficiary of either entity. The investment in Cronos GrowCo is accounted for as an equity method investment classified as &#x201c;Investments in equity method investments, net&#x201d; in the consolidated balance sheets. As of December 31, 2022, the investment in Natuera is accounted for as an equity security without a readily determinable fair value classified as &#x201c;Other Investments&#x201d; in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act on June 14, 2018 with the objective of cultivating and commercializing cannabis and cannabis products. Cronos GrowCo&#x2019;s economic performance is driven by the day-to-day operations of Cronos GrowCo, which are controlled by 2645485 Ontario Inc. (&#x201c;Mucci&#x201d;), the Company&#x2019;s joint venture partner. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company concluded that lower than expected sales forecasts combined with the increase to the aggregate principal amount of the GrowCo Credit Facility (as defined below) were indicators of impairment for the Company&#x2019;s equity method investment in Cronos GrowCo. Accordingly, the Company performed a quantitative impairment assessment in the third quarter of 2021 to compare the fair value of the investment in Cronos GrowCo to its carrying amount. The fair value was estimated using the discounted cash flow method. Significant inputs included discount rate, growth rates, and cash flow projections. As a result of this analysis, the Company concluded that as of September 30, 2021, the estimated fair value was higher than the carrying amount and no impairment charges were recorded. There were no such indicators of impairment present for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Natuera&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon formation, Natuera was a joint venture registered in Luxembourg with the objective of cultivating and commercializing hemp and cannabis products, and its economic performance is driven by the quantity and strains of cannabis grown. Until December 2022, the Company held variable interests in Natuera through its ownership of 50% of Natuera&#x2019;s common shares. An affiliate of Agroidea SAS, a Colombian agricultural services provider, owned the remaining 50% of Natuera&#x2019;s common shares (such affiliate, the &#x201c;Natuera JV Partner&#x201d;). In December 2022, Natuera entered into a $9.5&#160;million convertible bridge loan with the Natuera JV Partner and a new investment group, whereby the Natuera JV Partner and the new investment group provided $9.5&#160;million in exchange for convertible notes that were converted into equity immediately following the closing of the loan. Post-closing, the Company&#x2019;s ownership share was diluted to approximately 13.7% and the Company will no longer have any members on the board of directors of Natuera. Given these changes in ownership and board representation, the Company believes it no longer exerts significant influence over Natuera, has discontinued accounting for the investment under the equity method and has reclassified its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets as of December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company concluded that lower than expected sales forecasts as of December 31, 2021 were an other than temporary indicator of impairment for the Company&#x2019;s equity method investment in Natuera. Accordingly, the Company performed a qualitative assessment to determine whether there was any value remaining in the investment. As a result of this analysis, the Company concluded that, as of December 31, 2021, the estimated fair value was zero, and $167 was recorded as an impairment loss on equity method investments on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CLS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#x201c;Cannasoul Collaboration&#x201d;). Cronos Israel agreed to advance up to ILS 8,297 ($2,664) by a non-recourse loan (the &#x201c;Cannasoul Collaboration Loan&#x201d;) to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan bears interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#x2019;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#x2019;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company&#x2019;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 4 &#x201c;Loans Receivable, net&#x201d; for further information regarding loans receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amount of the investments in equity method investments, net is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i, ii, iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7% / 50% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On April 1, 2021, the Company and the Natuera JV Partner, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#x201c;Natuera Series A Loan&#x201d;), plus accrued interest, into equity of Natuera (&#x201c;Natuera Debt Conversion&#x201d;). Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and the Natuera JV Partner advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying amount of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximated the then fair value, to investments in equity accounted investees in respect of Natuera. See Note 4 &#x201c;Loans Receivable, net.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;As of December 31, 2021, the Company concluded that the estimated fair value of the investment in Natuera was lower than the carrying amount resulting in an impairment charge of $167 being recorded as an impairment loss on equity method investments in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets. As of December 31, 2022, the Company&#x2019;s ownership interest in Natuera was approximately 13.7%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s share of net income (losses) from equity investments accounted for under the equity method of accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitura&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;As of December 31, 2022, the Company held a 10% ownership interest in Vitura, and Vitura is no longer considered an equity-method investment. As of December 31, 2020, and up to December 16, 2021, the Company held a 31% ownership interest in Vitura and was considered an equity-method investment. The gross investment balance in Vitura was offset by equity losses as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;As of December 31, 2021, the combination of the Company&#x2019;s share of accumulated net losses and impairment charges was in excess of its equity investment in Natuera, and the net book value of the investment was zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of financial information for the Company&#x2019;s equity method investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the maximum exposure to loss from the Company&#x2019;s investments in equity method investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Net Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Exposure to Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Net Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Exposure to Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.24pt"&gt;Other investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist of investments in common shares and options of two companies in the cannabis industry. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;PharmaCann Option&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 14, 2021, the Company purchased an option (the &#x201c;PharmaCann Option&#x201d;) to acquire 473,787 shares of Class A Common Stock of PharmaCann, Inc. (&#x201c;PharmaCann&#x201d;), a vertically integrated cannabis company in the United States, at an exercise price of $0.0001 per share, representing approximately 10.5% of PharmaCann&#x2019;s issued and outstanding capital stock on a fully diluted basis as of the date of the PharmaCann Option, for an aggregate purchase price of approximately $110,392. The option exercise will be based upon various factors, including the status of U.S. federal cannabis legalization, as well as regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise. The Company has deemed its influence in PharmaCann to be non-significant. The PharmaCann Option is classified as an investment in an equity security without a readily determinable fair value. The Company measures the PharmaCann Option at cost less accumulated impairment charges, if any, and subsequently adjusted for observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The PharmaCann Option is reported as other investments on the consolidated balance sheet for the periods ended December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 28, 2022, PharmaCann closed its previously announced transaction with LivWell Holdings, Inc. (&#x201c;LivWell&#x201d;) pursuant to which PharmaCann acquired LivWell (the &#x201c;LivWell Transaction&#x201d;). LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#x2019;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately 6.4%. As of December 31, 2022, the Company&#x2019;s ownership percentage in PharmaCann on a fully diluted basis was approximately 6.3%. Under the terms of the Company&#x2019;s investment in PharmaCann, the Company&#x2019;s rights to nominate an observer or a director to the PharmaCann board of directors could be lost if the Company&#x2019;s ownership drops below 6% on a fully diluted basis and it sells or transfer all or any portion of the option (subject to certain exceptions). As a result, further dilution could adversely affect the Company&#x2019;s rights under the PharmaCann Option. The decrease in the Company&#x2019;s ownership percentage since acquisition does not materially affect the Company&#x2019;s rights under the PharmaCann Option.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first, third and fourth quarters of 2022, the Company identified adverse forecast changes in the financial performance of PharmaCann as indicators of impairment related to the PharmaCann Option and conducted analyses comparing the PharmaCann Option&#x2019;s carrying amount to its estimated fair value. The fair value was estimated using a combination of the income approach and the market approach. Under the income approach, significant inputs used in the discounted cash flow method include discount rate, growth rates, and cash flow projections. Under the market valuation approach, the key assumptions are the selected multiples and the discount for lack of marketability. As a result of these analyses, the Company recorded non-cash impairment charges of $11,238. $28,972 and $21,182 in the first, third and fourth quarters of 2022, respectively, as the difference between the carrying amount of the PharmaCann Option and its estimated fair value, in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the Company performed an assessment on the existence of impairment indicators on the PharmaCann Option and noted no indicators of impairment existed. As such, no impairment loss on the investment was recorded during the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Vitura (formerly known as Cronos Australia)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 14, 2021, Cronos Australia (now, Vitura Health Limited) entered into a merger agreement to acquire 100% of the issued shares of CDA Health Pty Ltd, an Australian medicinal cannabis company, subject to customary closing conditions, including shareholder approval (the &#x201c;Cronos Australia Merger&#x201d;). The Cronos Australia Merger closed on December 16, 2021. In connection with the closing of the Cronos Australia Merger, all advances made under the Company&#x2019;s A$1,500 unsecured loan to Cronos Australia, plus accrued interest and certain royalties payable, were converted into ordinary shares of Cronos Australia. In addition, the Company&#x2019;s ownership interest in Cronos Australia decreased to approximately 10% and the Company&#x2019;s number of Cronos Australia board seats was reduced from two to zero. On November 29, 2022, the shareholders of Cronos Australia approved the proposal to change the name of the company to &#x201c;Vitura Health Limited&#x201d; (the &#x201c;CAU Name Change&#x201d;). On December 2, 2022, in connection with the CAU Name Change, Vitura and the Company mutually agreed to terminate the intellectual property license that granted Vitura the right to use certain intellectual property of the Company, including, but not limited to, the &#x201c;Cronos&#x201d; name and the PEACE NATURALS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand. Vitura has 180 days following the date of termination to cease all usage of the Company&#x2019;s intellectual property. The reduction in ownership interest and loss of all board seats constituted a loss of significant influence and resulted in a reclassification on the consolidated balance sheet from investments in equity method investments using the equity method of accounting to other investments using the fair value method of accounting, with unrealized holding gains and losses included in net income (loss) on the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a gain on revaluation of other investments of $14,739 and $8,287, included in the gain on revaluation of financial instruments on the statements of net income (loss) and comprehensive income (loss), for the years ended December 31, 2022 and 2021, respectively. The Company&#x2019;s investment in Vitura was $21,993 and $8,000, included in other investments on the balance sheet, as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s other investments activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PharmaCann&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitura&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Disposal of investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s gain from disposals of investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aurora&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;During the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received 980,662 common shares of Aurora Cannabis Inc. (&#x201c;Aurora&#x201d;). The Company sold all 980,662 of the Aurora common shares during the year ended December 31, 2020, for gross proceeds of approximately $4,789, resulting in a $4,789 gain on disposal of investments being recorded on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i6584e6d786d847d69e0e7fc90b593c5f_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE5NjE_e776c671-6361-4609-b753-cb7acc414ceb"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ieae966ba01c1479dacbc7135663a609a_D20220101-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzMxMzE_ca48ec29-2767-4d02-8786-4f41eb3aaba1"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="icb4e552f78894f18936e22352d25dde5_D20220101-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzMyNTU_14910bfc-064a-4aee-baed-9172a29f275f"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i736040703d9b43138a6d1fbe16c1ea1a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2Njc5MzM_d6e3438b-0b73-4b94-9730-b0e1c22c26a2"
      unitRef="usd">9500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i736040703d9b43138a6d1fbe16c1ea1a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0ODQzNDA3MDIxMTUx_d6e3438b-0b73-4b94-9730-b0e1c22c26a2"
      unitRef="usd">9500000</us-gaap:DebtInstrumentFaceAmount>
    <cron:InvestmentOwnedPercentage
      contextRef="ied9879f7a9aa480189fcbf72c09fb055_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NjQ2OTk_2022653e-f0cc-4920-9cf1-97545c1bf040"
      unitRef="number">0.137</cron:InvestmentOwnedPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i01e84979c2174a3e959ae14445c4c0b6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzM5NDM_1b816f01-eae5-4cb0-b929-52c21cbd5a01"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i4dd42bcd2c914a09bf216a667b6e31d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzM5NTE_47a3951f-96ec-415b-8284-b6d3cdda5053"
      unitRef="usd">167000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NTY2OTU_655797db-d658-43b4-8bdc-b686661e85d6"
      unitRef="ils">8297000</cron:CollaborativeArrangementAmountOfAdvances>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE4NjkxNjk3NzEzNjUz_16eb5dcf-7ecf-4d01-b256-7e23d4b58336"
      unitRef="usd">2664000</cron:CollaborativeArrangementAmountOfAdvances>
    <cron:CollaborativeArrangementTermOfAgreement
      contextRef="ib83b7561b10e4723a7df91adaaef20db_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzQ1MTE_85c948d4-df45-4146-8115-9b0d9024409a">P2Y</cron:CollaborativeArrangementTermOfAgreement>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NTY3MDM_52e7cb88-1154-4de7-836b-2d37ba487813"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cron:CollaborativeArrangementPercentageOfProfitsToBeReceived
      contextRef="i8d787bdfa77d4a4eb6ac5ba4b4bdfc00_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzQ2NjI_fd03225b-249a-458f-a4c8-fb616a4f52d7"
      unitRef="number">0.70</cron:CollaborativeArrangementPercentageOfProfitsToBeReceived>
    <cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced
      contextRef="i8d787bdfa77d4a4eb6ac5ba4b4bdfc00_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzQ3MzQ_92f9fe41-50c1-4ba2-9c40-4612795b0d20"
      unitRef="number">1.50</cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced>
    <cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet
      contextRef="i8d787bdfa77d4a4eb6ac5ba4b4bdfc00_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzQ4MDI_c2628ede-de92-4bbc-a5bf-af105d2b80f1"
      unitRef="number">0.50</cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NTY3MDc_655797db-d658-43b4-8bdc-b686661e85d6"
      unitRef="ils">8297000</cron:CollaborativeArrangementAmountOfAdvances>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NzM5_c9e3b56d-2fbc-4042-801f-c125f7664aa6">&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amount of the investments in equity method investments, net is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i, ii, iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7% / 50% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On April 1, 2021, the Company and the Natuera JV Partner, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#x201c;Natuera Series A Loan&#x201d;), plus accrued interest, into equity of Natuera (&#x201c;Natuera Debt Conversion&#x201d;). Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and the Natuera JV Partner advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying amount of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximated the then fair value, to investments in equity accounted investees in respect of Natuera. See Note 4 &#x201c;Loans Receivable, net.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;As of December 31, 2021, the Company concluded that the estimated fair value of the investment in Natuera was lower than the carrying amount resulting in an impairment charge of $167 being recorded as an impairment loss on equity method investments in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets. As of December 31, 2022, the Company&#x2019;s ownership interest in Natuera was approximately 13.7%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s share of net income (losses) from equity investments accounted for under the equity method of accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitura&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;As of December 31, 2022, the Company held a 10% ownership interest in Vitura, and Vitura is no longer considered an equity-method investment. As of December 31, 2020, and up to December 16, 2021, the Company held a 31% ownership interest in Vitura and was considered an equity-method investment. The gross investment balance in Vitura was offset by equity losses as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;As of December 31, 2021, the combination of the Company&#x2019;s share of accumulated net losses and impairment charges was in excess of its equity investment in Natuera, and the net book value of the investment was zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of financial information for the Company&#x2019;s equity method investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s other investments activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PharmaCann&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitura&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NzQw_e62b549a-4f5d-41a1-9414-aba17643b5ed">&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amount of the investments in equity method investments, net is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i, ii, iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7% / 50% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On April 1, 2021, the Company and the Natuera JV Partner, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#x201c;Natuera Series A Loan&#x201d;), plus accrued interest, into equity of Natuera (&#x201c;Natuera Debt Conversion&#x201d;). Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and the Natuera JV Partner advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying amount of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximated the then fair value, to investments in equity accounted investees in respect of Natuera. See Note 4 &#x201c;Loans Receivable, net.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;As of December 31, 2021, the Company concluded that the estimated fair value of the investment in Natuera was lower than the carrying amount resulting in an impairment charge of $167 being recorded as an impairment loss on equity method investments in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheets. As of December 31, 2022, the Company&#x2019;s ownership interest in Natuera was approximately 13.7%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s share of net income (losses) from equity investments accounted for under the equity method of accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitura&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;As of December 31, 2022, the Company held a 10% ownership interest in Vitura, and Vitura is no longer considered an equity-method investment. As of December 31, 2020, and up to December 16, 2021, the Company held a 31% ownership interest in Vitura and was considered an equity-method investment. The gross investment balance in Vitura was offset by equity losses as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;As of December 31, 2021, the combination of the Company&#x2019;s share of accumulated net losses and impairment charges was in excess of its equity investment in Natuera, and the net book value of the investment was zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;As of December 31, 2022, the Company classifies its investment in Natuera as an investment in equity securities without a readily determinable fair value, presented in Other Investments on the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of financial information for the Company&#x2019;s equity method investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the maximum exposure to loss from the Company&#x2019;s investments in equity method investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Net Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Exposure to Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Net Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Exposure to Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ia965648dd525484799c2e977f7acaf53_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzMtMS0xLTEtMjEzMzM5_2774cd69-aac0-4b41-a19d-3f58cf0f0db0"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="ia965648dd525484799c2e977f7acaf53_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzMtMy0xLTEtMjEzMzM5_560b27b8-af12-4448-a40e-d456838da8ce"
      unitRef="usd">18755000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ie35ca828c220404d8779f0c05373f981_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzMtNS0xLTEtMjEzMzM5_f085ea2b-a71d-43d0-9aa9-17d2bf7eaecc"
      unitRef="usd">16764000</us-gaap:EquityMethodInvestments>
    <cron:InvestmentOwnedPercentage
      contextRef="ied9879f7a9aa480189fcbf72c09fb055_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzUtMS0xLTEtMjEzMzM5L3RleHRyZWdpb246YzQxNmU5ODY4Mzg2NGYxMjllMTQ0MGQzNjc0Y2Y2M2ZfMzg0ODI5MDY5NzI1Ng_e554994a-33b1-4935-a626-e4e69e4aae03"
      unitRef="number">0.137</cron:InvestmentOwnedPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ied9879f7a9aa480189fcbf72c09fb055_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzUtMS0xLTEtMjEzMzM5L3RleHRyZWdpb246YzQxNmU5ODY4Mzg2NGYxMjllMTQ0MGQzNjc0Y2Y2M2ZfMzg0ODI5MDY5NzI2Mg_c3b8e677-ec45-4053-9ebf-2e8cb635d414"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i6226d0a1598b4591a5b51ab3e76703b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzUtNS0xLTEtMjEzMzM5_9a25edff-75d4-415e-a75d-992f59afb8e2"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzYtMy0xLTEtMjEzMzM5_78ae9be9-dc27-4f61-8aee-f6ae964ec733"
      unitRef="usd">18755000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTpkYzNlOGU4YTRiZWU0MzI3OWE1MGZmZjYwYThiZTk4MC90YWJsZXJhbmdlOmRjM2U4ZThhNGJlZTQzMjc5YTUwZmZmNjBhOGJlOTgwXzYtNS0xLTEtMjEzMzM5_94e7edb0-76cd-495d-aef9-f38194852cac"
      unitRef="usd">16764000</us-gaap:EquityMethodInvestments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ieab708e963a4427d9d3c7720e25e4a43_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzYzODk_b5597b3f-2d9b-4c3a-b4d8-a5eb495118c7"
      unitRef="usd">15500000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage
      contextRef="iaf4bf3256f4340b98286607ff670aef5_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY0MjM_e2b41bf8-76cd-4559-b5e6-4ae9308fadee"
      unitRef="number">0.50</cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage
      contextRef="i556bef2858d7440aa6698fec9871e28e_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY0NzY_1ec59a5b-f62b-4155-b73c-7652dd0ac401"
      unitRef="number">0.50</cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i9d84efb4ac7543a7b30a39f637d3feac_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY0ODM_82d5e2c1-4044-4684-89e3-c9d63dcfca1d"
      unitRef="usd">7750000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ib684e46ce2ce4e94953b3cd65ed84eb3_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY0ODM_96e0cb54-dcde-4b20-9298-9df25f168c25"
      unitRef="usd">7750000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <us-gaap:NotesReceivableNet
      contextRef="iec61439c630842daa57b512a9ded6f1f_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY1OTU_bd580f65-7330-4f1a-a195-cd714478e79d"
      unitRef="usd">2013000</us-gaap:NotesReceivableNet>
    <us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="iec61439c630842daa57b512a9ded6f1f_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY2MjM_fbb96e19-b54a-48e1-b82c-79f8f3a3745c"
      unitRef="usd">540000</us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="ieab708e963a4427d9d3c7720e25e4a43_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzY2NTk_425b6fd5-70ab-4f22-977e-fbc5c2c158c2"
      unitRef="usd">2553000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i4dd42bcd2c914a09bf216a667b6e31d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NTg5MDA_a53566ce-dba7-49fa-86a2-59c9f8d0f4de"
      unitRef="usd">167000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <cron:InvestmentOwnedPercentage
      contextRef="ied9879f7a9aa480189fcbf72c09fb055_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NjgxMjQ_2022653e-f0cc-4920-9cf1-97545c1bf040"
      unitRef="number">0.137</cron:InvestmentOwnedPercentage>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i72bd56a3b81845f49fe8b58426c1d15c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzMtMy0xLTEtMjEzMzM5_1ae905dc-838b-4253-81e3-7f1ccba37471"
      unitRef="usd">-48000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id2dea108f6474d59838c2f8da2a2200d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzMtNS0xLTEtMjEzMzM5_fd1c39b5-5d2c-460f-a0b8-08884afa5606"
      unitRef="usd">-363000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i06a12ae20ea94eb79a945a18af0871d1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzQtMS0xLTEtMjEzMzM5_28af852b-1127-4345-a9f9-1cb656049ec3"
      unitRef="usd">3114000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i31af1706e07447a382a55519bec4d367_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzQtMy0xLTEtMjEzMzM5_16d034dc-f642-46e7-870d-b7d04cf0d249"
      unitRef="usd">-2518000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iecc2eafed6534c30b7a6637e2039b9b7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzQtNS0xLTEtMjEzMzM5_8ec5ad59-5944-4b91-8ce0-bb766fcdced6"
      unitRef="usd">-1537000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6774fc03d1d44059bc5e08321bc61875_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzYtMy0xLTEtMjE3MTE2_73871394-b72c-4d26-a80a-90a16867905e"
      unitRef="usd">-3747000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1be163b6b0ca4a5fae2fa3db98dc500e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzYtNS0xLTEtMjE3MTI0_fb8edfc0-140d-45c9-ad00-22c6bfac3c47"
      unitRef="usd">-2610000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzctMS0xLTEtMjEzMzM5_064b8a4f-5dc1-4df4-84b9-eb81ba665649"
      unitRef="usd">3114000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzctMy0xLTEtMjEzMzM5_dbcc0080-b96f-4f8d-8d2a-160491ff556f"
      unitRef="usd">-6313000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTphMGVkYWI0MTY5ZmI0MzRjYjIwZGJiOWFjNjMwOGQwZi90YWJsZXJhbmdlOmEwZWRhYjQxNjlmYjQzNGNiMjBkYmI5YWM2MzA4ZDBmXzctNS0xLTEtMjEzMzM5_ff6de51c-168a-4278-a850-0f81769054db"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <cron:InvestmentOwnedPercentage
      contextRef="ib48a5f922dc74080be8b4e6b57c7a04d_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NTY3OTQ_62131761-ca3b-4258-964c-c9a38364bfc1"
      unitRef="number">0.10</cron:InvestmentOwnedPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="if46b21ab0b3b47ce84759033415e34a3_I20211215"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE4NjkxNjk3NzEzNjYx_9a2e00e0-651b-431d-bf0e-b788abda121d"
      unitRef="number">0.31</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:AssetsCurrent
      contextRef="i5412eefc844e484bb12e39c21eac056f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzItMS0xLTEtMjEzMzM5_43ed32bd-01a7-41bd-ab9c-8c42232ec47a"
      unitRef="usd">21158000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i582e556b4ce74d03ba739d1baa4199e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzItMy0xLTEtMjEzMzM5_95d2c1f4-fd22-49cd-b926-b66f5059cc1d"
      unitRef="usd">5660000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic4575a982e5148c79aec9bf8a66c9c02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzItNS0xLTEtMjEzMzM5_685acca0-6e33-472c-a8b3-df1ff795e608"
      unitRef="usd">19126000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i5412eefc844e484bb12e39c21eac056f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzMtMS0xLTEtMjEzMzM5_f2ddde35-32fc-4ec4-b794-eb553ce97829"
      unitRef="usd">104227000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i582e556b4ce74d03ba739d1baa4199e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzMtMy0xLTEtMjEzMzM5_1c0aa5f7-142e-4119-aa5d-d4caf9f30a1c"
      unitRef="usd">125777000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ic4575a982e5148c79aec9bf8a66c9c02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzMtNS0xLTEtMjEzMzM5_3cb02467-12e2-4bf0-ab41-34f220e267dc"
      unitRef="usd">122099000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5412eefc844e484bb12e39c21eac056f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzQtMS0xLTEtMjEzMzM5_85fb6dbf-2926-49ce-b402-4628a3c0f51a"
      unitRef="usd">5593000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i582e556b4ce74d03ba739d1baa4199e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzQtMy0xLTEtMjEzMzM5_fdb98080-658b-4bcc-9b51-6866f5a62684"
      unitRef="usd">13457000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic4575a982e5148c79aec9bf8a66c9c02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzQtNS0xLTEtMjEzMzM5_79942113-866b-4ca2-b9d0-4bb720a7f077"
      unitRef="usd">24223000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i5412eefc844e484bb12e39c21eac056f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzUtMS0xLTEtMjEzMzM5_668722b6-2ef0-4282-80d5-8b8f28ffcc87"
      unitRef="usd">73779000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i582e556b4ce74d03ba739d1baa4199e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzUtMy0xLTEtMjEzMzM5_7e497986-656a-4396-b63d-76b9e3e3884e"
      unitRef="usd">81594000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ic4575a982e5148c79aec9bf8a66c9c02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo2N2U3MWU0YjIyOTQ0ZDE2OTJhOWQxMmJiOTE1ODFjMy90YWJsZXJhbmdlOjY3ZTcxZTRiMjI5NDRkMTY5MmE5ZDEyYmI5MTU4MWMzXzUtNS0xLTEtMjEzMzM5_cbcd994b-b9d0-47dd-86ff-9522ce4ec3ed"
      unitRef="usd">76313000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e8e633340c54e489bace8e93f8c9aaf_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzItMS0xLTEtMjEzMzM5_fa6ff4eb-fddf-4205-8e2e-e2ebefbe1da4"
      unitRef="usd">39110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i138038dc2b074762930cd415641ec771_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzItMy0xLTEtMjEzMzM5_f70abd3f-9580-4a63-acce-1634b9c55646"
      unitRef="usd">8186000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20a76be7bf924660b23e0d04d6d1d445_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzItNS0xLTEtMjEzMzM5_dc7bbe93-67af-457c-ac46-3969b786cb26"
      unitRef="usd">367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i3e8e633340c54e489bace8e93f8c9aaf_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzMtMS0xLTEtMjEzMzM5_e55b63f9-3daf-47e9-8f64-c7195e9ff992"
      unitRef="usd">24379000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i138038dc2b074762930cd415641ec771_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzMtMy0xLTEtMjEzMzM5_1f144586-f1a0-4b91-8b63-33e81d97651c"
      unitRef="usd">-5059000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i20a76be7bf924660b23e0d04d6d1d445_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzMtNS0xLTEtMjEzMzM5_175b5db5-417a-498d-9340-6c0321cebe84"
      unitRef="usd">-631000</us-gaap:GrossProfit>
    <us-gaap:ProfitLoss
      contextRef="i3e8e633340c54e489bace8e93f8c9aaf_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzQtMS0xLTEtMjEzMzM5_958737ef-220c-4d44-aef8-3524613db654"
      unitRef="usd">6569000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i138038dc2b074762930cd415641ec771_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzQtMy0xLTEtMjEzMzM5_c66d0486-925f-478a-9522-edd5345b8812"
      unitRef="usd">-12603000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i20a76be7bf924660b23e0d04d6d1d445_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo0OTgzNDFlMjkzYTI0YzFjODYzZWNhNGUwMzk5ZTQ4Mi90YWJsZXJhbmdlOjQ5ODM0MWUyOTNhMjRjMWM4NjNlY2E0ZTAzOTllNDgyXzQtNS0xLTEtMjEzMzM5_84a47380-c608-4893-839d-7b2252054e43"
      unitRef="usd">-11453000</us-gaap:ProfitLoss>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ia965648dd525484799c2e977f7acaf53_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzItMS0xLTEtMjEzMzM5_901d4417-c2ba-4852-9adb-2c3770fef7ba"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="i00ed681f413e454dbec8d917d6a28b38_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzItMy0xLTEtMjEzMzM5_2abca393-71aa-46b4-be97-50976d31298e"
      unitRef="usd">62368000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i00ed681f413e454dbec8d917d6a28b38_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzItNS0xLTEtMjEzMzM5_6af8c175-f801-4110-bba0-20e56108c3d1"
      unitRef="usd">19866000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <cron:OtherNetAssetsLiabilities
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzQtMy0xLTEtMjEzMzM5_9f5c9a92-a4d3-43eb-8b53-fc925ca1f26d"
      unitRef="usd">62368000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YTdjN2M5ODJlZjA0NWY0YTY4YmM0YzYzMTQxNjc5Zi90YWJsZXJhbmdlOjVhN2M3Yzk4MmVmMDQ1ZjRhNjhiYzRjNjMxNDE2NzlmXzQtNS0xLTEtMjEzMzM5_21a83e21-40bf-4a42-9321-696ac8976bdf"
      unitRef="usd">19866000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie35ca828c220404d8779f0c05373f981_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzItMS0xLTEtMjEzMzM5_c2dc0588-8bba-48c9-bac5-31bac3c47964"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="ie1b6b387f3bd48568496384bda710bc0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzItMy0xLTEtMjEzMzM5_eea35774-4cd1-4c23-a1bb-9bd6b4756d53"
      unitRef="usd">33674000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ie1b6b387f3bd48568496384bda710bc0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzItNS0xLTEtMjEzMzM5_3ef4327e-73c3-49eb-b7ba-1842cab4a641"
      unitRef="usd">21125000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i6226d0a1598b4591a5b51ab3e76703b5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzQtMS0xLTEtMjEzMzM5_6fc8111c-4a2c-4d60-ae95-f91dc21d1c2c"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="i01e84979c2174a3e959ae14445c4c0b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzQtMy0xLTEtMjEzMzM5_ec5d04dc-acb8-4be6-a7dc-61eeded53d5f"
      unitRef="usd">2712000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i01e84979c2174a3e959ae14445c4c0b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzQtNS0xLTEtMjEzMzM5_cb639c20-3aeb-4774-ae51-6f617478b149"
      unitRef="usd">7826000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <cron:OtherNetAssetsLiabilities
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzUtMy0xLTEtMjEzMzM5_093bd95d-3fb6-468f-9d34-2dc1bc6325b4"
      unitRef="usd">36386000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo4OGNlZWI1MDM1Yzg0NjYwYWVjZmQ0YTgwYWNlMmE5My90YWJsZXJhbmdlOjg4Y2VlYjUwMzVjODQ2NjBhZWNmZDRhODBhY2UyYTkzXzUtNS0xLTEtMjEzMzM5_0fe43a1c-658e-4106-9be0-4f027e0a3c67"
      unitRef="usd">28951000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i7a6151bf97b4479db1915de9cf54196a_D20210614-20210614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzkyODE_42a317ac-a2b4-4971-9901-0d1bb9352571"
      unitRef="shares">473787</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ica770eae2c9246a2afe81a80ce6bc6ec_I20210614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzk0Mzg_dfdf1135-fac5-4758-8555-40b37f34b9d1"
      unitRef="usdPerShare">0.0001</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzk0Nzk_f1a78c01-315c-4b83-88f9-524b6fffe193"
      unitRef="number">0.105</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzk2NTA_d13d4645-0021-45f0-8787-47c4967deb44"
      unitRef="usd">110392000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i55bbd96bb4154fef93d9f031c4651fa9_I20220228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE4NjkxNjk3NzEzNjY2_27bc860b-ec00-4cf7-b339-cc25aae9ea7a"
      unitRef="number">0.064</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i3306701595a04451b85d16301150c1ee_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE4NjkxNjk3NzEzNjcy_8954e235-22c4-42e3-b68c-ac86ffc24f2d"
      unitRef="number">0.063</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <cron:MergerAgreementThresholdOwnershipPercentage
      contextRef="i9d42dad636504862a15f3a4f67554aec_I20211012"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTQy_5e3a5ece-219a-4fdf-bd24-764e278adfbc"
      unitRef="number">0.06</cron:MergerAgreementThresholdOwnershipPercentage>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib2c9908a800e47b080fb9fb2cfd88973_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MDc5_5a78283a-13cd-4e6c-ae9f-7e723f72a9b7"
      unitRef="usd">11238000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i5e5776901e474b3abdf90733e7a30e62_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MDg4_5a25fae4-06e2-4a82-baee-63da1fde46f2"
      unitRef="usd">28972000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i53f60b165c164f1b89ebd97857c42986_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MDk3_52176de4-6cf2-4980-a709-080ad3c0b4e3"
      unitRef="usd">21182000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:UnsecuredDebt
      contextRef="ic075132149c24b6f980b4c2955ff29bb_I20210914"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyMDA5_50fd925b-bbe9-4386-a249-c6023689d44b"
      unitRef="aud">1500000</us-gaap:UnsecuredDebt>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3e0794b671294cf4a1a592fd95ab0288_I20211216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyMjUx_eedcc13e-5f4e-460c-bc9f-d56d0ad1205b"
      unitRef="number">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:NumberOfSeatsOnBoardOfDirectors
      contextRef="if46b21ab0b3b47ce84759033415e34a3_I20211215"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyMzI4_e446ba84-6aff-42a3-89e2-64f805ef3f94"
      unitRef="seat">2</cron:NumberOfSeatsOnBoardOfDirectors>
    <cron:NumberOfSeatsOnBoardOfDirectors
      contextRef="i3e0794b671294cf4a1a592fd95ab0288_I20211216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyMzM0_7a7f13ea-8d18-451b-89fe-6693e4f25e07"
      unitRef="seat">0</cron:NumberOfSeatsOnBoardOfDirectors>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NTg5ODE_b653df29-6d9b-47c2-a2f5-99fd773c5a88"
      unitRef="usd">14739000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i72bd56a3b81845f49fe8b58426c1d15c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEyODg4_302b3dcf-dd9f-436c-ba8e-0a413406155f"
      unitRef="usd">8287000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:OtherLongTermInvestments
      contextRef="ib48a5f922dc74080be8b4e6b57c7a04d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NTg5NTI_3d7ee372-f113-428e-9698-43ab5a4b3943"
      unitRef="usd">21993000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i3a0de233b3214d3bb109cdfb9f70e304_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzEwOTk1MTE2NTg5NDY_c6712cff-5741-41b3-9627-3463fee410e7"
      unitRef="usd">8000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherInvestments
      contextRef="i66ffd69d80d04eb29f72245ee158a8f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtMS0xLTEtMjI1ODg3_29fc8700-9d5f-49c6-9c93-c8dd34501db3"
      unitRef="usd">110392000</us-gaap:OtherInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i4aeb1d824d3f4e9984e927ae64cea18a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtMy0xLTEtMjI1ODg3_92dc31b3-3bf7-4f4d-ab10-cf9fa5b68cf8"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i4aeb1d824d3f4e9984e927ae64cea18a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtNS0xLTEtMjI1ODg3_e2946411-fcf1-439e-8b67-996ca3935dbf"
      unitRef="usd">61392000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i4aeb1d824d3f4e9984e927ae64cea18a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtNy0xLTEtMjI1ODg3_f9f26217-e16f-48e1-832c-df8ea434518e"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:OtherInvestments
      contextRef="ic2ab3c32bb7547b48229e1aa72f2da89_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzEtOS0xLTEtMjQ2NTky_a7858e64-2fd6-4c6e-b11d-6b163446e01a"
      unitRef="usd">49000000</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="i3a0de233b3214d3bb109cdfb9f70e304_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItMS0xLTEtMjI1ODg3_be34a15d-1502-49a6-aec5-0f5cae8176b7"
      unitRef="usd">8000000</us-gaap:OtherInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItMy0xLTEtMjI1ODg3_2debe7a0-925f-480a-b535-c2b224e8e1fa"
      unitRef="usd">14739000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItNS0xLTEtMjI1ODg3_6c9b0833-6c54-4c08-a518-4737a9f9658f"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i06ae3a4d40fd4d2ca164b6d1c2b89645_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItNy0xLTEtMjI1ODg3_bdc68fb4-98c6-48ef-961f-ba161a1d5f58"
      unitRef="usd">-746000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:OtherInvestments
      contextRef="ib48a5f922dc74080be8b4e6b57c7a04d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzItOS0xLTEtMjQ2NTky_abe6c6c5-7912-4062-9bd7-35c400474516"
      unitRef="usd">21993000</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtMS0xLTEtMjQ2NTk4_a6094cca-0efb-4dde-b45b-4f0aecc99ec0"
      unitRef="usd">118392000</us-gaap:OtherInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtMy0xLTEtMjQ2NjAy_606d5d2f-e0fd-409c-8b42-1c0144f098e8"
      unitRef="usd">14739000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtNS0xLTEtMjI1ODg3_c7189973-034d-41a4-a6a6-3f6e613e2bc3"
      unitRef="usd">61392000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtNy0xLTEtMjQ2NjEy_90883840-23f4-4e21-b8ea-0575953193d1"
      unitRef="usd">-746000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:OtherInvestments
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZTo1YWJhZDIxYjZkODY0YzlmODlmNzZiZDZmZTEyOTU0OC90YWJsZXJhbmdlOjVhYmFkMjFiNmQ4NjRjOWY4OWY3NmJkNmZlMTI5NTQ4XzMtOS0xLTEtMjQ2NTky_32bec878-99b9-440a-bdfa-aee377d4620c"
      unitRef="usd">70993000</us-gaap:OtherInvestments>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NzQ0_a29f606c-841e-4dd2-b91b-04096a050ee0">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s gain from disposals of investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aurora&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;During the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received 980,662 common shares of Aurora Cannabis Inc. (&#x201c;Aurora&#x201d;). The Company sold all 980,662 of the Aurora common shares during the year ended December 31, 2020, for gross proceeds of approximately $4,789, resulting in a $4,789 gain on disposal of investments being recorded on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="icf3a51f82e6c455ea2fbee1766559fd5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZToxZmM3NmQyMWJlYjU0ZGMyODgxYjI2ZjI5Mjc4NmY1ZC90YWJsZXJhbmdlOjFmYzc2ZDIxYmViNTRkYzI4ODFiMjZmMjkyNzg2ZjVkXzUtMS0xLTEtMjEzMzM5_9560c9a0-7a30-4289-a49f-8b13eaeae406"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="id93c9943632c46e680e9a9c7d3dca0db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZToxZmM3NmQyMWJlYjU0ZGMyODgxYjI2ZjI5Mjc4NmY1ZC90YWJsZXJhbmdlOjFmYzc2ZDIxYmViNTRkYzI4ODFiMjZmMjkyNzg2ZjVkXzUtMy0xLTEtMjEzMzM5_1f88f089-6595-4043-8a5f-d12c257fb84e"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ibdc8fdc92d5e4970acec520cba2b995b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90YWJsZToxZmM3NmQyMWJlYjU0ZGMyODgxYjI2ZjI5Mjc4NmY1ZC90YWJsZXJhbmdlOjFmYzc2ZDIxYmViNTRkYzI4ODFiMjZmMjkyNzg2ZjVkXzUtNS0xLTEtMjEzMzM5_00d6529e-c1c2-4c5b-a19e-dd230f6ee00c"
      unitRef="usd">4789000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <cron:InvestmentOwnedNumberOfSharesReceived
      contextRef="i444e948e17884088a02f8873d27fb530_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MTE2_d70d8ae7-1bcf-4d28-95a1-013b2ce20671"
      unitRef="shares">980662</cron:InvestmentOwnedNumberOfSharesReceived>
    <cron:InvestmentOwnedNumberOfSharesSold
      contextRef="i444e948e17884088a02f8873d27fb530_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE2NDkyNjc0NDY3MTI1_6710cb1a-4265-4f8c-bc93-50b6e1fdf58c"
      unitRef="shares">980662</cron:InvestmentOwnedNumberOfSharesSold>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="id93c9943632c46e680e9a9c7d3dca0db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NTQ4_d8e557e1-c03a-44dc-8209-c6f5ec1e4e93"
      unitRef="usd">4789000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="id93c9943632c46e680e9a9c7d3dca0db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDAvZnJhZzo0YTBkZWU4ZmY5YzM0NzMyYjNiYzQyYTZlZmRjZDI4Yi90ZXh0cmVnaW9uOjRhMGRlZThmZjljMzQ3MzJiM2JjNDJhNmVmZGNkMjhiXzE0NTY3_85853a48-9d8c-4f07-b8c8-9b598310d787"
      unitRef="usd">4789000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM1OTI_ca1cd35c-7be0-4a84-ae9d-e7f4612ee7d0">Loans Receivable, net &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans receivable, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Long-term portion of accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cronos GrowCo Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 23, 2019, the Company, as lender, and Cronos GrowCo, as borrower, entered into a senior secured credit agreement for an aggregate principal amount of C$100,000 (the &#x201c;GrowCo Credit Facility&#x201d;). In August 2021, the GrowCo Credit Facility was amended to increase the aggregate principal amount available to C$105,000. As a result of the increase in the aggregate principal amount of the GrowCo Credit Facility and lower than expected sales forecasts from Cronos GrowCo, the Company revalued its allowance for credit loss on the GrowCo Credit Facility resulting in an increase in the allowance of $12,748, which was recorded in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021. In conjunction with the aforementioned revaluation, the Company changed its expected credit loss valuation methodology from the historical credit loss method to the probability of default method. As of December&#160;31, 2022 and 2021, Cronos GrowCo had drawn C$104,000 ($76,730) and C$104,000 ($81,598), respectively, from the GrowCo Credit Facility. As of December 31, 2022, Cronos GrowCo had repaid C$4,000 ($3,073) in principal under the terms of the GrowCo Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 28, 2019, the Company entered into a promissory note receivable agreement (the &#x201c;Mucci Promissory Note&#x201d;) for C$16,350 (approximately $12,063) with Mucci. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci. On September 30, 2022, the Mucci Promissory Note was amended and restated to increase the interest rate from 3.95% to the Canadian Prime Rate plus 1.25%, change the interest payments from quarterly to annual, and defer Mucci&#x2019;s initial cash interest payment from September 30, 2022 to July 1, 2023. This debt modification resulted in an increase of approximately C$180 ($140) in interest income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cannasoul Collaboration Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of both December&#160;31, 2022 and 2021, CLS has received ILS 8,297 (approximately $2,359 and $2,664, respectively), from the Cannasoul Collaboration Loan. See Note 3 &#x201c;Investments&#x201d; for further information regarding the Cannasoul Collaboration Loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; credit loss allowances on the Company&#x2019;s long-term financial assets were comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Increase (decrease)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Increase (decrease)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera Series A Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;During the year ended December 31, 2021, $737 of expected credit losses on long-term financial assets was transferred to investments in equity method investments in relation to the Natuera Debt Conversion, as the carrying amount of the loan receivable, net, approximated fair value as of the date of transfer. During the years ended December 31, 2022 and 2021, $(662) and $12,939, respectively, were recorded to general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss) as a result of adjustments to our expected credit losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM1OTQ_6ddc82d2-d0f5-457e-b224-4d6744985ced">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans receivable, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Long-term portion of accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="if4061198d00b42a1b1c3273bd1300f1f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzMtMS0xLTEtMjEzMzM5_e25c32a8-6f40-47a5-b765-1fa9b16d12b1"
      unitRef="usd">4427000</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="iebf97cb5d7b14fcaba22a604151aa02c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzMtMy0xLTEtMjEzMzM5_4d0235d7-de59-432d-8ce7-d056372235c8"
      unitRef="usd">3138000</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableAccruedInterestCurrent
      contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzQtMS0xLTEtMjEzMzM5_c629cfa0-5ee8-47ba-b6ba-f41532eb59b4"
      unitRef="usd">4463000</cron:FinancingReceivableAccruedInterestCurrent>
    <cron:FinancingReceivableAccruedInterestCurrent
      contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzQtMy0xLTEtMjEzMzM5_fdb677c2-5813-42de-8448-f753d0faae69"
      unitRef="usd">2322000</cron:FinancingReceivableAccruedInterestCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzUtMS0xLTEtMjEzMzM5_b5127591-a947-48c9-98aa-3cba4222a93a"
      unitRef="usd">8890000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzUtMy0xLTEtMjEzMzM5_c32f3a9d-a72a-4471-b33d-6af3612141d7"
      unitRef="usd">5460000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="if4061198d00b42a1b1c3273bd1300f1f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzYtMS0xLTEtMjEzMzM5_b46c9247-d615-4932-96d2-dd580d46521e"
      unitRef="usd">56898000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="iebf97cb5d7b14fcaba22a604151aa02c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzYtMy0xLTEtMjEzMzM5_ced61089-04fd-4bd7-aec6-066e4e7d8863"
      unitRef="usd">64367000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i9f1e7c50392b48839d2e08df306850ff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzctMS0xLTEtMjEzMzM5_f5fe2da1-1804-43ca-b1cc-ac4971c0a7eb"
      unitRef="usd">13438000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i031e61530a214b9881c8d518d3c7a377_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzctMy0xLTEtMjEzMzM5_9fc9790a-1cc7-449a-ad60-deef4cf4dbe9"
      unitRef="usd">14019000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i5a8c1e543ab94dc7ae66690ab16e3743_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzgtMS0xLTEtMjEzMzM5_d3bcde7a-3f1a-4bd8-94c6-3676195e62d5"
      unitRef="usd">1837000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="icecc95374e7c42d79e927354f15a2d05_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzgtMy0xLTEtMjEzMzM5_f283fd59-6a1c-4303-8250-20464fdd24b6"
      unitRef="usd">2249000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableAccruedInterestNoncurrent
      contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzktMS0xLTEtMjEzMzM5_4e76b49f-5346-4b53-841e-3e38a28d1efc"
      unitRef="usd">172000</cron:FinancingReceivableAccruedInterestNoncurrent>
    <cron:FinancingReceivableAccruedInterestNoncurrent
      contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzktMy0xLTEtMjEzMzM5_0cb971bd-b493-4f96-a5d7-a7833d6e6009"
      unitRef="usd">0</cron:FinancingReceivableAccruedInterestNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzEwLTEtMS0xLTIxMzMzOQ_8c47f6b3-285f-4464-98ae-7766a339b589"
      unitRef="usd">72345000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzEwLTMtMS0xLTIxMzMzOQ_8a927322-066a-4489-b8e2-c315368c4206"
      unitRef="usd">80635000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesReceivableNet
      contextRef="i93ff25f41bfc48f685fe7999f7acb267_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzExLTEtMS0xLTIxMzMzOQ_30c7b8c0-3c5a-4e19-9690-b1db591a3498"
      unitRef="usd">81235000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="i7ecb9cbf167f4693998cbee4a5ae9a99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo3YzNjNGYzNDg5NWI0Y2E4YmU5MDM0NTU1ZGFlMTgwNy90YWJsZXJhbmdlOjdjM2M0ZjM0ODk1YjRjYThiZTkwMzQ1NTVkYWUxODA3XzExLTMtMS0xLTIxMzMzOQ_f3fe02f0-589b-48ef-a02d-fd7eb52cf065"
      unitRef="usd">86095000</us-gaap:NotesReceivableNet>
    <cron:FinancingReceivableFaceAmount
      contextRef="i9cd678b9cba6400b91b864e4539c08f3_I20190823"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzkwMA_d4dfa4fe-95a8-4853-b697-aa152328f673"
      unitRef="cad">100000000</cron:FinancingReceivableFaceAmount>
    <cron:FinancingReceivableFaceAmount
      contextRef="ia9a0f515dda54606a8ec5e2a496990a6_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM4NDgyOTA3MDIxMTc_a0d1bf57-399f-4fc6-9912-3b8677f09bd7"
      unitRef="cad">105000000</cron:FinancingReceivableFaceAmount>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE2NDkyNjc0NDY3OTg_a5792090-b223-4fb7-b051-4d66ba3577e6"
      unitRef="usd">12748000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzEwOTk1MTE2MzMxMzI_2cc21666-6a0b-4f3c-971d-a3d88aea25af"
      unitRef="cad">104000000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzEwOTk1MTE2MzMxNjg_4b8a1442-c15a-401f-9d08-59ac4fb1b96d"
      unitRef="usd">76730000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE3NDY_fe7a4c25-6295-4933-aca0-6167843afdf5"
      unitRef="cad">104000000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE3NTA_469bcf6f-96b8-4d59-b52c-dd3372e88a1a"
      unitRef="usd">81598000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE0ODQzNDA2OTgxMzQ2_9d5a9040-b50d-406f-82b4-4c55630cb132"
      unitRef="cad">4000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzEwOTk1MTE2Mzc3NTg_7c5711d3-6dae-4bfc-9e9f-637bb2f38b00"
      unitRef="usd">3073000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <cron:FinancingReceivableFaceAmount
      contextRef="icd137ffe84044ae29b17a0f26fcfbcc6_I20190628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE5MTI_1841cbe9-b44a-44e8-982e-6749165e17e4"
      unitRef="cad">16350000</cron:FinancingReceivableFaceAmount>
    <cron:FinancingReceivableFaceAmount
      contextRef="icd137ffe84044ae29b17a0f26fcfbcc6_I20190628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzEwOTk1MTE2Mzc4NTU_c2934199-065e-4d95-9a3d-25618ab8211f"
      unitRef="usd">12063000</cron:FinancingReceivableFaceAmount>
    <cron:FinancingReceivableInterestRateStatedPercentage
      contextRef="icd137ffe84044ae29b17a0f26fcfbcc6_I20190628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE4NjkxNjk3Njc3NjQ3_4e5beb09-cd53-4947-9c23-f0e841fef954"
      unitRef="number">0.0395</cron:FinancingReceivableInterestRateStatedPercentage>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRate
      contextRef="i4a758fc2d72741ca8bd4fd42269ec1a4_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE4NjkxNjk3Njc3NjU0_ff1144a1-f708-4a77-9710-a4eb5db3876f"
      unitRef="number">0.0125</us-gaap:LoansReceivableBasisSpreadOnVariableRate>
    <cron:FinancingReceivableInterestIncomeIncreaseFromDebtModification
      contextRef="i83da444fa44248408487072ea1d3c39e_D20220930-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE4NjkxNjk3Njc3NjYx_1e7d997e-2b3a-42e0-bf77-7ee613117dc6"
      unitRef="cad">180000</cron:FinancingReceivableInterestIncomeIncreaseFromDebtModification>
    <cron:FinancingReceivableInterestIncomeIncreaseFromDebtModification
      contextRef="i83da444fa44248408487072ea1d3c39e_D20220930-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE4NjkxNjk3Njc3NjY4_4956b84c-6c64-4052-b78a-c22c536f3809"
      unitRef="usd">140000</cron:FinancingReceivableInterestIncomeIncreaseFromDebtModification>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzI3OTc_62c7b1f8-3610-4e18-a9a6-01c5f3c5ed50"
      unitRef="ils">8297000</cron:CollaborativeArrangementInstallmentsReceived>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="if626a2f16cf6417e88022ae91d96abbc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzI3OTc_918349eb-df49-4574-ad48-6a42613eaa5e"
      unitRef="ils">8297000</cron:CollaborativeArrangementInstallmentsReceived>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="i1f00d6ff67484222ae48b7e588d07c45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzE0ODQzNDA2OTgxMzY1_1ed24ced-7888-4f63-aef7-be8802d56114"
      unitRef="usd">2359000</cron:CollaborativeArrangementInstallmentsReceived>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="if626a2f16cf6417e88022ae91d96abbc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzI4Mzc_b9571853-e6b0-4fe3-9a2b-98596892c0f7"
      unitRef="usd">2664000</cron:CollaborativeArrangementInstallmentsReceived>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM1OTE_50057435-a640-44b0-b3c3-379d70e9094c">&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; credit loss allowances on the Company&#x2019;s long-term financial assets were comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Increase (decrease)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Increase (decrease)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera Series A Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;During the year ended December 31, 2021, $737 of expected credit losses on long-term financial assets was transferred to investments in equity method investments in relation to the Natuera Debt Conversion, as the carrying amount of the loan receivable, net, approximated fair value as of the date of transfer. During the years ended December 31, 2022 and 2021, $(662) and $12,939, respectively, were recorded to general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss) as a result of adjustments to our expected credit losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="iebf97cb5d7b14fcaba22a604151aa02c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzEtMS0xLTEtMjEzMzM5_06850e43-07b3-483d-aeb8-3bd85ac43082"
      unitRef="usd">14089000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzEtMy0xLTEtMjEzMzM5_3771e41b-068b-4a09-89e1-80399fb27a68"
      unitRef="usd">-827000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="i310daf76cb31448db1eb956f40893392_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzEtNS0xLTEtMjEzMzM5_0f3ea522-dab3-4df6-b041-00ee26bf9a35"
      unitRef="usd">-807000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="if4061198d00b42a1b1c3273bd1300f1f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzEtNy0xLTEtMjEzMzM5_395102d1-a22b-4e21-999e-f30cedcffa36"
      unitRef="usd">12455000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i031e61530a214b9881c8d518d3c7a377_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzMtMS0xLTEtMjEzMzM5_a3b141bb-383b-489d-96aa-5b07da0c8c9e"
      unitRef="usd">90000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i30edf6082b0d4470941e510e7d37ba68_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzMtMy0xLTEtMjEzMzM5_b855a41d-8d19-4c99-a141-0ad4f8b4c150"
      unitRef="usd">4000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="i30edf6082b0d4470941e510e7d37ba68_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzMtNS0xLTEtMjEzMzM5_2a95f1e7-fc14-4674-a6ee-990adfc93883"
      unitRef="usd">-5000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i9f1e7c50392b48839d2e08df306850ff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzMtNy0xLTEtMjEzMzM5_b1a9fd4b-cf96-45d2-aa40-7c75f75a5029"
      unitRef="usd">89000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="icecc95374e7c42d79e927354f15a2d05_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzQtMS0xLTEtMjEzMzM5_015c5455-3661-46bb-afe1-45ce8fba3560"
      unitRef="usd">415000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i7200b06da62a43118c5cc7777451847f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzQtMy0xLTEtMjEzMzM5_8dc70a9d-7c4b-4c7b-8c82-174a5a7031e8"
      unitRef="usd">161000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="i7200b06da62a43118c5cc7777451847f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzQtNS0xLTEtMjEzMzM5_d418174b-2376-4840-b26d-8e5a7cb757a8"
      unitRef="usd">-54000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i5a8c1e543ab94dc7ae66690ab16e3743_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzQtNy0xLTEtMjEzMzM5_427886b7-e866-488c-a544-5d60297294d5"
      unitRef="usd">522000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzUtMS0xLTEtMjEzMzM5_832846f5-fd50-4cee-8197-3a6048031bf7"
      unitRef="usd">14594000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzUtMy0xLTEtMjEzMzM5_c9f77668-ce70-4546-9a72-d16c9ab7fc36"
      unitRef="usd">-662000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzUtNS0xLTEtMjEzMzM5_a9782f1d-df02-4161-a6d9-69218a3af41f"
      unitRef="usd">-866000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTpiZTczNDU1NzY1MTQ0ODZmYjc5NDZkNjk5NzhmMmI1Ny90YWJsZXJhbmdlOmJlNzM0NTU3NjUxNDQ4NmZiNzk0NmQ2OTk3OGYyYjU3XzUtNy0xLTEtMjEzMzM5_63b71c67-eac5-40cd-9245-33b2ae3b07e7"
      unitRef="usd">13066000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="if369a901d9af4bfd8ae3d2a027cee610_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzEtMS0xLTEtMjEzMzM5_c4bdc385-7b35-4b3e-9bc1-75b63a553f11"
      unitRef="usd">1546000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzEtMy0xLTEtMjEzMzM5_a5792090-b223-4fb7-b051-4d66ba3577e6"
      unitRef="usd">12748000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="i489d7bfbfa334a1db1fc8adee39ffda7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzEtNS0xLTEtMjEzMzM5_fe0fff15-29f1-494b-82d0-9faba588bd4c"
      unitRef="usd">-205000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="iebf97cb5d7b14fcaba22a604151aa02c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzEtNy0xLTEtMjEzMzM5_bd7073af-18a2-4519-99ee-0b873114da44"
      unitRef="usd">14089000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i3f45e6669daa4361a3421b8a2d98c0b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzItMS0xLTEtMjEzMzM5_e3216ed5-f69f-413c-b25b-1e91032f5358"
      unitRef="usd">721000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i4c64e7d2537944ffaf7e5b5f16883925_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzItMy0xLTEtMjEzMzM5_52e1d37d-cb3e-429c-b04a-5be131728eb3"
      unitRef="usd">-737000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="i4c64e7d2537944ffaf7e5b5f16883925_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzItNS0xLTEtMjEzMzM5_ce4aeafb-41bb-4442-860b-63107a8721f7"
      unitRef="usd">16000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i437da1842e044616977893cd552a72ee_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzItNy0xLTEtMjEzMzM5_ba277918-b04e-44f3-8a63-8d279c14b60c"
      unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i3320ad951dab401c84e0f90c4a96974c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzMtMS0xLTEtMjEzMzM5_01a1c706-9ba9-4776-b25c-e6d9f824706f"
      unitRef="usd">270000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i533957fd53ef49379dec9dedd211cf52_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzMtMy0xLTEtMjEzMzM5_f1217397-3bbc-468a-a8d6-a3aae2e6ea3f"
      unitRef="usd">-183000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="i533957fd53ef49379dec9dedd211cf52_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzMtNS0xLTEtMjEzMzM5_cde3d9e7-24d9-4785-93f0-37d971e5de25"
      unitRef="usd">3000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i031e61530a214b9881c8d518d3c7a377_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzMtNy0xLTEtMjEzMzM5_8e780952-5789-44f1-bd7a-24cd147c7943"
      unitRef="usd">90000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i2d18d46bab5242e3bfd554e73da9ea90_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzQtMS0xLTEtMjEzMzM5_ad422868-f43c-47f9-bf6a-9f2c9099b509"
      unitRef="usd">26000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i325878c284c54d7983006f5f7cca0186_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzQtMy0xLTEtMjEzMzM5_ae366358-cb33-444d-921b-7f910caa1ad2"
      unitRef="usd">374000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="i325878c284c54d7983006f5f7cca0186_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzQtNS0xLTEtMjEzMzM5_9ca42227-5577-43e2-b63c-f1f2ccfd9dd4"
      unitRef="usd">15000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="icecc95374e7c42d79e927354f15a2d05_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzQtNy0xLTEtMjEzMzM5_978204bb-6ba3-4b6b-aafd-1bb3628f970b"
      unitRef="usd">415000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzUtMS0xLTEtMjEzMzM5_44331a32-e48f-4577-bf4a-8bdc567f82a7"
      unitRef="usd">2563000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzUtMy0xLTEtMjEzMzM5_3c0e3557-b424-4a15-b3f9-2c98fead2c50"
      unitRef="usd">12202000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzUtNS0xLTEtMjEzMzM5_90f50259-a064-47b8-b1bb-8eef5f0d3b98"
      unitRef="usd">-171000</us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90YWJsZTo0MjA1OTMxOTQ2MmM0OWFhYjFjYjlkMDFiMTdlYzQ4Ni90YWJsZXJhbmdlOjQyMDU5MzE5NDYyYzQ5YWFiMWNiOWQwMWIxN2VjNDg2XzUtNy0xLTEtMjEzMzM5_4e695238-3c46-4466-9468-76eda1748a5e"
      unitRef="usd">14594000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i4c64e7d2537944ffaf7e5b5f16883925_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM4NDgyOTA3MDIxOTY_d99efa81-4636-45e6-b4c5-41472bc2802b"
      unitRef="usd">-737000</us-gaap:ProvisionForLoanLossesExpensed>
    <cron:FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzM4NDgyOTA3MDI0NDM_ffbf0a2e-8bb5-48b5-baa4-821d2a679f61"
      unitRef="usd">-662000</cron:FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment>
    <cron:FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDMvZnJhZzowMGUxZTQyNjZjMmM0MGRjODc0OGRhZTkxNzVjNjk3MS90ZXh0cmVnaW9uOjAwZTFlNDI2NmMyYzQwZGM4NzQ4ZGFlOTE3NWM2OTcxXzc2OTY1ODEzOTk0MzA_4dacc7aa-6791-4e8f-ba43-50bcf171ade9"
      unitRef="usd">12939000</cron:FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzMyNjQ_b84bd537-f5fe-437e-ba6e-217afee75dbb">Property, plant and equipment, net&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(109,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(114,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2022, 2021 and 2020, depreciation expense on property, plant and equipment was $8,667, $11,668 and $9,052, respectively, and was included in cost of sales as well as depreciation and amortization in operating expenses on the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company recognized an impairment charge of $1,507 related to leasehold improvements and other office equipment that it plans to include in any potential sublease agreement of the Company&#x2019;s corporate headquarters, encompassing approximately 29,000 square feet, in Toronto, Ontario, Canada. The determination to seek a sublease of the property and include leasehold improvements and other office equipment in any potential sublease agreement triggered the impairment charges. The impairment charge was recognized as impairment loss on long-lived assets on the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company concluded that indicators of impairment were present with respect to its Canadian asset group in connection with the previously anticipated wind-down and closure of the Company&#x2019;s facility in Stayner, Ontario. As a result, the Company compared the sum of the undiscounted future cash flows attributable to the Canadian asset group to their respective carrying amounts and recorded a non-cash impairment charge on long-lived assets of $113,917 as the difference between the carrying amount of the asset group and its estimated fair value for the year ended December 31, 2021, in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, in connection with the Company&#x2019;s reassessment of indicators of impairment relating to the U.S. segment&#x2019;s property, plant and equipment asset group for the quarter ended June 30, 2021, the Company concluded that triggers were present that indicated that the carrying amounts of those assets were not recoverable. Accordingly, the Company compared the sum of the undiscounted future cash flows attributable to the U.S. asset group (the lowest level for which identifiable cash flows are available) to their respective carrying amount and recorded a non-cash impairment charge on long-lived assets of $1,214 for the difference between the carrying amount of the asset group and its estimated fair values in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, the Company recognized an impairment charge of $1,039 related to leasehold improvements located within leased premises, encompassing approximately 6,000 square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leasehold improvements are being used and the expectation that, more likely than not, the leasehold improvements will be disposed of before the end of their useful life triggered an impairment. The impairment charges were recognized in the consolidated statements of net income (loss) and comprehensive income (loss) as an impairment loss on long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no impairment charges on property, plant and equipment during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5b69cfe90a884fb39eba1ca111fc6b2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzMtMi0xLTEtMjQyMzc3_759a6084-da55-4d10-b114-5ca8671a1b95"
      unitRef="usd">2556000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i05bc2d13ff4b4b3db4cbd143a6dd2d63_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzMtNC0xLTEtMjQxMzgw_de053f50-7a0d-43af-b4ad-9b4b6d78e41f"
      unitRef="usd">2822000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7bfb0d988c89434bae9a37fc057aca1e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzQtMi0xLTEtMjQyMzc3_fae56d33-4f95-4957-87f5-6c5e1e4d83b8"
      unitRef="usd">177095000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4c9593341e604e159c7bc62652cda7b0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzQtNC0xLTEtMjQyMzc3_07c3407e-78c8-4195-adb5-1a8628339091"
      unitRef="usd">188522000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i47c61698f6b548408440dcb1fe8bc8ac_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzUtMi0xLTEtMjQyMzc3_80864561-6eb6-44a7-bff7-750637569d62"
      unitRef="usd">19130000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if869afc8633e4ac0b98107ef318157c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzUtNC0xLTEtMjQyMzc3_653319ef-d0f7-44b9-b15d-af723a21b60c"
      unitRef="usd">18894000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic368bd11f0df40d4a8c0b2947fe070bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzYtMi0xLTEtMjQyMzc3_71a63bc7-eb7d-4e28-8cdc-25ab29dfb9e7"
      unitRef="usd">5345000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie265b91a4e9a4c02afb8d5eb309f1fcd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzYtNC0xLTEtMjQyMzc3_343f7404-845f-408a-8ac2-94326deab077"
      unitRef="usd">5937000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8c687afbf2874359b7b1e96d6171e47b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzctMi0xLTEtMjQyMzc3_512c97cb-f923-411a-b6ec-228b2839eff2"
      unitRef="usd">841000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3a1eeef365d9410ba49be0ad28e8a610_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzctNC0xLTEtMjQyMzc3_b62aba89-2ad6-48cc-aa80-9fac2db4964e"
      unitRef="usd">2502000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzgtMi0xLTEtMjQyMzc3_0b5b8518-0207-41bd-911e-0ca367f6e11b"
      unitRef="usd">35347000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzgtNC0xLTEtMjQyMzc3_5fa09aae-0df2-4dbd-b7a5-f9c859be2c73"
      unitRef="usd">30306000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <cron:AccumulatedImpairmentOfPropertyPlantAndEquipment
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzktMi0xLTEtMjQyMzc3_ac7886b4-2948-42df-bebf-54a4f63bacab"
      unitRef="usd">109063000</cron:AccumulatedImpairmentOfPropertyPlantAndEquipment>
    <cron:AccumulatedImpairmentOfPropertyPlantAndEquipment
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzktNC0xLTEtMjQyMzc3_8cffc6a4-081d-4027-b8fb-69249df8ee68"
      unitRef="usd">114301000</cron:AccumulatedImpairmentOfPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzEwLTItMS0xLTI0MTQyOQ_16322703-4986-4ded-96cf-fec13f4a0909"
      unitRef="usd">60557000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90YWJsZTpjNTg1ZGY1Y2QyZWM0YWJiOTUyOWRjMjE0YjhlNjc2Mi90YWJsZXJhbmdlOmM1ODVkZjVjZDJlYzRhYmI5NTI5ZGMyMTRiOGU2NzYyXzEwLTQtMS0xLTI0NjY3Mg_f3bedb19-6c81-4bdd-a8a6-e89eba3ad6e8"
      unitRef="usd">74070000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQzNTc_95e6c445-f925-446e-b604-6b339c3c6b8e"
      unitRef="usd">8667000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQzMzg_5b935e65-c613-48b1-b852-b4d8210d36b0"
      unitRef="usd">11668000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQzMjc_5d29517f-7d98-4ee5-8964-e6b9e6f7782c"
      unitRef="usd">9052000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i6ebea50f3dab40fe940962382c9edd7b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQzODQ_f9cf834f-5029-4898-8363-31cf458707ce"
      unitRef="usd">1507000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzg1MTc_0fbc85de-81e9-4555-a8a6-953c729b197f"
      unitRef="sqft">29000</cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i7e73aaf3d4da43618c18f1bb5254e468_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzM4NDgyOTA3MDQ0MDQ_dd5aea7e-f6d2-4abc-af28-d3b609655f95"
      unitRef="usd">113917000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i799ef2d8ae8143d3aabbb83e1a41d9c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzU0OTc1NTgxODc4NA_e4be4268-bc82-454d-b38b-d18791b77cf2"
      unitRef="usd">1214000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ib7c6daed2ada448ca0191eb31284605b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzE0ODA_c403ebdd-005c-4c3d-b1d2-35cfe8fba498"
      unitRef="usd">1039000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf
      contextRef="i2f24fa047ebd4cafa9ce6895143e5be7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzE1NzY_f49b5825-4802-41fe-8a41-f2655699a347"
      unitRef="sqft">6000</cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDYvZnJhZzpkMWZhZDcwMjQ2MmI0YjgzODA5ZjEwNmRhYTJlYWU4ZS90ZXh0cmVnaW9uOmQxZmFkNzAyNDYyYjRiODM4MDlmMTA2ZGFhMmVhZThlXzEwOTk1MTE2MzY3NTg_5e8d6bf6-2f59-43fa-b2e3-e340dedcda59"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzkxMjg_c6f8c04e-3a5e-45d4-a862-2ebcfe1a2deb">Goodwill and Intangible Assets, net&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Peace Naturals&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peace Naturals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated impairment charges on goodwill consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, the Company acquired all of the issued and outstanding shares of each of the four Redwood operating subsidiaries (collectively &#x201c;Redwood&#x201d;) for an aggregate consideration of $283,300 (the &#x201c;Redwood Acquisition&#x201d;), which included $227,191 in cash and 5,086,586 common shares of the Company with a fair value of $56,109. Goodwill attributable to the acquisition was $213,414. The Company is required to perform a quantitative analysis of goodwill to test for impairment on an annual basis or more frequently when events or changes in circumstances indicate that fair value of the reporting unit may be less than its carrying amount. Under ASC 350 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the qualitative assessment requires the consideration of factors such as recent market transactions, macroeconomic conditions, and changes in projected future cash flows or planned revenue or earnings of the reporting unit as indicators of impairment when determining the need for a quantitative assessment of impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company reassessed the existence of impairment indicators on goodwill associated with the U.S. reporting unit, derived from the Redwood Acquisition, and the Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand indefinite-lived intangible asset as of June 30, 2021, and determined that quantitative impairment analyses were required as of June 30, 2021 due to slower actual revenue growth as compared to previous revenue growth forecasts and significant pricing pressures brought about by increased competition and aggressive discounting in the U.S. reporting unit and associated with the Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand indefinite-lived intangible asset. As such, the Company reassessed its estimates and forecasts as of June 30, 2021, to determine the fair values of the reporting unit and intangible asset using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand. Significant inputs include discount rates, growth rates, and cash flow projections, and, for the Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand, royalty rate. These valuation inputs are considered Level 3 inputs as defined by ASC 820 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As a result of the analysis as of June 30, 2021, the Company concluded that the carrying amount of the U.S. reporting unit exceeded its fair value, which resulted in the recognition of an impairment charge of $178,414 on goodwill associated with its U.S. reporting unit on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the second quarter, represented indicators of impairment for the Company&#x2019;s U.S. reporting unit. Accordingly, the Company performed an interim impairment analysis as of June 30, 2020, which revealed the carrying amount of the reporting unit exceeded its fair value. As a result, the Company recorded an impairment charge of $35,000 on goodwill associated with its U.S. reporting unit for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Intangible assets, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net are comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,008)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ginkgo Exclusive Licenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CBGA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company achieved the final productivity target in respect of cannabigerolic acid (&#x201c;CBGA&#x201d;), under the Ginkgo Collaboration Agreement. As a result, on August 21, 2021, the Company issued 1,467,490 common shares at a share price of C$7.90 for total consideration given of C$11,593 ($9,042) to Ginkgo through the Ginkgo Collaboration Agreement for the achievement of commercialization and productivity milestones for CBGA. The estimated fair value of the exclusive license for CBGA (the &#x201c;CBGA Exclusive License&#x201d;) was $7,300 determined using a variation of the income approach called the relief-from-royalty method, which requires an estimate or forecast of the expected future cash flows. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years. The difference between the consideration paid to Ginkgo and the fair value of the exclusive license intangible asset of $1,784 was recognized as an impairment charge on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CBGVA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November, 2021, the Company achieved the final productivity target in respect of cannabigerovarinic acid (&#x201c;CBGVA&#x201d;). As a result, on November 12, 2021, the Company issued 1,467,490 common shares at a share price of C$7.12 for total consideration given of C$10,449 ($8,150) to Ginkgo. The estimated fair value of the exclusive license for CBGVA (the &#x201c;CBGVA Exclusive License&#x201d;) was $5,300 determined using a variation of the income approach called the relief-from-royalty method, which requires an estimate or forecast of the expected future cash flows. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years. The difference between the consideration paid to Ginkgo and the fair value of the exclusive license intangible asset of $3,008 was recognized as an impairment charge on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;THCVA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company achieved the final productivity target in respect of tetrahydrocannabivaric acid (&#x201c;THCVA&#x201d;) under the Ginkgo Collaboration Agreement. As a result, the Company issued 2,201,236 common shares at a share price of C$3.47, and made a cash payment of $600, for total consideration of C$8,412 ($6,522) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CBCA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2022, the Company achieved the early commercialization milestone in respect of cannabichromenic acid (&#x201c;CBCA&#x201d;) under the Ginkgo Collaboration Agreement. As a result, the Company issued 489,163 common shares at a share price of C$4.11 for total consideration of C$2,010 ($1,473) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CBCVA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company achieved the final productivity target in respect of cannabichromevarinic acid (&#x201c;CBCVA&#x201d;) under the Ginkgo Collaboration Agreement. As a result, the Company issued 1,467,490 common shares at a share price of C$3.44 for total consideration of C$5,048 ($3,724) to Ginkgo through the Ginkgo Collaboration Agreement. The definite-lived intangible asset is being amortized using the straight-line method over its estimated useful life of 10 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, the aggregate amortization expense on intangible assets was $2,751, $1,800 and $814, respectively, and was included in depreciation and amortization in operating expenses on the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated future amortization of definite-lived intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated impairment charges on intangible assets, net consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&#xae; brand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, in connection with the previously anticipated wind-down and closure of the Company&#x2019;s facility in Stayner, Ontario, the Company determined that the Peace Naturals Health Canada license associated with ongoing use of the Peace Naturals Campus for cannabis cultivation and production was also impaired. Accordingly, the Company recorded an impairment loss on long-lived assets in its ROW segment of $5,951 in the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As mentioned above, during third and fourth quarter of 2021, the fair value of each of the Company&#x2019;s Ginkgo exclusive licenses for two cannabinoids that achieved productivity milestones in 2021 were deemed to be lower than the consideration paid for each of those licenses. As a result, the Company recorded an aggregate impairment loss of $4,792 on long-lived assets for the year ended December&#160;31, 2021 in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company concluded the carrying amount of the Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand exceeded its fair value, which resulted in impairment charges of $56,500 on its Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand in the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk1MzA0_7f2cac1a-2c68-4900-8eb5-5a1100ca88a2"&gt;consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt; for the year ended December 31, 2021. Additionally, in the fourth quarter of 2021, due to the U.S. segment&#x2019;s sustained operating losses and lack of revenue growth, the Company performed an additional impairment test on Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand intangible asset. As a result, the Company concluded the carrying amount of the Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand exceeded its fair value, which resulted in an additional impairment charge of $1,000 on its Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand for the year ended December 31, 2021 in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter, represented indicators of impairment for the U.S. reporting unit&#x2019;s Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand. Accordingly, the Company performed an interim impairment analysis as of June 30, 2020, which concluded the carrying amount of the brand exceeded its fair value. As a result of the analysis, the Company recorded an impairment loss on indefinite-lived intangible assets of $5,000 on the consolidated statements of net income (loss) and comprehensive income (loss) for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Impairment charges on the Company&#x2019;s Health Canada licenses for the year ended December 31, 2020 are related to the discontinuation of Original B.C. Ltd. (&#x201c;OGBC&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzkxMjk_b49ede13-95f8-4fed-ae65-f684cf5ae9a8">&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Peace Naturals&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peace Naturals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated impairment charges on goodwill consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="i198f84bb8c8c4495a7592d90fa3b5554_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzItMS0xLTEtMjEzMzM5_dc1852d3-b995-44eb-a999-88157075c534"
      unitRef="usd">1033000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i198f84bb8c8c4495a7592d90fa3b5554_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzItMy0xLTEtMjEzMzM5_896951f4-b619-4c97-9d8c-53f8dee1ebcc"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i198f84bb8c8c4495a7592d90fa3b5554_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzItNS0xLTEtMjEzMzM5_5e8c9483-990d-4b79-bad0-0b73a46ee5b8"
      unitRef="usd">1033000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="ib098004c6d90459292103b62760beef6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzMtMS0xLTEtMjEzMzM5_0d4c4493-0a64-4c5a-9abd-09a614d2600b"
      unitRef="usd">213414000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ib098004c6d90459292103b62760beef6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzMtMy0xLTEtMjEzMzM5_c1c4023e-72ae-468b-b52f-ac3ceffd0e77"
      unitRef="usd">213414000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ib098004c6d90459292103b62760beef6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzMtNS0xLTEtMjEzMzM5_8a1edf00-f89b-417a-a3a3-8d1249f0d61f"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzQtMS0xLTEtMjEzMzM5_5dc9a8fb-b87f-4037-9223-fbba42397930"
      unitRef="usd">214447000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzQtMy0xLTEtMjEzMzM5_cd069b73-6c3c-4911-b19b-679a2fdce829"
      unitRef="usd">213414000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxNmMyNDFiOTFkODQ0M2Y4YjMzN2JmYWJkZGFkNWJjNi90YWJsZXJhbmdlOjE2YzI0MWI5MWQ4NDQzZjhiMzM3YmZhYmRkYWQ1YmM2XzQtNS0xLTEtMjEzMzM5_64ac4bcb-b573-4521-a315-1a6a67acb930"
      unitRef="usd">1033000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="ie2be1513878243dbbe968f845f1407aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzMtMS0xLTEtMjEzMzM5_4d73fb9f-fb01-4b88-81d0-53c1f22383ee"
      unitRef="usd">1098000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ie2be1513878243dbbe968f845f1407aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzMtMy0xLTEtMjEzMzM5_8adec6c4-3d8a-42fb-9fc6-4d3018ea591b"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ie2be1513878243dbbe968f845f1407aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzMtNS0xLTEtMjEzMzM5_eeb31f84-0075-4f14-a101-cfe4192a54bd"
      unitRef="usd">1098000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzQtMS0xLTEtMjEzMzM5_548b8e48-578f-4f25-b4da-583137a0fd32"
      unitRef="usd">213414000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzQtMy0xLTEtMjEzMzM5_f8140f42-1204-4821-8f23-048f087e4ba4"
      unitRef="usd">213414000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzQtNS0xLTEtMjEzMzM5_794a6337-ae1e-48fe-981c-131d54800937"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzUtMS0xLTEtMjEzMzM5_0c54358b-472b-4626-aa6c-e34c492b1cc0"
      unitRef="usd">214512000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzUtMy0xLTEtMjEzMzM5_aca6aa68-dc6f-41d6-ba59-ae25b3503612"
      unitRef="usd">213414000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNDZkY2E1ZWFmZmY0MGMzYjQ0ZGNkZjU3ZTYzZjZiNi90YWJsZXJhbmdlOmI0NmRjYTVlYWZmZjQwYzNiNDRkY2RmNTdlNjNmNmI2XzUtNS0xLTEtMjEzMzM5_8e415f5b-c4a5-47fc-b391-d790feaf714b"
      unitRef="usd">1098000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpmZWU4MzUwZGJkMzc0ZDRiOTlmYmY2NTE4NGU4MTdkZC90YWJsZXJhbmdlOmZlZTgzNTBkYmQzNzRkNGI5OWZiZjY1MTg0ZTgxN2RkXzMtMS0xLTEtMjEzMzM5_47eb04a4-e514-4f09-bd77-2197c7eeb15a"
      unitRef="usd">213414000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0d5db05218e34129ac787a7d7f694b92_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpmZWU4MzUwZGJkMzc0ZDRiOTlmYmY2NTE4NGU4MTdkZC90YWJsZXJhbmdlOmZlZTgzNTBkYmQzNzRkNGI5OWZiZjY1MTg0ZTgxN2RkXzMtMy0xLTEtMjEzMzM5_0b989870-03c2-4d1d-b7b3-c7e275fca4e3"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <cron:GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments
      contextRef="i0d5db05218e34129ac787a7d7f694b92_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpmZWU4MzUwZGJkMzc0ZDRiOTlmYmY2NTE4NGU4MTdkZC90YWJsZXJhbmdlOmZlZTgzNTBkYmQzNzRkNGI5OWZiZjY1MTg0ZTgxN2RkXzMtNS0xLTEtMjEzMzM5_2f92e5a6-4721-4952-8bee-ffc57c18e352"
      unitRef="usd">0</cron:GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ib098004c6d90459292103b62760beef6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpmZWU4MzUwZGJkMzc0ZDRiOTlmYmY2NTE4NGU4MTdkZC90YWJsZXJhbmdlOmZlZTgzNTBkYmQzNzRkNGI5OWZiZjY1MTg0ZTgxN2RkXzMtNy0xLTEtMjEzMzM5_31d37e54-37d9-495c-8f59-33a791c341c2"
      unitRef="usd">213414000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i2c74a7f5ddc94bfbb03e3906e64f0b91_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxM2Y0NGY3Yjc4M2E0YmQ5YTc5ZDI5MTA0Njg2ZTkxNS90YWJsZXJhbmdlOjEzZjQ0ZjdiNzgzYTRiZDlhNzlkMjkxMDQ2ODZlOTE1XzMtMS0xLTEtMjEzMzM5_d4f3d381-cf20-4e26-9f39-d69e9e272996"
      unitRef="usd">35000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i25737ffe6e95490d8d2ee87f9448d05a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxM2Y0NGY3Yjc4M2E0YmQ5YTc5ZDI5MTA0Njg2ZTkxNS90YWJsZXJhbmdlOjEzZjQ0ZjdiNzgzYTRiZDlhNzlkMjkxMDQ2ODZlOTE1XzMtMy0xLTEtMjEzMzM5_be8b4ea1-2b8c-4d2a-b656-3984d96d98d2"
      unitRef="usd">178414000</us-gaap:GoodwillImpairmentLoss>
    <cron:GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments
      contextRef="i25737ffe6e95490d8d2ee87f9448d05a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxM2Y0NGY3Yjc4M2E0YmQ5YTc5ZDI5MTA0Njg2ZTkxNS90YWJsZXJhbmdlOjEzZjQ0ZjdiNzgzYTRiZDlhNzlkMjkxMDQ2ODZlOTE1XzMtNS0xLTEtMjEzMzM5_c97f4033-a109-43b6-a36f-d89e765b483d"
      unitRef="usd">0</cron:GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia68b72d6fb624de59f43851c8ada21f0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZToxM2Y0NGY3Yjc4M2E0YmQ5YTc5ZDI5MTA0Njg2ZTkxNS90YWJsZXJhbmdlOjEzZjQ0ZjdiNzgzYTRiZDlhNzlkMjkxMDQ2ODZlOTE1XzMtNy0xLTEtMjEzMzM5_7043a890-bbfd-48a3-976e-5dbb33178efd"
      unitRef="usd">213414000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzUwMA_72993615-6af1-4c8f-9722-7c3cda63e71c"
      unitRef="subsidiary">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzU5Mw_6e087fa5-1feb-47c4-8a53-71f0d25df7c9"
      unitRef="usd">283300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzYxMg_084bd38a-d51e-47f3-bf9c-d86fb4edb373"
      unitRef="usd">227191000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzYyNw_415b488f-78a1-4c21-88f4-673cdf81f140"
      unitRef="shares">5086586</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i0fe344708a8d4a65bc32ff9f7e14dcd6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzY4MA_d498d1f8-5100-4248-8ed1-16e0d379ca86"
      unitRef="usd">56109000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:Goodwill
      contextRef="i0e10c61d155349978107170ade1b67bd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzcyOQ_cfa6dede-e611-46bc-bd3a-adb5ae3d17bd"
      unitRef="usd">213414000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i25737ffe6e95490d8d2ee87f9448d05a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM4NDk_be8b4ea1-2b8c-4d2a-b656-3984d96d98d2"
      unitRef="usd">178414000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3011f950a4e94248aeda6558c378e5b3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM5MzY_5552ad13-1d7a-474d-9d89-366affc27d5a"
      unitRef="usd">35000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzkxMzA_e2e2f9d4-1430-40ba-a818-1ac59c76aab4">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net are comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,008)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated impairment charges on intangible assets, net consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo exclusive licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&#xae; brand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzItMy0xLTEtMjEzMzM5_0d98a79b-4c00-486c-956a-3b39c72b5850"
      unitRef="usd">6037000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzItNS0xLTEtMjEzMzM5_19909272-55ef-4e7a-b1ea-e1558c201b3e"
      unitRef="usd">2388000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzItNy0xLTEtMjEzMzM5_5d6e1664-af2e-4eb2-966f-5c77816c7af8"
      unitRef="usd">76000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzItOS0xLTEtMjEzMzM5_13471d5e-afb2-49e7-b514-7a9d91706384"
      unitRef="usd">3573000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzMtMy0xLTEtMjEzMzM5_2d6d4b09-9ecc-4257-bf89-8d8b820107d7"
      unitRef="usd">8269000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzMtNS0xLTEtMjEzMzM5_0e3d5f89-ac4a-490c-a01c-027c40a80610"
      unitRef="usd">1771000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzMtNy0xLTEtMjEzMzM5_db0fb0d5-718c-4ff5-8fb2-6e3895cbdd3c"
      unitRef="usd">6498000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzMtOS0xLTEtMjEzMzM5_93ff77df-4e58-4d16-998d-cf0be7996c44"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzQtMy0xLTEtMjEzMzM5_95f59aa4-22a4-4438-af5c-b411500ebe69"
      unitRef="usd">27676000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzQtNS0xLTEtMjEzMzM5_3e1e378f-5bd9-4668-b0de-9a121ae8e0f6"
      unitRef="usd">1854000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzQtNy0xLTEtMjEzMzM5_c6b9f44b-2b09-4b86-ac69-1f99cc855f0c"
      unitRef="usd">4434000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzQtOS0xLTEtMjEzMzM5_7f93b49d-efbc-4972-92c6-de729d77651b"
      unitRef="usd">21388000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i77456131101b46f6b16bb4bde937116b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzUtMy0xLTEtMjEzMzM5_64003c44-847e-4cda-bfb3-cd8be4ce7e15"
      unitRef="usd">292000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i77456131101b46f6b16bb4bde937116b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzUtNS0xLTEtMjEzMzM5_910c4bd0-f93d-4d6e-a2b2-65c93149ec81"
      unitRef="usd">49000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i77456131101b46f6b16bb4bde937116b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzUtOS0xLTEtMjEzMzM5_f04084ea-08f1-47e9-a42a-3c53ed44ab21"
      unitRef="usd">243000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzYtMy0xLTEtMjEzMzM5_18c6c502-4622-4933-8966-258d1d8092d7"
      unitRef="usd">42274000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzYtNS0xLTEtMjEzMzM5_9737f32a-1144-47fc-9d37-672295674ab3"
      unitRef="usd">6062000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzYtNy0xLTEtMjEzMzM5_8e832ee4-463d-4cad-befd-22074b81be07"
      unitRef="usd">11008000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzYtOS0xLTEtMjEzMzM5_5a4c90e7-b514-4e24-8d2e-8495f11708c7"
      unitRef="usd">25204000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <cron:IndefiniteLivedIntangibleAssetsGross
      contextRef="idf526b01444e468cb8d268601d3ce639_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzctMy0xLTEtMjEzMzM5_d0a3fbc9-ddd2-40c9-814c-30554860aaaa"
      unitRef="usd">64000000</cron:IndefiniteLivedIntangibleAssetsGross>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="idf526b01444e468cb8d268601d3ce639_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzctNy0xLTEtMjEzMzM5_73c85ea4-c52e-42e9-8a04-556151f1102e"
      unitRef="usd">62500000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="idf526b01444e468cb8d268601d3ce639_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzctOS0xLTEtMjEzMzM5_d30d8867-bbc0-4ee1-9f56-d7ea5a333bf0"
      unitRef="usd">1500000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <cron:IndefiniteLivedIntangibleAssetsGross
      contextRef="ib30da315d1e048d1a112a4fd35422a60_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzgtMy0xLTEtMjEzMzM5_50b67e5e-ab2f-4506-a58e-286b0b9ba457"
      unitRef="usd">142000</cron:IndefiniteLivedIntangibleAssetsGross>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="ib30da315d1e048d1a112a4fd35422a60_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzgtNy0xLTEtMjEzMzM5_e6cd2545-2cca-46f6-9443-1710331b6548"
      unitRef="usd">142000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib30da315d1e048d1a112a4fd35422a60_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzgtOS0xLTEtMjEzMzM5_2a2e6bae-977a-4b83-a832-b8cc5571c573"
      unitRef="usd">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzktMy0xLTEtMjEzMzM5_e8bea359-967f-48d1-9e6f-36a270ecee5d"
      unitRef="usd">106416000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzktNS0xLTEtMjEzMzM5_d5e3d397-99b3-42bf-af66-2c64c3cda981"
      unitRef="usd">6062000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:IntangibleAssetsAccumulatedImpairment
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzktNy0xLTEtMjEzMzM5_550fd32f-87fd-44e2-a40b-06e4b3a0c4be"
      unitRef="usd">73650000</cron:IntangibleAssetsAccumulatedImpairment>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo5NzVkZjVhNThlNmQ0ZWYxODQ3M2FlMTM4YzI4YWNjNi90YWJsZXJhbmdlOjk3NWRmNWE1OGU2ZDRlZjE4NDczYWUxMzhjMjhhY2M2XzktOS0xLTEtMjEzMzM5_4a11f229-bbd7-4249-9b90-2dd28235bf74"
      unitRef="usd">26704000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzItMy0xLTEtMjEzMzM5_632ebb84-9b78-4045-8bfe-772fb101cd3b"
      unitRef="usd">5644000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzItNS0xLTEtMjEzMzM5_75923bcb-3a86-4fb8-a1a8-b63d6034822d"
      unitRef="usd">1595000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzItNy0xLTEtMjEzMzM5_03c170d5-4d66-4e68-b00a-6df9fefbaf39"
      unitRef="usd">4000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzItOS0xLTEtMjEzMzM5_3d23a065-23ad-4078-9319-8c9e13c67c0e"
      unitRef="usd">4045000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzMtMy0xLTEtMjEzMzM5_79402419-1cd3-47f8-85f5-f9556a9bda5b"
      unitRef="usd">8793000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzMtNS0xLTEtMjEzMzM5_aab898f4-ccff-45b8-8b8f-1094e974223b"
      unitRef="usd">1883000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzMtNy0xLTEtMjEzMzM5_fee747c5-2661-4845-b78a-71084722e246"
      unitRef="usd">6910000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzMtOS0xLTEtMjEzMzM5_1f600b67-6556-47dc-994a-8d6e522e0a67"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzQtMy0xLTEtMjI5MDQy_99c2e09a-b9ab-43fd-8b23-add135cac5cf"
      unitRef="usd">17330000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzQtNS0xLTEtMjI5MDYx_780083c9-2380-486f-a209-d7e60c164ec5"
      unitRef="usd">335000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzQtNy0xLTEtMjI5MDcz_502f32cb-c597-48d4-8760-a371ac305dbb"
      unitRef="usd">4752000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzQtOS0xLTEtMjQ2NzUy_dc393f62-04b7-438d-b35e-de9ed260ed4c"
      unitRef="usd">12243000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie918e80cfb4d4ce1bc3659d5c55122dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzUtMy0xLTEtMjEzMzM5_95892712-f4c5-4667-b00c-2084ee506643"
      unitRef="usd">330000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie918e80cfb4d4ce1bc3659d5c55122dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzUtNS0xLTEtMjEzMzM5_eeb13aa3-1348-4307-8c02-dd1a3c05d194"
      unitRef="usd">39000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie918e80cfb4d4ce1bc3659d5c55122dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzUtOS0xLTEtMjEzMzM5_1607785b-a762-4e1c-b37f-b7966b23850d"
      unitRef="usd">291000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzYtMy0xLTEtMjEzMzM5_ea6dd905-7da8-4dc5-b223-61327ed7c7a0"
      unitRef="usd">32097000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzYtNS0xLTEtMjEzMzM5_3c486972-1460-42f9-8427-a258eba82791"
      unitRef="usd">3852000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzYtNy0xLTEtMjEzMzM5_a4a9ca0c-8caa-4838-be15-e9380170a563"
      unitRef="usd">11666000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzYtOS0xLTEtMjEzMzM5_393a6e71-be2d-460d-af3a-28f1b95486b8"
      unitRef="usd">16579000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <cron:IndefiniteLivedIntangibleAssetsGross
      contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzctMy0xLTEtMjEzMzM5_d3d62941-bdb6-4477-8ada-66053f487fd2"
      unitRef="usd">64000000</cron:IndefiniteLivedIntangibleAssetsGross>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzctNy0xLTEtMjEzMzM5_afa9e5c4-41e8-4e3c-be88-42e53e1a8658"
      unitRef="usd">62500000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzctOS0xLTEtMjEzMzM5_f5a378bc-25cf-42d1-b759-d319d415048c"
      unitRef="usd">1500000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <cron:IndefiniteLivedIntangibleAssetsGross
      contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzgtMy0xLTEtMjEzMzM5_995c7788-f8f2-4305-aa2b-0c9555858a55"
      unitRef="usd">142000</cron:IndefiniteLivedIntangibleAssetsGross>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzgtNy0xLTEtMjEzMzM5_88f6f1a8-619f-4ade-bdf1-c9429ec1f0fa"
      unitRef="usd">142000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzgtOS0xLTEtMjEzMzM5_934df549-139f-4034-8375-f7e18cac68f7"
      unitRef="usd">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzktMy0xLTEtMjEzMzM5_73833968-76ab-411d-8373-f7459fd38521"
      unitRef="usd">96239000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzktNS0xLTEtMjEzMzM5_ce0210ff-6797-4d1b-9e82-12c625f04f74"
      unitRef="usd">3852000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:IntangibleAssetsAccumulatedImpairment
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzktNy0xLTEtMjEzMzM5_429cfb3e-47c7-4805-a2e0-8467525d3439"
      unitRef="usd">74308000</cron:IntangibleAssetsAccumulatedImpairment>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTo0YWUyNjJjOGRlZTk0ZjMwYTEyODAxNWRkOTk3ZDFlOS90YWJsZXJhbmdlOjRhZTI2MmM4ZGVlOTRmMzBhMTI4MDE1ZGQ5OTdkMWU5XzktOS0xLTEtMjEzMzM5_f2872a9b-b1dc-4a4b-bf92-f92dbd9d2e34"
      unitRef="usd">18079000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ib9aed4863ab04465a720fe0d99d7ada3_D20210821-20210821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk1NjI_f2082b02-9c67-484e-a2eb-a8dea6f2f017"
      unitRef="shares">1467490</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ifcca62b307af4573b49a49b9dc71ed48_I20210821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2MDM_8f53e33a-5a7b-4765-982b-a3032b63cbff"
      unitRef="cadPerShare">7.90</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i60b0e9b055b34cd29e30bd1cbbc8d4b9_D20210821-20210821"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2MjI_8c42df2f-987e-410c-83e3-505d53b00e27"
      unitRef="cad">11593000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i60b0e9b055b34cd29e30bd1cbbc8d4b9_D20210821-20210821"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2MzM_b393fd72-6792-4ac8-a791-7c980e64ba71"
      unitRef="usd">9042000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="ifcca62b307af4573b49a49b9dc71ed48_I20210821"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2MTE_3968e9fc-5175-406d-8f99-f58520d34680"
      unitRef="usd">7300000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i60b0e9b055b34cd29e30bd1cbbc8d4b9_D20210821-20210821"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk1MzA4_e43ab80e-fd48-42b7-939a-172c7310b1b8">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="i5f85047526a4440e97e49b14b9b8c149_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2NTE_313ce4f3-4514-448c-8677-daff01d85dd0"
      unitRef="usd">-1784000</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ie7349eab127d4a66a02ccea7ace9a86f_D20211112-20211112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk2ODg_57361b58-726c-414d-9a26-0db298ee2f7b"
      unitRef="shares">1467490</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i84b41514fd424c719fa65a8c6207ec1c_I20211112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4MjY_c6b2bb7d-4002-4519-8815-14de319c26de"
      unitRef="cadPerShare">7.12</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0d0cba209df1419b87b954ee194f4270_D20211112-20211112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4MzQ_05735395-51d5-431d-b0e3-3c33e55bf809"
      unitRef="cad">10449000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0d0cba209df1419b87b954ee194f4270_D20211112-20211112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4NDg_58725741-2f98-4877-b620-e1d91e7bad79"
      unitRef="usd">8150000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="i84b41514fd424c719fa65a8c6207ec1c_I20211112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4NTg_1db5190c-948e-490b-8dd8-654755c36c6a"
      unitRef="usd">5300000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0d0cba209df1419b87b954ee194f4270_D20211112-20211112"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzU0NjY_b471e94e-8da4-4f36-a60d-bc3ef79d5bb1">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="ifdd20292b768499ba18dd9f93ed614fc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5NTE_33260ea5-68b5-4264-ac84-cda683c5ce55"
      unitRef="usd">-3008000</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4a05578b3601443590c15854ed0c6306_D20220601-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE0ODQzNDA2OTk2MzM0_b1377f07-6d55-45c3-9870-0951c0fbfa4c"
      unitRef="shares">2201236</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i13628330308147e39eccb6f6d522273c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk4OTA_dd1c88ff-1800-4376-a6b4-e679e30a7e09"
      unitRef="cadPerShare">3.47</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5MDI_8b4a3ca2-20f9-4bb2-a4dc-e8d007e217f0"
      unitRef="usd">600000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5MjA_2588be54-a955-4252-9c64-5c6db52b1bb5"
      unitRef="cad">8412000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5NDA_b62020da-c789-4d63-af0f-aeb7f48e9deb"
      unitRef="usd">6522000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia7cfad7a8231412d8393fc568475167b_D20220601-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE4NjkxNjk3Njg3NTIy_a1324645-61f7-45ac-a979-b4bc1483bdcf">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i3b0b2dc9d6fc490f9bdff8729d2be639_D20221101-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5NjI_f83c3320-ca27-476a-91f1-926a0af1523a"
      unitRef="shares">489163</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ie08bda6b8bc94e68b9c9453c44196451_I20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5NzE_9c9b5601-d66e-4de0-923e-7e4a92fe3ae9"
      unitRef="cadPerShare">4.11</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8c5418b79bf345ebaf07317235767553_D20221101-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5OTg_18cdc55d-158f-45c0-a29e-c91020072594"
      unitRef="cad">2010000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8c5418b79bf345ebaf07317235767553_D20221101-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MDk5ODc_a45a5dc5-a3f2-471d-881f-d7c433667105"
      unitRef="usd">1473000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8c5418b79bf345ebaf07317235767553_D20221101-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE4NjkxNjk3Njg3NTM2_d593676b-0c95-4d08-bfd5-59f9ee37844b">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic478134f8b5943789c119b31b737e663_D20221201-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwMTA_b292caec-faed-4875-8413-bc0d24757a92"
      unitRef="shares">1467490</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i9c5f202e7a6844d084f318b1a5ed7a48_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwMjE_226f8b41-0872-4be4-81b0-801c92034336"
      unitRef="cadPerShare">3.44</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie9ad91752c734ce5a3109a2be336ffcf_D20221201-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwMzM_e61543ae-82d4-486a-a240-a84ad6b343dd"
      unitRef="cad">5048000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie9ad91752c734ce5a3109a2be336ffcf_D20221201-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwNDU_53390b7f-e634-4e38-a371-178976f5e6d5"
      unitRef="usd">3724000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie9ad91752c734ce5a3109a2be336ffcf_D20221201-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE4NjkxNjk3Njg3NTM3_0de2cb47-4d53-495b-b406-666c6fef0eeb">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM5OTc_a4e56cf8-709b-4519-b0b0-1ed338568f57"
      unitRef="usd">2751000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM5Nzk_3aa0a70e-3186-4ee9-a698-c0a8c3bea4f1"
      unitRef="usd">1800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzE2NDkyNjc0NTM5ODY_5d0c46f6-61d7-4509-8665-87d8f9b53af1"
      unitRef="usd">814000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzkxMjY_9192209c-ed36-4f4a-a3c0-3f742d2092a1">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated future amortization of definite-lived intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzEtMi0xLTEtMjEzMzM5_ffd8f8f1-19d7-431a-b0a1-9650dfda6787"
      unitRef="usd">3498000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzItMi0xLTEtMjEzMzM5_3abfffec-f2ac-4966-a068-1904f66e5b4a"
      unitRef="usd">3483000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzMtMi0xLTEtMjEzMzM5_36949e75-68a5-4930-8b5f-6d29569744f1"
      unitRef="usd">3207000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzQtMi0xLTEtMjEzMzM5_f3212d0e-729d-4c9f-874b-0c3a7b9d794c"
      unitRef="usd">2643000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzUtMi0xLTEtMjEzMzM5_b52f0ced-80d4-4c37-927d-d05db3f2a01f"
      unitRef="usd">2435000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzYtMi0xLTEtMjEzMzM5_f10a7074-58c6-4966-887e-6380717503cd"
      unitRef="usd">9938000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpjZDFlM2U4ZjRkYzI0YzJjYWZjNjRhOWI0MDY5NWJkYy90YWJsZXJhbmdlOmNkMWUzZThmNGRjMjRjMmNhZmM2NGE5YjQwNjk1YmRjXzctMi0xLTEtMjEzMzM5_5eadc9ba-c799-42f0-ae75-5f61f7427b99"
      unitRef="usd">25204000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzEtMS0xLTEtMjEzMzM5_58020af0-df40-4ba1-8fe3-faea164e4271"
      unitRef="usd">4000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzEtMy0xLTEtMjEzMzM5_3c209894-6a1a-4ed6-a398-c9758c92c381"
      unitRef="usd">76000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments
      contextRef="i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzEtNS0xLTEtMjEzMzM5_eba3cfe0-3815-4c35-928c-582c46fc4053"
      unitRef="usd">-4000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i755ce371ac6a447c827eb78a659cb733_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzEtNy0xLTEtMjEzMzM5_5d324bcf-f809-4928-aa36-ae99cc05df63"
      unitRef="usd">76000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzItMS0xLTEtMjEzMzM5_c16ab24c-8147-41c6-ad5e-58f74a495410"
      unitRef="usd">6910000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i9b8e682c2ca040fd975b5501a07eab0b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzItMy0xLTEtMjEzMzM5_3b21ac1c-23bc-497d-9f52-256af6f4ad31"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments
      contextRef="i9b8e682c2ca040fd975b5501a07eab0b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzItNS0xLTEtMjEzMzM5_c3d4b8d4-c06a-4271-bc02-37f2b31572b9"
      unitRef="usd">-412000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i4ca9c6f64b9f4376a90cee26c9cd5736_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzItNy0xLTEtMjEzMzM5_330a8360-c5ca-4ae5-a780-56c2e37fb1a0"
      unitRef="usd">6498000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzMtMS0xLTEtMjEzMzM5_19261ccc-4d16-4009-b4e3-fe1801967d9e"
      unitRef="usd">4752000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i4cac6295dd43471085e94c05e8edc47c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzMtMy0xLTEtMjEzMzM5_9e60f18e-c705-444d-b6b0-42815d4e9177"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments
      contextRef="i4cac6295dd43471085e94c05e8edc47c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzMtNS0xLTEtMjEzMzM5_615ca562-2b1c-422e-a998-7660dc9fdcc1"
      unitRef="usd">-318000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i6dd15a1aa77b4d48b6e5909f760b7b2d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzMtNy0xLTEtMjEzMzM5_fddeaea5-1472-4d3e-ad78-403337b91e48"
      unitRef="usd">4434000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzQtMS0xLTEtMjEzMzM5_5a415c07-c5f3-4855-af38-1fccf95dcfaf"
      unitRef="usd">62500000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod
      contextRef="if18d2c03d26d4706b4fbe1f740a27ad6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzQtMy0xLTEtMjEzMzM5_d3d2023e-ef29-408c-812c-623fc228bb98"
      unitRef="usd">0</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="idf526b01444e468cb8d268601d3ce639_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzQtNy0xLTEtMjEzMzM5_722abd1c-eb18-4978-b565-8d82937b3888"
      unitRef="usd">62500000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzUtMS0xLTEtMjEzMzM5_99322aea-4132-43c0-a2cf-eb8134e550a1"
      unitRef="usd">142000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod
      contextRef="ie54e4c678bed4bb18e9f07294b7c949a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzUtMy0xLTEtMjEzMzM5_63487f55-efce-41b8-8280-1ca5aaa66b3f"
      unitRef="usd">0</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="ib30da315d1e048d1a112a4fd35422a60_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzUtNy0xLTEtMjEzMzM5_5ce5998d-4574-483f-81c9-ced20915841c"
      unitRef="usd">142000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IntangibleAssetsAccumulatedImpairment
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzYtMS0xLTEtMjEzMzM5_9f487c5e-7404-4683-93be-bd95fdea7aa4"
      unitRef="usd">74308000</cron:IntangibleAssetsAccumulatedImpairment>
    <cron:IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzYtMy0xLTEtMjEzMzM5_062386d3-617e-4095-ba76-b924b1547512"
      unitRef="usd">76000</cron:IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod>
    <cron:IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzYtNS0xLTEtMjEzMzM5_cccb033f-2d63-4326-8e41-1a2c6e61542a"
      unitRef="usd">-734000</cron:IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments>
    <cron:IntangibleAssetsAccumulatedImpairment
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTpiNjc5YmQ3MDkwMTA0Y2EyOTNjNjMxMThhMzFlMGQ4YS90YWJsZXJhbmdlOmI2NzliZDcwOTAxMDRjYTI5M2M2MzExOGEzMWUwZDhhXzYtNy0xLTEtMjEzMzM5_64cbd44c-e835-40ec-93d0-575ad1ea5bc3"
      unitRef="usd">73650000</cron:IntangibleAssetsAccumulatedImpairment>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i68cc03c90b794e938ba29c4e01d7fff3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtMS0xLTEtMjI5OTA3_9cdbd8ea-5ec8-4395-9580-2b15665f3b66"
      unitRef="usd">0</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ic81f17ae580640a7b5c24a884c9ec3bc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtMy0xLTEtMjMwMDQ2_28765d76-56d5-4726-9589-3f4a7432910a"
      unitRef="usd">4000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments
      contextRef="ic81f17ae580640a7b5c24a884c9ec3bc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtNS0xLTEtMjMwMDQ2_8c937f75-9a72-4f4f-bc0b-a8e9101e1202"
      unitRef="usd">0</cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i193ecd1934b24649adc30b0af94378ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtNy0xLTEtMjQ2ODY2_df1cdbe2-9a13-480c-8ae3-5c9cdb2c5fd5"
      unitRef="usd">4000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i50cd01170d1f4a2bb1a30d020e35156b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtMS0xLTEtMjEzMzM5_e33fb546-c9a4-4c31-9ef8-49e81e4b636c"
      unitRef="usd">1053000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i9b6c8d5ea81343f7aa1f596a92eae8fb_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtMy0xLTEtMjEzMzM5_5dbf8f37-b484-46ae-88a6-89ac741eff57"
      unitRef="usd">5951000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments
      contextRef="i9b6c8d5ea81343f7aa1f596a92eae8fb_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtNS0xLTEtMjEzMzM5_96012ce2-41e1-4dcc-a325-74d0789bdd56"
      unitRef="usd">-94000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i68c5bd547ca145fda854a6fe88caecfc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzEtNy0xLTEtMjEzMzM5_fecdff94-9347-4598-8cf8-440e9d126fbe"
      unitRef="usd">6910000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i4f901df38e1c4d6d842edb34f8ab501e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzItMS0xLTEtMjEzMzM5_1437851d-9dd7-4ca1-a0b6-71d4f7a1c21e"
      unitRef="usd">0</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i90365f808213420099a7b087ef308b31_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzItMy0xLTEtMjEzMzM5_71857a67-b56e-4edb-9048-86a653f89a1e"
      unitRef="usd">4792000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments
      contextRef="i90365f808213420099a7b087ef308b31_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzItNS0xLTEtMjEzMzM5_7b97ad87-124b-43cc-afec-8c9924b0a583"
      unitRef="usd">-40000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments>
    <cron:FiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="iad18f350f48747109ed2f62fb103c1ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzMtNy0xLTEtMjQ2ODY2_456802c4-f5af-452d-bd32-747e6f185b78"
      unitRef="usd">4752000</cron:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i5f641a8b2e914e16a1d54db890c168b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzMtMS0xLTEtMjEzMzM5_e4835b20-d2d1-440d-a28c-278c52e547dd"
      unitRef="usd">5000000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod
      contextRef="ibbf9404540e541bb8747d3dbaff42a7e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzMtMy0xLTEtMjEzMzM5_baf7a7d3-3f0f-4a86-b653-b350c7228951"
      unitRef="usd">57500000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i94520bdab4b544a1a3dbb7a989765e98_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzMtNy0xLTEtMjEzMzM5_3bc13fac-d5dc-43b8-a00d-415592d318af"
      unitRef="usd">62500000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i4bf6a4d5e23042058bc74e814d9dba02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzUtMS0xLTEtMjI5OTA3_5de122d5-9014-4952-809b-7828ef035dcc"
      unitRef="usd">0</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod
      contextRef="ied1f671988d04e8dba89bbc4bc42a206_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzUtMy0xLTEtMjMwMDQ2_efcac2b2-134e-4b4a-afb7-f4bafb103253"
      unitRef="usd">142000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod>
    <cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment
      contextRef="i0f005ffd354e4072aeeaedc327ce3b95_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzUtNy0xLTEtMjQ2ODY2_93d0ada3-a6da-4917-9045-7f25bae96418"
      unitRef="usd">142000</cron:IndefiniteLivedIntangibleAssetsAccumulatedImpairment>
    <cron:IntangibleAssetsAccumulatedImpairment
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzQtMS0xLTEtMjEzMzM5_8c60dc35-bec8-4e5d-ba49-f27cb4a21d96"
      unitRef="usd">6053000</cron:IntangibleAssetsAccumulatedImpairment>
    <cron:IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzQtMy0xLTEtMjEzMzM5_29812f7e-db9e-4794-aa7f-28a238b9750e"
      unitRef="usd">68389000</cron:IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod>
    <cron:IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzQtNS0xLTEtMjEzMzM5_b9c8a2c1-6a33-4722-b5a9-1d0c3c0bd483"
      unitRef="usd">-134000</cron:IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments>
    <cron:IntangibleAssetsAccumulatedImpairment
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90YWJsZTplZjZmOGM3ZGJhNmI0OGJkYTI5MWRhZjE1NGM5NWQ2OS90YWJsZXJhbmdlOmVmNmY4YzdkYmE2YjQ4YmRhMjkxZGFmMTU0Yzk1ZDY5XzQtNy0xLTEtMjEzMzM5_8734800e-89ba-4bcf-a4ee-c5f830302722"
      unitRef="usd">74308000</cron:IntangibleAssetsAccumulatedImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i732550b3992f4da1853152fc684f8d1a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwNjQ_c882b290-f535-4304-bbf9-dc15724de25c"
      unitRef="usd">5951000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <cron:NumberOfImpairedIntangibles
      contextRef="ib273218a57a04f388d9cdc27f16e269e_D20210701-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzcxMzg_d1f73e56-d556-4158-b39b-54347690b2cc"
      unitRef="cannabinoid">2</cron:NumberOfImpairedIntangibles>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i90365f808213420099a7b087ef308b31_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzczMzg_a423c54a-47ff-4a52-a0b6-a1da418ad2f1"
      unitRef="usd">4792000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i7756c3f9244a44aea49da07e1988dd28_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAwODM_1c6d0017-97b5-4afe-949d-91e7c0cc9992"
      unitRef="usd">56500000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i79c67a1f55424125bc5bfeab113bb038_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAxMDI_4afbe23f-a358-405b-8f32-40b356089e18"
      unitRef="usd">1000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i999046b0a46e46a2bc0eee830f50363f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMDkvZnJhZzo5NzlhNTRjYmUzMzg0MDZjYjlmNzQ3ZmE1YjA4MmUyMi90ZXh0cmVnaW9uOjk3OWE1NGNiZTMzODQwNmNiOWY3NDdmYTViMDgyZTIyXzM4NDgyOTA3MTAxMjA_f02febcc-5ed2-4262-819a-f116f6e9a76f"
      unitRef="usd">5000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2MzM_132f0ce7-123c-4fd6-9771-943a6574fa9e">Leases &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into leases primarily for the land-use rights, office premises and equipment used in the production of cannabis, U.S. hemp-derived cannabinoids and other related products. The Company&#x2019;s leases have terms that range from three years to six years, excluding land use rights, which generally extend to 15 years. These leases often include options to extend the term of the lease for up to 10 years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company&#x2019;s consolidated balance sheet. The Company&#x2019;s finance leases were not material for any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow and other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows - cash paid for operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash activity - right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years) &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, the aggregate depreciation expense on right-of-use assets was $1,704, $1,934 and $1,310, respectively, and was included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, the Company recognized an impairment charge of $1,986 related to the right-of-use lease asset associated with the Company&#x2019;s corporate headquarters, encompassing approximately 29,000 square feet, in Toronto, Ontario, Canada, for which the Company determined it would seek a sublease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended, December 31, 2021, the Company recognized an impairment charge of $702 related to the right-of-use asset associated with leased premises, encompassing approximately 6,000 square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leased asset was being used and the expectation that, more likely than not, the leased asset would be abandoned before the end of the lease term triggered an impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s future minimum lease payments under operating leases for its premises due in future fiscal years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the minimum lease payments, the Company is required to pay realty taxes and other occupancy costs in accordance with the terms of the lease agreements.&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i14d64d8fee424bdfa513430ee56f747e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzI1OA_c5165079-d6a7-489f-bf5f-f1ebea627fa6">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i44985dd9b7e343f49061a23ef9ab42ec_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzI2NA_9c887387-7507-4df7-bbf0-44f3788f3c4b">P6Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i5b69cfe90a884fb39eba1ca111fc6b2e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzMyMQ_a1ead666-2120-45f0-b4fc-e3af7cdd51ce">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzQwOA_3157f147-706b-431b-80a8-cc648ec2d1cb">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2MzQ_2aebf8b6-da70-44ed-b8ad-7ceee075b21e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow and other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows - cash paid for operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash activity - right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years) &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzMtMS0xLTEtMjEzMzM5_ce771bde-cc61-42ce-8814-9e5805b59622"
      unitRef="usd">2209000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzMtMy0xLTEtMjEzMzM5_9997b2ab-f493-41f4-86a0-bbc0a092236d"
      unitRef="usd">2530000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzMtNS0xLTEtMjQzNjgz_25b1fc01-a871-46d1-a97a-2ae7b15dcccb"
      unitRef="usd">2479000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzQtMS0xLTEtMjEzMzM5_71c45482-8988-4d8b-ab52-358b5f6438ce"
      unitRef="usd">0</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzQtMy0xLTEtMjEzMzM5_f1420576-9215-4483-ac15-1f020271702f"
      unitRef="usd">10000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzQtNS0xLTEtMjQzNjgz_b554d397-aeb1-422d-9ca0-08f0769f4260"
      unitRef="usd">60000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzUtMS0xLTEtMjEzMzM5_433c2a36-1987-4ac9-aa1b-fb8b58ac29c7"
      unitRef="usd">2209000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzUtMy0xLTEtMjEzMzM5_2eae3767-ff5c-48b8-a9e8-9c59250f3468"
      unitRef="usd">2540000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzUtNS0xLTEtMjQ2OTAw_02b96607-3d2f-49a6-b977-342fbbebbef9"
      unitRef="usd">2539000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzgtMS0xLTEtMjEzMzM5_5e0c7aea-78d1-426b-be55-0aa31bcbaab7"
      unitRef="usd">2491000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzgtMy0xLTEtMjEzMzM5_1f6486b9-cd6e-49bf-8069-40852ae92196"
      unitRef="usd">2458000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzgtNS0xLTEtMjQzNzE4_90d5a1c9-3631-4815-a83f-f645c5573c64"
      unitRef="usd">2414000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzktMS0xLTEtMjEzMzM5_2bb71772-50b1-4714-824e-8cc8b32ddf05"
      unitRef="usd">443000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzktMy0xLTEtMjEzMzM5_b980f657-4fc9-4e59-b089-3f54a3730334"
      unitRef="usd">3277000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzktNS0xLTEtMjQzNzE4_b3b412e2-b33f-404f-8e93-583746ccc678"
      unitRef="usd">5332000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzExLTEtMS0xLTIxMzMzOQ_824bb6a5-c233-4951-888c-d033bd6d7cac">P4Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzExLTMtMS0xLTIxMzMzOQ_cbf0a313-d8dd-4ff9-bbe3-bbba95f1f49f">P4Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzExLTUtMS0xLTI0MzcyNw_b4a6550c-cdec-49a3-a069-fa86e96bfd6e">P5Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzEyLTEtMS0xLTIxMzMzOQ_bcbf3313-8f23-4ef3-bb47-f7880c5827c8"
      unitRef="number">0.0719</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzEyLTMtMS0xLTIxMzMzOQ_5b8e5733-5573-40f7-8f91-87815b08fe01"
      unitRef="number">0.0765</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTozMzkxMGE1MWZhODE0MmRjYjc0Mzc1MGNjZWFjNzk2Ny90YWJsZXJhbmdlOjMzOTEwYTUxZmE4MTQyZGNiNzQzNzUwY2NlYWM3OTY3XzEyLTUtMS0xLTI0MzcyNw_544bbf50-a301-4e92-987d-293b90db59ec"
      unitRef="number">0.0886</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease
      contextRef="i6710a5308fe240c785bbcd6e071db62b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2NDkyNjc0NDM0OTA_a2574013-0914-4427-b30c-dcecaff99ffa"
      unitRef="usd">1704000</us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease>
    <us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease
      contextRef="i7304849946e741a0aab1be7f1db2773b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2NDkyNjc0NDM0ODI_055edd60-576e-44c5-83b0-62223b21215a"
      unitRef="usd">1934000</us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease>
    <us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease
      contextRef="i11ee8c20fd4d40938bf05d4422a3ec42_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2NDkyNjc0NDM0ODY_c4b75f10-a341-4839-bb0b-c4bd5313c8b4"
      unitRef="usd">1310000</us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzczNzE_009ff30a-24ef-4680-8aa6-5aef0158e575"
      unitRef="usd">1986000</us-gaap:OperatingLeaseImpairmentLoss>
    <cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzU0OTc1NTgyMTEyNw_0fbc85de-81e9-4555-a8a6-953c729b197f"
      unitRef="sqft">29000</cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzgyNDI_95786558-fe2c-4f1e-ad4f-7d7379d239e5"
      unitRef="usd">702000</us-gaap:OperatingLeaseImpairmentLoss>
    <cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2NDkyNjc0NDY5MTI_7b9622d2-fb4e-4b79-846c-2d023601d142"
      unitRef="sqft">6000</cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90ZXh0cmVnaW9uOjI3Mzg2MWY5YTA2ZDRmNWU4NmMzM2EzMmE0NzZiMDNkXzE2MzU_359c6878-6df7-4998-8ac9-adb60d6ccae8">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s future minimum lease payments under operating leases for its premises due in future fiscal years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzEtMS0xLTEtMjEzMzM5_f1d79a30-7eb2-4baf-b128-fe1ff36003f7"
      unitRef="usd">1648000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzItMS0xLTEtMjEzMzM5_943e02b8-35b3-4fb2-8da5-49aac51a1c4a"
      unitRef="usd">1186000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzMtMS0xLTEtMjEzMzM5_835172ac-f258-44bc-961a-09d748b27af4"
      unitRef="usd">1049000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzQtMS0xLTEtMjEzMzM5_76223244-34ce-4a15-ab10-18cb6760f996"
      unitRef="usd">262000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzUtMS0xLTEtMjEzMzM5_cd741f7a-7e9c-476b-9b29-eeaebb1bb088"
      unitRef="usd">104000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzYtMS0xLTEtMjEzMzM5_b5231926-89ac-454f-ad0a-82eadd53e09c"
      unitRef="usd">556000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzctMS0xLTEtMjEzMzM5_17d67e6e-2e22-4196-952d-5dce905c547f"
      unitRef="usd">4805000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzgtMS0xLTEtMjEzMzM5_21e08f3c-df75-40e8-9bc3-fe9ca80810af"
      unitRef="usd">929000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTIvZnJhZzoyNzM4NjFmOWEwNmQ0ZjVlODZjMzNhMzJhNDc2YjAzZC90YWJsZTplYWEzYzBlYWQxOGE0MDhkYTBiODAxZmU4NjMwMjdhMS90YWJsZXJhbmdlOmVhYTNjMGVhZDE4YTQwOGRhMGI4MDFmZTg2MzAyN2ExXzktMS0xLTEtMjEzMzM5_3a1c2006-748f-4f7a-8695-9d456da90472"
      unitRef="usd">3876000</us-gaap:OperatingLeaseLiability>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc4Mzc_bf873fe9-68a1-4320-8294-091166e3d19d">Derivative Liabilities &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2019, the Company closed the previously announced investment in the Company (the &#x201c;Altria Investment&#x201d;) by Altria Group Inc. (&#x201c;Altria&#x201d;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company and one warrant of the Company (the &#x201c;Altria Warrant&#x201d;), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximate 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). On December 16, 2022, Altria notified the Company that it was irrevocably relinquishing all of its rights, title and interest in the Altria Warrant, effective immediately. As a result, the Company&#x2019;s liability associated with the Altria Warrant was reduced to nil, with the change recorded to gain on revaluation of derivative liabilities for the year ended December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#x201c;Investor Rights Agreement&#x201d;), the Company granted Altria certain rights, among others, summarized in this note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;The Altria Warrant entitled the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional 10% of the common shares of Cronos at a per share exercise price of C$19.00, which was set to expire on March 8, 2023. The Altria Warrant was irrevocably relinquished by Altria on December 16, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the research and development (&#x201c;R&amp;amp;D&#x201d;) partnership with Ginkgo, (refer to Note 9 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#x201c;Pre-emptive Rights&#x201d;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance; provided that if the consideration paid in connection with any such issuance is non-cash, the price per common share of the Company that would have been received had such common shares been issued for cash consideration will be determined by an independent committee (acting reasonably and in good faith); provided further that the price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Collaboration Agreement will be C$16.25 per common share. These rights may not be exercised if Altria&#x2019;s ownership percentage of the issued and outstanding shares of the Company falls below 20%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;c.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#x201c;Top-up Rights&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the 10 full days preceding such exercise by Altria; provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#x2019;s ownership percentage of the issued and outstanding shares of the Company falls below 20%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities on the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, Altria beneficially held 156,573,537 of the Company&#x2019;s common shares, an approximate 41% ownership interest in the Company (calculated on a non-diluted basis).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliations of the carrying amounts of the derivative liability are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fluctuations in the expected life of the derivative instruments and the Company&#x2019;s share price are primary drivers for the changes in the derivative valuations during each reporting period. As the period of time the derivative liability is expected to be outstanding decreases and the share price decreases, the fair value typically decreases for each related derivative instrument. Weighted-average expected life and share price are two of the significant observable inputs used in the fair value measurement of each of the Company&#x2019;s derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the derivative liabilities were determined using the Black-Scholes pricing model using the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at valuation date (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.44&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.44&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weight average expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at valuation date (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.98&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.79%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weight average expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of December&#160;31, 2022 and December&#160;31, 2021, the risk-free interest rate uses a range of approximately 3.81% to 4.37% and 0.16% to 1.10%, respectively, for the Pre-emptive Rights and Top-up Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of December&#160;31, 2022 and December&#160;31, 2021, the expected life uses a range of approximately 0.25 years to 2.75 years and 0.25 years to 3.75 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#x2019;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying amount of the derivative liability, there would also be an equal and opposite impact on net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10% decrease as of December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at issuance date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10% decrease as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside the Company&#x2019;s control, which could significantly affect the fair value of these derivative liabilities in future periods.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ia4b6c54c605e40e1b592903c9120fd37_D20190308-20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzMwNQ_a13cd936-c1a2-407e-8038-358f70ec7b71"
      unitRef="shares">149831154</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cron:ClassOfWarrantOrRightNumberOfWarrantsIssued
      contextRef="i7b7c43afd25849a08ea88b3240e2dd83_D20190308-20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzM0MQ_3c53e621-10f4-4b4e-b133-7ff3ea2ab8cb"
      unitRef="warrant">1</cron:ClassOfWarrantOrRightNumberOfWarrantsIssued>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i61396ac601174186a618ab85deae5ee4_I20190308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzUyNw_0167821c-e960-4a88-9b9c-de6a50ff5663"
      unitRef="number">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised
      contextRef="ibffb66e7dc494751857b498f2aaeb299_I20190308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc5Ng_8e56cc27-2aee-49aa-82b8-dae8d444623a"
      unitRef="number">0.55</cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised>
    <us-gaap:DerivativeLiabilities
      contextRef="i28817b99a60840b0a33d72934688a602_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzE0ODQzNDA2OTg2NjE1_52c0a261-4b39-4869-9c94-7e03209dca40"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage
      contextRef="i9715e946ec664da4bbd57f7a8c864d48_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzE4MDU_545eccd9-f828-4dac-8898-e88f5a68d0ac"
      unitRef="number">0.10</cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i221dd5e17e9844b58038afd4bc734784_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzE5MTY_45a5445c-ac10-47ff-b72c-665202edab0d"
      unitRef="cadPerShare">19.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="iaa6ab7221f554e87a7c8bf27eb2d5642_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzM4NDgyOTA3MDgwMTc_ea7a025c-5cad-4ba8-b67c-61e422315b24"
      unitRef="cadPerShare">16.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired
      contextRef="iaa6ab7221f554e87a7c8bf27eb2d5642_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzMyNjg_a8d00fb6-1533-4849-8d16-efd4475249c3"
      unitRef="number">0.20</cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired>
    <cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod
      contextRef="if1c27a3694484f45b570f0bb4e534e02_D20190308-20190308"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ1NjA_1d2621b6-8a63-4885-9338-5a06548a6ec4">P10D</cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod>
    <cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise
      contextRef="if1c27a3694484f45b570f0bb4e534e02_D20190308-20190308"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ2NTI_c76c8bd5-80cd-4778-bb93-3c935815d83a">P10D</cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ic2fe51cbfc3a4ec9b05ab28c2101a8fe_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5ODY_ab82bccb-880a-40e4-b512-59dce91dcbfd"
      unitRef="cadPerShare">16.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired
      contextRef="ic2fe51cbfc3a4ec9b05ab28c2101a8fe_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzUxOTk_8d591d81-c1b1-43c3-a5fe-e346ec748fc1"
      unitRef="number">0.20</cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="ie7edb25988ef4ca680ec0519a1f7a41c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzU0OTc1NTgyMjIwNQ_ba2b3acd-1cf2-45cc-af72-47b6a0fc487f"
      unitRef="shares">156573537</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie7edb25988ef4ca680ec0519a1f7a41c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzU0OTc1NTgyMjI1Ng_262e8804-bb48-4365-b116-f56658144d4e"
      unitRef="number">0.41</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc4Mzg_4dd60292-d5fe-446c-8577-2a5919ff1b95">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliations of the carrying amounts of the derivative liability are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzEtMS0xLTEtMjEzMzM5_3ea0f4ca-03ed-4211-ac03-d0324f6ec32f"
      unitRef="usd">-13720000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i2c1c7205fa134b8ea972b207eaabed88_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzEtMy0xLTEtMjEzMzM5_d350bc82-7c5a-4d10-a4d1-11bd0708320f"
      unitRef="usd">13431000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i2c1c7205fa134b8ea972b207eaabed88_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzEtNy0xLTEtMjEzMzM5_eb81950d-56c4-4227-8106-7f162b6c8e5b"
      unitRef="usd">289000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i28817b99a60840b0a33d72934688a602_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzEtOS0xLTEtMjEzMzM5_d3698f82-c511-4174-83de-aa94f095e2cc"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzItMS0xLTEtMjEzMzM5_aa9fef80-3e25-48ef-a464-00bbddf1b0b6"
      unitRef="usd">-180000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="iacbae512bdcf437c82335b9fc5c91440_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzItMy0xLTEtMjEzMzM5_dea7b344-5708-4fbb-80fb-4c0402076b54"
      unitRef="usd">179000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="iacbae512bdcf437c82335b9fc5c91440_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzItNy0xLTEtMjEzMzM5_8efa3664-e4a0-4637-aaa1-bc3c0f5da701"
      unitRef="usd">1000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i1937b23e84714a2daaa95f21590a01a0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzItOS0xLTEtMjEzMzM5_344c327a-1b6b-45fd-b170-a11fc4679245"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzMtMS0xLTEtMjEzMzM5_15572a5e-2fc2-4244-b75a-712f5ff0d895"
      unitRef="usd">-475000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i4c446ba0830b43c0b39a1930af1ab423_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzMtMy0xLTEtMjEzMzM5_44ca0932-c125-443f-a9b3-794b0f164659"
      unitRef="usd">450000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i4c446ba0830b43c0b39a1930af1ab423_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzMtNy0xLTEtMjEzMzM5_4214a7d9-7518-499e-87c5-e57a28ad0a4e"
      unitRef="usd">10000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ibb314c21396043bfbea5f9a42e79dd19_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzMtOS0xLTEtMjEzMzM5_e20c94ec-c840-4c8d-a06a-dddd6f77cd1a"
      unitRef="usd">-15000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzQtMS0xLTEtMjEzMzM5_69b0bc3e-7ccc-4dda-8a6d-c3f50d0f646b"
      unitRef="usd">-14375000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzQtMy0xLTEtMjEzMzM5_937f8f92-2374-4def-bda7-61e997f4c5e8"
      unitRef="usd">14060000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzQtNy0xLTEtMjEzMzM5_6eab003b-62b8-479b-a7e4-3a7dfc89751a"
      unitRef="usd">300000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToxMGVhZmUwYTVmOTE0OTEyOWYzYzYyZDIyNzNhYzEyNi90YWJsZXJhbmdlOjEwZWFmZTBhNWY5MTQ5MTI5ZjNjNjJkMjI3M2FjMTI2XzQtOS0xLTEtMjEzMzM5_402436ef-e779-47b3-bc1a-344f14ecdde2"
      unitRef="usd">-15000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="iefda9bc7439d4557845731f8c6e1ee83_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzEtMS0xLTEtMjEzMzM5_3890b421-0eac-405f-bb51-ca15d4f9c2fa"
      unitRef="usd">-138858000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i0fb9758c232649229074d49b3b8dc7fd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzEtMy0xLTEtMjEzMzM5_647abb02-39cf-4252-b949-dcac173f85e0"
      unitRef="usd">127099000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i0fb9758c232649229074d49b3b8dc7fd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzEtNy0xLTEtMjEzMzM5_84e374ae-6d9e-4db7-a2fe-5468b1eb6d4d"
      unitRef="usd">-1961000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzEtOS0xLTEtMjEzMzM5_dee2ae52-4f59-4433-8d8e-0c4d0482b454"
      unitRef="usd">-13720000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ie5f45cb877964c1ca42caca1ed6a175f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzItMS0xLTEtMjEzMzM5_fd83cb6a-ffe6-4c2b-b7d2-e06a1c1496d3"
      unitRef="usd">-12095000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i2e64ddadb77a4996af4ad68e0b33e84f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzItMy0xLTEtMjEzMzM5_a6b3d931-ff05-42f8-973a-fffe60ed6d56"
      unitRef="usd">12102000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i2e64ddadb77a4996af4ad68e0b33e84f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzItNy0xLTEtMjEzMzM5_a299762f-32cc-4728-b69b-1313451da48b"
      unitRef="usd">-187000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzItOS0xLTEtMjEzMzM5_be93b37d-2288-4991-9ff8-c1fbf17f6d1a"
      unitRef="usd">-180000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="if48a2cb5842349feb0ee8180de88046d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzMtMS0xLTEtMjEzMzM5_3f332502-9da8-46d0-88cf-62facd222ed7"
      unitRef="usd">-12457000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="icad90c5c09604a40bcda1aa60d6f4817_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzMtMy0xLTEtMjEzMzM5_6f631c2b-c0b9-47ec-ba69-3b5d55945039"
      unitRef="usd">12159000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="icad90c5c09604a40bcda1aa60d6f4817_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzMtNy0xLTEtMjEzMzM5_0c75eb34-7020-432b-8481-f18487c97a52"
      unitRef="usd">-177000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzMtOS0xLTEtMjEzMzM5_532fdbb7-fa19-435e-84b5-9ee878f6f584"
      unitRef="usd">-475000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzQtMS0xLTEtMjEzMzM5_a0a4b217-58ed-46c7-8dcb-62dddbf241f6"
      unitRef="usd">-163410000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzQtMy0xLTEtMjEzMzM5_f4bcadf4-d7e4-4b8f-9203-78a2a6f614d2"
      unitRef="usd">151360000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzQtNy0xLTEtMjEzMzM5_3bce6194-df14-4c16-a9a7-e4c2dd8d6130"
      unitRef="usd">-2325000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo1NjQwYzk2OTE5YTU0MTllYmE5MThjMzE1ZTg1ZDdiNi90YWJsZXJhbmdlOjU2NDBjOTY5MTlhNTQxOWViYTkxOGMzMTVlODVkN2I2XzQtOS0xLTEtMjEzMzM5_335d4670-244f-4592-b5a0-0d12c3151a99"
      unitRef="usd">-14375000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc4NDA_21169985-d0f3-4183-897b-25bfb93a9009">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the derivative liabilities were determined using the Black-Scholes pricing model using the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at valuation date (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.44&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.44&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weight average expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at valuation date (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.98&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.79%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weight average expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of December&#160;31, 2022 and December&#160;31, 2021, the risk-free interest rate uses a range of approximately 3.81% to 4.37% and 0.16% to 1.10%, respectively, for the Pre-emptive Rights and Top-up Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of December&#160;31, 2022 and December&#160;31, 2021, the expected life uses a range of approximately 0.25 years to 2.75 years and 0.25 years to 3.75 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ibc817e542af6414480289d7ee595ed36_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzItMy0xLTEtMjEzMzM5_a37bd92e-adf8-4fe3-b5e0-cef3cb4f1083"
      unitRef="cadPerShare">3.44</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ia898bc55623845b0ac1ef2856e3c821b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzItNS0xLTEtMjEzMzM5_91b4b824-9412-402d-aebc-f4bc55849488"
      unitRef="cadPerShare">3.44</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="id3070e38626248d882307c7013957190_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzMtMy0xLTEtMjEzMzM5_4f79ea4e-0906-42c5-87c1-3eb956dac40b"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ic82bd6cd39a9499088723cd61326ac33_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzMtNS0xLTEtMjEzMzM5_e0c79fe0-efe4-4f27-9aea-d83471f6a718"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i9c7419e5e8c447b3bc7c086770debb36_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzQtMy0xLTEtMjEzMzM5_8e5dccf6-faac-4c73-9dfa-3af2191d8820"
      unitRef="number">0.0414</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="id2adebb19e5a4a64b42095549e292edb_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzQtNS0xLTEtMjEzMzM5_faa9a283-f63b-420e-82e8-fc4db80458b1"
      unitRef="number">0.0428</us-gaap:DerivativeLiabilityMeasurementInput>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="ife021bb97d6549dba2eb6e2bc3cd674d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzUtMy0xLTEtMjEzMzM5_6a1bdda2-6508-47c5-bd39-e849aeb00c32">P0Y3M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="ifb6c95fc236e4a279b1175dd18180f45_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzUtNS0xLTEtMjEzMzM5_fb75cb4f-9a8a-45b8-92f3-c23b35f8ece1">P0Y7M2D</cron:DerivativeLiabilityUsefulLifeTerm>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ie8866b2b61a742bea498367daa68d8a6_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzYtMy0xLTEtMjEzMzM5_f739de5e-2c43-4ac2-a8de-cb54c7f18e6c"
      unitRef="number">0.73</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i7bfe6a0593fb41159cec5a4ea40d283e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzYtNS0xLTEtMjEzMzM5_3a75bf27-a5ec-4dc0-ac5f-8ed8b4a335a7"
      unitRef="number">0.73</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i0e7af0d7c0e94a61b25b0698337ffed9_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzctMy0xLTEtMjEzMzM5_c252982c-2aaa-456d-9305-06a36f8f44ef"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i1cff5c2fa201489099250164076db24e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyODQ5NzA2NTM4MTY0MTU3YTc5YjViZTE3MDE1YTg1Ni90YWJsZXJhbmdlOjI4NDk3MDY1MzgxNjQxNTdhNzliNWJlMTcwMTVhODU2XzctNS0xLTEtMjEzMzM5_0954e1c4-bbb3-47a3-beac-9b053e2f5248"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ic46e2540982d4ffa8221c6ad142b2e19_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzItMS0xLTEtMjEzMzM5_bfe87a33-8f97-4c5a-91dc-bccc9582f879"
      unitRef="cadPerShare">4.98</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i571abff367a8457cb1c603791998861e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzItMy0xLTEtMjEzMzM5_26f03c1a-7145-47b7-ae74-699d51125bfc"
      unitRef="cadPerShare">4.98</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ie9c6c121779f4779b344e53ba7e3d719_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzItNS0xLTEtMjEzMzM5_f8c0fd18-f03d-45da-8b53-d0f905475780"
      unitRef="cadPerShare">4.98</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i76d8bedf7986401cba0cb84c55fb63aa_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzMtMS0xLTEtMjEzMzM5_6a8121b8-8180-4c72-aba3-47eae6dc445d"
      unitRef="cadPerShare">19.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i07f1d462f24349299006395485505244_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzMtMy0xLTEtMjEzMzM5_33955547-20a3-4f1d-89e6-e9874b1eb65c"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="icbe71946d29442afbe7fba287fc77a14_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzMtNS0xLTEtMjEzMzM5_4e4eb13f-a6b0-44f0-9be9-ebf6aae760f5"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ia83a3433c61045068fbb79983853180d_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzQtMS0xLTEtMjEzMzM5_f3bb172a-e0ac-46e0-818a-cf70e24ddd6d"
      unitRef="number">0.0079</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="if393d0d16af2495990ea4ed129432655_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzQtMy0xLTEtMjEzMzM5_6b7a0ff7-a700-4485-ae50-3525d6b75c8b"
      unitRef="number">0.0039</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i913c98b4ac7e42aca4f52f0dd64e5065_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzQtNS0xLTEtMjEzMzM5_7f4fe87e-ba01-41c9-b671-0fb42e94b87d"
      unitRef="number">0.0050</us-gaap:DerivativeLiabilityMeasurementInput>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="id510aed093fc495cb9f8a14f00900436_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzUtMS0xLTEtMjEzMzM5_dfdfcab7-8e47-40bb-beb0-c878323966fb">P1Y2M4D</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i94acb806d58748d3b52065bda492be87_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzUtMy0xLTEtMjEzMzM5_af1e5eaf-0746-46a7-ad35-5c615b8e7c16">P0Y6M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="ibc6cb6f83fce4d5a80cc6961e26b5032_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzUtNS0xLTEtMjEzMzM5_0fd2c6ea-7fbb-45be-b7a3-e78dc00bd00f">P0Y9M18D</cron:DerivativeLiabilityUsefulLifeTerm>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i6c829f39e691422b9ee160f08c4ababb_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzYtMS0xLTEtMjEzMzM5_89eb8edd-4ca4-4928-95c6-3f9656380887"
      unitRef="number">0.80</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="iefd833c70e1648639eb7783f93944757_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzYtMy0xLTEtMjEzMzM5_d0855b52-a685-4360-8e1f-6addfad1fd82"
      unitRef="number">0.80</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="if138ace4b4c24c6dadebdaf0ce503a42_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzYtNS0xLTEtMjEzMzM5_10102a6b-4259-4655-8d50-e52d550c3f06"
      unitRef="number">0.80</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ib017ada887a44e6aa4841154972d1578_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzctMS0xLTEtMjEzMzM5_ebaf94fa-3824-451b-b101-0a3900f18124"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="icf75cd22b3fc4b0d8ebc327b92866198_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzctMy0xLTEtMjEzMzM5_4804d28f-d12a-44cc-a8de-93a2346b5085"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i9612d41d77f443cdb2bc20406257be78_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTo3NTQxMDQ0NTI4ZGU0NGVlYTFmMzQ0M2Q2MDY4Y2MwMS90YWJsZXJhbmdlOjc1NDEwNDQ1MjhkZTQ0ZWVhMWYzNDQzZDYwNjhjYzAxXzctNS0xLTEtMjEzMzM5_157c613d-2a5b-485d-9b4a-d783ad082536"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i98bb2201b5a14d879713cb2138319dea_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzE4NjkxNjk3NjgzNzkw_b28acd74-dfe9-4988-a11a-67e907e286dc"
      unitRef="number">0.0381</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="if87b98056c7642a8a360e6701396a2ba_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyMzE_eb035f97-c60e-40d9-a0fb-063c86ddb034"
      unitRef="number">0.0437</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i25b512c51525471c9d8ef40e569ddcda_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYxOTg_5cb33aba-d00d-4e59-802f-fb54e7a0ad76"
      unitRef="number">0.0016</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="if9ac729cb13646a08fc56813a3bb06e3_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyMDM_da780129-ea8c-47f7-8a5c-fef8c3020171"
      unitRef="number">0.0110</us-gaap:DerivativeLiabilityMeasurementInput>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i40a5d0b4996a4e9eabaf018f06c48779_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyNjI_c8d72cf0-5276-4a7a-bb43-b1a319d52475">P0Y3M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i8d3221f7d1804397b6efac52293924b5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyNzI_7da45385-173d-46a2-bfe0-8ad3a79ddc82">P2Y9M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="icfabefd19c3f47038000b89103cb9ddc_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyMzY_8f575bc6-26af-4102-ba38-3063add43c2e">P0Y3M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="iab4b623f778f4729b3d247924c503370_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzQ5NDc4MDIzMzYyNDY_38b2c416-5ac4-4d7c-8fa5-a23a95bf29bf">P3Y9M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90ZXh0cmVnaW9uOjQ0OTM4MDk4YzgyYjQ2OGM5MWNmZjA5YmJhNzkxMTRkXzc4MzY_27039dbe-68c5-482c-8536-86acbf1de128">&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#x2019;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying amount of the derivative liability, there would also be an equal and opposite impact on net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10% decrease as of December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at issuance date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10% decrease as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i1937b23e84714a2daaa95f21590a01a0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzItMy0xLTEtMjEzMzM5_c80a7e20-6e70-4809-9009-f2f0c7c004cc"
      unitRef="usd">0</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="ibb314c21396043bfbea5f9a42e79dd19_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzItNS0xLTEtMjEzMzM5_0635bb16-c0eb-4464-bbca-65ed09c9a44a"
      unitRef="usd">4000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i1937b23e84714a2daaa95f21590a01a0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzMtMy0xLTEtMjEzMzM5_48416bba-c26a-4175-a19b-1b591f5d1130"
      unitRef="usd">0</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="ibb314c21396043bfbea5f9a42e79dd19_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzMtNS0xLTEtMjEzMzM5_48304929-38b6-4d07-904b-dd3d9972a4f5"
      unitRef="usd">5000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i1937b23e84714a2daaa95f21590a01a0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzQtMy0xLTEtMjEzMzM5_b3cd08e9-a3bf-44d6-8517-1fe8a16e4be3"
      unitRef="usd">0</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="ibb314c21396043bfbea5f9a42e79dd19_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZToyZDM3ODc4NDQ1M2E0YThkOWU3ZjIxNTFiMzRjZWJkMi90YWJsZXJhbmdlOjJkMzc4Nzg0NDUzYTRhOGQ5ZTdmMjE1MWIzNGNlYmQyXzQtNS0xLTEtMjEzMzM5_936fe141-f7ff-4e43-85c2-bd75723223c3"
      unitRef="usd">6000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzItMS0xLTEtMjEzMzM5_10b363f3-d6d9-4c4c-bf2e-a525cae33e86"
      unitRef="usd">3970000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzItMy0xLTEtMjEzMzM5_39441ffd-ae7d-4220-b7a7-cdcdd618a371"
      unitRef="usd">80000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzItNS0xLTEtMjEzMzM5_2d5e4228-8c0c-4fcc-8f57-e7ab7f9ab288"
      unitRef="usd">123000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzMtMS0xLTEtMjEzMzM5_cda7cd68-d6ae-41b2-a1af-f980366cccc8"
      unitRef="usd">2971000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzMtMy0xLTEtMjEzMzM5_65ce370f-e419-4efb-aabe-6101d03fb0da"
      unitRef="usd">171000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzMtNS0xLTEtMjEzMzM5_a3bdcb28-cbbf-40b3-9c5b-8850faca289f"
      unitRef="usd">133000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i3d8966b6deea4e22966e81612eab4061_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzQtMS0xLTEtMjEzMzM5_eb0c0bb3-ae59-4802-9894-2cbd351fc807"
      unitRef="usd">5402000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="ib95bafb189fd4abdbbf394a634a0b887_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzQtMy0xLTEtMjEzMzM5_1614f4e7-4873-404e-b068-d3fd156b112c"
      unitRef="usd">96000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="ia9a8fca9c7fe43d687bbcfe8b9f99ec9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTUvZnJhZzo0NDkzODA5OGM4MmI0NjhjOTFjZmYwOWJiYTc5MTE0ZC90YWJsZTowZmU3NWFjMDM3ZGE0YTdhOTFlOTgzMWNjMmNhYWMyMy90YWJsZXJhbmdlOjBmZTc1YWMwMzdkYTRhN2E5MWU5ODMxY2MyY2FhYzIzXzQtNS0xLTEtMjEzMzM5_b56226a6-e868-49c7-9bfd-9bd646a8d9cf"
      unitRef="usd">155000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzExNDUx_65dab51d-6519-4a7e-bde0-5f52c4606f29">Commitments and Contingencies&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;R&amp;amp;D commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ginkgo.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On September 4, 2018, the Company announced an R&amp;amp;D partnership with Ginkgo to develop scalable and consistent production of a variety of certain common and lesser-known cannabinoids. As part of this partnership, Cronos agreed to issue up to 14,674,903 common shares of the Company (aggregate value of approximately $100,000 as of July 17, 2018 assuming all milestones are met, collectively the &#x201c;Ginkgo Equity Milestones&#x201d;) in tranches and $22,000 in cash subject to Ginkgo&#x2019;s achievement of certain milestones and to fund certain R&amp;amp;D expenses, including foundry access fees. During the years ended December 31, 2022 and December 31, 2021, 4,157,888 shares and 2,934,980 shares, respectively, of the Company&#x2019;s common stock were issued in conjunction with this partnership. No shares were issued for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Technion.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion &#x2013; Israel Institute of Technology (&#x201c;Technion&#x201d;). Research was focused on the use of cannabinoids and their role in regulating skin health and skin disorders. This research was conducted by Technion over a three-year period and concluded during the fourth quarter of 2021. During the year ended December 31, 2021, the Company funded $60 of cash payments related to this agreement. The Company had no further funding requirements as of both December 31, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the &#x201c;Services Agreement&#x201d;). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of 105% and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party. See Note 15 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its consolidated financial condition but could be material to its results of operations for any particular reporting period depending, in part, on its results for that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt"&gt;Class action complaints relating to restatement of 2019 interim financial statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its Chief Executive Officer and now former Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Securities Exchange Act of 1934 (the &#x201c;Exchange Act&#x201d;) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#x2019;s prior public statements about revenues and internal control were incorrect based on the Company&#x2019;s disclosures relating to the Audit Committee of the Board of Director&#x2019;s review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names (i) the Company, (ii) its Chief Executive Officer, (iii) now former Chief Financial Officer, (iv) former Chief Financial Officer and Chief Commercial Officer, and (v) current and former members of the Board of Directors (the &#x201c;Board&#x201d;) as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#x2019;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#x2019;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#x2019;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. On June 28, 2021, the Court dismissed motions brought by the plaintiff for leave to commence a claim for misrepresentation under the Ontario Securities Act and for certification of the action as a class action. The plaintiff appealed the Court&#x2019;s dismissal of the motions only with respect to the Company, the Chief Executive Officer, and the now former Chief Financial Officer; the remaining defendants were dismissed from the matter with prejudice, and the Company and all individual defendants agreed not to seek costs from plaintiff in connection with the dismissal of the motions. On September 26, 2022, the Court of Appeal for Ontario reversed the Superior Court&#x2019;s dismissal of the leave and certification motions, granted the plaintiff leave to proceed to bring a claim for misrepresentation under the Ontario Securities Act, and remitted the certification motion back to the Superior Court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt"&gt;Regulatory reviews relating to restatements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019 as well as the previously disclosed restatement of the second quarter of 2021 interim financial statements (collectively, the &#x201c;Restatements&#x201d;). The Company has been responding to all such requests for information and cooperating with all regulatory authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;U.S. Securities and Exchange Commission Settlement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 24, 2022, the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) issued an Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8(a) of the Securities Act of 1933 (the &#x201c;Securities Act&#x201d;) and Section 21(c) of the Exchange Act, Making Findings, and Imposing a Cease-and-Desist Order (the &#x201c;SEC Order&#x201d;) resolving the Restatements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreed to settle with the SEC, without admitting or denying the allegations described in the SEC Order. The SEC Order fully and finally disposes of the investigation of the Company by the SEC into the Restatements without the payment of any civil penalty or other amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The SEC Order required the Company to cease and desist from committing or causing any violations and any future violations of Section 17(a) of the Securities Act, Sections 10(b), 13(a), 13(b)(2)(B) of the Exchange Act and Rules 10b-5, 13a-13, 13a-15(a), 13a-16 and 12b-20 thereunder. Additionally, the Company agreed to certain undertakings, which include, among other things, retaining a qualified independent consultant (the &#x201c;Consultant&#x201d;) to engage in a review of, and make recommendations with respect to, certain of the Company&#x2019;s internal accounting controls and internal control over financing reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the SEC Order, the Company (i) lost its status as a well-known seasoned issuer for a period of three years, (ii) is unable to rely on the private offering exemptions provided by Regulations A and D under the Securities Act for a period of five years and (iii) is unable to rely on the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 for a period of three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;OSC Settlement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 24, 2022, the Ontario Capital Markets Tribunal approved a settlement agreement (the &#x201c;OSC Settlement&#x201d;) between the Company and the staff of the Ontario Securities Commission (the &#x201c;OSC&#x201d;), resolving the Restatements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the terms of the OSC Settlement, which fully and finally disposes the investigation of the Company by the OSC, Cronos agreed to pay a total of C$1.34&#160;million to fully settle the matter, and acknowledged that it had failed to comply with the requirement under Section 77 of the Securities Act (Ontario) to file interim financial reports in the manner set out therein and had acted in a manner contrary to the public interest. Additionally, the Company agreed to retain the Consultant to engage in a review of, and make recommendations with respect to, certain of the Company&#x2019;s internal accounting controls and internal control over financing reporting, on substantially the same terms as were required by the SEC pursuant the SEC Order. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt"&gt;Litigation relating to marketing, distribution and sale of products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of King&#x2019;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#x2019; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$500&#160;million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5&#160;million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. On January 31, 2022, upon consent of the Company and the plaintiffs, the court dismissed the case in its entirety as to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California&#x2019;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#x2019;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Annual Report, the plaintiff has not refiled the complaint.&lt;/span&gt;&lt;/div&gt;The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares
      contextRef="i32e3dc3e21e747538d80089fb902fe97_D20180904-20180904"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE2NDkyNjc0ODQ0NDY_55b63fa4-94fb-4747-8fbf-b3333e885d75"
      unitRef="shares">14674903</cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares>
    <cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned
      contextRef="ief5d3e80cebf424583d8885fadb9005d_I20180717"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE2NDkyNjc0ODQ0NDE_0deb2ec0-3a2a-4545-868b-7f7d4827cb37"
      unitRef="usd">100000000</cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned>
    <cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones
      contextRef="i32e3dc3e21e747538d80089fb902fe97_D20180904-20180904"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE2NDkyNjc0ODQ0NTA_d9a47211-360b-46c3-afc6-934037ea61a5"
      unitRef="usd">22000000</cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones>
    <cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones
      contextRef="i4e3f054fcf0e476495404c9892296850_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzM4NDgyOTA3NDAwNTU_aa854485-1f67-4da4-8236-54dc44f6a8ff"
      unitRef="shares">4157888</cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones>
    <cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones
      contextRef="i7032a2e2cd3c413ca31f86debd15d280_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzcwNQ_2aec7338-d7b9-4cc6-a08b-adc5679b43d4"
      unitRef="shares">2934980</cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones>
    <cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones
      contextRef="id8e84bad228742d08e985829ef125a7f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzc5NQ_61101973-ddfb-4e88-ac09-38900aac9ef5"
      unitRef="shares">0</cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones>
    <cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones
      contextRef="i9a7b1865015342c2b593cd0e0f101d00_D20181015-20181015"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzEzNjk_035471e4-f6c2-4e96-917d-9dd23b588b95"
      unitRef="usd">60000</cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones>
    <cron:LongtermPurchaseCommitmentMonthlyFeePercentage
      contextRef="ie33d0799ad12401f8fb8fe45edfe1dae_D20190218-20190218"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE5MTg_ab07a5c3-1458-4e8b-8588-86a7814fecf9"
      unitRef="number">1.05</cron:LongtermPurchaseCommitmentMonthlyFeePercentage>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="ieca7109f30f44b37987e0b2301dbcd00_D20200311-20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxODk5_7fd3c03e-c804-4261-9ce8-2a98873bc349"
      unitRef="shareholder">2</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ieca7109f30f44b37987e0b2301dbcd00_D20200311-20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxOTAw_d333d67e-e05f-47e3-b4d5-70b01eb563f7"
      unitRef="complaint">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i8b07f4aa5f60422f8eee91da858d2511_D20221024-20221024"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxOTEz_7846f3e6-cc9a-4648-ba6a-a288a2724803"
      unitRef="usd">1340000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i0440f861c18e4a33b1c366ca915c82bd_D20200616-20200616"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxOTI5_f913be5c-d3f1-4270-8e0b-07ffb9d049f1"
      unitRef="cad">500000000</us-gaap:LossContingencyDamagesSoughtValue>
    <cron:LossContingencyPunitiveDamagesSoughtValue
      contextRef="i0440f861c18e4a33b1c366ca915c82bd_D20200616-20200616"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMTgvZnJhZzowZmI5MjVkYzg1NjA0MjdmOTUwYzlkOWZhNjJkMjRmYy90ZXh0cmVnaW9uOjBmYjkyNWRjODU2MDQyN2Y5NTBjOWQ5ZmE2MmQyNGZjXzE4NjkxNjk3NzIxOTQ0_191ad3d3-05de-4021-a6f3-6691a52c9d35"
      unitRef="cad">5000000</cron:LossContingencyPunitiveDamagesSoughtValue>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTg_fd8b276c-fa4b-4754-a0d3-3bf1a533a99b">Share-based Compensation&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Share-based award plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has granted stock options, RSUs and DSUs to employees and non-employee directors under the Stock Option Plan dated May 26, 2015 (the &#x201c;2015 Stock Option Plan&#x201d;), the 2018 Stock Option Plan dated June 28, 2018 (the &#x201c;2018 Stock Option Plan&#x201d; and, together with the 2015 Stock Option Plan, the &#x201c;Prior Option Plans&#x201d;), the Employment Inducement Award Plan #1 (the &#x201c;Employment Inducement Award Plan&#x201d;), the 2020 Omnibus Equity Incentive Plan dated March 29, 2020 (the &#x201c;2020 Omnibus Plan&#x201d;) and the DSU plan dated August 10, 2019 (the &#x201c;DSU Plan&#x201d;). The Company can no longer make grants under the Prior Option Plans or the Employment Inducement Award Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total share-based compensation associated with the Company&#x2019;s stock options and RSUs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-classified awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt"&gt;Represents share-based compensation awards conditionally approved for grant to one of the Company&#x2019;s former executives for a fixed monetary value, but a variable number of shares. These awards were liability-classified until the number of shares was determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted the 2015 Stock Option Plan, which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Board to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, no further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 28, 2018, the shareholders of the Company approved the 2018 Stock Option Plan, which replaced the 2015 Stock Option Plan. The 2018 Stock Option Plan terminated the Company&#x2019;s ability to grant equity under the 2015 Stock Option Plan. As of June 25, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020, the date on which the 2020 Omnibus Plan was approved by the shareholders of the Company, no further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 29, 2020, the Board adopted the 2020 Omnibus Plan, which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, RSUs and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board (the &#x201c;Compensation Committee&#x201d;), and awards may be granted to eligible employees, non-employee directors and consultants. The 2020 Omnibus Plan terminated the Company&#x2019;s ability to grant equity awards under the 2018 Stock Option Plan and RSUs under the Employment Inducement Award Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options represent the right to purchase Company common shares on the date of exercise at a stated exercise price. The exercise price of an option generally must be at least equal to the fair market value of the Company common shares on the date of grant. Vesting conditions for grants of options are determined by the Compensation Committee. The typical vesting for stock option grants is quarterly vesting over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMwOTI_c056cf0d-d43a-4943-8813-3c750ae39789"&gt;three&lt;/span&gt; to five years. The maximum term of options granted under the 2020 Omnibus Plan is seven years. Participants under the 2020 Omnibus Plan are eligible to be granted options to purchase shares at an exercise price established upon approval of the grant by the Compensation Committee. When options are granted, the exercise price is, with respect to a particular date, the closing price as reported by the TSX or the Nasdaq and, if the shares are not traded on the TSX or the Nasdaq, any other stock exchange on which the Company&#x2019;s common shares are traded (as selected by the Compensation Committee in good faith taking into account applicable legal and tax requirements) on the immediately preceding trading day (the &#x201c;Fair Market Value&#x201d;). The 2020 Omnibus Plan does not authorize grants of options with an exercise price below the Fair Market Value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,939,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,735,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(966,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,350,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,867,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,598,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,939,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,836,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt"&gt;The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2022 and 2021, the fair value per option at grant date was C$2.94 and C$6.39, respectively. The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$4.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$9.19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price (per option)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$4.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$9.19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.39%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of options (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average Black-Scholes value at grant date (per option)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$2.94&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.39&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#x2019; and non-employees&#x2019; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#x2019;s share price, adjusted for the Company&#x2019;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock options outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options outstanding as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Omnibus Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,788,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422,069&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,550,074&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,139,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,489,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,127,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,350,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,939,330&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Restricted share units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs are granted under the 2020 Omnibus Plan. RSUs represent an equivalent amount of Company common shares on the date of issuance at fair value. Fair value is determined using the closing price of the trading day immediately preceding the date of grant. RSUs issued under the 2020 Omnibus Plan typically vest over a three-year period following the grant date and have no performance requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in RSUs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,140,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,151,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation and forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(489,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,725,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation and forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;RSUs granted in the period vest annually in equal installments over a three-year period from either the grant date or after a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzYwNDk_6e990025-ef0a-4b0c-8037-643bef788633"&gt;three&lt;/span&gt; or five year &#x201c;cliff-period.&#x201d; All RSUs are subject to such holder&#x2019;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;Equity grants for 2020, 2021 and 2022 were held back for certain executives of the Company in connection with ongoing investigations by the SEC and the OSC, which were subsequently settled on October 24, 2022. On August 5, 2022, the Compensation Committee approved the release of these held-back equity grants conditioned upon settlement of the SEC and OSC investigations. These RSUs vest in equal installments over a period of three years from what would have been their original grant dates had the grants not been withheld.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;The weighted-average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Deferred share units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 10, 2019, the Company established the DSU Plan pursuant to which its non-executive directors receive DSUs for Board services. The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX for awards made prior to 2022 and as reported by Nasdaq for awards made in 2022 on the trading day immediately preceding the date of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX for awards made prior to 2022 and as reported by Nasdaq for awards made in 2022 on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company&#x2019;s common shares at the reporting date and is recorded within other liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in DSUs: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granting and vesting of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granting and vesting of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in warrants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,987,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, there were no warrants outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(f)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"&gt;Liability-classified awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, the Compensation Committee conditionally approved the grant to one of the Company&#x2019;s former executives of share-based compensation awards for a fixed monetary amount, but a variable number of common shares. These awards were liability-classified until the number of common shares was determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers to equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, there were no liability-classified awards outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4ODk_c015adba-c703-4a8b-bae2-14a3bb211ee2">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total share-based compensation associated with the Company&#x2019;s stock options and RSUs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-classified awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt"&gt;Represents share-based compensation awards conditionally approved for grant to one of the Company&#x2019;s former executives for a fixed monetary value, but a variable number of shares. These awards were liability-classified until the number of shares was determined.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzItMS0xLTEtMjEzMzM5_92dd4f8b-1c23-4848-94fa-e93034b6e798"
      unitRef="usd">6778000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzItMy0xLTEtMjEzMzM5_ad9b6f25-13e9-4895-b7bf-ac4519955a15"
      unitRef="usd">7604000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5b4ceff8a6a64ff4a32fbf710974cb5d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzItNS0xLTEtMjEzMzM5_b2cd5f23-6df8-4687-8659-e00fd240ced3"
      unitRef="usd">7185000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzMtMS0xLTEtMjEzMzM5_4166d342-c9ac-405c-b2b6-185f0c4515f6"
      unitRef="usd">7740000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzMtMy0xLTEtMjEzMzM5_6a9fd633-4de9-451c-83f3-e864b9cfa882"
      unitRef="usd">2547000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i45a89728a31a45ceb354291ab7902edf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzMtNS0xLTEtMjEzMzM5_662a8769-355c-4f8a-ba16-80f58e838280"
      unitRef="usd">8176000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtMS0xLTEtMjI3Mjcw_ef5eb9d0-6c97-433c-a7ac-67adf7fd256d"
      unitRef="usd">597000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i55b7a35047644f16be6e005b2808de2d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtMy0xLTEtMjI3MjU3_41c07ffe-c135-4a81-86f2-2ce8e95eb773"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6b53e4753cb24279a0a7dfc9ee30e88a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtNS0xLTEtMjQ3MDYw_1782efb6-e43a-4e79-ba5f-ce3de72bf957"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtMS0xLTEtMjEzMzM5_4ca86701-b20c-4765-86b3-6c932ea2182c"
      unitRef="usd">15115000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtMy0xLTEtMjEzMzM5_24c82745-22bc-4661-b200-d5f67f5624b6"
      unitRef="usd">10151000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i52d59e2073a14df0bddb28f9c82e763b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpiOGYzZWI0ZmRlMTY0YzMyOTlhY2ZhOGZkZjM3MmIyMi90YWJsZXJhbmdlOmI4ZjNlYjRmZGUxNjRjMzI5OWFjZmE4ZmRmMzcyYjIyXzQtNS0xLTEtMjEzMzM5_4a2b2214-9580-4f0a-bd80-65fe257f3755"
      unitRef="usd">15361000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="if7b11f56bc6043d89eb5e2c45e96f100_I20180628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzExODg_ac9ec761-e3b0-4ae2-9b28-33dd43675a24"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i43b1c08236a742bba4d259f97022d2cd_I20200625"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzE3NTQ_92d11f8c-9b33-4dce-8da6-ce34c6750cf9"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i15bb15a14e724f26b792f23353fb1d1c_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMwOTg_57ba6c38-ea8c-422e-ba96-b01116fad993">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id078cb5a300848a5afd3b1a38b4f82dc_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzMxNjk_42080b6b-de24-4ad1-84e9-6e4b7c1d9aec">P7Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTE_f3ab5eeb-6383-45b1-90d9-4d6278d460f9">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,939,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,735,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(966,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,350,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,867,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,598,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,939,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,836,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt"&gt;The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock options outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options outstanding as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Omnibus Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,788,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422,069&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,550,074&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,139,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,489,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,127,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,350,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,939,330&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzEtMS0xLTEtMjEzMzM5_fefa8b3d-7e10-4179-aad4-ba9a54192121"
      unitRef="cadPerShare">7.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzEtMy0xLTEtMjEzMzM5_62dd7a7e-b559-43ba-8b3a-b0b63e8d0ab6"
      unitRef="shares">8939330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzEtNS0xLTEtMjEzMzM5_73865b78-5b6d-4368-b2a7-117f46afeafe">P2Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzItMS0xLTEtMjEzMzM5_7386bd1d-db2e-4f75-bce2-f044311de67d"
      unitRef="cadPerShare">4.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzItMy0xLTEtMjEzMzM5_26a879d1-9360-41eb-9129-725cfe31c49c"
      unitRef="shares">113947</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzMtMS0xLTEtMjEzMzM5_218833f2-281a-4c4e-814b-8926a36cff02"
      unitRef="cadPerShare">2.79</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzMtMy0xLTEtMjEzMzM5_d17e3ea2-5ccf-476a-a07c-197ad339eb5e"
      unitRef="shares">2735985</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzQtMS0xLTEtMjEzMzM5_29176eda-16a8-4696-bbcd-125a69a41c2d"
      unitRef="cadPerShare">5.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzQtMy0xLTEtMjEzMzM5_23a24425-7b16-4106-ac62-f19f37c4a0f8"
      unitRef="shares">966692</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzUtMS0xLTEtMjEzMzM5_00183d6e-f540-4cc4-82f2-537a5adc0552"
      unitRef="cadPerShare">10.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzUtMy0xLTEtMjEzMzM5_590cefe5-1a9f-4323-b65a-686b5f675e08"
      unitRef="shares">5350600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzUtNS0xLTEtMjEzMzM5_e10b56b3-8187-4632-a389-d43c3269543d">P0Y8M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzYtMS0xLTEtMjEzMzM5_92cf322e-570b-4aeb-8e95-0054462df158"
      unitRef="cadPerShare">11.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzYtMy0xLTEtMjEzMzM5_a8d3fd67-a25d-4e60-95b6-5f1925421a0e"
      unitRef="shares">3867887</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozNjJmZWQwN2RiMTI0ODgzYWMyMDA2NmEyZmQ4OTM4YS90YWJsZXJhbmdlOjM2MmZlZDA3ZGIxMjQ4ODNhYzIwMDY2YTJmZDg5MzhhXzYtNS0xLTEtMjEzMzM5_460d345c-66da-4812-8c33-348a43720627">P0Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzEtMS0xLTEtMjEzMzM5_f9644ad2-a25b-41fa-bc6d-ac6b558c407e"
      unitRef="cadPerShare">5.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzEtMy0xLTEtMjEzMzM5_cc5f7bf5-51ea-421c-ae0a-0760dbec8188"
      unitRef="shares">13755148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzEtNS0xLTEtMjEzMzM5_398d56c0-b793-40e4-b7db-1bc537884829">P2Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzItMS0xLTEtMjEzMzM5_0894f5a7-80d0-42ea-8fed-b1c0ad4e14ee"
      unitRef="cadPerShare">9.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzItMy0xLTEtMjEzMzM5_ddc7b21c-5e80-4c80-9d45-bc5ece831835"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzMtMS0xLTEtMjEzMzM5_29b7971e-d2d1-4cc5-aae6-f2b42d615210"
      unitRef="cadPerShare">2.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzMtMy0xLTEtMjEzMzM5_8a98f2a9-52ab-4b7a-bd10-d9ed56f08dd8"
      unitRef="shares">5598695</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzQtMS0xLTEtMjEzMzM5_06f5edce-ec6a-42fe-9d22-9c22ad3b3b2e"
      unitRef="cadPerShare">12.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzQtMy0xLTEtMjEzMzM5_d7b70737-ebc9-442c-924f-31bbef694b39"
      unitRef="shares">117123</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzUtMS0xLTEtMjEzMzM5_9d587f3f-d206-426c-8623-825573bb3f8c"
      unitRef="cadPerShare">7.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzUtMy0xLTEtMjEzMzM5_7da6488c-c4b2-40c4-81e1-3a39c05d8c15"
      unitRef="shares">8939330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzUtNS0xLTEtMjEzMzM5_67349616-e47d-4b58-b5a7-77ec63997493">P2Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzYtMS0xLTEtMjEzMzM5_66f4b58c-75cb-4265-a50d-a2e1450be0c9"
      unitRef="cadPerShare">6.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzYtMy0xLTEtMjEzMzM5_ef243358-2fe2-4bb8-b01f-8be49222e631"
      unitRef="shares">5836616</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTplYmEzNGVkNTA1ZmI0M2Q5OGFlZjExYjQwMGNlNmYxZS90YWJsZXJhbmdlOmViYTM0ZWQ1MDVmYjQzZDk4YWVmMTFiNDAwY2U2ZjFlXzYtNS0xLTEtMjEzMzM5_1bedda4d-dd6d-4ce5-b026-00ebfa4bac42">P1Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharePrice
      contextRef="iaec054e4771b4c90b5d921f053336fc3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzE2NDkyNjc0NTA1NTE_09719c3f-d521-4b38-b176-1fc45d66a4c5"
      unitRef="cadPerShare">2.94</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i671a3f82ae654e0995f259326a3baa25_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzE2NDkyNjc0NTA1NDI_2c45e39a-5ba9-4e66-b235-8efb03741bf9"
      unitRef="cadPerShare">6.39</us-gaap:SharePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTI_58d0cc4d-1a5f-43c2-a7f2-d2b6012a5b7d">The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$4.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$9.19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price (per option)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$4.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$9.19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.39%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of options (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average Black-Scholes value at grant date (per option)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$2.94&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.39&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;(i)The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#x2019; and non-employees&#x2019; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#x2019;s share price, adjusted for the Company&#x2019;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="i9c268295fba144a989d01a9bd99cf5f8_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzEtMS0xLTEtMjEzMzM5_aec71e91-dc34-48f3-b3ff-63f88dec1af3"
      unitRef="cadPerShare">4.20</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i0014408a0e804e82a06b2f923cd14abd_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzEtMy0xLTEtMjEzMzM5_65f9832f-7f99-476a-8ce6-282bba1ce0b9"
      unitRef="cadPerShare">9.19</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i9c268295fba144a989d01a9bd99cf5f8_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzItMS0xLTEtMjEzMzM5_331e5402-349b-47ee-888a-b0a32a1ea210"
      unitRef="cadPerShare">4.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i0014408a0e804e82a06b2f923cd14abd_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzItMy0xLTEtMjEzMzM5_c3fb2adf-9ddd-48ed-b689-3564e84b0497"
      unitRef="cadPerShare">9.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzMtMS0xLTEtMjEzMzM5_4f792944-7537-4b24-9fb3-34c889ba1d81"
      unitRef="number">0.0314</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzMtMy0xLTEtMjEzMzM5_b8b66518-8eca-4c51-b6cf-a81fec72f0ef"
      unitRef="number">0.0139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzQtMS0xLTEtMjEzMzM5_8bf64cad-3b4a-49e9-a538-24874d2b7bf5">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzQtMy0xLTEtMjEzMzM5_1a502489-26af-4af7-92ec-c2c27746caf7">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzUtMS0xLTEtMjEzMzM5_98469e92-dfcb-4656-a98a-6f542fe77db6"
      unitRef="number">0.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzUtMy0xLTEtMjEzMzM5_752692cf-ba83-4af0-831b-0aa872fccecf"
      unitRef="number">0.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzYtMS0xLTEtMjEzMzM5_058db739-b6c1-4d9c-8fcd-3ee3d19b36a5"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzYtMy0xLTEtMjEzMzM5_83d669e3-80f5-4fe1-843e-822e104b80ee"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue
      contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzctMS0xLTEtMjEzMzM5_d12905f7-ad33-4172-ab50-f275159d3edb"
      unitRef="cadPerShare">2.94</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue
      contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzctMy0xLTEtMjEzMzM5_ae55c2ce-0ae0-45a4-ae4d-b272fa828cc5"
      unitRef="cadPerShare">6.39</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzgtMS0xLTEtMjEzMzM5_72232a8e-0148-4466-9b2d-73390bc8b365"
      unitRef="number">0</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphNDk4Y2E2Y2IyMmE0NzBmOGM0N2Y2ZjE2ZTEzMjAyNy90YWJsZXJhbmdlOmE0OThjYTZjYjIyYTQ3MGY4YzQ3ZjZmMTZlMTMyMDI3XzgtMy0xLTEtMjEzMzM5_5a482bbf-725f-42f1-9f3e-910c63f7470e"
      unitRef="number">0</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i4da8bcc218e7495696143aafa8c5b34e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzItMS0xLTEtMjEzMzM5_21a7723e-d5b1-46e5-91ba-bbf1eb1ac614"
      unitRef="shares">2788947</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib632c4ab2a854cfb952e785b1c5b1f92_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzItMy0xLTEtMjEzMzM5_70f6602a-e2aa-4449-9c7f-444009857194"
      unitRef="shares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i82525d4a3a8f469f81973ca388451122_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzItNS0xLTEtMjEzMzM5_85b68241-7e90-4afd-82f5-d6fa336329e2"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2bafcc4c72134f0384d7d6c79566a00b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzMtMS0xLTEtMjEzMzM5_14af8fb4-c153-4888-86b2-ef4bbeb5bd21"
      unitRef="shares">1422069</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic81b826c9f6f47168c91d1cb32f0a31c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzMtMy0xLTEtMjEzMzM5_46592b38-8ab1-4c05-9871-c0187a01f32e"
      unitRef="shares">1550074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3da422e72bff47219c139aac3b9de694_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzMtNS0xLTEtMjEzMzM5_72b277e5-31c2-4dca-9086-c7d109b6d06e"
      unitRef="shares">1627715</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0d50f7ee161742d4869f0c80a6f2c830_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzQtMS0xLTEtMjEzMzM5_5405cf51-a148-43d9-9cec-68ec09e4a275"
      unitRef="shares">1139584</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3696af6fe23941a9aca7c712298dc6df_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzQtMy0xLTEtMjEzMzM5_e71f025e-d61e-416e-a470-e03405a5fc2a"
      unitRef="shares">4489256</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id1615a90b3b04370a4c4f8cdb7323bcb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzQtNS0xLTEtMjEzMzM5_8dc79857-a627-4414-868c-272e0682a583"
      unitRef="shares">10127433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzUtMS0xLTEtMjEzMzM5_8651c043-880e-4fd8-a98e-338a6519a6da"
      unitRef="shares">5350600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzUtMy0xLTEtMjEzMzM5_9886c788-5599-424e-97fd-e9b9f3126fc1"
      unitRef="shares">8939330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowNzE1MTFlZTUxZDU0ODJlOTY4NDdhM2JkNmU1ZWJhYS90YWJsZXJhbmdlOjA3MTUxMWVlNTFkNTQ4MmU5Njg0N2EzYmQ2ZTVlYmFhXzUtNS0xLTEtMjEzMzM5_0f8ad7cb-41b8-4035-b9e2-3573e21faa1e"
      unitRef="shares">13755148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTU_c5c22158-3988-46c6-b85a-ad6dd03a39c7">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc5MDE_29c3d252-672d-40c6-871b-2fca6ce49ba0">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in RSUs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,140,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,151,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation and forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(489,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,725,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation and forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;RSUs granted in the period vest annually in equal installments over a three-year period from either the grant date or after a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzYwNDk_6e990025-ef0a-4b0c-8037-643bef788633"&gt;three&lt;/span&gt; or five year &#x201c;cliff-period.&#x201d; All RSUs are subject to such holder&#x2019;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;Equity grants for 2020, 2021 and 2022 were held back for certain executives of the Company in connection with ongoing investigations by the SEC and the OSC, which were subsequently settled on October 24, 2022. On August 5, 2022, the Compensation Committee approved the release of these held-back equity grants conditioned upon settlement of the SEC and OSC investigations. These RSUs vest in equal installments over a period of three years from what would have been their original grant dates had the grants not been withheld.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;The weighted-average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i81cf921ce7a8454989e3197113c2db54_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzEtMS0xLTEtMjEzMzM5_7b9096d9-08a5-41cf-a847-f37d4b5199eb"
      unitRef="cadPerShare">9.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i81cf921ce7a8454989e3197113c2db54_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzEtMy0xLTEtMjEzMzM5_56bdc9b7-4c55-4937-bbd4-399ca94eda56"
      unitRef="shares">1225870</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzItMS0xLTEtMjEzMzM5_c8cf68cf-b939-4027-bee3-fa825f402bfd"
      unitRef="cadPerShare">4.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzItMy0xLTEtMjEzMzM5_d7e23710-998d-40b7-baec-8c1b68a37cd0"
      unitRef="shares">6140492</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzMtMS0xLTEtMjEzMzM5_c9fc3315-843c-445d-bbef-778976cae7c6"
      unitRef="cadPerShare">7.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzMtMy0xLTEtMjEzMzM5_0cc74250-e04f-477e-a1a8-5633b3f4e8c8"
      unitRef="shares">1151292</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzQtMS0xLTEtMjEzMzM5_536e53c1-11f5-405e-bdae-f4fead78b0ce"
      unitRef="cadPerShare">5.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzQtMy0xLTEtMjEzMzM5_95b73e1c-3e24-409b-87a2-aebd7cd71e54"
      unitRef="shares">489600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5a57a4ae358343efa921579efb8a3332_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzUtMS0xLTEtMjEzMzM5_94ef8086-70c8-4bf0-9bd4-28fabf3e5ff8"
      unitRef="cadPerShare">4.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5a57a4ae358343efa921579efb8a3332_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTphODFiNWExOGM1ZDY0NjU3ODgxNTY3YmEzMjVmOWRmYi90YWJsZXJhbmdlOmE4MWI1YTE4YzVkNjQ2NTc4ODE1NjdiYTMyNWY5ZGZiXzUtMy0xLTEtMjEzMzM5_9d958f05-d804-4644-9521-40a19558c6fe"
      unitRef="shares">5725470</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3e0f5c40899c45bab72391f0ad745e88_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzEtMS0xLTEtMjEzMzM5_a7cf855f-1f9b-4533-ae14-fd7e881f2f69"
      unitRef="cadPerShare">7.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3e0f5c40899c45bab72391f0ad745e88_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzEtMy0xLTEtMjEzMzM5_b1c33a90-2af9-42fa-8a81-0a109a0e5fc8"
      unitRef="shares">948357</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzItMS0xLTEtMjEzMzM5_cf2b11e2-fc8a-45a1-8651-edb801dc7d3e"
      unitRef="cadPerShare">11.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzItMy0xLTEtMjEzMzM5_2c474140-adaf-4afe-aeba-39cd57583bcb"
      unitRef="shares">576876</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzMtMS0xLTEtMjEzMzM5_044dcee5-cd28-4757-a7a0-432ad608d963"
      unitRef="cadPerShare">7.57</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzMtMy0xLTEtMjEzMzM5_b1f58235-570a-44e2-998d-2c8a318b2d83"
      unitRef="shares">158178</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzQtMS0xLTEtMjEzMzM5_77fa3fee-b53c-489b-9d32-9171c133b013"
      unitRef="cadPerShare">8.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzQtMy0xLTEtMjEzMzM5_5024d2cd-d196-4c08-8f0b-07b6e69b6d2f"
      unitRef="shares">141185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i81cf921ce7a8454989e3197113c2db54_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzUtMS0xLTEtMjEzMzM5_4c8f49e5-f0bd-4b6f-9193-0efd7a94a0c0"
      unitRef="cadPerShare">9.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i81cf921ce7a8454989e3197113c2db54_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDkzOGMxMDkxZjM0ZmJhOWYzMWRmZGQyY2Q0ZmZlMy90YWJsZXJhbmdlOjNkOTM4YzEwOTFmMzRmYmE5ZjMxZGZkZDJjZDRmZmUzXzUtMy0xLTEtMjEzMzM5_36591261-1c7e-472e-b8f7-47315965db33"
      unitRef="shares">1225870</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4ODg_109c7cd7-9868-4eff-9292-119dce235f68">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod
      contextRef="if649373ae72c46ac8d40aad21853ce38_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTY_35cefe4e-02c0-4499-9663-6af2e0dcc40f">P5Y</cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc5MDQ_f07afa07-bff5-4069-bae7-9478e813768a">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in DSUs: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granting and vesting of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granting and vesting of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="iaea6684c36904e87baf20b2725c37ceb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzEtMS0xLTEtMjEzMzM5_0308937a-bf3f-47d5-9008-da314cc331c7"
      unitRef="usd">408000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iaea6684c36904e87baf20b2725c37ceb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzEtMy0xLTEtMjEzMzM5_0c84605f-b8f3-4139-bc94-473135cd0e75"
      unitRef="shares">104442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i211045d7eac247689ade396e222267c3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzItMS0xLTEtMjEzMzM5_d116c96e-fb5b-4643-841a-f5d7336160e8"
      unitRef="usd">443000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod
      contextRef="i211045d7eac247689ade396e222267c3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzItMy0xLTEtMjEzMzM5_4c5e9c94-ab7e-418d-be34-f2a9f9fa741b"
      unitRef="shares">161290</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod>
    <cron:ShareBasedPaymentArrangementGainLossOnRevaluation
      contextRef="i211045d7eac247689ade396e222267c3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzQtMS0xLTEtMjEzMzM5_f44a2704-1b39-4900-adce-1efd4403b8c2"
      unitRef="usd">177000</cron:ShareBasedPaymentArrangementGainLossOnRevaluation>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="idf37dbf34d9e4ca2a9617b7383689d3e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzUtMS0xLTEtMjEzMzM5_0ee02375-2b48-4295-a908-9e04d020a031"
      unitRef="usd">674000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idf37dbf34d9e4ca2a9617b7383689d3e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTozZDhlZDUyZjcyZTk0MWRhOGJkYWMxOGNkYzVjZTMzYS90YWJsZXJhbmdlOjNkOGVkNTJmNzJlOTQxZGE4YmRhYzE4Y2RjNWNlMzNhXzUtMy0xLTEtMjEzMzM5_b7453d60-b97f-46f8-9aca-f4b07d740dd0"
      unitRef="shares">265732</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="i45e09226123b4314955596439da54b30_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzEtMS0xLTEtMjEzMzM5_4453cc5c-2b27-48fd-ae74-0fc1d848401c"
      unitRef="usd">577000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i45e09226123b4314955596439da54b30_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzEtMy0xLTEtMjEzMzM5_f509c2ec-1c3c-400f-b589-b7a918d35a08"
      unitRef="shares">83293</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzItMS0xLTEtMjEzMzM5_fbfc60ab-c1da-4579-a49a-26cfa5271fa5"
      unitRef="usd">354000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod
      contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzItMy0xLTEtMjEzMzM5_8d59d39e-8639-4812-b5dc-b1ff39c21aea"
      unitRef="shares">48913</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod>
    <cron:ShareBasedPaymentArrangementLiabilitiesSettled
      contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzMtMS0xLTEtMjEzMzM5_d3cddf3c-87d3-472d-bffd-14e92e56650d"
      unitRef="usd">203000</cron:ShareBasedPaymentArrangementLiabilitiesSettled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzMtMy0xLTEtMjEzMzM5_a7e5ca48-0824-4f8e-84f1-c2b03c53d9ae"
      unitRef="shares">27764</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <cron:ShareBasedPaymentArrangementGainLossOnRevaluation
      contextRef="i5719b0c7c883495695d48e2da8cbab91_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzQtMS0xLTEtMjEzMzM5_c0f5eb4b-ae28-4215-8781-ebcda4e9e535"
      unitRef="usd">320000</cron:ShareBasedPaymentArrangementGainLossOnRevaluation>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="iaea6684c36904e87baf20b2725c37ceb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzUtMS0xLTEtMjEzMzM5_b7ec741e-0d1c-43cf-8d85-42381f137362"
      unitRef="usd">408000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iaea6684c36904e87baf20b2725c37ceb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTowYzNkNDAzNTViMTc0MzgyOTBjN2E3NjhjZWEzYjgzNi90YWJsZXJhbmdlOjBjM2Q0MDM1NWIxNzQzODI5MGM3YTc2OGNlYTNiODM2XzUtMy0xLTEtMjEzMzM5_271deb5c-f855-4c53-a027-47812ffdaa94"
      unitRef="shares">104442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0Xzc4OTM_13c333f6-0ac3-4edd-b148-c28fd8ce5cf9">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in warrants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,987,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i44c6585cf14349b9a9f2167c67b4459e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzEtMS0xLTEtMjEzMzM5_e0612e87-a4e0-4e38-9cd9-5d852ddf6826"
      unitRef="cadPerShare">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i44c6585cf14349b9a9f2167c67b4459e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzEtMy0xLTEtMjEzMzM5_80890675-aac4-4a46-bd36-b1067116f413"
      unitRef="shares">7987349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i831f4a43963e485884c99ebee4119ee1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzItMS0xLTEtMjEzMzM5_18449195-15d6-44d5-bc8e-ea851347aea9"
      unitRef="cadPerShare">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i831f4a43963e485884c99ebee4119ee1_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzItMy0xLTEtMjEzMzM5_50d2a812-ef3b-425b-8833-1f9ea210d63c"
      unitRef="shares">7987349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia45aee9721104c22a2d6be5ae87f587a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzQtMS0xLTEtMjEzMzM5_72452967-ba46-4110-894f-18ada24b6638"
      unitRef="cadPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia45aee9721104c22a2d6be5ae87f587a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTpjYzQzZTk4NjZkNmE0MTBjYjIwNWI2MmQ3ODRkOWU2NC90YWJsZXJhbmdlOmNjNDNlOTg2NmQ2YTQxMGNiMjA1YjYyZDc4NGQ5ZTY0XzQtMy0xLTEtMjEzMzM5_88769bcc-26ee-4388-8774-6c5da0054664"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90ZXh0cmVnaW9uOmIyYzg3YzA1YTQ4YjQ5MjFiZTI3ZGUxZjJiMDE4ODk0XzE2NDkyNjc0NDMwMzEy_0cce9da1-3419-4e28-a747-3676eacf1007">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers to equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="i5443078b1c0d43fea330c2f7752fe5e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTo5NWNmMDUzM2FmNDc0NjFlYmY0ZDA4NDk0YTJjOGViYi90YWJsZXJhbmdlOjk1Y2YwNTMzYWY0NzQ2MWViZjRkMDg0OTRhMmM4ZWJiXzEtMS0xLTEtMjUzMTQ2_35353623-b944-4708-8648-3514503a06b6"
      unitRef="usd">0</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTo5NWNmMDUzM2FmNDc0NjFlYmY0ZDA4NDk0YTJjOGViYi90YWJsZXJhbmdlOjk1Y2YwNTMzYWY0NzQ2MWViZjRkMDg0OTRhMmM4ZWJiXzItMS0xLTEtMjUwMzY4_750efb11-5d70-4998-a0e2-66df5ec9873a"
      unitRef="usd">597000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:DeferredCompensationShareBasedArrangementsTransferToEquityAwards
      contextRef="i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTo5NWNmMDUzM2FmNDc0NjFlYmY0ZDA4NDk0YTJjOGViYi90YWJsZXJhbmdlOjk1Y2YwNTMzYWY0NzQ2MWViZjRkMDg0OTRhMmM4ZWJiXzMtMS0xLTEtMjUwNDIw_d84fe702-4b3e-4732-910e-06d1a2323fd0"
      unitRef="usd">597000</cron:DeferredCompensationShareBasedArrangementsTransferToEquityAwards>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="i3564953f2ea840f583b304e6f9918665_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjEvZnJhZzpiMmM4N2MwNWE0OGI0OTIxYmUyN2RlMWYyYjAxODg5NC90YWJsZTo5NWNmMDUzM2FmNDc0NjFlYmY0ZDA4NDk0YTJjOGViYi90YWJsZXJhbmdlOjk1Y2YwNTMzYWY0NzQ2MWViZjRkMDg0OTRhMmM4ZWJiXzUtMS0xLTEtMjUzMTQ4_9b574415-20ae-4439-9d7f-d9cbab0153ca"
      unitRef="usd">0</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzI_87444eaf-63b3-410d-860b-f3ad344ec496">Income Taxes&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial reporting purposes, loss from continuing operations before income taxes includes the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loss before income taxes above excludes losses from discontinued operations of $nil, $500 and $650 for the year ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) consists of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, 2021 and 2020, the Company&#x2019;s current income taxes payable were $32,956, $105 and $865, respectively, related to current income tax expense. Included in other receivables as of December&#160;31, 2022, 2021 and 2020 is $40, $543 and $nil, respectively, related to current income tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax differs from that computed using the combined Canadian federal and provincial statutory income tax rate of 26.5%. Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.199%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.199%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-taxable income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of provincial tax rate difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of tax rates outside of Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value gain on financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,873)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital gain on financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance recorded against the loss on discontinued operations is not reflected in the effective tax rate reconciliation presented above for continuing operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2022, the Company realized a capital gain for tax purposes of $479,800 as a result of Altria&#x2019;s irrevocable relinquishment of the Altria Warrant on December 16, 2022, resulting in an increase in the total income tax expense reported for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant components of the Company&#x2019;s deferred tax assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D investment tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224,776)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;padding-left:20.88pt;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Net deferred tax asset (liability) is reported as Other assets within our consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The realization of deferred tax assets is dependent on the Company&#x2019;s generating sufficient taxable income in the years that the temporary differences become deductible. A valuation allowance has been provided for the deferred tax assets that the Company determined did not meet the more-likely-than-not recognition threshold under U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022 and 2021, the Company&#x2019;s valuation allowance was $214,199 and $224,776, respectively. The valuation allowance decreased by $10,577 during the year ended December 31, 2022, and increased by $138,841 during the year ended December 31, 2021. The decrease in the valuation allowance during the year ended December 31, 2022, was primarily due to the recognition of a portion of deferred tax assets for which a valuation allowance was recorded in the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#x2019; taxable income of approximately $216,120, $134,593, $18,739, respectively. As of December&#160;31, 2021, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#x2019; taxable income of approximately $276,497, $117,983, and $24,843, respectively. The net operating losses in Canada will begin to expire, for purposes of carryforward, in fiscal year 2033. The net operating losses in the U.S. can be carried forward indefinitely for federal purposes. The net operating losses in Israel can be carried forward indefinitely. The decrease in net operating loss carry-forward balance reported in Canada was primarily due to the Company utilizing a portion of its net operating loss carry-forward balance in Canada to offset a portion of the capital gain realized as a result of Altria&#x2019;s irrevocable relinquishment of the Altria Warrant on December 16, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Utilization of the net operating loss carryforwards may be subject to limitations under the tax laws applicable in each tax jurisdiction due to ownership changes that could occur in the future. These ownership changes could limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax expense. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact the Company&#x2019;s effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the Company has various scientific research and experimental development investment tax credit carryforwards of $293 related to Canadian operations, which, if not utilized, will begin to expire in 2040. Investment tax credits are recognized when realization of the tax credits is more likely than not.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files federal income tax returns in Canada, Israel and the U.S. The Company has open tax years with the taxation jurisdictions. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;regulations and tax treaties, as they relate to the amount, timing, or inclusion of revenue and expense. As of December&#160;31, 2022, Peace Naturals is under examination with the Canadian Reserve Agency for tax years 2019 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Open Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 &#x2013; 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 &#x2013; 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 &#x2013; 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting guidance clarifies the accounting for uncertain tax positions and prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. Additionally, the authoritative guidance addresses the derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions. Only tax positions that meet the more-likely-than-not recognition threshold may be recognized. There were no identified unrecognized tax benefits as of December&#160;31, 2022 or December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, deferred income taxes have not been provided for any undistributed earnings from operations outside of Canada. The foreign subsidiaries have accumulated losses and as such the amount of undistributed earnings upon which income taxes have not been provided is immaterial to these consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzM_c3fabb28-996b-4809-aec6-bc565e4bfe9c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial reporting purposes, loss from continuing operations before income taxes includes the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie890eaff21934fd69d0a7950a5a10f27_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzItMi0xLTEtMjEzMzM5_f03ee662-7573-4749-9cf6-5ce8038e6326"
      unitRef="usd">-55502000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia60068e6af9e472faf93c6ad942fa0a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzItNC0xLTEtMjEzMzM5_6aa738b8-5365-483c-a15d-3f339385b186"
      unitRef="usd">-116267000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id22735cc325a45779460153828233a0d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzItNi0xLTEtMjEzMzM5_d454fe2a-df59-4313-a77e-1f320fdfdabc"
      unitRef="usd">12679000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie2f47442c54744328388ffe428c9d717_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzMtMi0xLTEtMjEzMzM5_f0c479fd-3d19-4e85-ad49-c2e9315505d7"
      unitRef="usd">-79057000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzMtNC0xLTEtMjEzMzM5_85ca3bab-95f7-43b4-b045-2e009a8c4475"
      unitRef="usd">-280868000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzMtNi0xLTEtMjEzMzM5_356aa3e2-c24c-43dc-908a-4d7b1d254f14"
      unitRef="usd">-85952000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzQtMi0xLTEtMjEzMzM5_817f17a2-728d-4b0f-9cb9-c5434b236ca5"
      unitRef="usd">-134559000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzQtNC0xLTEtMjEzMzM5_28db9007-5d4c-453d-9536-1297dff16826"
      unitRef="usd">-397135000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo0MjYxMmVkODQ0OTQ0ZTc3ODk1YzYxMDIyZjUzMGNkZC90YWJsZXJhbmdlOjQyNjEyZWQ4NDQ5NDRlNzc4OTVjNjEwMjJmNTMwY2RkXzQtNi0xLTEtMjEzMzM5_6d24ea00-adc4-4b90-90be-e2fdd1a0be53"
      unitRef="usd">-73273000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzM5NzI_159eadb1-ba45-48c2-b550-58efaaa4c1cc"
      unitRef="usd">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzE2NDkyNjc0NDY5OTU_103a656c-5202-40e6-947e-b92bbcb945a3"
      unitRef="usd">-500000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzE2NDkyNjc0NDcwMDA_189ccd72-aeee-40f4-919b-9165f4af11cd"
      unitRef="usd">-650000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzU_ce04cd2a-3bf9-4abc-bf46-a2933e06313a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) consists of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ie890eaff21934fd69d0a7950a5a10f27_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzMtMi0xLTEtMjEzMzM5_443f2bb2-b4f3-4e7a-9360-dd59f17ad8fe"
      unitRef="usd">34416000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ia60068e6af9e472faf93c6ad942fa0a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzMtNC0xLTEtMjEzMzM5_e511c412-6aa7-47f7-8a68-36de20227e38"
      unitRef="usd">-382000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="id22735cc325a45779460153828233a0d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzMtNi0xLTEtMjEzMzM5_1c68dd23-76b1-47c4-9712-52fff3fabfb8"
      unitRef="usd">1024000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ie2f47442c54744328388ffe428c9d717_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzQtMi0xLTEtMjEzMzM5_7185f1f4-c9ef-4c76-9a99-744b74f85699"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzQtNC0xLTEtMjEzMzM5_af7165ad-b684-4972-b2d1-1cf6c5a7dfd0"
      unitRef="usd">-89000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzQtNi0xLTEtMjEzMzM5_d7d4b465-c0fb-4d9d-b233-d9585f103d8d"
      unitRef="usd">323000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzUtMi0xLTEtMjEzMzM5_00e377f5-d647-4b2f-b380-846fd96390e7"
      unitRef="usd">34416000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzUtNC0xLTEtMjEzMzM5_6c3838f7-5754-4cf0-8bec-401b2b9d5c28"
      unitRef="usd">-471000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzUtNi0xLTEtMjEzMzM5_c0db3729-f5c3-4f85-9da6-18e2420dac32"
      unitRef="usd">1347000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie890eaff21934fd69d0a7950a5a10f27_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzctMi0xLTEtMjEzMzM5_eb974bbc-8537-4479-95a4-25ab67066dd1"
      unitRef="usd">-241000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia60068e6af9e472faf93c6ad942fa0a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzctNC0xLTEtMjEzMzM5_69045f12-f3e2-44bc-931e-9df729d3835b"
      unitRef="usd">40000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="id22735cc325a45779460153828233a0d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzctNi0xLTEtMjEzMzM5_c066a527-65f1-402b-a80f-ad8c336d9654"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie2f47442c54744328388ffe428c9d717_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzgtMi0xLTEtMjEzMzM5_b8cfef98-e74e-4af8-aa10-3db46f111bc9"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzgtNC0xLTEtMjEzMzM5_02dcfc25-f998-4004-8d31-c363a899b08b"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzgtNi0xLTEtMjEzMzM5_8e347eb7-2079-422f-8deb-682d8ae3c3cd"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzktMi0xLTEtMjEzMzM5_f8731a07-2e48-48d8-8c29-81ca5da4473d"
      unitRef="usd">-241000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzktNC0xLTEtMjEzMzM5_24b9cf1b-3428-47da-aac1-3698d63a55cf"
      unitRef="usd">40000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo1YjdjODM0MjQ1MjM0OWNjODc5Zjk0NTZhY2U2YWI0MC90YWJsZXJhbmdlOjViN2M4MzQyNDUyMzQ5Y2M4NzlmOTQ1NmFjZTZhYjQwXzktNi0xLTEtMjEzMzM5_2fa1f020-8175-4279-bb06-4d271d49dad8"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:TaxesPayableCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzM5ODc_5a9e947a-4083-452e-b64b-d19e6842dafe"
      unitRef="usd">32956000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzM5OTc_3227641d-1d60-441c-8a60-783c52156eb9"
      unitRef="usd">105000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwMDc_708cabb3-1c67-4155-9645-7ff2713cc65b"
      unitRef="usd">865000</us-gaap:TaxesPayableCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwMTc_7c6cb5e4-5f11-4b7b-af3f-ceb9826d2a44"
      unitRef="usd">40000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwMjg_28a9ca5e-15ac-475b-bd83-727589c992fc"
      unitRef="usd">543000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwMzI_1d49b9bb-fd83-4a93-a5e7-89f011d48209"
      unitRef="usd">0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzY_1289aaa3-8c6d-4429-9343-8334f2390e78">Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.199%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.199%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-taxable income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of provincial tax rate difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of tax rates outside of Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value gain on financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,873)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital gain on financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzItMi0xLTEtMjEzMzM5_7ee1a88e-7155-46e2-83b7-6f5af3ca0fcc"
      unitRef="usd">-134559000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzItNC0xLTEtMjEzMzM5_773f20fb-f29c-49f4-b735-4609b57d1ce5"
      unitRef="usd">-397135000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzItNi0xLTEtMjEzMzM5_33b536ec-4008-455a-8652-c80bfdfca9ee"
      unitRef="usd">-73273000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzMtMi0xLTEtMjEzMzM5_fd575568-0e87-4324-846a-2dcb5a0a331f"
      unitRef="number">0.265</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzMtNC0xLTEtMjEzMzM5_4ba537bc-4bf8-401c-85a6-6b977bd47cf1"
      unitRef="number">0.265</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzMtNi0xLTEtMjEzMzM5_1e2bc87b-438e-4085-89d0-c085e9ee389f"
      unitRef="number">0.265</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzQtMi0xLTEtMjEzMzM5_23c9a8c4-4771-4269-a0d2-94bc76764883"
      unitRef="usd">-35658000</cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount>
    <cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzQtNC0xLTEtMjEzMzM5_0e5233bd-a9a7-4602-a4a1-ee32775d28d8"
      unitRef="usd">-105241000</cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount>
    <cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzQtNi0xLTEtMjEzMzM5_897f6248-0f16-4937-b76c-b9ce8e5ce6da"
      unitRef="usd">-19417000</cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzYtMi0xLTEtMjEzMzM5_0a5bd4af-5f38-4bc1-81b9-5ad6012db1d4"
      unitRef="usd">2140000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzYtNC0xLTEtMjEzMzM5_d83bb794-b23e-474e-8361-7e508dfc035d"
      unitRef="usd">-39000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzYtNi0xLTEtMjEzMzM5_33590366-2033-4e9e-8d8d-7b9e46135623"
      unitRef="usd">711000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzctMi0xLTEtMjEzMzM5_7c92cd18-49b3-4962-aee7-e427b8d6094c"
      unitRef="usd">1198000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzctNC0xLTEtMjEzMzM5_cef772b8-e6fe-4aab-9ea4-cafcda43db6f"
      unitRef="usd">1667000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzctNi0xLTEtMjEzMzM5_d8558188-534a-4443-9710-ae74386d1054"
      unitRef="usd">2498000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzgtMi0xLTEtMjEzMzM5_90334747-0ca4-49c6-9cb4-32326d4682a5"
      unitRef="usd">836000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzgtNC0xLTEtMjEzMzM5_2a3f94d9-0262-4d70-96be-7deb499396ba"
      unitRef="usd">53000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzgtNi0xLTEtMjEzMzM5_c1ffe127-400a-4011-88f1-f97149678ed9"
      unitRef="usd">1364000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzktMi0xLTEtMjEzMzM5_cd48ead1-0ef8-4223-bf3b-15a8e3ecc3f3"
      unitRef="usd">1625000</cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount>
    <cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzktNC0xLTEtMjEzMzM5_bac47782-fdff-4b71-b9c3-cf69ec1ffe19"
      unitRef="usd">2917000</cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount>
    <cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzktNi0xLTEtMjEzMzM5_ab1a7737-5dc3-4b02-b278-adc91dd54db6"
      unitRef="usd">3146000</cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEwLTItMS0xLTIxMzMzOQ_aab857f0-a773-4899-bc3f-7313e908232d"
      unitRef="usd">-15000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEwLTQtMS0xLTIxMzMzOQ_e8c11a63-51de-43d4-ba3b-23d6eea331e7"
      unitRef="usd">-1000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEwLTYtMS0xLTIxMzMzOQ_016e4b93-5045-4e92-8204-18adaa263d8c"
      unitRef="usd">-15000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzExLTItMS0xLTIxMzMzOQ_6ac86575-e515-4ff2-be98-f2966cfe2c48"
      unitRef="usd">1848000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzExLTQtMS0xLTIxMzMzOQ_a819e3e1-4107-425d-b8f6-a6d58597769e"
      unitRef="usd">-1869000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzExLTYtMS0xLTIxMzMzOQ_81376c61-b875-4c8a-9ff4-5a8f497fdbf7"
      unitRef="usd">-362000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTItMS0xLTI0OTIwOA_1f6493d8-2a5f-497e-9ad2-14b80d54bb8c"
      unitRef="usd">11041000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTQtMS0xLTI0OTIwOA_1fbce260-bab4-4c66-b1d6-a7e65475dace"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTYtMS0xLTI0OTIwOA_6b8c71e6-6b90-4580-a653-8cfc173524f1"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTItMS0xLTIxMzMzOQ_ea9fefc7-f811-47f9-82a1-f462263d5226"
      unitRef="usd">3726000</cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount>
    <cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTQtMS0xLTIxMzMzOQ_f7d39661-94ab-4128-be39-5e8dd0c5f3f3"
      unitRef="usd">40111000</cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount>
    <cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEyLTYtMS0xLTIxMzMzOQ_cd9a093e-85d7-43e6-99ae-f5cb3302dbcb"
      unitRef="usd">34250000</cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEzLTItMS0xLTIxMzMzOQ_7063db37-96d5-4b4b-8722-98f505e8b4e5"
      unitRef="usd">-6873000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEzLTQtMS0xLTIxMzMzOQ_3c8e0a04-e6e7-4ca4-93e3-3fe545295b28"
      unitRef="usd">141639000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzEzLTYtMS0xLTIxMzMzOQ_266664ab-e0ec-4e19-af3c-1df11bce0530"
      unitRef="usd">48227000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTItMS0xLTI0MjgxNA_0354d26a-5300-47ae-916e-b3d8acc7e671"
      unitRef="usd">66193000</cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount>
    <cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTQtMS0xLTI0MjgxNA_1284b268-219d-4f9d-be03-f977dd0f1dca"
      unitRef="usd">0</cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount>
    <cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTYtMS0xLTI0MjgxNA_bd27fb06-67cd-4578-8518-47dd07d92bbe"
      unitRef="usd">0</cron:EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTItMS0xLTIxMzMzOQ_084e5530-7e5a-4844-9eb5-966e18b2f040"
      unitRef="usd">-154000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTQtMS0xLTIxMzMzOQ_58070633-db63-4661-9a21-6bc54a43e14b"
      unitRef="usd">476000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE0LTYtMS0xLTIxMzMzOQ_97c2c1ca-f37c-49fc-8a79-3d383a32ebce"
      unitRef="usd">867000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE1LTItMS0xLTIxMzMzOQ_1d3a6a28-c3c1-4a9b-bfe0-738e63a994a4"
      unitRef="usd">34175000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE1LTQtMS0xLTIxMzMzOQ_cf8ea9f5-1899-44b5-b3af-3f49c1482c84"
      unitRef="usd">-431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTo3OTkyNjQzNTdiNDY0ZmUyOTI0MTE0Yzc3YTNjYzViOS90YWJsZXJhbmdlOjc5OTI2NDM1N2I0NjRmZTI5MjQxMTRjNzdhM2NjNWI5XzE1LTYtMS0xLTIxMzMzOQ_c521f701-087f-487d-a006-b2f4f5199e83"
      unitRef="usd">1347000</us-gaap:IncomeTaxExpenseBenefit>
    <cron:CapitalGainRelinquishmentOfWarrant
      contextRef="i2c1c7205fa134b8ea972b207eaabed88_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzgzMDE_e179f018-c5a4-4391-a14c-20db6f6396a7"
      unitRef="usd">479800000</cron:CapitalGainRelinquishmentOfWarrant>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2Mzc_b80fc800-12bf-4182-8ef2-819ab00b72c7">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant components of the Company&#x2019;s deferred tax assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D investment tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224,776)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;padding-left:20.88pt;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Net deferred tax asset (liability) is reported as Other assets within our consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzMtMS0xLTEtMjEzMzM5_5a1856fa-2cec-40d5-ba3f-a6fbb3932966"
      unitRef="usd">98074000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzMtMy0xLTEtMjEzMzM5_4164d2f0-1713-4284-9d3b-947390b3cc7f"
      unitRef="usd">111373000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzQtMS0xLTEtMjEzMzM5_651fa72e-5fd7-46ae-8d91-1f0f03d0d9e5"
      unitRef="usd">2533000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzQtMy0xLTEtMjEzMzM5_f9a2bdef-f3a7-4d04-8d76-c4b73e57af8b"
      unitRef="usd">1047000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <cron:DeferredTaxAssetsDebtIssuanceCosts
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzUtMS0xLTEtMjEzMzM5_c0b33703-c630-4835-91b2-d4ae4be29026"
      unitRef="usd">1311000</cron:DeferredTaxAssetsDebtIssuanceCosts>
    <cron:DeferredTaxAssetsDebtIssuanceCosts
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzUtMy0xLTEtMjEzMzM5_111e8438-ed8b-4e3e-bf47-3f64591a07d2"
      unitRef="usd">2788000</cron:DeferredTaxAssetsDebtIssuanceCosts>
    <cron:DeferredTaxAssetsShareIssuanceCost
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzYtMS0xLTEtMjEzMzM5_738a32c3-dd14-4cf8-b9bc-d8ff5dfcc300"
      unitRef="usd">196000</cron:DeferredTaxAssetsShareIssuanceCost>
    <cron:DeferredTaxAssetsShareIssuanceCost
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzYtMy0xLTEtMjEzMzM5_dfcfc00a-1810-4863-9c62-31db29845f03"
      unitRef="usd">834000</cron:DeferredTaxAssetsShareIssuanceCost>
    <cron:DeferredTaxAssetsFinanceLeaseLiabilities
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzctMS0xLTEtMjEzMzM5_9804395e-a44b-4ec8-b211-42072ae61592"
      unitRef="usd">690000</cron:DeferredTaxAssetsFinanceLeaseLiabilities>
    <cron:DeferredTaxAssetsFinanceLeaseLiabilities
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzctMy0xLTEtMjEzMzM5_09e7c123-718c-4cbe-b731-0bf8771459a2"
      unitRef="usd">1847000</cron:DeferredTaxAssetsFinanceLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzgtMS0xLTEtMjEzMzM5_538d5c6f-22f3-4e2f-bb28-650af21ad13c"
      unitRef="usd">37662000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzgtMy0xLTEtMjEzMzM5_df710aa6-39a1-4f01-8ae4-59ec6f0fc865"
      unitRef="usd">38119000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzktMS0xLTEtMjEzMzM5_1b7d6965-9f1c-4dc9-9ac3-217784333416"
      unitRef="usd">13359000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzktMy0xLTEtMjEzMzM5_c08b9c40-f82b-42d2-8952-80958a17907c"
      unitRef="usd">900000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEwLTEtMS0xLTIxMzMzOQ_2385def3-5632-44f3-ad78-390592cf475b"
      unitRef="usd">53365000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEwLTMtMS0xLTIxMzMzOQ_f29ba1c3-48ee-45af-986b-97fbc83c3c2f"
      unitRef="usd">65088000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzExLTEtMS0xLTI0MjkyNQ_65fd18a7-5148-4ab0-89af-a24022ffbbf2"
      unitRef="usd">1287000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzExLTMtMS0xLTI0MjkyNQ_28b038e3-2342-41de-abbd-fced9a9350e3"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzExLTEtMS0xLTIxMzMzOQ_4192b408-42d6-43ba-a4df-5e6fde313fe1"
      unitRef="usd">2972000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzExLTMtMS0xLTIxMzMzOQ_5677ba65-e5df-414c-9b6e-d7e00b0be6a0"
      unitRef="usd">3633000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEzLTEtMS0xLTI0MjkyNQ_91177562-e0ca-46e1-9a27-0fb320a55d3e"
      unitRef="usd">293000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEzLTMtMS0xLTI0MjkyNQ_38caa9a2-9717-4c43-b3b5-900c3a2721a7"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEyLTEtMS0xLTIxMzMzOQ_8a65274a-d12d-4303-ae56-330f187af7ed"
      unitRef="usd">3099000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEyLTMtMS0xLTIxMzMzOQ_82a5fdba-1195-4401-804a-324aa24b1523"
      unitRef="usd">1450000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEzLTEtMS0xLTIxMzMzOQ_f61479c2-9c5d-43c7-b159-07047e43bd87"
      unitRef="usd">214841000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzEzLTMtMS0xLTIxMzMzOQ_776a5166-7ec2-4262-b213-92e0819f00df"
      unitRef="usd">227079000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzE0LTEtMS0xLTIxMzMzOQ_6e5df8fc-a0aa-4fb3-baf5-880334b6bc43"
      unitRef="usd">214199000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzE0LTMtMS0xLTIxMzMzOQ_45725577-dc6f-4b83-ac09-17032bb7fe83"
      unitRef="usd">224776000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzE1LTEtMS0xLTIxMzMzOQ_121f0beb-a77e-4a35-8526-bf7cf22897ce"
      unitRef="usd">642000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzE1LTMtMS0xLTIxMzMzOQ_32d1d935-a75d-47e8-b679-29dd82527fb6"
      unitRef="usd">2303000</us-gaap:DeferredTaxAssetsNet>
    <cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzIyLTEtMS0xLTIxMzMzOQ_2e1bf883-7076-4267-b220-55e58412d7d3"
      unitRef="usd">365000</cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzIyLTMtMS0xLTIxMzMzOQ_ac01dd6d-9c94-49b8-aadd-5702899548f9"
      unitRef="usd">1860000</cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzIzLTEtMS0xLTIxMzMzOQ_0bd11592-17b4-42f4-b481-5d5f8fcc8668"
      unitRef="usd">84000</us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzIzLTMtMS0xLTIxMzMzOQ_d9a1d146-503f-4f6c-8df2-dcdf8988ce45"
      unitRef="usd">483000</us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzI0LTEtMS0xLTIxMzMzOQ_6f2f144b-9428-4c5b-b328-4cf046f6d35d"
      unitRef="usd">449000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzI0LTMtMS0xLTIxMzMzOQ_04614cfb-6dfe-491b-aa0a-3895764e670a"
      unitRef="usd">2343000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzI1LTEtMS0xLTIxMzMzOQ_7311f03b-e8b5-4924-b5e6-4a9857efbd99"
      unitRef="usd">193000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90YWJsZTozNDNjOTVlMmM1OTM0OGY3ODQxMjRlMDg2YTVjNTBhMy90YWJsZXJhbmdlOjM0M2M5NWUyYzU5MzQ4Zjc4NDEyNGUwODZhNWM1MGEzXzI1LTMtMS0xLTIxMzMzOQ_ae5cc237-47f2-48de-99ae-b6013c4eb778"
      unitRef="usd">40000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzM4NDgyOTA3MTIyMzc_11aaf708-1286-4791-bd5e-d0bfb54762fd"
      unitRef="usd">214199000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzM4NDgyOTA3MTIyNDU_71cc7f9b-74ba-4262-b173-1656b9f77f34"
      unitRef="usd">224776000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="if64d9be38b984e93b7bb3510d65efa19_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzM4NDgyOTA3MTIxOTQ_3102e740-c327-41be-91af-7f683d70bf7c"
      unitRef="usd">-10577000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="i74a2533447d449bab879b0c4eab1b547_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzM4NDgyOTA3MTIyMjU_164fa997-b2d9-4bc6-8d70-d5e805cac082"
      unitRef="usd">138841000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i74ebbd8e3add46ca819ae30424a73e32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwNzA_1469f310-ef7c-4abc-8aa7-a9bc2222fb5b"
      unitRef="usd">216120000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i2f71b6661d4743cc8370d986af453519_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwNzU_636f5dad-f948-46a1-bd46-98d3560951e7"
      unitRef="usd">134593000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i27ccc99a2d3a4b069d7d181a25a422c1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwODA_ffa9fa61-159c-4923-b341-62593891e0a4"
      unitRef="usd">18739000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie8aeff2099214e2cb23e3338d1c407e2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQwOTk_8fa1aa33-5f99-448d-bc3f-ff388f5f26fb"
      unitRef="usd">276497000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="iece993f8cd4f47dea213f3a4127ea952_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQxMTM_538f8c45-997a-4b69-9467-168e92190de6"
      unitRef="usd">117983000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i21d99941dc0142a7be674f746ad9562a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzQxMjY_8d92150e-1b94-475e-9442-1b859f31674f"
      unitRef="usd">24843000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzEwOTk1MTE2MzUwNzk_b3547043-2eb2-45aa-a5b5-34ddeb6174ec"
      unitRef="usd">293000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:SummaryOfIncomeTaxExaminationsTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjQvZnJhZzpmYWQ3YTNiYWVlZmU0NjZhYjcxZWY1MmNlMWM4MzExYi90ZXh0cmVnaW9uOmZhZDdhM2JhZWVmZTQ2NmFiNzFlZjUyY2UxYzgzMTFiXzQ2MzA_a50c43fe-855f-4c0b-86ac-a4a587f28cdb">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Open Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 &#x2013; 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 &#x2013; 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 &#x2013; 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxExaminationsTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzUyMjE_3774f79d-7474-46c8-82e1-0906bc825cfa">Segment Information and Disaggregated Revenue&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment reporting is prepared on the same basis that the Company&#x2019;s chief operating decision maker (the &#x201c;CODM&#x201d;) manage the business, make operating decisions and assess the Company&#x2019;s performance. For the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company determined that it has the following two reportable segments: United States and Rest of World. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The United States operating segment consists of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;manufacture and distribution of U.S. hemp-derived products. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Rest of World operating segment is involved in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the cultivation, manufacture, and marketing of cannabis-derived products for the medical and adult-use markets&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODM to assess the performance of the segment and make decisions regarding the allocation of resources. The CODM reviews adjusted earnings (loss) before interest, tax, depreciation and amortization (&#x201c;Adjusted EBITDA&#x201d;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#x2019;s assessment of ongoing business performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below set forth our consolidated results of operations by segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of income from equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and indefinite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,351&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,283,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,925,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on indefinite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of income from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on other investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency transaction loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ix)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(x)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial statement review costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(xi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,031)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and indefinite-lived intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(viii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(x)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial statement review costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(xi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and indefinite-lived intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation of financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(viii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(x)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial statement review costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(xi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on disposal of investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(xii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;For the year ended December 31, 2021, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to our U.S. segment and impairment on an indefinite-lived trademark related to the ROW segment. For the year ended December 31, 2020, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to the U.S. segment. See Note 6 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;For the year ended December 31, 2022, impairment loss on long-lived assets relates to the Company&#x2019;s decision to seek a sublease for leased office space in Toronto, Ontario, Canada during the first quarter of 2022. For the year ended December 31, 2021, impairment loss on long-lived assets relates to impairment charges on property, plant and equipment and definite-lived intangible assets in the Canadian asset group, impairment charges for the differences between the consideration paid to Ginkgo for the achievement of two equity milestones in connection with the Ginkgo Collaboration Agreement and the fair values of the CBGA Exclusive License and CBGVA Exclusive License as well as impairment on leased premises in the U.S. segment. See Note 5 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x201d; and Note 6 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, the gain on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 8 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the year ended December 31, 2022 and 2021, gain on revaluation of financial instruments relates primarily to the Company&#x2019;s unrealized holding gain on its mark-to-market investment in Vitura as well as revaluations of financial liabilities resulting from DSUs. For the year ended December 31, 2020, (gain) loss on revaluation of financial instruments relates to revaluations of financial liabilities resulting from DSUs. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt"&gt;For the years ended December 31, 2021 and 2020, transaction costs represent legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:19.8pt"&gt;For the year ended December 31, 2022, impairment loss on other investments related to the PharmaCann Option for the difference between its fair value and carrying amount. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt"&gt;For the year ended December 31, 2022, other, net primarily related to $877 loss on disposal of assets and $384 of dividends declared by Vitura on the Company&#x2019;s 55,176,065 ordinary shares in the capital of Vitura. For the years ended December 31, 2021 and 2020, other, net is primarily related to (gain) loss on reclassification of held-for-sale assets and (gain) loss on disposal of assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(viii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.62pt"&gt;For the years ended December 31, 2021 and 2020, loss from discontinued operations relates to the discontinuance of OGBC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ix)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the year ended December 31, 2022, restructuring costs related to the employee-related severance costs and other restructuring costs associated with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. See Note 16 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(x)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, share-based compensation relates to the vesting expenses of share-based compensation awarded to employees under the Company&#x2019;s share-based award plans as described in Note 10. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(xi)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, financial statement review costs include costs related to the restatements of the Company&#x2019;s 2019 interim financial statements and second quarter 2021 interim financial statements, costs related to the Company&#x2019;s responses to requests for information from various regulatory authorities relating to such restatements and legal costs defending shareholder class action complaints brought against the Company as a result of the 2019 restatement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(xii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:18.36pt"&gt;For the year ended December 31, 2020, gain on disposal of investments is primarily comprised of the gain recorded related to the sale of common shares of Aurora, which were received in connection with the achievement of a milestone related to the Whistler Transaction in 2020 and as a result of the closing of the Whistler Transaction in 2019. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue attributed to a geographic region based on the location of the customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net were physically located in the following geographic regions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzI5NQ_bc80ae2b-2bf8-4100-9a47-25dd28ed8a78"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzY1OA_ecff44a5-f967-4360-97f7-fa3d77ce4afc"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzUyMTY_a70a006e-d051-48f4-962c-6b55ca50bc50">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below set forth our consolidated results of operations by segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of income from equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and indefinite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,351&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,283,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,925,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on indefinite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of income from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on other investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency transaction loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ix)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(x)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial statement review costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(xi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,031)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and indefinite-lived intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(viii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(x)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial statement review costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(xi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and indefinite-lived intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation of financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(viii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(x)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial statement review costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(xi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on disposal of investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(xii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;For the year ended December 31, 2021, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to our U.S. segment and impairment on an indefinite-lived trademark related to the ROW segment. For the year ended December 31, 2020, impairment loss on goodwill and indefinite-lived intangible assets relates to impairment on goodwill and intangible assets related to the U.S. segment. See Note 6 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;For the year ended December 31, 2022, impairment loss on long-lived assets relates to the Company&#x2019;s decision to seek a sublease for leased office space in Toronto, Ontario, Canada during the first quarter of 2022. For the year ended December 31, 2021, impairment loss on long-lived assets relates to impairment charges on property, plant and equipment and definite-lived intangible assets in the Canadian asset group, impairment charges for the differences between the consideration paid to Ginkgo for the achievement of two equity milestones in connection with the Ginkgo Collaboration Agreement and the fair values of the CBGA Exclusive License and CBGVA Exclusive License as well as impairment on leased premises in the U.S. segment. See Note 5 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x201d; and Note 6 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, the gain on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 8 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the year ended December 31, 2022 and 2021, gain on revaluation of financial instruments relates primarily to the Company&#x2019;s unrealized holding gain on its mark-to-market investment in Vitura as well as revaluations of financial liabilities resulting from DSUs. For the year ended December 31, 2020, (gain) loss on revaluation of financial instruments relates to revaluations of financial liabilities resulting from DSUs. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt"&gt;For the years ended December 31, 2021 and 2020, transaction costs represent legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:19.8pt"&gt;For the year ended December 31, 2022, impairment loss on other investments related to the PharmaCann Option for the difference between its fair value and carrying amount. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt"&gt;For the year ended December 31, 2022, other, net primarily related to $877 loss on disposal of assets and $384 of dividends declared by Vitura on the Company&#x2019;s 55,176,065 ordinary shares in the capital of Vitura. For the years ended December 31, 2021 and 2020, other, net is primarily related to (gain) loss on reclassification of held-for-sale assets and (gain) loss on disposal of assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(viii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.62pt"&gt;For the years ended December 31, 2021 and 2020, loss from discontinued operations relates to the discontinuance of OGBC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ix)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the year ended December 31, 2022, restructuring costs related to the employee-related severance costs and other restructuring costs associated with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. See Note 16 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(x)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, share-based compensation relates to the vesting expenses of share-based compensation awarded to employees under the Company&#x2019;s share-based award plans as described in Note 10. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(xi)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, financial statement review costs include costs related to the restatements of the Company&#x2019;s 2019 interim financial statements and second quarter 2021 interim financial statements, costs related to the Company&#x2019;s responses to requests for information from various regulatory authorities relating to such restatements and legal costs defending shareholder class action complaints brought against the Company as a result of the 2019 restatement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(xii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:18.36pt"&gt;For the year ended December 31, 2020, gain on disposal of investments is primarily comprised of the gain recorded related to the sale of common shares of Aurora, which were received in connection with the achievement of a milestone related to the Whistler Transaction in 2020 and as a result of the closing of the Whistler Transaction in 2019. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66239904fa4a427a997cee3b6eb5a236_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzItMS0xLTEtMjEzMzM5_e94974f5-7f32-4a34-b726-c03e07f00139"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36bf0818f4cd4583a8aae9102eb5d125_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzItMy0xLTEtMjEzMzM5_a201fb76-b2e1-4886-bdf3-20903e6aa433"
      unitRef="usd">63593000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55cfa304264f4cf8837ffe45ee192e62_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzItNS0xLTEtMjEzMzM5_9fe9ca93-4790-431a-91c4-2a06fa3f5525"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i121d4fac442e45c78f91d9bee9e1e16e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzItNy0xLTEtMjEzMzM5_6b65cea4-6745-41b8-9b03-5fd2a10022b9"
      unitRef="usd">63593000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29ebb9a852384198889ab7d716ed3e00_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzMtMS0xLTEtMjEzMzM5_6caf4700-af5a-46b0-bac4-cce178e45998"
      unitRef="usd">5155000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia97b43ae395a42af8a4d033428bd087c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzMtMy0xLTEtMjEzMzM5_1cdd8ffc-70c2-4fcd-a43c-f1b2389e853b"
      unitRef="usd">22522000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5c3d94cdeff43b89756b7af65fe6a0f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzMtNS0xLTEtMjEzMzM5_8bab5583-84e1-4ba0-aeac-700554a0d782"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eb44d5887f747f9b4ded07ef27d1ec9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzMtNy0xLTEtMjEzMzM5_55a17134-a0ca-4f32-8058-218efb3ef647"
      unitRef="usd">27677000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i982c9bead0644302a7a575aa8cd1fedb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzQtMS0xLTEtMjEzMzM5_207d9f24-6185-4d96-8e5b-07d39d863d94"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e4ff60cd583466bb936bd3d33219c85_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzQtMy0xLTEtMjEzMzM5_f87bb381-5030-427a-93a3-d8d67d788a00"
      unitRef="usd">634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3de187f960e94096af46a08a23476554_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzQtNS0xLTEtMjEzMzM5_be9bff18-94d9-4bb2-84bd-01c3e8a9a1fe"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91930e58e4134eceb3113536ceba2913_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzQtNy0xLTEtMjEzMzM5_f83d1ebe-bfb0-49a5-b7ba-821865f86c15"
      unitRef="usd">634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzUtMS0xLTEtMjEzMzM5_e5b15947-b641-4894-93f7-5c1efbf7a665"
      unitRef="usd">5155000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzUtMy0xLTEtMjEzMzM5_e83c0898-df5f-4f70-85d9-f6e859d41cc5"
      unitRef="usd">86749000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzUtNS0xLTEtMjEzMzM5_51f785f3-6bcf-4dc7-960a-0d6354b01124"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzUtNy0xLTEtMjEzMzM5_4f998ad9-3660-4524-b239-54846029fbf1"
      unitRef="usd">91904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzctMS0xLTEtMjEzMzM5_1686e1b4-0031-4aeb-88d9-eb8639f5112d"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzctMy0xLTEtMjEzMzM5_6ee018b7-14c1-4da1-83dc-c8db4790f643"
      unitRef="usd">3114000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzctNS0xLTEtMjEzMzM5_a3843eda-9104-4789-8f56-246394ae088b"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzctNy0xLTEtMjEzMzM5_1f115b80-c99e-4dfb-98e0-e6acbe330c9d"
      unitRef="usd">3114000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzktMS0xLTEtMjEzMzM5_a89282d6-e8c7-4611-bbff-59fc0240fde0"
      unitRef="usd">4519000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzktMy0xLTEtMjEzMzM5_dd9f18e1-8f59-4df4-8b4f-11cedb62e765"
      unitRef="usd">18031000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzktNS0xLTEtMjEzMzM5_d77ef701-7bc9-47f1-b6de-14f99d2f17e3"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzktNy0xLTEtMjEzMzM5_e7102e58-cd4a-4479-981b-fd5d7b74cc68"
      unitRef="usd">22550000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEwLTEtMS0xLTIxMzMzOQ_cc6b282c-9172-4291-9eef-80c7534dc5d0"
      unitRef="usd">1000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEwLTMtMS0xLTIxMzMzOQ_f475cc3c-22d4-483a-a718-15a81f54a618"
      unitRef="usd">12000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEwLTUtMS0xLTIxMzMzOQ_b1e66c64-37fe-47db-aebd-4136b2716934"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEwLTctMS0xLTIxMzMzOQ_1a0555c9-6b24-4284-b054-e92a8455d596"
      unitRef="usd">13000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzExLTEtMS0xLTIxMzMzOQ_bc5a2e80-91ac-4ce3-a6fc-f882933bffcc"
      unitRef="usd">4518000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzExLTMtMS0xLTIxMzMzOQ_76a68be9-a02a-45aa-9547-35b45c928f21"
      unitRef="usd">18019000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzExLTUtMS0xLTIxMzMzOQ_8f0553b0-5be7-4f4f-9ce6-bb53d2c52d3c"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzExLTctMS0xLTIxMzMzOQ_1636193e-2a21-4fb3-9dc9-d796e590adaa"
      unitRef="usd">22537000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:Assets
      contextRef="i9944daa8d13a40349de5a04ccb8ab1fc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEzLTEtMS0xLTIxMzMzOQ_430e5584-9ad4-4a11-a985-278313baae13"
      unitRef="usd">368588000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i05d2bf12c84540e9bc326f458b521a1c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEzLTMtMS0xLTIxMzMzOQ_fff250ad-40b4-4c76-bd65-ba8fa8f8d0a5"
      unitRef="usd">290799000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2da2282758b1459e82599ab18062858c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEzLTUtMS0xLTIxMzMzOQ_4ec79e1c-f7d4-48ce-8e6d-3163af18d3c7"
      unitRef="usd">553622000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzEzLTctMS0xLTIxMzMzOQ_7e371629-f8d9-4bf1-b57c-976e5dc122a8"
      unitRef="usd">1213009000</us-gaap:Assets>
    <us-gaap:DepreciationAndAmortization
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE0LTEtMS0xLTIxMzMzOQ_c63785ae-fb24-436f-896f-3f9176fad753"
      unitRef="usd">344000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE0LTMtMS0xLTIxMzMzOQ_891e90cb-5f17-42c4-a65b-287f0e38857e"
      unitRef="usd">5681000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE0LTUtMS0xLTIxMzMzOQ_d4cb9587-b198-4fbc-8e4d-149b6fe5b0ac"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE0LTctMS0xLTIxMzMzOQ_f441773c-e70e-43bb-9643-47a149a9cc41"
      unitRef="usd">6025000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE2LTEtMS0xLTIxMzMzOQ_6c567e38-cc65-4e4f-9281-ab288e55d378"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE2LTMtMS0xLTIxMzMzOQ_78801f06-3bbd-4b76-a203-92a041d852e8"
      unitRef="usd">3493000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE2LTUtMS0xLTIxMzMzOQ_e00d8c1b-0c11-4e50-a55a-924242cb9613"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE2LTctMS0xLTIxMzMzOQ_9ae31957-e42f-42db-a48f-301039cf0283"
      unitRef="usd">3493000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE4LTEtMS0xLTIxMzMzOQ_3a1ce424-3aa6-43ce-a00e-e621b9ea2e7b"
      unitRef="usd">-20134000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE4LTMtMS0xLTIxMzMzOQ_f843c575-aedc-40d2-a795-e1238ffcab59"
      unitRef="usd">-37230000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE4LTUtMS0xLTIxMzMzOQ_c3bcb2bd-2ae6-496b-a088-c487b7b66edd"
      unitRef="usd">-23244000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE4LTctMS0xLTIxMzMzOQ_8ca81331-6028-4abe-a9aa-20b9164f651c"
      unitRef="usd">-80608000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE5LTEtMS0xLTIxMzMzOQ_d7a9bb5b-60ac-4efe-8b39-8774eabd958a"
      unitRef="usd">183000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE5LTMtMS0xLTIxMzMzOQ_d4ade784-0cdd-402f-9d54-c9509aaa23ec"
      unitRef="usd">3268000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE5LTUtMS0xLTIxMzMzOQ_e66c347b-85a7-4aa8-a934-b29258d01c11"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZToxNjFlZDNkMzIwZGY0ZmZkOWRmY2Y3NGEwOWFlMTYzOS90YWJsZXJhbmdlOjE2MWVkM2QzMjBkZjRmZmQ5ZGZjZjc0YTA5YWUxNjM5XzE5LTctMS0xLTIxMzMzOQ_a9bb432e-7de4-48f7-8e10-43e5a8270159"
      unitRef="usd">3451000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8619acd4824f4abd8be3936adfc26c93_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzItMi0xLTEtMjEzMzM5_b0673f4b-cd8a-44fc-879f-2b66209179e2"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3b238bf872e4bb7840cf7d5fdb74e4e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzItNC0xLTEtMjEzMzM5_b0098f44-8516-41e0-acc7-927095740a04"
      unitRef="usd">55194000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i608ae05e92c14b879653819d1ae841a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzItNi0xLTEtMjEzMzM5_5e47fa83-3f13-4e9c-a095-702a4b5314a2"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a6d526d6e524c51b13f9269371efb1a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzItOC0xLTEtMjEzMzM5_6f1d7b51-9960-4d6d-b36d-f257dd79ef1f"
      unitRef="usd">55194000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i280bc038076a4e98bd7729e1879bfc22_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzMtMi0xLTEtMjEzMzM5_83a378bf-ff27-4481-8a8a-edd439c4d0a9"
      unitRef="usd">9874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i985cd0089e754ba184a2c698944d2406_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzMtNC0xLTEtMjEzMzM5_e61c7e13-16ca-422e-9f09-bb6bb9b42c83"
      unitRef="usd">8807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a793c6ff71d45a4a349e560143146c7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzMtNi0xLTEtMjEzMzM5_c7a659f4-f3f2-4178-990c-0f10f2ccedf5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0654c9ddca5d49809da1529bb6a3fc61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzMtOC0xLTEtMjEzMzM5_26d2a24d-25b7-458a-9872-322f2d594408"
      unitRef="usd">18681000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i556926f67c0d433b8621f2c3fee78568_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzQtMi0xLTEtMjEzMzM5_285ad325-7f84-40c4-b170-2b59bb464c9b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec2ab78532ff4381b0a60888ddda144c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzQtNC0xLTEtMjEzMzM5_44f47e11-fa8f-4f98-895d-0c5de8bc4caa"
      unitRef="usd">560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a07b966acb649a498c4e0cf5506ef30_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzQtNi0xLTEtMjEzMzM5_adafc1f1-1d47-4a90-9144-8bb901534770"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16a7e8af45ca4dcca2104af0c77f365e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzQtOC0xLTEtMjEzMzM5_55174ab5-4609-4244-97ae-ab0787f4974b"
      unitRef="usd">560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzUtMi0xLTEtMjEzMzM5_43f9deb2-7c1b-4696-ba0c-90a0f3de2b03"
      unitRef="usd">9874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzUtNC0xLTEtMjEzMzM5_9c6ba56b-d1b5-4231-95e1-cc9f31df264c"
      unitRef="usd">64561000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzUtNi0xLTEtMjEzMzM5_52bb4a00-8297-4810-aba2-35295cc2da18"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzUtOC0xLTEtMjEzMzM5_92c3264d-dbad-4822-a5ea-fdb2a39bf11c"
      unitRef="usd">74435000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzctMi0xLTEtMjEzMzM5_4847d903-ef46-4331-86ed-e76fbcd89a4a"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzctNC0xLTEtMjEzMzM5_3b06ba9e-3a42-47e2-9d80-3dc19b479ee1"
      unitRef="usd">-6313000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzctNi0xLTEtMjEzMzM5_de15b399-2d21-4fba-8c23-cecd8e515093"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzctOC0xLTEtMjEzMzM5_7f0ee64d-ad8a-45d9-b31d-cc76b67c4fe3"
      unitRef="usd">-6313000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzktMi0xLTEtMjEzMzM5_1125ca4a-b8d7-4635-b67f-e422d2d7a262"
      unitRef="usd">40000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzktNC0xLTEtMjEzMzM5_1d100590-61e7-4652-9bc3-fd498b54a9b7"
      unitRef="usd">9058000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzktNi0xLTEtMjEzMzM5_fbd3ba58-0434-443a-b5d5-79b93cf7e56c"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzktOC0xLTEtMjEzMzM5_e76d830d-d9a1-45fb-bae5-8ebb55dea5d3"
      unitRef="usd">9098000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEwLTItMS0xLTIxMzMzOQ_8892abe5-0cb3-4027-b5c4-0d9d044cb5b9"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEwLTQtMS0xLTIxMzMzOQ_4c656cde-136f-4259-94dd-5087dec0a2ca"
      unitRef="usd">27000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEwLTYtMS0xLTIxMzMzOQ_528532e1-f18a-4ba0-84d9-39f0360515a0"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEwLTgtMS0xLTIxMzMzOQ_ab60ddf6-5cbe-40a0-976a-78ad51a171d3"
      unitRef="usd">27000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzExLTItMS0xLTIxMzMzOQ_30d31c9e-c02b-4c80-ae0f-4765099c4227"
      unitRef="usd">40000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzExLTQtMS0xLTIxMzMzOQ_847465d1-6514-47cd-bdd1-317f587f9cc1"
      unitRef="usd">9031000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzExLTYtMS0xLTIxMzMzOQ_0bd1cb5b-594e-417f-a5e7-72e71c5059a7"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzExLTgtMS0xLTIxMzMzOQ_a6c2eae6-4c87-4d55-a66d-d4cd57aa8e8f"
      unitRef="usd">9071000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:Assets
      contextRef="i0b1cd4cc8c8d4241a55586d19c45fa4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEzLTItMS0xLTIxMzMzOQ_7ff8977c-3f2c-412e-8c3a-b20aa7f23316"
      unitRef="usd">462830000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id0dc209f811e486ea094251837a548eb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEzLTQtMS0xLTIxMzMzOQ_093a881e-ea2d-496c-a65e-d3d0c8c220f8"
      unitRef="usd">273484000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7023f167ac1f48888058f60a0238b324_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEzLTYtMS0xLTIxMzMzOQ_0d3331eb-76bf-4806-8692-c016475d05af"
      unitRef="usd">661424000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzEzLTgtMS0xLTIxMzMzOQ_8780dbdf-4029-48b8-9158-6aa17046976c"
      unitRef="usd">1397738000</us-gaap:Assets>
    <us-gaap:DepreciationAndAmortization
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE0LTItMS0xLTIxMzMzOQ_14680e32-6e93-4eda-87c4-da8e0e9a16e8"
      unitRef="usd">295000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE0LTQtMS0xLTIxMzMzOQ_3dcdcb49-1ccb-4d95-b7e8-ec966f01447a"
      unitRef="usd">4189000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE0LTYtMS0xLTIxMzMzOQ_dd5dfd46-a725-427b-a6e7-155c73162474"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE0LTgtMS0xLTIxMzMzOQ_f92d8d75-de2f-48e4-96d8-904465ad294b"
      unitRef="usd">4484000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE1LTItMS0xLTIxMzMzOQ_9e237b60-f743-4279-86d2-d90f93c3fda3"
      unitRef="usd">236019000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE1LTQtMS0xLTIxMzMzOQ_d57d3d98-4b41-4d45-94fc-beaa2b413dba"
      unitRef="usd">37000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE1LTYtMS0xLTIxMzMzOQ_b93d5c8b-e869-480d-b810-979dac695d0b"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE1LTgtMS0xLTIxMzMzOQ_df24c8cf-2727-4a85-a423-d447ce58b74b"
      unitRef="usd">236056000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE2LTItMS0xLTIxMzMzOQ_53b19023-91b8-4c9c-bc59-ec3c1e013f16"
      unitRef="usd">2955000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE2LTQtMS0xLTIxMzMzOQ_dfe2f6d1-eea9-4cbe-808e-b14109cfc9f5"
      unitRef="usd">124664000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE2LTYtMS0xLTIxMzMzOQ_5a57be45-151f-4487-af07-976202b30908"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE2LTgtMS0xLTIxMzMzOQ_0382c4bb-f0c2-4f50-954a-f577d5c44b1b"
      unitRef="usd">127619000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE3LTItMS0xLTIxMzMzOQ_78704f83-0a27-4cf7-8957-1c6ff6a5c783"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE3LTQtMS0xLTIxMzMzOQ_f4493980-c897-4184-a61d-40fe0d5bf9f4"
      unitRef="usd">-500000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE3LTYtMS0xLTIxMzMzOQ_2f653b67-c289-44bb-93ca-635abdef81fb"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE3LTgtMS0xLTIxMzMzOQ_614c5190-8a88-47bd-9db5-ba8c4bc951fa"
      unitRef="usd">-500000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE4LTItMS0xLTIxMzMzOQ_d478890b-e42a-4487-bb23-b85ddecb1242"
      unitRef="usd">-40717000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE4LTQtMS0xLTIxMzMzOQ_c58cfb91-8890-4c61-9327-3cf32fbd9780"
      unitRef="usd">-99139000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE4LTYtMS0xLTIxMzMzOQ_9a3ea1c7-674a-439c-8887-b8bc7bdff94a"
      unitRef="usd">-20607000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE4LTgtMS0xLTIxMzMzOQ_7e3e2c49-186a-487b-9bbc-f89335dd793d"
      unitRef="usd">-160463000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE5LTItMS0xLTIxMzMzOQ_6a2695c6-0a91-44aa-ae7d-ae6d6e7363d0"
      unitRef="usd">776000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE5LTQtMS0xLTIxMzMzOQ_a20de224-2bc1-47eb-9973-4e34b1a85955"
      unitRef="usd">10368000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE5LTYtMS0xLTIxMzMzOQ_b7c34531-717d-4cf2-8099-5aa5efa1d2e7"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3ODI5ZjY5ZmMwNzk0NTBlOWM0MTgxNzAxOGEwYjc5My90YWJsZXJhbmdlOjc4MjlmNjlmYzA3OTQ1MGU5YzQxODE3MDE4YTBiNzkzXzE5LTgtMS0xLTIxMzMzOQ_1a0e37f1-8edb-43c4-9c0a-0c6625654f87"
      unitRef="usd">11144000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fc4f046c82c4e989e9912e652e3393a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzItMi0xLTEtMjEzMzM5_6a55f01c-29fa-4485-8024-5a0a14d34cdf"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69792e5f365c4f74ac7fe11b6718f0e0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzItNC0xLTEtMjEzMzM5_30ab10ab-c451-42df-8a56-d6671909c526"
      unitRef="usd">27932000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6b10325aa474c3f90de9f43306e401c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzItNi0xLTEtMjEzMzM5_b13340df-194e-41c8-a768-b5d27843d4e3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c3b385a391141238bdff4bb41f0b9de_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzItOC0xLTEtMjEzMzM5_7d4c99c1-6866-4031-885b-5a794de20538"
      unitRef="usd">27932000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia591f2aa890f4f499b230f1be9abd0db_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzMtMi0xLTEtMjEzMzM5_404adcc1-9938-43c0-a3b7-e05c0b8e1196"
      unitRef="usd">9495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81106962b49a4c34889df90bb8006a1f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzMtNC0xLTEtMjEzMzM5_7398dee7-cb1e-47ef-b501-5d77e3670548"
      unitRef="usd">8759000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67f9ea95f9074479a6d1ec92df88530c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzMtNi0xLTEtMjEzMzM5_e2d7c205-a62d-4967-84ff-42037ad6e78d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6855068406142e9b4ea4b031e056d70_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzMtOC0xLTEtMjEzMzM5_7f393102-8d59-4f15-ac8e-9e678c3fa96c"
      unitRef="usd">18254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61bb5f5a360043fbb4ff433ca5adde3b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzQtMi0xLTEtMjEzMzM5_01371b5f-9f14-4c3b-9463-46f8be5f1248"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8712aa6fe7b7457d9c1f918bd39dc780_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzQtNC0xLTEtMjEzMzM5_707842b6-016d-4e34-b5be-a45cbf3eab9d"
      unitRef="usd">533000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d583d52c40242bca5743643c378dcb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzQtNi0xLTEtMjEzMzM5_d72583c8-b9b6-4205-a1b7-a120608cb1c3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i908b9b9a8ad74722858339b6ede02cc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzQtOC0xLTEtMjEzMzM5_411c6052-4951-4841-ae34-27edc651c8d5"
      unitRef="usd">533000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzUtMi0xLTEtMjEzMzM5_6841055b-ec1c-46c8-a7a6-bb11f7320acd"
      unitRef="usd">9495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzUtNC0xLTEtMjEzMzM5_3aac75ba-d08a-4804-801b-15750403abe5"
      unitRef="usd">37224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzUtNi0xLTEtMjEzMzM5_f876f2e7-adef-410b-bec5-b53aaa46701b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzUtOC0xLTEtMjEzMzM5_e656b868-ac27-4a58-909f-ed1d4cdf4209"
      unitRef="usd">46719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzctMi0xLTEtMjEzMzM5_3913fc0e-d3f9-410e-85a1-43f4c2e83365"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzctNC0xLTEtMjEzMzM5_8fcdf4e3-f2bc-4d69-8cb6-836dbd500d47"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzctNi0xLTEtMjEzMzM5_6dcf2087-b73f-4cf3-9007-68e8188ba341"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzctOC0xLTEtMjEzMzM5_949d7e20-9aca-44e4-9937-657cd909ea7f"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzktMi0xLTEtMjEzMzM5_d5ce069d-0aaf-4e90-a1c2-d2e93e31b64c"
      unitRef="usd">16000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzktNC0xLTEtMjEzMzM5_49158ce6-51dc-4de3-9c3e-9c18ee75c55b"
      unitRef="usd">18585000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzktNi0xLTEtMjEzMzM5_b5cdf771-82f3-4f1b-8162-806d4a60f8b6"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzktOC0xLTEtMjEzMzM5_c861cf9c-ab34-4de1-a8a5-fea215ad29bc"
      unitRef="usd">18601000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEwLTItMS0xLTIxMzMzOQ_f3b8818c-0ce7-45ec-accc-9ade2a76b4e4"
      unitRef="usd">34000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEwLTQtMS0xLTIxMzMzOQ_77c4bd0a-768e-4d3b-960a-58e648beae55"
      unitRef="usd">152000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEwLTYtMS0xLTIxMzMzOQ_cf083ec2-71cf-49b3-9c28-b17894e71fdf"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEwLTgtMS0xLTIxMzMzOQ_38380d51-15e6-46a6-b3df-2088f03b02c0"
      unitRef="usd">186000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzExLTItMS0xLTIxMzMzOQ_3221136a-66a1-4267-bc60-d15d23001df5"
      unitRef="usd">-18000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzExLTQtMS0xLTIxMzMzOQ_2afa4179-55ab-4c01-a89e-d3f0d8006613"
      unitRef="usd">18433000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzExLTYtMS0xLTIxMzMzOQ_58d04ffa-3da6-4a8a-824d-149cf2c8eb31"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzExLTgtMS0xLTIxMzMzOQ_482c668d-9db1-48e9-9bd6-e5c44e3a16f3"
      unitRef="usd">18415000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:Assets
      contextRef="i6c9ff55d7a0549fdadda5e620d11697b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEzLTItMS0xLTIxMzMzOQ_f5e32277-d201-45ae-bddd-a717ec7a1148"
      unitRef="usd">253745000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9101b37e3f454911b9d53d768c617ca0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEzLTQtMS0xLTIxMzMzOQ_7ecc4610-5e66-4f61-8c5b-809b05af60b9"
      unitRef="usd">388351000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if24c838134cc4114bf815abbed48d9a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEzLTYtMS0xLTIxMzMzOQ_5beb38c6-c9bd-49a4-8f01-62883bc691be"
      unitRef="usd">1283586000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iea9d63117e854b719984324586934e8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzEzLTgtMS0xLTIxMzMzOQ_d9c58ef8-46f2-41ce-a63d-d5987765613e"
      unitRef="usd">1925682000</us-gaap:Assets>
    <us-gaap:DepreciationAndAmortization
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE0LTItMS0xLTIxMzMzOQ_b1994f9f-c77c-4623-a005-3507adc2463d"
      unitRef="usd">234000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE0LTQtMS0xLTIxMzMzOQ_c05d9ff5-e017-4e2b-9e77-bb8680a8a671"
      unitRef="usd">2638000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE0LTYtMS0xLTIxMzMzOQ_198de8f7-dea1-49a5-ad3a-062f991fd85b"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE0LTgtMS0xLTIxMzMzOQ_6233f134-89bc-4d2f-861b-d4606b5499c4"
      unitRef="usd">2872000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE1LTItMS0xLTIxMzMzOQ_6eebdef2-6656-4175-98e7-59d3aad1a0e4"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE1LTQtMS0xLTIxMzMzOQ_e4b272aa-a1fe-4d2b-b2fb-fe6359db85fd"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE1LTYtMS0xLTIxMzMzOQ_a654270c-3460-4027-8460-9ca41246d8c1"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE1LTgtMS0xLTIxMzMzOQ_f582356d-d348-43d0-93f9-524b3a643e4d"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE2LTItMS0xLTIxMzMzOQ_1825304b-f31f-4803-b25b-cc370a59b908"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE2LTQtMS0xLTIxMzMzOQ_2b3ba979-7a52-4ba9-9323-9e6ddff38deb"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE2LTYtMS0xLTIxMzMzOQ_2532f391-936f-45e1-9ac1-15a797931351"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE2LTgtMS0xLTIxMzMzOQ_26019feb-a18e-4ae1-945a-8a7e8213b3a7"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE3LTItMS0xLTIxMzMzOQ_df9f72b8-e8b3-4162-8071-b52da59e780b"
      unitRef="usd">-28019000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE3LTQtMS0xLTIxMzMzOQ_4cd811c6-a814-45ab-8c7f-1b682dff5cfd"
      unitRef="usd">-98349000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE3LTYtMS0xLTIxMzMzOQ_234923be-ec18-40c4-b133-928f79ce3a61"
      unitRef="usd">-20885000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE3LTgtMS0xLTIxMzMzOQ_4e0edd0f-d65f-4c8d-8bb5-4cc4045404c8"
      unitRef="usd">-147253000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE4LTItMS0xLTIxMzMzOQ_6c9efb63-2ea7-4871-8e03-05b70a2aaf24"
      unitRef="usd">385000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE4LTQtMS0xLTIxMzMzOQ_d2bc41db-a19c-4680-8f6e-86adbdd78e4a"
      unitRef="usd">31027000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE4LTYtMS0xLTIxMzMzOQ_f8ba2e2f-bef6-469c-984f-053f0eb60842"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTo3YzJlZDM5NWM5OTc0MzE1Yjg2Yzc4ZTIyNWQ4YWMyYS90YWJsZXJhbmdlOjdjMmVkMzk1Yzk5NzQzMTViODZjNzhlMjI1ZDhhYzJhXzE4LTgtMS0xLTIxMzMzOQ_bfd14b0d-dc2d-4dfd-bb0e-f3390fe3dfed"
      unitRef="usd">31412000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:ProfitLoss
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzItMS0xLTEtMjEzMzM5_45d2c42b-9ce6-49a1-846e-2d4648a52906"
      unitRef="usd">-84194000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzItMy0xLTEtMjEzMzM5_b7152bec-506b-452f-95a2-589a53f8f7b7"
      unitRef="usd">-54129000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzItNS0xLTEtMjEzMzM5_6dac41a0-fc73-4dfb-a7f3-cf854d69173b"
      unitRef="usd">-30411000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzItNy0xLTEtMjEzMzM5_03bea143-2566-4070-9859-5e21cf265310"
      unitRef="usd">-168734000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzMtMS0xLTEtMjUyMjg1_9d934869-dfae-4aa0-9933-41d2c5c381f6"
      unitRef="usd">4518000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzMtMy0xLTEtMjUyMjg1_9356047d-d5f0-4e92-a193-f374d9fb64b5"
      unitRef="usd">18019000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzMtNS0xLTEtMjUyMjg1_7b8af782-2f27-4b23-93b5-91884288b5fb"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzMtNy0xLTEtMjUzMTY2_c10ba161-cdff-4927-a404-6e29e995d0ec"
      unitRef="usd">22537000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzQtMS0xLTEtMjUyMzAw_6a546086-4c59-4827-b6ae-1b493a97ccd3"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzQtMy0xLTEtMjUyMzAw_08c837cd-3f59-4f6f-8202-68707e69f867"
      unitRef="usd">34175000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzQtNS0xLTEtMjUyMzAw_be3c3549-52bb-45bf-95f1-27034baa8029"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzQtNy0xLTEtMjUzMTY2_2a5f5fae-78e4-41d9-85a2-910061e65952"
      unitRef="usd">34175000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtMS0xLTEtMjUyMjk2_4aea5cb9-59ce-4d9f-a3e1-5a79cb849d6b"
      unitRef="usd">1485000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtMy0xLTEtMjUyMjk2_be87a1e7-96c3-46bd-ad8d-8d337b5e9673"
      unitRef="usd">11637000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtNS0xLTEtMjUyMjk2_a681e8b1-a7da-47ac-bd87-cdc09a21483b"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtNy0xLTEtMjUzMTY2_6a19beba-b67c-46e1-829c-343af911dbd2"
      unitRef="usd">13122000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzYtMS0xLTEtMjUzMTY4_963168ec-310e-425e-8248-45c050db538c"
      unitRef="usd">-87227000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzYtMy0xLTEtMjUzMTY4_015f6fd3-4da0-48f0-9782-7369de4a2973"
      unitRef="usd">-26336000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzYtNS0xLTEtMjUzMTY4_cb91c80e-4587-47d6-a801-f0f7789acf48"
      unitRef="usd">-30411000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzYtNy0xLTEtMjUzMTY4_f4cc6a90-717b-45f0-99f6-94f2f610caa6"
      unitRef="usd">-143974000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtMS0xLTEtMjEzMzM5_ecf919c8-70e3-4821-ac48-fa80dcc78810"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtMy0xLTEtMjEzMzM5_8e0ae171-f9c5-41f3-a149-6dbd9686c6f6"
      unitRef="usd">3114000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtNS0xLTEtMjEzMzM5_89d7f4a8-c4bd-4b8d-a4ef-914230f44570"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzUtNy0xLTEtMjEzMzM5_fe6073d8-b74b-447b-9f5c-f66aa0d42888"
      unitRef="usd">3114000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzctMS0xLTEtMjEzMzM5_d62ebf06-27d9-4b06-be19-6d4712e2d903"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzctMy0xLTEtMjEzMzM5_e479b686-f50c-402a-be56-b3d9f5dfa3dc"
      unitRef="usd">3493000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzctNS0xLTEtMjEzMzM5_68d6bafe-9b7d-4d6a-9485-698718d9fc99"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzctNy0xLTEtMjEzMzM5_45a00dd8-b583-4772-80d3-b3d624fe75ee"
      unitRef="usd">3493000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzgtMS0xLTEtMjEzMzM5_68cba2dd-4126-407e-b642-534c1d4153b1"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzgtMy0xLTEtMjEzMzM5_af46d71f-6057-4bc4-a9f8-067c426a5883"
      unitRef="usd">14060000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzgtNS0xLTEtMjEzMzM5_bc29022d-d526-42f8-88dd-c61c9fc4b290"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzgtNy0xLTEtMjEzMzM5_e06fd0fc-386c-4320-ac7f-3d5c4202636a"
      unitRef="usd">14060000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzktMS0xLTEtMjEzMzM5_3a247c3e-117f-4f1e-b52d-8e672487a92d"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzktMy0xLTEtMjEzMzM5_ef4fcb90-4f97-43d7-97f4-a24b09e8ba65"
      unitRef="usd">14739000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzktNS0xLTEtMjEzMzM5_0d3a5695-2208-4b36-b628-df7d98f9cbff"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzktNy0xLTEtMjEzMzM5_e040cd0b-cedc-4f87-9a9b-5e9645dad9ef"
      unitRef="usd">14739000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzExLTEtMS0xLTIxMzMzOQ_5eb0865a-0321-4e03-9300-927aa911ca55"
      unitRef="usd">61392000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzExLTMtMS0xLTIxMzMzOQ_2eb81668-c0ea-4f73-aa27-4fac9db3dda8"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzExLTUtMS0xLTIxMzMzOQ_b7d13ced-9412-4fe4-8b66-99a41b2e8094"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzExLTctMS0xLTIxMzMzOQ_57c96998-32b7-40a6-85f4-b3b85a4b9c4e"
      unitRef="usd">61392000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTEtMS0xLTIzNTI3Nw_60c7abad-ff30-4cce-bcfd-fe07f7a9c7ba"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTMtMS0xLTIzNTI3Nw_718d8ec0-6a8b-4a4b-ad14-598bbea2a270"
      unitRef="usd">-2286000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTUtMS0xLTIzNTI3Nw_b9c38dc5-8f16-42bb-a2b6-57111e6d4610"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTctMS0xLTIzNjM4Mw_80fb1da1-3f73-4ff3-8b18-2292e0cdd62c"
      unitRef="usd">-2286000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTEtMS0xLTIxMzMzOQ_38bed297-f60a-4147-a5d9-56870d3a5120"
      unitRef="usd">-169000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTMtMS0xLTIxMzMzOQ_fc10843d-d38a-408b-8f34-cca70953b326"
      unitRef="usd">-324000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTUtMS0xLTIxMzMzOQ_abb5c7c5-b877-4e66-8360-4966ec638aa0"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzEyLTctMS0xLTIxMzMzOQ_5bdf1b17-d379-44d2-bfd8-3465bed28f27"
      unitRef="usd">-493000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RestructuringCosts
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTEtMS0xLTIyMzc4Ng_93874fcb-6a57-4d00-9a7c-a997abe9463f"
      unitRef="usd">1788000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTMtMS0xLTIyMzc4Ng_06c7211c-91ee-4433-8be1-9ae07c6410b2"
      unitRef="usd">3545000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTUtMS0xLTIyMzc4Ng_89775f42-34a0-4082-8d71-be47a451436f"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTctMS0xLTIzNjM4Mw_f8bae47b-4bfa-4953-9fd9-de4956633c39"
      unitRef="usd">5333000</us-gaap:RestructuringCosts>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTEtMS0xLTIxMzMzOQ_82671124-1536-48bc-9c9c-ee92174544f1"
      unitRef="usd">3744000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTMtMS0xLTIxMzMzOQ_824d631a-e0b4-40a5-a188-4b13f7daa523"
      unitRef="usd">11371000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTUtMS0xLTIxMzMzOQ_b02242cb-c60c-4a14-b490-974acd6083be"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE0LTctMS0xLTIxMzMzOQ_fb8b10f6-1303-4c74-a4d2-f50a0031f2c9"
      unitRef="usd">15115000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:RestatementReviewExpense
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTEtMS0xLTIxMzMzOQ_fff4c7c2-186e-4917-83e1-8f6d1cfaf98d"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTMtMS0xLTIxMzMzOQ_6c9a67c0-5319-41ff-916c-7191ffad8a35"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTUtMS0xLTIxMzMzOQ_de0be0d3-55cf-44f3-96d5-c59b84601961"
      unitRef="usd">7167000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE1LTctMS0xLTIxMzMzOQ_3cc8bb10-96a4-493e-8292-736553ee5655"
      unitRef="usd">7167000</cron:RestatementReviewExpense>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i1c86eb35f68642cc82a8337032d809b3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE4LTEtMS0xLTIxMzMzOQ_318f44e0-6fec-414d-b41e-2587f0eb8b56"
      unitRef="usd">-20134000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i25a7a24183f740688af01de4e8fff8ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE4LTMtMS0xLTIxMzMzOQ_c72f4836-4953-4ee6-a6ab-e71644ab77b7"
      unitRef="usd">-37230000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i8c9fe5cffdcc40ecaf3fe80a45027467_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE4LTUtMS0xLTIxMzMzOQ_db284900-b263-4c63-a5cb-5ea973b697f2"
      unitRef="usd">-23244000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTphNjM5Y2Y4NDdkZDQ0ZjA1YmI3YTZiMGUzZmE5MDY2OC90YWJsZXJhbmdlOmE2MzljZjg0N2RkNDRmMDViYjdhNmIwZTNmYTkwNjY4XzE4LTctMS0xLTIxMzMzOQ_e3920879-8e71-44f2-ab50-975ba1f1055d"
      unitRef="usd">-80608000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:ProfitLoss
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzItMS0xLTEtMjEzMzM5_aa7c2112-3e1d-49ca-956f-c7386423af98"
      unitRef="usd">-283883000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzItMy0xLTEtMjEzMzM5_97cd85b8-cd11-4a73-b8e4-531b1c99c3b6"
      unitRef="usd">-81811000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzItNS0xLTEtMjEzMzM5_ee6a8432-3286-4a91-99f9-2f9cecb29411"
      unitRef="usd">-31510000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzItNy0xLTEtMjEzMzM5_77fd6403-2ec8-48d7-9c27-fc34adaf4341"
      unitRef="usd">-397204000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzMtMS0xLTEtMjUyMzQ0_8f00af37-6532-4ece-b822-5f002d29319a"
      unitRef="usd">40000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzMtMy0xLTEtMjUyMzQ0_2d09372e-bc8d-452c-97e4-e9b7ca4aa3de"
      unitRef="usd">9031000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzMtNS0xLTEtMjUyMzQ0_1facea7e-ffd5-45bd-880f-0e1ab4d6c666"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzMtNy0xLTEtMjUzMTcy_896ef0f5-4442-42d0-a68f-d0afd3be6328"
      unitRef="usd">9071000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzQtMS0xLTEtMjUyMzQ0_0aded15a-30f3-4963-9d09-c5626ad65032"
      unitRef="usd">-89000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzQtMy0xLTEtMjUyMzQ0_54263cb0-be63-4f7e-8de6-8e8e6422fb78"
      unitRef="usd">-342000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzQtNS0xLTEtMjUyMzQ0_459b1605-9282-4ee5-a72c-907c8e4fbee9"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzQtNy0xLTEtMjUzMTcy_c9baa332-0664-4a8d-a9e4-76a8490fdd42"
      unitRef="usd">-431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtMS0xLTEtMjUyMzQ4_57261555-13dc-4636-a90a-b574a8b6d80a"
      unitRef="usd">917000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtMy0xLTEtMjUyMzQ4_8bf17258-c9c2-4af7-b55d-ab25820b6862"
      unitRef="usd">14485000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtNS0xLTEtMjUyMzQ4_d7d493d7-4bb5-455f-bb0d-a6207cf46577"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtNy0xLTEtMjUzMTcy_1b7b7d68-d175-43ff-b7ab-f0e2a359bfb9"
      unitRef="usd">15402000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtMS0xLTEtMjUzMTcy_ebc9ae96-5acf-4310-8ed8-aab76fd2d941"
      unitRef="usd">-283095000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtMy0xLTEtMjUzMTcy_a4bf12a1-0f1a-45b4-955f-aaf3a04ae289"
      unitRef="usd">-76699000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtNS0xLTEtMjUzMTcy_1a438a29-2661-48a9-b992-205b41afcec8"
      unitRef="usd">-31510000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtNy0xLTEtMjUzMTcy_83f3007a-f0aa-4d0a-ba88-8c7473e752a8"
      unitRef="usd">-391304000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtMS0xLTEtMjEzMzM5_7a5c7e2b-cdad-4704-b829-a8ac060c2d6c"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtMy0xLTEtMjEzMzM5_7f34f8b9-e991-48af-9c4c-46c351385786"
      unitRef="usd">-6313000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtNS0xLTEtMjEzMzM5_e92719cf-3f14-4bbe-bd80-f530ec7f7729"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzUtNy0xLTEtMjEzMzM5_437d2493-3040-4404-8f5a-eff7ae89e5ca"
      unitRef="usd">-6313000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtMS0xLTEtMjEzMzM5_437fef33-5615-4835-9d0e-b7be6dcd2633"
      unitRef="usd">236019000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtMy0xLTEtMjEzMzM5_676cfda4-7f0e-44e7-a051-2c324c0c51cd"
      unitRef="usd">37000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtNS0xLTEtMjEzMzM5_241e3bc1-45d0-4918-8287-7d268a790dab"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzYtNy0xLTEtMjEzMzM5_2203a01c-421a-489e-9a3b-b74b9fa4bdb9"
      unitRef="usd">236056000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzctMS0xLTEtMjIzODcx_043a7cc4-1e86-425d-a9b6-b14ba73f2b9e"
      unitRef="usd">2955000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzctMy0xLTEtMjIzODcx_dce8801b-1b56-44eb-ba33-5b7a1610d3f2"
      unitRef="usd">124664000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzctNS0xLTEtMjIzODcx_4b28fc28-86a5-4a26-9404-d8eef2922499"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzctNy0xLTEtMjM2Mzk5_7405a538-4c78-4226-886f-0a85fb19dfa6"
      unitRef="usd">127619000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzgtMS0xLTEtMjEzMzM5_81c6ed56-576f-48cb-9772-f58ed2a3b97c"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzgtMy0xLTEtMjEzMzM5_2f1a26f9-1b86-4bde-adc4-f180abf5e07d"
      unitRef="usd">151360000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzgtNS0xLTEtMjEzMzM5_9ee87744-363c-4943-a44e-0f1af06357a9"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzgtNy0xLTEtMjEzMzM5_dc884bbc-ff1d-43e5-a748-dfdf5c7c6e09"
      unitRef="usd">151360000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzktMS0xLTEtMjEzMzM5_0b670ff8-4223-4c76-827d-c813d631c67e"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzktMy0xLTEtMjEzMzM5_2dadb7c6-436b-4557-a5de-10646cce0136"
      unitRef="usd">8611000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzktNS0xLTEtMjEzMzM5_66d7e031-abda-49f8-84c2-a73db23a322c"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzktNy0xLTEtMjEzMzM5_6bb26de7-ab16-4bd0-a4de-26d856dd954c"
      unitRef="usd">8611000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:AcquisitionCosts
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEwLTEtMS0xLTIxMzMzOQ_9e2d70fd-f505-47f7-b8d2-526b3113ceff"
      unitRef="usd">0</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEwLTMtMS0xLTIxMzMzOQ_5f8c6249-90c1-459d-84cb-8851fd775832"
      unitRef="usd">0</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEwLTUtMS0xLTIxMzMzOQ_96e450ae-3d0a-4ffb-a2b0-1a5c8e570196"
      unitRef="usd">3801000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEwLTctMS0xLTIxMzMzOQ_039820be-f623-4558-955d-7a5aa58b3d6e"
      unitRef="usd">3801000</us-gaap:AcquisitionCosts>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEyLTEtMS0xLTIxMzMzOQ_cea68c3d-8967-420a-b852-c1a4b92d64ba"
      unitRef="usd">-3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEyLTMtMS0xLTIxMzMzOQ_6c04ff1a-84b0-435b-bfde-12d873f40111"
      unitRef="usd">733000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEyLTUtMS0xLTIxMzMzOQ_94464115-9de0-43df-b157-a6e236ac8d1a"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEyLTctMS0xLTIxMzMzOQ_f661aade-0b28-4cff-9b4d-7ae40daa0728"
      unitRef="usd">730000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEzLTEtMS0xLTIxMzMzOQ_a8453ad1-169d-4b82-99a0-bd2774eba744"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEzLTMtMS0xLTIxMzMzOQ_75e336cb-ccf2-4e9a-8e35-c9f9b8c5c9cc"
      unitRef="usd">-500000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEzLTUtMS0xLTIxMzMzOQ_d984fe22-b6b7-4a9e-8355-140f12705d62"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzEzLTctMS0xLTIxMzMzOQ_93e2bbdf-ccf0-4784-84bc-e6700e7b5a0f"
      unitRef="usd">-500000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE0LTEtMS0xLTIxMzMzOQ_f0aa0086-fd85-46c7-8a72-9dcb324d5feb"
      unitRef="usd">3401000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE0LTMtMS0xLTIxMzMzOQ_43065f45-fea2-4627-9c76-fa3dfa4c34d3"
      unitRef="usd">6750000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE0LTUtMS0xLTIxMzMzOQ_6725449b-5e84-4406-9b93-c906b7b71c5f"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE0LTctMS0xLTIxMzMzOQ_8e50a98a-23f0-4d21-b573-cfa97329bf8d"
      unitRef="usd">10151000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:RestatementReviewExpense
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE1LTEtMS0xLTIxMzMzOQ_08c8c926-696d-4175-84ea-8b6a84d66db5"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE1LTMtMS0xLTIxMzMzOQ_6c1c8923-3835-48d5-9da2-343702b9fff7"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE1LTUtMS0xLTIxMzMzOQ_34ab9fd7-60ee-4ee4-9fb1-2eede56bca8d"
      unitRef="usd">7102000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE1LTctMS0xLTIxMzMzOQ_59674d7b-54d8-4228-a060-60c8e715226f"
      unitRef="usd">7102000</cron:RestatementReviewExpense>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i48f10a9e2494416481c473dc40e2240f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE3LTEtMS0xLTIxMzMzOQ_8ab641c2-8682-454a-bc72-d761664614cc"
      unitRef="usd">-40717000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i5abd621d83964eaa99871ca5f6bac2ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE3LTMtMS0xLTIxMzMzOQ_a94965e3-32dc-45b6-9b56-ad1acb14feac"
      unitRef="usd">-99139000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ib9f56877c24949a6933041095690ce07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE3LTUtMS0xLTIxMzMzOQ_d08ec2f5-c38b-4036-a603-9652d074aa4f"
      unitRef="usd">-20607000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpkYWQwMDUyMWViODU0NzNkOTY3ZDQ3MTE2OGZmYjkwMC90YWJsZXJhbmdlOmRhZDAwNTIxZWI4NTQ3M2Q5NjdkNDcxMTY4ZmZiOTAwXzE3LTctMS0xLTIxMzMzOQ_3dbd143d-c02d-436b-a7d5-06f2ff37afbb"
      unitRef="usd">-160463000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:ProfitLoss
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzItMS0xLTEtMjEzMzM5_03bcdfe2-3b76-432c-a656-b37e6bd57e76"
      unitRef="usd">-77368000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzItMy0xLTEtMjEzMzM5_cbfd0710-a7b1-4e27-b992-41e7c94e1d7e"
      unitRef="usd">32671000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzItNS0xLTEtMjEzMzM5_448a7075-a08b-4cde-a747-d1277f87dfbe"
      unitRef="usd">-30573000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzItNy0xLTEtMjEzMzM5_21f12ba1-6795-47e5-9adc-6af2743cfb7b"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzMtMS0xLTEtMjUyNDEy_882ba1d4-11c7-445e-9734-e15e4c6101b9"
      unitRef="usd">-18000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzMtMy0xLTEtMjUyNDEy_5560068f-50e6-418d-8370-b4cabae3018e"
      unitRef="usd">18433000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzMtNS0xLTEtMjUyNDEy_73a14380-0f55-4f73-af0f-21cb30382725"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzMtNy0xLTEtMjUzMTc0_b374b6d7-4f1f-4534-b931-e71a95e6b389"
      unitRef="usd">18415000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzQtMS0xLTEtMjUyNDEy_761b0141-a807-46d7-808f-f773a1dd4fcc"
      unitRef="usd">323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzQtMy0xLTEtMjUyNDEy_e53b7cc7-a6e8-46a8-9773-6c10c558fc9b"
      unitRef="usd">1024000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzQtNS0xLTEtMjUyNDEy_e9e7afc8-6edf-4e1d-b5d4-74e2091eeb81"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzQtNy0xLTEtMjUzMTc0_8738342d-9a33-4b45-b8eb-166efb364689"
      unitRef="usd">1347000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtMS0xLTEtMjUyNDE2_4d56d619-45d6-46f7-a2f3-aa1a108e4afa"
      unitRef="usd">234000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtMy0xLTEtMjUyNDE2_b2546fcc-4972-4453-94d5-26f46cd6ead3"
      unitRef="usd">6811000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtNS0xLTEtMjUyNDE2_799e6fa7-f358-4303-9dd2-f5eec15db3d1"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtNy0xLTEtMjUzMTc0_2ccc591e-563a-4913-8f25-1a5f2a752f2e"
      unitRef="usd">7045000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtMS0xLTEtMjUzMTc0_eadd766d-91d1-4222-a843-3923e41714b6"
      unitRef="usd">-76793000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtMy0xLTEtMjUzMTc0_6a73462f-4f4e-457d-9702-0acba5c705bb"
      unitRef="usd">22073000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtNS0xLTEtMjUzMTc0_70dab76d-e043-43f6-9cf4-dca912dd3fd2"
      unitRef="usd">-30573000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtNy0xLTEtMjUzMTc0_3db0deff-2461-4ae6-9ee3-ea438039d405"
      unitRef="usd">-85293000</cron:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtMS0xLTEtMjEzMzM5_d2ae1b83-22ca-4e41-bced-a8a517035314"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtMy0xLTEtMjEzMzM5_9e612929-de16-445a-9fd3-a3521559fdb9"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtNS0xLTEtMjEzMzM5_7349e6b8-02f5-48e2-946d-aaea9416e4df"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzUtNy0xLTEtMjQ3Mzk1_a3d79825-10c5-4ea8-94a9-0125d9921449"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtMS0xLTEtMjEzMzM5_8be1bcad-b630-4e5f-85ee-c5e2adb8e791"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtMy0xLTEtMjEzMzM5_3759bdbc-5e5a-4c11-9211-6f9bf53551ea"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtNS0xLTEtMjEzMzM5_168e19a8-7667-422f-8477-0cd7d84dfc5c"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzYtNy0xLTEtMjEzMzM5_29729b43-2ef8-41ee-8bea-dd33ccc3ee40"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzgtMS0xLTEtMjEzMzM5_9a98c63a-4a2b-4c63-9ee3-751778a5ac11"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzgtMy0xLTEtMjEzMzM5_c433260f-57d9-4db4-bd2e-696fae7fd5d2"
      unitRef="usd">129254000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzgtNS0xLTEtMjEzMzM5_b1ce456d-f7ac-4b5d-ade4-80a3366bcf49"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzgtNy0xLTEtMjEzMzM5_f025c7da-7bf0-450a-b0ea-c5b492cbaf87"
      unitRef="usd">129254000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzktMS0xLTEtMjEzMzM5_8998ed5a-5833-4a1b-a4ac-249fc501fbfd"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzktMy0xLTEtMjEzMzM5_34bc2619-e84b-47f3-b523-e08ab34cb58d"
      unitRef="usd">-9000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzktNS0xLTEtMjEzMzM5_8e49b049-0f60-4d4a-b081-633042ccc6fc"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzktNy0xLTEtMjEzMzM5_3d390ef8-47d1-46a1-b0d1-45e61e70cbcf"
      unitRef="usd">-9000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:AcquisitionCosts
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEwLTEtMS0xLTIxMzMzOQ_416d99b1-9d73-43ce-ba28-f01f0ce7de18"
      unitRef="usd">40000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEwLTMtMS0xLTIxMzMzOQ_a98883ed-4df9-4d8d-8fcb-998486f5552a"
      unitRef="usd">0</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEwLTUtMS0xLTIxMzMzOQ_59512c08-0502-4ddd-948a-4c86fbdb7cb7"
      unitRef="usd">0</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEwLTctMS0xLTIxMzMzOQ_a647061a-e15b-4618-bde2-a9c03b55514d"
      unitRef="usd">40000</us-gaap:AcquisitionCosts>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEyLTEtMS0xLTIyMzk5NA_5f48d569-63e9-480e-98e3-235f184e2ed9"
      unitRef="usd">-20000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEyLTMtMS0xLTIyMzk5NA_c1e83e90-c74d-40ea-a557-5f58981b35be"
      unitRef="usd">-1805000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEyLTUtMS0xLTIyMzk5NA_252fb2f6-dc51-4f64-a42c-dccdd209ec43"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzEyLTctMS0xLTI0NzM5NQ_18531791-6490-42e0-8ca4-03b41b40f74e"
      unitRef="usd">-1825000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE0LTEtMS0xLTIxMzMzOQ_f42df566-e089-4fa6-9237-4b113e6aec0e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE0LTMtMS0xLTIxMzMzOQ_78ca0341-c104-4c4a-aada-d956a07143cf"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE0LTUtMS0xLTIxMzMzOQ_d0637d56-0573-468a-8cdf-5f207514b53b"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE0LTctMS0xLTIxMzMzOQ_5327dea5-2bd1-49ab-b11b-104863262313"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTEtMS0xLTIxMzMzOQ_dd69d7e3-c20b-4494-b84d-110a13c2e4b7"
      unitRef="usd">8714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTMtMS0xLTIxMzMzOQ_5fd3eecf-6f43-4a9b-8579-c3dd7542ca36"
      unitRef="usd">6647000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTUtMS0xLTIxMzMzOQ_40da5127-f315-4bc1-a854-5f8718f18b02"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTctMS0xLTIxMzMzOQ_6cc4c9a0-444b-4a1c-be34-7e243c387fae"
      unitRef="usd">15361000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:RestatementReviewExpense
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTEtMS0xLTIxMzMzOQ_0c8b1981-a020-4237-a01f-c13f4dfd534b"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTMtMS0xLTIxMzMzOQ_d9d1d697-0a79-479d-bd7b-f3ecbf2c271c"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTUtMS0xLTIxMzMzOQ_07d3a84d-6ba4-400d-b594-8442ed0ced0c"
      unitRef="usd">9688000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE1LTctMS0xLTI0NzM5NQ_e743a8e1-caec-4588-81d8-94a88f5aa756"
      unitRef="usd">9688000</cron:RestatementReviewExpense>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTEtMS0xLTIyNDAyMQ_7cd5c975-b4d9-499f-b94e-d4155055a91d"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTMtMS0xLTIyNDAyMQ_651946db-4da6-41f0-93f8-c4c1f39f6a7a"
      unitRef="usd">4789000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTUtMS0xLTIyNDAyMQ_403f476f-b5cb-44f6-8302-7120a9c77f2d"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE2LTctMS0xLTI0NzQ1OA_2dedddfc-1b5f-4082-b19c-1f41ba4b3f4f"
      unitRef="usd">4789000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="if44c1cdfa6c940fd977a237006beede0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE5LTEtMS0xLTIxMzMzOQ_28a1543f-201a-4220-afa4-97517dbac995"
      unitRef="usd">-28019000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic4d0e8f5f4344b048c737d36b8d8db89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE5LTMtMS0xLTIxMzMzOQ_3f42a392-9176-472f-8a65-326b2c8b110e"
      unitRef="usd">-98349000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i2d8d49b2a3e047b285ef65d9717b5e63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE5LTUtMS0xLTIxMzMzOQ_e5345ccf-2c80-4cb4-ab12-d9db7898e673"
      unitRef="usd">-20885000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjMjdjNWY5YjEwMmI0Yjk4OGIyYmNkN2ViYWVjZWJlNy90YWJsZXJhbmdlOmMyN2M1ZjliMTAyYjRiOTg4YjJiY2Q3ZWJhZWNlYmU3XzE5LTctMS0xLTIxMzMzOQ_d5d3d81f-60d5-471f-9732-180860ba039e"
      unitRef="usd">-147253000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ifd844fe64c4b404bb46e0d661e0f11cb_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzE2NDkyNjc0NTYxOTY_c1523aeb-9823-4142-a608-26ea3911909f"
      unitRef="usd">-877000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:Dividends
      contextRef="ifd844fe64c4b404bb46e0d661e0f11cb_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzEwOTk1MTE2NDIzMTM_2f423b60-3200-435e-bed6-750b98a64d30"
      unitRef="usd">384000</us-gaap:Dividends>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7260d7d8157b4cd88fc393c43daf539a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzEwOTk1MTE2NDIwMzM_7c43f952-adc7-40cd-a2cd-375f382e08a8"
      unitRef="shares">55176065</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90ZXh0cmVnaW9uOjY1MDA2YTRmMjgxMjQ0MTY5ZDMwNzAwZjRjMWY2NmU5XzUyMjM_56258bef-b121-49b6-8350-2f3ed70bae66">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue attributed to a geographic region based on the location of the customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net were physically located in the following geographic regions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie229aad448624a89855c1cd201833768_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzItMS0xLTEtMjEzMzM5_d59a5780-f073-483b-bacb-96528e9f5b8b"
      unitRef="usd">56233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie013c85f34934c4a9ef3fea20f60a42d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzItMy0xLTEtMjEzMzM5_cfa83138-0ab3-4948-ba0f-6d0a370c3e3a"
      unitRef="usd">50294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i193b7bc4af0a499ca3d6d6f0116acd86_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzItNS0xLTEtMjEzMzM5_c25aabf5-ddbe-4fa3-8d8e-a4127d8bc244"
      unitRef="usd">34538000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib404b8bdefcc4f2b8537e5847dcb9f04_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzMtMS0xLTEtMjEzMzM5_78507031-4d44-4d31-acf2-90cd1f6609e9"
      unitRef="usd">30516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc5ebc2d86264839b4b73bc4ee714946_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzMtMy0xLTEtMjEzMzM5_1cceb34f-0ef6-40b0-9355-f9f542858603"
      unitRef="usd">13376000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice3b1efcf3694f1599f386a8588accf4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzMtNS0xLTEtMjQ3NDMy_7483745d-9162-4968-bafc-bd6fc7b2d535"
      unitRef="usd">2539000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2f47442c54744328388ffe428c9d717_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzQtMS0xLTEtMjEzMzM5_ac3fd155-d8be-4e4d-8ede-2dc037213424"
      unitRef="usd">5155000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28085ac3313a4bc58d27734343ff5432_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzQtMy0xLTEtMjEzMzM5_95d19bd5-89d0-4480-9ae1-19f2f6115ae0"
      unitRef="usd">9874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74e5f9aeeb094f568a0007e88fa0096f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzQtNS0xLTEtMjEzMzM5_e67504b9-aae1-42c9-bdda-cc4d4601faf0"
      unitRef="usd">9495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib32dbd798ddd41e797792cebc95190b0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzUtMS0xLTEtMjEzMzM5_8ac8d316-d3a3-478a-ab18-176fc812693f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie46e12c969dc47b08571eacec89b355c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzUtMy0xLTEtMjEzMzM5_0edfda52-a734-4f94-b848-6b4ccbef68c4"
      unitRef="usd">891000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b9788ac9a6c4a99ae0b6378aa5fbeff_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzUtNS0xLTEtMjEzMzM5_554a95c2-97da-400c-99e7-56dd8a4f9f64"
      unitRef="usd">147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzYtMS0xLTEtMjEzMzM5_5db3dd0a-2187-43e7-8d8f-f2443767fdbd"
      unitRef="usd">91904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzYtMy0xLTEtMjEzMzM5_23afd3d6-5ebf-4258-8be5-b89bdf1dedc2"
      unitRef="usd">74435000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpiOTg0ZWI2MGE1ZWY0YTI3OTg3ZDM4NDdmNWE5YjRlYi90YWJsZXJhbmdlOmI5ODRlYjYwYTVlZjRhMjc5ODdkMzg0N2Y1YTliNGViXzYtNS0xLTEtMjEzMzM5_2fcd977f-85a4-4c1f-a46f-63b231e87976"
      unitRef="usd">46719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NoncurrentAssets
      contextRef="ib8948b89b8d243ea918ef9455a2869fd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzItMS0xLTEtMjEzMzM5_c767c84d-47a6-4087-bcf7-51d7e94f0014"
      unitRef="usd">40052000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i69c10d3f86f84221bdab6e26e7800896_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzItMy0xLTEtMjEzMzM5_8b49ecd5-3db0-4ba1-9210-66a1eb8f1562"
      unitRef="usd">49117000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ib6abf41ffd0443ed90c42968b76c69dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzMtMS0xLTEtMjEzMzM5_ae9c140b-5fbe-4a0f-9d57-8a434938c359"
      unitRef="usd">20251000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i070e08bd1da74fe0a694c34d5deabb5b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzMtMy0xLTEtMjEzMzM5_8531316e-8ed4-4546-a1e6-d1c445728adc"
      unitRef="usd">24473000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i8c7da359963f4407b13bec57ba12f46d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzQtMS0xLTEtMjEzMzM5_11948e97-2656-4474-9026-08316e442883"
      unitRef="usd">254000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="if30ffde831a0431e9db29021c4b5e73b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzQtMy0xLTEtMjEzMzM5_2449f0be-9f6b-406c-b9d3-613825ff6c23"
      unitRef="usd">480000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzUtMS0xLTEtMjEzMzM5_2b127a5f-be25-4a48-b1d1-a8392d79d2d8"
      unitRef="usd">60557000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMjcvZnJhZzo2NTAwNmE0ZjI4MTI0NDE2OWQzMDcwMGY0YzFmNjZlOS90YWJsZTpjOGUyODIzZTNiNzQ0N2IzYjllZTM0NWU2ZGU4NWJkNy90YWJsZXJhbmdlOmM4ZTI4MjNlM2I3NDQ3YjNiOWVlMzQ1ZTZkZTg1YmQ3XzUtMy0xLTEtMjEzMzM5_a3c58fcc-7be1-4ece-8bff-7ba0398224e7"
      unitRef="usd">74070000</us-gaap:NoncurrentAssets>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzU2OA_b1784998-4c9b-4af4-9029-d079a46adf95">Earnings (Loss) per Share&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (loss) per share from continued and discontinued operations are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic loss per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss from continuing operations attributable to the shareholders of Cronos&#160;Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding for computation for basic earnings per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic loss from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to the shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding from computation for basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted loss per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss used in the computation of basic loss from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment for exercise of rights on derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss used in the computation of diluted loss from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding used in the computation of basic loss per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Top-up Rights &#x2013; market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares for computation of diluted loss from continuing operations per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted loss per share from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to the shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares for computation of diluted loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total securities of 112,612,579, 125,195,001 and 151,338,762 were not included in the computation of diluted shares outstanding for the years ended December 31, 2022, 2021 and 2020, respectively, because the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzU2OQ_9399c58f-4d4f-4898-99d6-d2000b123b48">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (loss) per share from continued and discontinued operations are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic loss per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss from continuing operations attributable to the shareholders of Cronos&#160;Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding for computation for basic earnings per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic loss from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to the shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding from computation for basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted loss per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss used in the computation of basic loss from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment for exercise of rights on derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss used in the computation of diluted loss from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding used in the computation of basic loss per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Top-up Rights &#x2013; market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 24.62pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares for computation of diluted loss from continuing operations per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted loss per share from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to the shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares for computation of diluted loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376,961,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,390,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzMtMS0xLTEtMjI0MjYy_99360930-6fe5-49bb-860c-779025929d92"
      unitRef="usd">-168734000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzMtMy0xLTEtMjI0MjYy_9789724b-1894-4782-8c5b-03ddd187424c"
      unitRef="usd">-395607000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzMtNS0xLTEtMjI0MjYy_b31df59b-a27f-4d59-ab98-8e0dbf74132b"
      unitRef="usd">-72487000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzQtMS0xLTEtMjI0MjYy_6f7894de-3d6e-4e5f-bc29-868510616113"
      unitRef="shares">376961797</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzQtMy0xLTEtMjI0MjYy_70615d53-fc2b-497f-af93-fabb0a0ce95e"
      unitRef="shares">370390965</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzQtNS0xLTEtMjI0MjYy_3f3dad1f-a161-47e7-b9b1-b6fc6dcd3e29"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzUtMS0xLTEtMjQ3NTA5_4f258b40-aede-415e-8fce-10a61f7d3aba"
      unitRef="usdPerShare">-0.45</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzUtMy0xLTEtMjQ3NTA5_ba89d22a-56c2-46b1-b17b-fdd2a1079f46"
      unitRef="usdPerShare">-1.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzUtNS0xLTEtMjQ3NTA5_3797d5c5-ceb7-43d5-838c-66c8e48e2604"
      unitRef="usdPerShare">-0.21</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzctMS0xLTEtMjI0MzAx_e60eaf35-5315-4fc6-984f-d58902615488"
      unitRef="usd">0</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzctMy0xLTEtMjI0MzAx_13f157c9-16eb-4399-ba08-d109fece94f3"
      unitRef="usd">-500000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzctNS0xLTEtMjI0MzAx_bfbb8c14-6ac0-4d25-82b0-c636572a9dfe"
      unitRef="usd">-650000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzgtMS0xLTEtMjI0MzAx_2e67e741-5db8-41fa-be2e-29e8b7f7479b"
      unitRef="shares">376961797</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzgtMy0xLTEtMjI0MzAx_75d88107-e3fd-4500-9447-c58cbd00a08b"
      unitRef="shares">370390965</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzgtNS0xLTEtMjI0MzAx_27817499-018f-4b92-9f98-6acc327505b8"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzktMS0xLTEtMjQ3NTA5_7469f799-b1fe-41c6-8b37-7e2f0927f4a2"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzktMy0xLTEtMjQ3NTA5_d07c5979-56ff-473c-ad4e-c552d5fb8787"
      unitRef="usdPerShare">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzktNS0xLTEtMjQ3NTA5_a9f08662-ba32-436f-b0d9-f8c6790f5929"
      unitRef="usdPerShare">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzExLTEtMS0xLTIyNDU1NQ_cb9fa6c4-8af7-48cd-b353-d7ab9e3a2b0f"
      unitRef="usd">-168734000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzExLTMtMS0xLTIyNDU1NQ_9a6d820b-90d6-4571-ad16-989aab58090c"
      unitRef="usd">-395607000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzExLTUtMS0xLTIyNDU1NQ_1ba4db8a-ec59-4947-851d-ba1cd38f51e9"
      unitRef="usd">-72487000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:DilutiveSecurities
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEyLTEtMS0xLTIyNDU1NQ_3545e307-0575-406a-a86d-9ece4a89035b"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEyLTMtMS0xLTIyNDU1NQ_9cba970d-8d45-4fba-963d-3614dfce8f7c"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEyLTUtMS0xLTIyNDU1NQ_3a3ccd41-6e3e-42ba-9dba-1c78bb7afe17"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEzLTEtMS0xLTI0NzUxMw_ddb51591-3a57-4335-a50f-fd44fdc44913"
      unitRef="usd">-168734000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEzLTMtMS0xLTI0NzUxMw_4b143ce1-af1c-47e6-af31-022433adc1cc"
      unitRef="usd">-395607000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzEzLTUtMS0xLTI0NzUxMw_debe95bf-047a-4806-8d1e-a2708489e4b4"
      unitRef="usd">-72487000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE1LTEtMS0xLTIyNDU2OA_d6043886-4ef8-45f8-b661-c45d95daae9e"
      unitRef="shares">376961797</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE1LTMtMS0xLTIyNDU2OA_aab94936-e174-4d02-97af-f90a9a9dfa32"
      unitRef="shares">370390965</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE1LTUtMS0xLTIyNDU2OA_6b1a9575-193e-46fa-a724-94454f1b59e8"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i20c9a2151d6f4e979229b7d30b202741_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE3LTEtMS0xLTIyNDU2OA_6be79407-f408-469d-b3fd-16f5dfeb0ffe"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i831f4a43963e485884c99ebee4119ee1_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE3LTMtMS0xLTIyNDU2OA_2f1ca7dc-14fb-480a-ab24-8c050d723992"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8d869fdefbad4a6daafa64f95ebfe973_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE3LTUtMS0xLTIyNDU2OA_04a42e2c-a37f-4e3d-a0e7-00f70522aa1e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i467c0fe45b2a437bbff365f44a6dccfb_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE4LTEtMS0xLTIyNDU2OA_6c9fa165-bd15-4936-a078-88de6a33c970"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0cb6dfbd44dc4046815372a6579bc53d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE4LTMtMS0xLTIyNDU2OA_e20eb1b1-bd4e-47af-a2e1-06c742e41b96"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iaf758d42193e47efa6985fa375da7738_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE4LTUtMS0xLTIyNDU2OA_a7f2237d-5d4a-425e-a68f-b5fa3f099f6b"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE5LTEtMS0xLTIyNDU2OA_f78c161c-d3f3-4de2-b774-21161ff62716"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ifa6828e8819e41669c381f0a5cd08290_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE5LTMtMS0xLTIyNDU2OA_bf32ea10-b325-4457-8bcb-0ae1544e9786"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4d0a16223e8748fca5daa5a5b730a11e_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzE5LTUtMS0xLTIyNDU2OA_1e5d49f2-92d1-4866-a312-b650fc7ac741"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIwLTEtMS0xLTIyNDU2OA_7cb8b8c7-9cb0-48c4-b918-9cc3f6cdec3e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIwLTMtMS0xLTIyNDU2OA_b6d08ace-e038-4842-8059-ec7627962802"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIwLTUtMS0xLTIyNDU2OA_ca44ab58-f064-4de8-946c-867bbf957f71"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIxLTEtMS0xLTI0NzUxMw_6693f967-eeea-498a-9853-b8a7759372ca"
      unitRef="shares">376961797</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIxLTMtMS0xLTI0NzUxMw_1b1f6262-cd88-4923-a85a-debdf8a695e5"
      unitRef="shares">370390965</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIxLTUtMS0xLTI0NzUxMw_8bb69bbd-c47d-45cc-b832-695e9f47e611"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIyLTEtMS0xLTI0NzUxMw_51de2f7f-bdc4-4a22-8226-0894ad144d6a"
      unitRef="usdPerShare">-0.45</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIyLTMtMS0xLTI0NzUxMw_32beae1b-ab5a-4041-9ff3-914495336463"
      unitRef="usdPerShare">-1.07</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzIyLTUtMS0xLTI0NzUxMw_075a7858-8d40-45ad-82cc-6a7d91afb640"
      unitRef="usdPerShare">-0.21</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI0LTEtMS0xLTIyNDYxNw_55d2c1a8-05b6-4b64-96b6-ff8590503883"
      unitRef="usd">0</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI0LTMtMS0xLTIyNDYxNw_e8d780e6-9473-491f-aef8-2426b194ca74"
      unitRef="usd">-500000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI0LTUtMS0xLTIyNDYxNw_4c74e983-4542-4d7a-a265-b24dd23a3981"
      unitRef="usd">-650000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI1LTEtMS0xLTIyNDYyNQ_32cb0187-e62a-40cf-afc5-9137d2795790"
      unitRef="shares">376961797</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI1LTMtMS0xLTIyNDYyNQ_39bb8b93-d19b-42c4-907c-9ae11b88452e"
      unitRef="shares">370390965</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI1LTUtMS0xLTIyNDYyNQ_aa6d87b4-5eea-4c08-a150-e5e0eae0620c"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI2LTEtMS0xLTI0NzUxMw_2991db0b-249a-4772-8664-7b8732cbadd1"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI2LTMtMS0xLTI0NzUxMw_fc696e70-f65e-48b5-89c1-1b7f52c0b38b"
      unitRef="usdPerShare">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90YWJsZToyNGIwZDE5NmUwNzg0ZWE2YmMxNmRhOWMzNjBiNzVmMy90YWJsZXJhbmdlOjI0YjBkMTk2ZTA3ODRlYTZiYzE2ZGE5YzM2MGI3NWYzXzI2LTUtMS0xLTI0NzUxMw_83d17768-1530-4a95-9277-5e40004b36db"
      unitRef="usdPerShare">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzM3Ng_720dd82c-cbfa-4acc-a911-0818ce84ec9f"
      unitRef="shares">112612579</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzM4MA_42c36f6e-7c7a-4ce0-895b-74447fa5f1e5"
      unitRef="shares">125195001</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i65e5863f5ae84ebb9b605a9732d70675_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzAvZnJhZzo0NTgzZWUzODE1NzM0YzU2YmU5YjRmZmY3YjVmYWQ0NC90ZXh0cmVnaW9uOjQ1ODNlZTM4MTU3MzRjNTZiZTliNGZmZjdiNWZhZDQ0XzM4Nw_3a435032-c5e8-483c-b0a9-c7827d315287"
      unitRef="shares">151338762</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2Xzk4NTM_e4f525a4-c9e9-454b-b667-0acc2a9a5cd2">Financial Instruments&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Fair value measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with ASC 820 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt"&gt;On December 16, 2021, Cronos Australia (now, Vitura) closed their merger agreement to acquire CDA Health Pty Ltd, an Australian medicinal cannabis company. In connection with the closing of the Cronos Australia Merger, the Company&#x2019;s ownership interest in Cronos Australia decreased to approximately 10% and the Company&#x2019;s number of Cronos Australia board seats was reduced from two to zero which constituted a loss of significant influence. As such, the Company reclassified the investment from an investment in equity method investments under the equity method of accounting to other investments under the fair value method of accounting. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between fair value categories during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s assets that are measured at fair value on a non-recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt"&gt;On June 14, 2021, the Company purchased an option to acquire 473,787 shares of Class A Common Stock of PharmaCann, a vertically integrated cannabis company in the United States, at an exercise price of $0.0001 per share, representing approximately 10.5% of PharmaCann&#x2019;s issued and outstanding capital stock on a fully diluted basis as of the date of the PharmaCann Option, for an aggregate purchase price of approximately $110,392. On February 28, 2022, PharmaCann closed its previously announced transaction with LivWell pursuant to which PharmaCann acquired LivWell. LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#x2019;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately 6.4%. As of December 31, 2022, the Company&#x2019;s ownership percentage in PharmaCann on a fully diluted basis was approximately 6.3%. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between fair value categories during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Financial risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s activities expose it to a variety of financial risks, including credit risk, liquidity risk, market risk, interest rate risk, and foreign currency rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short term investments, loans receivable, and advances to joint ventures. The Company&#x2019;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $987,442 and $1,118,684 as of December&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.57pt"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had accounts receivable of $23,113 and $22,067 as of December&#160;31, 2022 and December&#160;31, 2021, respectively. An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than 120 days past due. As of December&#160;31, 2022, 2021 and 2020, the Company had $2, $8 and $9, respectively, in expected credit losses on receivables from contracts with customers in the ROW segment and $217, $104 and $65, respectively, in expected credit losses on receivables from contracts with customers in the U.S. segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company has assessed that there is a concentration of credit risk as 55% of the Company&#x2019;s accounts receivable were due from three customers with an established credit history with the Company. As of December&#160;31, 2021, 88% of the Company&#x2019;s accounts receivable were due from four customers with an established credit history with the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#x2019;s revenues. During the year ended December&#160;31, 2022, the Company earned a total net revenue before excise taxes of $63,509 from three major customers in the ROW segment, together accounting for 55% of the Company&#x2019;s total net revenue before excise taxes. During the year ended December&#160;31, 2021, the ROW segment earned a total net revenue before excise taxes of $41,603 from three major customers, together accounting for 56% of the Company&#x2019;s total net revenue before excise taxes. During the year ended December&#160;31, 2020, the ROW segment earned a total net revenue before excise taxes of $34,295 from four major customers, accounting for 63% of the Company&#x2019;s total net revenues before excise taxes. During the years ended December&#160;31, 2022, 2021, and 2020 the U.S. segment had no major customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.8pt"&gt; Cash and cash equivalents, short-term investments, and other receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held cash and cash equivalents of $764,644 and $886,973 as of December&#160;31, 2022 and December&#160;31, 2021, respectively. The short-term investments and related interest receivable of $113,077 and $117,684 as of December&#160;31, 2022 and December&#160;31, 2021, respectively, represent short-term investments with a maturity of less than a year and accrued interest. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#x2019; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liquidity risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#x2019;s accounts payable. The Company had trade accounts payable of $8,599 and $8,395 as of December&#160;31, 2022 and December&#160;31, 2021, respectively, included in accounts payable on the consolidated balance sheet. The Company&#x2019;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#x2019;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#x2019;s funding has primarily been provided in the form of capital raised through the issuance of common shares and warrants. As of December&#160;31, 2022, the Company has assessed a concentration of risk of vendors as 27% of accounts payable were due to one vendor. As of December&#160;31, 2021, the Company has assessed a concentration risk of vendors as 19% of accounts payable due to one vendor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Market risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Market risk is the risk that the fair value of, or future cash flows from, the Company&#x2019;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that unfavorable market conditions could result in dispositions of investments at less than their carrying amounts. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#x2019;s investments, which would have an adverse impact on the Company&#x2019;s results of operations, unless these would flow through other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages risk by having a portfolio of securities from multiple issuers, such that the Company was not materially exposed to any one issuer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those that possess a short term to maturity. A 10% change in the interest rate in effect on December&#160;31, 2022 and December&#160;31, 2021, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#x2019;s investment strategy as a result.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company had net interest income of $22,537 and $9,071, respectively. During the year ended December&#160;31, 2022, the Company&#x2019;s average variable interest rate increased approximately 3.5%. During the year ended December&#160;31, 2021, the Company&#x2019;s average variable interest rate did not change materially.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#x2019;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on investments in equity investments denominated in A$ and C$, and other assets and liabilities denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#x2019;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#x2019;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and December&#160;31, 2021, the Company had foreign currency gain (loss) on translation of $(50,616) and $8,192, respectively. A 10% change in the exchange rates for the foreign currencies would affect the carrying amounts of net assets by approximately $77,414 and $87,705 as of December&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2Xzk4NTQ_05cab89c-ad0d-47f7-8049-fa970a457b7c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt"&gt;On December 16, 2021, Cronos Australia (now, Vitura) closed their merger agreement to acquire CDA Health Pty Ltd, an Australian medicinal cannabis company. In connection with the closing of the Cronos Australia Merger, the Company&#x2019;s ownership interest in Cronos Australia decreased to approximately 10% and the Company&#x2019;s number of Cronos Australia board seats was reduced from two to zero which constituted a loss of significant influence. As such, the Company reclassified the investment from an investment in equity method investments under the equity method of accounting to other investments under the fair value method of accounting. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i397a3256afd747d8b6924425b8505d5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzItMS0xLTEtMjEzMzM5_4badb3eb-5146-401e-b497-cb98f580af61"
      unitRef="usd">764644000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i85e32c5a6a41470eb8b3053295eb1e32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzItMy0xLTEtMjEzMzM5_7c93c623-f7bb-45b1-a52e-9d1061bbce06"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzItNS0xLTEtMjEzMzM5_16a955bf-2934-4881-870e-69451eaa9376"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib95fa6c13bfb4c45adb4622b1026b433_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzItNy0xLTEtMjEzMzM5_5c2ee593-24c0-434e-9fd7-47a5a5355eee"
      unitRef="usd">764644000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i397a3256afd747d8b6924425b8505d5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzMtMS0xLTEtMjEzMzM5_0928d0cd-5d58-42e7-9b09-d9db2fbf2de1"
      unitRef="usd">113077000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i85e32c5a6a41470eb8b3053295eb1e32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzMtMy0xLTEtMjEzMzM5_e8d46ee2-26fe-41eb-898c-b6c1947ae2b4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzMtNS0xLTEtMjEzMzM5_c600f473-74c6-4864-84c2-00a1ac7841f0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib95fa6c13bfb4c45adb4622b1026b433_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzMtNy0xLTEtMjEzMzM5_37bad884-4417-4200-8291-eb9c0ca8ef44"
      unitRef="usd">113077000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherInvestments
      contextRef="i397a3256afd747d8b6924425b8505d5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzQtMS0xLTEtMjEzMzM5_baa2eff0-19ed-4c97-b9a1-3e4e4510bb81"
      unitRef="usd">21993000</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="i85e32c5a6a41470eb8b3053295eb1e32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzQtMy0xLTEtMjEzMzM5_b21f0656-e915-4f8e-89ea-39d4b964208b"
      unitRef="usd">0</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzQtNS0xLTEtMjEzMzM5_58bc2e04-2209-4b76-8d76-0b20f18684b4"
      unitRef="usd">0</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="ib95fa6c13bfb4c45adb4622b1026b433_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzQtNy0xLTEtMjEzMzM5_11a83db1-538a-4d02-b325-b10a654d1772"
      unitRef="usd">21993000</us-gaap:OtherInvestments>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i397a3256afd747d8b6924425b8505d5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzUtMS0xLTEtMjEzMzM5_44008373-1e25-48fa-9935-588951cf2cdc"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i85e32c5a6a41470eb8b3053295eb1e32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzUtMy0xLTEtMjEzMzM5_eaec61ae-6f09-4803-bb72-15fcb40fdab6"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i9d8c83ecf3cf4301b8f0553691349ce6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzUtNS0xLTEtMjEzMzM5_4be32524-8b9d-428c-afb8-a9114a2c2c38"
      unitRef="usd">15000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ib95fa6c13bfb4c45adb4622b1026b433_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTplMDgxYmE3YTQ3ODU0ZGE3ODA5ZjFjZDIwZTdlYmIzOC90YWJsZXJhbmdlOmUwODFiYTdhNDc4NTRkYTc4MDlmMWNkMjBlN2ViYjM4XzUtNy0xLTEtMjEzMzM5_b6fbde3b-dec3-45ff-8d5e-946c384d491c"
      unitRef="usd">15000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ideb28843c408441191244b00e0e9c9c9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzItMS0xLTEtMjEzMzM5_c20ed3d8-478a-43b3-a2f1-38fb87020c54"
      unitRef="usd">886973000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7178462e779b4050b4f4f598cd80ef6d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzItMy0xLTEtMjEzMzM5_e2e5fe3e-e819-4a3d-8f16-584da8359eba"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i578a803e2dfe4a57855a55c6ddd450a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzItNS0xLTEtMjEzMzM5_5c5d56e2-c825-435e-8f98-7707b416dda8"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i27823bddabff46fa96994e20b95dfdaa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzItNy0xLTEtMjEzMzM5_0d10dc2d-7fb7-45b8-b502-8ccb5e453c59"
      unitRef="usd">886973000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ideb28843c408441191244b00e0e9c9c9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzMtMS0xLTEtMjEzMzM5_aa6c245c-0e25-4c32-a175-a7e0a34accc7"
      unitRef="usd">117684000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7178462e779b4050b4f4f598cd80ef6d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzMtMy0xLTEtMjEzMzM5_ebbc4ffd-dec9-4a8a-a9d7-ba5d3c002d6d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i578a803e2dfe4a57855a55c6ddd450a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzMtNS0xLTEtMjEzMzM5_ba16b67b-1a10-4190-9989-e38adf1ae576"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i27823bddabff46fa96994e20b95dfdaa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzMtNy0xLTEtMjEzMzM5_3c3fec5b-7320-41bd-8f9b-0d956c4352be"
      unitRef="usd">117684000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherInvestments
      contextRef="ideb28843c408441191244b00e0e9c9c9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtMS0xLTEtMjI2MzMy_8b37bfef-5313-4b7c-bfe5-c81e1d48a7c4"
      unitRef="usd">8000000</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="i7178462e779b4050b4f4f598cd80ef6d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtMy0xLTEtMjI2Mzk5_c77b2b7c-043b-4f3a-8da4-612ee0d384c9"
      unitRef="usd">0</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="i578a803e2dfe4a57855a55c6ddd450a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtNS0xLTEtMjI2NDAy_53f38faf-019e-47a3-a47c-0368130df311"
      unitRef="usd">0</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="i27823bddabff46fa96994e20b95dfdaa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtNy0xLTEtMjQ3NTM4_48df2d61-d5f0-4eb7-8d5c-76f9a7adf9c1"
      unitRef="usd">8000000</us-gaap:OtherInvestments>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ideb28843c408441191244b00e0e9c9c9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtMS0xLTEtMjEzMzM5_a999b5c0-a86a-44e0-b1b1-122cd306224b"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i7178462e779b4050b4f4f598cd80ef6d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtMy0xLTEtMjEzMzM5_56ca1738-13b4-45e0-9d30-05f92908f19d"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i578a803e2dfe4a57855a55c6ddd450a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtNS0xLTEtMjEzMzM5_06965bc5-8ee4-49b1-bf2f-ee6a50a35624"
      unitRef="usd">14375000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i27823bddabff46fa96994e20b95dfdaa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTo4MGQ0ZTc0M2I0Yzc0NDQxYjlhYWViM2IxZDUzYjBjMC90YWJsZXJhbmdlOjgwZDRlNzQzYjRjNzQ0NDFiOWFhZWIzYjFkNTNiMGMwXzQtNy0xLTEtMjEzMzM5_aa79835f-dcfe-4903-9223-b2ca948f85cb"
      unitRef="usd">14375000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3e0794b671294cf4a1a592fd95ab0288_I20211216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2MzkxMjk_d96a148e-71cf-4c83-a3d5-dd90184bf2fe"
      unitRef="number">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:NumberOfSeatsOnBoardOfDirectors
      contextRef="if46b21ab0b3b47ce84759033415e34a3_I20211215"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE4NjkxNjk3Njg0MDUx_2fcde515-e4d5-4bfe-ab3e-20c89c4df883"
      unitRef="seat">2</cron:NumberOfSeatsOnBoardOfDirectors>
    <cron:NumberOfSeatsOnBoardOfDirectors
      contextRef="i3e0794b671294cf4a1a592fd95ab0288_I20211216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE4NjkxNjk3Njg0MDUy_d289ece0-95df-4393-92a7-2e8dfcd02320"
      unitRef="seat">0</cron:NumberOfSeatsOnBoardOfDirectors>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE0ODQzNDA2OTg3MTU4_d3a1db9d-ba74-4a48-99c8-7aff2231a096">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s assets that are measured at fair value on a non-recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:31.1pt"&gt;On June 14, 2021, the Company purchased an option to acquire 473,787 shares of Class A Common Stock of PharmaCann, a vertically integrated cannabis company in the United States, at an exercise price of $0.0001 per share, representing approximately 10.5% of PharmaCann&#x2019;s issued and outstanding capital stock on a fully diluted basis as of the date of the PharmaCann Option, for an aggregate purchase price of approximately $110,392. On February 28, 2022, PharmaCann closed its previously announced transaction with LivWell pursuant to which PharmaCann acquired LivWell. LivWell is a multi-state cannabis cultivation and retail leader based in Colorado. As a result of the LivWell Transaction, the Company&#x2019;s ownership percentage in PharmaCann on a fully diluted basis decreased to approximately 6.4%. As of December 31, 2022, the Company&#x2019;s ownership percentage in PharmaCann on a fully diluted basis was approximately 6.3%. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock>
    <us-gaap:OtherInvestments
      contextRef="i44db994827904092be31ae9e5e8445bc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTpiMzJlZjg1YmVjYWY0NGYwYmE5MzNmYmY4YTJkZDkyOC90YWJsZXJhbmdlOmIzMmVmODViZWNhZjQ0ZjBiYTkzM2ZiZjhhMmRkOTI4XzQtMS0xLTEtMjQ3Njky_68defd6a-99cf-4eb0-8872-dd3448aca1e0"
      unitRef="usd">0</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="i311fa3bfafef494e85ad86818daa0cdc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTpiMzJlZjg1YmVjYWY0NGYwYmE5MzNmYmY4YTJkZDkyOC90YWJsZXJhbmdlOmIzMmVmODViZWNhZjQ0ZjBiYTkzM2ZiZjhhMmRkOTI4XzQtMy0xLTEtMjQ3Njky_e2f22264-3cde-4dd4-8b71-c04f390baab0"
      unitRef="usd">0</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="ia2d176a72c724664bab57f3928bc0916_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTpiMzJlZjg1YmVjYWY0NGYwYmE5MzNmYmY4YTJkZDkyOC90YWJsZXJhbmdlOmIzMmVmODViZWNhZjQ0ZjBiYTkzM2ZiZjhhMmRkOTI4XzQtNS0xLTEtMjQ3Njky_124c13ac-0e6e-404e-8375-9fddcdcda68b"
      unitRef="usd">49000000</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="ieb4548315c1d4631b6983f6d50ea8397_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90YWJsZTpiMzJlZjg1YmVjYWY0NGYwYmE5MzNmYmY4YTJkZDkyOC90YWJsZXJhbmdlOmIzMmVmODViZWNhZjQ0ZjBiYTkzM2ZiZjhhMmRkOTI4XzItNy0xLTEtMjQ5NTEx_74febe16-58ec-4feb-9231-9af568eba878"
      unitRef="usd">49000000</us-gaap:OtherInvestments>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i7a6151bf97b4479db1915de9cf54196a_D20210614-20210614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDI0ODA_42a317ac-a2b4-4971-9901-0d1bb9352571"
      unitRef="shares">473787</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ica770eae2c9246a2afe81a80ce6bc6ec_I20210614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDI2Mzg_dfdf1135-fac5-4758-8555-40b37f34b9d1"
      unitRef="usdPerShare">0.0001</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDI2ODA_f1a78c01-315c-4b83-88f9-524b6fffe193"
      unitRef="number">0.105</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="ib42856d2271a499ca5388961200ae6d7_D20210614-20210614"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDI4NTI_d13d4645-0021-45f0-8787-47c4967deb44"
      unitRef="usd">110392000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i55bbd96bb4154fef93d9f031c4651fa9_I20220228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDM3MjY_27bc860b-ec00-4cf7-b339-cc25aae9ea7a"
      unitRef="number">0.064</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i3306701595a04451b85d16301150c1ee_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2NDM4NDg_8954e235-22c4-42e3-b68c-ac86ffc24f2d"
      unitRef="number">0.063</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTE5Njc_927ba784-bfb2-4f93-93cd-571667e6f318"
      unitRef="usd">987442000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTE5ODY_e5b98ae5-4b08-4968-8527-743c1b5a8d9c"
      unitRef="usd">1118684000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIwMzM_40100210-eb67-4637-b7f0-a9c477c3ea12"
      unitRef="usd">23113000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIwMjg_50859fe4-2a19-46ca-8308-6eb1658008bb"
      unitRef="usd">22067000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM0MDg_fc51078a-f408-4047-9425-dfb81d1bd6f3">P120D</us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i9fc469d3cfaa48f9808a8fd424589cd6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTMxMDk_a06634be-a145-4052-b512-93415b0962d1"
      unitRef="usd">2000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i251c1f541a4743728ff8c8cd8aad5a51_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTMxMTI_db17dbb8-ef0a-45f1-ba93-683e35db17b5"
      unitRef="usd">8000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i483292d9892e405c9fd41c2bc7fe6a89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzIxOTkwMjMyNjcwMTE_857038d6-30d6-4db4-8f74-412046ce86ce"
      unitRef="usd">9000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i3e29abb1c1a64038b0402ae05946449a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk0NTA_77c6cc71-52b4-4e7d-bbe5-619d19938ade"
      unitRef="usd">217000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ic58ad37f674b4bf1a74ec35c6f4e405c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk0NTg_21cf1034-e85a-417a-bfff-255e89f83c54"
      unitRef="usd">104000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5241cf1c2d3d48c6829684e7a67b759a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk0NjQ_d82458f9-fec1-4688-93b3-4a635e34daa0"
      unitRef="usd">65000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id544276629be4ca58e468c96a96b58ff_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxMjU_8c3e3645-e54e-4499-8a0b-7782b9a96830"
      unitRef="number">0.55</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7cbf0d27e1024f2585bc6bbba3a9248a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxMzE_42917971-a4da-419b-b401-bc7f54577985"
      unitRef="number">0.88</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib624948ee4414abca5cf322e8938b6b9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxMzU_5344c47c-62a7-4dd8-8831-c240d74b2a1b"
      unitRef="usd">63509000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia8cc4bddc3834a28956294a993ffb1bd_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxNTA_812c19f5-7d7b-44bf-b0ed-2179c178cdeb"
      unitRef="number">0.55</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i318dd49f5d5f4baf9c5d2dbbd7dae763_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxNTQ_521b98cf-bec4-4693-934a-e4c00a6f4d4c"
      unitRef="usd">41603000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i318dd49f5d5f4baf9c5d2dbbd7dae763_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxOTQ_fafc76ad-b1a9-4b60-9377-2e347f1be84e"
      unitRef="number">0.56</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i852bd7bd8fed4a99a245288e27159105_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIxOTg_48f62428-bf89-462a-81a9-4041fc8d99ed"
      unitRef="usd">34295000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3e6e844f23174cafad959fff0262ccd2_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyMDg_27b873a6-a22d-4f56-ac57-b79f1e787d33"
      unitRef="number">0.63</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyMzA_efce5304-9cc2-42cd-92b9-0c74b4bf3df8"
      unitRef="usd">764644000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyMzQ_5594a819-9285-4897-9331-88564e3e7717"
      unitRef="usd">886973000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyNjk_6563d078-31de-420e-a139-23e84f55e905"
      unitRef="usd">113077000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIyNzQ_bcbff856-917f-489b-a867-83118da5bbaf"
      unitRef="usd">117684000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIzMDk_04b9b5b9-2fe9-476c-bd73-e66a9efa727f"
      unitRef="usd">8599000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIzMDU_0f721e56-c46c-4e9e-9ab0-5d081f9f14df"
      unitRef="usd">8395000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0cfb8a95516c46b7ab49a044801b97ed_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIzMzk_f5548a92-4b8a-4f76-9649-a9c7fd49209d"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iddf4e03c7d9e40fa8a934f29b9d13609_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzE2NDkyNjc0NTIzNDQ_1b130608-79a3-4507-a969-f8ecbe624a38"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzU0OTc1NTgyNTM2Ng_661f93d3-64f1-45c7-8cf5-ce029f1a75f1"
      unitRef="usd">22537000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2Xzg1MjY_6b1ffd25-78b0-48f1-81be-c99796800979"
      unitRef="usd">9071000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM4NDgyOTA3MDg4Nzk_81082e04-e467-4e75-9534-c4017373a482"
      unitRef="number">0.035</cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk2MDg_f2d15d65-5c22-4962-835d-10842daeb51f"
      unitRef="usd">-50616000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie6bb24f01077460e86c46de9d6f0e92f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzEwOTk1MTE2Mzk2MTQ_f0655670-cd0d-444d-8324-79205fd41550"
      unitRef="usd">8192000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate
      contextRef="ia33af1f54aa342248ebe7045d0058626_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM4NDgyOTA3MDg4MTc_561d086e-1b02-468b-9d63-6d60adf5c09b"
      unitRef="usd">77414000</cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate>
    <cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM4NDgyOTA3MDg4MjM_88c4888b-543f-4afa-a8ac-1fd988c4b322"
      unitRef="usd">87705000</cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate>
    <cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate
      contextRef="i0b61d3b7b8334186a589bb519b652171_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzMvZnJhZzo3NzNhMDQ1NWRkNjY0NGM0YjI2MTQxNWEwYWFhZTZlNi90ZXh0cmVnaW9uOjc3M2EwNDU1ZGQ2NjQ0YzRiMjYxNDE1YTBhYWFlNmU2XzM4NDgyOTA3MDg4MjM_e4d59a64-182f-4bac-a828-fa7dbe103023"
      unitRef="usd">87705000</cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE0Nzg_d3914e7a-5812-4f52-a838-59856fa1c4bb">Related Party Transactions &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Altria&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a 45% equity interest in the Company. As of December 31, 2022, Altria beneficially held an approximately 41% ownership interest in the Company (calculated on a non-diluted basis).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#x201c;Altria Pinnacle&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Altria Pinnacle &#x2013; expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no amounts payable related to the consulting services with Altria Pinnacle as of December 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 8 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; for further information on the derivative liabilities related to the Altria Investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Cronos GrowCo&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company holds a variable interest in Cronos GrowCo through its ownership of 50% of Cronos GrowCo&#x2019;s common shares and senior secured debt in Cronos GrowCo. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x201d; for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company made the following purchases of cannabis products from Cronos GrowCo:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cronos GrowCo &#x2013; purchases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s outstanding payable balance to Cronos GrowCo was $2,519 and $82 as of December 31, 2022 and December 31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Additionally, on August 23, 2019, the Company, as lender, and Cronos GrowCo, as borrower, entered into the GrowCo Credit Facility. See additional information in Note 4 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Loans Receivable, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:24.91pt"&gt;Vendor Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;In November 2022, the Company entered into an agreement with an external vendor whereby the vendor would provide certain manufacturing services to the Company. The vendor then subcontracted out a portion of those services to another company whose chief executive officer is an immediate family member of an executive of the Company.  The Company has no direct contractual relationship with the related party.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;During the year-ended 2022, the Company purchased $645 of products and services under this agreement and had no outstanding accounts payable related to the agreement as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i61396ac601174186a618ab85deae5ee4_I20190308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE1MQ_b25c954d-7a9d-4a09-a045-0f8ffd0d911b"
      unitRef="number">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie7edb25988ef4ca680ec0519a1f7a41c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzI1Mw_d71977f8-2c90-46da-8f1f-36f692227a05"
      unitRef="number">0.41</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE0Nzk_aed802c2-55fc-4565-b4d8-73afa93842f0">&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#x201c;Altria Pinnacle&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Altria Pinnacle &#x2013; expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company made the following purchases of cannabis products from Cronos GrowCo:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cronos GrowCo &#x2013; purchases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i3f0e0dbaf50b44ab84666bd8bc9badcc_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkZDU0MzYyZjM2NWY0NGMyOWE2ZjBjMjEwYTIwOTQxNC90YWJsZXJhbmdlOmRkNTQzNjJmMzY1ZjQ0YzI5YTZmMGMyMTBhMjA5NDE0XzItMS0xLTEtMjEzMzM5_1b8ca1f6-d88d-40f1-a1ca-3fd9a9519bfc"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="idc524b86dcf94566bb86a2e924b61bb3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkZDU0MzYyZjM2NWY0NGMyOWE2ZjBjMjEwYTIwOTQxNC90YWJsZXJhbmdlOmRkNTQzNjJmMzY1ZjQ0YzI5YTZmMGMyMTBhMjA5NDE0XzItMy0xLTEtMjEzMzM5_b3b0e202-14a2-4ac2-b656-6081085df2e1"
      unitRef="usd">436000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i85d746ad8f524e279e4e4da9248e3e2a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkZDU0MzYyZjM2NWY0NGMyOWE2ZjBjMjEwYTIwOTQxNC90YWJsZXJhbmdlOmRkNTQzNjJmMzY1ZjQ0YzI5YTZmMGMyMTBhMjA5NDE0XzItNS0xLTEtMjEzMzM5_10a08de5-7582-4bda-b468-1ec3cec09aeb"
      unitRef="usd">1199000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="ibcc1ba88d12745e29a44781b9cb2a6b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzY0OQ_b6b22fdd-9f0f-46b0-96df-8a38a1e1411b"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="i7c47520415b84aa69148a3dd6909c4a3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzY0OQ_c69c5ade-64a5-45e8-b86e-f8ba1f2ac85e"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ia965648dd525484799c2e977f7acaf53_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4Xzk1Nw_465dd7af-b178-4d01-87bb-68b49d8b368c"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="iec05a6d229d94475b72ce77d3e52909d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkYWZhMTQwOTIwNmU0YzA2YTI5OThjZGNhODE3YThlZi90YWJsZXJhbmdlOmRhZmExNDA5MjA2ZTRjMDZhMjk5OGNkY2E4MTdhOGVmXzItMS0xLTEtMjEzMzM5_bc1f3631-5bca-412a-8bae-df75e5175f60"
      unitRef="usd">18144000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="ib982510dffea40dca9be2c62f5c6ee7b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkYWZhMTQwOTIwNmU0YzA2YTI5OThjZGNhODE3YThlZi90YWJsZXJhbmdlOmRhZmExNDA5MjA2ZTRjMDZhMjk5OGNkY2E4MTdhOGVmXzItMy0xLTEtMjEzMzM5_b928536d-8fa6-4580-a99a-7f9891d12107"
      unitRef="usd">4820000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i045cf7db853f4153bd9a03bb1868a622_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90YWJsZTpkYWZhMTQwOTIwNmU0YzA2YTI5OThjZGNhODE3YThlZi90YWJsZXJhbmdlOmRhZmExNDA5MjA2ZTRjMDZhMjk5OGNkY2E4MTdhOGVmXzItNS0xLTEtMjEzMzM5_8570ebfa-b819-48af-bc6f-1c068f273d85"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="ida3f84386d9149eaa1274948ebe8ec5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE2NDkyNjc0NDM5MTQ_2a1dca06-0596-4e45-83e8-e577905b5081"
      unitRef="usd">2519000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="i46ed54be0f0b436d89417a7a22f3beae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE2NDkyNjc0NDM5MTA_2be8720a-146d-45c8-abf0-8247ee1c8312"
      unitRef="usd">82000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="id5a8cde9e54943859cd78bbde842143f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzEwOTk1MTE2MzIzNDc_2ee57d84-1126-44d8-bdee-dd2acee9fca1"
      unitRef="usd">645000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="i92bdfdf7df22443d9e5a9d09d167facd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xMzYvZnJhZzplZjhjY2RlMTY1Yjk0Zjg2OWIwN2Y3YWNiYzBmNTA1OC90ZXh0cmVnaW9uOmVmOGNjZGUxNjViOTRmODY5YjA3ZjdhY2JjMGY1MDU4XzE0ODQzNDA2OTc5NTYx_eff10150-1f4a-45c5-963f-e95b00f6a252"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGV4dHJlZ2lvbjoxODAxYzFmM2JhNGU0NjBiYTdlNTZiZDM0MmQ0ZDVhZV8xODY5MTY5NzY3NzQ0Mw_8a31d279-bcf6-489f-8e20-b99a55d1687e">Restructuring&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, the Company initiated a strategic plan to realign the business around its brands, centralize functions and evaluate the Company&#x2019;s supply chain (the &#x201c;Realignment&#x201d;). As part of the Realignment, on February 28, 2022, the Board approved plans to leverage the Company&#x2019;s strategic partnerships to improve supply chain efficiencies and reduce manufacturing overhead by exiting its production facility in Stayner, Ontario, Canada (the &#x201c;Peace Naturals Campus&#x201d;). On February 27, 2023, the Board approved revisions to the Realignment, which are expected to result in the Company maintaining select components of its operations at the Peace Naturals Campus, namely distribution warehousing, certain R&amp;amp;D activities and manufacturing of certain of the Company&#x2019;s proprietary innovation products, while seeking to lease the remaining portions of the Peace Naturals Campus to third parties. The Realignment initiatives were intended to position the Company to drive profitable and sustainable growth over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, the Company recognized $5,333 of restructuring costs in connection with the Realignment, including the change in the nature of operations at the Peace Naturals Campus. Charges related thereto include employee-related costs such as severance, relocation and other termination benefits, as well as contract termination and other related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred the following restructuring costs by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s restructuring activity for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payments/Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCosts
      contextRef="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGV4dHJlZ2lvbjoxODAxYzFmM2JhNGU0NjBiYTdlNTZiZDM0MmQ0ZDVhZV8zODQ4MjkwNzAyMjk0_27a7a5b1-01f5-41a0-8f55-27bf9f5ab791"
      unitRef="usd">5333000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGV4dHJlZ2lvbjoxODAxYzFmM2JhNGU0NjBiYTdlNTZiZDM0MmQ0ZDVhZV8xODY5MTY5NzY3NzQ0NA_9a4ad5e5-2812-4d72-b9bf-c78c227b49e2">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred the following restructuring costs by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s restructuring activity for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payments/Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCosts
      contextRef="i650691423f5e4494934b0fa65dab6839_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF8yLTUtMS0xLTIzODg0Nw_cbafa08a-69e6-42fa-85ae-3593d9c02408"
      unitRef="usd">3544000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i2b8527b15bc047bdae7fdce3a2c33504_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF8yLTctMS0xLTIzODg0Nw_ef971f55-b6dc-4dee-a1da-b5c713cb8964"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i27ca2cc174af48b58d8f18abbbdf825c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF8zLTUtMS0xLTIzODg0Nw_f821117b-cf15-4db2-9d51-61e057ab5f3a"
      unitRef="usd">1789000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i3a1afdda86b9422f916cf73765514521_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF8zLTctMS0xLTIzODg0Nw_535e450b-e9d2-478c-8e96-8bc848378f49"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF80LTUtMS0xLTIzODg0Nw_06e2aab7-eda8-447c-9a1d-f9e1ac0c2bc1"
      unitRef="usd">5333000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i3c8b6276b83842cc84cda8a4835b64c2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6NDU1MjM1OWNiMjc3NDhlZGExNGUzZThjOTBlZTEyYzQvdGFibGVyYW5nZTo0NTUyMzU5Y2IyNzc0OGVkYTE0ZTNlOGM5MGVlMTJjNF80LTctMS0xLTIzODg0Nw_c6309de2-98a8-4624-a257-0e9b2f8733f0"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringReserve
      contextRef="i40b09d8040b24c29ba9f2d7d4f684f30_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8xLTEtMS0xLTIzODg0Nw_118eb963-03b7-4897-9cf5-8730d874821b"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i545194e7a7b74577856d5bd7b228128c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8xLTMtMS0xLTIzODg0Nw_4b847626-21d3-4866-a94b-ac69f46d1c53"
      unitRef="usd">3671000</us-gaap:RestructuringCharges>
    <cron:RestructuringReservePaymentsAndWriteoffs
      contextRef="i545194e7a7b74577856d5bd7b228128c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8xLTUtMS0xLTIzODg0Nw_cb69f866-25f4-4efe-8eea-176cf5b230ab"
      unitRef="usd">3268000</cron:RestructuringReservePaymentsAndWriteoffs>
    <us-gaap:RestructuringReserve
      contextRef="iade03f20736843e9b053a88f457f1fe8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8xLTktMS0xLTIzODg0Nw_78b4b9a8-19f3-4d08-b0aa-185619182be3"
      unitRef="usd">403000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6f994ee41e2c4a3d8727edc2735ef73d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8zLTEtMS0xLTIzODg0Nw_38ff31c9-b644-45fe-8958-bbaf3818bddc"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i034a94c610e3462d98907c2dcb109918_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8zLTMtMS0xLTIzODg0Nw_3981eac1-f841-4439-89e9-9e346a1f3971"
      unitRef="usd">1662000</us-gaap:RestructuringCharges>
    <cron:RestructuringReservePaymentsAndWriteoffs
      contextRef="i034a94c610e3462d98907c2dcb109918_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8zLTUtMS0xLTIzODg0Nw_3f054521-3a27-4c54-aad1-829859c38d92"
      unitRef="usd">1641000</cron:RestructuringReservePaymentsAndWriteoffs>
    <us-gaap:RestructuringReserve
      contextRef="i6e8955d83865472bb27bd4fb46bf1428_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV8zLTktMS0xLTIzODg0Nw_3c77bbcb-7902-4b95-a535-885c0515f21b"
      unitRef="usd">21000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i919ad19634e44f94b09180aaeb361f67_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV80LTEtMS0xLTIzODg0Nw_e7aeb1b2-25f3-4dd7-afbc-cc63afddc776"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV80LTMtMS0xLTIzODg0Nw_6f964496-979c-42ad-9734-26bcde7fa585"
      unitRef="usd">5333000</us-gaap:RestructuringCharges>
    <cron:RestructuringReservePaymentsAndWriteoffs
      contextRef="i9e4820af459f4e6984ec923ad159736e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV80LTUtMS0xLTIzODg0Nw_93fc8ba9-6def-4e48-aac9-4a1fb6f023cd"
      unitRef="usd">4909000</cron:RestructuringReservePaymentsAndWriteoffs>
    <us-gaap:RestructuringReserve
      contextRef="i1f6e48ecac9f43d98f834e8ae0047473_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xOTkwL2ZyYWc6MTgwMWMxZjNiYTRlNDYwYmE3ZTU2YmQzNDJkNGQ1YWUvdGFibGU6YmI1MDk1MWExYmQwNDBiOWFkZWE1OWQzYjI2MDE5ZDUvdGFibGVyYW5nZTpiYjUwOTUxYTFiZDA0MGI5YWRlYTU5ZDNiMjYwMTlkNV80LTktMS0xLTIzODg0Nw_0c955e79-398c-4fd7-9f84-2f0efa1079ff"
      unitRef="usd">424000</us-gaap:RestructuringReserve>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyOGUxMmIzNGU4MDRhYTA5NmFmZmFlNjlkZDZiOWFmL3NlYzoyMjhlMTJiMzRlODA0YWEwOTZhZmZhZTY5ZGQ2YjlhZl8xNDUvZnJhZzpkZmE1NTA2ZGMwOTY0ODc1YWUxYjJlZDc4OGJhZGU2NC90ZXh0cmVnaW9uOmRmYTU1MDZkYzA5NjQ4NzVhZTFiMmVkNzg4YmFkZTY0XzIwNDA_a3f84579-2646-4a55-a8ee-2df38c8a8605">Subsequent EventsIn March 2022, following the evaluation of our global supply chain, we announced the planned exit of our Peace Naturals Campus as part of the Realignment. Given the constantly evolving operating landscape Cronos participates in and our continued work towards building an efficient global supply chain, we continue to remain agile in our evaluation of our footprint and the market&#x2019;s capabilities. To that end, in February 2023, the Board approved plans to maintain select components of the Company&#x2019;s operations at the Peace Naturals Campus, namely distribution and warehousing, certain R&amp;amp;D activities and manufacturing of certain of the Company&#x2019;s proprietary innovation products.</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>120
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M58?<+2\ORKD_$VG3,A33!80Z9^?P\_*B0KHX$&RM:H;G3 B6J(\K2N 1)2^
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M1IRY;C([ VT;FWMID48E+FMZS,"% -I?68LO1IB7_?-8_ %02P,$%     @
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M_HOL#,4VWD)53?N7/'?::$06N\:H35<8:K IZ_W_XJ5KB),"-/$48%T!]KJ
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M]OX)%2+KN=L\%$/XT%1\L,!L"MOY; P$AW<+*]S]D*\V" ]2ZM.![57:\#@
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M8CDO.)9G+IRPR61<I-YR:5!^"]">S@,5,1V%99//6O+<)HN7VI2E>WWZD.8
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M#VJ?Y..]5=O2JNS05]EF;YU-KX&ZG=:R&VL+BEG-<O_8HK4L[J#4K%S0:RB
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M2D"S!20;KGASJ C(= -P4I7+5/02XPL.1WU(FB.(-N84.#*C,AYBDBN<RJL
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MI@RW-*4+2P)8SPWFV_:!%&R__EW\ U!+ P04    " !O/%Q62<99WID.
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M@7 MC5M0A#]<5DNC#"Y6T_9*/C_SM("'9I5T7AP#@$N$PTN9^(@GZ5(PL5C
MT?8*N")SGX2&Q.:J>=^%C/?YR'AM9(*AX[KN W;FC2>';&\P>9%BHS=UC%+/
MH.4\W2&@_%%(!?YR,+%4>*EU04]@/(B &N83D_9K("H,,E"+56,=A:IQ09A5
M/#>+B[F6L>1*8LL9'+R)8-<BV1G<?/=1N<?<>8\> )#"D8POETHL(7(KTM@
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MHO%X.1^%9#!,O&GY/KHQ'K=;?J1TJ2PMP/?"&#],:(/]/RBN_P%02P,$%
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M\:V*1F(:!F(RGDSND3=M+)VRO.G#EK[+;%E4<*W2"IG%XF<5W^CL1KPB%V$
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M(AFF)4JLI=!<>J XXU0$IKDY8\- ,[$:"U#'1?L _"BAJ)5L%G[ZLX.0>#8
M6:[%0G:F]>T@-8.A+C9.ET$/]]4D6NC(3[TR+R]\@?L 4/(*+'D<*VGE[?-'
M%OEA'?]&8:/,D *7W"#"A2T!9EM%@FMNXNS!&+,#2.2?>RRT&2;Y"CX@S1PE
M+P^0 MGD)3W\ NB0DS<T$^6IO@?.?/'[6-[-M$%^#\C. ,F=-D]>&KD5B -4
M -2ZMXY7/6JU_W5L# .>>YS:AU'2UPTAYC+,].P^BI79$(-;A_^K0-EG^ET%
M](U]7G<]:M^G@&K$R.G%<,Q"\!7 %<37.IB)V7?4(''SS.!=+Q9<2C6*JF&
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M*@KS+%7:LU9%AL*D\QM1R66F7'72_X+3$I&JJ&0FRE9@).VHD659))K%K+W
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M94(+\/VB+&W[AC;H?F!S\V]02P,$%     @ ;SQ<5M[G;M&3$   X#4  !D
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M%S"NE0"O'->WPK '&8=P#U1_Z8R'@@T CX)I*U(3TCNM!K8]W;L["#@?B.!
M^^=)@LA+IBH$0YN>H(&Q_-![<<1%4<@<V_*,D',<RP&&G(@Y^V^+.>@I\=RQ
M1V,QY\/XL14%B1ES;N#OQYSG#:Z',4=$"+#<WEP^T@VL]7TQ1\!NFJZYWX\Y
M)R1F@S@8X(7MC*07A:E.,$@P<7@DZ/!J2J1\0VBZ=8)AX+E((Y$/T>/8\@"I
M2"<Q4GD,MJS$I83A/A5Z2-6N%7J]IR"4(W<L3HY%&QS8MGM [/2O'[\@6L+
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MSY/4''1)9,XW6:WGU*2>=_3-# 5#R$R.RWF  1! RFR1]0>15B)/+V#""VA
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M?B&-S:3F%-^ZC$F5RU3;X3+C208,BE4_XIJN"*549,NWYPV;(,(7E6Y"U_2
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M(/ 1B4REJ'A=B#.YV5ASKP$3*M^+T? )^T0?]:)D/8*Q(XIS(VTFG$))+79
M7L!'F8+^PIJU\#M#&_U+60/HTPAFR.T\M,V)2D!@=F"GEX5> $L"="'44=H,
MR+L) 3H2$Q#E "X\'BS5<J>P*93?N@4MD(/#2&OE5R;K>%^)&B\@;/<9L"33
MU)0%IVA(8(X<MUFZ:%<?Q\L'XJ-2XN_(1R+$_'CX$A[04!KPS=%+0G2XUH[^
M*Z W*PNW@%'%7/F=4D5[(T+=I;$4"EG)J$R<A%JBS@(J^X]G"2IA_I\S13]
M':+-](:Q*?Z):/.W$FP @"+2M%G>E)"0HPZ^:39!N@9,IK-),KN>";>">IGM
M._)P<4L$UGCVHS?I)[K_ 4^LY1T !7 CMJC^J99"\%+0+ZFXR8[@AB* F/FA
MT/3U1T]F2,AX8$;=*YMJIT*E1%N<#P<0:D2^%!A*J+(,#D,V/02-P>63+F>U
MWVCGREB;PK6<QP<BD,J-)E6[(!1YS:(D&3*=,RQ$KW&51Z#F4M7G9AOQ+>LQ
MX1H)DL@E<'I)CU;:;F3J\GP^&@V3R<UX0%9[I^:V1!,OQM?!09+V'C$?4"L
M%6RU*1T(X!O$-H$<QZALP?@W>OL3&G/BP94RY(P ?"VJT>Y9]?2@7D9RBS7Z
M</W<D9U:QJ2;VQBJ7.VC\<NIM"<8FK-S$>";W%B9&<9.*MH<UE7*JW;YON'Z
MUY()O""%X>628+8MPTF[/9!AK@;3)X-3@?G[<T+9Z)"!R9/_+AP_G:-;K5L\
MRZW\]WV8&SH (JCN-W!"^" K%!MB&\]PN>@22F+'P4$&]\(*NI^@<(*_993>
MPG7L,L)%IS6*]\C!$%8*69DZ)(MLO&^^'Z (J*EW/NN U/RYPQ_G>;#?!D7J
M>>)@B$H+*SAA*KN1%IRRK T!77?\I/:<B:UIU$>AB9J"!Q]H;]$+YGH9FJU!
M9P"@*TVR8[;T$XH&HF-@,!E KE9_0B@"A6F*^Y#3J<9)E0X-(:,;)XWFIHO]
M'YX,F>209,M.5("OJ!-E^)C+(LYVNJ)3P40B)8!D%-[BL/"&C0W<L\5#8$%F
M6U!1K*Z?J6M%SBA0ZJJN<FJW6TO$2KD.FBJI4R6;0765>5$F@:5HR51:NV?9
MUJ27"#/PU<,A1A(Q,#P7+'!^<SU+IM,Q\WD^2D:C:VX1Y(F\38\=]3F4F]Q&
M\9R!)AN4BF][K-1VA)7,>BU)N6\\ 1^3P!(@:7@U^S)^;E&*8E=MV7,ENH$]
M(1/^P=6H]@I5U,%(B!->R:V A/N9K>;),4#,ZOO@^5R!D9FP%^7\X,X49I5I
MFW5QYH'G0YHP14RK>[!!DZ&L5)Q%E]:4&^S*$A/.(-TU$>K4,@ D>ZK3:YU+
M&R)[(ST\LHHX5"3(5B%56;6@L77 !; TC^.+YSN>,BLN#5"HJ #_7J]554XN
M!$H?M8_93CI3U 'GR@WIBJ_;-2R7J)1#M\"(\'0H:0]T&VI=EEUM0_P$F/.$
M)= DSVHJ%$2,>E;)HO2L=3QCUCIM/3OH]3I2^<YJZ 99:K&@X4_1S'Z04UIB
M!5,&,; 5J!B4=]PK<N5L;*S /V]]-81**/9@61_ RB55'9Z31%0B(7'//8V;
MC%#%,J99JB V<L_>N\EE$5&E7DB^*#^I#@+'Y\-\3%;S36R!^@S*IYX)Y=IH
M/.QZX .% 4\T:&-\&'8K:PKF<SQR?AV"]J8;@0FW?[U1(M@[:\@.6:"2(SIY
MY?NNJJ&_^_:G*@XB2(QFV'PTG(;+J\L_=O\?!A\'%0./JZ2@H=#!N3#8:'N0
MI/VHJ+*UW[3S(A9>AN*^MROL<7BNE1A-N/E?651:C0PL$O4<CB)7NU6C$J08
M^-Z^&87<5:.2$P.N1%Q??P%K"U/:+^6LG5,<RFJJ\TQ6!K #DBY7-.  3)+I
MFP'*6OYL6GL/Q/ONC3B%7_ (7KK6%VP\3A7436]UQN/\2EJ510QO!]GPI(XL
M 5])R>)M4[#N%1!=T;G7KWD5'F3^@ #4RQ543@:**(\)-.'UW%=Z>1]:VO.K
M27(YO&F[QH$J>H(,FYJEXO*J-8\A.1_PS$>Q]%BY8R??#OS?(/MTE%P-)P_(
M_H"@5_\908>_BZ"3:3*^N6P%V9&<!^)=31XOGGN4?.ZT!P=[5IGD"%$YFQ3F
M.$2?:M25)X?FL2@_FH8G_<U!MQCE0ZB3XWA2:74$P0FFFK]_455*#/2S'(NM
MG =)36?8+9*KPXU0N,?)_A<PU!HPG6(K #15P+!U:'ZA21=03@:WYLHD36W9
M8KTJ2$_IEXO)$\9KFK1E*='\>Z7:PV-!9^\\LZY.%*EY@[M$_R5>U,9S^Y4P
MJ#=M7LBY^:^V>\W,=85J.0\]>,;G!S(+I2>58#V&2GK\+I:"PDFZ"C';,FT$
M)R665#D6=8EQ/('OE!0\;6_/[[DCD#1Q)MECM]%I"IMFWM'HJSV<.+QL3Q2J
MXJ7F8Z=SX(/Q@ 7!(K2' LUVK9$ N2DH[+&"F@XN"-AOL '/Q:$CO>&T6JOC
M9'6!0I=V'1QUE[ MU'SX',?.=7)Y<Q-#.9D *;\H;J)%LW#8?KA=R*9TX&)R
MG<DP&,O9*/R:3?\(8(.'4QZ7>&HPMO0^4FN I!Q0/8T>KXHP)"##N'(!!] \
MH2F++-0Q32-6F>:Q9AF(=Z4E%^Z?"Z[12R_#J1Q-)Z 5D-'LQL8&OCC#,"?J
M7CL?[4R]H,SB- <>K"-SL:44<^J["5H,7Y=%&,)5#+*C]"N.]J(]*3J:F=&<
M)H7<BT<[<=^%CI6K[3@*MU*'ZCR4C7RHY6A^',;7:3@%B,<#),=.6D(D]UMZ
M@)ZJOQK8(<MFU&CB\?'L2>L8J_&JNHZF0[%"Q24/U.F/YJ.'B=%-/Q,]^[]O
M9IJ=S[T TCZU6B0T>XRM/2>(!: K]&/]OM<+9 &,6CA($)*7U!+[FN$4Z6K)
M2%S-8,,+*L&AZKE'_P8@RD"W6(1N<KYOT^N^X=*\24)1>CRO"*5)///DS$@N
MQA'>YJA_=KINJ[<0:$7BB+,9>,84RH=RK/6R6,BML6R]N+XU:8%Y\ZPZK&"2
MB&<7OX1".A6*;Z7^<%!_,(=T!]@!$*O/%.FLF8XG0U2W#I+A;2VOJ"*1BD^
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M*#@-SWVBCV;1BW1]*J4GU:A"?Q<I>(BEJ60.\I *F(B+>DFG/D23;O3N3**
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MW?S#[.H-K>>CUO.WV'_L0/XGQ1<#7]%5;<KG!!JKN1:5V4%H"6B/.F(J$=N
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M-OWX/@,W=/-A$FR?.FAI _?C-&SY 20G!KPOAW^:B(/Q25U_!U!+ P04
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M6VE=X41[5<-SIJ))Z@*>UD#[[98^"XKWM8%)]B4@>:,K7:NR/.#O>M_RV!:
M^%09_'2!ZQ"49SM= WUF=__UCR?+Y<FS3\<7Q]EW9V<?Z//ILWO'V;FN6V!9
MN("MLX-6=:9VN&H,9*WS4C4-$#M,WUK<(+)!_!/7S;NZAFWQZ!@S"(/MZNL1
M<IP!$AL=+933! A$D54VT^LU<*^,&.#>UC@/K ,,A_8)K+F6Y_&.ZJI G#5;
M0.S6EH6N&]SPZ>-GF?ZM,^WA>(:B'GJ*>G@S4@B;FR"IV\QS"YH" BF[0M.)
M".70O/CYG"=B%@:T RAJ38M7%H[^:FOR;?P8(!T0B4NVM2U+7/[2$AF:JM6
M=SB(.@.H<0P0#C'$%9 E')L1YJBR2U4;M2IU&*0('@0!J(<&\V$2@0.EVH()
MP<,!I*#Q/P=*!MQ9\\CA[+2E@Z?UG]^^=E2>[6RA2Z360L/#(#S@@FTU3%,G
MVY[?4;M5;A&AIB8BO&-F56]Q?PX4F*^R+2P*)T3W9@4GDP%@BV39Z&@9 #=\
M/7\HO&+O9(Y!0JT:4P#4>+QP [)UA\PB):#:[FAR_(BWBFG H1D14:NJ6>NZ
M9L@C0.B(#C1SH6=F)7RY&7,-"@.<[MOJ$H!T!#M!>D3!*U,B$F!M_477N0'N
MT$0"UU3KLM/(*NVE'*,<!B"#2,S?D;T33W(9#,&@]2);=7 Z5O,Q$;L3>!>T
M/;E%FNDUT!XSD6P'%&0+(FG/J(_?,BM.\!)=4GBXT@@]7&V=W2UMT]PC</&J
M [="+>]2I[\OOGX(@]^VM8$MAA,4P(4G]I@#S2D/5K8ZBJ^_HRXXP1^G?G)2
M2!:!R<]K6]DF>]O4"JX?@B3" 7&"8@_0 I0IXZ;9-3R<.W$R0.Y*E20Q2?-K
M!#&3R)^1"=D9\$7:C;!=O@,J#X)%UN)KI4L#G(36Z/8 7,*_YR3,(R]A'LU*
MAD] \@ RX!;X$?"&,=GR=3/\1-R-,3^%SPG9XF0^'@<I)UZ7 "8."(2#!6V\
M OL%1R =[=1G'99>9+]VQ89G(R'4@/FS9]02IU LX8-4 %B<)F)&+M4HG#1S
M+#;A8B/;B55U#]( #I&@"UP7QEH1$# /@'^IRLYC#<C'7"HTH[+2,*LRN$?]
M90^; .ARX)NFS? R(N.IX*]J<X3")P(<Q5L+HPR :VK"6QBPL;:X,D"2"*4!
MW@/C0+T[*F%1_*)5U<:@ )R=A9;E(?XY8']5:T&H7=4X86&O*OB:;L;1BG31
MO3H0/N-=@]9@K^BFP0> AD6#<)U6?9'Y"=P.'F.U$G^(, 27+&\[V+I3WH!O
MED56&#C\VLD/VT1T,W>1'ON+]'CV&IRK9LN, ?] :H5M>7IIMD!L?#0F2*>Q
MR_;GKS(SIM;,X$'PD8S)W:-;,*^!:Y8&GIZ:5ZY4C7=)%8;%/\C)UHC*9+//
M%9R[OV&RP"*R+NB6V]IL@%Y+N,UM5[/*2%RCUAK4*K)003:"70)G.[T;IYMZ
MTT*79+44($14#71V_D\:^/:'"\:6SG&U Q#:WC8&Y<[%^$:1)QA42/%2KEHW
MTFC!P5US+]H3R?B)/6T 52U=>%6E&T2([AJ8Z!I%17#,^"4<( YAFQ843C2.
M)G=!IQU,+)A:&^(^ZE*9$O7<(V"^1PV@$]&-Z#MJ[9%L@$4WV$Y@/>)H5+M0
M$WSK56-55TA%U12Y@,+GAR.\M#9\H^$$5R6SDIM(7J^,,U]@S65L[!]4B836
M4 FT5[RT[5K^4.M213K/OJMS."M-#WF$D2IPPZ/@7TFO1,^9MYLB:O &P<PF
MB2 (Q#F>]L3SM">SW.:MX^)CC.J&0[/PEVE2;E.K*T06B#E5PO5$V0/'7)!4
M8GRCC_'(5$?[VL+-:5""=*#+ [[@T(Y F)"2C;R@JN".P-= +2A2BMK$7R-&
M= VZ^ &G*KH<N1>92OH+^9)TL0A/RW>BCH4A..TA/,9,*!U#NCW()(W\AH;;
M+RB1?@$*2^TQD$PHW2,H%W2C $=J;UI5FM]9!-M(F*+^7](\(+E([1(<..97
ML+T!F]5D;Z#ZR'2ZR."*6\!!UWI-HNI:9$TH>/%>U<"S6+%,#XU(C*X\KDRH
M9%\"FMLP$&\6\#6 F(QE%.=P*[T9#**Z0<*^(I\M3@0,#'0X82#G-H#?D')3
M@5;3H:Y7@,:7M\!2H^L&^E^W!DS#%1,CK #63#9(I&VZ(SO./HBAS;AU,@*O
M4+=CMG/75*C[![-LC3(,\8^'V%A3@G6T5_EG!1Q]@TJ,V>_I+X;/(9;&(PT$
M$%'?T(AIM!^W("61@/?[THABV.S03]):6PJYD&&K@;A!=W/[27>,$F]/"A@^
M+_O$)^$1.=@8]7!H%?K32R0K> )MD'?)A XTX>^,:#J&1@>$@50@8W^17<'1
MH1:ZVY?VH+5X,/!VH'\NH2\G81<.5C">48HINA,_CI -DAMIH<P5R=03+0T%
M-EN#P$%R[9@CR!.0LW3 7<VFR KIC;@%J@RX1F/AA@$=[5%CSEM:CPF"Z!BV
MHMG[#K0$NH!BA9A,,[02Y%*<M>(Y(>ZE%7"BOF\I=;K =VC.X%F+F\G;+0 3
MD$=TM;_J=AUG;^#\;"VJ"5@*P4'K#M_3S]@$X5QAP:.=O21*J,DFA^OR63..
M_#6:$2;_]L+DW[,2X>=Q9YH9MSEO.U=V-NVU(Y[M/H"61M=)5" X%."YSA<0
M9#4K> 8O0M.MT5,G)\@6%BR"<B*(;%3&0$O(5%$09T73L5LQD?8L2F $0#N(
M]615/%58$J3D9UZ\!-8SH@62RRMX\KQV$( YS@9X8M4C5D5@>=;$PB.T*IN%
MJ\;6JXQH'(U7\KF*TY,6\[:HLP:=1J>300CFZ#!8T!1LJP$[JGJN6<V6(:)5
M/*FFO<:!2K<2EJ(G"T3-VK!JJ>2*FAP#BR9X<0SYJ<AI!\OF+?N/#Z2L\J]\
ME?2ECR*,KNX 4\3C$(>HOJ\ N_P]W6ST#[/48!>Z)QP:L,-+'WD@T7'%, D&
MV3BS)>I'(X0N[E T=_>VQ=V31;)*W9JBM,)TL!GQH8 )T:2L8^@_9D31AG[K
M%%(=>R<0)OBB=)_7PIMJO5$U14G(W8=J,>@%#0A6YY_?(:X-R>5+6UZR6X=L
MP@#@E!.;"!$)HQ*JB*0>7]KK:,6M,</<3D]"9/=DEB6]3ORUUQCYMYTK#5RX
M^ LZCDWJ\V;O%%$^>J[9!6[:6WB^4_<U4%XO:!,8FJ="5O<&3NSC[-.X=SNE
M-+81&R(+5!F8C:"SG[Q'1#%LIJ%/ -@.[K?_DUAXY.S1D]@4R_DO,AR=@XN0
M/ (#*(;>G(G$18\YQYI81^XP8$4KO57EFO<K4RUPFBN-3+MQX(A)3LJ7 V82
M)3$X!7 E8)YBA<4*=B,.'^<&0-!_[;Q'R,:BTWFRP9Q8)S'<M3*UZ"'$:^-!
M:^!8P&0P@85((%=U35Y6=NLLF%/M%(K+ B.X$@3"65+G)!K?R E7 5[0X:K#
MB!,3?P?B_UT\$Y4664&V&= ]30$7J>$'0*(W@$*<P(44YWA(E!UR.GOOWXL@
MGN<=7SE'-OPF6$&['?IK6@L:!ODWO),:T5P7(LQF [E>J >>0<R8XI&H3T9\
M)67G+,?L #S.2T#S7Y0IYU_T\@F%7B B(+#A'FF2ZP:FQ!SX5D2@8P$X"3+S
MV1^1/7"MZVH*QIOL;PI,LA%& ?P;X)&X.<<M[0J3:<1F0.LLWZIJ(U:NBW&@
MRQ/,1EN3MA0NX8AR!BQ4)A#^[,,UGFT,Z8:Q),_]%7Q][I(OPR5?SE[0#V(&
M+]A9E?U+[?;/@ED_>N6_;D9*3_%N@OE?$6?!OT,$148ST%*WZ]@9D#@D)/KE
M?QPPT^/L5?R\./TH0APH%S.XT!MTA'OQ).R"[,'D[QJ][LH,@TO>D' Q(%1\
M,%[4/,T^HAAXV9FR<$ZA$G,!2%T! &M[*<=^^A!EU/*$/.5-]@ZL!736'7I8
MH:<>RT-OP# AAY2$_+^P<^JA_$RN/0<3YBN0"X$\G(MP2_MH2W%*A M6>)S?
M &N@D40*MM/T:)8J^,,V&/[R:E LQ]#+@PH9&ZGLVL&#$M\SJ$L;]J>)?B%:
M VD8O5!FY)%;.$VRRM&KXAT$:,0<6%MIM;BQ_-&M=7)RG/80.3E!*+L !.=
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M4\"6"^,K=6^1<?7&N6M +00=LN$"PM%=2C47$07SI[,23D!EOX!NHS#%Z ,
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MA0 L-2W ^YE2MGL@ _TG^<O_ %!+ P04    " !O/%Q6]R#R2J "  "5!0
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M(QFL4BI$8[D$+'F,S%S=Y*V+_O@H-(\YCU\#5VM*EIM%- 4=":MA-0I.L^H
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MJ"GK;DSM7JQ:^M%PJBP-FGZYH,D>M3M ^S-%);5Y<09V_Q7&_P%02P,$%
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MN1%*D^LLJ\NZH!H,>+FD7**,-<D65,Z9(C\CI]XQ>(/\3'4M::'(M\1SW"#
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M%PQ9)\T!?)\)H;L7(Z"_"+WZ'U!+ P04    " !O/%Q6 YX-\M<#  #E"
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MREI5N.5*<-0D$>#]0J&^VQM2T'VUN_D'4$L#!!0    ( &\\7%:3*@TA5PD
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MQL](*XX5%7<'5.A45 ,(T99D^@B!(@_)!<M9 6S!RL#I'ZRH4;XV8" 0["@
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M+MRT=\O#]XK?A5DJ.!8U<@&B\7$.YW83O@&$!Z<W_MX]UPYN\7ZXDJ*6!A?
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M>LH^Z4G[SZ.%\Q"TH+H3QYZ>TK'B!B,@0A5.N@05=.W#<$&MAF*:1D0IKCE
MBFM>H@CA_9BPW_/->NK3V.,@D3@1<WR%%(9W?-LU"@SZL83J211:8:)F:92
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M*8"47L#O\PI)V=S0!-W_YO#R?U!+ P04    " !O/%Q6\,<_25,$  #1#0
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M0.T"Z'RIE-T8KD#WOXG_ %!+ P04    " !O/%Q6D$,A!R4#  #_!@  &0
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M#-(8Z/M8"-QN3(!Z]A[]!5!+ P04    " !O/%Q613;N14L#  !H#@  &0
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MM.M6H 6"!ML.PPZ*3=M"9"F3Z*;=KY\D)UX&)#X,Z\46);ZG1](F)SNE-Z9
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MN)$^_L_5;^?K1N?+'QYUV1)U[F>) =\!ZX;;[#;C:EYWZ3_N]:Q[8#KGTH#
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M3&Q&CN_L%A[H,M=VP8V')5G"'/13.9-FYK8N*2V *RHXDI"-G'O_;M*W\57
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M^_*D)LGG6W#]:NR,!;L6:8RJZ+][:6#.M1])C0'<1"RLDZLY;%\*3;('%$X
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M]*U9=G0F+;9%F6V:P=4:;)+T\>_HCV9'[ V8O#1 :08H!P,4Y84!XV; >.B
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M#+[1#FHA1K/QX8DE6N*.:CJJ&:AF#MR_%CJKC6K.P&UP7UINTEW.0]?.1[4
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M%NJ/Q87ZIW\X*09/SC*T;A_5-%334<U -1/5K$83?1TN.J&#:BZJ>:CFHUJ
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M5J8K6;8!S>_715$_O&D[N"_*7P^'O?@?4$L#!!0    ( &\\7%;9IK(;K@,
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M*LQ?6%6QC@51(23+*K#:04;S\I/<5T9L %Q_!\"K -YC0'\'H%<!>B\%]"M
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ME=XZC?/J7_)4KZN,R'J?%^FN;LRW8!<EA[_AW_7_B),&E+[2@-8-:-\&6MU
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M,!7@D00DVN'GF)P!JN;..7A2\R7<Q@2P)?C\LE%%)R%8<!)&$MPQ(<!UK&8
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MW=D?(+O%38Y4D6.AU4MRT ' _R^]!49]T=F3:6/NZL+<L:>?NQ!5%-$QY+=
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MR5)!VA>^XL/SC:'\1+)-MK?RS*1D27:X)C@D/ U0OR^9>G4M3M(;E-MS\_\
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MJ5(L?1K;C?H)@KUH8-21U>;D_P_CQJ5SXTE']F#]!+A8=4=HU?U<^0U [-\
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M '-_+81^:R0#%"?<\_\ 4$L#!!0    ( &\\7%8<0D'4_A@  #KE 0 9
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MZ7L^>RA:TP-M]:.:VC]L@(_;OI%;0U>KHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ
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M4,U%-0_5?%0+4"U$M0C58E1+4"U%M8S2FCE4SP$P%,\!\'.W*XO1SO&#3@N
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M3%2S4,U&-0?57%3S4,U'M0#50E2+4"U&M0354E3+**T9-4H=-6\Z.< 8G1P
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MWO,FH+#6FQ=IM?T+-HUM, #S=26*K!DL/<B2?/>??6L2<3  DHX!J!F CAV
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MKI%?O5_>WI2;F&@5JUW%:N=^SAM^P\8$6N0;J-9F<-?/^&!*:)$ADQ,:DY]
M!;FEF#!3+^37Q5@J@??\[[IH"A:WGD6_!\[E@DZ@;^"#+D$LP0@_?FC[UJ>Z
MH/Z3V49L3A6;T^0>8OI.78.%RLM5^KVT#!TWZ/;,Y3IXH_6!X&X%[NX#=^O
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M<*5X6APN@<8@3 =]?<ZYVC;,#>K=V.G_4$L#!!0    ( &\\7%:AYB[QW0,
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M5$H"7:*%VN^\H8#8"MTULN& 'DA%RJ9$9@V:XS>U&U(@]2N@;S5P+$FU1EV
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MJY'2\_8H:2>2U:9]+YE4AX$9%NKX!:X7J/<KQN3[1)\(_8&>_@%02P,$%
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M:XB"=HHJQ_+7(CF-+IPRDRNUMMT:K.#0V4!V"EBNU-J^:\2"5IJ9?\SB!>&
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M2I;KPPW!">%%@+J^8DR^G!0WJ+=-9_\!4$L#!!0    ( &\\7%8("G8:W <
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M</@F5??@4&A/Y)^8>N*I)@+6B/*N1PA7Y2&WG!B9%>?$E31XZBR&&V Q*!N
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M%G&5!=C?EU*:MY5L!]6K&]/_ %!+ P04    " !O/%Q6_K#MU- $  "O*@
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M4>WLZ,:]>@19$9"P$!(60<(P$,RHB'%=$>/_JU=;P==:#0D+(6'1V-)>2_^
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M0HEH0M*,LA1PLIH;E_!BB5SED%M\I^20-:Z!DO+(V).Z^1;-#4LQ(C$)A8+
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M*%QQ0;,*+#/($E(^\7-EQ [ = \ K I@[0/Z!P!V!;#?"NA7@'[A3"FE\"'
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MC4&8 /U\SKG:+LP&U<AL\@]02P,$%     @ ;SQ<5@C?3O?7!   11(  !D
M  !X;"]W;W)K<VAE971S+W-H965T.#,N>&ULK9AM;Z,X$,>_BL6M3JVT*=@\
MII=$:I-=7:7;NZK=O7MQNA<..,%:P#G;27K?_FR@0,"AJ;1O6C#_F<S/@\>#
M9T?&OXN4$ E>\JP0<RN5<G=KVR).28[%#=N10CW9,)YCJ6[YUA8[3G!2&N69
MC1PGL'-,"VLQ*\<>^6+&]C*C!7GD0.SS'//_[DG&CG,+6J\#3W2;2CU@+V8[
MO"7/1'[;/7)U9S=>$IJ30E!6 $XV<^L.WJY@I U*Q9^4'$7G&FB4-6/?]<U#
M,K<<'1')2"RU"ZS^'<B29)GVI.+XMW9J-;^I#;O7K]X_E_ *9HT%6;+L+YK(
M=&Y%%DC(!N\S^<2.OY(:R-?^8I:)\B\XUEK' O%>2);7QBJ"G!;5?_Q23T3'
M  9G#%!M@/H&WAD#MS9P+S7P:@.OG)D*I9R'%99X,>/L"+A6*V_ZHIS,TEKA
MTT+G_5ER]90J.[EX*&*6$_ 5OQ !)N#39D/*3.@1\(0E 4\D9D5,,XK+1%VM
MB,0T$]=*_>UY!:X^7(,/@!;@:\KV A>)F-E2!:;=VW$=Q'T5!#H3!$3@"RMD
M*L"G(B')J0-;$358Z!7K'HUZ7)'X!KCP(T .0H: EI>;0X/YZG)S9X3&;9+D
MEO[<-Y,$5E3$&1-[3L#?=VLAN5HX_YAFO/+HF3WJ:G(K=C@F<TN5"T'X@5B+
MGW^"@?.+:;9^I+/5#W)V,I->,Y/>F/?%;TP(L":J7A+USI:S*O6K;YK!RI-?
M>M+E\["80-?S_>G,/G0GQZ!SIR%T_5/=RJ +712ZC>R$R&^(_%&B=L6V/("K
MA6M"JEQ!IQ.#<X."7J3+RV2K-V4G0$$#%(P#O>P4$$FZ/&M2D V5)J3 ,/M^
MX$<])(,,.C[R8(_)I)MZ,#0SA0U3.,KT.RLFB@.OLR9-5VH5BVL34>4JZ(:
MH.?T@(8JM_=BK@R.0@C-)%%#$KU)HDKT7KUR&D:DF).)WG@3H+!4-R+*;<+$
M%0W"@7#:SY-!% 1A#VPH0E['TPG8M &;O@>,O&@6<V&8#GX^<H,>QU#CNSV*
MH02Z@6>F@$Z[GSOOX5 ;A$I)U6/%3$CS[NP89AWUJX)!A::PGQN#RH5>< :K
MTZ; "\H<8!NPX^R@UA#%65/J0$+58TZ*V%CU:M<G"P$.Z$RB/MNXHU,TU**A
M"]%>>010';J@"=&#2US@!!NYT#!MD==?40;5!$9!OUB89&Z SL"UG0L<W<X[
M<'&*BZTN?RVF$<HUE FG7Z>7!IG3)QJ3G.*T[0,<[Q\^8\K! 6=[ K;JHPJH
M5;6A!:Y>1]4BKU6?+.D9,L\PPR'J5PZ3S',@'+R,)G<>\L\QM@T%'.\HEF6B
MA,Z4)JW:?IRI+T1\;H'YPU""*'3[9$,9]& PV+<,.B]"Z,P>#-O& HYW%DN\
MHU+EZ?V9"P8!!0&<#OB&LL$[.28YQ6I["SC>7/PA4\*-81L: .A[_:B'*B\,
M^G$/15%P+B%M+P''FXF'ML.K]UMP5;=ZUQ]!08P-7^VSVZ*YJD$;U/.A;.*Y
M@T4T5*D>OP]F=[ZO<\*WY3F%4/OIOI#5-VDSVIR%W)4G +WQ>WU&4GZWMVZJ
M Y8OF&]I(4!&-LJE<Q.JD'AU9E'=2+8KO^+73$J6EY<IP0GA6J">;QB3KS?Z
M!YJ3H\7_4$L#!!0    ( &\\7%;(!2*:L@0  )\2   9    >&PO=V]R:W-H
M965T<R]S:&5E=#@T+GAM;*V8;6_;-A#'OPJA%44+S)%(R7I(;0-MC*(!NBW(
MP_::EFF;*"6Z)&TG^_0C)4>R14I)AKY)).ON^..)O/]1DP,7/^2&$ 4>"U;*
MJ;=1:GOI^S+?D ++"[XEI7ZRXJ+ 2M^*M2^W@N!EY50P'P5![!>8EMYL4OUV
M(V83OE.,EN1& +DK"BR>OA#&#U,/>L\_W-+U1ID?_-EDB]?DCJB'[8W0=WX3
M94D+4DK*2R#(:NI]AI=7*#0.E<7?E!SDR34P4UEP_L/<7"^G7F"("".Y,B&P
M_K<G5X0Q$TES_#P&]9HQC>/I]7/TK]7D]6066)(KSOZA2[69>JD'EF2%=TS=
M\L,W<IS0V,3+.9/57W XV@8>R'=2\>+HK D*6M;_\>,Q$2<.,.IQ0$<']%J'
M\.A09<ZOR:IIS;'"LXG@!R",M8YF+JK<5-YZ-K0TK_%."?V4:C\UNRYS7A!P
MCQ^)!"-PIY?)<L<(X"LP)RLB!%F:A^"SE$1)@,LE^$[Q@C*JJ/;X,"<*4R8_
M:M^'NSGX\.XC> =H">XW?">UM9SX2F.:P?S\B/2E1D(]2'.27X 0_@Y0@)##
M_>KU[O#<W=?):3*$F@RA*E[8&^^8!EREX-(UH3I"Y(Y@=N*EW.*<3#V]U201
M>^+-WO\&X^"3:WJ_*-C99,-FLN%0])EYU8Q+"7(LQ).N$@<LW.^PCC.NXIA:
ML9]E:9!$$W]_.A?;"D(8)F%C=D89-931(.5UJ8B>NP+D49<S25ZFK>/%)QQH
M'(8=6-L(!E'B1ATWJ.-!U&;UK&B)RYR6:Y!SJ9R08WO\$,(.I&V$DC1U0\8-
M9#P(>;?!@@ JY4XCD@K0Q1?;?%G<P;-MTC!RTR4-73)(][7*' &,Z'(-^(+1
M-382X$),K.'C+.@@VC8P[7O-:<.8#C+>,%RJJCJ2GSNZU3KGS&!J#1TF<8PZ
M@ ZK%,+,39@UA-D+>V:O=TP?6.98>N$XZX#95ED0N+%@T I0\-)FQN6:+K3H
M5!76*1B!-;+>OO&XP^<PB\=!W^Z )QH)7\Q=J;AX<K)!.W<H3;IHME5?YEIA
M@H-2,+NMR[\3"MEE(DNZ"\UA%<9A3W&&K8; 81&Y?8^+[:>Y;@.>EQQ06E=R
M70:IN_(= Y[C=LNSPZ@OA:V0P&$E^4MMB' 2V6(0!EEW0SBL8#3NHVHU PZ+
MQCU7F)EFM)8.D[RZ^7"2.A0!1FG4%0Z7'4J"I*>NP%8\X+!Z?">Z7]ACML-U
M8\[TT< 4;">LK0\C30OMS+H,490D<0]NJR9P6$[^U&>CUZ;6(2>1M8EL(Q0&
M?9NH%128OJ[M-(BL;;F=_2<<5*>W-J"_*MKYS%NA@L-*51TE1WPUVDDR]')L
M-1HY),%A!=.X9XNB5K70L&H]E/K0S.B_IK/C0A\62]V,YANM9,YUCVQE&J7=
M9MEE%*4]*PFUZH6&U<M134[6DY/6%JM1%'6WJ,L*A5$?[\EY:UC6WK!!CY'.
MSA>6;@P/]S^7,VK5$ VKH36=Y^0[NXGA8&\^2MKGKU'47?O^R=<#\^GF#RS6
MM)2ZWUYIK^ BT>ZB_AI2WRB^K3XH++A2O*@N-P0OB3 &^OF*<_5\8[Y1--^D
M9O\!4$L#!!0    ( &\\7%:^8/_C-P(  ,,$   9    >&PO=V]R:W-H965T
M<R]S:&5E=#@U+GAM;(5438_3,!#]*U:0$$C0M&ZWH))&:K<@]K"KJA5P0!R<
M9)I8Z]C!GC2[_QY_I*%(W7*)/?;,F_<F,TXZI1]-!8#DJ1;2+*,*L5G$L<DK
MJ)D9J0:DO3DH73.TIBYCTVA@A0^J14S'XWE<,RZC-/%G6YTFJD7!)6PU,6U=
M,_V\!J&Z932)3@<[7E;H#N(T:5@)>\!OS59;*QY0"EZ#-%Q)HN&PC%:3Q7KF
M_+W#=PZ=.=L3IR13ZM$9=\4R&CM"("!'A\#L<H1;$,(!61J_>\QH2.D"S_<G
M]"]>N]62,0.W2OS@!5;+Z&-$"CBP5N!.=5^AUW/C\'(EC/^2+OC.K7/>&E1U
M'VP9U%R&E3WU=3@+H/2% -H'4,\[)/(L-PQ9FFC5$>V\+9K;>*D^VI+CTOV4
M/6I[RVT<IGLH;8F1W,GP@WVE9$$VW+"RU% RA(+LX BR!?*>/#"MF2LD>;,!
M9%R8MTF,EHB#B_,^Z3HDI2\DG5!RKR16AGR6!13_ L16P2"#GF2LZ57$#>0C
M,IV\(W1,*3%!U!7<Z5">J<>=_J<\.VB41BY+\G.5&=2VF7Y=TAW09I?1W( M
M3,-R6$9V@@SH(T3IZU>3^?C3%:ZS@>OL&GKZT-89:*(.=E@<6Y8).)7"7"(;
MX.8>S@WO,:5)?#QG$)\U5@VZ].-C2*Y:B:''AM-A0E>A,?^ZA_&^9[KDTA !
M!QLZ'GVXB8@.(Q,,5(UOTTRA;7J_K>PK ]HYV/N#4G@R7(+AW4K_ %!+ P04
M    " !O/%Q6XUXQ-C$,  #R9   &0   'AL+W=O<FMS:&5E=',O<VAE970X
M-BYX;6RUG6]OVS@2A[^*X#L<6J!I)/Z3U$L"M.8NKL#N;=%L;U\<[H5J,XYN
M;<LK*4E[V ]_E.R89C@:6@G]IDV<'T><$2D^,Z3MBX>J_KVY5:J-OJV6Z^9R
M<MNVFW?GY\WL5JV*YFVU46O]EYNJ7A6M_K5>G#>;6A7SOM%J>4[B6)ROBG(]
MN;KH7_M47UU4=^VR7*M/==3<K59%_?V#6E8/EY-D\OC"YW)QVW8OG%]=;(J%
MNE;ME\VG6O]VOK<R+U=JW935.JK5S>7D??).YJ)KT"O^5:J'YN#GJ'/E:U7]
MWOWR<7XYB;L>J:6:M9V)0O]WKZ9JN>PLZ7[\L3,ZV5^S:WCX\Z/U'WOGM3-?
MBT9-J^5OY;R]O9QDDVBN;HJ[9?NY>OB'VCG$.WNS:MGT_T8/.VT\B69W35NM
M=HUU#U;E>OM_\6T7B(,&B1AH0'8-R-,&;* !W36@QS9@NP:LC\S6E3X.LFB+
MJXNZ>HCJ3JVM=3_TP>Q;:_?+=7??K]M:_[74[=JK:[70=[&-/JZW8ZB_%^MY
M),NF6"QJM2A:-8\^JWNUOE/1672M!][\;JFBZB9Z;-M=.'HE55N4R^:U%GVY
MEM&KO[Z^.&]U#[OKG,]VO?FP[0T9Z$U"HI^K=7O;1#^LYVIN&SC7KNW](X_^
M?2"H1:EF;R.:O(E(3 C0H>GQS1.@N3R^>8QX0_=WB_;VJ.=N?5:;JF[+]<*Z
M;__^2<NCCZU:-?^!8K^US6#;W0/F7;,I9NIRHI\@C:KOU>3J;W])1/QW*&XA
MC<E QJR8LGU,&6;]ZI_ZX5IOQS<4M&UCWC?N'J+W5WF2QRR.]?V\/PR(*TP9
MH]P12E?(1*IM'@@M1_C>$8XZ<GU;U/V\+->S:J6B5\NJT=/QIJY6D?KCKFR_
M1RO5WE9S+;A73=N-I 9R>7L9<=!!FB2 QZ[N3-"$NAX#0L:3>-!CL?=8H!Y_
M7+=*#XAVYS'DBW N30CGL>N,*\SC/'-]<75))N)DT)=T[TMZG"_JFU[3&]"9
MU(TC$.XI(".IZPED3;LRY$BV=R0;<U.B5SN'7K^)UJJ%W,J@>T3='D]=81ZG
MB>N9JTLREO!!U_*]:SGJVJ]56RRCHFD4/'%R][JDNT&YZPH@I7F:4F#$ =*<
M<)&107^2V*S^,>J15/J).BO-NE^LNH7E?_T+X/H=.[T1,7&?<E- R%CF/D4D
M("19BCAW@#8)/A)7FZ*L^P6S>Q1&VL5%5<T?RN6R][74C'%3KLM6G2TU?'8O
MM,5Z47[5>#-\DW<7/>ROX[LK(53$7 #>N](N1L//QH08]\E8]Y?5>K'S%7&0
MN,]_E@//&4"8D%0D[G"7@'3(/\-""8H%5S]U3O6KV[QL9AH;2[V$SR.=$M7]
M\(6=H_Z[YTK.>.PN&1(2"H[<.H,D"<XD[^?_U>BOG?GAP\=?Y7O0$>9>/(M%
M[#Y II!4PQ,3P%(-:EFJG\?#;AE 27!"^717SVYUDM9!RJ;N;E3[_4VT619Z
MB'83LJ.433=@!Y>*!&"3+4H\]=D5)AIBH.</A#LL01Y !D\2G$^^=,^6>73=
MZB0*'HUH^[%('M2:#&7-CIW!H20]8:J3H+ U.K AK<E0UNS &CQ+/'SVW&4!
M-3LZI "C$2#)D*$N:T?+$%^"(]\OV]5$#[_=@&RB/R/_O$:-CHY52&LRE#6[
M'&.(D\0GG-<$Q=FQ@0UJ38:R9@?6T"[!:==3QR N:/*$ ^ ."/,L!68F)&3Y
M<)9%#+D2G%R#53((AIT[=[T2B4IL%PV\$AQ>CRA=$!<O->H N20D!' 5D"7#
MZ3XQL$IP6#VF<D$@K 0\<66.%X ERH;=,'!*<#@=7[<@+CGJ&P0 ."2$;A!0
M)[/-V:X9#B4XA_KJ%L0M:E&1\0QRQ94R03(*N0/4WCA-&?*$,'1(\&K9Z+H%
M<:M=%,@&IH".Y$ 1%])AP]#@&1F-9P&*%OA%1Z^;0,6.BAA*_ $I7M\@!LT(
MCF;/!5GB%M2<4>!*]"B AL$I8(H:F*)X^>Y9)1#<YNA](+=\]S1(J,3VW- .
MQ6GGB H)=?GDC,0)!68])&5QF@!5<]!J%B/[-]1P#\6YY^7U$0J4Y#*@= ?H
MTA0H3P(ZF@T_P.G!1B;./V!>];E;?K7OOU7U<@ZZ%W8+,^P>YBDV,:FA,,I.
MN36,(M[HP(:T)D-9LP-KN)#B7.C)JZ@+;9E(&8#I@%(P+H#]*T!)4T*&\8(:
M%*0X"@9+K2C C. N,2 <V":&E.@^,36\2(_<71U.MZA+=!J^*9"E ,H\YL#.
M'6B28\]/@XGTR%U6).FB+GN=V77MG3^ #MHP!NWQX4(Y-2A'/2@W.O>BP*[H
MTU5XYYVKS*';*D&3C YO?###:0SG-%\"QH ]T#Q.<\ =2)I2<&<5D-(LHWSX
ML (S_,5P_AJ=@#&@_B0R8'8!0I9D0&H!"(F@P_DR,QS&1N^<!LC!\(N.76,9
M0&; G 5D0^$Q[,8\M:MG)E[,+4#!&\N ,"%,"&B,G^3HV,'9,;SV]:P$#+<Y
M>B  !3%PNQH28MO5S" 2PQ'IB&2, ;4MS31 W6@*2?,\H= C ))FE TG8\R0
M$L-)Z>7)& ,0B0B@J 8(DY@"2@F93&)[L;;]-8C$<$2:5K7.'(H6/@49=#\U
MJ#49RIH=-T-B+#MAXL6"%N:"6I.AK-F!-5#(<"CT'<SUE_'\$HE*[&.XAO8X
M3GOA#N)Z:VM3OT2B$MM%@W_<<[3.GT]Q_SDYOT2B$KOS!N^X!^^.R)VX?^?0
M+Y&HQ.Z]H2\^:N?PB%R)^\^\^242E=B^&'SB.#[Y\B+N(@OG5! @B06D0B2,
M ,P(2!.B\R+D\#,_.(2/L]#HQ(B[#./XYI5(5&*[8@B(XP1TFC0(O^C8%8^[
M0.2$!I/8H3&PQ#WUI&>F0-RM"#DWVRN1>.>>N3!S0SP<KST]*^G!;8Z^[6XI
MR@D2)K$]-TC"<20Y(M'A+E"<$4J@O690&HL82.-A:8:4$H7!%8'CRLL3'>'G
M%+]$HA+;-\,I N>4:;%>%U]+/5R7U8.JP<ZC%L8.S*#69"AK=O0,* ERPM1&
M!*UW!;4F0UFS VL83N ,YTEMA(M:@G*H4@8H.4]R 'H )4ES.ER]%X;B!$YQ
M3R99]&?TO%.S^&5&#YB@FY"AK-DA-E0I^"EG(HJLHP,;TIH,9<T.[,$[2''&
M]<U$+UY._1*)2NR.&P(5GG+=<9/.>Z0"O\SHL1&TLA?*FAUBP[GBE)4]$11X
M@UJ3H:S9@348+5Y4V1,N[ XM?ZYR:/D#3O2ARU]J^#G%^=F=B6@I';<V=EP$
MM29#6;,C:6@]34XXX=*@(!_4F@QES0ZL ?D4KWAZ)ESJ+W;Z)1*5V!TWH)SB
MH+R?6^I;6Q<SN*B"VQA]XX.>"@QES8Z?0?/TE*<"TZ! 'M2:#&7-#JP!\O1%
MIP)3MQQ+4I$"GVD!*),,.A@C027APZ<"4T/!*4[!SC1[=@Z'7VCTD EI38:R
M9@?YX ->3OF.YC0HIP>U)D-9LP-K.#W%Z]&^N>@6@N%W/@)"^)V/D!![YV-J
MR#C%R?CHB>C-Z_ +C1XO0=^"',J:_?E$!MBS4[X%.0O*[T&MR5#6[, :?L]>
M]!;D##BP23BTF0LHLPS:%X&$*1\^_I499,YP9(9F(IK7X?9&CXN@Y>Y0UNQ8
M&HK/3OFQA5E0O ]J38:R9@?6X'V&5]Y]$\X]Z.#,-*]$HA*[XP:?,QR??VEO
MX=TXO-WHFQVT5!W*FATS ^F9..4L"@KF0:W)4-;LP!HPS_!2NF\6N0<R!/0F
M4D#7?^*;,Y\ '?(ND^S@@Q=Q#NXGU;,S-]SXZ $2M%X=RIH=6$/E67[*F1>4
MQ(-:DZ&LV1^G:4@\QTOGGIF7^\^5^"42E=@=-Z2;XZ2+3C5O;H8;'SLB@EJ3
MH:S9@378G9_RR$D>E,&#6I.AK-F!-0R>O^C(20X=.0$6.4 '+G*0#EGD<H.\
M.8Z\CS,/S<5P&Z/'0=#"=2AK=OP,>>>G/$F2!\7SH-9D*&MV8 V>YR\Z2;)K
MS;&US"N1J&3;\?.#+X-8J7K1?ZE&$\VJNW6[_=Z$_:O[+^YXWW]=Q9/7/R3O
MY/;K-XR9[;>!_%S4BW+=1$MUHTW&;[N=B7K[!1O;7]IJTW_EQ->J;:M5_^.M
M*N:J[@3Z[S=5U3[^TEU@_S4G5_\'4$L#!!0    ( &\\7%9=9[TEGPX  !1_
M   9    >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;+5=T7+;N!7]%8[;Z61G
MXC4!D""9.IY)3*3-S&YW)][M/G3ZP$BPS*Y$>DG*3CK]^(*4(@C&Y24APR^)
M+1\<4(<@> _N)7CY6#>_MW=2=L&7S;IJWY[===W]FXN+=G$G-T7[?7TO*_67
MV[K9%)WZM5E=M/>-+)9#H\WZ@H8AO]@4975V=3E\]G-S=5EONW59R9^;H-UN
M-D7S];U<UX]OS\C9MP\^E:N[KO_@XNKROEC)&]G]>O]SHWZ[.+ LRXVLVK*N
M@D;>OCU[1]Z(+.T;#(A_EO*Q/?HYZ+_*Y[K^O?_EX_+M6=@?D5S+1==3%.J_
M!WDMU^N>21W''WO2LT.??</CG[^Q?QB^O/HRGXM67M?KW\IE=_?V+#T+EO*V
MV*Z[3_7CW^7^"\4]WZ)>M\._P>,>&YX%BVW;U9M]8W4$F[+:_5]\V0MQU$#Q
MP WHO@%]VH"/-&#[!NQI@VBD0;1O$,UM$.\;#%_]8O?=!^'RHBNN+IOZ,6AZ
MM&+K?QC4'UHKO<JJ'R@W7:/^6JIVW=6-7*G3W@4?J]V@&TY>M0SRLBU6JT:N
MBDXN@T_R059;&9P'-VJD+K=K&=2WP;OE?]0!JC^+]Q]_R=\%KW+9%>6Z_4[A
M?KW)@U=__N[RHE,'V7=UL=@?T/O= =&1 V+!CW75W;6!J)9R";2_QML3BA!<
M*'4.$M%O$KVG*&,N%]\'C+P.:$@I=$#/:Y[/;TZ YF)^\Q 1@QW&"QOXV,1X
M^23OZZ8KJY4Q<O[U@X(''SNY:?\-G?H==P1S]W/BF_:^6,BW9VK2:V7S(,^N
M_O(GPL._0K+[),M]D@E/9,8)B@XG*,+8K_ZA;B[KNFTA^=&6KO+OR.*!K+\=
M/5R=$YXF+ I#-= >CL4%H"Q+:&A#!0!-8IJ$QTA#E_B@2XSJ\K'JI/I675!6
MBWHC7P>5[""-4!97C79D_/C;4!JSQ)8(0&9A0FR! "!)(Q*/"L0/ O$)@7I=
M@J[X$L@O*@YI9?#JLZSD;=F!TSC*YBH4M[X5BT@2VSK9P/.( 3+9.,*B9%2D
MY"!2@HJ42_5M%J6^3Q:;?AK\[_ !I!)*YZI2 GPI0JFM$@",H] &"AN8A-'X
M6$H/,J6H3+N  -(#;>>J1PI<"Y&:68 I"("RC#!H"@*@:4PS-JI*=E E0U6Y
MN2N:(7#:34'!;5-O OG'MNR^JH!Y46^K/I@JJP<U3?4W67 .1[MP%3 #5"$$
MD,\&<D:8K9V-BV(R/GF34(>I(3X[;>Z+LAE"C_[N%JC+;U77R\=RO1ZNPU(%
M>[=E57;R?*V<1_]!5U2K\K,*58NVE;"8>*>N:N[9CK_]4QT!"&4\C+DM)0#M
M3PPBYE',3US%7-?5:J\<(A=*ZRP7 2;]S!Y4.0 D-.$D T2SH6-J4:T61=7Z
MF[+;P6"+'XKU=C?UJXMX*9ORH>AM;K NB\_ENNQ*"<N&\CO+1J%9+^0A(!P$
MC0D#L +$THS&T?B TZ:!H"'OF(3J@BTJ=3==JZNU[9KMZ*2'TSLKR" %$V:/
MIQR"IIP  0> S,:5T]$\P</YHTMUH6X?JY$1YC6RW[,9LSUA&1!G $A+%PQB
MBJ)#>8+'\K\T1=46NY6F1=V.C!FOD;Q7MIS843Q+0VA4V< (N0/H6)_@P?Z'
MNI'E2JFW;1I9+;X&W9&D8_81YW16U [1*4WM&V$. "V9,(@ID8[T"1[J_]3=
MR6;4)N*-G;6PXW#X3FCCSA,&S>:  TCI>&!/=&1/\-#^ASY@&"+79=DNZJHK
MJZT*&NI[V0SS.CQRO(;]Q([0+:%L2!Q".MDX'B,7F [U"1[K?Y+]#6W1;9M^
MC6Q\DO(:SA,[_(X9@\:1#;24P2#F.JH.XBD>Q \&Z+Q?UU\J23;](L.H<<:I
M7)6A=C"M B$"+#! R)#$P-P,<C).1D</U0$ZQ0/T#X? J.V*3@ZW?Q4[]7F7
MT:&$4SH+9@?2">' PA4(A)8: &#&TW1<+1V@TWD!NIJ0[NM6B398;-1%XXS.
M8MFQLR73)$0 D/,H2<>C2*KC;XK'WT\R-: B7D/L/9NQCILJCY(" PB *MJ(
M \L+%([<:3R^.$-UJ$WQ4/NZWFS4*&J[>O'[ZZ#MYRIEC;>=N@2K93^+OU+#
M;/<QN"!*[4A7!75QHAP4,[_']7QH#D&3*(LIS]A3=3RY %,_'953/"K_M5]]
M608W_8P%7W1>(W*O;+E7-N&+S3P3.KJG_ 63=-1KF.^5+??*)GRQF:=).PR*
M.XQ3E^%P6N<3Y),MW[,=S^:$ BO*PE>WIO;:QE#<QKQ3]\.F6)<%*+!7N^*5
M+??*)GRQF6=!NR2:O>1$Y=4\>67+O;()7VQFR8?V;0SW;3_L9Z?C 'M\>MJ3
MF;%?8EN':[Q7YPH.GVS"%YNIN#: ##> >?E0+F6UA 4FEL LM:?8:[P/9WU]
ML@E?;*:^VC(RW#(^-]9GME>+8Y+PD,=/3\)<9(X?LK/ GMA,@8_*Q'#'^=-N
M/5 IN9_CV^!_P:1#P$F="\3\5HCY+1%[B1HQIKTNBU[PQLN\IIN\LN5>V80O
M-O,T:4O-<$N-%?/A39U/0@S<M".2 ;4@#*IJ2UF: @LV$#9)&!]?]F/:Y;*I
M@K5Y%7TXC;-04 5:3("%+1 )Y"  '$'TT?:23=A+QX(^G,Y9)SL#90D$9+-2
MH*@#P#$ZON+'M EDN ETKN;#^9PELI-/)$J!G 0 S(@=4 L 1]EX_0;3/HWA
MV:SQ96.\H;,B0$%:FE *Y!T@J)J%PLS63T#8A"=(25^DO5$T(Z?UW*(^O _G
MRNSI.K1IB$ AIEC:UD3.A6<>JOCP3IW5\^J:(COKU1?\0;5K !0O^(NTW8EP
MNW/J2B-.ZZSL=)H,@- L!BYI7T=F"JKM37120=O\FD"<WUE9.R]F*3L)$2C$
M%.KH:10\J?;<RC^<WEFGR7JU?!HB4(BIDX[THXG'4V;5^>$DSFK8P?E(G9_7
M?H4O-E-J[1LBW#?,JA[$.9R5]IH$BZ8+X@ (4C<8:4\1X9[BI+I!G--9RVEC
MX;5#X8O-E%R;E @W*7@=(M[865O D7"@+!K  >8?0%%D$&HW$N%NY*021)S3
M62BOR:)HNAP/A9@/1&KK$N/696:-(L[B_$@D4#67I,#RB==NA2\V4VIM?&+<
M^+A4/N)4SGH#3]DD$;"L!P$CJ"8= *8)&5]FB+5-B7&;<DK9(T[IK-:T19F&
M"!1B:J,=1SS/<3@4.>*,SM)XS:9X91/Q;.<2:^<2X\YE1LTDSN LL&TKSFE(
MH ?J(6@4)M":(,B:/EF ,"4Z>J0>-RU@DJ^_J_2#\[>Z64/[=[S'29U5\UH&
MZ)5-^&(S3X\V.O%+E@'&7AV05[;<*YOPQ6:>)NVI8MQ384D^O*GS20 2+G%$
M*!#A0]"4I-"3CP"449Z,/P<1:^\3X]YG]J8=7EU0#.TK\'3*W,L$0+,0VI "
M)HW8> XBUH8HQ@V1:Z8/IW.6R[8F(YMW ,AS%@'/B@! $M+Q$)-KS\-QS^.<
M\L/YG/<Y =P/X="&,! R@K*# D#R)Q>J*99V+1QW+>.1#][0617;49Q3SACP
M,"@$33C/@'P* *4T3,8O.*Z-"L>-BI>D']Z'LX; TT/P7AX $M[, P"BNWEP
M;68X;F9>)@^(=^HLJ%>_PVV' ESU H"-B:V-#,>-S*G)/YS664[;A\"[?0!
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M=[]T]?WPCO'/==?5F^''.UDH ]T#U-]OZ[K[]DO?0?_V^.&PK_X/4$L#!!0
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M2LJ$)IHO9+'(_X)=B74&(,R$9$D9K$:0T+3XCU]*(?8"H'<B )4!Z#!@?"+
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M2MVO4O>MJ7^NDHZH*/-6-?&F/@(G6\@_*GGG0()CQ'#B'( " \B;.&8!II4
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M@"\!\A$"7V\Q>/[LA0:S[(Z!!@SN@('C$B,HD1I&V(4Q.LOP5-VJXJ&J>*B
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M$EM.\"H/BB/+M>V1%6.:]!:S_-@]7\Q8*B.:D'N.1!K'F'^[(A';SWM.[_7
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MNL2-%_/F)8(BM0TZIC8SM+/FL&_885^Q_Q\K!6Z]4N .3BNU@:XV@-)\4%H
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M%10:!W;BPURV:2^-:=\FC,NWDO)<[=^/5,C\6,[+03)J+; 6O4)?CS5;#-=
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M&N-? DBC@/MS(?1F81R4_QW!7U!+ P04    " !O/%Q66Q!\NLH"  #D!P
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MZR_8Z'$!9H(I]X1U[3LPSME2:5$V8!-!27G])D]-'K8 X?D!0-0 HN> W@%
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MH4W/=LO"C&&4UL&<SX70&\->T [VY"]02P,$%     @ ;SQ<5C+=#[+0 @
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MC?']\_,J:"/I5I5TZWA?46R=,5-D.)=QBA>*::N!%%PH\A6Y!F)?/4<YWWH
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M35UH,;6W3#\F:M]'@LF[L?03@SO@@F6AR%A,IN@SNJ)<<#1^1B.8RNT5Z#0
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M!WM*PC".W0A@;@5AB"'P-.((I@ T8$@8FO?@SOLH6+^G@O:_F./?4$L#!!0
M   ( &\\7%:7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%
MT)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI
M&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17
MB%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)
MT:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L
M?@!02P,$%     @ ;SQ<5IZFS_+4!@  8$(   \   !X;"]W;W)K8F]O:RYX
M;6S%G%MOFT@8AO_*R%>ME*QM;$Y54ZG-H1LIVT9QU-O5!,;VJ,"D,Y T_?4=
MH.E^N/C5WGSQ56+ ^/$,S//. ;]]-/;KG3%?Q?>RJ-S)9%O7]V^F4Y=M52G=
M7^9>57[/VMA2UOZEW4S=O54R=UNEZK*8!K-9-"VEKB;OWCZ?Z]I.Z0M3JZS6
MIO(;VPU?M'IT_^UO7XH'[?2=+G3]=#+I_B_41)2ZTJ7^H?*3R6PBW-8\_FVL
M_F&J6A:KS)JB.)G,^QU?E*UU]L?F50MY*^]<MZ66=S?2@YQ,HID_X5I;5W='
M=.>7GO%!^8/[5TUM+G11*WLF:_71FN9>5YOV-/Y;3,G7Z,KA^6]?B&_L_RE&
MLU[K3)V9K"E55??E:%71 E9NJ^_=1%2R5">34_.@K+B6&]5^*?\IEWG_!6M/
M1HK+OM%^A[W,.T8^GO=-KFMQ6?5O]GL)5@"P EZL4__:%#KWGYZ+#[*05:9$
M5[V$;P'X%H?B$Z^NI2602P"Y?$'(50O1OL$)LQ:?_$<2R!! A@>#/-U*>CE&
M #(Z'*1T6P(9 \B8%_*#S+YN?-M6Y4?^DG2ZP[NVROFW^:,)9 (@$U[(R^K!
M'V#LTY&H!C=S"IA2?B97=S5*&^49:I5GO$A71E9.W*A,Z0?I/WJWM.90&<S.
M\"'@WBO:5^&U;_AJ(:M<G']K]'W[OB/:KLR10N;,#OEH3/ZHBZ+CN_3W0+5I
M"<1[Y[SDCR@F,LF<62572CHUN/"0,N;,SCA3UE]Q;7@25UIV*4X/Z9 KYNRR
M*$O=WZE=K?IVN?9)3E79#B1RQ9Q9%JNMM.KXSM=J"UCZ,[G=9#5'FI@S>^*R
MRDRIQ*W\/BPS9(4YLQ96:M,>08-H5\%GVLG-AN:I.1+%G-D4Y])6_GISXM65
M<>ZU\,V@Z*J;IF;DC8#9&Q>Z\E%4R\*7I*MMLRNU 'DC8/;&3;O1WQ0^(-=/
MXM9ZQ<FN+SD@A+T.9F7<J+;0LKJQOI8I%!)$P"R(57/GU+>FO3W.'W;K$[DB
M8'8%#)S_!A0322-@E@;&7%!,I(V 61O#9"Q>W;:YS[VF>,@: ;LU?H?D439D
MCX#9'J-I>902R2-@E@>,S8/;98$4LF!6"(S-0TPDDP6S3/K8/%;)"V20!;-!
MQO/S*"8<ON)VRIZ,^@N48B+#+)@-0Z/J:!DBKRR8O0(SZ_!&05Y9,'ME;V;M
M"Y1B(K\LF/TRFEQ'ZQR99L%LFOT1MD.EF$@U"V;5#'+L6"$ND6&6S(;!@6Q)
M,9%AELR&P9@AQ43&63(;!V-&%!,99\EL'(P94TPX97+0/DU",9%[ELSNV>TL
MG*E:ZF)XBR/I+%^@,_/<6S@6GZ2U?2;Z!4HQD726+]BI.18K?\:\\5'75WFW
MAV(BZRQ?8-)D'/.+M%I23&2=Y<O-HWC,&_4@BZ:/19[T,YV^")%^0F;][)1F
M4Y;2/K6('Z6NQ)IB(OV$W!V<T4[M[^JGF$@_(;-^(.8@!8=(/R&S?G#GFPX"
MA4@_(;-^,":-1B&<LV?6#QXC&)0FLE#(;"&,.2A-9*&0V4(8DP;-$%DH9+80
MQJ1!,T06"IDMA#%IT(R0A2+N&?Y^_&HD' U27(04%+W,&-LP<G0;Q:EQ5.@1
M4E#$K: QS(O&]WZ5^$</EA A!47,"MHS-/A\!5!,I*#H("L ?I<NQ40*BI@5
M!#$'N2.""\>8%80QJ2DCI*"(64%P884XIIA(01&S@B#FL-*1@B)F!>T=7>^[
M&W2Y(%)0S*P@A%F;C&(B"\7,%H*E.:CT&%DH9K80P+R0FBYAB9&%XD/-_/1-
M$L5$%HJ9+00PV\%MBHDL%'// <%KDS;O,;)0?* E:3TF[0C%< $SLX4P)NT(
MQ<A",?=BM?V8K>,I)K)0S#X<1R9/=T<W,T,P$V2AA'TX;H"YVQVBF,A"";.%
M=C#/O[?5KH0_UQ^EB2R4,%MH%W.]5MVC4.T6<4.'BA-DH8390N#:/%-K:J$$
M62CAMA"<XJ?->X(LE!QT)0)MWA-DH83;0A"3-N\)LE#";2&(2<>Y$O@@S2&7
M3 _&N1)DH>102Z;[VYY@ILA"Z2$63H_.MJ3(0BFSA2#FH"^4(@NES!;:AWEJ
M5?NX*<5$%DJ9+;0/\TI_:W1.HT>*+)0R6V@?YF55*SN8I4Z1A5)F"^W#O#!6
MZ0T=ADV1A5)F"X$E7&WZI)C(0BFSA2#FB@[.I,A"*?N".+K2[(_X3C'A$YXO
MNB#NN)N^<.+N2?06)9CS&7[ND]E#NZ##U^\'H/ 9T%G_XP;=X>[=VURM=:7R
M3_Y#G-^>R2*[MJ+]TYTK6(;M@U7KIBA._;;/U961^?,/)#S_N,.[GU!+ P04
M    " !O/%Q68\012MT"  !<.P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QSS=N];N) &$;A6T&^@-CS/[,*J;9)N\H-(&(@"F"$O=KD[A>1 M[1
M%MM$/A4:(SZ.7#Q"9N;Q5[]?36_#<=R]G<;%QV%_')?-;II./]IV7._ZPVI\
M&$[]\?+.9C@?5M-E>=ZVI]7Z?;7M6]MUL3W?SVB>'N]G+EX^3_W_3!PVF[=U
M_W-8_S[TQ^D?@]L_P_E]W/7]U"Q>5N=M/RV;]F-_NSRVUQ?S<)G<+)Y?E\WY
M^=4T[=Q!5H+L_$%.@MS\05Z"_/Q!08+"_$%1@N+\04F"TOQ!68+R_$%%@LK\
M0:93&3M 4H4U0&NC7!N UT;!-@"QC9)M &8;1=L U#;*M@&X;11N Y#;*-T&
M8+=1O U ;ZMZ6X#>5O6V +UM]6,;H+=5O2U ;ZMZ6X#>5O6V +VMZFT!>EO5
MVP+TMJJW!>AM56\+T-NIW@Z@MU.]'4!OIWH[@-ZN>E@"T-NIW@Z@MU.]'4!O
MIWH[@-Y.]78 O9WJ[0!Z.]7; ?3VJK<'Z.U5;P_0VZO>'J"W5[T]0&]?/>P&
MZ.U5;P_0VZO>'J"W5[T]0&^O>GN WE[U]@"]@^H= 'H'U3L ] ZJ=P#H'53O
M - [J-X!H'>H_JP$Z!U4[P#0.ZC> :!W4+T#0.^@>@> WE'UC@"]H^H= 7I'
MU3L"](ZJ=P3H'57O"- [JMX1H'>L-IL ](ZJ=P3H'57O"- [JMX1H'=2O1-
M[Z1Z)X#>2?5. +V3ZIT >B?5.P'T3JIW NB=5.\$T#M5FP4!>B?5.P'T3JIW
M NB=5>\,T#NKWAF@=U:],T#OK'IG@-Y9]<X O;/JG0%Z9]4[ _3.JG<&Z)VK
MS=X O;/JG0%Z%]6[ /0NJG<!Z%U4[P+0NZC>!:!W4;T+0.^B>A> WD7U+@"]
MB^I= 'H7U;L ]"[581V WJ:KC^L _#9==6"G^T[!Q^ESWX^WHJ]U%?"=7D^7
MS_:W[[\NOR[6M^%*='N?,3[]!5!+ P04    " !O/%Q6?^!#S%L"  !-.0
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( &\\7%8=@A(*[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( &\\
M7%:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ ;SQ<5A9D2IO(!P  LRX  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( &\\
M7%;AJ$<T-@(  +,%   8              " @0P0  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " !O/%Q616^+(" '   P'P  &
M        @(%X$@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ ;SQ<5H\'M3T_ @  *@4  !@              ("!SAD  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( &\\7%9-76Z6%PD  ,@L   8
M              " @4,<  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " !O/%Q6V^AXXCT(  !O/   &               @(&0)0  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ ;SQ<5C#-^PET"0
MD2\  !@              ("! RX  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( &\\7%:&M\*FR"@  $6'   8              " @:TW
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !O/%Q6N] "
M[) "  "4!0  &               @(&K8   >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ ;SQ<5LO"P_WM%0  ED@  !D
M ("!<6,  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !O
M/%Q6:4;:^\4'  !Y%   &0              @(&5>0  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( &\\7%:/U#LBXP8   D4   9
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M970Q-BYX;6Q02P$"% ,4    " !O/%Q62XXV:/$.  !/+P  &0
M    @(&-OP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M &\\7%:Q.+HAL@P  &PC   9              " @;7.  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ ;SQ<5M[G;M&3$   X#4  !D
M             ("!GML  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " !O/%Q65EJR^I@$  #%#@  &0              @(%H[   >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( &\\7%9'IL DY1
M *4U   9              " @3?Q  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ ;SQ<5J!+BMB7!0  <PT  !D              ("!
M4P(! 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !O/%Q6
M<MC@TF,%  "(#   &0              @($A" $ >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( &\\7%9+)Q>,70,  %X'   9
M      " @;L- 0!X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ ;SQ<5@,'JN#R*   LI$  !D              ("!3Q$! 'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !O/%Q6X*9>9WH(  ">%P
M&0              @(%X.@$ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( &\\7%;W(/)*H (  )4%   9              " @2E# 0!X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ ;SQ<5FBBXE7N
M"   V28  !D              ("! $8! 'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " !O/%Q6449!%!H%   W#   &0
M@($E3P$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( &\\
M7%82)[,.3P,  (,'   9              " @794 0!X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ ;SQ<5E\]<M;I!@  %!T  !D
M         ("!_%<! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " !O/%Q6 YX-\M<#  #E"   &0              @($<7P$ >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( &\\7%8+EV@[TP8  ,$3
M   9              " @2IC 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ ;SQ<5I,J#2%7"0  =AL  !D              ("!-&H!
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !O/%Q6/.R5
M:^,&  "4$0  &0              @('"<P$ >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( &\\7%8B !<F[0X  /(P   9
M  " @=QZ 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M;SQ<5O#'/TE3!   T0T  !D              ("! (H! 'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " !O/%Q61T>=*!H&  !X$   &0
M            @(&*C@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( &\\7%94#XVUS@(  'L&   9              " @=N4 0!X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ ;SQ<5I!#(0<E P
M_P8  !D              ("!X)<! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " !O/%Q6;7)EKAL#  "'"P  &0              @($\
MFP$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( &\\7%9%
M-NY%2P,  &@.   9              " @8Z> 0!X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ ;SQ<5@.3"!NS @  T <  !D
M     ("!$*(! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &\\7%95;XL\9PP  ,Z3   9              "
M@4_" 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ ;SQ<
M5MFFLANN P  .1(  !D              ("![<X! 'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " !O/%Q6/K[>6GH%  !F+0  &0
M        @('2T@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( &\\7%901T/FC0,  %X0   9              " @8/8 0!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ ;SQ<5O=NMS&I"P  5I4
M !D              ("!1]P! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " !O/%Q6U'=:KF<%  "J&P  &0              @($GZ $
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( &\\7%;%!6-Z
M_ ,  *43   9              " @<7M 0!X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ ;SQ<5H\WB:*6!   %AT  !D
M ("!^/$! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " !O
M/%Q6C_[JWF$$  #M%@  &0              @('%]@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( &\\7%8<0D'4_A@  #KE 0 9
M          " @5W[ 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#
M%     @ ;SQ<5ODI;PU?!P  MCD  !D              ("!DA0" 'AL+W=O
M<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " !O/%Q6T^?AHOH"  #H
M"0  &0              @($H' ( >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM
M;%!+ 0(4 Q0    ( &\\7%8/8$/J= 4  *8?   9              " @5D?
M @!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ ;SQ<5LA*
MX,B3!   F1T  !D              ("!!"4" 'AL+W=O<FMS:&5E=',O<VAE
M970V,2YX;6Q02P$"% ,4    " !O/%Q6H>8N\=T#  "Y#0  &0
M    @('.*0( >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M &\\7%;N,>S3RP(  -P'   9              " @>(M @!X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ ;SQ<5D)[HR4)!0  91T  !D
M             ("!Y# " 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"
M% ,4    " !O/%Q6*+3YOX $  !"%0  &0              @($D-@( >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( &\\7%8("G8:W <
M )9'   9              " @=LZ @!X;"]W;W)K<VAE971S+W-H965T-C8N
M>&UL4$L! A0#%     @ ;SQ<5AJ_A[:@ P  =A   !D              ("!
M[D(" 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " !O/%Q6
M25(WU+(%  !+,   &0              @('%1@( >&PO=V]R:W-H965T<R]S
M:&5E=#8X+GAM;%!+ 0(4 Q0    ( &\\7%;V":H$QP,  ,X1   9
M      " @:Y, @!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%
M  @ ;SQ<5M#*"]NK!   QB$  !D              ("!K% " 'AL+W=O<FMS
M:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " !O/%Q6_K#MU- $  "O*@
M&0              @(&.50( >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+
M 0(4 Q0    ( &\\7%8#J1N)SP0  -T6   9              " @95: @!X
M;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ ;SQ<5GNJ].>4
M P  ,@L  !D              ("!FU\" 'AL+W=O<FMS:&5E=',O<VAE970W
M,RYX;6Q02P$"% ,4    " !O/%Q61P3[%64#   M$0  &0
M@(%F8P( >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( &\\
M7%9V*I=+4@(  *0%   9              " @0)G @!X;"]W;W)K<VAE971S
M+W-H965T-S4N>&UL4$L! A0#%     @ ;SQ<5IHE,HS9!   /A@  !D
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M=#@P+GAM;%!+ 0(4 Q0    ( &\\7%8$"[TT#P4  #(<   9
M  " @5=] @!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @
M;SQ<5L)9=:"6 P  /A,  !D              ("!G8(" 'AL+W=O<FMS:&5E
M=',O<VAE970X,BYX;6Q02P$"% ,4    " !O/%Q6"-].]]<$  !%$@  &0
M            @(%JA@( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4
M Q0    ( &\\7%;(!2*:L@0  )\2   9              " @7B+ @!X;"]W
M;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ ;SQ<5KY@_^,W @
MPP0  !D              ("!89 " 'AL+W=O<FMS:&5E=',O<VAE970X-2YX
M;6Q02P$"% ,4    " !O/%Q6XUXQ-C$,  #R9   &0              @('/
MD@( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( &\\7%9=
M9[TEGPX  !1_   9              " @3>? @!X;"]W;W)K<VAE971S+W-H
M965T.#<N>&UL4$L! A0#%     @ ;SQ<5F&&B@?X P  G10  !D
M     ("!#:X" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &\\7%8ATF[(408  !\L   9              "
M@>;' @!X;"]W;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @ ;SQ<
M5HVXY(K6 @  @P@  !D              ("!;LX" 'AL+W=O<FMS:&5E=',O
M<VAE970Y-"YX;6Q02P$"% ,4    " !O/%Q66Q!\NLH"  #D!P  &0
M        @(%[T0( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4 Q0
M   ( &\\7%8RW0^RT (  ,<'   9              " @7S4 @!X;"]W;W)K
M<VAE971S+W-H965T.38N>&UL4$L! A0#%     @ ;SQ<5M.Z-;[] P  .Q<
M !D              ("!@]<" 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX;6Q0
M2P$"% ,4    " !O/%Q61'MY#PD#  !5"P  &0              @(&WVP(
M>&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    ( &\\7%90:/!
ML (   8*   9              " @??> @!X;"]W;W)K<VAE971S+W-H965T
M.3DN>&UL4$L! A0#%     @ ;SQ<5NF) &M0 P  *A$  !H
M ("!WN$" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L! A0#%     @
M;SQ<5BG"D5U9 P  /@T  !H              ("!9N4" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#$N>&UL4$L! A0#%     @ ;SQ<5A[R!II2 P  TA0   T
M             ( !]^@" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !O/%Q6
MEXJ[',     3 @  "P              @ %T[ ( 7W)E;',O+G)E;'-02P$"
M% ,4    " !O/%Q6GJ;/\M0&  !@0@  #P              @ %=[0( >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ ;SQ<5F/$$4K= @  7#L  !H
M         ( !7O0" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ ;SQ<5G_@0\Q; @  33D  !,              ( !<_<" %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     &T ;0#T'0  __D"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>473</ContextCount>
  <ElementCount>502</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>132</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>16</UnitCount>
  <MyReports>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheet</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheet</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheet (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical</Role>
      <ShortName>Consolidated Balance Sheet (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Changes in Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Background, Basis of Presentation, and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Inventory, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Inventorynet</Role>
      <ShortName>Inventory, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Loans Receivable, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansReceivablenet</Role>
      <ShortName>Loans Receivable, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Property, Plant and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/PropertyPlantandEquipmentnet</Role>
      <ShortName>Property, Plant and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Goodwill and Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnet</Role>
      <ShortName>Goodwill and Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Derivative Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilities</Role>
      <ShortName>Derivative Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Share-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensation</Role>
      <ShortName>Share-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Segment Information and Disaggregated Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenue</Role>
      <ShortName>Segment Information and Disaggregated Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Earnings (Loss) per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningsLossperShare</Role>
      <ShortName>Earnings (Loss) per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Background, Basis of Presentation, and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Background, Basis of Presentation, and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Inventory, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InventorynetTables</Role>
      <ShortName>Inventory, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Inventorynet</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Investments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Loans Receivable, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansReceivablenetTables</Role>
      <ShortName>Loans Receivable, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/LoansReceivablenet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Property, Plant and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/PropertyPlantandEquipmentnetTables</Role>
      <ShortName>Property, Plant and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/PropertyPlantandEquipmentnet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Goodwill and Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables</Role>
      <ShortName>Goodwill and Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Leases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Derivative Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesTables</Role>
      <ShortName>Derivative Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/DerivativeLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Share-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationTables</Role>
      <ShortName>Share-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SharebasedCompensation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Segment Information and Disaggregated Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueTables</Role>
      <ShortName>Segment Information and Disaggregated Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenue</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Earnings (Loss) per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningsLossperShareTables</Role>
      <ShortName>Earnings (Loss) per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/EarningsLossperShare</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/FinancialInstruments</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/RelatedPartyTransactions</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Restructuring</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails</Role>
      <ShortName>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails</Role>
      <ShortName>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails</Role>
      <ShortName>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails</Role>
      <ShortName>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Background, Basis of Presentation, and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Inventory, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InventorynetDetails</Role>
      <ShortName>Inventory, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/InventorynetTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Investments - Schedule of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails</Role>
      <ShortName>Investments - Schedule of Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Investments - Revaluation of Other Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails</Role>
      <ShortName>Investments - Revaluation of Other Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Investments - Summary of Gain from Disposals of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails</Role>
      <ShortName>Investments - Summary of Gain from Disposals of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Loans Receivable, net - Schedule of Loan Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails</Role>
      <ShortName>Loans Receivable, net - Schedule of Loan Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Loans Receivable, net - Schedule of Expected Credit Loss Allowances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails</Role>
      <ShortName>Loans Receivable, net - Schedule of Expected Credit Loss Allowances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Property, Plant and Equipment, net - Schedule of Property, Plant &amp; Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails</Role>
      <ShortName>Property, Plant and Equipment, net - Schedule of Property, Plant &amp; Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Goodwill and Intangible Assets, net - Impairment Charges on Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Impairment Charges on Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Leases - Schedule of Lease Cost and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails</Role>
      <ShortName>Leases - Schedule of Lease Cost and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Leases - Schedule of Future Minimum Lease Payments for Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Future Minimum Lease Payments for Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Derivative Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails</Role>
      <ShortName>Derivative Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Commitments and Contingencies - R&amp;D Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails</Role>
      <ShortName>Commitments and Contingencies - R&amp;D Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Commitments and Contingencies - Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies - Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Share-based Compensation - Summary of Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails</Role>
      <ShortName>Share-based Compensation - Summary of Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Share-based Compensation - Stock Options Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails</Role>
      <ShortName>Share-based Compensation - Stock Options Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Share-based Compensation - Summary of the Changes in Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails</Role>
      <ShortName>Share-based Compensation - Summary of the Changes in Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Share-based Compensation - Fair Value of Options Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails</Role>
      <ShortName>Share-based Compensation - Fair Value of Options Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Share-based Compensation - Schedule of Stock Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails</Role>
      <ShortName>Share-based Compensation - Schedule of Stock Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Share-based Compensation - Restricted Share Units Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails</Role>
      <ShortName>Share-based Compensation - Restricted Share Units Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Share-based Compensation - Summary of Restricted Share Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails</Role>
      <ShortName>Share-based Compensation - Summary of Restricted Share Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Share-based Compensation - Summary of Deferred Share Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails</Role>
      <ShortName>Share-based Compensation - Summary of Deferred Share Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Share-based Compensation - Summary of Changes in Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails</Role>
      <ShortName>Share-based Compensation - Summary of Changes in Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Share-based Compensation - Liability-Classified Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails</Role>
      <ShortName>Share-based Compensation - Liability-Classified Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Income Taxes - Expense for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Expense for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Segment Information and Disaggregated Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueNarrativeDetails</Role>
      <ShortName>Segment Information and Disaggregated Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Segment Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails</Role>
      <ShortName>Segment Information and Disaggregated Revenue - Schedule of Segment Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Adjusted EBITDA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails</Role>
      <ShortName>Segment Information and Disaggregated Revenue - Schedule of Adjusted EBITDA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Revenue from External Customers by Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails</Role>
      <ShortName>Segment Information and Disaggregated Revenue - Schedule of Revenue from External Customers by Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Long-lived Assets by Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails</Role>
      <ShortName>Segment Information and Disaggregated Revenue - Schedule of Long-lived Assets by Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Earnings (Loss) per Share - Schedule of Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails</Role>
      <ShortName>Earnings (Loss) per Share - Schedule of Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/EarningsLossperShareTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails</Role>
      <ShortName>Financial Instruments - Schedule of Fair Value of Assets on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets on Nonrecurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails</Role>
      <ShortName>Financial Instruments - Schedule of Fair Value of Assets on Nonrecurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Financial Instruments - Credit Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails</Role>
      <ShortName>Financial Instruments - Credit Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Financial Instruments - Liquidity Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails</Role>
      <ShortName>Financial Instruments - Liquidity Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Financial Instruments - Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails</Role>
      <ShortName>Financial Instruments - Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Financial Instruments - Foreign Currency Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsForeignCurrencyRiskDetails</Role>
      <ShortName>Financial Instruments - Foreign Currency Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Related Party Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails</Role>
      <ShortName>Related Party Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions - Schedule of Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Restructuring - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RestructuringNarrativeDetails</Role>
      <ShortName>Restructuring - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Restructuring - Costs by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails</Role>
      <ShortName>Restructuring - Costs by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="cron-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Restructuring - Restructuring Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails</Role>
      <ShortName>Restructuring - Restructuring Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0547-EntityTaxIdentificationNumber-Missing] Submission type 10-K should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. cron-20221231.htm </Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  cron-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="cron-20221231.htm">cron-20221231.htm</File>
    <File>cron-20221231.xsd</File>
    <File>cron-20221231_cal.xml</File>
    <File>cron-20221231_def.xml</File>
    <File>cron-20221231_lab.xml</File>
    <File>cron-20221231_pre.xml</File>
    <File>exhibit1032-annashlimaklet.htm</File>
    <File>exhibit211-listofsubsidiar.htm</File>
    <File>exhibit231-consentofindepe.htm</File>
    <File>exhibit311-certificationof.htm</File>
    <File>exhibit312-certificationof.htm</File>
    <File>exhibit321-certificationof.htm</File>
    <File>exhibit322-certificationof.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cron-20221231_g1.jpg</File>
    <File>cron-20221231_g2.gif</File>
    <File>cron-20221231_g3.jpg</File>
    <File>cron-20221231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1599">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>126
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cron-20221231.htm": {
   "axisCustom": 1,
   "axisStandard": 45,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1599,
    "http://xbrl.sec.gov/dei/2022": 36
   },
   "contextCount": 473,
   "dts": {
    "calculationLink": {
     "local": [
      "cron-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cron-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cron-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cron-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cron-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cron-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 843,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://thecronosgroup.com/20221231": 1,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 7
   },
   "keyCustom": 87,
   "keyStandard": 415,
   "memberCustom": 64,
   "memberStandard": 62,
   "nsprefix": "cron",
   "nsuri": "http://thecronosgroup.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://thecronosgroup.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://thecronosgroup.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Restructuring - Costs by Segment (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
     "shortName": "Restructuring - Costs by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i650691423f5e4494934b0fa65dab6839_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i919ad19634e44f94b09180aaeb361f67_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Restructuring - Restructuring Activity (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails",
     "shortName": "Restructuring - Restructuring Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i919ad19634e44f94b09180aaeb361f67_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Loans Receivable, net",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://thecronosgroup.com/role/LoansReceivablenet",
     "shortName": "Loans Receivable, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Property, Plant and Equipment, net",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentnet",
     "shortName": "Property, Plant and Equipment, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Goodwill and Intangible Assets, net",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnet",
     "shortName": "Goodwill and Intangible Assets, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://thecronosgroup.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Derivative Liabilities",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilities",
     "shortName": "Derivative Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://thecronosgroup.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Share-based Compensation",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://thecronosgroup.com/role/SharebasedCompensation",
     "shortName": "Share-based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://thecronosgroup.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Segment Information and Disaggregated Revenue",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenue",
     "shortName": "Segment Information and Disaggregated Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://thecronosgroup.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Earnings (Loss) per Share",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://thecronosgroup.com/role/EarningsLossperShare",
     "shortName": "Earnings (Loss) per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Financial Instruments",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://thecronosgroup.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://thecronosgroup.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Restructuring",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://thecronosgroup.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://thecronosgroup.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Background, Basis of Presentation, and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Background, Basis of Presentation, and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Inventory, net (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://thecronosgroup.com/role/InventorynetTables",
     "shortName": "Inventory, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://thecronosgroup.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Loans Receivable, net (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://thecronosgroup.com/role/LoansReceivablenetTables",
     "shortName": "Loans Receivable, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Balance Sheet",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
     "shortName": "Consolidated Balance Sheet",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Property, Plant and Equipment, net (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetTables",
     "shortName": "Property, Plant and Equipment, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Goodwill and Intangible Assets, net (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables",
     "shortName": "Goodwill and Intangible Assets, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://thecronosgroup.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Derivative Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesTables",
     "shortName": "Derivative Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Share-based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationTables",
     "shortName": "Share-based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://thecronosgroup.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Segment Information and Disaggregated Revenue (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueTables",
     "shortName": "Segment Information and Disaggregated Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Earnings (Loss) per Share (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://thecronosgroup.com/role/EarningsLossperShareTables",
     "shortName": "Earnings (Loss) per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Related Party Transactions (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://thecronosgroup.com/role/RelatedPartyTransactionsTables",
     "shortName": "Related Party Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheet (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical",
     "shortName": "Consolidated Balance Sheet (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Restructuring (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://thecronosgroup.com/role/RestructuringTables",
     "shortName": "Restructuring (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i36cd7b767d4742089d1b42cfe6220c44_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails",
     "shortName": "Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i36cd7b767d4742089d1b42cfe6220c44_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i1b22fb74b27245199caf9dcb11234c12_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Property, Plant & Equipment, Useful Lives (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
     "shortName": "Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Property, Plant & Equipment, Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i1b22fb74b27245199caf9dcb11234c12_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails",
     "shortName": "Background, Basis of Presentation, and Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i48683b7d2b654014b86c178790a1f9b1_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails",
     "shortName": "Background, Basis of Presentation, and Summary of Significant Accounting Policies - Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cron:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Background, Basis of Presentation, and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cron:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Inventory, net (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://thecronosgroup.com/role/InventorynetDetails",
     "shortName": "Inventory, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Investments - Narrative (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ieae966ba01c1479dacbc7135663a609a_D20220101-20221130",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Investments - Schedule of Investments (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
     "shortName": "Investments - Schedule of Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ieab708e963a4427d9d3c7720e25e4a43_D20210401-20210401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:OtherNetAssetsLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
     "shortName": "Investments - Schedule of Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:OtherNetAssetsLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ExciseAndSalesTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i0b61d3b7b8334186a589bb519b652171_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Investments - Revaluation of Other Investments (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails",
     "shortName": "Investments - Revaluation of Other Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Investments - Summary of Gain from Disposals of Investments (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails",
     "shortName": "Investments - Summary of Gain from Disposals of Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "icf3a51f82e6c455ea2fbee1766559fd5_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NotesAndLoansReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Loans Receivable, net - Schedule of Loan Receivable (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails",
     "shortName": "Loans Receivable, net - Schedule of Loan Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i83da444fa44248408487072ea1d3c39e_D20220930-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:FinancingReceivableInterestIncomeIncreaseFromDebtModification",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i0b61d3b7b8334186a589bb519b652171_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Loans Receivable, net - Schedule of Expected Credit Loss Allowances (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
     "shortName": "Loans Receivable, net - Schedule of Expected Credit Loss Allowances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "iea9d63117e854b719984324586934e8e_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Property, Plant and Equipment, net - Schedule of Property, Plant & Equipment (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails",
     "shortName": "Property, Plant and Equipment, net - Schedule of Property, Plant & Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
     "shortName": "Property, Plant and Equipment, net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Goodwill (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, net - Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, net - Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, net - Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i213ce03ecaa746eab2dd1a12204b5ccb_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Changes in Shareholders\u2019 Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i213ce03ecaa746eab2dd1a12204b5ccb_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i0b61d3b7b8334186a589bb519b652171_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:FiniteLivedIntangibleAssetsAccumulatedImpairment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Goodwill and Intangible Assets, net - Impairment Charges on Intangible Assets, Net (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
     "shortName": "Goodwill and Intangible Assets, net - Impairment Charges on Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://thecronosgroup.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Leases - Schedule of Lease Cost and Other Information (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails",
     "shortName": "Leases - Schedule of Lease Cost and Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Leases - Schedule of Future Minimum Lease Payments for Operating Leases (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails",
     "shortName": "Leases - Schedule of Future Minimum Lease Payments for Operating Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61396ac601174186a618ab85deae5ee4_I20190308",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Derivative Liabilities - Narrative (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
     "shortName": "Derivative Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ie7edb25988ef4ca680ec0519a1f7a41c_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i0b61d3b7b8334186a589bb519b652171_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
     "shortName": "Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "iea9d63117e854b719984324586934e8e_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ic46e2540982d4ffa8221c6ad142b2e19_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
     "shortName": "Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ic46e2540982d4ffa8221c6ad142b2e19_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i3d8966b6deea4e22966e81612eab4061_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
     "shortName": "Derivative Liabilities - Schedule of Sensitivity Analysis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i3d8966b6deea4e22966e81612eab4061_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i05001d975789445693497618980033e5_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Commitments and Contingencies - R&D Commitments (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails",
     "shortName": "Commitments and Contingencies - R&D Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i4e3f054fcf0e476495404c9892296850_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cron:StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i0440f861c18e4a33b1c366ca915c82bd_D20200616-20200616",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Commitments and Contingencies - Contingencies (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails",
     "shortName": "Commitments and Contingencies - Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i0440f861c18e4a33b1c366ca915c82bd_D20200616-20200616",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Share-based Compensation - Summary of Stock-based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails",
     "shortName": "Share-based Compensation - Summary of Stock-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i52d59e2073a14df0bddb28f9c82e763b_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i9c268295fba144a989d01a9bd99cf5f8_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Share-based Compensation - Stock Options Narrative (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
     "shortName": "Share-based Compensation - Stock Options Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "if7b11f56bc6043d89eb5e2c45e96f100_I20180628",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i0b61d3b7b8334186a589bb519b652171_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Share-based Compensation - Summary of the Changes in Options (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails",
     "shortName": "Share-based Compensation - Summary of the Changes in Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i9c268295fba144a989d01a9bd99cf5f8_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Share-based Compensation - Fair Value of Options Issued (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails",
     "shortName": "Share-based Compensation - Fair Value of Options Issued (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i9c268295fba144a989d01a9bd99cf5f8_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Share-based Compensation - Schedule of Stock Options Outstanding (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
     "shortName": "Share-based Compensation - Schedule of Stock Options Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i4da8bcc218e7495696143aafa8c5b34e_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i7546e296aecc43a18fadef3d2de6900d_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Share-based Compensation - Restricted Share Units Narrative (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails",
     "shortName": "Share-based Compensation - Restricted Share Units Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
      "reportCount": 1,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Share-based Compensation - Summary of Restricted Share Units Activity (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails",
     "shortName": "Share-based Compensation - Summary of Restricted Share Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i3e0f5c40899c45bab72391f0ad745e88_I20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Share-based Compensation - Summary of Deferred Share Units Activity (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
     "shortName": "Share-based Compensation - Summary of Deferred Share Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i211045d7eac247689ade396e222267c3_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i44c6585cf14349b9a9f2167c67b4459e_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Share-based Compensation - Summary of Changes in Warrants (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
     "shortName": "Share-based Compensation - Summary of Changes in Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i44c6585cf14349b9a9f2167c67b4459e_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Share-based Compensation - Liability-Classified Awards (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
     "shortName": "Share-based Compensation - Liability-Classified Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i18a71c926a944aab8a0d793f6b5a4742_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:DeferredCompensationShareBasedArrangementsTransferToEquityAwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Background, Basis of Presentation, and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Background, Basis of Presentation, and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Income Taxes - Expense for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
     "shortName": "Income Taxes - Expense for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
     "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Segment Information and Disaggregated Revenue - Narrative (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueNarrativeDetails",
     "shortName": "Segment Information and Disaggregated Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Segment Data (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails",
     "shortName": "Segment Information and Disaggregated Revenue - Schedule of Segment Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Adjusted EBITDA (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
     "shortName": "Segment Information and Disaggregated Revenue - Schedule of Adjusted EBITDA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:EarningsBeforeInterestTaxesDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Revenue from External Customers by Geographic Areas (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails",
     "shortName": "Segment Information and Disaggregated Revenue - Schedule of Revenue from External Customers by Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ie229aad448624a89855c1cd201833768_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Segment Information and Disaggregated Revenue - Schedule of Long-lived Assets by Geographic Areas (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails",
     "shortName": "Segment Information and Disaggregated Revenue - Schedule of Long-lived Assets by Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Inventory, net",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://thecronosgroup.com/role/Inventorynet",
     "shortName": "Inventory, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Earnings (Loss) per Share - Schedule of Earnings (Loss) Per Share (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails",
     "shortName": "Earnings (Loss) per Share - Schedule of Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails",
     "shortName": "Financial Instruments - Schedule of Fair Value of Assets on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ib95fa6c13bfb4c45adb4622b1026b433_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets on Nonrecurring Basis (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
     "shortName": "Financial Instruments - Schedule of Fair Value of Assets on Nonrecurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ieb4548315c1d4631b6983f6d50ea8397_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Financial Instruments - Credit Risk (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
     "shortName": "Financial Instruments - Credit Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Financial Instruments - Liquidity Risk (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails",
     "shortName": "Financial Instruments - Liquidity Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i0cfb8a95516c46b7ab49a044801b97ed_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeExpenseNonoperatingNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Financial Instruments - Interest Rate Risk (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails",
     "shortName": "Financial Instruments - Interest Rate Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Financial Instruments - Foreign Currency Risk (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsForeignCurrencyRiskDetails",
     "shortName": "Financial Instruments - Foreign Currency Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "ia33af1f54aa342248ebe7045d0058626_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i7c47520415b84aa69148a3dd6909c4a3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Related Party Transactions - Narrative (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
     "shortName": "Related Party Transactions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i7c47520415b84aa69148a3dd6909c4a3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i3f0e0dbaf50b44ab84666bd8bc9badcc_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions - Schedule of Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i3f0e0dbaf50b44ab84666bd8bc9badcc_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20221231.htm",
      "contextRef": "i61f8d8395e4e4485b2bad1b2b20f41b4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Restructuring - Narrative (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://thecronosgroup.com/role/RestructuringNarrativeDetails",
     "shortName": "Restructuring - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 132,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Israel"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2015StockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Stock Option Plan [Member]",
        "label": "2015 Stock Option Plan [Member]",
        "terseLabel": "2015 Stock Option Plan"
       }
      }
     },
     "localname": "A2015StockOptionPlanMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2018StockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Stock Option Plan [Member]",
        "label": "2018 Stock Option Plan [Member]",
        "terseLabel": "2018 Stock Option Plan"
       }
      }
     },
     "localname": "A2018StockOptionPlanMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2020OmnibusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Omnibus Plan",
        "label": "2020 Omnibus Plan [Member]",
        "terseLabel": "2020 Omnibus Plan"
       }
      }
     },
     "localname": "A2020OmnibusPlanMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AccruedIncomeAndSalesAndExciseTaxesPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Income and Sales and Excise Taxes Payable, Current",
        "label": "Accrued Income and Sales and Excise Taxes Payable, Current",
        "terseLabel": "Accrued taxes"
       }
      }
     },
     "localname": "AccruedIncomeAndSalesAndExciseTaxesPayableCurrent",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_AccruedLiabilitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Liabilities, Policy",
        "label": "Accrued Liabilities, Policy [Policy Text Block]",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesPolicyPolicyTextBlock",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cron_AccumulatedImpairmentOfPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Impairment Of Property, Plant, And Equipment",
        "label": "Accumulated Impairment Of Property, Plant, And Equipment",
        "negatedTerseLabel": "Less: accumulated impairment charges"
       }
      }
     },
     "localname": "AccumulatedImpairmentOfPropertyPlantAndEquipment",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization",
        "label": "Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization",
        "terseLabel": "Adjusted EBITDA"
       }
      }
     },
     "localname": "AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_AltriaGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Group, Inc. [Member]",
        "label": "Altria Group, Inc. [Member]",
        "terseLabel": "Altria Group, Inc."
       }
      }
     },
     "localname": "AltriaGroupInc.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Investment [Member]",
        "label": "Altria Investment [Member]",
        "terseLabel": "Altria Investment"
       }
      }
     },
     "localname": "AltriaInvestmentMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaPinnacleLLC.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Pinnacle LLC. [Member]",
        "label": "Altria Pinnacle LLC. [Member]",
        "terseLabel": "Altria Pinnacle LLC"
       }
      }
     },
     "localname": "AltriaPinnacleLLC.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaVenturesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Ventures Inc. [Member]",
        "label": "Altria Ventures Inc. [Member]",
        "terseLabel": "Altria Ventures"
       }
      }
     },
     "localname": "AltriaVenturesInc.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Warrant [Member]",
        "label": "Altria Warrant [Member]",
        "terseLabel": "Altria Warrant",
        "verboseLabel": "Altria Warrant"
       }
      }
     },
     "localname": "AltriaWarrantMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://thecronosgroup.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cron_AuroraCannabisInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aurora Cannabis Inc. [Member]",
        "label": "Aurora Cannabis Inc. [Member]",
        "terseLabel": "Aurora"
       }
      }
     },
     "localname": "AuroraCannabisInc.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AustraliaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Australia",
        "label": "Australia [Member]",
        "terseLabel": "Australia"
       }
      }
     },
     "localname": "AustraliaMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_BuildingAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Building And Equipment",
        "label": "Building And Equipment [Member]",
        "terseLabel": "Office Premises and Equipment"
       }
      }
     },
     "localname": "BuildingAndEquipmentMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CBCALicensingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CBCA Licensing Agreement",
        "label": "CBCA Licensing Agreement [Member]",
        "terseLabel": "CBCA Licensing Agreement"
       }
      }
     },
     "localname": "CBCALicensingAgreementMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CBCVALicensingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CBCVA Licensing Agreement",
        "label": "CBCVA Licensing Agreement [Member]",
        "terseLabel": "CBCVA Licensing Agreement"
       }
      }
     },
     "localname": "CBCVALicensingAgreementMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CBGALicensingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CBGA Licensing Agreement",
        "label": "CBGA Licensing Agreement [Member]",
        "terseLabel": "CBGA Licensing Agreement"
       }
      }
     },
     "localname": "CBGALicensingAgreementMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CBGVALicensingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CBGVA Licensing Agreement",
        "label": "CBGVA Licensing Agreement [Member]",
        "terseLabel": "CBGVA Licensing Agreement"
       }
      }
     },
     "localname": "CBGVALicensingAgreementMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CanadianPrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Prime Rate",
        "label": "Canadian Prime Rate [Member]",
        "terseLabel": "Canadian Prime Rate"
       }
      }
     },
     "localname": "CanadianPrimeRateMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannabisExtractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannabis Extracts [Member]",
        "label": "Cannabis Extracts [Member]",
        "terseLabel": "Cannabis extracts"
       }
      }
     },
     "localname": "CannabisExtractsMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannabisFlowerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannabis Flower [Member]",
        "label": "Cannabis Flower [Member]",
        "terseLabel": "Cannabis flower"
       }
      }
     },
     "localname": "CannabisFlowerMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannabisPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannabis Purchases",
        "label": "Cannabis Purchases [Member]",
        "terseLabel": "Cannabis Purchases"
       }
      }
     },
     "localname": "CannabisPurchasesMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannasoulAnalyticsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannasoul Analytics Ltd.",
        "label": "Cannasoul Analytics Ltd. [Member]",
        "terseLabel": "Cannasoul Analytics Ltd."
       }
      }
     },
     "localname": "CannasoulAnalyticsLtdMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannasoulCollaborationLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannasoul Collaboration Loan",
        "label": "Cannasoul Collaboration Loan [Member]",
        "terseLabel": "Cannasoul Collaboration Loan"
       }
      }
     },
     "localname": "CannasoulCollaborationLoanMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CapitalGainRelinquishmentOfWarrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Gain, Relinquishment Of Warrant",
        "label": "Capital Gain, Relinquishment Of Warrant",
        "terseLabel": "Capital gain on relinquishment of warrant"
       }
      }
     },
     "localname": "CapitalGainRelinquishmentOfWarrant",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period",
        "label": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period",
        "terseLabel": "Exercise price, volume-weighted average price, measurement period"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise",
        "label": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise",
        "terseLabel": "Exercise price, volume-weighted average price, measurement period, days preceding exercise"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Maximum Additional Subscription Percentage",
        "label": "Class Of Warrant Or Right, Maximum Additional Subscription Percentage",
        "terseLabel": "Maximum additional subscription percentage"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Minimum Ownership Percentage Required",
        "label": "Class Of Warrant Or Right, Minimum Ownership Percentage Required",
        "terseLabel": "Exercise rights, minimum ownership percentage"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMinimumOwnershipPercentageRequired",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_ClassOfWarrantOrRightNumberOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Number Of Warrants Issued",
        "label": "Class Of Warrant Or Right, Number Of Warrants Issued",
        "terseLabel": "Number of warrants issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsIssued",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_CollaborativeArrangementAmountOfAdvances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Amount Of Advances",
        "label": "Collaborative Arrangement, Amount Of Advances",
        "terseLabel": "Collaboration agreement, amount of advances"
       }
      }
     },
     "localname": "CollaborativeArrangementAmountOfAdvances",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_CollaborativeArrangementInstallmentsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Installments Received",
        "label": "Collaborative Arrangement, Installments Received",
        "terseLabel": "Collaborative arrangement, installment received"
       }
      }
     },
     "localname": "CollaborativeArrangementInstallmentsReceived",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_CollaborativeArrangementPercentageOfProfitsToBeReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Percentage Of Profits To Be Received",
        "label": "Collaborative Arrangement, Percentage Of Profits To Be Received",
        "terseLabel": "Collaborative arrangement, percentage of profits to be received"
       }
      }
     },
     "localname": "CollaborativeArrangementPercentageOfProfitsToBeReceived",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met",
        "label": "Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met",
        "terseLabel": "Collaborative arrangement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met"
       }
      }
     },
     "localname": "CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced",
        "label": "Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced",
        "terseLabel": "Collaborative arrangement, profits to be received, maximum percentage of amounts advanced"
       }
      }
     },
     "localname": "CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Term Of Agreement",
        "label": "Collaborative Arrangement, Term Of Agreement",
        "terseLabel": "Collaborative arrangement, term of agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementTermOfAgreement",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_ConsultingServicesArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting Services Arrangement",
        "label": "Consulting Services Arrangement [Member]",
        "terseLabel": "Consulting Services Arrangement"
       }
      }
     },
     "localname": "ConsultingServicesArrangementMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ConsultingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting Services [Member]",
        "label": "Consulting Services [Member]",
        "terseLabel": "Consulting Services"
       }
      }
     },
     "localname": "ConsultingServicesMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosAustraliaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Australia Limited [Member]",
        "label": "Cronos Australia Limited [Member]",
        "terseLabel": "Vitura"
       }
      }
     },
     "localname": "CronosAustraliaLimitedMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Group, Inc. [Member]",
        "label": "Cronos Group, Inc. [Member]",
        "terseLabel": "Cronos Group, Inc."
       }
      }
     },
     "localname": "CronosGroupInc.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGrowCoCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos GrowCo Credit Facility [Member]",
        "label": "Cronos GrowCo Credit Facility [Member]",
        "terseLabel": "GrowCo Credit Facility"
       }
      }
     },
     "localname": "CronosGrowCoCreditFacilityMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGrowingCompanyInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Growing Company Inc. [Member]",
        "label": "Cronos Growing Company Inc. [Member]",
        "terseLabel": "Cronos GrowCo"
       }
      }
     },
     "localname": "CronosGrowingCompanyInc.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosIsraelG.S.CultivationsLtd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Israel G.S. Cultivations Ltd. [Member]",
        "label": "Cronos Israel G.S. Cultivations Ltd. [Member]",
        "terseLabel": "Cronos Israel G.S. Cultivations Ltd."
       }
      }
     },
     "localname": "CronosIsraelG.S.CultivationsLtd.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosIsraelG.S.ManufacturingLtd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Israel G.S. Manufacturing Ltd. [Member]",
        "label": "Cronos Israel G.S. Manufacturing Ltd. [Member]",
        "terseLabel": "Cronos Israel G.S. Manufacturing Ltd."
       }
      }
     },
     "localname": "CronosIsraelG.S.ManufacturingLtd.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosIsraelG.S.StoreLtd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Israel G.S. Store Ltd. [Member]",
        "label": "Cronos Israel G.S. Store Ltd. [Member]",
        "terseLabel": "Cronos Israel G.S. Store Ltd."
       }
      }
     },
     "localname": "CronosIsraelG.S.StoreLtd.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosIsraelGSPharmacyLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Israel G.S. Pharmacies Ltd. [Member]",
        "label": "Cronos Israel G.S. Pharmacy Ltd. [Member]",
        "terseLabel": "Cronos Israel G.S. Pharmacy Ltd."
       }
      }
     },
     "localname": "CronosIsraelGSPharmacyLtdMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_DeferredCompensationShareBasedArrangementsTransferToEquityAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Share-Based Arrangements, Transfer to Equity Awards",
        "label": "Deferred Compensation Share-Based Arrangements, Transfer to Equity Awards",
        "negatedTerseLabel": "Transfers to equity awards"
       }
      }
     },
     "localname": "DeferredCompensationShareBasedArrangementsTransferToEquityAwards",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]",
        "label": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]",
        "terseLabel": "Weighted average grant date fair value",
        "verboseLabel": "Financial liability"
       }
      }
     },
     "localname": "DeferredCompensationSharebasedArrangementsLiabilityRollForward",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_DeferredShareUnitsDSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Share Units (DSUs) [Member]",
        "label": "Deferred Share Units (DSUs) [Member]",
        "terseLabel": "Deferred Share Units (DSUs)"
       }
      }
     },
     "localname": "DeferredShareUnitsDSUsMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_DeferredTaxAssetsDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Debt Issuance Costs",
        "label": "Deferred Tax Assets, Debt Issuance Costs",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsDebtIssuanceCosts",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DeferredTaxAssetsFinanceLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Finance Lease Liabilities",
        "label": "Deferred Tax Assets, Finance Lease Liabilities",
        "terseLabel": "Finance lease obligation"
       }
      }
     },
     "localname": "DeferredTaxAssetsFinanceLeaseLiabilities",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DeferredTaxAssetsShareIssuanceCost": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Share Issuance Cost",
        "label": "Deferred Tax Assets, Share Issuance Cost",
        "terseLabel": "Share issuance cost"
       }
      }
     },
     "localname": "DeferredTaxAssetsShareIssuanceCost",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset",
        "label": "Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset",
        "negatedTerseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DerivativeInstrumentsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instruments [Roll Forward]",
        "label": "Derivative Instruments [Roll Forward]",
        "terseLabel": "Derivative Instruments [Roll Forward]"
       }
      }
     },
     "localname": "DerivativeInstrumentsRollForward",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_DerivativeLiabilityUsefulLifeTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Liability, Useful Life, Term",
        "label": "Derivative Liability, Useful Life, Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "DerivativeLiabilityUsefulLifeTerm",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_EarningsBeforeInterestTaxesDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Before Interest, Taxes, Depreciation And Amortization",
        "label": "Earnings Before Interest, Taxes, Depreciation And Amortization",
        "terseLabel": "EBITDA"
       }
      }
     },
     "localname": "EarningsBeforeInterestTaxesDepreciationAndAmortization",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Capital Gain, Financial Liabilities, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Capital Gain, Financial Liabilities, Amount",
        "terseLabel": "Capital gain on financial liabilities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCapitalGainFinancialLiabilitiesAmount",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount",
        "label": "Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount",
        "terseLabel": "Expected income tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities, Amount",
        "negatedTerseLabel": "Fair value gain on financial liabilities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilitiesAmount",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs, Amount",
        "terseLabel": "Non-deductible transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCostsAmount",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FacilityInStaynerOntarioCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility in Stayner, Ontario, Canada",
        "label": "Facility in Stayner, Ontario, Canada [Member]",
        "terseLabel": "Facility in Stayner, Ontario, Canada"
       }
      }
     },
     "localname": "FacilityInStaynerOntarioCanadaMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative Asset (Liability) Gain (Loss), Statement Of Income, Extensible List, Not Disclosed Flag",
        "label": "Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative Asset (Liability) Gain (Loss), Statement Of Income, Extensible List, Not Disclosed Flag",
        "terseLabel": "Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative Asset (Liability) Gain (Loss), Statement Of Income, Extensible List, Not Disclosed Flag"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative, Asset (Liability) Gain (Loss), Statement Of Other Comprehensive Income, Extensible List, Not Disclosed Flag",
        "label": "Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative, Asset (Liability) Gain (Loss), Statement Of Other Comprehensive Income, Extensible List, Not Disclosed Flag",
        "terseLabel": "Fair Value, Recurring Basis, Unobservable Input Reconciliation, Net Derivative, Asset (Liability) Gain (Loss), Statement Of Other Comprehensive Income, Extensible List, Not Disclosed Flag"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_FinancingReceivableAccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Accrued Interest, Current",
        "label": "Financing Receivable, Accrued Interest, Current",
        "terseLabel": "Add: Accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableAccruedInterestCurrent",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableAccruedInterestNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Accrued Interest, Noncurrent",
        "label": "Financing Receivable, Accrued Interest, Noncurrent",
        "terseLabel": "Add: Long-term portion of accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableAccruedInterestNoncurrent",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableBeforeAccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Before Accrued Interest, Current",
        "label": "Financing Receivable, Before Accrued Interest, Current",
        "terseLabel": "Current portion of loans receivable, before accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableBeforeAccruedInterestCurrent",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableBeforeAccruedInterestNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Before Accrued Interest, Noncurrent",
        "label": "Financing Receivable, Before Accrued Interest, Noncurrent",
        "terseLabel": "Long term portion of loans receivable, before accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableBeforeAccruedInterestNoncurrent",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Credit Loss, Expense (Reversal), Including Transferred Into Investment",
        "label": "Financing Receivable, Credit Loss, Expense (Reversal), Including Transferred Into Investment",
        "terseLabel": "Financing receivable, credit loss, expense, including transferred into investment"
       }
      }
     },
     "localname": "FinancingReceivableCreditLossExpenseReversalIncludingTransferredIntoInvestment",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Face Amount",
        "label": "Financing Receivable, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "FinancingReceivableFaceAmount",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableInterestIncomeIncreaseFromDebtModification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Interest Income, Increase From Debt Modification",
        "label": "Financing Receivable, Interest Income, Increase From Debt Modification",
        "terseLabel": "Increase in interest income from debt modification"
       }
      }
     },
     "localname": "FinancingReceivableInterestIncomeIncreaseFromDebtModification",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableInterestRateStatedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Interest Rate, Stated Percentage",
        "label": "Financing Receivable, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "FinancingReceivableInterestRateStatedPercentage",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_FiniteLivedIntangibleAssetsAccumulatedImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Impairment",
        "label": "Finite-Lived Intangible Assets, Accumulated Impairment",
        "negatedLabel": "Accumulated impairment charges",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedImpairment",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments",
        "negatedLabel": "Foreign exchange effect"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FourMajorCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Major Customers",
        "label": "Four Major Customers [Member]",
        "terseLabel": "Four Major Customers"
       }
      }
     },
     "localname": "FourMajorCustomersMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_GainLossOnDisposalOfInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Disposal of Investments",
        "label": "Gain (Loss) on Disposal of Investments",
        "negatedLabel": "Gain on disposal of investments"
       }
      }
     },
     "localname": "GainLossOnDisposalOfInvestments",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_GinkgoBioworksInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ginkgo Bioworks Inc. [Member]",
        "label": "Ginkgo Bioworks Inc. [Member]",
        "terseLabel": "Ginkgo"
       }
      }
     },
     "localname": "GinkgoBioworksInc.Member",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_GinkoExclusiveLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ginko Exclusive Licenses",
        "label": "Ginko Exclusive Licenses [Member]",
        "terseLabel": "Ginkgo exclusive licenses"
       }
      }
     },
     "localname": "GinkoExclusiveLicensesMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Impaired, Accumulated Impairment Loss, Translation and Purchase Accounting Adjustments",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign exchange effect"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLossTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_HealthCanadaLicensingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Canada Licensing Agreements [Member]",
        "label": "Health Canada Licensing Agreements [Member]",
        "terseLabel": "Health Canada licenses"
       }
      }
     },
     "localname": "HealthCanadaLicensingAgreementsMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Of Intangible Asset, Finite-Lived, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag",
        "label": "Impairment Of Intangible Asset, Finite-Lived, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag",
        "terseLabel": "Impairment Of Intangible Asset, Finite-Lived, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "cron_IntangibleAssetsAccumulatedImpairment",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-Lived Intangible Assets, Accumulated Impairment",
        "label": "Indefinite-Lived Intangible Assets, Accumulated Impairment",
        "negatedLabel": "Accumulated impairment charges",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsAccumulatedImpairment",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-Lived Intangible Assets, Accumulated Impairment, Impairment in Period",
        "label": "Indefinite-Lived Intangible Assets, Accumulated Impairment, Impairment in Period",
        "negatedLabel": "Impairment charges"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsAccumulatedImpairmentImpairmentInPeriod",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_IndefiniteLivedIntangibleAssetsGross": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-Lived Intangible Assets, Gross",
        "label": "Indefinite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsGross",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_IntangibleAssetsAccumulatedImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Accumulated Impairment",
        "label": "Intangible Assets, Accumulated Impairment",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance",
        "negatedTotalLabel": "Accumulated impairment charges"
       }
      }
     },
     "localname": "IntangibleAssetsAccumulatedImpairment",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Accumulated Impairment, Impairment in Period",
        "label": "Intangible Assets, Accumulated Impairment, Impairment in Period",
        "negatedTotalLabel": "Impairment charges"
       }
      }
     },
     "localname": "IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments",
        "label": "Intangible Assets, Accumulated Impairment, Translation and Purchase Accounting Adjustments",
        "negatedTotalLabel": "Foreign exchange effect"
       }
      }
     },
     "localname": "IntangibleAssetsAccumulatedImpairmentTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InterestReceivedNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Received, Net",
        "label": "Interest Received, Net",
        "terseLabel": "Interest received"
       }
      }
     },
     "localname": "InterestReceivedNet",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentOwnedNumberOfSharesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Owned, Number Of Shares Received",
        "label": "Investment Owned, Number Of Shares Received",
        "terseLabel": "Shares received (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedNumberOfSharesReceived",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_InvestmentOwnedNumberOfSharesSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Owned, Number Of Shares Sold",
        "label": "Investment Owned, Number Of Shares Sold",
        "terseLabel": "Investment owned, number of shares sold (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedNumberOfSharesSold",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_InvestmentOwnedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Owned, Percentage",
        "label": "Investment Owned, Percentage",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "InvestmentOwnedPercentage",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)",
        "verboseLabel": "Advances to affiliates"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees",
        "terseLabel": "Transfer to investments in equity accounted investees"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, Funding Commitment Percentage",
        "label": "Investments In And Advances To Affiliates, Funding Commitment Percentage",
        "terseLabel": "Funding commitment percentage"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "cron_IsraeliCodesLicensingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israeli Codes, Licensing Agreements [Member]",
        "label": "Israeli Codes, Licensing Agreements [Member]",
        "terseLabel": "Israeli codes"
       }
      }
     },
     "localname": "IsraeliCodesLicensingAgreementsMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Area Of Land To Be Disposed Of",
        "label": "Lessee, Operating Lease, Area Of Land To Be Disposed Of",
        "terseLabel": "Lessee, operating lease, area of land to be disposed of"
       }
      }
     },
     "localname": "LesseeOperatingLeaseAreaOfLandToBeDisposedOf",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "cron_LiabilityClassifiedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability Classified Awards",
        "label": "Liability Classified Awards [Member]",
        "terseLabel": "Liability Classified Awards"
       }
      }
     },
     "localname": "LiabilityClassifiedAwardsMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_LivWellHoldingsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LivWell Holdings, Inc.",
        "label": "LivWell Holdings, Inc. [Member]",
        "terseLabel": "LivWell Holdings, Inc."
       }
      }
     },
     "localname": "LivWellHoldingsIncMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_LoanReceivableNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Receivable, Name [Axis]",
        "label": "Loan Receivable, Name [Axis]",
        "terseLabel": "Loan Receivable, Name [Axis]"
       }
      }
     },
     "localname": "LoanReceivableNameAxis",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_LoanReceivableNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Loan Receivable, Name [Axis]",
        "label": "Loan Receivable, Name [Domain]",
        "terseLabel": "Loan Receivable, Name [Domain]"
       }
      }
     },
     "localname": "LoanReceivableNameDomain",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares",
        "label": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares",
        "terseLabel": "Common shares issuable (up to) (in shares)"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned",
        "label": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned",
        "terseLabel": "Common shares issuable, value assigned"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_LongtermPurchaseCommitmentMonthlyFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Monthly Fee, Percentage",
        "label": "Long-term Purchase Commitment, Monthly Fee, Percentage",
        "terseLabel": "Monthly fee, percentage of direct and indirect service costs"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentMonthlyFeePercentage",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Payments Subject To Milestones",
        "label": "Long-term Purchase Commitment, Payments Subject To Milestones",
        "terseLabel": "Payments subject to milestones"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentPaymentsSubjectToMilestones",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_LossContingencyPunitiveDamagesSoughtValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Punitive Damages Sought, Value",
        "label": "Loss Contingency, Punitive Damages Sought, Value",
        "terseLabel": "Punitive damages sought"
       }
      }
     },
     "localname": "LossContingencyPunitiveDamagesSoughtValue",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ManufacturingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Services",
        "label": "Manufacturing Services [Member]",
        "terseLabel": "Manufacturing Services"
       }
      }
     },
     "localname": "ManufacturingServicesMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_MeasurementInputSubscriptionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Subscription Price [Member]",
        "label": "Measurement Input, Subscription Price [Member]",
        "terseLabel": "Subscription price (in canadian dollars per share)"
       }
      }
     },
     "localname": "MeasurementInputSubscriptionPriceMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_MergerAgreementThresholdOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Agreement, Threshold Ownership Percentage",
        "label": "Merger Agreement, Threshold Ownership Percentage",
        "terseLabel": "Merger agreement, threshold ownership percentage"
       }
      }
     },
     "localname": "MergerAgreementThresholdOwnershipPercentage",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_NatuEraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NatuEra [Member]",
        "label": "NatuEra [Member]",
        "terseLabel": "Natuera"
       }
      }
     },
     "localname": "NatuEraMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NatuEraSeriesALoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NatuEra Series A Loan [Member]",
        "label": "NatuEra Series A Loan [Member]",
        "terseLabel": "Natuera Series A Loan"
       }
      }
     },
     "localname": "NatuEraSeriesALoanMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NatueraJVPartnerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Natuera JV Partner",
        "label": "Natuera JV Partner [Member]",
        "terseLabel": "Natuera JV Partner"
       }
      }
     },
     "localname": "NatueraJVPartnerMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NoncashSellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Selling And Marketing Expense",
        "label": "Noncash Selling And Marketing Expense",
        "terseLabel": "Non-cash sales and marketing"
       }
      }
     },
     "localname": "NoncashSellingAndMarketingExpense",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_NumberOfImpairedIntangibles": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Impaired Intangibles",
        "label": "Number of Impaired Intangibles",
        "terseLabel": "Number of impaired cannabinoids"
       }
      }
     },
     "localname": "NumberOfImpairedIntangibles",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_NumberOfSeatsOnBoardOfDirectors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Seats on Board of Directors",
        "label": "Number of Seats on Board of Directors",
        "terseLabel": "Number of seats on board of directors"
       }
      }
     },
     "localname": "NumberOfSeatsOnBoardOfDirectors",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_OSCSettlementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OSC Settlement",
        "label": "OSC Settlement [Member]",
        "terseLabel": "OSC Settlement"
       }
      }
     },
     "localname": "OSCSettlementMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OneVendorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Vendor",
        "label": "One Vendor [Member]",
        "terseLabel": "One Vendor"
       }
      }
     },
     "localname": "OneVendorMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OntarioIncMucciPromissoryNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ontario Inc. Mucci Promissory Note [Member]",
        "label": "Ontario Inc. Mucci Promissory Note [Member]",
        "terseLabel": "Mucci Promissory Note"
       }
      }
     },
     "localname": "OntarioIncMucciPromissoryNoteMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OtherCostOfGoodsAndServicesSold": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Cost Of Goods And Services Sold",
        "label": "Other Cost Of Goods And Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "OtherCostOfGoodsAndServicesSold",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Countries [Member]",
        "label": "Other Countries [Member]",
        "terseLabel": "Other countries"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OtherInvestmentsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Investments",
        "label": "Other Investments [Roll Forward]",
        "terseLabel": "Other Investments [Roll Forward]"
       }
      }
     },
     "localname": "OtherInvestmentsRollForward",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_OtherNetAssetsLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Net Assets (Liabilities)",
        "label": "Other Net Assets (Liabilities)",
        "terseLabel": "Other Net Assets (Liabilities)"
       }
      }
     },
     "localname": "OtherNetAssetsLiabilities",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_PeaceNaturalsReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Peace Naturals Reporting Unit [Member]",
        "label": "Peace Naturals Reporting Unit [Member]",
        "terseLabel": "Peace Naturals"
       }
      }
     },
     "localname": "PeaceNaturalsReportingUnitMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PharmacannMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacann",
        "label": "Pharmacann [Member]",
        "terseLabel": "Pharmacann"
       }
      }
     },
     "localname": "PharmacannMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PreEmptiveRightsAndTopUpRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-Emptive Rights And Top-Up Rights",
        "label": "Pre-Emptive Rights And Top-Up Rights [Member]",
        "terseLabel": "Pre-Emptive Rights and Top-Up Rights"
       }
      }
     },
     "localname": "PreEmptiveRightsAndTopUpRightsMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PreemptiveRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-emptive Rights [Member]",
        "label": "Pre-emptive Rights [Member]",
        "verboseLabel": "Pre-emptive Rights"
       }
      }
     },
     "localname": "PreemptiveRightsMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ProceedsFromDividends": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Dividends",
        "label": "Proceeds From Dividends",
        "terseLabel": "Dividend proceeds"
       }
      }
     },
     "localname": "ProceedsFromDividends",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_RealignmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realignment",
        "label": "Realignment [Member]",
        "terseLabel": "Realignment"
       }
      }
     },
     "localname": "RealignmentMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/RestructuringNarrativeDetails",
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RedwoodHoldingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redwood Holding Group, LLC [Member]",
        "label": "Redwood Holding Group, LLC [Member]",
        "terseLabel": "Redwood"
       }
      }
     },
     "localname": "RedwoodHoldingGroupLLCMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RedwoodReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redwood Reporting Unit [Member]",
        "label": "Redwood Reporting Unit [Member]",
        "terseLabel": "Redwood"
       }
      }
     },
     "localname": "RedwoodReportingUnitMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RestOfWorldSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest Of World Segment [Member]",
        "label": "Rest Of World Segment [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestOfWorldSegmentMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RestatementReviewExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restatement Review Expense",
        "label": "Restatement Review Expense",
        "verboseLabel": "Financial statement review costs"
       }
      }
     },
     "localname": "RestatementReviewExpense",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_RestructuringReservePaymentsAndWriteoffs": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve, Payments and Writeoffs",
        "label": "Restructuring Reserve, Payments and Writeoffs",
        "negatedTerseLabel": "Payments/Write-offs"
       }
      }
     },
     "localname": "RestructuringReservePaymentsAndWriteoffs",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)",
        "terseLabel": "Expected annualized volatility"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)",
        "terseLabel": "Share price at issuance date"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)",
        "terseLabel": "Weighted average expected life"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]",
        "terseLabel": "Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]",
        "label": "Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Sensitivity Analysis"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate",
        "label": "Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate",
        "terseLabel": "Impact of ten percent change in exchange rate"
       }
      }
     },
     "localname": "SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsForeignCurrencyRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent",
        "label": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent",
        "terseLabel": "Impact of change in average variable rate, percent"
       }
      }
     },
     "localname": "SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Cliff Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Cliff Period",
        "terseLabel": "Cliff period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardCliffPeriod",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_ShareBasedPaymentArrangementGainLossOnRevaluation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Gain (Loss) On Revaluation",
        "label": "Share-based Payment Arrangement, Gain (Loss) On Revaluation",
        "negatedTerseLabel": "Gain on revaluation"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementGainLossOnRevaluation",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ShareBasedPaymentArrangementLiabilitiesSettled": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Liabilities Settled",
        "label": "Share-Based Payment Arrangement, Liabilities Settled",
        "negatedTerseLabel": "Liabilities settled"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementLiabilitiesSettled",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period",
        "terseLabel": "Granting and vesting of DSUs (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate",
        "terseLabel": "Forfeiture rate"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average Black-Scholes value at grant date (per option) (in Canadian dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cron_StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Research And Development Milestones",
        "label": "Stock Issued During Period, Shares, Research And Development Milestones",
        "terseLabel": "Share issuance pursuant to research and development milestone (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesResearchAndDevelopmentMilestones",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_StockIssuedDuringPeriodSharesShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Share-based Payment Arrangement",
        "label": "Stock Issued During Period, Shares, Share-based Payment Arrangement",
        "terseLabel": "Activities relating to share-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedPaymentArrangement",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Research And Development Milestones",
        "label": "Stock Issued During Period, Value, Research And Development Milestones",
        "terseLabel": "Share issuance pursuant to research and development milestones"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueResearchAndDevelopmentMilestones",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_StockIssuedDuringPeriodValueTopupRightsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Top-up Rights Exercised",
        "label": "Stock Issued During Period, Value, Top-up Rights Exercised",
        "terseLabel": "Top-up rights out-of-period adjustment"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueTopupRightsExercised",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised",
        "label": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised",
        "terseLabel": "Ownership percentage, if warrant exercised"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_TechnionResearchAndDevelopmentFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technion Research And Development Foundation [Member]",
        "label": "Technion Research And Development Foundation [Member]",
        "terseLabel": "Technion"
       }
      }
     },
     "localname": "TechnionResearchAndDevelopmentFoundationMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ThreeMajorCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Major Customers",
        "label": "Three Major Customers [Member]",
        "terseLabel": "Three Major Customers"
       }
      }
     },
     "localname": "ThreeMajorCustomersMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_TopupRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top-up Rights [Member]",
        "label": "Top-up Rights [Member]",
        "verboseLabel": "Top-up Rights"
       }
      }
     },
     "localname": "TopupRightsMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. District Court of Eastern District of New York Vs. Cronos [Member]",
        "label": "U.S. District Court of Eastern District of New York Vs. Cronos [Member]",
        "terseLabel": "U.S. District Court of Eastern District of New York Vs. Cronos"
       }
      }
     },
     "localname": "U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_UnitedStatesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States Segment [Member]",
        "label": "United States Segment [Member]",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "UnitedStatesSegmentMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_VendorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor",
        "label": "Vendor [Member]",
        "terseLabel": "Vendor"
       }
      }
     },
     "localname": "VendorMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_WhistlerMedicalMarijuanaCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Whistler Medical Marijuana Company [Member]",
        "label": "Whistler Medical Marijuana Company [Member]",
        "terseLabel": "Whistler"
       }
      }
     },
     "localname": "WhistlerMedicalMarijuanaCompanyMember",
     "nsuri": "http://thecronosgroup.com/20221231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r328",
      "r604",
      "r605",
      "r608",
      "r609",
      "r664",
      "r753",
      "r879",
      "r882",
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r328",
      "r604",
      "r605",
      "r608",
      "r609",
      "r664",
      "r753",
      "r879",
      "r882",
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r328",
      "r381",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r409",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r493",
      "r495",
      "r496",
      "r880",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r328",
      "r381",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r409",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r493",
      "r495",
      "r496",
      "r880",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r325",
      "r326",
      "r500",
      "r502",
      "r765",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r415",
      "r784",
      "r885",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r524",
      "r674",
      "r710",
      "r754",
      "r755",
      "r781",
      "r790",
      "r799",
      "r884",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r524",
      "r674",
      "r710",
      "r754",
      "r755",
      "r781",
      "r790",
      "r799",
      "r884",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r415",
      "r784",
      "r885",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r411",
      "r679",
      "r782",
      "r797",
      "r876",
      "r877",
      "r885",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r411",
      "r679",
      "r782",
      "r797",
      "r876",
      "r877",
      "r885",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r516",
      "r524",
      "r555",
      "r556",
      "r557",
      "r670",
      "r674",
      "r710",
      "r754",
      "r755",
      "r781",
      "r790",
      "r799",
      "r871",
      "r884",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r516",
      "r524",
      "r555",
      "r556",
      "r557",
      "r670",
      "r674",
      "r710",
      "r754",
      "r755",
      "r781",
      "r790",
      "r799",
      "r871",
      "r884",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r325",
      "r326",
      "r500",
      "r502",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r283",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r369",
      "r429",
      "r430",
      "r589",
      "r612",
      "r613",
      "r614",
      "r615",
      "r640",
      "r656",
      "r657",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r283",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r369",
      "r429",
      "r430",
      "r589",
      "r612",
      "r613",
      "r614",
      "r615",
      "r640",
      "r656",
      "r657",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r283",
      "r334",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r348",
      "r369",
      "r589",
      "r612",
      "r613",
      "r614",
      "r640",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r853",
      "r854",
      "r919",
      "r929",
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r412",
      "r413",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r783",
      "r798",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r412",
      "r413",
      "r738",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r783",
      "r798",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r887",
      "r931",
      "r932",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Cronos Group, Inc."
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r754",
      "r755",
      "r936",
      "r938",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r30",
      "r796"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]",
        "terseLabel": "Accounts Payable"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r9",
      "r30"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable, trade, current"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r417",
      "r418"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff": {
     "auth_ref": [
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period for when accounts receivable, classified as noncurrent, is considered past due to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Accounts Receivable, Noncurrent, Threshold Period Past Due, Writeoff",
        "terseLabel": "Accounts receivable, threshold period past due, writeoff"
       }
      }
     },
     "localname": "AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r15",
      "r242",
      "r262"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails",
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r133",
      "r291"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accumulated depreciation, depletion and amortization of property, plant and equipment.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)",
        "terseLabel": "Aggregate depreciation expense"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r44",
      "r45",
      "r296",
      "r704",
      "r716",
      "r720"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r42",
      "r45",
      "r188",
      "r657",
      "r711",
      "r712",
      "r820",
      "r821",
      "r822",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquisitionCosts": {
     "auth_ref": [
      "r238",
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.",
        "label": "Acquisition Costs, Period Cost",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "AcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow and other information"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22",
      "r796"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r563",
      "r564",
      "r565",
      "r839",
      "r840",
      "r841",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition",
        "terseLabel": "Accelerated restricted share units vesting out-of-period adjustment"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r158",
      "r159",
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Activities relating to share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r559"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Grants"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r103",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r297",
      "r419",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Current expected credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForLoanAndLeaseLossesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Allowance for Loan and Lease Losses [Roll Forward]",
        "terseLabel": "Allowance for Loan and Lease Losses [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForLoanAndLeaseLossesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r73",
      "r118",
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total anti-dilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r241",
      "r261",
      "r295",
      "r322",
      "r389",
      "r401",
      "r407",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r604",
      "r608",
      "r629",
      "r796",
      "r880",
      "r881",
      "r934"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r286",
      "r300",
      "r322",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r604",
      "r608",
      "r629",
      "r796",
      "r880",
      "r881",
      "r934"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r322",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r604",
      "r608",
      "r629",
      "r880",
      "r881",
      "r934"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r106",
      "r420",
      "r437",
      "r695"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r530",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BridgeLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place.",
        "label": "Bridge Loan [Member]",
        "terseLabel": "Bridge Loan"
       }
      }
     },
     "localname": "BridgeLoanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building and leasehold improvements"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r601",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r601",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Consideration transferred, common shares (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r177",
      "r178",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r177",
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Consideration transferred, common shares, amount"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CanadaRevenueAgencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Canada.",
        "label": "Canada Revenue Agency [Member]",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CanadaRevenueAgencyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r75",
      "r289",
      "r759"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents and short-term investments"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r68",
      "r75",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r68",
      "r231"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "auth_ref": [
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "verboseLabel": "Establishment of a Commercial Cannabis Analytical Testing Laboratoy"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r478",
      "r479",
      "r740",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r839",
      "r840",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21",
      "r796"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Share capital (authorized for issue as of December 31, 2022 and 2021: unlimited; shares outstanding as of December 31, 2022 and 2021: 380,575,403 and 374,952,693, respectively)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r46",
      "r304",
      "r306",
      "r315",
      "r700",
      "r707"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to Cronos Group"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r184",
      "r185",
      "r203",
      "r304",
      "r306",
      "r314",
      "r699",
      "r706"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income (loss) attributable to non-controlling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r183",
      "r203",
      "r304",
      "r306",
      "r313",
      "r698",
      "r705"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r792",
      "r868",
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r89",
      "r90",
      "r226",
      "r227",
      "r415",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r89",
      "r90",
      "r226",
      "r227",
      "r415",
      "r721",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r89",
      "r90",
      "r226",
      "r227",
      "r415",
      "r739",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.",
        "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure",
        "terseLabel": "Maximum exposure to credit risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r89",
      "r90",
      "r226",
      "r227",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r87",
      "r89",
      "r90",
      "r91",
      "r226",
      "r229",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r89",
      "r90",
      "r226",
      "r227",
      "r415",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r186",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r190",
      "r192",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable interest entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r99",
      "r400",
      "r401",
      "r402",
      "r403",
      "r409",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r172",
      "r585",
      "r593",
      "r831"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r88",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r232",
      "r234",
      "r498",
      "r639",
      "r779",
      "r780"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r36",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.",
        "label": "Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount",
        "negatedTerseLabel": "Gain on revaluation of financial instruments",
        "terseLabel": "Gain (loss) on revaluation of financial instruments"
       }
      }
     },
     "localname": "DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.",
        "label": "Deferred Compensation Share-Based Arrangements, Liability, Current and Noncurrent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r73",
      "r172",
      "r586",
      "r592",
      "r593",
      "r831"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r18",
      "r19",
      "r243",
      "r258",
      "r580"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r573",
      "r574"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "auth_ref": [
      "r916"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.",
        "label": "Deferred Tax Asset, Interest Carryforward",
        "terseLabel": "Interest expense carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetInterestCarryforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r581"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r169",
      "r916"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Assets, Investments",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r915"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r915"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r169",
      "r916"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Tax loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r169",
      "r916"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r167",
      "r169",
      "r916"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "R&amp;D investment tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r169",
      "r916"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Reserve"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r161",
      "r915"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains": {
     "auth_ref": [
      "r169",
      "r916"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on foreign currency transactions.",
        "label": "Deferred Tax Liabilities, Unrealized Currency Transaction Gains",
        "negatedLabel": "Unrealized foreign exchange"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r73",
      "r131"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r73",
      "r384"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease": {
     "auth_ref": [
      "r462",
      "r655"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of depreciation expense.",
        "label": "Depreciation, Excluding Lessor Asset under Operating Lease",
        "terseLabel": "Depreciation expense on right-of-use assets"
       }
      }
     },
     "localname": "DepreciationExcludingLessorAssetUnderOperatingLease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r220",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Liabilities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r209",
      "r211",
      "r213",
      "r214",
      "r218",
      "r219",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r301",
      "r302",
      "r628",
      "r767"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input",
        "terseLabel": "Derivative liability, measurement input"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r215",
      "r217",
      "r219",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r206",
      "r207",
      "r209",
      "r210",
      "r216",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DilutiveSecurities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share",
        "terseLabel": "Adjustment for exercise of rights on derivative liabilities"
       }
      }
     },
     "localname": "DilutiveSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r529",
      "r560",
      "r561",
      "r562",
      "r567",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r148",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Summary of Outstanding Warrants"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": {
     "auth_ref": [
      "r0",
      "r1",
      "r6"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax",
        "verboseLabel": "Income (loss) from discontinued operations, net of income taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r5",
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Assets held for sale and discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r145",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r30",
      "r487",
      "r488",
      "r489",
      "r495",
      "r496",
      "r497",
      "r661",
      "r832"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "terseLabel": "Current portion due to non-controlling interests"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r250",
      "r270",
      "r487",
      "r488",
      "r489",
      "r495",
      "r496",
      "r497",
      "r661",
      "r832"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties",
        "terseLabel": "Amounts payable"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r37",
      "r487",
      "r488",
      "r489",
      "r495",
      "r496",
      "r497",
      "r661",
      "r832"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
        "label": "Due to Related Parties, Noncurrent",
        "terseLabel": "Non-current portion due to non-controlling interests"
       }
      }
     },
     "localname": "DueToRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r83",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings (loss) per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Net loss from continuing operations per share"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r366",
      "r367",
      "r368",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r630"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of foreign currency translation on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r323",
      "r576",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee termination benefits"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r144",
      "r282",
      "r308",
      "r309",
      "r310",
      "r334",
      "r335",
      "r336",
      "r338",
      "r345",
      "r348",
      "r372",
      "r428",
      "r504",
      "r563",
      "r564",
      "r565",
      "r588",
      "r589",
      "r613",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r657",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r285",
      "r322",
      "r426",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r285",
      "r322",
      "r426",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "auth_ref": [
      "r814",
      "r830",
      "r852",
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment loss"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r823",
      "r824",
      "r829"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Gain on disposal of investments",
        "terseLabel": "Gain on disposal of investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Summarized Financial Information [Abstract]",
        "terseLabel": "Equity Method Investment, Summarized Financial Information [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r109",
      "r390",
      "r815"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "verboseLabel": "Equity method investments, net"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r67",
      "r111",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r107",
      "r259",
      "r800",
      "r801",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "auth_ref": [
      "r423"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "negatedLabel": "Impairment charges",
        "negatedTerseLabel": "Impairment loss on other investments",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExciseAndSalesTaxes": {
     "auth_ref": [
      "r312"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.",
        "label": "Excise and Sales Taxes",
        "negatedTerseLabel": "Excise taxes"
       }
      }
     },
     "localname": "ExciseAndSalesTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r616",
      "r617",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of Fair Values of Derivative Liabilities"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": {
     "auth_ref": [
      "r221",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).",
        "label": "Fair Value Measurements, Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets on Nonrecurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r501",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r617",
      "r667",
      "r668",
      "r669",
      "r779",
      "r780",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r616",
      "r617",
      "r619",
      "r620",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r501",
      "r517",
      "r522",
      "r617",
      "r667",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r501",
      "r517",
      "r522",
      "r617",
      "r668",
      "r779",
      "r780",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r501",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r617",
      "r669",
      "r779",
      "r780",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r501",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r667",
      "r668",
      "r669",
      "r779",
      "r780",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r616",
      "r617",
      "r619",
      "r620",
      "r623",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r624",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r224",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Carrying Amounts"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": {
     "auth_ref": [
      "r621",
      "r625"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Gain on revaluation"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r225",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "negatedTerseLabel": "Foreign exchange effect"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": {
     "auth_ref": [
      "r221",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss": {
     "auth_ref": [
      "r435"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of accrued interest on financing receivable.",
        "label": "Financing Receivable, Accrued Interest, before Allowance for Credit Loss",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation": {
     "auth_ref": [
      "r855"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) allowance for credit loss on financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation",
        "terseLabel": "Foreign exchange effect"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLosses": {
     "auth_ref": [
      "r102",
      "r297",
      "r431",
      "r432",
      "r434",
      "r756",
      "r757",
      "r758",
      "r943"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Financing Receivable, Allowance for Credit Loss [Line Items]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Line Items]"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life (in years)",
        "verboseLabel": "Intangible assets, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r293",
      "r458"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r455",
      "r457",
      "r458",
      "r460",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": {
     "auth_ref": [
      "r920"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r124",
      "r681"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r119",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r124",
      "r680"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofEstimatedFutureAmortizationofDefiniteLivedIntangibleAssetsDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "negatedTerseLabel": "Period decrease"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Finite-Lived Intangible Assets [Roll Forward]",
        "terseLabel": "Finite-lived Intangible Assets [Roll Forward]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r923",
      "r924"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "terseLabel": "Foreign exchange effect"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r74",
      "r923",
      "r924"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedTerseLabel": "Foreign currency transaction loss",
        "terseLabel": "Foreign currency transaction loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "negatedTerseLabel": "Gain on revaluation of derivative liabilities",
        "terseLabel": "Gain on revaluation of derivative liabilities"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r58",
      "r105",
      "r813"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "(Income) loss from investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "terseLabel": "Loss on disposal of assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r292",
      "r442",
      "r694",
      "r774",
      "r796",
      "r857",
      "r864"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "totalLabel": "Net",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Impairment loss on goodwill and indefinite-lived intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of goodwill and indefinite-lived intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r444",
      "r451",
      "r774"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Goodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r444",
      "r451",
      "r774"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Goodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedPeriodEndLabel": "Balance at end of period",
        "negatedPeriodStartLabel": "Balance at beginning of period",
        "negatedTerseLabel": "Accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r73",
      "r443",
      "r448",
      "r454",
      "r774"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Impairment charges",
        "terseLabel": "Goodwill, impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r54",
      "r322",
      "r389",
      "r400",
      "r406",
      "r409",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r629",
      "r773",
      "r880"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit",
        "verboseLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of indefinite-lived intangible asset excluding goodwill.",
        "label": "Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r829",
      "r870"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "cron_IntangibleAssetsAccumulatedImpairmentImpairmentInPeriod",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "negatedLabel": "Impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r829",
      "r870"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets, indefinite-lived (excluding goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Other than Temporary Impairment Losses, Investments",
        "terseLabel": "Impairment loss on other investments"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r73",
      "r130",
      "r135"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment loss on long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r49",
      "r240",
      "r253",
      "r277",
      "r389",
      "r400",
      "r406",
      "r409",
      "r702",
      "r773"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r389",
      "r400",
      "r406",
      "r409",
      "r773"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r183",
      "r322",
      "r337",
      "r389",
      "r400",
      "r406",
      "r409",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r615",
      "r629",
      "r773",
      "r880"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Loss from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r47",
      "r251",
      "r254",
      "r273",
      "r316",
      "r337",
      "r339",
      "r340",
      "r342",
      "r343",
      "r353",
      "r363",
      "r364",
      "r615",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic loss from continuing operations per share (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r47",
      "r273",
      "r276",
      "r316",
      "r337",
      "r339",
      "r340",
      "r342",
      "r343",
      "r353",
      "r363",
      "r364",
      "r365",
      "r615",
      "r701",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted loss per share from continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r6",
      "r274",
      "r285",
      "r597"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Loss from discontinued operations",
        "terseLabel": "Loss from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r51",
      "r274",
      "r276",
      "r316",
      "r358",
      "r363",
      "r364",
      "r944",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Basic loss from discontinued operations per share (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r204",
      "r358",
      "r363",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Diluted loss from discontinued operations per share (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r50",
      "r73",
      "r109",
      "r252",
      "r272",
      "r386"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Share of income from equity accounted investments",
        "terseLabel": "Share of income (loss) from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r55",
      "r822"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax",
        "terseLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r463",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r323",
      "r577",
      "r578",
      "r584",
      "r590",
      "r595",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r324",
      "r347",
      "r348",
      "r387",
      "r575",
      "r591",
      "r596",
      "r709"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)",
        "totalLabel": "Income tax expense (benefit), net"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r307",
      "r571",
      "r572",
      "r578",
      "r579",
      "r583",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Changes in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r570",
      "r576"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Effect of change in tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Effect of tax rates outside of Canada"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Non-deductible share-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "Effect of provincial tax rate difference"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxExemptIncome": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount",
        "negatedTerseLabel": "Non-taxable income (loss)"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxExemptIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r69",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r249",
      "r271",
      "r817"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Taxes receivable, current"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedTerseLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r354",
      "r355",
      "r356",
      "r365"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Dilutive effect of Top-up Rights - market price (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r354",
      "r355",
      "r357",
      "r365",
      "r528"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r456",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r120",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Indefinite-Lived Intangible Assets [Roll Forward]",
        "terseLabel": "Indefinite-Lived Intangible Assets [Roll Forward]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r123",
      "r676",
      "r677",
      "r678",
      "r680",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Definite life intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r117",
      "r122"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Total intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r233",
      "r256",
      "r311",
      "r383",
      "r638"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 7.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "negatedLabel": "Interest income, net",
        "terseLabel": "Interest income, net",
        "totalLabel": "Interest income (expense), net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Untied States"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/Inventorynet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r115",
      "r761"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r299",
      "r760",
      "r796"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r288",
      "r298",
      "r371",
      "r438",
      "r440",
      "r441",
      "r675",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r115",
      "r763"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventorySuppliesNetOfReserves": {
     "auth_ref": [
      "r114",
      "r764"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods.",
        "label": "Inventory, Supplies, Net of Reserves",
        "terseLabel": "Supplies and consumables"
       }
      }
     },
     "localname": "InventorySuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r115",
      "r762"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r57",
      "r382"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r278",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of shares.",
        "label": "Investment Owned, Balance, Shares",
        "terseLabel": "Balance held (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r425",
      "r946"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r722",
      "r723",
      "r724",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r722",
      "r723",
      "r724",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Israel.",
        "label": "Israel Tax Authority [Member]",
        "terseLabel": "Israel"
       }
      }
     },
     "localname": "IsraelTaxAuthorityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r652",
      "r795"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Cost and Other Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments for Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, extension term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r33",
      "r322",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r605",
      "r608",
      "r609",
      "r629",
      "r772",
      "r880",
      "r934",
      "r935"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r246",
      "r266",
      "r796",
      "r830",
      "r852",
      "r922"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r287",
      "r322",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r605",
      "r608",
      "r609",
      "r629",
      "r796",
      "r880",
      "r934",
      "r935"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r16",
      "r17",
      "r322",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r605",
      "r608",
      "r609",
      "r629",
      "r880",
      "r934",
      "r935"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Ginkgo exclusive licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock": {
     "auth_ref": [
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a company, excluding disclosure for allowance for credit losses. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Also excludes disclosure for financing receivables.",
        "label": "Loans, Notes, Trade and Other Receivables, Excluding Allowance for Credit Losses [Text Block]",
        "terseLabel": "Loan Receivable, Net"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LoansReceivableBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage added to reference rate used to compute variable rate on loan receivable.",
        "label": "Loans Receivable, Basis Spread on Variable Rate",
        "terseLabel": "Loans receivable, basis spread on variable rate"
       }
      }
     },
     "localname": "LoansReceivableBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LoansReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount of money or property, or a portion thereof, leant to a borrower (debtor) in exchange for a promise to repay the amount borrowed plus interest at a date certain in the future.",
        "label": "Loans Receivable [Member]",
        "terseLabel": "Loans Receivable"
       }
      }
     },
     "localname": "LoansReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of items purchased under a long-term purchase commitment.",
        "label": "Category of Item Purchased [Axis]",
        "terseLabel": "Category of Item Purchased [Axis]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.",
        "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased [Domain]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Long-Term Purchase Commitment [Line Items]",
        "terseLabel": "Long-term Purchase Commitment [Line Items]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long-Term Purchase Commitment [Table]",
        "terseLabel": "Long-term Purchase Commitment [Table]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r141",
      "r142",
      "r480",
      "r481",
      "r482",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r141",
      "r142",
      "r480",
      "r481",
      "r482",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r873",
      "r874",
      "r875"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r141",
      "r142",
      "r480",
      "r481",
      "r482",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of putative class action complaints"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of alleged shareholders"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Weight average expected life"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Expected annualized volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Weighted average risk-free interest rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Share price at valuation date (in canadian dollars per share)"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r40",
      "r245",
      "r265",
      "r322",
      "r426",
      "r485",
      "r488",
      "r489",
      "r490",
      "r496",
      "r497",
      "r629"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r68",
      "r71",
      "r74"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r52",
      "r74",
      "r255",
      "r275",
      "r285",
      "r303",
      "r305",
      "r310",
      "r322",
      "r337",
      "r339",
      "r340",
      "r342",
      "r343",
      "r347",
      "r348",
      "r362",
      "r389",
      "r400",
      "r406",
      "r409",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r615",
      "r629",
      "r773",
      "r880"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net loss attributable to Cronos Group"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r187",
      "r202",
      "r303",
      "r305",
      "r347",
      "r348",
      "r822"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Basic loss per share computation"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "auth_ref": [
      "r351",
      "r365"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic",
        "terseLabel": "Net loss from continuing operations attributable to the shareholders of Cronos\u00a0Group",
        "verboseLabel": "Net loss used in the computation of basic loss from continuing operations per share"
       }
      }
     },
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted": {
     "auth_ref": [
      "r352",
      "r359",
      "r360",
      "r361",
      "r365"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted",
        "totalLabel": "Net loss used in the computation of diluted loss from continuing operations per share"
       }
      }
     },
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.",
        "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic",
        "terseLabel": "Loss from discontinued operations attributable to the shareholders of Cronos Group"
       }
      }
     },
     "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders.",
        "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted",
        "terseLabel": "Loss from discontinued operations attributable to the shareholders of Cronos Group"
       }
      }
     },
     "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Adoption of new accounting pronouncements and New accounting pronouncements not yet adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r181",
      "r504",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r417",
      "r418",
      "r696"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Current portion of loans receivable, net",
        "totalLabel": "Total current portion of loans receivable"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Non-current portion of loans receivable, net",
        "totalLabel": "Total long-term portion of loans receivable"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r417",
      "r436"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Loans receivable",
        "totalLabel": "Total loans receivable"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of operating subsidiaries acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r389",
      "r400",
      "r406",
      "r409",
      "r773"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r646",
      "r795"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r925"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Operating lease, impairment loss"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r642"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofFutureMinimumLeasePaymentsforOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r642"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Current portion of lease obligation"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r642"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Non-current portion of lease obligation"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r643",
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows - cash paid for operating lease obligations"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r641"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r651",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate \u2013 operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r650",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (years) \u2013 operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r8",
      "r81",
      "r95",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Background, Basis of Presentation, and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r294"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign exchange gain (loss) on translation",
        "verboseLabel": "Foreign exchange gain (loss) on translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/FinancialInstrumentsForeignCurrencyRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInvestments": {
     "auth_ref": [
      "r269",
      "r816"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments classified as other.",
        "label": "Other Investments",
        "periodEndLabel": "Other Investments, ending balance",
        "periodStartLabel": "Other Investments, beginning balance",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonRecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestments": {
     "auth_ref": [
      "r268",
      "r816"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term investments classified as other.",
        "label": "Other Long-Term Investments",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherLongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash operating activities, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 8.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r775",
      "r776",
      "r777",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other restructuring costs"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for Legal Settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromLoansReceivable": {
     "auth_ref": [
      "r76",
      "r77"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services.",
        "label": "Payments for (Proceeds from) Loans Receivable",
        "negatedTerseLabel": "Repayments (advances) on loan receivables"
       }
      }
     },
     "localname": "PaymentsForProceedsFromLoansReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r825",
      "r826"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r318"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Withholding taxes paid on equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r63",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Purchase of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Purchase of intangible assets, net of disposals",
        "terseLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLoansReceivable": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services.",
        "label": "Payments to Acquire Loans Receivable",
        "terseLabel": "Draw downs"
       }
      }
     },
     "localname": "PaymentsToAcquireLoansReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "terseLabel": "Payments to acquire other investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property, plant and equipment, net of disposals"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Advance to non-controlling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r819"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfLoansReceivable": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.",
        "label": "Proceeds from Collection of Loans Receivable",
        "terseLabel": "Proceeds from loans receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfLoansReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r827",
      "r828"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi": {
     "auth_ref": [
      "r319",
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Proceeds from Sale of Equity Securities, FV-NI",
        "terseLabel": "Proceeds from sale of equity securities, FV-NI"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r285",
      "r303",
      "r305",
      "r320",
      "r322",
      "r337",
      "r347",
      "r348",
      "r389",
      "r400",
      "r406",
      "r409",
      "r426",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r603",
      "r606",
      "r607",
      "r615",
      "r629",
      "r702",
      "r773",
      "r793",
      "r794",
      "r822",
      "r880"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Additions",
        "terseLabel": "Purchase of property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r136",
      "r741",
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r132",
      "r290"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r134",
      "r267",
      "r703",
      "r796"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, plant &amp; equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "verboseLabel": "Schedule of Property, Plant and Equipment, Useful Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant &amp; equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r317",
      "r433"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Changes in expected credit losses on long-term financial assets"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForLoanLossesExpensed": {
     "auth_ref": [
      "r433",
      "r697"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable.",
        "label": "Financing Receivable, Credit Loss, Expense (Reversal)",
        "terseLabel": "Increase in the allowance",
        "verboseLabel": "Increase (decrease)"
       }
      }
     },
     "localname": "ProvisionForLoanLossesExpensed",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r523",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r281",
      "r660",
      "r661",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expense"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r523",
      "r660",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r658",
      "r659",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r453",
      "r454",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r453",
      "r454",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual obligation to provide funding of research and development costs over periods that initially exceed one year or the normal operating cycle, if longer.",
        "label": "Research and Development Arrangement [Member]",
        "terseLabel": "Research and Development Arrangement"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r160",
      "r280",
      "r942"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "verboseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r465",
      "r467",
      "r470",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Repurposing Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r73",
      "r471",
      "r473",
      "r872"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "verboseLabel": "Expenses"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r466",
      "r467",
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/RestructuringNarrativeDetails",
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/RestructuringNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/RestructuringNarrativeDetails",
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/RestructuringNarrativeDetails",
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r467",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring Reserve, Ending Balance",
        "periodStartLabel": "Restructuring Reserve, Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r145",
      "r264",
      "r715",
      "r720",
      "r796"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r282",
      "r334",
      "r335",
      "r336",
      "r338",
      "r345",
      "r348",
      "r428",
      "r563",
      "r564",
      "r565",
      "r588",
      "r589",
      "r613",
      "r711",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r380",
      "r381",
      "r399",
      "r404",
      "r405",
      "r411",
      "r412",
      "r415",
      "r513",
      "r514",
      "r679"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "totalLabel": "Net revenue",
        "verboseLabel": "Net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r380",
      "r381",
      "r399",
      "r404",
      "r405",
      "r411",
      "r412",
      "r415",
      "r513",
      "r514",
      "r679"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Net revenue, before excise taxes"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r415",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r515",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r649",
      "r795"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Non-cash activity - right-of-use assets obtained in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]",
        "terseLabel": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.",
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "terseLabel": "Percentage of ownership after transaction"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsonNonrecurringBasisDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Loan Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Expense for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings (Loss) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r82",
      "r86",
      "r353",
      "r358",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r155",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r112",
      "r285",
      "r322",
      "r426",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r616",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": {
     "auth_ref": [
      "r758",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Table]"
       }
      }
     },
     "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofExpectedCreditLossAllowancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r119",
      "r123",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r119",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets Amortization Methods and Rates",
        "verboseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r774",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income (Loss) before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r10",
      "r27",
      "r28",
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.",
        "label": "Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]",
        "terseLabel": "Summary of Changes in Warrants and DSUs"
       }
      }
     },
     "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetScheduleofPropertyPlantEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r236",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Schedule of Related Party Transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r466",
      "r467",
      "r468",
      "r469",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/RestructuringNarrativeDetails",
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r137",
      "r138",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Plan Information and Restructuring-Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r48",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Consolidated Entities"
       }
      }
     },
     "localname": "ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Data and Adjusted EBITDA"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r150",
      "r151",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Summary of Liability-Classified Awards"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r525",
      "r527",
      "r530",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Share Units Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Fair Value of Options Issued"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in stock options.",
        "label": "Schedule of Stock Options Roll Forward [Table Text Block]",
        "terseLabel": "Summary of the Changes in Options"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule of Subsidiary or Equity Method Investee [Table]",
        "terseLabel": "Schedule of Subsidiary or Equity Method Investee [Table]"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsSummaryofGainfromDisposalsofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r191",
      "r194",
      "r197",
      "r199",
      "r200",
      "r604",
      "r605",
      "r608",
      "r609",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r191",
      "r194",
      "r197",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Future Amortization of Definite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r377",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r415",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r469",
      "r475",
      "r774",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r377",
      "r378",
      "r379",
      "r389",
      "r392",
      "r403",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information and Disaggregated Revenue"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Cancellation and forfeitures (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancellation and forfeitures (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r542",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of DSUs",
        "verboseLabel": "Number of RSUs"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r542",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance at end of period (in dollars per share)",
        "periodStartLabel": "Balance at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Liabilities settled (in shares)",
        "negatedTerseLabel": "Exercise of warrants (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Exercise of warrants (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Exercise price (per option) (in Canadian dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected annualized volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Future awards to be granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Cancellation of options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancellation, forfeiture and expiry of options (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Issuance of options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Number of options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (in dollars per share)",
        "periodStartLabel": "Balance at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r530",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationLiabilityClassifiedAwardsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Issuance of options (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r533",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by supplier.",
        "label": "Supplier [Axis]",
        "terseLabel": "Supplier [Axis]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.",
        "label": "Supplier [Domain]",
        "terseLabel": "Supplier [Domain]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price at grant date (in Canadian dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life of options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average remaining contractual term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-Term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r247",
      "r248",
      "r260",
      "r818"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r647",
      "r795"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r284",
      "r377",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r415",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r464",
      "r469",
      "r475",
      "r774",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
      "http://thecronosgroup.com/role/RestructuringCostsbySegmentDetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationandDisaggregatedRevenueScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r38",
      "r144",
      "r282",
      "r308",
      "r309",
      "r310",
      "r334",
      "r335",
      "r336",
      "r338",
      "r345",
      "r348",
      "r372",
      "r428",
      "r504",
      "r563",
      "r564",
      "r565",
      "r588",
      "r589",
      "r613",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r657",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesRDCommitmentsDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r372",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r20",
      "r21",
      "r144",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r20",
      "r21",
      "r144",
      "r145",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofRestrictedShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r20",
      "r21",
      "r144",
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "verboseLabel": "Consideration given"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r24",
      "r25",
      "r104",
      "r796",
      "r830",
      "r852",
      "r922"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total equity attributable to shareholders of Cronos Group"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r181",
      "r182",
      "r201",
      "r282",
      "r283",
      "r309",
      "r334",
      "r335",
      "r336",
      "r338",
      "r345",
      "r428",
      "r504",
      "r563",
      "r564",
      "r565",
      "r588",
      "r589",
      "r613",
      "r631",
      "r632",
      "r636",
      "r657",
      "r712",
      "r713",
      "r830",
      "r852",
      "r922"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "Capital stock"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.",
        "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary or Equity Method Investee [Line Items]",
        "terseLabel": "Subsidiary or Equity Method Investee [Line Items]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfIncomeTaxExaminationsTextBlock": {
     "auth_ref": [
      "r164",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded.",
        "label": "Summary of Income Tax Examinations [Table Text Block]",
        "terseLabel": "Summary of Income Tax Examinations"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxExaminationsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplementary cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes payable, current"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Lord Jones brand"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetImpairmentChargesonIntangibleAssetsNetDetails",
      "http://thecronosgroup.com/role/GoodwillandIntangibleAssetsnetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "verboseLabel": "Summary of Gain from Disposals of Investments"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r466",
      "r467",
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/RestructuringRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnfavorableRegulatoryActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A enacted or proposed action, ruling or regulation that is likely to or possibly will have an adverse effect on the entity's financial position or results of operations, excluding tax matters.",
        "label": "Unfavorable Regulatory Action [Member]",
        "terseLabel": "Unfavorable Regulatory Action"
       }
      }
     },
     "localname": "UnfavorableRegulatoryActionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized gain"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsRevaluationofOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebt": {
     "auth_ref": [
      "r16",
      "r244",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Unsecured Debt",
        "terseLabel": "Unsecured loan"
       }
      }
     },
     "localname": "UnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r373",
      "r374",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Valuation Allowance [Line Items]",
        "terseLabel": "Valuation Allowance [Line Items]"
       }
      }
     },
     "localname": "ValuationAllowanceLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r833",
      "r834",
      "r835",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowanceTable": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.",
        "label": "Valuation Allowance [Table]",
        "terseLabel": "Valuation Allowance [Table]"
       }
      }
     },
     "localname": "ValuationAllowanceTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r329",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)",
        "terseLabel": "Valuation allowance increase (decrease)"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r193",
      "r198"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Maximum Exposure to Loss"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "verboseLabel": "Ownership interest"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrant"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedCompensationSummaryofChangesinWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r352",
      "r365"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted-average number of common shares for computation of diluted loss from continuing operations per share (in shares)",
        "verboseLabel": "Weighted-average number of common shares for computation of diluted loss from discontinued operations per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r350",
      "r365"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average number of common shares outstanding (in shares)",
        "verboseLabel": "Weighted-average number of common shares outstanding used in the computation of basic earnings (loss) per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Diluted loss per share computation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossperShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 16
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32787-111569",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f,g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL120267963-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.18)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919398-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3095-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r803": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r804": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r805": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r806": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r807": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r808": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r809": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r811": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r812": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>127
<FILENAME>0001656472-23-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001656472-23-000015-xbrl.zip
M4$L#!!0    ( &\\7%;#DKIN--D% (;5/0 1    8W)O;BTR,#(R,3(S,2YH
M=&WL?5N7$T>R[OO^%3X^KZ?MO$1>PFO&9V' ;/;AX@%L;WB9%9$9";+5$EM2
M ^U??R+5%VC ,XU1MZJ$& _H4BJ5ZOOBFI$1?_N_;PZG7[V2Q7(RG_W]:_N-
M^?JK__O]W_[7P<%___#HWE>WYN7H4&:KKVXNA%92OWH]6;WXZM<JR]^_:HOY
MX5>_SA>_3U[1P<'Z,S?G+X\7D^<O5E\YX_Q[;RZ^8_;6LL2#W%H^@ !XP)7A
MH$#S8*Q8X?A_GG]G&SNN/A[4(N$ BO$'K.\=&$,)8R8LC?]/_<ZY+-:Q!\D&
MB Q&:HTD8JV1D5K_VA<K_77Z"V?+[Y:+U=^_?K%:O?SNVV\;+?F;^>+YM_KB
MMWJI[NO3@]Y,)[/?SP][_?KU-Z_]^D"+B-^NWST[=/+FPG%O>#%='^F,]=].
M9GJH]%MX=GB9'\U6B^/SSZR/7TKYYOG\U;>G;UZXE*/5XL^^P."W^N[I@7]^
MM?W'GY]M>?"<Z.6'=^#TC0M?767R\>O4-R[>+GUS\J=7V6_#<D6S(F_OV>I
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M;]A00^A10!M^*GITGN,&:\)R"5R#.OQD(;1*.0#%)CD7DM)&T-QQ7)[C!E>
MJLW-!],@)TC6H%37HFMLC2^61[ X-PK/<7. "=HLV936'?TBEHO7X+J&$H)U
MKHZ@ 'U<GN,&9]A <(9[U2P' (W6^EIX(LR88A#,PT=NZ)[C!M=@FS&AK3U%
M 9,<B9#4/E&YB&<<\*2JL7B.F\.*4:&!'#UQ[T<5*#G3Q%3$FM0V^]/UO.Q.
MZ]CTP5!!.R\_/6G\VYW#^4S.RT_?<1H/Y[/'JWGY?5,-%SY=*=_\X<Z-#Y7Q
MU:\RY@-WV8*_=P_]G!Z>I5!T&DPF:A"29XU. !EK2;8S[VSLTW!Y-5QTWY^V
MY/ZB1GAWYM=/&DZ]T%CJ'(TZ>:5W\=U#'QP=RH)6\_-[^HGCP3[X?'_QELSF
MAY/9QTY[>F/Z52W_U7DOG.+;BU?_[Y8XHX;+@FQ"8 ^E.A0-H*LMS"578!R1
M'APN7[>OC4++P4 *KJ^P@2*>1)51'^/+N5C $96OC ?FZR]MD>0!A=BZU$M;
M(AE7BE"B(D@YGC0JM_K''9P]&"K,(_-J?MD&PVQGSB49]NZAG\&P# PVV/6H
M)5!7!AO%/MLY.I.DV+.DW8")-6!X+T8Z[R+V697!IC Y@[59L*KODX:B(&(1
M&KAD1J03!@S=]B6SU:KG0\<I9D!DLKE6;.BE1I77LNLF?BLX;Z.1-JFSGC+[
MV->3?4!3;,@JT2KGT9MX6ND?S[;2#WB+Y4AL_+7F_]_??Q OOY5_4UL5?739
M>^--MI#$HY3"L<4:G'/)GW;K&C*OAHONQ>F"<3/3!2F51C515I4.UM7LT;<2
MU RD8.-Y<XTQ:(3A(K=]N?1LV-6"-;8":!IR;2TGA]7QNHAH#;,]W^)EAPOS
M2!3_J6MQ\_H]"]?=PDMO/+.;(9B8S)4B9RX($C.C_AM\ 0T;(@1[6OFTY]6H
M>'6Q\,IN:*!M"6 S)^3F(0A3,\G;Y'Q(,87@1Z2+AHO<]C5"@92MAY8YK"OJ
ML%B+["TGGR3&,YC="'85CTPU;"&:79=E7O=F9RRAZ0DED;JK4$V&WFJ6+051
MC_9TF71/K+$1ZVIZ@B!5M"FXDCP4">2M05+GU_O86FDCTD8#AFX .H&S>I^N
MN$(&3*N8 H=@+)DDI$'0B'I9C*!">/L-+Z!0B0Y#K>![.7$.@E!,D"Q5/9"R
MJWAO-7^QA:G&-E=7C*\N5D@F,C06VQ(8<HEJ'!',@ZQIW3["T@M?2TR9I0*S
MS8(:%SH$3@4!Z8M!^(HJ8;>/<,Q%);B@T= ?!'UF<EA C*VIM>:'WYMH=!NN
M-M?#J&3;;"()V415NHE#<=!'@!64XGEG5XBWAN+V%XN#*=58FTRU#314TL#:
MFZJD$A]L.-TROCORNO4]=IL35N18^I 0Z@DXWQ*1;0$CH1.2W'A7A74 0=!V
MRCH:JA%M/HLM4&/MD](K]]PKL<:^LF.2NJU5]PT*J/$QM-PKXCTX8Q#[H+G<
M9V69S'Y,#>R'B]SVY3*T")8R.T$+8B/9&J!R[F57O1'N\.5RD,'JE8@D<T,P
M$,!H)&J9^^[TZBM3:^ HR8A$<I"@;5\:@5LD4+?(>:-*-V0N"?H$D8H*LW&[
M+HU7O\5V<](H&G/$9#'G:A0CQ2<C<P']SY$S8YAJ/FC0MB^-R;L0#'M$UZ"2
MS<';X%J)6=W6:G>A*?)?[M:_CXXV.E?(*==LII#(@ 9)N6*IQ:5FH[B(9Y8]
MC8!IXW&VTW7 _,X>[-F,>#*;3^K'&SF_<\#9N2X_5"Z%6'Q#!T#ZGQ!@[<O)
M:^M4W9B&RFVN6?#>&?U,\X<EIIZ6"^# NL E<.N[;ZWO0QM.267-GE1C)94U
MUTXJ1#00V1!$@4B.BQ&1[$T+QD??OLBVYCM$JJUT6-?X.$+-340U%==&H2\J
M*+%"; F2#+_*\O*C5'\XFJS'&;Q[T.?2:[E8??=(F73Z/?WI?679X='A2$HG
M 3"'6I&3]-4D0!,M.2\-B<%)V1/@TPE ;T9$@)BLH>"-Z@ 'IJ0<F$N-8I*M
M'-V8:BKOSLK\4,[+KN_-"[V=:W)VT!V9B8;LRH$;]5!%=;E:Z%&OY/:;EWH^
MV<7:G.0-])W_ZC@DL&1(/5$6#9&K1L_)CVG%> 00;R7BL%9=P>),JU#!]/*K
M9D*%WIC<2P$W(N=P!!!OQ54CX%@"E&B"@!'+?2)M+[FS'7:?3J>3^=X9[/3!
M4"%^?#YYZS%-Y6%;;WYYQU#?F*X6$[H[>R7+U=7O9>B3R?R!R9> \_U#/T<I
M<RK@J5475#>3R4(YLU<;+*[6[$<$YSIJ>MA^I<5"G9"'BT>3YR]6'\!Y^O:.
M8'F>G7Q]\K,^GID\??.3LY+1>HRDHFZM6NP<*=I,K(ZZD 2-U4[FRPV1$U4F
MW]V3YS2]O;Z>#UBPGB6G*OZ;33C>C_6GU:.N04ZVV-V7U8MY?:LW/GQ5UJ'\
MN[NG]*_Y\K)7]5E.^_N$^YQZAM8XJC=7"V#OY9%#8@WDFB,2=HA[?JSY<7,^
M6\ZGDZIB7=??-Y'EVSCMW I-KK:.98.XNYQM8D2*)D.?9^)]30X]Q)SU-3?\
M:'W+MN)*0FA,MF],BU)BA*I^&M>06J)<<H33CL[#E,9/0^4J';*K$1=G:PUB
MDV &X)"-S^IQ ?=]PBD/V(P.3EPVB I1)$Z*35\?DSZ,OFBXVD=[NJHWT(T?
ME9_Z4OS+'H^NWQF+=6FVN$0^]M'ET"!P2*899I#@08S;H9#DR?SET<NK F?[
MP65Q38(MW(HGD-+;N!.[7'J6CW*3\8O8E0)X)=(E22J[@#E+@T(Q&RDF6"2K
MK@+8 :^T[&.ZZ_ B?<T8(\<JHC+KG#Z1;*-U0@PFVN$/"1J,L[+!<4"NV)*<
M"8VL!\Y"F!SWEN9$+#7G$2V/#2A-MYUU,,; U-AFU!B N#(WCT#1 QG..8U?
MPJ[3\=SDV,C"I/Z*XUKZJ/B2G?>!L950T *8'1*RJT=H^W)FT2=V7C(D"^0J
M$6%HS@8TU)LU#=?3&0Z*5^)B$*KS7PA+:@*^QIR82Y.LHH:H8<+X%> UA04;
MU'U0 "*3R=XP^-(WS9 *D*%F>P66WR'==VU!]Y;<"_86-,3V& UX;BP4&A(X
M25BKQ?&KO>N2K@UVAFR5L&\%]5BA3\?H$Q=MRR5*KY@905NBX015F]L :AIC
M"KDX[R*@AKHF005DS[FJ;:HC*D@;4E"UG<ERH4$HG%/""!HLJ[XK5,A*C613
M:..7L&MU]C8G9$XBU$J54R) C-2 U.43]3"Z:]YV2,BN.:C:BIPUR.0*AZP^
M(6 3-FJ_;#95<C80Z_CE[+J\BPWVS:.*IH1BNL='8+A4LD31U*APV;1#(G9]
MOOMVMI$7A4L"..I=?0"R<1EK$@D8I/HX?-_]_DEM8?_4W=G+H]7;O2]_=L1Z
MJO5/BTGY=^72(]+35Y,VR9BYA!"=U_B!#14KS>40Q9?L+._),7@-<R6\J-XD
M(SY'%QWDFK/3%THRUF-(%K^\/.<&^+C^V@_(>,3+LIB\[/M +L/)H1!$M0/7
M6*I'0G7!3<[)^5*CU;B7BO?C)\CEA7;/C??GVR2P*$%R 4CLN:1B<DQ)/7KF
M(7L<']GR^JMT"DB]\4H6]'RH_L05FLM'D^7O/^K5W%6$%[)</5(_="1$K(XZ
MXSH7"2@"@S,8 J X[)UF]T0<F!K<00XVT6".&5.-2KS*Y(2C."[=6B:H(U@$
M&PX9AZ,5^V[<HC?@B2RNH!W"]E?\&L>"H17GHP"YA&QM"K7:GIAK$/:T'9L.
MW77&2LXQLN-H*8'CWNXN^Y@J4=0 E@;L=8Y/^ZVCD5_F4UI-INN2Y5&8XL1-
M(IF OC%8&[!(4<=0F6*JRWX$':%&H6C&20XCB9JI&JE*+YRU[ *;J"K$I]:D
M[D")RW#4QYDINC5YU7]X'9$[;TMKH;A&ZOM 1H/H@H())L7*#O8ZY(MG2 $-
M[P(8S*Y":Y25#B52M>J4.+$CJ$0=PY+*&#?<A&2)6U.GE'JQ7F'EA?$)+:+Z
MKJ?CCO;,&--*[.;((5ABL<ZFA WT+_;0-R<S)?$U[=7&N%9B-\<+]2OZ:-F6
M,*N780N3*9RAA- X>J(Q\V(CJUY?M$DQO=4E1-<<>$"':$ST&""'8((#&#X[
MAA>U#& M=G,$*2QJ/"!6A]!+P'IS5":74RLID=T!@GQIZ_0;W)N:/7GPOD1K
M()B8&W-27]3WF4;9U.%R8SBI_4\Q&E?H25W[ NGF6-@\^FJJC:1&#(.:L-XD
MHEI56-[%$/8L'**1W$$BHO4%,P.5)&HJ"T$+KIE:HP9B)NZ).#1CO(,<K,$:
MDFK0MZ+*L#"VK%Y:,T8]>_!CF!]Y?62\TC7PL825V]]@@JHQ.9M80TZ0J^?@
M5%MR)0U(6?(8M@H-1X$.QY)?8[W(EO9%Q<*Q9=6T C50-J5$C%9<Y&"\V]-V
M;'9_UQD;2W:HX9)$M. <HXB-IIE<@)B8A^N@7E<QR5B,]M6L(+6:O2_)*"L@
M1^4)IZ3J#3T"I/#E]8 ;#"V'PI!F?2:U=@S%08FU[XZHU$S1^-;327OJ<3-D
M$'9HG.1@8Q-5RCD1@$0BR+U($C"Y:D/*PR?'M909?=$FIK042E77HZ<GV-0L
M7+Q+C"[':'$$'!F/B;GV$K@-9E*C=15L3:D!^%+9<7$&3'0AL8Q!E8S"SHR9
M(9FY;Q_B0!9J3IBL+^S4/_$6J]!PRVC_\ECD3:JHV^^JJ!NSJG3\>>MT'/,F
MS:PV+)L02XK@*)./1N*ZW44?1S\R.EYJ2/.>CL.EHPL<K"O!!A<@V8*U#]8P
M$B+66NJ :_[VVG$P=-Q@V@"I)(>%K8\0R>160LS6DV<V4?RXZ+C7CB.G(Q@*
MU?"Z\2<("C$U8W,SL4#OU3J"K>G#6,$>N;+^W#6<K>Q2S]7W\8"IVFS 8^(H
MC4IP#CTZX)'V5=BP4AU'8<>71][2B*55B\4W2,9G)19GM$9C]^Z9CF#)?!@4
M^\(U[U96SXF!H_,MI:SD=<B^.DBJ=$LPWB<S O+N->^72E[OQ-?BQ5E)D(+/
M575OQL9H7!-<U]BI1X$&#LX>#(V\9^#>F\^>=[+\=+0H+V@I-^>'AY/U_,L?
MCF_J[7D^7QP_;'=7<GY$O<C 1[(4TG<4]5OR2J;SE_W#-SI7GJ]YN0GM?'-^
MU".CEPKN\7LS..],9K\_G_\PF;^>+WY?7LT8S@MS=O.!P0,#EV#<^X=^3CNE
M%JJ7;(IP P<A^YIS#HVJ<LZ$]>8@)5JR:4^T$1/MG7G RIUT8-,F(G3QS01H
MI1F!% $#&"B8^SR<F,.8AAX^7BE3^F=.AO,JAU[.9_IT>9$JG5OSV>/5O/R^
M Z38?J2AP84C)ZY47\#Z0GVR5>SE2C94E\?@K.T9M%6/J6;)P%2=RPE<-5DP
MA^Q0FG6!TLF,('/&H$%/E]DSR%R>069C#$)*;',,Q@8/KC@.Z$LU8IJ2IAIS
MXG/KXW!P]F"H#!J]*_1$RHN9'OCQZ_A1/UBI;[^_<D_<*K_"Y3SQ"X=^CB?N
M?34)D:IU8-0.-LY-($AM8BO)FH<:!^I7GCW8.1ZN27!S/EL>35>3V?/'LG@U
M*;*\/@*>5&O^HE]TM)#K"/HTC%-W*E^&:N\=^CE4*Y2LP>9- V"?,"<Q[+SJ
M.RZG*D^-IK<G1E,?N,%2;;*:/%_KA&X^C]ZSE3_I35(>O3UH$_1Y>[:;RMQW
MR//S-X^_N359*H/*2CFV6,W;;5HJTV9GK\[; WG]5*WI+\MO;NI'YE>=Q5*+
MZ@_L)2UJ/]3]-7H=S28GW%KV7E\OYM,JBW/*')[D$D]NTCL'G)WK[/VSY_UD
M'YRXJ#LTI<EL]?'3GK]]F9->7*ICDQH0A18-.->RB* J7'4CJPO6GD2QUC@X
M.'LP3F%X+*O55.HU"</#QS=/OO 26OOS8U<UPNXRF;/W#_T,)6H C :KMM@L
M0-ZS+3[&0FC#>FK2J1*--AZ</1@L;^;+I5K=;G)E5B:R_$'M8K> #]O;EX\O
MLNGG6:-7\P7Q5![)\Z,IK=2HWRB;X-75Z/8-J-)X8.,E5>F[AWX&R2"F8KH7
MR([ )U[W%0UJM2G64AJ/*,5VXS4MZH<+3;=5;\^/1=8![<.7UP#D5C)=IG"L
MC2M +6 @9HTVDZ,8$G()?DP#PP<#Y%823H&A2&N9(D5HZCAXU[AU=SI!X5!'
MD'!:KR_+\BS=]':5^7&1&>F=^&DAKR;SH^7T^)&\G"]64C>ET@?#G:VDFE+H
M3<,QDI0"GFQN5*7YZJI$-&8,0Z+^#9"=5CW0D;J&\F=UNI>/'O^\BQJ]4<PN
M2\X6!6R,6'RVS5#0"#H['-/:Q:# W(I6AT 9D\OD+4$HPCZ 0TN<T#BI8UA&
M&)Y6WPY_MJ+9;::^@<=%0O7-B3.9FM"WR($@@1NO9E\'\_<FQ.LF!^N2K?X%
M=7W83I:_AL")?#"]I &:C2Q1C-$(+)M<Q8W85=\JEMOII<3!2Z^D*^S )21#
MJ;:"(MZHZ::]7A\+?;:BUH.K <69Y/O^]6:X5E4##4MVDJ+G+Y(^HT2R);:V
MA<@E&O UHW 05R (QF:-.:USC&ZPBZH_36GV_FJE7G-X)V;NA^Q"I'ZQ6C$>
MN/-%S\^I5NP9>HW,?%P/#F6"Z@(V3.H[5%=.VN";WKQD9 S(.\V DV2Z"QM@
M@-I[*LF7/F$',%8.;%R+U@:-^)*4LV5OAP=G#X9*A8UA<SG[\5?V,&W 3/@#
MAY=<;WGWT,^)XP*S[<UJ)#EH+FK\[YKS/OC&MMHQ4.3J=P\-*8E[_12I)N6B
M8;TW)D.F0*VJ92&?&5IV=0P4N7XM\J]-F#,/#V<3/EI>PGR-DC,DQ0300#19
MAH*&0T5GFPG>^]B*'U7CH2OJ/3T0=V-S[7UB4JV@*H$D*O8&,31U.+V+Y)G(
M[0>-# ?T#7:\*RYFIU"S.A% F+$:2\@5L;30\G E?6"0;'#DNU$D3"8CV8"H
M/)K(KJ'SI5H@'O#\LX%!LL'>/I4RE^)LE@08^CP&\$2-<@GLQS!>?2N.S)6(
M!T?O^F0!1SE :8S!2<J!K4)A54R&+Q[;QF)S<I%=<*$"><H-(K9L,?5=D3E#
M4 A.L!ADFGDH6)B-8>&86BE0DK,>FO$9:JJQ)%57D8SAL>JH3\T7#D5/E6PY
MNUBPQ0;)QERP9V38NV;(VS)6/76]>&Q.5_E*X-14.&Z]T8[%8CT2%<_8R]E@
MK+KJ>O'8G+XR-9B6^JP@VW="0U;[84HV%)LKV9O1ZJM/7.$:BK[RZM62ZBIQ
M'D%#0"J42E(CCKF66-MH]=6UXK'!F9LJ&('0L&<#/AF" BV7RLD[SX5'JZ^N
M%8_-Z:MLBT87MD@B]6X!,XI7=]=:7USE,(*1]=LN>[P2,0D4$@&)#]F#ET:*
M44@HC3-Y[]WPS<B 8-F@-1'30@&3$0L$)DYJ5GJY>4T0).?A:Z\!P;(Y):;.
M572A>(,^0;$IYTH.I+20<HLB(ZC[O?HFI=M&?OLEQ2V"$L231DL%(I5<P1!5
M9W/P17P>*4VNI:S@"Z()"<68H6CHT%<J$E-SAEWJ&B85&<'DUX]5#-^2)HN%
MPM<[/ZSAN_7XYRLH%[X2=TAOMX%0DU!QD&)&JN(QBM,_,14_ LD= C;;EZW:
M?*K</%04*.0(HTT:^V6OH%8_@B6G@<C6YGQ:=5P-JACI36?P%C"$@!$\5@K
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M@X"Y7:]O@Z'<-[I^V+-Z7<<Q;,<T-H@1;8GHT1*H?-?KFKVNYUI@/?N^:_M
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M$/4''Z?"U?TBXUBL<,FKI,A_-?M9R)1*O;J%>7D:@]B9NV7Y0M;_'F95]&'
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M&G?_N%E-,:R=5RK+^C^_L5F%XEX.^V-LW!IL#Y@+M]T9>\F6/$U^L;ME&!O
M,+H[KTZC_$)[P_PBS;9,8[V8!NR.X3XLU[A[K^:*FU-C':\[-]#@EH&L#0/I
M[[SZD&0\3V/,;CTKX'L-XUW"--IRDS7B)K!5=O^7XR;FEIEL"C,Q3;#5LW2,
MR\RWW&.MN ?NS2_(/:PM]]@8[N'LO'K'!RS6@(?XG+ 0MTQDO9B(\TLR$7O+
M1#:&B;@[KX[@%NV,A;R8:OM1CIFPDXQO.<E:<1+8)\?X.4ZRC9==&R_;U(!9
MB3BR!IS?N3?.O](LMYQ_=8YBV<#Y16$%IKDMJ-F0W5\/_IY$Q;0%5\24>U?+
M>M..L$HXRRFA6/2GTMY/,G_(<I%^+.ZM=8&X3ZGRV"2R!H1P2ZF"-."8OYQ^
MVKU__731!+EE<N-1&-0IAT=>SC0CWWQ-3G_P,Z??P9GKP9FS'N3,%>EX/0Y<
M;VL0;HI:8.NH%LSA?*!=.,GS2(*#[-9P8-Z4*!Y[:1((2"B\!IC.)!9@1"=C
M+H:T]4^ME?S'S78>.$UG'=C1[I8?;0H_ZH*X_!/AGJ*"JB6(M< 'L?J]\ECE
MVJZ73@K5BASS?+;L9IW8#>YE[R>=6!O(;MPMM]D4;N.:.Z\J?>:L0L1#KG,V
M&8]C^AU+[K&KU):]K!-[P396O5_,LNIO><NF\!;#=G=>[1%(6"X*@P-47M@@
MXY+)?$3,W%T!4L@(QS51OV+%,=Y0,:=MI&X]N1!MLV$^#!]:)S6GO[6J-H<7
M.0;PHI2P6(5R0SE$ 5I16W:R5NP$=^J79"?;JH@-8B?VSJL30FHYK)!?MHQD
MO1B)C8S$^36*,K7^WE.KQUP4>WPLQG']6&Y#E+V=5W4/[BD?L(RZNK]),W@9
MHFUF41Y$LE4!0;:_S_@EHBD=)OE8]C!XLKQF(V/<M*T_S6NV^8K7YRMN:L+B
M.FF9AK[5,C=%RS0M$X4%MJU)$7#OH.P?<Z+ZQZ ENZ=@ K6WV&4$_65;%]E:
MJ:*TD8;9_>5L6L/8<IO-X3;.SJN*Q>S5NEMMN<EZ<1/GX;C)V@3^C&V=_P:Q
M$G?GE:R!F&HG5PFH*L-H3*B*$C#Y-4\XZ# 8V!/?DRI3)6+*C$I9@8'(^LT*
MC"U+6B^6Y/ZB"LX6/V!SN))M5(#MQ%K0D09\*6\PFW-L]"OZ2X#-)9(6A FF
M'<);QX@TOK6PUHT!V<8ORH"VV ,;Q(!LQ#^*$C\:@]Y3RW1ZP[E,N>399>1O
M<Q+6C;O8=\!=MN[]:]W[?VV]^S\A#33C_J ('IMA/$%!T$-7VS#RH@)TS 4)
M^-J9/^3!)-Y*@G63!!3H[5TG"99VQ;E-?Y>OD[R(PNG#9Y30MGQ(8FIFCQE.
M5U'.M20M1,=X:AV:4D<R+9)-IFL7MJH.5)3S?5/SIV=T 5;=FOK+QG7TF?'R
MN6ID):^138?EMZWRXRQ-TGSVTRL^^\E$74/:EOPPG63J4QH]OE(\4'N;I9,Q
MV'U^IT6-L0(R!>EFG#W]<C5,XWBJI5?8*SN?>'D41"R+A$8'MX78+C6&E0*J
M$$_YFD9PQ#&E@W) Q-,N>5[(VANA&,+3$*C$F]+\N4 6&?%BF 8OZ2.0V",U
M!Y\E"?.B<GHCSBA[A&OC&!LAIC"*9*IA_@B.#)Z+(U6_A=J )Y-[ZEE=T1P]
M\454 (G[*U#AGIS38S87I\W!E1MC)S?JXL8*L:8MV?:,2A7B6 ,Y$%U2C2;P
M=#@?V*02?I([DZ11 +]%>3JB[FG,I]]S%A?2S4 _XBOD-?.;_*%SUM&&?#16
MNSQD8H]QMW$8 WAY0B>F=E?]!CJ27*,'[0ZRR)_$0(-PZ Y'XRR]%+)GUZ>9
MFKKAX@$MSQY]\(;!DU]'<:P.:'T9\%5M6@<@7CGQ($IC[9DZIZ_WU7WB""Z<
MHA)^VJ&VF*[5I[#,ZM7EVLPWK-T\_GN.7#$3_!*Y+8N2O,Y988>!:6E 8@''
M9M&"A]"OU.U1_IY>=X7'XS09X-+ATRB7E6/5,3 $V($TQL[.R'_@_4!4$;ZX
M==WS:'C8]A >ISB_G,*(39$'8I^^JPCXUZ20+-WHV2^1%\'NVJ[Y4LNG(P^T
MFI;FP27YQ!_6)XW=J$$.82]$T>V/7B1$4$L4&$VU*S9MB3,*;X@RN%^DS%UR
M8M!9+GH6XG-8#KL#IU@*F' 2@] K\.3B(2"]KL:YM9A=M=1#<:MRT7JX2#O:
M1ZX%:6ULM#D3$)LP-=EY#0^46&2?)!BLLL2:J*]IFC66%"<X&L,^,"VK^2MI
M$:G_(KPKS7)Q:I&EC^&"M(RU3.B!.):R:;DW;=$RS0SE*9R97=A6?Y(AL<""
MC5""+E-!D)*HZ24UK"3.$6"G/.3+5\,(R Z1/B:9I%\\(^K)+2",1;H1L%-X
M?_.(2I8F'ZTXF"!W_.*?I2Z24;_.^D!>DDA9^+R]V?M 3C)0.9(5[MV=O7=W
M@B!H<?-N%'G+GG#X[FSF$;A_AWG&>!QI9T-^P>,[IZ>-:=3IF!W3NOL.?X;5
ML6S[AQY[_2OM;G<[6+MWE\T3'[5BP+V]JDV$_NS@FT^5NEI&!AUQR"%(3)"2
MVMX_M3%(BW\^7UI@8#CKUNW1O<GS2-/>)7U;=0W6+*/5F.+=.78EST(F9RQM
ML+L12X8-E5> U5MIPK_:PAG;A?NQA=-O<RP]YE\,,M#_@K8<H>]S'H;7S7KM
M:KIV83!,LN-5J&;9G'^4#,C$6:L5,3J6;O1^9BUN<WI^A?4T'7LECK1=SQ7I
MTS:,GV-4(?W9*$9U-DZ+'^=2-T]X+3?:01#)GY_N#QV<S5PRLV=WMTMVRR5S
M%K"3)Q!=1$]9/AF-1) ,(U,5)%3 <S^+/!YHZ%Q%IRY8HG\C_&48P8<R&(:^
M6HUBD' W^8EKCWCFRQQ/^$YX\_ 9813#_0Q#!B+NK@GO[?..MM19)4=MX>J-
MTYR@?E\(3^PEKYQ%_VJFU<@=T*M;F =R;5+,WR+6_]5_O.RWV7!R[6]\=A3\
M[\X*=<CZCKIIF%5FZH"WO8RSBS8+0;=_P>(K-LUW?FN2#U!*?;[+9M<DJN44
MM,T'N060W\ZK<_)P L529L&&3@(!EI;TA;V>6QGF(B/T4=/1-BHBLG@B9QC>
M9[%VG!:\"31Q!3^VWZ7I!?Y>H7[^\)P?,TS:".U0A$X+4G\B9$&4^*HZ&F,]
M%.J;"P>!4"E#'2T9&A.1GUR[$I*C"KF%DRR)\J%6I*TJE%[U>Z'@2>E,Q8XR
MD4"15Q'PLX.],K4%KU6O&TQ K*39%"09C"/B*BF@@F2%86),*J@*PE-9!JX&
MS4?C.)VJ7&+QV1B^1R 1-BF&:0:+2W'3? SB %-Q*#K(ARP.5: 9EJE$-!*1
M5 S?PI= R@4(,0P*$_W$DG[JU^-[9[^O30%74:8@J)2%M)X>(U:3BMI53"NO
MEC9F5V)F/HRZ %7!CW("27F&(2 1Y8VG9:[/<CJO4A<J_<!C.2S-9"S71,3[
M1$ W2X!6^#>,(S-9%L)A,4;H*6]IXRS]RLMRD1P4F[& ;L&1>CR.>)B+Z.#<
MP@(E8M#8CSG+XJD&E G[B@HHAB43AME!LXN_?%(=[1!6*QUQS<=N1*UK+L7\
M"1@:*!48\:\K5A2T#N>V$#,TH@1.]0"65^A;9=:66)C91*LXNH"]F/T4)C.7
MHU6EDI2?Y<-T$@>SGXK8^NRGB)2.^?3%7*X7&*8X/3;W>-@Q4,WXW*/4IM93
MQ,0ARB/@7IB]D&8!)?>,,Y[GY2Z/AYE8\BH3)@%V6\*W#S(VPGW'G;T$K9<I
M;!_@.6E(;*5V2(@TE Y+P#\4Q_=5LXE\?C5K0>7:>FI#3+I(Z/FPOT'5T@*U
MY@*9XF#:N8Y.Q'QX@]QCEH@EJ!V'=!PEXB>@' [T5\P>C +D!<=/!Y,H0(0*
M2DT0BSLS=97G4?L<QEL['"'SBU4CS.9:R.?%XNOFA1>),&I!8J#"@OAW:Y:I
MJCP7^.[%TI61]F\;?4@O#'?A4HB/(JQQ*UZT\:([7QQSI<4A&NZ^?+S<OY?-
MY;(ZM!9UNA=).4*@HLQ@29).@+0#^((6E?)RZAETI]7G#26 $@RS=(!<I:6!
M\@#BC&"3\4L>AO#*VMN$X8HL^(J#6(%__0IE69WK%J:*PGDAKE3FEK9J*2UP
MY<1'&0-O3.G$IJ)M#7R'TTR(I2F=0H,K$\27J;%%]=HF!8KAO5QN5M\W'>X"
MAXV?)/51MB1P :$W42ZV4#2E4B5U!LPU*SL0:<!2D3J!:T8QIA##M<!II@G/
M6MH)8OM':8-(WW,&[/F846)H#IK8:%RF33\ODS;%0< T3Z0=J>Q@33_\$F;I
MB"ZZ@@UL!YA& $/"7%-*D)5ZHA)Q0/C!Q!<?HPXG]6B1([AP,"^WI'7GI$4,
MS!,4 LQ%,!U2J&N[>'=;*/(U00D8@!F 1DG(\J%Z+//_GH"5HV7L2D.U Q==
M4I54&; S14263Z5R52G[5_2KJ!2@Y/TJ_[BZ9B^MS !%U!4MRU,&^GP*-G3)
M=I'3;:GOWL6J<E50_8)2X]'P\"GU,ERT8R7WJ>V9M-J!M)LE%RTE)B,?,QTC
M)A*,4=B*,HN&R*Q(#-]8W8DE 0K:I,Y WT;)Q2 %)JLN?%]=6/)1DIGRRM=1
M"I;%1:[]GL;X'GAG@VK%957B_)8 [Y7]@65"5@[E7PL3&=2I $RQ.!VCLC0:
M\0P]:_!.RL+^-F8RZ;O@_E#8R41-0&I@VJ.Y#+_(!PBE4"F$_P9N^+*LB0!2
M ]8I:DB00S9K1V3YE3H&TGS<LJ,'8T<$PSOATOP5^O$@2V$OA(DIO5-LC'F7
MXAHPV9'A;,_LP^T2*;L34H3K>@GL#(QB@LZ#22;M'[*4A$%3ZLNMU36!4@IE
MW.?1N)AQ9LZ\/6=811+Y1#C;4WL_UE&:#%)R2H/RYQ?*2HJ!.(!;"\45-RD0
MKC0XI64IF=PMK9B.I2Z WMJ<:J!8 (IO&YVCP)3)-<WJ:D'( Z">F%Q>EQ&5
M<K?09YI%Z+*"EQ#Q39)( '](9S^1[5AHT%*Y0,.Y)2E*&ON2^K!$5$Q)LGU-
MB1QRBTJ'8DHZB?2'DC< ?;4CZ@^YY4'W17.SU%5SI)?4A50TX@'Y+V<)ZFL#
M\3V=%#EH'026)RGMG@A"U";#75=#+K^A$>5J1CS8LJG[(9E!1@7$&=@L5\@L
M4)H$8.[BS_DD1^4"-A"53JP=K&VVK..68D34<9==&N/R<]AXC!<@/ZL9Y"2S
M2I)$,DRP5 ZT%.5^WVJ4#^->D3H\YC%--3_C>#IQEV,V2> 8>D >@11"DTSX
M6NFBEKJ"% J?J9#IHL)KM!HH=#@981Q8B#>EHC:%WE8=N:=SKIP2+>TRDMN/
M-?\AQW\YAN\9UI0&::Z8.FF9,6) \'$A F65&&FXNU[OUUWQ-4MQNYEWOYEE
M[D%=>5.AFUD6BL&9R@R0T:&R!EL9#4WQ7=]:#"*16EA,9YQA\K%*T_B01 (?
MEXKVE%,!.4+I4:! H> D0DO%-(JRVACYAO9L&5%=RUKRYTV>0JX)'^PH):/J
M*R73"^B!;](T$+B:V62@[0:@ST1DBU&:3,V/]F9_MW+1EK?370>82N%+N(KE
M3]@_6/2$-W(ASJG4OIZC4W_Y^=Z"6]^S0H$3GZNR?=F-H1E#.3^9"_")G4 '
MXR7P;7C*@J0?C2)L=[@U6UYP3SK_+?F!R!H68!LE-=$6P^IB#?ZTCLTRZW.&
MW1Q-XD%Y[NLO#:5;<,$3ZZ=NGZ,E() BPAKV2Y-N/YQ59TY.+^:7"" DJ+=.
MLB*A#!7+Y41V[QG4ZI:'3QY=3+)&<RGJ?V\SLA][+-N,[&LRLK?RX&?D096&
M6(]$-NSVW;B ):A!RDD H+P6;51"0 6OZ[Q9WG]87ESI)^-)ED^02Z/F2<AN
M?A:-A>=9%<9H 0VN!#OHM0CA:ZL@W#U!5/H[I4&4>%WU_(IO&$)$#PY\GH[G
M--?W0Y:-&"+@:2?T;2U$J-6^;,2)J\_KX&PB,PC!MPAH3:H+(D)"WU,U58J.
M0_(6SBH?BV8C N&LF"@G!6D2]0@G9A$K@V/&/UIZ'^IH=,I[65LCRJ+[SK6E
MYTOZ6HL*L5^XN*IUV%+W@^9J(%J9<$664:\RD2@1J1O:!9_*HH2$QRJ%<+M/
M#[9/E%R51Y7%@K!9:?V#I>>-C!E,P]INU[U[B MX7SQM'J$8G2H811(NG6F9
M'*==@2V!!TRDC:@H$!6N8%E/EL;"LQ"64--E'O V+'C?9T^**8%)2#5D&?][
M0CB%B/8*FEZ4D<R,TWRFC 2D+6(_YF"JJ\=<@<W-RZ1:V&9@H!&:*HAGV4Q7
M&Z1I@/4@V^-Z/TK_K&;4R#L4>OS)7X?[;:.O8888'T5^?7MJ)[Y*:!0?R,+X
M^<S%4D\J4V 5#P?CP)N(NL"9_-V (X=00X*'8%V S'6AFI*:^VH(UQ:(?YE/
M.(:'>,X)B5JZDA;,IQKT5(8=@:M,A&);9<"TJB$V\F'D))6[LB4SY48R_Z)<
M%AE/KU^+8U+AK:T"<4\DWLRC4=DU(]QNEM'ZAS$0$^@(Q17GB7:*%6:,MNW#
M109'@VO/9"8DYHYCVA4((**WYV7]J8R,M&KBJ:QVTZJ[\YG"!BR*8_E0"^/T
M:DL ]Z22($:P2)"N6 C:D:58 Z%3"*6_NN#L8*]AS>+O)PCT-%=&LNCN$UF4
M4JNJ7A*D.3G;@ZO4$Q8ADM/PI_B33-A#%8HR>)- DM$(HT"2OT5EA[="\):X
M0+<*&X^1"P,?K'M:U$QI9HUQ[96W-M#.MR3Z #P*E2@E*AK.!.S1@*4J6,""
MPB3DF2AUXZIB6V!^GY;!%6U?/;1&BA(=W^A;5HOTLY% (V_0>^/R^3J3^AB5
M&P4U/:SG:U\DJ-OEG(&)C*@%*(JSEL:9*+LN]<$&^3T%!.^]"K<'YW9=_7I*
M4 452A!\ *I84OHA1 0L$N:0*/*_XF5*5#,<7Q;_PX:7A<ZH^HQ9)C0?V)X)
M)6@ RV"B#FD\\4#NH8%VR:*80@4#M+ 2F8B5PSM\U.5%KEU9"="JHG,,K+-I
M'DF5+FE@!Y0#HC?B!4@5,0\&7"Y/7I]EJYHC(0Y<4M:!A\H>4A$.KZ/]GE[!
M%T!)J.&ED\$0FWZ@@RZ>*AQ]@LD/-16@4X,OW0/E=/(A4\HHR&."-4 )X</'
M<!1A^V$=L?24D@II#N3NP]U*"GS?"-87_9\=[?R6^Q4EEVD,8X-WR"X$336\
MK"'/)]Y741*MJB3+5<4B_!1V%9/!TPKUG9$/4P%0J<PK;)1PM?Q\K<WQ.;_E
MF9E!O5"U?*5/H4Z/M*A7<)_(0!' ^9BP2$8J';]X(J %,GC"A?A8@0%014V)
M!E 3SR^T9]'SZ]R^C2K3=LXN174494Y%,F6B2HJH.X;QH;5R:^%(F:MEGJFI
M?@GCF1^0>ENQP!]3JW EU)"[JH]LB9J"2[$,LQ[OI56_%$R8K?Q=7("YO- 2
M1UGW/]':EY-&FHG*&M\H"T2*,5]6B[DG5G7Y/B]R-0+GP +E@>Q5)!@5Y1]0
M!0YEVHL%R> PQV!NBNI0?,.L?[,JV*M5]>&8+I^KY(KE12(^&U<6N;"]B_&D
MJ%XGRZJCFFG^X[6&,"H85"5(:HD>I4I3HQ_DOLH8+M=>8$;,XD60E8[2H!&
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M%;:J(P<(+RC^7/I *NM->"#%BHJ?:8W1^Y-,F[#:'I^F4C.2B0:HX$]BK$=
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MHT7M!W_EL)YU)YT8K7OOQ CS\]NP9IAQ^4+TTYRNW)?MT0.$C='+GIPO'WV
M=Q$U? (SNT4H\3HJK'=W?'Q->G&3Q,/S@R/-Z&BO/YP='A^<G2VOAEU'ZV#Q
MG-X*E]E&S61)28"(VT0SG1R%W5XH'"ZIT;T7OB<ZDJ_1KP22?@]DSLB+F/"@
MC#/T38T)G!U=M"+?/:14.71/4;9@H1F&H;WGZ'D_*S*.KL:S">CGFJ7K+>T\
MA3&A J'*E(Z<OS3S=R"A$VH $//Q$ P*+9D0S H,_?\9;=OHMAW=;L-JV:(A
MQ17W<GPF?#\LBG'^XK??8 X^S1>[5X\[?CKZK?**2&]<Z=C*L3-BW0.TX(%1
MUEGP3-&,L.QX63KGU0-0$P$+3P37JLM:HHTRX824VB7:@*5IF4B[7/4K$PW[
MA,I3VS[2(NN&@TBPS*IW!4HW*N>TN'/G4[#D3T2-W0AFK(HJT'52VE(QV.J5
M,2*)#^@R]2^J/J,* .;\[+_-YJ+BKN/=L_W=/[6W<>K!VAV)$@YUSS'+ _9W
M>5MUM("EDR<@GXZ\-"Y+VTY/CA6ZY$8M_V)6N<\KJ"3)1EY+5_%FS&ZI&W'Q
M?$\N,3687VW&Y%:4#0P=$4EZ*<)\ T'F311D :>%!RTJ9,L^;Q)1MYTRBGE)
MC(93*]F)2(%'>'ZRN%APB3XOBK[)V$Q5TC73]45U$JAEEH+Q3P$H;<Q$%2O%
MQ_,Q.D4]..6$LBB=0664%KT,622Z$E>3+8>-LX9K(U_ 16O($<,TCM*.O%IZ
MRV!^(G(B??&2;\_<I/)/<NULC-Q_>"].YF['6:G4<\[.1.IK6W0W3(:2AR41
MHK-&&!?__H?1LQ^Q0G7G54M[?["[=P ,]_S#Z>Z[L^T:WGX-Z0B]2[- ^P/4
MJ/N)=3SQ)=P0O>B6HDOV4YNN[N!:=]&5<WY!ZK?L " KV3 6CJK@,(TIE@;B
M)TQ]48&,ZK((B6:-5G1ERN?R]K_7+@_^NB;]@6\1AUPC/ (;F<+.JX'L/LEJ
MDA5AFFJ"6N85W$+\KZIH;_?T7O94ZG%B6X4R)7SS4M,4%69S29P)+["KXW;S
M'G7S>%XP#XSHH529J^)'M7N8ACO%M*(HN1ZE9;M?#[!?) I5/M (-,!"9$O=
M9*1MB,YSK8:C/ _:&1^,A/]]@^9TK:JC0K+%,"/H$6"-H/Z(6;XHNP_4VYFH
M1".D ]4M%6O 09I^3+,X4$XH#!MCYEWM@?@VF4V"$G7 TT'&QD,0P!EH2XUB
MTZ(&MBVK3BL05!7A+DJ37J$&Y2J#EU!YYE[0V9 HPBTU\,;^;,8,;_2]4AIK
MF:),\L#+HR!BA$;S#(82JX+N5D6'P56:!J7/M(*,X"5"3D,=N*E+5YG8JXX'
M;\LNP[PERO]%0OLPS2GU&Q.F925"52NBT+0;/8$J=^[FF]3:8]K4I+IOB)"Y
M96IIU:C\L-&(H$H<%OW(-V/RUY_X1/MCDG#-L+'[@6F4CM4/9[ME]W6:; OA
MV, "1]2X*TPZ*OG"5 4*I-R@]@MP"G."&KD5F']+H1)6&>0$5(%O^*?>@;4P
M,(5(N -:HD!.X'U@01!"#7RCU"X8I*%WG'_5$K]SRC);L(O7= L0E7;-5')9
M74=Y8(7(XZ[@$&3#X]HP_FG 0&PLFHM)#M:FCHYZ+>8BJ*2..F&/%5CQ@2\C
M+EDZV)77GLSE(:6Y>5G*@KJ\#=.TP*AN67Q5-A/ &]!77C2T_E8-?862TF ,
M(HU#B  $-TT#'HMLM/E4_G*?*!O1:R!HS:&*-?LH2* _;-M6*YVHIEMODT#(
M@H@&B/_6\](J&)WJX7+FN>#X5Y1C61MYJ=;4"Z)+S!X:N9H5YE#&L?!@B-HD
MU:4B7%S:T&HH4+B@M4MHB2B32P1PI4BC6B75E41!BXDB"\(#$CH5BC<JIB*5
M2\.ZB'DI*8JIZ-(R-7AA(>43X5UON)=-D .9+O$OLU5?;S].D19QJ6"=J0IS
MMH3D773Y$:E*L;H9EB"_+OE!'>U4Z,OU8A)?DI!Z:)WEJ<_.JQ&HIW;*&X@C
MC+!JN2W:BU5'?Z:46>I L<C;%F<.6W'CTK,@[6B[\T#I"X;0(->28BJF2: R
M2<$&,YQS.6,,.!JL.2^SNBM6V.W8_Z*!P7C*KCN6H3;NKD=RA0QR9@ 6#.!#
M%="OP_;.OCI:*OH772V+AF#.6#:7B*P.K)SBV:4L$R]39542?FT27LI &861
ME.FTLLS*H]JD I&=KE^? ,S^7$ S:MU_+5\5JL@KL+8LILQF.A$A5:B(IC?(
MMZ@$J4H 4!*\#B I*Q;X-P4Z]+Q!<ZVR>+@LS!(3DE5KF!E#<N>ZU:QT]3D^
MNP:H.PL3_=8E9]=^>"B>;?KM-OWV\=-OUTI]N:7=>2R;$)_Y0QY,8"\/M3VI
M +1/)3#K;@58\C14N%(3,'71@$\(6/Q)>P-<7WN-6C,*<XXYF%5UEN@+F_$1
M)KD.:E7A)60'I@KB>:BMIZR<C:7]*C#H:H*&GK)77716780XYPU,^[-:+V69
M7/@'2T@=-?K*G*:'GNWO"B3# *5RA%ZU#,?3C,5H03K"VB1_OL(=Y6?-ZH%/
MP=X;U6VW(\R\HG>BI4;6 %,IM[ $TA:JVX14,%:OP\%8:Z5FSJ D8MDB=>/)
MI6(P2ZGS)?J+OI0U2SC?RGI)2TL1H0Y4P5!-VU!?-XK:!:!4H  PKWTEHD"6
MB(0WT4.-'&"/R? %7I62PV%VC1J>SCE8R157[#)"V >L<JQU)*]OU22)J52_
M:2A33=:T5<(6X.7[![LM#6B#:LS(^5[V 2=DG!K:EV DM?NK_#TRC98-]RF8
MCA\Y'#;*R>;)0-H49+!7W+5$PIYGR@O[-:)[Y&V47 PP&5GY#]]7Z#A$:E@2
M)UT/O $4#^0AT7X#[?3?;#1^N5\?3/U%""1 #3:H1AC/D*#)23;3]%P 'XO=
MK<%<926.O."E<Z @Z&2I@$&HH*#JEK>0@6X(2=PRNM.(KFW&#&_$PV_,J>;C
MDY%"45A"_01*.;N$WQ&RMJ@&Q?B.!(=21Z.,ZI1<'MD/@F3X)181/+>-!>(2
M'NF:&.$Z+*%A8G%4@AH9"UCI)Z\Y$ZM ;L-/+L^UIK+7:M)%\1%2+<2#GS=U
MC-H5E;(Q@]KU7J LSCBS&]?4_.ODM4)?<$VUJ&&V4U_<LX(A %I5TM-PWB_"
M#&M469P/&2Y-&3YX5P2@J4D0Q5RMW!N>59U1U; 7?+=H[&S!Z F,Y6.4)-&8
M VD>L20J4H^IY&^ZKU2XD+%C@+SDU#/HUI'::)K089XQKB*.<3#K5S+T?RE7
MB=3R)"(5?OH7 G$Q[7>!>_1. ANH^8IOJRFB0  +:3JW6KN([ 1'@*E'J.5
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M""(L&%,W2M.NW<2LZ<Q.&U46(4:LFRS*@Q KQ P;ABR3>1Z6KVB%?D:/HCC
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M)>"0,B-!?,-/3Z?#+ L7?$K1[VMIZA.4YO:*1'=DD-Z=6<;C_JFG<;]* FA
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M!3'WN$;3&/J?^YC2SI1^?<1G+(X4(_1-FY(5*AIB*#N12Y=A5PYH&09%\Y;
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MKD<HU_V9Q*%"N6Z4DD&!U%(I&311;R!^B2PSNZCU04/ZV*0GO1-CW_<!?'T
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MSLL)RPHE&@Y8LU*EQA#44/24$4V>R6H?+ZQP-YG232!*Y"E<%U4/.8S&@4<
M^,!?MP7.M/,W'?&1J?W,<)@SNES&\(ASM8P$B<,L#OO<95S= %%N@\5Q5OF3
MZ9B'+]%)7ICVC>_%^\XS!)'F3-"(_'9EKB+R@4BUC<](+;?J-T2&=<[_"D_D
M5]W1TJ3.0Z7K"*X?X4YU,Y&&L/>R$^P[5 8H,\E=MGSEZIRXYLSW9WFZR3NF
M '% &U:3H:=AV.+W%@FWL?\PD/ 8*A]/J.JA&];>[BTE-4+G5#+*/Y_Y9KXH
MZ%B .;X\6K*RJDK=?0MV]P4@IPF7S2^&8XHJ0:7U+L7@6%O_/E3K4(C@KJK(
MS\ @;J=W]M%[4"8"P2[1U@*Q7?7'= L<58+D[(U:TW+=M['C[Y5M:ATS(E7/
M'[TA8LQI8Q*K3X ]<NT!%O9P=&"C:X FU_#Y]89:$(S$,!DO8 ;2Q%XANEHP
M9!FK.&B)9K"B(I0B7+KM!)WA8F3@!HHE";>5S9+/K.MB*2JYLMJ6N"GK!/%3
MJ3 TM1W#_R=U?CDR$!%.JV%"#6]G@9/!6!!]!8YJ(9!U77M8OW#K]16&BP/D
MA@= 3%U#N"[D6LSV5>GVX=\VJVJ6130<<L]9X+!ZW<+C0L GSN0.$9!ID4?L
M^7FND9!&&.5GL&5I^#):XIPK-$"JRSG9VBU<X(MM-8'B^=!3F9X5C:N< $-*
M,S#X^V="CAX6$,P, FF#V.&=@UMGL/X1+3K8[O%-=(5ANSNI[ LB/4D<IKMW
MW[XG%%(IS<1+.5=Q*.?#@V@PPR0N5A$FBW=S_;FG87VJCMJC8CUJC%6!<_&
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M(2;S8FH!J.E2M0H?I_'.M:?HD?DHD[1,"!_$2>>!@M_(1@57%UZ4:V]MQ5.
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MF-PTE\H+*D8Z.V9W7()S$6>=H,)_7'^_TDJ0X\0?NWS*IW$!,E FP[(F>Z7
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M4!*#VE[L"5,&R"<9,Y:EV(2R3E4\.RFW);D".MQ_J6I7 TRG4U?Q,!&(GF9
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MEX/]B"AO<;MN.B.%]:UC*4,N$)0.T P-NPAD]V#C34*-QT^FC9A"N[I0P;7
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M>6+WJ3A"VE\H#6UFMXOGCXI4><O@6W<I=3\<1[]_W+#7^J7"MKYGQ4Q9+.=
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M].9WC]";1^C-E].)WPCTYK4#$-,QE>G:3[ ?VN',M(^Y4IO"KPD[W&Z8G64
MQ&:#JP;:GE#D&J&J  "(+7.$=/Z"N2Q;Q/N7@1*'+,"JMXM4OV8P>D0/]5*B
M-CT$K_X'NJ8D9NFO:HT%QD',+[%KIJ\RH=P,2#Y>!WKG'O_4IUD.8L]9.#*9
MF8Z#V@P-O._Y;%%=5FN06/?M',:8_B&W/8K,\* @*'C&98&9]S&])MD.]EQ;
M;;,OI:1CV0L B<JO*;]"$Z9)&#;B%OOG@NZ-#5RO#9@;_Q3.FUUE,0!%)PO
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MBY"P)5UXC75$U[NI^?8P#,"L+>MSHP;[]S@:\3BFU?COW_R>_BFF4S8XPD2
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M0[YEB@;,F">H.2=Y":N H^L]G8(N'.MN$,-0.@#"AK4CLA/4[<RA"F8F:ID
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M1M< T8Z/A%)YV$51?ZXNQ=6+ TCB&V+<)%3V^;J9TP[48UV9__B'$,>I(4X
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M9E"RKQ^A9(]0LB^G$P\22O9BL4#.])QP5G)XIOCHM?:GNME2[CUVM?F1F?0
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MMYQA<TQ*R'[KT:Q-^P2*$XR6IV&L.3;*7:2^OV3^^Z5CKXL>K<1XH--BXMO
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M$G7-IKJ_<5GL9+Q0G:%%-B50$Z@H(Y*1^- _ HO#T#EJ0NA\B4;>=<PH5CF
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M+'8UT-/.""=YX"6)+A<H%RC(F.A&MZQX%/)9,;47V#C<=#M /I1YPZ^Z&*'
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MH+K\R-IE6;VMV-1EB50>"E^6N)3&BI*GF!2%_E2)$^+"=ML$[80+/ZV,);X
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MD3^_1Z#2)D1Y!)<(8_SHW;C.KW 8%2B'^53IYQ-9F]3Y2,4C%PJYJ9U444X
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M))D@J >UAFOYL0.;$J22'\HQ=!U'7J "MWH[<SP*-'8%FGK)'B[;($:116-
M6QHN=HG.0RBNSBG4(VTY7[PT*Q"\U>:<1N()UK?6ZZU[Z\7-EI]\()D*NO6?
MGFZ#8SB!\]04?I2(=SE9$R7GI%T@WO/0KR3>E1^CV#G8>51E8E!,BN= ]R4,
MO:'.>EIRFE@SI?@][7'%RPC0:^60<NP=/#?4Z511'!U;A"IIR<C]WD+GV@OG
M3830BA!VFSJ3)MBW/9-X\CJ38 J&?C*$=4GB:!=UDDZWU_F_<;_US]GX!V!#
MV;)+)19QM#_[]JXXACWX*&6>@2DM'Z8Q\&4Y#P?=]NP;GIQ'FE#&+14T)\+4
M(T1F"KU9JM[J?[S#^I30NWT;1+1S]- FHX?3W&KSB<X2^']??UDNM^C23YF_
M>*W;:_7Z_:67VZW.TFNK7MLY:!T<'C:O/3CJKO7:GVC?>.^ //"(_></O1]*
M%!2J$1SL%M"$0S"E#C*0=W(1Z7'AV@S[547CM]W9-Z=3)%9\69FTF*H>6^H=
MWF69$NF^]S)EF(NLU_*EN.]L69YOTWRES(R5,U297M/D+0OJ-4V[J-VO/_.$
MW_%()W_[UJ5H7136Y;$XXQ;RQ;MU.%J<!7=!F6XJ3LGRV;:=[9IS-4'\^+ Y
MVG.CL[-5DV-UK0K'\WN1%.>R/&B-\=(]U_I%T&OU@KX0>JV>'--K0S,-S30T
MT]#,-M#,&OKPXU/4DVBB=5-&N9< 1P[OKXEN^Z%[)&5T:\]=]?P.#UN];OW4
MT>\H*;:=;A])6&PMW5;/[^B@U=]O:*>AG4UTC4ZGU>TVQ-,0ST;$TV_UUN(\
M]U54&UWU$;>)N]:U&U6UCB=OB:JZU]K;;U35&M/M*Y48[7;KL-,03T,\FQ!/
M%V1TKR&>AG@V(9[>?JN_EJ'3Z*K/N$UY]\1&8:WG\5L2Z^_OM8YZC<9:8\)]
MI7*C?=C:.VR(IR&>38CGJ-WJ-^9.0SR;S*^+>?.-=W7;R;!41MPHK'4[?4L4
M5K 7>WN-PEICPGV=8N.HUSK:,.&PH9W73CN'K=Y10SL-[6R4#+#7VE_+UFG4
MU6U)7#UJ=-5Z';WJ^77[G=9ADPY09\)]I3*CO=\Z:/QC#?%L1#S]O5:OWQ!/
M0SR;$,_A06NO20?8=C*T4U<;9;5F)V^)LMH^ IG?**LU)MQ7*C(ZG5:O458;
MXMDL=[7?ZC2YJPWQ;$0\>WNM_;6(IU%6MREWM=%8:W;\EJ0"= Y;!P>-QEIC
MPGVE<J/3:W6;7("&>#:9WT&[==3D C2TLUE<I]/JK$4\C<*Z1:FKC;Y:L].W
M'%=UOTD'J#/AOE*QT>TU2%8-\6PVO[V]5KO15QO:V61^^^W60:.N;CL5VJFK
MW85^&74_>:]35SWHM_I-,D"=Z?9U2HRCHU;WH*&=AG8VF%^OV^KO-;33T,XF
MM+/?ZC1IJ]M.A5;::J.HUNW@+5%4#UN'30Y G>GV=0J,3N>HM=_X5!OBV4C;
M.&AR !K:V9!VCEJ])VEBU6BJ3YBSVJBK=3M]U?/;WVL=-.A5=:;;URDU.KUV
MJ]<XQQKBV4CEZ+5Z38U50SL;T<[>FD@DC;JZ/1FKC;9:M\-7/;^C3JM]V&BK
M-:;;URDT.OW]5J=I#M 0ST8)JX>M?J.M-K2S$>T<M/;7LI(;;75;$E8[C:I:
MKY.WI+@*@5P:SVJ="?=UB@P$D>DV\%4-\6PRO\,&#*"AG4UI9Z^UUR0";#L5
MVBFKC:I:LX.W#+>JV[0%J#?AODZ)T=D_;/6;ZJJ&>#;$K5H/V+VAG89V%JN1
MUTL^:E35;<I9;?35FIV^I5@ W28+H,YT^SJE1F?_J(&M:HAGL_GU#UK=)M^Y
MH9V-:*?;.FC  +:="LLYJXVV6K/#5SV_O4ZKWV^TU1K3[>L4&IW#PU:G:9O9
M$,^&T%7[C6.^H9U-YM<%OK,6[33:ZK;DK'8;5;5>)V^IJMIN4E;K3+>O4V)T
M#HY:_2;ML"&>C=2-H]9!T_NLH9T-458/7T4_@/*U.FFJ=L;J.HKJJKENV[';
M7$]=.<MM.775T^L=M-KUZ 5PQ[%Y1&%1)Z+=7%;4@FB7E56U6WOKZZ@-Y324
M8]+S[P/,VQ!.0SB&Y:S)<=;03I^"K!KEM")'M=%0:W7R&@VU$1>U(]IE(%6]
M5G?]@']#.0WEY!IJ9WV$JH9P&L(Q+&?-%*.MUE#YF:6C>]D*;#EK]0[]]8ZU
MJMVQW4B]?? B;,NI7J+](KSVMFN_#]V#1Y-4+^U$;"3(7LR)6.:)Z;?::^6T
M-639D.7W:T[<:J^5^= 094.4W].8/%P+*ON.=7A.D^&GS!N$"O[K!]<__PW^
M1P]]ZB7C(-)#WR\2XC_G:1:,;A][W0_O6O8N+OO_\R,LOQ-$URK-E._$D=/]
MJ7OP4^<0?H.AQ,.O3IS@;X?R6Q#YZIL+_QF&<UPU)U'\]%1%F1./')AVX*O(
M3UO.KT$*Z^7<*B]QX!>\V[(;6G\;)#_]?!+/;FE]<>^/WI$MX5QF7N1[B>_\
MU9O.WCE?XCCYZU\.NYV#=ZGK>/2)-("QPN<NZ98OSH<P'GAARSD.0X?>E\+(
M8$VNE=\R!%7>EZ6[\#.-;>ESQ?V$E;[CL<#_SQ^";O=0=;J#7E\=MON>US[:
M]T8C3^T?^?[^X,@;_5_OX(<[O]7IFH]]1_V>2.7LZO23L]]R+DXO3R_^.'U_
MU^K@6=O_#J.M)NS/<>9XLUD()Q;.Y'(2D(=Z>"AG<1ID0%=O$Q5Z67"MWMT$
M?C81#F4_);O1SA_Q!L!1YMGR1RQ:&\)14<DS+<Q>K[@6]O].$CV:F3=6NX-$
M>5]WO1$,]JT7WGBWZ0\_%7<:MME>P&5S7Y<B1J,GFSAS7%\-X\2C#9L#(TOP
M+AB.MS5C<2:)&OWG#W^YFUL L[A"TD8F^+>?O-I.X@2^ ^<AI3E44.9=9/0P
MGMMOK\=SOX/ /FKMK\^'#UK.I^//QQ]./YU^OA+9>.F\/[L\^?WR\NS\LW/\
M^3W\__''?UR>73KGOSJ_GGT^_GQR=OS1.3G__/[L2M\#W/SWCU=TR_F7TXMC
MO'"YIN!;JLB0'E32VV!]0F^6JK?Z'^_\()V%WNW;(*))TD/OBE\ 3:VL=]$'
M^;+PFZ.CUD&WBRQ'?+;R8>%&+>)&)662K_5!YSQ<>K7=ZBR]MNJM6,G6/WCE
MK]UK=0Z6/VF_]0YON];.VZB;6^\SMQXMW'I?:X^HO!%)#^;F_=X//_\R3^&A
M-'7.8;6O W53P=?+.[BXV379P2W8IRB^]Q;M]9?L27,27\Q)W/_AYPN%=@98
MW-<JC&?3)3I6<Q:?[RS")NWM;?-97*[V-1;=$QS:([*&R#/IH3?N0J7S,$O1
MPCN?*7YSX0P_A__ :1C(UC"0(VSUUC"0AH$P/>QU?_CY<CZ%I;U%GC$*(B\:
M!EZ(GG!B)+7U$^',R,O1>5?K.3@7YW\V2M@V\5#<E?U.PT,;'BKTL'<'#Q4V
M5&->"C/\O779:OC05O$AV)7];L.'&C[$]+#?P1AVM/NAMGP&9W!\_,7YI+QT
M#MRSX3?;Q&]P=QI^T_ ;(W\.?_CY8_"O>> 'V:WC1;YSXLV"#!2?"Y7&\V38
M'.#M.L"X8?N-\Z<YP)JA]W_X^20):#.<X^$PGD<99ER>IEDP];+F^&[7\<7M
MVC]<=7RW*IMXS5WXY$7>6&&L4>?K.GZ0#N<II>NB5($;PMLT2(O&]3".?,JC
MI'N2/.X1F[B' \_,DAB3B^$MJ0/[/9_-0OJ8D\4N/9E.XGGH.P,%[_!\S%>&
M-_]S'@WIW3=!-G&=;*+PUSS,D@\CS> 'BI3*.$*Z(8KA^+C.S2083APO49+]
MK.@#9_"$<XACS28PQ.,HFI/0G,5)AOG4O\;)U.FT=__+V:$;<&&Z[7>%^^BW
MSKLW,+C84=$$AJ-HG,0(4LR&QJ.,ZS%/[#7!4>)/,\QUAG48Z.P+%5T'21SA
M7);GOFXQ(5WA4EFD QN6>0',&);SQDO\W8]Q_!77Y#+?LFSB99C*'H?7L/]!
M^I77!W8?F!4\G 4J;3EKKL9W2OI;<SE@ULXT)LH; 3UY?%0&\3RKH@BD')[_
MR!L2X< ]FC1<)U6*J;:CB?&)XXGTQK>H3 ;#-2:K4XB>,\HI)Y*6D]?J>#L7
MZP+VV?G5&V9QL@T+YB+SGJDA9L^'MVXU6ZS@2&MFZ_;NSM8MZ9?/=8ZK<W<K
MLN/6YLU%I7E[>-,)R)F8Q+.'Y4%1?$VU$\Z8*G*<H1=%WB"(X@ 5S2D,\!;_
M.PTR%*T@[P;S("3Q!NP^F<_H66#6*@R!C)!H0.H#?P.K= "&J7^-LAKNEO=R
MF0]V)0#AJ8:3"&8]9@,6GO/GP\SQ\PRHEO,GZ "@.\P\EBOP?218X)S!(+QU
M5*A@],KH"/.I2ASU#3X?*! CKI-/U@P;9PWW!D-GD-!G@<)'H%S$+;E;5"$L
M6P)ASI-+(N+7,+O20UJW2)W+&>@EP\F3'.I]K(&[6\==+(A!ZMOMM2KRL@=>
MJMA\^NM?.@?]IV:3*TG2=;Z<'I^<.I^/KWZ_./YXV:SA!GD^2)8?X\1W_@Z6
MS=/(EA>^A/?1O+>5N_\>A2BO8N"(R4T W N-(1^+0H5'XDBQ*A3V *RD_$;4
M!$8J0;:9HIU481T!\\67B%YUPL+!*!+Z9\-#[5]O5/F7>6KK;/(C*+[Z5QH-
M?E)8^(<DGL^<LVC8<IT@0V,C 7E##^-LZ(^;21R"5(AO(IAR.A^D@1]X( I(
MS8;'1E:)(;_EGS%P=^<:1 V&/.1MNCP6_F:_#!J=L((@SW#^ZE]S]+E.53:)
M_7?T$PB(J9Z#%G1Z(E,%VTEWS4*/:VY1IJ+6A2.#]^)(]5\C9ZRB>>ILE]9Z
M(G-Z=@:'*S?SDHP55; ?:4WM^F8O#$&#2 +6:L!\ GI/0-^&?UFJ#?P5I#%H
M"UB@/*2_4R_$F\@MX8D[0^Y9W&0,R#L3-9WI79YXO,>XVSB,,7R<U!7[*?L!
M.F+*H1<=CY-@. ^!!N&PG4W1;<)^DN,AS;3;[AS:<\3W[-(D@3)E5GX0A\Z.
M/H2_O-<^BIHPM:4$6:V87\*>9FI\6X_)K:./@Y7_-46"&28*5=IK+YPK8COI
MQ$L4<#9T+2$/&L5#-$O&Z*T:H:M@B)Z&E%<$U-I9$L3H6%;IVS67IU=<'OQ3
M',H"BW98N6#\$R(,1-G;W<[ALQ6/$ZWO/Z/N4%JN/FHZ/_P\3N(;8DF6N8!,
MQ;(^Q MV#YOF7;.GS[FG8ISRMK*%&(P"8,-B/H/H$#T"S.,L"09S\OU%*KN)
MDZ_-YCWKYH%>!ZI?D$[$#Z!&HP#4+A"T>O<P1''K#"=>$)%BVNS7<^X7B4+>
M*]^9@EF;!?]>Q_/T,G4>XXR\5&,I#ZS#+%<2WI\8^6/C<@(&WGCB )\$78@G
M^-:HVU& 1A@%CXQAM6,9HZ1&RV-:\[4-RPLX^BA[_XR3T*]ZP<7YG^7G6\[5
M1($%;8\(1RNQ.WQXK.)QXLTF(,X3T+TH[!E)X/%&29Q'F2"/'XS(Q,Z,KS/&
M'X"D4PIVPK/*@T<77KMV&&R;]_I*FSNRF Z\<3X"TPQ-;Q?^2KZJK"0[X>O&
MU#(6CRQ>:FA&[:*'6B5#\F)D7A#26R9Q2BE1:*VCT1B!(@6L/8I4F!K[RZ8L
MCM_2[T_N2>L?/,B5UC^\VY?VU$Z$E;M-ZFU-&/&=9&MQ!XPE2-#:UT2$MCLY
M'.+(M:@:SC7[$YBT)27 !$(,&8_$.S=5/F4#D:/#AW?NSH']R+EH.6>1<^)%
MGN^9L(;PEY185,'Y!1)%1?"P-AMSPM:N'/(M[/ +WQ18H7U'GNGP!3B3<CY[
MY*1(G2])_$]TN:%#SK@=BO?DSS)#1!>)S!E58HQUAV2F@G;L)7@$;^&$NLYY
ME'E@PA;&5/KZB3>=S:T/X(I=P<F&-?DMIC!/ZGS,_);K?(U@03#_1);L5Y7@
M+G)$WKA+%J]5#=ZK&/XMTL"?010%,P6[_<D#?@*J).W669IX*N0,%O&6YEN6
M[\C9IY/=#\=?7/['IR\<Q,9_O__B8"X$&!A#21=(T/F8B#]R@?2LX2V0G9^@
ME3(*XQM<8Q!BNPG0BZ2D!#E#Y$$'AACY)3HV1NM@U&@,"*)P-*Z'DCLUT!3+
M4Z(WMYQCGW.'O! CSAXYVC3.("-*:I!R0^@3%?KHNTWB;Y0<!W3>:?\'.P%!
M!TS3.3G". $6?OTC0$)Q?E->F$V<C\&4F+S>;KZ:[S"F:*@$WEDFEN,Y3BT,
M//T*30UP.&#^@L"(0S!W1J"=#>?L?G%.OZ&X&2MKL^$N<N&EM]-!'&KR_N/L
MRO:&EV;::QVLF"L>"J"I!C+/<&P$3"GDZ)7@R=9,7M@WR0L-SMYSCZ7!V;L;
M9\_.A'M^9:K:AJT$N:F#BGA/6_WD_(^S][N=HWI,;B4W!47&H !WVYTCU+:<
M>)X1%Z1HIA/%L)VD!@0$\@NT#^+].DCF8-?II0#9"9(5L88S]IBBXC0'^0BW
M@.4+*M-E('FT4?X4*1SIC-*#O6$2IQQF0W^=LD-B.I;F+FH<K!Y2H-NA<"Y%
MA(V=KG7IA +"<!!!K>/0.*MJ_#B./8%#/8Y@Z22A&3;#5U-TY7-@F)P+6NDX
M3\:@"_Z;> !Y$O(IF><X<9J7PJ,XSXQ"]!BO1"4.?IZBTNC!]%.M 8BK$L82
MQ=-;"5FCIRR%%X%= E\,=4U0GDM[:VP5T1QLLT+"#TI'^/4 674=P^XF$;L_
M8 Q3S@B3=70YR1NS!ES.QT93?AX%PV#FL7IOKW^%PR2+XZ^HCUZSZGVM<"O@
MI1EG)3J\%JF]V<,PIA)%HC6>H,F795="Y'M9G-PZ_YI[8(=F>,4%E6V*6TP+
M2[#7<[%2,-LK@S.#9)T"A<I2!PG83U-\$G8$*1P^"9,>YIF[:4QYZ.BND#0W
M&#O/M#"CJ=14 HW/@>3TGT#<<'&@%/I]4D[3"(.14,2UE]R2MU.-$Z4H])<[
MD$J;<HT6TSRU]X4W@PV!PGXX*9VS8"K9^)ZF-5"YVRXL9&9R18((E4TY?O 9
M0\)%J@NBD6**9=L&S^S0 ^/5U_;OK7D=A3CQ&HP0%M?Y)RC+J:\7%?/[P"QQ
M!M[P*RPW'$&*IF.47T)E$\_G%2.Y"LJ7I/[OPGQB(.'"CC.6J:$75_^KFG!X
M2\$,W?6R7=QYAQY?/PE]F]EX-0?2NT(K#RL(AVT)DW$Y8P5-4;+;R@S7+7!;
MO+HQQVTY?ZHBO<"NH24TC=&Z3G31"? LLLC@1#BP]Q@^5:[F87$TCI%T%N8,
M!FAJSQ&LFSD?@<)BB.4&S"KP<;XJ2LFC0X].F,=SKLA(9;>ZUD/!H8IO\;0F
M:DH%$'&D]$6@"2LX_R*HZBRR""'"4#5R(6$]Q-UR-D*YNU/@6\);S<[HNAV;
MO:+(#)B3V%*22B74KN8+\<@ML:)X.)S#.@QO4=!Y0V9X063\PL#A0Y6E1=4!
M^08Q%Z"R4 ITV#<'Q +2#GLFF%HCW,V"(! 7@%7407?8G\-3 *I!I,8>9]KK
MLX;?2B=QDNU2GM"22BH[5:C@/ GLY<_H(.0BQ<,-0:T-WF8'-O%_PU !=:.4
M0'F$[#JF@AV%PPEFIA+%AZVY31U?SF&,#VEQ@6$;7$B:"=Y,F@&(5O2%D @J
MJF?YE:H@";:"@)U =_Z-S"**,^=6X:[0;%(@=^(_Z(3EY1LE\;0X-QT:)(WA
MILA&-/N@12\L"/.7E^"MMIW$^?FRJ'4 -!@YH(2A]H/I)A[E$GG,]U5$<O[O
M<^!:H YT'$EKN_:&0 ^>D?'YB6/=-HR'7WUTGAG5)O.^JD@3Z"A(4MC'X!ON
M039).:D-7@^[DH;QS8(&L7!2E+]X5D"_@HW%+!O@Q;FOD369#@],CY-J"[V4
M&#-S&Y$3YR 20!Z1!B7IF6;A8*W0LPO+$Q2,(!@XJS?"CTK<@?2:,HN(XF@7
MM0P@1T(G(O:0 CGR<:!G+%4Z/SK_/5<#-:2SKCST4J)G]!UHIC>P (DK[*OP
M.3H]6C6#)<?8IRBE\H&6<XJ!1OVWPW49DH/$:6=&/^2N,;M%70RYKM:@*H<M
M7GR7"C#A#M!ATY19 0?M9A/:#N*5YN7,%5!?!*X VKHE/O1.IGKG@'SC&RJ]
MQ*2J:!>>2&&A@41F,PJ]9+<SUE8,&6)M)]P\PU AC&],C](F:'%QRRUIS)1X
M+6EW]--6)0OS^!EG>NID+3%X:-E+[Q'EGJF&//E<#LLY8$P2.'P,V< _;O!Y
ME 6CP@$<J!&.F%RLO#D6,3'9S^),* VW,D&7M'UK@5JPN)>5)>W>7B6M*D74
M"^&<6H.EK:MFG[EX95V&7 %E[BBW63SRW*@E9(3F@KVD)RR\?GU%!71F/R:9
MB<F"HL>S%EK0@PO3 ;*E3WH.!AL2)!B]U]'=#%<B.B]@\T]B2B*2*DB2A".4
M2,;KLF@Z\;KY5",&1\2C^T5,5>MQN@C!?KW13^; 4SP*,?'ILQ47V-<T1D(+
M8Q35J25ED>U,!R*]JSQ,N/\D.^B#7&Z0JSYIX3L#E>N&0+3'&5>!H&L$M'L5
MD RA1)8YSPG(#=XWA#GJ=<KU+^23^,99@I%$F-D[UE"1=_$28^AR2LJ$&)YQ
MH?*9&"V0,Z,# &OW*#U6\#%\]E20_BK/\\)I0@YO%W:G5%A]+SR#%V&NO5>8
M$<.YQ;QHRPF<U.>!"@-U+4R'^(&EA(,^-4$^,>'*#-]F%G85S4V 'AT\+"#S
M*+49='$%BGU8 ##2GDE+,G)N!'PZ! )@&H^P?BF[40@:P,KD4_(?]$,!OYM'
M_J[LT8C^[]WSA1:HXY[)!?P-KH1XM>YQE&J";8IJ'P[\OAT[^0OF@X%X_"*9
MCU],2<3I-QA@*DX%MN$6:/FY?*9DJB!L!Z>CV)D\ZMN,9X1.S(9.-Z?3\7PZ
M1:=07B3#Z3+ L";.Y?GO%_^+H8]FA1]6.2GKY_QZ>OKQ?__ZE\/^8?>=2UG'
M8AJC-8V&0J1NC%7Q=D.EIRF >)P"B.-9 L8A\IZWS4EXC)-P A9(<HOI?,K9
M^>UVD 3^&]?IM*>4(WGUVPGZAD %'GYM"/\Y"?_O<W%TOJUD7,[[T],OSON+
MT^-/_^N<_/*YN(7([O;X3[C6[.A6[.CY,(O%>]XPL\=A9E=)3 YN^$<P"Y7S
M"_&V[ML.D/W[MW 2,(M:GX/W="P:3K=MY\(.*RWC=IVW/=RQ__?DEQ.L,!C'
M), 6F5[/[/8:N_OZTL+WFD[J38;W]DQBXPSOE93TU#&R0ET.9L5Z81HS)@F7
MPR2*(07!E"0+'MTCU]Y,"<8?UQU9A:_X<^C-H^%$(J.F+FZ@.#5  E\(6#6.
M=?X(L<OU1=?W7[#.'BS8'S#Q>XRR$;!/8$//Q[!0*XT)I6;.>V#YTW\[OX0@
M,P>D2/W7/)TX.P>@3H%\_?_ DGCC=';'B3<E<FXV]3DW]9-7,@_K:D \:XWV
M29QBD/A#@@D'QXC.3MSX2QQZB?,)2SG_B!.@1&?GL-UVIN.?QG@4"L=@>=AI
M:X*>(+0^(Z#: +.E"N(K%SLW".0Z(A&6E\::< 3GU% 2F^O\.L?0\LD$#C7<
M?0R'')?PTSG7MYA7YB6?-:?09S5Q&6V74GQ3UAETM<S>+EHW[,!NM_8PHW&:
MLM4C&]C"4EQ*$2]OMS&<WX,RH4*PESZX\,H>OY(,J \5]+#B6XO;710QZ7RP
M6R=$A'O&I,\J\9^#"(B.81CKV-/ *+LWI2QVG<U("1$C&U @GS$E2#/F""94
M,^U\"**OXYA2M8!",+'"-VBB0:C2#/%&3&E_'I*Q@2LWT'T;!>0I'-2<(0T:
M2*:RQ)O<^DDL^X2IQ$."%360 R V_SC6B /-SCWGSFE=0'9/]FPX26(XQ^5]
M._GEQ&Q;$PO=)D=I8=_PQ%7MW4//W):+W4L#O((:DEUQ#&+X]QFV2ZK'O.^2
MP[^J03+'%L^P][UB&@[FB&*9LT\5U,$(P<W)YV0!XE+%@A:K%XHFA4+;RG\(
MR!?'-6I4U !ZH:*<TND,I+*4V5+YL)70RRF)E>!$KA-Y4TP]+>" <BDYPOD2
MA*]K:BAT5PR&/\OA$:C\^9K+V+B4UD*7LLM8=1IGCLI.[;Q0&4L"F%)R:YI]
MQ%&>-EX/^EC_7'2Z_X%I$S,$(JH1O,1=!^ 3T4:>A/9+["54J?6>D._C)$70
M()PT'(1"&Q,D?#).7+#HORKG0YRH*,T4UD0BTM'$"Y(I@C!\ 1(D= ;N)@KJ
MZ<@Y_::&<U)GSQ$J524MYQ/\?_X.*G/'RG,@=)B=U$/<\Z5D<;&)ADT00[#;
M9IGA]6TJ\8T<!D^*V)#-Z[?RM^FO8@6YJ@EAW[7O>0)0B>N9S;XB7^7[>#Y4
M&:[])2@QP.G^@(7-5]]U/JJQ%[K _,;SD*$1CD<C6"_F*B=Q,HNIK@],YH2X
M!5 'AK]H5Z4"COH%87+]U%1+"99 H3:.:41&A 6\5,]"G%9CG=-#B&K/.(UP
MSWA.C0+E!ETC9F>;2]D)XA[04H28$3Z"E;X%QKE0;$KM?G:IX5HU8Z0%H<]7
MK$FFP,#G%3\.@7M[SIG)9^>?V91S<@G\)3?V^(XO$P^H$<'TG/.98?X:J$$#
M@ IP90#T]N^R#5G[S/8[J3MWS2\C[^/D5H&]'(R!X0"!C5>0^&\"4G&A1>E?
M01"_L[&&[D73MIT -/T%"_>I7E4>1C ;>7+AR[C3A>_BB;!G<2-UM1\4T S0
M(3?B9&2#XKP6WGME=<W*]($Q=WST!FG+^84K!!&.3Q\(6=KE0SDY/<=O:7JG
MTBX$471V8(WDUZ5:RF0^>*,!?/17>6B+'R0<R-"[)96-A)-669%Q.Q;".@[+
M5!=1795'E9IYAS($5:>JQ5!9O<:D!(N'BMLZT$B3&88JD[&B+%>M(8K/Q8"K
M!%0?O(#3N?PT/OBP=3O=O>[1TQXV.P'+=?ZN1B/G[]XP'F#-+,5Q<_V!Q/0'
MYK<%P6\>J!3[56SVCK,J']GY'"?PGV-@A<#LWY0^MD*&V,A4^P:HR0.VNBMJ
M#WYE%7:I_24S:FJWD&'[)'QEWGP!.09#JVI4<K0/$/9Q2!5R-WGQFF\?_YE\
M<6KZ[>I",VK57O@]38/4G&M$-+ Z#F $'3@&TBVA,R Z42;F7[%-G89W>N$2
MI.#,629#_N[A1W^+PRDKITC=OYK:/ZV$LFB(N,8> T*^&GJ^LCH?,S5X>:]N
MBS"X1HW1J6@ 9+ Q8%D.?-$"PN?JXH2 \!:.SP?&I%D4 ;_*"*Y0!;9ZRF;.
M'TBIUQB_$$ ;Z;I,E#_4'<;]8$S%=4$T2D!Q2N8$NRTD3+YMDGR8R278&8PF
M GJ6I&4,2R<;QY\8M87PIH"3)[[68PCT"Q2?J?X!>*^G)WB)/6U\X X@2V%6
M(#Z(!>MUABD,"9)I093IV>*QI1W-UT\OT4?8!S1W]-^7>E*B$'SAEY>7TG:?
MX+H2FMO,PZ:HD2EO#3'JEYI^$7!Y*G#N^,HXX?)[7C@?VSA91:8,=$_G>#@$
M3C2\=8O"B7@-=Y/6[<<,X)VL/N(V)&$ FPN< 6MSA["..%D")<+J5RRJQ4"N
M#OFQWX(KT0EXEAARD /"Z37W%<8K:#H^>Q?P_73>=E'%!J4X(I+): 4ST58^
M>-/!TYI;VUF#V6%&D[ EBG9J/2S.>Y;M7>2UT.?&\56/F=[9H=NS.Y:+ADD[
M6UV^/RSM-W?F1KO/.3MSN>WT@49T_F0DNF&8[_./X<$Y!C%]FU)8VY)&)X5*
M],K5=ZT6<CCD%2WLM<^3SJ^B:D6C,0G(=J<FGI)[TNT)UJ;_&L8WRXGU]25
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M1?N!EY>#FLO:41.VQ4YG!FP;08NMIX0.VODC"/0>SK/ECRP@7#X3?>P=EMK
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MY7$B-&-HQCANQK!;IMW6&D,SAF:,7#>=IMEMEN^^?DC&(/_H5<3@=7$L3HF
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M')7D_FO/:&N[[1R0DO+?29#:A+=@#P><?3MG8YCL:S:]9P_ABU=9W0)J1-W
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MP#ZQ*KI+YC&':63=)UYYA5.E.UW3;E4$%JKVL&::<O=)N4W3ULBZIY6+<$R
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M#Y1*(%I0#AG_#TSH-R Y_" Z!Y$V4X54/;9BQX7CA\7+7D_IJ>D(3 2$_L/
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M/KG&]QY\#IL1PIDR#+.CG)2#6^V!V0>3R>JT*5I,*YK!"0A'6.R.[W%PB(*
MD?D?PHH"VB''#4>+$"T@$G@&EOK9Z;U[-<QVN=!K=);X+1S]^V0_GWFB:Z=%
M>V6]H0N-B,\,2_A:P' 7GK<@ 8E-FL&9+#:&)9$YQ@^];CN]9-ILY_Y@@:UM
MJ;\G&63D99!)X0^@ :*I'_K]7J-9ZBT]Q49?^9:5UKM(X1"+!Q4P*7 '\#U+
M#R;[XOEX8<4##_92LK=W6W?/M%C#7B;"[XF71RDAJ7= "3"PS"F;A_QU_,<;
M$ /S*7MX[7HT-7KH3?:%6(&7K[C#%XJO4V.YT10&LRS^DV^67S?HJUPVC_BN
MTV[T>_;*KYL-:^5WZX8%3K&;G9V&7?]=J[/;J,<UV?Y6PV[9'OQPL#?]\II)
M5/:^QTLA?P&#.B3GZ';(0;8*PJ62WV3I5F>;M5>OX^N?G(%93+:0*K7WW0J^
M(&.OVOOVV&[PZH)/;>.VZ0FO-ZY@XYJ'+L@_:'HL7H:26;LNO/MD_8OR]''<
M]0A;K+_:N=-G_;XYV &5L(Q\J$')C:;CNM.QU6F97:NK"5D3<LT)N=TV^[T2
M"%;[(N0G@G*MG]V$J2&NC'J?22/JI8S[K;>BCAUIS3+[;5MCK57W@.R^V1^4
ML.[T">V_Z-?J'+ SX,D[P\EMRF/%>(U[!M@@)'JZ9T!U#\AJF>TRBE:?T+Y/
MJ&4V.^5M=FV6E]_J7\9CS(/QQYC= U]X:3YN%,"X<4G3FDO]4S/3P0KL:CN]
MPB?4-@?-O7;PUH=4_I"ZIE4:GJ=ZEGJE93M9YTGM-XKM/<'>G%:0]-&[4VU&
M/;-LVVS9Y;N@/='VU..F0+/(2;/(P */I40O!LTBFD5.C$5LR^SV:L<BQX!_
M5YP93GGR2FW,74A)\LI'-4^(WX#[(WR/-$R=\T4JO>:U*WPK(%VH$D0LZIZ+
M_Z4H_0_]?@H#(G"TX,!7)++E*CVL3BM;3R+**G+P!VIAM9>Y(8"W_=#MIN7<
M6(CMAHF3DJFG3@'RC!_:=J; )#M\#!&"!;@2R8$*LOS \'SO7"POXC/$0%@@
MND%8"%2BHGO,V8,L='%P:0@%%,-OL9D/XN)O^L"4=7I,X&D11@H5HF>JQ+W5
M,"59##(6+R<M2Z>-"7.G$X9<EM*H0"6XM[:M%-;DT'Q2_"*LSN C4>$&_V0C
MZK>*\#\C[MZAJ"/\%+$%M(]RBR/V?>DK>#I8(%@8S@>^D8_3OQ8!+" 4<TLP
MV.I>9U/,=._C_(6\6#EL(=D1BS0A4:@LLD"8%>63Y(29K<I!)WG#&GE&+-;+
M5LAE!)PL3=M"J"%'QOP10ZE\!D$R8Y?,\XRK&"%0F96$/%.9:AZ@6(@>@">G
M3"(.HK"9)_B#MS#SB."^$JXEF$7'#8>+(.0)(L?4A_-11(#R;GL57*K$19HB
M5 Q.9T7%LC+2<3+_K_&M=VV9OR(H =MR_\:< P'29*MX9RS,V3*M1EMA9#'P
M9OZWFHU.8KYLS>Y9HP@Q!2?^E.K&2:<"?[F$ *4:(>R>!4[MT3?7E*4&**H"
MOAX+J3)4^%["IW(6D(BC:F*!SXCTA-C.6"+/[I@[)0&:7)BJLA!^*2PY+@OJ
MP71,(!L4W"UXS[V!6#+X!,SX3OX>M@ LL8"*H^_Y=$K6+(U/1B+\Y YHSU^$
M1IA4M:/P]N"9B3L/Y83HE^(YCN ,?TA4 D3[18  )#\'C@?GF4(^P%1F'(3_
MO1]\$_@5 J]!/<B:T.MZ'Q$V!V$7 D1]&.5)58(^<"*'L8]@G )"TR,,Y$4&
M*<(?PGIBB(OB<OW7]=BQDCKQ Z'3U6-IFQ!<B#52!VPJ@/?0^QDN7!+C$@P#
M$5FX ;,<<=.XXQ-W%&/N@7GFQ%Z>4%A<C"/<--($?FJ[Y;$=A*)) 1Z(] 3P
M"<+]S1:SU"N3M!HC;\!/0Q[/.?+A_-!L;J=FLRDP;L&23EU[Z<C1-R M+#M!
MA?G"QSBH;WSR03;TJ@GLD26^PUA? L-#.M^(=H>Q27+(4T29,((/DD@ @7WT
MB\$^B-IB<!77(X ;E"HU$;=ESR_OC!"%Q@$-<D:.2K90F2]9LT0O >?DCQD,
MW#<>PS[!#C 0,%/$I0XW"8C+P/?\$-L%W%_Z!'J2@Q-J-F3GL)CE05H$[)Y2
MO5QX'[T_/0$I)#P? V 4+4J@J6'*0W 7Z>%E>7$!-HI0A4L>IHJ#-"5S&8;(
M2YAV124,+>:+LC\>KP1HT)8"Y^GES>GA2O96XTIJB,A#ST5#1&X-$5DOV^!S
M$C5-7:OJ1P\(3+%@YDJT"$6V&T;BAB;U)=4?HP,N/722\GX S@?B,XY\#.82
M(%H<3  SPE_<3E3A;41\-/%@Q;</J_$6E6LCC)<M,'H<^N/HG@6@Y< B<;$C
M#3:(,<+%? X3Q_ $^#TR?L$B!G^PZ4/DCA#V4?3S*5JZLF#/]^(6&L2)RJ^4
M^=#:.3E/IF@1X'&).@Y&#4=TPH7GCL1:Y:PV&4H2$JYP@A3O:S4Z&4,I<9>:
MC6[6@EKI-%6QOT1)KONR"AM^&RZLE?D]PWY+<SC&+X3=_C9A1FF#Q]&TY#)9
MMH/YV?4Q+A8:_R,BNZ%IO/=&#>-,VJ_B9]),>VFJ 3PEZB:HNC#LI#!"/#7U
M;HOX%4/6LL>7P.#'*R)@S5!R)_6^^.;Y]U/NW%)_0#(61=LKSW=Q @Z<2?"P
M)=\L@93FO(H8#7+#2M(81&]+GLJY"8-JN@F7()+<&,X2(8[IA&XY6.,Z/O$X
M./OM8-N[[1=5MW_67Y0$+B6G&1<B2P,#A;_ A)#A:A(!*7DUE*Q.F"CQ^K\N
MG%M!B<,'$)@>N%4J3F^UMV M*V(OBCG>SP=)+Z*M61)^A*R&ES,D0 DF\MW%
MQ>=8X(;*7@D3ZAOHN\P6LS!<S.;2P"2 ;%$3B),(B+FYDT1],%^H,/](Q*01
M]GGJA[+!X"B6=M&JI"79=]"A^[ MURT-OA6SDPT9Q:O2AG3B"CE]2 *%N[Y#
MS4#"S*8$U%G-Y?<8;*0?(0E.'V0 GU+,I$S' #QS.'7&054(YCRN1=KG#XAK
M"7\\&$-.&52H>KT&25)Q@2 PNJ6I+SKKX)$]P$Z.4;_%UU"@7"FS+"J8J\-#
M8).AN W/7DJ%(L^K)E'B#1:HJN^M:NK[GY,T9M/XF?K9 $E^%LD$2LK@]6)&
ML/KPY37LK#L&^@(F463\9V"!4[$1T RER^U8UK-T'[*B:BYW)6XOB]2/H/-$
M[^%Q7J3*'N5Q?T?<L!+KK!#[RD:YH=JI\G["O9BXL%="K 1 DLY<3(*Y]7V'
M.BU1-3I(@"#-:(V3(9#N\+*$E(!080$?8XIKF!"NZ\A.$]FLC2$Y?VXT%:-B
MKNYWF<F#Q$I34=I)I,YNP_CE^PAF*/-WP+-QHSC9EGTWV"*:^('4<4"DM]AI
M@YJDG8-CYN/*N/H\U=?+WL-Q#^7<*X16&F'!@Q,W8HL; &/N7=QWW,LT9U_F
M7(5?*2V7]-(9YBZ_%!:7#YXCAW,)L7_<\O?Q/.0)TDP$9D"4J/:'V%^C[&">
M2U0NF-2036F#PPGGU#TZ[KJ:CHA=*L"F@=> +HS;M2;TH^Z1<A3BF^0X-B<?
M5T[MO<?V\*(?B9G8.=+,$MNO'CAN /X;S;2X2RQFL</OQ9.BS]]07"'"V ['
M7";7BZTC8C,FJ(K:T2=\@ 2&XQ)'"FOO$O/IO(>$P02[<3(?B;HP%TGD0F58
M,+;?J!%.W*0[5!1AFM*'U.A[PNQS85'>0\.X1HI,HS*%$R0;2D+-*5E3XA;5
MH,(?82U&BP V=N:'>'YW/A#6>2)7Z&?P8G@!&') =C+'(MU/VL/T?-1-429@
MDJDN6Z^,W&"TF&'O.SH:9&.0?!3)X7++4\8&&F:IG)/%"4G$V/>4UN8SV7$Q
MMF>IY,&XQ5$#DB+^BN,0W?#B:2\H363"T_M=[)+*X^(%3%*1*IE^M>*$P=QE
MF!%'1H!\=(A):G/L8QP+9BFQ5Q-*TL1&W=BX 5(LN OF#V^%/2%;@N,!4, X
M%E*JY4$-?N#01RP4R7E;+"[[/B&)PI0#B<&D> Q%HT,B5$6486+=-)9/<A-R
MU^F@P$1OH )=)TS\8$9<'J<!":9&4I6MHJDX8QUQY?)<\=(_U6_X7L$<F=>C
M26CUWH1%.Y)L'1SY8B[D.JABSD:3):>+/+Z:>"4E[;5W('Z(1$6FI<-!F $O
MGD_=.Q'?!>O"1:(2+G$]]N I5RR4E!^I3;C4JBK*1HU06-R6')A*E=+2+D;.
M![KM\/D,,VW'06)!D#(QD&E! (U -H3$.ZIPCG.ZR:($>3^E2>#]$KP1?!&\
M;44/*'TE35UFF0LVA2^D )4MM%).6'AN?*< /X7?C5@0/%#*N1 )&5$B^^IF
MR]82W2>?&#XH\C(_'!B<G#MA+@B"LTBX.IUN37BS5.\]VJAEUY(VL2RIN23:
MUSBLB0J4'DT<OTS3,]$\QHN9,+:]LL1"<K.8:(C,TNFGC\5WOG$.>-K@7.C@
M3,<Z?*6<8&S/<"?50U*O*!7"\:2RL\G<9"EC"C*#[1^?8^3J// ?V#2M@I1>
MP ?P9XS_!0OO>2(=W49GFPR,Y7PE).;S5J.@.14:82+;Y?_]P^JUGSL M9;"
MC2&8ZTXC$T1RO?E"25*/C]; :@ X_]O O\=<2O&O3']$-%>_RL)0^LI,Y(L^
MIL<?$]A;D@5P\V,S/651>7"H.F+K"MCP Q77M9)OL2'FF*Z*0=A?7%\:?;MI
M5"L(^BL*I-])('WD#"\##MU1L5&M#7KN\]IXW;1&R(_)V5V2\J)K:BIFT(("
M:X0& 4*,?2LP!;YA06S20A4<Y+&\M%CZ3AHX>.=!FK/\I!P^P@5F)V9*19^Y
M4DE&"+E0P\*>D[<L=+5"K7FE4HT#S/?T*Z'($Q-!>&C"&$/WDSK;IA; +N9$
MXHF%HHDO6K^)@D=P3K$E9*ZNR2<ZO1S<OL[!U3FXU5E$77-PMZE\#;%#MF/\
M=\$"S F%DTJ:ZBKW 8J/BG<&V832LF*1$C![?:50FQH(=[II#39&L4)4'# $
MRGX9'Z-$B*RV:!BRD)S*=,7%Y'^Q5[8;D7Q4IQ[)@EH1:L,KR^5ULS3RFPD"
MB%DWFME$-BQ(5[9)NS]/9E<;CLAX3(Y=JO@DJA$"]XCL2J6&TT]R(J=L]$W)
M')$>$D7VL=NA*</N\I):N.QI1I^ '8H-=HIP)H&A*'!O;\6'0G.K[O?EU>_O
MWY[+EO#JA9J7YZ''<E"KDV.? _,.;*GGIXD Z9,QC\17G-3<.PUOA'%8(=V$
M;.1!<],3<),($W)G*7Z(>7<^Q35A;E;SGS4)$>X Y"0NU!+/O![KW!0*E8%%
MB?L@EL@BB2I$R7I8BA'(ZV28]-]DD(G'XFMBK"JG>*5X&[(I4#28U_0XRLQX
M:,KSH"0,<0U$E_E;O4N5I=+O<?B, BC%+J3\E*ZW0N&.91/DA !?S'TOD^PH
M@\/IE1L+0953,>=P(1-)\''7 SDE;@T67GR-BR]>>/(Z$Q]:"N@DE?AJ5#3-
MQDS4TU+^I>/3]8C</G@+RMF1.R<=(!2)"-QE+BOH4;QTIML,"A$+64H:99FJ
ME3Q&X1U_QSH!TP@Q$CCS[V#[17S01V>04U)C/ B]"TXX<Y$I!DC3.$5E#_Z=
M/HAI,.+'\H"<0AJ@V;-IZ%-0(' I1R =Y3Y E>?X]UX8*_\X(21'"S>9MQ>N
M'1XN)$.8(?S+#2=TBXMP++2D89S5EUV8N","S0@'![242U:!52,ZF%$@7);2
M21-K(QV< +;@:)((B4P1,J;NF(M#2O<S_D[PC$A0R%PS8+B%X@IRR7$&4?P^
MD5_'93*-O*R(4X?3-&Q&]^49!LU6>21H2W3%E5_-<6J/#[YW*VVQH[G>75H3
M489:MSB;!ZZ$]\PATID%D'2;;%9QNR48!'5&_NVY6UY* 9-2$6]P4\C,K'R,
MKV[)S"T0PS%EF^EE8=X"PBPE4?1%$T%A*_D=)2TJ0M(#^0U+OQ7I'VXH.5+P
M.?/DSS!Q>"X$#.V!^/>*S'G<A=@?D8\FZ?2Y*"DQ7!S1=,-$%8?R*R4178FY
M4L!75"5@:1=FT0 1NELO<29"_R(\3*(@%D %VTH16V43A,A E(E$KDE)L_"4
MRTI0O^>8WZ=>4L8:!L00$WEM*"73Q%*7,J_S9%4PB3ATO?8B??W\U.T,J7(P
MO1G-[%?J59K%%_W9M-F,WA4Q;%*10Q[=\SBCMB";('O#O+1>TI9%K\9<PI$*
M)BO"8P_"D\XSJ/3]U/-$,C=B?VC9LT"2?V-,@"9A3\SEJ0MHWV02RAS=,)-&
M@IOMDXFI+M43)A!(7]<A>"Z:F6"T(Q#0F3R'PA2', %+%+R?HWTU9R8A1'$1
MN38E?YL4!RDWZ#BE"/8#D7J<O-7,I*&J$LU4;)<-#+9,T/)^6Y3F@/X6IKW4
M+,5)%\1/J:^3%:ZY-(<U+& "S9'%6KQ>!?DF%JM@'1X'):KU4JD6!R6=#_8H
MFZ/$MU"EK46U-9>!V%*TO659)$P5NEI+$F,+YX#*/,Z98)ED9!6Y$P]>=3%$
M"N:R,LGH95-F#PNR2NQMYN678N;>S!QR')(\M-C/BBC*C,5AGB=20F4YS*:9
MH+@<<C(,R/B@9U'-SB</(?%YXEI3TER2V7\NTS;3":.IE22.4)02E/R0N$8F
M68LD7"IR6O,8#\6+XBQ<Z0+S&;C#A& 9QF7M:M@V#'T$98]?ICC8&_> U'HQ
M#2C$(M ]U61@15 D67?Q\%+)Q;61*_.S""0^3Z*[)FT)!]0!03N*A&]*%8AL
M-#$33/SD S*\XY^2,1:B6I3?QXYRT6!$,[%/FC5YZ'?D? NGDRN[@KBD8W2;
M3>GA<LJT3BF-Q*SK*R4!V=QONO7V1O)ZA60 _,"?N2,9D0A'://$4\^L-S/G
M=+Y(R7(L"7T2N[^!*(BX(7-JU2YE1D4<,X*_0)P1"ALHI1.A"'+A"$QU;)0T
MZ62)996:JH?B'$&18*$06CQE&0!;G;A1D+!QL4X&D>^4#\*)7 J1:D&(S$K(
M7K#SBC2+I)!/C"#?E4PQ41M9DYC*1D*EBB22<1PI!;/^E C4);I:T0MI!L?-
M:C-:W53YPBW\%S=[D5%DTA^#OG^;EE6/W0"$0?:B1\"$ *&06G5DV'"5473/
M4_$; SZ&<:&>!$N>^P2=/.',D:\*3<5]O<]8;_ OD;\3<OX-52OV#0+^)6@3
M)NEU_?6;=($(^%]I09)KK4%U0N?^^'P1(ZTF0C"KIU:O(E=(M.6<K/0>7"UQ
MI[)S3N4C2VC#ZMQIJ@A$'J/%I->:$KU8 -JF\1LZ09@<&F:B8%)83!00?U"N
M/N.]3B$L)9=QU0HB;.O,V2@%H&0#RGM.\9;R\]UB7O$M+1?,O=P:IF'\C/>0
ML<9=^KZ@(C)_@4O]%?)ZOZ@.,EN<J72WV:Y 4V>&I9EA YT9IC/#JK.(H\P,
M4_7_BBRIIS0 +IG''#=KWRTK\]3>EV&:0LLZ]N&*QI1EH0O/67T7D*1)H/N\
MXB4-XUJY!RR87"ZWA8%5OS*<6CC117*KM\)Y(Y<+[ MRHM+ 2J3X3&L]0^6F
M8<Q&,KCO&=<1>_ P5'L%'A5X<::8'DNQ>=;,)S_8'Z[GN7-^:QH?F>=&_I!E
M1DN[MN1VC$6@NH>+2'A?_NI=$M^Y@9+NE#_/.!D]MMF5UG'+EE>A-D=SS!HT
M!IFTOSQ,7:>:L#6?UT?<Z@5MO1&'YA@\KS^2.'\BR5041Y!.TP79AT   @++
M!S.7[&X,I4LHJ1B[\CKI%?,Y[163U!JMK8,DC ]@&H+O2()Q; 34(TS&I.!O
MK%PB"&<@SA%).N7(1HDPJ,2O=\-P(>X1EG!9-BS7Q;FYLFE9QI=RTJO)'/R8
M,NL&2+95WY$@CPAYA.HT&%V<KIE-_LIZ^4:49.32!1V-+,>@F.+6Y:S;;=!3
M5["Z058^)P&:E84]ZX-3)/!EY0N-(?.J2*E)E!R*#LN+WOQ)9..PN6A.JCI7
M5ZDVC%\V'V[N"E*M9#\"0?/>,RX6MS %:<\I4N,7P:T?W2GLL>]QRM^%_1))
M=2J.M-@_<+(1OPM^ OL8P^)>_OSN(@;%!5M.AAC@R#BQF10 :J #89[C5FDB
M6BXX^8=!/N<^$[96(K7Y&QRJ;J#A* P3BYHX#,-)]DD@7:+JM%LU ?92.]6%
M8F"IB\<%+M5(XX?+I*3D:#"TVN:<1HT)C:1K_!#N//*!U:1P3YC*="<F=H5
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M5QO_O9F3OW%:::U)TDY< \-YD"LV" **Z2=8*&Q5GC+4UHM[1R4(W$0PUZ:
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MK$@B;)0[3&&F 5L<C%><!T07UK<-J\8MW+2YW+1:?5NX:0%NFE&XR7P2<Z6
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MGXS$-"$15+(DL"@8F( 18.5LDJF>$61KBY.5FK"?0^I1&+6Z_>'/':5<WU1
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MK_DN4=U%OU?5R([[]A]?CH8CT\O+5UKTU\9:YWNS<X33GA6CP&EG\H8#(U2
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M$H!1$T!3(@ S%XV01NI0^6U,L+8B=94$-D/_/?AB%JDJW@X*F:/_%N./!8;
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M)1:I%I[HG&JD]'(5?>/_O]6F[/T>*GWQ@"+@J1DE]-@./L?<&>\I.??OS5J
M#<CK_S9V85"'.[VP-UG^E]]RFY38<)]K<9\WRW8!;(&G1E/$/&>(LV21PS8@
M:9,5G/F(%=@%C-^X!\JFNO:?-KVNUR:X KTVJL0:B7G1-$C41Q6L150JA7A.
M_W,*S'W+$O.@4ZAD<N9?F^E'B[#UM,EYO79!0\YW2LY+ED%R0BI*%!(N=Q3
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MR?0("D2Z9P3%&!GB+B:DB?*(,Z&5\YBX-=;=-)&*'R/8#(?7&_4'IS^>Y_1
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M'O&4&/S&,")2@10 $P<4X&?;5+>U64.\I&$*F\D4[C/$TK""^V$%RX"V6/A
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MME>M]P^TA;OT19M':I=W(BO5@9E)%7 C6S&LPJMZ6<?MPF*/!\/"KB;-V]K
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M/"=2>THD3W4B9")AI\W:T)IKPPMOE..&,5; MDP3HZCW)K5P),[:T&$U2,P
ML(WUN$5:[]6OGNZJR M3&%7DIO!X-Z$I5Y3)M% 41IGY9Y/6NXD)>T,[Z)B8
MS=$H+V\9W^V?S4>L"[1RATOFOG6*HM\*A11E]%:?A13@(_T-DY8\O$,[_TMH
M%A5C:_>DUS'C80LW3;O\<RI;H?*W%??6]&=\V6=O [A]F=B ,>Z8@8KO#]^J
M,>6V/GZ*?_@I1'P;.:UAS+/P:<]C*9O;H9SS,HTV^"ZQ8I1$& ,WM8#EMT,^
M8;AUP=GMGY99CH&R(&(.SN#H5XG<'SY^&D[N&BH4J%CB&M K879"@+-F'X@
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M?:2<")6Z2-%30AF%[\8ZM64]LN"+=$9U*6'_Q(!!4V4>Q@.Q>E&X0US:CP#
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MN[*:E,PW[N)O4R1[Y9M7;R<N+WI=@G,TAUB*@?\0!\8?,-$=IA+GKSVYHA^
MDP9_#AA0\09@\I<A@G\A[4?S2^63U=W^<,GE?LC/_QZR>ANX .W6(6C(7GE/
M-3P"9YL$U->>QHJ,C58922JS_1N("4<=4-8#>W1>)70?!G9N'/81S XF)9S"
MV3*H*K1Z\;P -?_?<1__$X#_A_'Z):CI2 A0@H4%+"RKEUUJ8<K[*&)/_14
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M+FS7?^]$%,9@4_ZQN?EW+'#5C;T[.PK7<>%J!X,G%?-&#)LL3$BYJHAYQ:^
MEIRL6J_,T9JJ\NYAYS(E&Y;LW(\J%;+:L[XT0KR-MV,-Q8C;H6(G1D'%3T@"
M'TXVU[O&!JXTY)N(*_A7+ [^J63VH>+G7UI[X-&;P"J-6O2#QX?M:!S+2E !
M_(. O(<^1'>[ ;AQN$BO83<6ZC7\H.6[G0"*4R'15^C^H^KM#M\^:+[]4B36
M"F&U7=(V#4=>NU98M#G-.4%V#$"*.H+;QGA>'U;UI($971:\@XW5<W$*?>\H
M!.CK+KMZ'JH([D19PE2%TAP?+("ICQLH.)4:GWIQ1#^M\]("\F*(#/<'@_X9
MWJ9B8?6@@R '>!S4ZXUE01T[[LYHX##MNCOL3_!?P]AKW(5R'+Z*>9(R\GHX
MP'3C,XR<DGY1##$S.1 *X*P-.H<5ME$ .XZ]B(M5=SWBQ&/\#UG2X_ [> NL
M UCF;"<1"+\&&(VM8M%9&>TP'MX8+I=#-*V.>[127ED,Y<Q#]T\:N,NA("K&
M5IL-MBL&\QAUKRP,T!X5H@0F9$Q1(U0@ZI$*(HK7X@,CC <:CF=%C;W9.#-B
MXOM59\2S1*T'=?7GN.>OU%89:"M, 0B9QZU&ZG&EF"389K\L^PY,>&ET??0@
MN5&6P?PZ#DL3HGW!7D$PUH]X/1!46J<$KU^LN+)EBBMKV:X>5/980/6UC?8'
MDZ8K>R#>2,2+D-C-8>SF^0)@8M0!86AA1T^HI69U4',;-VN\7$,E!Y#HJ3>&
MFX;)Q#0['GK9Z'VY*ZM!WVU'9BNV([/[V)%WPL"]P:9==,^ +44DP*NB/RI_
M=;T Z",H#7HMRY)NM!Z<[0L3A_J#\XD!LS+AD/,Z'-+9/GE+MX_?)COTP\G.
MWOOSW<_;?/]B'W[_YWAW[S#9I]MT_V*G.Q\.>7>^O[=_OKWW/OORQWZZL_4.
MGNL>[QS#[]#&[M:'X_V++\?;])]BY_C3@: P1P)93Z6SA)G$$9WQA B?2FW
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MG>6,6[ ^V")W!0%?-#B_Z!LW*"!J[N%GX^;NE?IOKS_U8(R@;MJ2X3A^YM=
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M-2\4I<[F#,P*XZ5A8$'RW.8Z86YQ$3]=E_!?6<)/=[:^GB.Q\,[>?K:[]_Y
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MHM:(/\\,1.=9=?9^$']NGV7>@ *Z36'<Z@&1S)\!=X,EN>Y$7J.-'P?JY5J
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M$AN6P$XF4G@B>0(3TD07C-)">4Z-EJ78$#P0F_N3]RNQ>0&Q.6;[^82%!.E
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M"M?D@F,9+^=)>V@@XW'S\C9<B]A)$IA33N?"LEI:H8US@A@G<S<)4KD67QX
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M)$ENZ1=:",D\*+HP?^23",5;IHD/EQ@/_^Z2K8W/EUL[Q[A^N;[/@_5>68M
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MOZC*Y&WOL)9:G7.XV!E(M^N7[>(&/8^G/G'Y7K-[P^$VWORX5+2KUJ"V!C"
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M^^E:V8ZQJAW%Z/#<G7545L 7W6H-T"$?#[D3&:[B!5EO_24TO-_Y:VL3$5/
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MKW)OC9=)<I>K"BII#08=H-(;'T"A9F[%6T4$GPXCIU1?ID$&[K!!)GJ/.!6
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MT;Q*%)97%.K9=&A%A>+@U20#OIT&]NP GE$DP9"HG T*1$'7B)A2VNK*5WM
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MM,?()ACL&]L\L^?=M=]N^FK@E@UO;O*WW_;LUSPXO"[$XDNHSE@0<U@.]!,
MU&FQU?)W^M?//N)ZNQ<'55"OISP#OMA6WG\KOEPF/R_]HWR\EF?=_5FB]>6Q
M\YSSEC,@EN'1YHQQ_+*5,]7;?;AK*//2OZY_62]"MH.=;BT?F8BG@Z)4 Z<*
M;%L?%O'7&<,BA$Y$?&Y_])0>#4X&P1A@4T/;_J8,2 PJ#__#+LU8BL-.-NW_
MTZ!41T*!U4:-N;782)O 098F -<U-NVKM8W=7$RZ) F_V95]B/>9T:SR Y2(
M!L.?8JO&S/F0+F'L1 Y":9* *3!K")/!4[AS)):8@3,"U\3P+G,NPJ7P1"0G
M-8PC1FN"U]AI#O]&(?E4 [94-9^G \^\*'L)LH.HH#T <GZ03RC::[VCRK.)
M^6!7GNWQ-I=S'Z>5).F<PR4BCYQKX:BS@<!/BA,GC@_3N<C,CN#U-E<[:3(!
MN?( I])N6M\\/J\?>0R46^SLYHTSD'R?-%+8N$'U!X<=1B0&QK20.@F5MU"5
MF-QGK\TE E$Z1WF"-5:*2QRU]%R&F)-P<#0TS7# KQ*!18M _>)XGP$<6X4C
M8D1+!,!HD)5&(X^M]LQ%RU,^75K3TXY29RB9"PA$%%JR)&S4/#IGG,3"&L5H
M4%@J44H!'DD!?K@45 L]T/7-O7T1,*A< I>:A)S/B0W24@JD5=#).,%L7FA-
M)F,]M=&&%3C(S?,!2\\FH-'*G5[*" XLTFD'UNFJHNH-:P(?:)^6 >76P<BT
M=!_C;.>8?_>S&I'WL4ECX4A_&$._&=OI9W4>RK/]U^7TP^#Y2]:Y"^/Y9[/M
MCU^=@![_R.6'##$PR<8C,#B /HE;9)G'B"7%:8!WJ(5ICZ#&ISFBTNG'5:5I
M8Z5.!A4?;B@)R/L=D=%N#HW:7)6XF:M$O%GPEGK95.<JX%5V\?'9@3WMQC>C
M7]Z..I@W6N5#EA>]O?F%8K(_3?F%@[>O@D;K>! X&G:+'W[S\.WU\JVQED2#
M]Y19)TK=^C9>)_=\CPEQKRM_-EBBU['4,]VV[&TTG(PI[>)NZPJWF(].Z?HV
M"%L^38^S\?9"$R&E4E3>E69ANGMSHXO5'5,YV=K*^QBO==Y;A1YX\-!LO'77
M?9YUYBZ#P^M>9Q_!^1[^Q70*M"P3PR2XM8Q3RG5T46$.;!(#E:=R>OK&?/VK
M)\E1';Y_]RPV_X[;,)C#%^[/#7H(GA[E_H#;]"O_?O3G\=[%%MZ[^/UH[]OW
MH_K1GX<[W[;@'GNB_NWWX[WSL1Z")_7<'_#B^^[A2?W3GT?;1_#_21W&N$WK
MGSZ(O2-@8D?'9._DSR-P#7K;C?$>@@E\ )T((B;[!HQ8Y+ ER$B!0PI6*JWR
M3C WDSD!<[80G$N-'M0D<![T'^N[N@K(!6K'[X7^=_28O;P'G6^^IN)]!7US
M0]]>M)W=LW:%>(M#O*U)Q&/6@0#G;$EJ/>)&2F2!I@, 8IZDC,)Q6R*>GCPR
M<+^FJ<^":ZO):L5CL-J9<&W*?%6XMD!<.^S$%UY@[VF1;7L*LDG#352Y*I\5
M@&P,(^U$0C)0(Z11O SHLQK%DU6'[L?E*L8V,[+)BK&]3&3[V.YW*F!;'+!]
MGN*D,EBY@"/*I1H0]R8AK7@^:,>L<N"XFD%-/<DKRO;DP*8JRO9"@0T^6P';
MXH#MZR2P.4$3]C$@C?.)',\4,E0%%+ (CH&#BDG*P,:9J!C;DVKH[F'LQ#(=
MON)M+P_>WN6%K3!N\1BW-X6\D9QEIC@2VLM!O$WGKN"2::R($ICYD!M &_;@
M'88E(F\S;+\_UN[L5>Y'$=K]G-A1[JY4>[</G9H*=&<'W7KL5;BZ.%SUD[@J
MH@W>N%PQUAC$@4@BFX-_(N6RG9R"8VR .XH:Q9.)G0_:NGV0%CT(D'\K<\ZN
M'_:\=B!T:;,#YSQ/MG75"J6=BBO%*@::-9'G.GE QCMN(AA7RD$0A&5&><]<
MDI$(CY6B:[=<AXWV&/Y+(#S<!&[  3$AIF"%P];[5<W ?.=]_Z3?+/,O)QK-
M=*>>=*F5&<AE/8RR;=>=&9<_?>B5R:]D>%U(N?A,2''OVSY#VF8UV$<<K)IM
M0(M/B%VA+-??+<!RY[R8EM[ZNN9C:P*M7_%D?&QWX*_YA";,1>L@%C'GL?1>
M\8Q42>'7)N-+._7.;"<^4E[SK(&!DT8(S;AB@8$'N_[/^M2_S.'[$\.B#_"3
MN]SDP8 3R3"P^U06=XQIV.#X5M_?=]JMGT9;K[CV%7B_%&^_43_R8N_D<ZX_
MG$LOXCWZX7QGMP[>_O:/[=W#P^V+C\WM3Y_YWI=Q;W^+PO<UOF]Z&-L[& =\
M[^Z6V*;P[\6''SN?P*O_]O7L^^;A89FG_67<V]>8PB)A%!+'B#M+D$Z1Y9*/
MED@>P=\G:QM3JG4]=WKVI6*L\#F5"M*6&M*XEIHY%:B3@F/"G9:>**T,MB09
M1^8N,G$%7),GRP?05Y[2K%!M7E0['\]8]!0;;3B2EEC$8Y#(LER"P"BAO:&>
M:4 U-=DE<[5A[>[!5(#WV@#O:?%NK&7ZO4C=;@<>MUF&C]^UPK_['?!*NQ$^
MFLN;P:R_"SD 6E9TJ)!R3J2LC_._Z"SS*6($B"ARII! AFJ/A*:YMH?G6+!I
M_&\YSNA5:%FAY;/10R6$CTP1ZZ7E7'E-571*6RF,=XJQNW:[*X_W21!OG!N*
MP"AW/J&DL4$<T Y9RX @1F.\QR(DR5:!&[Z&;,E_1=OL'1;O;<L&6S0;OBSS
M=&M@^M&R'E<&DZ3VP@4!:&0)%RE8+;B5*6J=&WDD_TA1N%>0D/-$@+4U&:+S
M1%I'N4>:Y&KFQ -6!1&!HB7%+3>"D]SPO6:F=*6;';,>E.-X/Q[V[,G,J^*8
M&:>C!$).O<4<IV"4<$)@8K&*UF'W>(&HZXJ=&C]B0!>QTZYT>EZ=G@A0.0J\
MD7A$F<O% E1 )@F*J) VR<1M@"7<R#VZ"'W[K.G+E6HONVI7,9?E5OZ)F(MG
M@3L=./)86I1WV')+-8J82M0Q(A1UN14QH97BKYCBS[6[Y*WQ,DGN3.),26LP
MN(U4>N.#4.S.9/F*JC^_9D^8=8:M9A(C+SQHMHT"6:4Q$M+3".KM -<S59]6
M]>Q9J/IKR%\:-A"+/WRS7]9W?E <874/A\\#3C80G9C B6O%%<$F!IHD!0'&
MS!-GJSC"DH/3]F0<@1@JB??@;@0B$<B(08[G5)](-"9&JF  %WA-B4GB,7?L
M<Q%'<ZJ:#XO>X/762VI$")QEK=8B&NZQB#H&SY6OX@C+KM/CA,-$B1/1$7F%
M!>*<!^2DP^!4:"("CX8HM; X0J7:+UJUJSC"<BO_1!Q!$O RA*2(.@)6G=*(
MK#$:*2EQ\"8%[W-=/K*H"LN5XB\C59<A$&&)M4HY'KAV,@J#35(2.^5HJ.((
MRZ_9XV8]A1!MM (1KBCP=0::'90&TLX84\Z0R'6FZH#URT'5GSH9H3PL_1R:
M^4>[$XK?VZVKZ,%"1R'7Q0S#F-)E.B>9(+8^Y1RW P,\Z*8*J*_XV^)1!C[C
M]#G@!V&L(>?KJ%TU#Z0;+BAVP3KN!.> [2PXIZS11DG@=7JFZ,M6:]3[J8+U
MYX#USU,.6UE>5LI 7B2&N!8"V<0T(LG[!-S=)YO6-B2MB2FM$9\H/GP_NO;L
MVSZKXJ>!LQZHQRQ0&;C"TO'D8JZK@RU5-LB90S#WUO%KO[7^#<_;KL(S"U/X
M<1X78)TQ!?86$S7 WG1.XJ(>2<J2IU0[9_1RI'E4:C^_V@_7K5JFY5ZF>9A7
M2()*APGG/'*IO0.TEEIB$IB/DIF9G.F*>3TW$$\XU(I2ZP+Q*#JB<[Z=1D[D
M5L5!4P,>-=-:+Q?S>@T[\[L=&^*)[1Q76_&W0Q).&(N4 A, 25A1&Z.-P3.J
M?&3.B$=T!BO4F0-UOD[Z>\8PP)UH$2>,(I[;4%OJ$X"0)HQ'(; E:QN$5_OM
M*Z2[<ZANS"KKI=(N!N[ \D230(,-=\H;;FSE[*VRMH]S#,FX5DD(</9\!)5W
M&FFJ,2+>"FNME(ZE:B]^5=7^?LY>M4Q+S*P<P\$R(@*)F.M ++ HRTNF!69;
MXD=T]BJLG0MK)P]Q^RB,T0%QH3CBFB6DB3?(QT"Q(4)SXI>(63UT>W3F0A3#
MZZJ.#8\[-2\' [&3)#"GG&:,$RVMT,8Y08R3@A)%9O0NJPC7DR+BWA1?,Z?J
M>Q&1XA@046J&#',1N6!$"M$J:_G:AN(UAA=P]N0Y.S94&%IAZ%)AJ"1)!\V,
MB.#N<RT<=380^$EQ C>0S^OFW].OKQ!T/@0=YY184J9E8$@2!?X[-@(YJR1R
MAG)'!%>"T <6!EH]]%Q@D;0*5RM<G2=ZN@!8G7:DH3K'\,S .UD/P7N'&;CP
M-$B&.*,2Z<@)(I9Z&25 +[4 O%-RG>^7>K%"\%N!; 6RCWS2^X$]&ZL P#.A
MZ,3V$_<N<.Y1U$P ?8T>&18P$DJ V8Q6.)_K6K*:% M(<5FREHVWM@]D5>N\
M%]+@K1ILU3KOF7J!V=Y8ZSSRBGNC5:WSKDU&U3IONKJ,6N<5;)K"/%%NZ[.6
M@JNZYKW6'@+SE>OVF'F#G3(\&J:=I<;SB$E0P+('+03PHY[=?WD9@,WO1]]/
M=CYML^^??C^LGVSAG4^_'Y>NU+<_#[\??2#U3]NB_NTSW9EPP?XZJ9_L\;V+
M<+QW\@'& V[:R9^'VT?'/[Y_^GBRO?L5[UT<D^^;>^)F,[TM 2X;VS<^N*"C
M12)ZC3@S AFA<:[/ 8Q0).:D7'0&X%*U5*D:I[Q6T)LGY.0U2439"*HA.;;*
M"4^YU9I[$SUS@UI%9!38_TGRR2OMJ_=T '<98]H^V][\3/>I5E($)9&002"N
MJ,P 9Q!+W"K.J"'8OKQNH56CJ KO'D#R%@9WCU^1K2*&"\'-JQW.(6YJ;YA*
M"NB@S?6<$D^YXKM#5D> 3!()+/R+)H85A%806G67?_&X=\D7X5Z;>W0_) (N
M<:2 >R07/,(>:1L9$KG)@:->I"!6@"\^476[9]7&JM7>G) DL ^8$(4# >^'
M.D<LPP%3')D@0KHGB-V]T!R*9PC@C;HA,Y:<X!)Y8WGNADR0B2D7#(F:1.XD
MD_E860T+MAS].U:F M#*J+5QTNL@HLTE&EA2UI(DC+2&1AMU<H\7G*HT^S$B
M5Y==?UW2B2GDN,['HVQ$6EN)M+%><0(<0JBU#5$S@E2:O3J:_;2*757(7VZM
MG\@L-Q((F ?_ S2<(!Z\1Y91@10/6&GC0A!R;<,L*K&\TOMEM.A53^S55^R)
M OG1AY0,1X;EGMC":*1])NH<1Q,(E<G%I>J)_1I2GI:HT=ZJD!*>#"8A,1V)
MYT$&S6D,CO&DK1.8Q"H!:'EA:6M*B[T<C18D(!,"P!(8'&2QDTB1P(%Q$D])
M7(X28(^2YO/"]7JN, )F4B2-8:49IQ@;8Y7#6L7$L':,5&&$E5#PB3K"1 ME
MI<K5@R/B@-7(8 [D0UHI6-+&DD$/3?-LE:<JS7[<,,+#%;L*(RRWUD^$$90S
MR@:M$*'<Y3J^'EGP0,#E,+DV"+9",]#Z25>CLNC+K?=52^Q7I-C;D_D)7$B-
MJ><H"9L0%S0@%QA%L,!1)K#U3NEG;HG]^C(1KEKL#1O6W6P:5P4X)S(1DN3$
M:D>C(3P2:4D0/#AML"=2.S53$*%J6O+<Z#29C< U$XYB%&@@.;09D*7:(ZJT
M%S0*KD+(>Y;X^7J65'L7CURBVB7#,1<<PW(3YS+U""PXFQ*G5L7Y<L<?HX-
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M_T8A^52#M *1><"1W_NM6.+@[1[H,$_EM-,^BKYTAN S_M(/?;_SU]8F(J:
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MCID/WA-LG0M]Z]MXG=SZWL]N2]BZ5.9>M_WY>TS0:K#Z]K?';CNE0,I(Z !
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M%-Y(G/K./4&D>8*H< -0()I)2UE07!)NJ(=-UR)2(C0VF!C<6$D>/:\O6$E
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M\V69%0]O-VY0B^$F<[_&ICR1!5R=FO*3,G-.VMYWPCT9.SY,R]G#B0[2\B#
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MFJ]9)H-/^BG"'Z3)D+:F@NH4(3C,^O$D'2".TP&2VIS36& +AU7.CPV3AZ4
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MV-@2YM$NTG0D>\Z$=&6]EWE8X91E G,E.4]$NB@CQL+!'JI#I$]S%)6:/V-
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M+. L4Z3,<&*-]59Y12@U.G@94A5KK D,C,<:49&$J8@H2!(1)S(BRQ5&$3,
M""N2IW9CB]>Y-G4J9 4#:PT# =P 80UVS&'.%+;<\Z1])G"AS'E7!3;K 0.3
MIQS!JWP.BBR$+HASPI&6VB.J:,124RLT V\ UPE$-IQ-\O0]'PZ\A,.,_>[
MMFZOII]#P>)5CU4M=$]S;7UQVO2@@L-51T'+F$TD"6XMXY1R'5U4F(N L="2
MRBHF6@<4G,)2JJ4@'C8^I#4&9R@%G5E*(V),6_B3L3* ,R3J3."ZG'+6^]R'
M(94M3^8WG"2!.>4T8YQH"1N9<0[FTDE!B2)58+,FMCP>V!BMI5=:(R&RT"GE
M$1F5 HK&F<0(E<F3C2U=-\S4&7MB6Y[A$&4>MKR6,4JT)DA&B(I:<*>(,9HS
MRF%G-HQ'':L893TL>B)&P4G;H#)].'$:<<P$<B92Q(1BD9)D+<F'+ZRNA*@3
MKN=T^C*G3?7AL<TE84*I_S/1H__+YMEKC<.W]M(NUN8G6H"*QN'?_&+$F&;Z
M^C%V ;YI"IS^&/N#7K/H_"X[V3,0]1_;J?P<;=D?__I4\A44;>IP/["L8]F%
M/]&&M%DKWGW)@5"#X<;_.VW^ +3*O[7!)@9%1WW9OP]HW&X#2I?@/&J[+R@N
MX4W-?O_4=GQ!?IELLU=286[6WEW^G$D20BPY"?+(+JD&?*M;_%RJ;0_;[@<]
M6[27!GM>:[;;,33ABUKG\*;H8QA]=/3MQ>T.;RB/Y-=W7AN<GV33@\MEUH1:
MI@JHV=JO!'&4X#)2(VWTGC-+=+(A)A9H/O?'.,RJ/_60;:?XYW-)[_#?@J)B
MN@3.&4 23.2*;C.'_SO"OOVY8[^8T[WVSOG!Q3=V</&:',!V<7#\0>P>OVL>
M[N^P0QC[X3&,9?LMW]O^CO]WX?G>_J>O7GAX[D(C!AX@XM)+Y+2PR 89 F:6
M&:\VM@9'O1A1%@L:5[,9L7]<8S6X0?=0\'0<V1^QUNGF]Q83D!=\+QM-KYC!
M_N8$ <1M"TJ2I(-F1D0>.=?"46<#@7\I3K#/\5D6E#^*X;05]]+TI74%:\79
M^*<,:N6"@FWQ1W-POI_WEWT8TA\M^/O+6S<"?OY*C0<S%A1)10-X%[!NM"(.
MT>2M])$;9\%SB^#$G<"S'_1.XU2&CJ7:>F?A[  TMD/*CDM>%W^4L0@@M%-
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MB#JN$:=&(&NP1B9B'C#%%L-4;DG%YQ3#K +WTAS3)!7WTBWIE8<!274^M#9
M-,&BKKA@06+DC$J(RP089+U%B3NL@N(X!+RQ1:6H*_;H\Z$E */[,"^-M<-,
M[WVIJB!?:A7D/6KU5JHD[X$UC>OZ.*H*Q4JHOJI0?%C<RD7$AE()#J7CC' C
MA#"2,Q.LX([AZ8+25=QZA[MX=G#1^-[8?GW1V/_<W-WW>/?BV_G>_A_'#?J6
M-8Z/C@^_O+TX./YVT6B.NXM_'._2#WAW>Y<TONS\;%Q\N-C;WA&[[W?9P;ZG
MX&JV#O8;S;WM73JU0I&#M^B]\!"W4H6X3@'9J#C"R9.@N>:8^"P8N#)BT'/*
M,E?8]\*Q;VJT_3#XJZ+MM8'/\6@["6P\C1X1GV5\,$[("6V04]80'9BP6&]L
M:5:GYM&%3DM2C+E*ONXC:R[7*7LXZ<L)18S#7GFM&2"9-")P'6FPVCOK#+E#
M>.BEEU8^$>A,*:U,+GF)K4/@HF4=>&60Y<8B*GVR@BH"_VYL,7'/LX;%>5_W
M. %8)Y.;ZD(\TNJJ>LCULNUQAT('80(S$6F9:WHTH>!0!(\<28F!JT%LM!M;
M7-<-N:=#L43B7DOM,_SGBOUC1#-3%1$NWHFXLXCPVKS\54Y+Y4G<"VVFZ*L'
MYD-($+EH%5@6:@F92"4@PJ.A44@I<-C8HE-$2*L*PA4TWP4[)(M/;E2NR +!
M8=P5L2H*;[E&6%..>-+@E/!$D*<.,R]8,#8".*BZDI.1QC+*L:^4%]+M]^_?
MRK!6:/6<SL9:=RP\$:1,Z5CP.(GHN$,VTEPE201X'IJ@Z'RPX'-$P7+F@DYV
M>MV&)U728G%M!DL4,:Y#-T$E!UW)05>\4=4^.;Y/3NDF<"IZQ4E$.!"/./,)
MZ: %[)A,DT288I(N@#=JJ;L)YE.P48%I!:85Z5:%Q[_&X_%4"%4D1"<\2EH
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M((!:GMQEA4,/QZ&)M*56TCCO$94Q(LZT1EHICJ07P6(LN)1\G7#HT:5[2U.
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M!.F,3>]!1!Y54@Z6[-\_VXU]B1=9:=OD%Z@8#88_1U;-R/.QZA=5,DS@B$D
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M+>>CT-E2=.;K:H?1F.?\'&0YS\:3![4#Y SB%"MJHR3"@/$D33T5NE&F4_&
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MCW B.%$P14(2):?Q"< <2\&]"<%;$;C1V 1+!#5 ]I8E+TD1Z)N&]9H3@\I
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MRY2D%5YIUHS3E2NH;!;"-Z;\^@J<$4-X8?CM;E@OF%X2TS7_0^+<,*,Q\MH
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M50#N@P:1O;"]GG6=82MU^Y_CX#X"<+]WW6+[9ZY9W+ACOO]=]OQTP9=_-+X
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M-B(R2I5" 28%<?"5D LA( LQ4_3*$I+[6%'!VHIO-G7_&@"/@MN'\=U6(]:
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MSBIRR*K$D$]:\" -4<SM[#'<YF2QM7OAN,)Q3YWC)$DZ:&8$N&Z<:^&HLX'
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M&.QU9V9,$6V"2MQJY+D+B#L=D.4Q(4,X91!T<J&*P=Y:8&^XGD,QV!O+S9C
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M 4(HH8"&N?8.&:4H2D+'0"US1M5WR*;L1#7XJ'#]V2$_!.[B<CT0X0O;48E
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M;]FR>@8HKETO*2A^-!0?SJ-8).TE\"^"6#<7,# AQT0.:2U("DH)S6A!\3-
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MJ:C@W#@D(H1+G&.)C#,,>8.E4P[86]1W K=@N[G8KO_(3S'=&P#X@BBBHX"
M2UM$619% B7("04 3]8H1HU+.A=[QVTBFN2:EQR17ZX+Q Y' *.J!_$@?N[
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M'/(<5 63QZ]\E[4:-U#_O9&A:3:1KW)6L?Z:'Q6E3]?O:SOHP:@-?XY Y?$
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M'$\F*>V))!X%EACB(5+DE.((#%5)4I)4D<79,\L0D*V/8B[5?#!>--51:V+
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M(MCV-()%'93&42+#%4/<D(1L[B5#.96.&.ZMXBOK N/[NRLU<-7 ]9*:1M;
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M__OC"V_N;N]'G@05EB-OHLFIO XY*17"8 E0:W*G-[K2.'/:-S+T"8.# L.
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M$K?44\]T;H%2:^K+U=1%N>VUIBY24V<"Y#*Y$)G+<0^&N$@)Z2 B,ER"CO+
M#?%+IJGW;&]9<\N]! :T>K UM]RSXI8C-;=<S2U7<\LMVZS5W'(UMUS-+??T
M1?<OM^X^1$>UYLQSK#DGQ!#*N<,XXF@\_*_XP3/MG>NZ^RL]YB[?_N,]_KSK
M\3;=PGL_/&YNOO^>K[WWZ9\6O/;]\^;''WM'OQUM3WO,1P??/F_^W6[^> _O
M_WT$_\)W?\_/<?CYTQ:\]ON7YFZSM?W']K>YW'*>XAA8T(BK?*[-'$.6)H*8
M3DXK3+$7?&5=:[EJU*(.MFN&I9>,?2\4^!11FDL:E3*.8X$=3SP)HWW0."89
M'ACX7MSQVR-BWLSQ&XTB1191U,0@;EE .A&)A.;!:B9,=+9F6*H![W4#G@"#
M0&,6:4B16_A+""N$ER$$+K"5-> M*^#-)A][$82,%'F=TX:8B !X1B.EL'*<
MP)):70->#7BO&_"HTI0YT 67$I?)&FD,CQ0[(T(*UM:N[7*CWK29AP/!P=.
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M.B0:)$%!)(QX="K7JGND9#)6V9",)\MG,[_X%(2:4.YI//97S$3U%([[../
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M[]H?'>P+K(5)D2-JB8&U]Q9I!LZOC [V'XVQ=@[6GJYB.2=S<C'^;F,#-D'
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MA[%,/;P,@^QT)Q^K6LKJ,>!6<)7NU]@K],&%(:O;&S%MW>[[HT!X#E;#;![
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M"D)?A/9+9^%F4H$;MYVE1YZ@(AK_.ZU*"WKXR8?NY?LMU5/?IGU3PA$'9Y/
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MFSB?D\3M97U,"W6B>C1OK(S#8=/)42+=A+%#PJG.Q"?2'?9_C0#GW*QM'C9
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M5QUD2^&8>D"3-(XB&N8I;3?DAA]UC"*0#3YE$3K<L\F@GIVPY.V!,6B']7B
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MONL%K*)4E,T@R&_NS@VLYGG:&H64/OI$U#_K> M@8]H!ZL.7K^>Y]9!/QZV
M?%% R<OSFC[A[&3S[<OZFM8XG=,5D'_GGU\N-Z5E'UJ7D FUMO;22O"F-03!
MUD>(@]:V52NRUS6:[E=C'X9X3)M,PY#MB!+MQD*.47C!YZ<]&?*7MTMDXY$;
MYH:OH?MMOB2<3?^;RB2;*$E'#SYR$+/))$8O(V11+*$)2I3>FGL7?&/:LAJ&
M88-)J_.51F\HGRPW?0!:SMOB9/V:L$QG7Y[3FI8?IO.6A/ C.[6;!IB7_NWF
M89C/3W!V]DBTHTRM8@1MBN(I,/H8^$>L;1M&)Y-*[RW1KA/8<9]LX%+G02CY
M> +O%Q"?/3LOYY<W6O\T;T=(&_?@5UJ_6K+Z_CQ)$:V+K9UOT8Q.NE:L6!TX
M0I5"0K*R]Z'-MMC&M,DV#-$&D=+ 5[F]/M/%5[!/5Q\7*YQ-E*]H9#)094SM
M>EH%&*4"*Z440:/![IVF=L4XIEVY(9770%+K>:GP)LGCVKRO+DAKF12*R$(F
M@JC+YM9VA&"J!RF2BQE-,JI_#=7#N,:T83=4B-E9.GU[?'\E4RQGC5JSK178
MZL<( 74E:.=;JJ9@;?=JJ:\C&M-&W3!<Z2B18Z2"[Y7/SGR.,J %CZWOB<RM
MRE]D\#IYK)B-[5YB/V@5P^XK>J5&4U>OBDP!<FF7T+MH(*%W(%BXQBJ27O6^
MT7NW%CLCJ,88G&5?:=*SBWSZZN5[NJ+='^$_G9?-3V<B+/]U<NJM7!0.:#8Q
MU10-4CG'BBE%2*THV&4D_D<X:[KG2@XRDS'M%(Z)MR/@S1&+/O9:WAQX?95!
MJ (U&,-F.M200,E"I23OF<%'K_=X#!MTD4-^YEO\0'-J+5Z$C91<U1 <RL:_
M"M'S%RVB+!C;"6'O&L-[H(RJ#> (Z'CWT=5A$OPF:K2B%ZYZ'< ZU6[]3 E2
M:Q!ET67A352J]$XU.5J-UM@+3AZ)U8]/I$%+GZP+;%.S!V';O8?"1$#5<CJ"
M)&MCTEKTOG3PP=*G'M4X2G+<2^39-:@6C&H=N3,[#D60*U8X=B!ZGSD_4(WS
MR&;C4.'?6XFUUY(/TD44I4Z&^"E2$EN/$8Z08B0+0>4<JA<A8/?D\_NZB(ZD
M,J63L/==Y4?J9]YN,?QQMOB]:\?RRP\=MB?Y/>#[=1UO [ L/TWYTW[X\MNJ
M97J<GBBT\B,.Q#Z=ML5W1FCCE(<4%0=;E3(DB=0>[RA3+L6&WMOTVZ,[>.,+
MOVS6FX-1'BT3E8V5W\2M=RV&5L0D;UQW5K;[@24O"VD0F-G%%04]]MZQV!'B
MJ*S-0#2[M3TVH!3[M?D\ _EV\33_ZV3:',9K2=.KB<G1^]9"R6W:"Z,-$+3C
ML D9L-6Z8/<,]@=!C:H)R9'IU$=2W0ET@^4W;N6;$"EAVP8QKU "8[6':(V!
M:JJ76<LJ0N\-I>V0C:J)\.-JID-DUK/O\ 6@UH)M4W+<*M#77U[6T^+C!NXR
M46K2FCY)G2VXX%O+!NM;A9AEF"AE:2>!W;?B=@8YID+/8Y%L4$$.9P#O2VZ/
MRD9A"X&UIFE7=*UFJ$(245<C"V+MG;2[+;8=D];^4#JLJ]R&8]6==QB7FHPM
MABVT9JZ;V$Y-8W)0M"6;@JZU>Q[X5L!V3%C[8_+I8(D-1R9>BX^T7']Y-</Y
MFO5JH_ZF'G9BC+;%!07!J5:!TVY$+]: ,J5174?IN^=);(UNQQRV/R:M^LBN
MSSTN5TWT\VE;AWE9353QAB/.#*B=X>E65IA!:8BF)DODE+R9>'3/[2UW?ORH
MDM.&Y4"G->Z7H<9S;?\VRGUBCVQS1_9JO9SF-97V M/Q^B^NO/,5+:?-L.9E
MNTOR.9W^]^+<Z\7G_)ZC47J-:WI1>7G:W9*%E67TH&+KH*=9389B+'C%$W?%
MEAIZ;QP<=X8'Y[IO/N5EO?K)+^<'S6$2?0QLB"H$8WG1;940?-M2MRB]KR)F
MT[LS] #3&%7&W7B?FEMI^(],J'Y%[W<KYA^G<YSGZXH9?2+=SL]=\^Q-P+;?
M%0H43"B=1(EF@+M)MT0WIF.W;XC' XE_:'K>Y3=8@RE2C1"RL&!2U9 ,&WI"
M#D)MH.J[;T[M>T[UN(6^WSX]#Q7_T/2\.'>_@D_HB$JD!"6Z!$9*!2BE@^IM
MC%&(S%K_./2\ ]V8-DV_?7H>*O['H*=&)7WFR3O3NC%C8.TN5  ;G;(B"B=$
M[[KU?>FY^SI<[9_)W\_HKD::,IB0DA)0C>= 4=C$1! <***P@?6)2:IW$+4-
MKC$YZ /QZ6OM3KN(JV=2\0W%LLDQN#S)6TU,,+4X?L9]I,AV2#5_7@?(%5&F
MI(.JO</"AU%]"Z?XO5G4659]]@%O%VB_K%=WO;.JCI1J&<"Y-6LE!<G*"#H$
M*;%0S/G&.<4].X(/#/0MG,7W(D3WA1]0G3S-N7456;W"+YO$ %42ZD@!R(C<
MJOU:$_B0H<8J/0=B7G=O>_H@J#$YBX^F2PX1U!'X<R6WQ*9"P3F.B:)F0^ER
M!B2/'+>CT!AJ82MZ- KME@WTV"?IQZ/1GO(:EDG+D[8(%U4MYU0/WLIL.;2N
MHK1B&@ZW@W098L)2BJIDS0 %>=O"&U4+F$>D50?A';=_<Q;6<H!<@55I:0Z]
M@L S!RPBLA(-(JC>I3K?6O_F(_&IN[AZIBQ^FJYXH7Y<+)\O3M*ZGLS.5>C$
M4<A8O )4M?6@C!X2_\,KD$66QF@9!^A<<2^>;^#XO3=QNHEG>+OV\Q33='8Z
MY81>F&0BB"*9RM4DB,9GT)%=.*>%B-3[8&L;7-L0*/ZQ"-1=7$>^T,1)966U
M%7R.[1#"YI9L$L"Y4JKC5V3M77K8[4(3*?Y@7.HNL0&UTJLE,=KRG"HMEU3.
MBFG9 &_VK,ZK3FKVV1<#0H< QCO!OINH4"F59&T1W@_0=F /I%O1[;&+T(;7
M7=V%.H@VN[H+)BA'53==_FII5[$&B)Y]/%+*QVAC$;+[=M/=4+:BT-&:KQ]?
M8^TKE7XW0=YY0<<D6I).200?#=,UJI8ZZRK$B"Z$JJK,W6^!O!/)5@0Y6N_T
MXQ"D@TP>IPU_TB6V-I/@O&\YO3I"5$C ? [HJ533O8:\=QM^>;RNY\<ATV "
M'-!-:EIQSG_4YIYCB-K9"%ZW(NXL%<>3P0&24]I+)V(8/FJ[ F@K$OWQ=[3W
M%=$ O?&OVE!C1$UHD0F<6IH/L0V-KK58=S:UKH&B.UON!+(52QZ[XJO[AN+!
M(NES^MZZ</%TOW+%LA+( 6&4$'6[5TE+]L;;]?2((A6R-5J\D09US_G[@T-M
M180_R,;R (M__*LT7/0ZVQR!P[D$AC:-])T&;UTI+LA"U#NQI^=5&C+\895*
M1\%U[V3?*'^]9;KQVAM3'&2C,ABF-B0C'5"1U1$Y3*IWIN6]8+8B3OR#$:>/
M:'J>:9WW]E8FQXR803C#%K$E :"0$5@MYBR\J[+V=E)VZ[VN_F![Q'NN_6-4
M7Z6J@\D%H=A86W.%=M3:.A E]IYR2<7CD=JP/5A]M=<S<%&Z>Z5ESN9)O6LQ
MBJ<L753MFJ1VJ4U@US')##Y;CC2DM8H&..K=!>(WD+9]*,N^UH:FMQ 'Z/#P
MRW2^:"UR-IMJ[Q<S%LEJ@D77@NB!XU/;.@-XP,K ;."U,$K4*H=JGG4WHF\A
M<[L[D?K)J#MO7M.L=>I\NWB+G]O%@0T4SYQY?L_F+,<SE3U,":7&PMYGU&Q7
MK(!<+67RR5G5N^YK7ZS?0E+X4%P;5*X#][_] ?,_VZ_FA6%.5XO*@<^*)[7Y
M:)R7-VW)EU\6]<WTW7Q:I[GU0SE-R]GT49]-,R_C[4R+Y^T&X-E>W7.'AM2G
M]^Y1%ZY3Y][;HYWNX*\GMB2*1A)HS[0T*"U$(@(I%1;ELC>Z=WK O6 .5;=G
M']S\<UJUC#*<_4B74\T*M1=5@=95\%0=/_$A$T3' 7W4; !R[QCZZXC&Y.[U
M8<A-1=E1(GTW6;XR7:$L9L.182SMWA%T'!FF ('M0;4ZV3C,=8%;/A6/VZ1B
M&)9TE$B_BV[98"V^$)V9^#M@%2-<=%*#]=B*LY, =B0C%(,^:"R9OW0FRH.@
MQM0Q8ABN])5+GQ.B:X433]D#P!D;^'EY\3E/5]<J*<XQINHPY1HA8VM7EG2"
MR%X00U9"9ULE!?>0M[3?T&.JP^O+D".(8F"7_/P4_,N<U@>XT7=]3!_7]T&
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M7?8;K2W$&V[#XF6T>?EX)1G=ZAPML* 8J")%T@Y-@=:>L:[@CO8)[ACHQ>I
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M\SYR;)V)L@)&%Z_?5S&GGV'RA6X /UQ"2W1:YF(<4T[42LD^UVK;B>42N(G
MN;OK 'E0Q=O&.24E-Y%E'T7$?I[!5>%(E3W7AIE4\_"=EBQPLMC)4"]6)I3J
M;OV1!VJ'77WL:2CQ<$DU]$)L*F1'NT NEJQ8*6I?-A<)BO>%^0AT Y>)@#YT
M('^%)3:;V_C'BK6QAF\54>N"XP0K;.XE_FWE&0^179\5-AT6JU  [1J*=OH
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MJOB:WD.M0(M<"F:%JX%%DLY5,)KQ8+A2&FK7FC_?0X^CPP'OH?NHY9$>L[I
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MUT=YRWST@M$WA5)@>4FF$P\>&N6$U=],N*TK_Q.P?VQ'1CL0SQB(C]JZ.M]
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M\D% WX"!T4XA/9B@=S!=+HPNH'HR+38">AQSHJ'BIGU)O0=#8C.XZ N@R9S
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M0PC>EP?UFK=C;#I(.%"*=+MTA\F4-C+G.DB&L<4 "=,.DF;%@M-"0Y&%XI.
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MUOB(0N=HA :FM*&5)R]4M^OD34\X.ZLW4>4 '>6;'>,?OKT-5_AI-O_VOM3
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M&J22+[-IO6=?;KDR"9$B"D#K;.TW1@@4>X!VD6<47&)J?9GTHD#GZ*^WL\
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M;3P$Y704R5@4K1LD#@>@+3[&L>"GCTU&P<W[\B1-<W.ZZL)RR%H#$SR#$K)
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MC5 4#,YN<XB_X=6%E9;1HAP(YQPH5?FX31*0A"H^28>B^63M+G*=,3J:F6,
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M+R937"QN ;K<ZXJBT$1D#0H5KY6?%&.BUB +RS%&[U&U9LUZ4:!S=P?;6V6
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M;W0'H8&D9+$%<]#.\(B:%'_$%  C]W%G#*C[ZT=N&U*./@'A<JVS3W1_)<6
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M?X"8H^S%NG8-L%&OI7WLR<) E+V]BVYR+/;7&86OTC@^M!BV&Q39E!J!>R#
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MR5?'%"]>/[C7+,VO,(6;FHA+N);HL<&["[C3#\A-WVJ\!]3.VC3U RO#MQK
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M+5MSB/"RSHT2LF5(E=>QOL$A\1UW$%L]AM_0&?'=3*)^?D3>N1J]$=<.GVZ
MR$C*[$N7L#/#4AFU3GHT=LVU_<6[4U;\ *F&R,MN8F;R;<[ ?,F@*;\^>2R^
MY&?EM4/#.01,% M,/U"L?4%B.JZBD#J#YA]&J!*=YAS8W"+G/9W?+_P9\&WU
M,5,,CE,'K8B94[?0-,%G7VN81PE-MXU-WB&GOK?^K*"TU[:;E%#JC.Z'T-!K
MH3).EG(7]GIO ,>$/<TYSPI]/8A8O2:^7/^X0^9,!W7 8\24IB_XDPV<;NU3
M-KGS0N=1WGW65WU8G\_X&F:^';0:Z8\Q]PJ3%-9*6IGM$JY/-R"/HMJM92$<
M(WDKQB@;'>4_!TWUYQ+,L>U.Z8J'/C? =[^Y;P%BJ*X2**RSS@LW\?GL>' I
M!0YSO_3'I<ZJU>?2%,*VQ"Q)MUF6+3^6&_B?).DC>YH[M?P0YSJ6B2*"IU?"
MA'-:UB+8PXVW=J24<X(W037>, @@R/NNE6@FS]+Y%\V7@T$8=H*$G)[9/7BV
MT^3DP/T>E,G,[*KYP]4M!RJKIV@J$8"?=J2$[!5:?L;"'#3INI/8)BM,&;[[
M>//V?O>FT&9P8TVC.<8N,$&64JG3W7+[US]VQG.^WP!CBO/>Y[MY0P%Z2.;]
MZJIZ%Z+%@3)[[U*3XU\V"W8E A?%P2]$CA.@<JA;XDU0C3;^\GMN<>"=2]],
MP^;WG9XA\EQ>2UH *\)9$"1K\\VCE2!B7_85-^(PA &":R<2'NR1N^K@8Y%,
M'$R!C:^I^)WI3:)5@FBL6 +GRR=8KUZ^X68&J(!=[OQ0/([\(4;.6'HZL]1(
M!98/]2\(?I['E**I476EO.QJGKY4SV<W<J5_UOZ9F]G@*LFS^/ZK([F^+0SS
M@[%-2M?!=T.?/4F3](LPX66XD4\?B' ,#@$-!!:R9[NH>;A9M;C?9QT@8IZ9
MMF F^BYKW0)Y:R+86'L%#A6-RS#),]%@WH+L<A)<-#[31'(P504=U\A]S[/1
MW B.NI!.*V&-03-"17,IE_AQUXY'#X0P50I3OUT#0>:R87N]3;-@]ASXE&8[
MHC-1D5W=S('TRM@H#>>0)<[]N2\!$W-_1V:5'AP4MM]N!<N,OO_VKC+AHCIQ
M(5TRO0I/Y%Z8/&ZP$0-PPJ/!VE>WPR**W$ZHG/UQ'GC'GT?FU9]GJCI'>$./
ML'#"/)+7$@;VIYM1+D%];FVO4@B855)I;P"3NCQ41@</B@!.=-9GJ/Z1[[:K
M0$\NT&K7&Y$)=7')>I]5YBZ,/$7SNRM@-1"I<GHQO@A^"ISYW8:;?I7=*['[
MLJ*ENS*K-U>>;.XG"\NG39108'#Q]Z"%? TW%X_P1.'%8P'>G.Q78;GY<Y,L
M8*?<N^BG2XTW0&_Y'H'D]@]'O134G5FB3NL#Y2EYPU>S#715::J;7?[));_N
M@#BCHW%J.%E.22:N<]JMBD9@Y+"R0XYPK?H,E82'C/B>%FT\.844"C@U^/7@
M>P'64:K-TJ"P F-3HP].:[1CU"UH\ GH>7C+!O6O3@(PY6^,U,215Z#?N5?D
MJH=SXSC96[+RI>$L9"0'W4'6G)(9S)BG+Z,>PXAR<;C.AE5X'Y_%>ZGY"FB:
MLDLX)G<T_]$TLF ,D;PMWBB<U\CM=U7%K1UV7RYN/9E[J;MLG.#3PY05R4E&
M3"J4\S2I;?<=(X^3>#<Q#Z$VL8,G>1\%">X+0:!4U(FAI^=2J>-3H>']AJ+6
M@P11UC*YH5VUS8QO\F'_8B$MG:PH_0"S]8IK;H!?7W9)953\6?OG,6<HUWC&
M#G<>B' "P_&@%C\=KC^I[N30X\2<T\:4Y7N>7*/RGK3$,=20Z<VOUNJ$$]$U
MT(%H,]?KT>JRI<5#V3 BOI2$[^49QRXQ-+50R(9SWML_TLXMI,[RK,<_W!J5
M!P(D^>6F=3/MP-S3LO3^_O#A/:M:Q$L)7?%:E5QQPY!0\MQ&_!=ELCF2VZ(D
M9Z#0AX\"F"=EEV$9[B'GIK?=497#^%XFRJ<D6P#6&77 +"X]_V2T(^X'':9P
M3DT^003^J\XK#\TSZU*_%]78^C)!LBC^_&MZTLM4N02B'5TP[6ZZP5P/'\4-
M\.+3=DL:-F>:\O+HJT_NFM74X<B9NV,]@YZWU+#47G=VD !)T;MQ.@8S8"5\
M0Q.$(RX4/%!97."+5SOJP3"*VM[+  YM_U6];H6'MJ_CX12:$=:6;?,J0(FP
M6[G33P_B1;N,R<H):ZS87E&V TN@333X\8-12O7"!KJ*H?RDQ#8S@XMR5!0R
MXP1X7.<7?8'!VDB6<OI*QQF]X3B8@O72W7K?PU'YL1;9') ZP@;V3!K3(M[P
MY8^/'SA7*@' USY^)>>[1W<-9<G_I@+WJLI</XJX4.F93;*;^M1HH&(?*C$B
M_/'CNA?8L$-.4 [/N<OK<P _*K!D:8\V27])W_"+_N[D4%SC#%,M7\KW(_G1
M+T YM3Q  LCHI: #L\TGVL73"Z0-]X08?^;0RW,1+#$FPIYGPO7>-2Q!&E&&
M/;,&S]-N@-T&"+E1M*[6;BDA))J7A[:7A0F5N7%$O*RO7@E5T:E-5N+:%Q:A
M]KK7H;<0$LP2M1HB>Z&-8(T^%%O1ZV41J&UKCL3A&^F."V?'34JY&X?[T]!=
MFL2B?"XO@!<1%2VK!H^7&0AZ="4K[CW[6;3-UOMZI$@G-)E: 0)-&Q69;'6)
M\F&1J(V%W(%>]!RYV=^SS9^A>)E$8J8YQ ^2P@'.9"V]Q$@@I &F,**21-A
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M;PO-4>>X_;,ENR,7#"DRV]&CK400]_FM]*@N%AT;\0TM-'#<D:WF9R/"(E?
M8>ZZG%-!,(AKAK?J",(VL]-WMB4Q;\8)\F\S'>%FQR,;#+5>=&.SXCG79NX4
M<@<U%XF^,\W9-O?EM!3'=]%GJ7HB03!@T#R:&ZWLL J^W[.-%D R.*W$2]L,
M7)4;0B)%3%@1.#T2\7!&5DH#U:^&O'/B/DEE]&]]GT[4'D6:JZ!Q_<;!D8?9
M)?9^C2FPSDAOX@=QE255G^'TYIK\+^*_QS1?[8N'@63C$(35CA/U#B#0#LVE
M=9)CVFS:7J/D>%#A!5<95[)#!,HG<RTFF,Q+RC>X2=&Z\ :XTUMH\2?HU0X5
M(7>QAJ@WHGUJ,.E)2%U;S9V"Z93)]K%>5JJBF>U<991M[=I*?^&* T5VHR[1
MRG .(P[7U/7A!ZR&C=Q8/U!H-I]S7/IB5IZO-TVSS?9GE\/P/SG?Y\P<>,9L
M2":[QV63*D2?*P@E"[_<:-XQD4#,=7DSE$0_K_^RF!WQME^A?(7?<D; %U\K
M*XG*]YZ*]S9G@EQQR!WN_'\(V/^Z1-2]*8.E_EW/P/W"^)WP;P08V1L@U?(V
MFCOM? 4.BW)3#U+APS(.3KIB]#H>-(*:G_^H;EQ%R3G,=$C;YBY![H@1O%KA
MS]GQ947CPCJ1_18FBHCQL0V7R(X'",Z2D;15\E([>[^"R&'N4[S&1!2CW[C(
M#BI?]9YJ/J.VV)V"<5(\</,8%O3J&9(UG%= P(O85F!6B'I3Y%GISB/$ NYV
MEJ4_0]&&::RT=ZK==2;,\*-8+OFJ8-CHY$QO&],-0)GT':<*9%JLBNO>28%^
MEMXAJ47#JH$P4M%N=X'Y]_22^]FXF8Y<\TRV$Q6J?892JDX=BIR_;0*!_?Y4
MGPS= (DB>A_L5AFB4>%*"(:58-M5OK7S[5CGZ<.[[,=)E,O.DEUG!&62%W[X
MMZD/^U]ADS2-,WD$ID(Y!<J"OAZ>7)/.)WS.8LKM4F0MI<HE"&#/H43Y6'Y5
M:3R_5EJ9X,"EH7\%.:S"E_/8,Y+H)XYN5T+Z=YM09T5^#4W[=>#1/^O8#%'=
MX/H]LS@?H-/4:2L;+S9[2PCK4B74PQ@.;>2%$F%*:T=3"?4DX?!,OM5OZX'L
MIF=Z#(M&0[]UJ8<(EGY5<[7,;2('WE7):OHZBFF>KNVOW=VA.*%*=O49A+3&
M:BU-MX;)4^] *%G4CV),:*<J1UD8[S[=YLC]N)2J.13U%'&7IY?,SD^CCC.N
MKC+[X*LC1%1[$%@[2'5J8<F9QMIC=9IT.K+^M.^$MJI\@C'&=%8^J[5K3/82
MZC?=ZCX)*9 ;R#L-QK5/,5HR-C;9D]997,I;<RF9EZLG2QF] 805T^D(DD*-
M)*+8D.#JJE5H\/?+D>K(TT22+NH:"\N4(=F$O+KW/656%CD0IHPMM%NA T-B
M_(/QLQN P=1!G.%5]=*9S6L:W+=>KR?%[C^+3\5)($Y4E&=5U5]=W*5)6GEM
MU./EPO9# S=THO^VM-[5,/%8/Z+[S4":1!KNC=BIMM1=7JI(?YD58D!XV1[W
MB7&);GDM9,=%-AC&#($X(,4_O/72\HY;NQCD'.? Z5O,66/<V5!+K6I@))-X
MO6#W3FPX<MO!"#*$:VG!%1[FZJ>K,@!B7K)C!6U-'O"S!ZKHCM1Q:A,<O[<8
M&84<)0[,S_%M0&(VC*=_306(E.[FW%,SO-!E,*XPZ-6[^JHJ(IH#\\;9TT/C
M(:)TIL\&9=61--P%Q]1*:2ET6.ROKD(_N)9+OV76Y%LFL[%!&'8?W]:NHBR]
MI(]51]G5#Y3I'IEB*5S,5R3-_ZH)MKT6JL(P&:[VMXA+#(ZZ3=#K:V)DM=LT
M:=#*B+&P]_$N+[0\FMP7OLL.94YM,8OLSK.<IK_H0G+!LI!RE7UQ?@T5OFXK
MQ7,Q=<="K"^^R"ES8SD&>!16AWEJ!.NTO7XSW2M$1"A)*=E%,$5"1SENGH?*
M7'^+7 O;GDJQ7^T.N)("V0&RE+^_OP]J.;A-.[.H70PIDK6'V?V!\6.J#&-I
M<5B:Y1 WR%H/*VJF8AY#!QU!NZT/'AU^%C1=4G5RX>@GR,BCD-\G?.,VGRSS
M@H 580C7L??>Z&9Y8!UN,-452REQ5YJ+\7EPO%OX+KY?N$F9;\7.HM=*4>7U
M/LW):DO"HI31PT]15F,Z@^@^W\2^Q CA/0\0%522T91L23!I]L&\L_<IV_G[
M-V\N?OOKJD3*FI4$O)[@1)3$FZNS4BY&7MWOPN<Z>>G&[J.&!:0>)> + P1:
M2'LY":6OC4BJ# WX&-7G^S.GGW!]Q$.N)Y6%V"F[="5W]HS:4**HJ&[OUHNH
M:MXJZ_9,J+KK+&)5<O0^#L;86;AYN;#L#=;Z7#Z4J%T/$G7(&\2VH'C>S"GX
M97=PV(<&C"1&A;\7V9FM:2 VC)<^YY85L7$IMF?GX$ Y!X8-OXR3^&G.L:6&
MM<V&<^%312B*M:FGY]>75K68EEFJ7FA_/OFV.4V)S"4E3WT0LUO[^_Y ^@-E
M[\;=-O@-0+IC(C)Q)*MF0]V15+[X%C->'T,?4'8G?M43*JF]],E:IS[RQ7>S
MG&SX'JK!H>Q03$:B=C(?8I-P+HF]LD.Z ;%NB79';+OBL'JB"[/*-OD.SR"@
M517($L724&)@]C*H7917]9Y$<&6XK*A3F@D4UH7O<]M!=@@;_]9+@MH,?*UI
M-+K_#5W"!V+E]L9P<A2<X[KK)9U*2P\QM#O2TUGI/U=@:4!<Q%I&&@X6AHDU
MD11UC%"Z1 B[/^.[ 63G-R-V2UP/3&(041N\J_1I=PEZ3T1;19C?CRXW?,*4
M'2PU,;W@V-E]6*O.A"BL:1UBBJ5G)E7$&62[H-K%A2:&N)#&7*E >Y3;S5FU
M;3+X>HZ8_I1#CJ(L4'I-% !G%M9T!N(&2&!AF/9TNFV+XF'[?V;O,JR4,HOG
M)HV5O_>6:)3;*[D!(C[;P%EQJ\H*Q_ASF6(YFMM5.\8]ARY#15_? "]=E9$#
M<JTAUJ6(L\38=IUR3;CFW1T?7:U"R,)%(K;JW!V%Y8"?R:[R?U3ISJ2J$HZ4
MFM)[4G[/XN[<,MYQY5EYY3>X%@]#0WRK#&&5GQN;6M[;GM.4N>-<-ZETG#@Z
M1W-]W."[JAM:YY>[TO.23U#O[B0)> @CU+D244\P3-WS]<2MH]Q+!IOFAW C
MN6)'JA=%D;!.*I-[/S7=BI:PIH.)CW1O@% !Q34Q4S@D3JR:P,# Q+95HZ."
MG$+L)Q]XZ!453@MM!4"T+"^Y?EH-"8Y>%44V1'S#1"#.BNMYAZGZSQ^79$D\
MTI&-LQP78>SURTF16T\W33Z</!;F5!^N .T?F$S5O*?J];DCG4KGK$8]N]-Q
M[QM2,T)6:3V81E:"X:M=HESJON*%7QR>"--P0HF,)FN:PA?&,;KE/:&22+
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M/W;2R35>K3"9^X*B[,;<F]:] 0PF^ 3X/V#]&LQZ+XVS"VYH<+!SL7!@;OA
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MW>#B;\6KIN#9AZH#'T-K=Y(RD*STN^2[$$I9MU^-FQ/H>W+U;[Q]J2B"CQ^
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MF*//HTD3\,H^E,3:GF,+)394@1H=G/<K'KN.@*J[4=_LI.$1ET7S!#B[ZMK
M"2,MRFSDQW%^_KMA3V6%K,)#6DO:8\'$'/;:C7[7RG@R>7+M=W":G%MY1RG]
MH.5 XEDEC1Q!VS1Q^0_.B\_O\0!!&RKM20E)#P!JYQP7)IK,7<.F6&:2N^68
M?0SCUIV9EQ-J\RHX"M: /=6>;5R,A[FUOU8^2W+7%1HHPP7&I=>#1Y&2>1L@
ML@B-\H]Z.AW$W_[UH,H%[>L/D"T?6?_8*VUR<) VJBO,J<CA:7155:K]I<?J
MSVLK7RZHSY7O-/=L$^@I>/K#_?;LS"!^\@/ -RF#!YA)_MN@?1+'/*@:8HM:
M"T,2=W+Y.^EN5QH*K(Y5U8*=AK'H%?(M4C\"R"4Z]UP;59I0, ME^-79$B/X
MDZO QBDJ\37\T>M!(CD;+8]YEB'VU48S#TTT;3IKX7_F _X.W,0<J@47[&4*
M\$S4>N(Z&50D'^,+?5/<]]7E1.@CB=IZ1W*MU8(%0LXN47I_S.Y.9+X$M3O0
M>OQ?]++]&H?:^A!QL_0.F-*U#+0H&@X\JKVJ> #0K3T D-P#[Z1Z;HAQ^3]
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M2U=HK0+1G2)V87JY+[/SM^Z73-VOD9^37ZZ^@N(RM9D3MO9>YI,1:L4>:%.
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M!EP@.Y=[61EGY#2J:Y+D'%VV3>LWU:;I(<U/KZP>W^[6-'OL4>,9(&HB!>]
M_ZTY*G"Z>JW::C=_(8.SOM^J]#VBICH2557DF_@G2@^ OCWT11?+5!&W\O1S
MATU5 PH+S5+ R.@(/+6'.<]*R:A+ 7QV;!O7@P4Z,.X<"2U#LM,_K;M3) 8Z
M%_G@D^VT7! 3)X4'D4HXF>@V3A^'O^=/63*.]!%EYOW;("4X\!,OF,9W &!_
MV,6)NHX0OQ?KOXG,<ZDYK(7]MZXQ_57YZ<)!F<>VH/QYHN\O935,TJ87GB$T
MKC=3AI[6V)](,"> 42L.7B(_EX\) D7*L2"Z,6IRVDA2F<MCFS>KQ[];'D]!
M'@#""8H<&R2NLK<XL0H<]X6>3/*38*MQ)UUW[\IS+))BS_=OTO0_=&')28O:
M^->ZL"SM,X4Q L\3Q-Q\Q5QR/1:<Y;YIOZ'_1\T@9*N$!>.:X?IA<G03B$+C
MRHQ8\SNZ='%7R'WS%N9SP7'U7DK\]I:<\HM#-:;[8]8@W56X?'58_J*&0%6#
M-W="9<!"R(':H/3Z4_F)V$ .C5^8XQ/Q@4_/FO]\G<CRYX<@ 7$CSOC;>0S\
MKN2*./LM>;10J8U.A='^M:?3U5X/@/JO]<I?W,@SXO'/A7UD/^7B3$@<BC2(
M?QGOH ]^FYH-?+L1" 33W4HY-U3NHY;,/E5%9C&LLF90L."<\GVB"RQ"3W7B
MAE"8F?;;V$G,3D=OA$I^4Y6G41P&)=?D> 718TQ4NZ!HJ;[3IUT9?LSJ7H4K
M)JW-W<-;OU*"?15RE_WOJ7P<22^_7Z7S=#%LVA=9G/*14/QE_-L 8V6;#:1?
M%@KSRB$;QQ+K/9OV4G^NQZ<XUO96C(^WEF.7[<8Z6$VL95+B=IWP+2-R3:W1
MR=N^AO]HVZ-KCMW^?/7KUE.*YGC71]J!CA.!% Z!;*&#YP.Y)+;M'77M(N8.
MNJVX9RMEGZ@? ! 6^!F\T-UX-U$(H@0^"PGP\/4 +OZ>;S'W_T7UVRW\]6.F
M@IYA_/CX['LJ5%*_XP9Y5)=/=%&8=EMW]LHXEVO<8S;\^&]NDW8L<11+P<)-
MW=&[)M/C=05KHXXL\2E5 SDCOGH./FRU1AQ .'':63:E]Q9%Z..:EW\DU,3_
M@<<_7!0W8A"_UU>+%Z:=2$Y-9>J_4"<.!BW25*%+85C:5O3'XMTH002T+7,<
MN:SW;2R,HVR(5ECMKV%8:G:VDX62N1DBP5Q :"!3LK"LL<:EQ)0#094:'B3,
M=M-RGF\WS<KN@:Q)9'P40<LZW?^'1?^<I5B:@N>:T#& ?E[F5LL$ML8T>6*8
M)"G;QJZS[LBE?5!A%M7W[M'9M'('FJL=A'1#RG0MN^7]M6.82/MY'*P._[K9
MY YJ)'&J=F2E0'662DFU:(*9\ZW*R*?30"A&?)^@QQ=*!1"^/P(C2/6-VP]1
MS*D\:V(7^.1]'2\3E]9D-0RK-LSJ7H6*LP:3/(G2FZGR#. ZU)GAH# QADV-
M[-:7#=_D?<$W<EHF^^T,9]C/_'NXD9:*.-;3F_\W*81C92!:+:)\Q9O)" :U
MY+*)M14+#G?I?3/6%.YX!?XE]:JQ:E.P<G_OXE=$/:=M-M[UDF:B&)R9F54V
M5V\01/3O$T]GT@=8V5K;T,ZQXQ5E&3:>[=',+U)=K;N9O=AKX:XD0YB8RCUS
M5DQ5X9J]5+=+DF:[2=;/8W2=6HKA8%4V59,WNN=]W PEN +(BHEZ-^/EI*S5
M=2N/K;ZM=M8AS H=B-8'>5*J:H%I)N\^-Z'6\I#OA-ZA HH;:74<T",V<:D\
MR6FZOWU=DLN'+VL^HUIZ7,@Q'K YOQFI\W6!E@EJL5\_;)=4D*KF6JK,G]Z+
M#<C);UC00MZ@J:]2U\TX9RN)Y6'M_6H,Q &38FV)JFSHE-3+&S%$4/CE.B'X
MBYDLS*_]B_9N6C"[;*7(!FE!%F&S6SR9WYQ=!+?)1&*@9.:4C@!4\BI94U7I
MA=[9[C()>:?7VG.T=QA"UB8/]K*(]FW/=U49GP> UR-#+&X(D[A!;E[\#3'/
MMW5U-,% *_O]<P&1WW;K'+%+J'E8$#&XWJ5AG['2]KRSZ, J?87@JQUJ#/=E
M[/_-79%Y #!BI#31$U&?IYH^\HUCN)7.>[FD+>]5W2R>@R=ZVM=#FJSM*I?S
M>&+.!).IJ#=GM6O*Y&)OG=N28B0E6QX )'>OTY-57PZ4:HL2FAY[)F08^CU5
ME,FW@UU>&AR=!EX'$6,G!$;>.@G9)+"S6+W" P06_\0JS"+6.%"\28SV-ZH1
M:+:YQEO'CL]I.KW?Y)(-+X9U@RC,UU%,_7H8%^59RUGQBDZIC[>O!CQV*75M
MS 989(.8>'C5_KX!3+Q&LX98(Y/(S?9NBBR/3PIYP=ODMJP;&TG%D.&"Y0-S
M$K16\8; %X13)M(F2ZL]Z-)MM>8F0R4H5.E,JN'3A<2EE^_\P&EDW.88J:#G
M1GF58;GD$?@\O3PZ=^6,W/I2'.=<H<,NP*92R<N.&@784F(,-9]32YH@.FT7
MFY8[7@*/65NLP'W].6'O!;HSSL4=KI6M=Y9D<=T5C[.]:[3_--E[M>Y@5T.1
M\BKS7P[0L,>MCP39N^.]SJVV/UL@S0/</ 9!CXJ=6%G\53JGH*.%MQTFOE?%
M5P:N8&6<IN74K=">(&)@.TZN08EC9EHBMYG"?F$L0E*;^ 5XVT)5A<!DF3UV
M?K+K&3BU?^V9F>WH>U_!V/"\<::(D<2I:X^)-6[7(S#-&H2X%A45S3TC3D[I
M(#Q</LSDJZO.3JZ@0"RXLO$R^;$-3EV><HXVXQWNC/@M<=C&=IAND\".0&=?
M>'O4#$<8KE*B\'HP=R9@"_H&'7CX8;ZJZ9YKXE;,,)YD/)[H/4"/U14_15+*
MR?5MG;25,*$>>1($9S.'I":F4>,='XPGM$4XJ#"&GO6M9OX/Z6%<S6JWU)GY
MV&'[JY=A2P>3IB;J5#1I7._J50)F.^6E[UY.J3NG#+:E?RT8T:"._E@(#W*[
M"5LN493O4,&,M!,$-\P)&@P8D\1;@NR76B9) H:??FL0)%S##UN-PFWUKV$P
MP@29.NGU2*7N^^!7R'F/C#JZRD9&#+_PR$OWC!OJI:]L[6)QO,X,F"LH''A4
M9>E(GL,Y]KUWWL6M$=%/UO$V+"1;7S(N_TO@\TY)/X%"<].(U6UV4IA?L#8H
M A# N4&>E*D:O28 @@VS)I4UT]@(8)-$KKA/@+:;ZW(&U7;R? BF/')'6B>_
M%F.S+96>LHY5/')VG]5U^ BYE=]\"40*D[()>ER54+R3'E1I[_-V<$V()Z/O
MQ2B]1>M[48-\..HR7U_AOVI5I';P,20 8<3_>9GE@B%MQ.,?D&_!E;&CGJ"0
M(SZ[_ES.*:A!(;S<WL?1P_E.4MI^N;W^4E>>_*S*&!\24@6NO]GL#4+%8LK>
MD;4@#IO\B598;I66)NNNZ#^M]FU.@U3!=#JUZ)JH#;3PTMD!+8]=D/-(,?&@
M"5N\744W86BE=+7UIE1?R":Q6-6>R(NYXVER^IY;8W($Z#@1CKJ ?[^CQP1C
M'Z$_9&K5CY&E![$E;FB<W6=:]KB3:Y^T-).C)L46%3@@;--R1@7EDX@HK5FG
MYQ3+[:3EO#@P[20$ -"]VH.7R+>S# )@OMV:=?P1N'@ 8#*-@6M&PZ*JSUA&
M(MG!IV>[8;G9\_/3F%'U%NRLOD/NICK.297N\ZE*.WRUBME40AF&37E,#1^F
MM'P1DV^X O95F*AZ->I5<%#;.EA(#Y33:=UGL\96M0WU;-<ITBLP8,R0W4?+
M.<^G^V,*$E1$2+$5Y6NJ[GUR6Y4B^4P>IWG74<87Y,S@ @5J#)4Z:C<*-"41
M\Y^)!L$G^OA/#$9^5*D]>^HG..4*3^_T+)@-NS(J":+,&C2' #VM2H,HV:=N
MK?ZA+S=\HV"R<35/(?9HX&+,C\8JB?SF5V[Q_PTNW(B/KT< W)<,8D#3[)U)
M:DY!,#&S%VU=,W4OZ6R?/4\@,]AA@\"S\5I<C \NUFDP<#,TZ6#4ADF,ETE)
M?/'VY?2C9D# *2^E7!ER0K/<]FI\J<JGH!<QJC%;ARL1>:OWV16T.[ZB3.7N
M][=!+."=WV[/.O$;Q'KD7/H;PJ7+3X([$/</#X *BWQ38 4CH! 5UK,F@'J'
M+<N\NQ(H74N2L6P*I/QZ^82:@,!=6)YNJE,W]@4%LIL>2OBY_4)!)/7=MVMM
MSS.)GTZ1G DB$:W:5]]Q<A=T<HEJ>%O1P.@[)N3.O.>JJ:.DSY/D^]:2/9<"
M/!PNX/H3867(YGP!R"+Y,5M\V SC>8(/@J5V)L\8);"/.OFU G6K/C1)O#47
M_'E#XM,K3K(M)R186.A @9E'=#:F=[%VV09H]+\YNZK'B[(GKV$1&8(3)G3E
M%!X&,F!2$27^+NRZ]<D$N7-(86,N[&'!GFH-DMSOS,Q&_):!$<2"^?( Z+U)
M7_V']5']_A&54;>_J>8G0]??]DPK,&.JI]^G6F#L-OD$G%6MIMZY>&W_7I11
M^"+#GCI,HBU?AM> %JC:[96]#3#I7_/:#1?B/*MIC#$=:CY:_%LHD(TW87['
MO&4=C$EW+,'(PHU58Z!XX&2F/3V=R#GIA<>]^"?FDD>6V=7@OY$BL2?.U5W\
MX(;>]$S6*H2\X!7?$+2F137@\1+X6;318PYF5L"QB3D;*C&]Z(ZD;AIB9R=Q
MOM]\D.1A3?_-Y!4\@QKE7:T2\.I<D<[EOP;,,&I\XN,?+MK,JH:X.'6Q<^-5
M[@_<D[G8"!,6OM]R'%C>6?'#JE=,!4*Q<L_\S%D4-/].F4A1O5+U'.H+!O\-
M'M0OP@A4:6RXL"J$_!KMT)JG"81[9IS9NF&K9G)_$UF\7R#$9_ZG&W00BE\.
M2_]!%%%B&H_*'2,[$\GJV8"'(NLAD>;A'@M;>%-0=N28U& @:YC^U.<1:5@=
MU7G/_9\H*Y!.V%KS8<\= U<2FO;$S*!OJ7&-%)THM:;D>*[DE5COJQJ)GZL"
MYD[VRUWI14>.BU!+Y5+-J*Z>[\;:;ST P+\004(C(2Q2"1 CNXWN)V:'=)5M
M"6][*>3&>("\Y.6'>SCR%0-W#$@^( Y850?M$W=B%^ SH#EEHNS2.&ZU2TFZ
M\H)??7@3QY7\;1Q2*.JT\?C5A $FI6(,J5$IUEOH@*;_],'468 ;I2*-?[P"
MWHU/DD9SQTATQW1Q-[RIC9I8$OA:65DP"!M_%3:SF:O>LYN?;VM;6KWF2*?7
MZSS_:NUD\_>MK.;4L'@4CD;;CLK^\3?71X[KV*<0^KA7D0)! \W#@B4]\DU%
M8<_G6VU9UA\ 2C<7<Q@3E#.\UTWUE^,KV56O2&5K3^^NX8.U*@R96)Y.ON#_
M-P7O_YWS!T <B'0#O1:RN_2\I,DJHHICDY*LA.N2L*7@BELA)-NKVL<,?1H)
M!96NK*P=ZK-^IFB(LVE7Y@\G;Z_(_N;GF4].B?$/H/W6\O(TI#C#I:J0T 15
MM(5%TT5]P_4=D@MV5U'C3B9O,%G#&"#IP@0NLT8=_<>$'#7UKX0AW]I(6SU"
MA8/RWOY55D>'+A[Z)9:6&4H,#%P,;I@NK3 YQCD0BSG'*CXV/6$++6*51G9N
M]G73W>%5[M&U.Q=08CQ-^?/L0WJ(A'X*'U4'DV2?]XB3I/9FXF(> 'IAL)L?
M\?H*#+4_NFO%P844@ZX+YZN$#$,;0=J=JYCU04E60A3LICF_-T-E%"P6F:O\
M1_6<NQ9_/AK#MUF<%^9)! $%V$F6DX8-L^;Y.+_Z^V?KB(P)/\!OXV)H-[0)
M#?-;3WHVI\#^1J'EDU'_4HPA/V\_L,,T&+"QR2Z]M9L)V,<R.3#FP2PH#PSV
M.9HSXQL83B5JM9Q2VE5Q'P#$+>QN(-YX@.PMMFDCZYU=KS#&RJ0CK^Y9M-I4
M6\K.ZT_+9DERFV5LB6L_AL :R*B^3LH!\8!':,\.&]GO&B[/HZQG&I+= Q:N
M*A-HK[3CILT.&*]CN^L;"5KM!1HU9']$JG^P?J1_X %GOAZ4#;;#%/98$%S(
ML'B1>OOS?#AW<?#9;<][U6&:--C@.4;<=_8[JC>(1*+[:0O*[&":7F"B&\1'
M7LVW=/?/-HC @>*I2G^^6K&?K!"<<SP NA/2[AT+\\D%X_I8%="D_QD=+%7G
M(02828+L]BB0K[I713TM,&1*%]4=?6NXJ-.P O;7TW\$Z0//3BQR'>3==_-Z
M/OD;J/Y/)?(>&/_(32HQ_<*8?>CB\#52W28PMO#O/8$O70PD4,ZDF.U?4P5I
M.=%Z@VRZT1(7^C$BP '&.E),^?X\S<S=9]1X!_(47[D(XT2S\^V&J]7@^_._
MBI+JW&6DM9LUS$_.$TP0\P-5?.H:T5ZC 38"2.+[W*J=X&"<)NL42>&>_9D;
MYDF13*[R@(W;X1IQ$#Y8[WT: :G4E<I_7*T):L?I/H"DD]CY^4LGT&9Z5.7Q
MG3R'_M+)#[>K]#]-7+P-98ATOO@DMU!1I>7L^22'41LDJ:T)SQ';M$T';_BO
MY+1YF6>&Y!L)/W_5Y^)\30PF]5^E#!#3#M.;FC(#Z34(>7SMP9YQA32OF+14
MJ+@]3YU(4Y/IZ7GTX[K7@N8@LT(P!R%6R*=@5CQKE88_<>TJM8FVXKV.5*!U
M<$+SDN(B3V3W+C[?FC>Y:RTLPOF<@Q\ C['/_>[6?>AKC*>ZN/H#4.8N#&IE
M@DY..;;1GG3$9Q%7) /:?R+ 0A%?=_R)JKV(.,BK^5L8(^8"P1=[69YC>4:?
MF0C+7X%B@Q6JG>S>:>BW2LTA.9MOC9XKP>@G,I).-KO?HM>CSD?1LIN<#X!$
MSHC"J8MH[&AI48Z[$IX"QLY*ELZBRCU7>.Z2'LK?W&5"3@%>W/1N3 ISL"IU
M@CZ1=;[W'?.?")$3( ^#T)7N_0%\CI2?)P,EZF]/[/9<X0:_9-Q4$#)<_0(B
M\CKT)[#-&C(2+N3XI5;=C_VK9Y;#XC?)WM^X3H%Q&; @%%\5A<,8S1.J#8WZ
MG>/*-5-XVS]1G9</.774%\J+_O/;D+N L@.?I:@PJ*-(:VN;^L7?V>7JA3P"
MQ0V*NA_1S"?QE_A90-8[4H095;]#Y7XFQ/ME\1CR->W*#R-1^I:3&[(<1>9[
MQ\%3H2:\3<G.Z8TTOHX,*9/!#V*UR9:NLFDDCV_B[<(4QP\W@H*=($Z_#GRZ
MGD54>QZ:N#24><L-]7_9> #4!V].\YE7YY'>.90N)PB]QB1XN102+,1(9*K+
MJ2_J:^Z&3(:V'O&587P1+^YH-OQ9V AN%2TD]^<Q.\XFN1B$:GUL)U*;SEZ!
MHC%Q%V;\75]D2"U>F']<U90W%,[ 0@!P?QFZ#R((9/WM"?X,G1'<(2+/UACU
M]]P$-,NP64NS1#'G^KI$.7Y2>+[*'>=4-"OW=K3+26LOC)K2><DJ1OL)39=B
M?P4N]2<JX[/#=A ,&(^E-6.]DE?6_@>^,X;P;"+Z<+.>C4A=ZHTS47G'J=-&
M)Y .Z56%#?]O^J$,50Z>]SXDP/;?+R^X@@6_T6B( '"^:7\Y,[/N<\>,#E#"
MJXV+DE><;UF++7E'!,RTE*@X+#>?*?WE6 F_<'4EL:!Q:?R+?>; *)4@01Q'
M_H2)L-V-PD:CK3]EN\W<E1H/<Y/L&%4OJ6=A; X6>C4#I2@SCW)B/#QV$N@J
MT\,:J<4KZ/;3'Q#)[58!_$K[:ZB^H!V-HT+EK+ES*O;M.5J@;$DM)KLX]T-#
MPZ>YOOCS_QE,T $I4\TP*:A#_=#93]!<B<C]/UA]RA'4RZ=^!+Q&OG*@%I#R
MY/]9!:EV1,HET/4#*44WN35S?"]>*&&]["S^28P<_T@[ML[1ACV^4FO17=Z;
M)-L?V78?-)#+B$Z,7&/Z(]&AL3SFRF2XV9+N\1]%!G,PV6I=Y%=)40.&G6"Y
M1/OLNT\8%WM:%X5YC6E=132!*:\SI[8^_81Y.(6%IL'8R[&UVN[&"B.,.['%
M\0N=KU_-]7T25^52;OO(O>*;%3=EI.5O#QV=I,7/'2T87#C:6_C3<9=NUA8I
M0K9\;4R8=T)RZ]Z +P*ENJ8].XX-^M:$6M _$M/IOYWU7>&0]KW)->/\:+8>
MFW+SY,!S/2Z7?E:.2R++,=\.Q#8MA><YS8S#6.(.^P9@3_2 2^/[[@Z:42X)
M,6@@@62F.5(?I\31 0%N3Q$_A^KZI+&2HV&Y!2I?FD-J,-;_!/(!@*!#B\0I
MS@3-&ZJ'T+0E?_9-<06,VGGZ]LHL3ZAU<=HOY0Q4IR)V7K>BM6.]@"T6T;L3
MR33>< J=?[;YQQ21!.SPN+B20!%&[:#,DB*;Y!68#OFD]<7/Z4CHR4R%M]5E
M.,+60G*)4>E]?@GI PQ57CDB.P$O]U]?/QV-$>!D^)Q:;2R%\QVE1")?<?#D
MC%0*(5FU$13=S+@;5I-YJOECH/.X>"4/FOB(C5E*A3BXQU7ESUQGX/]^CJ+&
MT/5WB;:<7=Y+\D7IA.<$JNOM;6;[>_X;JHX([@B(4N'RXD'SU)B'RY.^S#14
MRVN<8*,>G'$0E-3[,JL*'*6*VBY=\EI]N]3'?JUY1L ?0.UE??2"8L@,PC)9
MF#BUV>^Q8L_8F?TVY8#64'=+4(PCR*MA',PPO-,F1')'W-&(IOT/\F')N]#2
MF^2/V9)S2UMHP"))R =\YKSOE% RZ6KD]"9=L(LS-!JB[ER3;6N_%1-T6OJ^
M._%+.DPH)MW\Z:R<_*.48E);E@]#O]FLQ@\ZW+:=AKAW)@+#YL5)RMTV\ACV
M^BR+#MI]8HZV6QSM6N81 _!O?H/<6H; JUJ^%(P_R@.F[_=F?T:"Z0% =I!B
M5IG,"Y62K(]X,K0CJ&3CEJR^&0]XXS<?=N?U'WAMQ*A1?7TL.,3-\>77-%Q_
M42QA2DIO=6RPG.!I7Q U5&93 LV5Y%)LT6'IPCZ=-40WFIW*[_SJ=/=42/[>
M<<7*^QNU3_S@[_QZ2B*]_0&%ALLJ?PW43N9-9%L Z8]?7M_T#P( !]JUP_DJ
M$;X^ \ P204)@UEQ:YK(9L+?,"O9&CNXR@/ ,4\Y5X0!DX-TH2JJQU#UI_06
M#Q(Y.9JF#@?CS(:&$N'-4)T0N"[!$^4L/$C[C3!HYR7FBAQNK=>-,>@>QXRW
M.'GOM6O_5;U+]:$"PVSE11!=TV!"M0-0,*.B/OUL\P&0*QJ";<8;I_]<(SV$
M[) E?MRT+V@U+0Y3%_0>JP#;F_)&<I^L&ZIIK4&WF%FCFB&EL#5!M'=5"6=>
M]&EWHP!>X(F#DW5 U4QXNFV 6%-;N1P1FOT#2JO8B1?.6F!-+$([_X0\O=4R
M_JN*-8<7G+!5G.3*@A+",7OA4( .BFC2;T/3YF1\MF"W6^[A/@7X)M>,+/0$
MMN)_\ZT!."[Y1(/L*Q)4QDFOE@92;".5\GBU>5AFMCRB5( I-2ZHI/A&%\:]
MT;(]G^=O-C2(T1P"]W/FZ^91=1+:FA@71!7[H $K=VV]R!<IG(8H!6/:V]\5
M"[G_0/E0,9$0GLN<.ZH*-0EF\LKM].[P95.7TZW!OI2YJE'!!#P?1DWW:T:Q
M.>B/8J*_ V<^=M,JXV/)YBCWR/D7M.A3<O('>[#A\P(H50,S$X3DCW/G;Q,!
ME6$RO?JRJO<H_6!YW/_[#V+<_U\@@BE7)\JQMWT3.ES:_,.S)ZG1H68KU^^N
M</N>#_I?L$+ ;!<>N.)U5X!&#Y9S5<BL.*&R=-D=4ADPOC)K)HO,2[HC^,69
M#O,G<J[,XGT'XZU693C;5FI6G@_+OABJ*>3;S4O$"OUC*4E68E0]BZZAG9@I
M\6=1D>^XO^(2-VBY60LG)T6C8*1BRM->[V1'9N?F^S*/@ESJSNHGBC55$/QN
MY#]5X*&%B=J 7W.GP2![:18GSSQ&=J*PQY$5P!6W2?&X7O-%=GF_)]N-0HN;
M ^TP(LD6'Y>BZDE*&<.Q%RQ='S?(G1:O2@^!#?=S"0&6-(.M4TJ^0C^NHCWW
M.0Q-DZFE=5V)V/"FJ]T4650'+"+6%R+N?#9D$O,\;-<=6D-I^T)FAH&EY@8%
M#/""2Q=\3#RFIJ?=MI4"LEPF]IRGYYSZAZO\HVV);;IN CE?LC#!G%+,C4F%
M;=*(I-ZPN!LU?!4H!I"UIJ\1U.AFACR;-Y_-=)+?TFNG>VXH2#?/7'Z3J.+_
MGM#Z?T<AK(&RN.-.-N=W8[53U:;-(G,^W1V?;YG;!%V)+6QM(#NY-];[35P>
M[^D<,H:[C59]H2#T 5BM26ZI=)>HG<*5S/$"T+*&,Q!24(1=PS1EGQ'M&\FK
M."K5IA;+5PA?-H_XR]W,_3MRM &2_R6N?2#KU .@^35 %7]P2MV<X*BH' ^O
M^21/\Q/>@3'?CORK]<'K<SI,%)J,G$QE/7!RS=8T:![*03[Q*,MQHSO"0+=F
M.9##3-L=?N^0- +,*H<C[?'V#_AZ@2IH>+^C^+P<%9(*N4[V8E6@0BJ35F2F
M#!^-G7H:H()3HX?B3KK( ]IW?YU:'FF-P]WY,S&!!]PIS98*LD[&87E#K:-(
M\'\/M42"BR8*FWU],WLAJ3\\IY[%H!#LQ;W@84J]3N75_;2?!Q. B'$6^ #$
M9'^ING+\"%P#;+3>*5U5RR+:C3#K2-8*(5A;PGIT)>?GIJD3]-;K_+MEJ@)>
M_Z">-KDD;71I_Z$+LT2V<5I%F;*E"YL#/YN780F>'#/)KJPOQP9>,-$8GAPW
M[&8\+T"6G!7RJGL>6+B_QA)-['FCMJ!\^>2=QR&2/.JI&KLV_A<Z';(&[<KZ
M?[,L^)?U9<WG>HP%8M_+@@+F2<1Q]ORL(/<%C"(I_3F]$GZ#TW*[=6J:](#;
M34O/.YTTHXV&]P<TF;(R="1:@%@:[]M"D'B]L!PE]36@%'&*"WF)267O19@9
MZ$XVO=$='+S@'U$\R0[MQQ+D6>K;W6=XS:;2+EWE//<;2HPZ \R[H/(V>E&V
MA?<=-=K,2S]UFU%] ]]6A-F^+3!E$;((B_I=LG@7;I*JJLV5)KV?+'%D@W2\
M;G!I-#.35#V5:_IKG73J?B3KF4_V9'2#*P]QS,*E\>).N[(C8ME?IJ4I_*G[
M@ %_CR=<9D+)>'-#)0X2=]_P4D6L==E!LFY9A;P$R:@"-+@C?+LGA'UA?^5W
MON\Z(/$[I>_D\ZM?-<_C_ZJI]R>+&D6-!$-^\U4W=;1T-2<B1\#5SU)\_A=3
M;QD5A1>U?0^-=$J7I*1TE_PID1(%:160'#H&&%+I!@%!NI'N'IH!Z>Z8&3IG
MR$'J\7[6>[_K^7"^G4]G[;A^9ZV]+XXD*:__,5Z<PA,O PLC \N+5$LW[ QC
M$P?JU$58-7_P]#S 80W0*M\?W4008E7P=3VZ4EVD>4'E]X!$[MO4&E!-[B.W
M@^4S,7-#1U%89).\ON9%NN[/575*/U&VH3,]JKL+)8:T38*F&@*9P\UG]^\G
M"9EV^QX&$LU(G@ BR  \P!.@46;1* _\MK&UVYQF\#H!5N53NER]2J[[./?N
M80'[>K)V''Q4 M9.[VNQ< FI//6,7-&>63&S#/B]H7K)HT?F!^[YMM+5WYLC
MB=P<,B<P9QG(]*J=8S<;M64;_OP$D'_A7(B49N[:QYK;KZ%>X$2I]SZ//^WS
M[539N@D(7SF8_&65$ZP@9:D2Z\U*\>RR!@^]J(8:BA>ZE(V[T^$*U>$(ZZ(+
M2MKWI\?V_%\+&9 NE)1PV<YD(A?!9P?N\!^)2ZNB<GQL8M(02C@#$HD^;$54
M>5I0S%":=D4?&46N]?XV%?USE%WA[TR_X(TW8[?:K5>TJ(O2^H^9%6U5M1RV
M_F*5#HY5C7YTQ5MT5J3O11-60"O XK&W\8L2%S\%L21</Y ;8-4N41[Z,/^3
MN7RPA1^FEF"QQ+;,BP%OE,RGD)U"F;&-I9<L+#!+;=VM,Y+)3PLN12O%'1SZ
M]>JT2M,#=],D,F7.WCDD.G[S(# &+":(IB6:;2;)*^VKA\?NR$WT"??7DS;6
MG/6C-/0ZO.W2DD PJ>1MXL9A[_3NUQ6!DR$Y*'>S#V_\GMN0#@[ -9 D5[L+
MG5H#UD!Y%Q.9?,B>2SPXGX1F(G;THD5,K4%;UMO?5MH)GP K] NGYUJ6SP[<
MM&NMUQU:ZE;4%^D(H *7PPKS VBC+8_U@U)35$F99P )YP65U#/1TIOXX\C>
MDZR4?=Z^PPULT]F2>VFTFV34KG)X6QN%3.YU<S:4>0\(\#+Q&<BE.W+'/Q%_
M D2D3;:2,RX:\$G>R:7D]C77@-U0[/UI)7O&2.V<.F"+:^MT]:K+HCW)TLV0
M_-%DDQ &Z DPD/95_%\1JV)^2?/E%Z@@6I7IE^S(\-79@=Z!(0MU(&G-BN'@
MF:>U[%ZS)C8R9&T+/)U['8RU*(9A?F]5B+X;(#O*):OY:MWHGL;,, O<>+W4
MR[FTY:XNMXVHQ:RX9^Z,,$8O.TI&G@RTS*B+]IX#5UU%[G[Z\X#]P*U#.'Y!
MUR1A*(D_FU!FC YZR2A6X(9?L# /(U2&I V/H>/;FILNDJNX$%0!QSJ4V<AI
MUXV[[/!I[&C<XE_'2 WJ"DF:VWJU'4L/N/*[C4!XK;G?6PL[_AH/Z_IA3T]2
M3$LQZ MXQ3]@&_I!&0[)J9%"]VZ=D1Z9X"\V52D=T-"_VY6]BAG;RB%/0?=:
M]5PI[+&RLVSEAC:Z$"]O@I(7/^1<FJGL1%4[64Q_B8E0# J?H$K##HEO.J#'
MB[S<?&Y7JC\E&-M\?$;QQXJ=J).91-2"G"9XU03M%@1G<*&T3SIP77Y[]I!>
M5-S8PHF+8"P"LCI_N%4XZ&'U%%^]%T*Y1( ED=5]&]>'LFI-KZTOF/ R3T/=
ME2>+?G=+*#@)>0WC<<,VH\G7#OQ:OD,X8QSC3"8TWZT<7DN-:?-N.WT9_J#Q
MR750 VJ1!6,A=Z1_ L1>2E6?"9Q>3A*/B9N6 VV,DSEB(]C="U@9]'A_QWJL
MI5AD(R_4IJ].+*$^-'Y>Q5=9?X^30MP(A@EY1KVPO9Q01V9/@,&.$X59]5:D
M4.A)9>.EAO9U'0=^'13[9>CO577!\4:K\C\)\#Q2<F1Z1@"*4@6_6ZR]B,&H
M=BSOT6QQC1KU!.B5I[M*B*$WQ+6J%_!Y>8FO8'D/+KMW/"; "#.8;]("TFBV
MS@EIX7\R'R-W'_/#P6KC")8?-ZMD83BX\2L-%=<"BJ5VG8-7G;Q$AE3R[HV5
M\M133.[%:E$N P*&BX,M\8MI;IRG><!5G)+LGY6.;(RJC [!)-(<4X]L:$MD
MKNEYIWBQ=J6CU,L]5>Z?5AQ$/-Y;UI+O\5K%>]#^@\R\<U<'59[(!9,G0)07
MC\MG"+\^)D_JF]3>=98Q-1(U*J1C/=*EW]$2^QXX>^PEN^_%D%0L_]!Z/N"P
MR/#G&(N[X/130$-(-.[GPT#.^4O+V 4+^<7[EP$%!S<D+]*DK:RZWGZ5X$C$
M ':>($X3JD0MT.8%AX^L+0UHE_+^<FBY1@J.D:#8OFMO;+P,YILMR?%S1,H'
MSTDF=(0%ZC]#B&)KLBZ)0[J(J7FO#$ZXH.^*VSGMB$'6-A%E[Y[10! QV-2^
MQ@PMV6O8PH*,7Q]+'_'<<U <+G1*\<'O2>SRG7B69_NI&P_,ON5"O+YV],@S
MG]>2R<9T-"@5+IW.OG,^KT6F>9#RD9D%G8^\4T5]TV8.<[T)<KA[X2@ROOL$
M*.3!3P'WOF'$2"7,LN6'1J-JR#XZ9!JV>10[QN^>S[R.KQ'*")=#^A[U5J_V
M/@%<4F 1L9>KJXJ\*T-KNDP#M9_S?[17J&;9[NI)R1-\6PAA[H+=92MJHF%P
M&M3;X_:2/"MM>CC,C3%MQV-G8&DUT55>1S;9X_#J8B$%_B ZL(E3TRD ?]M;
M<R #;C 1^)-X[LLSH[;OUDN0YS4"N!8_\S/M;)?/2A[9[5"*G2%%<*KI(I2>
MEQ5$8W]!=PPT;Y CLQ];0)*<E;X?>W?5N0FZ8\CDVQ?YMBRQ?C4E#$*D5.<Z
M50(+/A@O>GH+YQA*32&+L$:.LNY2?MTIC;N#60J7C?NXD\\^AF%KWUBSF7U7
M-(3N&'>30;B.-L@ALYT2*ZEQJ9?3E>GTA3TSE?K'6-Z#>/P3]8S +>#5,*X?
M;M*7O\5#;8YP[+N FI5F=1>?9W9)KB ]9!X[MGLQ%.*N*_D$(#!Z\P_R<\OM
M5ZH+B>-_^5POB94DRKUD9:O]_C#U)O;J[Z( [ D0(W/2'7JO7X[OY-50:&'Z
M!"A5P5)JL6>GMK4!@'MX+T)B8Y%\):BT7QXHRY[G)O_N*LLGG%I;.26+%-W]
MP(O6+F4+QS^59F?<#9;;ZV$6F153C/T[5 QG,EG!WYTU9(B)[+7;:\<D9V-0
M(S&W!O9\NHAON@S(WFG.MZ%>CT6MF;[-1Z1Q_=\Y<B-H9D(,6%&R7\N%:!5D
M>9SY@P;3V&5L-2.+2-1==!CAH@PM]I/L5V0.ZA- 0@[Y/G)U=G;.<T8HS]*U
M#-\2[N/]H=W. NBX+03+>PPIB'_K)W2QL7?ZF],6^.;C06T2Q.!A5['O6P=+
MD$K\9SD&VZ_U("C\NABWT <S_2.GXKZW2KTZW=W):M8V(M17U@(3^5\[YF05
M.OY?=07^Y]+9X0S.?P+(I4RK,\D@I@!R?81G:#-+9@HN+A?B_<]%&E&WG/AN
MK?$1_DE7R@DF@+5%&_KK7)JHP!<9QV#Q+K4D6)G.L@OMP] /(IO(;4'7PG+&
MO>2Y3D=8N'"<&LASF'4RJ0AM.*$HP9]U?^,$F/"[-?/?;;HBQCU#N S&H-S<
M!+K#Q? D"C2> #N%WRZPN>/&E#DNP@A/+"(\-S#1ZB5*JME=/Y+!B1RO;EN,
M\$KQTIR[-*%B&-M)H/Z^XPTGEF=G5Q^@DUX!8BEM3"/\59OQW3"C$Z^:;\R<
M61^/ AE2^M-M=];VIW[GWA1*L2!9<7RT4)M]* L.^J[PEL((*8K-I1.#)P"X
M3K'8V\?/-@+L6#!TX[U@TA76]_4E/@G^E2'CMU/\%\%RJ_U!N)S([EA^.>6M
M7"K*DCI<NQ)][NQGVV7_XIQYC<C5=] ?.QE*L6OTGO$<RH0;E,B-K*%/T>E"
MBU=RZ%FNC6[%6:@X;S=;SQ2#87,YPCD>"64<1']KI_DS#YR+C3(_OQACVE8\
MPOXJO\2(J1\I12M]H!0?9(F*BSEL0']=\KVAD9#T]71I>Z'"&"(<[\/16T\B
M!95#C'9_U7:*:NHB4(.E"KTPNX0.[UW%=U7?_#?+5J>9-L,1H+"AVAP8SFJU
MY/L$\,28+ :/WRE:,.C&&$XEXJV<?(W)48P80SRB\P)(*WG^/V]#:L:+04<7
MCAN1HE<#Q=M)2[P%(<F:\C@2I^<K?1.F%0>(EI8H'TW^:FH]OV0_HS!0X:!)
MQ% ".73K"8!S6[LO/,RB-V>,3Y)W!;T)H-JJ@RKQ8)J;#K2?#250C< V<<VU
M2] .BX^*7M0X;_M+ZWKW'-QR-*]/Q*J$>EAP&]=T_5WL/7@?SW</^M<FY'\0
MG5SK)PPU.5<"%1C HMU/@.^FNF8'UPF\7&L9UH0WFXQU".XEJ^A;+D)2<M#J
MNSFA@NB]]^WQDNV=61=-2AS)NE@A/=<]5$1_Y9\ =@E85;VQ3)J+4A>J92L!
MMTZ/J5TE:V@6N.JVR5"*IZ 7H1@!5TN.J6-D>A8NH()ZE#FOA@MBAJH.<X3=
MC1*:\G">[]2&;EG(GIK6[]-EJROE9><%-4QRU8N9V^HC'ZM(B@O-1H ^&&OU
M; _XIZ2N(#&<A/I&8ME!&9UN+Y?RPZ0C>HZDL^8<F_?M(>>*WJOO^4*?W;:C
MS$A:[N1,'"$ON^;/P%K>AN?>&? [F32&>%<6J9Y]!0M %4N$(J-8+HTX)*.*
M]R"S'T9%>?<K_ GPZ9K[KG3_68UV1T=+;4/FZ;EUZ :VB!9?%B\/'4?N6ST\
MXJ)[<B1S\C!"[<ZZ#&_2ET^#8:W:._=/)Q2>D'"OXB:_^VT+J'"A,^4Y8C(#
MW_TSGP*.Z>?:H55E>B6<4_HM^C*!^MZL<=;I4WK?\^L-KN37&Y^:(4JL6"P@
MHA9I1*S;0N>F"3I]2^MHH6ON7K;"WH)5ZJ*Z46O;8+8F,QXK]_>V%3*/E&.Z
M4[;LJ+Y[J6JG[7SU9GKU),VU:TFE5=1JSNV4;UI.?,N?S\;T3C/GT5'B86?\
M.^9.U<7*;I\U:7PACZY.]N%#[J 0#L:+P_:@2*\#3<N&\;* K#73I'6N!*?@
M/8C[*^%)B\I[O7^:*8IC,A3",@)(!)J.[GRA#>KTYCDZM,.:DA-]G@J;Q&^N
M\&!.*5$5>79:4A?;Z]R/MK3"J$V*C6]#9)Y/AAD6#K PB'=3@[Z,+8'<5 ;C
MB@T-/W5BG/:/L:/=\>BHBW()Y&P1_L/.@3R@E =B!M!L921T-IA<MY4HX&CQ
M,OM%_^N9K=G&F(\G0%;SND':'N;'[2N.<SO,'2K]_]]/G%0!'8),?XOZT?^^
M-J,QVT^$3B@?VX6]!"F<917.&"^#H!Y2@6_&6)(^ :8[-?,DHYRL8,Y;.#]K
M.B-)%*K;:CP+@N6^D*[P+GH(W'QOLJ/3Q%932;H:-BG^_3BC-DYS_$C6KO)B
M5[*S];SW!L V?.^XSM<?9/\E?+)?>#R$P6RTJVZ8]NT%>DK4;U(?M1GG"7+I
M5!0H27$48]7^3?LL\XPA7@#F$?:V@<>6M04OVB?\D<G1KX C1V&.VY$#.%(8
MD\*=Y7%S6LQR9-H\?1X,H&41< 3++= 80KK3M44M#MAO]!P\?O<U4%M%?HKD
M&= /54.,<*]T$.OJ/8XW&P>.>'D;-W]OBAG[W+L=+P4/%I;31-[TYW /+/XU
MK]B TFIP>W)P37ECYH=OXS0T2(E/[&\ 4"S?2B"MR(D**Q_. 3N(13Z=LF@P
M[@&3,IO![C-Z' !SE\>JL4(-D:M@X;5I\(SB+SGK/GWA'[(DQ\T@Q5=,T&+[
M*?9>\00*L!4J"UADGT/_Z[7*SU/N#Z_2K_@XOG\.D+@X=0S1#5_<H$2]7D9O
MK/ XU525A&Z^^V*RP!<1]?WM9/PKM-SET931HCC.25QUL2UG23Z0>+ZQD$)%
M!,^0>0MIQS09)VX9L<%:NRC6)7/.)^KQ6Z;?J;F%?)CAM!I.ED7BD2R]_7>A
MZ0G0+\2$9A\R+-2H;V_+YB*V";*B\_Q"BOT$\%F3I)W4MWQ[H$"(3/_.D:XW
M<_F+27I>TS]EGJ9[ KK#$DFM[<5"CHXQ85F2]-,N^>;RBF*C7ZHC$T'+^9XT
M6>[;A"8[ZQ2-3$7%1Z$JSJ;.,.Y0ZY<<[P1WO.3(E _YAII80FG^XM9Z/0'"
M,H_L;_C2M#17W<E\5UBR:G130V[$3S[LF83'P!,P!ESDJ&6/9.3>FFCC'NV"
M9EM;4LJ@UM('0WYZ;!!L=.E#7;EB^+V-0[M0%'#U<]CCQU/2.SKY@'J/.<K5
MZ:.P!3E16$(,Y'GCW*RG>Z=_E0N<P;;YDZ_!I5-H*<0MOBFL!*PTWXE7H0SK
MCF;WU$VM7T1@0UT+2W_*OAK&OCZ#CBGGU*BJ CUP=MIU[<4\^A O.73H/OJ3
M]Y;;D<7FSU4$_U'#9V>-OEV%Z738(_>&<D2GF@R]&IL%7B2-#+RC'L:;-Y.<
M=MS_?6L*GT^V5V2JCCV[]M?6D;H9:9%E3Q/B58>ZDUQ<41&SZ#X!'#[B+X^?
MM/ZWV1;[&[#D#?%]I%!2R*C,UGJ-A#3 B64-YMD:V^><1JM^:4IXITJ#N5S?
MY.J]R7UC+MF[HIV33MPT7FDD$LD1;V_&LI'AG6&*G>7,4[K*:&@[4/I-!6U;
MLVEB"J7J6]&+C\3B&_-NP%I*7N8*8232LP1[HKP&6D3'@5L!O$&"/(6RVI??
M($'LN3!LC!&N+@:+Q7\PV]&G);L*M;6E(U]=,5'#>H/>Q_,8TE2,JF AO02)
M"46T<\:U\X8UQ&VSDF:JZ4T$/>?JS(7/IT*C(6P6!R=<2XT!7-PA&FOYI3E2
MVXD)UNX!S5A*(VSH=;CYUP\I&@E]F6!GI?C%=]U?,YX 6\JIZHCHRUQL]!:Z
MP/1$TF#69D9\_-7OC8]_>NM:7??[SUY>W3 I8]^O%NR3H?UU4<X-05\$:\3H
MOH3_X6OD>C$NJS93?PGL$/XVI,NZV UBZ/F[D V/2:!&YP[H.TK>-#]SHB?T
MBL/<EOS0\_D\EI&$!XO/L#X&5CJHS?UA&FX:P# P2TC\>AEW"='*?>..,67+
M+5_+L!C[C\,#R=MTGX."!G-8NN@M\FXT;0062.:]L?\[28!-Z$=-8A,QIQ;#
M5_?EW% J_1#:&49SY8+U)X#]88J:>Y)8D+N(.HHR41VX 66:C+T41W&'7IES
MI@NY.?>Q/RSCC44@/Y4B\TB,^H.H# 640/YPZM8I\?U'O?/[YL6@DZ$'W(!G
MT/Q)S,TA8MR[@2 2P4\S;'<?!BB@GLV(7'F][6I9I"84_*4"9&2&[!X2PAG$
MK0.Z^'L1.0@)<-$FOQ0./51GI9S^<><U7*;;]_*R0!%&B$IKRE<C,5PNNGM+
M>*G&?L45+*<R&/@2Z5Q,?#M5*:=<JNTG-YHM>V)/G)3;044G\&T*W*48WG:&
M=;#!.M]T!P)+VG/.#Y!81_U,(J[("KQ-4!V:<O?_?35$VFT&YD%I7YXHE,))
M20]IB +M3SM%G4X#JV(S=Z\FL4#I=T+'Z3FLDB8ZYZ'R"AC8%*\>61I6"D7/
MA2?6_*(!6F?,2V 9I#4S$3K@Y8)7_8;9#9(+O>!+RNEWY@[2$\'%=5>FGC3_
M6!H"YKE ?WO@T^](/Y$DY#N[ T[M2C7<NPUHR95*B5#IN+JUE)I\1%N^C\9W
M?J%;S^.;(Q_#S[NNO%U<D!-[.BE*@B?WP9RECQS\$=4^Z5S_!.@3+9%,Y]SM
MIQC#E>C%9&G]AG+)R(C_","8#YQX)/NE/25XKUV63T-?3NC2"NZCEA9X F Z
M!T:3^ET[6).I ET8GZ,J]?_+9_^/EB#O$T 6\/(2GZ>@\PANT52E6V/'3(SL
M.OIHX2AXYN'+LMD2@JMI^3K0&:0H*#H.^(S>['_^*(7N*+(S\6C^V2X08[9I
M80).QO9A>/'64U[''X\[)T(6KMC;Q?YF%G@5A&LV6GPD/%&!*;_*TJ0YQ]O!
M&*6C8$;V#,$8W95WL(&/]D+)[$K?6Y9SU8C7AGO-?Q09[W;$O?#&06"5_X9P
MHAT50I!_#P,L!VAHZI<.U<XW=M)>8PL.&W/A^P %\Z/,3MA=SY3&$B*"J)\_
MGLM30O^*-\:4ZWPVUS#!$=%13_LOC^@YZ\G:*R6Y6,9%55L/N#P>=$4R1&##
M-G3D]+32^2OW:-K2JE0(4WNNH!HOZ+BTMNS^0SY:(8AD$"6K5]<>#^OL")^M
M$B+K]_'(+F^M5K[MCM) <,1N&]ELK:M;HBRBRA,H;^F=4CZ_:*YK>P*\:3 T
M>*Q-:'V NJUA*5$+RDG"NB-RR *"]&9HC.;$=ARC:DPP. <N9(G/G=G9^3UR
M870W-4SS]_;P)T#TZ4+[U^ Z.[*U9Z=56V[TFJ'/+JH9"'/DNUS=+%4/VJ/'
MRRWM1<VJU@?+QS*4*G\_ 43"+41>+1%AX%E9[[WH3(=SA\D%H4@':/Y:_"*P
MSV&<K6V>'GM\9]X*V,,Z\YC*XL%:E 8TP%73H0D%=A"9*1JE^'-7SQ.3H5/9
MHL03CM[4H?6C+&9EJ2UX5S(^>W-+/+Z1DQOK?Y9*N( :O/1^9E[D.=JTWP_+
M]"BJ:#WNP_>_WX5O9V)W>?2:D=&$[NJ&W"M=IKT;$LTHVU5@SA_$VWG/O6?^
MI>L8D!=JRM@!._()3P!35B;Q?[HNGAV^&^93A<:TG9EKSB_19LYWR+-.C\U"
M;-H[^2].=M/(&=C#<RGV']FG8Y-NV\'^$^JG)>I?1H^-V&OJ&,DMS19#[W70
MS\1/KH9:MD)H[3TX5AR9VIQW14!T1XT("*FRTG0ZC)@;NE(:XMPI7+3_UTQ&
MH:)1HIP1]7->]R_T]F.#K"N^H@\MAAM4O>(>;Z[QSD<WXI&G?1:>*9#^W(A2
M!BK,UQ3U\N'8G2"W^A5?/\7>8 Y.EQTBP.!U*_>>6:?L8V%A8)/['CP]7A!&
MK@4/^(^']F$.8GR_B->%)82.@>D4PSB4JP_]@E9*V00J^;?MJYUILP#EC9]L
MT5%_,4$U%FBVK7%9E:88@SD;&K^!_/RPAG99_8OGT1(3A%[\ZH#LM@D/V())
M6DPIXGU7SIWI0I'!3^-,'HQ/RA<<Z[N:O;WZC<R_(FO^0V:G#VP^__A+6V1"
MB&1Y7<+Y*JC^(4?3()A: W#RX<,'?,"MKQC&/@N9W&</.+'>O0)2+A3X#DE[
M13@@K47KIZ#QR.\:()K0J28,P;5#J"!+8YH87DV*;(P"":5&7X6)=&=XW!KE
MHVEZZ-6#/3WLB\O3X&8,OT8 %UPN^X7UUS?2W+_0Q*XMBJ3.-G04S>6N,^&T
M;%%XN6!RI9A-["^ABM]E5'I#9^F*,BZ2)VP^:2IT8J )+FIHT.%0=703_*!3
M25SC"L.&B%Y\,*[]ST+2SP:.J+8?1+9E['2!RM4ELO(>6X^EWG\-,]RJ0:^O
M/625'=I:9[.N"+H'LN5E/.*K_(X0+A%[ABW(Q]SRPY51P:5*BI'Y?N8)C2U;
MNB$[K%XVI'P/2C <>$7N7WH42UQ=3$]Y08<=U*4V0?!GGY8QWB]KL1;,U=Z.
M? +$X(9QJ#%)FLX.%0,!TJ:.8;)<<4'+',+03S1KB]I;";@K('78>@6Z7DIA
M_DO]QIJ&KZG3<$JB\,,LD6WL>9:;A4\!V!@Y_P08TFPZ,3$6&Q=<Z%DZJ-A.
M8X1HU>IY[^6L0XL!?NI#'?O\@12.+ XMDIA>&OIN?1U2*]!]M< \([JMS3B*
M V::61C*(M.VJ3E:BF/N\J[L%%PW331=SO\]6$1S>P]+SLBW[%X3'>!5N";P
MV%V\;J))3K':\(PHYJ"A_.\7B'++G,WLJ;.EC@>C#[DF%MLV[1IY8_Q#Y"4K
M<T&PPBR*N<XND.FPO:L(->G@.5(:_9^T,<THA]61I228=38L8LB%D.H"O[4Q
M;>N,,7;U#RDL"=K,5S?S%3*G^+6+LG_!26&]>J,YU\GZ"T!7?OUGCLX4V;?>
M'O&Z/'2@@!!B(^Q3#.TO+63E%S=R_@+EGY-2V+&OMD.R+O-(;0NBBRN/GIO@
MQGG]=FC %Q"P$F+/U>GQ2W8%G&KDJ:X@P%[_Q,@C=K--=RN-3)39X&<L+':_
MYX];-XK!XGOO0*5PR<&2)#E*)[ B['Q7-(#_%[-R[EELUATK(M_AZ!^L&RDA
MBRJ"RH,&S@PGG@"-Z]RC#'X%C!>Y<&F%GWFV[)]ANG1@Z_:$]ZC!@7:A"!6\
MEMG/MR;Z2UM/@'W@9%YO]>'NZ6(OGR.,)<*/BH:^<OH6H@:OZV71E?'9S@$Q
MC?ND#K6$B1-K#:;3+":0_"IA"$NM.E[*:,)[BVV_W=-'1*0F(J_K )A!#D7\
M/MAT[$0QUZZ4%(*,0*K"JSUYKDG0E)"146;3V 7%^"MBK5X9H>O%B/S9\%Q@
MBG]I5T6"%.5-*@+/T8ON<TM6BOD@%?[MS5NT/^PL.O.--LR2>M.^W9/BML%.
ME#NK643!G=Q'<"K020+_Z)1O08X-N=D?2-!,6+14L4[;6>["=5O\@S(E90IK
M'\!(T%T)^B*O#W,$ZNK/$#G1=3?8?.P\]8CXDY6 JFK'=6_9).ID*#M\M;D&
M\AMW_IQJ8\QJ\-Q81_G3=]Q[Y6H/J+ FHNL-HM_/KK;SN5L&5WV7UJ@T%E;H
MD<A]?+<(*E1ZPK=&NT2+W[7DH.CC(IO[24BR*Q[<CGR7F1+-D+?ODV2Y\;+-
M_@6+W6QU8?@AX,X7(T=^"3N+_%O/A&/^'(02S6U0FSG?*6_C9/,.>Z$.?SOV
M;SD3_GU7^=^4=5!<<?CJ0%6!B8KW)V)'DI%27MSWFCQ0LX>>_H2N.2/3&Z.L
M+-+R/-+T>[S"P2W+%9%-U4R0BY4F9ZCT]7E'X9=2O-,6I<!2.KS<,L?=JJ!W
M*0;H01B3X3/@V5:*8335'#QB) F:]6TX4T%BA);#.OA-JA0<DIKG]+]_>?_O
MH;YX IPH;(W"0+TX$2M1[]QZS]WNXP(P+.4"9Y\ YQ3(LP>WW-MB+'5UY._3
M@YJ)O*&)W27NY3.OUX\?NFJQMAL:=;[C\AK_I9R5HSQ<I!SZ&[%$CX1R+!P;
M\@PQ$FVU.B]-4E],AC9%-MTVFKX4Z_T]\K7WLH9T>7QG9?EWCK-S\78Z]__,
MCBA\XEN_U_3G!;EN'-SX_"Z#_3R0J/ 1J\BB4F6-W4-'(O"D\D@83%$D55MG
M1,-"G0+8.0PAL>_4*P]'Q=>WN#FVSK"S'F8TK[&*Y67A9B95 V2@-U!U\F4B
MY<]!@=<T9.!6&Y[WA5M[IW70O J(Y'RED)!8B/6"=R!7,AF@:W;\--\N8I>!
M+5*DXEQ'$Q DQ(M*BW*X$%Z );Q)]6!?.Y3L,S=XEY+WAX\J3$?I-IR*:*<N
M&G %@LC8X:FV)S^>Z=;.)9*[8&H+K#F[)6H5J6#)@^X=2681GU.TVTS-+29.
M;W\&%6T." @ GP!'66],[(-8E&>+P3N\Q^YT(4X7X42*P@M52PX^S0R07K\%
M[5#P4I2Z7,#Z'TF/@RP]619]M(HABAEBH#LO\%_[?V&9IS=F8>^T3C9[B5L8
MV"\%LA("^::=Q(Z8>.=,[=.\K[VWME5=*(;R'@"8$*Y&EF6?9IFQ]JH?-\H+
M6Z__7+1^<I>,!1Y*XS18M)4\3F>&U9_.5UVN*].$UG(LG.>Z)1X&O<&QVG?@
M&SKIM@\B;'\"%!_(=&I#_S9&07?-WF=&#$UBH$O?MDV?AC<0&0F?V']IZ5<?
M9@M1XR!S]?/.4Z\TL;_V"\J]9K"K>IP6SG$1>'V6&$S(Z"/%."LNSZV[4&DQ
M:E0?>KU\:U<:*[.WB-?=Y6L9_,BVMJK,F;U0 A&<_6S6'V0=<5+'<R+>\7G)
M"CTG"?%(VMQGED5"HY:XHJI,UL:"=D* R4^ 3>+P!QZL1 C:RA^FU;( >6[1
M]!VQ]TN]-;&K:O-.+O?'7Y;A&I/#3FJ$J1"=?;V<FWQ:H=W&A^M<20I3#2G6
M>,2W;_>1+^K Q/;P;,*A'+:9^]<W].&Y/B\AM7,?3U5'^O\+:G<U(IS=<3)4
M#/\:8?Q0**=99H\%+ [/:?9QYU[/#!A=/*A+?\10FC2J 3R47%K>8APEE=X<
M[S@%]4P%[?^Y^;L+847K*-*CN>[4.?A/(38-N5NIOI8]EPH#4^R2,)88FL%-
MDF-GCH#%-*OC=*6KC>#/W=2\@45_C7[<>Z!3Q4^[W+:.7JX0"VX2!G%HT.VF
MG#EM)_Q@)%G;JP94Z\(DXTK0/H@, 2]7Y$=SQ>4:A-LWPG)6:>;?[J1U\BA-
M1#870@-= ><K/WE<=YKM6DMTWG4T/A^<"P:9]SCOV??NX8;D["'9[_0A5,N:
M%6:^^^?=2^<[T4JM'PP.P@U[CH4O*W.C;RJV+*D/(#*SU57:FRG7?.."]A)-
MQS@-J5!I@TU:6, KL*,ZN@:N^.Q H !DH.=RC&*7(_:R"__8PI@H_7DQMUR>
M;^Z1?)_"8?'B*$<$^7!=^-M,BF6%/BIJ@;PQZ;LM4=X6QG>I"='8+:P69&GD
M_4N407\+?%7WSZM7&ZMFKZF''G7'9+:KW4G<\Y!*E::Y830RWBD"V:5QG6\R
MQ1R_SY[\% OQN*&.D#J)_>13\Z9A]KAQVW/V>*O)F,&_DIP7U\4@9.2F@@K_
M@O39X5_U$$3+M$$_5-7QX(?IJJ9K\H86+?:(E]NWR&FE28Y+5HPI[Q7UZ,LJ
M;Q3PLBWGJZ/4F8JOC7HJ&QNI_,2,TN5NFRX-FF3V^,;C %F<'3?E>S4:^3;%
MTGRH6S*)3EK*JK>7"0!84',!8R$7!Q2XYQ'/5QY;7_?;TTTN3Q!Y3PG*'!OD
MR),68TF?15@2 \$J6YZ+8C%'V:26T7^WE,M6A?MYP#@V$W1^\<+HRVJ((C58
M%5G@:\&+K$>'KTL]3DVS"/;/]<>F7!+P_48'P!:0-<%B<<SZ47G?1$DU:=/=
MT*+D:",ZR8%-69-T_;13N\9(+]%B^Y6 WZ49Y6M$N#[>=TFA_;3LU9HG2C2S
M"(O0Z=1<#11UT5H(5:;]9M(<$86HF5H#PI(>U/VN79<(S6=T)[8<+=G1VAK_
M7">#MYB,0IJU@437Y!CL@2#L?H:.;/J>SB<GL7M2*6@Z]DT_Q/?'P#+72W:&
M>"ELDO N/(UY@:NNYY/OZSE6-Y12H*V?3C[A3W:+82"8Z=$,OQUJL)\ 9#6(
M^ FN3>:XTA!&AZ"5)<R:_)5GBALUCK6S)V(=^)6-1W95P'SSND&*L _,/1_^
M9R_1!R_Y-Y/J,Z?B3#J>+8W-L2/\-=-*CT$Z)9T1.NA\^-UV&ZK(S^P=6I A
MK=E1:NJA_ N3L\PGA%PLH@S*4(:UPC=ZE1$X>:=MA^N]ROB7(TDE)UQIIH[%
M#,,BKL3!VV\BW:7L(*5JL/C/LQ>I,J\41P]6VBPC<TG5X_+JV^KFK&>:XL3'
MTGR2]G8F1$CPY2/8DVZC 1>*48%$**,8B-@SL+"-FT-:HC*E@]-;_?R=&#R$
M-]:GL!'X_[CEP3B18MZ2]#>1SF#E4BU*4UTG8,&%!:RY4I,<("HJ[-+I%JQ9
M30-]Q$6G/P'P/YP\=B-PYC[5*;,;KV*&_H>WRTV0MV5]3OKF2@@?U*&+XHK*
ME^EU\[XPJ<QU,/7@UYNH:)K.LAUUF]P84M[*FA*=; K@4T%.AEV&(3L7C0RQ
M++^N>[&!'N=JW[ 3]IA#G''5<=)KJ-.1LPC2<#GV+8.B(^_T.@>]4;Z)=P*[
M!\M1(QRQDJI[4QX''O"]F).JPGFPHE>AJ8H=,'#$UJ7IOXOQ5NJ?.+M2*;N\
M)))I!Z%N?;U((SAII,"7N5-@H5&KTN:!#X8-.^-S)H]8K[V%8'$(!3JI)I 3
M;8&=9BFF[@_D^2JH6F>8S#-R^+K5:E*';[G3%T8<-/@\G6S5T7MZ&< 1W=OX
M<'Q:6*AA PCUZ*7=RQ\$0?L9[DB_/\IW-Z+#/LO'72;Q&][8$!9II;3&VO(N
M669XQ!7Y+38ZYI(=+VK'[_73UT0X)\5SMG7.&XJU(%A_ !J8NWEZ\TBYD9LA
M<MJPW)@<EGDO 5)@\,\>BQ6>Y@%C.F6OB-.'+1])N+;W7_&9]< Y^JW:5&:>
M1IOX_5)VD!V:(XALF"6$J2*^=JH8W81RM%P0$_AZ\W;&*IIGN[O1*.%$A-_A
MIYY&CQ0WGA3 MLKO+"20V>X1LR%#;%("?KA_VMK9RCHBE(<(EI8+],TCJ8YV
M;%=ET&3G?1$Z-N8*8-(4WS-4I+]DF*0.^MK4-2!CUB#>U-S$.MAY(2B2APB9
M-/OKB2>&?^G'4Q#,GH/O_-G.^8MFP>=P32J1W#+QZ$=L9&R\B2[!?BRT'"CS
M0O=1UG1>16]!H'&U@T'31WXA7S+5A8"\#2DIZZ[45\;OO_4)4P,;(TV!<>H2
M:C3K"5083S]MZOJMIK[-]Z95EP7=[D)Z8/@7DE"]K);\7"._K<F^JMJ,I=4V
M(?)7V2BCM7>O>-V6+ITQ^JPOT5%"OY&C+AI$NSW(.F0D/X3/^I=\MAC@Z07O
M)FSBZ:1!G-&B9=^G_(F7WM1K&E84L>(&>'')1V#=E<YT_>Z$PB>#FXA-M'2?
M@Y1^=JH6G?_.=F9G/+GYG )UU;C,(X2PH[\SV]0B=SK;4T8Q)U13^SC':J5P
M;)NQ149#F8QU&-A+I"7O,0)\RHK76DP@;=[L*[DV"V*-C2!2^7D:7T069<)0
MITOO[$'.R_G\VO@A<18[$<WB@,+C11FG[?L+XV&-/];6 SK*C%@+D)104>).
M-SKF=]$TX C^)2;=MKPO9J;]/HX"37.:8I1L\1I%>G\.U0@20:SQPL8T?A+9
M)>AW1SHS:?UJS789*C\!T?Q77_*J@X3'G73.F#H3J+X:?>"TPL;<8R3*R:C)
M.55@1Z<,*;"F]S^^F!-[ F M:[@^/QT8FR%",!0Q>#PN_I'G(>\_A-!-Q]?Y
MV):L'S)S9^*-I9L$-#Y/*Y1+$PE% ))& -XW94[W=,^[*U5A9Z2^,N$-'CS)
M\-T-0T=3V@@]QB= Y;]*[;F%,^%AOA@%85BQ!*WV;U#6H[BJ*M8F2G9O2[,M
M&!P_3R<I]:4,8W&775'O0X2[IQ^I0)QYR)(,%V#Y(9& $VM+I$OFNU=,'9"U
MO:SM1-DI4?8^/Z^FFT$^<R$M%U$U)&=(DZ;B7O%VH6/*JA1Q[FOY(X,>VD4%
M;M#JP)( IIEZ\<K(*KG0F?#Q1[9[AQ_V3P "_ZU9O"#) <GMI(2,O:[T8+R;
M9M35ZIFY8HAGAR(FFN'MC+CLJ+__)/^XQ^Y87F.UCR+'1:A;KA(/5DT-Q4.)
M.%\D6+S@H.XYN?FZ7#+.Y/A.&2#0)<N?],WU@%<2EEKOCTM>=V)?W1/2PE^;
M$?J'KJ%<,]4SYOUEZK>DCW)ZCU3XE]HR*Y/]%L];6F0%G"Z/E&A3!NQB1KB1
M')D#: ^$KYQ__H9#J8X_@V<G"-C">%L7W.I2K8G':&W59+5Y;X;D ZFM:+OH
MA1[=J4V;F"MP7&2=6F;0J6-EA=)&NX1W&M6@L_\+9$:N@&S[]88^N-3,L1]#
M[^N_?U:3U^05WBP&>--8\$X?WZO;YVF":GZ;;Q=7*G7\#N,WKKM1PS.(G5O9
MC&P,(EXAS/9YUU(;%47P-?&EQWYAN>*;V[V!($I/%]PUBR6P6,0)_??COIL!
MR;B]45&?)=,:^<>S/'E[L#3L"1"=(]H<KF%^"?IX%O .M<[]\PD DAX+MLK3
M+I]$*!W[A1>C<OLMO_RZD[S[@G!_95IA+KQL):4H.0&0VKHPP\U >=!$<9X-
M9"N?=/;02X/%,1,5-]2D[A-F6M@?<HJ[8X/Z=!':NGJ*ZQ^D6&(:;,^I_1_I
M.GH+UO(ZY^_'R#A$2Y2OAL;TZ)D,0 ^L"TJ.H+/+EWT_O8 B^JZUR=*4!=MY
MDZAS:3JHN-RC^"^=A8W9#U,UAB,0QP"U@8!Z29VQ(]J-C"> 9X+?K=!@(",$
MJ1Y;X^F3>G^D/F8 317\[FQ$>W">$R!]6:EY6BU833PX=ZXMRIC!X3X61#F.
M87642P&V1,;_ GK8LD0&0LN.^RA+1U]&=5!\!P1^CT;ITH+-%JZR'186U5'4
M]^WNC?Z9A!S-2;ER/P#)_E8<'K>+OTQ[_2LV58" M,-=PV4*6P_AQ_W)((?C
M1L4('Z/V[\*<13<M25QWXP3;# Q=K;UVHSL?,?WVY-P;B:X2< YS:"%S#)HH
MDM)R\\+0J0.(>&/<]H4FEO#8FCMH=6XOI+?&-.>J"BPKL#/>>%W"X.T3OFYH
MS-ZSGV<MS!0ACEBH4L@N;0EO=$3??[#R_MT LAT0"4A[7-? <Y!-G9 7[@54
M^67,OI@&,U W9_BM\#\GQ],4+**HY.U,3<K*RML/_!PLQ4Z%?PL=:( *)5S*
M WLZ?:]H.6(^-IHG.9#C69A+D4^T8ORP6B.R@5369"NPQ_#5,"VK6G'\5=UN
M'ZP_-'G[DWQBM8YI[2.LEPX[EEE-:1<2D_>_0T48_^^QP+K34_EY+RI%V-NF
M)C\!+E#\U]AK&!^*G=YN8,[6T*2XE/'FVE@'!KU2E &<!Q%9'DRCF6^T34MG
M!1CY5Q9*8C*J1713;3&W;:4XMD/Z*<_C RC5T2B8$#%(4G=63C'_D)0?WTI+
MP@9#!S&JN58GVVHP(KZ5^<;^_%"OI,G-S>5SLHV_W4#R)TS7O$01'5Q-A/0>
M]?XCA1N<\&9:@6'I8 5+Y"3EP[Q@FM8!%1+<D/ #(4U>PPCN"XVYR>%$D0Z,
MOS[4>O#01%KD.N.WZ3;>&FC@T7KA@;][ DXL=1QY%_LL*#M_0F%=BH,6PIFB
M4=Q-<4#@OU3JU/\9*%7=T=-->/GL*F_%C!Q4L#&DIG6BAF[T+E&2BL<VN_W.
MTCGV9BO65ERK)T<,]?47RH&8;TCFAXE\=N,[SI.F$8U/[S]X:^?=5XP*$B#8
MF?Q#Y29<2"SMVL.VVX?B%UQ70OM6WVL&IW 3Y",(6\]?N>=='1B&QV:>AOD&
MV..F%)H?U%46]$G;TM!$KNK^+##ZI/3.=(<5T?*BJP&N&_M(Z[ @B:<WMSM_
M6ACAY&UHE/Z,:E#3!KO$BD421::KTUI#CP0WNTDTO$!+[)G>O>5/HXNK?CY?
M[]8!<#Y^1BOGMA"2?7;\3ZBZ$(-RY+^<6=8GO)L#[KSE7)SX'4LZWH@<2'37
M<0LYLICE[D_ ^7/WJZ]=2?%XN2!AF. VHH?^M!0Y"364B:_[[&MEX_53\)T=
MD^2 Q@@@WCN["FW5%1!"-+VFS#BE4:_Z(D)=)?&/FC)>:][;74M8>JAU;"'(
M5 OP!/!>?_]HE7GQ/U9]D[6<2W./+ XI=HMUV2-$R9">H.5$\-$3("&0^D1,
MCWV/"M4=%\CLH#>"PNLS_%N:N!1A ")[(R*<VJKW/HMR<5=Z>V'L\15:$K&L
ML%BSTIQ:+B$J.H#2[+C;L#;&.YP_=8[B=TKF;7_5ST<4JI Z<JA(T$GZ^\^,
M.=IA6#8 @?G3X^R<?+(+2^[L/;J#"9+M F,)Q])#,1>@: OF!"5%2_S/\]KT
M_!(!/=QRB_I;77RZ:&GDAE8-]88J]?Q N/^(:&OG=W"=D#<KZ:3;P;A7NV2X
MG.16!T.4&%!F5?L[F^^._@6U?F[&A"963DFGZ*!?-*A^(B@RAR<I(:+JE'Y6
M==I80S("VYF?A)*# HH-^TCT61N@:(Y>A6^2-R; /N8A'Q.K]2S-P_BAL_SX
M O'>K%_ISMX?7TY&F33&R#ANB"1>49BN=KIVNQJ-9_+'=[U_;_%\,<TG82"S
M\7IW5[B50R?RD]( 8(;,<$$HG2"I//66G76QS!1LUKW AM=G03PO?L4HOF19
MO]HVB13=4XPGK<TCS95SA %=-.:U;R)9YR/;$S/.A)SZTIS.W:O_0%E.@N*\
M%+#GCN5L'G)A7;;O4]XNBL$-E!?@C"<GV!E#L(>I@#<WO9<G!O"F^1^D0!0I
M;#>_U-X(ZT\:\,CK&5ZLY)]"Y$0 CIU#(#[2=D Q0K\?QED7Q68(E#F<][ZE
MN%I9']*\_7$QX1>BQ*C0@1P=>,F84 9B4%K8B=/Z-2ZXJR7Y@\0WZDVYU7Z%
M<1"QYWJ07KCC&9:]Q,+K%?<4%:^JM=]1 )9 GF7->Y 4>Y,W"ZD"G]F!7PC2
M9:!OP:2IPE??8HV1OWO=R#D#JK[?S[B7,@5"P';N;U) *;"3"[M'-NL7-I%A
M\;=^,*CV1BSHZ@KP/\MU!IX D7Z2<>S3+KKASCFO.+ONI!)5;>GD;I.%&5Z1
M^%\Q:?9>/R@\KKZ?W8+4IHPWMRISO .R^^5$X&6BX_BO9"VI@KX>HBPY$>9"
MV4[3OLFC@H'Z=:U?.5NY%?WE]G*]D=T)3?*$.D^ [QYO9__E)AN**-8<*&!K
MGS;%7+*[$T5T>]1"()R0'@R0_V:\<'E&:F_@8#*_YIV6&-N9S#)%4I33X^XX
M?B^/6XA2'UR \"\ K>N1"VD[E_XOU<<]N.W7_+U8PF4H/,4VPUO:=XN?-Z%D
M]<R_GHNV$TN0&?Y9W.\>"IBTN#VRB 9\(,@#X *8RLB:SB7C+Z,ZI1_R8>;
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M+;+F^ +VBU!6-H'LH50?@E\C)R"XA'7%BQFL@1>OJUCLMT:FZNC"^'R:X]5
M/GL<%6]!2#" "0>@^0\-V(/_!<,#UE#*KTNA8H<'U9/:NVU/P>[!*UJ%J_Z'
M=(1E\$]"XY1!>D_;8.C$%X4(BKU]C1J?&BIT'*H9/FJ>TF_Q3)AA>&E0_"(_
MG>+R'*Y$LCM!PT&>(QRO)-R\V2B6Z1@)MH$1J^C\8*0D8\U%8X>XW2ZFH)\
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M\E[1_!TZLJ5(PU2=;GAT<.12P2<YS@9!6\9!._?P)SCO2K6E3SLXQSIC[:3
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M_'9M\VR;/Z:<Q'!U)R +8+J>"E)RV,J\S<V8F\D>G$ 3NN:;PT6%-E61<?T
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M)W3/S<-2ENC;XNB;F9PC#?O[%-LT>&F](O;3/ZL[FVNY+K+RD]Z:;F7<D=P
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MX[8UL)"#C71"=< I4G93+^%"'B0[>82I^E;1:M&6S?D#F79 6==[,6ANUP5
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MIC&(HJF1X:E00^(CH_%G#Z1EAP99VRT6@N4C5:;%-BAM76V7!;,]/9,#A@N
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M(1N=N@-O@?\/7V<9%67TM?U14)0:0.D8)$2Z>V! I51:.A60[AI@8 CI&$)
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M_NM%#]6^!T#287NU9XB#[=0V>DQ:UG#MT$/?.B"VU4?8[[%7#5;(^[5BT</
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M=>ED:%T+KXC-GS,879Z]SDL&)7>/['Y9G]_-;L5M7Z[/VA1GX #DH,))2.@
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M1F#/Z*_B,TN+=F[?F-D'+4NK[FSG>;Y4G*,?:9Y*,&3K/2E"U6NKY199.1_
MILM>W0/(I',_8JA/2:@K\OP>_6A?5UTYUC##3IJ&3G(DGEI.M&5B*,DR R<=
MM$P7$M) /Q&[QG5L&,OT-TB) #I_OU-J>OZ%Y&$7489$&\4GAE%^CXL;&W1
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M]NP88Z0P]OY'7_H+J.X! ?BG]P#26QU,T4^C9Q6[:.N)WT'6R:HXA4C<RWL
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M_HC":7%!7N0N"3?LN=V#@-TKG>'V!V A\!OTNU&]/[5U2?D7KQ4 1;3_ZC>
M!(Y_+6_0Z>/K=**(WPS[*DIU>*T]UZC/3K6.+!M+;.-.N]6>&1M)X'C6W'XT
M>U8, JI!>A#$CZGQ-.O_^82ZP+);;0!,<U;F'I"!O ?(Z(>NEP1CLM=_+E5<
MI+=CHQXV9=\*__W$&YVI"K.<@-?!",H7GV@KY=0_ZW%R(83"-ZG\A$]W0OQ$
M,,W=%_QS2F")LG@2"GK9#\$ *H"(+$Y,XGG2K[A!=R:Z(V9<X ;5K@D0FJ,
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M[=?;ZI6E3[H/ZY*C/C=H1H>E4FT%[#U]X"19F27O&'!T_O[XL?5L!J.3.\'
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M4R7^CKCQ^>8]X+$N5\H@(RB)8?5X-C_TJK('2X[<J"T>TR1N]U#Y(IO^H_.
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M(5]RAC323H"$V/T9.&TO-A7YX?8/;U*FX>5<0G&\@>%VDEIBH$8%TY$F>!E
MWHI/0X\J:R(I0S=W9%##V(WCQ#:O-7\S@F2<QB?^=,&?[#>Q8)V/-X> Y# C
MLGO 8Y&HZWX%PG@A[Y!O"-1#W5*)K1Q!_>1T:W2N$>,SS&1)$-3Q!&;947J+
M_""05B% 'Y5UNO!$R!9?G0)C+*O=#WYB2QK1)/CV^,W<UY+D,9LWK3H'0>V<
MK_QN1S<%TMQP&<_.A %MX9S_P[!*VW\5>IF#%:@M3&,4LWDH<$X<NO@"^;*D
MEEC04>6@]([&Q>\J\7:[V^#:77#(SGBO'=^%_OR\U#W@L\@QQ#G)*JO6+<H-
M2;]286)9=0P]'&J$;AY%-C\:BK:7^K"JHZ+S>MG]2R#[LE22\;FT(OI6 K=6
MNY4V.K# 6W1JS.,)+'%892F,BSB^VV:06[6I*/,-V>TDO1E[HTK;'5/]9!.?
M"K?#R[$S"/'\[M,7GS^2H%]ODP[-7FGW:4D$=?UD_:L'ZDJD87*)W&!X5WHC
M*WR00>3MX."4!_-2'.^/P K1S2N;QYC*'9V8M1[YT_RSK3S<[0*N9*Q'"8/+
MZEV@^U='MH;TWO=!\WPL'#U'N[ZFO6?"XR/_G7OBQ,LQ=#;$J$:PJK]45* A
MRC()-&BLRN8+OH'DP@RL->X!9L/0JJY;PXW'S _>JY/'@3[&*)]???TZ".N!
MQ<W-+6NB4PG#]I-_G-8""+W(NCZ):CI%YE]%TJ/\I H[[$C;D',/AO4C7&E!
M35'G [>37VR5?/VKP"AYKRF7L88]5).?MQ,Z43_"ZZ7Z.4'<W1+-VDMN<Z(Z
MRETZ4]/JB2?5:/=.W$X@L>LE:_S7Q?#;Z"UI=R8<2).V]7"^$-%AWO^Q]IKR
M9*IZR]L,NTJ2:I4#)['BI7+K)?L;?+LZ7%@Z\WJ"UXOV-",2)'@/^";:(BJ@
MKURNUC18G$/Z2NDRX^Y!K?C9_)Y!;FLS_A[H"3JHJ[%@$$:UZCN6(I_VDN5]
M/<AP^:5=-U,0GAE]NHZ:X#AO);& TADQ,6\&1-_K:]#A"V:V*MZL5W^ W\4,
M^*G%'JJ*4[J\'3D](MEY;5TG7:"OUSGZ/ [BQGJL? AAK\G "T1!R!?W/*]O
MD9_*Z9B#R9O&WRU.4=@C1$#7D6N'ZZZ@B/^Y23Z<*W'Z1NU*,;H!G)44Q<-G
MTI"^L^#3&4;Y?>ONZB8/-QB]W%D1HC;)]W4^<F=Z;K&S.#9.IM"!@M^^YVS!
MNPRA/3R]&=&?[X#,K:^Q&UM0&JL]^R(.SL\=S#,TT)F?_2 HW%@N*<?XB**6
M#E$K1I\ANP,9<RU<=-&J&G>MH44=;K3)TT8KW_E]Y2C%&_GHT ZBF90R+&G/
MVBZE*6$39T67(=W-9A7O 3K.,DAD \X*L6 +[=/RT@?0?!EH89>!T. MA1M#
M4U9*R&IS^SPPY(Z1:N0@5:T&!\E;-A UJ_@[,@9_;:G^R7\Q_'^(^']3,3FV
M#,.AD]$!1OMCGXD#U9-##WE?@"7*:(Y'[@$D^-R+M3L!5KBX:U\/D!%-K-NT
MI$'KUI41VE;L*0_@;OM]FLZ2.31A!QEF"!=T=U!%\V-KL,DHRD++A76L9SXK
M76YRL3[>"(Y&M$B(!IQ)%D)WUNHPG_6SR@-RG[Z]_<-Q1!1 $^(KAI^^UNVY
MWT2+9BPKG%^!V-EV,2O(N!SGW_3\LDSR?C]QV,3J+5.._;JZH[_O-A;V5?_;
M^DNC7^=MN./U,1+A$>?1Y8&J:./@_:(U,OUYU<]A^.B"+@ PI@2YXA#T>]3[
M,549^.BKM,/M*Y2;^.>LGQ$9N0,^,]?:7-<0I79%](W98<7)ZZL@ [B@##VP
MM;WZVB)4[+:E9Q_N<4>YL^.XUV-V^,$#T08@3J].!WO8W>0@WQIL-GAK8W1W
M3>\!P5'":=7T0&?H3TQS$!,F^MLY"4HR+RQNZC-H;2WS'F!^"O8_T"O#K=B*
M50_T4]XQP,1'U E__Y3PX_CKP<^N5+CTS_TO7!$>1,XOMJ"X :^(IKTPB<(0
M8)+!%WVEM!A^EYZM"8R!5@JNS91_@N[[G01XG<+J]%SCC$K*$T4$YW%OQ_GR
M-]"#>(7Q\<ZZ!7:NB 26#V$U)C6;ZM(DCH+SZ:A&CJ%XCC3S8RBT8S>JL*N1
MTFZ$B:%NF@UE]X7T"=9S3ZL>,:#TB6"$?R".D1(.@I0*KVO:9VMYNL8%"<9A
MHS"<6.,[MA10]Z2YVB"7:5 IJ' 1D;G-[S4-7($$SR$ZG-Q1QF2[&O(Y\KRS
MN9_UH,%WNY;^D?[I@6,-<X>[T+W9DA+C@10/HKC7=^P<K-,S=2+?T_^[:O#@
M$4$;9:7NE@GH-%( L@G9,?P;WCY^X2Y.\=,F9=]#M0RMH5@S/GQ.=**[2+0/
M#2,L]'RTALB[*4Q!&W?^A+?,M6_?L5I7\@B($XE2E?\\E@L,^(B0\G0%+4(7
M+1#XUJVGS$T>V.YLN"5V??%5 <\-UVNU6<F0/F6&6KU^TH\3]N038Q44SX6$
M0-_C)%4&1:9UQMAT*_9Z.F)[OM%;YBCN&&R%5PAC^(*10OFL)F,YVP95(N]
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M,DF\M=;;\@2I@4:V0VBP\2V)=?N,O'%]<P=]LO;3Y/1^[^(<'<4UNH77W@E
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MD- [ZN7D\:]#/^]2'W>#F22[;]'Z" ,M9#O??_U.#?26\H2YSP4C)-Y1>6L
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M/!E%M/]&#6,-N_^?>JPB:M%+:\K6I/XY^1QO6I5[6#]/Q6C Z(?M0NZW1/<
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MD_U<US<^;*?]]UADVG_>;^M>K:2TEUHL1OM.BLFD0A[57$B*#V!  ((]AUH
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MDLQP3C%;'A[PQH*_#Y_#OAS5)[BWTV[!U*:Q&'O)5P[Q[L@?-\JG!. -N>M
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MKE4+RRM,QA'<D(7X Y[_ )5Y'H$OB'QYK>H6VJ>.+]?#>FDS7E[<7+1JT&[
M(CR1N8= <X]^A]!\%:_XL\7_  G\9PZI-)>PPV<D&FWS0>6]T/+DW#WX"<]<
MMR2:\N\-3#2M)MBT4,EMJEU9W.URJI-]ED<2VY8D ,=ROAB,C'=A0!]0^#+#
M0=.\-6L?ABQ-A93*94CDC,<D@Z>8P;YB2 #EN<$5L7I(T^X*R31'RFQ) @>1
M..JJ006'8$')['I7SMXO76?!WBY(KW6+W3;*^7S[OQ-9V9EENG=L[-VX;$7
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M% ,EF8\!>G4G. *VM7GM/#RW6G63?8H+5MDUCH]R+>. =A=WA!>60X_U2>A
MZ4 >CQ?'CPH+A8M4L]9TE'.!+?6.U#_WRS']*YJ_^%MZLD^J_#2\T?5=!U1O
M.?2=042VY;GF,]L9.,%6'3)K'\$M>ZC?V=I86]T-+NIT^UA;>YN+6YBW N,7
M#;3D9!8*",YKJ(+4_"#XE6%E92R?\(EXDE,2V[L6%G<\ 8)Z Y Y/3.<[0:
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MWXKUFT;3%AMP-MHLLC/*6^8X)W* #T";CWSVVK?"$WO@_P +6&EZL=-U7PV
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ME9A/8Z9;,P/&U].U(HWY1L#^-=%9Z'+X*^+_ (.BF*B.\AU&Q1E?.Z(2R31
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M J_>;W '7(K>\+^!]%U#2M!L]'29_#FEW#WDTL\04:M<@*$E )R4!WGD8.%
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MO,=O'[XX)'U()QP#5K_A6WBW7\2^,O'VH)N^]9Z-_H\2CTW?Q?4K65HOBO\
MX1^T^Q:!IUGH^C6MN+IS.C,]M;'&V>XP06FEQ\D0Y^;)/04B?%?Q-KNJW.E>
M$]#\_5I" ()F!ATZ,9^>9@!^])/*[MJ[5'+;@09<N_V=O"=VA,NHZVT^/]=)
M=([$^^4]:XGQ%\%+_P %1?VEH?B2Y>W7)D0,UJPX_P">J[E7IU8*O')SBH?&
M=[XELM6BTK7O'&JZKKLV,Z/X<C*+'GD LN,GN!L)QR<9S6;H.J_$G_A+)M)T
M^>^GO;:W\_\ L[6Y")I8^"4#DAB.0<!ER.W% &]X.\;^,"XA\,^(8?$DD/\
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M)X4EFC1IWV1*S &1MI;"^IVJQP.P)[5XK=R16_C_ %V&W#+'>>3J4((QO61
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M<A<X OICM_[Z0?IZ5ZK!HGQ5L6++XMT;5,<JE[I_E!O8F/!%+-\1=9\+[?\
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MY:?UKRCPCK(N-=L6#G_2+ZWP<@;FNK5[>=O8>:JC_P#56G_PG:>%=8\/>)@
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M +;03C+'ZD<GUKEEAE*IS,W59J'*?07[-'B.$Z=JOAR>55F687<",W+AE"N
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MKIZYY([#Q/X5T;QGHIT_7+5;F!OFC=3AXV[,C=C^A[Y% S&\.7&K>(-8N/\
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MC"[O%QIRF89MK??Y"(%ZAPB.Y/!RP)ZYKE-&^#GCOQ))]I_LAK*.5BS37Q$
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M0Y[))F*7/K\P/K7)KX)T:WU+S-'U:\T'Q-:YDAC:W-I-*<GA8'.R3/\ TR<
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M5/E2W$RPM$/5')!'\N.:^9_B)X5L=$>)]&\4Z9K^EJ=L1BNX7NH!_=8*<NH
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MO)D9CNWS?4G.W\_2@#E_ 'PIUOXD7ZZ]XJGN(-+?'[Y^);D  !8P> H  SC
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ML'675Y[[5Y>K"67RXV/KA,-_X\:] T;PAX=\/8.B:+8V3@8\R*!0Y^K=3^=
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M$F#>14U*@9$*X_[J%">IWIM C_!&>6+4;-!;\-GIYE[4Q2I[WRLE6QYXJY*
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MBGSX>?GFWRHV+%]>E@Y?AL1I6F'U.,N).L?VJC$N"QXQI)TG',/(S/PS64!
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M2N%>_C]-=L@ 3X5A\@A0_SW/O3;[N2'R9/7A0FN03GT#7,L]WXFG7FPZ4AG
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M1VN9+#NPS*/4\PB@E&18\)Z]_\&JS<;F!!5VECX\3Z6B3QB6///]J1/$/1]
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M;@LNM4/S5S9;YDW8,JR>#N]"'@$$:$LR=>X'VJXPCKG?(Y(F!AQT8\*  N[
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MA9].$=)D:R#HC3#]*XI.2K7/FOA+ \O.S=;_!- WH'^54Y BEL4Z%-\F7U0
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M0[ WN"2,$1FA<+N/?E<I(/^4D#-%D=KIH7$93!,AVTU80A#.=\-]2H3#;4#
MP^VN2(+N^@3GJ-0W>,,FZM*KT)BU-E%05=O=U6;Z$L>9_S)>C"'0((3H5="$
M']WNC:18Q<K^+](4L@TUX)2G^27+(O 1@/L(@._U34ULMHV<.#&S7ME?TUL
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MP-!EX[5D:MQ^HXBX0K2J3F]O5TKOQ&,FK]PA# %4OQ\3M3^CH$_HCFJ(<VU
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MB 'XESJ4EVL1X(_*@[_\]D_Y4_Z4/^5/^5/^E/]#Y:V#B8T3N;2MK;&KA0T
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MPQ^=0,$C(" A(F$C(V,S$.,3,_R[Y;D#P$1XA01= PU%";S"A(+&A'KN <@
M  H6ZB_RSZD!U"MH&%@X> 1$).27!K48P"LH:.A7,-"PL# P+W>]7NX#,)BP
M6!3LXG"OE0W@*>VQ.;[$9"%0O:WLQ%&9.*7F-'3P0T3"Q<,G(*1Y0TM'S\#%
MS</+QR\@\4Y22EI&]KWJQT]JZAJ:6D;&)J9FYA:6CD[.+JY@-W?_@,"@X)#0
ML-BX;_$)B=^3DK-S<O/R"PJ+BJNJ:VKKZAL:F[JZ>WK[^@<&AR:GIF=FY^87
M%C<@FUO;.[M[^P=GYQ>75]<WM[_O_K +"H"&^F?Y5^W"?+'K%0P,- S\'W9!
MO7+]HP$F#"P%.QR6N#*\@?UK2HXO"-AO8[(J.Q&I.%5.<0P=)I!PJ;DV:,[^
M,.TOEOW;#//[#UGV-\/^Q:Y%  4:ZF7RH#$!4>!.*HPN\]6?^#<!G>.L][@,
M(AJZJ._+-6)Y(E$3IV"M\'306:<CXR<?2NS@ _\S-U8@2L!.^UH4RY/A="VL
M%E2!I7,;+5M;>W&YY*4<44_/PK_&2O!A\\M2_E3:8CK/J4)E(3A%X<S5[Z3T
M\$&BH,O:13^'NW4:98%NV]NDDTF<9)3O@'SB 0^29CC7@WC&JUW7'*Q5CYOS
M8=(?&?01B-R;1%T:=;QU;/;-)(Z]%>T=/ET&SWM*S(V%/'4^%G[F+/I!:Y:T
M[95!9%^_?3G&=Z13$=U&<1M[HG8:'>JD?;]$I_XN7*UEJJR<Q##%ZC;F_2X*
MF^+J(6/],Q  #XDY+3R5 Z>(BY"=MPTXL]O2M=_SL%>;W;4WGU^-BH9SYQ5[
M4MTKAI3"AB_U9VG=6EJ_'HJ9'TF$@;MO$"*.^^JXZ,N7\1K<K37=;AY)=$^F
MU1+>?7K DVSOM[H_2Y3(N--(AT9$U)4:U>%2+@,N44B4.7O]2_^UIY$11*/"
M)K9;H;HU+=N3; 4%EBJNCS=*F''"D_=447O"J1U!FOLX@WDUOFRPZ$ %T9A2
MR:40X;U)U+1> \&)[FZW*(+^+:?XM%6M;%E>[*^/#2T2-C^'L-ZRH6T3GXW9
MN@,7&=@'>KQGGZ(#6N@M"E?W2:F]<'7U/WIHRK<TSU)64@7TK9S;#7? 7&[B
M\$9X.ON4//W$U:/^,5UNY0S/<Z:SK/5A0B:6Z0O-MIV4#"UI@'/9?AOR/+B@
MOXWB#+Y'$.3UGK&14IX#@65'L;HK3'UGJ7I'B-C8UW&,.]+Y5%W;O].;YC0_
MU+E .G?U8$)_7U:X)Z]LG(V5Z"$X\Q.RW\*Q.32\U!QS[ME8L-&M]N88[FV5
M:9MX\:)E[ @3IF8L3"S/[30+9^=N+/LHU*\'_E)PP@Y9F/_[IH;6Z5)G@LU)
M2+H$>:@?27'8 F"6?3EB?5O101BQAN&4001F\9"3UX/#L%36::9VG6W88O]D
MF_H9*N9Q*N,K4O3[6^?B)8G-AMR99Z!ZK<=US-'$K6 (HJT3'1^]LD5L##TP
M,,8%U?E >H;:>Q+)M:0A!"K66:[-C?G51!9J%E,@%Z G7\A8#W41OXQ/QT]L
MG[=!0J1WVYFY FY6/JL(X>)N2=:H62*A/!D(6N0RQ/NI_%19/;V%!:_W?7;B
MB0R\JWJ6$<SM0W:@15QYZ\"+(9=/'00Y&@HD!?$!:*4N9ZD1CE^7%*$>)$[%
MVB>?B"P7H<W5582NST"80S0_7&D9"<0DZ-;]%G9OW1. C0?YS0I"D#X:EX:5
MLVS9@SP(4C?QIJ':A\)F^Y.@'%W7$4T<>60CB:"Z8O[#NX:SX![;H$0>7G5<
MN]7N0NFB_2).!J:S#H>HI,[%Y?*-5 R0\A.:SKRY'M;499H48Y%3!J9DZ8&Z
M:V#,\3R/[C=@C7T=4+11='=]8" *9XV>U>.?9&'.GJSFNDFP.236D47N&R,,
M9+S *G40'_4*!"P]M<_@JO/GS9/)@FP"@[(@S.\%H;P_LM=*#'/X/VAL[J=^
M7H]RU)NJK0A(C@HLT[AMUIUS&AZ18A95KIP];IN*CR.7)?ILQ2#.1P(>[!,_
M%J$$4[189R_FQ=];)->E."4V.>_)0^@_WNBM1\_!IWZ^D.AX$CAS:<Z5/V-4
M&9^3FSC&/1=DQGGS#+Q/\][X.A@!*W36.8A/(@:?(AKJ1"!D#[D5LC_C[5U$
M25B</M-<W*^O#NFAB.+36$8A9>^'SO-"+VBMB]M@=!-9<O8 61A77#<7L'(-
M%*4=RQ 8PLEV[/SPA-] ?@:0#]H8&Z??U,5PIQEJW]M#LS,2.:'&X]OF2[<Z
MN\ZV6T\=,WON?[Z F#_,Z^3T-V V:C@@C(H?FD/O5@3H4<DK]FC1](?5/@,D
MVI:+<<OR(-3M;M0WET%\44Q;=9A?=@',B,=QQQI1O%\7#[)3GT58I_//WK51
MQTXI31AG"'BZ@+[VXAW; !ALKF9U;B+!.9Y\9ZVKK1LGMPHMX@4'A/I!9A[A
M_&4]^<=7%R&++MYP\#>R8Q(9+1Q.)_ZD#+6$TL$LW-84+?2YOZ _!FU3Q=V_
M?8OXN2RF.K;'F,S;OLY7(#I:*R$KSY.NJ7'BY-CIOJ)6+-P>Q"EU@.)+S/$5
M--SRXH)8<J=FTA/6W"4#0K(@5R_<+%><X=)>IOB%&S[!1C@1V:VYZH>/IX'/
M0)00(D]X[H@UZL]$C"'2[215A(UHAMQ=Z,F&5NGU_"S[35:B@^MZE[=KNE,[
M_HJ!6_9;8QP%WX]??>7X>,XA(TP'+2@WTR*Q67*" &8APS@0^%3_0(5A>9>?
M9<'#<OS]2"E;-;;EJ^Q)7.JL_PJH';W%R&N#OT6Z".2N5Y*MLSJO8\GIEN@2
MUQ-L=R&%3 ]-E<_7@4]34=]U@FG!LXH_ZTE;M'_=1CM1\[VF.;=)W4-N_AM*
M$3D</C_YE[B.31PSA5LWB+6BYDR+W&::G$+#;,&4\933O3R_L;8<ETFG5?M/
MS=!=\DW:"B@QH?[N=BS/MQFPSH]$>M,G1K-Q\H3I\86UPVY32RV^Q+)IO?$W
M:(U]TI(5[\Z.PSU\3M-%7W=",C MZIM< MYH7#Z*9T6Y8@:MT$$S.:Z1SYJ%
MM,'I__)!$!+-DG8U0P^YE%GD.PZ(HG!R\.QAPG-!X+]OE1)XK1=<=FMXHW*K
MZ+P10O/%UG32NZ=*D"U"-+&>^DNJV9+(--2F5FIB&\*I;?<)CN[M4L]%;XG^
M_IQ 9NMT;C)U2/_.^^(PCH]^#@4N8M#):]-/C!:D++?-ZXRB,."P'0_]&EU4
M*80$,):8\@>#&;_@^XJHANL1IZ:"[C*M^ZYG *UFOIPI8!6OY4?Z5=*:5?@K
M6'NRX5A98F/6-D;UWB?4:>YG($0/><YJITY.%PZ4V"BKZ=\0H\32@>U_H^ @
M"7R\K:XXN'/)R#9/)VXE=,F"D+P7A&VC;UF2<G-5?CS\C%[4"0]#".\K)+'A
M@Z^M:_'$,U,KCR:C:UMZ-3@R';%YC)\"_7EKZQFH$KGVUA4-24?T(32O*S'P
M=EHQ^M DM\)S8WJ&/0!>;IV^?(A"8W/D0L6#R*^%']7J$X*:Y,L"4S^$Y^_)
MT4?MIQ1]&^)@#^SC7"-R<( */OVE-</:]NI74^!QGIN]!]YU=*(CT^'YF_$E
MNYXMH_H\M_X((5G(R:VX-]%(SFWP1[]K+Y;S\YUWS7&\;[ U1=W&QKI^[ J#
MVLE0GRC,W6UJ-S(0#^Z@3E>+N$:KUOK9FFME&YR5_ WZ%!!_S6WO<>??*G.Y
MM_O&SNZL6C-VJ[GR)!HZJ,GV_ @Y+X8B3HU%Q!][V=?'0MI$9[FC2<&FN]T"
M(]OI<:\MPEUQ\J;ZJ&-/G(K+L7U]7/'7[^[G\AX89EBO2%S[8P[PYGAE01#Z
MC7K-'3.,/@%*/^]/I/YAD,L,WZ:=I/5?PMRU)"*@VQ8YVZ)!3KDW4R 4$TRH
MA;1-^TW\70)($R@:YO89Z-9C/(.]Z6Z5$P.ANMO6#J/]B VN2_7#SXK Z+CZ
MW1K$1^/+9XW><_?0CNY-JC-<;JDHO!L1N[BCUORUYO1WJ5 ]_S +WR*X(MLL
MG5';C;;!GEB9PM5EKQA.5C30#?89Z#RR5;CUVF FZEH,RA#)V7C4=);.4%F-
MD2<W]32 )K8A-Z+Z,L?MHS7AS7H;U]74%UXLOSZ/]33>$:LIO%B58((:.^2M
M2O9=P)FJSAPZ]I0VS%,.+\J)]36H*>TR&2_2AI6\OJHAM4;MG<CG3SKKK^O-
M^Y7D+3Q53F>>DB!CZ/(%MTN]=8,09F=F%F;(3!*E'Z]0R#?T1)+J&#7GM86E
M[C.P'NOMVS*CJ0=YR_%!VT(=W5&E@8B\<)0?!)U"K/ DC#_.*@*<];%7P2('
M!$P;7D1J04]G>E+=#-%)1H)N_/NIWMA0G3R198L/\K,M./FWU3WJ],\ @F?U
MXIA;D<QDV6 C+/5RPQ86'CET?5B%\^:C?H_HJQ9F@SQ+/)[5-W.VAI.DVS2,
M7(I$$%ED%.*OQ;+$3^>ME&3P:_UG=3[X-;-K"^?F1@J8<+:\/R_B+R(;EK[,
M\8]9;C_PGKK?2-X.NT$TCX^,QU4\4D8$1G0COBXK%%:QJV2)=<5T"N.= ANU
M:1Y2M;>5D!'.O@S,!\V->SG:6GD>9H$G!V(WT99E'++40_Y-FM#=^KH' 2\6
M6^B%97.!ZP((JHAI3/8TMZSF;AS:1S_-C^L<7SD$U<EH_9^H]O0QA10K;@5L
MD87+6ZE15#^!_/8HW^:$3$,-\SHNY;G#!XEN4#_UDYTF^9CX6+A%9AQ6< XN
M/(C^$K&Z&@'<1'M94?7WTYE.+Q=](ENTK=(IYU0F(:O,FK%T5(X#H6*_[9?X
ML7]Y$6G-B5#H/HC6GV6$'''IHRW1C/0>K/D4K,JS,66.U5-@B_!LDK%*=.J=
M]*=CM)])E6S(I8F S*>D9BG;&UY7OYJH4&I03;A;]YBU#6U!A0CZD) 1> I-
M.]U[*>RL6#LC,W\B7M*EC(X?5/S.L2%-8C_M@ _-V8U>:OXD.MM&<+!*,5TK
M*!A)OK:_F#KY#.0OY31&?AN.3OIB58+9M_8!:E3CEN%I=_--T0:_"/GMLH;F
MOOVJ-.4O^9U$4\#/99/XSFRU^1F  5-IO/A5X6US7U-@V4F(,X+D#SD< UN+
M5W7O[(]_1\FHR))XN;UI*UK/P,@@ R?V)'./!%@7F4LH5EWD.9OOC*U9471%
MM6!Y%4*/49VYAAB='7H+/<VWV2+RAD0%S2K:R3?X?X[0L8;'7TL8Y<PH<[TA
MS+M[FN)ITEK3B11N83/C\3,]C\@P-V@WM6^&)NBSUYE[X#0+\MG0>0P^5/;I
M4KTF]C%_+/=A/1)T3&OL&UGV^KF9:EJA!Z:"O"-EG_!4SEZ^M91_/]=]MJ_N
MKY2P$2L+$_'S5R54Y]"YS$F_.W!U\-L!_?4>QZ\G1D4B3Z6SH% WVS+=7C.+
M@M51(XP2SP8H?#0']I@.$H&Y\;;7+UE9\R'G,]#E^!AZ7<%Y(SK_9#/R_8F5
M,W57F*_7?E&]BUTTT-,H"YQWE!^L-VO#C6S!',ZI'=R?L,81(1"3BA*U0)[\
M$B8QP,$]"3YHWF1D)*#%W>#(WL,)2UZ7R4'8*>V*93,D1.9Z$G':HD'J.=O3
M+A]$R[N^['3<VTC(&.;(]9LH#6[!1DUR-9-'B&VHF)T4%,PF;5B9V^D-A+D_
MV).RK-"<5V NB%5/YI@E/RVG(80.,[$+;F4:\Q -(EL^];(AGE;YU(X]O&D_
M#7L&S-RDR19$+2Y:?D;XE&[:<*8_TD'_? 8VD*=%-UQ]NDA>2"1\WS.P\ S,
M^RR*V%Y/N:V:I543+$4V'$7LMCIGP%^A2IW(G^6Z1^5Y>%MY2KA:PR0ZUI3&
M9.H6(PI![;'QEZW=2ERAW^JNG7[__1((_NAG855MYZ)E3-#;OI[(?NTE$NR8
MG-+VD*&"1*B>@4"OHCUXN;ECO:LI-<UW==6#7Y_T$Q"HLHBJQU'LY "W$G"U
MDFV #]KQU3. !TKV:MW)<R7-*UQ<';[VQXCQ'4;].8_?0?[(6'%K7U([U\MH
M[HD*&<,"5W0SF]!>E_553<HD3$;\-B"9L.O9].4G$-J,"EK:()F-*0!#*TZ>
ME.WX=^-5Z>H.BVQ9U,>.5(H)'=/Z2>/OU)0)017>ND*6VVA.2Z^_[C6U&(,$
MG$J'M QBWX3 DM<IDF^6.%[806V)HGG3@/U$@YXH)A_DBU8'[7VRU_3WW%/G
MF"83PWC5(V04UH=4P;N^B,>,$S4D@GU/%*>V =RZC#T.DL3N'U45JI<?YE0Y
M.$AZ>OJ/VQY'C54&,IH/^ME?6-:*)U+-:?SV2BSHSG-RQ,(-)7J;/F9TB];<
MNC1"?+-<8#-#Z50MW'&C'=I\D?NBEV8D,-7N_7BL4E4AC)\8W]T7,2)? S%:
MD=U6;&4QV/_5H#Q[I>$DC'3SL5%E8O'MY#>]<K$-Z48^Z.69@]XSZ>#7O;BX
M=7@JF97: ^4L1ZL4E"O2!,N4Y*F #@4_# 9"/S^ GZ GF-[=_58?>P%OEGPZ
M4:ZQ=NJU'6<C'&764J Q>"FN[\1J.EF_IXQ7>9JR-N7#].49]0UN/J@G1)JD
M!RI9(U23B)J!TP;(@@X:(%=ON#4P(JTEZ?.G*8\L" \7+'*ZUZ;16 6Y:79'
MEKY*4%L$BSHK6A&H;BQ+07 ;VB\,Y/7N56)9J4@-EWN93)F.-\T3!9LW,\<
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M6BHW<-M8P.FI&TG]'0-+^PR0PGC',V-#24LG:]:<V]!P-"ER:<\#&M2EF:D
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MPE:0IE(, <G@WI]@W1<=.A5@?!\&=%_4KI!],&N)OO=6Y@&J JVW,(V*U.-
M;"*!#NC05*ER8R'VV@_OY.'8;69=('3.B 0="8B[.V2)HHZ!*G;>%CG Z<S2
M7#IO]PGFX$;S"J$/IOEDOZ>IV['VN^\*8XPG9F@L?0B"]E^^U$JQP0+N)#A?
M#._J M$RC(K;K_-*71J:9_7>A<9*PB3$<D900 -^/62M?5KU%,F,(53IJ^\2
MZ+$%9"((=&4&R*,RHR[_1B[^0V#@;@@\)H6))S2?T=Q$0::S.J)V!H[XKCHO
MB_ZCQPY_N!FPY6EF_0P@XA;E@C5XCVF_ZQ\PUF!<C_^@Y-QO4\6_^>0CH>ML
M[X,^.%O.G8$_U)NHV7A>ZJ" ._1*A1)JOS4BUF=)7#?O+TO 03)SO(V!X30<
M I*8<%]>0M=7"WT&Z'Q$ZAK)0ETN6 ,2-:NB9%DND0MK-6*(8&>I[F=N?C(S
M;*XV#>3*9LD:?MX[(-!P(K_D @[^>+P=3]&7+9$5%W0WN,.W)<\R_PQ4HWT(
M\%G2)%%\=,0I@:!J<K&BK5G:I)LM&)C)]&N2D3&@NUA!'5N*HEBP9MT:=BLF
M/0R'9(_T^#]I?>AWBKQM9G\PAU;[^T#]H\6D8%G_UM*":VNM4*-I=2'Z1 YS
M%>\)!DKBL*_>/!-IT2;+ML1"K2DR_'?"G%WN&6_Q#QBR@9GD'2&:9P!K^$B_
M.[JCLN%>/O.J+C51QX,Q5,F#O#S]/T&FRAW[2>GUD?9>F>?5R+\]-JZMU!Y\
M)379V,$\\/NC20H\GPH\M1*\M*0C(5GXSAEI'/6B6K0#2X[OL7;[<E<]DDL+
MJ2DBC09';+$8@]L83F:3=X$[U^\K$O'#[7K#B\5Y-K91Q_,@,_DMJ/UZX;U7
MJUG%"_LN53IZ0Y\HEQHHN:(OB%EPQ(WB.CH*U97:,Y3KHY8^V/X81O]^$S>X
M_8T:"V^(RN4X"=Z&<WGKXZ)W=(&%O-VB\S>>,4>*!-=(P$+G9=)(<R]6RY7@
M8\!1BR>Z9]B+^E$VM8XF!3V>!1-"@G9G.D)G\?89+,X41C2N</ <?)O$5Z2P
M?M:J'_#<4Q<75S03?[P$)<GBY>P(ZB>Y@-])2+%+8.OY?=TR;*@7AT(88OG&
M9#!S%>*;,G+QM#C&^L%Z^?=OC\W9LC2.]8,R,'?X=F3.PK48)3MTA U!M(O'
MXZ&'4=AXMB^[Z(]:N,FV@2?ZF8A5UZ3KWJAIN7K\\[.MPZ4U05>S-KYR*J7Q
MDRM1#'#8KOYI1H@S;&MDS;U:;7NMAMHT'507]]##X?I@;&:YNJ\X]\%')3AT
M/^;R,B&\_,XB"V4+WIC>*@^-!&ZECJ\:"(/*S40_$/L.7<H._A5J4)DHWS#)
MPBP55/?#0L:8EX>2DM]0W]-$>G59<3B"9"5DUS0,*,BSK--:32.Y3N)+7OW@
M.\_PZ4LW(WVG&@S&1U]Q&$QU1I%?"DE7R-K-@@O6G@FV K! OT/9-)LP$3E&
M=\S %A:]4Z1RK2 [36_D:)H=0:R<=AY4?"*P[B=10862ZY^A1_?J$0=K9:EU
M*R%42-X1BRGV+3&>I.';2KU,K%*HDYJ[CS5_E]1S6.34^\D6.$?133<W$\,"
MQK'F4)?JHAOHN-*09L1=7(?Y$11?(K>VFV\'I/0"Z.U$]/U&C6X,H,S_[S,L
MF-.?RMH/GG.E-1Z5'EZ%XDY2A50Q+$YU3%NE$[Q8V?4)Q1I&(96=VPEWGIBW
M:)MRT\[A?%999[V3RWJ_SEI[5)D4MM_-+Y9JQCNVQBA2\9.3N6N#539V96),
M8S[IB65RPHZ.*ZK ;49_R-"*]16Q:VZW5AA=/-B4JYF\(N!JAMXH 9D'@':]
M6OU;LZ]7LVG)C0.<E]^?>X<U@@*#>6(DF9+NJP:4C YPVN/E) %3L&?CY/>A
MXBJBDK2AL@;HW38Q/@+26YP"S46R!__M9Z!BN.*1C,9\'.I_H/=_@4Y_-.LB
M,Y(PZ<2",ZJ[<H&V%8'Q*GK2&V$LMI/T5'2M_5\14UD^& \J[3,%'^9OW5D/
M?V'922S+X!Q3D]SJLXB6/P/NP"\FJ[++%9'5OB%VG-H:.13VBG>2 !V9&*RB
MI+2]/6I>:3VO"I/2VR!9:L= 26CJN'DH,>*RW;"KO&GGFLK)2X."O1MD6^Z=
MO%+A<ED_^G ,YF6&+VP$S/.7Q4WPO<)XJA,)%Y^8"]B2S7-C#-/EQ+>')HZU
MX["R5/!<%-A3B3_/"F<$7+6_MKSQ?A-U-S0G/VW3>Y0?5[P?;8<=8AAHYJR9
M\SNL"Y\1NMK5=%0P V5O:D^+;/Z$9;.EP:,DI<@T#!J)4U[PI]C;GV)P'U J
M]\4(V0>M"S6# R&-=6E\QI_W*3/L.W%&'@2;7$Y_)K_;>)K(7!G.X_<NK<3<
MYG%/&Z^1CSNPF-,CR)!NB%,Y-8B:=:'9G2(^JFD6'H6_*T*_F7;P/K693\>?
M_9P(2<^F#)/CG66B2CCHVX* 0,T.F%_TOIOG1J,@HE!2O_87(PV6Q!D\:!/2
MY=C40-PX4CN?D[)+3/PZ:!Y#<:YB%,WC9!00XQ-< <T%Q1HB"K&'E)&)ZR?C
MZU@FYCQ^3[EA\%E-1!']%:ZNJ!/<W1Q7MN_:1MOH!_)H53LW!M,JD:[R48-5
ML*"$>3C)KM-**EX\G9&VIXVRYK0O_$T6N.K]4H#:]7CYOHVI#1:UWF'_E]NX
MCC>^?)&JFUP\ GG+N'>,<K8&'LQIPV,>Q!QQV(XRDU+!%#F]+;[LSL.H#3#$
M+NF$9VI)D-8W1(\L!G4F+#\&]G<"!A=_9J8U!^%#CR(,P).#HZI/]?M(>68^
MSW G'5T&@NZ#Y$6-79472D/.N8*9@U#9Q&N,GT[;\(Y9B_;TT3W9:8,/YSZ=
MLH2;N!)[Z\1X)1"$Q0NZ(HH-0T=VI/+\T2/@\DV=R'D#U4CZZPJ83#=YQ9?L
MC&'&V".%E]0W=1!/K[C'I\KRVA]R5KA*PJ@[E3]^E3=X3](-)]M!L(*2LQUO
MY]:'[ZHL1D+SUU20N#_D&8"H0N3Q]/4H.'Q,5S-D\JF&C9X..^%_Q)04% O,
MQL,U9JWNNYH$J-O5?!BR&X[Q[;@F/T<O+/9^/6,VTR*(DKC.DF4S G+/\:6-
M^.;I@<6+;@KGRU/X[TGPB@6"J@OV5;3["W6E4>H5MSLQ!]VTHW"D:0D(.C:%
M9M0SM-OOO5K+BO=%-!&MW9SK-D=^MYF>QP3AV;[5($Y7C\! ;)$H[=]X?/5+
M.9:3\UV6P1<%0C>-P"CN&S.&G.59O. 65[BLC>#F:?B,0LWEVOA+P@^L3C '
M,D/%-A3X0$>]6,?KU"GG$UA+K;J2S .7NRW#"QD4[:/9*GG4GA2[*GRC9"XU
M J-4TIS\"34AT8TT;;DSYMDBGV*+R5Y'RZ_"94'?KXLU\;]]/4X6_TJ0Z,O!
M<W$>!LSAW04D)W?BQE$NXM>G#.9_(@H94/)G3CUU@!,^J%_PE';+8] YX'&W
MWDAQ;/T&]YFJ?P5.$3(F&+:Y6+>7B3([H:+[7KOQQ#9/TX#M\?NH&@X,(/.I
MGY9$06:PCS&]X91Y)KW5Q&M#>X3U0WUU?2Q?&8M3?\,K37R"-T-C9#_?9F_Y
MV1%E?)\SDP0<V_#&N>5Q;]0:9KCEY#H+1^M?$<G1ULOD+M7.PR6\=;56<8,F
M3R\%9?\[YHR15;=NTKOWL: LF\E="53;R/0I$X'C)_[G+[X. IB= Y#:/UZ-
M5)\EI&2_%W)VA%CC*;6W-%ZPU"QYW$H.+0SAO(,AX*GNK7H#\\)]$W)NP\G,
MHO6G]%7\Y6.WR:=I Q1)4G>-2QL&N](;.D<YHZYR9(9*V880;K"!S"# _ZL;
MC&MVI>@&YB3YY$A0'$HR%ZEK.EP\?6WW)D'79\SH#7+_SCXQ;M ]QY9ET!%W
MR@9FM-G\4,_X+CYZ;,K%VLGFHB^79610;8%E8N)U'9XLUYUG%W*NDH_+MH11
M>@MI#M5+NO!E#)S6(IMUBWN^,_PQ_1GX^*6^Y_/4NT@6N^)T+3B^97$F*'+H
M?IR!O6(N16SS<_.*"AV:251192RPR\&:]^/)=6+,!G*#PF$_-4#C\P$#7;=T
MG_N(G=7&2N6<_J3,@'/8!!J1]B- =F6TLTL%3;SUR6##0_:RIVKFV);;2;;E
M:"[.H1^_$P'G_3-0)<5H8/2.21E'CK@2FF"3^.F5+X?D4Z4/[+<[FS227(?&
M>['IU-S*3/)7A2E?F#C<3/H)2,2ZSZ(#:T= DLU5M=-XRD%W!Z(UFGH*S(;:
MGZQ'L(24.;=_8"2,?JQ78*S)]N5+(Y,X0\T(+V4-BLZV$/!4LS9QQDG(H^Z3
MZ1]!PUC*'&+_+&(3*ZK'6/<_Z\R&<:2-^D%VNH6B4&?1XCHAIM<ZWZOQY 1Z
MD.R[YP1)H^1236.([W9E.GML(W#P8 ;A.>T/RFNN"[7A1DRS=KHW>@98\3A(
M*@N4^]R$'L?[:[5.5R,?_3=^Z0KG7>Q(LMJ+L)DEA5I0BQQNIYR5XW7<?7M)
M'(24GJBFU:"--G8]&#&M*<QM6&1^)KY'@&']-A$PZGV_GHYX>0 P?IN%.I,.
M5>W^-9I4<-@X@R#Z2S\H:&V9V-9^#X.4>+8_Q#E^W(G_)$+*31W1UJ9@)]V4
MPBC"HQI#E#"Z6X!SSYU!W)&NH2UI$7*]CH)8X)AHL,?90?*-[DB,\(^3#YP.
M3\TISS*TJ5X>%5FS0G->Y66B8;#_A[K>N@\Y0C@(VT/I:*.@]N*[P,BVHGQ=
M#;V")&MGY&X.'S=\'(/?K\7P&0MOZ^5)Y:^#X:KK YNFRM6PGHZP<ZU$I6WW
M==H?J-)Y6LYPL[R<\_9.<E?7:&XG=V:,(W\6H;"S)@]#!RMOP2/Q#>ZZP#I[
MOTI;ZGQ9"JQM)[+,^<M8;JR("PW/0$N6_AZD20#H.8U*\LH%>RX=E-C4.ZRN
MK,@D3-;$%*0Y4G=*<!19(0*C$P-E37\<NHU03M]6]S%#PO,ON%K96NO"<=D(
M?FN6*Y;+T 7GC\O<+Q3<WMT=' N*(II/<0DD-/V,E2?X7<:,1^JYV@]#>?D[
MU5U=U<C$-G__^IJ''<&Z+%O#(-*=DJXKN@-*[/4?;^/4O!NS%L#!LHF*TS')
MO-O&4DO4+"*'(2N?.K?8]K6PE>"1C2#,BIUW>6W!FTEM$V8.3WHI%4=(U;SF
M-L &S:4-SOWG+75G95VMI34M.9 'C"ON!;TL9;P$8]$!@K"D9Z+/)CHF6.]N
M$ED?5S\ 1,"/]UJ&:[^OPYI:FIF 3GT816K[(O[[:0W4U0@.:GR3EH;V4B]U
M52X[$XAZ,HFD Q\V=:M2>'#KJJ@0*-=_$B,5'?QMY?FVW4_O7<:H3.(S0'X_
MIZRAQUU?E]*Y&#&7J&^H31=YH&?%9)U.MLKT'8CS:R1WD))V!U:R&UK1(2[1
M1?.+1'O<@D2#;\(F(?Q.X;51R(DFBO1Y[(?Z:=]08FZ"[/^2_'\ZX4:6%U@$
MA?_ZOAZ&?4%M9F6EKWHDADM7&GTK:[7"9%SG=P=A/#9*8.1'HMPE2OW*@_;P
M?Q'WEF%U-5VVZ")X<'?7X.X:@FP(&MS=-B[!/1!< R00W(+[QIW@KF$C04/P
MC3O<?*?/\YQ^W^[S==^^W<_]4?_66B5CUIAC5LVJM467E+'!5TVV(ABU?4IP
M-+XB0=Z1>6C/4;D=#47IVEG;L33%^1!//ZRAPO!1:%F*LDB6GX(ASC(N=3K8
MRDH8@7)]]MM?MX9#I1!2@D52=-=(3E4R-\<%E%895KZ3CZ.AXK\ZU*I-.6OE
M$<G>W_?>DR+CTS;PCNX>#4 L /FYF[9DH^F.UDBN(A>?7+EGV'8M<,A^@&2(
M2*./*<_\7(G\U:3V8\,"LT)A&-[[*,<4PW[LE+"1ZN,%69:<PM@X:7@$HI#=
MCCFAT.+JY[*$2JX]:$>OR7>?2I2MK(]+&;USL@RMH2J"H@K$2<$JR&[ )'$@
M#8P-6E6::T](=%7NF9]FF:)9[]?'ZMA;2ZL+D].]'F8)^J#VX@8\<'[029SM
MYT<PUQB#"IVX@O;*ZK;O"*U4'26PQ0HB1FJ3XQD4SVJUSND=5YM_5 &[Y5B&
M"N">F/(,."X1[Y))B9_KM3)];&RC(C &BT!JS=R:WI<BI%WINR]'>)AKO-;W
M$8;[X@U/YRS)7)41S&+7:E659 Y)8SG 30[R85484Z5/,P?17S-63O_KA4YC
MHV_["YT,-U&ERW8FR_HKVJV>97(9<M7\1>T\MXNT&L?)^2GATCF?'S[ ]>1B
MJ>>W+_=B;*%P/,C:V#G;;$/W[6,(2RI6UL2$&YH"8NA*&0(#5KW9NEUX?&5*
MO0<6,W.P[!:_B612O(W"FJ:/TGD&J'(QTZ)W:4X'/C6A.E84+82[[*)1EA(E
M5P40JKUU"$@=KHK%EI.G_K?!UO]007K_\<\DN@TZ.#MX!N2']?G_[0Z2#F>Y
M/P@6'^?!SN'9S-1A#86\EZZR9M^KXQK#FGL9K8KKG:/>H.<ONL$49PD4MH[/
M++L$Q8PJGPP6($K,P8&_!PK,/M!(Y&#F.7J*[G-,&\0$<7Z!4\-/]X1G&$"]
M]>ZA3D6J#NNDVZ,4RLJ?KJR>SX<HQ82YHD@#B4AQQ!'4]:]6!(X!^&1,N$TQ
M\+I)E#%K<\WY90"#V! 3I"UZ!HL%93T@?.N<_ISBRP@C2@(\&"\>7NW&%2;
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M]8M^9G@AP.:'%I09GN=:)N(7]Y7P,=^P_S/00.*@*V=T&FKDHG4F<HR<>T&
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MABPW',+:8NA:[GVGO_1(CIHJ]7TTT"7KMM7GVQD[SA1^V9+-MFT';6OL%[H
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MPS#H<YM@!MSP (XW_YJZ%/GDE7S41:='G*^X"L[,LNX'ISO4?""AG"Y#?3-
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M=Z%5G;@5 P4 <;MZ'L9$%T#IL3ZD--WX6IA:6]-DUL\E>GZK4 X4*3:/GY)
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M[DFV,&1BW7:&:@<PMU9% D;02P6;82&N)5):!_< 6'UU)'=<-2,H.#) I!<
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M3/H5N-.(,<I =+Z@]68! M$7&K?1%9D8C8 2A#SF7R.RM.[H%XMS,4F_*.;
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M*/'W>X%5$G-*^Z]/5/#6>B_#3G#_]/3K5;4\?R-/J[4[:E%3:T3R*/_L\@>
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M>,H@X8:9>2\ YNA7Z4O_=:<]F?NY_P%02P,$%     @ ;SQ<5@NB*N>IDP$
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M:_Y^LIUQ)^KGS#V8D9^]H9]T;'*ER](<EYV%62QD%D009T) E$H.L3 %H(,
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M),((.QVKL6]Z:MK4(@6B@0H><SEW+#/BP+R=/ W#Y\ "=>0<WX;=%GA5LW.
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M!":\2BDO4DA3*F ::[>#H0P1ZK08-0C*J?DL]:HZVU]5WZX_UH?-%V5U!$R
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M?JX45R?#8HY<XN,DQJFC_M4_FD/^X0QG422"(( B1C%$811"S&(&@X03&<J
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M!21*,PXQE8$Y9:3T=YPE4#"&HRC0_Q&A4_RJ7WQ3DXG/Z[L[6CR:1&\[-3'
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MP1F7_>30"<>49;$UQ"P+5=EW*V,J-W9C#MC:<ZE"NO6?JU(.UBLC*J;O#KE
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M6G&POKZ?]]*N &_7>K>)9[YHBDL3VE67^_U(R]7KM?R]T'.=I5(SDH5I&*D
M,BY3B (<0R)3";G$E$428YHX[7KUAS(U2=D4>"HVIER!56N"292N;0#WV@A3
MI>\*?&_L</-V+N@Z.P]HG X96*\V??%IIR^V=ER!C25-479@; &O3;_\?JY?
MG#VERRGUY#U= &14C^IRPIYZ61Z>>&ETP<?")#]=/7[4;ZK)]67B&>Z-MU=O
M1U.1D  Q!7$2,8@2@2!%@L 8<:I22F02.9VKL6UX:C+:HKT"%=Y-MI7[^DC)
M91$"9_K -23 '[,#Z^%EI%ZPRV_'D/=M_3/-/M,^OAT9IS?N+>_O$8?_2O]G
M:?)*?'^U?%5(D:_>4I[/JWBKZJP:PQPGF30G?"(,M2XQB'&D)XLHE"A (4D3
MJ]J$5JU-39)JI*"&"EJL#N'C9^GM%A[OI VL-C54<)RV\Z<">_#G$'WOD\>1
M@N\OY-,M^MZ6G\[@^[,/&2_VWM:>O=![ZYM\U9W>)*1^1>_S%9UOJN(0%4>9
MJ3T=,*[=0AYGD* HA6'*LE0$0HK0,4FK;=-34^%7W_3?9&EJ*6^K"-!Z!]WX
M,_.<,M-%N2S_>FF5ZI/=8><A#D/RP*I]HF[U-I]] WV0LJ_NC U6S/IDP\]<
MU?H<(>?+6Y]]0@_/L3V=6T^LI?@@5[-4_X]DF80)15JSE!8NPK&":1AJ]S%5
M).)6]9).-3 U9=K4$"T:C ZNS3'^++S!"UD97$H:0EIX56KH"UEQ\/$N9&<D
MM\Z1)3<WKH."3L_MV'WC.6L=J/?\LZ[K>@:J:\?AMNKPS[K?UV43-\33ZG0C
MA:')9X$$9I#))(-49%G"HTQDS"TZ_6@S4Q.T+4I0PW2,P#I#JIT3=3E5 ZM<
M#Y;<8\\[2? 5<'Z\D7&CS#L-/0@M[[[ZX@RHM%AH-ZG\*(LJT\7K?+Y>2?'R
M\=7R[FZYJ.(ZZQ5C'%(6Q1&%&34I[%&80))& N(X# (<1P*E5N&8%V"8FGCL
MI?!LC#"[;* RXPHTAEP!]@AJ6T!ES!70'FN3B_C+]V7]R_8X[Z6I5*T[U'4+
M8)!N&EBXGJ6'+LG)ZLJQ_P2MU@B>*UNK*T4=J5N='W6QW-[=SY>/4GZ6Q4/.
M9=7J2SUC%;I%D^BB+O0[KUX9_9.I6L*7MXO\OV6S96O2P9?;XK(TP3B*4NVE
M95$$44"UTQ8%!/(XYID03/&(]!1EOT@G)]WKN[LJFX+2'HW&!YFQ#>P:YY8\
M9_B^=M;KY^O!H57=F (K6T"3L0M<%X59-+VK8EZ:GA/5:FFS!&3LN@)UZ;U&
MPL$@=8L'[P'_FN\9YW-]&8:AN^/[,5"#EX4ZGCOL_O)QY^"[;JHZFTC""$DL
M*$Q3D>G9?X(@C3&!&4DHSA@7 76JS'D)F*E]*W:R1!B(O<Z*7M0Y=LH_%N4#
MB[LCV[U#%"^AR7.08B\HSQ*F> EIIP(5+WIFSS-M><FKX_IK*9JMHN6B_+B<
MY_QQZW"E:9+1@%%(F)(0J4B[V2@.8!8(%B.4TBAUBE.T:G5JXM<<W/XFYP*H
M95&EYZS<*K%C3;M-K<UQ/-%FU1%V^N>=WH&%;A<OV *^ C5D\+7Y<Q GU8DL
M7R?:K-H<]T";"PT'Y]F<;NX=/[.\DU_HCZ=C@@9QFO D@4F6<(BP%)!$/(,X
M"E(M39*23#A&RQQM:&IZ5.,$*_JCH^JN&Y5V\N*#H,$WHRMN-,9Q1.0<)?X"
M5XXW,W:82J>Q1X)2NJ_O)PB;R)8JYQ MBD?]5?Y."[%S !Q%-)51QJ%F,H"(
M*66V<BE$G'.49)%4F=-6C46;4Y.);2Q7G41K%_0%)_!MV+>3$\^<#JPLE]/I
M+"X.!'G2&9L61Y4<!PJ>JH_+K3UBX<Q!,EEG_FDK-#7QZ8%,."9)!K,PB$P>
M$ *)"$T82<IY&K-(**M)4W<S4Y.;"BBHD&Y+ESE$@9WFLUM-_+$TL( <):C/
M 8G33#E$S7EA;*38.;=7RRUT[BP/G0%TI^\>+XSNK 5[P73GK^X94B?+4LJM
MYIH@Y$]R(;_3^1=9W,TXX6&HN(22*0Q1B!%DVA># D4QQYE):.8T63O3WM34
M<>L]S W2*Z!]8;DHS1ZK;O[.,=+N#-=V[I='!@=6SAKIU<[IA/<UB0U<\*6+
M0O<P/#MB?,7CG6EMW, \.],/(O0L;^LG+6U^I)O%T?1)'^3J8R%7],=,*D2B
M-%,PB40*D6(,4JD$3*,TI9)1',9.Y<IM&YZ:V%3IP+2R%/*!SM=U),=2 ;'-
M'K9S?,I->JS[(D493ED4P2!#"**("4BX_HFH(.!1E(D4L;9*X)=GZI+]HH%?
M_@_I&;NOPQ#O_L"?B=TL>)K74\GR-/0K4(/W]\UPI<O3Q\.ZV5&_(JYD//V<
M.-_?,UJDVM=KDFQM#GVB)$E0PA ,B*00)6;+4U$*PUC(B(0B"]RV/(^V,K4O
M1@.O.6'K&-=QE$8[E;F8G($EI<9WU::^&^0T;"<'OL(LCK8Q;OQ$EYD'@1&=
M%_=8K?M8++F4HJJL_CI_R(5<B'*6!?H%R 2&(8F4=E)0#%F4I1"+-%&$)#A6
MRGJE[F@34QOH+3!PWZ!U6'<ZSJ'%ZMS%S P\REM\P  $&X074^.P''<Q12,M
MQ;E2Y;88U\E"YT+<\3O'6X3K1+ZW -=]99]T3G2QH+J'YZ^6<_W+91V$8:+)
MFE5A@FC <( A35 ($4M,%4\90<0)CBF-94+M5>Y<:U,3O U>L >XJH7FDI3H
M',D6,NB3NH$5L8NU7CF=SM'GDM/)(XUCY73J\Q(Z9G*R9*4[D].YAXR8R<G2
MGOU,3K8W]9LP?I(/<K&61KG?_-#BM:#SS2;*R\=?Y/*VH/??<GYM4K!4QVNV
M$5:18"A.> PE0ZF67I%J$4XBF)! "$$E$21TF59>@&5J$KU[0K4Q"YBW ;2&
M[6R7LD>PM0U4QKG-5B_I0[LY[4@],_ 7H$='#'JDS .KGN;2ER 9=<;M@;*G
M\W(?C^RKO2N:+Z1H#RQ?<_WE7L_-POUKJ7*>KV:8B"A :0 #P@A$E :0(1'#
ME 8QR])4T"1VD]AS34Y-25O$0#:07;7Q+,>V$NB3N<&5KB%MDQWAQ0Y>T #^
MR:>4V;+C3;'.-CBR,-D2<*@_UG=>FJ?@[>F*?W7R$!(+%-$X@F% D9:;+(&$
MI 12R94(9)QA8C6M=F]Z:K*SZ\"]/5/]\K+4+F<[Q4Z?AJ%Z8)WRR/(%!_IM
M"?-^0O]LP\]TY-Z6D--GZ*V?T&-Q\,AA4JV9Q;IJJLJJMRV-,0O-WB9B(224
MF50J$8:81A3&$8_B0,@T0/8+A2XM3TW0KH7X*WB_7-Q"$YP'[I=%&ZE!:Q-
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M=@2[_[D>&<*1'_U6<-!*#K3HH",[. @_Y&3>$6J'$_OQ()_H)-\O]&ZG_</
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M]#Z]VV2CO"\JTAWB??E#PU[[=_P_=_DF-Y;$6]-X<DE%%E.4ZE=\Q%+3DC.
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M)K-(6KEGHTDX-_[Y4)0R?U@#^5/+K%D?2*4DMTS6&6\?^\EK%KLS,NNUZBU
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MS:MWE1G1KWX_]B;PZ^RYW1ON%?9QY->AV< S)>P'O;H%['O-S /<-NKH*+<
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MN=[<C+%:9' D\Z*>1Z1A!HWDP(ANW[W?!O=^]AL!S9'IT >03F, '. 9-!S
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MM,Q-'E4[//N]=M_,"_8PA"4(0\5BED*"9*(=*"(A9C&&81(KE 2"(6S5!V;
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MI#3FD(5<1OI1#X5;:^HS:\SMN=Z+"(R,X,]:2N<N?J=8VCW<-R(T\M/M"LZ
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M!$9&<*S( KS=P]XHL__H MS],'T%? Z6&X"FMPES+FM//&IN "RG,^>&W&1
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M77&5F+$,\P1B75<%)1)#'+,(QLJL(2C,:"QR8V?YH9[F1@VMK!:.XH,X#K.
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MD;__SK_I6*1?B_+VL<[GOKG_*&FU+U2QI!&.!!$)S#"F$(DDA(HW4RBBF+
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MPX0?)B^XICQ>/]5?Q<UZ7?Q#E? ?5QOY82L?JJ4(4IT&E4 991E$ZGU(PEA
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M@KG1QL$A JCJZ;'5TZ,YO7&H.F$_*(;'-F-"/?;!S0'*6OK:A[.37]]@[34
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MP^1I33+H<-*5QAR E^N'Q9NN^T2EP6;;G.Q_655_OY$;_NV!EG^W^3JI")#
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M?S?W@3=;..<[G",OP[56L%8+]%4_.+UB/T#_N59_4 .PZ+(*]S  -0A@JU
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M52.K7F@?=M):G!.[#8C!"?WH,(_,(UI^J!4 G09@K\("[ :@U4*9H^#WZ0;
MXK!^](&8Z,!^G &Q.[._"LO!<WNWEJ<[N[]*\X/S^^M:NO8,OU<?^>-J(VNG
MD"4F"4DBG$&64JS,0YV(5UN+J624QUA2&=KE=1SL;FYK2?^<NB<O^$M+W)3#
M=#[9/PFW[0'_M2!.>,YOC=\5Y_U#L'@_]C_9V2N=_@\I?OX28/ M-UIY2ZMO
M:LNJ_WC_/T^K9[K6K7\NUBO^8W]Z'?&4<T8%C-) 0I01"AD/(\CRF- H"D(:
MIS;L8M3KW$A&2UL?]7#]@]S+7?]C]:THM\WBOMH/DQWIF V&&?=XAWAD"MJA
M6__0$UG91;70X*_VSU$N&ZS@\D1-9GU.RE!6,+PD*KN7'?FJ>'@LY3>=P.:Y
M]9/])+>W^1W]KOZV?A*KS?UG-1-U:.S!$=T9'_DX"@E%"8<BI3E$04@@RV@,
M"9+*I$H83W-A$P#A63XK#IP@Z.% /; >.IV:9/@,N?#U!F5LUCP8CX,@AZ;L
ME[YEHM\78*<G:!4]NN08/<9AI%'P1<:>I9N6ML>!]HC@1^K&)6$CW6RHFD?K
MFPU=_]BN>/5Q*]KD>#&529*$%'*DZ!QE"8&*RD,8D#3 3(@HQT;A"Y<ZFI^!
MVHH*=K(")>PO-ED'!V U.#'U!-;HIN9IG)S2- X 9I.DT0]P4Z5HM/W0+#,T
M7@9C.#_CP/L39F>\K,5A;D:#YZ=.7E;_YT[UJLSZS^H3^*0^BC;2*9(DRZFR
MF2-,%,E*B2".\P@&(4VCE). YQ.E*#LOY-P(NI84:%&O+C#C<20-SS)?>7Q&
M7A-LAF;"S%Z7L7OU_%T#(OZ;9.FZ#+*_7%P&?;D$!JZ5M4U;OZ/6^F R(2Q&
M @H4AQ#%,8,T#1*8<4X%3T6$$_/2C"<ZF!VYUB)V?G@V<68GP NR &5<IE F
M+(&(X!!2C".8L21*$Y'R@-+ELRQ9,05\_8[^30 TV"Q<"<K8"\(!&BY;@U.P
MV$0H7@?/5#&(EC!9!AB>QV XA/#$>Q,&"9Z7^C ,<."Y:U(%U0&$7R27J[K@
M^9)*DB<<)S!,$JI,]2B#-"81% %-,X(IBH312C#8R]R6@R;PM=S)MP#<)@)Y
M&%$SD_EJG$:FN'Z.&_"EAY3WU&*#2'A-3/.RCU=(*7-&S=/)8,X][& $?M;5
M'!YUG$(34-(N.9SEDK$TAIRR7)DR:H_.9!9"F<<)CE" LR"T,&5.]S(_:T;)
M"5M!VP ;BZ7[#)0&1LWU\(P\Z8]Q<;%MS@!D8=Y<#]1$%HX+8'96SC 4@X;.
MF5>GLW6&93\P=RX\ZF;Q?)'/<O,DNWQ:NBSDGZOMM[=/U5:Q:[F[EKJI*ITE
M5BB^7?),JLTO59N[."40\1A#++, RI!%$A-$*++R9G*086[6DKXJ+ALU%ET*
M/-ED$'%(:N@R*&8FU<A0C\R]K?3[](-:?O"/4@!T&O1OZCLEM(7FSQ:[ D)/
MEIJ+!)/:<5= ]-+*NZ8IQ]N>;<'__E!53U*\J\OA-,G^F[#%3_*?^E?5,A0L
M24B*((X85B28Y9#%E$+*PT02D0946)&@6;=SX[TVX'=5R^T><FV(N>%-BW<D
M1Z:U6F#02 P:D7?54QJIM2_2/\T3'L,9[8#R=5%BUNFT5Q]60!Q=9MB][2.)
M]>D2KYTOD>J_+NA:2[",98A$GC+(D8Y^1IA"QL( 1LH0YOHWF;"*;'&69&[<
M54M6^V .E]3>%;KR4O[*?2!M#LU&'IYI#M9,RF-KCW?UN\>BHFOMK'GFN4-G
M3IUYIQG]X1Q%5Z:A=@!_E"33-G*\8@II![B&$T2[-.C&S@<UN(\K;>L%HJVT
M7:="D>*&5;4MNXQ2M6/.:00#P@1$5$K(,A)#)E".\RQ.,YG;L+.S)#-FYST!
M*\4>GYH#*SO6=1\@,]:=!/:165<SY"'S[A31_NU=BI^>+@O0:@/^ZO3QZ/5S
M-::>R-1=CDG)]&JX7I+I]0VZ'DGV:M&JO\CR67Y15M>O1:F=?Y819XS$RI8-
M I$KRDPU6TH!:2+B+.((1P&R.WX<[&]NQ'A8>[F5%_RE)0:MR)9>D9< -SU:
M] ;CZ,>(5R#H<%YHA(NWL\'AWB8^!S12_?C,S^PU.WH1<K5\KZS![8\;(=3G
M5+U5/]Z6=\4_FV6494(F3$(>QTCMD<,<XA0%,$U#&DC&1)0)$TH9Z&-N--*(
M"5HY%T!+JG $6E8S^A@"=)@R/,$T,DTX(61,#P88G*"$2O)?[HOG_U1O-VR@
M?MB3P%";DTQ\ Z6ZR6[RJ)O]L"MD^;ZME+BSY1&7C& 60Q2S%"+!&"2(1Q#'
M,:.,92B+K-(SG^UI;I-]7\'5K7KD>4C-; ,O0(T\W?<8=4*.LJNY"(4G0^!\
M/Y.: !?5?;GX7W[!C15^7VV*4E',+O0]1"1/,AQH;RX,49ZGD-"$PA1%L<[5
MDD32:AOQLH.Y<<"G8@/[ >JK5DY+*CC"T8P!KD%GBNNW=B?['W7F%+WJ3QW=
M?PX@3W1PU/RD+'!.N9>3_^QSKE?Y=%N'$]WFOZXV=,-7=/VYJ%9UL%&W@L4R
MS7BH+/Z<QY$.58D@89)!F=(PHBF+:&P7B&G0Z=RX82>SOB+920TZL4T60O<!
M,",0W[".3BI7(^IPGV\.D;?;?(,N)[[+-P?A^";?XETW2GHG'TNIVM5-OO_>
M.B]]5-N?HM0N3-L_-JJMG0WT4=)*+J.0$RS3$/)(9X^KBT)PD<* TR36166"
MS,I2<9!A;H355Z';TP#U8ZD]8V&1PR?U=ZJ5L31O7,;'C,!&1GUD/NM+OP [
M^4&C0.UJN05/6@6PWTC52OCCMRL0]$1W+A),RGY70/22#*]IRM7'Z5EQ;U'^
M^$+_^5TQ<:GHM[FN;P^!JV64Y"@*)861OO9!21Y"S$,,XSC-2<J%C&*C>JSF
M7<Z-^92@X*&3U-;UZ"*^9E3F%[61F6LG[ )H[';R[ER".IE]N@&9XN/-W^=B
MAQ,[]I@"<.S!8_SFM7G V[+27^2C3KFFTZKE1?E0\]V;'^TOFW*4A*>,12&#
M@JN-(2(T@03K3)?:MY*S@"!LQ3H.,LR-AOH9KULYP4X+T%-C =B/W1-7%@DU
M'S'#/>6XXS#V%G.4(;@B&[DUB-Y3E)M+\$IYRZTA.I_,W+XI^_OR&V7TJ='7
M27:6)$D)Y1F',2':]!(!I"GED L49@E.68*-LB"\:'=NQ-:*!K1LYO?@?: N
MWWT[JC\RGQAI;G6_?4)/ISOM?CN3W6.?$+Y_=WWJUU>D%_RL:U8N2:YLBYQS
M* )>&QJYFF,Y@1$*PC#':29#^Z2 ==-SFV9-X=NF4B?=@OLZ^XU0!E\=9/&6
M;JA8T>NC+7K8&IH$3HB-O=+78-52>4ZJ=Z"ISU1X3</3)[ [4.ADVKG#)ZYT
M,=&NL6]I6?[(&]^T:IEP@E*2A#!-=9W)O"Y4EZ50L#R)N:1"$*-"=9>[FMN4
MWI_[U5[[O"^KH[O),;QFL]@/:"//ZMXYJ<;KK1%>[OXF9Z'P[7!RW-'K>)R<
M5?BLR\GY-]QHXH;SXDF7\* _:M?YD@K9YH9:1FF0)SD5, M("!&-,LB0X#"(
MHQ %- IH:'6F,-#7W(BB$Q4\-K(NP%9+ZYAA; AD,[;P!-W8YGF'VN<.M;L&
M->_9Q@SP\,090SU-2AH&*K]D#9-7G -@I'I)UP)Z)Y_ENGC4>_G6'VZ9IZG
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M9!9D+"80!V&F-K-40!+F# K"DSR+HR!/D(T/R9403N9#LO8-I-D^[CIX1E[
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M0N_M8P(S)R+$ZT--S23LRW56.UFC=2.L(Y7$=7SM[$(8U 8V#7O ]F)&7_H
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MU<MQJNN7C]Q O.G4^9N^T- [?*J:%-<-H&"><LI(#A1G""!!"<"9]H6(*(A
M&252"!=#,H",DS-"Z_6VJOE?JJBN-%Z_0,/GCCFU,V(O/%,#&\  39QW;9IK
M3:M*O$K7X%W$!IR*EV[+W"'A7Z,!<S_$P5HM6PSEV=!(B(I=D\[-YN-A\9I^
M*S=TWF0HI$2A!*<0L,ST3TV$ E3;?0"E">2AG#*1.#4QZAIM:L9\+VQD"BZ!
M_LAY+:]CEZ).B.TL<C#@!K:M!YA]:C!K1!VB&9$-**$:$'6.-6[3(1NUSQH-
M6=WDN1/=I4Q_5.^7>N=KR@GJDXC_(^?BW7+U^UK.DECO2C,D01(K[4ZJPA#M
M"Z;=24P%@WE!$J<N0E:C3LVF7"C*F&O9FPH,+]H$*_ M-Z^A(1UZ*[N3]RXR
M\C:]72N)[R(C,E#+E>G'&'!GZX)1J'VNU9CC[GI=8#C; SO=[!GZOYJ]KK>U
M4B5< )J1%*"BT#^9;#9MA' >)QJ,PBJYMW>DJ1F?W_1CGY:1_,'GVZKUHEN]
M13^REJ'\OT!UQ< )_]90A K OVP5@+6Z9R'UP#G_AYT%WI5KPV)>[:3>Z;];
MST@,)90J WD<YP 1I7<[19:!6/LIG#,JX]0J=Z%SE*D9A5TOBUK2)HX15;*Z
M]_LX![7;)@2#:F![X(625\^/JRC<U/3C_*FC=_VXJMBEMA_7+_8H\KG$U,GY
M:EOUF)?Z-=F\KGG+9EF:%)PD*> P9@!AG@*&F?8B:4%SE.<IYO9L&=;#3LTD
MZ+WB_Q<UHIJJ\$I6AW(7>[R[C<-P* YL+:XP C>(MG+?18WD@T#K4%PT",0C
MU1N%@MJM",D9L<ZZ)/NGC5>JY*SA4?62^]U!B>H:DJ4S\J594@B:01J;)M80
MH#2G@"$N ='^7<%2%B,3@[+O*N,XOI.A'Z'C3"L^H W9V6)'=L:7S\_+]N"R
MHC _(*0S%XA#VCKS\N@+#*?KUGR+RSH)QAQ_[AGMO ]"76=9X)P1F.<@3HH$
M(*IBP#@N ,^S#&8F.UG F7X66][(/!ABG@_E^*O,M-#>63W9^J]?=J[M0@X#
MSM_ KH03'^%=U&@T./U@'W+#\@Q>'7T*A()]T%@R!_8^QK<?TTJOQZ:"\OVN
M2X<D<8$S0P_(,@J0@BF@'&& 3<X/YQ!GC+DU8CH;8VI;G+V(-[1$N82EG3VZ
M$:&A@QV.X'BT7KJJ?K">2^<CC-QLZ:J*YUV6KE_J>?:A5^K7U0+])!?\YP>Z
MV:YDTY";QDAD)!$ 4@$-YY3V?BE- -%&0")%B(R=:OD[QIK:1U]UWSF0]2ZJ
MI?5L>MZ%LN5)2!CLACX+\8;-_3RD'Y!0)R(=(XU[)M*O\MFIB,4MGFG$_*L4
MV[G\J':=WIJ-^J/9PQ\T%J)0R!@SD*1$[Z93R;0!R0F0K(@E%'F&L5-C(=N!
MIV926KF-/^[9U=$:<SN;,@22 QN8BR#N0G;1'Y7@PQ1UNJ(5*F?6=MAQ$V$=
MP3C+;G6]_X9:!]:?1,M.DVC?T7+U#SK?FBKY[7.=46O:9_"Z8<YS,F.*IADK
M*% LQ@"A' (F( <0JH+C)%?:17(N>1A$U*D9PE:X:%ZJP_('CY*'8:;6TGI.
M8L*&MK>W%T 8=:-*W^A X;MH]QH8G0-700PZ+2&+(881=/R:B$$!OU@:,>R(
M/DTUTCC!7S9ZT:HK, Q?0=M9@Y-89GKG',LX X@(!AA)*4"8Y'$:,YCG5G6V
M/>-,S= ;0:-*TJ8*JF+D<.DA<1U2BW2 ,$ -;& O8^35<.,Z6"Y=-X* -M*)
MOB]XCNTW>B'I[L%Q_?81&W'TZG#<C:/_<@\+><H]=<_U6[*=FR:4!WT?%,(L
MRS@#*#:-B(6AA1*H *K(9)+AE.8LWO73[#]_MQ_9Z@4_Z9TYPLG[@:Q1N:\)
MX7J%>W+BO[>#W]3Q481SP%&&3"<^!"C+&$@%QDK%""*D6OCKI+LO&[K:O. D
MG$HQW%2\DD_E8F&R%AB=F^+MX.CGF,<0)1@P+(C>5:8,X#S%("U$+M*X4#S#
MQ^B_78@7Q[Z58< ]8]U$;RC8+;R)< B.Q=UQ1I)Y:$DL6LWX@NG@;00'=23'
MXW9PW5P0)YPZO1&[)XWGF#AI=N2CN-WI7OSQP-7J?BM*/2WWFXU<U^_4NSE]
MFJ$"FVH/"2C%,4 J-;F!N796<J28U(B3++6M_K@^S-2V<P^OWWV.&E&C UDC
M(ZQ]_4<'KMUF.!Q:0YM>+Z"<2D#Z<?"J >EX[&A%(/VJ'5:!6%SM>72P?7ZF
MJY_F@*+A W_[@SZ7BSI_<7_4EL4)8MIM TQ(;0NDXH D- <BDS2F"4]%YD9]
M9#?NU(Q#(W9]+K>CT3\4W3&\;PF_9:P^/*A#!]Y[\1SVL-,-L% A<<M1QXUO
MNT%Q%JQVO-TCKO)9TGGYM##^3MN4*DE(KJ  24P@0 Q20&#&08YCA1,IH:34
M.N!\]OBIV9X# 1TV,^>H6>P";\)B8)-Q()M/_/@<#X>-W$VXC+1ILWE-W+9E
M5[7NW(*=WS7>=NNJQ$=;J^M7^?E2_35>KZ1:KN3]?+[\TP1XWBU7KU=2>W4F
M?VU&>1K#E&<@%:;%7J9_HCB!0#*1DCR+,<9.+9IO$V=JUL^O^C;0U-BY7^,!
M/K")M2TA994ZT4Z?JE:JUBAZ'Y3T,0RT@?RW&X49U:T+ ]RIMQ?HJ2,S^YJ6
M"IN?#XOU9E4MQ.N/FZ]R]?B5+BZ229Z4(57_^(9NY"Z]8A;'L<EM@$#D- 4H
M41)@O1<&4M($%8A"S*S\S\EI-C7C7TFH38\IHA3+^9RN#DHKQR(1#O[Z6&[J
MIR+OA!:H /EZ-3K1 3Q1A4^TT0!UT1F?U9]6ET0&JH,DP GP'0\U_R_-DAQ<
MK[\&M_)0TQF,D7DP 3UYG/<'96_DMY7D=?M+_?-<5AHMQ/WS<K4I_[OZ^^O]
MERII'Q9\9=J7O)'U[S.DXB3)%0*,FP[ 4NK=FM!_%)F <99FJ>1.Y*W#BCNU
M!?W^Z6E5I59$XD#92/XP+YQEXL-($VVW2D]G^@9>>@\3  XUO8MVNE:]Z ZU
MO8OZNM75Y'&MVM$OK>+7?3MW;NQ19B@4N?:PPH[+SCT*\&?TWN.,>FM5Z6&N
MOLGN6(BV058IUW_70VWUMOGC0N^SMZN5WG#K5;=<GY1!"KW64 (SH'*" $I3
MO0W%<0PH1I3A!"&4.W48#2K=U%:>P]+*@YH=_:>F"["V7SM]HDHAW^K5$'-K
MN4=\J1D;>I]W<;+NVJDRJ\B!>E&KWX4Y'*EF-B#\P0MK0\CV0M6W 6&]7J(;
M<A"_96'7*?&+?#ID$4<)36-*,2AX+$PYE;;M><%!(7,:)PRGDCKQLU\99VJF
M>M\>M)73S1)?@]/.I@8 :6#K>([/ (3L/3 $LE+71AG5WO2H>FHY^B[W/=W0
M3JFITJRZI;Y>KC>S5*)$I3D$21IK_XXA"0A)"Y EHH 9@T6<6G$P7Q]B:E]^
M)2'0(SU'\VI#R)>N)[X7<+2-M]^"SN"!;P.,D:YMF?RZ"QF/8/,UY8-%?<\&
M&#G\>DW!\SCHU2MO;PIUFM7_KER4&UGU/)IE-$D$RP0@<5$8LE8*,$H1H(A
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M;%;E/I4O4"CWWN)F9-:KS>Q]N2F?JF#!:[J6]S_*]0S"-(]CT_0"(VD8$W-
MTBP! FGK0I$4^L6R\3LN/WYJSL9>0I.-)Z,_C)"6">I7 .PV$K?#,O0NQ0T1
MZ\^]6_&N+US?>?!UZS_MO^PK#QWE8^Y6J/U^>Z[R\PL^K99<2K%^IX5YO9S/
M9;4A_ZC>+^EBO8^PS"2EF%'M(Q1):O(?9 H(3CF 6:HDA%RQ&+KL(2S'G=I'
MWHI=5P;.C; ')PQN[H$M]':NP@" #FP>CK'<RVS<A4KJ@Y!P.!_!$:= _H+M
MJ*/Z#HY0G/H1KK=[=@C>=2QO&@_OJ"0>%FJY>JZ,X:N?S3_NM^A))B$A,@:Y
M9!@@P@Q/7TP!DSA%0J8"2^[41MA/CJD9L,,$XD;6Z W=T*HLZU[\O^W:\*._
M??7P^.;>L06QYT39F;<1X!_8W%U"?D]#<Z#%G:G?:*\8,DGW1DQ#]4CVE&+<
M1LJW0776;?G&Q[F94B'+V=O%IMS\?+U=K0Y',RE<6[-1@P5CF #3WU0[=Q@"
M$A,,I"0$J@+%G" ;6]DWT-2,82UKU A[\#76XMK9OUYTNPU<2,P&MF"^<%D;
M)ELL+EB>M>1_>UI^_T_]B-KHZ!_VMJ;WP:,8$UOU6FMA?;V?9_595GTT/M'5
MYF=U/EX?QG[2K\M7O;FL_+K#:V9",<D(8]J1X@(@_0=#7(A!ED/":)% 1)T:
M^+D*,#7SL1/4S5%RQMW.0QH2S8$-2R-65,D5'0A_%^W$KW>)1U>&\X1\L0OD
M CD//ZKOXPO.J=/C_1Q/6N;G;_/E3RF_F%P@TU>K23''^C^IE!"D>BL(4(9S
M0(B"ID]<P1,EH6)64>F><:9FK%HQ(SW8<[FHP[),+J0JG3M#7$'6SDX%P&MH
M/Z>%:B?B (GZ/3"$XF2^,LJXG,S=JIYQ,O=<[FD.E#(!JO;$ZY'^^*PMS7$I
MX?WFG=1/I//*O]+S]_/HXEE!$,ECK !66.^3($> %CD!)M:4,J$XY6ZFXW:9
M)F=F6I5,6KTY!][0']%*"^IH8@+,EJ4Y&G<.AC9=._B;8W@M8F1D/"G^OC--
M)ANEHIU6IS?M"#\#FKUP<(<RD0$D&M><AH/PS/0&?+1'O=1KDQ/\4?V3KK3=
MWWQ<?2Z?OF[^7B[*Y^WSCN)XSYGZ6?Y[:YI"SI1 %&=Y#K#,<H 2D0&<D0+$
ML>!%EB4PUB/8%D9Y"C$Y0_Q#BUBN9;0R\J_OHN=:A6BYXXK^YL."[#M'W=9X
M+.0'-K^5!J;A8*-#]'$555K<18T>T9ZJ>Z])U*HRPCPX%!^-,!\C51D--B]N
ME40W MI9,N3[[/%J@V[4_J@(Z-9G>2Q.50M+1M=2F 0ZN5C7JZ$1X$F:=_C5
MS_TEG^A/\U?W?]*5..0QW#Y_,W>MWRU72I:;[4I6KFK*4X@X$D D:080*7)
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M7KK@PD/ROT8IAO^4!"O2N$$$3YHD\_P/R\6RI5*IU^LFZ#Z#*:2,PQ@4/"L
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MEYIIQV.K@6:B^V K]* C'GT-A-?QX=A0@_CV$ZL"PHNGWQ=EW9% ,9%EI$A
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M(,PHH FA "-.<IA"G#+93L4G6U*EL6;E5*#A)NC5CA:)U8PX0\Y)(2"A1<:
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M#,8T#8,TEX3;%7^?F7YSH]C];=7!?FL/(4"?#[9?'4KM+FO1[[GVD-J/C.C
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M=H%/NO(E77UY2Y_4"P";[>S<P>9Y-FD1.U'P90$Z8=UM<LQ <;3GN-#9I%L
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M(K]9A/GMF\*[%+6T'C#75YPR&-H/C@,W'KT3F[Q#8R ]2-0X#3V'PU-;+70
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MILY4(T?814_' ZM"-]FZYGU%[R!E/_S]4(TL6@B]@^/XX6UT4%>_3(>15%Y
MLD&"$I@H_!)(.XCYJ+.C0Z9U\G(83O9#[@_5,Z,#E7=C-,^E0'%:V@H"\Z4<
M+GI,.W2:9>' U%%Q*CD'3B8# @NGT\"+;%I/Z'L,??N!](=JL3&8>CJPN=NW
MVIOR(Q39,T^.>\ZI@ JU^ZGE'KAT:!-JEUCK=.+EZOO!YH?HKW&D:#NP1U=:
MQ.UE< ,O)4NK@&*VVC,D2@A"1Q"&?%5GL41L7NGU6"+W@]@/U8QC6$5U8)ZN
M,$BQD&%:UR0 C^3/,I3@ZL.DF*5/:*,*V/H9_14"]D/0#]6PXW !=V"G=AJD
M;IEX=FL[R\L6XV2%A386.*;:?)G":&<#!Y]ER2DK,L.M7^P\DL3]$/9#]?<8
M4DD=6*B=4UXF[I$)DI(NF\J*!#X:!.E5$49I$YHW+WZL S44< 95\MU^U6,D
MW@%6[ILA=/>-,HER\]5LJ\W\OT^W-WP7(4>B2"-06 %H%4D!$ZO38#@@=\9K
MIKW#U@//AN%D[&%]3X?A#I#0P7ZX10#GK!R4]E'29F^"A^!23?M$^IMV)(/L
MI61%D*?;VC]LS,+88P*?;@>,J?L.7-=[V-]S5$TLVI0,R=$?JA"[/LI0WUJD
MR-!RW3RI?23)W4Q^&1/:S77;MQ6?.-3.(D,P4FRFRSKPC!<@_GPNR<?@6U_[
MW4/.V',%NX#@HW32@:4\'Q3[#I>;9C7O:_E[FL[.&HV<2PNUL#Y9#;0]:NI"
M*P@F1DBTDX3G)FO5.K;?C[+] K,?ZO'R "KIP(X]?!=)_/X25M.T87J2$VT@
MZVO=)*\5YD&"=SD#NL*L0:UY;(VX1Y(X;DY@")0\^OKX<)7]*(A\,9V=GC?R
MFA3.I9.:D5DO A2OQ1X^:! N%H_96!N?OM;A&I'C1OF]H/)@M?UXL[:>?P[S
M3[B:SC?,7AT'>86IX^9KW;?,P#.U]N:P_?S FS,F+S L4S'2.0%2D8^G=* C
MGF&!P#,/TG/MF_=NV8NP9M<^'VL8->%2EQ S U,??2LTY"=K36PFCB2 J IK
MW<_H*@7=I-X;8>'.&YS'R[N#0_2"^JU$:F2TF-=M^^S;=#4I*D;/K *1^::=
M<QU2H +(X!QZE<G<MSXP[R6H$RP=H.F[0'.TV#O T#4>7BQ.PG0^$:E$KUT&
M%S,%Z,QZ(#^2@Z1OQBPLQ^8#6F\EI!/,'*_H6Q^V'2/U#J#S_'+&ZJ]X$G$Y
MB=*GPFDO*1XYJ%1T+;*@R%MQ86QB=<9T^YS852)&C@R/5^S=DVP/D'(','F6
M\V:N;YB]"]/\>OX\?)FNP^R,&8HY9(K.0\):5(K(2#2:@V%,,SJ[I6@^@>9>
M@D8.X9K#IYWT.X#2>0^0\TCWC NT67AI(N0@+7F ,4 TC )-G9+4/NG4_+2Z
MG9)Q[SC;@Z>!O#M S;.43D].9S6RO:LXX=RREF0="Z%VUI!D7A.%$C4U8K)(
MTEGAN6KM,N]-W+B7C ,8ID&TT@'<;K_Z/..%92T\4P9,\(8D%C)$Y62=/Q]\
M*#X9U[J0[CYZQKTV; ^J9K+O $<7T<<;,L&;=[03Y:(5,1:PBIP^%;F$Z'VN
MF8_,HI>6J=9-\VY2T4DI6\,X_C !=P 1,I-+#"M\@=O_OI[?S).]I[WP:K'\
M,RSSA/&0LG <,C)BSPL$QU* (DJ,&',*N75#D4>2V$G ?R B;MZ6#*:>#M"W
M$YEN+@=6;T_7JW68U_JV"3*/R7A;0].S4HQ(.Y(88@6SR]*PUC[Y??2,BZM!
M@7!WON XK1R,L"^XG"[J)=)RW>@@O"ZK@\HH8XQ!.*8@*U9GBS$+7HLZ\2FC
MC4%KV;Q/0QO*QSUPGQ*[(VAZ=)1O9M9O&'^]6IUB?K$9A_=N^^F;#7PYR.Q=
M^+ZI=%HNZZ7L9C2085XHQAR47!@H0R>5T\)"*5F$S)00XEJISLUKY^-(&#?I
M\13P?$(5=7"L7SZ^6'U<W)$^W/ ;K\_6>X\D[M5TC1]P^76:<"NA6H;R:;[Y
ME$UGTTF*G.(X)R"'9$%1< ].*#J)N(DI%IU];MWF86B>QDW./*6)[@H=(^Z6
MAVW"[<.6?YW.Z(A:S)%"B^1KGW4!2L7:/%44\-PB!">M%8%B6>N.-]T/D3%N
M"J@/\]U459V"<K.['F14AY"2R'1"4= +*D=)C-)F+,5Z(Y+1>'U4[>,PN1<5
MX[97'AN2[17U(SD5-P;V;J9$3].F+)'D]3N=%:L'CY*)9Y+DK@S0^<'KKN40
MZF65#E*6S*R6LG6P]\0LCMOWN4N78P3L]&SL/RZ^G'YY/_WT>;UZ^0V7:4K2
MF6A$RXSQ@-8E4,[JVJR=@A$9O8NQ!./+T0;^MI5''W0XOE$_6B$=&/*=%A4L
M"14R49Y"-+7P-H&S68+5QACIG7"R]<211S8%&7+8X9.9OP,EW@%6!FH%03(H
MW+,(+ A;)]D&B%YPD,F7HI7TBK?NA3!B4Y!!^T4_&8@[@$('&^+>NQEF'5/*
M)I#2D'@E*H@N<V#$AI%"*H.M*R&/OS'[/__*[#%J.?(RX>4\]W1A9BBRY&@-
MT+:J<PJJ2%UP$)4RGG/N)6M]OC_AA=F@W:1_M!NSQZBZ*<B?[J5F6'U^-5O\
MN;K*QI'O,B\^=.A7F+=3W_[-Y<5"%\_KDK'6^OJ</-E"Z"2(!E\D!%9T]*Q8
M@:WGQ=Q'3X.VJ_4SR:G^.B7)_?+]]U6=*7DQM/X9.1Y?-T/Z+A\8BLATS *,
MU12A>9,AD-&G3>JX*!@X9\UK-A]-92>%4\<BZ)8FKD.JJP.?\$IXIWCQY&KD
M7(=:%!G!>TE_X]K0MY)(MG6WPUZZ; ZMY_MBZOV%W@%<=I*A]2PGF6WJ%#\N
MSKL]X)6^QQ\7CQ6K2%AL(E? Q61("H5V:RD9O!0FF.!*SKHQ"(?F:>0I\D\+
M[:X TL&&N?UF8%)T$23* MK5X5.^6*A7O( A6=K^1EO1/+BYE9)Q[6Y?:+D>
MW!RON@X ^ )IY;1MPD-_G^%99NO920W0_KGE20=M4I()L+[!5,(5<"%R,"D(
M^A\KTK8?0_\P7>-:SJ[!V5RM!T/U*R[CHA%8_[98Y#^GLQDQ\IHT/?\TC3-\
MMEJ1G"\&DD^2DTZ9)"'&;*M#;\B79P@Q<6**<RM<ZV=(^] U;B%JUV!MKM8.
M[.HEY6_+F\7\TYOI5\P;GE;_@;/\:K$DF4Y",!I5$I "DBME,Y+ #()(*BNI
MG;U19'?\DZ=]"!NW8K1KL+97;&=HO1QEO@D_&::$8"WY^\K6XG!'FT[1?K-:
MT/F@F[?:O)V4<0M!?QA$'JJ\#C#XMS"=5^&]G>\RD:3-*AD+3"JL1042@K4*
M-#.8,'(M<^NLTZV$C%OUV37^CE?<X]'GM^B;XZ=Z&?%Q !"^P.7T*XFKU@*0
MD$ZWPL?UNR6NP[>)YTK&S!PD] 44*P$\E@*Q.%V*U(4WGPV^+VWCUE[^(%!M
MJ-Y^T+L1XXH435[(B\5I7)?3V;.4%J=U0W)31"R!0\HIUX:WDB2H#0B?)1>\
M]LAI'1?=1\^X%9==H[29&L>N_]W9;M/5E\4JS*YZ*+:H(K-GH$,=N&&5@R!9
M BE8DD&BRGR_<M\'%AJW'+-+K#77S[%6\'BTG0GW VZJ1Y[-\Z]A^0=6F;W\
M5O.S."&"65%1 N.!?))@#$1!?V1G,7&I%4EJ+[P]N-3(Q9/]0JZMDCH(6^ZN
M#SW?7;_/EQAFTW]BGL@L?%&2TPX*'A3]'XD-(P0M6< 8+7D7C<_@Q] W<E5E
MEZ@=7,_]N(^;,NASR6_$?+XGF5;1*Z9K/Y::2B#/(_"D(>DLBN?D>5Q_>-FF
MJ/TV8D:NG^P:I&TTV \B;Q:K7DCN[&G=A=BTMR9Y6P"9I6/#*0ZNH(%B@XQU
MSHQQK2M#]J=N/\S^U[S]&4C'';@&-SD[C^)([CC]NND1:!C:I"T'D\F]5C*2
MCQTB@^2\BJA=MGJ R4$/TM5;2[(VF'@0>D<JJ&O+6<^&2[Y6DZ \EOHH*:<4
M0:7:7IOG#,5EHTOP,I@!YJ@]0%5O[<2>"'='*:=GU+U;XI<PS2_.R#IS1RCN
MVW"\O3>=J!)5J/.RO?,2E/$*G*0_./,NNY($*ZTO>0ZCM+=N8D^$SN9*[!FQ
M-0$VIU^:UEVHO2D:'9BB8BV_UD!.=)6ESXZ):#@?'I@[!/76R>N)\'>H2GJ&
MV;FG\2Y\/W,SE(V!PC++8P*%=82Z\PE8MB)HJ45BS4N!'B*JM^Y;3^P$'J*:
M7L..Y6F-X6J$]S%\PPO6N&+9*4M^14IU3)1,$#EYN$J%3!Q;+43K486/(*^W
M5EM/A[\&ZNH9B6^F(4YGFQS"A"QV?<*N@>>DB1/K(%J,D+V0@FL6;7@R".[0
MU5L'JZ?%WJ$*Z@!T^[]HFJ02DM*H0?H:9&6O(3#E:4\)&Y,+GC4O+MN?NG%C
MC2=^%S:0T@Z'XX*VV)!PW%ZSWR%(H[QWAD,LQM0=+4B07D"6UA>69#2EM2OX
M>"K'#47Z@&<K)79@-8FUA)@WD],_A!EN;N;7I\OI^OO;LKVCKQ[(!TSU>W4?
M*F94*CF <?5!LJ3#)P8CP3 2JV+".-NZ(]"CB>SRV7@SU-PL&QM0A3U@=-N]
MOO;93/]Y.EWBA\^+Y9J"])/=HB7A6$K2DY/",NWS: U$R<AECIISE RE:^U/
M[D58E^^\!\-B<U6-6E]V)UO;KD:_XOKS(N]R9J1G27@&QJ0Z!9='B"H:R"PX
M)0,+MK0N#]^7MB[]RB?#80N%C9]6W)32[=K[%],JSGDF]]@:82POM(FR)$9J
MLZR$'K)%7CCGRHO]^O;?^O%=>GVMP=-(NAV=F*\6RUU^WBS"?/>*&TM),=L(
MWNHZ>U(D()$Q"((;(ZW4(0UEK>ZG;-P$]$BVJJ&RQK=4=QIB8I&"M?7W=[,P
M7Y.K6@WS9HS 1$AG'/,%=.W#I1PJ"%D&",5IYZUSHGFKT?VI&S<E/?;IV49I
M':/R6O^!U<3%Z--FP*\*#I1)CO@J'FSF!;7A*IG!HXGK1(V;FAX;@T>IJ#_H
M7;/VFXJ*6V0YT3D%$8R%F.NH5R5RG8OI@#MIN=<B\:<ZH^\B<=P7?7T<UDW4
MUP](]Q?JA"3'5'*6_.':;<!( =[3>2!YU%9&SCUK?6KO3]VX#P"?&)H#*:W?
MNY17TWF8I]L%J9EF@6L!UG*LTU8S>!89H,[6U%%^+CW17<H]5'89YCSQ74HK
M)784=7]<_#J=+VK^?=,K\*P1^L1R1W$:NCHG1=%1P *%<EY"\(PG38YR5JU[
M5M]/49>W),WP<*<_>;1RNDI)O\?9YNQ?? S?_C%=?ZX,D?3(/[FC4:4,K';/
MU^"L)8_$2O)(=$*0T285-9?.MB[_/Y36+J].A@;HH KMQ\7<]9YWG.J-(WV+
MB">&IQ2D21"4(BZ3*Q C[5>,.6)Q6F31>K[2(TGL\H)E,+0.J+X.CO+]I3D)
MT1?/DH/"E0<5*,R+3B-D9IE.Q92(K>WI_M1U>6\S%"8'4EH' =#+4C"MWY:7
MW]+G,/^$[\D6OYU79NO_UVSLUS#;'A[GLT7K/SR;YZO?V/G)"5H?#.,"G%>,
M0LWZ;D<X ]SER&E_VLA:9S@'8*/+O/Q0(=38,.C ,!_%[';JZ<WBY[/95+MB
MW8IZXI-.FY[#M242*!$-Q&P5)(H'3+8V&-GZE?;3<MCEG<)0^Z=C\'1PR!QG
M1XI**;&<:S_Y6"<22O#!%^+=*(T4ACC1V@T:_N!XZEN++H'_*-4>.8?OPSHL
MUQV@.:GLK?2!W%#/Z50,%H+CG+X4R4AA,K+6C8^&1_-37W3TB>;'J+:7T:FG
M7[[,-I/LPNSYV22[U_.R6)YL57PN5.:M=E)FT.@%!=FZ3DU0&60Q)C.?;,#6
M=\5[DC9R7\0G!N@0^AJ[I^OY5-9M11IF$NG$Z^)D(*$8+0*H[&I/6N4 )6<A
MU+1YON8=WU%S>LN'CSPZ<@@-+AJ*LX-0[,H[Y6F>.&V9IVT#4@M?.[]GB,9Y
M* P%N;K(,+?.T%XC8=S[@B$QTT+FS2#3?#SR+R']4;\US[^$U72U*.]V/CK,
M\X?3DY.P_+XH'Z:?YM,R3;4*<=NL83-2>C9--==YA<_]9B@W6KG1H.4AY-!H
M&O/-92[P[%1BS"8$GDUUJ'0&E[F%9%RT*;*23?/9G'=2<W0OU.6G,#\;E'8Y
M]WH[1&U7&V_+65HYS"Y'8K^8KM)LL3I=UC=X]^KH(ZGE%UKWCTD2J"UR! JD
M)!E]K2%*7< 8J5T00JK2NBK@J7D<>9AD&^3>:+G:,U#Z-?7G+9V^S\G%.\!@
M7_G]1F;W;IH:&<^+!7;T?H[!J$F=BB?@.M,)SET&3_J$J'D(I/#(F_>BN(><
MXWW"&Q]]B6!T11=E+,A0.[Q[H\%'SL#YP'(A#\;$UJ;N/GK&;G7:!A,W/<1&
M&NC;AIP_:CW0A%QY$]O&@MQ*42,#<L?K53H\_L=B.E__G;X@/5\>;!R]00P<
M=/095' *8F(.2@Q8"G*E3>MY X\D\>@;\=N7NPWT1KI !WF L'EMKC6#$"WM
M*^0N9NXC*O\TPNC." V)JQN7U\-HK%\S=>T!YX$.SRV?TLAH/41?(]NUT]WX
MLLI'8N:Z.&"1=*LL'771&P;&6J8M(<GYUHGJ6\@XU@9M!/C;8DU>^C+DB[ZX
M.RN]_'9V._QL-EO\25$ OEHLGQ-"I^O:<'_7O<\\J91JI5/*BC!?9R[Y&$!*
M1$[[P>KF-TXMZ1_7CAV+L>NV:C3-]FO-KCP!#CM/@ ^T:_=^7B,+MS_-C6S=
MG>^D+UU[.L=\M!)8\;IVL9,03:F-/3USO&A.87[[,N;[B6I0RGW[ K>=[:YP
MKEUAH',NH)2T=7A(@12U-C(X*6-K;^PQ](UKQ]KBYY::[6'TU*_5^MMBD?^<
MSHCA?/W]^(%VZX%/;&2Y'D-W(]MUON2SFTO>DJ*PP0634(&7]5"S)D*,(H-.
M"KU3AL?FSWX?1>#1 Z'W6>QRMVCFH@^6(I;,(R@1!/B,!I))*81BA&_^W/1Q
M%(YKUX;#UHU)S\/IK5\K]Z96HAZ4"SO[S581Y2UT-+).VX^^@$BQQ46.$4SM
M&TB0<'7 '0<>=2XR\2)*ZP3750J.CAV1,(D7!4C;#]_)@'!M3>8%G+/U.2IR
M<*PHX/6<MYG3SFA=2W$_1>/:CR.T?R.T:R?X?@W"Y93[W<[V!]B'VS^HD;G8
M@\I&UN-RI==SPM#I>9;S/S!_NE+^=\MIE+@N'GV"XD6B(X+ $#EGX+G5P9*_
M+43KQ,P1Y!YKEPY8>N>*.LL2I8MT4CO:E]%[\+I8\,ZZI&64-O'Q1=6)37LJ
M3%XW@$^FX7[-X_/%R<ET>_U  =;SQ:;B N>'%I'=]W&-3.7>%#<RF#OK/;NV
MWBUP9$X*&[4!Z4--M08$9W*!Z',IB@M$UMI;>12!1[\EV6>QRTW"4N)"E4WK
M)E<OK2Q$XP.@4BZGXEC6K<W@XR@<U_ -AZT;#T6&TUN_QFW3)23>:*5R@%V[
MXY,:F;1]Z&SE_ETH^VW97>RLU<KSQ6J]NB3GO)W%)019YHS7]N BT*'G4H 0
MG  3T;-8."^A=:[K.(J/=@+W7?V7W=4O-Y*TPDMO%# 3-$F-1=I2R@/7)M<<
MCA#-*RZ.)'ED5_#I\'G#&WQ"5?=K,W>>51Q647;YZ\TJRNZ@J%E)ZMGGWW+D
M2I%5$+4)I>6Z5OEDPI- \$9K83#88%M'O/>0T^R9TFU'?O:E"%8BR%3;LT83
MP0DA(<C:4ZLDI]P3L-J)&6J%B3L?+1VK@7X-R ?\5 WCSG,O"M.(W?#ITW+;
M.>T]?L7Y*1[DA^W]X:U<L\.X:62:SE9_CU\6R\WCW(N[;\4+CX2-(I4A_SPB
MA%(L",5C*BF'$EJWF+B+EJ-?=%_[W%O#$9:*<5F#$2AK.,+ BYC!<99-RLYP
M;%TJL@=9([_+;8&-&\^U&RNC7S/U,BSGQ."JEJA]P6U#R4,LTJV?T\CX/$QC
MJZ+ZLX7>G2UR@27RG87CQD**N1Y)BDZ]4)MP:R:P<,\E:VUG[J+EZ#+Y:Y][
M"6@NHBLQ6Y#>*3K0C8"0R8]'YS17G$()*09FLA.;T@0'-ZK=FPB^7TMR\:AQ
MYQ+A$$MRZ^<TLB0/T]BJQ'VZ^J-F&'^?)URNPW1^I9.(<RZ(PC*(>CZ1ACDY
MM\Z!0RWHC,+H1>MT\+T$'9\-IT^=KY?;/ &M=+M;C\$E)<%[=*"L2^"RJB.;
M/<^ZR$P2:)X#?YBND<O4F^'D9J:[L4[ZM3QGF:EW8;G^_G$9YBN2'7WH0=;G
MSL]J9('VH[790YO;%]MM/.*2Q42'CB7]:QL("9).MJ)94-E&%YL;H@=H.M86
MW?7YM\$_"J&2UA%RQ$SL1]I:.3"*$X(2"3'IZQ,R!V._/\O4$CO7C=-02NK9
M1E6'(]4AW/-/AQFFW0]H9HWNI*J9"=I98=.%;Z/Y6]JK*5M$$76"JL@(JHXA
M\CPX2$ZGB$PZV3SQNC=QQQNE!Q:Z_<UKB,5$172;0L!W')Q/KI;7\&B*2@5;
MQV.'T#FVF1H"7S?MU<#ZZ]=P?3B-*_S/4_JPEU\/#>EN?$:KK/2]M+5*/E];
MY )0V6D*W#.CZ#]Y4 8E!*L=1.TS2X;.)=ZZXOPN6HYO)WKU<R]!+(Q7.3I#
M9VY]76:]A^A2!LL+MRH81-;:0[R3F+$;0#; P<V^H"T$WZ_U:-._;OQ^?GWV
M]1NKOU])!IT7"@P=974FI:_MOP5H*8L.3*30O$/=</W]-@IX6ZXM\'W[YTY9
M2RF!\ZR@>(R@.&J(11=PQ:B 3GIK6U>T[D=9M[WT'H.2ZW9Q *5TT!_W2E?
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M#@_6@378%5I?G!% 3-Y6IW3]"9 KRM06,76T,JC$ @2A(S!IO&19)&P^N?U
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MAL2$%:$^P'(&25B&0D:K@DFH6\_*>X:D8:#A+_'BF$(H'6#LX08KNVD(G[[
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MI_J6#NWZ<0B-,T\.FP OZQF$-S-(GYF1+:.W24)B( VQ3P9@X%0D]LEBR<Y
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MB,884(4!A\AT;1P+WD<Z#"5*GV2$@0,5'_SX3CKWCQ+3@U?_WCR;6^J/S!Y
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M(FU@>42A]N.I#K)#=@WTB<I/ZQ_^X84T+A_:;S)(M@N>N"DRQ?H&2JR(1C'
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MIYCG"9G% "$8ZZ-KW0'A&9+FN9\FA5)+(72@@"ZLPH^8SC>[Z%&M3UV?GWU
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M$SQ:WCI-\ $RVOFYE_/&M[^MSW"[8SN=S,N17JO/-TM?MM)*%J0H@D7C:[-
MJ1EDNN=#S-X;'[G3TY5 C2)U7K?A4.0\[L%.)Z^YK\T?S_7U"W>B+6A1AR%)
MF4E="\5B(<??.1$K0WV^.RCMD;ORX<_OQ;V<4*[KMDSN#R=739*#=,;I.F'0
MQ)IG8%DHF6S$HNE>KZ-VRK R[L=6F+$TJH7<GL;!'DR<&PFOKKN;OUJ_HK67
M9Z\AU3YH5Z_/$4P!I0(3/%25FPV+]7%;EI)!Y@)X=V++DS7=CZ_4%3+VD>3#
M3>,;L'5NC+PC.6R6ZS>K].MY2LOWQ+SE=KO>U,:Q>+D?8\ &[6D#MM[,@?;C
M=Q,FE14I2HXR#?/P!RPV8TU<>Z2T9N[<8-D%/K?K\]-7ZU/ZW7ISX;P0WRXW
MX]!F$4C?TC:0Z>(T<<H[9D*PT9DL,A^H4)Y9:<92M D42DNV=O!\/=16^^G[
M+;OM*AN2!Z>2-(8IKSS3T18&B3N&D+SE2OJ06A=)'D)O+T_=T]O'1Y=N!TC^
M<0=7YYR4%21+9]#7TXB>KG>G,W,Y%!"A3NUN'<I^B(YY/;/CH>#>U. #1=(!
MK.X\WUUJ>4!ML21DF4>R!)"NCBC(6?%9V>0ABA1:-RAXD)!>GH;VE>^Z-;,[
M0,Q5.^$/<'9QA KWT>I"*KO4B';VD44ND069="A)QG(WZM:LP_,5#;V$XHYW
M]1TDA<Y0='FR,-4Y9EPQ92*=+"!.>+0UY",UH*_QGM8Y!/>IZ&-@P7Y2?0(B
M>["X P\/\A)6=6;,;@^7ZC* 5"CHP$CER#?E1K)8:H\+$R0W14LM!G;_>WB!
M?A"PC]#6C3G8@:JHER^IULT&5I\OAK/7DQ%3D 4Y.;999::%32PH%5G0:*3B
M,>?4N@KK04)Z"=L?[^HY7!X=@.H6^951OZU7</.36QU.KNK.0C8A 43R$WR=
MU4$[BYY[!KJXX*%VZFUMY(PD<5Z]U0 4=YW["274 0!O/;#]CB</[JQV@'H/
MF[/OG]:/_>TK%T)9S8OD3"4@+Q:BIKTGPXQ,&(2'D'1K?ZTE_3._'TP)M'4G
M4M\;\;_C)J[GKH95WEJ9,SG=MDZ^!.L9V<62\:*SQ0Q!RD$=2N:NAFW>MFD.
M.^"HTNR['A:S(V7 (TO68>WQDEFHIGFUJ9/E,AD]*$+P/[$>=A0*AM?#CA%)
M!R[N1;3M9 6GW\^6:?OV[+HA>RW?=(&3:^92S<X7+ 0!S'";K)28M(X_0NNY
M^.7]1;JMBATEQ ?CEP=RM,/!V+M#8V- <,:Q+$6N19J1>4O^N]=&Y62XTG90
M5N>4(]7M7^62:R*%#I%T><@,1%F42"P[#G0> .IY2,QYKU&7Y*,8U.ORKS1B
M?91DAXU8'\/F#OS2\;.[M0Y.>U48#YK<$*5(PQH)+*(L8+P7<#=UK]F[_<L>
ML3X*&0>/6!\CI@YP^(.*)^U^)W;Z]F8T:N0:/>GT7(*C(RLM\X"6<6UY<(8'
MBZT+HX?2-@AU[J]P74XJM;G-](=R2;"L-TB[W9QCOCJ#%PVRSQ9HLH3@,XNZ
MYGL;.MR .C)KC;!)V1"2&&2ZCURXHS2<9J)?'TD.'6+LD5UY*T!+[YB 7%.Z
M(^VOUFX;Q56=V2RPN'W1=0"N)DLLG 57#7C?P1WZ",M^P^L-!9-D<>!9X8;L
M79\L ^"&A9P-70&0>&Y]>3Y+U+S)/)/";1K![(^T]1F<'N]^_&V]2I?;,T6A
M(/N"Y:#K  #'F<]9,%7[=X9@4(AAI8+CUYXW8-_/+;FG-/J_*&]MS*/65B?!
MA,N6]'6AC8%2C$=+9BPFX>6P<J$QJ\X;">KANMQ3 EW?F+?V%$/@)0G'7,#(
M=!2<!>/)>=<JFD1^-B^MN]0/H6O>Q]F9[\T]Q3/CU?G#GG[8R\+YH#BJ0(Z+
M]$Q+38Y+,I%E[:770:/DDUAE/U Q[^/%\>"T/^L[M+M>0\++"7!".EY<"*R8
M6+,\;63!EUIP#L[S;-"*83UUGUQF$$K\BT1)8QYW<+N]WZQ_7VY)-J_7F\JJ
MVIH0M[_\^0U76\R+Q+W-M9F^3X*\VV*J=QLT(Y9IX3'2[1T;JYVG*1H$KO B
MP36!2'H &'R_F"V^/DG_=;[<X!V>+:*T#NK(>JE"O&A.'7T.+/EBE,6H?/,T
MVN=H&O9JRE\VREK*I0><W>IP69,D<9<Y^:[<W9:A707 Q% K8!IT8>!#J34T
M.?IDE6AN2 TD;1CJ7N9C_912ZO#YX<KKK14V'\]JG/<];E(5YV=< %F003G+
M5')TL(K,S',?F8LN&Y5EBJ;L:X4]M? P?/VU'NV;":(##7>'83_!=KG]2,1
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M9Y]OR<7>;C_BY]UV+AIH)NX3>LM\KF4+2CH6E1+,&$-\<E&FT#QO^BF"7DB
MZA#[JIU >D#7!>V71XX[RW4!Q\C+R;4()K(8.&?@> HN:8ZN=0G"#P3,;)VW
M$^Q=R.S-Y;DMHG^LEF>8=YRY8L>E&@TA^>!]8LZXP'0HB86BB"E!%A>PI"*'
M/;8_NL3,:-A?9NOF#.Q 4PQX^ TJ18T)F4^*U^)3RR(B,A$DW;":#HX[6H;[
MV][:%<WA\>\GF@[ UBKL^7Y707PUX.=GO/C_PA8NB=ED AHMF,9 /B^&7"L^
M+00IBRT3]*V<<$>=NHE[XF^B&'@#,'1P-&Z'8=^N5Y_?UE%")]LMGFW_CJ?Y
M]7KS#]J4<\G2+6)8,"'51HUTN8 T#(#KG*/+/+0>^3*(L$[=SC9 ;2^:N<V_
MMV0%([XCII&,:$/UP)S0L:']P2I_6O^$/R^WW]9;S._* JV7&'1FANA@VKA,
MCK6Q+*$&%5W(8> @]3&K=I]ZL0^@IN5]O^T+_K9>YS^6I\3,VIX!5I^7M8?$
M[@#]4+Y_]?<.B)+ONU2C@'F3G3:*G5^M<7*?%D)8.EUO:R'!=3P4D_=(ZLLC
MU.$9.X\E%:9B",)F4);+QC?+* +;Q=2OEKTPT*TMHA1?F)>1S/(L HLYD?_/
M(W*ME,34>M^/D#*OL3<=6AZ/GN\OB0X,M@_XK1JGJ\_U*6#WE)0DMT:3FU=4
MTN3Y.ZA>7V; C10>G"="&T/I'A&]!,(/$.V]3N.'\+DWH%S-IW"ET%*:)8.Z
MCGROHRD27?/%<B/(FA#06NL\0,;<+<8/$NQ3,-F#RW.;Y.\1$M;I(QLXW?ZP
MF:MA-#F"KCW?C+1U6B,G5S;1CC2/PD0A##=ND!G^W$H=H6(?.:ZG8NK<"/F
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M?MI QDK^5?,:R$#.;JQ]FZ5G&CRR:+1E14L=(90"SC7&X%T:N@;8X4)?-Y1
M!PAZ/>(P<I^4YRDPEVQDVG++HD#)C#,R(5FFWC8?T-/XZCU"(X?)K]ZI1-8W
M&A\^N2IA5,6S4)L]:TD,C2[;.@HR(#G;"71K=3>2Q'FUX610&0[)@^76 2S?
M+A.NMC4B^WF#/S2+*\8D;Y-G4G'-=$%.KES<):> L< Q-$]G?928;J%V. 3N
MMN]K(H^YGTC^CG!Z]N6BG>7C.\K6J4R<8LG5Q!6;' .,R))%Y[/5(..==]9'
MWDD&+3>O_WH,#$W$^KG!].JGOYW<W\F536HXY&05LZEP,FOKJW3T@M$/A5)@
M>4EF$(:>6F5>^^MHT&G&Z X0\\_'=T*:DF<,A'UM7>5/(/YX8I),*>8<T<3!
MD'E\F7D3;(Z)F4:LGA\TKQ[?B ]('%*6\;CC3W$5_?1%)E>GL&N'92!F'E]E
MWB&:1X1,(T9W@)@GL$^$TDZT8ZX.FM61U^G%6K"B583B 0,,*SA^<IE!F+%_
M!<PT8G4'/M=5D]V3]%_GR^UR)ZSJIH:<G"["L<0%6?BVD'%?C&"<UU)K#5HV
MCP$]0LJ\E]<1'YQ:B*)31-5OZ9A<GKS C:.[.-;9U[R>/,,@2L^45EQI$;R^
MVQIC$FS]0-2\7GT3T0^ T_YRF/M^NVP"\??U:2:E^[>:G_OV[:LKTZ[F3IO
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M)%[=</K.^P3TA6?N0K$ES _?2FFWM3N]H7>T6%\F>.GO+JP)H+14#$W*Y&J
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M3->S%92)UBD+/FJLR;%TZV>Z^DMVQ3#4,K@V Y(>+#SFQ)LCQ/<T# [@Y<A
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MLOL)Q.\RBQ?.2568%) LJWM@)(+':$'K+)QA1MCF.PJV4[0;Y,XW3])0'OV
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M?3V^ALOO EYW)7H7@K2)42Z E'7%AF7U8*F D#(X;VU)OG4EY,[$=>+(G!Y
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M-."HTTZ7XYD,V>,OCXN2%K*<-6/LR+"HLR'?EN_.<+O8(!IA<S48A7;D@+,
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M['X]39?7N39Q+19(_\T?PE\7(:4HZDPXE6R='Y@,>&LBV*3HIBCEM6YMV1U
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M)BDVWZ>X,W%=JKP#,3$[A8 Z0-Y/U_AA=H]U$URL!P6LIJ6LEZ5=.*Z<X-8
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MJ<D4Y9J,E/P$L7&P.=BV(9"20FIRRF5$.3F3//==.]@<;-N#K=3)P>9@VZ9
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MO&!I;'4*. ),]2[K8P@YF^*3%ACOB ?X2C,U%999Y>VV#&((P!BN%V0RY?>
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MR:T!VP.-G/MO>HYV]!QASS033_&/=J03GDF3U<Z."-,G_/180'U6;%5H'J[
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MXW[:WIN1V:>_INDNC%[^"5!+ P04    " !O/%Q62^+;T4T(  !%*@  '@
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M'FCHW)_I.=K2<P0]XTP\QS_8H4YX(4U6?W- F#ZAIX<"ZC?E9A7GX9H;V%I
M*%UJ_#+PBIBU0YJ9_:M@^AQRP$S>DT_(*M/0 ##;1!C'EV#%$]<.2O(ETZZR
MM>:2.A#F&7F)FV+.Y%@H@'7!%Z.D8.Z$P61#(YB@6N  A-<-+G\DV%)F,)>[
M=6Q<XG?LJ@P'ARRP.59**: _S"3%I ##<DXL-0'4\ IC51C!TY"C(? VU.?L
MA7CZL# ]/"!,UQN;F-Z;V3:@O3\G[HUP6!43P1"XU*B$8C:@!D"/4A713#6;
M(PNP+NA02&%G*!.V=8OKS('0X<LOD373%:GKDLY3/J TTRG@VSA9$X9*,^>
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M8<86RJ,,*AJ^8+R=0,TU+50!M('T+'J98$ CF"R.89?V.W>#R3/-UH.[HY4
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M,#(R,3(S,2YH=&U02P$"% ,4    " !O/%Q62;U_C)P=  "X9P$ $0
M        @ %CV04 8W)O;BTR,#(R,3(S,2YX<V102P$"% ,4    " !O/%Q6
MEPM:,;<Q  #K^P$ %0              @ $N]P4 8W)O;BTR,#(R,3(S,5]C
M86PN>&UL4$L! A0#%     @ ;SQ<5KGJ+O3;Q   5,P( !4
M ( !&"D& &-R;VXM,C R,C$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( &\\7%9"
MEV>I_BT  ',O   4              "  2;N!@!C<F]N+3(P,C(Q,C,Q7V<Q
M+FIP9U!+ 0(4 Q0    ( &\\7%;9DS5W&1H  '4:   4              "
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M2P$"% ,4    " !O/%Q6B%6,WM@: 0#3 PT %0              @ %CS@L
M8W)O;BTR,#(R,3(S,5]P<F4N>&UL4$L! A0#%     @ ;SQ<5A$O'V=;"
MW"X  !X              ( !;ND, &5X:&EB:70Q,#,R+6%N;F%S:&QI;6%K
M;&5T+FAT;5!+ 0(4 Q0    ( &\\7%9M,NX[4@0  .TV   >
M  "  07R# !E>&AI8FET,C$Q+6QI<W1O9G-U8G-I9&EA<BYH=&U02P$"% ,4
M    " !O/%Q6K&_=SR8#  #5"@  '@              @ &3]@P 97AH:6)I
M=#(S,2UC;VYS96YT;V9I;F1E<&4N:'1M4$L! A0#%     @ ;SQ<5A3X]EUF
M"   BRH  !X              ( !]?D, &5X:&EB:70S,3$M8V5R=&EF:6-A
M=&EO;F]F+FAT;5!+ 0(4 Q0    ( &\\7%9+XMO130@  $4J   >
M      "  9<"#0!E>&AI8FET,S$R+6-E<G1I9FEC871I;VYO9BYH=&U02P$"
M% ,4    " !O/%Q6AB#2MV0&  "M&P  '@              @ $@"PT 97AH
M:6)I=#,R,2UC97)T:69I8V%T:6]N;V8N:'1M4$L! A0#%     @ ;SQ<5DMR
M$J50!@  GAL  !X              ( !P!$- &5X:&EB:70S,C(M8V5R=&EF
C:6-A=&EO;F]F+FAT;5!+!08     $0 1 *8$  !,& T    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
